19228880	2009	FASEB J.	1530-6860	ALL_TEXT_1/3	1	3	2944	SYMBOL|DICTIONARY|EXTRACTED	gstm1	GSTM1	22#27	19228880-1-113-141	D001943	LONGTERM|DISEASE|DT|DICTIONARY	breast cancer	breast cancer	63#76		The results show that GSTM1(-/-) confers an increased risk for breast cancer development compared with that in GSTM1-present individuals (+/+ and +/-), which was subsequently confirmed by a meta-analysis of all of the 41 relevant studies (odds ratio: 1.10, P<0.001).
19228880	2009	FASEB J.	1530-6860	ALL_TEXT_1/3	1	3	2944	SYMBOL|DICTIONARY|EXTRACTED	gstm1	GSTM1	111#116	19228880-1-113-141	D001943	LONGTERM|DISEASE|DT|DICTIONARY	breast cancer	breast cancer	63#76		The results show that GSTM1(-/-) confers an increased risk for breast cancer development compared with that in GSTM1-present individuals (+/+ and +/-), which was subsequently confirmed by a meta-analysis of all of the 41 relevant studies (odds ratio: 1.10, P<0.001).
9845763	1999	Zhonghua Yi Xue Yi Chuan Xue Za Zhi	1003-9406	TITLE	0	0	6532	LONGTERM|DICTIONARY	serotonin transporter	serotonin transporter	41#62	NaN	D001714	LONGTERM|DISEASE|DT|DICTIONARY	bipolar disorder	bipolar disorder	73#89		[Association of VNTR region of the human serotonin transporter gene with bipolar disorder among the Han Chinese].
11774187	2002	Mol. Diagn.	1084-8592	CONCLUSION	3	9	3077	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	hfe	HFE	55#58	11774187-0-0-15	D006432	SYMBOL|EXTRACTED	hh	HH	5#7	11774187-1-0-26	When HH is clinically and/or histologically suspected, HFE gene sequencing of formalin-fixed, paraffin-embedded liver biopsy specimens is a rapid and cost-effective approach to genotypic diagnosis of HH.
11774187	2002	Mol. Diagn.	1084-8592	CONCLUSION	3	9	3077	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	hfe	HFE	55#58	11774187-0-0-15	D006432	SYMBOL|EXTRACTED	hh	HH	200#202	11774187-1-0-26	When HH is clinically and/or histologically suspected, HFE gene sequencing of formalin-fixed, paraffin-embedded liver biopsy specimens is a rapid and cost-effective approach to genotypic diagnosis of HH.
9620294	1998	J. Invest. Dermatol.	0022-202X	ALL_TEXT_1/3	1	1	5727	LONGTERM|DICTIONARY	patched	PATCHED	13#20	NaN	D001478	LONGTERM|DISEASE|DT|DICTIONARY	basal cell nevus syndrome	basal cell nevus syndrome	146#171		Mutations in PATCHED (PTC), the human homolog of the Drosophila patched gene, have been identified in most exons of the gene in patients with the basal cell nevus syndrome and in sporadic basal cell carcinomas.
9620294	1998	J. Invest. Dermatol.	0022-202X	ALL_TEXT_1/3	1	1	5727	LONGTERM|DICTIONARY	patched	PATCHED	13#20	NaN	D018295	LONGTERM|DICTIONARY	sporadic basal cell carcinomas	sporadic basal cell carcinomas	179#209		Mutations in PATCHED (PTC), the human homolog of the Drosophila patched gene, have been identified in most exons of the gene in patients with the basal cell nevus syndrome and in sporadic basal cell carcinomas.
9620294	1998	J. Invest. Dermatol.	0022-202X	ALL_TEXT_1/3	1	1	5727	LONGTERM|DICTIONARY	patched	patched	64#71	NaN	D001478	LONGTERM|DISEASE|DT|DICTIONARY	basal cell nevus syndrome	basal cell nevus syndrome	146#171		Mutations in PATCHED (PTC), the human homolog of the Drosophila patched gene, have been identified in most exons of the gene in patients with the basal cell nevus syndrome and in sporadic basal cell carcinomas.
9620294	1998	J. Invest. Dermatol.	0022-202X	ALL_TEXT_1/3	1	1	5727	LONGTERM|DICTIONARY	patched	patched	64#71	NaN	D018295	LONGTERM|DICTIONARY	sporadic basal cell carcinomas	sporadic basal cell carcinomas	179#209		Mutations in PATCHED (PTC), the human homolog of the Drosophila patched gene, have been identified in most exons of the gene in patients with the basal cell nevus syndrome and in sporadic basal cell carcinomas.
12006918	2002	J Cardiovasc Risk	1350-6277	TITLE	0	0	3990	SYMBOL|GENE|GN|DICTIONARY	hepatic lipase	Hepatic lipase	0#14		D003327	LONGTERM|DISEASE|DT|DICTIONARY	coronary heart disease	coronary heart disease	56#78		Hepatic lipase gene -514 C/T polymorphism and premature coronary heart disease.
17036313	2007	Am. J. Med. Genet. A	1552-4825	ALL_TEXT_2/3	2	6	2706	LONGTERM|DICTIONARY	connexin 26	connexin 26	33#44		D006319	SYMBOL|DICTIONARY|EXTRACTED	snhl	SNHL	108#112	17036313-1-0-26	The status of the V37I allele of connexin 26 (GJB2 amino acid product) with regards to its association with SNHL has been controversial.
17036313	2007	Am. J. Med. Genet. A	1552-4825	ALL_TEXT_2/3	2	6	2706	SYMBOL|DICTIONARY|EXTRACTED	gjb2	GJB2	46#50	17036313-4-30-36	D006319	SYMBOL|DICTIONARY|EXTRACTED	snhl	SNHL	108#112	17036313-1-0-26	The status of the V37I allele of connexin 26 (GJB2 amino acid product) with regards to its association with SNHL has been controversial.
17036313	2007	Am. J. Med. Genet. A	1552-4825	ALL_TEXT_2/3	2	4	2706	SYMBOL|()|DICTIONARY|EXTRACTED	gjb2	GJB2	43#47	17036313-4-30-36	C537845	SYMBOL|DICTIONARY|EXTRACTED	autosomal recessive non-syndromic snhl	autosomal recessive non-syndromic SNHL	78#116	17036313-1-0-26	Mutations of the gap junction beta-2 gene (GJB2) emerge as a leading cause of autosomal recessive non-syndromic SNHL.
11774187	2002	Mol. Diagn.	1084-8592	METHODS AND RESULTS	2	2	3077	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	hfe	HFE	31#34	11774187-0-0-15	D006432	SYMBOL|EXTRACTED	hh	HH	78#80	11774187-1-0-26	We investigated the utility of HFE gene sequence analysis in the diagnosis of HH in 61 prospectively accrued formalin-fixed, paraffin-embedded liver biopsy specimens with clinical or histologic features suggestive of HH.
11774187	2002	Mol. Diagn.	1084-8592	METHODS AND RESULTS	2	2	3077	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	hfe	HFE	31#34	11774187-0-0-15	D006432	SYMBOL|EXTRACTED	hh	HH	217#219	11774187-1-0-26	We investigated the utility of HFE gene sequence analysis in the diagnosis of HH in 61 prospectively accrued formalin-fixed, paraffin-embedded liver biopsy specimens with clinical or histologic features suggestive of HH.
11774187	2002	Mol. Diagn.	1084-8592	BACKGROUND	1	1	3077	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	hfe	HFE	100#103	11774187-0-0-15	D006432	LONGTERM|DICTIONARY	hereditary hemochromatosis	Hereditary hemochromatosis	0#26		Hereditary hemochromatosis (HH) is a common disease predominantly characterized by mutations of the HFE gene.
11774187	2002	Mol. Diagn.	1084-8592	BACKGROUND	1	1	3077	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	hfe	HFE	100#103	11774187-0-0-15	D006432	SYMBOL|EXTRACTED|()	hh	HH	28#30	11774187-1-0-26	Hereditary hemochromatosis (HH) is a common disease predominantly characterized by mutations of the HFE gene.
17036313	2007	Am. J. Med. Genet. A	1552-4825	TITLE	0	0	2706	LONGTERM|DICTIONARY	connexin 26	connexin 26	5#16		D006319	LONGTERM|DICTIONARY	sensorineural hearing loss	sensorineural hearing loss	41#67		V37I connexin 26 allele in patients with sensorineural hearing loss: evidence of its pathogenicity.
17509612	2007	J. Mol. Cell. Cardiol.	0022-2828	ALL_TEXT_2/3	2	6	57158	SYMBOL|DICTIONARY|EXTRACTED	jph2	JPH2	15#19	17509612-1-0-14	D002312	LONGTERM|DICTIONARY	hcm	HCM	0#3	NaN	HCM-associated JPH2 mutations were engineered and functionally characterized using immunocytochemistry, cell morphometry measurements, and live cell confocal calcium imaging.
17509612	2007	J. Mol. Cell. Cardiol.	0022-2828	ALL_TEXT_2/3	2	4	57158	SYMBOL|DICTIONARY|EXTRACTED	jph2	JPH2	25#29	17509612-1-0-14	D002312	LONGTERM|DICTIONARY	hypertrophic cardiomyopathy	hypertrophic cardiomyopathy	80#107		To this end, we explored JPH2 as a novel candidate gene for the pathogenesis of hypertrophic cardiomyopathy (HCM) in humans.
17509612	2007	J. Mol. Cell. Cardiol.	0022-2828	ALL_TEXT_2/3	2	4	57158	SYMBOL|DICTIONARY|EXTRACTED	jph2	JPH2	25#29	17509612-1-0-14	D002312	SYMBOL|EXTRACTED|()	hcm	HCM	109#112	17509612-4-80-107	To this end, we explored JPH2 as a novel candidate gene for the pathogenesis of hypertrophic cardiomyopathy (HCM) in humans.
19061983	2009	Am. J. Hum. Genet.	1537-6605	TITLE	0	0	9197	SYMBOL|DICTIONARY	slc33a1	SLC33A1	23#30		D015419	LONGTERM|DICTIONARY	autosomal dominant spastic paraplegia	autosomal-dominant spastic paraplegia	81#118		A missense mutation in SLC33A1, which encodes the acetyl-CoA transporter, causes autosomal-dominant spastic paraplegia (SPG42).
19061983	2009	Am. J. Hum. Genet.	1537-6605	TITLE	0	0	9197	SYMBOL|DICTIONARY	slc33a1	SLC33A1	23#30		C567262	SYMBOL|()|DICTIONARY|EXTRACTED	spg42	SPG42	120#125	19061983-0-81-118	A missense mutation in SLC33A1, which encodes the acetyl-CoA transporter, causes autosomal-dominant spastic paraplegia (SPG42).
17509612	2007	J. Mol. Cell. Cardiol.	0022-2828	ALL_TEXT_1/3	1	3	57158	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	jph2	JPH2	13#17	17509612-1-0-14	D009202	LONGTERM|DICTIONARY	cardiomyopathy	cardiomyopathy	62#76		Furthermore, JPH2 gene expression is down-regulated in murine cardiomyopathy models.
17509612	2007	J. Mol. Cell. Cardiol.	0022-2828	TITLE	0	0	57158	SYMBOL|DICTIONARY|EXTRACTED	jph2	JPH2	13#17		D002312	LONGTERM|DICTIONARY	hypertrophic cardiomyopathy	hypertrophic cardiomyopathy	57#84		Mutations in JPH2-encoded junctophilin-2 associated with hypertrophic cardiomyopathy in humans.
17509612	2007	J. Mol. Cell. Cardiol.	0022-2828	TITLE	0	0	57158	LONGTERM|DICTIONARY	junctophilin 2	junctophilin-2	26#40		D002312	LONGTERM|DICTIONARY	hypertrophic cardiomyopathy	hypertrophic cardiomyopathy	57#84		Mutations in JPH2-encoded junctophilin-2 associated with hypertrophic cardiomyopathy in humans.
15286153	2004	J. Med. Genet.	1468-6244	ALL_TEXT_3/3	3	3	83715	SYMBOL|DICTIONARY	espn	ESPN	24#28		D015837	LONGTERM|DICTIONARY	vestibular dysfunction	vestibular dysfunction	64#86		A recessive mutation of ESPN is known to cause hearing loss and vestibular dysfunction in the jerker mouse.
15286153	2004	J. Med. Genet.	1468-6244	ALL_TEXT_3/3	3	3	83715	SYMBOL|DICTIONARY	espn	ESPN	24#28		D034381	LONGTERM|DICTIONARY	hearing loss	hearing loss	47#59	NaN	A recessive mutation of ESPN is known to cause hearing loss and vestibular dysfunction in the jerker mouse.
15286153	2004	J. Med. Genet.	1468-6244	TITLE	0	0	83715	SYMBOL|DICTIONARY	espn	ESPN	13#17		D030342	LONGTERM|DICTIONARY	autosomal recessive deafness	autosomal recessive deafness	24#52		Mutations of ESPN cause autosomal recessive deafness and vestibular dysfunction.
15286153	2004	J. Med. Genet.	1468-6244	TITLE	0	0	83715	SYMBOL|DICTIONARY	espn	ESPN	13#17		D015837	LONGTERM|DICTIONARY	vestibular dysfunction	vestibular dysfunction	57#79		Mutations of ESPN cause autosomal recessive deafness and vestibular dysfunction.
15286153	2004	J. Med. Genet.	1468-6244	ALL_TEXT_1/3	1	1	83715	SYMBOL|DICTIONARY	dfnb36	DFNB36	33#39		D015837	LONGTERM|DICTIONARY	vestibular areflexia	vestibular areflexia	139#159		We mapped a human deafness locus DFNB36 to chromosome 1p36.3 in two consanguineous families segregating recessively inherited deafness and vestibular areflexia.
15286153	2004	J. Med. Genet.	1468-6244	ALL_TEXT_1/3	1	1	83715	SYMBOL|DICTIONARY	dfnb36	DFNB36	33#39		D003638	LONGTERM|DICTIONARY	deafness	deafness	18#26	NaN	We mapped a human deafness locus DFNB36 to chromosome 1p36.3 in two consanguineous families segregating recessively inherited deafness and vestibular areflexia.
15286153	2004	J. Med. Genet.	1468-6244	ALL_TEXT_1/3	1	1	83715	SYMBOL|DICTIONARY	dfnb36	DFNB36	33#39		D030342	LONGTERM|DICTIONARY	recessively inherited deafness	recessively inherited deafness	104#134	NaN	We mapped a human deafness locus DFNB36 to chromosome 1p36.3 in two consanguineous families segregating recessively inherited deafness and vestibular areflexia.
17509612	2007	J. Mol. Cell. Cardiol.	0022-2828	ALL_TEXT_3/3	3	8	57158	LONGTERM|DICTIONARY	junctophilin 2	junctophilin-2	71#85		D006965	LONGTERM|DICTIONARY	cardiomyocyte hyperplasia	cardiomyocyte hyperplasia	159#184	NaN	Functionally, each human mutation caused (i) protein reorganization of junctophilin-2, (ii) perturbations in intracellular calcium signaling, and (iii) marked cardiomyocyte hyperplasia.
17509612	2007	J. Mol. Cell. Cardiol.	0022-2828	ALL_TEXT_3/3	3	9	57158	LONGTERM|DICTIONARY	junctophilin 2	junctophilin-2	59#73		D002312	SYMBOL|EXTRACTED	hcm	HCM	142#145	17509612-4-80-107	The molecular and functional evidence implicates defective junctophilin-2 and disrupted calcium signaling as a novel pathogenic mechanism for HCM and establishes HCM as the first human disease associated with genetic defects in JPH2.
17509612	2007	J. Mol. Cell. Cardiol.	0022-2828	ALL_TEXT_3/3	3	9	57158	LONGTERM|DICTIONARY	junctophilin 2	junctophilin-2	59#73		D002312	SYMBOL|EXTRACTED	hcm	HCM	162#165	17509612-4-80-107	The molecular and functional evidence implicates defective junctophilin-2 and disrupted calcium signaling as a novel pathogenic mechanism for HCM and establishes HCM as the first human disease associated with genetic defects in JPH2.
17509612	2007	J. Mol. Cell. Cardiol.	0022-2828	ALL_TEXT_3/3	3	9	57158	LONGTERM|DICTIONARY	junctophilin 2	junctophilin-2	59#73		D030342	LONGTERM|DICTIONARY	genetic defects	genetic defects	209#224	NaN	The molecular and functional evidence implicates defective junctophilin-2 and disrupted calcium signaling as a novel pathogenic mechanism for HCM and establishes HCM as the first human disease associated with genetic defects in JPH2.
17509612	2007	J. Mol. Cell. Cardiol.	0022-2828	ALL_TEXT_3/3	3	9	57158	SYMBOL|DICTIONARY|EXTRACTED	jph2	JPH2	228#232	17509612-1-0-14	D002312	SYMBOL|EXTRACTED	hcm	HCM	142#145	17509612-4-80-107	The molecular and functional evidence implicates defective junctophilin-2 and disrupted calcium signaling as a novel pathogenic mechanism for HCM and establishes HCM as the first human disease associated with genetic defects in JPH2.
17509612	2007	J. Mol. Cell. Cardiol.	0022-2828	ALL_TEXT_3/3	3	9	57158	SYMBOL|DICTIONARY|EXTRACTED	jph2	JPH2	228#232	17509612-1-0-14	D002312	SYMBOL|EXTRACTED	hcm	HCM	162#165	17509612-4-80-107	The molecular and functional evidence implicates defective junctophilin-2 and disrupted calcium signaling as a novel pathogenic mechanism for HCM and establishes HCM as the first human disease associated with genetic defects in JPH2.
17509612	2007	J. Mol. Cell. Cardiol.	0022-2828	ALL_TEXT_3/3	3	9	57158	SYMBOL|DICTIONARY|EXTRACTED	jph2	JPH2	228#232	17509612-1-0-14	D030342	LONGTERM|DICTIONARY	genetic defects	genetic defects	209#224	NaN	The molecular and functional evidence implicates defective junctophilin-2 and disrupted calcium signaling as a novel pathogenic mechanism for HCM and establishes HCM as the first human disease associated with genetic defects in JPH2.
12150336	2003	J. Endocrinol. Invest.	0391-4097	ALL_TEXT_3/3	3	10	846	SYMBOL|EXTRACTED	car	CaR	10#13	12150336-1-4-28	D049950	SYMBOL|EXTRACTED|DISEASE|DN	phpt	PHPT	57#61	12150336-1-345-372	The A986S CaR polymorphism is the most common in Italian PHPT patients and the allotype AS does not appear to play a relevant role in the pathogenesis of PHPT and its severity.
12150336	2003	J. Endocrinol. Invest.	0391-4097	ALL_TEXT_3/3	3	10	846	SYMBOL|EXTRACTED	car	CaR	10#13	12150336-1-4-28	D049950	SYMBOL|EXTRACTED	phpt	PHPT	154#158	12150336-1-345-372	The A986S CaR polymorphism is the most common in Italian PHPT patients and the allotype AS does not appear to play a relevant role in the pathogenesis of PHPT and its severity.
20504252	2010	Pharmacogenomics	1744-8042	PATIENTS &amp; METHODS	3	5	3358	SYMBOL|DICTIONARY	htr2c	HTR2C	35#40		D012559	LONGTERM|DICTIONARY	schizophrenic	schizophrenic	107#120	NaN	We investigated the association of HTR2C, LEP and INSIG2 SNPs with antipsychotic-induced BWG in 128 German schizophrenic patients.
20504252	2010	Pharmacogenomics	1744-8042	PATIENTS &amp; METHODS	3	5	3358	SYMBOL|DICTIONARY	htr2c	HTR2C	35#40		D015430	LONGTERM|DICTIONARY	bwg	BWG	89#92	NaN	We investigated the association of HTR2C, LEP and INSIG2 SNPs with antipsychotic-induced BWG in 128 German schizophrenic patients.
20504252	2010	Pharmacogenomics	1744-8042	PATIENTS &amp; METHODS	3	5	3952	SYMBOL|DICTIONARY|EXTRACTED	lep	LEP	42#45	20504252-4-189-195	D012559	LONGTERM|DICTIONARY	schizophrenic	schizophrenic	107#120	NaN	We investigated the association of HTR2C, LEP and INSIG2 SNPs with antipsychotic-induced BWG in 128 German schizophrenic patients.
20504252	2010	Pharmacogenomics	1744-8042	PATIENTS &amp; METHODS	3	5	3952	SYMBOL|DICTIONARY|EXTRACTED	lep	LEP	42#45	20504252-4-189-195	D015430	LONGTERM|DICTIONARY	bwg	BWG	89#92	NaN	We investigated the association of HTR2C, LEP and INSIG2 SNPs with antipsychotic-induced BWG in 128 German schizophrenic patients.
20504252	2010	Pharmacogenomics	1744-8042	PATIENTS &amp; METHODS	3	5	51141	SYMBOL|DICTIONARY|EXTRACTED	insig2	INSIG2	50#56	20504252-4-153-175	D012559	LONGTERM|DICTIONARY	schizophrenic	schizophrenic	107#120	NaN	We investigated the association of HTR2C, LEP and INSIG2 SNPs with antipsychotic-induced BWG in 128 German schizophrenic patients.
20504252	2010	Pharmacogenomics	1744-8042	PATIENTS &amp; METHODS	3	5	51141	SYMBOL|DICTIONARY|EXTRACTED	insig2	INSIG2	50#56	20504252-4-153-175	D015430	LONGTERM|DICTIONARY	bwg	BWG	89#92	NaN	We investigated the association of HTR2C, LEP and INSIG2 SNPs with antipsychotic-induced BWG in 128 German schizophrenic patients.
9620294	1998	J. Invest. Dermatol.	0022-202X	TITLE	0	0	5727	LONGTERM|DICTIONARY	patched	PATCHED	41#48	NaN	D001478	LONGTERM|DISEASE|DT|DICTIONARY	basal cell nevus syndrome	basal cell nevus syndrome	113#138		Identification of mutations in the human PATCHED gene in sporadic basal cell carcinomas and in patients with the basal cell nevus syndrome.
9620294	1998	J. Invest. Dermatol.	0022-202X	TITLE	0	0	5727	LONGTERM|DICTIONARY	patched	PATCHED	41#48	NaN	D018295	LONGTERM|DICTIONARY	sporadic basal cell carcinomas	sporadic basal cell carcinomas	57#87		Identification of mutations in the human PATCHED gene in sporadic basal cell carcinomas and in patients with the basal cell nevus syndrome.
9498099	1998	Clin. Chim. Acta	0009-8981	TITLE	0	0	4023	LONGTERM|GENE|GN|DICTIONARY	lipoprotein lipase	lipoprotein lipase	38#56		D010190	LONGTERM|DICTIONARY	pancreatitis	pancreatitis	104#116		A novel Glu421Lys substitution in the lipoprotein lipase gene in pregnancy-induced hypertriglyceridemic pancreatitis.
20504252	2010	Pharmacogenomics	1744-8042	TITLE	0	0	3358	SYMBOL|DICTIONARY	htr2c	HTR2C	15#20		D015430	LONGTERM|DICTIONARY	weight gain	weight gain	78#89	NaN	Association of HTR2C, but not LEP or INSIG2, genes with antipsychotic-induced weight gain in a German sample.
20504252	2010	Pharmacogenomics	1744-8042	TITLE	0	0	3952	SYMBOL|DICTIONARY|EXTRACTED	lep	LEP	30#33		D015430	LONGTERM|DICTIONARY	weight gain	weight gain	78#89	NaN	Association of HTR2C, but not LEP or INSIG2, genes with antipsychotic-induced weight gain in a German sample.
20504252	2010	Pharmacogenomics	1744-8042	TITLE	0	0	51141	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	insig2	INSIG2	37#43		D015430	LONGTERM|DICTIONARY	weight gain	weight gain	78#89	NaN	Association of HTR2C, but not LEP or INSIG2, genes with antipsychotic-induced weight gain in a German sample.
12747597	2003	Clin. Chem. Lab. Med.	1434-6621	ALL_TEXT_2/3	2	5	1636	SYMBOL|DICTIONARY	ace	ACE	8#11		D003324	SYMBOL|DISEASE|DN|DICTIONARY|EXTRACTED	cad	CAD	141#144	12747597-2-92-115	The I/D ACE and A1166C AT1R genotypes separately were not significantly associated with the left ventricular size and function parameters in CAD patients.
12747597	2003	Clin. Chem. Lab. Med.	1434-6621	ALL_TEXT_2/3	2	5	185	SYMBOL|DICTIONARY	at1r	AT1R	23#27		D003324	SYMBOL|DISEASE|DN|DICTIONARY|EXTRACTED	cad	CAD	141#144	12747597-2-92-115	The I/D ACE and A1166C AT1R genotypes separately were not significantly associated with the left ventricular size and function parameters in CAD patients.
22388936	2012	Hum. Mol. Genet.	1460-2083	ALL_TEXT_3/3	3	4	23400	SYMBOL|DICTIONARY	atp13a2	ATP13A2	13#20		C537177	LONGTERM|DISEASE|DT|DICTIONARY	kufor rakeb syndrome	Kufor-Rakeb syndrome	42#62		Mutations in ATP13A2 are a known cause of Kufor-Rakeb syndrome (KRS), a rare parkinsonian phenotype with juvenile onset.
22388936	2012	Hum. Mol. Genet.	1460-2083	ALL_TEXT_3/3	3	4	23400	SYMBOL|DICTIONARY	atp13a2	ATP13A2	13#20		C537177	SYMBOL|()|DICTIONARY|EXTRACTED	krs	KRS	64#67	22388936-4-42-62	Mutations in ATP13A2 are a known cause of Kufor-Rakeb syndrome (KRS), a rare parkinsonian phenotype with juvenile onset.
22388936	2012	Hum. Mol. Genet.	1460-2083	ALL_TEXT_3/3	3	4	23400	SYMBOL|DICTIONARY	atp13a2	ATP13A2	13#20		D010300	LONGTERM|DICTIONARY	parkinsonian	parkinsonian	77#89	NaN	Mutations in ATP13A2 are a known cause of Kufor-Rakeb syndrome (KRS), a rare parkinsonian phenotype with juvenile onset.
20724655	2011	J. Lipid Res.	1539-7262	ALL_TEXT_2/3	2	3	338	LONGTERM|DICTIONARY	apolipoprotein b	apolipoprotein B	47#63		C566031	LONGTERM|DICTIONARY	triglyceride	triglyceride	93#105	NaN	We sought to determine if genetic variation in apolipoprotein B (APOB), an essential core of triglyceride-rich lipoprotein formation, may account for some of the inter-individual differences observed in triglyceride (TG) response to fenofibrate treatment.
20724655	2011	J. Lipid Res.	1539-7262	ALL_TEXT_2/3	2	3	338	LONGTERM|DICTIONARY	apolipoprotein b	apolipoprotein B	47#63		C566031	LONGTERM|DICTIONARY	triglyceride	triglyceride	203#215	NaN	We sought to determine if genetic variation in apolipoprotein B (APOB), an essential core of triglyceride-rich lipoprotein formation, may account for some of the inter-individual differences observed in triglyceride (TG) response to fenofibrate treatment.
20724655	2011	J. Lipid Res.	1539-7262	ALL_TEXT_2/3	2	3	338	LONGTERM|DICTIONARY	apolipoprotein b	apolipoprotein B	47#63		C566031	LONGTERM|DICTIONARY	tg	TG	217#219	NaN	We sought to determine if genetic variation in apolipoprotein B (APOB), an essential core of triglyceride-rich lipoprotein formation, may account for some of the inter-individual differences observed in triglyceride (TG) response to fenofibrate treatment.
20724655	2011	J. Lipid Res.	1539-7262	ALL_TEXT_2/3	2	3	338	SYMBOL|()|DICTIONARY|EXTRACTED	apob	APOB	65#69	20724655-3-47-63	C566031	LONGTERM|DICTIONARY	triglyceride	triglyceride	93#105	NaN	We sought to determine if genetic variation in apolipoprotein B (APOB), an essential core of triglyceride-rich lipoprotein formation, may account for some of the inter-individual differences observed in triglyceride (TG) response to fenofibrate treatment.
20724655	2011	J. Lipid Res.	1539-7262	ALL_TEXT_2/3	2	3	338	SYMBOL|()|DICTIONARY|EXTRACTED	apob	APOB	65#69	20724655-3-47-63	C566031	LONGTERM|DICTIONARY	triglyceride	triglyceride	203#215	NaN	We sought to determine if genetic variation in apolipoprotein B (APOB), an essential core of triglyceride-rich lipoprotein formation, may account for some of the inter-individual differences observed in triglyceride (TG) response to fenofibrate treatment.
20724655	2011	J. Lipid Res.	1539-7262	ALL_TEXT_2/3	2	3	338	SYMBOL|()|DICTIONARY|EXTRACTED	apob	APOB	65#69	20724655-3-47-63	C566031	LONGTERM|DICTIONARY	tg	TG	217#219	NaN	We sought to determine if genetic variation in apolipoprotein B (APOB), an essential core of triglyceride-rich lipoprotein formation, may account for some of the inter-individual differences observed in triglyceride (TG) response to fenofibrate treatment.
19753311	2009	Mol. Vis.	1090-0535	CONCLUSIONS	4	12	1128	SYMBOL|DICTIONARY	chrm1	CHRM1	15#20		D009216	LONGTERM|DICTIONARY	high myopia	high myopia	57#68		S1, S2, and S4 CHRM1 had a co-operative association with high myopia.
19753311	2009	Mol. Vis.	1090-0535	CONCLUSIONS	4	11	1128	SYMBOL|DICTIONARY	chrm1	CHRM1	56#61		D009216	LONGTERM|DICTIONARY	high myopia	high myopia	112#123		Our results suggest that the S2 and S4 polymorphisms of CHRM1 are associated with susceptibility for developing high myopia.
16183801	2006	J. Med. Genet.	1468-6244	ALL_TEXT_1/3	1	1	4204	SYMBOL|DICTIONARY	mecp2	MECP2	0#5		D015518	LONGTERM|DISEASE|DT|DICTIONARY	rett syndrome	Rett syndrome	65#78		MECP2 mutations are identifiable in approximately 80% of classic Rett syndrome (RTT), but less frequently in atypical RTT.
16183801	2006	J. Med. Genet.	1468-6244	ALL_TEXT_1/3	1	1	4204	SYMBOL|DICTIONARY	mecp2	MECP2	0#5		D015518	SYMBOL|()|DICTIONARY|EXTRACTED	rtt	RTT	80#83	16183801-1-65-78	MECP2 mutations are identifiable in approximately 80% of classic Rett syndrome (RTT), but less frequently in atypical RTT.
16183801	2006	J. Med. Genet.	1468-6244	ALL_TEXT_1/3	1	1	4204	SYMBOL|DICTIONARY	mecp2	MECP2	0#5		D015518	SYMBOL|DICTIONARY|EXTRACTED	rtt	RTT	118#121	16183801-1-65-78	MECP2 mutations are identifiable in approximately 80% of classic Rett syndrome (RTT), but less frequently in atypical RTT.
19220408	2009	Epilepsia	1528-1167	DISCUSSION	4	7	8645	SYMBOL|DICTIONARY	task 2	TASK-2	35#41		D012640	LONGTERM|DICTIONARY	seizure	seizure	207#214		Our findings suggest that elevated TASK-2 immunoreactivity in neurons may contribute to rapid adaptive responses (presumably for extracellular alkalinization), which result in hyperpolarization and regulate seizure activity.
16324400	2008	Zhonghua Yi Xue Za Zhi	0376-2491	RESULTS	3	8	672	SYMBOL|DICTIONARY	brca1	BRCA1	18#23		D001943	LONGTERM|DISEASE|DT|DICTIONARY	breast cancer	breast cancer	77#90		The prevalence of BRCA1 and BRCA2 mutations in the patients with early-onset breast cancer was 12% and 4%, respectively.
16324400	2008	Zhonghua Yi Xue Za Zhi	0376-2491	RESULTS	3	8	675	SYMBOL|DICTIONARY	brca2	BRCA2	28#33		D001943	LONGTERM|DISEASE|DT|DICTIONARY	breast cancer	breast cancer	77#90		The prevalence of BRCA1 and BRCA2 mutations in the patients with early-onset breast cancer was 12% and 4%, respectively.
19228880	2009	FASEB J.	1530-6860	ALL_TEXT_1/3	1	1	2944	LONGTERM|DICTIONARY	glutathione s transferase m1	glutathione S-transferase M1	113#141		D001943	LONGTERM|DISEASE|DT|DICTIONARY	breast cancer	breast cancer	154#167		Although a number of studies have been conducted to address the relation between a gene deletion polymorphism of glutathione S-transferase M1 (GSTM1) and breast cancer, no definite conclusion has been reached and no clear risk pattern has yet to emerge for GSTM1.
19228880	2009	FASEB J.	1530-6860	ALL_TEXT_1/3	1	1	2944	SYMBOL|()|DICTIONARY|EXTRACTED	gstm1	GSTM1	143#148	19228880-1-113-141	D001943	LONGTERM|DISEASE|DT|DICTIONARY	breast cancer	breast cancer	154#167		Although a number of studies have been conducted to address the relation between a gene deletion polymorphism of glutathione S-transferase M1 (GSTM1) and breast cancer, no definite conclusion has been reached and no clear risk pattern has yet to emerge for GSTM1.
19228880	2009	FASEB J.	1530-6860	ALL_TEXT_1/3	1	1	2944	SYMBOL|DICTIONARY|EXTRACTED	gstm1	GSTM1	257#262	19228880-1-113-141	D001943	LONGTERM|DISEASE|DT|DICTIONARY	breast cancer	breast cancer	154#167		Although a number of studies have been conducted to address the relation between a gene deletion polymorphism of glutathione S-transferase M1 (GSTM1) and breast cancer, no definite conclusion has been reached and no clear risk pattern has yet to emerge for GSTM1.
15522251	2005	Biol. Psychiatry	0006-3223	TITLE	0	0	348	SYMBOL|DICTIONARY	apoe	APOE	112#116		D000544	LONGTERM|DISEASE|DT|DICTIONARY	alzheimer disease	Alzheimer's disease	77#96		Cerebrospinal fluid beta-amyloid1-42 and tau in control subjects at risk for Alzheimer's disease: the effect of APOE epsilon4 allele.
15522251	2005	Biol. Psychiatry	0006-3223	BACKGROUND	1	2	348	SYMBOL|DICTIONARY	apoe	APOE	82#86		D000544	SYMBOL|EXTRACTED	ad	AD	156#158	15522251-1-109-128	Numerous lines of evidence have also suggested that individuals with at least one APOE epsilon4 allele on chromosome 19 are at increased risk of developing AD.
11774187	2002	Mol. Diagn.	1084-8592	METHODS AND RESULTS	2	4	3077	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	hfe	HFE	96#99	11774187-0-0-15	D006432	SYMBOL|EXTRACTED	hh	HH	26#28	11774187-1-0-26	Changes characteristic of HH were present in 16 (26%) of the cases, and 54% of the cases showed HFE gene mutations.
19220408	2009	Epilepsia	1528-1167	RESULTS	3	5	8645	SYMBOL|DICTIONARY	task 2	TASK-2	13#19		D013226	SYMBOL|EXTRACTED	se	SE	94#96	19220408-4-6-24	In addition, TASK-2 immunoreactivity is gradually increased in perivascular regions following SE.
16490169	2006	Acta Pharmacol. Sin.	1671-4083	CONCLUSION	4	10	1565	SYMBOL|GENE|GN|DICTIONARY	cyp2d6	CYP2D6	30#36		D012559	LONGTERM|DICTIONARY	schizophrenia	schizophrenia	180#193		The C100T polymorphism of the CYP2D6 gene and the C163A polymorphism of the CYP1A2 gene may be associated with neuroleptic drug-induced tardive dyskinesia in Chinese patients with schizophrenia.
16490169	2006	Acta Pharmacol. Sin.	1671-4083	CONCLUSION	4	10	1565	SYMBOL|GENE|GN|DICTIONARY	cyp2d6	CYP2D6	30#36		D004409	LONGTERM|DICTIONARY	tardive dyskinesia	tardive dyskinesia	136#154		The C100T polymorphism of the CYP2D6 gene and the C163A polymorphism of the CYP1A2 gene may be associated with neuroleptic drug-induced tardive dyskinesia in Chinese patients with schizophrenia.
16490169	2006	Acta Pharmacol. Sin.	1671-4083	CONCLUSION	4	10	1544	SYMBOL|GENE|GN|DICTIONARY	cyp1a2	CYP1A2	76#82		D012559	LONGTERM|DICTIONARY	schizophrenia	schizophrenia	180#193		The C100T polymorphism of the CYP2D6 gene and the C163A polymorphism of the CYP1A2 gene may be associated with neuroleptic drug-induced tardive dyskinesia in Chinese patients with schizophrenia.
16490169	2006	Acta Pharmacol. Sin.	1671-4083	CONCLUSION	4	10	1544	SYMBOL|GENE|GN|DICTIONARY	cyp1a2	CYP1A2	76#82		D004409	LONGTERM|DICTIONARY	tardive dyskinesia	tardive dyskinesia	136#154		The C100T polymorphism of the CYP2D6 gene and the C163A polymorphism of the CYP1A2 gene may be associated with neuroleptic drug-induced tardive dyskinesia in Chinese patients with schizophrenia.
17341859	2007	Dermatology (Basel)	1018-8665	TITLE	0	0	6256	SYMBOL|GENE|GN|GT|DICTIONARY	retinoid x receptor	retinoid X receptor	6#25		D011565	LONGTERM|DICTIONARY	plaque psoriasis	plaque psoriasis	48#64		Three retinoid X receptor gene polymorphisms in plaque psoriasis and psoriasis guttata.
17341859	2007	Dermatology (Basel)	1018-8665	TITLE	0	0	6256	SYMBOL|GENE|GN|GT|DICTIONARY	retinoid x receptor	retinoid X receptor	6#25		D011565	LONGTERM|DICTIONARY	psoriasis	psoriasis	69#78		Three retinoid X receptor gene polymorphisms in plaque psoriasis and psoriasis guttata.
15522251	2005	Biol. Psychiatry	0006-3223	CONCLUSIONS	4	9	348	SYMBOL|DICTIONARY	apoe	APOE	19#23		D000544	SYMBOL|EXTRACTED	ad	AD	56#58	15522251-1-109-128	The association of APOE epsilon4 allele and lower, more AD-like levels of CSF beta-amyloid(1-42) in older control subjects is consistent with previous studies showing possible neuroimaging and cognitive abnormalities with epsilon4 carriers and suggests that CSF beta-amyloid(1-42) decreases might represent an early biomarker of AD.
15522251	2005	Biol. Psychiatry	0006-3223	CONCLUSIONS	4	9	348	SYMBOL|DICTIONARY	apoe	APOE	19#23		D000544	SYMBOL|EXTRACTED	ad	AD	329#331	15522251-1-109-128	The association of APOE epsilon4 allele and lower, more AD-like levels of CSF beta-amyloid(1-42) in older control subjects is consistent with previous studies showing possible neuroimaging and cognitive abnormalities with epsilon4 carriers and suggests that CSF beta-amyloid(1-42) decreases might represent an early biomarker of AD.
15522251	2005	Biol. Psychiatry	0006-3223	CONCLUSIONS	4	9	348	SYMBOL|DICTIONARY	apoe	APOE	19#23		D003072	LONGTERM|DICTIONARY	cognitive abnormalities	cognitive abnormalities	193#216		The association of APOE epsilon4 allele and lower, more AD-like levels of CSF beta-amyloid(1-42) in older control subjects is consistent with previous studies showing possible neuroimaging and cognitive abnormalities with epsilon4 carriers and suggests that CSF beta-amyloid(1-42) decreases might represent an early biomarker of AD.
9535411	1998	Hypertension	0194-911X	ALL_TEXT_2/3	2	4	183	LONGTERM|GENE|GN|DICTIONARY	angiotensinogen	angiotensinogen	8#23		D007674	LONGTERM|DICTIONARY	nephropathy	nephropathy	159#170		For the angiotensinogen gene, the frequency of the genotype 235T/235T, known to be associated with essential hypertension, was higher among case subjects with nephropathy than in control subjects without this complication.
9535411	1998	Hypertension	0194-911X	ALL_TEXT_2/3	2	4	183	LONGTERM|GENE|GN|DICTIONARY	angiotensinogen	angiotensinogen	8#23		D006973	LONGTERM|DICTIONARY	hypertension	hypertension	109#121		For the angiotensinogen gene, the frequency of the genotype 235T/235T, known to be associated with essential hypertension, was higher among case subjects with nephropathy than in control subjects without this complication.
15472214	2004	J. Clin. Endocrinol. Metab.	0021-972X	ALL_TEXT_2/3	2	4	5468	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	ppar gamma	PPAR-gamma	71#81	15472214-3-0-48	D011085	SYMBOL|DICTIONARY|EXTRACTED	pcos	PCOS	138#142	15472214-1-0-25	The aim of this study was to investigate the putative influence of the PPAR-gamma gene Pro12Ala polymorphism on the adiponectin levels in PCOS and healthy women.
15472214	2004	J. Clin. Endocrinol. Metab.	0021-972X	ALL_TEXT_2/3	2	4	9370	LONGTERM|DICTIONARY	adiponectin	adiponectin	116#127	NaN	D011085	SYMBOL|DICTIONARY|EXTRACTED	pcos	PCOS	138#142	15472214-1-0-25	The aim of this study was to investigate the putative influence of the PPAR-gamma gene Pro12Ala polymorphism on the adiponectin levels in PCOS and healthy women.
9535411	1998	Hypertension	0194-911X	TITLE	0	0	183	LONGTERM|GENE|GN|DICTIONARY	angiotensinogen	angiotensinogen	53#68		D003928	LONGTERM|DICTIONARY	diabetic nephropathy	diabetic nephropathy	78#98		Gender-specific association of M235T polymorphism in angiotensinogen gene and diabetic nephropathy in NIDDM.
9535411	1998	Hypertension	0194-911X	TITLE	0	0	183	LONGTERM|GENE|GN|DICTIONARY	angiotensinogen	angiotensinogen	53#68		D003924	LONGTERM|DICTIONARY|EXTRACTED	niddm	NIDDM	102#107		Gender-specific association of M235T polymorphism in angiotensinogen gene and diabetic nephropathy in NIDDM.
15472214	2004	J. Clin. Endocrinol. Metab.	0021-972X	TITLE	0	0	5468	LONGTERM|GENE|GN|DICTIONARY	peroxisome proliferator activated receptor gamma	peroxisome proliferator-activated receptor-gamma	31#79		D011085	LONGTERM|DISEASE|DT|DICTIONARY	polycystic ovary syndrome	polycystic ovary syndrome	137#162		Lack of an association between peroxisome proliferator-activated receptor-gamma gene Pro12Ala polymorphism and adiponectin levels in the polycystic ovary syndrome.
15472214	2004	J. Clin. Endocrinol. Metab.	0021-972X	TITLE	0	0	9370	LONGTERM|DICTIONARY	adiponectin	adiponectin	111#122	NaN	D011085	LONGTERM|DISEASE|DT|DICTIONARY	polycystic ovary syndrome	polycystic ovary syndrome	137#162		Lack of an association between peroxisome proliferator-activated receptor-gamma gene Pro12Ala polymorphism and adiponectin levels in the polycystic ovary syndrome.
19539307	2010	J Psychiatr Res	1879-1379	ALL_TEXT_3/3	3	9	55300	SYMBOL|DICTIONARY|EXTRACTED	pi4k2b	PI4K2B	37#43	19539307-4-19-61	D001714	LONGTERM|DISEASE|DT|DICTIONARY	bipolar disorder	bipolar disorder	63#79		There is no evidence to suggest that PI4K2B is contributing to bipolar disorder in this family but a role for this gene in schizophrenia has not been excluded.
19539307	2010	J Psychiatr Res	1879-1379	ALL_TEXT_3/3	3	9	55300	SYMBOL|DICTIONARY|EXTRACTED	pi4k2b	PI4K2B	37#43	19539307-4-19-61	D012559	LONGTERM|DICTIONARY	schizophrenia	schizophrenia	123#136		There is no evidence to suggest that PI4K2B is contributing to bipolar disorder in this family but a role for this gene in schizophrenia has not been excluded.
8930979	1997	Neuroreport	0959-4965	ALL_TEXT_1/3	1	1	5663	LONGTERM|DICTIONARY|GENE|GA	presenilin 1	presenilin-1	111#123		D000544	LONGTERM|DISEASE|DT|DICTIONARY	alzheimer's disease	Alzheimer's disease	151#170		Previous work suggests an association between allele 1 and the 1-1 genotype of an intronic polymorphism in the presenilin-1 (PS-1) gene and late onset Alzheimer's disease.
8930979	1997	Neuroreport	0959-4965	ALL_TEXT_1/3	1	1	5663	SYMBOL|()|GENE|GN|DICTIONARY|EXTRACTED	ps 1	PS-1	125#129	8930979-1-111-123	D000544	LONGTERM|DISEASE|DT|DICTIONARY	alzheimer's disease	Alzheimer's disease	151#170		Previous work suggests an association between allele 1 and the 1-1 genotype of an intronic polymorphism in the presenilin-1 (PS-1) gene and late onset Alzheimer's disease.
8930979	1997	Neuroreport	0959-4965	TITLE	0	0	5663	LONGTERM|DICTIONARY	ps-1	PS-1	22#26	NaN	D000544	LONGTERM|DISEASE|DT|DICTIONARY	alzheimer's disease	Alzheimer's disease	64#83		Association between a PS-1 intronic polymorphism and late onset Alzheimer's disease.
19539307	2010	J Psychiatr Res	1879-1379	TITLE	0	0	55300	SYMBOL|DICTIONARY|EXTRACTED	pi4k2b	PI4K2B	109#115		D001714	LONGTERM|DISEASE|DT|DICTIONARY	bipolar disorder	bipolar disorder	77#93		A case-control association study and family-based expression analysis of the bipolar disorder candidate gene PI4K2B.
19539307	2010	J Psychiatr Res	1879-1379	ALL_TEXT_2/3	2	5	55300	SYMBOL|DICTIONARY|EXTRACTED	pi4k2b	PI4K2B	0#6		D001714	LONGTERM|DISEASE|DT|DICTIONARY	bipolar disorder	bipolar disorder	150#166		PI4K2B is a strong functional candidate as it is a member of the phosphatidylinositol pathway, which is targeted by lithium for therapeutic effect in bipolar disorder.
19539307	2010	J Psychiatr Res	1879-1379	ALL_TEXT_2/3	2	6	55300	SYMBOL|DICTIONARY|EXTRACTED	pi4k2b	PI4K2B	43#49	19539307-4-19-61	D001523	LONGTERM|DICTIONARY	psychiatric illness	psychiatric illness	96#115		Two approaches were undertaken to test the PI4K2B candidate gene as a susceptibility factor for psychiatric illness.
19539307	2010	J Psychiatr Res	1879-1379	ALL_TEXT_3/3	3	7	55300	SYMBOL|DICTIONARY|EXTRACTED	pi4k2b	PI4K2B	69#75	19539307-4-19-61	D001714	LONGTERM|DISEASE|DT|DICTIONARY	bipolar disorder	bipolar disorder	95#111		First, a case-control association study, using tagging SNPs from the PI4K2B genomic region, in bipolar disorder (n=368), schizophrenia (n=386) and controls (n=458) showed association with a two-marker haplotype in schizophrenia but not bipolar disorder (rs10939038 and rs17408391, global P=0.005, permuted global P=0.039).
19539307	2010	J Psychiatr Res	1879-1379	ALL_TEXT_3/3	3	7	55300	SYMBOL|DICTIONARY|EXTRACTED	pi4k2b	PI4K2B	69#75	19539307-4-19-61	D012559	LONGTERM|DICTIONARY	schizophrenia	schizophrenia	121#134		First, a case-control association study, using tagging SNPs from the PI4K2B genomic region, in bipolar disorder (n=368), schizophrenia (n=386) and controls (n=458) showed association with a two-marker haplotype in schizophrenia but not bipolar disorder (rs10939038 and rs17408391, global P=0.005, permuted global P=0.039).
19539307	2010	J Psychiatr Res	1879-1379	ALL_TEXT_3/3	3	7	55300	SYMBOL|DICTIONARY|EXTRACTED	pi4k2b	PI4K2B	69#75	19539307-4-19-61	D012559	LONGTERM|DICTIONARY	schizophrenia	schizophrenia	214#227		First, a case-control association study, using tagging SNPs from the PI4K2B genomic region, in bipolar disorder (n=368), schizophrenia (n=386) and controls (n=458) showed association with a two-marker haplotype in schizophrenia but not bipolar disorder (rs10939038 and rs17408391, global P=0.005, permuted global P=0.039).
19539307	2010	J Psychiatr Res	1879-1379	ALL_TEXT_3/3	3	7	55300	SYMBOL|DICTIONARY|EXTRACTED	pi4k2b	PI4K2B	69#75	19539307-4-19-61	D001714	LONGTERM|DISEASE|DT|DICTIONARY	bipolar disorder	bipolar disorder	236#252		First, a case-control association study, using tagging SNPs from the PI4K2B genomic region, in bipolar disorder (n=368), schizophrenia (n=386) and controls (n=458) showed association with a two-marker haplotype in schizophrenia but not bipolar disorder (rs10939038 and rs17408391, global P=0.005, permuted global P=0.039).
12939326	2003	Invest. Ophthalmol. Vis. Sci.	0146-0404	RESULTS	3	4	1280	SYMBOL|GENE|GN|DICTIONARY	col2a1	COL2A1	67#73		D012163	SYMBOL|EXTRACTED	rrd	RRD	4#7	12939326-1-61-113	The RRD cosegregated fully with a chromosomal region harboring the COL2A1 gene with maximum lod scores of 6.09 (family A) and 4.97 (family B).
10533957	1999	Cardiovasc. Pathol.	1054-8807	ALL_TEXT_2/3	2	10	4023	LONGTERM|DICTIONARY	lipoprotein lipase	lipoprotein lipase	82#100		D009202	SYMBOL|EXTRACTED	mn	MN	156#158	10533957-3-51-70	Potentiation of lipolysis by intravenous injections of phospholipase A2 (PLA2) or lipoprotein lipase (LPL) to rats treated with ISO substantially augmented MN.
10533957	1999	Cardiovasc. Pathol.	1054-8807	ALL_TEXT_2/3	2	10	4023	SYMBOL|()|DICTIONARY|EXTRACTED	lpl	LPL	102#105	10533957-10-82-100	D009202	SYMBOL|EXTRACTED	mn	MN	156#158	10533957-3-51-70	Potentiation of lipolysis by intravenous injections of phospholipase A2 (PLA2) or lipoprotein lipase (LPL) to rats treated with ISO substantially augmented MN.
19800393	2010	Neurosci. Lett.	1872-7972	ALL_TEXT_1/3	1	1	120892	SYMBOL|DICTIONARY	lrrk2	LRRK2	49#54		D010300	LONGTERM|DISEASE|DN|DT|DICTIONARY	parkinson disease	Parkinson's Disease	69#88		The results of mutation screening of 24 exons of LRRK2 in 60 Iranian Parkinson's Disease patients are presented.
23423710	2013	Arch. Toxicol.	1432-0738	ALL_TEXT_3/3	3	11	1786	SYMBOL|DICTIONARY|EXTRACTED	dnmt1	DNMT1	36#41	23423710-9-13-36	D001249	LONGTERM|DICTIONARY	asthma	asthma	165#171		We proposed for the first time that DNMT1 played a key role in PDGF-induced RASM cell phenotypic switching and Aza-CdR is promising in intervening ASM remodeling in asthma.
17509612	2007	J. Mol. Cell. Cardiol.	0022-2828	ALL_TEXT_2/3	2	5	57158	SYMBOL|DICTIONARY|EXTRACTED	jph2	JPH2	179#183	17509612-1-0-14	D002312	SYMBOL|EXTRACTED	hcm	HCM	247#250	17509612-4-80-107	Using polymerase chain reaction, denaturing high performance liquid chromatography, and direct DNA sequencing, comprehensive open reading frame/splice site mutational analysis of JPH2 was performed on DNA obtained from 388 unrelated patients with HCM.
16956834	2006	Haematologica	1592-8721	ALL_TEXT	1	1	1906	LONGTERM|DICTIONARY	endothelin 1	endothelin 1	19#31		D056586	LONGTERM|DISEASE|DT|DICTIONARY	acute chest syndrome	acute chest syndrome	190#210		The association of endothelin 1 (ET-1) and endothelial constitutive nitric oxide synthase (ecNOS) gene polymorphisms (G5665T and T8002C, VNTR and T-786C respectively) with the occurrence of acute chest syndrome and painful vaso-occlusive crises was evaluated in homozygous SS children.
16956834	2006	Haematologica	1592-8721	ALL_TEXT	1	1	1906	LONGTERM|DICTIONARY	endothelin 1	endothelin 1	19#31		D010146	LONGTERM|DICTIONARY	painful vaso-occlusive crises	painful vaso-occlusive crises	215#244		The association of endothelin 1 (ET-1) and endothelial constitutive nitric oxide synthase (ecNOS) gene polymorphisms (G5665T and T8002C, VNTR and T-786C respectively) with the occurrence of acute chest syndrome and painful vaso-occlusive crises was evaluated in homozygous SS children.
16956834	2006	Haematologica	1592-8721	ALL_TEXT	1	1	1906	SYMBOL|EXTRACTED|()	et 1	ET-1	33#37	16956834-1-19-31	D056586	LONGTERM|DISEASE|DT|DICTIONARY	acute chest syndrome	acute chest syndrome	190#210		The association of endothelin 1 (ET-1) and endothelial constitutive nitric oxide synthase (ecNOS) gene polymorphisms (G5665T and T8002C, VNTR and T-786C respectively) with the occurrence of acute chest syndrome and painful vaso-occlusive crises was evaluated in homozygous SS children.
16956834	2006	Haematologica	1592-8721	ALL_TEXT	1	1	1906	SYMBOL|EXTRACTED|()	et 1	ET-1	33#37	16956834-1-19-31	D010146	LONGTERM|DICTIONARY	painful vaso-occlusive crises	painful vaso-occlusive crises	215#244		The association of endothelin 1 (ET-1) and endothelial constitutive nitric oxide synthase (ecNOS) gene polymorphisms (G5665T and T8002C, VNTR and T-786C respectively) with the occurrence of acute chest syndrome and painful vaso-occlusive crises was evaluated in homozygous SS children.
16956834	2006	Haematologica	1592-8721	ALL_TEXT	1	1	4846	SYMBOL|()|GENE|GN|DICTIONARY	ecnos	ecNOS	91#96		D056586	LONGTERM|DISEASE|DT|DICTIONARY	acute chest syndrome	acute chest syndrome	190#210		The association of endothelin 1 (ET-1) and endothelial constitutive nitric oxide synthase (ecNOS) gene polymorphisms (G5665T and T8002C, VNTR and T-786C respectively) with the occurrence of acute chest syndrome and painful vaso-occlusive crises was evaluated in homozygous SS children.
16956834	2006	Haematologica	1592-8721	ALL_TEXT	1	1	4846	SYMBOL|()|GENE|GN|DICTIONARY	ecnos	ecNOS	91#96		D010146	LONGTERM|DICTIONARY	painful vaso-occlusive crises	painful vaso-occlusive crises	215#244		The association of endothelin 1 (ET-1) and endothelial constitutive nitric oxide synthase (ecNOS) gene polymorphisms (G5665T and T8002C, VNTR and T-786C respectively) with the occurrence of acute chest syndrome and painful vaso-occlusive crises was evaluated in homozygous SS children.
17509612	2007	J. Mol. Cell. Cardiol.	0022-2828	ALL_TEXT_1/3	1	2	57158	SYMBOL|DICTIONARY|EXTRACTED	jph2	JPH2	0#4		D009202	LONGTERM|DICTIONARY	cardiomyopathy	cardiomyopathy	103#117		JPH2 knockout mice showed disrupted calcium transients, altered junctional membrane complex formation, cardiomyopathy, and embryonic lethality.
17509612	2007	J. Mol. Cell. Cardiol.	0022-2828	ALL_TEXT_1/3	1	2	57158	SYMBOL|DICTIONARY|EXTRACTED	jph2	JPH2	0#4		D020964	LONGTERM|DICTIONARY	embryonic lethality	embryonic lethality	123#142	NaN	JPH2 knockout mice showed disrupted calcium transients, altered junctional membrane complex formation, cardiomyopathy, and embryonic lethality.
16956834	2006	Haematologica	1592-8721	ALL_TEXT	1	2	1906	SYMBOL|EXTRACTED	et 1	ET-1	38#42	16956834-1-19-31	D056586	LONGTERM|DISEASE|DT|DICTIONARY	acute chest syndrome	acute chest syndrome	145#165		This retrospective study reveals that ET-1 T8002 and ecNOS C-786 alleles are associated with, respectively, an increased and a decreased risk of acute chest syndrome.
18798262	2008	Int. J. Cancer	1097-0215	ALL_TEXT_2/3	2	6	4851	SYMBOL|GENE|GN|DICTIONARY	notch1	Notch1	70#76		D008223	LONGTERM|DICTIONARY	mouse lymphomas	mouse lymphomas	33#48		We analyzed 103 chemical-induced mouse lymphomas for mutations in the Notch1 gene using single strand conformation analysis (SSCA) and DNA sequencing.
18951054	2008	Mol. Genet. Metab.	1096-7206	ALL_TEXT_1/3	1	2	4547	SYMBOL|DICTIONARY|EXTRACTED	mttp	MTTP	21#25	18951054-1-4-44	D008659	LONGTERM|DISEASE|DT|DICTIONARY	metabolic syndrome	metabolic syndrome	53#71		Associations between MTTP variants and traits of the metabolic syndrome are carried out in relatively small cohorts and are not consistent.
15956634	2005	JAMA	1538-3598	RESULTS	5	12	348	SYMBOL|DICTIONARY|EXTRACTED	apoe	APOE	80#84	15956634-1-0-16	D051436	LONGTERM|DISEASE|DT|DICTIONARY	chronic kidney disease	chronic kidney disease	15#37		Excess risk of chronic kidney disease in African Americans was not explained by APOE alleles.
11248061	2001	Proc. Natl. Acad. Sci. U.S.A.	0027-8424	ALL_TEXT_3/3	3	10	675	SYMBOL|DICTIONARY	brca2	BRCA2	144#149		D001943	LONGTERM|DISEASE|DT|DICTIONARY	breast cancer	breast cancer	41#54		This effect was largely due to increased breast cancer risk with an HR of 3.46 (95% confidence interval 1.3-9.2, P = 0.01) for breast cancer in BRCA2 carriers who were RAD51-135C heterozygotes.
11248061	2001	Proc. Natl. Acad. Sci. U.S.A.	0027-8424	ALL_TEXT_3/3	3	10	675	SYMBOL|DICTIONARY	brca2	BRCA2	144#149		D001943	LONGTERM|DISEASE|DT|DICTIONARY	breast cancer	breast cancer	127#140		This effect was largely due to increased breast cancer risk with an HR of 3.46 (95% confidence interval 1.3-9.2, P = 0.01) for breast cancer in BRCA2 carriers who were RAD51-135C heterozygotes.
11248061	2001	Proc. Natl. Acad. Sci. U.S.A.	0027-8424	ALL_TEXT_3/3	3	10	5888	SYMBOL|NUMBER|DICTIONARY	rad51	RAD51	168#173		D001943	LONGTERM|DISEASE|DT|DICTIONARY	breast cancer	breast cancer	41#54		This effect was largely due to increased breast cancer risk with an HR of 3.46 (95% confidence interval 1.3-9.2, P = 0.01) for breast cancer in BRCA2 carriers who were RAD51-135C heterozygotes.
11248061	2001	Proc. Natl. Acad. Sci. U.S.A.	0027-8424	ALL_TEXT_3/3	3	10	5888	SYMBOL|NUMBER|DICTIONARY	rad51	RAD51	168#173		D001943	LONGTERM|DISEASE|DT|DICTIONARY	breast cancer	breast cancer	127#140		This effect was largely due to increased breast cancer risk with an HR of 3.46 (95% confidence interval 1.3-9.2, P = 0.01) for breast cancer in BRCA2 carriers who were RAD51-135C heterozygotes.
11248061	2001	Proc. Natl. Acad. Sci. U.S.A.	0027-8424	ALL_TEXT_3/3	3	11	5888	SYMBOL|DICTIONARY	rad51	RAD51	0#5		D010051	LONGTERM|DISEASE|DT|DICTIONARY	ovarian cancer	ovarian cancer	28#42		RAD51 status did not affect ovarian cancer risk.
11248061	2001	Proc. Natl. Acad. Sci. U.S.A.	0027-8424	ALL_TEXT_3/3	3	12	5888	SYMBOL|NUMBER|DICTIONARY	rad51	RAD51	19#24		D001943	LONGTERM|DISEASE|DT|DICTIONARY	breast cancer	breast cancer	112#125		These results show RAD51-135C is a clinically significant modifier of BRCA2 penetrance, specifically in raising breast cancer risk at younger ages.
11248061	2001	Proc. Natl. Acad. Sci. U.S.A.	0027-8424	ALL_TEXT_3/3	3	12	675	SYMBOL|DICTIONARY	brca2	BRCA2	70#75		D001943	LONGTERM|DISEASE|DT|DICTIONARY	breast cancer	breast cancer	112#125		These results show RAD51-135C is a clinically significant modifier of BRCA2 penetrance, specifically in raising breast cancer risk at younger ages.
18798262	2008	Int. J. Cancer	1097-0215	ALL_TEXT_1/3	1	1	4851	SYMBOL|DICTIONARY	notch1	Notch1	11#17		D008223	LONGTERM|DICTIONARY	lymphomas	lymphomas	107#116		Activating Notch1 mutations have been reported in human T-lineage acute lymphoblastic leukemia (T-ALL) and lymphomas from genetically modified mice.
18798262	2008	Int. J. Cancer	1097-0215	ALL_TEXT_1/3	1	1	4851	SYMBOL|DICTIONARY	notch1	Notch1	11#17		D054198	LONGTERM|DICTIONARY	t-lineage acute lymphoblastic leukemia	T-lineage acute lymphoblastic leukemia	56#94		Activating Notch1 mutations have been reported in human T-lineage acute lymphoblastic leukemia (T-ALL) and lymphomas from genetically modified mice.
16393683	2006	Am. J. Clin. Pathol.	0002-9173	ALL_TEXT_1/3	1	1	3077	SYMBOL|DICTIONARY	hfe	HFE	27#30		D008107	LONGTERM|DISEASE|DT|DICTIONARY	liver disease	liver disease	118#131		We compared the results of HFE genotype with tests for iron binding saturation (IBS) in 190 consecutive patients with liver disease using 2 IBS cutoff levels: 45% and 60%.
16393683	2006	Am. J. Clin. Pathol.	0002-9173	ALL_TEXT_1/3	1	1	3077	SYMBOL|DICTIONARY	hfe	HFE	27#30		D019190	LONGTERM|DICTIONARY	iron binding saturation	iron binding saturation	55#78	NaN	We compared the results of HFE genotype with tests for iron binding saturation (IBS) in 190 consecutive patients with liver disease using 2 IBS cutoff levels: 45% and 60%.
12913211	2004	Neurology	1526-632X	ALL_TEXT	1	1	246744	LONGTERM|GENE|GN|DICTIONARY	saitohin	Saitohin	82#90		D000544	LONGTERM|DICTIONARY	ad	AD	152#154	NaN	Recent reports are inconclusive in showing that the Q7R polymorphism of the novel Saitohin gene, nested in intron 9 of the tau gene, is associated with AD.
16393683	2006	Am. J. Clin. Pathol.	0002-9173	ALL_TEXT_3/3	3	7	3077	SYMBOL|DICTIONARY	hfe	HFE	44#47		D008107	LONGTERM|DISEASE|DT|DICTIONARY	liver disease	liver disease	294#307		Patients with a wild-type genotype (lacking HFE variants) and elevated IBS were far more likely to have an iron binding capacity less than 250 microg/dL (<44.8 micromol/L) than those with saturation values less than 45%, suggesting that a significant percentage of elevated IBS test results in liver disease are false-positives associated with decreased synthetic capacity.
16393683	2006	Am. J. Clin. Pathol.	0002-9173	ALL_TEXT_3/3	3	8	3077	SYMBOL|DICTIONARY	hfe	HFE	194#197		D008107	LONGTERM|DISEASE|DT|DICTIONARY	liver disease	liver disease	249#262		Nevertheless, an appreciable number of patients with elevated IBS had normal iron binding capacity, indicating the complexity of relationships among iron absorption and binding, disease status, HFE genotype, and other potential modifying factors in liver disease.
12378512	2002	Hum. Pathol.	0046-8177	ALL_TEXT_3/3	3	8	7157	SYMBOL|DICTIONARY	p53	p53	202#205		D006394	LONGTERM|DICTIONARY	angiosarcomas	angiosarcomas	99#112		Methylated p14(ARF) appeared in the context of a methylated p16(INKa) promoter in 3 cases of the 5 angiosarcomas methylated at p14(ARF). p14(ARF) aberrant methylation was not related to the presence of p53 mutations, which was detected in 6 of 19 (32%) cases.
12378512	2002	Hum. Pathol.	0046-8177	ALL_TEXT_3/3	3	8	1029	LONGTERM|DICTIONARY	p14	p14	11#14	NaN	D006394	LONGTERM|DICTIONARY	angiosarcomas	angiosarcomas	99#112		Methylated p14(ARF) appeared in the context of a methylated p16(INKa) promoter in 3 cases of the 5 angiosarcomas methylated at p14(ARF). p14(ARF) aberrant methylation was not related to the presence of p53 mutations, which was detected in 6 of 19 (32%) cases.
12378512	2002	Hum. Pathol.	0046-8177	ALL_TEXT_3/3	3	8	1029	LONGTERM|DICTIONARY	p16	p16	60#63	NaN	D006394	LONGTERM|DICTIONARY	angiosarcomas	angiosarcomas	99#112		Methylated p14(ARF) appeared in the context of a methylated p16(INKa) promoter in 3 cases of the 5 angiosarcomas methylated at p14(ARF). p14(ARF) aberrant methylation was not related to the presence of p53 mutations, which was detected in 6 of 19 (32%) cases.
12378512	2002	Hum. Pathol.	0046-8177	ALL_TEXT_3/3	3	8	1029	LONGTERM|DICTIONARY	p14	p14	127#130	NaN	D006394	LONGTERM|DICTIONARY	angiosarcomas	angiosarcomas	99#112		Methylated p14(ARF) appeared in the context of a methylated p16(INKa) promoter in 3 cases of the 5 angiosarcomas methylated at p14(ARF). p14(ARF) aberrant methylation was not related to the presence of p53 mutations, which was detected in 6 of 19 (32%) cases.
12378512	2002	Hum. Pathol.	0046-8177	ALL_TEXT_3/3	3	8	1029	LONGTERM|DICTIONARY	p14	p14	137#140	NaN	D006394	LONGTERM|DICTIONARY	angiosarcomas	angiosarcomas	99#112		Methylated p14(ARF) appeared in the context of a methylated p16(INKa) promoter in 3 cases of the 5 angiosarcomas methylated at p14(ARF). p14(ARF) aberrant methylation was not related to the presence of p53 mutations, which was detected in 6 of 19 (32%) cases.
12378512	2002	Hum. Pathol.	0046-8177	ALL_TEXT_3/3	3	9	7157	SYMBOL|DICTIONARY	p53	p53	38#41		D009369	LONGTERM|DICTIONARY	tumors	tumors	106#112		Alterations of the INK4a-ARF locus or p53 as were not established independent prognostic factors in these tumors.
11948460	2002	Int. J. Cancer	0020-7136	ALL_TEXT_1/3	1	4	999	SYMBOL|DICTIONARY	cdh1	CDH1	66#70		D009369	LONGTERM|DISEASE|DT|DICTIONARY	cancer	cancer	98#104		The aim of this study was to investigate if germline mutations in CDH1 could explain the risk for cancer in HPC families with an excess of gastric and breast cancer.
11948460	2002	Int. J. Cancer	0020-7136	ALL_TEXT_1/3	1	4	999	SYMBOL|DICTIONARY	cdh1	CDH1	66#70		D011471	SYMBOL|GFAM|FN|DICTIONARY|EXTRACTED	hpc	HPC	108#111	11948460-3-17-43	The aim of this study was to investigate if germline mutations in CDH1 could explain the risk for cancer in HPC families with an excess of gastric and breast cancer.
11948460	2002	Int. J. Cancer	0020-7136	ALL_TEXT_1/3	1	4	999	SYMBOL|DICTIONARY	cdh1	CDH1	66#70		D001943	LONGTERM|DISEASE|DT|DICTIONARY	gastric and breast cancer	gastric and breast cancer	139#164		The aim of this study was to investigate if germline mutations in CDH1 could explain the risk for cancer in HPC families with an excess of gastric and breast cancer.
11948460	2002	Int. J. Cancer	0020-7136	ALL_TEXT_2/3	2	5	999	SYMBOL|DICTIONARY	cdh1	CDH1	136#140		D011471	SYMBOL|GFAM|FN|DICTIONARY|EXTRACTED	hpc	HPC	29#32	11948460-3-17-43	In total, 17 members from 13 HPC families and 3 members from 3 families with hereditary gastric cancer (HGC) were screened for germline CDH1 sequence alterations using PCR/Denaturing HPLC for initial screening of nucleotide variants followed by confirmatory direct sequencing analysis.
11948460	2002	Int. J. Cancer	0020-7136	ALL_TEXT_2/3	2	5	999	SYMBOL|DICTIONARY	cdh1	CDH1	136#140		D013274	LONGTERM|DISEASE|DT|DICTIONARY	hereditary gastric cancer	hereditary gastric cancer	77#102		In total, 17 members from 13 HPC families and 3 members from 3 families with hereditary gastric cancer (HGC) were screened for germline CDH1 sequence alterations using PCR/Denaturing HPLC for initial screening of nucleotide variants followed by confirmatory direct sequencing analysis.
8094979	1993	Biol. Psychiatry	0006-3223	ALL_TEXT_1/3	1	1	1813	LONGTERM|GENE|GN|GT|DICTIONARY	dopamine d2 receptor	dopamine D2 receptor	89#109		D000437	LONGTERM|DICTIONARY	alcoholism	alcoholism	120#130		The allelic association of TaqI A restriction fragment length polymorphism (RFLP) of the dopamine D2 receptor gene with alcoholism was examined in 78 Japanese alcoholics and compared with Japanese controls.
20630504	2011	Fertil. Steril.	1556-5653	ALL_TEXT	1	1	84467	LONGTERM|GENE|GN|DICTIONARY	fibrillin 3	fibrillin-3	82#93		D011085	LONGTERM|DISEASE|DT|DICTIONARY	polycystic ovary syndrome	polycystic ovary syndrome	183#208		In an attempt to evaluate the association between allele 8 (A8) of D19S884 in the fibrillin-3 gene and circulating transforming growth factor (TGF)  and inhibin levels in women with polycystic ovary syndrome (PCOS), we studied 120 similarly aged women from families with PCOS and compared 40 women with PCOS who did not have A8 (A8- PCOS) with 40 women with PCOS who had A8 (A8+ PCOS) and 40 normally menstruating women who did not have either PCOS or A8 (A8- Non-PCOS).
20630504	2011	Fertil. Steril.	1556-5653	ALL_TEXT	1	1	84467	LONGTERM|GENE|GN|DICTIONARY	fibrillin 3	fibrillin-3	82#93		D011085	SYMBOL|()|DICTIONARY|EXTRACTED	pcos	PCOS	210#214	20630504-1-183-208	In an attempt to evaluate the association between allele 8 (A8) of D19S884 in the fibrillin-3 gene and circulating transforming growth factor (TGF)  and inhibin levels in women with polycystic ovary syndrome (PCOS), we studied 120 similarly aged women from families with PCOS and compared 40 women with PCOS who did not have A8 (A8- PCOS) with 40 women with PCOS who had A8 (A8+ PCOS) and 40 normally menstruating women who did not have either PCOS or A8 (A8- Non-PCOS).
20630504	2011	Fertil. Steril.	1556-5653	ALL_TEXT	1	1	84467	LONGTERM|GENE|GN|DICTIONARY	fibrillin 3	fibrillin-3	82#93		D011085	SYMBOL|DICTIONARY|EXTRACTED	pcos	PCOS	272#276	20630504-1-183-208	In an attempt to evaluate the association between allele 8 (A8) of D19S884 in the fibrillin-3 gene and circulating transforming growth factor (TGF)  and inhibin levels in women with polycystic ovary syndrome (PCOS), we studied 120 similarly aged women from families with PCOS and compared 40 women with PCOS who did not have A8 (A8- PCOS) with 40 women with PCOS who had A8 (A8+ PCOS) and 40 normally menstruating women who did not have either PCOS or A8 (A8- Non-PCOS).
20630504	2011	Fertil. Steril.	1556-5653	ALL_TEXT	1	1	84467	LONGTERM|GENE|GN|DICTIONARY	fibrillin 3	fibrillin-3	82#93		D011085	SYMBOL|DICTIONARY|EXTRACTED	pcos	PCOS	304#308	20630504-1-183-208	In an attempt to evaluate the association between allele 8 (A8) of D19S884 in the fibrillin-3 gene and circulating transforming growth factor (TGF)  and inhibin levels in women with polycystic ovary syndrome (PCOS), we studied 120 similarly aged women from families with PCOS and compared 40 women with PCOS who did not have A8 (A8- PCOS) with 40 women with PCOS who had A8 (A8+ PCOS) and 40 normally menstruating women who did not have either PCOS or A8 (A8- Non-PCOS).
20630504	2011	Fertil. Steril.	1556-5653	ALL_TEXT	1	1	84467	LONGTERM|GENE|GN|DICTIONARY	fibrillin 3	fibrillin-3	82#93		D011085	SYMBOL|DICTIONARY|EXTRACTED	pcos	PCOS	334#338	20630504-1-183-208	In an attempt to evaluate the association between allele 8 (A8) of D19S884 in the fibrillin-3 gene and circulating transforming growth factor (TGF)  and inhibin levels in women with polycystic ovary syndrome (PCOS), we studied 120 similarly aged women from families with PCOS and compared 40 women with PCOS who did not have A8 (A8- PCOS) with 40 women with PCOS who had A8 (A8+ PCOS) and 40 normally menstruating women who did not have either PCOS or A8 (A8- Non-PCOS).
20630504	2011	Fertil. Steril.	1556-5653	ALL_TEXT	1	1	84467	LONGTERM|GENE|GN|DICTIONARY	fibrillin 3	fibrillin-3	82#93		D011085	SYMBOL|DICTIONARY|EXTRACTED	pcos	PCOS	359#363	20630504-1-183-208	In an attempt to evaluate the association between allele 8 (A8) of D19S884 in the fibrillin-3 gene and circulating transforming growth factor (TGF)  and inhibin levels in women with polycystic ovary syndrome (PCOS), we studied 120 similarly aged women from families with PCOS and compared 40 women with PCOS who did not have A8 (A8- PCOS) with 40 women with PCOS who had A8 (A8+ PCOS) and 40 normally menstruating women who did not have either PCOS or A8 (A8- Non-PCOS).
20630504	2011	Fertil. Steril.	1556-5653	ALL_TEXT	1	1	84467	LONGTERM|GENE|GN|DICTIONARY	fibrillin 3	fibrillin-3	82#93		D011085	SYMBOL|DICTIONARY|EXTRACTED	pcos	PCOS	380#384	20630504-1-183-208	In an attempt to evaluate the association between allele 8 (A8) of D19S884 in the fibrillin-3 gene and circulating transforming growth factor (TGF)  and inhibin levels in women with polycystic ovary syndrome (PCOS), we studied 120 similarly aged women from families with PCOS and compared 40 women with PCOS who did not have A8 (A8- PCOS) with 40 women with PCOS who had A8 (A8+ PCOS) and 40 normally menstruating women who did not have either PCOS or A8 (A8- Non-PCOS).
20630504	2011	Fertil. Steril.	1556-5653	ALL_TEXT	1	1	84467	LONGTERM|GENE|GN|DICTIONARY	fibrillin 3	fibrillin-3	82#93		D011085	SYMBOL|DICTIONARY|EXTRACTED	pcos	PCOS	445#449	20630504-1-183-208	In an attempt to evaluate the association between allele 8 (A8) of D19S884 in the fibrillin-3 gene and circulating transforming growth factor (TGF)  and inhibin levels in women with polycystic ovary syndrome (PCOS), we studied 120 similarly aged women from families with PCOS and compared 40 women with PCOS who did not have A8 (A8- PCOS) with 40 women with PCOS who had A8 (A8+ PCOS) and 40 normally menstruating women who did not have either PCOS or A8 (A8- Non-PCOS).
20630504	2011	Fertil. Steril.	1556-5653	ALL_TEXT	1	1	84467	LONGTERM|GENE|GN|DICTIONARY	fibrillin 3	fibrillin-3	82#93		D011085	SYMBOL|DICTIONARY|EXTRACTED	pcos	PCOS	465#469	20630504-1-183-208	In an attempt to evaluate the association between allele 8 (A8) of D19S884 in the fibrillin-3 gene and circulating transforming growth factor (TGF)  and inhibin levels in women with polycystic ovary syndrome (PCOS), we studied 120 similarly aged women from families with PCOS and compared 40 women with PCOS who did not have A8 (A8- PCOS) with 40 women with PCOS who had A8 (A8+ PCOS) and 40 normally menstruating women who did not have either PCOS or A8 (A8- Non-PCOS).
20630504	2011	Fertil. Steril.	1556-5653	ALL_TEXT	1	1	28886	LONGTERM|DICTIONARY	a8- pcos	A8- PCOS	330#338	NaN	D011085	LONGTERM|DISEASE|DT|DICTIONARY	polycystic ovary syndrome	polycystic ovary syndrome	183#208		In an attempt to evaluate the association between allele 8 (A8) of D19S884 in the fibrillin-3 gene and circulating transforming growth factor (TGF)  and inhibin levels in women with polycystic ovary syndrome (PCOS), we studied 120 similarly aged women from families with PCOS and compared 40 women with PCOS who did not have A8 (A8- PCOS) with 40 women with PCOS who had A8 (A8+ PCOS) and 40 normally menstruating women who did not have either PCOS or A8 (A8- Non-PCOS).
20630504	2011	Fertil. Steril.	1556-5653	ALL_TEXT	1	1	28886	LONGTERM|DICTIONARY	a8- pcos	A8- PCOS	330#338	NaN	D011085	SYMBOL|()|DICTIONARY|EXTRACTED	pcos	PCOS	210#214	20630504-1-183-208	In an attempt to evaluate the association between allele 8 (A8) of D19S884 in the fibrillin-3 gene and circulating transforming growth factor (TGF)  and inhibin levels in women with polycystic ovary syndrome (PCOS), we studied 120 similarly aged women from families with PCOS and compared 40 women with PCOS who did not have A8 (A8- PCOS) with 40 women with PCOS who had A8 (A8+ PCOS) and 40 normally menstruating women who did not have either PCOS or A8 (A8- Non-PCOS).
20630504	2011	Fertil. Steril.	1556-5653	ALL_TEXT	1	1	28886	LONGTERM|DICTIONARY	a8- pcos	A8- PCOS	330#338	NaN	D011085	SYMBOL|DICTIONARY|EXTRACTED	pcos	PCOS	272#276	20630504-1-183-208	In an attempt to evaluate the association between allele 8 (A8) of D19S884 in the fibrillin-3 gene and circulating transforming growth factor (TGF)  and inhibin levels in women with polycystic ovary syndrome (PCOS), we studied 120 similarly aged women from families with PCOS and compared 40 women with PCOS who did not have A8 (A8- PCOS) with 40 women with PCOS who had A8 (A8+ PCOS) and 40 normally menstruating women who did not have either PCOS or A8 (A8- Non-PCOS).
20630504	2011	Fertil. Steril.	1556-5653	ALL_TEXT	1	1	28886	LONGTERM|DICTIONARY	a8- pcos	A8- PCOS	330#338	NaN	D011085	SYMBOL|DICTIONARY|EXTRACTED	pcos	PCOS	304#308	20630504-1-183-208	In an attempt to evaluate the association between allele 8 (A8) of D19S884 in the fibrillin-3 gene and circulating transforming growth factor (TGF)  and inhibin levels in women with polycystic ovary syndrome (PCOS), we studied 120 similarly aged women from families with PCOS and compared 40 women with PCOS who did not have A8 (A8- PCOS) with 40 women with PCOS who had A8 (A8+ PCOS) and 40 normally menstruating women who did not have either PCOS or A8 (A8- Non-PCOS).
20630504	2011	Fertil. Steril.	1556-5653	ALL_TEXT	1	1	28886	LONGTERM|DICTIONARY	a8- pcos	A8- PCOS	330#338	NaN	D011085	SYMBOL|DICTIONARY|EXTRACTED	pcos	PCOS	334#338	20630504-1-183-208	In an attempt to evaluate the association between allele 8 (A8) of D19S884 in the fibrillin-3 gene and circulating transforming growth factor (TGF)  and inhibin levels in women with polycystic ovary syndrome (PCOS), we studied 120 similarly aged women from families with PCOS and compared 40 women with PCOS who did not have A8 (A8- PCOS) with 40 women with PCOS who had A8 (A8+ PCOS) and 40 normally menstruating women who did not have either PCOS or A8 (A8- Non-PCOS).
20630504	2011	Fertil. Steril.	1556-5653	ALL_TEXT	1	1	28886	LONGTERM|DICTIONARY	a8- pcos	A8- PCOS	330#338	NaN	D011085	SYMBOL|DICTIONARY|EXTRACTED	pcos	PCOS	359#363	20630504-1-183-208	In an attempt to evaluate the association between allele 8 (A8) of D19S884 in the fibrillin-3 gene and circulating transforming growth factor (TGF)  and inhibin levels in women with polycystic ovary syndrome (PCOS), we studied 120 similarly aged women from families with PCOS and compared 40 women with PCOS who did not have A8 (A8- PCOS) with 40 women with PCOS who had A8 (A8+ PCOS) and 40 normally menstruating women who did not have either PCOS or A8 (A8- Non-PCOS).
20630504	2011	Fertil. Steril.	1556-5653	ALL_TEXT	1	1	28886	LONGTERM|DICTIONARY	a8- pcos	A8- PCOS	330#338	NaN	D011085	SYMBOL|DICTIONARY|EXTRACTED	pcos	PCOS	380#384	20630504-1-183-208	In an attempt to evaluate the association between allele 8 (A8) of D19S884 in the fibrillin-3 gene and circulating transforming growth factor (TGF)  and inhibin levels in women with polycystic ovary syndrome (PCOS), we studied 120 similarly aged women from families with PCOS and compared 40 women with PCOS who did not have A8 (A8- PCOS) with 40 women with PCOS who had A8 (A8+ PCOS) and 40 normally menstruating women who did not have either PCOS or A8 (A8- Non-PCOS).
20630504	2011	Fertil. Steril.	1556-5653	ALL_TEXT	1	1	28886	LONGTERM|DICTIONARY	a8- pcos	A8- PCOS	330#338	NaN	D011085	SYMBOL|DICTIONARY|EXTRACTED	pcos	PCOS	445#449	20630504-1-183-208	In an attempt to evaluate the association between allele 8 (A8) of D19S884 in the fibrillin-3 gene and circulating transforming growth factor (TGF)  and inhibin levels in women with polycystic ovary syndrome (PCOS), we studied 120 similarly aged women from families with PCOS and compared 40 women with PCOS who did not have A8 (A8- PCOS) with 40 women with PCOS who had A8 (A8+ PCOS) and 40 normally menstruating women who did not have either PCOS or A8 (A8- Non-PCOS).
20630504	2011	Fertil. Steril.	1556-5653	ALL_TEXT	1	1	28886	LONGTERM|DICTIONARY	a8- pcos	A8- PCOS	330#338	NaN	D011085	SYMBOL|DICTIONARY|EXTRACTED	pcos	PCOS	465#469	20630504-1-183-208	In an attempt to evaluate the association between allele 8 (A8) of D19S884 in the fibrillin-3 gene and circulating transforming growth factor (TGF)  and inhibin levels in women with polycystic ovary syndrome (PCOS), we studied 120 similarly aged women from families with PCOS and compared 40 women with PCOS who did not have A8 (A8- PCOS) with 40 women with PCOS who had A8 (A8+ PCOS) and 40 normally menstruating women who did not have either PCOS or A8 (A8- Non-PCOS).
11948460	2002	Int. J. Cancer	0020-7136	ALL_TEXT_1/3	1	1	999	SYMBOL|()|GENE|GN|DICTIONARY	cdh1	CDH1	37#41		D013274	LONGTERM|DICTIONARY	diffuse gastric and lobular breast cancers	diffuse gastric and lobular breast cancers	92#134		Somatic mutations in the E-cadherin (CDH1) gene have frequently been reported in cases with diffuse gastric and lobular breast cancers.
19388002	2010	Am. J. Med. Genet. B Neuropsychiatr. Genet.	1552-485X	ALL_TEXT_1/3	1	1	775	SYMBOL|()|GENE|GN|DICTIONARY	cacna1c	CACNA1C	74#81		D001714	LONGTERM|DISEASE|DT|DICTIONARY	bipolar disorder	bipolar disorder	114#130		Variations in voltage-dependent calcium channel L-type, alpha 1C subunit (CACNA1C) gene have been associated with bipolar disorder in a recent meta-analysis of genome-wide association studies [Ferreira et al., 2008].
11895872	2002	Cancer Epidemiol. Biomarkers Prev.	1055-9965	ALL_TEXT_3/3	3	9	1586	SYMBOL|DICTIONARY	cyp17	CYP17	31#36		D011471	LONGTERM|DISEASE|DT|DICTIONARY	prostate cancer	prostate cancer	79#94		These results suggest that the CYP17 A2/A2 genotype predicts susceptibility to prostate cancer in white men with a family history of the disease.
15279649	2004	Eur. J. Oral Sci.	0909-8836	ALL_TEXT_1/3	1	2	64127	SYMBOL|DICTIONARY	nod2	NOD2	174#178		D010518	LONGTERM|DICTIONARY	periodontitis	periodontitis	246#259		As the destruction of periodontal tissue is mediated via activation of NF-kappaB, with subsequent transcription of proinflammatory cytokines, the c-insertion mutation of the NOD2/CARD15 gene might contribute to the proposed genetic background of periodontitis.
15279649	2004	Eur. J. Oral Sci.	0909-8836	ALL_TEXT_1/3	1	2	64127	SYMBOL|GENE|GN|DICTIONARY	card15	CARD15	179#185		D010518	LONGTERM|DICTIONARY	periodontitis	periodontitis	246#259		As the destruction of periodontal tissue is mediated via activation of NF-kappaB, with subsequent transcription of proinflammatory cytokines, the c-insertion mutation of the NOD2/CARD15 gene might contribute to the proposed genetic background of periodontitis.
15279649	2004	Eur. J. Oral Sci.	0909-8836	ALL_TEXT_1/3	1	2	4790	LONGTERM|DICTIONARY	nf-kappab	NF-kappaB	71#80	NaN	D010518	LONGTERM|DICTIONARY	periodontitis	periodontitis	246#259		As the destruction of periodontal tissue is mediated via activation of NF-kappaB, with subsequent transcription of proinflammatory cytokines, the c-insertion mutation of the NOD2/CARD15 gene might contribute to the proposed genetic background of periodontitis.
17470138	2007	Clin. Genet.	0009-9163	ALL_TEXT_2/3	2	4	6934	SYMBOL|DICTIONARY|EXTRACTED	tcf7l2	TCF7L2	153#159	17470138-1-25-54	D003924	SYMBOL|DICTIONARY|EXTRACTED	t2d	T2D	179#182	17470138-1-95-110	In order to minimize potential confounding because of the presence of population stratification in the sample, we evaluated the association of the three TCF7L2 polymorphisms with T2D by using the program admixmap to fit a logistic regression model incorporating individual ancestry, sex, age, body mass index and education.
17470138	2007	Clin. Genet.	0009-9163	TITLE	0	0	6934	SYMBOL|DICTIONARY|EXTRACTED	tcf7l2	TCF7L2	15#21		D003924	LONGTERM|DICTIONARY	type 2 diabetes	type 2 diabetes	41#56		Association of TCF7L2 polymorphisms with type 2 diabetes in Mexico City.
17470138	2007	Clin. Genet.	0009-9163	ALL_TEXT_1/3	1	1	6934	SYMBOL|()|DICTIONARY|EXTRACTED	tcf7l2	TCF7L2	61#67	17470138-1-25-54	D003924	LONGTERM|DICTIONARY	type 2 diabetes	type 2 diabetes	95#110		Polymorphisms within the transcription factor 7-like 2 gene (TCF7L2) have been associated with type 2 diabetes (T2D) in several recent studies.
17470138	2007	Clin. Genet.	0009-9163	ALL_TEXT_1/3	1	1	6934	SYMBOL|()|DICTIONARY|EXTRACTED	tcf7l2	TCF7L2	61#67	17470138-1-25-54	D003924	SYMBOL|()|DICTIONARY|EXTRACTED	t2d	T2D	112#115	17470138-1-95-110	Polymorphisms within the transcription factor 7-like 2 gene (TCF7L2) have been associated with type 2 diabetes (T2D) in several recent studies.
20237358	2010	Reprod Sci	1933-7205	ALL_TEXT_2/3	2	4	6347	SYMBOL|DICTIONARY|EXTRACTED	mcp 1	MCP-1	35#40	20237358-1-49-79	D000292	SYMBOL|DICTIONARY|EXTRACTED	pid	PID	194#197	20237358-1-131-158	The increased expression of plasma MCP-1 was significantly correlated with the cell counts of white blood cells (WBCs) in blood and the level of plasma C-reactive protein (CRP) of patients with PID before they received treatment.
20237358	2010	Reprod Sci	1933-7205	ALL_TEXT_2/3	2	4	1401	LONGTERM|GENE|GT|DICTIONARY	c reactive protein	C-reactive protein	152#170		D000292	SYMBOL|DICTIONARY|EXTRACTED	pid	PID	194#197	20237358-1-131-158	The increased expression of plasma MCP-1 was significantly correlated with the cell counts of white blood cells (WBCs) in blood and the level of plasma C-reactive protein (CRP) of patients with PID before they received treatment.
20237358	2010	Reprod Sci	1933-7205	ALL_TEXT_2/3	2	4	1401	SYMBOL|()|DICTIONARY|EXTRACTED	crp	CRP	172#175	20237358-4-152-170	D000292	SYMBOL|DICTIONARY|EXTRACTED	pid	PID	194#197	20237358-1-131-158	The increased expression of plasma MCP-1 was significantly correlated with the cell counts of white blood cells (WBCs) in blood and the level of plasma C-reactive protein (CRP) of patients with PID before they received treatment.
15479186	2005	Clin. Genet.	0009-9163	ALL_TEXT_3/3	3	7	1585	SYMBOL|GENE|GN|DICTIONARY	cyp11b2	CYP11B2	75#82		D006973	LONGTERM|DICTIONARY	hypertension	hypertension	125#137		These results indicate that the Lys173 and the IC-conversion allele of the CYP11B2 gene confer an increased risk for stage-2 hypertension in northern Han Chinese women.
15479186	2005	Clin. Genet.	0009-9163	TITLE	0	0	1585	LONGTERM|GENE|GN|DICTIONARY	aldosterone synthase	aldosterone synthase	27#47		D006973	LONGTERM|DICTIONARY	hypertension	hypertension	85#97		Haplotypic analyses of the aldosterone synthase gene CYP11B2 associated with stage-2 hypertension in northern Han Chinese.
15479186	2005	Clin. Genet.	0009-9163	TITLE	0	0	1585	SYMBOL|DICTIONARY	cyp11b2	CYP11B2	53#60		D006973	LONGTERM|DICTIONARY	hypertension	hypertension	85#97		Haplotypic analyses of the aldosterone synthase gene CYP11B2 associated with stage-2 hypertension in northern Han Chinese.
15479186	2005	Clin. Genet.	0009-9163	ALL_TEXT_1/3	1	1	1585	LONGTERM|GENE|GN|DICTIONARY	aldosterone synthase	aldosterone synthase	87#107		D006973	LONGTERM|DICTIONARY	hypertension	hypertension	189#201		The objective of this study was to investigate the association of polymorphisms in the aldosterone synthase gene CYP11B2 (-344T/C, Lys173/Arg, and an intronic conversion [IC]) with stage-2 hypertension in northern Han Chinese.
15479186	2005	Clin. Genet.	0009-9163	ALL_TEXT_1/3	1	1	1585	SYMBOL|DICTIONARY	cyp11b2	CYP11B2	113#120		D006973	LONGTERM|DICTIONARY	hypertension	hypertension	189#201		The objective of this study was to investigate the association of polymorphisms in the aldosterone synthase gene CYP11B2 (-344T/C, Lys173/Arg, and an intronic conversion [IC]) with stage-2 hypertension in northern Han Chinese.
16230779	2006	Endocrine	1355-008X	TITLE	0	0	5979	SYMBOL|DICTIONARY	ret	RET	0#3		D013964	LONGTERM|DISEASE|DT|DICTIONARY	medullary thyroid carcinoma	medullary thyroid carcinoma	31#58		RET polymorphisms and sporadic medullary thyroid carcinoma in a Portuguese population.
21297633	2011	Nat. Genet.	1546-1718	ALL_TEXT_3/3	3	3	347051	LONGTERM|DICTIONARY	p < 5	P < 5	39#44	NaN	D003093	LONGTERM|DICTIONARY	ulcerative colitis	ulcerative colitis	81#99		We identified 29 additional risk loci (P < 5  10(-8)), increasing the number of ulcerative colitis-associated loci to 47.
19774492	2010	Mol. Biol. Rep.	1573-4978	TITLE	0	0	7128	SYMBOL|GENE|GN|DICTIONARY	tnfaip3	TNFAIP3	40#47		D008180	LONGTERM|DICTIONARY	systemic lupus erythematosus	systemic lupus erythematosus	72#100		A single-nucleotide polymorphism of the TNFAIP3 gene is associated with systemic lupus erythematosus in Chinese Han population.
15307921	2004	AIDS Res. Hum. Retroviruses	0889-2229	ALL_TEXT_1/3	1	2	1234	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	ccr5	CCR5	31#35	15307921-0-60-78	D015658	LONGTERM|DISEASE|DT|DICTIONARY	hiv infection	HIV infection	72#85		A 32-base pair deletion of the CCR5 gene (CCR5Delta32) protects against HIV infection because the frame shift leads to a truncated protein not expressed on the cell surface.
15670652	2005	Neurosci. Lett.	0304-3940	ALL_TEXT_1/3	1	1	6622	SYMBOL|DICTIONARY	snca	SNCA	47#51		D010300	LONGTERM|DICTIONARY	parkinson disease	Parkinson's disease	103#122		It remains unclear whether genetic variants in SNCA (the alpha-synuclein gene) alter risk for sporadic Parkinson's disease (PD).
15670652	2005	Neurosci. Lett.	0304-3940	ALL_TEXT_1/3	1	1	6622	SYMBOL|DICTIONARY	snca	SNCA	47#51		D010300	SYMBOL|EXTRACTED|()	pd	PD	124#126	15670652-1-103-122	It remains unclear whether genetic variants in SNCA (the alpha-synuclein gene) alter risk for sporadic Parkinson's disease (PD).
15670652	2005	Neurosci. Lett.	0304-3940	ALL_TEXT_1/3	1	1	6622	SYMBOL|GENE|GN|DICTIONARY	alpha synuclein	alpha-synuclein	57#72		D010300	LONGTERM|DICTIONARY	parkinson disease	Parkinson's disease	103#122		It remains unclear whether genetic variants in SNCA (the alpha-synuclein gene) alter risk for sporadic Parkinson's disease (PD).
15670652	2005	Neurosci. Lett.	0304-3940	ALL_TEXT_1/3	1	1	6622	SYMBOL|GENE|GN|DICTIONARY	alpha synuclein	alpha-synuclein	57#72		D010300	SYMBOL|EXTRACTED|()	pd	PD	124#126	15670652-1-103-122	It remains unclear whether genetic variants in SNCA (the alpha-synuclein gene) alter risk for sporadic Parkinson's disease (PD).
15670652	2005	Neurosci. Lett.	0304-3940	TITLE	0	0	1121	SYMBOL|DICTIONARY	rep1	Rep1	73#77		D010300	LONGTERM|DISEASE|DT|DICTIONARY	parkinson disease	Parkinson's disease	100#119		Australian data and meta-analysis lend support for alpha-synuclein (NACP-Rep1) as a risk factor for Parkinson's disease.
15670652	2005	Neurosci. Lett.	0304-3940	TITLE	0	0	6622	LONGTERM|DICTIONARY	alpha-synuclein	alpha-synuclein	51#66	NaN	D010300	LONGTERM|DISEASE|DT|DICTIONARY	parkinson disease	Parkinson's disease	100#119		Australian data and meta-analysis lend support for alpha-synuclein (NACP-Rep1) as a risk factor for Parkinson's disease.
12102452	2003	Clin. Auton. Res.	0959-9851	PRINCIPAL CONCLUSIONS	3	10	1636	SYMBOL|DICTIONARY|EXTRACTED	ace	ACE	87#90	12102452-2-113-142	D009203	LONGTERM|DICTIONARY	myocardial infarction	myocardial infarction	233#254		These findings may reflect the relative lack of importance of the I/D polymorphism and ACE activity in determining plasma and tissue angiotensin II concentration after a major stimulus to the renin-angiotensin system as occurs after myocardial infarction.
12102452	2003	Clin. Auton. Res.	0959-9851	PRINCIPAL CONCLUSIONS	3	10	183	LONGTERM|DICTIONARY	angiotensin ii	angiotensin II	133#147		D009203	LONGTERM|DICTIONARY	myocardial infarction	myocardial infarction	233#254		These findings may reflect the relative lack of importance of the I/D polymorphism and ACE activity in determining plasma and tissue angiotensin II concentration after a major stimulus to the renin-angiotensin system as occurs after myocardial infarction.
15670652	2005	Neurosci. Lett.	0304-3940	ALL_TEXT_1/3	1	2	1121	SYMBOL|DICTIONARY	rep1	Rep1	44#48		D010300	SYMBOL|EXTRACTED	pd	PD	151#153	15670652-1-103-122	The polymorphic mixed sequence repeat (NACP-Rep1) in the promoter region of SNCA has been previously examined as a potential susceptibility factor for PD with conflicting results.
15670652	2005	Neurosci. Lett.	0304-3940	ALL_TEXT_1/3	1	2	6622	SYMBOL|DICTIONARY	snca	SNCA	76#80		D010300	SYMBOL|EXTRACTED	pd	PD	151#153	15670652-1-103-122	The polymorphic mixed sequence repeat (NACP-Rep1) in the promoter region of SNCA has been previously examined as a potential susceptibility factor for PD with conflicting results.
15670652	2005	Neurosci. Lett.	0304-3940	ALL_TEXT_3/3	3	5	1121	SYMBOL|DICTIONARY	rep1	Rep1	72#76		D010300	SYMBOL|EXTRACTED	pd	PD	167#169	15670652-1-103-122	Combined analysis including all previously published ancestral European Rep1 data yielded a highly significant association between the 0 allele and a reduced risk for PD (OR=0.79, 95% CI 0.70-0.89, p=0.0001).
19773262	2010	Haematologica	1592-8721	RESULTS	3	11	6125	SYMBOL|DICTIONARY	rpl5	RPL5	86#90		D000014	LONGTERM|DICTIONARY	malformations	malformations	55#68		Remarkably, we observed a higher percentage of somatic malformations in patients with RPL5 and RPL11 mutations.
19773262	2010	Haematologica	1592-8721	RESULTS	3	11	6135	SYMBOL|DICTIONARY	rpl11	RPL11	95#100		D000014	LONGTERM|DICTIONARY	malformations	malformations	55#68		Remarkably, we observed a higher percentage of somatic malformations in patients with RPL5 and RPL11 mutations.
19773262	2010	Haematologica	1592-8721	RESULTS	3	12	6125	SYMBOL|DICTIONARY	rpl5	RPL5	40#44		D000014	LONGTERM|DICTIONARY	malformations	malformations	72#85		A close association was evident between RPL5 mutations and craniofacial malformations, and between hand malformations and RPL11 mutations.
19773262	2010	Haematologica	1592-8721	RESULTS	3	12	6125	SYMBOL|DICTIONARY	rpl5	RPL5	40#44		D000014	LONGTERM|DICTIONARY	malformations	malformations	104#117		A close association was evident between RPL5 mutations and craniofacial malformations, and between hand malformations and RPL11 mutations.
19773262	2010	Haematologica	1592-8721	RESULTS	3	12	6135	SYMBOL|DICTIONARY	rpl11	RPL11	122#127		D000014	LONGTERM|DICTIONARY	malformations	malformations	72#85		A close association was evident between RPL5 mutations and craniofacial malformations, and between hand malformations and RPL11 mutations.
19773262	2010	Haematologica	1592-8721	RESULTS	3	12	6135	SYMBOL|DICTIONARY	rpl11	RPL11	122#127		D000014	LONGTERM|DICTIONARY	malformations	malformations	104#117		A close association was evident between RPL5 mutations and craniofacial malformations, and between hand malformations and RPL11 mutations.
19388002	2010	Am. J. Med. Genet. B Neuropsychiatr. Genet.	1552-485X	ALL_TEXT_1/3	1	3	775	SYMBOL|GENE|GN|DICTIONARY	cacna1c	CACNA1C	217#224		D003866	LONGTERM|DICTIONARY	depression	depression	73#83		Caucasian non-Hispanic participants in the STAR*D study of treatment for depression for whom DNA was available (N = 1213) were genotyped at two single-nucleotide polymorphisms (SNPs) (rs10848635 and rs1006737) in the CACNA1C gene.
8822954	1996	Blood	0006-4971	ALL_TEXT_3/3	3	10	2821	SYMBOL|DICTIONARY|EXTRACTED	gpi	GPI	40#43	8822954-1-32-59	D005955	LONGTERM|DICTIONARY	gpi deficiency	GPI deficiency	133#147		The molecular characterization of human GPI variants, therefore, may provide new insights into the genotype-phenotype correlation of GPI deficiency as well as the structure-function relationship of this enzyme.
1352745	1992	Clin. Exp. Immunol.	0009-9104	ALL_TEXT_1/3	1	1	1378	SYMBOL|DICTIONARY	c3br	C3bR	51#55		D003922	SYMBOL|NUMBER|DICTIONARY|EXTRACTED	iddm	IDDM	157#161	1352745-0-64-99	Expression of the erythrocyte complement receptor (C3bR = CR1 = CD35) and its genomic polymorphism (HindIII RFLP) was studied in a group of 80 patients with IDDM, 31 healthy siblings and 101 healthy blood donors.
1352745	1992	Clin. Exp. Immunol.	0009-9104	ALL_TEXT_1/3	1	1	1378	SYMBOL|EXTRACTED	cr1	CR1	58#61	1352745-0-7-10	D003922	SYMBOL|NUMBER|DICTIONARY|EXTRACTED	iddm	IDDM	157#161	1352745-0-64-99	Expression of the erythrocyte complement receptor (C3bR = CR1 = CD35) and its genomic polymorphism (HindIII RFLP) was studied in a group of 80 patients with IDDM, 31 healthy siblings and 101 healthy blood donors.
1352745	1992	Clin. Exp. Immunol.	0009-9104	ALL_TEXT_1/3	1	1	1378	SYMBOL|DICTIONARY	cd35	CD35	64#68		D003922	SYMBOL|NUMBER|DICTIONARY|EXTRACTED	iddm	IDDM	157#161	1352745-0-64-99	Expression of the erythrocyte complement receptor (C3bR = CR1 = CD35) and its genomic polymorphism (HindIII RFLP) was studied in a group of 80 patients with IDDM, 31 healthy siblings and 101 healthy blood donors.
16774538	2006	Tissue Antigens	0001-2815	ALL_TEXT_1/3	1	2	4312	SYMBOL|GENE|GN|DICTIONARY	mmp 1	MMP-1	57#62		D055113	LONGTERM|DICTIONARY	chronic periodontitis	chronic periodontitis	94#115		This study aimed to evaluate the association between the MMP-1 promoter gene polymorphism and chronic periodontitis susceptibility and/or severity in a Chinese population.
18043699	2009	Eur J Clin Nutr	1476-5640	ALL_TEXT_2/3	2	2	27087	LONGTERM|DICTIONARY	leu7	Leu7	84#88	NaN	D009765	LONGTERM|DICTIONARY	obesity	obesity	42#49		The current study evaluated the impact of obesity on the disease risk linked to the Leu7Pro polymorphism of preproNPY in 393 elderly subjects.
18043699	2009	Eur J Clin Nutr	1476-5640	ALL_TEXT_2/3	2	2	4852	LONGTERM|DICTIONARY	prepronpy	preproNPY	108#117	NaN	D009765	LONGTERM|DICTIONARY	obesity	obesity	42#49		The current study evaluated the impact of obesity on the disease risk linked to the Leu7Pro polymorphism of preproNPY in 393 elderly subjects.
19104460	2009	Neuroreport	1473-558X	TITLE	0	0	5444	SYMBOL|DICTIONARY	pon1	PON1	20#24		D000690	LONGTERM|DICTIONARY	amyotrophic lateral sclerosis	amyotrophic lateral sclerosis	51#80		Interaction between PON1 and population density in amyotrophic lateral sclerosis.
16774538	2006	Tissue Antigens	0001-2815	ALL_TEXT_1/3	1	1	4312	SYMBOL|GENE|GN|DICTIONARY	mmp 1	MMP-1	81#86		D009362	LONGTERM|DICTIONARY	metastasis	metastasis	191#201		A single nucleotide polymorphism in the promoter region of -1607 bp of the human MMP-1 gene has been found to be associated with an increased risk of various inflammatory diseases and cancer metastasis.
16774538	2006	Tissue Antigens	0001-2815	ALL_TEXT_3/3	3	8	4312	SYMBOL|GENE|GN|DICTIONARY	mmp 1	MMP-1	65#70		D055113	LONGTERM|DICTIONARY	chronic periodontitis	chronic periodontitis	129#150		This study suggests that a single nucleotide polymorphism in the MMP-1 promoter region of -1607 bp may be associated with severe chronic periodontitis in a Chinese population.
12140136	2003	Lung Cancer	0169-5002	ALL_TEXT_3/3	3	6	2948	SYMBOL|GENE|GN|DICTIONARY	gstm4	GSTM4	69#74		D008175	LONGTERM|DISEASE|DT|DICTIONARY	lung cancer	lung cancer	83#94		This is the first report on the implication of a polymorphism in the GSTM4 gene in lung cancer risk.
15274044	2005	Am. J. Med. Genet. B Neuropsychiatr. Genet.	1552-4841	ALL_TEXT_1/3	1	2	3062	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	ox2r	OX2R	49#53	15274044-1-13-23	D012893	LONGTERM|DICTIONARY	sleep disorders	sleep disorders	270#285		This evidence suggests that the structure of the OX2R gene, and its homologue, the OX1R gene, both members of the G protein-coupled receptor (GPCR) family, and the gene encoding the peptide ligands, the prepro-orexin/hypocretin gene, may be variables in the etiology of sleep disorders.
15274044	2005	Am. J. Med. Genet. B Neuropsychiatr. Genet.	1552-4841	ALL_TEXT_1/3	1	2	3061	SYMBOL|GENE|GN|DICTIONARY	ox1r	OX1R	83#87		D012893	LONGTERM|DICTIONARY	sleep disorders	sleep disorders	270#285		This evidence suggests that the structure of the OX2R gene, and its homologue, the OX1R gene, both members of the G protein-coupled receptor (GPCR) family, and the gene encoding the peptide ligands, the prepro-orexin/hypocretin gene, may be variables in the etiology of sleep disorders.
15274044	2005	Am. J. Med. Genet. B Neuropsychiatr. Genet.	1552-4841	ALL_TEXT_1/3	1	2	3060	LONGTERM|DICTIONARY	prepro orexin	prepro-orexin	203#216		D012893	LONGTERM|DICTIONARY	sleep disorders	sleep disorders	270#285		This evidence suggests that the structure of the OX2R gene, and its homologue, the OX1R gene, both members of the G protein-coupled receptor (GPCR) family, and the gene encoding the peptide ligands, the prepro-orexin/hypocretin gene, may be variables in the etiology of sleep disorders.
15274044	2005	Am. J. Med. Genet. B Neuropsychiatr. Genet.	1552-4841	ALL_TEXT_1/3	1	1	3062	SYMBOL|()|GENE|GN|DICTIONARY|EXTRACTED	ox2r	OX2R	27#31	15274044-1-13-23	D009290	LONGTERM|DICTIONARY	narcolepsy	narcolepsy	68#78		The orexin-2/hypocretin-2 (OX2R) receptor gene is mutated in canine narcolepsy and disruption of the prepro-orexin/hypocretin ligand gene results in both an animal model of narcolepsy and sporadic cases of the human disease.
15274044	2005	Am. J. Med. Genet. B Neuropsychiatr. Genet.	1552-4841	ALL_TEXT_1/3	1	1	3062	SYMBOL|()|GENE|GN|DICTIONARY|EXTRACTED	ox2r	OX2R	27#31	15274044-1-13-23	D009290	LONGTERM|DICTIONARY	narcolepsy	narcolepsy	173#183		The orexin-2/hypocretin-2 (OX2R) receptor gene is mutated in canine narcolepsy and disruption of the prepro-orexin/hypocretin ligand gene results in both an animal model of narcolepsy and sporadic cases of the human disease.
15274044	2005	Am. J. Med. Genet. B Neuropsychiatr. Genet.	1552-4841	ALL_TEXT_1/3	1	1	3060	LONGTERM|DICTIONARY	prepro orexin	prepro-orexin	101#114		D009290	LONGTERM|DICTIONARY	narcolepsy	narcolepsy	68#78		The orexin-2/hypocretin-2 (OX2R) receptor gene is mutated in canine narcolepsy and disruption of the prepro-orexin/hypocretin ligand gene results in both an animal model of narcolepsy and sporadic cases of the human disease.
15274044	2005	Am. J. Med. Genet. B Neuropsychiatr. Genet.	1552-4841	ALL_TEXT_1/3	1	1	3060	LONGTERM|DICTIONARY	prepro orexin	prepro-orexin	101#114		D009290	LONGTERM|DICTIONARY	narcolepsy	narcolepsy	173#183		The orexin-2/hypocretin-2 (OX2R) receptor gene is mutated in canine narcolepsy and disruption of the prepro-orexin/hypocretin ligand gene results in both an animal model of narcolepsy and sporadic cases of the human disease.
20504252	2010	Pharmacogenomics	1744-8042	RESULTS	4	8	3358	SYMBOL|DICTIONARY	htr2c	HTR2C	45#50		D015430	LONGTERM|DICTIONARY	bwg	BWG	151#154	NaN	We report a significant association of three HTR2C SNPs (rs498207, rs3813928 and rs3813929) and of the respective haplotype with antipsychotic-induced BWG.
10702401	2000	Am. J. Pathol.	0002-9440	ALL_TEXT_2/3	2	5	2130	SYMBOL|DICTIONARY	ews	EWS	38#41		D012512	SYMBOL|EXTRACTED	es	ES	17#19	10702401-1-4-19	In a group of 86 ES/PNET with defined EWS-ETS fusions (45 EWS-FLI1 type 1, 27 EWS-FLI1 non-type 1, 14 EWS-ERG), we assessed proliferation rate by immunostaining for Ki-67 using MIB1 antibody (n = 85), apoptosis by TUNEL assay (n = 66), and IGF-1R expression by immunostaining with antibody 1H7 (n = 78).
10702401	2000	Am. J. Pathol.	0002-9440	ALL_TEXT_2/3	2	5	2130	SYMBOL|DICTIONARY	ews	EWS	102#105		D012512	SYMBOL|EXTRACTED	es	ES	17#19	10702401-1-4-19	In a group of 86 ES/PNET with defined EWS-ETS fusions (45 EWS-FLI1 type 1, 27 EWS-FLI1 non-type 1, 14 EWS-ERG), we assessed proliferation rate by immunostaining for Ki-67 using MIB1 antibody (n = 85), apoptosis by TUNEL assay (n = 66), and IGF-1R expression by immunostaining with antibody 1H7 (n = 78).
10702401	2000	Am. J. Pathol.	0002-9440	ALL_TEXT_2/3	2	5	57534	SYMBOL|DICTIONARY	mib1	MIB1	177#181		D012512	SYMBOL|EXTRACTED	es	ES	17#19	10702401-1-4-19	In a group of 86 ES/PNET with defined EWS-ETS fusions (45 EWS-FLI1 type 1, 27 EWS-FLI1 non-type 1, 14 EWS-ERG), we assessed proliferation rate by immunostaining for Ki-67 using MIB1 antibody (n = 85), apoptosis by TUNEL assay (n = 66), and IGF-1R expression by immunostaining with antibody 1H7 (n = 78).
10702401	2000	Am. J. Pathol.	0002-9440	ALL_TEXT_2/3	2	5	3480	SYMBOL|EXTRACTED	igf 1r	IGF-1R	240#246	10702401-4-228-256	D012512	SYMBOL|EXTRACTED	es	ES	17#19	10702401-1-4-19	In a group of 86 ES/PNET with defined EWS-ETS fusions (45 EWS-FLI1 type 1, 27 EWS-FLI1 non-type 1, 14 EWS-ERG), we assessed proliferation rate by immunostaining for Ki-67 using MIB1 antibody (n = 85), apoptosis by TUNEL assay (n = 66), and IGF-1R expression by immunostaining with antibody 1H7 (n = 78).
10702401	2000	Am. J. Pathol.	0002-9440	ALL_TEXT_2/3	2	5	2130	SYMBOL|GFAM|FN|DICTIONARY	ews	EWS	58#61		D012512	SYMBOL|EXTRACTED	es	ES	17#19	10702401-1-4-19	In a group of 86 ES/PNET with defined EWS-ETS fusions (45 EWS-FLI1 type 1, 27 EWS-FLI1 non-type 1, 14 EWS-ERG), we assessed proliferation rate by immunostaining for Ki-67 using MIB1 antibody (n = 85), apoptosis by TUNEL assay (n = 66), and IGF-1R expression by immunostaining with antibody 1H7 (n = 78).
10702401	2000	Am. J. Pathol.	0002-9440	ALL_TEXT_2/3	2	5	2313	SYMBOL|GFAM|FN|DICTIONARY	fli1	FLI1	62#66		D012512	SYMBOL|EXTRACTED	es	ES	17#19	10702401-1-4-19	In a group of 86 ES/PNET with defined EWS-ETS fusions (45 EWS-FLI1 type 1, 27 EWS-FLI1 non-type 1, 14 EWS-ERG), we assessed proliferation rate by immunostaining for Ki-67 using MIB1 antibody (n = 85), apoptosis by TUNEL assay (n = 66), and IGF-1R expression by immunostaining with antibody 1H7 (n = 78).
10702401	2000	Am. J. Pathol.	0002-9440	ALL_TEXT_2/3	2	5	2130	SYMBOL|DICTIONARY	ews	EWS	78#81		D012512	SYMBOL|EXTRACTED	es	ES	17#19	10702401-1-4-19	In a group of 86 ES/PNET with defined EWS-ETS fusions (45 EWS-FLI1 type 1, 27 EWS-FLI1 non-type 1, 14 EWS-ERG), we assessed proliferation rate by immunostaining for Ki-67 using MIB1 antibody (n = 85), apoptosis by TUNEL assay (n = 66), and IGF-1R expression by immunostaining with antibody 1H7 (n = 78).
10702401	2000	Am. J. Pathol.	0002-9440	ALL_TEXT_2/3	2	5	2313	SYMBOL|DICTIONARY	fli1	FLI1	82#86		D012512	SYMBOL|EXTRACTED	es	ES	17#19	10702401-1-4-19	In a group of 86 ES/PNET with defined EWS-ETS fusions (45 EWS-FLI1 type 1, 27 EWS-FLI1 non-type 1, 14 EWS-ERG), we assessed proliferation rate by immunostaining for Ki-67 using MIB1 antibody (n = 85), apoptosis by TUNEL assay (n = 66), and IGF-1R expression by immunostaining with antibody 1H7 (n = 78).
12827651	2003	Am. J. Hematol.	0361-8609	TITLE	0	0	4524	SYMBOL|DICTIONARY	mthfr	MTHFR	20#25		D015470	LONGTERM|DICTIONARY	acute leukemia	acute leukemia	82#96		Characterization of MTHFR, GSTM1, GSTT1, GSTP1, and CYP1A1 genotypes in childhood acute leukemia.
12827651	2003	Am. J. Hematol.	0361-8609	TITLE	0	0	2944	SYMBOL|DICTIONARY	gstm1	GSTM1	27#32		D015470	LONGTERM|DICTIONARY	acute leukemia	acute leukemia	82#96		Characterization of MTHFR, GSTM1, GSTT1, GSTP1, and CYP1A1 genotypes in childhood acute leukemia.
12827651	2003	Am. J. Hematol.	0361-8609	TITLE	0	0	2952	SYMBOL|DICTIONARY	gstt1	GSTT1	34#39		D015470	LONGTERM|DICTIONARY	acute leukemia	acute leukemia	82#96		Characterization of MTHFR, GSTM1, GSTT1, GSTP1, and CYP1A1 genotypes in childhood acute leukemia.
12827651	2003	Am. J. Hematol.	0361-8609	TITLE	0	0	2950	SYMBOL|DICTIONARY	gstp1	GSTP1	41#46		D015470	LONGTERM|DICTIONARY	acute leukemia	acute leukemia	82#96		Characterization of MTHFR, GSTM1, GSTT1, GSTP1, and CYP1A1 genotypes in childhood acute leukemia.
12827651	2003	Am. J. Hematol.	0361-8609	TITLE	0	0	1543	SYMBOL|DICTIONARY	cyp1a1	CYP1A1	52#58		D015470	LONGTERM|DICTIONARY	acute leukemia	acute leukemia	82#96		Characterization of MTHFR, GSTM1, GSTT1, GSTP1, and CYP1A1 genotypes in childhood acute leukemia.
20064547	2010	Mech. Ageing Dev.	1872-6216	ALL_TEXT_3/3	3	7	4780	SYMBOL|DICTIONARY	nfe2l2	NFE2L2	33#39		D000544	SYMBOL|EXTRACTED	ad	AD	83#85	20064547-1-0-19	However, one haplotype allele of NFE2L2 was associated with 2 years earlier age at AD onset (p(c)=0.013) and 4 years earlier age at surgery for posterior subcapsular cataract (p(c)=0.019).
20064547	2010	Mech. Ageing Dev.	1872-6216	ALL_TEXT_3/3	3	7	4780	SYMBOL|DICTIONARY	nfe2l2	NFE2L2	33#39		D002386	LONGTERM|DICTIONARY	cataract	cataract	166#174		However, one haplotype allele of NFE2L2 was associated with 2 years earlier age at AD onset (p(c)=0.013) and 4 years earlier age at surgery for posterior subcapsular cataract (p(c)=0.019).
20064547	2010	Mech. Ageing Dev.	1872-6216	ALL_TEXT_2/3	2	6	4780	SYMBOL|DICTIONARY	nfe2l2	NFE2L2	0#6		D000544	SYMBOL|EXTRACTED	ad	AD	50#52	20064547-1-0-19	NFE2L2 and KEAP1 were not associated with risk of AD or cataract.
20064547	2010	Mech. Ageing Dev.	1872-6216	ALL_TEXT_2/3	2	6	4780	SYMBOL|DICTIONARY	nfe2l2	NFE2L2	0#6		D002386	LONGTERM|DICTIONARY	cataract	cataract	56#64		NFE2L2 and KEAP1 were not associated with risk of AD or cataract.
20064547	2010	Mech. Ageing Dev.	1872-6216	ALL_TEXT_2/3	2	6	9817	SYMBOL|DICTIONARY	keap1	KEAP1	11#16		D000544	SYMBOL|EXTRACTED	ad	AD	50#52	20064547-1-0-19	NFE2L2 and KEAP1 were not associated with risk of AD or cataract.
20064547	2010	Mech. Ageing Dev.	1872-6216	ALL_TEXT_2/3	2	6	9817	SYMBOL|DICTIONARY	keap1	KEAP1	11#16		D002386	LONGTERM|DICTIONARY	cataract	cataract	56#64		NFE2L2 and KEAP1 were not associated with risk of AD or cataract.
17067442	2007	Clin. Exp. Rheumatol.	0392-856X	RESULTS	3	7	4210	SYMBOL|DICTIONARY	mefv	MEFV	270#274		D018771	LONGTERM|DICTIONARY	arthralgia	arthralgia	58#68		The presence of febrile episodes more than four per year, arthralgia, past diagnosis for acute rheumatic fever, rheumatoid arthritis and prophylaxis of penicillin, acute rheumatic fever, and rheumatoid arthritis were significantly higher in asymptomatic parents for the MEFV mutations compared to controls.
17067442	2007	Clin. Exp. Rheumatol.	0392-856X	RESULTS	3	7	4210	SYMBOL|DICTIONARY	mefv	MEFV	270#274		D012213	LONGTERM|DICTIONARY	acute rheumatic fever	acute rheumatic fever	89#110		The presence of febrile episodes more than four per year, arthralgia, past diagnosis for acute rheumatic fever, rheumatoid arthritis and prophylaxis of penicillin, acute rheumatic fever, and rheumatoid arthritis were significantly higher in asymptomatic parents for the MEFV mutations compared to controls.
17067442	2007	Clin. Exp. Rheumatol.	0392-856X	RESULTS	3	7	4210	SYMBOL|DICTIONARY	mefv	MEFV	270#274		D001172	LONGTERM|DICTIONARY	rheumatoid arthritis	rheumatoid arthritis	112#132		The presence of febrile episodes more than four per year, arthralgia, past diagnosis for acute rheumatic fever, rheumatoid arthritis and prophylaxis of penicillin, acute rheumatic fever, and rheumatoid arthritis were significantly higher in asymptomatic parents for the MEFV mutations compared to controls.
17067442	2007	Clin. Exp. Rheumatol.	0392-856X	RESULTS	3	7	4210	SYMBOL|DICTIONARY	mefv	MEFV	270#274		D012213	LONGTERM|DICTIONARY	acute rheumatic fever	acute rheumatic fever	164#185		The presence of febrile episodes more than four per year, arthralgia, past diagnosis for acute rheumatic fever, rheumatoid arthritis and prophylaxis of penicillin, acute rheumatic fever, and rheumatoid arthritis were significantly higher in asymptomatic parents for the MEFV mutations compared to controls.
17067442	2007	Clin. Exp. Rheumatol.	0392-856X	RESULTS	3	7	4210	SYMBOL|DICTIONARY	mefv	MEFV	270#274		D001172	LONGTERM|DICTIONARY	rheumatoid arthritis	rheumatoid arthritis	191#211		The presence of febrile episodes more than four per year, arthralgia, past diagnosis for acute rheumatic fever, rheumatoid arthritis and prophylaxis of penicillin, acute rheumatic fever, and rheumatoid arthritis were significantly higher in asymptomatic parents for the MEFV mutations compared to controls.
19228880	2009	FASEB J.	1530-6860	ALL_TEXT_3/3	3	10	2944	SYMBOL|DICTIONARY|EXTRACTED	gstm1	GSTM1	46#51	19228880-1-113-141	D001943	LONGTERM|DISEASE|DT|DICTIONARY	breast cancer	breast cancer	76#89		We recommend that a more complicated role for GSTM1 should be considered in breast cancer risk prediction.
12932609	2003	J. Am. Coll. Cardiol.	0735-1097	CONCLUSIONS	5	13	136319	LONGTERM|DICTIONARY	myotrophin	myotrophin	45#55	NaN	D006333	SYMBOL|EXTRACTED	hf	HF	66#68	12932609-1-73-86	There is evidence of early activation of the myotrophin system in HF, which is more evident in males.
12034804	2002	Neurology	0028-3878	TITLE	0	0	3552	LONGTERM|DICTIONARY	interleukin-1	interleukin-1	4#17	NaN	D000544	LONGTERM|DICTIONARY	ad	AD	74#76	NaN	Are interleukin-1 gene polymorphisms risk factors or disease modifiers in AD?
11712802	2001	Anticancer Res.	0250-7005	ALL_TEXT_2/3	2	9	1440	SYMBOL|DICTIONARY	g csf	G-CSF	83#88		D009503	LONGTERM|DICTIONARY	febrile neutropenia	febrile neutropenia	26#45		Five patients experienced febrile neutropenia, which was successfully treated with G-CSF and broad-spectrum antibiotics.
14521605	2004	J. Thromb. Haemost.	1538-7933	BACKGROUND	1	2	2811	LONGTERM|DICTIONARY	gpibalpha	GPIbalpha	128#137	NaN	C536458	LONGTERM|DISEASE|DT|DICTIONARY	platelet type von willebrand disease	Platelet-type von Willebrand disease	0#36		Platelet-type von Willebrand disease (plt-VWD) is a congenital bleeding disorder characterized by gain-of-function mutations of GPIbalpha.
14521605	2004	J. Thromb. Haemost.	1538-7933	BACKGROUND	1	2	2811	LONGTERM|DICTIONARY	gpibalpha	GPIbalpha	128#137	NaN	C536458	SYMBOL|EXTRACTED|()	plt vwd	plt-VWD	38#45	14521605-2-0-36	Platelet-type von Willebrand disease (plt-VWD) is a congenital bleeding disorder characterized by gain-of-function mutations of GPIbalpha.
14521605	2004	J. Thromb. Haemost.	1538-7933	BACKGROUND	1	2	2811	LONGTERM|DICTIONARY	gpibalpha	GPIbalpha	128#137	NaN	D025861	LONGTERM|DISEASE|DT|DICTIONARY	congenital bleeding disorder	congenital bleeding disorder	52#80		Platelet-type von Willebrand disease (plt-VWD) is a congenital bleeding disorder characterized by gain-of-function mutations of GPIbalpha.
21565994	2012	Biol. Reprod.	1529-7268	ALL_TEXT_1/3	1	1	3948	LONGTERM|GENE|GN|DICTIONARY	lactate dehydrogenase c	lactate dehydrogenase C	69#92		D007248	LONGTERM|DICTIONARY	male infertility	male infertility	112#128		We demonstrated previously that disruption of the germ cell-specific lactate dehydrogenase C gene (Ldhc) led to male infertility due to defects in sperm function, including a rapid decline in sperm ATP levels, a decrease in progressive motility, and a failure to develop hyperactivated motility.
10433910	1999	Development	0950-1991	ALL_TEXT_1/3	1	3	145258	LONGTERM|DICTIONARY	gsc	Gsc	19#22	NaN	D016537	LONGTERM|DICTIONARY	beta-galactosidase	beta-galactosidase	51#69	NaN	In these chimeras, Gsc-null cells were marked with beta-galactosidase (beta-gal) activity using the ROSA26 lacZ allele.
10433910	1999	Development	0950-1991	ALL_TEXT_1/3	1	3	145258	LONGTERM|DICTIONARY	gsc	Gsc	19#22	NaN	D016537	LONGTERM|DICTIONARY	beta-gal	beta-gal	71#79	NaN	In these chimeras, Gsc-null cells were marked with beta-galactosidase (beta-gal) activity using the ROSA26 lacZ allele.
10433910	1999	Development	0950-1991	ALL_TEXT_1/3	1	3	14910	LONGTERM|DICTIONARY	rosa26	ROSA26	100#106	NaN	D016537	LONGTERM|DICTIONARY	beta-galactosidase	beta-galactosidase	51#69	NaN	In these chimeras, Gsc-null cells were marked with beta-galactosidase (beta-gal) activity using the ROSA26 lacZ allele.
10433910	1999	Development	0950-1991	ALL_TEXT_1/3	1	3	14910	LONGTERM|DICTIONARY	rosa26	ROSA26	100#106	NaN	D016537	LONGTERM|DICTIONARY	beta-gal	beta-gal	71#79	NaN	In these chimeras, Gsc-null cells were marked with beta-galactosidase (beta-gal) activity using the ROSA26 lacZ allele.
10433910	1999	Development	0950-1991	ALL_TEXT_1/3	1	1	145258	LONGTERM|DICTIONARY	goosecoid	Goosecoid	61#70	NaN	D019465	LONGTERM|DICTIONARY	craniofacial defects	craniofacial defects	91#111	NaN	Mice homozygous for a targeted deletion of the homeobox gene Goosecoid (Gsc) have multiple craniofacial defects.
10433910	1999	Development	0950-1991	ALL_TEXT_1/3	1	1	145258	LONGTERM|DICTIONARY	gsc	Gsc	72#75	NaN	D019465	LONGTERM|DICTIONARY	craniofacial defects	craniofacial defects	91#111	NaN	Mice homozygous for a targeted deletion of the homeobox gene Goosecoid (Gsc) have multiple craniofacial defects.
12827651	2003	Am. J. Hematol.	0361-8609	ALL_TEXT_2/3	2	5	2952	SYMBOL|DICTIONARY	gstt1	GSTT1	9#14		D054198	SYMBOL|EXTRACTED|DISEASE|DN	all	ALL	58#61	12827651-2-26-54	Although GSTT1 null genotype was insignificantly lower in ALL patients (20.9%) than controls (22.7%), it was significantly underrepresented in ANLL patients (6.5%) (P = 0.05, OR 0.24, 95% CI 0.05-1.03).
12827651	2003	Am. J. Hematol.	0361-8609	ALL_TEXT_2/3	2	5	2952	SYMBOL|DICTIONARY	gstt1	GSTT1	9#14		D015470	SYMBOL|DISEASE|DN|DICTIONARY|EXTRACTED	anll	ANLL	143#147	12827651-2-73-104	Although GSTT1 null genotype was insignificantly lower in ALL patients (20.9%) than controls (22.7%), it was significantly underrepresented in ANLL patients (6.5%) (P = 0.05, OR 0.24, 95% CI 0.05-1.03).
15472214	2004	J. Clin. Endocrinol. Metab.	0021-972X	ALL_TEXT_3/3	3	10	9370	LONGTERM|DICTIONARY	adiponectin	adiponectin	36#47	NaN	D011085	SYMBOL|DICTIONARY|EXTRACTED	pcos	PCOS	115#119	15472214-1-0-25	No significant differences in serum adiponectin concentrations were observed between and within genotype groups in PCOS and control women.
1363805	1993	Hum. Mutat.	1059-7794	ALL_TEXT_1/3	1	1	34	LONGTERM|DICTIONARY	medium chain acyl-coa dehydrogenase	Medium chain acyl-CoA dehydrogenase	0#35	NaN	C536038	LONGTERM|DICTIONARY	medium chain acyl-coa dehydrogenase	Medium chain acyl-CoA dehydrogenase	0#35	NaN	Medium chain acyl-CoA dehydrogenase (MCAD) catalyzes the first reaction of the beta-oxidation cycle for 4-10-carbon fatty acids.
19021638	2009	Clin. Genet.	1399-0004	ALL_TEXT_1/3	1	3	55636	SYMBOL|DICTIONARY	chd7	CHD7	25#29		D017436	SYMBOL|EXTRACTED	ks	KS	50#52	19021638-1-0-17	We performed analysis of CHD7 in 36 patients with KS and 20 patients with normosmic idiopathic hypogonadotropic hypogonadism (nIHH) in whom mutations in KAL1, FGFR1, PROK2 and PROKR2 genes were excluded.
19021638	2009	Clin. Genet.	1399-0004	ALL_TEXT_1/3	1	3	55636	SYMBOL|DICTIONARY	chd7	CHD7	25#29		D007006	LONGTERM|DICTIONARY	hypogonadotropic hypogonadism	hypogonadotropic hypogonadism	95#124		We performed analysis of CHD7 in 36 patients with KS and 20 patients with normosmic idiopathic hypogonadotropic hypogonadism (nIHH) in whom mutations in KAL1, FGFR1, PROK2 and PROKR2 genes were excluded.
19021638	2009	Clin. Genet.	1399-0004	ALL_TEXT_1/3	1	3	3730	SYMBOL|DICTIONARY	kal1	KAL1	153#157		D017436	SYMBOL|EXTRACTED	ks	KS	50#52	19021638-1-0-17	We performed analysis of CHD7 in 36 patients with KS and 20 patients with normosmic idiopathic hypogonadotropic hypogonadism (nIHH) in whom mutations in KAL1, FGFR1, PROK2 and PROKR2 genes were excluded.
19021638	2009	Clin. Genet.	1399-0004	ALL_TEXT_1/3	1	3	3730	SYMBOL|DICTIONARY	kal1	KAL1	153#157		D007006	LONGTERM|DICTIONARY	hypogonadotropic hypogonadism	hypogonadotropic hypogonadism	95#124		We performed analysis of CHD7 in 36 patients with KS and 20 patients with normosmic idiopathic hypogonadotropic hypogonadism (nIHH) in whom mutations in KAL1, FGFR1, PROK2 and PROKR2 genes were excluded.
19021638	2009	Clin. Genet.	1399-0004	ALL_TEXT_1/3	1	3	2260	SYMBOL|DICTIONARY	fgfr1	FGFR1	159#164		D017436	SYMBOL|EXTRACTED	ks	KS	50#52	19021638-1-0-17	We performed analysis of CHD7 in 36 patients with KS and 20 patients with normosmic idiopathic hypogonadotropic hypogonadism (nIHH) in whom mutations in KAL1, FGFR1, PROK2 and PROKR2 genes were excluded.
19021638	2009	Clin. Genet.	1399-0004	ALL_TEXT_1/3	1	3	2260	SYMBOL|DICTIONARY	fgfr1	FGFR1	159#164		D007006	LONGTERM|DICTIONARY	hypogonadotropic hypogonadism	hypogonadotropic hypogonadism	95#124		We performed analysis of CHD7 in 36 patients with KS and 20 patients with normosmic idiopathic hypogonadotropic hypogonadism (nIHH) in whom mutations in KAL1, FGFR1, PROK2 and PROKR2 genes were excluded.
19021638	2009	Clin. Genet.	1399-0004	ALL_TEXT_1/3	1	3	60675	SYMBOL|DICTIONARY	prok2	PROK2	166#171		D017436	SYMBOL|EXTRACTED	ks	KS	50#52	19021638-1-0-17	We performed analysis of CHD7 in 36 patients with KS and 20 patients with normosmic idiopathic hypogonadotropic hypogonadism (nIHH) in whom mutations in KAL1, FGFR1, PROK2 and PROKR2 genes were excluded.
19021638	2009	Clin. Genet.	1399-0004	ALL_TEXT_1/3	1	3	60675	SYMBOL|DICTIONARY	prok2	PROK2	166#171		D007006	LONGTERM|DICTIONARY	hypogonadotropic hypogonadism	hypogonadotropic hypogonadism	95#124		We performed analysis of CHD7 in 36 patients with KS and 20 patients with normosmic idiopathic hypogonadotropic hypogonadism (nIHH) in whom mutations in KAL1, FGFR1, PROK2 and PROKR2 genes were excluded.
19021638	2009	Clin. Genet.	1399-0004	ALL_TEXT_1/3	1	3	128674	SYMBOL|GENE|GN|DICTIONARY	prokr2	PROKR2	176#182		D017436	SYMBOL|EXTRACTED	ks	KS	50#52	19021638-1-0-17	We performed analysis of CHD7 in 36 patients with KS and 20 patients with normosmic idiopathic hypogonadotropic hypogonadism (nIHH) in whom mutations in KAL1, FGFR1, PROK2 and PROKR2 genes were excluded.
19021638	2009	Clin. Genet.	1399-0004	ALL_TEXT_1/3	1	3	128674	SYMBOL|GENE|GN|DICTIONARY	prokr2	PROKR2	176#182		D007006	LONGTERM|DICTIONARY	hypogonadotropic hypogonadism	hypogonadotropic hypogonadism	95#124		We performed analysis of CHD7 in 36 patients with KS and 20 patients with normosmic idiopathic hypogonadotropic hypogonadism (nIHH) in whom mutations in KAL1, FGFR1, PROK2 and PROKR2 genes were excluded.
20628598	2010	PLoS ONE	1932-6203	METHODOLOGY/PRINCIPAL FINDINGS	2	5	2645	SYMBOL|DICTIONARY|EXTRACTED	gck	GCK	77#80	20628598-1-140-151	D018149	LONGTERM|DICTIONARY	fpg	FPG	56#59	NaN	In addition to our previous report for association with FPG, the A-allele of GCK rs1799884 was also associated with reduced homeostasis model assessment of beta-cell function (HOMA-B) (P=0.0015).
19191329	2009	Hum. Mutat.	1098-1004	ALL_TEXT_1/3	1	4	6261	SYMBOL|DICTIONARY	ryr1	RYR1	35#39		D008305	SYMBOL|EXTRACTED	mh	MH	54#56	19191329-1-0-22	Molecular genetic testing based on RYR1 mutations for MH diagnosis is challenging, because the causative mutations, most of which are private, are distributed throughout the RYR1 gene.
19191329	2009	Hum. Mutat.	1098-1004	ALL_TEXT_1/3	1	4	6261	SYMBOL|GENE|GN|DICTIONARY	ryr1	RYR1	174#178		D008305	SYMBOL|EXTRACTED	mh	MH	54#56	19191329-1-0-22	Molecular genetic testing based on RYR1 mutations for MH diagnosis is challenging, because the causative mutations, most of which are private, are distributed throughout the RYR1 gene.
20857490	2011	Int. J. Cancer	1097-0215	ALL_TEXT_3/3	3	11	9149	SYMBOL|GENE|GN|DICTIONARY	mirk	Mirk	83#87		D010051	LONGTERM|DICTIONARY	ovarian cancers	ovarian cancers	106#121		Because Mirk is expressed at low levels in most normal adult tissues, the elevated Mirk protein levels in ovarian cancers may present a novel therapeutic target, in particular for quiescent tumor cells which are difficult to eradicate by conventional therapies targeting dividing cells.
20857490	2011	Int. J. Cancer	1097-0215	ALL_TEXT_3/3	3	11	9149	SYMBOL|GENE|GN|DICTIONARY	mirk	Mirk	83#87		D009369	LONGTERM|DISEASE|DT|CLINE|CN|DICTIONARY	tumor	tumor	190#195		Because Mirk is expressed at low levels in most normal adult tissues, the elevated Mirk protein levels in ovarian cancers may present a novel therapeutic target, in particular for quiescent tumor cells which are difficult to eradicate by conventional therapies targeting dividing cells.
19191329	2009	Hum. Mutat.	1098-1004	ALL_TEXT_1/3	1	2	6261	SYMBOL|()|GENE|GN|DICTIONARY	ryr1	RYR1	60#64		D008305	SYMBOL|EXTRACTED	mh	MH	189#191	19191329-1-0-22	Today, genetic investigations on ryanodine receptor type 1 (RYR1) gene and alpha1 subunit of the dihydropyridine receptor (DHPR) (CACNA1S) gene have improved the procedures associated with MH diagnosis.
19191329	2009	Hum. Mutat.	1098-1004	ALL_TEXT_1/3	1	2	779	SYMBOL|()|GENE|GN|DICTIONARY	cacna1s	CACNA1S	130#137		D008305	SYMBOL|EXTRACTED	mh	MH	189#191	19191329-1-0-22	Today, genetic investigations on ryanodine receptor type 1 (RYR1) gene and alpha1 subunit of the dihydropyridine receptor (DHPR) (CACNA1S) gene have improved the procedures associated with MH diagnosis.
19191329	2009	Hum. Mutat.	1098-1004	ALL_TEXT_1/3	1	3	6261	SYMBOL|DICTIONARY	ryr1	RYR1	45#49		D008305	SYMBOL|EXTRACTED	mh	MH	24#26	19191329-1-0-22	In approximately 50% of MH cases a causative RYR1 mutation was found.
20100586	2011	Biol. Blood Marrow Transplant.	1523-6536	ALL_TEXT_1/3	1	2	7124	SYMBOL|GENE|GN|DICTIONARY	tnf alpha	TNF-alpha	0#9		D006086	SYMBOL|EXTRACTED	agvhd	aGVHD	91#96	20100586-1-117-148	TNF-alpha gene polymorphisms are associated with rejection after organ transplantation and aGVHD in matched related donor blood and marrow transplantation (BMT) recipients.
16181776	2006	Prostaglandins Leukot. Essent. Fatty Acids	0952-3278	TITLE	0	0	7122	SYMBOL|DICTIONARY	cldn5	CLDN5	38#43		D012559	LONGTERM|DICTIONARY	schizophrenia	schizophrenia	107#120		A study of the combined effect of the CLDN5 locus and the genes for the phospholipid metabolism pathway in schizophrenia.
12843182	2003	J. Clin. Endocrinol. Metab.	0021-972X	TITLE	0	0	7040	LONGTERM|DICTIONARY	latency associated peptide	latency-associated peptide	25#51		D003966	LONGTERM|DISEASE|DT|DICTIONARY	camurati engelmann disease	Camurati-Engelmann disease	67#93		A mutation affecting the latency-associated peptide of TGFbeta1 in Camurati-Engelmann disease enhances osteoclast formation in vitro.
19191329	2009	Hum. Mutat.	1098-1004	ALL_TEXT_2/3	2	8	6261	SYMBOL|DICTIONARY	ryr1	RYR1	70#74		D008305	SYMBOL|DISEASE|DN|DICTIONARY	mhs	MHS	17#20		The 13 remaining MHS patients presented no known variants, neither in RYR1 nor in the CACNA1S binding regions to RYR1.
19191329	2009	Hum. Mutat.	1098-1004	ALL_TEXT_2/3	2	8	779	SYMBOL|DICTIONARY	cacna1s	CACNA1S	86#93		D008305	SYMBOL|DISEASE|DN|DICTIONARY	mhs	MHS	17#20		The 13 remaining MHS patients presented no known variants, neither in RYR1 nor in the CACNA1S binding regions to RYR1.
19191329	2009	Hum. Mutat.	1098-1004	ALL_TEXT_2/3	2	8	6261	SYMBOL|DICTIONARY	ryr1	RYR1	113#117		D008305	SYMBOL|DISEASE|DN|DICTIONARY	mhs	MHS	17#20		The 13 remaining MHS patients presented no known variants, neither in RYR1 nor in the CACNA1S binding regions to RYR1.
16585476	2006	Arch. Gen. Psychiatry	0003-990X	OBJECTIVE	2	3	1815	SYMBOL|DICTIONARY	drd4	DRD4	32#36		D001289	LONGTERM|DICTIONARY	attention deficit hyperactivity disorder	attention-deficit/hyperactivity disorder	144#184		To test the hypothesis that the DRD4 seven-repeat allele and DAT1 ten-repeat allele would prove useful in identifying a subset of children with attention-deficit/hyperactivity disorder (ADHD) who have compromised intellectual functions.
16585476	2006	Arch. Gen. Psychiatry	0003-990X	OBJECTIVE	2	3	1815	SYMBOL|DICTIONARY	drd4	DRD4	32#36		D001289	SYMBOL|()|DICTIONARY|EXTRACTED	adhd	ADHD	186#190	16585476-3-144-184	To test the hypothesis that the DRD4 seven-repeat allele and DAT1 ten-repeat allele would prove useful in identifying a subset of children with attention-deficit/hyperactivity disorder (ADHD) who have compromised intellectual functions.
16585476	2006	Arch. Gen. Psychiatry	0003-990X	OBJECTIVE	2	3	6531	SYMBOL|DICTIONARY	dat1	DAT1	61#65		D001289	LONGTERM|DICTIONARY	attention deficit hyperactivity disorder	attention-deficit/hyperactivity disorder	144#184		To test the hypothesis that the DRD4 seven-repeat allele and DAT1 ten-repeat allele would prove useful in identifying a subset of children with attention-deficit/hyperactivity disorder (ADHD) who have compromised intellectual functions.
16585476	2006	Arch. Gen. Psychiatry	0003-990X	OBJECTIVE	2	3	6531	SYMBOL|DICTIONARY	dat1	DAT1	61#65		D001289	SYMBOL|()|DICTIONARY|EXTRACTED	adhd	ADHD	186#190	16585476-3-144-184	To test the hypothesis that the DRD4 seven-repeat allele and DAT1 ten-repeat allele would prove useful in identifying a subset of children with attention-deficit/hyperactivity disorder (ADHD) who have compromised intellectual functions.
15886814	2005	Thromb. Haemost.	0340-6245	ALL_TEXT_1/3	1	2	1524	LONGTERM|DICTIONARY	cx3cr1	CX3CR1	23#29	NaN	D002318	LONGTERM|DISEASE|DT|DICTIONARY	cardiovascular disease	cardiovascular disease	123#145		The M280 allele of the CX3CR1T280M polymorphism modulates leukocyte recruitment and is associated with lower prevalence of cardiovascular disease.
16585476	2006	Arch. Gen. Psychiatry	0003-990X	RESULTS	7	8	1815	SYMBOL|DICTIONARY	drd4	DRD4	57#61		D001289	SYMBOL|DICTIONARY|EXTRACTED	adhd	ADHD	171#175	16585476-3-144-184	We present replicated evidence that polymorphisms in the DRD4 and DAT1 genes were associated with variation in intellectual functioning among children diagnosed as having ADHD, apart from severity of their symptoms.
16585476	2006	Arch. Gen. Psychiatry	0003-990X	RESULTS	7	8	6531	SYMBOL|GENE|GN|DICTIONARY	dat1	DAT1	66#70		D001289	SYMBOL|DICTIONARY|EXTRACTED	adhd	ADHD	171#175	16585476-3-144-184	We present replicated evidence that polymorphisms in the DRD4 and DAT1 genes were associated with variation in intellectual functioning among children diagnosed as having ADHD, apart from severity of their symptoms.
20628598	2010	PLoS ONE	1932-6203	METHODOLOGY/PRINCIPAL FINDINGS	2	4	4544	SYMBOL|DICTIONARY|EXTRACTED	mtnr1b	MTNR1B	16#22	20628598-1-28-49	D018149	LONGTERM|DICTIONARY	fpg	FPG	118#121	NaN	The G-allele of MTNR1B rs10830963 and the C-alleles of both G6PC2 rs16856187 and rs478333 were associated with higher FPG (0.0034<P<6.6x10(-5)) in healthy controls.
20628598	2010	PLoS ONE	1932-6203	METHODOLOGY/PRINCIPAL FINDINGS	2	4	57818	SYMBOL|DICTIONARY|EXTRACTED	g6pc2	G6PC2	60#65	20628598-1-60-130	D018149	LONGTERM|DICTIONARY	fpg	FPG	118#121	NaN	The G-allele of MTNR1B rs10830963 and the C-alleles of both G6PC2 rs16856187 and rs478333 were associated with higher FPG (0.0034<P<6.6x10(-5)) in healthy controls.
23440206	2013	Proc. Natl. Acad. Sci. U.S.A.	1091-6490	TITLE	0	0	2475	LONGTERM|DICTIONARY	mammalian target of rapamycin	mammalian target of rapamycin	40#69		D015473	SYMBOL|DICTIONARY|EXTRACTED	pml	PML	0#3		PML mediates glioblastoma resistance to mammalian target of rapamycin (mTOR)-targeted therapies.
23440206	2013	Proc. Natl. Acad. Sci. U.S.A.	1091-6490	TITLE	0	0	2475	LONGTERM|DICTIONARY	mammalian target of rapamycin	mammalian target of rapamycin	40#69		D005909	LONGTERM|DICTIONARY	glioblastoma	glioblastoma	13#25		PML mediates glioblastoma resistance to mammalian target of rapamycin (mTOR)-targeted therapies.
23440206	2013	Proc. Natl. Acad. Sci. U.S.A.	1091-6490	TITLE	0	0	21977	SYMBOL|EXTRACTED|()	mtor	mTOR	71#75	23440206-0-40-69	D015473	SYMBOL|DICTIONARY|EXTRACTED	pml	PML	0#3		PML mediates glioblastoma resistance to mammalian target of rapamycin (mTOR)-targeted therapies.
23440206	2013	Proc. Natl. Acad. Sci. U.S.A.	1091-6490	TITLE	0	0	21977	SYMBOL|EXTRACTED|()	mtor	mTOR	71#75	23440206-0-40-69	D005909	LONGTERM|DICTIONARY	glioblastoma	glioblastoma	13#25		PML mediates glioblastoma resistance to mammalian target of rapamycin (mTOR)-targeted therapies.
23440206	2013	Proc. Natl. Acad. Sci. U.S.A.	1091-6490	ALL_TEXT_1/3	1	1	21977	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	mtor	mTOR	142#146	23440206-0-40-69	D005909	LONGTERM|DICTIONARY	glioblastomas	glioblastomas	93#106		Despite their nearly universal activation of mammalian target of rapamycin (mTOR) signaling, glioblastomas (GBMs) are strikingly resistant to mTOR-targeted therapy.
23440206	2013	Proc. Natl. Acad. Sci. U.S.A.	1091-6490	ALL_TEXT_1/3	1	1	21977	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	mtor	mTOR	142#146	23440206-0-40-69	D005909	SYMBOL|PLURAL|()|DICTIONARY|EXTRACTED	gbms	GBMs	108#112	23440206-1-93-106	Despite their nearly universal activation of mammalian target of rapamycin (mTOR) signaling, glioblastomas (GBMs) are strikingly resistant to mTOR-targeted therapy.
23440206	2013	Proc. Natl. Acad. Sci. U.S.A.	1091-6490	ALL_TEXT_3/3	3	3	21977	SYMBOL|EXTRACTED	mtor	mTOR	7#11	23440206-0-40-69	D015473	SYMBOL|DICTIONARY|EXTRACTED	pml	PML	111#114	23440206-2-146-168	Direct mTOR inhibitors and EGF receptor (EGFR) inhibitors that block downstream mTOR signaling promote nuclear PML expression in GBMs, and genetic overexpression and knockdown approaches demonstrate that PML prevents mTOR and EGFR inhibitor-dependent cell death.
23440206	2013	Proc. Natl. Acad. Sci. U.S.A.	1091-6490	ALL_TEXT_3/3	3	3	21977	SYMBOL|EXTRACTED	mtor	mTOR	7#11	23440206-0-40-69	D015473	SYMBOL|DICTIONARY|EXTRACTED	pml	PML	204#207	23440206-2-146-168	Direct mTOR inhibitors and EGF receptor (EGFR) inhibitors that block downstream mTOR signaling promote nuclear PML expression in GBMs, and genetic overexpression and knockdown approaches demonstrate that PML prevents mTOR and EGFR inhibitor-dependent cell death.
23440206	2013	Proc. Natl. Acad. Sci. U.S.A.	1091-6490	ALL_TEXT_3/3	3	3	21977	SYMBOL|EXTRACTED	mtor	mTOR	7#11	23440206-0-40-69	D005909	SYMBOL|PLURAL|DICTIONARY|EXTRACTED	gbms	GBMs	129#133	23440206-1-93-106	Direct mTOR inhibitors and EGF receptor (EGFR) inhibitors that block downstream mTOR signaling promote nuclear PML expression in GBMs, and genetic overexpression and knockdown approaches demonstrate that PML prevents mTOR and EGFR inhibitor-dependent cell death.
23440206	2013	Proc. Natl. Acad. Sci. U.S.A.	1091-6490	ALL_TEXT_3/3	3	3	21977	SYMBOL|EXTRACTED	mtor	mTOR	217#221	23440206-0-40-69	D015473	SYMBOL|DICTIONARY|EXTRACTED	pml	PML	111#114	23440206-2-146-168	Direct mTOR inhibitors and EGF receptor (EGFR) inhibitors that block downstream mTOR signaling promote nuclear PML expression in GBMs, and genetic overexpression and knockdown approaches demonstrate that PML prevents mTOR and EGFR inhibitor-dependent cell death.
23440206	2013	Proc. Natl. Acad. Sci. U.S.A.	1091-6490	ALL_TEXT_3/3	3	3	21977	SYMBOL|EXTRACTED	mtor	mTOR	217#221	23440206-0-40-69	D015473	SYMBOL|DICTIONARY|EXTRACTED	pml	PML	204#207	23440206-2-146-168	Direct mTOR inhibitors and EGF receptor (EGFR) inhibitors that block downstream mTOR signaling promote nuclear PML expression in GBMs, and genetic overexpression and knockdown approaches demonstrate that PML prevents mTOR and EGFR inhibitor-dependent cell death.
23440206	2013	Proc. Natl. Acad. Sci. U.S.A.	1091-6490	ALL_TEXT_3/3	3	3	21977	SYMBOL|EXTRACTED	mtor	mTOR	217#221	23440206-0-40-69	D005909	SYMBOL|PLURAL|DICTIONARY|EXTRACTED	gbms	GBMs	129#133	23440206-1-93-106	Direct mTOR inhibitors and EGF receptor (EGFR) inhibitors that block downstream mTOR signaling promote nuclear PML expression in GBMs, and genetic overexpression and knockdown approaches demonstrate that PML prevents mTOR and EGFR inhibitor-dependent cell death.
23440206	2013	Proc. Natl. Acad. Sci. U.S.A.	1091-6490	ALL_TEXT_3/3	3	3	1956	SYMBOL|GENE|GN|DICTIONARY	egf receptor	EGF receptor	27#39		D015473	SYMBOL|DICTIONARY|EXTRACTED	pml	PML	111#114	23440206-2-146-168	Direct mTOR inhibitors and EGF receptor (EGFR) inhibitors that block downstream mTOR signaling promote nuclear PML expression in GBMs, and genetic overexpression and knockdown approaches demonstrate that PML prevents mTOR and EGFR inhibitor-dependent cell death.
23440206	2013	Proc. Natl. Acad. Sci. U.S.A.	1091-6490	ALL_TEXT_3/3	3	3	1956	SYMBOL|GENE|GN|DICTIONARY	egf receptor	EGF receptor	27#39		D015473	SYMBOL|DICTIONARY|EXTRACTED	pml	PML	204#207	23440206-2-146-168	Direct mTOR inhibitors and EGF receptor (EGFR) inhibitors that block downstream mTOR signaling promote nuclear PML expression in GBMs, and genetic overexpression and knockdown approaches demonstrate that PML prevents mTOR and EGFR inhibitor-dependent cell death.
23440206	2013	Proc. Natl. Acad. Sci. U.S.A.	1091-6490	ALL_TEXT_3/3	3	3	1956	SYMBOL|GENE|GN|DICTIONARY	egf receptor	EGF receptor	27#39		D005909	SYMBOL|PLURAL|DICTIONARY|EXTRACTED	gbms	GBMs	129#133	23440206-1-93-106	Direct mTOR inhibitors and EGF receptor (EGFR) inhibitors that block downstream mTOR signaling promote nuclear PML expression in GBMs, and genetic overexpression and knockdown approaches demonstrate that PML prevents mTOR and EGFR inhibitor-dependent cell death.
23440206	2013	Proc. Natl. Acad. Sci. U.S.A.	1091-6490	ALL_TEXT_3/3	3	4	21977	SYMBOL|EXTRACTED	mtor	mTOR	86#90	23440206-0-40-69	D015473	SYMBOL|DICTIONARY|EXTRACTED	pml	PML	17#20	23440206-2-146-168	Low doses of the PML inhibitor, arsenic trioxide, abrogate PML expression and reverse mTOR kinase inhibitor resistance in vivo, thus markedly inhibiting tumor growth and promoting tumor cell death in mice.
23440206	2013	Proc. Natl. Acad. Sci. U.S.A.	1091-6490	ALL_TEXT_3/3	3	4	21977	SYMBOL|EXTRACTED	mtor	mTOR	86#90	23440206-0-40-69	D015473	SYMBOL|DICTIONARY|EXTRACTED	pml	PML	59#62	23440206-2-146-168	Low doses of the PML inhibitor, arsenic trioxide, abrogate PML expression and reverse mTOR kinase inhibitor resistance in vivo, thus markedly inhibiting tumor growth and promoting tumor cell death in mice.
23440206	2013	Proc. Natl. Acad. Sci. U.S.A.	1091-6490	ALL_TEXT_3/3	3	4	21977	SYMBOL|EXTRACTED	mtor	mTOR	86#90	23440206-0-40-69	D009369	LONGTERM|DISEASE|DT|CLINE|CN|DICTIONARY	tumor	tumor	180#185		Low doses of the PML inhibitor, arsenic trioxide, abrogate PML expression and reverse mTOR kinase inhibitor resistance in vivo, thus markedly inhibiting tumor growth and promoting tumor cell death in mice.
23440206	2013	Proc. Natl. Acad. Sci. U.S.A.	1091-6490	ALL_TEXT_3/3	3	4	21977	SYMBOL|EXTRACTED	mtor	mTOR	86#90	23440206-0-40-69	D009369	LONGTERM|DICTIONARY	tumor	tumor	153#158		Low doses of the PML inhibitor, arsenic trioxide, abrogate PML expression and reverse mTOR kinase inhibitor resistance in vivo, thus markedly inhibiting tumor growth and promoting tumor cell death in mice.
23440206	2013	Proc. Natl. Acad. Sci. U.S.A.	1091-6490	ALL_TEXT_3/3	3	5	21977	SYMBOL|EXTRACTED	mtor	mTOR	48#52	23440206-0-40-69	D015473	SYMBOL|DICTIONARY|EXTRACTED	pml	PML	41#44	23440206-2-146-168	These results identify a unique role for PML in mTOR and EGFR inhibitor resistance and provide a strong rationale for a combination therapeutic strategy to overcome it.
1352745	1992	Clin. Exp. Immunol.	0009-9104	ALL_TEXT_3/3	3	5	1378	SYMBOL|EXTRACTED	cr1	CR1	107#110	1352745-0-7-10	D003922	SYMBOL|DICTIONARY|EXTRACTED	iddm	IDDM	98#102	1352745-0-64-99	No significant association was found between the presence or absence of the HLA risk antigens for IDDM and CR1 expression.
20628598	2010	PLoS ONE	1932-6203	METHODOLOGY/PRINCIPAL FINDINGS	2	7	4544	SYMBOL|DICTIONARY|EXTRACTED	mtnr1b	MTNR1B	53#59	20628598-1-28-49	D018149	LONGTERM|DICTIONARY	fpg	FPG	95#98	NaN	Meta-analyses strongly supported additive effects of MTNR1B rs10830963 and G6PC2 rs16856187 on FPG.
20628598	2010	PLoS ONE	1932-6203	METHODOLOGY/PRINCIPAL FINDINGS	2	7	57818	SYMBOL|DICTIONARY|EXTRACTED	g6pc2	G6PC2	75#80	20628598-1-60-130	D018149	LONGTERM|DICTIONARY	fpg	FPG	95#98	NaN	Meta-analyses strongly supported additive effects of MTNR1B rs10830963 and G6PC2 rs16856187 on FPG.
20663522	2010	J. Urol.	1527-3792	CONCLUSIONS	4	9	1113	LONGTERM|DICTIONARY	chromogranin a	chromogranin A	31#45		D011471	LONGTERM|DISEASE|DT|DICTIONARY	prostate cancer	prostate cancer	93#108		Polymorphism and expression of chromogranin A and endothelin-1 have clinical significance in prostate cancer.
20663522	2010	J. Urol.	1527-3792	CONCLUSIONS	4	9	1906	LONGTERM|DICTIONARY	endothelin 1	endothelin-1	50#62		D011471	LONGTERM|DISEASE|DT|DICTIONARY	prostate cancer	prostate cancer	93#108		Polymorphism and expression of chromogranin A and endothelin-1 have clinical significance in prostate cancer.
12694583	2004	Tissue Antigens	0001-2815	ALL_TEXT_1/3	1	2	3105	SYMBOL|DICTIONARY	hla-a, -b, and -drb1	HLA-A, -B, and -DRB1	79#99		D006111	LONGTERM|DISEASE|DT|DICTIONARY	graves disease	Graves' disease	58#73		To evaluate the association of HLA type in Taiwanese with Graves' disease, the HLA-A, -B, and -DRB1 alleles in a total of 236 Taiwanese adults with Graves' disease and 533 racially matched normal control subjects were examined using the PCR-SSOP (sequence specific oligonucleotide probe) technique.
12694583	2004	Tissue Antigens	0001-2815	ALL_TEXT_1/3	1	2	3105	SYMBOL|DICTIONARY	hla-a, -b, and -drb1	HLA-A, -B, and -DRB1	79#99		D006111	LONGTERM|DISEASE|DT|DICTIONARY	graves disease	Graves' disease	148#163		To evaluate the association of HLA type in Taiwanese with Graves' disease, the HLA-A, -B, and -DRB1 alleles in a total of 236 Taiwanese adults with Graves' disease and 533 racially matched normal control subjects were examined using the PCR-SSOP (sequence specific oligonucleotide probe) technique.
12694583	2004	Tissue Antigens	0001-2815	ALL_TEXT_1/3	1	2	3106	SYMBOL|DICTIONARY	hla-a, -b, and -drb1	HLA-A, -B, and -DRB1	79#99		D006111	LONGTERM|DISEASE|DT|DICTIONARY	graves disease	Graves' disease	58#73		To evaluate the association of HLA type in Taiwanese with Graves' disease, the HLA-A, -B, and -DRB1 alleles in a total of 236 Taiwanese adults with Graves' disease and 533 racially matched normal control subjects were examined using the PCR-SSOP (sequence specific oligonucleotide probe) technique.
12694583	2004	Tissue Antigens	0001-2815	ALL_TEXT_1/3	1	2	3106	SYMBOL|DICTIONARY	hla-a, -b, and -drb1	HLA-A, -B, and -DRB1	79#99		D006111	LONGTERM|DISEASE|DT|DICTIONARY	graves disease	Graves' disease	148#163		To evaluate the association of HLA type in Taiwanese with Graves' disease, the HLA-A, -B, and -DRB1 alleles in a total of 236 Taiwanese adults with Graves' disease and 533 racially matched normal control subjects were examined using the PCR-SSOP (sequence specific oligonucleotide probe) technique.
12694583	2004	Tissue Antigens	0001-2815	ALL_TEXT_1/3	1	2	3123	SYMBOL|DICTIONARY	hla-a, -b, and -drb1	HLA-A, -B, and -DRB1	79#99		D006111	LONGTERM|DISEASE|DT|DICTIONARY	graves disease	Graves' disease	58#73		To evaluate the association of HLA type in Taiwanese with Graves' disease, the HLA-A, -B, and -DRB1 alleles in a total of 236 Taiwanese adults with Graves' disease and 533 racially matched normal control subjects were examined using the PCR-SSOP (sequence specific oligonucleotide probe) technique.
12694583	2004	Tissue Antigens	0001-2815	ALL_TEXT_1/3	1	2	3123	SYMBOL|DICTIONARY	hla-a, -b, and -drb1	HLA-A, -B, and -DRB1	79#99		D006111	LONGTERM|DISEASE|DT|DICTIONARY	graves disease	Graves' disease	148#163		To evaluate the association of HLA type in Taiwanese with Graves' disease, the HLA-A, -B, and -DRB1 alleles in a total of 236 Taiwanese adults with Graves' disease and 533 racially matched normal control subjects were examined using the PCR-SSOP (sequence specific oligonucleotide probe) technique.
12694583	2004	Tissue Antigens	0001-2815	ALL_TEXT_1/3	1	2	3105	SYMBOL|DICTIONARY	hla-a, -b, and -drb1	HLA-A, -B, and -DRB1	79#99		D006111	LONGTERM|DISEASE|DT|DICTIONARY	graves disease	Graves' disease	58#73		To evaluate the association of HLA type in Taiwanese with Graves' disease, the HLA-A, -B, and -DRB1 alleles in a total of 236 Taiwanese adults with Graves' disease and 533 racially matched normal control subjects were examined using the PCR-SSOP (sequence specific oligonucleotide probe) technique.
12694583	2004	Tissue Antigens	0001-2815	ALL_TEXT_1/3	1	2	3105	SYMBOL|DICTIONARY	hla-a, -b, and -drb1	HLA-A, -B, and -DRB1	79#99		D006111	LONGTERM|DISEASE|DT|DICTIONARY	graves disease	Graves' disease	148#163		To evaluate the association of HLA type in Taiwanese with Graves' disease, the HLA-A, -B, and -DRB1 alleles in a total of 236 Taiwanese adults with Graves' disease and 533 racially matched normal control subjects were examined using the PCR-SSOP (sequence specific oligonucleotide probe) technique.
12694583	2004	Tissue Antigens	0001-2815	ALL_TEXT_1/3	1	2	3106	SYMBOL|DICTIONARY	hla-a, -b, and -drb1	HLA-A, -B, and -DRB1	79#99		D006111	LONGTERM|DISEASE|DT|DICTIONARY	graves disease	Graves' disease	58#73		To evaluate the association of HLA type in Taiwanese with Graves' disease, the HLA-A, -B, and -DRB1 alleles in a total of 236 Taiwanese adults with Graves' disease and 533 racially matched normal control subjects were examined using the PCR-SSOP (sequence specific oligonucleotide probe) technique.
12694583	2004	Tissue Antigens	0001-2815	ALL_TEXT_1/3	1	2	3106	SYMBOL|DICTIONARY	hla-a, -b, and -drb1	HLA-A, -B, and -DRB1	79#99		D006111	LONGTERM|DISEASE|DT|DICTIONARY	graves disease	Graves' disease	148#163		To evaluate the association of HLA type in Taiwanese with Graves' disease, the HLA-A, -B, and -DRB1 alleles in a total of 236 Taiwanese adults with Graves' disease and 533 racially matched normal control subjects were examined using the PCR-SSOP (sequence specific oligonucleotide probe) technique.
12694583	2004	Tissue Antigens	0001-2815	ALL_TEXT_1/3	1	2	3123	SYMBOL|DICTIONARY	hla-a, -b, and -drb1	HLA-A, -B, and -DRB1	79#99		D006111	LONGTERM|DISEASE|DT|DICTIONARY	graves disease	Graves' disease	58#73		To evaluate the association of HLA type in Taiwanese with Graves' disease, the HLA-A, -B, and -DRB1 alleles in a total of 236 Taiwanese adults with Graves' disease and 533 racially matched normal control subjects were examined using the PCR-SSOP (sequence specific oligonucleotide probe) technique.
12694583	2004	Tissue Antigens	0001-2815	ALL_TEXT_1/3	1	2	3123	SYMBOL|DICTIONARY	hla-a, -b, and -drb1	HLA-A, -B, and -DRB1	79#99		D006111	LONGTERM|DISEASE|DT|DICTIONARY	graves disease	Graves' disease	148#163		To evaluate the association of HLA type in Taiwanese with Graves' disease, the HLA-A, -B, and -DRB1 alleles in a total of 236 Taiwanese adults with Graves' disease and 533 racially matched normal control subjects were examined using the PCR-SSOP (sequence specific oligonucleotide probe) technique.
12059121	2002	Mayo Clin. Proc.	0025-6196	TITLE	0	0	3077	SYMBOL|GENE|GN|DICTIONARY	hfe	HFE	87#90		D006432	LONGTERM|DICTIONARY	hemochromatosis	hemochromatosis	14#29		Prevalence of hemochromatosis-related symptoms among individuals with mutations in the HFE gene.
12059121	2002	Mayo Clin. Proc.	0025-6196	OBJECTIVE	1	1	3077	SYMBOL|DICTIONARY	hfe	HFE	87#90		D006432	LONGTERM|DICTIONARY	hemochromatosis	hemochromatosis	31#46		To determine the prevalence of hemochromatosis-related symptoms in homozygotes for the HFE mutation C282Y compared with controls without HFE mutations identified through a large screening program of subjects attending a health appraisal center.
12059121	2002	Mayo Clin. Proc.	0025-6196	OBJECTIVE	1	1	3077	SYMBOL|DICTIONARY	hfe	HFE	137#140		D006432	LONGTERM|DICTIONARY	hemochromatosis	hemochromatosis	31#46		To determine the prevalence of hemochromatosis-related symptoms in homozygotes for the HFE mutation C282Y compared with controls without HFE mutations identified through a large screening program of subjects attending a health appraisal center.
12059121	2002	Mayo Clin. Proc.	0025-6196	SUBJECTS AND METHODS	2	2	3077	SYMBOL|DICTIONARY	hfe	HFE	157#160		D006432	LONGTERM|DICTIONARY	hemochromatosis	hemochromatosis	55#70		Presence of symptoms commonly associated with clinical hemochromatosis was ascertained by self-report on a written questionnaire among C282Y homozygotes and HFE wild-type subjects of white or Hispanic ethnicity identified from screening 41,599 adult subjects between March 1999 and August 2001.
20100586	2011	Biol. Blood Marrow Transplant.	1523-6536	ALL_TEXT_2/3	2	8	7124	LONGTERM|DICTIONARY	tnf-alpha	TNF-alpha	0#9	NaN	D006086	SYMBOL|EXTRACTED	agvhd	aGVHD	70#75	20100586-1-117-148	TNF-alpha genotypes were not correlated with the overall incidence of aGVHD.
9759613	1998	Thromb. Haemost.	0340-6245	ALL_TEXT_1/3	1	1	462	LONGTERM|DICTIONARY	antithrombin	antithrombin	34#46	NaN	D020152	LONGTERM|DICTIONARY	antithrombin	antithrombin	34#46	NaN	The molecular basis of hereditary antithrombin (AT) deficiency has been investigated in ten Belgian and three Dutch unrelated kindreds.
9759613	1998	Thromb. Haemost.	0340-6245	ALL_TEXT_1/3	1	1	462	LONGTERM|DICTIONARY	antithrombin	antithrombin	34#46	NaN	D020152	LONGTERM|DICTIONARY	at	AT	48#50	NaN	The molecular basis of hereditary antithrombin (AT) deficiency has been investigated in ten Belgian and three Dutch unrelated kindreds.
9759613	1998	Thromb. Haemost.	0340-6245	ALL_TEXT_1/3	1	1	462	LONGTERM|DICTIONARY	at	AT	48#50	NaN	D020152	LONGTERM|DICTIONARY	antithrombin	antithrombin	34#46	NaN	The molecular basis of hereditary antithrombin (AT) deficiency has been investigated in ten Belgian and three Dutch unrelated kindreds.
9759613	1998	Thromb. Haemost.	0340-6245	ALL_TEXT_1/3	1	1	462	LONGTERM|DICTIONARY	at	AT	48#50	NaN	D020152	LONGTERM|DICTIONARY	at	AT	48#50	NaN	The molecular basis of hereditary antithrombin (AT) deficiency has been investigated in ten Belgian and three Dutch unrelated kindreds.
12059121	2002	Mayo Clin. Proc.	0025-6196	CONCLUSIONS	4	9	3077	SYMBOL|DICTIONARY	hfe	HFE	106#109		D006432	LONGTERM|DICTIONARY	hemochromatosis	hemochromatosis	73#88		Results of this study indicate that many of the symptoms associated with hemochromatosis are common among HFE wild types and that clinical penetrance of the C282Y/C282Y genotype in regard to these symptoms is low.
24997986	2015	Nat. Genet.	1546-1718	TITLE	0	0	1956	LONGTERM|DICTIONARY	erbb	ErbB	104#108	NaN	D005706	LONGTERM|DISEASE|DT|DICTIONARY	gallbladder carcinoma	gallbladder carcinoma	44#65		Whole-exome and targeted gene sequencing of gallbladder carcinoma identifies recurrent mutations in the ErbB pathway.
15522251	2005	Biol. Psychiatry	0006-3223	BACKGROUND	1	3	348	SYMBOL|DICTIONARY	apoe	APOE	131#135		D000544	SYMBOL|EXTRACTED	ad	AD	55#57	15522251-1-109-128	We tested these CSF markers in groups of subjects with AD and healthy older control subjects, using the absence or presence of the APOE epsilon4 allele as a predictive variable in the search for possible prognostic biomarkers of AD.
15522251	2005	Biol. Psychiatry	0006-3223	BACKGROUND	1	3	348	SYMBOL|DICTIONARY	apoe	APOE	131#135		D000544	SYMBOL|EXTRACTED	ad	AD	229#231	15522251-1-109-128	We tested these CSF markers in groups of subjects with AD and healthy older control subjects, using the absence or presence of the APOE epsilon4 allele as a predictive variable in the search for possible prognostic biomarkers of AD.
19875396	2010	Europace	1532-2092	ALL_TEXT_3/3	3	5	6331	SYMBOL|DICTIONARY	scn5a	SCN5A	96#101		D001145	LONGTERM|DICTIONARY	arrhythmia	arrhythmia	19#29	NaN	In our patient, no arrhythmia occurred but the proarrhythmic potential of SSRI in patients with SCN5A mutations cannot be excluded.
20816194	2010	J. Allergy Clin. Immunol.	1097-6825	CONCLUSION	5	10	6774	SYMBOL|DICTIONARY|EXTRACTED	stat3	STAT3	26#31	20816194-2-32-82	D007589	SYMBOL|EXTRACTED	hies	HIES	112#116	20816194-1-0-19	We expanded the number of STAT3 mutations and validated that the NIH score sensitively identifies patients with HIES.
18786162	2009	Genes Brain Behav.	1601-183X	ALL_TEXT_2/3	2	5	627	SYMBOL|DICTIONARY|EXTRACTED	bdnf	BDNF	19#23	18786162-2-80-113	D000303	LONGTERM|DICTIONARY	anterior cingulate cortex	anterior cingulate cortex	173#198		Individuals of the BDNF Val/Val genotype showed progressive atrophy in the left medial temporal areas, whereas the BDNF Met allele carriers showed additional changes in the anterior cingulate cortex (ACC), posterior cingulate cortex (PCC) and the precuneus.
18786162	2009	Genes Brain Behav.	1601-183X	ALL_TEXT_2/3	2	5	627	SYMBOL|DICTIONARY|EXTRACTED	bdnf	BDNF	19#23	18786162-2-80-113	D000303	LONGTERM|DICTIONARY	anterior cingulate cortex	anterior cingulate cortex	173#198		Individuals of the BDNF Val/Val genotype showed progressive atrophy in the left medial temporal areas, whereas the BDNF Met allele carriers showed additional changes in the anterior cingulate cortex (ACC), posterior cingulate cortex (PCC) and the precuneus.
18786162	2009	Genes Brain Behav.	1601-183X	ALL_TEXT_2/3	2	5	627	SYMBOL|DICTIONARY|EXTRACTED	bdnf	BDNF	19#23	18786162-2-80-113	D001284	LONGTERM|DICTIONARY	atrophy	atrophy	60#67	NaN	Individuals of the BDNF Val/Val genotype showed progressive atrophy in the left medial temporal areas, whereas the BDNF Met allele carriers showed additional changes in the anterior cingulate cortex (ACC), posterior cingulate cortex (PCC) and the precuneus.
18786162	2009	Genes Brain Behav.	1601-183X	ALL_TEXT_2/3	2	5	627	SYMBOL|DICTIONARY|EXTRACTED	bdnf	BDNF	115#119	18786162-2-80-113	D000303	LONGTERM|DICTIONARY	anterior cingulate cortex	anterior cingulate cortex	173#198		Individuals of the BDNF Val/Val genotype showed progressive atrophy in the left medial temporal areas, whereas the BDNF Met allele carriers showed additional changes in the anterior cingulate cortex (ACC), posterior cingulate cortex (PCC) and the precuneus.
18786162	2009	Genes Brain Behav.	1601-183X	ALL_TEXT_2/3	2	5	627	SYMBOL|DICTIONARY|EXTRACTED	bdnf	BDNF	115#119	18786162-2-80-113	D000303	LONGTERM|DICTIONARY	anterior cingulate cortex	anterior cingulate cortex	173#198		Individuals of the BDNF Val/Val genotype showed progressive atrophy in the left medial temporal areas, whereas the BDNF Met allele carriers showed additional changes in the anterior cingulate cortex (ACC), posterior cingulate cortex (PCC) and the precuneus.
18786162	2009	Genes Brain Behav.	1601-183X	ALL_TEXT_2/3	2	5	627	SYMBOL|DICTIONARY|EXTRACTED	bdnf	BDNF	115#119	18786162-2-80-113	D001284	LONGTERM|DICTIONARY	atrophy	atrophy	60#67	NaN	Individuals of the BDNF Val/Val genotype showed progressive atrophy in the left medial temporal areas, whereas the BDNF Met allele carriers showed additional changes in the anterior cingulate cortex (ACC), posterior cingulate cortex (PCC) and the precuneus.
18786162	2009	Genes Brain Behav.	1601-183X	ALL_TEXT_3/3	3	7	348	SYMBOL|EXTRACTED	apoe	ApoE	24#28	18786162-1-25-41	D001284	LONGTERM|DICTIONARY	atrophy	atrophy	64#71	NaN	The noncarriers for the ApoE epsilon4 allele showed progressive atrophy in the bilateral medial temporal areas.
18786162	2009	Genes Brain Behav.	1601-183X	TITLE	0	0	627	LONGTERM|GENE|GT|DICTIONARY	brain derived neurotrophic factor	brain-derived neurotrophic factor	14#47		D000544	LONGTERM|DISEASE|DT|DICTIONARY	alzheimer disease	Alzheimer's disease	125#144		Effect of the brain-derived neurotrophic factor and the apolipoprotein E polymorphisms on disease progression in preclinical Alzheimer's disease.
18786162	2009	Genes Brain Behav.	1601-183X	TITLE	0	0	348	LONGTERM|DICTIONARY	apolipoprotein e	apolipoprotein E	56#72		D000544	LONGTERM|DISEASE|DT|DICTIONARY	alzheimer disease	Alzheimer's disease	125#144		Effect of the brain-derived neurotrophic factor and the apolipoprotein E polymorphisms on disease progression in preclinical Alzheimer's disease.
18786162	2009	Genes Brain Behav.	1601-183X	ALL_TEXT_1/3	1	1	348	LONGTERM|DICTIONARY	apolipoprotein e	apolipoprotein E	25#41		D000544	LONGTERM|DISEASE|DT|DICTIONARY	alzheimer disease	Alzheimer's disease	121#140		Genetic factors, such as apolipoprotein E (ApoE) polymorphisms, are thought to play an important role in the etiology of Alzheimer's disease (AD).
18786162	2009	Genes Brain Behav.	1601-183X	ALL_TEXT_1/3	1	1	348	LONGTERM|DICTIONARY	apolipoprotein e	apolipoprotein E	25#41		D000544	SYMBOL|EXTRACTED|()	ad	AD	142#144	18786162-1-121-140	Genetic factors, such as apolipoprotein E (ApoE) polymorphisms, are thought to play an important role in the etiology of Alzheimer's disease (AD).
18786162	2009	Genes Brain Behav.	1601-183X	ALL_TEXT_1/3	1	1	348	SYMBOL|EXTRACTED|()	apoe	ApoE	43#47	18786162-1-25-41	D000544	LONGTERM|DISEASE|DT|DICTIONARY	alzheimer disease	Alzheimer's disease	121#140		Genetic factors, such as apolipoprotein E (ApoE) polymorphisms, are thought to play an important role in the etiology of Alzheimer's disease (AD).
18786162	2009	Genes Brain Behav.	1601-183X	ALL_TEXT_1/3	1	1	348	SYMBOL|EXTRACTED|()	apoe	ApoE	43#47	18786162-1-25-41	D000544	SYMBOL|EXTRACTED|()	ad	AD	142#144	18786162-1-121-140	Genetic factors, such as apolipoprotein E (ApoE) polymorphisms, are thought to play an important role in the etiology of Alzheimer's disease (AD).
18786162	2009	Genes Brain Behav.	1601-183X	ALL_TEXT_1/3	1	2	627	LONGTERM|GENE|GT|DICTIONARY|GA	brain derived neurotrophic factor	brain-derived neurotrophic factor	80#113		D000544	SYMBOL|EXTRACTED	ad	AD	166#168	18786162-1-121-140	Recent association studies have suggested that the Val66Met polymorphism in the brain-derived neurotrophic factor (BDNF) gene could play a role in the development of AD.
18786162	2009	Genes Brain Behav.	1601-183X	ALL_TEXT_1/3	1	2	627	SYMBOL|()|GENE|GN|DICTIONARY|EXTRACTED	bdnf	BDNF	115#119	18786162-2-80-113	D000544	SYMBOL|EXTRACTED	ad	AD	166#168	18786162-1-121-140	Recent association studies have suggested that the Val66Met polymorphism in the brain-derived neurotrophic factor (BDNF) gene could play a role in the development of AD.
18786162	2009	Genes Brain Behav.	1601-183X	ALL_TEXT_1/3	1	3	627	SYMBOL|DICTIONARY|EXTRACTED	bdnf	BDNF	37#41	18786162-2-80-113	D000544	SYMBOL|EXTRACTED	ad	AD	99#101	18786162-1-121-140	To identify genotypic effects of the BDNF and the ApoE genes on disease progression in preclinical AD, we assessed morphological changes using serial magnetic resonance imaging during the preclinical period of AD in 35 individuals.
18786162	2009	Genes Brain Behav.	1601-183X	ALL_TEXT_1/3	1	3	627	SYMBOL|DICTIONARY|EXTRACTED	bdnf	BDNF	37#41	18786162-2-80-113	D000544	SYMBOL|EXTRACTED	ad	AD	210#212	18786162-1-121-140	To identify genotypic effects of the BDNF and the ApoE genes on disease progression in preclinical AD, we assessed morphological changes using serial magnetic resonance imaging during the preclinical period of AD in 35 individuals.
18786162	2009	Genes Brain Behav.	1601-183X	ALL_TEXT_1/3	1	3	348	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	apoe	ApoE	50#54	18786162-1-25-41	D000544	SYMBOL|EXTRACTED	ad	AD	99#101	18786162-1-121-140	To identify genotypic effects of the BDNF and the ApoE genes on disease progression in preclinical AD, we assessed morphological changes using serial magnetic resonance imaging during the preclinical period of AD in 35 individuals.
18786162	2009	Genes Brain Behav.	1601-183X	ALL_TEXT_1/3	1	3	348	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	apoe	ApoE	50#54	18786162-1-25-41	D000544	SYMBOL|EXTRACTED	ad	AD	210#212	18786162-1-121-140	To identify genotypic effects of the BDNF and the ApoE genes on disease progression in preclinical AD, we assessed morphological changes using serial magnetic resonance imaging during the preclinical period of AD in 35 individuals.
12492589	2003	Br. J. Haematol.	0007-1048	ALL_TEXT_2/3	2	4	2214	LONGTERM|NUMBER|DICTIONARY	fcgammariiia	FcgammaRIIIa	138#150		D016553	SYMBOL|DICTIONARY|EXTRACTED	itp	ITP	245#248	12492589-1-129-160	The genotypic frequencies for two Fcgamma receptor single nucleotide polymorphisms, FcgammaRIIa-131 arginine (R) versus histidine (H) and FcgammaRIIIa-158 valine (V) versus phenylalanine (F) were examined in 98 children diagnosed with childhood ITP.
16150646	2006	Clin. Immunol.	1521-6616	TITLE	0	0	2212	LONGTERM|DICTIONARY	fcgamma-receptor iia	Fcgamma-receptor IIA	0#20	NaN	D011008	LONGTERM|DISEASE|DT|DICTIONARY	pneumococcal infection	pneumococcal infection	43#65		Fcgamma-receptor IIA genotype and invasive pneumococcal infection.
16454982	2006	Chin. Med. J.	0366-6999	TITLE	0	0	668	SYMBOL|GENE|GN|DICTIONARY	foxl2	FOXL2	12#17		C562419	LONGTERM|DICTIONARY	blepharophimosis-ptosis-epicanthus inversus syndrome	blepharophimosis-ptosis-epicanthus inversus syndrome	58#110		Three novel FOXL2 gene mutations in Chinese patients with blepharophimosis-ptosis-epicanthus inversus syndrome.
16454982	2006	Chin. Med. J.	0366-6999	TITLE	0	0	668	SYMBOL|GENE|GN|DICTIONARY	foxl2	FOXL2	12#17		C562419	LONGTERM|DICTIONARY	blepharophimosis-ptosis-epicanthus inversus syndrome	blepharophimosis-ptosis-epicanthus inversus syndrome	58#110		Three novel FOXL2 gene mutations in Chinese patients with blepharophimosis-ptosis-epicanthus inversus syndrome.
16454982	2006	Chin. Med. J.	0366-6999	TITLE	0	0	668	SYMBOL|GENE|GN|DICTIONARY	foxl2	FOXL2	12#17		C562419	LONGTERM|DICTIONARY	blepharophimosis-ptosis-epicanthus inversus syndrome	blepharophimosis-ptosis-epicanthus inversus syndrome	58#110		Three novel FOXL2 gene mutations in Chinese patients with blepharophimosis-ptosis-epicanthus inversus syndrome.
14695532	2004	Hum. Mutat.	1098-1004	TITLE	0	0	2548	SYMBOL|()|DICTIONARY|EXTRACTED	gaa	GAA	68#71	14695532-0-34-61	D006009	LONGTERM|DICTIONARY	glycogen storage disease type ii	glycogen storage disease type II	122#154		Twenty-two novel mutations in the lysosomal alpha-glucosidase gene (GAA) underscore the genotype-phenotype correlation in glycogen storage disease type II.
17509612	2007	J. Mol. Cell. Cardiol.	0022-2828	ALL_TEXT_3/3	3	10	57158	SYMBOL|DICTIONARY|EXTRACTED	jph2	JPH2	116#120	17509612-1-0-14	D009202	LONGTERM|DICTIONARY	cardiomyopathies	cardiomyopathies	33#49		Whether susceptibility for other cardiomyopathies, such as dilated cardiomyopathy, can be conferred by mutations in JPH2 warrants investigation.
17509612	2007	J. Mol. Cell. Cardiol.	0022-2828	ALL_TEXT_3/3	3	10	57158	SYMBOL|DICTIONARY|EXTRACTED	jph2	JPH2	116#120	17509612-1-0-14	D002311	LONGTERM|DICTIONARY	dilated cardiomyopathy	dilated cardiomyopathy	59#81		Whether susceptibility for other cardiomyopathies, such as dilated cardiomyopathy, can be conferred by mutations in JPH2 warrants investigation.
20857490	2011	Int. J. Cancer	1097-0215	ALL_TEXT_1/3	1	2	9149	SYMBOL|DICTIONARY	dyrk1b	dyrk1B	33#39		D010051	LONGTERM|DISEASE|DT|CLINE|CN|DICTIONARY	ovarian cancer	ovarian cancer	71#85		The serine/threonine kinase Mirk/dyrk1B was expressed in each of seven ovarian cancer cell lines and in 21 of 28 resected human ovarian cancers, and upregulated in 60% of the cancers.
20857490	2011	Int. J. Cancer	1097-0215	ALL_TEXT_1/3	1	2	9149	SYMBOL|DICTIONARY	dyrk1b	dyrk1B	33#39		D010051	LONGTERM|DICTIONARY	ovarian cancers	ovarian cancers	128#143		The serine/threonine kinase Mirk/dyrk1B was expressed in each of seven ovarian cancer cell lines and in 21 of 28 resected human ovarian cancers, and upregulated in 60% of the cancers.
20857490	2011	Int. J. Cancer	1097-0215	ALL_TEXT_1/3	1	2	9149	SYMBOL|DICTIONARY	dyrk1b	dyrk1B	33#39		D009369	LONGTERM|DICTIONARY	cancers	cancers	175#182		The serine/threonine kinase Mirk/dyrk1B was expressed in each of seven ovarian cancer cell lines and in 21 of 28 resected human ovarian cancers, and upregulated in 60% of the cancers.
19715891	2010	Transplant. Proc.	1873-2623	BACKGROUND	1	3	4153	SYMBOL|DICTIONARY	mbl2	MBL2	41#45		D003586	SYMBOL|()|DISEASE|DN|DICTIONARY	cytomegalovirus (cmv) disease	Cytomegalovirus (CMV) disease	83#112		Our aim was to evaluate the influence of MBL2 polymorphisms in the invasiveness of Cytomegalovirus (CMV) disease after solid organ transplantation.
19715891	2010	Transplant. Proc.	1873-2623	TITLE	0	0	4153	LONGTERM|GENE|GN|DICTIONARY	mannose binding lectin	mannose-binding lectin	13#35		D003586	LONGTERM|DISEASE|DT|DICTIONARY	cytomegalovirus disease	cytomegalovirus disease	78#101		Influence of mannose-binding lectin gene polymorphisms on the invasiveness of cytomegalovirus disease after solid organ transplantation.
16168956	2005	Biochem. Biophys. Res. Commun.	0006-291X	ALL_TEXT_3/3	3	8	3309	SYMBOL|DICTIONARY	hspa5	HSPA5	51#56		D001714	LONGTERM|DISEASE|DT|DICTIONARY	bipolar disorder	bipolar disorder	163#179		These findings suggested promotor polymorphisms of HSPA5 may affect the interindividual variability of ER stress response and may confer a genetic risk factor for bipolar disorder.
16168956	2005	Biochem. Biophys. Res. Commun.	0006-291X	ALL_TEXT_3/3	3	8	3309	SYMBOL|DICTIONARY	hspa5	HSPA5	51#56		D015775	LONGTERM|DICTIONARY	er	ER	103#105	NaN	These findings suggested promotor polymorphisms of HSPA5 may affect the interindividual variability of ER stress response and may confer a genetic risk factor for bipolar disorder.
20628598	2010	PLoS ONE	1932-6203	BACKGROUND	1	1	4544	LONGTERM|DICTIONARY	melatonin receptor 1b	melatonin receptor 1B	28#49		D003924	LONGTERM|DICTIONARY	type 2 diabetes	type 2 diabetes	223#238		Previous studies identified melatonin receptor 1B (MTNR1B), islet-specific glucose 6 phosphatase catalytic subunit-related protein (G6PC2), glucokinase (GCK) and glucokinase regulatory protein (GCKR) as candidate genes for type 2 diabetes (T2D) acting through elevated fasting plasma glucose (FPG).
20628598	2010	PLoS ONE	1932-6203	BACKGROUND	1	1	4544	LONGTERM|DICTIONARY	melatonin receptor 1b	melatonin receptor 1B	28#49		D003924	SYMBOL|()|DICTIONARY|EXTRACTED	t2d	T2D	240#243	20628598-1-223-238	Previous studies identified melatonin receptor 1B (MTNR1B), islet-specific glucose 6 phosphatase catalytic subunit-related protein (G6PC2), glucokinase (GCK) and glucokinase regulatory protein (GCKR) as candidate genes for type 2 diabetes (T2D) acting through elevated fasting plasma glucose (FPG).
20628598	2010	PLoS ONE	1932-6203	BACKGROUND	1	1	4544	LONGTERM|DICTIONARY	melatonin receptor 1b	melatonin receptor 1B	28#49		D018149	LONGTERM|DICTIONARY	fasting plasma glucose	fasting plasma glucose	269#291	NaN	Previous studies identified melatonin receptor 1B (MTNR1B), islet-specific glucose 6 phosphatase catalytic subunit-related protein (G6PC2), glucokinase (GCK) and glucokinase regulatory protein (GCKR) as candidate genes for type 2 diabetes (T2D) acting through elevated fasting plasma glucose (FPG).
20628598	2010	PLoS ONE	1932-6203	BACKGROUND	1	1	4544	LONGTERM|DICTIONARY	melatonin receptor 1b	melatonin receptor 1B	28#49		D018149	LONGTERM|DICTIONARY	fpg	FPG	293#296	NaN	Previous studies identified melatonin receptor 1B (MTNR1B), islet-specific glucose 6 phosphatase catalytic subunit-related protein (G6PC2), glucokinase (GCK) and glucokinase regulatory protein (GCKR) as candidate genes for type 2 diabetes (T2D) acting through elevated fasting plasma glucose (FPG).
20628598	2010	PLoS ONE	1932-6203	BACKGROUND	1	1	4544	SYMBOL|()|DICTIONARY|EXTRACTED	mtnr1b	MTNR1B	51#57	20628598-1-28-49	D003924	LONGTERM|DICTIONARY	type 2 diabetes	type 2 diabetes	223#238		Previous studies identified melatonin receptor 1B (MTNR1B), islet-specific glucose 6 phosphatase catalytic subunit-related protein (G6PC2), glucokinase (GCK) and glucokinase regulatory protein (GCKR) as candidate genes for type 2 diabetes (T2D) acting through elevated fasting plasma glucose (FPG).
20628598	2010	PLoS ONE	1932-6203	BACKGROUND	1	1	4544	SYMBOL|()|DICTIONARY|EXTRACTED	mtnr1b	MTNR1B	51#57	20628598-1-28-49	D003924	SYMBOL|()|DICTIONARY|EXTRACTED	t2d	T2D	240#243	20628598-1-223-238	Previous studies identified melatonin receptor 1B (MTNR1B), islet-specific glucose 6 phosphatase catalytic subunit-related protein (G6PC2), glucokinase (GCK) and glucokinase regulatory protein (GCKR) as candidate genes for type 2 diabetes (T2D) acting through elevated fasting plasma glucose (FPG).
20628598	2010	PLoS ONE	1932-6203	BACKGROUND	1	1	4544	SYMBOL|()|DICTIONARY|EXTRACTED	mtnr1b	MTNR1B	51#57	20628598-1-28-49	D018149	LONGTERM|DICTIONARY	fasting plasma glucose	fasting plasma glucose	269#291	NaN	Previous studies identified melatonin receptor 1B (MTNR1B), islet-specific glucose 6 phosphatase catalytic subunit-related protein (G6PC2), glucokinase (GCK) and glucokinase regulatory protein (GCKR) as candidate genes for type 2 diabetes (T2D) acting through elevated fasting plasma glucose (FPG).
20628598	2010	PLoS ONE	1932-6203	BACKGROUND	1	1	4544	SYMBOL|()|DICTIONARY|EXTRACTED	mtnr1b	MTNR1B	51#57	20628598-1-28-49	D018149	LONGTERM|DICTIONARY	fpg	FPG	293#296	NaN	Previous studies identified melatonin receptor 1B (MTNR1B), islet-specific glucose 6 phosphatase catalytic subunit-related protein (G6PC2), glucokinase (GCK) and glucokinase regulatory protein (GCKR) as candidate genes for type 2 diabetes (T2D) acting through elevated fasting plasma glucose (FPG).
20628598	2010	PLoS ONE	1932-6203	BACKGROUND	1	1	57818	LONGTERM|GENE|GT|DICTIONARY	islet specific glucose 6 phosphatase catalytic subunit related protein	islet-specific glucose 6 phosphatase catalytic subunit-related protein	60#130		D003924	LONGTERM|DICTIONARY	type 2 diabetes	type 2 diabetes	223#238		Previous studies identified melatonin receptor 1B (MTNR1B), islet-specific glucose 6 phosphatase catalytic subunit-related protein (G6PC2), glucokinase (GCK) and glucokinase regulatory protein (GCKR) as candidate genes for type 2 diabetes (T2D) acting through elevated fasting plasma glucose (FPG).
20628598	2010	PLoS ONE	1932-6203	BACKGROUND	1	1	57818	LONGTERM|GENE|GT|DICTIONARY	islet specific glucose 6 phosphatase catalytic subunit related protein	islet-specific glucose 6 phosphatase catalytic subunit-related protein	60#130		D003924	SYMBOL|()|DICTIONARY|EXTRACTED	t2d	T2D	240#243	20628598-1-223-238	Previous studies identified melatonin receptor 1B (MTNR1B), islet-specific glucose 6 phosphatase catalytic subunit-related protein (G6PC2), glucokinase (GCK) and glucokinase regulatory protein (GCKR) as candidate genes for type 2 diabetes (T2D) acting through elevated fasting plasma glucose (FPG).
20628598	2010	PLoS ONE	1932-6203	BACKGROUND	1	1	57818	LONGTERM|GENE|GT|DICTIONARY	islet specific glucose 6 phosphatase catalytic subunit related protein	islet-specific glucose 6 phosphatase catalytic subunit-related protein	60#130		D018149	LONGTERM|DICTIONARY	fasting plasma glucose	fasting plasma glucose	269#291	NaN	Previous studies identified melatonin receptor 1B (MTNR1B), islet-specific glucose 6 phosphatase catalytic subunit-related protein (G6PC2), glucokinase (GCK) and glucokinase regulatory protein (GCKR) as candidate genes for type 2 diabetes (T2D) acting through elevated fasting plasma glucose (FPG).
20628598	2010	PLoS ONE	1932-6203	BACKGROUND	1	1	57818	LONGTERM|GENE|GT|DICTIONARY	islet specific glucose 6 phosphatase catalytic subunit related protein	islet-specific glucose 6 phosphatase catalytic subunit-related protein	60#130		D018149	LONGTERM|DICTIONARY	fpg	FPG	293#296	NaN	Previous studies identified melatonin receptor 1B (MTNR1B), islet-specific glucose 6 phosphatase catalytic subunit-related protein (G6PC2), glucokinase (GCK) and glucokinase regulatory protein (GCKR) as candidate genes for type 2 diabetes (T2D) acting through elevated fasting plasma glucose (FPG).
20628598	2010	PLoS ONE	1932-6203	BACKGROUND	1	1	57818	SYMBOL|()|DICTIONARY|EXTRACTED	g6pc2	G6PC2	132#137	20628598-1-60-130	D003924	LONGTERM|DICTIONARY	type 2 diabetes	type 2 diabetes	223#238		Previous studies identified melatonin receptor 1B (MTNR1B), islet-specific glucose 6 phosphatase catalytic subunit-related protein (G6PC2), glucokinase (GCK) and glucokinase regulatory protein (GCKR) as candidate genes for type 2 diabetes (T2D) acting through elevated fasting plasma glucose (FPG).
20628598	2010	PLoS ONE	1932-6203	BACKGROUND	1	1	57818	SYMBOL|()|DICTIONARY|EXTRACTED	g6pc2	G6PC2	132#137	20628598-1-60-130	D003924	SYMBOL|()|DICTIONARY|EXTRACTED	t2d	T2D	240#243	20628598-1-223-238	Previous studies identified melatonin receptor 1B (MTNR1B), islet-specific glucose 6 phosphatase catalytic subunit-related protein (G6PC2), glucokinase (GCK) and glucokinase regulatory protein (GCKR) as candidate genes for type 2 diabetes (T2D) acting through elevated fasting plasma glucose (FPG).
20628598	2010	PLoS ONE	1932-6203	BACKGROUND	1	1	57818	SYMBOL|()|DICTIONARY|EXTRACTED	g6pc2	G6PC2	132#137	20628598-1-60-130	D018149	LONGTERM|DICTIONARY	fasting plasma glucose	fasting plasma glucose	269#291	NaN	Previous studies identified melatonin receptor 1B (MTNR1B), islet-specific glucose 6 phosphatase catalytic subunit-related protein (G6PC2), glucokinase (GCK) and glucokinase regulatory protein (GCKR) as candidate genes for type 2 diabetes (T2D) acting through elevated fasting plasma glucose (FPG).
20628598	2010	PLoS ONE	1932-6203	BACKGROUND	1	1	57818	SYMBOL|()|DICTIONARY|EXTRACTED	g6pc2	G6PC2	132#137	20628598-1-60-130	D018149	LONGTERM|DICTIONARY	fpg	FPG	293#296	NaN	Previous studies identified melatonin receptor 1B (MTNR1B), islet-specific glucose 6 phosphatase catalytic subunit-related protein (G6PC2), glucokinase (GCK) and glucokinase regulatory protein (GCKR) as candidate genes for type 2 diabetes (T2D) acting through elevated fasting plasma glucose (FPG).
20628598	2010	PLoS ONE	1932-6203	BACKGROUND	1	1	2645	LONGTERM|DICTIONARY	glucokinase	glucokinase	140#151		D003924	LONGTERM|DICTIONARY	type 2 diabetes	type 2 diabetes	223#238		Previous studies identified melatonin receptor 1B (MTNR1B), islet-specific glucose 6 phosphatase catalytic subunit-related protein (G6PC2), glucokinase (GCK) and glucokinase regulatory protein (GCKR) as candidate genes for type 2 diabetes (T2D) acting through elevated fasting plasma glucose (FPG).
20628598	2010	PLoS ONE	1932-6203	BACKGROUND	1	1	2645	LONGTERM|DICTIONARY	glucokinase	glucokinase	140#151		D003924	SYMBOL|()|DICTIONARY|EXTRACTED	t2d	T2D	240#243	20628598-1-223-238	Previous studies identified melatonin receptor 1B (MTNR1B), islet-specific glucose 6 phosphatase catalytic subunit-related protein (G6PC2), glucokinase (GCK) and glucokinase regulatory protein (GCKR) as candidate genes for type 2 diabetes (T2D) acting through elevated fasting plasma glucose (FPG).
20628598	2010	PLoS ONE	1932-6203	BACKGROUND	1	1	2645	LONGTERM|DICTIONARY	glucokinase	glucokinase	140#151		D018149	LONGTERM|DICTIONARY	fasting plasma glucose	fasting plasma glucose	269#291	NaN	Previous studies identified melatonin receptor 1B (MTNR1B), islet-specific glucose 6 phosphatase catalytic subunit-related protein (G6PC2), glucokinase (GCK) and glucokinase regulatory protein (GCKR) as candidate genes for type 2 diabetes (T2D) acting through elevated fasting plasma glucose (FPG).
20628598	2010	PLoS ONE	1932-6203	BACKGROUND	1	1	2645	LONGTERM|DICTIONARY	glucokinase	glucokinase	140#151		D018149	LONGTERM|DICTIONARY	fpg	FPG	293#296	NaN	Previous studies identified melatonin receptor 1B (MTNR1B), islet-specific glucose 6 phosphatase catalytic subunit-related protein (G6PC2), glucokinase (GCK) and glucokinase regulatory protein (GCKR) as candidate genes for type 2 diabetes (T2D) acting through elevated fasting plasma glucose (FPG).
20628598	2010	PLoS ONE	1932-6203	BACKGROUND	1	1	2645	SYMBOL|()|DICTIONARY|EXTRACTED	gck	GCK	153#156	20628598-1-140-151	D003924	LONGTERM|DICTIONARY	type 2 diabetes	type 2 diabetes	223#238		Previous studies identified melatonin receptor 1B (MTNR1B), islet-specific glucose 6 phosphatase catalytic subunit-related protein (G6PC2), glucokinase (GCK) and glucokinase regulatory protein (GCKR) as candidate genes for type 2 diabetes (T2D) acting through elevated fasting plasma glucose (FPG).
20628598	2010	PLoS ONE	1932-6203	BACKGROUND	1	1	2645	SYMBOL|()|DICTIONARY|EXTRACTED	gck	GCK	153#156	20628598-1-140-151	D003924	SYMBOL|()|DICTIONARY|EXTRACTED	t2d	T2D	240#243	20628598-1-223-238	Previous studies identified melatonin receptor 1B (MTNR1B), islet-specific glucose 6 phosphatase catalytic subunit-related protein (G6PC2), glucokinase (GCK) and glucokinase regulatory protein (GCKR) as candidate genes for type 2 diabetes (T2D) acting through elevated fasting plasma glucose (FPG).
20628598	2010	PLoS ONE	1932-6203	BACKGROUND	1	1	2645	SYMBOL|()|DICTIONARY|EXTRACTED	gck	GCK	153#156	20628598-1-140-151	D018149	LONGTERM|DICTIONARY	fasting plasma glucose	fasting plasma glucose	269#291	NaN	Previous studies identified melatonin receptor 1B (MTNR1B), islet-specific glucose 6 phosphatase catalytic subunit-related protein (G6PC2), glucokinase (GCK) and glucokinase regulatory protein (GCKR) as candidate genes for type 2 diabetes (T2D) acting through elevated fasting plasma glucose (FPG).
20628598	2010	PLoS ONE	1932-6203	BACKGROUND	1	1	2645	SYMBOL|()|DICTIONARY|EXTRACTED	gck	GCK	153#156	20628598-1-140-151	D018149	LONGTERM|DICTIONARY	fpg	FPG	293#296	NaN	Previous studies identified melatonin receptor 1B (MTNR1B), islet-specific glucose 6 phosphatase catalytic subunit-related protein (G6PC2), glucokinase (GCK) and glucokinase regulatory protein (GCKR) as candidate genes for type 2 diabetes (T2D) acting through elevated fasting plasma glucose (FPG).
20628598	2010	PLoS ONE	1932-6203	BACKGROUND	1	1	2646	LONGTERM|GENE|GT|DICTIONARY	glucokinase regulatory protein	glucokinase regulatory protein	162#192		D003924	LONGTERM|DICTIONARY	type 2 diabetes	type 2 diabetes	223#238		Previous studies identified melatonin receptor 1B (MTNR1B), islet-specific glucose 6 phosphatase catalytic subunit-related protein (G6PC2), glucokinase (GCK) and glucokinase regulatory protein (GCKR) as candidate genes for type 2 diabetes (T2D) acting through elevated fasting plasma glucose (FPG).
20628598	2010	PLoS ONE	1932-6203	BACKGROUND	1	1	2646	LONGTERM|GENE|GT|DICTIONARY	glucokinase regulatory protein	glucokinase regulatory protein	162#192		D003924	SYMBOL|()|DICTIONARY|EXTRACTED	t2d	T2D	240#243	20628598-1-223-238	Previous studies identified melatonin receptor 1B (MTNR1B), islet-specific glucose 6 phosphatase catalytic subunit-related protein (G6PC2), glucokinase (GCK) and glucokinase regulatory protein (GCKR) as candidate genes for type 2 diabetes (T2D) acting through elevated fasting plasma glucose (FPG).
20628598	2010	PLoS ONE	1932-6203	BACKGROUND	1	1	2646	LONGTERM|GENE|GT|DICTIONARY	glucokinase regulatory protein	glucokinase regulatory protein	162#192		D018149	LONGTERM|DICTIONARY	fasting plasma glucose	fasting plasma glucose	269#291	NaN	Previous studies identified melatonin receptor 1B (MTNR1B), islet-specific glucose 6 phosphatase catalytic subunit-related protein (G6PC2), glucokinase (GCK) and glucokinase regulatory protein (GCKR) as candidate genes for type 2 diabetes (T2D) acting through elevated fasting plasma glucose (FPG).
20628598	2010	PLoS ONE	1932-6203	BACKGROUND	1	1	2646	LONGTERM|GENE|GT|DICTIONARY	glucokinase regulatory protein	glucokinase regulatory protein	162#192		D018149	LONGTERM|DICTIONARY	fpg	FPG	293#296	NaN	Previous studies identified melatonin receptor 1B (MTNR1B), islet-specific glucose 6 phosphatase catalytic subunit-related protein (G6PC2), glucokinase (GCK) and glucokinase regulatory protein (GCKR) as candidate genes for type 2 diabetes (T2D) acting through elevated fasting plasma glucose (FPG).
20628598	2010	PLoS ONE	1932-6203	BACKGROUND	1	1	2646	SYMBOL|()|DICTIONARY|EXTRACTED	gckr	GCKR	194#198	20628598-1-162-192	D003924	LONGTERM|DICTIONARY	type 2 diabetes	type 2 diabetes	223#238		Previous studies identified melatonin receptor 1B (MTNR1B), islet-specific glucose 6 phosphatase catalytic subunit-related protein (G6PC2), glucokinase (GCK) and glucokinase regulatory protein (GCKR) as candidate genes for type 2 diabetes (T2D) acting through elevated fasting plasma glucose (FPG).
20628598	2010	PLoS ONE	1932-6203	BACKGROUND	1	1	2646	SYMBOL|()|DICTIONARY|EXTRACTED	gckr	GCKR	194#198	20628598-1-162-192	D003924	SYMBOL|()|DICTIONARY|EXTRACTED	t2d	T2D	240#243	20628598-1-223-238	Previous studies identified melatonin receptor 1B (MTNR1B), islet-specific glucose 6 phosphatase catalytic subunit-related protein (G6PC2), glucokinase (GCK) and glucokinase regulatory protein (GCKR) as candidate genes for type 2 diabetes (T2D) acting through elevated fasting plasma glucose (FPG).
20628598	2010	PLoS ONE	1932-6203	BACKGROUND	1	1	2646	SYMBOL|()|DICTIONARY|EXTRACTED	gckr	GCKR	194#198	20628598-1-162-192	D018149	LONGTERM|DICTIONARY	fasting plasma glucose	fasting plasma glucose	269#291	NaN	Previous studies identified melatonin receptor 1B (MTNR1B), islet-specific glucose 6 phosphatase catalytic subunit-related protein (G6PC2), glucokinase (GCK) and glucokinase regulatory protein (GCKR) as candidate genes for type 2 diabetes (T2D) acting through elevated fasting plasma glucose (FPG).
20628598	2010	PLoS ONE	1932-6203	BACKGROUND	1	1	2646	SYMBOL|()|DICTIONARY|EXTRACTED	gckr	GCKR	194#198	20628598-1-162-192	D018149	LONGTERM|DICTIONARY	fpg	FPG	293#296	NaN	Previous studies identified melatonin receptor 1B (MTNR1B), islet-specific glucose 6 phosphatase catalytic subunit-related protein (G6PC2), glucokinase (GCK) and glucokinase regulatory protein (GCKR) as candidate genes for type 2 diabetes (T2D) acting through elevated fasting plasma glucose (FPG).
20663522	2010	J. Urol.	1527-3792	RESULTS	3	7	1906	LONGTERM|DICTIONARY	endothelin 1	endothelin-1	7#19		D011471	LONGTERM|DICTIONARY	prostate cancers	prostate cancers	47#63		Higher endothelin-1 expression was observed in prostate cancers (p = 0.011), especially those with a higher Gleason score (p = 0.042).
14695532	2004	Hum. Mutat.	1098-1004	ALL_TEXT_2/3	2	3	2548	SYMBOL|()|DICTIONARY|EXTRACTED	gaa	GAA	122#125	14695532-0-34-61	D006009	LONGTERM|DICTIONARY	gsdii	GSDII	33#38	NaN	We have investigated 29 cases of GSDII and thereby identified 55 pathogenic mutations of the acid alpha-glucosidase gene (GAA) encoding acid maltase.
16168956	2005	Biochem. Biophys. Res. Commun.	0006-291X	TITLE	0	0	3309	SYMBOL|DICTIONARY	hspa5	HSPA5	28#33		D001714	LONGTERM|DISEASE|DT|DICTIONARY	bipolar disorder	bipolar disorder	61#77		Functional polymorphisms of HSPA5: possible association with bipolar disorder.
16168956	2005	Biochem. Biophys. Res. Commun.	0006-291X	ALL_TEXT_1/3	1	2	3309	SYMBOL|DICTIONARY	hspa5	HSPA5	65#70		D001714	LONGTERM|DISEASE|DT|DICTIONARY	bipolar disorder	bipolar disorder	88#104		Previously, we preliminarily reported the genetic association of HSPA5 (GRP78/BiP) with bipolar disorder.
16168956	2005	Biochem. Biophys. Res. Commun.	0006-291X	ALL_TEXT_1/3	1	2	3309	SYMBOL|DICTIONARY	grp78	GRP78	72#77		D001714	LONGTERM|DISEASE|DT|DICTIONARY	bipolar disorder	bipolar disorder	88#104		Previously, we preliminarily reported the genetic association of HSPA5 (GRP78/BiP) with bipolar disorder.
18194365	2008	Tissue Antigens	0001-2815	TITLE	0	0	26191	SYMBOL|GENE|GN|DICTIONARY	ptpn22	PTPN22	36#42		D002446	LONGTERM|DISEASE|DT|DICTIONARY	celiac disease	celiac disease	67#81		The functional R620W variant of the PTPN22 gene is associated with celiac disease.
18194365	2008	Tissue Antigens	0001-2815	ALL_TEXT_1/3	1	1	26191	SYMBOL|DICTIONARY	ptpn22	PTPN22	40#46		D001327	LONGTERM|DICTIONARY	autoimmune disorders	autoimmune disorders	142#162		The functional (R620W) variant of human PTPN22 (protein tyrosine phosphatase non-receptor 22) gene has been implicated in the risk to several autoimmune disorders, including type 1 diabetes, Graves' disease, rheumatoid arthritis and systemic lupus erythematosus.
18194365	2008	Tissue Antigens	0001-2815	ALL_TEXT_1/3	1	1	26191	SYMBOL|DICTIONARY	ptpn22	PTPN22	40#46		D006111	LONGTERM|DISEASE|DT|DICTIONARY	graves disease	Graves' disease	191#206		The functional (R620W) variant of human PTPN22 (protein tyrosine phosphatase non-receptor 22) gene has been implicated in the risk to several autoimmune disorders, including type 1 diabetes, Graves' disease, rheumatoid arthritis and systemic lupus erythematosus.
18194365	2008	Tissue Antigens	0001-2815	ALL_TEXT_1/3	1	1	26191	SYMBOL|DICTIONARY	ptpn22	PTPN22	40#46		D001172	LONGTERM|DICTIONARY	rheumatoid arthritis	rheumatoid arthritis	208#228		The functional (R620W) variant of human PTPN22 (protein tyrosine phosphatase non-receptor 22) gene has been implicated in the risk to several autoimmune disorders, including type 1 diabetes, Graves' disease, rheumatoid arthritis and systemic lupus erythematosus.
18194365	2008	Tissue Antigens	0001-2815	ALL_TEXT_1/3	1	1	26191	SYMBOL|DICTIONARY	ptpn22	PTPN22	40#46		D008180	LONGTERM|DICTIONARY	systemic lupus erythematosus	systemic lupus erythematosus	233#261		The functional (R620W) variant of human PTPN22 (protein tyrosine phosphatase non-receptor 22) gene has been implicated in the risk to several autoimmune disorders, including type 1 diabetes, Graves' disease, rheumatoid arthritis and systemic lupus erythematosus.
18194365	2008	Tissue Antigens	0001-2815	ALL_TEXT_1/3	1	1	26191	SYMBOL|DICTIONARY	ptpn22	PTPN22	40#46		D003920	LONGTERM|DICTIONARY	diabetes	diabetes	181#189		The functional (R620W) variant of human PTPN22 (protein tyrosine phosphatase non-receptor 22) gene has been implicated in the risk to several autoimmune disorders, including type 1 diabetes, Graves' disease, rheumatoid arthritis and systemic lupus erythematosus.
18194365	2008	Tissue Antigens	0001-2815	ALL_TEXT_1/3	1	1	26191	LONGTERM|DICTIONARY	protein tyrosine phosphatase non-receptor 22	protein tyrosine phosphatase non-receptor 22	48#92		D001327	LONGTERM|DICTIONARY	autoimmune disorders	autoimmune disorders	142#162		The functional (R620W) variant of human PTPN22 (protein tyrosine phosphatase non-receptor 22) gene has been implicated in the risk to several autoimmune disorders, including type 1 diabetes, Graves' disease, rheumatoid arthritis and systemic lupus erythematosus.
18194365	2008	Tissue Antigens	0001-2815	ALL_TEXT_1/3	1	1	26191	LONGTERM|DICTIONARY	protein tyrosine phosphatase non-receptor 22	protein tyrosine phosphatase non-receptor 22	48#92		D006111	LONGTERM|DISEASE|DT|DICTIONARY	graves disease	Graves' disease	191#206		The functional (R620W) variant of human PTPN22 (protein tyrosine phosphatase non-receptor 22) gene has been implicated in the risk to several autoimmune disorders, including type 1 diabetes, Graves' disease, rheumatoid arthritis and systemic lupus erythematosus.
18194365	2008	Tissue Antigens	0001-2815	ALL_TEXT_1/3	1	1	26191	LONGTERM|DICTIONARY	protein tyrosine phosphatase non-receptor 22	protein tyrosine phosphatase non-receptor 22	48#92		D001172	LONGTERM|DICTIONARY	rheumatoid arthritis	rheumatoid arthritis	208#228		The functional (R620W) variant of human PTPN22 (protein tyrosine phosphatase non-receptor 22) gene has been implicated in the risk to several autoimmune disorders, including type 1 diabetes, Graves' disease, rheumatoid arthritis and systemic lupus erythematosus.
18194365	2008	Tissue Antigens	0001-2815	ALL_TEXT_1/3	1	1	26191	LONGTERM|DICTIONARY	protein tyrosine phosphatase non-receptor 22	protein tyrosine phosphatase non-receptor 22	48#92		D008180	LONGTERM|DICTIONARY	systemic lupus erythematosus	systemic lupus erythematosus	233#261		The functional (R620W) variant of human PTPN22 (protein tyrosine phosphatase non-receptor 22) gene has been implicated in the risk to several autoimmune disorders, including type 1 diabetes, Graves' disease, rheumatoid arthritis and systemic lupus erythematosus.
18194365	2008	Tissue Antigens	0001-2815	ALL_TEXT_1/3	1	1	26191	LONGTERM|DICTIONARY	protein tyrosine phosphatase non-receptor 22	protein tyrosine phosphatase non-receptor 22	48#92		D003920	LONGTERM|DICTIONARY	diabetes	diabetes	181#189		The functional (R620W) variant of human PTPN22 (protein tyrosine phosphatase non-receptor 22) gene has been implicated in the risk to several autoimmune disorders, including type 1 diabetes, Graves' disease, rheumatoid arthritis and systemic lupus erythematosus.
17094469	2006	Anticancer Res.	0250-7005	ALL_TEXT_3/3	3	6	4193	SYMBOL|DICTIONARY	mdm2	MDM2	69#73		D001749	LONGTERM|DISEASE|DT|DICTIONARY	bladder cancer	bladder cancer	146#160		To the best of our knowledge, this is the first study reporting that MDM2 T309G polymorphism may be a potential genetic susceptibility factor for bladder cancer.
17094469	2006	Anticancer Res.	0250-7005	ALL_TEXT_3/3	3	5	4193	SYMBOL|DICTIONARY	mdm2	MDM2	42#46		D001749	LONGTERM|DISEASE|DT|DICTIONARY	bladder cancer	bladder cancer	70#84		These results show an association between MDM2 T309G polymorphism and bladder cancer in our study group.
9865924	1999	Clin. Cancer Res.	1078-0432	ALL_TEXT_1/3	1	3	1728	SYMBOL|DICTIONARY|EXTRACTED	nqo1	NQO1	162#166	9865924-0-35-57	D064420	LONGTERM|DICTIONARY	cytotoxicity	cytotoxicity	185#197	NaN	Previously, 2,5-diaziridinyl-3,6-dimethyl-1,4-benzoquinone (MeDZQ) was identified as a potential antitumor agent based on its high rate of bioactivation by human NQO1 and its selective cytotoxicity to cells containing elevated NQO1.
9865924	1999	Clin. Cancer Res.	1078-0432	ALL_TEXT_1/3	1	3	1728	SYMBOL|DICTIONARY|EXTRACTED	nqo1	NQO1	227#231	9865924-0-35-57	D064420	LONGTERM|DICTIONARY	cytotoxicity	cytotoxicity	185#197	NaN	Previously, 2,5-diaziridinyl-3,6-dimethyl-1,4-benzoquinone (MeDZQ) was identified as a potential antitumor agent based on its high rate of bioactivation by human NQO1 and its selective cytotoxicity to cells containing elevated NQO1.
19225526	2009	Genes Immun.	1476-5470	ALL_TEXT_2/3	2	4	6775	SYMBOL|DICTIONARY	stat4	STAT4	32#37		D006402	LONGTERM|DICTIONARY	hematologic disorders	hematologic disorders	56#77		It was showed that rs7574865 of STAT4 is also linked to hematologic disorders and potentially some other subphenotypes of the disease.
17405833	2007	Ann. Rheum. Dis.	0003-4967	CONCLUSIONS	4	8	3458	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	ifn gamma	IFN-gamma	23#32	17405833-1-21-37	D009220	SYMBOL|PLURAL|DICTIONARY|EXTRACTED	iims	IIMs	92#96	17405833-1-111-145	Genetic markers in the IFN-gamma gene demonstrate significant allelic associations with the IIMs in a UK Caucasian population.
18949411	2009	Oncol. Rep.	1021-335X	ALL_TEXT_3/3	3	9	2264	SYMBOL|DICTIONARY	fgfr4	FGFR4	23#28		D002289	LONGTERM|DICTIONARY|EXTRACTED	nsclc	NSCLC	78#83	18949411-1-145-171	Therefore, the role of FGFR4 polymorphism is a prognostic marker for advanced NSCLC in Japanese patients.
18949411	2009	Oncol. Rep.	1021-335X	TITLE	0	0	2264	LONGTERM|DICTIONARY	fibroblast growth factor receptor 4	Fibroblast growth factor receptor 4	0#35		D008175	LONGTERM|DISEASE|DT|DICTIONARY	lung cancer	lung cancer	74#85		Fibroblast growth factor receptor 4 mutation and polymorphism in Japanese lung cancer.
18949411	2009	Oncol. Rep.	1021-335X	ALL_TEXT_1/3	1	1	2264	SYMBOL|DICTIONARY	fgfr4	FGFR4	20#25		D002289	LONGTERM|DISEASE|DT|DICTIONARY	non small cell lung cancer	non-small cell lung cancer	145#171		We investigated the FGFR4 mutation status at the kinase domain and FGFR4 single nucleotide polymorphism (SNP) at codon 388 in surgically treated non-small cell lung cancer (NSCLC) cases.
18949411	2009	Oncol. Rep.	1021-335X	ALL_TEXT_1/3	1	1	2264	SYMBOL|DICTIONARY	fgfr4	FGFR4	20#25		D002289	LONGTERM|()|DICTIONARY|EXTRACTED	nsclc	NSCLC	173#178	18949411-1-145-171	We investigated the FGFR4 mutation status at the kinase domain and FGFR4 single nucleotide polymorphism (SNP) at codon 388 in surgically treated non-small cell lung cancer (NSCLC) cases.
18949411	2009	Oncol. Rep.	1021-335X	ALL_TEXT_1/3	1	1	2264	SYMBOL|DICTIONARY	fgfr4	FGFR4	67#72		D002289	LONGTERM|DISEASE|DT|DICTIONARY	non small cell lung cancer	non-small cell lung cancer	145#171		We investigated the FGFR4 mutation status at the kinase domain and FGFR4 single nucleotide polymorphism (SNP) at codon 388 in surgically treated non-small cell lung cancer (NSCLC) cases.
18949411	2009	Oncol. Rep.	1021-335X	ALL_TEXT_1/3	1	1	2264	SYMBOL|DICTIONARY	fgfr4	FGFR4	67#72		D002289	LONGTERM|()|DICTIONARY|EXTRACTED	nsclc	NSCLC	173#178	18949411-1-145-171	We investigated the FGFR4 mutation status at the kinase domain and FGFR4 single nucleotide polymorphism (SNP) at codon 388 in surgically treated non-small cell lung cancer (NSCLC) cases.
18949411	2009	Oncol. Rep.	1021-335X	ALL_TEXT_1/3	1	3	2264	SYMBOL|DICTIONARY	fgfr4	FGFR4	0#5		D008175	LONGTERM|DISEASE|DN|DT|DICTIONARY	lung cancer	lung cancer	40#51		FGFR4 mutations were not present in our lung cancer patients.
18949411	2009	Oncol. Rep.	1021-335X	ALL_TEXT_2/3	2	6	1956	SYMBOL|DICTIONARY	egfr	EGFR	0#4		D008175	LONGTERM|DICTIONARY	lung cancers	lung cancers	67#79		EGFR mutation status was not correlated with the FGFR4 genotype of lung cancers.
18949411	2009	Oncol. Rep.	1021-335X	ALL_TEXT_2/3	2	6	2264	SYMBOL|DICTIONARY	fgfr4	FGFR4	49#54		D008175	LONGTERM|DICTIONARY	lung cancers	lung cancers	67#79		EGFR mutation status was not correlated with the FGFR4 genotype of lung cancers.
17405833	2007	Ann. Rheum. Dis.	0003-4967	RESULTS	3	7	3458	SYMBOL|EXTRACTED	ifn gamma	IFN-gamma	19#28	17405833-1-21-37	D009220	LONGTERM|DICTIONARY	myositis	myositis	276#284		The microsatellite IFN-gamma CA(14) allele was associated with risk for IIMs overall (OR 3.3, 95% CI 1.4 to 7.8), the strongest association being observed within the anti-U1-ribonucleoprotein (RNP) group (OR 6.0, 95% CI 1.5 to 23.1), and persisting after adjustment for known myositis human leucocyte antigen (HLA) class II associations.
17405833	2007	Ann. Rheum. Dis.	0003-4967	RESULTS	3	7	3458	SYMBOL|EXTRACTED	ifn gamma	IFN-gamma	19#28	17405833-1-21-37	D009220	SYMBOL|PLURAL|DICTIONARY|EXTRACTED	iims	IIMs	72#76	17405833-1-111-145	The microsatellite IFN-gamma CA(14) allele was associated with risk for IIMs overall (OR 3.3, 95% CI 1.4 to 7.8), the strongest association being observed within the anti-U1-ribonucleoprotein (RNP) group (OR 6.0, 95% CI 1.5 to 23.1), and persisting after adjustment for known myositis human leucocyte antigen (HLA) class II associations.
17405833	2007	Ann. Rheum. Dis.	0003-4967	RESULTS	3	7	55599	LONGTERM|DICTIONARY	anti-u1-ribonucleoprotein	anti-U1-ribonucleoprotein	166#191	NaN	D009220	LONGTERM|DICTIONARY	myositis	myositis	276#284		The microsatellite IFN-gamma CA(14) allele was associated with risk for IIMs overall (OR 3.3, 95% CI 1.4 to 7.8), the strongest association being observed within the anti-U1-ribonucleoprotein (RNP) group (OR 6.0, 95% CI 1.5 to 23.1), and persisting after adjustment for known myositis human leucocyte antigen (HLA) class II associations.
17405833	2007	Ann. Rheum. Dis.	0003-4967	RESULTS	3	7	55599	LONGTERM|DICTIONARY	anti-u1-ribonucleoprotein	anti-U1-ribonucleoprotein	166#191	NaN	D009220	SYMBOL|PLURAL|DICTIONARY|EXTRACTED	iims	IIMs	72#76	17405833-1-111-145	The microsatellite IFN-gamma CA(14) allele was associated with risk for IIMs overall (OR 3.3, 95% CI 1.4 to 7.8), the strongest association being observed within the anti-U1-ribonucleoprotein (RNP) group (OR 6.0, 95% CI 1.5 to 23.1), and persisting after adjustment for known myositis human leucocyte antigen (HLA) class II associations.
12915675	2003	J. Clin. Endocrinol. Metab.	0021-972X	TITLE	0	0	4353	LONGTERM|GENE|GN|DICTIONARY	myeloperoxidase	myeloperoxidase	114#129		D050197	LONGTERM|DICTIONARY	atherosclerosis	atherosclerosis	51#66		Effect of long-term hormone replacement therapy on atherosclerosis progression in postmenopausal women relates to myeloperoxidase promoter polymorphism.
12915675	2003	J. Clin. Endocrinol. Metab.	0021-972X	TITLE	0	0	4353	LONGTERM|GENE|GN|DICTIONARY	myeloperoxidase	myeloperoxidase	114#129		D016609	LONGTERM|DICTIONARY	hormone replacement therapy	hormone replacement therapy	20#47	NaN	Effect of long-term hormone replacement therapy on atherosclerosis progression in postmenopausal women relates to myeloperoxidase promoter polymorphism.
21285140	2011	Am J Psychiatry	1535-7228	TITLE	0	0	7434	SYMBOL|DICTIONARY|EXTRACTED	vipr2	VIPR2	123#128		D012559	LONGTERM|DICTIONARY	schizophrenia	schizophrenia	24#37		Copy number variants in schizophrenia: confirmation of five previous findings and new evidence for 3q29 microdeletions and VIPR2 duplications.
18034620	2008	Pharmacogenomics	1744-8042	TITLE	0	0	4524	SYMBOL|DICTIONARY|EXTRACTED	mthfr	MTHFR	19#24		D001172	LONGTERM|DICTIONARY	rheumatoid arthritis	rheumatoid arthritis	80#100		677C>T and 1298A>C MTHFR polymorphisms affect methotrexate treatment outcome in rheumatoid arthritis.
18034620	2008	Pharmacogenomics	1744-8042	CONCLUSION	4	6	4524	SYMBOL|NUMBER|DICTIONARY|EXTRACTED	mthfr	MTHFR	42#47	18034620-2-0-35	D001172	SYMBOL|EXTRACTED	ra	RA	115#117	18034620-1-52-72	The results of our study suggest that the MTHFR 677T and 1298C alleles may be associated with an increased rate of RA remission in patients treated with MTX receiving high doses of folic acid supplementation.
8930979	1997	Neuroreport	0959-4965	ALL_TEXT_3/3	3	4	5663	SYMBOL|EXTRACTED	ps 1	PS-1	31#35	8930979-1-111-123	D000544	LONGTERM|DICTIONARY	ad	AD	133#135	NaN	These results suggest that the PS-1 polymorphism, or a locus in linkage disequilibrium with it, acts as a risk factor for late onset AD.
18997459	2009	Ann. Nutr. Metab.	1421-9697	CONCLUSION	4	12	7124	SYMBOL|EXTRACTED	tnfalpha	TNFalpha	130#138	18997459-1-141-168	D054058	LONGTERM|DISEASE|DT|DICTIONARY	acute coronary syndrome	acute coronary syndrome	17#40		In patients with acute coronary syndrome, atorvastatin increases lumbar spine BMD solely in patients with the G/G genotype of the TNFalpha-308 G/A polymorphism.
21983886	2012	Arch. Toxicol.	1432-0738	ALL_TEXT_2/3	2	6	2052	SYMBOL|DICTIONARY	ephx1	EPHX1	49#54		D054198	LONGTERM|DICTIONARY	childhood all	childhood ALL	239#252		We also evaluated whether haplotype analysis for EPHX1 Tyr113His polymorphism together with DNA protein XRCC1 Arg399Gln variant known for its deficient DNA repair capacity would represent more prominent risk factors for the development of childhood ALL.
21983886	2012	Arch. Toxicol.	1432-0738	ALL_TEXT_2/3	2	6	7515	SYMBOL|DICTIONARY	xrcc1	XRCC1	104#109		D054198	LONGTERM|DICTIONARY	childhood all	childhood ALL	239#252		We also evaluated whether haplotype analysis for EPHX1 Tyr113His polymorphism together with DNA protein XRCC1 Arg399Gln variant known for its deficient DNA repair capacity would represent more prominent risk factors for the development of childhood ALL.
21983886	2012	Arch. Toxicol.	1432-0738	ALL_TEXT_3/3	3	7	2052	SYMBOL|DICTIONARY	ephx1	EPHX1	53#58		D054198	LONGTERM|DICTIONARY	childhood all	childhood ALL	150#163		Accordingly, the co-presence of Tyr113His variant of EPHX1 and Arg399Gln variant of XRCC1 in the same individuals significantly increased the risk of childhood ALL up to 2.1-fold (OR = 2.1, P = 0.03).
21983886	2012	Arch. Toxicol.	1432-0738	ALL_TEXT_3/3	3	7	7515	SYMBOL|DICTIONARY	xrcc1	XRCC1	84#89		D054198	LONGTERM|DICTIONARY	childhood all	childhood ALL	150#163		Accordingly, the co-presence of Tyr113His variant of EPHX1 and Arg399Gln variant of XRCC1 in the same individuals significantly increased the risk of childhood ALL up to 2.1-fold (OR = 2.1, P = 0.03).
21983886	2012	Arch. Toxicol.	1432-0738	ALL_TEXT_1/3	1	2	2052	SYMBOL|DICTIONARY	ephx1	EPHX1	72#77		D054198	SYMBOL|EXTRACTED|()	all	ALL	181#184	21983886-2-141-179	In this study, we firstly aimed to investigate the relationship between EPHX1 Tyr113His and His139Arg variants, and the risk of incidence of childhood acute lymphoblastic leukemia (ALL) in Turkish population, comprised of 190 healthy controls and 167 ALL patients.
21983886	2012	Arch. Toxicol.	1432-0738	ALL_TEXT_1/3	1	2	2052	SYMBOL|DICTIONARY	ephx1	EPHX1	72#77		D054198	SYMBOL|EXTRACTED|DISEASE|DN	all	ALL	251#254	21983886-2-141-179	In this study, we firstly aimed to investigate the relationship between EPHX1 Tyr113His and His139Arg variants, and the risk of incidence of childhood acute lymphoblastic leukemia (ALL) in Turkish population, comprised of 190 healthy controls and 167 ALL patients.
21983886	2012	Arch. Toxicol.	1432-0738	ALL_TEXT_1/3	1	2	2052	SYMBOL|DICTIONARY	ephx1	EPHX1	72#77		D054198	LONGTERM|DICTIONARY	acute lymphoblastic leukemia	acute lymphoblastic leukemia	151#179		In this study, we firstly aimed to investigate the relationship between EPHX1 Tyr113His and His139Arg variants, and the risk of incidence of childhood acute lymphoblastic leukemia (ALL) in Turkish population, comprised of 190 healthy controls and 167 ALL patients.
21983886	2012	Arch. Toxicol.	1432-0738	TITLE	0	0	2052	SYMBOL|DICTIONARY	ephx1	EPHX1	37#42		D054198	LONGTERM|DICTIONARY	acute lymphoblastic leukemia	acute lymphoblastic leukemia	85#113		Association between polymorphisms of EPHX1 and XRCC1 genes and the risk of childhood acute lymphoblastic leukemia.
21983886	2012	Arch. Toxicol.	1432-0738	TITLE	0	0	7515	SYMBOL|GENE|GN|DICTIONARY	xrcc1	XRCC1	47#52		D054198	LONGTERM|DICTIONARY	acute lymphoblastic leukemia	acute lymphoblastic leukemia	85#113		Association between polymorphisms of EPHX1 and XRCC1 genes and the risk of childhood acute lymphoblastic leukemia.
16230376	2005	Cancer Res.	0008-5472	ALL_TEXT_3/3	3	9	374	LONGTERM|DICTIONARY	amphiregulin	amphiregulin	36#48		D002289	LONGTERM|DICTIONARY|EXTRACTED	nsclc	NSCLC	162#167	16230376-1-146-172	Our data suggest that the status of amphiregulin and TGF-alpha in serum can be an important predictor of the resistance to gefitinib among patients with advanced NSCLC.
16230376	2005	Cancer Res.	0008-5472	ALL_TEXT_3/3	3	9	7039	LONGTERM|DICTIONARY|EXTRACTED	tgf alpha	TGF-alpha	53#62	16230376-1-33-65	D002289	LONGTERM|DICTIONARY|EXTRACTED	nsclc	NSCLC	162#167	16230376-1-146-172	Our data suggest that the status of amphiregulin and TGF-alpha in serum can be an important predictor of the resistance to gefitinib among patients with advanced NSCLC.
16230376	2005	Cancer Res.	0008-5472	ALL_TEXT_3/3	3	8	374	LONGTERM|DICTIONARY	amphiregulin	Amphiregulin	0#12		D002289	LONGTERM|DICTIONARY|EXTRACTED	nsclc	NSCLC	40#45	16230376-1-146-172	Amphiregulin or TGF-alpha positivity in NSCLC tissues was significantly higher in male, nonadenocarcinomas, and smokers.
16230376	2005	Cancer Res.	0008-5472	ALL_TEXT_3/3	3	8	7039	LONGTERM|DICTIONARY|EXTRACTED	tgf alpha	TGF-alpha	16#25	16230376-1-33-65	D002289	LONGTERM|DICTIONARY|EXTRACTED	nsclc	NSCLC	40#45	16230376-1-146-172	Amphiregulin or TGF-alpha positivity in NSCLC tissues was significantly higher in male, nonadenocarcinomas, and smokers.
18804097	2009	Brain Res.	1872-6240	ALL_TEXT_3/3	3	8	6532	SYMBOL|DICTIONARY	slc6a4	SLC6A4	437#443		D001321	LONGTERM|DICTIONARY	autism	autism	484#490		However, the interesting finding of strong linkage disequilibrium (LD) between the markers and significant disease-specific distortion in the distribution of HTT-3'UTR-SNP genotypes (T1chi(2)=5.19, P=0.02; OR=2.89, 95% CI=1.13-7.41) and the specific haplotypes of the two markers (LRS=11.85, p(c)=0.02), with higher frequencies of T/T genotype and 10-T haplotype in autistic cases suggests that either these markers or nearby markers of SLC6A4 that are in LD, may pose a risk towards autism in the Eastern Indian population.
1976809	1990	J. Rheumatol.	0315-162X	ALL_TEXT_3/3	3	7	720	SYMBOL|GENE|GN|DICTIONARY	c4a	C4A	206#209		D008180	SYMBOL|DICTIONARY|EXTRACTED	sle	SLE	70#73	1976809-1-73-101	Our results indicate that C4AQ0 may contribute to the pathogenesis of SLE beyond the ethnical differences but Japanese patients with SLE have a different genetic background from Caucasian patients with the C4A gene deleted.
1976809	1990	J. Rheumatol.	0315-162X	ALL_TEXT_3/3	3	7	720	SYMBOL|GENE|GN|DICTIONARY	c4a	C4A	206#209		D008180	SYMBOL|DICTIONARY|EXTRACTED	sle	SLE	133#136	1976809-1-73-101	Our results indicate that C4AQ0 may contribute to the pathogenesis of SLE beyond the ethnical differences but Japanese patients with SLE have a different genetic background from Caucasian patients with the C4A gene deleted.
15583997	2005	Zhonghua Yi Xue Yi Chuan Xue Za Zhi	1003-9406	TITLE	0	0	1585	LONGTERM|GENE|GN|DICTIONARY	aldosterone synthase	aldosterone synthase	45#65		D006973	LONGTERM|DICTIONARY	hypertension	hypertension	94#106		[Association of the T(-344)C polymorphism of aldosterone synthase gene CYP11B2 with essential hypertension in Xinjiang Kazakh isolated group].
15583997	2005	Zhonghua Yi Xue Yi Chuan Xue Za Zhi	1003-9406	TITLE	0	0	1585	SYMBOL|DICTIONARY	cyp11b2	CYP11B2	71#78		D006973	LONGTERM|DICTIONARY	hypertension	hypertension	94#106		[Association of the T(-344)C polymorphism of aldosterone synthase gene CYP11B2 with essential hypertension in Xinjiang Kazakh isolated group].
18804097	2009	Brain Res.	1872-6240	ALL_TEXT_2/3	2	4	6532	SYMBOL|DICTIONARY	slc6a4	SLC6A4	90#96		D001321	LONGTERM|DICTIONARY	autism	autism	102#108		Our recent report on 5-HTTLPR marker represents the first study on genetic association of SLC6A4 with autism in the Indian population.
16230376	2005	Cancer Res.	0008-5472	ALL_TEXT_2/3	2	6	374	LONGTERM|DICTIONARY	amphiregulin	amphiregulin	45#57		D002289	LONGTERM|DISEASE|DN|DICTIONARY|EXTRACTED	nsclc	NSCLC	18#23	16230376-1-146-172	Gefitinib-treated NSCLC patients whose serum amphiregulin or TGF-alpha was positive showed a poorer tumor-specific survival (P = 0.037 and 0.002, respectively, by univariate analysis) compared with those whose serum amphiregulin or TGF-alpha concentrations were negative.
16230376	2005	Cancer Res.	0008-5472	ALL_TEXT_2/3	2	6	7039	LONGTERM|DICTIONARY|EXTRACTED	tgf alpha	TGF-alpha	61#70	16230376-1-33-65	D002289	LONGTERM|DISEASE|DN|DICTIONARY|EXTRACTED	nsclc	NSCLC	18#23	16230376-1-146-172	Gefitinib-treated NSCLC patients whose serum amphiregulin or TGF-alpha was positive showed a poorer tumor-specific survival (P = 0.037 and 0.002, respectively, by univariate analysis) compared with those whose serum amphiregulin or TGF-alpha concentrations were negative.
16230376	2005	Cancer Res.	0008-5472	ALL_TEXT_2/3	2	6	374	LONGTERM|DICTIONARY	amphiregulin	amphiregulin	216#228		D002289	LONGTERM|DISEASE|DN|DICTIONARY|EXTRACTED	nsclc	NSCLC	18#23	16230376-1-146-172	Gefitinib-treated NSCLC patients whose serum amphiregulin or TGF-alpha was positive showed a poorer tumor-specific survival (P = 0.037 and 0.002, respectively, by univariate analysis) compared with those whose serum amphiregulin or TGF-alpha concentrations were negative.
16230376	2005	Cancer Res.	0008-5472	ALL_TEXT_2/3	2	6	7039	LONGTERM|DICTIONARY|EXTRACTED	tgf alpha	TGF-alpha	232#241	16230376-1-33-65	D002289	LONGTERM|DISEASE|DN|DICTIONARY|EXTRACTED	nsclc	NSCLC	18#23	16230376-1-146-172	Gefitinib-treated NSCLC patients whose serum amphiregulin or TGF-alpha was positive showed a poorer tumor-specific survival (P = 0.037 and 0.002, respectively, by univariate analysis) compared with those whose serum amphiregulin or TGF-alpha concentrations were negative.
18804097	2009	Brain Res.	1872-6240	ALL_TEXT_1/3	1	2	6532	SYMBOL|()|DICTIONARY	slc6a4	SLC6A4	28#34		D001321	LONGTERM|DICTIONARY	autism	autism	122#128		Serotonin transporter gene (SLC6A4) that regulates synaptic serotonin level has been investigated as a candidate gene for autism, but consensus opinion on possible association is still lacking.
18804097	2009	Brain Res.	1872-6240	ALL_TEXT_2/3	2	3	6532	SYMBOL|DICTIONARY	slc6a4	SLC6A4	193#199		D001321	LONGTERM|DISEASE|DN|DICTIONARY	autism	autism	274#280		Converging evidences of platelet-hyperserotoninemia in approximately 25% of the patients, betterment of ritualistic behavior on administration of SSRI and linkage to chromosome 17q11 harboring SLC6A4, supports the hypothesis that SLC6A4 polymorphisms may contribute towards autism pathology.
18804097	2009	Brain Res.	1872-6240	ALL_TEXT_2/3	2	3	6532	SYMBOL|DICTIONARY	slc6a4	SLC6A4	230#236		D001321	LONGTERM|DISEASE|DN|DICTIONARY	autism	autism	274#280		Converging evidences of platelet-hyperserotoninemia in approximately 25% of the patients, betterment of ritualistic behavior on administration of SSRI and linkage to chromosome 17q11 harboring SLC6A4, supports the hypothesis that SLC6A4 polymorphisms may contribute towards autism pathology.
18804097	2009	Brain Res.	1872-6240	TITLE	0	0	6532	SYMBOL|DICTIONARY	slc6a4	SLC6A4	112#118		D001321	LONGTERM|DICTIONARY	autism	autism	124#130		Population-based association study and contrasting linkage disequilibrium pattern reveal genetic association of SLC6A4 with autism in the Indian population from West Bengal.
16230376	2005	Cancer Res.	0008-5472	ALL_TEXT_1/3	1	2	374	LONGTERM|DICTIONARY	amphiregulin	amphiregulin	52#64		D004194	LONGTERM|DICTIONARY	stable disease	stable disease	195#209	NaN	Of 14 cases that revealed above the cutoff line for amphiregulin in serum, 12 responded poorly to gefitinib, whereas 18 of the 36 cases showing below the cutoff revealed partial response (PR) or stable disease (SD; P = 0.026).
16230376	2005	Cancer Res.	0008-5472	ALL_TEXT_1/3	1	2	374	LONGTERM|DICTIONARY	amphiregulin	amphiregulin	52#64		D004194	LONGTERM|DICTIONARY	sd	SD	211#213	NaN	Of 14 cases that revealed above the cutoff line for amphiregulin in serum, 12 responded poorly to gefitinib, whereas 18 of the 36 cases showing below the cutoff revealed partial response (PR) or stable disease (SD; P = 0.026).
17347480	2007	Circ. Res.	1524-4571	ALL_TEXT_3/3	3	13	7442	SYMBOL|DICTIONARY	trpv1	TRPV1	35#40		D009765	LONGTERM|DICTIONARY	obesity	obesity	90#97		We conclude that the activation of TRPV1 channels by capsaicin prevented adipogenesis and obesity.
17347480	2007	Circ. Res.	1524-4571	ALL_TEXT_3/3	3	12	7442	SYMBOL|DICTIONARY	trpv1	TRPV1	102#107		D009765	LONGTERM|DICTIONARY	obesity	obesity	60#67		The oral administration of capsaicin for 120 days prevented obesity in male wild type mice but not in TRPV1 knockout mice assigned to high fat diet.
14717963	2004	J. Thromb. Haemost.	1538-7933	ALL_TEXT_1/3	1	1	4524	LONGTERM|DICTIONARY	methylenetetrahydrofolate reductase	methylenetetrahydrofolate reductase	129#164		D009203	LONGTERM|DICTIONARY	myocardial infarction	myocardial infarction	62#83		In young women data are limited about the association between myocardial infarction (MI) and hyperhomocysteinemia, low folate or methylenetetrahydrofolate reductase (MTHFR) genotypes.
14717963	2004	J. Thromb. Haemost.	1538-7933	ALL_TEXT_1/3	1	1	4524	LONGTERM|DICTIONARY	methylenetetrahydrofolate reductase	methylenetetrahydrofolate reductase	129#164		D009203	SYMBOL|EXTRACTED|()	mi	MI	85#87	14717963-1-62-83	In young women data are limited about the association between myocardial infarction (MI) and hyperhomocysteinemia, low folate or methylenetetrahydrofolate reductase (MTHFR) genotypes.
14717963	2004	J. Thromb. Haemost.	1538-7933	ALL_TEXT_1/3	1	1	4524	LONGTERM|DICTIONARY	methylenetetrahydrofolate reductase	methylenetetrahydrofolate reductase	129#164		D020138	LONGTERM|DICTIONARY	hyperhomocysteinemia	hyperhomocysteinemia	93#113		In young women data are limited about the association between myocardial infarction (MI) and hyperhomocysteinemia, low folate or methylenetetrahydrofolate reductase (MTHFR) genotypes.
14717963	2004	J. Thromb. Haemost.	1538-7933	ALL_TEXT_1/3	1	1	4524	SYMBOL|()|DICTIONARY|EXTRACTED	mthfr	MTHFR	166#171	14717963-0-29-64	D009203	LONGTERM|DICTIONARY	myocardial infarction	myocardial infarction	62#83		In young women data are limited about the association between myocardial infarction (MI) and hyperhomocysteinemia, low folate or methylenetetrahydrofolate reductase (MTHFR) genotypes.
14717963	2004	J. Thromb. Haemost.	1538-7933	ALL_TEXT_1/3	1	1	4524	SYMBOL|()|DICTIONARY|EXTRACTED	mthfr	MTHFR	166#171	14717963-0-29-64	D009203	SYMBOL|EXTRACTED|()	mi	MI	85#87	14717963-1-62-83	In young women data are limited about the association between myocardial infarction (MI) and hyperhomocysteinemia, low folate or methylenetetrahydrofolate reductase (MTHFR) genotypes.
14717963	2004	J. Thromb. Haemost.	1538-7933	ALL_TEXT_1/3	1	1	4524	SYMBOL|()|DICTIONARY|EXTRACTED	mthfr	MTHFR	166#171	14717963-0-29-64	D020138	LONGTERM|DICTIONARY	hyperhomocysteinemia	hyperhomocysteinemia	93#113		In young women data are limited about the association between myocardial infarction (MI) and hyperhomocysteinemia, low folate or methylenetetrahydrofolate reductase (MTHFR) genotypes.
15940757	2005	J. Rheumatol.	0315-162X	CONCLUSION	4	10	2944	SYMBOL|DICTIONARY	gstm1	GSTM1	56#61		D001172	SYMBOL|EXTRACTED	ra	RA	110#112	15940757-1-129-149	These results suggest that the deletion polymorphism of GSTM1 is associated with increased susceptibility for RA, particularly among individuals who are not carriers of the HLA-DRB 1 SE.
15940757	2005	J. Rheumatol.	0315-162X	CONCLUSION	4	10	2944	SYMBOL|DICTIONARY	gstm1	GSTM1	56#61		D012753	LONGTERM|DICTIONARY	se	SE	183#185	NaN	These results suggest that the deletion polymorphism of GSTM1 is associated with increased susceptibility for RA, particularly among individuals who are not carriers of the HLA-DRB 1 SE.
15940757	2005	J. Rheumatol.	0315-162X	CONCLUSION	4	10	3123	SYMBOL|DICTIONARY	hla drb 1	HLA-DRB 1	173#182		D001172	SYMBOL|EXTRACTED	ra	RA	110#112	15940757-1-129-149	These results suggest that the deletion polymorphism of GSTM1 is associated with increased susceptibility for RA, particularly among individuals who are not carriers of the HLA-DRB 1 SE.
15940757	2005	J. Rheumatol.	0315-162X	CONCLUSION	4	10	3123	SYMBOL|DICTIONARY	hla drb 1	HLA-DRB 1	173#182		D012753	LONGTERM|DICTIONARY	se	SE	183#185	NaN	These results suggest that the deletion polymorphism of GSTM1 is associated with increased susceptibility for RA, particularly among individuals who are not carriers of the HLA-DRB 1 SE.
12843182	2003	J. Clin. Endocrinol. Metab.	0021-972X	ALL_TEXT_3/3	3	5	7040	LONGTERM|DICTIONARY	tgfbeta1	TGFbeta1	12#20	NaN	D003966	SYMBOL|DISEASE|DN|DICTIONARY|EXTRACTED	ced	CED	185#188	12843182-1-0-26	Total serum TGFbeta1 levels were similar in affected and unaffected subjects, but concentrations of active TGFbeta1 in conditioned medium of osteoclast cultures was higher in the three CED patients than in the unaffected family member.
12843182	2003	J. Clin. Endocrinol. Metab.	0021-972X	ALL_TEXT_3/3	3	5	7040	LONGTERM|DICTIONARY	tgfbeta1	TGFbeta1	107#115	NaN	D003966	SYMBOL|DISEASE|DN|DICTIONARY|EXTRACTED	ced	CED	185#188	12843182-1-0-26	Total serum TGFbeta1 levels were similar in affected and unaffected subjects, but concentrations of active TGFbeta1 in conditioned medium of osteoclast cultures was higher in the three CED patients than in the unaffected family member.
14717963	2004	J. Thromb. Haemost.	1538-7933	TITLE	0	0	4524	LONGTERM|DICTIONARY	methylenetetrahydrofolate reductase	methylenetetrahydrofolate reductase	29#64		D009203	LONGTERM|DICTIONARY	myocardial infarction	myocardial infarction	109#130		Folate, homocysteine levels, methylenetetrahydrofolate reductase (MTHFR) 677C --> T variant, and the risk of myocardial infarction in young women: effect of female hormones on homocysteine levels.
14717963	2004	J. Thromb. Haemost.	1538-7933	TITLE	0	0	4524	SYMBOL|()|NUMBER|DICTIONARY|EXTRACTED	mthfr	MTHFR	66#71	14717963-0-29-64	D009203	LONGTERM|DICTIONARY	myocardial infarction	myocardial infarction	109#130		Folate, homocysteine levels, methylenetetrahydrofolate reductase (MTHFR) 677C --> T variant, and the risk of myocardial infarction in young women: effect of female hormones on homocysteine levels.
12915675	2003	J. Clin. Endocrinol. Metab.	0021-972X	ALL_TEXT_1/3	1	1	4353	LONGTERM|DICTIONARY	myeloperoxidase	Myeloperoxidase	0#15		D050197	LONGTERM|DICTIONARY	atherosclerotic lesions	atherosclerotic lesions	71#94	NaN	Myeloperoxidase (MPO) is an oxidative enzyme present in phagocytes and atherosclerotic lesions.
12915675	2003	J. Clin. Endocrinol. Metab.	0021-972X	ALL_TEXT_1/3	1	1	4353	SYMBOL|()|DICTIONARY|EXTRACTED	mpo	MPO	17#20	12915675-1-0-15	D050197	LONGTERM|DICTIONARY	atherosclerotic lesions	atherosclerotic lesions	71#94	NaN	Myeloperoxidase (MPO) is an oxidative enzyme present in phagocytes and atherosclerotic lesions.
19363267	2009	J. Alzheimers Dis.	1875-8908	ALL_TEXT_3/3	3	5	348	SYMBOL|DICTIONARY	apoe	APOE	108#112		D000544	SYMBOL|EXTRACTED	ad	AD	62#64	19363267-1-111-130	Logistic regression analysis showed that the highest risk for AD was found for individuals who co-inherited APOE epsilon4 allele, PRNP codon 129 homozygosity, PRND codon 174 Thr allele, and CYP46 rs754203 g allele.
19363267	2009	J. Alzheimers Dis.	1875-8908	ALL_TEXT_3/3	3	5	5621	SYMBOL|DICTIONARY	prnp	PRNP	130#134		D000544	SYMBOL|EXTRACTED	ad	AD	62#64	19363267-1-111-130	Logistic regression analysis showed that the highest risk for AD was found for individuals who co-inherited APOE epsilon4 allele, PRNP codon 129 homozygosity, PRND codon 174 Thr allele, and CYP46 rs754203 g allele.
19363267	2009	J. Alzheimers Dis.	1875-8908	ALL_TEXT_3/3	3	5	23627	SYMBOL|DICTIONARY	prnd	PRND	159#163		D000544	SYMBOL|EXTRACTED	ad	AD	62#64	19363267-1-111-130	Logistic regression analysis showed that the highest risk for AD was found for individuals who co-inherited APOE epsilon4 allele, PRNP codon 129 homozygosity, PRND codon 174 Thr allele, and CYP46 rs754203 g allele.
19363267	2009	J. Alzheimers Dis.	1875-8908	ALL_TEXT_3/3	3	5	10858	SYMBOL|DICTIONARY	cyp46	CYP46	190#195		D000544	SYMBOL|EXTRACTED	ad	AD	62#64	19363267-1-111-130	Logistic regression analysis showed that the highest risk for AD was found for individuals who co-inherited APOE epsilon4 allele, PRNP codon 129 homozygosity, PRND codon 174 Thr allele, and CYP46 rs754203 g allele.
23440206	2013	Proc. Natl. Acad. Sci. U.S.A.	1091-6490	ALL_TEXT_2/3	2	2	5371	SYMBOL|()|GENE|GN|DICTIONARY|EXTRACTED	pml	PML	170#173	23440206-2-146-168	D009369	LONGTERM|DISEASE|DT|CLINE|CN|DICTIONARY	tumor	tumor	44#49		We analyzed GBM cell lines, patient-derived tumor cell cultures, and clinical samples from patients in phase 1 clinical trials, and find that the promyelocytic leukemia (PML) gene mediates resistance to mTOR-targeted therapies.
23440206	2013	Proc. Natl. Acad. Sci. U.S.A.	1091-6490	ALL_TEXT_2/3	2	2	21977	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	mtor	mTOR	203#207	23440206-0-40-69	D009369	LONGTERM|DISEASE|DT|CLINE|CN|DICTIONARY	tumor	tumor	44#49		We analyzed GBM cell lines, patient-derived tumor cell cultures, and clinical samples from patients in phase 1 clinical trials, and find that the promyelocytic leukemia (PML) gene mediates resistance to mTOR-targeted therapies.
8909447	1996	Neurology	0028-3878	ALL_TEXT_2/3	2	3	5621	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	prp	PrP	50#53	8909447-1-50-63	D007562	LONGTERM|DISEASE|DT|DICTIONARY	creutzfeldt jakob disease	Creutzfeldt-Jakob disease	102#127		Using this system, we found a new mutation of the PrP gene in a patient with pathologically confirmed Creutzfeldt-Jakob disease and a negative family history for dementia.
8909447	1996	Neurology	0028-3878	ALL_TEXT_2/3	2	3	5621	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	prp	PrP	50#53	8909447-1-50-63	D003704	LONGTERM|DICTIONARY	dementia	dementia	162#170		Using this system, we found a new mutation of the PrP gene in a patient with pathologically confirmed Creutzfeldt-Jakob disease and a negative family history for dementia.
20207535	2010	Eur. J. Cancer	1879-0852	ALL_TEXT_3/3	3	9	2952	SYMBOL|DICTIONARY	gstt1	GSTT1	11#16		D015179	LONGTERM|DISEASE|DT|DICTIONARY	increased colorectal cancer	increased colorectal cancer	48#75		Similarly, GSTT1 null allele carriers exhibited increased colorectal cancer risk in Caucasian populations (pooled OR=1.312, 95% CI: 1.119-1.538, random effects); the association in Chinese subjects was not significant (pooled OR=1.068, 95% CI: 0.788-1.449, random effects).
20237592	2010	Can. J. Physiol. Pharmacol.	1205-7541	ALL_TEXT_1/3	1	3	7349	SYMBOL|EXTRACTED	ucn	Ucn	47#50	20237592-1-28-37	D006973	LONGTERM|DICTIONARY	hypertensive	hypertensive	68#80	NaN	After 8 weeks of intravenous administration of Ucn in spontaneously hypertensive rats (SHR), serum and tissue sACE, angiotensin II (Ang II), nitric oxide (NO), Ang-(1-7), and tissue chymase activities were evaluated.
20237592	2010	Can. J. Physiol. Pharmacol.	1205-7541	ALL_TEXT_1/3	1	3	183	LONGTERM|DICTIONARY	angiotensin ii	angiotensin II	116#130		D006973	LONGTERM|DICTIONARY	hypertensive	hypertensive	68#80	NaN	After 8 weeks of intravenous administration of Ucn in spontaneously hypertensive rats (SHR), serum and tissue sACE, angiotensin II (Ang II), nitric oxide (NO), Ang-(1-7), and tissue chymase activities were evaluated.
20237592	2010	Can. J. Physiol. Pharmacol.	1205-7541	ALL_TEXT_1/3	1	3	29265	LONGTERM|DICTIONARY	chymase	chymase	182#189	NaN	D006973	LONGTERM|DICTIONARY	hypertensive	hypertensive	68#80	NaN	After 8 weeks of intravenous administration of Ucn in spontaneously hypertensive rats (SHR), serum and tissue sACE, angiotensin II (Ang II), nitric oxide (NO), Ang-(1-7), and tissue chymase activities were evaluated.
20207535	2010	Eur. J. Cancer	1879-0852	ALL_TEXT_2/3	2	8	2944	SYMBOL|DICTIONARY	gstm1	GSTM1	0#5		D015179	LONGTERM|DISEASE|DT|DICTIONARY	increased colorectal cancer	increased colorectal cancer	37#64		GSTM1 null allele carriers exhibited increased colorectal cancer risk in Caucasian populations (pooled OR=1.150, 95% confidence interval (CI): 1.060-1.248, random effects); no significant association was detected for Chinese subjects (pooled OR=1.025, 95% CI: 0.903-1.163, fixed effects).
20646601	2010	Zhonghua Yi Xue Za Zhi	0376-2491	CONCLUSION	4	9	1956	LONGTERM|GENE|GT|DICTIONARY	epidermal growth factor receptor	epidermal growth factor receptor	153#185		D015179	LONGTERM|DISEASE|DT|DICTIONARY	colorectal cancer	colorectal cancer	34#51		Detection of K-ras gene status in colorectal cancer will help to select the patients likely to benefit from the monoclonal antibody therapy of targeting epidermal growth factor receptor.
20646601	2010	Zhonghua Yi Xue Za Zhi	0376-2491	CONCLUSION	4	9	3845	LONGTERM|DICTIONARY	k-ras	K-ras	13#18	NaN	D015179	LONGTERM|DISEASE|DT|DICTIONARY	colorectal cancer	colorectal cancer	34#51		Detection of K-ras gene status in colorectal cancer will help to select the patients likely to benefit from the monoclonal antibody therapy of targeting epidermal growth factor receptor.
20854105	2011	Genet Test Mol Biomarkers	1945-0257	CONCLUSIONS	4	10	9156	SYMBOL|DICTIONARY|EXTRACTED	exo1	EXO1	69#73	20854105-1-65-78	D015179	SYMBOL|DICTIONARY|EXTRACTED	crc	CRC	109#112	20854105-1-23-40	Our results provide evidence diagnosing that the Leu/Leu genotype of EXO1 showed an inverse association with CRC.
16495393	2006	N. Engl. J. Med.	1533-4406	METHODS	2	4	2064	SYMBOL|DICTIONARY	her2/neu	HER2/neu	44#52		D009369	LONGTERM|DICTIONARY	tumors	tumors	20#26		The 232 women whose tumors had an amplified HER2/neu gene were further assigned to receive or not to receive nine weekly trastuzumab infusions.
16495393	2006	N. Engl. J. Med.	1533-4406	METHODS	2	4	2064	SYMBOL|GENE|GN|DICTIONARY	her2/neu	HER2/neu	44#52		D009369	LONGTERM|DICTIONARY	tumors	tumors	20#26		The 232 women whose tumors had an amplified HER2/neu gene were further assigned to receive or not to receive nine weekly trastuzumab infusions.
20683028	2010	Anticancer Res.	1791-7530	RESULTS AND CONCLUSION	3	7	10	SYMBOL|NUMBER|DICTIONARY	nat2	NAT2	17#21		D001943	LONGTERM|DISEASE|DN|DT|DICTIONARY	breast cancer	breast cancer	70#83		In addition, the NAT2*5 alelle was more statistically correlated with breast cancer patients rather than the controls (p=0.02).
16391475	2006	Dement Geriatr Cogn Disord	1420-8008	ALL_TEXT_1/3	1	3	627	SYMBOL|DICTIONARY|EXTRACTED	bdnf	BDNF	62#66	16391475-1-0-33	D000544	SYMBOL|EXTRACTED	ad	AD	112#114	16391475-1-146-165	Some previous studies, though not all, have demonstrated that BDNF C270T polymorphisms might be associated with AD susceptibility.
16391475	2006	Dement Geriatr Cogn Disord	1420-8008	ALL_TEXT_1/3	1	2	627	SYMBOL|DICTIONARY|EXTRACTED	bdnf	BDNF	96#100	16391475-1-0-33	D000544	SYMBOL|EXTRACTED	ad	AD	116#118	16391475-1-146-165	This is because it has an important role in neuronal survival, and a decreased central level of BDNF is observed in AD.
16391475	2006	Dement Geriatr Cogn Disord	1420-8008	ALL_TEXT_1/3	1	1	627	LONGTERM|GENE|GT|DICTIONARY	brain derived neurotrophic factor	Brain-derived neurotrophic factor	0#33		D000544	LONGTERM|DISEASE|DT|DICTIONARY	alzheimer disease	Alzheimer's disease	146#165		Brain-derived neurotrophic factor (BDNF), a member of the neurotrophic factor family, may represent a candidate gene conferring susceptibility to Alzheimer's disease (AD).
16391475	2006	Dement Geriatr Cogn Disord	1420-8008	ALL_TEXT_1/3	1	1	627	LONGTERM|GENE|GT|DICTIONARY	brain derived neurotrophic factor	Brain-derived neurotrophic factor	0#33		D000544	SYMBOL|EXTRACTED|()	ad	AD	167#169	16391475-1-146-165	Brain-derived neurotrophic factor (BDNF), a member of the neurotrophic factor family, may represent a candidate gene conferring susceptibility to Alzheimer's disease (AD).
16391475	2006	Dement Geriatr Cogn Disord	1420-8008	ALL_TEXT_1/3	1	1	627	SYMBOL|()|DICTIONARY|EXTRACTED	bdnf	BDNF	35#39	16391475-1-0-33	D000544	LONGTERM|DISEASE|DT|DICTIONARY	alzheimer disease	Alzheimer's disease	146#165		Brain-derived neurotrophic factor (BDNF), a member of the neurotrophic factor family, may represent a candidate gene conferring susceptibility to Alzheimer's disease (AD).
16391475	2006	Dement Geriatr Cogn Disord	1420-8008	ALL_TEXT_1/3	1	1	627	SYMBOL|()|DICTIONARY|EXTRACTED	bdnf	BDNF	35#39	16391475-1-0-33	D000544	SYMBOL|EXTRACTED|()	ad	AD	167#169	16391475-1-146-165	Brain-derived neurotrophic factor (BDNF), a member of the neurotrophic factor family, may represent a candidate gene conferring susceptibility to Alzheimer's disease (AD).
16391475	2006	Dement Geriatr Cogn Disord	1420-8008	TITLE	0	0	627	LONGTERM|GENE|GN|GT|DICTIONARY	brain derived neurotrophic factor	brain-derived neurotrophic factor	4#37		D000544	LONGTERM|DISEASE|DT|DICTIONARY	alzheimer disease	Alzheimer's disease	86#105		The brain-derived neurotrophic factor gene as a possible susceptibility candidate for Alzheimer's disease in a chinese population.
12325071	2002	Ann. Neurol.	0364-5134	ALL_TEXT_3/3	3	8	2705	SYMBOL|DICTIONARY|EXTRACTED	cx32	Cx32	0#4		D020279	LONGTERM|DICTIONARY	central nervous system dysfunction	central nervous system dysfunction	25#59		Cx32 mutations may cause central nervous system dysfunction by reducing the number of functioning gap junctions between oligodendrocytes and astrocytes, making both cells more susceptible to abnormalities of intercellular exchange of ions and small molecules in situations of metabolic stress.
12325071	2002	Ann. Neurol.	0364-5134	ALL_TEXT_3/3	3	8	2705	SYMBOL|DICTIONARY|EXTRACTED	cx32	Cx32	0#4		D020279	LONGTERM|DICTIONARY	central nervous system dysfunction	central nervous system dysfunction	25#59		Cx32 mutations may cause central nervous system dysfunction by reducing the number of functioning gap junctions between oligodendrocytes and astrocytes, making both cells more susceptible to abnormalities of intercellular exchange of ions and small molecules in situations of metabolic stress.
16391475	2006	Dement Geriatr Cogn Disord	1420-8008	ALL_TEXT_2/3	2	5	627	SYMBOL|DICTIONARY|EXTRACTED	bdnf	BDNF	15#19	16391475-1-0-33	D000544	SYMBOL|EXTRACTED	ad	AD	118#120	16391475-1-146-165	We also tested BDNF Val66Met-C270T haplotypes for an interaction with the apolipoprotein E upsilon4 (APOE4) allele in AD.
16391475	2006	Dement Geriatr Cogn Disord	1420-8008	ALL_TEXT_2/3	2	5	348	SYMBOL|()|DICTIONARY	apoe4	APOE4	101#106		D000544	SYMBOL|EXTRACTED	ad	AD	118#120	16391475-1-146-165	We also tested BDNF Val66Met-C270T haplotypes for an interaction with the apolipoprotein E upsilon4 (APOE4) allele in AD.
16391475	2006	Dement Geriatr Cogn Disord	1420-8008	ALL_TEXT_2/3	2	5	348	LONGTERM|DICTIONARY	apolipoprotein e upsilon4	apolipoprotein E upsilon4	74#99		D000544	SYMBOL|EXTRACTED	ad	AD	118#120	16391475-1-146-165	We also tested BDNF Val66Met-C270T haplotypes for an interaction with the apolipoprotein E upsilon4 (APOE4) allele in AD.
9535412	1998	Hypertension	0194-911X	ALL_TEXT_2/3	2	4	966	SYMBOL|DICTIONARY	min 1	min(-1	202#208		D006973	LONGTERM|DICTIONARY	hypertensive	hypertensive	59#71	NaN	The response to acetylcholine was significantly reduced in hypertensive patients versus control subjects: at the highest dose (30 microg/min), forearm blood flow was 13.9+/-6.3 mL x 100 mL tissue(-1) x min(-1) in hypertensives versus 27.1+/-9.7 mL x 100 mL tissue(-1) x min(-1) in the controls (P<.001); similarly, vascular resistance was 10.6+/-5.6 U in hypertensive patients and 4.9+/-1.9 U in normotensive subjects.
9535412	1998	Hypertension	0194-911X	ALL_TEXT_2/3	2	4	966	SYMBOL|DICTIONARY	min 1	min(-1	202#208		D006973	LONGTERM|DICTIONARY	hypertensives	hypertensives	213#226	NaN	The response to acetylcholine was significantly reduced in hypertensive patients versus control subjects: at the highest dose (30 microg/min), forearm blood flow was 13.9+/-6.3 mL x 100 mL tissue(-1) x min(-1) in hypertensives versus 27.1+/-9.7 mL x 100 mL tissue(-1) x min(-1) in the controls (P<.001); similarly, vascular resistance was 10.6+/-5.6 U in hypertensive patients and 4.9+/-1.9 U in normotensive subjects.
9535412	1998	Hypertension	0194-911X	ALL_TEXT_2/3	2	4	966	SYMBOL|DICTIONARY	min 1	min(-1	202#208		D006973	LONGTERM|DICTIONARY	hypertensive	hypertensive	355#367	NaN	The response to acetylcholine was significantly reduced in hypertensive patients versus control subjects: at the highest dose (30 microg/min), forearm blood flow was 13.9+/-6.3 mL x 100 mL tissue(-1) x min(-1) in hypertensives versus 27.1+/-9.7 mL x 100 mL tissue(-1) x min(-1) in the controls (P<.001); similarly, vascular resistance was 10.6+/-5.6 U in hypertensive patients and 4.9+/-1.9 U in normotensive subjects.
9535412	1998	Hypertension	0194-911X	ALL_TEXT_2/3	2	4	966	SYMBOL|DICTIONARY	min 1	min(-1	270#276		D006973	LONGTERM|DICTIONARY	hypertensive	hypertensive	59#71	NaN	The response to acetylcholine was significantly reduced in hypertensive patients versus control subjects: at the highest dose (30 microg/min), forearm blood flow was 13.9+/-6.3 mL x 100 mL tissue(-1) x min(-1) in hypertensives versus 27.1+/-9.7 mL x 100 mL tissue(-1) x min(-1) in the controls (P<.001); similarly, vascular resistance was 10.6+/-5.6 U in hypertensive patients and 4.9+/-1.9 U in normotensive subjects.
9535412	1998	Hypertension	0194-911X	ALL_TEXT_2/3	2	4	966	SYMBOL|DICTIONARY	min 1	min(-1	270#276		D006973	LONGTERM|DICTIONARY	hypertensives	hypertensives	213#226	NaN	The response to acetylcholine was significantly reduced in hypertensive patients versus control subjects: at the highest dose (30 microg/min), forearm blood flow was 13.9+/-6.3 mL x 100 mL tissue(-1) x min(-1) in hypertensives versus 27.1+/-9.7 mL x 100 mL tissue(-1) x min(-1) in the controls (P<.001); similarly, vascular resistance was 10.6+/-5.6 U in hypertensive patients and 4.9+/-1.9 U in normotensive subjects.
9535412	1998	Hypertension	0194-911X	ALL_TEXT_2/3	2	4	966	SYMBOL|DICTIONARY	min 1	min(-1	270#276		D006973	LONGTERM|DICTIONARY	hypertensive	hypertensive	355#367	NaN	The response to acetylcholine was significantly reduced in hypertensive patients versus control subjects: at the highest dose (30 microg/min), forearm blood flow was 13.9+/-6.3 mL x 100 mL tissue(-1) x min(-1) in hypertensives versus 27.1+/-9.7 mL x 100 mL tissue(-1) x min(-1) in the controls (P<.001); similarly, vascular resistance was 10.6+/-5.6 U in hypertensive patients and 4.9+/-1.9 U in normotensive subjects.
11641043	2002	Toxicol. Lett.	0378-4274	ALL_TEXT_3/3	3	10	3845	LONGTERM|DICTIONARY	k-ras	K-ras	172#177	NaN	D009369	LONGTERM|DICTIONARY	tumors	tumors	160#166		It appears that the mechanism of enhanced susceptibility of TGF-beta1+/- mice to urethane-induced lung carcinogenesis does not involve selective development of tumors with K-ras mutations.
11641043	2002	Toxicol. Lett.	0378-4274	ALL_TEXT_3/3	3	10	7040	LONGTERM|DICTIONARY	tgf-beta1	TGF-beta1	60#69	NaN	D009369	LONGTERM|DICTIONARY	tumors	tumors	160#166		It appears that the mechanism of enhanced susceptibility of TGF-beta1+/- mice to urethane-induced lung carcinogenesis does not involve selective development of tumors with K-ras mutations.
16391475	2006	Dement Geriatr Cogn Disord	1420-8008	ALL_TEXT_3/3	3	9	627	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	bdnf	BDNF	27#31	16391475-1-0-33	D000544	SYMBOL|EXTRACTED	ad	AD	83#85	16391475-1-146-165	These results suggest that BDNF genetic variation may possibly affect the risk for AD, particularly in subjects who are negative for APOE4.
16391475	2006	Dement Geriatr Cogn Disord	1420-8008	ALL_TEXT_3/3	3	9	348	SYMBOL|DICTIONARY	apoe4	APOE4	133#138		D000544	SYMBOL|EXTRACTED	ad	AD	83#85	16391475-1-146-165	These results suggest that BDNF genetic variation may possibly affect the risk for AD, particularly in subjects who are negative for APOE4.
16391475	2006	Dement Geriatr Cogn Disord	1420-8008	ALL_TEXT_3/3	3	8	348	SYMBOL|DICTIONARY	apoe	APOE	44#48		D000544	SYMBOL|EXTRACTED	ad	AD	177#179	16391475-1-146-165	Stratification of the data according to the APOE status showed that in APOE4 allele bearers there was no significant difference in the frequency of haplotype 66Val-270C between AD and controls (p = 0.125), although there was a significant difference between the two groups in non-APOE4 carriers (p = 0.002).
16391475	2006	Dement Geriatr Cogn Disord	1420-8008	ALL_TEXT_3/3	3	8	348	SYMBOL|DICTIONARY	apoe4	APOE4	71#76		D000544	SYMBOL|EXTRACTED	ad	AD	177#179	16391475-1-146-165	Stratification of the data according to the APOE status showed that in APOE4 allele bearers there was no significant difference in the frequency of haplotype 66Val-270C between AD and controls (p = 0.125), although there was a significant difference between the two groups in non-APOE4 carriers (p = 0.002).
16391475	2006	Dement Geriatr Cogn Disord	1420-8008	ALL_TEXT_3/3	3	8	348	SYMBOL|DICTIONARY	apoe4	APOE4	280#285		D000544	SYMBOL|EXTRACTED	ad	AD	177#179	16391475-1-146-165	Stratification of the data according to the APOE status showed that in APOE4 allele bearers there was no significant difference in the frequency of haplotype 66Val-270C between AD and controls (p = 0.125), although there was a significant difference between the two groups in non-APOE4 carriers (p = 0.002).
16507146	2006	Arthritis Res. Ther.	1478-6362	ALL_TEXT_2/3	2	5	3586	SYMBOL|DICTIONARY	il 10	IL-10	170#175		D008180	SYMBOL|DISEASE|DN|DICTIONARY|EXTRACTED	sle	SLE	58#61	16507146-1-103-131	To this end, TNFalpha serum levels were quantified in 171 SLE patients and 215 healthy controls by ELISA techniques and polymorphisms at positions -1,082 and -308 of the IL-10 and TNFalpha gene promoters were determined by PCR amplification followed by hybridization with fluorescent-labeled allele-specific probes in 192 SLE patients and 343 matched controls.
16507146	2006	Arthritis Res. Ther.	1478-6362	ALL_TEXT_2/3	2	5	3586	SYMBOL|DICTIONARY	il 10	IL-10	170#175		D008180	SYMBOL|DISEASE|DN|DICTIONARY|EXTRACTED	sle	SLE	322#325	16507146-1-103-131	To this end, TNFalpha serum levels were quantified in 171 SLE patients and 215 healthy controls by ELISA techniques and polymorphisms at positions -1,082 and -308 of the IL-10 and TNFalpha gene promoters were determined by PCR amplification followed by hybridization with fluorescent-labeled allele-specific probes in 192 SLE patients and 343 matched controls.
16507146	2006	Arthritis Res. Ther.	1478-6362	ALL_TEXT_2/3	2	5	7124	LONGTERM|DICTIONARY	tnfalpha	TNFalpha	13#21	NaN	D008180	SYMBOL|DISEASE|DN|DICTIONARY|EXTRACTED	sle	SLE	58#61	16507146-1-103-131	To this end, TNFalpha serum levels were quantified in 171 SLE patients and 215 healthy controls by ELISA techniques and polymorphisms at positions -1,082 and -308 of the IL-10 and TNFalpha gene promoters were determined by PCR amplification followed by hybridization with fluorescent-labeled allele-specific probes in 192 SLE patients and 343 matched controls.
16507146	2006	Arthritis Res. Ther.	1478-6362	ALL_TEXT_2/3	2	5	7124	LONGTERM|DICTIONARY	tnfalpha	TNFalpha	13#21	NaN	D008180	SYMBOL|DISEASE|DN|DICTIONARY|EXTRACTED	sle	SLE	322#325	16507146-1-103-131	To this end, TNFalpha serum levels were quantified in 171 SLE patients and 215 healthy controls by ELISA techniques and polymorphisms at positions -1,082 and -308 of the IL-10 and TNFalpha gene promoters were determined by PCR amplification followed by hybridization with fluorescent-labeled allele-specific probes in 192 SLE patients and 343 matched controls.
16507146	2006	Arthritis Res. Ther.	1478-6362	ALL_TEXT_2/3	2	5	7124	LONGTERM|DICTIONARY	tnfalpha	TNFalpha	180#188	NaN	D008180	SYMBOL|DISEASE|DN|DICTIONARY|EXTRACTED	sle	SLE	58#61	16507146-1-103-131	To this end, TNFalpha serum levels were quantified in 171 SLE patients and 215 healthy controls by ELISA techniques and polymorphisms at positions -1,082 and -308 of the IL-10 and TNFalpha gene promoters were determined by PCR amplification followed by hybridization with fluorescent-labeled allele-specific probes in 192 SLE patients and 343 matched controls.
16507146	2006	Arthritis Res. Ther.	1478-6362	ALL_TEXT_2/3	2	5	7124	LONGTERM|DICTIONARY	tnfalpha	TNFalpha	180#188	NaN	D008180	SYMBOL|DISEASE|DN|DICTIONARY|EXTRACTED	sle	SLE	322#325	16507146-1-103-131	To this end, TNFalpha serum levels were quantified in 171 SLE patients and 215 healthy controls by ELISA techniques and polymorphisms at positions -1,082 and -308 of the IL-10 and TNFalpha gene promoters were determined by PCR amplification followed by hybridization with fluorescent-labeled allele-specific probes in 192 SLE patients and 343 matched controls.
12325071	2002	Ann. Neurol.	0364-5134	ALL_TEXT_1/3	1	2	2705	SYMBOL|DICTIONARY|EXTRACTED	cx32	Cx32	0#4		C535919	SYMBOL|DICTIONARY|EXTRACTED	cmtx	CMTX	87#91	12325071-1-9-36	Cx32 is widely expressed in brain and peripheral nerve, yet clinical manifestations of CMTX mainly arise from peripheral neuropathy.
12325071	2002	Ann. Neurol.	0364-5134	ALL_TEXT_1/3	1	2	2705	SYMBOL|DICTIONARY|EXTRACTED	cx32	Cx32	0#4		D010523	LONGTERM|DICTIONARY	peripheral neuropathy	peripheral neuropathy	110#131		Cx32 is widely expressed in brain and peripheral nerve, yet clinical manifestations of CMTX mainly arise from peripheral neuropathy.
16702373	2006	Cancer Epidemiol. Biomarkers Prev.	1055-9965	ALL_TEXT_1/3	1	1	4683	SYMBOL|()|GENE|GN|DICTIONARY	nbs1	NBS1	34#38		D009369	LONGTERM|DICTIONARY	cancers	cancers	166#173		The Nijmegen breakage syndrome 1 (NBS1) gene, which participates in DNA double strand break repair, has been postulated to be a susceptibility factor for a number of cancers, including prostate cancer.
16702373	2006	Cancer Epidemiol. Biomarkers Prev.	1055-9965	ALL_TEXT_1/3	1	1	4683	SYMBOL|()|GENE|GN|DICTIONARY	nbs1	NBS1	34#38		D011471	LONGTERM|DISEASE|DT|DICTIONARY	prostate cancer	prostate cancer	185#200		The Nijmegen breakage syndrome 1 (NBS1) gene, which participates in DNA double strand break repair, has been postulated to be a susceptibility factor for a number of cancers, including prostate cancer.
16702373	2006	Cancer Epidemiol. Biomarkers Prev.	1055-9965	ALL_TEXT_1/3	1	1	4683	SYMBOL|()|GENE|GN|DICTIONARY	nbs1	NBS1	34#38		D049932	LONGTERM|DISEASE|DT|NUMBER|DICTIONARY|GENE|GA	nijmegen breakage syndrome 1	Nijmegen breakage syndrome 1	4#32		The Nijmegen breakage syndrome 1 (NBS1) gene, which participates in DNA double strand break repair, has been postulated to be a susceptibility factor for a number of cancers, including prostate cancer.
17309100	2007	Proteomics	1615-9853	ALL_TEXT_2/3	2	5	3569	SYMBOL|DICTIONARY	il6	IL6	139#142		D008228	LONGTERM|DICTIONARY	non hodgkin lymphoma	non-Hodgkin lymphoma	104#124		Serum from a random sample of control participants in an ongoing population-based case-control study of non-Hodgkin lymphoma was pooled by IL6 genotype and used to screen for the optimal SELDI-TOF MS arrays for analysis.
17309100	2007	Proteomics	1615-9853	ALL_TEXT_2/3	2	5	3569	SYMBOL|DICTIONARY	il6	IL6	139#142		D009103	LONGTERM|DICTIONARY	ms	MS	197#199	NaN	Serum from a random sample of control participants in an ongoing population-based case-control study of non-Hodgkin lymphoma was pooled by IL6 genotype and used to screen for the optimal SELDI-TOF MS arrays for analysis.
17309100	2007	Proteomics	1615-9853	ALL_TEXT_1/3	1	2	3569	SYMBOL|DICTIONARY	il 6	IL-6	5#9		D007249	LONGTERM|DICTIONARY	inflammation	inflammation	105#117	NaN	Both IL-6 and the IL6 -174G>C promoter polymorphism have been linked to various diseases associated with inflammation.
17309100	2007	Proteomics	1615-9853	ALL_TEXT_1/3	1	2	3569	SYMBOL|DICTIONARY	il6	IL6	18#21		D007249	LONGTERM|DICTIONARY	inflammation	inflammation	105#117	NaN	Both IL-6 and the IL6 -174G>C promoter polymorphism have been linked to various diseases associated with inflammation.
11079451	2001	J. Endocrinol. Invest.	0391-4097	TITLE	0	0	367	LONGTERM|GENE|GT|DICTIONARY	androgen receptor	Androgen receptor	0#17		D007248	LONGTERM|DICTIONARY	male infertility	male infertility	49#65		Androgen receptor polymorphisms and mutations in male infertility.
11079451	2001	J. Endocrinol. Invest.	0391-4097	ALL_TEXT_1/3	1	2	367	LONGTERM|GENE|GT|DICTIONARY|GA	androgen receptor	androgen receptor	87#104		D007248	LONGTERM|DICTIONARY	male infertility	male infertility	56#72		To determine the contribution of genetic aberrations to male infertility, the X-linked androgen receptor (AR) gene was examined for mutations and polymorphisms in a large cohort of infertile men.
11245417	2001	Cancer Res.	0008-5472	TITLE	0	0	10	LONGTERM|DICTIONARY	n acetyltransferase 2	N-acetyltransferase 2	53#74		D009369	LONGTERM|DISEASE|DT|DICTIONARY	cancer	cancer	23#29		Age-associated risk of cancer among individuals with N-acetyltransferase 2 (NAT2) mutations and mutations in DNA mismatch repair genes.
11245417	2001	Cancer Res.	0008-5472	TITLE	0	0	10	SYMBOL|()|DICTIONARY|EXTRACTED	nat2	NAT2	76#80	11245417-0-53-74	D009369	LONGTERM|DISEASE|DT|DICTIONARY	cancer	cancer	23#29		Age-associated risk of cancer among individuals with N-acetyltransferase 2 (NAT2) mutations and mutations in DNA mismatch repair genes.
17309100	2007	Proteomics	1615-9853	ALL_TEXT_3/3	3	8	3569	SYMBOL|DICTIONARY	il6	IL6	191#194		D012769	LONGTERM|DICTIONARY	heat shock	heat shock	114#124	NaN	Additionally, we corroborate previous findings of an association of the -174C allele with lower autoantibodies to heat shock protein 60 and confirm the absence of any association between the IL6 -174G>C genotype and serum IL-6 levels.
17309100	2007	Proteomics	1615-9853	ALL_TEXT_3/3	3	8	3569	SYMBOL|DICTIONARY	il 6	IL-6	222#226		D012769	LONGTERM|DICTIONARY	heat shock	heat shock	114#124	NaN	Additionally, we corroborate previous findings of an association of the -174C allele with lower autoantibodies to heat shock protein 60 and confirm the absence of any association between the IL6 -174G>C genotype and serum IL-6 levels.
16882462	2007	Ann Epidemiol	1047-2797	RESULTS	3	6	6043	LONGTERM|DICTIONARY	e2/2, e2/3	E2/2, E2/3	66#76	NaN	D005705	LONGTERM|DISEASE|DT|DICTIONARY	gallbladder disease	gallbladder disease	150#169		The presence of the other rare isoform, epsilon2 (i.e., genotypes E2/2, E2/3, and E2/4 versus others) was associated with a modest increased risk for gallbladder disease (relative risk, 1.28; 95% CI, 1.05-1.57).
16882462	2007	Ann Epidemiol	1047-2797	RESULTS	3	6	6044	LONGTERM|DICTIONARY	e2/2, e2/3	E2/2, E2/3	66#76	NaN	D005705	LONGTERM|DISEASE|DT|DICTIONARY	gallbladder disease	gallbladder disease	150#169		The presence of the other rare isoform, epsilon2 (i.e., genotypes E2/2, E2/3, and E2/4 versus others) was associated with a modest increased risk for gallbladder disease (relative risk, 1.28; 95% CI, 1.05-1.57).
16882462	2007	Ann Epidemiol	1047-2797	RESULTS	3	6	6925	LONGTERM|DICTIONARY	e2/2, e2/3	E2/2, E2/3	66#76	NaN	D005705	LONGTERM|DISEASE|DT|DICTIONARY	gallbladder disease	gallbladder disease	150#169		The presence of the other rare isoform, epsilon2 (i.e., genotypes E2/2, E2/3, and E2/4 versus others) was associated with a modest increased risk for gallbladder disease (relative risk, 1.28; 95% CI, 1.05-1.57).
9865924	1999	Clin. Cancer Res.	1078-0432	ALL_TEXT_2/3	2	6	1728	SYMBOL|DICTIONARY|EXTRACTED	nqo1	NQO1	108#112	9865924-0-35-57	D064420	LONGTERM|DICTIONARY	toxicity	toxicity	34#42	NaN	RH1 exhibited a greater selective toxicity (ratio of IC50s in H596:H460 and BE:HT29) to cells with elevated NQO1 activity relative to MeDZQ.
12631109	2004	Kidney Int.	0085-2538	TITLE	0	0	1285	SYMBOL|DICTIONARY	col4a3	COL4A3	79#85		D051437	LONGTERM|DICTIONARY	renal failure	renal failure	35#48		Preemptive ramipril therapy delays renal failure and reduces renal fibrosis in COL4A3-knockout mice with Alport syndrome.
12631109	2004	Kidney Int.	0085-2538	TITLE	0	0	1285	SYMBOL|DICTIONARY	col4a3	COL4A3	79#85		D009394	LONGTERM|DISEASE|DT|DICTIONARY	alport syndrome	Alport syndrome	105#120		Preemptive ramipril therapy delays renal failure and reduces renal fibrosis in COL4A3-knockout mice with Alport syndrome.
12631109	2004	Kidney Int.	0085-2538	TITLE	0	0	1285	SYMBOL|DICTIONARY	col4a3	COL4A3	79#85		D007674	LONGTERM|DICTIONARY	reduces renal fibrosis	reduces renal fibrosis	53#75		Preemptive ramipril therapy delays renal failure and reduces renal fibrosis in COL4A3-knockout mice with Alport syndrome.
12802709	2003	Am J Perinatol	0735-1631	ALL_TEXT_3/3	3	7	7124	SYMBOL|EXTRACTED	tnf alpha	TNF-alpha	33#42	12802709-1-64-91	D002581	LONGTERM|DICTIONARY	cervical incompetence	cervical incompetence	75#96	NaN	There were no differences in the TNF-alpha polymorphism between women with cervical incompetence and controls or between women with cervical incompetence who delivered before versus after 28 weeks.
12802709	2003	Am J Perinatol	0735-1631	ALL_TEXT_3/3	3	7	7124	SYMBOL|EXTRACTED	tnf alpha	TNF-alpha	33#42	12802709-1-64-91	D002581	LONGTERM|DICTIONARY	cervical incompetence	cervical incompetence	132#153	NaN	There were no differences in the TNF-alpha polymorphism between women with cervical incompetence and controls or between women with cervical incompetence who delivered before versus after 28 weeks.
14697747	2004	Clin. Immunol.	1521-6616	ALL_TEXT_1/3	1	1	1234	SYMBOL|GENE|GN|DICTIONARY	ccr5	CCR5	31#35		D003141	LONGTERM|DICTIONARY	infectious diseases	infectious diseases	106#125		A 32-base-pair deletion in the CCR5 gene was previously shown to influence the susceptibility for several infectious diseases.
23423710	2013	Arch. Toxicol.	1432-0738	ALL_TEXT_3/3	3	10	1786	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	dnmt1	DNMT1	23#28	23423710-9-13-36	D018235	LONGTERM|DICTIONARY	asthmatic asm	asthmatic ASM	162#175		Selective depletion of DNMT1 protein by Aza-CdR inhibited PDGF-induced RASM cell phenotypic switching, revealing DNMT1-mediated DNA methylation was implicated in asthmatic ASM remodeling.
23423710	2013	Arch. Toxicol.	1432-0738	ALL_TEXT_3/3	3	10	1786	SYMBOL|DICTIONARY|EXTRACTED	dnmt1	DNMT1	113#118	23423710-9-13-36	D018235	LONGTERM|DICTIONARY	asthmatic asm	asthmatic ASM	162#175		Selective depletion of DNMT1 protein by Aza-CdR inhibited PDGF-induced RASM cell phenotypic switching, revealing DNMT1-mediated DNA methylation was implicated in asthmatic ASM remodeling.
20663522	2010	J. Urol.	1527-3792	PURPOSE	1	1	1113	LONGTERM|DICTIONARY	chromogranin a	chromogranin A	45#59		D011471	LONGTERM|DISEASE|DT|DICTIONARY	prostate cancer	prostate cancer	108#123		We investigated the clinical significance of chromogranin A and endothelin-1 polymorphism and expression in prostate cancer.
20663522	2010	J. Urol.	1527-3792	PURPOSE	1	1	1906	LONGTERM|DICTIONARY	endothelin 1	endothelin-1	64#76		D011471	LONGTERM|DISEASE|DT|DICTIONARY	prostate cancer	prostate cancer	108#123		We investigated the clinical significance of chromogranin A and endothelin-1 polymorphism and expression in prostate cancer.
17116328	2007	Placenta	0143-4004	CONCLUSION	4	10	183	SYMBOL|DICTIONARY|EXTRACTED	agt	AGT	4#7	17116328-2-37-52	D000037	LONGTERM|DICTIONARY	placental abruption	placental abruption	56#75	NaN	The AGT Thr235 mutation was observed more frequently in placental abruption.
17116328	2007	Placenta	0143-4004	CONCLUSION	4	11	183	SYMBOL|DICTIONARY|EXTRACTED	agt	AGT	0#3		D000037	LONGTERM|DICTIONARY	placental abruption	placental abruption	56#75	NaN	AGT Thr235 mutation may be considered a risk factor for placental abruption.
17185997	2007	Clin. Pharmacol. Ther.	0009-9236	ALL_TEXT_3/3	3	8	6331	SYMBOL|DICTIONARY	scn5a	SCN5A	4#9		D001281	SYMBOL|EXTRACTED	af	AF	103#105	17185997-2-38-57	The SCN5A R558 allele, present in one-third of the population, thus constitutes a risk factor for lone AF and may increase susceptibility to sodium channel blocker-induced proarrhythmia.
11248061	2001	Proc. Natl. Acad. Sci. U.S.A.	0027-8424	ALL_TEXT_2/3	2	7	672	SYMBOL|DICTIONARY	brca1	BRCA1	6#11		D009369	LONGTERM|DISEASE|DT|DICTIONARY	cancer	cancer	176#182		Among BRCA1 carriers, RAD51-135C frequency was similar in healthy and affected women [6.1% (3 of 49) and 9.9% (12 of 121), respectively], and RAD-135C did not influence age of cancer diagnosis [Hazard ratio (HR) = 1.18 for disease in RAD51-135C heterozygotes, not significant].
11248061	2001	Proc. Natl. Acad. Sci. U.S.A.	0027-8424	ALL_TEXT_2/3	2	7	5888	SYMBOL|NUMBER|DICTIONARY	rad51	RAD51	22#27		D009369	LONGTERM|DISEASE|DT|DICTIONARY	cancer	cancer	176#182		Among BRCA1 carriers, RAD51-135C frequency was similar in healthy and affected women [6.1% (3 of 49) and 9.9% (12 of 121), respectively], and RAD-135C did not influence age of cancer diagnosis [Hazard ratio (HR) = 1.18 for disease in RAD51-135C heterozygotes, not significant].
11248061	2001	Proc. Natl. Acad. Sci. U.S.A.	0027-8424	ALL_TEXT_2/3	2	7	5888	SYMBOL|NUMBER|DICTIONARY	rad51	RAD51	234#239		D009369	LONGTERM|DISEASE|DT|DICTIONARY	cancer	cancer	176#182		Among BRCA1 carriers, RAD51-135C frequency was similar in healthy and affected women [6.1% (3 of 49) and 9.9% (12 of 121), respectively], and RAD-135C did not influence age of cancer diagnosis [Hazard ratio (HR) = 1.18 for disease in RAD51-135C heterozygotes, not significant].
11248061	2001	Proc. Natl. Acad. Sci. U.S.A.	0027-8424	ALL_TEXT_1/3	1	3	5888	SYMBOL|DICTIONARY	rad51	RAD51	102#107		D001943	LONGTERM|DISEASE|DT|DICTIONARY	breast cancer	breast cancer	127#140		A preliminary report suggested that a single nucleotide polymorphism in the 5' untranslated region of RAD51 (135C/G) increases breast cancer risk in BRCA1 and BRCA2 carriers.
11248061	2001	Proc. Natl. Acad. Sci. U.S.A.	0027-8424	ALL_TEXT_1/3	1	3	672	SYMBOL|DICTIONARY	brca1	BRCA1	149#154		D001943	LONGTERM|DISEASE|DT|DICTIONARY	breast cancer	breast cancer	127#140		A preliminary report suggested that a single nucleotide polymorphism in the 5' untranslated region of RAD51 (135C/G) increases breast cancer risk in BRCA1 and BRCA2 carriers.
11248061	2001	Proc. Natl. Acad. Sci. U.S.A.	0027-8424	ALL_TEXT_1/3	1	3	675	SYMBOL|DICTIONARY	brca2	BRCA2	159#164		D001943	LONGTERM|DISEASE|DT|DICTIONARY	breast cancer	breast cancer	127#140		A preliminary report suggested that a single nucleotide polymorphism in the 5' untranslated region of RAD51 (135C/G) increases breast cancer risk in BRCA1 and BRCA2 carriers.
11248061	2001	Proc. Natl. Acad. Sci. U.S.A.	0027-8424	TITLE	0	0	5888	SYMBOL|GENE|GN|DICTIONARY	rad51	RAD51	40#45		D009369	LONGTERM|DISEASE|DT|DICTIONARY	cancer	cancer	60#66		A single nucleotide polymorphism in the RAD51 gene modifies cancer risk in BRCA2 but not BRCA1 carriers.
11248061	2001	Proc. Natl. Acad. Sci. U.S.A.	0027-8424	TITLE	0	0	675	SYMBOL|DICTIONARY	brca2	BRCA2	75#80		D009369	LONGTERM|DISEASE|DT|DICTIONARY	cancer	cancer	60#66		A single nucleotide polymorphism in the RAD51 gene modifies cancer risk in BRCA2 but not BRCA1 carriers.
11248061	2001	Proc. Natl. Acad. Sci. U.S.A.	0027-8424	TITLE	0	0	672	SYMBOL|DICTIONARY	brca1	BRCA1	89#94		D009369	LONGTERM|DISEASE|DT|DICTIONARY	cancer	cancer	60#66		A single nucleotide polymorphism in the RAD51 gene modifies cancer risk in BRCA2 but not BRCA1 carriers.
11248061	2001	Proc. Natl. Acad. Sci. U.S.A.	0027-8424	ALL_TEXT_1/3	1	1	672	SYMBOL|DICTIONARY	brca1	BRCA1	0#5		D061325	LONGTERM|DISEASE|DT|DICTIONARY	breast and ovarian cancer	breast and ovarian cancer	56#81		BRCA1 and BRCA2 carriers are at increased risk for both breast and ovarian cancer, but estimates of lifetime risk vary widely, suggesting their penetrance is modified by other genetic and/or environmental factors.
11248061	2001	Proc. Natl. Acad. Sci. U.S.A.	0027-8424	ALL_TEXT_1/3	1	1	675	SYMBOL|DICTIONARY	brca2	BRCA2	10#15		D061325	LONGTERM|DISEASE|DT|DICTIONARY	breast and ovarian cancer	breast and ovarian cancer	56#81		BRCA1 and BRCA2 carriers are at increased risk for both breast and ovarian cancer, but estimates of lifetime risk vary widely, suggesting their penetrance is modified by other genetic and/or environmental factors.
17185997	2007	Clin. Pharmacol. Ther.	0009-9236	TITLE	0	0	6331	SYMBOL|DICTIONARY	scn5a	SCN5A	25#30		D001281	LONGTERM|DICTIONARY	atrial fibrillation	atrial fibrillation	55#74		A common polymorphism in SCN5A is associated with lone atrial fibrillation.
17185997	2007	Clin. Pharmacol. Ther.	0009-9236	ALL_TEXT_1/3	1	1	6331	SYMBOL|()|DICTIONARY	scn5a	SCN5A	28#33		D001145	LONGTERM|DICTIONARY	arrhythmias	arrhythmias	68#79	NaN	The cardiac sodium channel (SCN5A) is a target for the treatment of arrhythmias.
17185997	2007	Clin. Pharmacol. Ther.	0009-9236	ALL_TEXT_1/3	1	2	6331	SYMBOL|DICTIONARY	scn5a	SCN5A	103#108		D001281	LONGTERM|DICTIONARY	atrial fibrillation	atrial fibrillation	38#57		We hypothesized that vulnerability to atrial fibrillation (AF) could be caused by genetic variation in SCN5A.
17185997	2007	Clin. Pharmacol. Ther.	0009-9236	ALL_TEXT_1/3	1	2	6331	SYMBOL|DICTIONARY	scn5a	SCN5A	103#108		D001281	SYMBOL|EXTRACTED|()	af	AF	59#61	17185997-2-38-57	We hypothesized that vulnerability to atrial fibrillation (AF) could be caused by genetic variation in SCN5A.
11245417	2001	Cancer Res.	0008-5472	ALL_TEXT_3/3	3	5	10	SYMBOL|DICTIONARY|EXTRACTED	nat2	NAT2	28#32	11245417-0-53-74	D015179	SYMBOL|DICTIONARY|EXTRACTED	crc	CRC	89#92	11245417-1-150-167	These findings suggest that NAT2 genotype may be an important factor in tumorigenesis of CRC and cancers related to hereditary nonpolyposis CRC among individuals with mismatch repair defects.
11245417	2001	Cancer Res.	0008-5472	ALL_TEXT_3/3	3	5	10	SYMBOL|DICTIONARY|EXTRACTED	nat2	NAT2	28#32	11245417-0-53-74	D009369	LONGTERM|DICTIONARY	cancers	cancers	97#104		These findings suggest that NAT2 genotype may be an important factor in tumorigenesis of CRC and cancers related to hereditary nonpolyposis CRC among individuals with mismatch repair defects.
11245417	2001	Cancer Res.	0008-5472	ALL_TEXT_3/3	3	5	10	SYMBOL|DICTIONARY|EXTRACTED	nat2	NAT2	28#32	11245417-0-53-74	D015179	SYMBOL|DICTIONARY|EXTRACTED	crc	CRC	140#143	11245417-1-150-167	These findings suggest that NAT2 genotype may be an important factor in tumorigenesis of CRC and cancers related to hereditary nonpolyposis CRC among individuals with mismatch repair defects.
20663522	2010	J. Urol.	1527-3792	RESULTS	3	5	1113	LONGTERM|DICTIONARY	chromogranin a	chromogranin A	35#49		D011471	LONGTERM|DISEASE|DT|DICTIONARY	prostate cancer	prostate cancer	12#27		In men with prostate cancer higher chromogranin A immunohistochemistry grade was associated with higher stage and higher Gleason score (p = 0.011 and 0.044, respectively).
11248061	2001	Proc. Natl. Acad. Sci. U.S.A.	0027-8424	ALL_TEXT_3/3	3	9	675	SYMBOL|DICTIONARY	brca2	BRCA2	21#26		D061325	LONGTERM|DISEASE|DT|DICTIONARY	breast and/or ovarian cancer	breast and/or ovarian cancer	72#100		Survival analysis in BRCA2 carriers showed RAD51-135C increased risk of breast and/or ovarian cancer with an HR of 4.0 [95% confidence interval 1.6-9.8, P = 0.003].
11248061	2001	Proc. Natl. Acad. Sci. U.S.A.	0027-8424	ALL_TEXT_3/3	3	9	5888	SYMBOL|NUMBER|DICTIONARY	rad51	RAD51	43#48		D061325	LONGTERM|DISEASE|DT|DICTIONARY	breast and/or ovarian cancer	breast and/or ovarian cancer	72#100		Survival analysis in BRCA2 carriers showed RAD51-135C increased risk of breast and/or ovarian cancer with an HR of 4.0 [95% confidence interval 1.6-9.8, P = 0.003].
20208132	2010	Cell. Oncol.	1875-8606	CONCLUSION	4	13	596	SYMBOL|GFAM|FN|DICTIONARY	bcl 2	BCL-2	42#47		D002292	SYMBOL|PLURAL|DICTIONARY|EXTRACTED	rccs	RCCs	131#135	20208132-3-48-69	Additionally, inhibition of antiapoptotic BCL-2 family members might provide a possible way to overcome chemotherapy resistance of RCCs.
20208132	2010	Cell. Oncol.	1875-8606	CONCLUSION	4	12	835	LONGTERM|DICTIONARY	caspase 2	caspase-2	27#36		D002292	SYMBOL|PLURAL|DICTIONARY|EXTRACTED	rccs	RCCs	87#91	20208132-3-48-69	Furthermore, it shows that caspase-2 participates in chemotherapy-induced apoptosis in RCCs although it is not mandatory for it.
11159742	2001	Carcinogenesis	0143-3334	ALL_TEXT_3/3	3	10	2944	SYMBOL|DICTIONARY	gstm1	GSTM1	21#26		D004715	LONGTERM|DICTIONARY	endometriosis	endometriosis	49#62		We conclude that the GSTM1 null allele is not an endometriosis susceptibility allele, however, it may predispose endometriotic lesions to malignant transformation to endometrioid and clear cell ovarian cancer.
11159742	2001	Carcinogenesis	0143-3334	ALL_TEXT_3/3	3	10	2944	SYMBOL|DICTIONARY	gstm1	GSTM1	21#26		D010051	LONGTERM|DISEASE|DT|DICTIONARY	malignant transformation to endometrioid and clear cell ovarian cancer	malignant transformation to endometrioid and clear cell ovarian cancer	138#208		We conclude that the GSTM1 null allele is not an endometriosis susceptibility allele, however, it may predispose endometriotic lesions to malignant transformation to endometrioid and clear cell ovarian cancer.
11159742	2001	Carcinogenesis	0143-3334	ALL_TEXT_3/3	3	10	2944	SYMBOL|DICTIONARY	gstm1	GSTM1	21#26		D001927	LONGTERM|DICTIONARY	endometriotic lesions	endometriotic lesions	113#134	NaN	We conclude that the GSTM1 null allele is not an endometriosis susceptibility allele, however, it may predispose endometriotic lesions to malignant transformation to endometrioid and clear cell ovarian cancer.
20628598	2010	PLoS ONE	1932-6203	METHODOLOGY/PRINCIPAL FINDINGS	2	3	4544	SYMBOL|DICTIONARY|EXTRACTED	mtnr1b	MTNR1B	45#51	20628598-1-28-49	D003924	SYMBOL|DISEASE|DN|DICTIONARY|EXTRACTED	t2d	T2D	203#206	20628598-1-223-238	Five single nucleotide polymorphisms (SNPs), MTNR1B rs10830963, G6PC2 rs16856187 and rs478333, GCK rs1799884 and GCKR rs780094, were genotyped in 1644 controls (583 adults and 1061 adolescents) and 1342 T2D patients.
20628598	2010	PLoS ONE	1932-6203	METHODOLOGY/PRINCIPAL FINDINGS	2	3	57818	SYMBOL|DICTIONARY|EXTRACTED	g6pc2	G6PC2	64#69	20628598-1-60-130	D003924	SYMBOL|DISEASE|DN|DICTIONARY|EXTRACTED	t2d	T2D	203#206	20628598-1-223-238	Five single nucleotide polymorphisms (SNPs), MTNR1B rs10830963, G6PC2 rs16856187 and rs478333, GCK rs1799884 and GCKR rs780094, were genotyped in 1644 controls (583 adults and 1061 adolescents) and 1342 T2D patients.
20628598	2010	PLoS ONE	1932-6203	METHODOLOGY/PRINCIPAL FINDINGS	2	3	2645	SYMBOL|DICTIONARY|EXTRACTED	gck	GCK	95#98	20628598-1-140-151	D003924	SYMBOL|DISEASE|DN|DICTIONARY|EXTRACTED	t2d	T2D	203#206	20628598-1-223-238	Five single nucleotide polymorphisms (SNPs), MTNR1B rs10830963, G6PC2 rs16856187 and rs478333, GCK rs1799884 and GCKR rs780094, were genotyped in 1644 controls (583 adults and 1061 adolescents) and 1342 T2D patients.
20628598	2010	PLoS ONE	1932-6203	METHODOLOGY/PRINCIPAL FINDINGS	2	3	2646	SYMBOL|DICTIONARY|EXTRACTED	gckr	GCKR	113#117	20628598-1-162-192	D003924	SYMBOL|DISEASE|DN|DICTIONARY|EXTRACTED	t2d	T2D	203#206	20628598-1-223-238	Five single nucleotide polymorphisms (SNPs), MTNR1B rs10830963, G6PC2 rs16856187 and rs478333, GCK rs1799884 and GCKR rs780094, were genotyped in 1644 controls (583 adults and 1061 adolescents) and 1342 T2D patients.
17039310	2007	Mod Rheumatol	1439-7595	TITLE	0	0	6288	SYMBOL|GENE|GN|DICTIONARY	saa1	SAA1	0#4		D000686	LONGTERM|DICTIONARY	aa amyloidosis	AA amyloidosis	40#54		SAA1 gene polymorphisms and the risk of AA amyloidosis in Japanese patients with rheumatoid arthritis.
17039310	2007	Mod Rheumatol	1439-7595	TITLE	0	0	6288	SYMBOL|GENE|GN|DICTIONARY	saa1	SAA1	0#4		D001172	LONGTERM|DICTIONARY	rheumatoid arthritis	rheumatoid arthritis	81#101		SAA1 gene polymorphisms and the risk of AA amyloidosis in Japanese patients with rheumatoid arthritis.
20663522	2010	J. Urol.	1527-3792	TITLE	0	0	1113	LONGTERM|DICTIONARY	chromogranin a	chromogranin a	56#70		D011471	LONGTERM|DISEASE|DT|DICTIONARY	prostate cancer	prostate cancer	91#106		Clinical significance of polymorphism and expression of chromogranin a and endothelin-1 in prostate cancer.
20663522	2010	J. Urol.	1527-3792	TITLE	0	0	1906	LONGTERM|DICTIONARY	endothelin 1	endothelin-1	75#87		D011471	LONGTERM|DISEASE|DT|DICTIONARY	prostate cancer	prostate cancer	91#106		Clinical significance of polymorphism and expression of chromogranin a and endothelin-1 in prostate cancer.
15128052	2004	Pharmacogenetics	0960-314X	ALL_TEXT_1/3	1	3	5465	SYMBOL|DICTIONARY	pparalpha	PPARalpha	125#134		D003324	LONGTERM|DICTIONARY	coronary atherosclerosis	Coronary Atherosclerosis	33#57		We genotyped 372 Lipoprotein and Coronary Atherosclerosis Study subjects for seven single nucleotide polymorphisms (SNPs) in PPARalpha (-35 089A>C, 484C>G), delta (-4401C>T, 294T>C) and gamma (34C>G, 25 506C>T, 161C>T) by restriction mapping or 5' exonuclease assay.
15128052	2004	Pharmacogenetics	0960-314X	TITLE	0	0	5465	SYMBOL|DICTIONARY	pparalpha	PPARalpha	11#20		D003324	LONGTERM|DICTIONARY	coronary atherosclerosis	coronary atherosclerosis	105#129		Effects of PPARalpha, gamma and delta haplotypes on plasma levels of lipids, severity and progression of coronary atherosclerosis and response to statin therapy in the lipoprotein coronary atherosclerosis study.
15128052	2004	Pharmacogenetics	0960-314X	TITLE	0	0	5465	SYMBOL|DICTIONARY	pparalpha	PPARalpha	11#20		D003324	LONGTERM|DICTIONARY	coronary atherosclerosis	coronary atherosclerosis	180#204		Effects of PPARalpha, gamma and delta haplotypes on plasma levels of lipids, severity and progression of coronary atherosclerosis and response to statin therapy in the lipoprotein coronary atherosclerosis study.
19360657	2009	Autism Res	1939-3806	ALL_TEXT_1/3	1	1	6505	SYMBOL|DICTIONARY	slc1a1	SLC1A1	60#66		D009771	LONGTERM|DISEASE|DT|DICTIONARY	obsessive compulsive disorder	obsessive-compulsive disorder	149#178		Reports identified the neuronal glutamate transporter gene, SLC1A1 (OMIM 133550, chromosome 9p24), as a positional and functional candidate gene for obsessive-compulsive disorder (OCD).
19360657	2009	Autism Res	1939-3806	ALL_TEXT_1/3	1	1	6505	SYMBOL|DICTIONARY	slc1a1	SLC1A1	60#66		D009771	SYMBOL|()|DICTIONARY|EXTRACTED	ocd	OCD	180#183	19360657-1-149-178	Reports identified the neuronal glutamate transporter gene, SLC1A1 (OMIM 133550, chromosome 9p24), as a positional and functional candidate gene for obsessive-compulsive disorder (OCD).
14697747	2004	Clin. Immunol.	1521-6616	ALL_TEXT_3/3	3	8	1234	SYMBOL|DICTIONARY	ccr5	CCR5	84#88		D010518	LONGTERM|DISEASE|DN|DICTIONARY	periodontitis	periodontitis	31#44		The allele frequencies between periodontitis patients and the control group for the CCR5-Delta32 mutation were not significantly different (P=0.801).
20959826	2011	Br. J. Cancer	1532-1827	RESULTS	3	8	3845	SYMBOL|DICTIONARY	kras	KRAS	92#96		D009369	LONGTERM|DISEASE|DT|DICTIONARY	rectal cancer	rectal cancer	52#65		In the Cox regression analysis, only when colon and rectal cancer were analysed separately, KRAS mutation was a negative predictor for OS in patients with rectal cancer and DFS in those with stage II colon cancer.
20959826	2011	Br. J. Cancer	1532-1827	RESULTS	3	8	3845	SYMBOL|DICTIONARY	kras	KRAS	92#96		D009369	LONGTERM|DISEASE|DT|DICTIONARY	rectal cancer	rectal cancer	155#168		In the Cox regression analysis, only when colon and rectal cancer were analysed separately, KRAS mutation was a negative predictor for OS in patients with rectal cancer and DFS in those with stage II colon cancer.
20959826	2011	Br. J. Cancer	1532-1827	RESULTS	3	8	3845	SYMBOL|DICTIONARY	kras	KRAS	92#96		D009369	LONGTERM|DISEASE|DT|DICTIONARY	stage ii colon cancer	stage II colon cancer	191#212		In the Cox regression analysis, only when colon and rectal cancer were analysed separately, KRAS mutation was a negative predictor for OS in patients with rectal cancer and DFS in those with stage II colon cancer.
20959826	2011	Br. J. Cancer	1532-1827	RESULTS	3	8	3845	SYMBOL|DICTIONARY	kras	KRAS	92#96		C567932	LONGTERM|DICTIONARY	os	OS	135#137	NaN	In the Cox regression analysis, only when colon and rectal cancer were analysed separately, KRAS mutation was a negative predictor for OS in patients with rectal cancer and DFS in those with stage II colon cancer.
20959826	2011	Br. J. Cancer	1532-1827	RESULTS	3	8	3845	SYMBOL|DICTIONARY	kras	KRAS	92#96		D004194	LONGTERM|DICTIONARY	dfs	DFS	173#176	NaN	In the Cox regression analysis, only when colon and rectal cancer were analysed separately, KRAS mutation was a negative predictor for OS in patients with rectal cancer and DFS in those with stage II colon cancer.
14697747	2004	Clin. Immunol.	1521-6616	ALL_TEXT_3/3	3	9	1234	SYMBOL|DICTIONARY	ccr5	CCR5	54#58		D010510	LONGTERM|DISEASE|DT|DICTIONARY	periodontal disease	periodontal disease	98#117		The present study revealed no association between the CCR5-Delta32 mutation and susceptibility to periodontal disease.
20350254	2010	Ann. Med.	1365-2060	RESULTS	3	5	3606	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	il 18	IL-18	48#53	20350254-1-0-14	D050197	LONGTERM|DICTIONARY	atherosclerosis	atherosclerosis	107#122		According to adjusted analysis of variance, the IL-18 gene polymorphism did not associate with subclinical atherosclerosis in the whole study population.
15111581	2004	Invest. Ophthalmol. Vis. Sci.	0146-0404	METHODS	2	2	348	SYMBOL|DICTIONARY|EXTRACTED	apoe	APOE	17#21	15111581-1-25-41	D008268	SYMBOL|DISEASE|DN|DICTIONARY|EXTRACTED	amd	AMD	60#63	15111581-1-60-92	The frequency of APOE alleles was analyzed in 632 unrelated AMD patients and 206 unrelated controls, all of whom were of white ancestry.
9149321	1997	Psychiatr. Genet.	0955-8829	ALL_TEXT_1/3	1	1	6532	LONGTERM|DICTIONARY	serotonin transporter	serotonin transporter	120#141	NaN	D003866	LONGTERM|DISEASE|DT|DICTIONARY	depressive disorder	depressive disorder	175#194		We have recently reported an association between a polymorphism of a variable number tandem repeat (VNTR) region of the serotonin transporter gene and susceptibility to major depressive disorder.
15111581	2004	Invest. Ophthalmol. Vis. Sci.	0146-0404	TITLE	0	0	348	LONGTERM|DICTIONARY	apolipoprotein e	apolipoprotein E	15#31		D008268	LONGTERM|DICTIONARY	age related macular degeneration	age-related macular degeneration	63#95		Association of apolipoprotein E alleles with susceptibility to age-related macular degeneration in a large cohort from a single center.
11397889	2001	J. Clin. Endocrinol. Metab.	0021-972X	ALL_TEXT_1/3	1	2	4843	SYMBOL|GENE|GN|DICTIONARY	nos2	NOS2	64#68		D003920	LONGTERM|DICTIONARY|GFAM|FA	diabetes mellitus	diabetes mellitus	185#202		We performed a mutational scanning of all 27 exons of the human NOS2 gene and linkage transmission disequilibrium testing of identified NOS2 polymorphisms in a Danish nationwide type 1 diabetes mellitus (IDDM) family collection.
11397889	2001	J. Clin. Endocrinol. Metab.	0021-972X	ALL_TEXT_1/3	1	2	4843	SYMBOL|DICTIONARY	nos2	NOS2	136#140		D003920	LONGTERM|DICTIONARY|GFAM|FA	diabetes mellitus	diabetes mellitus	185#202		We performed a mutational scanning of all 27 exons of the human NOS2 gene and linkage transmission disequilibrium testing of identified NOS2 polymorphisms in a Danish nationwide type 1 diabetes mellitus (IDDM) family collection.
15111581	2004	Invest. Ophthalmol. Vis. Sci.	0146-0404	RESULTS	3	7	348	SYMBOL|DICTIONARY|EXTRACTED	apoe	APOE	140#144	15111581-1-25-41	D008268	SYMBOL|DISEASE|DN|DICTIONARY|EXTRACTED	amd	AMD	15#18	15111581-1-60-92	In the cohort, AMD patients with a positive family history exhibited a significant 3.5 years earlier age at diagnosis (P = 0.001); however, APOE alleles did not appear to modulate the age at diagnosis of AMD.
15111581	2004	Invest. Ophthalmol. Vis. Sci.	0146-0404	RESULTS	3	7	348	SYMBOL|DICTIONARY|EXTRACTED	apoe	APOE	140#144	15111581-1-25-41	D008268	SYMBOL|DICTIONARY|EXTRACTED	amd	AMD	204#207	15111581-1-60-92	In the cohort, AMD patients with a positive family history exhibited a significant 3.5 years earlier age at diagnosis (P = 0.001); however, APOE alleles did not appear to modulate the age at diagnosis of AMD.
15111581	2004	Invest. Ophthalmol. Vis. Sci.	0146-0404	METHODS	2	4	348	SYMBOL|DICTIONARY|EXTRACTED	apoe	APOE	21#25	15111581-1-25-41	D008268	SYMBOL|GFAM|FN|DICTIONARY|EXTRACTED	amd	AMD	57#60	15111581-1-60-92	The association with APOE was explored in the context of AMD subtypes, family history status, possible interaction with smoking, and distribution of age at diagnosis of AMD.
15111581	2004	Invest. Ophthalmol. Vis. Sci.	0146-0404	METHODS	2	4	348	SYMBOL|DICTIONARY|EXTRACTED	apoe	APOE	21#25	15111581-1-25-41	D008268	SYMBOL|DICTIONARY|EXTRACTED	amd	AMD	169#172	15111581-1-60-92	The association with APOE was explored in the context of AMD subtypes, family history status, possible interaction with smoking, and distribution of age at diagnosis of AMD.
12694583	2004	Tissue Antigens	0001-2815	TITLE	0	0	3123	SYMBOL|DICTIONARY	drb1	DRB1	36#40		D006111	LONGTERM|DISEASE|DT|DICTIONARY	graves disease	Graves' disease	56#71		The association of HLA -A, -B, and -DRB1 genotypes with Graves' disease in Taiwanese people.
12694583	2004	Tissue Antigens	0001-2815	ALL_TEXT_2/3	2	3	3123	SYMBOL|DICTIONARY	drb1	DRB1	53#57		D006111	LONGTERM|DISEASE|DT|DICTIONARY	graves disease	Graves' disease	83#98		The prevalence of HLA-A*0207, -B*2704, -B*4601, and -DRB1*0901 among patients with Graves' disease was found to be increased, with odds ratios (OR) of 2.21, 3.82, 1.76 and 1.62, respectively.
15111581	2004	Invest. Ophthalmol. Vis. Sci.	0146-0404	CONCLUSIONS	4	9	348	SYMBOL|DICTIONARY|EXTRACTED	apoe	APOE	13#17	15111581-1-25-41	D008268	SYMBOL|DICTIONARY|EXTRACTED	amd	AMD	33#36	15111581-1-60-92	How distinct APOE alleles affect AMD susceptibility warrants further investigation.
12694583	2004	Tissue Antigens	0001-2815	ALL_TEXT_2/3	2	4	3123	SYMBOL|DICTIONARY	drb1	DRB1	191#195		D006111	LONGTERM|DISEASE|DT|DICTIONARY	graves disease	Graves' disease	102#117		However, after correction for multiple comparisons, the relative risk of HLA-A*0207 susceptibility to Graves' disease remained statistically significant and the haplotype HLA-A*3303 -B*5801 -DRB1*0301 had a significantly protective effect.
20010906	2010	Int J Obes (Lond)	1476-5497	METHODS	2	3	4828	SYMBOL|DICTIONARY|EXTRACTED	nmb	NMB	29#32	20010906-1-0-12	D009765	LONGTERM|DICTIONARY	obesity	obesity	51#58		The association between four NMB polymorphisms and obesity-related phenotypes was investigated in the Healthy Lifestyle in Europe by Nutrition in Adolescence cross-sectional study (n=1144, 12-17-year-old European adolescents).
11244489	2001	Mol. Psychiatry	1359-4184	TITLE	0	0	7124	LONGTERM|GENE|GN|DICTIONARY	tumor necrosis factor alpha	tumor necrosis factor alpha	27#54		D012559	LONGTERM|DICTIONARY	schizophrenia	schizophrenia	77#90		Association between -G308A tumor necrosis factor alpha gene polymorphism and schizophrenia.
15318030	2005	Psychiatr. Genet.	0955-8829	TITLE	0	0	151056	LONGTERM|GENE|GN|DICTIONARY	phospholipase a2	phospholipase A2	32#48		D012559	LONGTERM|DICTIONARY	schizophrenia	schizophrenia	60#73		Allelic association analysis of phospholipase A2 genes with schizophrenia.
15772682	2005	Genes Immun.	1466-4879	ALL_TEXT_3/3	3	8	3586	SYMBOL|DICTIONARY|EXTRACTED	il 10	IL-10	27#32	15772682-2-0-14	D012594	LONGTERM|DICTIONARY	scleroderma	scleroderma	73#84		These results suggest that IL-10 genotypes contribute to the etiology of scleroderma.
11244489	2001	Mol. Psychiatry	1359-4184	ALL_TEXT_2/3	2	4	7124	LONGTERM|DICTIONARY	tumor necrosis factor alpha	tumor necrosis factor alpha	14#41		D020258	LONGTERM|DICTIONARY	neurotoxic	neurotoxic	118#128	NaN	In particular tumor necrosis factor alpha (TNFalpha), depending on its concentration, can exert both neurotrophic and neurotoxic effects and influence neural cell growth and proliferation.
11244489	2001	Mol. Psychiatry	1359-4184	ALL_TEXT_2/3	2	4	7124	SYMBOL|EXTRACTED|()	tnfalpha	TNFalpha	43#51	11244489-4-14-41	D020258	LONGTERM|DICTIONARY	neurotoxic	neurotoxic	118#128	NaN	In particular tumor necrosis factor alpha (TNFalpha), depending on its concentration, can exert both neurotrophic and neurotoxic effects and influence neural cell growth and proliferation.
11244489	2001	Mol. Psychiatry	1359-4184	ALL_TEXT_2/3	2	5	7124	SYMBOL|EXTRACTED|GENE|GN	tnfalpha	TNFalpha	10#18	11244489-4-14-41	D012559	LONGTERM|DICTIONARY	schizophrenia	schizophrenia	133#146		Moreover, TNFalpha gene is located on the small arm of chromosome 6 (6p21.1-21.3), a locus associated with genetic susceptibility to schizophrenia.
12181642	2002	J. Hum. Genet.	1434-5161	ALL_TEXT_2/3	2	5	7421	SYMBOL|DICTIONARY|EXTRACTED	vdr	VDR	36#39	12181642-2-77-95	D011471	LONGTERM|DISEASE|DT|DICTIONARY	portuguese prostate cancer	Portuguese prostate cancer	58#84		In the present study, we determined VDR TaqI genotypes in Portuguese prostate cancer cases ( n = 163) and controls ( n = 211), a southern European population.
18061279	2008	J. Neuroimmunol.	0165-5728	TITLE	0	0	627	SYMBOL|DICTIONARY	bdnf	BDNF	0#4		D009103	LONGTERM|DICTIONARY	multiple sclerosis	multiple sclerosis	62#80		BDNF A196G and C270T gene polymorphisms and susceptibility to multiple sclerosis in the Polish population. Gender differences.
20018409	2012	Neurobiol. Aging	1558-1497	ALL_TEXT_1/3	1	1	120892	LONGTERM|DICTIONARY	leucine rich repeat kinase 2	leucine-rich repeat kinase-2	140#168		D000544	LONGTERM|DISEASE|DT|DICTIONARY	alzheimer disease	Alzheimer's disease	53#72		Overlapping neurodegenerative pathologies (including Alzheimer's disease, AD) have been described in Parkinson's disease (PD) patients with leucine-rich repeat kinase-2 (LRRK2) mutations.
20018409	2012	Neurobiol. Aging	1558-1497	ALL_TEXT_1/3	1	1	120892	LONGTERM|DICTIONARY	leucine rich repeat kinase 2	leucine-rich repeat kinase-2	140#168		D010300	LONGTERM|DISEASE|DN|DICTIONARY	parkinson disease	Parkinson's disease	101#120		Overlapping neurodegenerative pathologies (including Alzheimer's disease, AD) have been described in Parkinson's disease (PD) patients with leucine-rich repeat kinase-2 (LRRK2) mutations.
20018409	2012	Neurobiol. Aging	1558-1497	ALL_TEXT_1/3	1	1	120892	LONGTERM|DICTIONARY	leucine rich repeat kinase 2	leucine-rich repeat kinase-2	140#168		D010300	SYMBOL|()|DISEASE|DN|DICTIONARY|EXTRACTED	pd	PD	122#124	20018409-1-101-120	Overlapping neurodegenerative pathologies (including Alzheimer's disease, AD) have been described in Parkinson's disease (PD) patients with leucine-rich repeat kinase-2 (LRRK2) mutations.
20018409	2012	Neurobiol. Aging	1558-1497	ALL_TEXT_1/3	1	1	120892	SYMBOL|()|DICTIONARY|EXTRACTED	lrrk2	LRRK2	170#175	20018409-1-140-168	D000544	LONGTERM|DISEASE|DT|DICTIONARY	alzheimer disease	Alzheimer's disease	53#72		Overlapping neurodegenerative pathologies (including Alzheimer's disease, AD) have been described in Parkinson's disease (PD) patients with leucine-rich repeat kinase-2 (LRRK2) mutations.
20018409	2012	Neurobiol. Aging	1558-1497	ALL_TEXT_1/3	1	1	120892	SYMBOL|()|DICTIONARY|EXTRACTED	lrrk2	LRRK2	170#175	20018409-1-140-168	D010300	LONGTERM|DISEASE|DN|DICTIONARY	parkinson disease	Parkinson's disease	101#120		Overlapping neurodegenerative pathologies (including Alzheimer's disease, AD) have been described in Parkinson's disease (PD) patients with leucine-rich repeat kinase-2 (LRRK2) mutations.
20018409	2012	Neurobiol. Aging	1558-1497	ALL_TEXT_1/3	1	1	120892	SYMBOL|()|DICTIONARY|EXTRACTED	lrrk2	LRRK2	170#175	20018409-1-140-168	D010300	SYMBOL|()|DISEASE|DN|DICTIONARY|EXTRACTED	pd	PD	122#124	20018409-1-101-120	Overlapping neurodegenerative pathologies (including Alzheimer's disease, AD) have been described in Parkinson's disease (PD) patients with leucine-rich repeat kinase-2 (LRRK2) mutations.
14558082	2003	Arthritis Rheum.	0004-3591	TITLE	0	0	3458	LONGTERM|DICTIONARY	interferon gamma	interferon-gamma	21#37		D001172	LONGTERM|DICTIONARY	rheumatoid arthritis	rheumatoid arthritis	109#129		Polymorphisms in the interferon-gamma/interleukin-26 gene region contribute to sex bias in susceptibility to rheumatoid arthritis.
14558082	2003	Arthritis Rheum.	0004-3591	TITLE	0	0	55801	LONGTERM|GENE|GN|DICTIONARY	interleukin 26	interleukin-26	38#52		D001172	LONGTERM|DICTIONARY	rheumatoid arthritis	rheumatoid arthritis	109#129		Polymorphisms in the interferon-gamma/interleukin-26 gene region contribute to sex bias in susceptibility to rheumatoid arthritis.
19115972	2009	Clin. Infect. Dis.	1537-6591	ALL_TEXT_3/3	3	3	3106	SYMBOL|NUMBER|DICTIONARY	hla b	HLA-B	68#73		D015658	LONGTERM|DISEASE|DT|DICTIONARY	human immunodeficiency virus infection	human immunodeficiency virus infection	28#66		In 534 Korean patients with human immunodeficiency virus infection, HLA-B*5701 status was determined by polymerase chain reaction with HLA-B*5701-specific primers.
19115972	2009	Clin. Infect. Dis.	1537-6591	ALL_TEXT_3/3	3	3	3106	SYMBOL|NUMBER|DICTIONARY	hla b	HLA-B	135#140		D015658	LONGTERM|DISEASE|DT|DICTIONARY	human immunodeficiency virus infection	human immunodeficiency virus infection	28#66		In 534 Korean patients with human immunodeficiency virus infection, HLA-B*5701 status was determined by polymerase chain reaction with HLA-B*5701-specific primers.
20628598	2010	PLoS ONE	1932-6203	CONCLUSIONS/SIGNIFICANCE	3	8	4544	SYMBOL|DICTIONARY|EXTRACTED	mtnr1b	MTNR1B	19#25	20628598-1-28-49	D006943	LONGTERM|DICTIONARY	hyperglycemia	hyperglycemia	202#215		Common variants of MTNR1B, G6PC2 and GCK are associated with elevated FPG and impaired insulin secretion, both individually and jointly, suggesting that these risk alleles may precipitate or perpetuate hyperglycemia in predisposed individuals.
20628598	2010	PLoS ONE	1932-6203	CONCLUSIONS/SIGNIFICANCE	3	8	4544	SYMBOL|DICTIONARY|EXTRACTED	mtnr1b	MTNR1B	19#25	20628598-1-28-49	D003072	LONGTERM|DICTIONARY	impaired insulin secretion	impaired insulin secretion	78#104	NaN	Common variants of MTNR1B, G6PC2 and GCK are associated with elevated FPG and impaired insulin secretion, both individually and jointly, suggesting that these risk alleles may precipitate or perpetuate hyperglycemia in predisposed individuals.
20628598	2010	PLoS ONE	1932-6203	CONCLUSIONS/SIGNIFICANCE	3	8	4544	SYMBOL|DICTIONARY|EXTRACTED	mtnr1b	MTNR1B	19#25	20628598-1-28-49	D018149	LONGTERM|DICTIONARY	fpg	FPG	70#73	NaN	Common variants of MTNR1B, G6PC2 and GCK are associated with elevated FPG and impaired insulin secretion, both individually and jointly, suggesting that these risk alleles may precipitate or perpetuate hyperglycemia in predisposed individuals.
20628598	2010	PLoS ONE	1932-6203	CONCLUSIONS/SIGNIFICANCE	3	8	57818	SYMBOL|DICTIONARY|EXTRACTED	g6pc2	G6PC2	27#32	20628598-1-60-130	D006943	LONGTERM|DICTIONARY	hyperglycemia	hyperglycemia	202#215		Common variants of MTNR1B, G6PC2 and GCK are associated with elevated FPG and impaired insulin secretion, both individually and jointly, suggesting that these risk alleles may precipitate or perpetuate hyperglycemia in predisposed individuals.
20628598	2010	PLoS ONE	1932-6203	CONCLUSIONS/SIGNIFICANCE	3	8	57818	SYMBOL|DICTIONARY|EXTRACTED	g6pc2	G6PC2	27#32	20628598-1-60-130	D003072	LONGTERM|DICTIONARY	impaired insulin secretion	impaired insulin secretion	78#104	NaN	Common variants of MTNR1B, G6PC2 and GCK are associated with elevated FPG and impaired insulin secretion, both individually and jointly, suggesting that these risk alleles may precipitate or perpetuate hyperglycemia in predisposed individuals.
20628598	2010	PLoS ONE	1932-6203	CONCLUSIONS/SIGNIFICANCE	3	8	57818	SYMBOL|DICTIONARY|EXTRACTED	g6pc2	G6PC2	27#32	20628598-1-60-130	D018149	LONGTERM|DICTIONARY	fpg	FPG	70#73	NaN	Common variants of MTNR1B, G6PC2 and GCK are associated with elevated FPG and impaired insulin secretion, both individually and jointly, suggesting that these risk alleles may precipitate or perpetuate hyperglycemia in predisposed individuals.
20628598	2010	PLoS ONE	1932-6203	CONCLUSIONS/SIGNIFICANCE	3	8	2645	SYMBOL|DICTIONARY|EXTRACTED	gck	GCK	37#40	20628598-1-140-151	D006943	LONGTERM|DICTIONARY	hyperglycemia	hyperglycemia	202#215		Common variants of MTNR1B, G6PC2 and GCK are associated with elevated FPG and impaired insulin secretion, both individually and jointly, suggesting that these risk alleles may precipitate or perpetuate hyperglycemia in predisposed individuals.
20628598	2010	PLoS ONE	1932-6203	CONCLUSIONS/SIGNIFICANCE	3	8	2645	SYMBOL|DICTIONARY|EXTRACTED	gck	GCK	37#40	20628598-1-140-151	D003072	LONGTERM|DICTIONARY	impaired insulin secretion	impaired insulin secretion	78#104	NaN	Common variants of MTNR1B, G6PC2 and GCK are associated with elevated FPG and impaired insulin secretion, both individually and jointly, suggesting that these risk alleles may precipitate or perpetuate hyperglycemia in predisposed individuals.
20628598	2010	PLoS ONE	1932-6203	CONCLUSIONS/SIGNIFICANCE	3	8	2645	SYMBOL|DICTIONARY|EXTRACTED	gck	GCK	37#40	20628598-1-140-151	D018149	LONGTERM|DICTIONARY	fpg	FPG	70#73	NaN	Common variants of MTNR1B, G6PC2 and GCK are associated with elevated FPG and impaired insulin secretion, both individually and jointly, suggesting that these risk alleles may precipitate or perpetuate hyperglycemia in predisposed individuals.
16182378	2006	J. Neuroimmunol.	0165-5728	ALL_TEXT_2/3	2	6	1234	SYMBOL|DICTIONARY	ccr5	CCR5	14#18		D009103	SYMBOL|EXTRACTED	ms	MS	125#127	16182378-1-63-81	A deletion in CCR5 (CCR5*Delta32), which encodes a truncated, non-functional protein, has been associated with late onset of MS and a favorable prognosis.
16182378	2006	J. Neuroimmunol.	0165-5728	ALL_TEXT_2/3	2	6	1234	SYMBOL|DICTIONARY	ccr5	CCR5	20#24		D009103	SYMBOL|EXTRACTED	ms	MS	125#127	16182378-1-63-81	A deletion in CCR5 (CCR5*Delta32), which encodes a truncated, non-functional protein, has been associated with late onset of MS and a favorable prognosis.
16911713	2006	Am. J. Reprod. Immunol.	1046-7408	ALL_TEXT_3/3	3	5	6690	LONGTERM|DICTIONARY	psti	PstI	14#18	NaN	D004715	LONGTERM|DICTIONARY	endometriosis	endometriosis	80#93		Genotypes for PstI polymorphisms did not differ significantly among control and endometriosis (P = 0.058).
16956834	2006	Haematologica	1592-8721	TITLE	0	0	4846	SYMBOL|GENE|GN|DICTIONARY	ecnos	ecNOS	9#14		D056586	LONGTERM|DISEASE|DT|DICTIONARY	acute chest syndrome	acute chest syndrome	55#75		ET-1 and ecNOS gene polymorphisms andsusceptibility to acute chest syndrome and painful vaso-occlusive crises in children with sickle cell anemia.
16956834	2006	Haematologica	1592-8721	TITLE	0	0	4846	SYMBOL|GENE|GN|DICTIONARY	ecnos	ecNOS	9#14		D000755	LONGTERM|DICTIONARY	sickle cell anemia	sickle cell anemia	127#145		ET-1 and ecNOS gene polymorphisms andsusceptibility to acute chest syndrome and painful vaso-occlusive crises in children with sickle cell anemia.
16956834	2006	Haematologica	1592-8721	TITLE	0	0	4846	SYMBOL|GENE|GN|DICTIONARY	ecnos	ecNOS	9#14		D010146	LONGTERM|DICTIONARY	painful vaso-occlusive crises	painful vaso-occlusive crises	80#109		ET-1 and ecNOS gene polymorphisms andsusceptibility to acute chest syndrome and painful vaso-occlusive crises in children with sickle cell anemia.
16956834	2006	Haematologica	1592-8721	TITLE	0	0	1906	LONGTERM|DICTIONARY	et-1	ET-1	0#4	NaN	D056586	LONGTERM|DISEASE|DT|DICTIONARY	acute chest syndrome	acute chest syndrome	55#75		ET-1 and ecNOS gene polymorphisms andsusceptibility to acute chest syndrome and painful vaso-occlusive crises in children with sickle cell anemia.
16956834	2006	Haematologica	1592-8721	TITLE	0	0	1906	LONGTERM|DICTIONARY	et-1	ET-1	0#4	NaN	D000755	LONGTERM|DICTIONARY	sickle cell anemia	sickle cell anemia	127#145		ET-1 and ecNOS gene polymorphisms andsusceptibility to acute chest syndrome and painful vaso-occlusive crises in children with sickle cell anemia.
16956834	2006	Haematologica	1592-8721	TITLE	0	0	1906	LONGTERM|DICTIONARY	et-1	ET-1	0#4	NaN	D010146	LONGTERM|DICTIONARY	painful vaso-occlusive crises	painful vaso-occlusive crises	80#109		ET-1 and ecNOS gene polymorphisms andsusceptibility to acute chest syndrome and painful vaso-occlusive crises in children with sickle cell anemia.
20810130	2011	J. Neurol. Sci.	1878-5883	CONCLUSIONS	4	11	3123	SYMBOL|DICTIONARY	hla drb1	HLA-DRB1	68#76		D009103	SYMBOL|EXTRACTED	ms	MS	109#111	20810130-1-0-18	Our results show the importance of epistatic interactions among the HLA-DRB1 alleles, modifying the risk for MS as well as its clinical severity.
11397889	2001	J. Clin. Endocrinol. Metab.	0021-972X	TITLE	0	0	4843	LONGTERM|DICTIONARY	inducible nitric oxide synthase	inducible nitric oxide synthase	21#52	NaN	D003920	LONGTERM|DICTIONARY	diabetes	diabetes	68#76		Linkage of the human inducible nitric oxide synthase gene to type 1 diabetes.
18946768	2009	J. Recept. Signal Transduct. Res.	1532-4281	ALL_TEXT_1/3	1	1	1956	SYMBOL|DICTIONARY	egfr	EGFR	33#37		D009369	LONGTERM|DICTIONARY	cancers	cancers	92#99		Overexpression or dysfunction of EGFR and other ErbBs is known to be involved in many human cancers.
18074359	2008	Am. J. Med. Genet. A	1552-4833	ALL_TEXT_3/3	3	9	55636	SYMBOL|DICTIONARY	chd7	CHD7	28#32		D058747	LONGTERM|DISEASE|DT|DICTIONARY	charge syndrome	CHARGE syndrome	120#135		We find that alterations in CHD7 can result in a very mild phenotype, characterized by only a few minor symptoms of the CHARGE syndrome clinical spectrum.
18074359	2008	Am. J. Med. Genet. A	1552-4833	ALL_TEXT_1/3	1	4	55636	SYMBOL|DICTIONARY	chd7	CHD7	97#101		D058747	LONGTERM|DISEASE|DT|DICTIONARY	familial charge syndrome	familial CHARGE syndrome	125#149		We observed somatic and germline mosaicism as well as parent-to-child transmission of non-mosaic CHD7 mutations as causes of familial CHARGE syndrome.
18074359	2008	Am. J. Med. Genet. A	1552-4833	TITLE	0	0	55636	SYMBOL|GENE|GN|DICTIONARY	chd7	CHD7	33#37		D058747	LONGTERM|DISEASE|DT|DICTIONARY	familial charge syndrome	Familial CHARGE syndrome	0#24		Familial CHARGE syndrome and the CHD7 gene: a recurrent missense mutation, intrafamilial recurrence and variability.
18074359	2008	Am. J. Med. Genet. A	1552-4833	ALL_TEXT_1/3	1	1	55636	SYMBOL|GENE|GN|DICTIONARY	chd7	CHD7	86#90		D058747	LONGTERM|DISEASE|DT|DICTIONARY	charge syndrome	CHARGE syndrome	0#15		CHARGE syndrome is an autosomal dominant condition that is caused by mutations in the CHD7 gene.
18074359	2008	Am. J. Med. Genet. A	1552-4833	ALL_TEXT_1/3	1	1	55636	SYMBOL|GENE|GN|DICTIONARY	chd7	CHD7	86#90		D030342	LONGTERM|DICTIONARY	autosomal dominant condition	autosomal dominant condition	22#50	NaN	CHARGE syndrome is an autosomal dominant condition that is caused by mutations in the CHD7 gene.
19450125	2009	Pharmacogenomics	1744-8042	RESULTS	3	7	54658	SYMBOL|NUMBER|DICTIONARY	ugt1a1	UGT1A1	33#39		D009503	LONGTERM|DICTIONARY	neutropenia	neutropenia	61#72		No association was found between UGT1A1*28 or c.-3156G>A and neutropenia.
18555606	2008	Neurosci. Lett.	0304-3940	TITLE	0	0	348	SYMBOL|DICTIONARY|EXTRACTED	apoe	APOE	91#95		D000544	LONGTERM|DISEASE|DT|DICTIONARY	alzheimer disease	Alzheimer's disease	56#75		CSF beta-amyloid 1-42 and tau in Tunisian patients with Alzheimer's disease: the effect of APOE epsilon4 allele.
14567462	2004	Dig Liver Dis	1590-8658	AIMS	1	1	1080	LONGTERM|DICTIONARY|GENE|GA	cystic fibrosis transmembrane conductance regulator	cystic fibrosis transmembrane conductance regulator	139#190		D015209	LONGTERM|DICTIONARY	primary sclerosing cholangitis	primary sclerosing cholangitis	22#52		In patients with with primary sclerosing cholangitis we investigated the major histocompatibility complex (MHC) genes and mutations of the cystic fibrosis transmembrane conductance regulator (CFTR) gene.
14567462	2004	Dig Liver Dis	1590-8658	AIMS	1	1	1080	SYMBOL|()|GENE|GN|DICTIONARY|EXTRACTED	cftr	CFTR	192#196	14567462-1-139-190	D015209	LONGTERM|DICTIONARY	primary sclerosing cholangitis	primary sclerosing cholangitis	22#52		In patients with with primary sclerosing cholangitis we investigated the major histocompatibility complex (MHC) genes and mutations of the cystic fibrosis transmembrane conductance regulator (CFTR) gene.
25356585	2015	PLoS ONE	1932-6203	RESULTS	3	9	1513	LONGTERM|DICTIONARY	cathepsin k	Cathepsin K	0#11		D005909	SYMBOL|DICTIONARY|EXTRACTED	gbm	GBM	150#153	25356585-2-126-149	Cathepsin K immunohistochemical staining and western blotting showed that only proteolytically inactive proforms of cathepsin K were overexpressed in GBM tissues and cells.
25356585	2015	PLoS ONE	1932-6203	RESULTS	3	9	1513	LONGTERM|DICTIONARY	cathepsin k	cathepsin K	116#127		D005909	SYMBOL|DICTIONARY|EXTRACTED	gbm	GBM	150#153	25356585-2-126-149	Cathepsin K immunohistochemical staining and western blotting showed that only proteolytically inactive proforms of cathepsin K were overexpressed in GBM tissues and cells.
20042177	2010	Am. J. Ophthalmol.	1879-1891	PURPOSE	1	2	5444	LONGTERM|DICTIONARY	paraoxonase 1	Paraoxonase 1	0#13		D008268	SYMBOL|DICTIONARY|EXTRACTED	amd	AMD	126#129	20042177-1-0-32	Paraoxonase 1 (PON1) protects against oxidative damage and has been evaluated for its involvement in aging diseases including AMD.
20042177	2010	Am. J. Ophthalmol.	1879-1891	PURPOSE	1	2	5444	SYMBOL|()|DICTIONARY|EXTRACTED	pon1	PON1	15#19	20042177-2-0-13	D008268	SYMBOL|DICTIONARY|EXTRACTED	amd	AMD	126#129	20042177-1-0-32	Paraoxonase 1 (PON1) protects against oxidative damage and has been evaluated for its involvement in aging diseases including AMD.
17442289	2007	Clin. Chim. Acta	0009-8981	TITLE	0	0	1571	SYMBOL|DICTIONARY	cyp2e1	CYP2E1	15#21		D029424	LONGTERM|DISEASE|DT|DICTIONARY	chronic obstructive pulmonary disease	chronic obstructive pulmonary disease	55#92		Association of CYP2E1 and NAT2 gene polymorphisms with chronic obstructive pulmonary disease.
17442289	2007	Clin. Chim. Acta	0009-8981	TITLE	0	0	10	SYMBOL|GENE|GN|DICTIONARY	nat2	NAT2	26#30		D029424	LONGTERM|DISEASE|DT|DICTIONARY	chronic obstructive pulmonary disease	chronic obstructive pulmonary disease	55#92		Association of CYP2E1 and NAT2 gene polymorphisms with chronic obstructive pulmonary disease.
20042177	2010	Am. J. Ophthalmol.	1879-1891	TITLE	0	0	5444	LONGTERM|GENE|GN|DICTIONARY	paraoxonase 1	paraoxonase 1	21#34		D008268	LONGTERM|DICTIONARY	macular degeneration	macular degeneration	73#93		Protective effect of paraoxonase 1 gene variant Gln192Arg in age-related macular degeneration.
18163425	2008	Prostate	0270-4137	RESULTS	3	9	8797	SYMBOL|DICTIONARY	tnfrsf10a	TNFRSF10A	0#9		D009369	LONGTERM|DISEASE|DT|DICTIONARY	tumor	tumor	45#50		TNFRSF10A genotypes were not associated with tumor stage, grade, risk group or age at diagnosis.
18163425	2008	Prostate	0270-4137	BACKGROUND	1	1	8797	LONGTERM|DICTIONARY	death receptor 4	Death receptor 4	0#16		D009369	LONGTERM|DISEASE|DT|DICTIONARY	cancer	cancer	125#131		Death receptor 4, encoded by the TNFRSF10A gene, is an important mediator of apoptosis and its dysfunction may be related to cancer development and distant tumor spread.
18163425	2008	Prostate	0270-4137	BACKGROUND	1	1	8797	LONGTERM|DICTIONARY	death receptor 4	Death receptor 4	0#16		D009369	LONGTERM|DISEASE|DT|DICTIONARY	tumor	tumor	156#161		Death receptor 4, encoded by the TNFRSF10A gene, is an important mediator of apoptosis and its dysfunction may be related to cancer development and distant tumor spread.
18163425	2008	Prostate	0270-4137	BACKGROUND	1	1	8797	SYMBOL|GENE|GN|DICTIONARY	tnfrsf10a	TNFRSF10A	33#42		D009369	LONGTERM|DISEASE|DT|DICTIONARY	cancer	cancer	125#131		Death receptor 4, encoded by the TNFRSF10A gene, is an important mediator of apoptosis and its dysfunction may be related to cancer development and distant tumor spread.
18163425	2008	Prostate	0270-4137	BACKGROUND	1	1	8797	SYMBOL|GENE|GN|DICTIONARY	tnfrsf10a	TNFRSF10A	33#42		D009369	LONGTERM|DISEASE|DT|DICTIONARY	tumor	tumor	156#161		Death receptor 4, encoded by the TNFRSF10A gene, is an important mediator of apoptosis and its dysfunction may be related to cancer development and distant tumor spread.
18163425	2008	Prostate	0270-4137	TITLE	0	0	8797	LONGTERM|DICTIONARY	death receptor 4	death receptor 4	59#75		D011471	LONGTERM|DISEASE|DT|DICTIONARY	prostate cancer	prostate cancer	114#129		The Glu228Ala polymorphism in the ligand binding domain of death receptor 4 is associated with increased risk for prostate cancer metastases.
18163425	2008	Prostate	0270-4137	TITLE	0	0	8797	LONGTERM|DICTIONARY	death receptor 4	death receptor 4	59#75		D009362	LONGTERM|DICTIONARY	metastases	metastases	130#140		The Glu228Ala polymorphism in the ligand binding domain of death receptor 4 is associated with increased risk for prostate cancer metastases.
18163425	2008	Prostate	0270-4137	BACKGROUND	1	3	8797	SYMBOL|DICTIONARY	tnfrsf10a	TNFRSF10A	57#66		D011471	LONGTERM|DISEASE|DT|DICTIONARY	prostate cancer	prostate cancer	109#124		Aim of the present study was to evaluate the role of the TNFRSF10A polymorphism in metastatic progression of prostate cancer after radiation therapy.
18163425	2008	Prostate	0270-4137	BACKGROUND	1	2	8797	SYMBOL|DICTIONARY	tnfrsf10a	TNFRSF10A	36#45		D009369	LONGTERM|DISEASE|DT|DICTIONARY	tumor	tumor	215#220		A single nucleotide polymorphism in TNFRSF10A (Glu228Ala, rs20576) within a conserved region of the extracellular cysteine-rich domain of death receptor 4 has been associated with an increased risk for a variety of tumor entities.
18163425	2008	Prostate	0270-4137	BACKGROUND	1	2	8797	LONGTERM|DICTIONARY	death receptor 4	death receptor 4	138#154		D009369	LONGTERM|DISEASE|DT|DICTIONARY	tumor	tumor	215#220		A single nucleotide polymorphism in TNFRSF10A (Glu228Ala, rs20576) within a conserved region of the extracellular cysteine-rich domain of death receptor 4 has been associated with an increased risk for a variety of tumor entities.
19141225	2009	Zhonghua Yu Fang Yi Xue Za Zhi	0253-9624	OBJECTIVE	1	1	10332	SYMBOL|DICTIONARY	dc signr	DC-SIGNR	37#45		D006526	LONGTERM|DICTIONARY	hcv	HCV	229#232	NaN	To study the distribution of DC-SIGN/DC-SIGNR alleles among drug user (DUs) populations with or without HIV/HCV infection in Shenzhen, and to evaluate the role of these alleles in the construction of genetic resistance to HIV or HCV and screen out the anti-HIV/HCV gene in Shenzhen.
19141225	2009	Zhonghua Yu Fang Yi Xue Za Zhi	0253-9624	OBJECTIVE	1	1	10332	SYMBOL|DICTIONARY	dc signr	DC-SIGNR	37#45		D006526	LONGTERM|DICTIONARY	hcv	HCV	261#264	NaN	To study the distribution of DC-SIGN/DC-SIGNR alleles among drug user (DUs) populations with or without HIV/HCV infection in Shenzhen, and to evaluate the role of these alleles in the construction of genetic resistance to HIV or HCV and screen out the anti-HIV/HCV gene in Shenzhen.
18042412	2008	Blood Cells Mol. Dis.	1096-0961	ALL_TEXT_1/3	1	1	3077	SYMBOL|GENE|GN|DICTIONARY	hfe	HFE	59#62		D006432	LONGTERM|DICTIONARY	hereditary hemochromatosis	hereditary hemochromatosis	168#194		We describe a novel heterozygous mutation in exon 3 of the HFE-gene that was co-inherited with Cys282Tyr in two unrelated Dutch men both presenting a classical form of hereditary hemochromatosis.
18042412	2008	Blood Cells Mol. Dis.	1096-0961	TITLE	0	0	3077	SYMBOL|GENE|GN|DICTIONARY	hfe	HFE	36#39		D006432	LONGTERM|DISEASE|DN|DICTIONARY	hemochromatosis	hemochromatosis	109#124		A novel (Leu183Pro-)mutation in the HFE-gene co-inherited with the Cys282Tyr mutation in two unrelated Dutch hemochromatosis patients.
19141225	2009	Zhonghua Yu Fang Yi Xue Za Zhi	0253-9624	CONCLUSION	4	9	10332	SYMBOL|DICTIONARY	dc signr	DC-SIGNR	40#48		D006526	LONGTERM|DICTIONARY	hcv	HCV	104#107	NaN	The results might indicate that DC-SIGN/DC-SIGNR polymorphism might not influence the susceptibility to HCV.
19478460	2009	J. Clin. Invest.	1558-8238	ALL_TEXT_3/3	3	6	6531	SYMBOL|DICTIONARY	slc6a3	SLC6A3	54#60		D009069	LONGTERM|DICTIONARY	movement disorders	movement disorders	106#124		Identification of the molecular basis of IPD suggests SLC6A3 as a candidate susceptibility gene for other movement disorders associated with parkinsonism and/or dystonic features.
19478460	2009	J. Clin. Invest.	1558-8238	ALL_TEXT_3/3	3	6	6531	SYMBOL|DICTIONARY	slc6a3	SLC6A3	54#60		D010302	LONGTERM|DICTIONARY	parkinsonism	parkinsonism	141#153		Identification of the molecular basis of IPD suggests SLC6A3 as a candidate susceptibility gene for other movement disorders associated with parkinsonism and/or dystonic features.
19478460	2009	J. Clin. Invest.	1558-8238	ALL_TEXT_3/3	3	6	6531	SYMBOL|DICTIONARY	slc6a3	SLC6A3	54#60		D020821	LONGTERM|DICTIONARY	dystonic	dystonic	161#169	NaN	Identification of the molecular basis of IPD suggests SLC6A3 as a candidate susceptibility gene for other movement disorders associated with parkinsonism and/or dystonic features.
19478460	2009	J. Clin. Invest.	1558-8238	ALL_TEXT_3/3	3	5	6531	SYMBOL|DICTIONARY	slc6a3	SLC6A3	34#40		D009069	LONGTERM|DISEASE|DT|DICTIONARY	complex movement disorder	complex movement disorder	139#164		Thus, in humans, loss-of-function SLC6A3 mutations that impair DAT-mediated dopamine transport activity are associated with an early-onset complex movement disorder.
19478460	2009	J. Clin. Invest.	1558-8238	ALL_TEXT_3/3	3	5	6531	SYMBOL|DICTIONARY|EXTRACTED	dat	DAT	63#66	19478460-1-59-79	D009069	LONGTERM|DISEASE|DT|DICTIONARY	complex movement disorder	complex movement disorder	139#164		Thus, in humans, loss-of-function SLC6A3 mutations that impair DAT-mediated dopamine transport activity are associated with an early-onset complex movement disorder.
19478460	2009	J. Clin. Invest.	1558-8238	ALL_TEXT_1/3	1	2	6531	SYMBOL|DICTIONARY	slc6a3	Slc6a3	28#34		D006948	LONGTERM|DISEASE|DN|DICTIONARY	hyperactivity	hyperactivity	61#74		In addition, the homozygous Slc6a3 knockout mouse displays a hyperactivity phenotype.
19478460	2009	J. Clin. Invest.	1558-8238	TITLE	0	0	6531	LONGTERM|DICTIONARY	dopamine transporter	dopamine transporter	63#83		C567730	LONGTERM|DICTIONARY	parkinsonism-dystonia	parkinsonism-dystonia	114#135		Homozygous loss-of-function mutations in the gene encoding the dopamine transporter are associated with infantile parkinsonism-dystonia.
16254428	2006	Dement Geriatr Cogn Disord	1420-8008	RESULTS	3	8	348	SYMBOL|EXTRACTED	apoe	ApoE	57#61	16254428-1-33-49	D015431	LONGTERM|DICTIONARY	weight loss	weight loss	17#28	NaN	The incidence of weight loss was significantly higher in ApoE epsilon4 carriers (n = 11; 9.6%) than in ApoE epsilon4 noncarriers (n = 1; 1.2%) during this 16-week study, even though 92% of patients who complained of weight loss completed this 16-week trial successfully.
16254428	2006	Dement Geriatr Cogn Disord	1420-8008	RESULTS	3	8	348	SYMBOL|EXTRACTED	apoe	ApoE	57#61	16254428-1-33-49	D015431	LONGTERM|DICTIONARY	weight loss	weight loss	216#227	NaN	The incidence of weight loss was significantly higher in ApoE epsilon4 carriers (n = 11; 9.6%) than in ApoE epsilon4 noncarriers (n = 1; 1.2%) during this 16-week study, even though 92% of patients who complained of weight loss completed this 16-week trial successfully.
16254428	2006	Dement Geriatr Cogn Disord	1420-8008	RESULTS	3	8	348	SYMBOL|EXTRACTED	apoe	ApoE	103#107	16254428-1-33-49	D015431	LONGTERM|DICTIONARY	weight loss	weight loss	17#28	NaN	The incidence of weight loss was significantly higher in ApoE epsilon4 carriers (n = 11; 9.6%) than in ApoE epsilon4 noncarriers (n = 1; 1.2%) during this 16-week study, even though 92% of patients who complained of weight loss completed this 16-week trial successfully.
16254428	2006	Dement Geriatr Cogn Disord	1420-8008	RESULTS	3	8	348	SYMBOL|EXTRACTED	apoe	ApoE	103#107	16254428-1-33-49	D015431	LONGTERM|DICTIONARY	weight loss	weight loss	216#227	NaN	The incidence of weight loss was significantly higher in ApoE epsilon4 carriers (n = 11; 9.6%) than in ApoE epsilon4 noncarriers (n = 1; 1.2%) during this 16-week study, even though 92% of patients who complained of weight loss completed this 16-week trial successfully.
19484476	2009	J. Cancer Res. Clin. Oncol.	1432-1335	TITLE	0	0	672	SYMBOL|DICTIONARY	brca1	BRCA1	17#22		D001943	LONGTERM|DISEASE|DT|DICTIONARY	breast cancer	breast cancer	70#83		Polymorphisms in BRCA1, BRCA1-interacting genes and susceptibility of breast cancer in Chinese women.
19484476	2009	J. Cancer Res. Clin. Oncol.	1432-1335	TITLE	0	0	672	SYMBOL|DICTIONARY	brca1	BRCA1	24#29		D001943	LONGTERM|DISEASE|DT|DICTIONARY	breast cancer	breast cancer	70#83		Polymorphisms in BRCA1, BRCA1-interacting genes and susceptibility of breast cancer in Chinese women.
19484476	2009	J. Cancer Res. Clin. Oncol.	1432-1335	PURPOSE	1	1	83990	SYMBOL|()|DICTIONARY|EXTRACTED	brip1	BRIP1	49#54	19484476-1-0-47	D009369	LONGTERM|DISEASE|DT|DICTIONARY	tumor	tumor	112#117		BRCA1-interacting protein C-terminal helicase 1 (BRIP1) and zinc finger protein 350 (ZNF350) work with BRCA1 in tumor suppression procedures.
19484476	2009	J. Cancer Res. Clin. Oncol.	1432-1335	PURPOSE	1	1	59348	LONGTERM|DICTIONARY	zinc finger protein 350	zinc finger protein 350	60#83		D009369	LONGTERM|DISEASE|DT|DICTIONARY	tumor	tumor	112#117		BRCA1-interacting protein C-terminal helicase 1 (BRIP1) and zinc finger protein 350 (ZNF350) work with BRCA1 in tumor suppression procedures.
19484476	2009	J. Cancer Res. Clin. Oncol.	1432-1335	PURPOSE	1	1	59348	SYMBOL|()|DICTIONARY|EXTRACTED	znf350	ZNF350	85#91	19484476-1-60-83	D009369	LONGTERM|DISEASE|DT|DICTIONARY	tumor	tumor	112#117		BRCA1-interacting protein C-terminal helicase 1 (BRIP1) and zinc finger protein 350 (ZNF350) work with BRCA1 in tumor suppression procedures.
19484476	2009	J. Cancer Res. Clin. Oncol.	1432-1335	PURPOSE	1	1	672	SYMBOL|DICTIONARY	brca1	BRCA1	103#108		D009369	LONGTERM|DISEASE|DT|DICTIONARY	tumor	tumor	112#117		BRCA1-interacting protein C-terminal helicase 1 (BRIP1) and zinc finger protein 350 (ZNF350) work with BRCA1 in tumor suppression procedures.
19484476	2009	J. Cancer Res. Clin. Oncol.	1432-1335	PURPOSE	1	1	56916	LONGTERM|DICTIONARY	helicase 1	helicase 1	37#47		D009369	LONGTERM|DISEASE|DT|DICTIONARY	tumor	tumor	112#117		BRCA1-interacting protein C-terminal helicase 1 (BRIP1) and zinc finger protein 350 (ZNF350) work with BRCA1 in tumor suppression procedures.
19484476	2009	J. Cancer Res. Clin. Oncol.	1432-1335	PURPOSE	1	1	672	LONGTERM|DICTIONARY	brca1	BRCA1	0#5		D009369	LONGTERM|DISEASE|DT|DICTIONARY	tumor	tumor	112#117		BRCA1-interacting protein C-terminal helicase 1 (BRIP1) and zinc finger protein 350 (ZNF350) work with BRCA1 in tumor suppression procedures.
17257320	2007	Tissue Antigens	0001-2815	TITLE	0	0	3123	SYMBOL|DICTIONARY	drb1	DRB1	56#60		D006509	LONGTERM|DISEASE|DN|DICTIONARY	hepatitis b virus infection	hepatitis B virus infection	20#47		Association between hepatitis B virus infection and HLA-DRB1 genotyping in Shaanxi Han patients in northwestern China.
17257320	2007	Tissue Antigens	0001-2815	TITLE	0	0	3123	SYMBOL|DICTIONARY	drb1	DRB1	56#60		D006509	LONGTERM|DISEASE|DT|DICTIONARY	hepatitis b virus infection	hepatitis B virus infection	20#47		Association between hepatitis B virus infection and HLA-DRB1 genotyping in Shaanxi Han patients in northwestern China.
12058348	2002	Am. J. Hum. Genet.	0002-9297	ALL_TEXT_2/3	2	2	5781	SYMBOL|DICTIONARY	ptpn11	PTPN11	178#184		D009634	SYMBOL|EXTRACTED	ns	NS	108#110	12058348-1-390-405	We screened nine patients with ML/LEOPARD syndrome (including a mother-daughter pair) and two children with NS who had multiple caf au lait spots, for mutations in the NS gene, PTPN11, and found, in 10 of 11 patients, one of two new missense mutations, in exon 7 or exon 12.
12058348	2002	Am. J. Hum. Genet.	0002-9297	ALL_TEXT_2/3	2	2	5781	SYMBOL|DICTIONARY	ptpn11	PTPN11	178#184		D044542	SYMBOL|EXTRACTED	ml/leopard syndrome	ML/LEOPARD syndrome	31#50	12058348-1-0-19	We screened nine patients with ML/LEOPARD syndrome (including a mother-daughter pair) and two children with NS who had multiple caf au lait spots, for mutations in the NS gene, PTPN11, and found, in 10 of 11 patients, one of two new missense mutations, in exon 7 or exon 12.
12058348	2002	Am. J. Hum. Genet.	0002-9297	ALL_TEXT_2/3	2	2	5781	SYMBOL|DICTIONARY	ptpn11	PTPN11	178#184		D044542	LONGTERM|DISEASE|DT|DICTIONARY	ml/leopard syndrome	ML/LEOPARD syndrome	31#50		We screened nine patients with ML/LEOPARD syndrome (including a mother-daughter pair) and two children with NS who had multiple caf au lait spots, for mutations in the NS gene, PTPN11, and found, in 10 of 11 patients, one of two new missense mutations, in exon 7 or exon 12.
12058348	2002	Am. J. Hum. Genet.	0002-9297	TITLE	0	0	5781	SYMBOL|GENE|GN|DICTIONARY	ptpn11	PTPN11	68#74		D044542	LONGTERM|DICTIONARY	multiple-lentigines/leopard and noonan syndromes	multiple-lentigines/LEOPARD and Noonan syndromes	12#60		Grouping of multiple-lentigines/LEOPARD and Noonan syndromes on the PTPN11 gene.
12058348	2002	Am. J. Hum. Genet.	0002-9297	TITLE	0	0	5781	SYMBOL|GENE|GN|DICTIONARY	ptpn11	PTPN11	68#74		D044542	LONGTERM|DICTIONARY	multiple-lentigines/leopard and noonan syndromes	multiple-lentigines/LEOPARD and Noonan syndromes	12#60		Grouping of multiple-lentigines/LEOPARD and Noonan syndromes on the PTPN11 gene.
19484476	2009	J. Cancer Res. Clin. Oncol.	1432-1335	CONCLUSION	4	7	672	SYMBOL|DICTIONARY	brca1	BRCA1	0#5		D001943	LONGTERM|DISEASE|DT|DICTIONARY	breast cancer	breast cancer	74#87		BRCA1 and ZNF350 may jointly contribute to individuals' susceptibility of breast cancer in Chinese women.
19484476	2009	J. Cancer Res. Clin. Oncol.	1432-1335	CONCLUSION	4	7	672	SYMBOL|DICTIONARY	brca1	BRCA1	0#5		D020191	LONGTERM|DICTIONARY	may jointly	may jointly	17#28	NaN	BRCA1 and ZNF350 may jointly contribute to individuals' susceptibility of breast cancer in Chinese women.
19484476	2009	J. Cancer Res. Clin. Oncol.	1432-1335	CONCLUSION	4	7	59348	SYMBOL|DICTIONARY|EXTRACTED	znf350	ZNF350	10#16	19484476-1-60-83	D001943	LONGTERM|DISEASE|DT|DICTIONARY	breast cancer	breast cancer	74#87		BRCA1 and ZNF350 may jointly contribute to individuals' susceptibility of breast cancer in Chinese women.
19484476	2009	J. Cancer Res. Clin. Oncol.	1432-1335	CONCLUSION	4	7	59348	SYMBOL|DICTIONARY|EXTRACTED	znf350	ZNF350	10#16	19484476-1-60-83	D020191	LONGTERM|DICTIONARY	may jointly	may jointly	17#28	NaN	BRCA1 and ZNF350 may jointly contribute to individuals' susceptibility of breast cancer in Chinese women.
11951178	2002	Am. J. Hum. Genet.	0002-9297	ALL_TEXT_2/3	2	6	1270	SYMBOL|DICTIONARY	cntf	CNTF	16#20		D004194	LONGTERM|DICTIONARY	motoneuron disease	motoneuron disease	44#62	NaN	Such hSOD-1G93A/CNTF-deficient mice develop motoneuron disease at a significantly earlier stage than hSOD-1G93A/CNTF-wild-type mice.
11951178	2002	Am. J. Hum. Genet.	0002-9297	ALL_TEXT_2/3	2	6	1270	SYMBOL|DICTIONARY	cntf	CNTF	112#116		D004194	LONGTERM|DICTIONARY	motoneuron disease	motoneuron disease	44#62	NaN	Such hSOD-1G93A/CNTF-deficient mice develop motoneuron disease at a significantly earlier stage than hSOD-1G93A/CNTF-wild-type mice.
16507928	2007	Obstet Gynecol	1873-233X	CONCLUSION	4	8	355	SYMBOL|GENE|GN|DICTIONARY	tnfrsf6	TNFRSF6	87#94		D017359	LONGTERM|DISEASE|DT|DICTIONARY	hellp syndrome	HELLP syndrome	152#166		A single A>G nucleotide substitution at position -670 in the maternal but not neonatal TNFRSF6 gene coding for Fas is associated with a higher risk for HELLP syndrome.
11951178	2002	Am. J. Hum. Genet.	0002-9297	TITLE	0	0	6647	SYMBOL|DICTIONARY|EXTRACTED	sod 1	SOD-1	68#73		C531617	LONGTERM|DICTIONARY	familial amyotrophic lateral sclerosis	familial amyotrophic lateral sclerosis	22#60		Early onset of severe familial amyotrophic lateral sclerosis with a SOD-1 mutation: potential impact of CNTF as a candidate modifier gene.
11951178	2002	Am. J. Hum. Genet.	0002-9297	TITLE	0	0	1270	SYMBOL|DICTIONARY	cntf	CNTF	104#108		C531617	LONGTERM|DICTIONARY	familial amyotrophic lateral sclerosis	familial amyotrophic lateral sclerosis	22#60		Early onset of severe familial amyotrophic lateral sclerosis with a SOD-1 mutation: potential impact of CNTF as a candidate modifier gene.
11951178	2002	Am. J. Hum. Genet.	0002-9297	ALL_TEXT_1/3	1	1	6647	SYMBOL|()|GENE|GN|DICTIONARY|EXTRACTED	sod 1	SOD-1	53#58	11951178-1-29-51	D000690	LONGTERM|DICTIONARY	amyotrophic lateral sclerosis	amyotrophic lateral sclerosis	122#151		Mutations in the copper/zinc superoxide dismutase 1 (SOD-1) gene are found in approximately 20% of patients with familial amyotrophic lateral sclerosis (FALS), or amyotrophic lateral sclerosis 1.
11951178	2002	Am. J. Hum. Genet.	0002-9297	ALL_TEXT_1/3	1	1	6647	SYMBOL|()|GENE|GN|DICTIONARY|EXTRACTED	sod 1	SOD-1	53#58	11951178-1-29-51	D000690	LONGTERM|DICTIONARY	amyotrophic lateral sclerosis	amyotrophic lateral sclerosis	163#192		Mutations in the copper/zinc superoxide dismutase 1 (SOD-1) gene are found in approximately 20% of patients with familial amyotrophic lateral sclerosis (FALS), or amyotrophic lateral sclerosis 1.
16507928	2007	Obstet Gynecol	1873-233X	RESULTS	3	5	355	SYMBOL|NUMBER|DICTIONARY	tnfrsf6	TNFRSF6	51#58		D017359	LONGTERM|DISEASE|DT|DICTIONARY	hellp syndrome	HELLP syndrome	171#185		Moreover, patients with homozygous carriage of the TNFRSF6-670*G allele were more likely than those homozygous for the wild type of the Fas gene (TNFRSF6-670*A/A) to have HELLP syndrome (P = .006; odds ratio 4.0, 95% confidence interval 1.7-9.8).
16507928	2007	Obstet Gynecol	1873-233X	RESULTS	3	5	355	SYMBOL|NUMBER|DICTIONARY	tnfrsf6	TNFRSF6	146#153		D017359	LONGTERM|DISEASE|DT|DICTIONARY	hellp syndrome	HELLP syndrome	171#185		Moreover, patients with homozygous carriage of the TNFRSF6-670*G allele were more likely than those homozygous for the wild type of the Fas gene (TNFRSF6-670*A/A) to have HELLP syndrome (P = .006; odds ratio 4.0, 95% confidence interval 1.7-9.8).
16507928	2007	Obstet Gynecol	1873-233X	RESULTS	3	4	355	SYMBOL|NUMBER|DICTIONARY	tnfrsf6	TNFRSF6	36#43		D017359	LONGTERM|DISEASE|DT|DICTIONARY	hellp syndrome	HELLP syndrome	129#143		Pregnant women heterozygous for the TNFRSF6-670 genotype were more likely than those homozygous for TNFRSF6-670*A allele to have HELLP syndrome (P = .01; odds ratio 2.7, 95% confidence interval 1.2-5.9).
16507928	2007	Obstet Gynecol	1873-233X	RESULTS	3	4	355	SYMBOL|NUMBER|DICTIONARY	tnfrsf6	TNFRSF6	100#107		D017359	LONGTERM|DISEASE|DT|DICTIONARY	hellp syndrome	HELLP syndrome	129#143		Pregnant women heterozygous for the TNFRSF6-670 genotype were more likely than those homozygous for TNFRSF6-670*A allele to have HELLP syndrome (P = .01; odds ratio 2.7, 95% confidence interval 1.2-5.9).
16507928	2007	Obstet Gynecol	1873-233X	RESULTS	3	7	355	SYMBOL|DICTIONARY	tnfrsf6	TNFRSF6	56#63		D017359	LONGTERM|DISEASE|DT|DICTIONARY	hellp syndrome	HELLP syndrome	17#31		In patients with HELLP syndrome, no association between TNFRSF6 genotype distribution and severity of hemolysis, platelet counts or liver enzymes levels was noted.
16507928	2007	Obstet Gynecol	1873-233X	RESULTS	3	7	355	SYMBOL|DICTIONARY	tnfrsf6	TNFRSF6	56#63		D006461	LONGTERM|DICTIONARY	hemolysis	hemolysis	102#111	NaN	In patients with HELLP syndrome, no association between TNFRSF6 genotype distribution and severity of hemolysis, platelet counts or liver enzymes levels was noted.
16507928	2007	Obstet Gynecol	1873-233X	RESULTS	3	6	355	SYMBOL|NUMBER|DICTIONARY	tnfrsf6	TNFRSF6	13#20		D017359	LONGTERM|DISEASE|DT|DICTIONARY	hellp syndrome	HELLP syndrome	80#94		In contrast, TNFRSF6-670 genotype distribution of neonates born to mothers with HELLP syndrome was not statistically different from that found in neonates born to healthy pregnant women (P = .4).
16507928	2007	Obstet Gynecol	1873-233X	OBJECTIVE	1	1	355	SYMBOL|DICTIONARY	tnfrsf6	TNFRSF6	97#104		D006461	LONGTERM|DICTIONARY	hemolysis	hemolysis	125#134	NaN	To estimate whether an A>G polymorphism at position -670 in the gene coding for Fas (gene symbol TNFRSF6) is associated with hemolysis, elevated liver enzymes, low platelets (HELLP) syndrome.
19141695	2009	Am. J. Clin. Nutr.	1938-3207	CONCLUSIONS	5	12	2695	SYMBOL|DICTIONARY|EXTRACTED	gip	GIP	0#3		D065626	SYMBOL|DICTIONARY|EXTRACTED	nash	NASH	72#76	19141695-4-139-154	GIP response to SFA ingestion is prolonged in nondiabetic patients with NASH and is correlated with liver disease, an unfavorable dynamic adipokine profile, and beta cell dysfunction, which provides a rationale for GIP antagonism in these subjects.
19141695	2009	Am. J. Clin. Nutr.	1938-3207	CONCLUSIONS	5	12	2695	SYMBOL|DICTIONARY|EXTRACTED	gip	GIP	0#3		D008107	LONGTERM|DISEASE|DT|DICTIONARY	liver disease	liver disease	100#113		GIP response to SFA ingestion is prolonged in nondiabetic patients with NASH and is correlated with liver disease, an unfavorable dynamic adipokine profile, and beta cell dysfunction, which provides a rationale for GIP antagonism in these subjects.
19141695	2009	Am. J. Clin. Nutr.	1938-3207	CONCLUSIONS	5	12	2695	SYMBOL|DICTIONARY|EXTRACTED	gip	GIP	215#218	19141695-2-0-44	D065626	SYMBOL|DICTIONARY|EXTRACTED	nash	NASH	72#76	19141695-4-139-154	GIP response to SFA ingestion is prolonged in nondiabetic patients with NASH and is correlated with liver disease, an unfavorable dynamic adipokine profile, and beta cell dysfunction, which provides a rationale for GIP antagonism in these subjects.
19141695	2009	Am. J. Clin. Nutr.	1938-3207	CONCLUSIONS	5	12	2695	SYMBOL|DICTIONARY|EXTRACTED	gip	GIP	215#218	19141695-2-0-44	D008107	LONGTERM|DISEASE|DT|DICTIONARY	liver disease	liver disease	100#113		GIP response to SFA ingestion is prolonged in nondiabetic patients with NASH and is correlated with liver disease, an unfavorable dynamic adipokine profile, and beta cell dysfunction, which provides a rationale for GIP antagonism in these subjects.
19141695	2009	Am. J. Clin. Nutr.	1938-3207	RESULTS	4	11	3875	LONGTERM|DICTIONARY	cytokeratin 18	Cytokeratin-18	0#14		D065626	SYMBOL|DICTIONARY|EXTRACTED	nash	NASH	118#122	19141695-4-139-154	Cytokeratin-18 fragments increased significantly postprandially in both groups but more consistently in patients with NASH; their increase was predicted by postprandial adiponectin and FFA responses.
19141695	2009	Am. J. Clin. Nutr.	1938-3207	RESULTS	4	11	9370	LONGTERM|DICTIONARY	adiponectin	adiponectin	169#180	NaN	D065626	SYMBOL|DICTIONARY|EXTRACTED	nash	NASH	118#122	19141695-4-139-154	Cytokeratin-18 fragments increased significantly postprandially in both groups but more consistently in patients with NASH; their increase was predicted by postprandial adiponectin and FFA responses.
11802810	2002	Jpn. J. Cancer Res.	0910-5050	ALL_TEXT_3/3	3	6	540	SYMBOL|GENE|GN|DICTIONARY	atp7b	ATP7B	0#5		D002277	LONGTERM|DISEASE|DT|DICTIONARY	carcinoma	carcinoma	47#56		ATP7B gene expression in poorly differentiated carcinoma was significantly higher than that in well- / moderately differentiated carcinoma (P = 0.012).
19423162	2009	Leuk. Res.	1873-5835	ALL_TEXT_3/3	3	7	7157	SYMBOL|DICTIONARY	p53	p53	9#12		D015470	SYMBOL|DICTIONARY|EXTRACTED	aml	AML	161#164	19423162-4-141-163	When the p53 and MDM2 polymorphisms were combined, no multiplicative joint effect between the MDM2 GG and p53 Pro/Pro genotypes exists in the risk of developing AML.
19423162	2009	Leuk. Res.	1873-5835	ALL_TEXT_3/3	3	7	4193	SYMBOL|DICTIONARY	mdm2	MDM2	17#21		D015470	SYMBOL|DICTIONARY|EXTRACTED	aml	AML	161#164	19423162-4-141-163	When the p53 and MDM2 polymorphisms were combined, no multiplicative joint effect between the MDM2 GG and p53 Pro/Pro genotypes exists in the risk of developing AML.
19423162	2009	Leuk. Res.	1873-5835	ALL_TEXT_3/3	3	7	4193	SYMBOL|DICTIONARY	mdm2	MDM2	94#98		D015470	SYMBOL|DICTIONARY|EXTRACTED	aml	AML	161#164	19423162-4-141-163	When the p53 and MDM2 polymorphisms were combined, no multiplicative joint effect between the MDM2 GG and p53 Pro/Pro genotypes exists in the risk of developing AML.
19423162	2009	Leuk. Res.	1873-5835	ALL_TEXT_3/3	3	7	7157	SYMBOL|DICTIONARY	p53	p53	106#109		D015470	SYMBOL|DICTIONARY|EXTRACTED	aml	AML	161#164	19423162-4-141-163	When the p53 and MDM2 polymorphisms were combined, no multiplicative joint effect between the MDM2 GG and p53 Pro/Pro genotypes exists in the risk of developing AML.
20979931	2011	Int J Clin Pharmacol Ther	0946-1965	CONCLUSIONS	4	6	2067	SYMBOL|DICTIONARY|EXTRACTED	ercc1	ERCC1	25#30	20979931-2-224-269	D009422	LONGTERM|DICTIONARY	neuropathy	neuropathy	125#135		Our results suggest that ERCC1, C118T and GSTP1 Ile105Val polymorphisms are more strongly related to the time until onset of neuropathy than to the grade of neuropathy.
20979931	2011	Int J Clin Pharmacol Ther	0946-1965	CONCLUSIONS	4	6	2067	SYMBOL|DICTIONARY|EXTRACTED	ercc1	ERCC1	25#30	20979931-2-224-269	D009422	LONGTERM|DICTIONARY	neuropathy	neuropathy	157#167		Our results suggest that ERCC1, C118T and GSTP1 Ile105Val polymorphisms are more strongly related to the time until onset of neuropathy than to the grade of neuropathy.
20979931	2011	Int J Clin Pharmacol Ther	0946-1965	CONCLUSIONS	4	6	2950	SYMBOL|DICTIONARY	gstp1	GSTP1	42#47		D009422	LONGTERM|DICTIONARY	neuropathy	neuropathy	125#135		Our results suggest that ERCC1, C118T and GSTP1 Ile105Val polymorphisms are more strongly related to the time until onset of neuropathy than to the grade of neuropathy.
20979931	2011	Int J Clin Pharmacol Ther	0946-1965	CONCLUSIONS	4	6	2950	SYMBOL|DICTIONARY	gstp1	GSTP1	42#47		D009422	LONGTERM|DICTIONARY	neuropathy	neuropathy	157#167		Our results suggest that ERCC1, C118T and GSTP1 Ile105Val polymorphisms are more strongly related to the time until onset of neuropathy than to the grade of neuropathy.
16254428	2006	Dement Geriatr Cogn Disord	1420-8008	TITLE	0	0	348	LONGTERM|DICTIONARY	apolipoprotein e	apolipoprotein E	14#30		D000544	LONGTERM|DISEASE|DT|DICTIONARY	alzheimer disease	Alzheimer's disease	115#134		Effect of the apolipoprotein E epsilon4 allele on the efficacy and tolerability of galantamine in the treatment of Alzheimer's disease.
19563289	2009	J. Periodontol.	0022-3492	BACKGROUND	1	2	3552	SYMBOL|DICTIONARY	il 1a	IL-1A	93#98		D009203	LONGTERM|DICTIONARY	acute myocardial infarction	acute myocardial infarction	148#175		The aim of this study was to evaluate the impact of the composite IL-1 genotype (allele 2 at IL-1A -889 and IL-1B +3954) in the association between acute myocardial infarction (AMI) and periodontitis.
19563289	2009	J. Periodontol.	0022-3492	BACKGROUND	1	2	3552	SYMBOL|DICTIONARY	il 1a	IL-1A	93#98		D009203	SYMBOL|()|DICTIONARY|EXTRACTED	ami	AMI	177#180	19563289-2-148-175	The aim of this study was to evaluate the impact of the composite IL-1 genotype (allele 2 at IL-1A -889 and IL-1B +3954) in the association between acute myocardial infarction (AMI) and periodontitis.
19563289	2009	J. Periodontol.	0022-3492	BACKGROUND	1	2	3552	SYMBOL|DICTIONARY	il 1a	IL-1A	93#98		D010518	LONGTERM|DICTIONARY	periodontitis	periodontitis	186#199		The aim of this study was to evaluate the impact of the composite IL-1 genotype (allele 2 at IL-1A -889 and IL-1B +3954) in the association between acute myocardial infarction (AMI) and periodontitis.
19563289	2009	J. Periodontol.	0022-3492	BACKGROUND	1	2	3553	SYMBOL|DICTIONARY	il 1b	IL-1B	108#113		D009203	LONGTERM|DICTIONARY	acute myocardial infarction	acute myocardial infarction	148#175		The aim of this study was to evaluate the impact of the composite IL-1 genotype (allele 2 at IL-1A -889 and IL-1B +3954) in the association between acute myocardial infarction (AMI) and periodontitis.
19563289	2009	J. Periodontol.	0022-3492	BACKGROUND	1	2	3553	SYMBOL|DICTIONARY	il 1b	IL-1B	108#113		D009203	SYMBOL|()|DICTIONARY|EXTRACTED	ami	AMI	177#180	19563289-2-148-175	The aim of this study was to evaluate the impact of the composite IL-1 genotype (allele 2 at IL-1A -889 and IL-1B +3954) in the association between acute myocardial infarction (AMI) and periodontitis.
19563289	2009	J. Periodontol.	0022-3492	BACKGROUND	1	2	3553	SYMBOL|DICTIONARY	il 1b	IL-1B	108#113		D010518	LONGTERM|DICTIONARY	periodontitis	periodontitis	186#199		The aim of this study was to evaluate the impact of the composite IL-1 genotype (allele 2 at IL-1A -889 and IL-1B +3954) in the association between acute myocardial infarction (AMI) and periodontitis.
19237575	2009	Proc. Natl. Acad. Sci. U.S.A.	1091-6490	ALL_TEXT_2/3	2	3	965	SYMBOL|DICTIONARY	cd58	CD58	25#29		D009103	SYMBOL|EXTRACTED	ms	MS	89#91	19237575-1-0-18	These efforts identify a CD58 variant that provides further evidence of association with MS (P = 1.1 x 10(-6), OR 0.82) and the single protective effect within the CD58 locus is captured by the rs2300747(G) allele.
19237575	2009	Proc. Natl. Acad. Sci. U.S.A.	1091-6490	ALL_TEXT_2/3	2	3	965	SYMBOL|DICTIONARY	cd58	CD58	164#168		D009103	SYMBOL|EXTRACTED	ms	MS	89#91	19237575-1-0-18	These efforts identify a CD58 variant that provides further evidence of association with MS (P = 1.1 x 10(-6), OR 0.82) and the single protective effect within the CD58 locus is captured by the rs2300747(G) allele.
19237575	2009	Proc. Natl. Acad. Sci. U.S.A.	1091-6490	TITLE	0	0	965	SYMBOL|DICTIONARY	cd58	CD58	16#20		D009103	LONGTERM|DICTIONARY	multiple sclerosis	multiple sclerosis	30#48		The role of the CD58 locus in multiple sclerosis.
19237575	2009	Proc. Natl. Acad. Sci. U.S.A.	1091-6490	ALL_TEXT_3/3	3	6	965	SYMBOL|DICTIONARY	cd58	CD58	77#81		D009103	SYMBOL|EXTRACTED	ms	MS	340#342	19237575-1-0-18	Functional investigations suggest a potential mechanism whereby increases in CD58 expression, mediated by the protective allele, up-regulate the expression of transcription factor FoxP3 through engagement of the CD58 receptor, CD2, leading to the enhanced function of CD4(+)CD25(high) regulatory T cells that are defective in subjects with MS.
19237575	2009	Proc. Natl. Acad. Sci. U.S.A.	1091-6490	ALL_TEXT_3/3	3	6	50943	SYMBOL|DICTIONARY	foxp3	FoxP3	180#185		D009103	SYMBOL|EXTRACTED	ms	MS	340#342	19237575-1-0-18	Functional investigations suggest a potential mechanism whereby increases in CD58 expression, mediated by the protective allele, up-regulate the expression of transcription factor FoxP3 through engagement of the CD58 receptor, CD2, leading to the enhanced function of CD4(+)CD25(high) regulatory T cells that are defective in subjects with MS.
19237575	2009	Proc. Natl. Acad. Sci. U.S.A.	1091-6490	ALL_TEXT_3/3	3	6	965	SYMBOL|GENE|GN|DICTIONARY	cd58	CD58	212#216		D009103	SYMBOL|EXTRACTED	ms	MS	340#342	19237575-1-0-18	Functional investigations suggest a potential mechanism whereby increases in CD58 expression, mediated by the protective allele, up-regulate the expression of transcription factor FoxP3 through engagement of the CD58 receptor, CD2, leading to the enhanced function of CD4(+)CD25(high) regulatory T cells that are defective in subjects with MS.
19237575	2009	Proc. Natl. Acad. Sci. U.S.A.	1091-6490	ALL_TEXT_3/3	3	6	3559	SYMBOL|DICTIONARY	cd25	CD25	274#278		D009103	SYMBOL|EXTRACTED	ms	MS	340#342	19237575-1-0-18	Functional investigations suggest a potential mechanism whereby increases in CD58 expression, mediated by the protective allele, up-regulate the expression of transcription factor FoxP3 through engagement of the CD58 receptor, CD2, leading to the enhanced function of CD4(+)CD25(high) regulatory T cells that are defective in subjects with MS.
19237575	2009	Proc. Natl. Acad. Sci. U.S.A.	1091-6490	ALL_TEXT_3/3	3	6	920	LONGTERM|DICTIONARY	cd4	CD4	268#271	NaN	D009103	SYMBOL|EXTRACTED	ms	MS	340#342	19237575-1-0-18	Functional investigations suggest a potential mechanism whereby increases in CD58 expression, mediated by the protective allele, up-regulate the expression of transcription factor FoxP3 through engagement of the CD58 receptor, CD2, leading to the enhanced function of CD4(+)CD25(high) regulatory T cells that are defective in subjects with MS.
9391065	1998	Proc. Natl. Acad. Sci. U.S.A.	0027-8424	ALL_TEXT_1/3	1	1	6010	LONGTERM|DICTIONARY	rhodopsin	rhodopsin	54#63		D012174	LONGTERM|DICTIONARY	autosomal dominant retinitis pigmentosa	autosomal dominant retinitis pigmentosa	107#146		Two different mutations of the active-site Lys-296 in rhodopsin, K296E and K296M, have been found to cause autosomal dominant retinitis pigmentosa (ADRP).
9391065	1998	Proc. Natl. Acad. Sci. U.S.A.	0027-8424	ALL_TEXT_1/3	1	1	6010	LONGTERM|DICTIONARY	rhodopsin	rhodopsin	54#63		D012174	SYMBOL|EXTRACTED|()	adrp	ADRP	148#152	9391065-1-107-146	Two different mutations of the active-site Lys-296 in rhodopsin, K296E and K296M, have been found to cause autosomal dominant retinitis pigmentosa (ADRP).
16181776	2006	Prostaglandins Leukot. Essent. Fatty Acids	0952-3278	ALL_TEXT_3/3	3	6	5321	SYMBOL|DICTIONARY	pla2g4a	PLA2G4A	37#44		D012559	LONGTERM|DICTIONARY	schizophrenia	schizophrenia	70#83		The present results suggest that the PLA2G4A locus may be involved in schizophrenia and its combination with the CLDN5 gene may increase further the risk for the illness.
16181776	2006	Prostaglandins Leukot. Essent. Fatty Acids	0952-3278	ALL_TEXT_3/3	3	6	7122	SYMBOL|GENE|GN|DICTIONARY	cldn5	CLDN5	113#118		D012559	LONGTERM|DICTIONARY	schizophrenia	schizophrenia	70#83		The present results suggest that the PLA2G4A locus may be involved in schizophrenia and its combination with the CLDN5 gene may increase further the risk for the illness.
19408338	2009	Inflamm. Bowel Dis.	1536-4844	CONCLUSIONS	4	10	2312	LONGTERM|DICTIONARY	filaggrin	Filaggrin	0#9		D015212	SYMBOL|DICTIONARY|EXTRACTED	ibd	IBD	41#44	19408338-1-10-36	Filaggrin null-alleles have no effect on IBD susceptibility but contribute to coexistent eczema and food allergy.
19408338	2009	Inflamm. Bowel Dis.	1536-4844	CONCLUSIONS	4	10	2312	LONGTERM|DICTIONARY	filaggrin	Filaggrin	0#9		D004485	LONGTERM|DICTIONARY	eczema	eczema	89#95		Filaggrin null-alleles have no effect on IBD susceptibility but contribute to coexistent eczema and food allergy.
19408338	2009	Inflamm. Bowel Dis.	1536-4844	CONCLUSIONS	4	10	2312	LONGTERM|DICTIONARY	filaggrin	Filaggrin	0#9		D005512	LONGTERM|DICTIONARY	food allergy	food allergy	100#112		Filaggrin null-alleles have no effect on IBD susceptibility but contribute to coexistent eczema and food allergy.
19648156	2009	Br J Anaesth	1471-6771	CONCLUSIONS	4	11	6261	SYMBOL|DICTIONARY	ryr1	RYR1	42#46		D008305	SYMBOL|EXTRACTED	mh	MH	110#112	19648156-1-0-22	Differences in phenotype severity between RYR1 variants may explain the variability in clinical penetrance of MH during anaesthesia and why some variants have been associated with exercise-induced rhabdomyolysis and heat stroke.
19648156	2009	Br J Anaesth	1471-6771	CONCLUSIONS	4	11	6261	SYMBOL|DICTIONARY	ryr1	RYR1	42#46		D020521	LONGTERM|DICTIONARY	heat stroke	heat stroke	216#227		Differences in phenotype severity between RYR1 variants may explain the variability in clinical penetrance of MH during anaesthesia and why some variants have been associated with exercise-induced rhabdomyolysis and heat stroke.
19648156	2009	Br J Anaesth	1471-6771	CONCLUSIONS	4	11	6261	SYMBOL|DICTIONARY	ryr1	RYR1	42#46		D012206	LONGTERM|DICTIONARY	rhabdomyolysis	rhabdomyolysis	197#211	NaN	Differences in phenotype severity between RYR1 variants may explain the variability in clinical penetrance of MH during anaesthesia and why some variants have been associated with exercise-induced rhabdomyolysis and heat stroke.
9391065	1998	Proc. Natl. Acad. Sci. U.S.A.	0027-8424	TITLE	0	0	6010	LONGTERM|DICTIONARY	rhodopsin	rhodopsin	97#106		D012174	LONGTERM|DICTIONARY	autosomal dominant retinitis pigmentosa	autosomal dominant retinitis pigmentosa	138#177		Synthesis and characterization of a novel retinylamine analog inhibitor of constitutively active rhodopsin mutants found in patients with autosomal dominant retinitis pigmentosa.
12378512	2002	Hum. Pathol.	0046-8177	TITLE	0	0	7157	LONGTERM|DICTIONARY	p53	p53	25#28	NaN	D008113	LONGTERM|DICTIONARY	angiosarcomas of the liver	angiosarcomas of the liver	48#74		Abnormalities of the ARF-p53 pathway in primary angiosarcomas of the liver.
18512809	2008	Arthritis Rheum.	0004-3591	OBJECTIVE	1	4	3586	SYMBOL|DICTIONARY	il10	IL10	53#57		D014890	SYMBOL|EXTRACTED	wg	WG	100#102	18512809-1-0-24	This study was undertaken to determine the impact of IL10 polymorphisms on the pathogenesis of both WG and CSS in large cohorts.
18512809	2008	Arthritis Rheum.	0004-3591	OBJECTIVE	1	4	3586	SYMBOL|DICTIONARY	il10	IL10	53#57		D015267	SYMBOL|DICTIONARY|EXTRACTED	css	CSS	107#110	18512809-1-34-56	This study was undertaken to determine the impact of IL10 polymorphisms on the pathogenesis of both WG and CSS in large cohorts.
18083240	2008	J. Neuroimmunol.	0165-5728	TITLE	0	0	7124	SYMBOL|DICTIONARY	tnf	TNF	0#3		D000690	SYMBOL|DISEASE|DN|DICTIONARY|EXTRACTED	als	ALS	34#37		TNF and sTNFR1/2 plasma levels in ALS patients.
18083240	2008	J. Neuroimmunol.	0165-5728	ALL_TEXT_2/3	2	2	7132	SYMBOL|DICTIONARY	tnf r1	TNF-R1	83#89		D000690	SYMBOL|DICTIONARY|EXTRACTED	als	ALS	172#175	18083240-1-82-111	In this study a significantly higher level of TNF-alpha and its soluble receptors, TNF-R1 and TNF-R2, has been found in plasma of patients affected by the sporadic form of ALS compared to normal subjects.
18083240	2008	J. Neuroimmunol.	0165-5728	ALL_TEXT_2/3	2	2	7133	SYMBOL|DICTIONARY	tnf r2	TNF-R2	94#100		D000690	SYMBOL|DICTIONARY|EXTRACTED	als	ALS	172#175	18083240-1-82-111	In this study a significantly higher level of TNF-alpha and its soluble receptors, TNF-R1 and TNF-R2, has been found in plasma of patients affected by the sporadic form of ALS compared to normal subjects.
18083240	2008	J. Neuroimmunol.	0165-5728	ALL_TEXT_2/3	2	2	7124	LONGTERM|DICTIONARY	tnf-alpha	TNF-alpha	46#55	NaN	D000690	SYMBOL|DICTIONARY|EXTRACTED	als	ALS	172#175	18083240-1-82-111	In this study a significantly higher level of TNF-alpha and its soluble receptors, TNF-R1 and TNF-R2, has been found in plasma of patients affected by the sporadic form of ALS compared to normal subjects.
9391065	1998	Proc. Natl. Acad. Sci. U.S.A.	0027-8424	ALL_TEXT_2/3	2	4	6010	LONGTERM|DICTIONARY	rhodopsin	rhodopsin	113#122		D012174	SYMBOL|EXTRACTED	adrp	ADRP	175#179	9391065-1-107-146	Unfortunately, however, amine derivatives of 11-cis-retinal, although highly effective against a K296G mutant of rhodopsin, were without affect on the two naturally occurring ADRP mutants, presumably because of the greater steric bulk of Glu and Met side chains in comparison to Gly.
15308589	2005	Carcinogenesis	0143-3334	ALL_TEXT_1/3	1	2	1548	SYMBOL|DICTIONARY|EXTRACTED	cyp2a6	CYP2A6	161#167	15308589-1-56-75	D008175	LONGTERM|DISEASE|DT|DICTIONARY	lung cancer	lung cancer	105#116		The purpose of this study was to clarify whether or not the alterations of smoking behavior and risk for lung cancer could be found in subjects possessing novel CYP2A6 variants discovered recently.
9554754	1998	Hum. Mutat.	1059-7794	TITLE	0	0	367	LONGTERM|GENE|GT|DICTIONARY	androgen receptor	androgen receptor	60#77		D013734	SYMBOL|DISEASE|DT|DICTIONARY	complete androgen insensitivity syndrome	complete androgen insensitivity syndrome	95#135		A new missense substitution at a mutational hot spot of the androgen receptor in siblings with complete androgen insensitivity syndrome.
15308589	2005	Carcinogenesis	0143-3334	TITLE	0	0	1548	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	cyp2a6	CYP2A6	14#20		D008175	LONGTERM|DISEASE|DT|DICTIONARY	lung cancer	lung cancer	99#110		Evaluation of CYP2A6 genetic polymorphisms as determinants of smoking behavior and tobacco-related lung cancer risk in male Japanese smokers.
15308589	2005	Carcinogenesis	0143-3334	ALL_TEXT_1/3	1	1	1548	SYMBOL|()|DICTIONARY|EXTRACTED	cyp2a6	CYP2A6	77#83	15308589-1-56-75	D008175	LONGTERM|DISEASE|DT|DICTIONARY	lung cancer	lung cancer	111#122		We reported previously that subjects homozygous for the cytochrome P450 2A6 (CYP2A6) (*)4 have a lower risk of lung cancer.
15308589	2005	Carcinogenesis	0143-3334	ALL_TEXT_2/3	2	6	1548	SYMBOL|DICTIONARY|EXTRACTED	cyp2a6	CYP2A6	68#74	15308589-1-56-75	D008175	LONGTERM|DISEASE|DT|DICTIONARY	lung cancer	lung cancer	272#283		When participants were classified into four groups according to the CYP2A6 genotypes, group 1 ((*)1/(*)1), group 2 (heterozygotes for the (*)1 and a variant allele), group 3 (heterozygotes and homozygotes for variant alleles except for (*)4/(*)4) and group 4 ((*)4/(*)4), lung cancer risk was found to be less in subjects with the variant of CYP2A6 alleles [group 2, OR of 0.59 [95% confidence interval (CI), 0.44-0.79]; group 3, OR of 0.52 (95% CI, 0.37-0.72); group 4, OR of 0.30 (95% CI, 0.16-0.57)].
15308589	2005	Carcinogenesis	0143-3334	ALL_TEXT_2/3	2	6	1548	SYMBOL|DICTIONARY|EXTRACTED	cyp2a6	CYP2A6	342#348	15308589-1-56-75	D008175	LONGTERM|DISEASE|DT|DICTIONARY	lung cancer	lung cancer	272#283		When participants were classified into four groups according to the CYP2A6 genotypes, group 1 ((*)1/(*)1), group 2 (heterozygotes for the (*)1 and a variant allele), group 3 (heterozygotes and homozygotes for variant alleles except for (*)4/(*)4) and group 4 ((*)4/(*)4), lung cancer risk was found to be less in subjects with the variant of CYP2A6 alleles [group 2, OR of 0.59 [95% confidence interval (CI), 0.44-0.79]; group 3, OR of 0.52 (95% CI, 0.37-0.72); group 4, OR of 0.30 (95% CI, 0.16-0.57)].
15308589	2005	Carcinogenesis	0143-3334	ALL_TEXT_2/3	2	5	1548	SYMBOL|DICTIONARY|EXTRACTED	cyp2a6	CYP2A6	147#153	15308589-1-56-75	D008175	LONGTERM|DISEASE|DT|DICTIONARY	lung cancer	lung cancer	85#96		Even after adjustment with cigarette consumption, the adjusted odds ratios (ORs) for lung cancer were significantly lower in subjects who harbored CYP2A6(*)1/(*)4, (*)1/(*)7, (*)1/(*)9, (*)1/(*)10, (*)4/(*)4, (*)4/(*)7, (*)4/(*)9, (*)7/(*)7 and (*)7/(*)9 genotypes than those who possessed the (*)1/(*)1 genotype (P < 0.05).
20377893	2010	BMC Med. Genet.	1471-2350	METHODS	2	4	60314	SYMBOL|DICTIONARY	myg1	MYG1	51#55		D014820	LONGTERM|DISEASE|DN|DICTIONARY	vitiligo	vitiligo	117#125		Nine single nucleotide polymorphisms (SNPs) in the MYG1 locus were investigated by SNPlex assay and/or sequencing in vitiligo patients (n = 124) and controls (n = 325).
15308589	2005	Carcinogenesis	0143-3334	ALL_TEXT_3/3	3	9	1548	SYMBOL|DICTIONARY|EXTRACTED	cyp2a6	CYP2A6	31#37	15308589-1-56-75	D008175	LONGTERM|DISEASE|DT|DICTIONARY	lung cancer	lung cancer	154#165		These results suggest that the CYP2A6 is one of the principal determinants affecting not only smoking behavior but also susceptibility to tobacco-related lung cancer.
20236202	2011	J Eur Acad Dermatol Venereol	1468-3083	TITLE	0	0	412	SYMBOL|GENE|GN|DICTIONARY	sts	STS	16#19		D016114	LONGTERM|DICTIONARY	x linked ichthyosis	X-linked ichthyosis	55#74		Analysis of the STS gene in 40 patients with recessive X-linked ichthyosis: a high frequency of partial deletions in a Spanish population.
20236202	2011	J Eur Acad Dermatol Venereol	1468-3083	BACKGROUND	1	2	412	LONGTERM|DICTIONARY	steroid sulphatase	steroid sulphatase	34#52	NaN	D040181	LONGTERM|DICTIONARY	rxli	RXLI	0#4	NaN	RXLI is caused by a deficiency in steroid sulphatase (STS), whose gene has been located on the X chromosome (locus Xp22.3).
20724907	2010	Am. J. Med. Sci.	1538-2990	TITLE	0	0	348	LONGTERM|DICTIONARY	apolipoprotein e	apolipoprotein E	25#41		D000544	LONGTERM|DISEASE|DT|DICTIONARY	alzheimer disease	Alzheimer's disease	120#139		Genetic polymorphisms in apolipoprotein E and glutathione peroxidase 1 genes in the Ecuadorian population affected with Alzheimer's disease.
20724907	2010	Am. J. Med. Sci.	1538-2990	TITLE	0	0	2876	LONGTERM|GENE|GN|DICTIONARY	glutathione peroxidase 1	glutathione peroxidase 1	46#70		D000544	LONGTERM|DISEASE|DT|DICTIONARY	alzheimer disease	Alzheimer's disease	120#139		Genetic polymorphisms in apolipoprotein E and glutathione peroxidase 1 genes in the Ecuadorian population affected with Alzheimer's disease.
9865924	1999	Clin. Cancer Res.	1078-0432	ALL_TEXT_3/3	3	9	1728	SYMBOL|DICTIONARY|EXTRACTED	nqo1	NQO1	188#192	9865924-0-35-57	D064420	LONGTERM|DICTIONARY	cytotoxicity	cytotoxicity	219#231	NaN	In comparison to the parental cell line, RH1, MeDZQ, and mitomycin C were significantly more cytotoxic to BE-NQ7 cells (17-, 7-, and 3-fold, respectively), confirming that the presence of NQO1 is sufficient to increase cytotoxicity of these antitumor quinones.
19276544	2009	J. Alzheimers Dis.	1387-2877	ALL_TEXT_3/3	3	4	348	SYMBOL|EXTRACTED	apoe	ApoE	50#54	19276544-1-175-191	D000544	SYMBOL|EXTRACTED	ad	AD	152#154	19276544-1-143-162	However, the observed association was confined to ApoE epsilon4 non-carriers, thus suggesting a possible role of GAB2 as an independent risk factor for AD.
19276544	2009	J. Alzheimers Dis.	1387-2877	ALL_TEXT_3/3	3	4	9846	SYMBOL|DICTIONARY	gab2	GAB2	113#117		D000544	SYMBOL|EXTRACTED	ad	AD	152#154	19276544-1-143-162	However, the observed association was confined to ApoE epsilon4 non-carriers, thus suggesting a possible role of GAB2 as an independent risk factor for AD.
19423162	2009	Leuk. Res.	1873-5835	ALL_TEXT_2/3	2	4	4193	SYMBOL|DICTIONARY	mdm2	MDM2	28#32		D015470	LONGTERM|DICTIONARY	acute myeloid leukemia	acute myeloid leukemia	141#163		To investigate whether that MDM2 SNP309 and p53 codon 72 polymorphism should be at least partially responsible for genetic susceptibility to acute myeloid leukemia (AML), both polymorphisms were determined in a case-control study consisting of 231 AML patients and 128 normal individuals.
19423162	2009	Leuk. Res.	1873-5835	ALL_TEXT_2/3	2	4	4193	SYMBOL|DICTIONARY	mdm2	MDM2	28#32		D015470	SYMBOL|()|DICTIONARY|EXTRACTED	aml	AML	165#168	19423162-4-141-163	To investigate whether that MDM2 SNP309 and p53 codon 72 polymorphism should be at least partially responsible for genetic susceptibility to acute myeloid leukemia (AML), both polymorphisms were determined in a case-control study consisting of 231 AML patients and 128 normal individuals.
19423162	2009	Leuk. Res.	1873-5835	ALL_TEXT_2/3	2	4	4193	SYMBOL|DICTIONARY	mdm2	MDM2	28#32		D015470	SYMBOL|DISEASE|DN|DICTIONARY|EXTRACTED	aml	AML	248#251	19423162-4-141-163	To investigate whether that MDM2 SNP309 and p53 codon 72 polymorphism should be at least partially responsible for genetic susceptibility to acute myeloid leukemia (AML), both polymorphisms were determined in a case-control study consisting of 231 AML patients and 128 normal individuals.
19423162	2009	Leuk. Res.	1873-5835	ALL_TEXT_2/3	2	4	7157	SYMBOL|DICTIONARY	p53	p53	44#47		D015470	LONGTERM|DICTIONARY	acute myeloid leukemia	acute myeloid leukemia	141#163		To investigate whether that MDM2 SNP309 and p53 codon 72 polymorphism should be at least partially responsible for genetic susceptibility to acute myeloid leukemia (AML), both polymorphisms were determined in a case-control study consisting of 231 AML patients and 128 normal individuals.
19423162	2009	Leuk. Res.	1873-5835	ALL_TEXT_2/3	2	4	7157	SYMBOL|DICTIONARY	p53	p53	44#47		D015470	SYMBOL|()|DICTIONARY|EXTRACTED	aml	AML	165#168	19423162-4-141-163	To investigate whether that MDM2 SNP309 and p53 codon 72 polymorphism should be at least partially responsible for genetic susceptibility to acute myeloid leukemia (AML), both polymorphisms were determined in a case-control study consisting of 231 AML patients and 128 normal individuals.
19423162	2009	Leuk. Res.	1873-5835	ALL_TEXT_2/3	2	4	7157	SYMBOL|DICTIONARY	p53	p53	44#47		D015470	SYMBOL|DISEASE|DN|DICTIONARY|EXTRACTED	aml	AML	248#251	19423162-4-141-163	To investigate whether that MDM2 SNP309 and p53 codon 72 polymorphism should be at least partially responsible for genetic susceptibility to acute myeloid leukemia (AML), both polymorphisms were determined in a case-control study consisting of 231 AML patients and 128 normal individuals.
14623371	2004	Schizophr. Res.	0920-9964	ALL_TEXT_3/3	3	3	7124	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	tnf alpha	TNF-alpha	51#60	14623371-1-0-27	D012559	LONGTERM|DICTIONARY	schizophrenia	schizophrenia	113#126		The present study examined the hypothesis that the TNF-alpha gene -308G/A polymorphism confers susceptibility to schizophrenia in 205 patients with schizophrenia compared with 192 controls.
14623371	2004	Schizophr. Res.	0920-9964	ALL_TEXT_3/3	3	3	7124	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	tnf alpha	TNF-alpha	51#60	14623371-1-0-27	D012559	LONGTERM|DICTIONARY	schizophrenia	schizophrenia	148#161		The present study examined the hypothesis that the TNF-alpha gene -308G/A polymorphism confers susceptibility to schizophrenia in 205 patients with schizophrenia compared with 192 controls.
20211941	2010	Toxicol. Sci.	1096-0929	ALL_TEXT_3/3	3	7	4780	SYMBOL|DICTIONARY	nrf2	Nrf2	88#92		D020258	LONGTERM|DICTIONARY	neurotoxicity	neurotoxicity	143#156	NaN	This outcome is associated with an increased basal resistance, but more so, an enhanced Nrf2 response to lesioning that attenuated the ensuing neurotoxicity.
20211941	2010	Toxicol. Sci.	1096-0929	ALL_TEXT_2/3	2	5	4780	SYMBOL|DICTIONARY	nrf2	Nrf2	82#86		D020258	LONGTERM|DICTIONARY	neurotoxicity	neurotoxicity	126#139	NaN	Here, we extend these results to show that multiple methods of astrocyte-specific Nrf2 overexpression provide protection from neurotoxicity in vivo.
16757160	2007	Respir Med	0954-6111	OBJECTIVES	2	3	3566	SYMBOL|GENE|GN|DICTIONARY	il-4 receptor	IL-4 receptor	57#70		D001249	LONGTERM|DICTIONARY	asthma	asthma	109#115		To determine whether Ile50Val and Q576R polymorphisms of IL-4 receptor alpha chain gene were associated with asthma and higher level of total IgE in Chinese, Malay and Indian populations.
10527839	1999	Biochem. Biophys. Res. Commun.	0006-291X	TITLE	0	0	2	LONGTERM|DNA|NN|DICTIONARY	alpha 2 macroglobulin	alpha(2) macroglobulin	23#45		D000544	LONGTERM|DISEASE|DT|DICTIONARY	late onset alzheimer disease	late-onset Alzheimer's disease	67#97		Association between an alpha(2) macroglobulin DNA polymorphism and late-onset Alzheimer's disease.
10527839	1999	Biochem. Biophys. Res. Commun.	0006-291X	ALL_TEXT_1/3	1	1	2	LONGTERM|GENE|GN|DICTIONARY	alpha 2 macroglobulin	alpha(2) macroglobulin	83#105		D000544	LONGTERM|DISEASE|DT|DICTIONARY	late onset alzheimer disease	late-onset Alzheimer's disease	121#151		An association between a five-base-pair deletion/insertion DNA polymorphism at the alpha(2) macroglobulin gene (A2M) and late-onset Alzheimer's disease (LOAD) has been recently described.
10527839	1999	Biochem. Biophys. Res. Commun.	0006-291X	ALL_TEXT_1/3	1	1	2	LONGTERM|GENE|GN|DICTIONARY	alpha 2 macroglobulin	alpha(2) macroglobulin	83#105		D000544	SYMBOL|EXTRACTED|()	load	LOAD	153#157	10527839-1-121-151	An association between a five-base-pair deletion/insertion DNA polymorphism at the alpha(2) macroglobulin gene (A2M) and late-onset Alzheimer's disease (LOAD) has been recently described.
10527839	1999	Biochem. Biophys. Res. Commun.	0006-291X	ALL_TEXT_1/3	1	1	2	SYMBOL|EXTRACTED|()	a2m	A2M	112#115	10527839-1-83-105	D000544	LONGTERM|DISEASE|DT|DICTIONARY	late onset alzheimer disease	late-onset Alzheimer's disease	121#151		An association between a five-base-pair deletion/insertion DNA polymorphism at the alpha(2) macroglobulin gene (A2M) and late-onset Alzheimer's disease (LOAD) has been recently described.
10527839	1999	Biochem. Biophys. Res. Commun.	0006-291X	ALL_TEXT_1/3	1	1	2	SYMBOL|EXTRACTED|()	a2m	A2M	112#115	10527839-1-83-105	D000544	SYMBOL|EXTRACTED|()	load	LOAD	153#157	10527839-1-121-151	An association between a five-base-pair deletion/insertion DNA polymorphism at the alpha(2) macroglobulin gene (A2M) and late-onset Alzheimer's disease (LOAD) has been recently described.
19546348	2009	Exp. Biol. Med. (Maywood)	1535-3699	ALL_TEXT_1/3	1	1	3091	LONGTERM|DICTIONARY	hypoxia-inducible factor-1	Hypoxia-inducible factor-1	0#26	NaN	D009369	LONGTERM|DISEASE|DT|DICTIONARY	facilitates tumor	facilitates tumor	134#151		Hypoxia-inducible factor-1 (HIF-1), an important genetic component of angiogenesis, becomes stable as a response to tumor hypoxia and facilitates tumor survival.
19546348	2009	Exp. Biol. Med. (Maywood)	1535-3699	ALL_TEXT_1/3	1	1	3091	LONGTERM|DICTIONARY	hypoxia-inducible factor-1	Hypoxia-inducible factor-1	0#26	NaN	D000860	LONGTERM|DICTIONARY	hypoxia	hypoxia	122#129	NaN	Hypoxia-inducible factor-1 (HIF-1), an important genetic component of angiogenesis, becomes stable as a response to tumor hypoxia and facilitates tumor survival.
19546348	2009	Exp. Biol. Med. (Maywood)	1535-3699	ALL_TEXT_1/3	1	1	3091	LONGTERM|DICTIONARY	hif-1	HIF-1	28#33	NaN	D009369	LONGTERM|DISEASE|DT|DICTIONARY	facilitates tumor	facilitates tumor	134#151		Hypoxia-inducible factor-1 (HIF-1), an important genetic component of angiogenesis, becomes stable as a response to tumor hypoxia and facilitates tumor survival.
19546348	2009	Exp. Biol. Med. (Maywood)	1535-3699	ALL_TEXT_1/3	1	1	3091	LONGTERM|DICTIONARY	hif-1	HIF-1	28#33	NaN	D000860	LONGTERM|DICTIONARY	hypoxia	hypoxia	122#129	NaN	Hypoxia-inducible factor-1 (HIF-1), an important genetic component of angiogenesis, becomes stable as a response to tumor hypoxia and facilitates tumor survival.
8094979	1993	Biol. Psychiatry	0006-3223	TITLE	0	0	1813	LONGTERM|GENE|GN|GT|DICTIONARY	dopamine d2 receptor	dopamine D2 receptor	68#88		D000437	LONGTERM|DICTIONARY	alcoholism	alcoholism	32#42		Association between severity of alcoholism and the A1 allele of the dopamine D2 receptor gene TaqI A RFLP in Japanese.
17300681	2007	Int. J. Gynecol. Cancer	1048-891X	ALL_TEXT_1/3	1	1	5243	LONGTERM|DICTIONARY	p glycoprotein	P-glycoprotein	4#18		D063646	LONGTERM|DICTIONARY	carcinogenesis	carcinogenesis	155#169		The P-glycoprotein (P-gp) plays an important role in carcinogen distribution and is connected with cell differentiation and apoptotic processes leading to carcinogenesis.
17300681	2007	Int. J. Gynecol. Cancer	1048-891X	ALL_TEXT_1/3	1	1	5243	SYMBOL|EXTRACTED|()	p gp	P-gp	20#24	17300681-1-4-18	D063646	LONGTERM|DICTIONARY	carcinogenesis	carcinogenesis	155#169		The P-glycoprotein (P-gp) plays an important role in carcinogen distribution and is connected with cell differentiation and apoptotic processes leading to carcinogenesis.
20096741	2010	Hum. Immunol.	1879-1166	ALL_TEXT_3/3	3	6	7422	SYMBOL|DICTIONARY	vegf	VEGF	64#68		D011471	SYMBOL|EXTRACTED	pca	PCa	188#191	20096741-1-0-15	Furthermore, the TAG and CAG haplotypes at positions HSP70-hom, VEGF -1154 and VEGF -634 exhibited a two-fold (OR = 0.46; p = 0.014) and a seven-fold (OR = 0.14; p = 0.00005) reduction in PCa risk, respectively.
20096741	2010	Hum. Immunol.	1879-1166	ALL_TEXT_3/3	3	6	7422	SYMBOL|DICTIONARY	vegf	VEGF	79#83		D011471	SYMBOL|EXTRACTED	pca	PCa	188#191	20096741-1-0-15	Furthermore, the TAG and CAG haplotypes at positions HSP70-hom, VEGF -1154 and VEGF -634 exhibited a two-fold (OR = 0.46; p = 0.014) and a seven-fold (OR = 0.14; p = 0.00005) reduction in PCa risk, respectively.
20096741	2010	Hum. Immunol.	1879-1166	ALL_TEXT_3/3	3	6	3308	SYMBOL|DICTIONARY	hsp70	HSP70	53#58		D011471	SYMBOL|EXTRACTED	pca	PCa	188#191	20096741-1-0-15	Furthermore, the TAG and CAG haplotypes at positions HSP70-hom, VEGF -1154 and VEGF -634 exhibited a two-fold (OR = 0.46; p = 0.014) and a seven-fold (OR = 0.14; p = 0.00005) reduction in PCa risk, respectively.
20096741	2010	Hum. Immunol.	1879-1166	ALL_TEXT_1/3	1	2	7422	SYMBOL|DICTIONARY	vegf	VEGF	47#51		D011471	SYMBOL|EXTRACTED	pca	PCa	115#118	20096741-1-0-15	Our previous single-locus analysis showed that VEGF and HSP70-hom polymorphisms were significantly associated with PCa susceptibility and prognosis.
20096741	2010	Hum. Immunol.	1879-1166	ALL_TEXT_1/3	1	2	3308	SYMBOL|DICTIONARY	hsp70	HSP70	56#61		D011471	SYMBOL|EXTRACTED	pca	PCa	115#118	20096741-1-0-15	Our previous single-locus analysis showed that VEGF and HSP70-hom polymorphisms were significantly associated with PCa susceptibility and prognosis.
12525557	2003	J. Med. Genet.	1468-6244	TITLE	0	0	1545	SYMBOL|GENE|GN|DICTIONARY	cyp1b1	CYP1B1	0#6		C565547	LONGTERM|DICTIONARY	congenital glaucoma	congenital glaucoma	32#51		CYP1B1 gene analysis in primary congenital glaucoma in Indonesian and European patients.
18178632	2008	J. Med. Genet.	1468-6244	METHODS	2	2	1029	SYMBOL|GENE|GN|DICTIONARY	cdkn2a	CDKN2A	19#25		D008545	LONGTERM|DICTIONARY	melanoma	melanoma	125#133		We resequenced the CDKN2A gene, including the p14ARF variant and promoter regions, in approximately 703 registry ascertained melanoma cases and 691 population based controls from Iceland, a country in which the incidence of melanoma has increased rapidly.
18178632	2008	J. Med. Genet.	1468-6244	METHODS	2	2	1029	SYMBOL|GENE|GN|DICTIONARY	cdkn2a	CDKN2A	19#25		D008545	LONGTERM|DICTIONARY	melanoma	melanoma	224#232		We resequenced the CDKN2A gene, including the p14ARF variant and promoter regions, in approximately 703 registry ascertained melanoma cases and 691 population based controls from Iceland, a country in which the incidence of melanoma has increased rapidly.
18178632	2008	J. Med. Genet.	1468-6244	METHODS	2	2	1029	SYMBOL|DICTIONARY	p14arf	p14ARF	46#52		D008545	LONGTERM|DICTIONARY	melanoma	melanoma	125#133		We resequenced the CDKN2A gene, including the p14ARF variant and promoter regions, in approximately 703 registry ascertained melanoma cases and 691 population based controls from Iceland, a country in which the incidence of melanoma has increased rapidly.
18178632	2008	J. Med. Genet.	1468-6244	METHODS	2	2	1029	SYMBOL|DICTIONARY	p14arf	p14ARF	46#52		D008545	LONGTERM|DICTIONARY	melanoma	melanoma	224#232		We resequenced the CDKN2A gene, including the p14ARF variant and promoter regions, in approximately 703 registry ascertained melanoma cases and 691 population based controls from Iceland, a country in which the incidence of melanoma has increased rapidly.
18178632	2008	J. Med. Genet.	1468-6244	BACKGROUND	1	1	1029	SYMBOL|DICTIONARY	cdkn2a	CDKN2A	9#15		D008545	LONGTERM|DICTIONARY	melanoma	melanoma	69#77		Germline CDKN2A mutations have been observed in 20-40% of high risk, melanoma prone families; however, little is known about their prevalence in population based series of melanoma cases and controls.
18178632	2008	J. Med. Genet.	1468-6244	BACKGROUND	1	1	1029	SYMBOL|DICTIONARY	cdkn2a	CDKN2A	9#15		D008545	LONGTERM|DICTIONARY	melanoma	melanoma	172#180		Germline CDKN2A mutations have been observed in 20-40% of high risk, melanoma prone families; however, little is known about their prevalence in population based series of melanoma cases and controls.
18178632	2008	J. Med. Genet.	1468-6244	TITLE	0	0	1029	SYMBOL|DICTIONARY	cdkn2a	CDKN2A	0#6		D008545	LONGTERM|DICTIONARY	melanoma	melanoma	21#29		CDKN2A mutations and melanoma risk in the Icelandic population.
18178632	2008	J. Med. Genet.	1468-6244	CONCLUSIONS	4	7	1029	SYMBOL|DICTIONARY	cdkn2a	CDKN2A	107#113		D008545	LONGTERM|DICTIONARY	melanoma	melanoma	41#49		This population based study of Icelandic melanoma cases and controls showed a frequency of disease related CDKN2A mutant alleles ranging from 0.7% to 1.0%, thus expanding our knowledge about the frequency of CDKN2A mutations in different populations.
18178632	2008	J. Med. Genet.	1468-6244	CONCLUSIONS	4	7	1029	SYMBOL|DICTIONARY	cdkn2a	CDKN2A	208#214		D008545	LONGTERM|DICTIONARY	melanoma	melanoma	41#49		This population based study of Icelandic melanoma cases and controls showed a frequency of disease related CDKN2A mutant alleles ranging from 0.7% to 1.0%, thus expanding our knowledge about the frequency of CDKN2A mutations in different populations.
20096741	2010	Hum. Immunol.	1879-1166	ALL_TEXT_3/3	3	8	3305	SYMBOL|DICTIONARY	hsp70 hom	HSP70-hom	62#71		D011471	SYMBOL|EXTRACTED	pca	PCa	123#126	20096741-1-0-15	Our findings confirm the role of at-risk haplotype across the HSP70-hom/VEGF gene cluster in determining susceptibility to PCa.
20096741	2010	Hum. Immunol.	1879-1166	ALL_TEXT_3/3	3	8	7422	SYMBOL|GENE|GN|DICTIONARY	vegf	VEGF	72#76		D011471	SYMBOL|EXTRACTED	pca	PCa	123#126	20096741-1-0-15	Our findings confirm the role of at-risk haplotype across the HSP70-hom/VEGF gene cluster in determining susceptibility to PCa.
11769724	2002	Zhonghua Nei Ke Za Zhi	0578-1426	CONCLUSION	4	9	348	SYMBOL|DICTIONARY	apoe4	ApoE4	7#12		D000544	SYMBOL|EXTRACTED	ad	AD	75#77	11769724-1-28-45	AD and ApoE4 were closely related.ApoE epsilon 4 was a dangerous factor of AD and ApoE 4 allele made contribution to the heterogenicity of AD.
11769724	2002	Zhonghua Nei Ke Za Zhi	0578-1426	CONCLUSION	4	9	348	SYMBOL|DICTIONARY	apoe4	ApoE4	7#12		D000544	SYMBOL|EXTRACTED	ad	AD	139#141	11769724-1-28-45	AD and ApoE4 were closely related.ApoE epsilon 4 was a dangerous factor of AD and ApoE 4 allele made contribution to the heterogenicity of AD.
11769724	2002	Zhonghua Nei Ke Za Zhi	0578-1426	CONCLUSION	4	9	348	SYMBOL|EXTRACTED	apoe	ApoE	34#38	11769724-1-56-72	D000544	SYMBOL|EXTRACTED	ad	AD	75#77	11769724-1-28-45	AD and ApoE4 were closely related.ApoE epsilon 4 was a dangerous factor of AD and ApoE 4 allele made contribution to the heterogenicity of AD.
11769724	2002	Zhonghua Nei Ke Za Zhi	0578-1426	CONCLUSION	4	9	348	SYMBOL|EXTRACTED	apoe	ApoE	34#38	11769724-1-56-72	D000544	SYMBOL|EXTRACTED	ad	AD	139#141	11769724-1-28-45	AD and ApoE4 were closely related.ApoE epsilon 4 was a dangerous factor of AD and ApoE 4 allele made contribution to the heterogenicity of AD.
11769724	2002	Zhonghua Nei Ke Za Zhi	0578-1426	CONCLUSION	4	9	348	SYMBOL|DICTIONARY	apoe 4	ApoE 4	82#88		D000544	SYMBOL|EXTRACTED	ad	AD	75#77	11769724-1-28-45	AD and ApoE4 were closely related.ApoE epsilon 4 was a dangerous factor of AD and ApoE 4 allele made contribution to the heterogenicity of AD.
11769724	2002	Zhonghua Nei Ke Za Zhi	0578-1426	CONCLUSION	4	9	348	SYMBOL|DICTIONARY	apoe 4	ApoE 4	82#88		D000544	SYMBOL|EXTRACTED	ad	AD	139#141	11769724-1-28-45	AD and ApoE4 were closely related.ApoE epsilon 4 was a dangerous factor of AD and ApoE 4 allele made contribution to the heterogenicity of AD.
10541293	1999	J. Am. Soc. Nephrol.	1046-6673	TITLE	0	0	5311	SYMBOL|GENE|GN|DICTIONARY	pkd2	PKD2	25#29		D007674	LONGTERM|DISEASE|DT|DICTIONARY	polycystic kidney disease	polycystic kidney disease	49#74		Aberrant splicing in the PKD2 gene as a cause of polycystic kidney disease.
17300681	2007	Int. J. Gynecol. Cancer	1048-891X	ALL_TEXT_2/3	2	5	5243	SYMBOL|DICTIONARY	mdr1	MDR1	26#30		D016889	LONGTERM|DISEASE|DT|DICTIONARY	endometrial cancer	endometrial cancer	60#78		We have hypothesized that MDR1 polymorphism could influence endometrial cancer susceptibility.
19210878	2009	Clin. Exp. Rheumatol.	0392-856X	ALL_TEXT_3/3	3	5	26191	SYMBOL|DICTIONARY	ptpn22	PTPN22	15#21		D008180	SYMBOL|DICTIONARY|EXTRACTED	sle	SLE	90#93	19210878-1-134-162	Women with the PTPN22 TT and PTPN22 CT genotypes displayed a 2.016-fold increased risk of SLE (95% CI=1.324 - 3.070, P=0.0014).
19210878	2009	Clin. Exp. Rheumatol.	0392-856X	ALL_TEXT_3/3	3	5	26191	SYMBOL|DICTIONARY	ptpn22	PTPN22	29#35		D008180	SYMBOL|DICTIONARY|EXTRACTED	sle	SLE	90#93	19210878-1-134-162	Women with the PTPN22 TT and PTPN22 CT genotypes displayed a 2.016-fold increased risk of SLE (95% CI=1.324 - 3.070, P=0.0014).
19210878	2009	Clin. Exp. Rheumatol.	0392-856X	ALL_TEXT_2/3	2	4	26191	SYMBOL|NUMBER|DICTIONARY	ptpn22	PTPN22	31#37		D008180	SYMBOL|DICTIONARY|EXTRACTED	sle	SLE	80#83	19210878-1-134-162	We found a contribution of the PTPN22 1858 C>T polymorphism to the incidence of SLE.
19210878	2009	Clin. Exp. Rheumatol.	0392-856X	ALL_TEXT_3/3	3	7	26191	SYMBOL|GENE|GN|DICTIONARY	ptpn22	PTPN22	71#77		D008180	SYMBOL|DICTIONARY|EXTRACTED	sle	SLE	88#91	19210878-1-134-162	Our results confirm an association of the 1858 C>T polymorphism of the PTPN22 gene with SLE, which was previously observed in other populations.
19210878	2009	Clin. Exp. Rheumatol.	0392-856X	ALL_TEXT_1/3	1	1	26191	SYMBOL|()|NUMBER|DICTIONARY	ptpn22	PTPN22	50#56		D008180	LONGTERM|DICTIONARY	systemic lupus erythematosus	systemic lupus erythematosus	134#162		The protein tyrosine phosphatase non-receptor 22 (PTPN22) 1858 C>T poly-morphic variant gene (rs2476601) displays an association with systemic lupus erythematosus (SLE) and other autoimmune diseases.
19210878	2009	Clin. Exp. Rheumatol.	0392-856X	ALL_TEXT_1/3	1	1	26191	SYMBOL|()|NUMBER|DICTIONARY	ptpn22	PTPN22	50#56		D008180	SYMBOL|()|DICTIONARY|EXTRACTED	sle	SLE	164#167	19210878-1-134-162	The protein tyrosine phosphatase non-receptor 22 (PTPN22) 1858 C>T poly-morphic variant gene (rs2476601) displays an association with systemic lupus erythematosus (SLE) and other autoimmune diseases.
19210878	2009	Clin. Exp. Rheumatol.	0392-856X	ALL_TEXT_1/3	1	1	26191	SYMBOL|()|NUMBER|DICTIONARY	ptpn22	PTPN22	50#56		D001327	LONGTERM|DICTIONARY	autoimmune diseases	autoimmune diseases	179#198		The protein tyrosine phosphatase non-receptor 22 (PTPN22) 1858 C>T poly-morphic variant gene (rs2476601) displays an association with systemic lupus erythematosus (SLE) and other autoimmune diseases.
19210878	2009	Clin. Exp. Rheumatol.	0392-856X	ALL_TEXT_1/3	1	1	26191	LONGTERM|DICTIONARY	protein tyrosine phosphatase non-receptor 22	protein tyrosine phosphatase non-receptor 22	4#48		D008180	LONGTERM|DICTIONARY	systemic lupus erythematosus	systemic lupus erythematosus	134#162		The protein tyrosine phosphatase non-receptor 22 (PTPN22) 1858 C>T poly-morphic variant gene (rs2476601) displays an association with systemic lupus erythematosus (SLE) and other autoimmune diseases.
19210878	2009	Clin. Exp. Rheumatol.	0392-856X	ALL_TEXT_1/3	1	1	26191	LONGTERM|DICTIONARY	protein tyrosine phosphatase non-receptor 22	protein tyrosine phosphatase non-receptor 22	4#48		D008180	SYMBOL|()|DICTIONARY|EXTRACTED	sle	SLE	164#167	19210878-1-134-162	The protein tyrosine phosphatase non-receptor 22 (PTPN22) 1858 C>T poly-morphic variant gene (rs2476601) displays an association with systemic lupus erythematosus (SLE) and other autoimmune diseases.
19210878	2009	Clin. Exp. Rheumatol.	0392-856X	ALL_TEXT_1/3	1	1	26191	LONGTERM|DICTIONARY	protein tyrosine phosphatase non-receptor 22	protein tyrosine phosphatase non-receptor 22	4#48		D001327	LONGTERM|DICTIONARY	autoimmune diseases	autoimmune diseases	179#198		The protein tyrosine phosphatase non-receptor 22 (PTPN22) 1858 C>T poly-morphic variant gene (rs2476601) displays an association with systemic lupus erythematosus (SLE) and other autoimmune diseases.
19210878	2009	Clin. Exp. Rheumatol.	0392-856X	TITLE	0	0	26191	LONGTERM|DICTIONARY	protein tyrosine phosphatase non-receptor 22	protein tyrosine phosphatase non-receptor 22	42#86		D008180	LONGTERM|DICTIONARY	systemic lupus erythematosus	systemic lupus erythematosus	90#118		Contribution of the R620W polymorphism of protein tyrosine phosphatase non-receptor 22 to systemic lupus erythematosus in Poland.
19210878	2009	Clin. Exp. Rheumatol.	0392-856X	ALL_TEXT_2/3	2	3	26191	SYMBOL|NUMBER|DICTIONARY	ptpn22	PTPN22	41#47		D008180	SYMBOL|DICTIONARY|EXTRACTED	sle	SLE	93#96	19210878-1-134-162	We therefore examined the association of PTPN22 1858 C>T polymorphism with susceptibility to SLE in the Polish population, among patients with SLE (n=150) and controls (n=300).
19210878	2009	Clin. Exp. Rheumatol.	0392-856X	ALL_TEXT_2/3	2	3	26191	SYMBOL|NUMBER|DICTIONARY	ptpn22	PTPN22	41#47		D008180	SYMBOL|DICTIONARY|EXTRACTED	sle	SLE	143#146	19210878-1-134-162	We therefore examined the association of PTPN22 1858 C>T polymorphism with susceptibility to SLE in the Polish population, among patients with SLE (n=150) and controls (n=300).
20630504	2011	Fertil. Steril.	1556-5653	ALL_TEXT	1	2	28886	LONGTERM|DICTIONARY	a8- pcos	A8- PCOS	0#8	NaN	D011085	SYMBOL|DICTIONARY|EXTRACTED	pcos	PCOS	4#8	20630504-1-183-208	A8- PCOS is associated with higher levels of TGF-1 compared with A8+ PCOS or A8- Non-PCOS, similar levels of TGF-2 compared with A8+ PCOS but lower levels of TGF-2 compared with A8- Non-PCOS, and lower levels of inhibin B and aldosterone compared with A8+ PCOS.
20630504	2011	Fertil. Steril.	1556-5653	ALL_TEXT	1	2	28886	LONGTERM|DICTIONARY	a8- pcos	A8- PCOS	0#8	NaN	D011085	SYMBOL|DICTIONARY|EXTRACTED	pcos	PCOS	70#74	20630504-1-183-208	A8- PCOS is associated with higher levels of TGF-1 compared with A8+ PCOS or A8- Non-PCOS, similar levels of TGF-2 compared with A8+ PCOS but lower levels of TGF-2 compared with A8- Non-PCOS, and lower levels of inhibin B and aldosterone compared with A8+ PCOS.
20630504	2011	Fertil. Steril.	1556-5653	ALL_TEXT	1	2	28886	LONGTERM|DICTIONARY	a8- pcos	A8- PCOS	0#8	NaN	D011085	SYMBOL|DICTIONARY|EXTRACTED	pcos	PCOS	86#90	20630504-1-183-208	A8- PCOS is associated with higher levels of TGF-1 compared with A8+ PCOS or A8- Non-PCOS, similar levels of TGF-2 compared with A8+ PCOS but lower levels of TGF-2 compared with A8- Non-PCOS, and lower levels of inhibin B and aldosterone compared with A8+ PCOS.
20630504	2011	Fertil. Steril.	1556-5653	ALL_TEXT	1	2	28886	LONGTERM|DICTIONARY	a8- pcos	A8- PCOS	0#8	NaN	D011085	SYMBOL|DICTIONARY|EXTRACTED	pcos	PCOS	135#139	20630504-1-183-208	A8- PCOS is associated with higher levels of TGF-1 compared with A8+ PCOS or A8- Non-PCOS, similar levels of TGF-2 compared with A8+ PCOS but lower levels of TGF-2 compared with A8- Non-PCOS, and lower levels of inhibin B and aldosterone compared with A8+ PCOS.
20630504	2011	Fertil. Steril.	1556-5653	ALL_TEXT	1	2	28886	LONGTERM|DICTIONARY	a8- pcos	A8- PCOS	0#8	NaN	D011085	SYMBOL|DICTIONARY|EXTRACTED	pcos	PCOS	189#193	20630504-1-183-208	A8- PCOS is associated with higher levels of TGF-1 compared with A8+ PCOS or A8- Non-PCOS, similar levels of TGF-2 compared with A8+ PCOS but lower levels of TGF-2 compared with A8- Non-PCOS, and lower levels of inhibin B and aldosterone compared with A8+ PCOS.
20630504	2011	Fertil. Steril.	1556-5653	ALL_TEXT	1	2	28886	LONGTERM|DICTIONARY	a8- pcos	A8- PCOS	0#8	NaN	D011085	SYMBOL|DICTIONARY|EXTRACTED	pcos	PCOS	259#263	20630504-1-183-208	A8- PCOS is associated with higher levels of TGF-1 compared with A8+ PCOS or A8- Non-PCOS, similar levels of TGF-2 compared with A8+ PCOS but lower levels of TGF-2 compared with A8- Non-PCOS, and lower levels of inhibin B and aldosterone compared with A8+ PCOS.
24277619	2014	Am. J. Med. Genet. B Neuropsychiatr. Genet.	1552-485X	TITLE	0	0	217	SYMBOL|DICTIONARY	aldh2	ALDH2	0#5		D000437	LONGTERM|DICTIONARY	alcohol dependence	alcohol dependence	23#41		"ALDH2 is associated to alcohol dependence and is the major genetic determinant of ""daily maximum drinks"" in a GWAS study of an isolated rural Chinese sample."
15057872	2004	Mol. Carcinog.	0899-1987	ALL_TEXT_2/3	2	4	3482	SYMBOL|GENE|GN|DICTIONARY	igf2r	Igf2r	145#150		D006528	SYMBOL|PLURAL|DICTIONARY|EXTRACTED	hccs	HCCs	40#44	15057872-1-162-187	Total RNA was extracted from individual HCCs for assessment of mutations within exons 27, 28, 31, 33, and 34, and aberrant transcript of the M6p/Igf2r gene by reverse transcription (RT)-polymerase chain reaction (PCR)-single strand conformation polymorphism (SSCP) and RT-PCR analyses, respectively.
12032588	2002	J. Hum. Genet.	1434-5161	ALL_TEXT_1/3	1	1	4000	SYMBOL|GENE|GN|DICTIONARY	lmna	LMNA	17#21		D030342	LONGTERM|DICTIONARY	genetic disorders	genetic disorders	133#150		Mutations in the LMNA gene encoding lamins A and C by alternative splicing have been found to cause at least four different kinds of genetic disorders: autosomal dominant Emery-Dreifuss muscular dystrophy (EDMD2; MIM 181350); limb-girdle muscular dystrophy type 1B (LGMD1B; MIM 159001); dilated cardiomyopathy type 1A (CMD1A; MIM 115200); and familial partial lipodystrophy (FPLD; MIM 151660).
12032588	2002	J. Hum. Genet.	1434-5161	ALL_TEXT_1/3	1	1	4000	SYMBOL|GENE|GN|DICTIONARY	lmna	LMNA	17#21		D020389	LONGTERM|DISEASE|DT|DICTIONARY	autosomal dominant emery dreifuss muscular dystrophy	autosomal dominant Emery-Dreifuss muscular dystrophy	152#204		Mutations in the LMNA gene encoding lamins A and C by alternative splicing have been found to cause at least four different kinds of genetic disorders: autosomal dominant Emery-Dreifuss muscular dystrophy (EDMD2; MIM 181350); limb-girdle muscular dystrophy type 1B (LGMD1B; MIM 159001); dilated cardiomyopathy type 1A (CMD1A; MIM 115200); and familial partial lipodystrophy (FPLD; MIM 151660).
12032588	2002	J. Hum. Genet.	1434-5161	ALL_TEXT_1/3	1	1	4000	SYMBOL|GENE|GN|DICTIONARY	lmna	LMNA	17#21		C535898	LONGTERM|DICTIONARY	limb girdle muscular dystrophy type 1b	limb-girdle muscular dystrophy type 1B	226#264		Mutations in the LMNA gene encoding lamins A and C by alternative splicing have been found to cause at least four different kinds of genetic disorders: autosomal dominant Emery-Dreifuss muscular dystrophy (EDMD2; MIM 181350); limb-girdle muscular dystrophy type 1B (LGMD1B; MIM 159001); dilated cardiomyopathy type 1A (CMD1A; MIM 115200); and familial partial lipodystrophy (FPLD; MIM 151660).
12032588	2002	J. Hum. Genet.	1434-5161	ALL_TEXT_1/3	1	1	4000	SYMBOL|GENE|GN|DICTIONARY	lmna	LMNA	17#21		D052496	LONGTERM|DICTIONARY	familial partial lipodystrophy	familial partial lipodystrophy	343#373		Mutations in the LMNA gene encoding lamins A and C by alternative splicing have been found to cause at least four different kinds of genetic disorders: autosomal dominant Emery-Dreifuss muscular dystrophy (EDMD2; MIM 181350); limb-girdle muscular dystrophy type 1B (LGMD1B; MIM 159001); dilated cardiomyopathy type 1A (CMD1A; MIM 115200); and familial partial lipodystrophy (FPLD; MIM 151660).
12032588	2002	J. Hum. Genet.	1434-5161	ALL_TEXT_1/3	1	1	4000	SYMBOL|GENE|GN|DICTIONARY	lmna	LMNA	17#21		D009202	LONGTERM|DICTIONARY	cardiomyopathy type 1a	cardiomyopathy type 1A	295#317	NaN	Mutations in the LMNA gene encoding lamins A and C by alternative splicing have been found to cause at least four different kinds of genetic disorders: autosomal dominant Emery-Dreifuss muscular dystrophy (EDMD2; MIM 181350); limb-girdle muscular dystrophy type 1B (LGMD1B; MIM 159001); dilated cardiomyopathy type 1A (CMD1A; MIM 115200); and familial partial lipodystrophy (FPLD; MIM 151660).
12032588	2002	J. Hum. Genet.	1434-5161	ALL_TEXT_1/3	1	1	4000	SYMBOL|DICTIONARY	cmd1a	CMD1A	319#324		D030342	LONGTERM|DICTIONARY	genetic disorders	genetic disorders	133#150		Mutations in the LMNA gene encoding lamins A and C by alternative splicing have been found to cause at least four different kinds of genetic disorders: autosomal dominant Emery-Dreifuss muscular dystrophy (EDMD2; MIM 181350); limb-girdle muscular dystrophy type 1B (LGMD1B; MIM 159001); dilated cardiomyopathy type 1A (CMD1A; MIM 115200); and familial partial lipodystrophy (FPLD; MIM 151660).
12032588	2002	J. Hum. Genet.	1434-5161	ALL_TEXT_1/3	1	1	4000	SYMBOL|DICTIONARY	cmd1a	CMD1A	319#324		D020389	LONGTERM|DISEASE|DT|DICTIONARY	autosomal dominant emery dreifuss muscular dystrophy	autosomal dominant Emery-Dreifuss muscular dystrophy	152#204		Mutations in the LMNA gene encoding lamins A and C by alternative splicing have been found to cause at least four different kinds of genetic disorders: autosomal dominant Emery-Dreifuss muscular dystrophy (EDMD2; MIM 181350); limb-girdle muscular dystrophy type 1B (LGMD1B; MIM 159001); dilated cardiomyopathy type 1A (CMD1A; MIM 115200); and familial partial lipodystrophy (FPLD; MIM 151660).
12032588	2002	J. Hum. Genet.	1434-5161	ALL_TEXT_1/3	1	1	4000	SYMBOL|DICTIONARY	cmd1a	CMD1A	319#324		C535898	LONGTERM|DICTIONARY	limb girdle muscular dystrophy type 1b	limb-girdle muscular dystrophy type 1B	226#264		Mutations in the LMNA gene encoding lamins A and C by alternative splicing have been found to cause at least four different kinds of genetic disorders: autosomal dominant Emery-Dreifuss muscular dystrophy (EDMD2; MIM 181350); limb-girdle muscular dystrophy type 1B (LGMD1B; MIM 159001); dilated cardiomyopathy type 1A (CMD1A; MIM 115200); and familial partial lipodystrophy (FPLD; MIM 151660).
12032588	2002	J. Hum. Genet.	1434-5161	ALL_TEXT_1/3	1	1	4000	SYMBOL|DICTIONARY	cmd1a	CMD1A	319#324		D052496	LONGTERM|DICTIONARY	familial partial lipodystrophy	familial partial lipodystrophy	343#373		Mutations in the LMNA gene encoding lamins A and C by alternative splicing have been found to cause at least four different kinds of genetic disorders: autosomal dominant Emery-Dreifuss muscular dystrophy (EDMD2; MIM 181350); limb-girdle muscular dystrophy type 1B (LGMD1B; MIM 159001); dilated cardiomyopathy type 1A (CMD1A; MIM 115200); and familial partial lipodystrophy (FPLD; MIM 151660).
12032588	2002	J. Hum. Genet.	1434-5161	ALL_TEXT_1/3	1	1	4000	SYMBOL|DICTIONARY	cmd1a	CMD1A	319#324		D009202	LONGTERM|DICTIONARY	cardiomyopathy type 1a	cardiomyopathy type 1A	295#317	NaN	Mutations in the LMNA gene encoding lamins A and C by alternative splicing have been found to cause at least four different kinds of genetic disorders: autosomal dominant Emery-Dreifuss muscular dystrophy (EDMD2; MIM 181350); limb-girdle muscular dystrophy type 1B (LGMD1B; MIM 159001); dilated cardiomyopathy type 1A (CMD1A; MIM 115200); and familial partial lipodystrophy (FPLD; MIM 151660).
20630504	2011	Fertil. Steril.	1556-5653	TITLE	0	0	84467	LONGTERM|GENE|GN|DICTIONARY	fibrillin 3	fibrillin-3	17#28		D011085	LONGTERM|DISEASE|DT|DICTIONARY	polycystic ovary syndrome	polycystic ovary syndrome	94#119		A variant in the fibrillin-3 gene is associated with TGF- and inhibin B levels in women with polycystic ovary syndrome.
12032588	2002	J. Hum. Genet.	1434-5161	ALL_TEXT_2/3	2	4	4000	SYMBOL|GENE|GN|DICTIONARY	lmna	LMNA	40#44		C535898	SYMBOL|DISEASE|DN|DICTIONARY	lgmd1b	LGMD1B	149#155		We performed a mutation analysis of the LMNA gene by direct sequencing and found two different missense mutations: R249Q and R377L, in the EDMD2 and LGMD1B patient, respectively.
12032588	2002	J. Hum. Genet.	1434-5161	ALL_TEXT_3/3	3	5	4000	SYMBOL|GENE|GN|DICTIONARY	lmna	LMNA	67#71		D020389	SYMBOL|DISEASE|DN|DICTIONARY	edmd2	EDMD2	137#142		The R249Q mutation is located within the central rod domain of the LMNA gene, and has been described in at least five unrelated sporadic EDMD2 patients.
11583755	2001	Lancet	0140-6736	ALL_TEXT_2/3	2	2	1493	SYMBOL|()|GENE|GN|DICTIONARY|EXTRACTED	ctla4	CTLA4	159#164	11583755-2-137-155	D006111	LONGTERM|DISEASE|DT|DICTIONARY	graves disease	Graves' disease	58#73		We investigated two major genetic susceptibility loci for Graves' disease in ophthalmopathy; the MHC class II region and the cytotoxic T lymphocyte antigen-4 (CTLA4) gene.
11583755	2001	Lancet	0140-6736	ALL_TEXT_2/3	2	2	1493	SYMBOL|()|GENE|GN|DICTIONARY|EXTRACTED	ctla4	CTLA4	159#164	11583755-2-137-155	D049970	LONGTERM|DICTIONARY	ophthalmopathy	ophthalmopathy	77#91		We investigated two major genetic susceptibility loci for Graves' disease in ophthalmopathy; the MHC class II region and the cytotoxic T lymphocyte antigen-4 (CTLA4) gene.
11583755	2001	Lancet	0140-6736	ALL_TEXT_2/3	2	2	1493	LONGTERM|NUMBER|DICTIONARY|GENE|GA	cytotoxic t lymphocyte antigen-4	cytotoxic T lymphocyte antigen-4	125#157		D006111	LONGTERM|DISEASE|DT|DICTIONARY	graves disease	Graves' disease	58#73		We investigated two major genetic susceptibility loci for Graves' disease in ophthalmopathy; the MHC class II region and the cytotoxic T lymphocyte antigen-4 (CTLA4) gene.
11583755	2001	Lancet	0140-6736	ALL_TEXT_2/3	2	2	1493	LONGTERM|NUMBER|DICTIONARY|GENE|GA	cytotoxic t lymphocyte antigen-4	cytotoxic T lymphocyte antigen-4	125#157		D049970	LONGTERM|DICTIONARY	ophthalmopathy	ophthalmopathy	77#91		We investigated two major genetic susceptibility loci for Graves' disease in ophthalmopathy; the MHC class II region and the cytotoxic T lymphocyte antigen-4 (CTLA4) gene.
15886521	2005	Exp. Mol. Med.	1226-3613	ALL_TEXT_1/3	1	1	2068	SYMBOL|DICTIONARY	ercc2	ERCC2	57#62		D001943	LONGTERM|DISEASE|DT|DICTIONARY	breast cancer	breast cancer	147#160		To evaluate the relationship of genetic polymorphisms of ERCC2 and ERCC4 genes, both involved in nucleotide excision repair (NER), and the risk of breast cancer, a hospital-based case-control study was conducted in Korea.
15886521	2005	Exp. Mol. Med.	1226-3613	ALL_TEXT_1/3	1	1	2072	SYMBOL|GENE|GN|DICTIONARY	ercc4	ERCC4	67#72		D001943	LONGTERM|DISEASE|DT|DICTIONARY	breast cancer	breast cancer	147#160		To evaluate the relationship of genetic polymorphisms of ERCC2 and ERCC4 genes, both involved in nucleotide excision repair (NER), and the risk of breast cancer, a hospital-based case-control study was conducted in Korea.
15886521	2005	Exp. Mol. Med.	1226-3613	TITLE	0	0	2068	SYMBOL|DICTIONARY	ercc2	ERCC2	36#41		D009765	LONGTERM|DICTIONARY	obesity	Obesity	0#7		Obesity and genetic polymorphism of ERCC2 and ERCC4 as modifiers of risk of breast cancer.
15886521	2005	Exp. Mol. Med.	1226-3613	TITLE	0	0	2068	SYMBOL|DICTIONARY	ercc2	ERCC2	36#41		D001943	LONGTERM|DISEASE|DT|DICTIONARY	breast cancer	breast cancer	76#89		Obesity and genetic polymorphism of ERCC2 and ERCC4 as modifiers of risk of breast cancer.
15886521	2005	Exp. Mol. Med.	1226-3613	TITLE	0	0	2072	SYMBOL|DICTIONARY	ercc4	ERCC4	46#51		D009765	LONGTERM|DICTIONARY	obesity	Obesity	0#7		Obesity and genetic polymorphism of ERCC2 and ERCC4 as modifiers of risk of breast cancer.
15886521	2005	Exp. Mol. Med.	1226-3613	TITLE	0	0	2072	SYMBOL|DICTIONARY	ercc4	ERCC4	46#51		D001943	LONGTERM|DISEASE|DT|DICTIONARY	breast cancer	breast cancer	76#89		Obesity and genetic polymorphism of ERCC2 and ERCC4 as modifiers of risk of breast cancer.
15886521	2005	Exp. Mol. Med.	1226-3613	ALL_TEXT_3/3	3	7	2072	SYMBOL|DICTIONARY	ercc4	ERCC4	45#50		D001943	LONGTERM|DISEASE|DT|DICTIONARY	breast cancer	breast cancer	94#107		Interactive effect was also observed between ERCC4 genotype and body mass idnex (BMI) for the breast cancer risk; the ERCC4 C allele containing genotypes posed a 1.7-fold (95% CI: 0.96-2.93) breast cancer risk in obese women (BMI>25 kg/m(2)) with a borderline significance.
15886521	2005	Exp. Mol. Med.	1226-3613	ALL_TEXT_3/3	3	7	2072	SYMBOL|DICTIONARY	ercc4	ERCC4	45#50		D001943	LONGTERM|DISEASE|DT|DICTIONARY	breast cancer	breast cancer	191#204		Interactive effect was also observed between ERCC4 genotype and body mass idnex (BMI) for the breast cancer risk; the ERCC4 C allele containing genotypes posed a 1.7-fold (95% CI: 0.96-2.93) breast cancer risk in obese women (BMI>25 kg/m(2)) with a borderline significance.
15886521	2005	Exp. Mol. Med.	1226-3613	ALL_TEXT_3/3	3	7	2072	SYMBOL|DICTIONARY	ercc4	ERCC4	45#50		D009765	LONGTERM|DICTIONARY	obese	obese	213#218		Interactive effect was also observed between ERCC4 genotype and body mass idnex (BMI) for the breast cancer risk; the ERCC4 C allele containing genotypes posed a 1.7-fold (95% CI: 0.96-2.93) breast cancer risk in obese women (BMI>25 kg/m(2)) with a borderline significance.
15886521	2005	Exp. Mol. Med.	1226-3613	ALL_TEXT_3/3	3	7	2072	SYMBOL|DICTIONARY	ercc4	ERCC4	118#123		D001943	LONGTERM|DISEASE|DT|DICTIONARY	breast cancer	breast cancer	94#107		Interactive effect was also observed between ERCC4 genotype and body mass idnex (BMI) for the breast cancer risk; the ERCC4 C allele containing genotypes posed a 1.7-fold (95% CI: 0.96-2.93) breast cancer risk in obese women (BMI>25 kg/m(2)) with a borderline significance.
15886521	2005	Exp. Mol. Med.	1226-3613	ALL_TEXT_3/3	3	7	2072	SYMBOL|DICTIONARY	ercc4	ERCC4	118#123		D001943	LONGTERM|DISEASE|DT|DICTIONARY	breast cancer	breast cancer	191#204		Interactive effect was also observed between ERCC4 genotype and body mass idnex (BMI) for the breast cancer risk; the ERCC4 C allele containing genotypes posed a 1.7-fold (95% CI: 0.96-2.93) breast cancer risk in obese women (BMI>25 kg/m(2)) with a borderline significance.
15886521	2005	Exp. Mol. Med.	1226-3613	ALL_TEXT_3/3	3	7	2072	SYMBOL|DICTIONARY	ercc4	ERCC4	118#123		D009765	LONGTERM|DICTIONARY	obese	obese	213#218		Interactive effect was also observed between ERCC4 genotype and body mass idnex (BMI) for the breast cancer risk; the ERCC4 C allele containing genotypes posed a 1.7-fold (95% CI: 0.96-2.93) breast cancer risk in obese women (BMI>25 kg/m(2)) with a borderline significance.
23313952	2013	Nat. Genet.	1546-1718	ALL_TEXT_3/3	3	7	4665	SYMBOL|DICTIONARY	nab2	NAB2	24#28		D054364	SYMBOL|DICTIONARY|EXTRACTED	sft	SFT	70#73	23313952-1-35-57	These studies establish NAB2-STAT6 as the defining driver mutation of SFT and provide an example of how neoplasia can be initiated by converting a transcriptional repressor of mitogenic pathways into a transcriptional activator.
23313952	2013	Nat. Genet.	1546-1718	ALL_TEXT_3/3	3	7	4665	SYMBOL|DICTIONARY	nab2	NAB2	24#28		D009369	LONGTERM|DICTIONARY	neoplasia	neoplasia	104#113		These studies establish NAB2-STAT6 as the defining driver mutation of SFT and provide an example of how neoplasia can be initiated by converting a transcriptional repressor of mitogenic pathways into a transcriptional activator.
23313952	2013	Nat. Genet.	1546-1718	ALL_TEXT_3/3	3	7	6778	SYMBOL|DICTIONARY	stat6	STAT6	29#34		D054364	SYMBOL|DICTIONARY|EXTRACTED	sft	SFT	70#73	23313952-1-35-57	These studies establish NAB2-STAT6 as the defining driver mutation of SFT and provide an example of how neoplasia can be initiated by converting a transcriptional repressor of mitogenic pathways into a transcriptional activator.
23313952	2013	Nat. Genet.	1546-1718	ALL_TEXT_3/3	3	7	6778	SYMBOL|DICTIONARY	stat6	STAT6	29#34		D009369	LONGTERM|DICTIONARY	neoplasia	neoplasia	104#113		These studies establish NAB2-STAT6 as the defining driver mutation of SFT and provide an example of how neoplasia can be initiated by converting a transcriptional repressor of mitogenic pathways into a transcriptional activator.
15886521	2005	Exp. Mol. Med.	1226-3613	ALL_TEXT_3/3	3	5	2068	SYMBOL|DICTIONARY	ercc2	ERCC2	130#135		D001943	LONGTERM|DISEASE|DT|DICTIONARY	breast cancer	breast cancer	99#112		Although no significant association was observed between the genetic polymorphisms and the risk of breast cancer, women with both ERCC2 A allele- and ERCC4 C allele-containing genotypes showed a 2.6-fold risk (95% CI: 1.02-6.48) of breast cancer compared to women concurrently carrying the ERCC2 GG and ERCC4 TT genotypes.
15886521	2005	Exp. Mol. Med.	1226-3613	ALL_TEXT_3/3	3	5	2068	SYMBOL|DICTIONARY	ercc2	ERCC2	130#135		D001943	LONGTERM|DISEASE|DT|DICTIONARY	breast cancer	breast cancer	232#245		Although no significant association was observed between the genetic polymorphisms and the risk of breast cancer, women with both ERCC2 A allele- and ERCC4 C allele-containing genotypes showed a 2.6-fold risk (95% CI: 1.02-6.48) of breast cancer compared to women concurrently carrying the ERCC2 GG and ERCC4 TT genotypes.
15886521	2005	Exp. Mol. Med.	1226-3613	ALL_TEXT_3/3	3	5	2072	SYMBOL|DICTIONARY	ercc4	ERCC4	150#155		D001943	LONGTERM|DISEASE|DT|DICTIONARY	breast cancer	breast cancer	99#112		Although no significant association was observed between the genetic polymorphisms and the risk of breast cancer, women with both ERCC2 A allele- and ERCC4 C allele-containing genotypes showed a 2.6-fold risk (95% CI: 1.02-6.48) of breast cancer compared to women concurrently carrying the ERCC2 GG and ERCC4 TT genotypes.
15886521	2005	Exp. Mol. Med.	1226-3613	ALL_TEXT_3/3	3	5	2072	SYMBOL|DICTIONARY	ercc4	ERCC4	150#155		D001943	LONGTERM|DISEASE|DT|DICTIONARY	breast cancer	breast cancer	232#245		Although no significant association was observed between the genetic polymorphisms and the risk of breast cancer, women with both ERCC2 A allele- and ERCC4 C allele-containing genotypes showed a 2.6-fold risk (95% CI: 1.02-6.48) of breast cancer compared to women concurrently carrying the ERCC2 GG and ERCC4 TT genotypes.
15886521	2005	Exp. Mol. Med.	1226-3613	ALL_TEXT_3/3	3	5	2068	SYMBOL|DICTIONARY	ercc2	ERCC2	290#295		D001943	LONGTERM|DISEASE|DT|DICTIONARY	breast cancer	breast cancer	99#112		Although no significant association was observed between the genetic polymorphisms and the risk of breast cancer, women with both ERCC2 A allele- and ERCC4 C allele-containing genotypes showed a 2.6-fold risk (95% CI: 1.02-6.48) of breast cancer compared to women concurrently carrying the ERCC2 GG and ERCC4 TT genotypes.
15886521	2005	Exp. Mol. Med.	1226-3613	ALL_TEXT_3/3	3	5	2068	SYMBOL|DICTIONARY	ercc2	ERCC2	290#295		D001943	LONGTERM|DISEASE|DT|DICTIONARY	breast cancer	breast cancer	232#245		Although no significant association was observed between the genetic polymorphisms and the risk of breast cancer, women with both ERCC2 A allele- and ERCC4 C allele-containing genotypes showed a 2.6-fold risk (95% CI: 1.02-6.48) of breast cancer compared to women concurrently carrying the ERCC2 GG and ERCC4 TT genotypes.
15886521	2005	Exp. Mol. Med.	1226-3613	ALL_TEXT_3/3	3	5	2072	SYMBOL|DICTIONARY	ercc4	ERCC4	303#308		D001943	LONGTERM|DISEASE|DT|DICTIONARY	breast cancer	breast cancer	99#112		Although no significant association was observed between the genetic polymorphisms and the risk of breast cancer, women with both ERCC2 A allele- and ERCC4 C allele-containing genotypes showed a 2.6-fold risk (95% CI: 1.02-6.48) of breast cancer compared to women concurrently carrying the ERCC2 GG and ERCC4 TT genotypes.
15886521	2005	Exp. Mol. Med.	1226-3613	ALL_TEXT_3/3	3	5	2072	SYMBOL|DICTIONARY	ercc4	ERCC4	303#308		D001943	LONGTERM|DISEASE|DT|DICTIONARY	breast cancer	breast cancer	232#245		Although no significant association was observed between the genetic polymorphisms and the risk of breast cancer, women with both ERCC2 A allele- and ERCC4 C allele-containing genotypes showed a 2.6-fold risk (95% CI: 1.02-6.48) of breast cancer compared to women concurrently carrying the ERCC2 GG and ERCC4 TT genotypes.
15022317	2004	Arthritis Rheum.	0004-3591	CONCLUSION	4	8	3123	SYMBOL|DICTIONARY	drb1	DRB1	26#30		D001172	SYMBOL|EXTRACTED	ra	RA	56#58	15022317-1-0-20	At least 1 additional non-DRB1 susceptibility locus for RA exists in an interval that encompasses the junction of the class III and I regions.
14695532	2004	Hum. Mutat.	1098-1004	ALL_TEXT_3/3	3	7	2548	SYMBOL|DICTIONARY|EXTRACTED	gaa	GAA	146#149	14695532-0-34-61	D006009	LONGTERM|DICTIONARY	gsdii	GSDII	82#87	NaN	The outcome of our analysis underscores the notion that the clinical phenotype of GSDII is largely dictated by the nature of the mutations in the GAA alleles.
15886521	2005	Exp. Mol. Med.	1226-3613	ALL_TEXT_3/3	3	8	2068	SYMBOL|DICTIONARY	ercc2	ERCC2	49#54		D001943	LONGTERM|DISEASE|DT|DICTIONARY	breast cancer	breast cancer	124#137		Our finding suggests that the combined effect of ERCC2 Asp(312)Asn and ERCC4 Ser(835)Ser genotypes might be associated with breast cancer risk in Korean women.
15886521	2005	Exp. Mol. Med.	1226-3613	ALL_TEXT_3/3	3	8	2072	SYMBOL|DICTIONARY	ercc4	ERCC4	71#76		D001943	LONGTERM|DISEASE|DT|DICTIONARY	breast cancer	breast cancer	124#137		Our finding suggests that the combined effect of ERCC2 Asp(312)Asn and ERCC4 Ser(835)Ser genotypes might be associated with breast cancer risk in Korean women.
12930595	2004	Thyroid	1050-7256	ALL_TEXT_1/3	1	3	7253	SYMBOL|EXTRACTED	tshr	TSHr	60#64	12930595-1-13-26	D006111	SYMBOL|EXTRACTED|DISEASE|DN	gd	GD	89#91	12930595-1-82-97	Polymerase chain reaction products of exon 1 and 10e of the TSHr were generated from 164 GD patients (109 Chinese, 34 Malays, and 21 Indians) and 240 individuals with no thyroid illnesses (74 Chinese, 84 Malays, and 82 Indians).
12930595	2004	Thyroid	1050-7256	ALL_TEXT_1/3	1	1	7253	SYMBOL|EXTRACTED|()	tshr	TSHr	28#32	12930595-1-13-26	D006111	LONGTERM|DISEASE|DT|DICTIONARY|GENE|GA	graves disease	Graves' disease	82#97		Thyrotropin (TSH) receptor (TSHr) mutations have been investigated in relation to Graves' disease (GD) genetic susceptibility under the hypothesis that a modified antigen may have novel immunogenic properties.
17768272	2007	Arch. Gen. Psychiatry	0003-990X	CONTEXT	1	1	4988	SYMBOL|()|DICTIONARY|EXTRACTED	oprm1	OPRM1	211#216	17768272-1-186-204	D000437	LONGTERM|DICTIONARY	alcoholism	alcoholism	86#96		Clinical trials have suggested a modest effect of naltrexone as a pharmacotherapy for alcoholism, and a recent study has suggested that the effects may be moderated by variations in the mu-opioid receptor gene (OPRM1).
15824176	2005	Cancer Epidemiol. Biomarkers Prev.	1055-9965	ALL_TEXT_3/3	3	10	367	SYMBOL|EXTRACTED	ar	AR	31#33	15824176-1-4-21	D011471	LONGTERM|DISEASE|DT|DICTIONARY	metastatic prostate cancer	metastatic prostate cancer	133#159		These results suggest that the AR-E211 A allele, in linkage with the functional repeat sequences, is associated with a lower risk of metastatic prostate cancer and a lower risk of alopecia.
15824176	2005	Cancer Epidemiol. Biomarkers Prev.	1055-9965	ALL_TEXT_3/3	3	10	367	SYMBOL|EXTRACTED	ar	AR	31#33	15824176-1-4-21	D000505	LONGTERM|DICTIONARY	alopecia	alopecia	180#188		These results suggest that the AR-E211 A allele, in linkage with the functional repeat sequences, is associated with a lower risk of metastatic prostate cancer and a lower risk of alopecia.
19073975	2008	N. Engl. J. Med.	1533-4406	CONCLUSIONS	4	10	79068	SYMBOL|DICTIONARY|EXTRACTED	fto	FTO	4#7	19073975-1-17-48	D009765	LONGTERM|DICTIONARY	obesity	obesity	49#56		The FTO variant that confers a predisposition to obesity does not appear to be involved in the regulation of energy expenditure but may have a role in the control of food intake and food choice, suggesting a link to a hyperphagic phenotype or a preference for energy-dense foods.
19350278	2009	Pediatr. Nephrol.	1432-198X	ALL_TEXT_1/3	1	3	6092	SYMBOL|GENE|GN|DICTIONARY	robo2	ROBO2	35#40		D014718	SYMBOL|DICTIONARY|EXTRACTED	vur	VUR	85#88	19350278-1-23-45	Two recent studies have found that ROBO2 gene missense mutations are associated with VUR.
19406470	2009	Leuk. Res.	1873-5835	ALL_TEXT_2/3	2	4	3569	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	il6	IL6	58#61	19406470-1-20-33	D009190	SYMBOL|DICTIONARY|EXTRACTED	mds	MDS	155#158	19406470-1-101-125	Therefore we determined the Asp358Ala polymorphism of the IL6 receptor gene and the -174 G>C promoter polymorphism of the IL6 gene in blood samples of 102 MDS and 100 MM patients and 99 age- and sex-matched hospitalized controls had been tested for this purpose as well.
19406470	2009	Leuk. Res.	1873-5835	ALL_TEXT_2/3	2	4	3569	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	il6	IL6	58#61	19406470-1-20-33	D009101	SYMBOL|EXTRACTED|DISEASE|DN	mm	MM	167#169	19406470-1-136-152	Therefore we determined the Asp358Ala polymorphism of the IL6 receptor gene and the -174 G>C promoter polymorphism of the IL6 gene in blood samples of 102 MDS and 100 MM patients and 99 age- and sex-matched hospitalized controls had been tested for this purpose as well.
19406470	2009	Leuk. Res.	1873-5835	ALL_TEXT_2/3	2	4	3569	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	il6	IL6	122#125	19406470-1-20-33	D009190	SYMBOL|DICTIONARY|EXTRACTED	mds	MDS	155#158	19406470-1-101-125	Therefore we determined the Asp358Ala polymorphism of the IL6 receptor gene and the -174 G>C promoter polymorphism of the IL6 gene in blood samples of 102 MDS and 100 MM patients and 99 age- and sex-matched hospitalized controls had been tested for this purpose as well.
19406470	2009	Leuk. Res.	1873-5835	ALL_TEXT_2/3	2	4	3569	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	il6	IL6	122#125	19406470-1-20-33	D009101	SYMBOL|EXTRACTED|DISEASE|DN	mm	MM	167#169	19406470-1-136-152	Therefore we determined the Asp358Ala polymorphism of the IL6 receptor gene and the -174 G>C promoter polymorphism of the IL6 gene in blood samples of 102 MDS and 100 MM patients and 99 age- and sex-matched hospitalized controls had been tested for this purpose as well.
19406470	2009	Leuk. Res.	1873-5835	TITLE	0	0	3569	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	il6	IL6	24#27		D009190	LONGTERM|DICTIONARY	myelodysplasia	myelodysplasia	67#81		Comparative analysis of IL6 promoter and receptor polymorphisms in myelodysplasia and multiple myeloma.
19406470	2009	Leuk. Res.	1873-5835	TITLE	0	0	3569	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	il6	IL6	24#27		D009101	LONGTERM|DICTIONARY	multiple myeloma	multiple myeloma	86#102		Comparative analysis of IL6 promoter and receptor polymorphisms in myelodysplasia and multiple myeloma.
19406470	2009	Leuk. Res.	1873-5835	ALL_TEXT_1/3	1	1	3569	LONGTERM|DICTIONARY	interleukin 6	interleukin 6	20#33		D009190	LONGTERM|DISEASE|DT|DICTIONARY	myelodysplastic syndrome	myelodysplastic syndrome	101#125		The serum levels of interleukin 6 (IL6) are known to be elevated in two diseases of the elderly age, myelodysplastic syndrome (MDS) and multiple myeloma (MM).
19406470	2009	Leuk. Res.	1873-5835	ALL_TEXT_1/3	1	1	3569	LONGTERM|DICTIONARY	interleukin 6	interleukin 6	20#33		D009190	SYMBOL|()|DICTIONARY|EXTRACTED	mds	MDS	127#130	19406470-1-101-125	The serum levels of interleukin 6 (IL6) are known to be elevated in two diseases of the elderly age, myelodysplastic syndrome (MDS) and multiple myeloma (MM).
19406470	2009	Leuk. Res.	1873-5835	ALL_TEXT_1/3	1	1	3569	LONGTERM|DICTIONARY	interleukin 6	interleukin 6	20#33		D009101	LONGTERM|DICTIONARY	multiple myeloma	multiple myeloma	136#152		The serum levels of interleukin 6 (IL6) are known to be elevated in two diseases of the elderly age, myelodysplastic syndrome (MDS) and multiple myeloma (MM).
19406470	2009	Leuk. Res.	1873-5835	ALL_TEXT_1/3	1	1	3569	LONGTERM|DICTIONARY	interleukin 6	interleukin 6	20#33		D009101	SYMBOL|EXTRACTED|()	mm	MM	154#156	19406470-1-136-152	The serum levels of interleukin 6 (IL6) are known to be elevated in two diseases of the elderly age, myelodysplastic syndrome (MDS) and multiple myeloma (MM).
19406470	2009	Leuk. Res.	1873-5835	ALL_TEXT_1/3	1	1	3569	SYMBOL|()|DICTIONARY|EXTRACTED	il6	IL6	35#38	19406470-1-20-33	D009190	LONGTERM|DISEASE|DT|DICTIONARY	myelodysplastic syndrome	myelodysplastic syndrome	101#125		The serum levels of interleukin 6 (IL6) are known to be elevated in two diseases of the elderly age, myelodysplastic syndrome (MDS) and multiple myeloma (MM).
19406470	2009	Leuk. Res.	1873-5835	ALL_TEXT_1/3	1	1	3569	SYMBOL|()|DICTIONARY|EXTRACTED	il6	IL6	35#38	19406470-1-20-33	D009190	SYMBOL|()|DICTIONARY|EXTRACTED	mds	MDS	127#130	19406470-1-101-125	The serum levels of interleukin 6 (IL6) are known to be elevated in two diseases of the elderly age, myelodysplastic syndrome (MDS) and multiple myeloma (MM).
19406470	2009	Leuk. Res.	1873-5835	ALL_TEXT_1/3	1	1	3569	SYMBOL|()|DICTIONARY|EXTRACTED	il6	IL6	35#38	19406470-1-20-33	D009101	LONGTERM|DICTIONARY	multiple myeloma	multiple myeloma	136#152		The serum levels of interleukin 6 (IL6) are known to be elevated in two diseases of the elderly age, myelodysplastic syndrome (MDS) and multiple myeloma (MM).
19406470	2009	Leuk. Res.	1873-5835	ALL_TEXT_1/3	1	1	3569	SYMBOL|()|DICTIONARY|EXTRACTED	il6	IL6	35#38	19406470-1-20-33	D009101	SYMBOL|EXTRACTED|()	mm	MM	154#156	19406470-1-136-152	The serum levels of interleukin 6 (IL6) are known to be elevated in two diseases of the elderly age, myelodysplastic syndrome (MDS) and multiple myeloma (MM).
19406470	2009	Leuk. Res.	1873-5835	ALL_TEXT_2/3	2	3	3569	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	il6	IL6	116#119	19406470-1-20-33	D009101	SYMBOL|EXTRACTED	mm	MM	60#62	19406470-1-136-152	Scarce and contradictory comparative data are available for MM and to our best knowledge this is the first study on IL6 promoter and IL6 receptor (IL6R) polymorphism in MDS.
19406470	2009	Leuk. Res.	1873-5835	ALL_TEXT_2/3	2	3	3569	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	il6	IL6	116#119	19406470-1-20-33	D009190	SYMBOL|DICTIONARY|EXTRACTED	mds	MDS	169#172	19406470-1-101-125	Scarce and contradictory comparative data are available for MM and to our best knowledge this is the first study on IL6 promoter and IL6 receptor (IL6R) polymorphism in MDS.
19406470	2009	Leuk. Res.	1873-5835	ALL_TEXT_2/3	2	3	3569	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	il6	IL6	133#136	19406470-1-20-33	D009101	SYMBOL|EXTRACTED	mm	MM	60#62	19406470-1-136-152	Scarce and contradictory comparative data are available for MM and to our best knowledge this is the first study on IL6 promoter and IL6 receptor (IL6R) polymorphism in MDS.
19406470	2009	Leuk. Res.	1873-5835	ALL_TEXT_2/3	2	3	3569	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	il6	IL6	133#136	19406470-1-20-33	D009190	SYMBOL|DICTIONARY|EXTRACTED	mds	MDS	169#172	19406470-1-101-125	Scarce and contradictory comparative data are available for MM and to our best knowledge this is the first study on IL6 promoter and IL6 receptor (IL6R) polymorphism in MDS.
18650507	2008	N. Engl. J. Med.	1533-4406	CONCLUSIONS	4	13	10599	SYMBOL|DICTIONARY	slco1b1	SLCO1B1	38#45		D009135	LONGTERM|DICTIONARY	myopathy	myopathy	116#124		We have identified common variants in SLCO1B1 that are strongly associated with an increased risk of statin-induced myopathy.
19276544	2009	J. Alzheimers Dis.	1387-2877	TITLE	0	0	9846	SYMBOL|GENE|GN|DICTIONARY	gab2	GAB2	15#19		D000544	LONGTERM|DISEASE|DT|DICTIONARY	alzheimer disease	Alzheimer's disease	63#82		Implication of GAB2 gene polymorphism in Italian patients with Alzheimer's disease.
20485448	2010	J. Hum. Genet.	1435-232X	ALL_TEXT_3/3	3	8	4210	SYMBOL|DICTIONARY	mefv	MEFV	64#68		D010505	SYMBOL|DISEASE|DN|DICTIONARY|EXTRACTED	fmf	FMF	108#111	20485448-1-0-28	Therefore, our study supports the rising evidence that a single MEFV mutation could be associated with mild FMF symptoms.
20977478	2011	J. Neurochem.	1471-4159	TITLE	0	0	6470	SYMBOL|DICTIONARY|EXTRACTED	shmt1	Shmt1	70#75		D012559	LONGTERM|DICTIONARY	schizophrenia	schizophrenia	99#112		Analysis of strain-dependent prepulse inhibition points to a role for Shmt1 (SHMT1) in mice and in schizophrenia.
20977478	2011	J. Neurochem.	1471-4159	TITLE	0	0	6470	SYMBOL|()|DICTIONARY|EXTRACTED	shmt1	SHMT1	77#82	20977478-0-70-75	D012559	LONGTERM|DICTIONARY	schizophrenia	schizophrenia	99#112		Analysis of strain-dependent prepulse inhibition points to a role for Shmt1 (SHMT1) in mice and in schizophrenia.
20166877	2010	Autoimmunity	1607-842X	TITLE	0	0	26191	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	ptpn22	PTPN22	47#53		D001327	LONGTERM|DICTIONARY	autoimmune diseases	autoimmune diseases	139#158		Allele and haplotype frequency distribution in PTPN22 gene across variable ethnic groups: Implications for genetic association studies for autoimmune diseases.
20166877	2010	Autoimmunity	1607-842X	ALL_TEXT_1/3	1	1	26191	LONGTERM|DICTIONARY|GENE|GA	protein tyrosine phosphatase non receptor type 22	protein tyrosine phosphatase non-receptor type 22	30#79		D001327	LONGTERM|DICTIONARY	autoimmune diseases	autoimmune diseases	140#159		The rs2476601-T allele at the protein tyrosine phosphatase non-receptor type 22 (PTPN22) gene has been consistently associated with several autoimmune diseases in European-derived populations.
20166877	2010	Autoimmunity	1607-842X	ALL_TEXT_1/3	1	1	26191	SYMBOL|()|GENE|GN|DICTIONARY|EXTRACTED	ptpn22	PTPN22	81#87	20166877-1-30-79	D001327	LONGTERM|DICTIONARY	autoimmune diseases	autoimmune diseases	140#159		The rs2476601-T allele at the protein tyrosine phosphatase non-receptor type 22 (PTPN22) gene has been consistently associated with several autoimmune diseases in European-derived populations.
12918850	2003	J. Heart Valve Dis.	0966-8519	CONCLUSION	4	11	2200	SYMBOL|DICTIONARY|EXTRACTED	fbn1	FBN1	45#49	12918850-6-49-60	D008945	SYMBOL|DICTIONARY|EXTRACTED	mvp	MVP	14#17	12918850-3-50-71	Patients with MVP have higher frequencies of FBN1 exon 15 TT and exon 27 GG genotypes, which supports a role of the FBN1 exon 15 and 27 polymorphisms in determining the risk of MVP among the Chinese population in Taiwan.
12918850	2003	J. Heart Valve Dis.	0966-8519	CONCLUSION	4	11	2200	SYMBOL|DICTIONARY|EXTRACTED	fbn1	FBN1	45#49	12918850-6-49-60	D008945	SYMBOL|DICTIONARY|EXTRACTED	mvp	MVP	177#180	12918850-3-50-71	Patients with MVP have higher frequencies of FBN1 exon 15 TT and exon 27 GG genotypes, which supports a role of the FBN1 exon 15 and 27 polymorphisms in determining the risk of MVP among the Chinese population in Taiwan.
12918850	2003	J. Heart Valve Dis.	0966-8519	CONCLUSION	4	11	2200	SYMBOL|DICTIONARY|EXTRACTED	fbn1	FBN1	116#120	12918850-6-49-60	D008945	SYMBOL|DICTIONARY|EXTRACTED	mvp	MVP	14#17	12918850-3-50-71	Patients with MVP have higher frequencies of FBN1 exon 15 TT and exon 27 GG genotypes, which supports a role of the FBN1 exon 15 and 27 polymorphisms in determining the risk of MVP among the Chinese population in Taiwan.
12918850	2003	J. Heart Valve Dis.	0966-8519	CONCLUSION	4	11	2200	SYMBOL|DICTIONARY|EXTRACTED	fbn1	FBN1	116#120	12918850-6-49-60	D008945	SYMBOL|DICTIONARY|EXTRACTED	mvp	MVP	177#180	12918850-3-50-71	Patients with MVP have higher frequencies of FBN1 exon 15 TT and exon 27 GG genotypes, which supports a role of the FBN1 exon 15 and 27 polymorphisms in determining the risk of MVP among the Chinese population in Taiwan.
12918850	2003	J. Heart Valve Dis.	0966-8519	RESULTS	3	10	2200	SYMBOL|DICTIONARY|EXTRACTED	fbn1	FBN1	59#63	12918850-6-49-60	D008945	SYMBOL|DICTIONARY|EXTRACTED	mvp	MVP	135#138	12918850-3-50-71	There was no significant difference in the distribution of FBN1 intron C genotypes (p = 0.58) and allelic frequency (p = 0.34) between MVP cases and controls.
20237358	2010	Reprod Sci	1933-7205	ALL_TEXT_1/3	1	1	6347	LONGTERM|DICTIONARY	monocyte chemotactic protein 1	monocyte chemotactic protein 1	49#79		D000292	LONGTERM|DICTIONARY	pelvic inflammatory disease	pelvic inflammatory disease	131#158		Our goal was to compare the expression of plasma monocyte chemotactic protein 1 (MCP-1) and the gene polymorphism in patients with pelvic inflammatory disease (PID) and healthy controls.
20237358	2010	Reprod Sci	1933-7205	ALL_TEXT_1/3	1	1	6347	LONGTERM|DICTIONARY	monocyte chemotactic protein 1	monocyte chemotactic protein 1	49#79		D000292	SYMBOL|()|DICTIONARY|EXTRACTED	pid	PID	160#163	20237358-1-131-158	Our goal was to compare the expression of plasma monocyte chemotactic protein 1 (MCP-1) and the gene polymorphism in patients with pelvic inflammatory disease (PID) and healthy controls.
20237358	2010	Reprod Sci	1933-7205	ALL_TEXT_1/3	1	1	6347	SYMBOL|()|DICTIONARY|EXTRACTED	mcp 1	MCP-1	81#86	20237358-1-49-79	D000292	LONGTERM|DICTIONARY	pelvic inflammatory disease	pelvic inflammatory disease	131#158		Our goal was to compare the expression of plasma monocyte chemotactic protein 1 (MCP-1) and the gene polymorphism in patients with pelvic inflammatory disease (PID) and healthy controls.
20237358	2010	Reprod Sci	1933-7205	ALL_TEXT_1/3	1	1	6347	SYMBOL|()|DICTIONARY|EXTRACTED	mcp 1	MCP-1	81#86	20237358-1-49-79	D000292	SYMBOL|()|DICTIONARY|EXTRACTED	pid	PID	160#163	20237358-1-131-158	Our goal was to compare the expression of plasma monocyte chemotactic protein 1 (MCP-1) and the gene polymorphism in patients with pelvic inflammatory disease (PID) and healthy controls.
20237358	2010	Reprod Sci	1933-7205	TITLE	0	0	6347	LONGTERM|DICTIONARY	monocyte chemotactic protein 1	monocyte chemotactic protein 1	47#77		D000292	LONGTERM|DISEASE|DT|DICTIONARY	pelvic inflammatory disease	pelvic inflammatory disease	95#122		Significantly elevated concentration of plasma monocyte chemotactic protein 1 of patients with pelvic inflammatory disease.
22119709	2012	Toxicol. Appl. Pharmacol.	1096-0333	ALL_TEXT_2/3	2	5	3586	SYMBOL|DICTIONARY	il 10	IL-10	135#140		D003092	LONGTERM|DICTIONARY	colitis	colitis	72#79		JWH-133 effectively attenuated the overall clinical score, and reversed colitis-associated pathogenesis and decrease in body weight in IL-10(-/-) mice.
15927975	2006	Circulation	1524-4539	TITLE	0	0	1910	LONGTERM|GENE|GT|DICTIONARY	endothelin b receptor	endothelin B receptor	76#97		D006976	LONGTERM|DICTIONARY	pulmonary arterial hypertension	pulmonary arterial hypertension	136#167		Development of occlusive neointimal lesions in distal pulmonary arteries of endothelin B receptor-deficient rats: a new model of severe pulmonary arterial hypertension.
15927975	2006	Circulation	1524-4539	TITLE	0	0	1910	LONGTERM|GENE|GT|DICTIONARY	endothelin b receptor	endothelin B receptor	76#97		D001157	LONGTERM|DICTIONARY	occlusive neointimal lesions	occlusive neointimal lesions	15#43	NaN	Development of occlusive neointimal lesions in distal pulmonary arteries of endothelin B receptor-deficient rats: a new model of severe pulmonary arterial hypertension.
11425413	2001	Lancet	0140-6736	TITLE	0	0	64127	SYMBOL|GENE|GN|DICTIONARY	nod2	NOD2	42#46		D003424	LONGTERM|DISEASE|DT|DICTIONARY	crohn disease	Crohn's disease	56#71		Association between insertion mutation in NOD2 gene and Crohn's disease in German and British populations.
11425413	2001	Lancet	0140-6736	ALL_TEXT_2/3	2	4	64127	SYMBOL|GENE|GN|DICTIONARY	nod2	NOD2	46#50		D015212	SYMBOL|DICTIONARY|EXTRACTED	ibd	IBD	177#180	11425413-1-37-63	Methods We sequenced the coding region of the NOD2 gene and genotyped an insertion polymorphism affecting the leucine-rich region of the protein product in 512 individuals with IBD from 309 German or British families, 369 German trios (ie, German patients with sporadic IBD and their unaffected parents), and 272 normal controls.
11425413	2001	Lancet	0140-6736	ALL_TEXT_2/3	2	4	64127	SYMBOL|GENE|GN|DICTIONARY	nod2	NOD2	46#50		D015212	SYMBOL|DICTIONARY|EXTRACTED	ibd	IBD	270#273	11425413-1-37-63	Methods We sequenced the coding region of the NOD2 gene and genotyped an insertion polymorphism affecting the leucine-rich region of the protein product in 512 individuals with IBD from 309 German or British families, 369 German trios (ie, German patients with sporadic IBD and their unaffected parents), and 272 normal controls.
19276544	2009	J. Alzheimers Dis.	1387-2877	ALL_TEXT_3/3	3	3	9846	SYMBOL|GENE|GN|DICTIONARY	gab2	GAB2	46#50		D000544	SYMBOL|EXTRACTED	ad	AD	70#72	19276544-1-143-162	Our results support a possible implication of GAB2 genetic variant in AD.
9759613	1998	Thromb. Haemost.	0340-6245	ALL_TEXT_3/3	3	7	462	LONGTERM|DICTIONARY	at	AT	82#84	NaN	D020152	LONGTERM|DICTIONARY	at	AT	82#84	NaN	In these cases, Southern blot and polymorphism analysis of different parts of the AT gene proved useful for diagnosis.
19687159	2010	Eur. Heart J.	1522-9645	CONCLUSION	3	9	3606	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	il 18	IL-18	28#33	19687159-1-4-18	D006973	LONGTERM|DICTIONARY	hypertension	Hypertension	0#12		Hypertension interacts with IL-18 gene promoter -137 G/C polymorphism, affecting the risk of SCD and the development of coronary atherosclerosis.
19687159	2010	Eur. Heart J.	1522-9645	CONCLUSION	3	9	3606	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	il 18	IL-18	28#33	19687159-1-4-18	D003324	LONGTERM|DICTIONARY	coronary atherosclerosis	coronary atherosclerosis	120#144		Hypertension interacts with IL-18 gene promoter -137 G/C polymorphism, affecting the risk of SCD and the development of coronary atherosclerosis.
19687159	2010	Eur. Heart J.	1522-9645	METHODS AND RESULTS	2	8	3606	SYMBOL|DICTIONARY|EXTRACTED	il 18	IL-18	149#154	19687159-1-4-18	D006973	LONGTERM|DICTIONARY	hypertension	hypertension	101#113		According to gene expression analysis of atherosclerotic tissue samples obtained from live patients, hypertension also interacted significantly with IL-18 genotype affecting the expression of IL-18 (P = 0.030) mRNA and interferon-gamma mRNA (P = 0.004).
19687159	2010	Eur. Heart J.	1522-9645	METHODS AND RESULTS	2	8	3606	SYMBOL|DICTIONARY|EXTRACTED	il 18	IL-18	149#154	19687159-1-4-18	D050197	LONGTERM|DICTIONARY	atherosclerotic	atherosclerotic	41#56	NaN	According to gene expression analysis of atherosclerotic tissue samples obtained from live patients, hypertension also interacted significantly with IL-18 genotype affecting the expression of IL-18 (P = 0.030) mRNA and interferon-gamma mRNA (P = 0.004).
19687159	2010	Eur. Heart J.	1522-9645	METHODS AND RESULTS	2	8	3606	SYMBOL|DICTIONARY|EXTRACTED	il 18	IL-18	192#197	19687159-1-4-18	D006973	LONGTERM|DICTIONARY	hypertension	hypertension	101#113		According to gene expression analysis of atherosclerotic tissue samples obtained from live patients, hypertension also interacted significantly with IL-18 genotype affecting the expression of IL-18 (P = 0.030) mRNA and interferon-gamma mRNA (P = 0.004).
19687159	2010	Eur. Heart J.	1522-9645	METHODS AND RESULTS	2	8	3606	SYMBOL|DICTIONARY|EXTRACTED	il 18	IL-18	192#197	19687159-1-4-18	D050197	LONGTERM|DICTIONARY	atherosclerotic	atherosclerotic	41#56	NaN	According to gene expression analysis of atherosclerotic tissue samples obtained from live patients, hypertension also interacted significantly with IL-18 genotype affecting the expression of IL-18 (P = 0.030) mRNA and interferon-gamma mRNA (P = 0.004).
19687159	2010	Eur. Heart J.	1522-9645	METHODS AND RESULTS	2	8	3458	LONGTERM|GFAM|FN|DICTIONARY	interferon gamma	interferon-gamma	219#235		D006973	LONGTERM|DICTIONARY	hypertension	hypertension	101#113		According to gene expression analysis of atherosclerotic tissue samples obtained from live patients, hypertension also interacted significantly with IL-18 genotype affecting the expression of IL-18 (P = 0.030) mRNA and interferon-gamma mRNA (P = 0.004).
19687159	2010	Eur. Heart J.	1522-9645	METHODS AND RESULTS	2	8	3458	LONGTERM|GFAM|FN|DICTIONARY	interferon gamma	interferon-gamma	219#235		D050197	LONGTERM|DICTIONARY	atherosclerotic	atherosclerotic	41#56	NaN	According to gene expression analysis of atherosclerotic tissue samples obtained from live patients, hypertension also interacted significantly with IL-18 genotype affecting the expression of IL-18 (P = 0.030) mRNA and interferon-gamma mRNA (P = 0.004).
9759613	1998	Thromb. Haemost.	0340-6245	TITLE	0	0	462	LONGTERM|DICTIONARY	antithrombin	antithrombin	23#35	NaN	D020152	LONGTERM|DICTIONARY	antithrombin	antithrombin	23#35		The molecular basis of antithrombin deficiency in Belgian and Dutch families.
17419075	2007	Osteoarthr. Cartil.	1063-4584	CONCLUSIONS	4	14	2099	SYMBOL|DICTIONARY|EXTRACTED	esr1	ESR1	59#63	17419075-1-85-94	D009410	LONGTERM|DICTIONARY	joint degeneration	joint degeneration	87#105	NaN	Additional work is required to understand how the intron I ESR1 polymorphism may alter joint degeneration.
19687159	2010	Eur. Heart J.	1522-9645	TITLE	0	0	3606	LONGTERM|GENE|GN|DICTIONARY	interleukin 18	Interleukin 18	0#14		D006973	LONGTERM|DICTIONARY	hypertension	hypertension	58#70		Interleukin 18 gene promoter polymorphism: a link between hypertension and pre-hospital sudden cardiac death: the Helsinki Sudden Death Study.
19687159	2010	Eur. Heart J.	1522-9645	TITLE	0	0	3606	LONGTERM|GENE|GN|DICTIONARY	interleukin 18	Interleukin 18	0#14		D003645	LONGTERM|DICTIONARY	sudden death	Sudden Death	123#135	NaN	Interleukin 18 gene promoter polymorphism: a link between hypertension and pre-hospital sudden cardiac death: the Helsinki Sudden Death Study.
19687159	2010	Eur. Heart J.	1522-9645	TITLE	0	0	3606	LONGTERM|GENE|GN|DICTIONARY	interleukin 18	Interleukin 18	0#14		D016757	LONGTERM|DICTIONARY	sudden cardiac death	sudden cardiac death	88#108	NaN	Interleukin 18 gene promoter polymorphism: a link between hypertension and pre-hospital sudden cardiac death: the Helsinki Sudden Death Study.
19687159	2010	Eur. Heart J.	1522-9645	METHODS AND RESULTS	2	5	3606	SYMBOL|DICTIONARY|EXTRACTED	il 18	IL-18	96#101	19687159-1-4-18	D006973	LONGTERM|DICTIONARY	hypertension	hypertension	115#127		According to adjusted logistic regression analysis, there was a significant interaction between IL-18 genotype and hypertension impacting on the risk of SCD due to coronary heart disease (CHD) (P = 0.011) and the severity of autopsy-verified CAD (P = 0.026).
19687159	2010	Eur. Heart J.	1522-9645	METHODS AND RESULTS	2	5	3606	SYMBOL|DICTIONARY|EXTRACTED	il 18	IL-18	96#101	19687159-1-4-18	D003327	LONGTERM|DISEASE|DT|DICTIONARY	coronary heart disease	coronary heart disease	164#186		According to adjusted logistic regression analysis, there was a significant interaction between IL-18 genotype and hypertension impacting on the risk of SCD due to coronary heart disease (CHD) (P = 0.011) and the severity of autopsy-verified CAD (P = 0.026).
19687159	2010	Eur. Heart J.	1522-9645	METHODS AND RESULTS	2	5	3606	SYMBOL|DICTIONARY|EXTRACTED	il 18	IL-18	96#101	19687159-1-4-18	D003327	SYMBOL|()|DICTIONARY|EXTRACTED	chd	CHD	188#191	19687159-5-164-186	According to adjusted logistic regression analysis, there was a significant interaction between IL-18 genotype and hypertension impacting on the risk of SCD due to coronary heart disease (CHD) (P = 0.011) and the severity of autopsy-verified CAD (P = 0.026).
19687159	2010	Eur. Heart J.	1522-9645	METHODS AND RESULTS	2	5	3606	SYMBOL|DICTIONARY|EXTRACTED	il 18	IL-18	96#101	19687159-1-4-18	D003324	SYMBOL|DICTIONARY|EXTRACTED	cad	CAD	242#245	19687159-3-78-101	According to adjusted logistic regression analysis, there was a significant interaction between IL-18 genotype and hypertension impacting on the risk of SCD due to coronary heart disease (CHD) (P = 0.011) and the severity of autopsy-verified CAD (P = 0.026).
21264219	2011	PLoS ONE	1932-6203	BACKGROUND	1	3	205428	LONGTERM|DICTIONARY|GENE|GA	deleted in autism 1	Deleted-In-Autism-1	98#117		D001321	LONGTERM|DICTIONARY	autism	autism	84#90		Most ASDs have a genetic origin and one gene recently implicated in the etiology of autism is the Deleted-In-Autism-1 (DIA1) gene.
21264219	2011	PLoS ONE	1932-6203	BACKGROUND	1	3	205428	SYMBOL|()|GENE|GN|DICTIONARY|EXTRACTED	dia1	DIA1	119#123	21264219-3-98-117	D001321	LONGTERM|DICTIONARY	autism	autism	84#90		Most ASDs have a genetic origin and one gene recently implicated in the etiology of autism is the Deleted-In-Autism-1 (DIA1) gene.
15128052	2004	Pharmacogenetics	0960-314X	ALL_TEXT_3/3	3	11	5467	SYMBOL|DICTIONARY	ppard	PPARD	0#5		D003324	LONGTERM|DICTIONARY	coronary atherosclerosis	coronary atherosclerosis	96#120		PPARD and PPARG haplotypes are independent determinants of plasma levels of lipids, severity of coronary atherosclerosis and its response to therapy.
15128052	2004	Pharmacogenetics	0960-314X	ALL_TEXT_3/3	3	11	5468	SYMBOL|DICTIONARY	pparg	PPARG	10#15		D003324	LONGTERM|DICTIONARY	coronary atherosclerosis	coronary atherosclerosis	96#120		PPARD and PPARG haplotypes are independent determinants of plasma levels of lipids, severity of coronary atherosclerosis and its response to therapy.
19267885	2010	J. Cell. Mol. Med.	1582-4934	ALL_TEXT_3/3	3	7	4524	SYMBOL|GENE|GN|DICTIONARY	mthfr	MTHFR	19#24		D002659	SYMBOL|PLURAL|DICTIONARY|EXTRACTED	asds	ASDs	111#115	19267885-1-0-25	The results of the MTHFR gene analysis showed a normal distribution of the C677T polymorphism in children with ASDs, but the frequency of the 677T allele was slightly more prevalent in AD patients.
16352452	2006	Mol. Genet. Metab.	1096-7192	ALL_TEXT_1/3	1	1	3073	LONGTERM|DICTIONARY	hexa	HexA	113#117	NaN	D013661	LONGTERM|DISEASE|DT|DICTIONARY	tay sachs disease	Tay-Sachs disease	13#30		A DNA-proven Tay-Sachs disease (TSD) carrier and his brother were found to have serum percent Hexosaminidase A (%HexA) enzymatic activities in the non-carrier range, while the leukocyte %HexA profiles clearly identified them as TSD heterozygotes.
16352452	2006	Mol. Genet. Metab.	1096-7192	ALL_TEXT_1/3	1	1	3073	LONGTERM|DICTIONARY	hexa	HexA	113#117	NaN	D013661	SYMBOL|()|DICTIONARY|EXTRACTED	tsd	TSD	32#35	16352452-1-13-30	A DNA-proven Tay-Sachs disease (TSD) carrier and his brother were found to have serum percent Hexosaminidase A (%HexA) enzymatic activities in the non-carrier range, while the leukocyte %HexA profiles clearly identified them as TSD heterozygotes.
16352452	2006	Mol. Genet. Metab.	1096-7192	ALL_TEXT_1/3	1	1	3073	LONGTERM|DICTIONARY	hexa	HexA	113#117	NaN	D013661	SYMBOL|DICTIONARY|EXTRACTED	tsd	TSD	228#231	16352452-1-13-30	A DNA-proven Tay-Sachs disease (TSD) carrier and his brother were found to have serum percent Hexosaminidase A (%HexA) enzymatic activities in the non-carrier range, while the leukocyte %HexA profiles clearly identified them as TSD heterozygotes.
16352452	2006	Mol. Genet. Metab.	1096-7192	ALL_TEXT_1/3	1	1	3073	LONGTERM|DICTIONARY	hexa	HexA	187#191	NaN	D013661	LONGTERM|DISEASE|DT|DICTIONARY	tay sachs disease	Tay-Sachs disease	13#30		A DNA-proven Tay-Sachs disease (TSD) carrier and his brother were found to have serum percent Hexosaminidase A (%HexA) enzymatic activities in the non-carrier range, while the leukocyte %HexA profiles clearly identified them as TSD heterozygotes.
16352452	2006	Mol. Genet. Metab.	1096-7192	ALL_TEXT_1/3	1	1	3073	LONGTERM|DICTIONARY	hexa	HexA	187#191	NaN	D013661	SYMBOL|()|DICTIONARY|EXTRACTED	tsd	TSD	32#35	16352452-1-13-30	A DNA-proven Tay-Sachs disease (TSD) carrier and his brother were found to have serum percent Hexosaminidase A (%HexA) enzymatic activities in the non-carrier range, while the leukocyte %HexA profiles clearly identified them as TSD heterozygotes.
16352452	2006	Mol. Genet. Metab.	1096-7192	ALL_TEXT_1/3	1	1	3073	LONGTERM|DICTIONARY	hexa	HexA	187#191	NaN	D013661	SYMBOL|DICTIONARY|EXTRACTED	tsd	TSD	228#231	16352452-1-13-30	A DNA-proven Tay-Sachs disease (TSD) carrier and his brother were found to have serum percent Hexosaminidase A (%HexA) enzymatic activities in the non-carrier range, while the leukocyte %HexA profiles clearly identified them as TSD heterozygotes.
19267885	2010	J. Cell. Mol. Med.	1582-4934	ALL_TEXT_1/3	1	2	4524	SYMBOL|GENE|GN|DICTIONARY	mthfr	MTHFR	159#164		D001321	SYMBOL|EXTRACTED	ad	AD	213#215	19267885-1-63-80	The current study investigated the metabolites in the methionine cycle, the transsulphuration pathway, folate, vitamin B(12) and the C677T polymorphism of the MTHFR gene in three groups of children diagnosed with AD (n= 15), AS (n= 5) and PDD-NOS (n= 19) and their age- and sex-matched controls (n= 25).
19267885	2010	J. Cell. Mol. Med.	1582-4934	ALL_TEXT_1/3	1	2	4524	SYMBOL|GENE|GN|DICTIONARY	mthfr	MTHFR	159#164		D020817	SYMBOL|EXTRACTED	as	AS	225#227	19267885-1-87-106	The current study investigated the metabolites in the methionine cycle, the transsulphuration pathway, folate, vitamin B(12) and the C677T polymorphism of the MTHFR gene in three groups of children diagnosed with AD (n= 15), AS (n= 5) and PDD-NOS (n= 19) and their age- and sex-matched controls (n= 25).
19267885	2010	J. Cell. Mol. Med.	1582-4934	TITLE	0	0	4524	SYMBOL|GENE|GN|DICTIONARY	mthfr	MTHFR	49#54		D002659	LONGTERM|DICTIONARY	autism spectrum disorders	autism spectrum disorders	90#115		One carbon metabolism disturbances and the C677T MTHFR gene polymorphism in children with autism spectrum disorders.
14732601	2004	Biol. Psychiatry	0006-3223	RESULTS	3	6	9145	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	syngr1	SYNGR1	63#69	14732601-3-8-22	D012559	LONGTERM|DICTIONARY	schizophrenia	schizophrenia	110#123		We found a novel nonsense mutation (Trp27Ter) in exon 2 of the SYNGR1 gene in a family multiply affected with schizophrenia.
19190165	2009	Cancer Epidemiol. Biomarkers Prev.	1055-9965	TITLE	0	0	10111	SYMBOL|DICTIONARY	rad50	Rad50	0#5		D001943	LONGTERM|DISEASE|DT|DICTIONARY	familial breast cancer	familial breast cancer	53#75		Rad50 c.687delT does not contribute significantly to familial breast cancer in a French population.
14732601	2004	Biol. Psychiatry	0006-3223	BACKGROUND	1	3	9145	LONGTERM|DICTIONARY	synaptogyrin 1	Synaptogyrin 1	8#22		D012559	LONGTERM|DICTIONARY	schizophrenia	schizophrenia	175#188		Because Synaptogyrin 1 (SYNGR1), associated with presynaptic vesicles in neuronal cells, lies within 1 million base pairs of this marker, it is a potential candidate gene for schizophrenia.
14732601	2004	Biol. Psychiatry	0006-3223	BACKGROUND	1	3	9145	SYMBOL|()|DICTIONARY|EXTRACTED	syngr1	SYNGR1	24#30	14732601-3-8-22	D012559	LONGTERM|DICTIONARY	schizophrenia	schizophrenia	175#188		Because Synaptogyrin 1 (SYNGR1), associated with presynaptic vesicles in neuronal cells, lies within 1 million base pairs of this marker, it is a potential candidate gene for schizophrenia.
20722399	2011	Chem. Res. Toxicol.	1520-5010	ALL_TEXT_3/3	3	7	4780	SYMBOL|DICTIONARY|EXTRACTED	nrf2	Nrf2	68#72	20722399-2-25-68	D009369	LONGTERM|DISEASE|DT|CLINE|CN|DICTIONARY	cancer	cancer	76#82		Together, these results indicate that MC-LR-induced upregulation of Nrf2 in cancer cells promotes liver cancer cell growth and suggest a positive role of Nrf2 in tumorigenesis.
20722399	2011	Chem. Res. Toxicol.	1520-5010	ALL_TEXT_3/3	3	7	4780	SYMBOL|DICTIONARY|EXTRACTED	nrf2	Nrf2	68#72	20722399-2-25-68	D008113	LONGTERM|DISEASE|DT|CLINE|CN|DICTIONARY	liver cancer	liver cancer	98#110		Together, these results indicate that MC-LR-induced upregulation of Nrf2 in cancer cells promotes liver cancer cell growth and suggest a positive role of Nrf2 in tumorigenesis.
20722399	2011	Chem. Res. Toxicol.	1520-5010	ALL_TEXT_3/3	3	7	4780	SYMBOL|DICTIONARY|EXTRACTED	nrf2	Nrf2	154#158	20722399-2-25-68	D009369	LONGTERM|DISEASE|DT|CLINE|CN|DICTIONARY	cancer	cancer	76#82		Together, these results indicate that MC-LR-induced upregulation of Nrf2 in cancer cells promotes liver cancer cell growth and suggest a positive role of Nrf2 in tumorigenesis.
20722399	2011	Chem. Res. Toxicol.	1520-5010	ALL_TEXT_3/3	3	7	4780	SYMBOL|DICTIONARY|EXTRACTED	nrf2	Nrf2	154#158	20722399-2-25-68	D008113	LONGTERM|DISEASE|DT|CLINE|CN|DICTIONARY	liver cancer	liver cancer	98#110		Together, these results indicate that MC-LR-induced upregulation of Nrf2 in cancer cells promotes liver cancer cell growth and suggest a positive role of Nrf2 in tumorigenesis.
15279649	2004	Eur. J. Oral Sci.	0909-8836	TITLE	0	0	64127	SYMBOL|DICTIONARY	nod2	NOD2	29#33		D010510	LONGTERM|DISEASE|DT|DICTIONARY	periodontal disease	periodontal disease	63#82		The 3020insC mutation of the NOD2/CARD15 gene in patients with periodontal disease.
15279649	2004	Eur. J. Oral Sci.	0909-8836	TITLE	0	0	64127	SYMBOL|GENE|GN|DICTIONARY	card15	CARD15	34#40		D010510	LONGTERM|DISEASE|DT|DICTIONARY	periodontal disease	periodontal disease	63#82		The 3020insC mutation of the NOD2/CARD15 gene in patients with periodontal disease.
20722399	2011	Chem. Res. Toxicol.	1520-5010	TITLE	0	0	4780	SYMBOL|DICTIONARY|EXTRACTED	nrf2	Nrf2	14#18		D008113	LONGTERM|DISEASE|DT|CLINE|CN|DICTIONARY	liver cancer	liver cancer	61#73		Activation of Nrf2 by microcystin-LR provides advantages for liver cancer cell growth.
12789280	2003	Oncogene	0950-9232	ALL_TEXT_2/3	2	4	4157	SYMBOL|DICTIONARY	mc1r	MC1R	28#32		D008545	LONGTERM|DICTIONARY	melanoma	melanoma	151#159		One such pigmentation gene, MC1R, has not only been found to be a low penetrance melanoma gene but has also been shown to act as a genetic modifier of melanoma risk in individuals carrying CDKN2A mutations.
12789280	2003	Oncogene	0950-9232	ALL_TEXT_2/3	2	4	1029	SYMBOL|DICTIONARY	cdkn2a	CDKN2A	189#195		D008545	LONGTERM|DICTIONARY	melanoma	melanoma	151#159		One such pigmentation gene, MC1R, has not only been found to be a low penetrance melanoma gene but has also been shown to act as a genetic modifier of melanoma risk in individuals carrying CDKN2A mutations.
12789280	2003	Oncogene	0950-9232	ALL_TEXT_3/3	3	5	1029	SYMBOL|DICTIONARY	cdkn2a	CDKN2A	122#128		D008545	LONGTERM|DICTIONARY	melanoma	melanoma	105#113		Most recently, an environmental agent, ultraviolet radiation, has also been established as a modifier of melanoma risk in CDKN2A mutation carriers.
12078789	2002	Ann. Thorac. Surg.	0003-4975	TITLE	0	0	7124	LONGTERM|GENE|GT|DICTIONARY	tumor necrosis factor	tumor necrosis factor	74#95		D000140	LONGTERM|DICTIONARY	lactic acidosis	Lactic acidosis	0#15		Lactic acidosis after cardiac surgery is associated with polymorphisms in tumor necrosis factor and interleukin 10 genes.
12078789	2002	Ann. Thorac. Surg.	0003-4975	TITLE	0	0	3586	LONGTERM|GENE|GN|DICTIONARY	interleukin 10	interleukin 10	100#114		D000140	LONGTERM|DICTIONARY	lactic acidosis	Lactic acidosis	0#15		Lactic acidosis after cardiac surgery is associated with polymorphisms in tumor necrosis factor and interleukin 10 genes.
16824064	2006	J. Gastroenterol. Hepatol.	0815-9319	RESULTS	3	9	5928	LONGTERM|DICTIONARY	msi	MSI	26#29	NaN	D013274	SYMBOL|EXTRACTED	gc	GC	110#112	16824064-1-0-17	High and low frequency of MSI (MSI-H and MSI-L) and MSS were detected in 16 (8.8%), 14 (7.7%) and 151 (83.4%) GC cases, respectively.
16824064	2006	J. Gastroenterol. Hepatol.	0815-9319	RESULTS	3	9	5928	LONGTERM|DICTIONARY	msi	MSI	26#29	NaN	C536652	LONGTERM|DICTIONARY	msi	MSI	26#29	NaN	High and low frequency of MSI (MSI-H and MSI-L) and MSS were detected in 16 (8.8%), 14 (7.7%) and 151 (83.4%) GC cases, respectively.
16824064	2006	J. Gastroenterol. Hepatol.	0815-9319	RESULTS	3	9	5928	LONGTERM|DICTIONARY	msi	MSI	26#29	NaN	C536652	LONGTERM|DICTIONARY	msi-l	MSI-L	41#46	NaN	High and low frequency of MSI (MSI-H and MSI-L) and MSS were detected in 16 (8.8%), 14 (7.7%) and 151 (83.4%) GC cases, respectively.
16824064	2006	J. Gastroenterol. Hepatol.	0815-9319	RESULTS	3	9	5928	LONGTERM|DICTIONARY	msi	MSI	26#29	NaN	C538322	LONGTERM|DICTIONARY	msi-h	MSI-H	31#36	NaN	High and low frequency of MSI (MSI-H and MSI-L) and MSS were detected in 16 (8.8%), 14 (7.7%) and 151 (83.4%) GC cases, respectively.
16824064	2006	J. Gastroenterol. Hepatol.	0815-9319	RESULTS	3	9	5928	LONGTERM|DICTIONARY	msi-l	MSI-L	41#46	NaN	D013274	SYMBOL|EXTRACTED	gc	GC	110#112	16824064-1-0-17	High and low frequency of MSI (MSI-H and MSI-L) and MSS were detected in 16 (8.8%), 14 (7.7%) and 151 (83.4%) GC cases, respectively.
16824064	2006	J. Gastroenterol. Hepatol.	0815-9319	RESULTS	3	9	5928	LONGTERM|DICTIONARY	msi-l	MSI-L	41#46	NaN	C536652	LONGTERM|DICTIONARY	msi	MSI	26#29	NaN	High and low frequency of MSI (MSI-H and MSI-L) and MSS were detected in 16 (8.8%), 14 (7.7%) and 151 (83.4%) GC cases, respectively.
16824064	2006	J. Gastroenterol. Hepatol.	0815-9319	RESULTS	3	9	5928	LONGTERM|DICTIONARY	msi-l	MSI-L	41#46	NaN	C536652	LONGTERM|DICTIONARY	msi-l	MSI-L	41#46	NaN	High and low frequency of MSI (MSI-H and MSI-L) and MSS were detected in 16 (8.8%), 14 (7.7%) and 151 (83.4%) GC cases, respectively.
16824064	2006	J. Gastroenterol. Hepatol.	0815-9319	RESULTS	3	9	5928	LONGTERM|DICTIONARY	msi-l	MSI-L	41#46	NaN	C538322	LONGTERM|DICTIONARY	msi-h	MSI-H	31#36	NaN	High and low frequency of MSI (MSI-H and MSI-L) and MSS were detected in 16 (8.8%), 14 (7.7%) and 151 (83.4%) GC cases, respectively.
15279649	2004	Eur. J. Oral Sci.	0909-8836	ALL_TEXT_3/3	3	6	64127	SYMBOL|DICTIONARY	nod2	NOD2	63#67		D003424	LONGTERM|DISEASE|DT|DICTIONARY	crohn disease	Crohn's disease	17#32		Hence, unlike in Crohn's disease, the 3020insC mutation of the NOD2/CARD15 gene does not seem to influence the pathophysiology of periodontitis.
15279649	2004	Eur. J. Oral Sci.	0909-8836	ALL_TEXT_3/3	3	6	64127	SYMBOL|DICTIONARY	nod2	NOD2	63#67		D010518	LONGTERM|DICTIONARY	periodontitis	periodontitis	130#143		Hence, unlike in Crohn's disease, the 3020insC mutation of the NOD2/CARD15 gene does not seem to influence the pathophysiology of periodontitis.
15279649	2004	Eur. J. Oral Sci.	0909-8836	ALL_TEXT_3/3	3	6	64127	SYMBOL|GENE|GN|DICTIONARY	card15	CARD15	68#74		D003424	LONGTERM|DISEASE|DT|DICTIONARY	crohn disease	Crohn's disease	17#32		Hence, unlike in Crohn's disease, the 3020insC mutation of the NOD2/CARD15 gene does not seem to influence the pathophysiology of periodontitis.
15279649	2004	Eur. J. Oral Sci.	0909-8836	ALL_TEXT_3/3	3	6	64127	SYMBOL|GENE|GN|DICTIONARY	card15	CARD15	68#74		D010518	LONGTERM|DICTIONARY	periodontitis	periodontitis	130#143		Hence, unlike in Crohn's disease, the 3020insC mutation of the NOD2/CARD15 gene does not seem to influence the pathophysiology of periodontitis.
21040232	2012	Eur. J. Neurol.	1468-1331	TITLE	0	0	6324	SYMBOL|GENE|GN|DICTIONARY	scn1b	SCN1B	73#78		D012640	LONGTERM|DICTIONARY	febrile seizures	febrile seizures	110#126		New mutation c.374C>T and a putative disease-associated haplotype within SCN1B gene in Tunisian families with febrile seizures.
12078789	2002	Ann. Thorac. Surg.	0003-4975	RESULTS	3	8	3586	SYMBOL|NUMBER|DICTIONARY|EXTRACTED	il 10	IL-10	62#67	12078789-5-131-145	D000140	LONGTERM|DICTIONARY	lactic acidosis	lactic acidosis	91#106		All 4 study patients homozygous for TNF-beta1 and carrying an IL-10-1082A allele developed lactic acidosis (p = 0.02).
7987717	1995	Zhonghua Yi Xue Za Zhi	0376-2491	TITLE	0	0	3126	LONGTERM|DICTIONARY	dr4	DR4	28#31	NaN	D001172	LONGTERM|DICTIONARY	rheumatoid arthritis	rheumatoid arthritis	56#76		[The molecular basis of HLA DR4 alleles associated with rheumatoid arthritis in a Chinese population].
17603938	2007	Free Radic. Biol. Med.	0891-5849	ALL_TEXT_3/3	3	11	4318	SYMBOL|DICTIONARY	mmp 9	MMP-9	31#36		D013276	LONGTERM|DICTIONARY	gastric ulceration	gastric ulceration	136#154		These findings furnish a novel MMP-9-mediated pathway and its inhibition via proinflammatory cytokines by famotidine in ethanol-induced gastric ulceration.
12150336	2003	J. Endocrinol. Invest.	0391-4097	ALL_TEXT_1/3	1	1	846	LONGTERM|GENE|GT|DICTIONARY	calcium sensing receptor	calcium-sensing receptor	4#28		D049950	LONGTERM|DICTIONARY	primary hyperparathyroidism	primary hyperparathyroidism	345#372		The calcium-sensing receptor (CaR) polymorphism A986S has been found to be associated with higher serum calcium levels in normal subjects, suggesting that this amino acid change might decrease the inhibitory activity of the mutated receptor, render the parathyroid cells more prone to proliferate, and eventually increase the risk of developing primary hyperparathyroidism (PHPT).
12150336	2003	J. Endocrinol. Invest.	0391-4097	ALL_TEXT_1/3	1	1	846	LONGTERM|GENE|GT|DICTIONARY	calcium sensing receptor	calcium-sensing receptor	4#28		D049950	SYMBOL|EXTRACTED|()	phpt	PHPT	374#378	12150336-1-345-372	The calcium-sensing receptor (CaR) polymorphism A986S has been found to be associated with higher serum calcium levels in normal subjects, suggesting that this amino acid change might decrease the inhibitory activity of the mutated receptor, render the parathyroid cells more prone to proliferate, and eventually increase the risk of developing primary hyperparathyroidism (PHPT).
12150336	2003	J. Endocrinol. Invest.	0391-4097	ALL_TEXT_1/3	1	1	846	SYMBOL|EXTRACTED|()	car	CaR	30#33	12150336-1-4-28	D049950	LONGTERM|DICTIONARY	primary hyperparathyroidism	primary hyperparathyroidism	345#372		The calcium-sensing receptor (CaR) polymorphism A986S has been found to be associated with higher serum calcium levels in normal subjects, suggesting that this amino acid change might decrease the inhibitory activity of the mutated receptor, render the parathyroid cells more prone to proliferate, and eventually increase the risk of developing primary hyperparathyroidism (PHPT).
12150336	2003	J. Endocrinol. Invest.	0391-4097	ALL_TEXT_1/3	1	1	846	SYMBOL|EXTRACTED|()	car	CaR	30#33	12150336-1-4-28	D049950	SYMBOL|EXTRACTED|()	phpt	PHPT	374#378	12150336-1-345-372	The calcium-sensing receptor (CaR) polymorphism A986S has been found to be associated with higher serum calcium levels in normal subjects, suggesting that this amino acid change might decrease the inhibitory activity of the mutated receptor, render the parathyroid cells more prone to proliferate, and eventually increase the risk of developing primary hyperparathyroidism (PHPT).
11895872	2002	Cancer Epidemiol. Biomarkers Prev.	1055-9965	TITLE	0	0	1586	SYMBOL|GENE|GN|DICTIONARY	cyp17	CYP17	22#27		D011471	LONGTERM|DISEASE|DT|DICTIONARY	prostate cancer	prostate cancer	45#60		A polymorphism in the CYP17 gene and risk of prostate cancer.
17067442	2007	Clin. Exp. Rheumatol.	0392-856X	CONCLUSIONS	4	10	4210	SYMBOL|DICTIONARY	mefv	MEFV	20#24		D007249	LONGTERM|DICTIONARY	inflammation	inflammation	72#84	NaN	We suggest that one MEFV mutation may indeed be conferring a heightened inflammation as suggested by the increased frequency in inflammatory symptoms.
14697642	2004	Cancer Genet. Cytogenet.	0165-4608	ALL_TEXT_3/3	3	9	7157	SYMBOL|DICTIONARY	tp53	TP53	51#55		D001943	LONGTERM|DICTIONARY	breast cancers	breast cancers	17#31		About 19% of the breast cancers examined carried a TP53 mutation in exons 4-9.
18186798	2008	Int. J. Immunogenet.	1744-313X	ALL_TEXT_3/3	3	9	7422	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	vegf	VEGF	29#33	18186798-1-0-34	D010505	SYMBOL|DICTIONARY|EXTRACTED	fmf	FMF	114#117	18186798-3-93-121	Present results suggest that VEGF gene 936 C/T polymorphism does not seem to be associated with susceptibility to FMF and its clinical manifestations.
25256182	2015	Stroke	1524-4628	RESULTS	3	7	9734	SYMBOL|DICTIONARY	hdac9	HDAC9	37#42		D002532	SYMBOL|EXTRACTED	ia	IA	64#66	25256182-1-95-117	A novel region on chromosome 7, near HDAC9, was associated with IA (rs10230207; P=4.1410(-8)).
7981680	1995	Hum. Mol. Genet.	0964-6906	ALL_TEXT_3/3	3	6	3481	SYMBOL|DICTIONARY|EXTRACTED	igf ii	IGF-II	191#197	7981680-1-0-29	D019042	LONGTERM|DICTIONARY	muscle tumors	muscle tumors	25#38		Among different types of muscle tumors, relaxation of imprinting seems to arise prevalently in rhabdomyosarcomas, since we have detected only one case of partial reactivation of the maternal IGF-II allele out of 7 leiomyosarcomas tested.
7981680	1995	Hum. Mol. Genet.	0964-6906	ALL_TEXT_3/3	3	6	3481	SYMBOL|DICTIONARY|EXTRACTED	igf ii	IGF-II	191#197	7981680-1-0-29	D012208	LONGTERM|DICTIONARY	rhabdomyosarcomas	rhabdomyosarcomas	95#112		Among different types of muscle tumors, relaxation of imprinting seems to arise prevalently in rhabdomyosarcomas, since we have detected only one case of partial reactivation of the maternal IGF-II allele out of 7 leiomyosarcomas tested.
7981680	1995	Hum. Mol. Genet.	0964-6906	ALL_TEXT_3/3	3	6	3481	SYMBOL|DICTIONARY|EXTRACTED	igf ii	IGF-II	191#197	7981680-1-0-29	D007890	LONGTERM|DICTIONARY	leiomyosarcomas	leiomyosarcomas	214#229		Among different types of muscle tumors, relaxation of imprinting seems to arise prevalently in rhabdomyosarcomas, since we have detected only one case of partial reactivation of the maternal IGF-II allele out of 7 leiomyosarcomas tested.
18186798	2008	Int. J. Immunogenet.	1744-313X	ALL_TEXT_1/3	1	3	7422	SYMBOL|DICTIONARY|EXTRACTED	vegf	VEGF	144#148	18186798-1-0-34	D010505	LONGTERM|DICTIONARY	familial mediterranean fever	familial Mediterranean fever	93#121		It is known that neutrophils are the major cell population involved in acute inflammation in familial Mediterranean fever (FMF) and the role of VEGF in these cells may be crucial.
18186798	2008	Int. J. Immunogenet.	1744-313X	ALL_TEXT_1/3	1	3	7422	SYMBOL|DICTIONARY|EXTRACTED	vegf	VEGF	144#148	18186798-1-0-34	D010505	SYMBOL|()|DICTIONARY|EXTRACTED	fmf	FMF	123#126	18186798-3-93-121	It is known that neutrophils are the major cell population involved in acute inflammation in familial Mediterranean fever (FMF) and the role of VEGF in these cells may be crucial.
18186798	2008	Int. J. Immunogenet.	1744-313X	ALL_TEXT_1/3	1	3	7422	SYMBOL|DICTIONARY|EXTRACTED	vegf	VEGF	144#148	18186798-1-0-34	D007249	LONGTERM|DICTIONARY	inflammation	inflammation	77#89	NaN	It is known that neutrophils are the major cell population involved in acute inflammation in familial Mediterranean fever (FMF) and the role of VEGF in these cells may be crucial.
18186798	2008	Int. J. Immunogenet.	1744-313X	TITLE	0	0	7422	LONGTERM|GENE|GN|GT|DICTIONARY	vascular endothelial growth factor	vascular endothelial growth factor	12#46		D010505	LONGTERM|DICTIONARY	familial mediterranean fever	familial Mediterranean fever	90#118		Analysis of vascular endothelial growth factor gene 936 C/T polymorphism in patients with familial Mediterranean fever.
18186798	2008	Int. J. Immunogenet.	1744-313X	ALL_TEXT_3/3	3	7	7422	SYMBOL|NUMBER|DICTIONARY|EXTRACTED	vegf	VEGF	9#13	18186798-1-0-34	D010505	SYMBOL|DICTIONARY|EXTRACTED	fmf	FMF	77#80	18186798-3-93-121	Although VEGF 936 TT genotype was found to be more frequent in patients with FMF than in healthy controls (6.7% vs. 1.6%, respectively), the difference was not significant (OR = 4.28, 95% CI = 0.81-22.67, P = 0.108).
18186798	2008	Int. J. Immunogenet.	1744-313X	ALL_TEXT_2/3	2	6	7422	SYMBOL|NUMBER|DICTIONARY|EXTRACTED	vegf	VEGF	39#43	18186798-1-0-34	D010505	SYMBOL|DICTIONARY|EXTRACTED	fmf	FMF	87#90	18186798-3-93-121	Genotype and allele frequencies of the VEGF 936 C/T polymorphism between patients with FMF and healthy control groups were not significantly different (OR = 0.74, 95% CI = 0.40-1.37, P = 0.335 for CT genotype; OR = 1.11, 95% CI = 0.67-1.83, P = 0.700, for T allele).
18186798	2008	Int. J. Immunogenet.	1744-313X	ALL_TEXT_2/3	2	5	7422	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	vegf	VEGF	131#135	18186798-1-0-34	D010505	SYMBOL|DICTIONARY|EXTRACTED	fmf	FMF	161#164	18186798-3-93-121	Polymerase chain reaction-restriction fragment length polymorphism technique was used to determine 936 C/T polymorphism within the VEGF gene in 75 patients with FMF and 122 non-related healthy controls.
18186798	2008	Int. J. Immunogenet.	1744-313X	ALL_TEXT_2/3	2	4	7422	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	vegf	VEGF	92#96	18186798-1-0-34	D010505	SYMBOL|DICTIONARY|EXTRACTED	fmf	FMF	139#142	18186798-3-93-121	The aim of this study was to investigate whether the 936 C/T functional polymorphism of the VEGF gene is associated with susceptibility to FMF and its relationship with the main clinical features of the disease.
15675129	2005	Clin. Exp. Rheumatol.	0392-856X	RESULTS	3	7	3458	SYMBOL|EXTRACTED	ifn gamma	IFN-gamma	102#111	15675129-2-112-128	D013700	SYMBOL|DISEASE|DN|DICTIONARY|EXTRACTED	gca	GCA	6#9	15675129-1-61-81	Also, GCA patients with visual ischemic manifestations exhibited a significantly reduced frequency of IFN-gamma allele *4 compared with those without visual manifestations (17.9% versus 42.5%; p = 0.05 [OR: 0.36, 95% CI: 0.13-1.00]).
15675129	2005	Clin. Exp. Rheumatol.	0392-856X	RESULTS	3	7	3458	SYMBOL|EXTRACTED	ifn gamma	IFN-gamma	102#111	15675129-2-112-128	D014786	LONGTERM|DICTIONARY	visual ischemic	visual ischemic	24#39	NaN	Also, GCA patients with visual ischemic manifestations exhibited a significantly reduced frequency of IFN-gamma allele *4 compared with those without visual manifestations (17.9% versus 42.5%; p = 0.05 [OR: 0.36, 95% CI: 0.13-1.00]).
15675129	2005	Clin. Exp. Rheumatol.	0392-856X	RESULTS	3	6	3458	SYMBOL|EXTRACTED	ifn gamma	IFN-gamma	26#35	15675129-2-112-128	D013700	SYMBOL|DISEASE|DN|DICTIONARY|EXTRACTED	gca	GCA	70#73	15675129-1-61-81	However, the frequency of IFN-gamma allele *4 (128 bp) was reduced in GCA patients (33.1%) compared with isolated PMR patients (46.2%).
15675129	2005	Clin. Exp. Rheumatol.	0392-856X	RESULTS	3	6	3458	SYMBOL|EXTRACTED	ifn gamma	IFN-gamma	26#35	15675129-2-112-128	D011111	SYMBOL|DISEASE|DN|DICTIONARY|EXTRACTED	isolated pmr	isolated PMR	105#117	15675129-1-92-114	However, the frequency of IFN-gamma allele *4 (128 bp) was reduced in GCA patients (33.1%) compared with isolated PMR patients (46.2%).
17203290	2007	Immunogenetics	0093-7711	ALL_TEXT_3/3	3	9	3565	SYMBOL|DICTIONARY	il 4	IL-4	19#23		D007676	SYMBOL|DICTIONARY|EXTRACTED	esrd	ESRD	83#87	17203290-1-29-52	Combination of low IL-4 and high IL-6 genotypes were significantly associated with ESRD showing the highest risk, i.e.
17203290	2007	Immunogenetics	0093-7711	ALL_TEXT_3/3	3	9	3569	SYMBOL|DICTIONARY	il 6	IL-6	33#37		D007676	SYMBOL|DICTIONARY|EXTRACTED	esrd	ESRD	83#87	17203290-1-29-52	Combination of low IL-4 and high IL-6 genotypes were significantly associated with ESRD showing the highest risk, i.e.
17203290	2007	Immunogenetics	0093-7711	ALL_TEXT_2/3	2	8	3565	SYMBOL|DICTIONARY	il 4	IL-4	27#31		D005921	LONGTERM|DICTIONARY	glomerulonephritis	glomerulonephritis	67#85		Significant association of IL-4 was also observed in patients with glomerulonephritis (p=0.001).
9535411	1998	Hypertension	0194-911X	ALL_TEXT_3/3	3	7	183	LONGTERM|GENE|GN|DICTIONARY	angiotensinogen	angiotensinogen	30#45		D003928	LONGTERM|DICTIONARY	diabetic nephropathy	diabetic nephropathy	136#156		DNA polymorphism M235T in the angiotensinogen gene, which is associated with higher expression of this gene, contributes to the risk of diabetic nephropathy in NIDDM men but not in women.
9535411	1998	Hypertension	0194-911X	ALL_TEXT_3/3	3	7	183	LONGTERM|GENE|GN|DICTIONARY	angiotensinogen	angiotensinogen	30#45		D003924	LONGTERM|DICTIONARY|EXTRACTED	niddm	NIDDM	160#165	9535411-1-78-117	DNA polymorphism M235T in the angiotensinogen gene, which is associated with higher expression of this gene, contributes to the risk of diabetic nephropathy in NIDDM men but not in women.
15675129	2005	Clin. Exp. Rheumatol.	0392-856X	TITLE	0	0	3458	LONGTERM|GENE|GN|DICTIONARY	interferon gamma	Interferon-gamma	0#16		D013700	LONGTERM|DICTIONARY	giant cell arteritis	giant cell arteritis	82#102		Interferon-gamma gene microsatellite polymorphisms in patients with biopsy-proven giant cell arteritis and isolated polymyalgia rheumatica.
15675129	2005	Clin. Exp. Rheumatol.	0392-856X	TITLE	0	0	3458	LONGTERM|GENE|GN|DICTIONARY	interferon gamma	Interferon-gamma	0#16		D011111	LONGTERM|DICTIONARY	polymyalgia rheumatica	polymyalgia rheumatica	116#138		Interferon-gamma gene microsatellite polymorphisms in patients with biopsy-proven giant cell arteritis and isolated polymyalgia rheumatica.
12939427	2004	Neurology	1526-632X	RESULTS	4	9	4155	SYMBOL|DICTIONARY|EXTRACTED	mbp	MBP	31#34	12939427-1-4-24	D003711	LONGTERM|DICTIONARY	mbp	MBP	31#34	NaN	A significant association with MBP alleles was also observed in the nonstratified groups, owing mainly to the contribution of the DR4- and DR5-positive individuals.
12939427	2004	Neurology	1526-632X	RESULTS	4	9	3126	LONGTERM|DICTIONARY	dr4	DR4	130#133	NaN	D003711	LONGTERM|DICTIONARY	mbp	MBP	31#34	NaN	A significant association with MBP alleles was also observed in the nonstratified groups, owing mainly to the contribution of the DR4- and DR5-positive individuals.
12939427	2004	Neurology	1526-632X	RESULTS	4	9	8795	LONGTERM|DICTIONARY	dr5	DR5	139#142	NaN	D003711	LONGTERM|DICTIONARY	mbp	MBP	31#34	NaN	A significant association with MBP alleles was also observed in the nonstratified groups, owing mainly to the contribution of the DR4- and DR5-positive individuals.
19549929	2009	Toxicol Pathol	1533-1601	ALL_TEXT_3/3	3	7	7137	LONGTERM|DICTIONARY	ctni	cTnI	74#78	NaN	D066126	LONGTERM|DICTIONARY	cardiotoxicity	cardiotoxicity	127#141	NaN	Additional attributes, including low cost and rapid turnaround time, made cTnI concentration in serum invaluable for detecting cardiotoxicity, exploring structure-activity relationships, and prioritizing development of compounds with improved safety profiles early in drug discovery.
17203290	2007	Immunogenetics	0093-7711	TITLE	0	0	3569	SYMBOL|DICTIONARY	il 6	IL-6	47#51		D007676	SYMBOL|DISEASE|DT|DICTIONARY	end stage renal disease	end-stage renal disease	102#125		Association of interleukin (IL)-4 intron-3 and IL-6 -174 G/C gene polymorphism with susceptibility to end-stage renal disease.
17203290	2007	Immunogenetics	0093-7711	ALL_TEXT_2/3	2	5	3565	SYMBOL|DICTIONARY	il 4	IL-4	63#67		D007676	SYMBOL|DISEASE|DN|DICTIONARY|EXTRACTED	esrd	ESRD	85#89	17203290-1-29-52	Significant difference was observed in genotype frequencies of IL-4 and IL-6 between ESRD patients and control group (p<0.001 and p=0.032, respectively).
17203290	2007	Immunogenetics	0093-7711	ALL_TEXT_2/3	2	5	3569	SYMBOL|DICTIONARY	il 6	IL-6	72#76		D007676	SYMBOL|DISEASE|DN|DICTIONARY|EXTRACTED	esrd	ESRD	85#89	17203290-1-29-52	Significant difference was observed in genotype frequencies of IL-4 and IL-6 between ESRD patients and control group (p<0.001 and p=0.032, respectively).
9865924	1999	Clin. Cancer Res.	1078-0432	ALL_TEXT_3/3	3	10	1728	SYMBOL|DICTIONARY|EXTRACTED	nqo1	NQO1	48#52	9865924-0-35-57	D009369	LONGTERM|DICTIONARY	tumors	tumors	97#103		These data suggest that RH1 may be an effective NQO1-directed antitumor agent for the therapy of tumors with elevated NQO1 activity, such as NSCLC.
9865924	1999	Clin. Cancer Res.	1078-0432	ALL_TEXT_3/3	3	10	1728	SYMBOL|DICTIONARY|EXTRACTED	nqo1	NQO1	48#52	9865924-0-35-57	D002289	LONGTERM|DICTIONARY|EXTRACTED	nsclc	NSCLC	141#146	9865924-1-92-118	These data suggest that RH1 may be an effective NQO1-directed antitumor agent for the therapy of tumors with elevated NQO1 activity, such as NSCLC.
9865924	1999	Clin. Cancer Res.	1078-0432	ALL_TEXT_3/3	3	10	1728	SYMBOL|DICTIONARY|EXTRACTED	nqo1	NQO1	118#122	9865924-0-35-57	D009369	LONGTERM|DICTIONARY	tumors	tumors	97#103		These data suggest that RH1 may be an effective NQO1-directed antitumor agent for the therapy of tumors with elevated NQO1 activity, such as NSCLC.
9865924	1999	Clin. Cancer Res.	1078-0432	ALL_TEXT_3/3	3	10	1728	SYMBOL|DICTIONARY|EXTRACTED	nqo1	NQO1	118#122	9865924-0-35-57	D002289	LONGTERM|DICTIONARY|EXTRACTED	nsclc	NSCLC	141#146	9865924-1-92-118	These data suggest that RH1 may be an effective NQO1-directed antitumor agent for the therapy of tumors with elevated NQO1 activity, such as NSCLC.
16824064	2006	J. Gastroenterol. Hepatol.	0815-9319	BACKGROUND AND AIM	1	3	5928	LONGTERM|DICTIONARY	msi	MSI	76#79	NaN	C536652	LONGTERM|DICTIONARY	msi	MSI	76#79	NaN	The relationship between Hp-induced inflammation and the mutator pathway of MSI remains unclear.
16824064	2006	J. Gastroenterol. Hepatol.	0815-9319	BACKGROUND AND AIM	1	3	5928	LONGTERM|DICTIONARY	msi	MSI	76#79	NaN	D007249	LONGTERM|DICTIONARY	inflammation	inflammation	36#48	NaN	The relationship between Hp-induced inflammation and the mutator pathway of MSI remains unclear.
12170472	2002	Zhonghua Yi Xue Yi Chuan Xue Za Zhi	1003-9406	TITLE	0	0	54578	LONGTERM|DICTIONARY	udp-glucuronosyltransferase 1f	UDP-glucuronosyltransferase 1F	25#55	NaN	D006528	LONGTERM|DISEASE|DT|DICTIONARY	hepatocellular carcinoma	hepatocellular carcinoma	78#102		[Genetic polymorphism of UDP-glucuronosyltransferase 1F and susceptibility to hepatocellular carcinoma].
19039244	2009	Neuroepidemiology	1423-0208	TITLE	0	0	3119	SYMBOL|DICTIONARY	hla dqb1	HLA DQB1	65#73		D009290	LONGTERM|DICTIONARY	narcolepsy	narcolepsy	39#49		Active and passive smoking and risk of narcolepsy in people with HLA DQB1*0602: a population-based case-control study.
19039244	2009	Neuroepidemiology	1423-0208	TITLE	0	0	3119	SYMBOL|DICTIONARY	hla dqb1	HLA DQB1	65#73		D015208	LONGTERM|DICTIONARY	smoking	smoking	19#26	NaN	Active and passive smoking and risk of narcolepsy in people with HLA DQB1*0602: a population-based case-control study.
19039244	2009	Neuroepidemiology	1423-0208	CONCLUSION	4	8	3119	SYMBOL|DICTIONARY	hla dqb1	HLA DQB1	69#77		D009290	LONGTERM|DICTIONARY	narcolepsy	narcolepsy	41#51		Passive smoking may be a risk factor for narcolepsy in subjects with HLA DQB1*0602.
19039244	2009	Neuroepidemiology	1423-0208	CONCLUSION	4	8	3119	SYMBOL|DICTIONARY	hla dqb1	HLA DQB1	69#77		D015208	LONGTERM|DICTIONARY	smoking	smoking	8#15	NaN	Passive smoking may be a risk factor for narcolepsy in subjects with HLA DQB1*0602.
12102452	2003	Clin. Auton. Res.	0959-9851	AIMS	1	2	1636	SYMBOL|()|GENE|GN|DICTIONARY|EXTRACTED	ace	ACE	144#147	12102452-2-113-142	D009203	LONGTERM|DICTIONARY	myocardial infarction	myocardial infarction	189#210		The primary objective of this study was to determine the effect of an insertion/deletion polymorphism within the angiotensin-converting enzyme (ACE) gene on HRV in the early stages after a myocardial infarction at a time when cardiac autonomic control is deranged.
19383228	2009	J. Int. Med. Res.	0300-0605	ALL_TEXT_3/3	3	8	1636	SYMBOL|DICTIONARY|EXTRACTED	ace	ACE	40#43	19383228-1-52-81	C536170	LONGTERM|DICTIONARY	dd	DD	25#27	NaN	It is concluded that the DD genotype of ACE is a risk factor for recurrent wheezing in early childhood.
14717963	2004	J. Thromb. Haemost.	1538-7933	ALL_TEXT_3/3	3	11	4524	SYMBOL|NUMBER|DICTIONARY|EXTRACTED	mthfr	MTHFR	67#72	14717963-0-29-64	D009203	SYMBOL|EXTRACTED	mi	MI	32#34	14717963-1-62-83	Low folate is a risk factor for MI, particularly in women with the MTHFR 677TT genotype.
10488956	1999	Atherosclerosis	0021-9150	ALL_TEXT_1/3	1	1	1636	LONGTERM|GENE|GT|DICTIONARY	angiotensin i converting enzyme	angiotensin I-converting enzyme	85#116		D009203	LONGTERM|DICTIONARY	myocardial infarction	myocardial infarction	369#390		We analyzed the evolution with age of the frequencies of the I/D polymorphism of the angiotensin I-converting enzyme (ACE), a1166c of the angiotensin II AT1 receptor (AT1R), M235T of the angiotensinogen (AGT) and A225V of their methylenetetrahydrofolate reductase (MTHFR) gene in a healthy (H) population and the subsequent comparison to age- and sex-matched groups of myocardial infarction (MI) subjects.
10488956	1999	Atherosclerosis	0021-9150	ALL_TEXT_1/3	1	1	1636	LONGTERM|GENE|GT|DICTIONARY	angiotensin i converting enzyme	angiotensin I-converting enzyme	85#116		D009203	SYMBOL|EXTRACTED|()	mi	MI	392#394	10488956-1-369-390	We analyzed the evolution with age of the frequencies of the I/D polymorphism of the angiotensin I-converting enzyme (ACE), a1166c of the angiotensin II AT1 receptor (AT1R), M235T of the angiotensinogen (AGT) and A225V of their methylenetetrahydrofolate reductase (MTHFR) gene in a healthy (H) population and the subsequent comparison to age- and sex-matched groups of myocardial infarction (MI) subjects.
10488956	1999	Atherosclerosis	0021-9150	ALL_TEXT_1/3	1	1	1636	SYMBOL|()|DICTIONARY|EXTRACTED	ace	ACE	118#121	10488956-1-85-116	D009203	LONGTERM|DICTIONARY	myocardial infarction	myocardial infarction	369#390		We analyzed the evolution with age of the frequencies of the I/D polymorphism of the angiotensin I-converting enzyme (ACE), a1166c of the angiotensin II AT1 receptor (AT1R), M235T of the angiotensinogen (AGT) and A225V of their methylenetetrahydrofolate reductase (MTHFR) gene in a healthy (H) population and the subsequent comparison to age- and sex-matched groups of myocardial infarction (MI) subjects.
10488956	1999	Atherosclerosis	0021-9150	ALL_TEXT_1/3	1	1	1636	SYMBOL|()|DICTIONARY|EXTRACTED	ace	ACE	118#121	10488956-1-85-116	D009203	SYMBOL|EXTRACTED|()	mi	MI	392#394	10488956-1-369-390	We analyzed the evolution with age of the frequencies of the I/D polymorphism of the angiotensin I-converting enzyme (ACE), a1166c of the angiotensin II AT1 receptor (AT1R), M235T of the angiotensinogen (AGT) and A225V of their methylenetetrahydrofolate reductase (MTHFR) gene in a healthy (H) population and the subsequent comparison to age- and sex-matched groups of myocardial infarction (MI) subjects.
10488956	1999	Atherosclerosis	0021-9150	ALL_TEXT_1/3	1	1	183	LONGTERM|DICTIONARY	angiotensinogen	angiotensinogen	187#202		D009203	LONGTERM|DICTIONARY	myocardial infarction	myocardial infarction	369#390		We analyzed the evolution with age of the frequencies of the I/D polymorphism of the angiotensin I-converting enzyme (ACE), a1166c of the angiotensin II AT1 receptor (AT1R), M235T of the angiotensinogen (AGT) and A225V of their methylenetetrahydrofolate reductase (MTHFR) gene in a healthy (H) population and the subsequent comparison to age- and sex-matched groups of myocardial infarction (MI) subjects.
10488956	1999	Atherosclerosis	0021-9150	ALL_TEXT_1/3	1	1	183	LONGTERM|DICTIONARY	angiotensinogen	angiotensinogen	187#202		D009203	SYMBOL|EXTRACTED|()	mi	MI	392#394	10488956-1-369-390	We analyzed the evolution with age of the frequencies of the I/D polymorphism of the angiotensin I-converting enzyme (ACE), a1166c of the angiotensin II AT1 receptor (AT1R), M235T of the angiotensinogen (AGT) and A225V of their methylenetetrahydrofolate reductase (MTHFR) gene in a healthy (H) population and the subsequent comparison to age- and sex-matched groups of myocardial infarction (MI) subjects.
10488956	1999	Atherosclerosis	0021-9150	ALL_TEXT_1/3	1	1	4524	LONGTERM|DICTIONARY|GENE|GA	methylenetetrahydrofolate reductase	methylenetetrahydrofolate reductase	228#263		D009203	LONGTERM|DICTIONARY	myocardial infarction	myocardial infarction	369#390		We analyzed the evolution with age of the frequencies of the I/D polymorphism of the angiotensin I-converting enzyme (ACE), a1166c of the angiotensin II AT1 receptor (AT1R), M235T of the angiotensinogen (AGT) and A225V of their methylenetetrahydrofolate reductase (MTHFR) gene in a healthy (H) population and the subsequent comparison to age- and sex-matched groups of myocardial infarction (MI) subjects.
10488956	1999	Atherosclerosis	0021-9150	ALL_TEXT_1/3	1	1	4524	LONGTERM|DICTIONARY|GENE|GA	methylenetetrahydrofolate reductase	methylenetetrahydrofolate reductase	228#263		D009203	SYMBOL|EXTRACTED|()	mi	MI	392#394	10488956-1-369-390	We analyzed the evolution with age of the frequencies of the I/D polymorphism of the angiotensin I-converting enzyme (ACE), a1166c of the angiotensin II AT1 receptor (AT1R), M235T of the angiotensinogen (AGT) and A225V of their methylenetetrahydrofolate reductase (MTHFR) gene in a healthy (H) population and the subsequent comparison to age- and sex-matched groups of myocardial infarction (MI) subjects.
10488956	1999	Atherosclerosis	0021-9150	ALL_TEXT_1/3	1	1	4524	SYMBOL|()|GENE|GN|DICTIONARY|EXTRACTED	mthfr	MTHFR	265#270	10488956-1-228-263	D009203	LONGTERM|DICTIONARY	myocardial infarction	myocardial infarction	369#390		We analyzed the evolution with age of the frequencies of the I/D polymorphism of the angiotensin I-converting enzyme (ACE), a1166c of the angiotensin II AT1 receptor (AT1R), M235T of the angiotensinogen (AGT) and A225V of their methylenetetrahydrofolate reductase (MTHFR) gene in a healthy (H) population and the subsequent comparison to age- and sex-matched groups of myocardial infarction (MI) subjects.
10488956	1999	Atherosclerosis	0021-9150	ALL_TEXT_1/3	1	1	4524	SYMBOL|()|GENE|GN|DICTIONARY|EXTRACTED	mthfr	MTHFR	265#270	10488956-1-228-263	D009203	SYMBOL|EXTRACTED|()	mi	MI	392#394	10488956-1-369-390	We analyzed the evolution with age of the frequencies of the I/D polymorphism of the angiotensin I-converting enzyme (ACE), a1166c of the angiotensin II AT1 receptor (AT1R), M235T of the angiotensinogen (AGT) and A225V of their methylenetetrahydrofolate reductase (MTHFR) gene in a healthy (H) population and the subsequent comparison to age- and sex-matched groups of myocardial infarction (MI) subjects.
15958759	2005	Ann. Rheum. Dis.	0003-4967	CONCLUSION	5	10	4210	SYMBOL|DICTIONARY	mefv	MEFV	0#4		D001172	SYMBOL|EXTRACTED	ra	RA	104#106	15958759-2-60-80	MEFV, and particularly the E148Q mutation, is an independent modifier of the clinical manifestations of RA.
15958759	2005	Ann. Rheum. Dis.	0003-4967	CONCLUSION	5	11	4210	SYMBOL|DICTIONARY	mefv	MEFV	56#60		D001327	LONGTERM|DISEASE|DT|DICTIONARY	autoimmune disease	autoimmune disease	28#46		This is the second Th1-type autoimmune disease in which MEFV mutations have been shown to aggravate the clinical status.
11340230	2001	Stroke	1524-4628	CONCLUSIONS	4	11	348	SYMBOL|DICTIONARY	apoe	APOE	55#59		D013345	SYMBOL|DICTIONARY|EXTRACTED	sah	SAH	115#118	11340230-1-42-65	Our findings show a significant genetic association of APOE polymorphism with outcome after spontaneous aneurysmal SAH.
11340230	2001	Stroke	1524-4628	CONCLUSIONS	4	11	348	SYMBOL|DICTIONARY	apoe	APOE	55#59		D000783	LONGTERM|DICTIONARY	aneurysmal	aneurysmal	104#114	NaN	Our findings show a significant genetic association of APOE polymorphism with outcome after spontaneous aneurysmal SAH.
20513142	2010	Hum. Mutat.	1098-1004	ALL_TEXT_3/3	3	6	4208	SYMBOL|DICTIONARY	mef2c	MEF2C	153#158		D008607	LONGTERM|DICTIONARY	mental retardation	mental retardation	71#89		We therefore performed mutational analysis in 362 patients with severe mental retardation and found two truncating and two missense de novo mutations in MEF2C, establishing defects in this transcription factor as a novel relatively frequent autosomal dominant cause of severe mental retardation accounting for as much as 1.1% of patients.
20513142	2010	Hum. Mutat.	1098-1004	ALL_TEXT_3/3	3	6	4208	SYMBOL|DICTIONARY	mef2c	MEF2C	153#158		D008607	LONGTERM|DICTIONARY	mental retardation	mental retardation	276#294		We therefore performed mutational analysis in 362 patients with severe mental retardation and found two truncating and two missense de novo mutations in MEF2C, establishing defects in this transcription factor as a novel relatively frequent autosomal dominant cause of severe mental retardation accounting for as much as 1.1% of patients.
15126571	2004	J. Clin. Endocrinol. Metab.	0021-972X	ALL_TEXT_1/3	1	1	1583	SYMBOL|DICTIONARY	cyp11a	CYP11A	0#6		D011085	LONGTERM|DISEASE|DT|DICTIONARY	polycystic ovary syndrome	polycystic ovary syndrome	110#135		CYP11A, the gene encoding p450scc, a key enzyme in steroid biosynthesis, is a strong biological candidate for polycystic ovary syndrome (PCOS) susceptibility.
15126571	2004	J. Clin. Endocrinol. Metab.	0021-972X	ALL_TEXT_1/3	1	1	1583	SYMBOL|DICTIONARY	cyp11a	CYP11A	0#6		D011085	SYMBOL|()|DICTIONARY|EXTRACTED	pcos	PCOS	137#141	15126571-1-110-135	CYP11A, the gene encoding p450scc, a key enzyme in steroid biosynthesis, is a strong biological candidate for polycystic ovary syndrome (PCOS) susceptibility.
15126571	2004	J. Clin. Endocrinol. Metab.	0021-972X	ALL_TEXT_1/3	1	1	1583	SYMBOL|DICTIONARY	p450scc	p450scc	26#33		D011085	LONGTERM|DISEASE|DT|DICTIONARY	polycystic ovary syndrome	polycystic ovary syndrome	110#135		CYP11A, the gene encoding p450scc, a key enzyme in steroid biosynthesis, is a strong biological candidate for polycystic ovary syndrome (PCOS) susceptibility.
15126571	2004	J. Clin. Endocrinol. Metab.	0021-972X	ALL_TEXT_1/3	1	1	1583	SYMBOL|DICTIONARY	p450scc	p450scc	26#33		D011085	SYMBOL|()|DICTIONARY|EXTRACTED	pcos	PCOS	137#141	15126571-1-110-135	CYP11A, the gene encoding p450scc, a key enzyme in steroid biosynthesis, is a strong biological candidate for polycystic ovary syndrome (PCOS) susceptibility.
15126571	2004	J. Clin. Endocrinol. Metab.	0021-972X	TITLE	0	0	1583	SYMBOL|GENE|GN|DICTIONARY	cyp11a	CYP11A	49#55		D011085	LONGTERM|DISEASE|DT|DICTIONARY	polycystic ovarian syndrome	polycystic ovarian syndrome	76#103		Large-scale analysis of the relationship between CYP11A promoter variation, polycystic ovarian syndrome, and serum testosterone.
15126571	2004	J. Clin. Endocrinol. Metab.	0021-972X	ALL_TEXT_1/3	1	2	1583	SYMBOL|DICTIONARY	cyp11a	CYP11A	54#60		D007690	LONGTERM|DICTIONARY	polycystic	polycystic	149#159		Four of the five published studies that have examined CYP11A for evidence of linkage and/or association have reported significant relationships with polycystic ovary (PCO) status and/or serum testosterone levels.
15126571	2004	J. Clin. Endocrinol. Metab.	0021-972X	ALL_TEXT_2/3	2	4	1583	SYMBOL|GENE|GN|DICTIONARY	cyp11a	CYP11A	10#16		D011085	SYMBOL|DISEASE|DN|DICTIONARY|EXTRACTED	pcos	PCOS	152#156	15126571-1-110-135	A pair of CYP11A promoter microsatellites, including the pentanucleotide (D15S520) previously implicated in trait susceptibility, were genotyped in 371 PCOS patients of United Kingdom origin, using both case-control and family-based association methods, and in 1589 women from a population-based birth cohort from Finland characterized for PCO symptomatology and testosterone levels.
14650112	2004	Isr. Med. Assoc. J.	1565-1088	CONCLUSIONS	5	9	154	LONGTERM|DICTIONARY	beta 2ar	beta 2AR	28#36	NaN	D013224	LONGTERM|DICTIONARY	asthmatics	asthmatics	69#79		The genetic distribution of beta 2AR polymorphisms in severe Israeli asthmatics is not different from that of non-asthmatic Israelis and therefore its clinical impact on asthma is probably minimal.
14650112	2004	Isr. Med. Assoc. J.	1565-1088	CONCLUSIONS	5	9	154	LONGTERM|DICTIONARY	beta 2ar	beta 2AR	28#36	NaN	D001249	LONGTERM|DICTIONARY	asthma	asthma	170#176		The genetic distribution of beta 2AR polymorphisms in severe Israeli asthmatics is not different from that of non-asthmatic Israelis and therefore its clinical impact on asthma is probably minimal.
22772592	2012	Mol. Pharmacol.	1521-0111	ALL_TEXT_3/3	3	9	285440	SYMBOL|GENE|GN|DICTIONARY	cyp4v2	CYP4V2	21#27		C535440	SYMBOL|DICTIONARY|EXTRACTED	bcd	BCD	92#95	22772592-1-0-44	We demonstrated that CYP4V2 protein is expressed at high levels in ocular target tissues of BCD, that the enzyme is metabolically active toward PUFAs, and that the functional deficit among patients with BCD who carry the H331P variant is most likely a consequence of the instability of the mutant protein.
22772592	2012	Mol. Pharmacol.	1521-0111	ALL_TEXT_3/3	3	9	285440	SYMBOL|GENE|GN|DICTIONARY	cyp4v2	CYP4V2	21#27		C535440	SYMBOL|DICTIONARY|EXTRACTED	bcd	BCD	203#206	22772592-1-0-44	We demonstrated that CYP4V2 protein is expressed at high levels in ocular target tissues of BCD, that the enzyme is metabolically active toward PUFAs, and that the functional deficit among patients with BCD who carry the H331P variant is most likely a consequence of the instability of the mutant protein.
19363267	2009	J. Alzheimers Dis.	1875-8908	ALL_TEXT_1/3	1	1	348	SYMBOL|DICTIONARY	apoe	APOE	38#42		D000544	LONGTERM|DISEASE|DT|DICTIONARY	alzheimer disease	Alzheimer's disease	111#130		We studied eight polymorphisms within APOE, PRNP, PRND, and CYP46 genes in 213 Polish late-onset patients with Alzheimer's disease (AD) and 171 non-demented elderly controls.
19363267	2009	J. Alzheimers Dis.	1875-8908	ALL_TEXT_1/3	1	1	348	SYMBOL|DICTIONARY	apoe	APOE	38#42		D000544	SYMBOL|EXTRACTED|()	ad	AD	132#134	19363267-1-111-130	We studied eight polymorphisms within APOE, PRNP, PRND, and CYP46 genes in 213 Polish late-onset patients with Alzheimer's disease (AD) and 171 non-demented elderly controls.
19363267	2009	J. Alzheimers Dis.	1875-8908	ALL_TEXT_1/3	1	1	5621	SYMBOL|DICTIONARY	prnp	PRNP	44#48		D000544	LONGTERM|DISEASE|DT|DICTIONARY	alzheimer disease	Alzheimer's disease	111#130		We studied eight polymorphisms within APOE, PRNP, PRND, and CYP46 genes in 213 Polish late-onset patients with Alzheimer's disease (AD) and 171 non-demented elderly controls.
19363267	2009	J. Alzheimers Dis.	1875-8908	ALL_TEXT_1/3	1	1	5621	SYMBOL|DICTIONARY	prnp	PRNP	44#48		D000544	SYMBOL|EXTRACTED|()	ad	AD	132#134	19363267-1-111-130	We studied eight polymorphisms within APOE, PRNP, PRND, and CYP46 genes in 213 Polish late-onset patients with Alzheimer's disease (AD) and 171 non-demented elderly controls.
19363267	2009	J. Alzheimers Dis.	1875-8908	ALL_TEXT_1/3	1	1	23627	SYMBOL|DICTIONARY	prnd	PRND	50#54		D000544	LONGTERM|DISEASE|DT|DICTIONARY	alzheimer disease	Alzheimer's disease	111#130		We studied eight polymorphisms within APOE, PRNP, PRND, and CYP46 genes in 213 Polish late-onset patients with Alzheimer's disease (AD) and 171 non-demented elderly controls.
19363267	2009	J. Alzheimers Dis.	1875-8908	ALL_TEXT_1/3	1	1	23627	SYMBOL|DICTIONARY	prnd	PRND	50#54		D000544	SYMBOL|EXTRACTED|()	ad	AD	132#134	19363267-1-111-130	We studied eight polymorphisms within APOE, PRNP, PRND, and CYP46 genes in 213 Polish late-onset patients with Alzheimer's disease (AD) and 171 non-demented elderly controls.
19363267	2009	J. Alzheimers Dis.	1875-8908	ALL_TEXT_1/3	1	1	10858	SYMBOL|GENE|GN|DICTIONARY	cyp46	CYP46	60#65		D000544	LONGTERM|DISEASE|DT|DICTIONARY	alzheimer disease	Alzheimer's disease	111#130		We studied eight polymorphisms within APOE, PRNP, PRND, and CYP46 genes in 213 Polish late-onset patients with Alzheimer's disease (AD) and 171 non-demented elderly controls.
19363267	2009	J. Alzheimers Dis.	1875-8908	ALL_TEXT_1/3	1	1	10858	SYMBOL|GENE|GN|DICTIONARY	cyp46	CYP46	60#65		D000544	SYMBOL|EXTRACTED|()	ad	AD	132#134	19363267-1-111-130	We studied eight polymorphisms within APOE, PRNP, PRND, and CYP46 genes in 213 Polish late-onset patients with Alzheimer's disease (AD) and 171 non-demented elderly controls.
15956634	2005	JAMA	1538-3598	CONCLUSIONS	6	13	348	SYMBOL|DICTIONARY|EXTRACTED	apoe	APOE	0#4		D051436	LONGTERM|DISEASE|DT|DICTIONARY	chronic kidney disease	chronic kidney disease	24#46		APOE variation predicts chronic kidney disease progression, independent of diabetes, race, lipid, and nonlipid risk factors.
15956634	2005	JAMA	1538-3598	CONCLUSIONS	6	13	348	SYMBOL|DICTIONARY|EXTRACTED	apoe	APOE	0#4		D003920	LONGTERM|DICTIONARY	diabetes	diabetes	75#83		APOE variation predicts chronic kidney disease progression, independent of diabetes, race, lipid, and nonlipid risk factors.
22772592	2012	Mol. Pharmacol.	1521-0111	ALL_TEXT_2/3	2	5	285440	SYMBOL|GENE|GN|DICTIONARY	cyp4v2	CYP4V2	47#53		D065306	LONGTERM|DICTIONARY	cornea	cornea	112#118	NaN	Immunohistochemical analyses demonstrated that CYP4V2 protein was present in epithelial cells of the retina and cornea and the enzyme was localized to endoplasmic reticulum.
19523860	2011	Urol. Oncol.	1873-2496	ALL_TEXT_1/3	1	1	7157	SYMBOL|DICTIONARY	tp53	TP53	58#62		D001749	LONGTERM|DICTIONARY	bladder tumors	bladder tumors	108#122		Several studies have investigated the association between TP53 Arg72Pro and an increased risk of developing bladder tumors, with controversial results.
22772592	2012	Mol. Pharmacol.	1521-0111	ALL_TEXT_1/3	1	1	285440	SYMBOL|GENE|GN|DICTIONARY	cyp4v2	CYP4V2	127#133		C535440	LONGTERM|DISEASE|DT|DICTIONARY	bietti crystalline corneoretinal dystrophy	Bietti's crystalline corneoretinal dystrophy	0#44		Bietti's crystalline corneoretinal dystrophy (BCD) is a recessive degenerative eye disease caused by germline mutations in the CYP4V2 gene.
22772592	2012	Mol. Pharmacol.	1521-0111	ALL_TEXT_1/3	1	1	285440	SYMBOL|GENE|GN|DICTIONARY	cyp4v2	CYP4V2	127#133		C535440	SYMBOL|()|DICTIONARY|EXTRACTED	bcd	BCD	46#49	22772592-1-0-44	Bietti's crystalline corneoretinal dystrophy (BCD) is a recessive degenerative eye disease caused by germline mutations in the CYP4V2 gene.
22772592	2012	Mol. Pharmacol.	1521-0111	ALL_TEXT_1/3	1	1	285440	SYMBOL|GENE|GN|DICTIONARY	cyp4v2	CYP4V2	127#133		D015785	LONGTERM|DISEASE|DT|DICTIONARY	recessive degenerative eye disease	recessive degenerative eye disease	56#90		Bietti's crystalline corneoretinal dystrophy (BCD) is a recessive degenerative eye disease caused by germline mutations in the CYP4V2 gene.
22772592	2012	Mol. Pharmacol.	1521-0111	TITLE	0	0	285440	SYMBOL|DICTIONARY	cyp4v2	CYP4V2	0#6		C535440	LONGTERM|DISEASE|DT|DICTIONARY	bietti crystalline dystrophy	Bietti's crystalline dystrophy	10#40		CYP4V2 in Bietti's crystalline dystrophy: ocular localization, metabolism of -3-polyunsaturated fatty acids, and functional deficit of the p.H331P variant.
22772592	2012	Mol. Pharmacol.	1521-0111	ALL_TEXT_1/3	1	3	285440	SYMBOL|DICTIONARY	cyp4v2	CYP4V2	192#198		C535440	SYMBOL|DICTIONARY|EXTRACTED	bcd	BCD	212#215	22772592-1-0-44	In the present study, we analyzed the expression of CYP4 family members in human tissues and conducted functional studies with the wild-type and p.H331P enzymes, to elucidate the link between CYP4V2 activity and BCD.
16094257	2005	Psychiatr. Genet.	0955-8829	CONCLUSIONS	4	7	57132	LONGTERM|DICTIONARY	chmp1.5	CHMP1.5	17#24	NaN	D001714	LONGTERM|DISEASE|DT|DICTIONARY	bipolar disorder	bipolar disorder	68#84		Variation in the CHMP1.5 gene does not appear to be associated with bipolar disorder.
19147210	2009	Gynecol. Oncol.	1095-6859	CONCLUSIONS	4	8	2492	SYMBOL|DICTIONARY	fshr	FSHR	25#29		D010051	LONGTERM|DISEASE|DT|DICTIONARY	epithelial ovarian cancer	epithelial ovarian cancer	75#100		We could not confirm the FSHR Ala307-Ser680 haplotype as a risk factor for epithelial ovarian cancer in Caucasian women.
11069835	2000	Am. J. Respir. Crit. Care Med.	1073-449X	ALL_TEXT_1/3	1	2	1080	SYMBOL|GENE|GN|DICTIONARY	cftr	CFTR	65#69		D008171	LONGTERM|DISEASE|DT|DICTIONARY	lung disease	lung disease	99#111		The 5T allele in intron 8 (IVS8) causes abnormal splicing in the CFTR gene, and is associated with lung disease when it occurs in cis with a missense mutation in the CFTR gene, R117H.
11069835	2000	Am. J. Respir. Crit. Care Med.	1073-449X	ALL_TEXT_1/3	1	2	1080	SYMBOL|GENE|GN|DICTIONARY	cftr	CFTR	65#69		D003550	LONGTERM|DICTIONARY	cftr	CFTR	65#69	NaN	The 5T allele in intron 8 (IVS8) causes abnormal splicing in the CFTR gene, and is associated with lung disease when it occurs in cis with a missense mutation in the CFTR gene, R117H.
11069835	2000	Am. J. Respir. Crit. Care Med.	1073-449X	ALL_TEXT_1/3	1	2	1080	SYMBOL|GENE|GN|DICTIONARY	cftr	CFTR	65#69		D003550	LONGTERM|DICTIONARY	cftr	CFTR	166#170	NaN	The 5T allele in intron 8 (IVS8) causes abnormal splicing in the CFTR gene, and is associated with lung disease when it occurs in cis with a missense mutation in the CFTR gene, R117H.
11069835	2000	Am. J. Respir. Crit. Care Med.	1073-449X	ALL_TEXT_1/3	1	2	1080	SYMBOL|GENE|GN|DICTIONARY	cftr	CFTR	166#170		D008171	LONGTERM|DISEASE|DT|DICTIONARY	lung disease	lung disease	99#111		The 5T allele in intron 8 (IVS8) causes abnormal splicing in the CFTR gene, and is associated with lung disease when it occurs in cis with a missense mutation in the CFTR gene, R117H.
11069835	2000	Am. J. Respir. Crit. Care Med.	1073-449X	ALL_TEXT_1/3	1	2	1080	SYMBOL|GENE|GN|DICTIONARY	cftr	CFTR	166#170		D003550	LONGTERM|DICTIONARY	cftr	CFTR	65#69	NaN	The 5T allele in intron 8 (IVS8) causes abnormal splicing in the CFTR gene, and is associated with lung disease when it occurs in cis with a missense mutation in the CFTR gene, R117H.
11069835	2000	Am. J. Respir. Crit. Care Med.	1073-449X	ALL_TEXT_1/3	1	2	1080	SYMBOL|GENE|GN|DICTIONARY	cftr	CFTR	166#170		D003550	LONGTERM|DICTIONARY	cftr	CFTR	166#170	NaN	The 5T allele in intron 8 (IVS8) causes abnormal splicing in the CFTR gene, and is associated with lung disease when it occurs in cis with a missense mutation in the CFTR gene, R117H.
24211273	2014	Toxicol. Appl. Pharmacol.	1096-0333	TITLE	0	0	1268	SYMBOL|GENE|GN|DICTIONARY	cb1	CB1	114#117		D064420	LONGTERM|DICTIONARY	cytotoxicity	Cytotoxicity	0#12	NaN	Cytotoxicity of synthetic cannabinoids on primary neuronal cells of the forebrain: the involvement of cannabinoid CB1 receptors and apoptotic cell death.
19147210	2009	Gynecol. Oncol.	1095-6859	TITLE	0	0	2492	SYMBOL|DICTIONARY	fshr	FSHR	21#25		D010051	LONGTERM|DISEASE|DT|DICTIONARY	ovarian cancer	ovarian cancer	43#57		The haplotype of two FSHR polymorphisms in ovarian cancer--a potential role of ethnology in risk modification.
12000493	2002	Pediatr Allergy Immunol	0905-6157	ALL_TEXT_3/3	3	13	6915	SYMBOL|GENE|GN|DICTIONARY	tbxa2r	TBXA2R	64#70		C565292	LONGTERM|DICTIONARY	atopic asthma	atopic asthma	159#172		In conclusion, our results suggest that the T924C marker in the TBXA2R gene is associated, in Chinese children, with an increased susceptibility of developing atopic asthma.
12000493	2002	Pediatr Allergy Immunol	0905-6157	ALL_TEXT_3/3	3	11	6915	SYMBOL|DICTIONARY	tbxa2r	TBXA2R	34#40		D013224	LONGTERM|DISEASE|DN|DICTIONARY	asthmatic	asthmatic	10#19		Among our asthmatic patients, the TBXA2R T924C polymorphism correlated with the concentration of cat-specific IgE in serum (p = 0.046).
11069835	2000	Am. J. Respir. Crit. Care Med.	1073-449X	TITLE	0	0	1080	SYMBOL|GENE|GN|DICTIONARY	cftr	CFTR	55#59		D008171	LONGTERM|DISEASE|DT|DICTIONARY	lung disease	Lung disease	0#12		Lung disease associated with the IVS8 5T allele of the CFTR gene.
11069835	2000	Am. J. Respir. Crit. Care Med.	1073-449X	TITLE	0	0	1080	SYMBOL|GENE|GN|DICTIONARY	cftr	CFTR	55#59		D003550	LONGTERM|DICTIONARY	cftr	CFTR	55#59	NaN	Lung disease associated with the IVS8 5T allele of the CFTR gene.
24211273	2014	Toxicol. Appl. Pharmacol.	1096-0333	ALL_TEXT_3/3	3	9	1268	SYMBOL|GENE|GN|DICTIONARY	cb1	CB1	119#122		D064420	LONGTERM|DICTIONARY	cytotoxicity	cytotoxicity	30#42	NaN	Our results indicate that the cytotoxicity of synthetic cannabinoids towards primary neuronal cells is mediated by the CB1 receptor, but not by the CB2 receptor, and further suggest that caspase cascades may play an important role in the apoptosis induced by these synthetic cannabinoids.
24211273	2014	Toxicol. Appl. Pharmacol.	1096-0333	ALL_TEXT_3/3	3	9	1269	SYMBOL|GENE|GN|DICTIONARY	cb2	CB2	148#151		D064420	LONGTERM|DICTIONARY	cytotoxicity	cytotoxicity	30#42	NaN	Our results indicate that the cytotoxicity of synthetic cannabinoids towards primary neuronal cells is mediated by the CB1 receptor, but not by the CB2 receptor, and further suggest that caspase cascades may play an important role in the apoptosis induced by these synthetic cannabinoids.
11069835	2000	Am. J. Respir. Crit. Care Med.	1073-449X	ALL_TEXT_1/3	1	1	1080	SYMBOL|()|GENE|GN|DICTIONARY	cftr	CFTR	87#91		D003550	LONGTERM|DICTIONARY	cystic fibrosis	Cystic fibrosis	0#15		Cystic fibrosis is caused by mutations in the cystic fibrosis transmembrane regulator (CFTR) gene.
11069835	2000	Am. J. Respir. Crit. Care Med.	1073-449X	ALL_TEXT_1/3	1	1	1080	SYMBOL|()|GENE|GN|DICTIONARY	cftr	CFTR	87#91		D003550	LONGTERM|DICTIONARY	cystic fibrosis transmembrane regulator	cystic fibrosis transmembrane regulator	46#85		Cystic fibrosis is caused by mutations in the cystic fibrosis transmembrane regulator (CFTR) gene.
21844576	2012	Ann. Clin. Lab. Sci.	1550-8080	TITLE	0	0	593	SYMBOL|GENE|GN|DICTIONARY	bckdha	BCKDHA	82#88		D008375	LONGTERM|DISEASE|DT|DICTIONARY	maple syrup urine disease	maple syrup urine disease	27#52		Three Korean patients with maple syrup urine disease: four novel mutations in the BCKDHA gene.
15142050	2004	Clin Transplant	0902-0063	DISCUSSION	4	17	348	LONGTERM|DICTIONARY	apo e4	apo E4	21#27	NaN	D050197	LONGTERM|DICTIONARY	atherosclerosis	atherosclerosis	98#113		The ultimate role of apo E4 gene polymorphism as a risk factor for development and progression of atherosclerosis in RTRs should be sought in further studies.
17846284	2007	Circulation	1524-4539	BACKGROUND	1	1	183	LONGTERM|DICTIONARY	angiotensinogen	Angiotensinogen	0#15		D002318	LONGTERM|DICTIONARY	cardiovascular hemostasis	cardiovascular hemostasis	91#116	NaN	Angiotensinogen, a key protein in the renin-angiotensin system, plays an important role in cardiovascular hemostasis.
17846284	2007	Circulation	1524-4539	BACKGROUND	1	1	5972	LONGTERM|DICTIONARY	renin	renin	38#43		D002318	LONGTERM|DICTIONARY	cardiovascular hemostasis	cardiovascular hemostasis	91#116	NaN	Angiotensinogen, a key protein in the renin-angiotensin system, plays an important role in cardiovascular hemostasis.
17846284	2007	Circulation	1524-4539	TITLE	0	0	183	LONGTERM|GENE|GN|DICTIONARY	angiotensinogen	angiotensinogen	41#56		D003327	LONGTERM|DISEASE|DT|DICTIONARY	coronary heart disease	coronary heart disease	91#113		Quantitative assessment of the effect of angiotensinogen gene polymorphisms on the risk of coronary heart disease.
17846284	2007	Circulation	1524-4539	METHODS AND RESULTS	2	3	183	LONGTERM|DICTIONARY	angiotensinogen	angiotensinogen	61#76		D003327	SYMBOL|DICTIONARY|EXTRACTED	chd	CHD	121#124	17846284-2-105-127	We performed a meta-analysis of 43 associations studies on 2 angiotensinogen polymorphisms (M235T and T174M) and risk of CHD published before March 2007, including a total of 13,478 CHD cases and 17,024 controls.
17846284	2007	Circulation	1524-4539	METHODS AND RESULTS	2	3	183	LONGTERM|DICTIONARY	angiotensinogen	angiotensinogen	61#76		D003327	SYMBOL|DICTIONARY|EXTRACTED	chd	CHD	182#185	17846284-2-105-127	We performed a meta-analysis of 43 associations studies on 2 angiotensinogen polymorphisms (M235T and T174M) and risk of CHD published before March 2007, including a total of 13,478 CHD cases and 17,024 controls.
17846284	2007	Circulation	1524-4539	BACKGROUND	1	2	183	LONGTERM|GENE|GN|DICTIONARY	angiotensinogen	angiotensinogen	72#87		D003327	LONGTERM|DISEASE|DT|DICTIONARY	coronary heart disease	coronary heart disease	105#127		Many studies have examined the association between polymorphisms in the angiotensinogen gene and risk of coronary heart disease (CHD), but the results have been inconsistent.
17846284	2007	Circulation	1524-4539	BACKGROUND	1	2	183	LONGTERM|GENE|GN|DICTIONARY	angiotensinogen	angiotensinogen	72#87		D003327	SYMBOL|()|DICTIONARY|EXTRACTED	chd	CHD	129#132	17846284-2-105-127	Many studies have examined the association between polymorphisms in the angiotensinogen gene and risk of coronary heart disease (CHD), but the results have been inconsistent.
19523860	2011	Urol. Oncol.	1873-2496	ALL_TEXT_3/3	3	5	7157	LONGTERM|DICTIONARY	tp53	TP53	13#17	NaN	D001749	LONGTERM|DISEASE|DT|DICTIONARY	bladder cancer	bladder cancer	282#296		However, the TP53Arg72Pro genotype disappeared as a susceptibility factor both in the multivariate regression analysis and in a univariate regression analysis adjusted for gender, age, and smoking, suggesting that it was connected with one of these factors in the predisposition to bladder cancer.
20485448	2010	J. Hum. Genet.	1435-232X	ALL_TEXT_1/3	1	1	4210	SYMBOL|GENE|GN|DICTIONARY	mefv	MEFV	126#130		D010505	LONGTERM|DICTIONARY	familial mediterranean fever	Familial Mediterranean fever	0#28		Familial Mediterranean fever (FMF) is an autoinflammatory disorder generally caused by recessively inherited mutations in the MEFV gene.
20485448	2010	J. Hum. Genet.	1435-232X	ALL_TEXT_1/3	1	1	4210	SYMBOL|GENE|GN|DICTIONARY	mefv	MEFV	126#130		D010505	SYMBOL|()|DICTIONARY|EXTRACTED	fmf	FMF	30#33	20485448-1-0-28	Familial Mediterranean fever (FMF) is an autoinflammatory disorder generally caused by recessively inherited mutations in the MEFV gene.
20485448	2010	J. Hum. Genet.	1435-232X	ALL_TEXT_1/3	1	1	4210	SYMBOL|GENE|GN|DICTIONARY	mefv	MEFV	126#130		D056660	LONGTERM|GENE|GN|DISEASE|DT|DICTIONARY	autoinflammatory disorder	autoinflammatory disorder	41#66		Familial Mediterranean fever (FMF) is an autoinflammatory disorder generally caused by recessively inherited mutations in the MEFV gene.
19549929	2009	Toxicol Pathol	1533-1601	ALL_TEXT_1/3	1	1	7137	LONGTERM|DICTIONARY	cardiac troponin i	Cardiac troponin I	0#18		D009202	LONGTERM|DICTIONARY	myocardial injury	myocardial injury	44#61	NaN	Cardiac troponin I is a useful biomarker of myocardial injury, but its use in mice and application to early drug discovery are not well described.
23264560	2013	Dis Model Mech	1754-8411	ALL_TEXT_3/3	3	12	4838	SYMBOL|DICTIONARY	nodal	NODAL	22#27		D016142	SYMBOL|DICTIONARY|EXTRACTED	hpe	HPE	109#112	23264560-1-0-17	The inhibitors of the NODAL and SHH pathways, even at low concentration, acted synergistically to promote an HPE-like phenotype.
23264560	2013	Dis Model Mech	1754-8411	ALL_TEXT_3/3	3	12	6469	SYMBOL|DICTIONARY	shh	SHH	32#35		D016142	SYMBOL|DICTIONARY|EXTRACTED	hpe	HPE	109#112	23264560-1-0-17	The inhibitors of the NODAL and SHH pathways, even at low concentration, acted synergistically to promote an HPE-like phenotype.
11069835	2000	Am. J. Respir. Crit. Care Med.	1073-449X	ALL_TEXT_2/3	2	5	1080	SYMBOL|GENE|GN|DICTIONARY	cftr	CFTR	120#124		D003550	LONGTERM|DICTIONARY	cftr	CFTR	120#124	NaN	One patient's genotype is 5T-TG12-M470V/5T-TG12-M470V, and the other is DeltaF508/5T-TG12-M470V; full sequencing of the CFTR gene revealed no other mutation on the same allele as the 5T variant.
19753311	2009	Mol. Vis.	1090-0535	RESULTS	3	9	1128	SYMBOL|DICTIONARY	chrm1	CHRM1	49#54		D009216	LONGTERM|DICTIONARY	high myopia	high myopia	102#113		Logistic regression test revealed S1, S2, and S4 CHRM1 as all being significant in the development of high myopia.
20724907	2010	Am. J. Med. Sci.	1538-2990	INTRODUCTION	1	1	348	LONGTERM|DICTIONARY	apolipoprotein e	apolipoprotein E	67#83		D000544	LONGTERM|DISEASE|DT|DICTIONARY	alzheimer disease	Alzheimer disease	184#201		The main objective of this study is to determine the prevalence of apolipoprotein E (Apo E) and glutathione peroxidase 1 (GPX1) polymorphisms and their influence on the development of Alzheimer disease (AD) in the Ecuadorian population.
20724907	2010	Am. J. Med. Sci.	1538-2990	INTRODUCTION	1	1	348	LONGTERM|DICTIONARY	apolipoprotein e	apolipoprotein E	67#83		D000544	SYMBOL|EXTRACTED|()	ad	AD	203#205	20724907-1-184-201	The main objective of this study is to determine the prevalence of apolipoprotein E (Apo E) and glutathione peroxidase 1 (GPX1) polymorphisms and their influence on the development of Alzheimer disease (AD) in the Ecuadorian population.
20724907	2010	Am. J. Med. Sci.	1538-2990	INTRODUCTION	1	1	2876	LONGTERM|DICTIONARY	glutathione peroxidase 1	glutathione peroxidase 1	96#120		D000544	LONGTERM|DISEASE|DT|DICTIONARY	alzheimer disease	Alzheimer disease	184#201		The main objective of this study is to determine the prevalence of apolipoprotein E (Apo E) and glutathione peroxidase 1 (GPX1) polymorphisms and their influence on the development of Alzheimer disease (AD) in the Ecuadorian population.
20724907	2010	Am. J. Med. Sci.	1538-2990	INTRODUCTION	1	1	2876	LONGTERM|DICTIONARY	glutathione peroxidase 1	glutathione peroxidase 1	96#120		D000544	SYMBOL|EXTRACTED|()	ad	AD	203#205	20724907-1-184-201	The main objective of this study is to determine the prevalence of apolipoprotein E (Apo E) and glutathione peroxidase 1 (GPX1) polymorphisms and their influence on the development of Alzheimer disease (AD) in the Ecuadorian population.
20724907	2010	Am. J. Med. Sci.	1538-2990	INTRODUCTION	1	1	2876	SYMBOL|()|DICTIONARY|EXTRACTED	gpx1	GPX1	122#126	20724907-1-96-120	D000544	LONGTERM|DISEASE|DT|DICTIONARY	alzheimer disease	Alzheimer disease	184#201		The main objective of this study is to determine the prevalence of apolipoprotein E (Apo E) and glutathione peroxidase 1 (GPX1) polymorphisms and their influence on the development of Alzheimer disease (AD) in the Ecuadorian population.
20724907	2010	Am. J. Med. Sci.	1538-2990	INTRODUCTION	1	1	2876	SYMBOL|()|DICTIONARY|EXTRACTED	gpx1	GPX1	122#126	20724907-1-96-120	D000544	SYMBOL|EXTRACTED|()	ad	AD	203#205	20724907-1-184-201	The main objective of this study is to determine the prevalence of apolipoprotein E (Apo E) and glutathione peroxidase 1 (GPX1) polymorphisms and their influence on the development of Alzheimer disease (AD) in the Ecuadorian population.
21313874	2011	Pak. J. Biol. Sci.	1028-8880	TITLE	0	0	3458	LONGTERM|DICTIONARY	interferon gamma	Interferon-gamma	0#16		D002006	LONGTERM|DICTIONARY	brucellosis	brucellosis	83#94		Interferon-gamma low producer genotype +5644 over presented in patients with focal brucellosis.
11216915	2001	J. Cancer Res. Clin. Oncol.	0171-5216	CONCLUSIONS	4	6	1588	SYMBOL|DICTIONARY	cyp19	CYP19	6#11		D016889	LONGTERM|DISEASE|DT|DICTIONARY	endometrial cancer	endometrial cancer	70#88		Thus, CYP19 polymorphism might be one of the genetic risk factors for endometrial cancer development.
11216915	2001	J. Cancer Res. Clin. Oncol.	0171-5216	TITLE	0	0	1588	SYMBOL|GENE|GN|DICTIONARY	cyp19	CYP19	0#5		D016889	LONGTERM|DISEASE|DN|DT|DICTIONARY	endometrial cancer	endometrial cancer	27#45		CYP19 gene polymorphism in endometrial cancer patients.
11216915	2001	J. Cancer Res. Clin. Oncol.	0171-5216	METHODS	2	3	1588	SYMBOL|DICTIONARY|GENE|GA	cyp19	CYP19	18#23		D016889	LONGTERM|DISEASE|DN|DT|DICTIONARY	endometrial cancer	endometrial cancer	60#78		Here, we compared CYP19 (aromatase) gene polymorphism in 85 endometrial cancer patients and in 110 non-affected women.
15809232	2005	Alcohol Alcohol.	0735-0414	AIMS	1	1	348	LONGTERM|DICTIONARY	apolipoprotein e	apolipoprotein E	32#48		D050197	LONGTERM|DICTIONARY	atherosclerosis	atherosclerosis	133#148		To investigate the influence of apolipoprotein E (APOE) and angiotensin-converting enzyme (ACE) gene polymorphisms on carotid artery atherosclerosis in alcoholism.
15809232	2005	Alcohol Alcohol.	0735-0414	AIMS	1	1	348	LONGTERM|DICTIONARY	apolipoprotein e	apolipoprotein E	32#48		D000437	LONGTERM|DICTIONARY	alcoholism	alcoholism	152#162		To investigate the influence of apolipoprotein E (APOE) and angiotensin-converting enzyme (ACE) gene polymorphisms on carotid artery atherosclerosis in alcoholism.
15809232	2005	Alcohol Alcohol.	0735-0414	AIMS	1	1	348	SYMBOL|()|DICTIONARY|EXTRACTED	apoe	APOE	50#54	15809232-1-32-48	D050197	LONGTERM|DICTIONARY	atherosclerosis	atherosclerosis	133#148		To investigate the influence of apolipoprotein E (APOE) and angiotensin-converting enzyme (ACE) gene polymorphisms on carotid artery atherosclerosis in alcoholism.
15809232	2005	Alcohol Alcohol.	0735-0414	AIMS	1	1	348	SYMBOL|()|DICTIONARY|EXTRACTED	apoe	APOE	50#54	15809232-1-32-48	D000437	LONGTERM|DICTIONARY	alcoholism	alcoholism	152#162		To investigate the influence of apolipoprotein E (APOE) and angiotensin-converting enzyme (ACE) gene polymorphisms on carotid artery atherosclerosis in alcoholism.
15809232	2005	Alcohol Alcohol.	0735-0414	AIMS	1	1	1636	SYMBOL|()|GENE|GN|DICTIONARY|EXTRACTED	ace	ACE	91#94	15809232-1-60-89	D050197	LONGTERM|DICTIONARY	atherosclerosis	atherosclerosis	133#148		To investigate the influence of apolipoprotein E (APOE) and angiotensin-converting enzyme (ACE) gene polymorphisms on carotid artery atherosclerosis in alcoholism.
15809232	2005	Alcohol Alcohol.	0735-0414	AIMS	1	1	1636	SYMBOL|()|GENE|GN|DICTIONARY|EXTRACTED	ace	ACE	91#94	15809232-1-60-89	D000437	LONGTERM|DICTIONARY	alcoholism	alcoholism	152#162		To investigate the influence of apolipoprotein E (APOE) and angiotensin-converting enzyme (ACE) gene polymorphisms on carotid artery atherosclerosis in alcoholism.
15809232	2005	Alcohol Alcohol.	0735-0414	TITLE	0	0	348	LONGTERM|DICTIONARY	apolipoprotein e	apolipoprotein E	17#33		D002340	LONGTERM|DICTIONARY	carotid atherosclerosis	carotid atherosclerosis	78#101		Polymorphisms of apolipoprotein E and angiotensin-converting enzyme genes and carotid atherosclerosis in heavy drinkers.
8837968	1996	Acta Psychiatr Scand	0001-690X	TITLE	0	0	4908	LONGTERM|DICTIONARY|GENE|GA	neurotrophin 3	neurotrophin-3	26#40		D012559	LONGTERM|DICTIONARY	schizophrenia	schizophrenia	71#84		An association study of a neurotrophin-3 (NT-3) gene polymorphism with schizophrenia.
8837968	1996	Acta Psychiatr Scand	0001-690X	TITLE	0	0	4908	SYMBOL|()|GENE|GN|DICTIONARY|EXTRACTED	nt 3	NT-3	42#46	8837968-0-26-40	D012559	LONGTERM|DICTIONARY	schizophrenia	schizophrenia	71#84		An association study of a neurotrophin-3 (NT-3) gene polymorphism with schizophrenia.
15809232	2005	Alcohol Alcohol.	0735-0414	RESULTS	3	5	348	SYMBOL|DICTIONARY	apo e	APO E	22#27		D050197	LONGTERM|DICTIONARY	atherosclerotic	atherosclerotic	72#87	NaN	Subjects carrying the APO E epsilon4 allele were more liable to develop atherosclerotic changes in carotid arteries compared with subjects with the epsilon3/3 genotype, which showed statistical significance in patients under 50 years of age.
15809232	2005	Alcohol Alcohol.	0735-0414	CONCLUSIONS	4	7	348	SYMBOL|DICTIONARY	apo e	APO E	0#5		D002340	LONGTERM|DICTIONARY	carotid atherosclerosis	carotid atherosclerosis	44#67		APO E polymorphism can increase the risk of carotid atherosclerosis development in an alcoholic subject.
15738346	2005	Hypertension	1524-4563	ALL_TEXT_1/3	1	3	10891	SYMBOL|DICTIONARY	pgc 1alpha	PGC-1alpha	37#47		D006973	LONGTERM|DICTIONARY	hypertension	hypertension	95#107		The common Gly482Ser polymorphism of PGC-1alpha has previously shown association with arterial hypertension among Austrian men.
19773262	2010	Haematologica	1592-8721	CONCLUSIONS	4	14	6125	SYMBOL|DICTIONARY	rpl5	RPL5	74#78		D029503	LONGTERM|DICTIONARY	diamond blackfan anemia	Diamond-Blackfan anemia	106#129		Genotype-phenotype data suggest that mutation screening should begin with RPL5 and RPL11 in patients with Diamond-Blackfan anemia with malformations.
19773262	2010	Haematologica	1592-8721	CONCLUSIONS	4	14	6125	SYMBOL|DICTIONARY	rpl5	RPL5	74#78		D000014	LONGTERM|DICTIONARY	malformations	malformations	135#148		Genotype-phenotype data suggest that mutation screening should begin with RPL5 and RPL11 in patients with Diamond-Blackfan anemia with malformations.
19773262	2010	Haematologica	1592-8721	CONCLUSIONS	4	14	6135	SYMBOL|DICTIONARY	rpl11	RPL11	83#88		D029503	LONGTERM|DICTIONARY	diamond blackfan anemia	Diamond-Blackfan anemia	106#129		Genotype-phenotype data suggest that mutation screening should begin with RPL5 and RPL11 in patients with Diamond-Blackfan anemia with malformations.
19773262	2010	Haematologica	1592-8721	CONCLUSIONS	4	14	6135	SYMBOL|DICTIONARY	rpl11	RPL11	83#88		D000014	LONGTERM|DICTIONARY	malformations	malformations	135#148		Genotype-phenotype data suggest that mutation screening should begin with RPL5 and RPL11 in patients with Diamond-Blackfan anemia with malformations.
9886312	1999	Br. J. Haematol.	0007-1048	ALL_TEXT_3/3	3	5	2815	SYMBOL|DICTIONARY	gpix	GPIX	218#222		D001791	LONGTERM|DICTIONARY	platelet agglutination	platelet agglutination	158#180	NaN	Infusion of 1-desamino-8-D-arginine vasopressin normalized bleeding time in the two severely affected patients, although it did not modify ristocetin-induced platelet agglutination or membrane expression of GPIbalpha, GPIX, GPIIb-IIIa and GMP-140.
9886312	1999	Br. J. Haematol.	0007-1048	ALL_TEXT_3/3	3	5	2815	SYMBOL|DICTIONARY	gpix	GPIX	218#222		D006470	LONGTERM|DICTIONARY	bleeding	bleeding	59#67	NaN	Infusion of 1-desamino-8-D-arginine vasopressin normalized bleeding time in the two severely affected patients, although it did not modify ristocetin-induced platelet agglutination or membrane expression of GPIbalpha, GPIX, GPIIb-IIIa and GMP-140.
9886312	1999	Br. J. Haematol.	0007-1048	ALL_TEXT_3/3	3	5	6403	SYMBOL|DICTIONARY	gmp 140	GMP-140	239#246		D001791	LONGTERM|DICTIONARY	platelet agglutination	platelet agglutination	158#180	NaN	Infusion of 1-desamino-8-D-arginine vasopressin normalized bleeding time in the two severely affected patients, although it did not modify ristocetin-induced platelet agglutination or membrane expression of GPIbalpha, GPIX, GPIIb-IIIa and GMP-140.
9886312	1999	Br. J. Haematol.	0007-1048	ALL_TEXT_3/3	3	5	6403	SYMBOL|DICTIONARY	gmp 140	GMP-140	239#246		D006470	LONGTERM|DICTIONARY	bleeding	bleeding	59#67	NaN	Infusion of 1-desamino-8-D-arginine vasopressin normalized bleeding time in the two severely affected patients, although it did not modify ristocetin-induced platelet agglutination or membrane expression of GPIbalpha, GPIX, GPIIb-IIIa and GMP-140.
9886312	1999	Br. J. Haematol.	0007-1048	ALL_TEXT_3/3	3	5	2811	LONGTERM|DICTIONARY	gpibalpha	GPIbalpha	207#216	NaN	D001791	LONGTERM|DICTIONARY	platelet agglutination	platelet agglutination	158#180	NaN	Infusion of 1-desamino-8-D-arginine vasopressin normalized bleeding time in the two severely affected patients, although it did not modify ristocetin-induced platelet agglutination or membrane expression of GPIbalpha, GPIX, GPIIb-IIIa and GMP-140.
9886312	1999	Br. J. Haematol.	0007-1048	ALL_TEXT_3/3	3	5	2811	LONGTERM|DICTIONARY	gpibalpha	GPIbalpha	207#216	NaN	D006470	LONGTERM|DICTIONARY	bleeding	bleeding	59#67	NaN	Infusion of 1-desamino-8-D-arginine vasopressin normalized bleeding time in the two severely affected patients, although it did not modify ristocetin-induced platelet agglutination or membrane expression of GPIbalpha, GPIX, GPIIb-IIIa and GMP-140.
11069835	2000	Am. J. Respir. Crit. Care Med.	1073-449X	ALL_TEXT_3/3	3	9	1080	SYMBOL|GENE|GN|DICTIONARY	cftr	CFTR	159#163		D008171	LONGTERM|DISEASE|DT|DICTIONARY	cf-like lung disease	CF-like lung disease	176#196		These data suggest that the 5T polythymidine tract sequence on specific haplotype backgrounds (TG12 and M470V) may cause a low level of full-length functional CFTR protein and CF-like lung disease.
11069835	2000	Am. J. Respir. Crit. Care Med.	1073-449X	ALL_TEXT_3/3	3	9	1080	SYMBOL|GENE|GN|DICTIONARY	cftr	CFTR	159#163		D003550	LONGTERM|DICTIONARY	cftr	CFTR	159#163	NaN	These data suggest that the 5T polythymidine tract sequence on specific haplotype backgrounds (TG12 and M470V) may cause a low level of full-length functional CFTR protein and CF-like lung disease.
9886312	1999	Br. J. Haematol.	0007-1048	ALL_TEXT_1/3	1	2	2811	LONGTERM|DICTIONARY	gpibalpha	GPIbalpha	28#37	NaN	D001791	LONGTERM|DICTIONARY	platelet agglutination	platelet agglutination	75#97	NaN	Despite surface expression, GPIbalpha failed to support ristocetin-induced platelet agglutination and to bind two conformation-dependent monoclonal antibodies, suggesting a qualitative defect.
9886312	1999	Br. J. Haematol.	0007-1048	ALL_TEXT_1/3	1	1	2815	SYMBOL|DICTIONARY	gpix	GPIX	122#126		D001606	LONGTERM|DISEASE|DT|DICTIONARY	bernard soulier syndrome	Bernard-Soulier syndrome	29#53		We describe a new variant of Bernard-Soulier syndrome characterized by almost normal amounts of GPIb and severely reduced GPIX and GPV.
19190165	2009	Cancer Epidemiol. Biomarkers Prev.	1055-9965	ALL_TEXT_3/3	3	7	10111	SYMBOL|DICTIONARY	rad50	Rad50	69#74		D001943	LONGTERM|DISEASE|DT|DICTIONARY	breast cancer	breast cancer	89#102		These data together suggest that although founder mutations may make Rad50 a significant breast cancer risk factor in certain populations, it is not a factor in others.
18548239	2008	Eur. J. Clin. Pharmacol.	1432-1041	CONCLUSIONS	4	13	3458	SYMBOL|GENE|GN|DICTIONARY	ifn gamma	IFN-gamma	26#35		D014581	LONGTERM|DICTIONARY	urticaria	urticaria	64#73		The allele 18CA repeat in IFN-gamma gene may be associated with urticaria.
18548239	2008	Eur. J. Clin. Pharmacol.	1432-1041	CONCLUSIONS	4	12	3459	SYMBOL|EXTRACTED|GENE|GN	ifnr1	IFNR1	22#27	18548239-2-71-91	D004342	LONGTERM|DICTIONARY	allergic	allergic	82#90	NaN	The Met/Val allele in IFNR1 gene may have a protective role in the non-penicillin allergic population.
15255109	2004	Ophthalmic Genet.	1381-6810	PURPOSE	1	1	1545	SYMBOL|()|DICTIONARY	cyp1b1	CYP1B1	45#51		C565547	LONGTERM|DICTIONARY	congenital glaucoma	congenital glaucoma	82#101		To determine the role of cytochrome P450IBI (CYP1B1) mutations in causing primary congenital glaucoma (PCG) in a cohort of Native Americans from Quito, Ecuador.
15699697	2005	J. Pediatr. Gastroenterol. Nutr.	0277-2116	CONCLUSION	4	11	1080	SYMBOL|DICTIONARY	cftr	CFTR	34#38		D010188	LONGTERM|DICTIONARY	pancreatic insufficiency	pancreatic insufficiency	50#74		In patients carrying class 1 or 2 CFTR mutations, pancreatic insufficiency develops in the first months of life.
17116328	2007	Placenta	0143-4004	OBJECTIVE	1	2	183	LONGTERM|DICTIONARY	angiotensinogen	angiotensinogen	37#52		D011225	LONGTERM|DICTIONARY	preeclampsia	preeclampsia	181#193	NaN	Previous studies have shown that the angiotensinogen (AGT) Thr235 mutation is associated with abnormal remodeling of the uterine spiral arteries and occurs at higher frequencies in preeclampsia.
17116328	2007	Placenta	0143-4004	OBJECTIVE	1	2	183	SYMBOL|()|DICTIONARY|EXTRACTED	agt	AGT	54#57	17116328-2-37-52	D011225	LONGTERM|DICTIONARY	preeclampsia	preeclampsia	181#193	NaN	Previous studies have shown that the angiotensinogen (AGT) Thr235 mutation is associated with abnormal remodeling of the uterine spiral arteries and occurs at higher frequencies in preeclampsia.
18162506	2008	Diabetes	1939-327X	CONCLUSIONS	4	12	3630	LONGTERM|DICTIONARY	insulin	Insulin	0#7	NaN	D003920	LONGTERM|DICTIONARY	diabetic	diabetic	55#63	NaN	Insulin gene mutation screening is recommended for all diabetic patients diagnosed before 1 year of age.
20977478	2011	J. Neurochem.	1471-4159	ALL_TEXT_3/3	3	12	6470	SYMBOL|DICTIONARY|EXTRACTED	shmt1	Shmt1	27#32		D012559	LONGTERM|DICTIONARY	schizophrenia	schizophrenia	149#162		These results suggest that Shmt1 (SHMT1), but not Srr, is likely to be one of the genetic components regulating PPI in mice and possibly relevant to schizophrenia.
20977478	2011	J. Neurochem.	1471-4159	ALL_TEXT_3/3	3	12	6470	SYMBOL|()|DICTIONARY|EXTRACTED	shmt1	SHMT1	34#39	20977478-0-70-75	D012559	LONGTERM|DICTIONARY	schizophrenia	schizophrenia	149#162		These results suggest that Shmt1 (SHMT1), but not Srr, is likely to be one of the genetic components regulating PPI in mice and possibly relevant to schizophrenia.
11044587	2000	Neurosci. Lett.	0304-3940	ALL_TEXT_1/3	1	1	6532	SYMBOL|()|DICTIONARY	5 htt	5-HTT	110#115		D000544	LONGTERM|DISEASE|DT|DICTIONARY	alzheimers disease	Alzheimers's disease	176#196		The role of the deletion/insertion polymorphism within the promoter region of the serotonin transporter gene (5-HTT) is under discussion as a potential genetic risk factor for Alzheimers's disease (AD).
11044587	2000	Neurosci. Lett.	0304-3940	ALL_TEXT_1/3	1	1	6532	SYMBOL|()|DICTIONARY	5 htt	5-HTT	110#115		D000544	SYMBOL|EXTRACTED|()	ad	AD	198#200	11044587-1-176-196	The role of the deletion/insertion polymorphism within the promoter region of the serotonin transporter gene (5-HTT) is under discussion as a potential genetic risk factor for Alzheimers's disease (AD).
19070929	2009	J. Hepatol.	0168-8278	RESULTS	3	8	1116	SYMBOL|DICTIONARY	ykl 40	YKL-40	71#77		D007239	LONGTERM|DICTIONARY	hcv infected	HCV infected	81#93	NaN	Functionally, the G allele was associated with reduced serum levels of YKL-40 in HCV infected patients (P=0.002).
19070929	2009	J. Hepatol.	0168-8278	CONCLUSIONS	4	9	1116	SYMBOL|GENE|GN|DICTIONARY	chi3l1	CHI3L1	4#10		D008103	LONGTERM|DICTIONARY	liver fibrosis	liver fibrosis	125#139		The CHI3L1 promoter polymorphism -131G-->C determines YKL-40 serum levels and is associated with the severity of HCV-induced liver fibrosis.
19070929	2009	J. Hepatol.	0168-8278	CONCLUSIONS	4	9	1116	SYMBOL|DICTIONARY	ykl 40	YKL-40	54#60		D008103	LONGTERM|DICTIONARY	liver fibrosis	liver fibrosis	125#139		The CHI3L1 promoter polymorphism -131G-->C determines YKL-40 serum levels and is associated with the severity of HCV-induced liver fibrosis.
19070929	2009	J. Hepatol.	0168-8278	METHODS	2	4	1116	SYMBOL|DICTIONARY	ykl 40	YKL-40	33#39		D005355	LONGTERM|DICTIONARY	fibrosis	fibrosis	13#21	NaN	Histological fibrosis scores and YKL-40 serum levels (ELISA) were associated with CHI3L1 -131G-->C by quantitative and qualitative genetic analyses and corrected by multivariate analysis.
19070929	2009	J. Hepatol.	0168-8278	METHODS	2	4	1116	SYMBOL|DICTIONARY	chi3l1	CHI3L1	82#88		D005355	LONGTERM|DICTIONARY	fibrosis	fibrosis	13#21	NaN	Histological fibrosis scores and YKL-40 serum levels (ELISA) were associated with CHI3L1 -131G-->C by quantitative and qualitative genetic analyses and corrected by multivariate analysis.
19070929	2009	J. Hepatol.	0168-8278	RESULTS	3	5	1116	SYMBOL|DICTIONARY	chi3l1	CHI3L1	0#6		D008103	LONGTERM|DICTIONARY	liver fibrosis	liver fibrosis	68#82		CHI3L1 -131G-->C genotype was strongly associated with the stage of liver fibrosis in the screening (n=265, P=0.001) and validation cohort (n=175, P=0.009).
19070929	2009	J. Hepatol.	0168-8278	BACKGROUND/AIMS	1	2	1116	SYMBOL|DICTIONARY	chi3l1	CHI3L1	58#64		D008103	LONGTERM|DICTIONARY	liver fibrosis	liver fibrosis	114#128		We assessed whether a functional promoter polymorphism in CHI3L1, encoding YKL-40, is associated with HCV-induced liver fibrosis and influences YKL-40 serum concentrations.
19070929	2009	J. Hepatol.	0168-8278	BACKGROUND/AIMS	1	2	1116	SYMBOL|DICTIONARY	ykl 40	YKL-40	75#81		D008103	LONGTERM|DICTIONARY	liver fibrosis	liver fibrosis	114#128		We assessed whether a functional promoter polymorphism in CHI3L1, encoding YKL-40, is associated with HCV-induced liver fibrosis and influences YKL-40 serum concentrations.
19070929	2009	J. Hepatol.	0168-8278	BACKGROUND/AIMS	1	2	1116	SYMBOL|DICTIONARY	ykl 40	YKL-40	144#150		D008103	LONGTERM|DICTIONARY	liver fibrosis	liver fibrosis	114#128		We assessed whether a functional promoter polymorphism in CHI3L1, encoding YKL-40, is associated with HCV-induced liver fibrosis and influences YKL-40 serum concentrations.
19070929	2009	J. Hepatol.	0168-8278	METHODS	2	3	1116	SYMBOL|DICTIONARY	chi3l1	CHI3L1	4#10		D007239	LONGTERM|DICTIONARY	hcv infected	HCV infected	75#87	NaN	The CHI3L1 -131G-->C promoter polymorphism was genotyped in two cohorts of HCV infected patients (n=440) by 5'-endonuclease assays.
19070929	2009	J. Hepatol.	0168-8278	TITLE	0	0	1116	SYMBOL|DICTIONARY	chi3l1	CHI3L1	26#32		D008103	LONGTERM|DICTIONARY	liver fibrosis	liver fibrosis	64#78		A functional variation in CHI3L1 is associated with severity of liver fibrosis and YKL-40 serum levels in chronic hepatitis C infection.
19070929	2009	J. Hepatol.	0168-8278	TITLE	0	0	1116	SYMBOL|DICTIONARY	chi3l1	CHI3L1	26#32		D019698	LONGTERM|DISEASE|DN|DICTIONARY	chronic hepatitis c infection	chronic hepatitis C infection	106#135		A functional variation in CHI3L1 is associated with severity of liver fibrosis and YKL-40 serum levels in chronic hepatitis C infection.
19070929	2009	J. Hepatol.	0168-8278	TITLE	0	0	1116	SYMBOL|DICTIONARY	ykl 40	YKL-40	83#89		D008103	LONGTERM|DICTIONARY	liver fibrosis	liver fibrosis	64#78		A functional variation in CHI3L1 is associated with severity of liver fibrosis and YKL-40 serum levels in chronic hepatitis C infection.
19070929	2009	J. Hepatol.	0168-8278	TITLE	0	0	1116	SYMBOL|DICTIONARY	ykl 40	YKL-40	83#89		D019698	LONGTERM|DISEASE|DN|DICTIONARY	chronic hepatitis c infection	chronic hepatitis C infection	106#135		A functional variation in CHI3L1 is associated with severity of liver fibrosis and YKL-40 serum levels in chronic hepatitis C infection.
19070929	2009	J. Hepatol.	0168-8278	BACKGROUND/AIMS	1	1	1116	SYMBOL|DICTIONARY	ykl 40	YKL-40	0#6		D005355	LONGTERM|DICTIONARY	fibrosis	fibrosis	85#93	NaN	YKL-40 is a chitinase-like protein involved in matrix remodelling and a non-invasive fibrosis marker.
18272905	2008	N. Engl. J. Med.	1533-4406	TITLE	0	0	3575	SYMBOL|DICTIONARY	il7ra	IL7RA	0#5		D009103	LONGTERM|DICTIONARY	multiple sclerosis	multiple sclerosis	42#60		IL7RA polymorphisms and susceptibility to multiple sclerosis.
12000493	2002	Pediatr Allergy Immunol	0905-6157	ALL_TEXT_1/3	1	2	6915	SYMBOL|GENE|GN|DICTIONARY	tbxa2r	TBXA2R	30#36		D001249	LONGTERM|DICTIONARY	asthma	asthma	83#89		The T924C polymorphism in the TBXA2R gene was recently found to be associated with asthma in Japanese adults but not in children.
16352452	2006	Mol. Genet. Metab.	1096-7192	ALL_TEXT_3/3	3	7	3073	LONGTERM|DICTIONARY	hexa	HexA	166#170	NaN	D013661	SYMBOL|DICTIONARY|EXTRACTED	tsd	TSD	130#133	16352452-1-13-30	Given the high frequency of the [delTG (+) 619A>G] haplotype in the Ashkenazi Jewish population (approximately 10%), up to 10% of TSD carriers may have normal serum %HexA values with low total Hex.
16352452	2006	Mol. Genet. Metab.	1096-7192	ALL_TEXT_3/3	3	7	3074	LONGTERM|DICTIONARY	hex	Hex	193#196	NaN	D013661	SYMBOL|DICTIONARY|EXTRACTED	tsd	TSD	130#133	16352452-1-13-30	Given the high frequency of the [delTG (+) 619A>G] haplotype in the Ashkenazi Jewish population (approximately 10%), up to 10% of TSD carriers may have normal serum %HexA values with low total Hex.
19021638	2009	Clin. Genet.	1399-0004	ALL_TEXT_3/3	3	9	55636	SYMBOL|DICTIONARY	chd7	CHD7	126#130		C563261	LONGTERM|DICTIONARY	aplasia	aplasia	90#97		If such features are present, particularly deafness, dysmorphic ears and/or hypoplasia or aplasia of the semicircular canals, CHD7 sequencing is recommended.
19021638	2009	Clin. Genet.	1399-0004	ALL_TEXT_3/3	3	9	55636	SYMBOL|DICTIONARY	chd7	CHD7	126#130		D003638	LONGTERM|DICTIONARY	deafness	deafness	43#51	NaN	If such features are present, particularly deafness, dysmorphic ears and/or hypoplasia or aplasia of the semicircular canals, CHD7 sequencing is recommended.
19021638	2009	Clin. Genet.	1399-0004	ALL_TEXT_3/3	3	9	55636	SYMBOL|DICTIONARY	chd7	CHD7	126#130		D004426	LONGTERM|DICTIONARY	dysmorphic ears and/or hypoplasia	dysmorphic ears and/or hypoplasia	53#86	NaN	If such features are present, particularly deafness, dysmorphic ears and/or hypoplasia or aplasia of the semicircular canals, CHD7 sequencing is recommended.
10702401	2000	Am. J. Pathol.	0002-9440	ALL_TEXT_2/3	2	4	3480	SYMBOL|EXTRACTED|()	igf-1r)	IGF-1R)	258#265	10702401-4-228-256	D009369	LONGTERM|DISEASE|DT|CLINE|CN|DICTIONARY	tumor	tumor	116#121		We sought to determine whether the observed covariation of structure, function, and clinical course correlates with tumor cell kinetic parameters such as proliferative rate and apoptosis, and with expression of the receptor for insulin-like growth factor I (IGF-1R).
12140136	2003	Lung Cancer	0169-5002	TITLE	0	0	2948	SYMBOL|GENE|GN|DICTIONARY	gstm4	GSTM4	29#34		D008175	LONGTERM|DISEASE|DT|DICTIONARY	lung cancer	lung cancer	78#89		A T2517C polymorphism in the GSTM4 gene is associated with risk of developing lung cancer.
12140136	2003	Lung Cancer	0169-5002	ALL_TEXT_1/3	1	2	2944	SYMBOL|DICTIONARY	gstm1	GSTM1	65#70		D009369	LONGTERM|DISEASE|DT|DICTIONARY	cancer	cancer	89#95		While there are many contradicting reports on the association of GSTM1 polymorphisms and cancer development, no studies exist to date describing polymorphisms in GSTM4.
12140136	2003	Lung Cancer	0169-5002	ALL_TEXT_1/3	1	2	2948	SYMBOL|DICTIONARY	gstm4	GSTM4	162#167		D009369	LONGTERM|DISEASE|DT|DICTIONARY	cancer	cancer	89#95		While there are many contradicting reports on the association of GSTM1 polymorphisms and cancer development, no studies exist to date describing polymorphisms in GSTM4.
19021638	2009	Clin. Genet.	1399-0004	TITLE	0	0	55636	SYMBOL|DICTIONARY	chd7	CHD7	0#4		D017436	LONGTERM|DISEASE|DT|DICTIONARY	kallmann syndrome	Kallmann syndrome	52#69		CHD7 mutations in patients initially diagnosed with Kallmann syndrome--the clinical overlap with CHARGE syndrome.
19021638	2009	Clin. Genet.	1399-0004	TITLE	0	0	55636	SYMBOL|DICTIONARY	chd7	CHD7	0#4		D058747	LONGTERM|DISEASE|DT|DICTIONARY	charge syndrome	CHARGE syndrome	97#112		CHD7 mutations in patients initially diagnosed with Kallmann syndrome--the clinical overlap with CHARGE syndrome.
19021638	2009	Clin. Genet.	1399-0004	ALL_TEXT_1/3	1	2	55636	SYMBOL|GENE|GN|DICTIONARY	chd7	CHD7	46#50		D058747	LONGTERM|DISEASE|DT|DICTIONARY	charge syndrome	CHARGE syndrome	0#15		CHARGE syndrome is caused by mutations in the CHD7 gene.
19021638	2009	Clin. Genet.	1399-0004	ALL_TEXT_2/3	2	5	55636	SYMBOL|DICTIONARY	chd7	CHD7	27#31		D058747	LONGTERM|DISEASE|DT|DICTIONARY	charge syndrome	CHARGE syndrome	94#109		In retrospect, these three CHD7-positive patients showed additional features that are seen in CHARGE syndrome.
19021638	2009	Clin. Genet.	1399-0004	ALL_TEXT_2/3	2	4	55636	SYMBOL|DICTIONARY	chd7	CHD7	54#58		D017436	SYMBOL|EXTRACTED	ks	KS	12#14	19021638-1-0-17	Three of 56 KS/nIHH patients had de novo mutations in CHD7.
19021638	2009	Clin. Genet.	1399-0004	ALL_TEXT_2/3	2	6	55636	SYMBOL|DICTIONARY	chd7	CHD7	0#4		D058747	LONGTERM|DISEASE|DN|DT|DICTIONARY	charge syndrome	CHARGE syndrome	95#110		CHD7 mutations can be present in KS patients who have additional features that are part of the CHARGE syndrome phenotype.
24997986	2015	Nat. Genet.	1546-1718	ALL_TEXT_3/3	3	7	1956	LONGTERM|DICTIONARY	erbb	ErbB	110#114	NaN	D005706	SYMBOL|EXTRACTED	gbc	GBC	72#75	24997986-1-17-38	These findings provide insight into the somatic mutational landscape in GBC and highlight the key role of the ErbB signaling pathway in GBC pathogenesis.
24997986	2015	Nat. Genet.	1546-1718	ALL_TEXT_3/3	3	7	1956	LONGTERM|DICTIONARY	erbb	ErbB	110#114	NaN	D005706	SYMBOL|EXTRACTED	gbc	GBC	136#139	24997986-1-17-38	These findings provide insight into the somatic mutational landscape in GBC and highlight the key role of the ErbB signaling pathway in GBC pathogenesis.
24997986	2015	Nat. Genet.	1546-1718	ALL_TEXT_3/3	3	5	1956	SYMBOL|DICTIONARY	egfr	EGFR	36#40		D005706	SYMBOL|EXTRACTED	gbc	GBC	162#165	24997986-1-17-38	Moreover, ErbB signaling (including EGFR, ERBB2, ERBB3, ERBB4 and their downstream genes) is the most extensively mutated pathway, affecting 36.8% (21/57) of the GBC samples.
24997986	2015	Nat. Genet.	1546-1718	ALL_TEXT_3/3	3	5	2064	SYMBOL|DICTIONARY	erbb2	ERBB2	42#47		D005706	SYMBOL|EXTRACTED	gbc	GBC	162#165	24997986-1-17-38	Moreover, ErbB signaling (including EGFR, ERBB2, ERBB3, ERBB4 and their downstream genes) is the most extensively mutated pathway, affecting 36.8% (21/57) of the GBC samples.
24997986	2015	Nat. Genet.	1546-1718	ALL_TEXT_3/3	3	5	2065	SYMBOL|DICTIONARY	erbb3	ERBB3	49#54		D005706	SYMBOL|EXTRACTED	gbc	GBC	162#165	24997986-1-17-38	Moreover, ErbB signaling (including EGFR, ERBB2, ERBB3, ERBB4 and their downstream genes) is the most extensively mutated pathway, affecting 36.8% (21/57) of the GBC samples.
24997986	2015	Nat. Genet.	1546-1718	ALL_TEXT_3/3	3	5	2066	SYMBOL|DICTIONARY	erbb4	ERBB4	56#61		D005706	SYMBOL|EXTRACTED	gbc	GBC	162#165	24997986-1-17-38	Moreover, ErbB signaling (including EGFR, ERBB2, ERBB3, ERBB4 and their downstream genes) is the most extensively mutated pathway, affecting 36.8% (21/57) of the GBC samples.
21497595	2011	Eur. J. Pharmacol.	1879-0712	ALL_TEXT_3/3	3	11	2056	LONGTERM|DICTIONARY	erythropoietin	erythropoietin	15#29		D007249	LONGTERM|DICTIONARY	inflammation	inflammation	149#161	NaN	In conclusion, erythropoietin promotes inflammatory cell apoptosis, drives inflammatory and apoptotic cells into tubular lumens, eventually leads to inflammation clearance, renoprotection and tissue remodelling through caspase-3 and IL-1 in isolated haemoperfused kidneys.
21497595	2011	Eur. J. Pharmacol.	1879-0712	ALL_TEXT_3/3	3	11	2056	LONGTERM|DICTIONARY	erythropoietin	erythropoietin	15#29		D007674	LONGTERM|DICTIONARY	haemoperfused kidneys	haemoperfused kidneys	251#272	NaN	In conclusion, erythropoietin promotes inflammatory cell apoptosis, drives inflammatory and apoptotic cells into tubular lumens, eventually leads to inflammation clearance, renoprotection and tissue remodelling through caspase-3 and IL-1 in isolated haemoperfused kidneys.
21497595	2011	Eur. J. Pharmacol.	1879-0712	ALL_TEXT_3/3	3	11	836	LONGTERM|DICTIONARY	caspase 3	caspase-3	219#228		D007249	LONGTERM|DICTIONARY	inflammation	inflammation	149#161	NaN	In conclusion, erythropoietin promotes inflammatory cell apoptosis, drives inflammatory and apoptotic cells into tubular lumens, eventually leads to inflammation clearance, renoprotection and tissue remodelling through caspase-3 and IL-1 in isolated haemoperfused kidneys.
21497595	2011	Eur. J. Pharmacol.	1879-0712	ALL_TEXT_3/3	3	11	836	LONGTERM|DICTIONARY	caspase 3	caspase-3	219#228		D007674	LONGTERM|DICTIONARY	haemoperfused kidneys	haemoperfused kidneys	251#272	NaN	In conclusion, erythropoietin promotes inflammatory cell apoptosis, drives inflammatory and apoptotic cells into tubular lumens, eventually leads to inflammation clearance, renoprotection and tissue remodelling through caspase-3 and IL-1 in isolated haemoperfused kidneys.
21497595	2011	Eur. J. Pharmacol.	1879-0712	ALL_TEXT_3/3	3	11	3553	LONGTERM|DICTIONARY	il-1b	IL-1b	233#238	NaN	D007249	LONGTERM|DICTIONARY	inflammation	inflammation	149#161	NaN	In conclusion, erythropoietin promotes inflammatory cell apoptosis, drives inflammatory and apoptotic cells into tubular lumens, eventually leads to inflammation clearance, renoprotection and tissue remodelling through caspase-3 and IL-1 in isolated haemoperfused kidneys.
21497595	2011	Eur. J. Pharmacol.	1879-0712	ALL_TEXT_3/3	3	11	3553	LONGTERM|DICTIONARY	il-1b	IL-1b	233#238	NaN	D007674	LONGTERM|DICTIONARY	haemoperfused kidneys	haemoperfused kidneys	251#272	NaN	In conclusion, erythropoietin promotes inflammatory cell apoptosis, drives inflammatory and apoptotic cells into tubular lumens, eventually leads to inflammation clearance, renoprotection and tissue remodelling through caspase-3 and IL-1 in isolated haemoperfused kidneys.
16741941	2006	Am. J. Med. Genet. B Neuropsychiatr. Genet.	1552-4841	ALL_TEXT_3/3	3	8	627	SYMBOL|DICTIONARY|EXTRACTED	bdnf	BDNF	74#78	16741941-1-52-85	D019964	LONGTERM|DICTIONARY	mood disorders	mood disorders	100#114		These results are consistent with previous studies pointing to a role for BDNF in susceptibility to mood disorders.
12492589	2003	Br. J. Haematol.	0007-1048	ALL_TEXT_3/3	3	7	2214	LONGTERM|NUMBER|DICTIONARY	fcgammariiia	FcgammaRIIIa	34#46		D016553	SYMBOL|DICTIONARY|EXTRACTED	itp	ITP	105#108	12492589-1-129-160	Both the FcgammaRIIa-131H and the FcgammaRIIIa-158V were significantly over-represented in children with ITP versus the control subjects (P-values 0.03).
18512809	2008	Arthritis Rheum.	0004-3591	CONCLUSION	4	10	3586	SYMBOL|DICTIONARY	il10	IL10	77#81		D015267	SYMBOL|DICTIONARY|EXTRACTED	css	CSS	158#161	18512809-1-34-56	Because the IL10.2 haplotype has been correlated reproducibly with increased IL10 expression, the possible role of IL-10 in the pathogenesis of ANCA-negative CSS needs to be further elucidated.
18512809	2008	Arthritis Rheum.	0004-3591	CONCLUSION	4	10	3586	SYMBOL|DICTIONARY|EXTRACTED	il 10	IL-10	115#120	18512809-3-21-35	D015267	SYMBOL|DICTIONARY|EXTRACTED	css	CSS	158#161	18512809-1-34-56	Because the IL10.2 haplotype has been correlated reproducibly with increased IL10 expression, the possible role of IL-10 in the pathogenesis of ANCA-negative CSS needs to be further elucidated.
19300429	2009	Obesity (Silver Spring)	1930-7381	TITLE	0	0	10135	SYMBOL|GENE|GN|DICTIONARY	visfatin	visfatin	22#30		D009765	LONGTERM|DICTIONARY	obesity	obesity	85#92		A rare variant in the visfatin gene (NAMPT/PBEF1) is associated with protection from obesity.
19300429	2009	Obesity (Silver Spring)	1930-7381	TITLE	0	0	10135	SYMBOL|DICTIONARY	nampt	NAMPT	37#42		D009765	LONGTERM|DICTIONARY	obesity	obesity	85#92		A rare variant in the visfatin gene (NAMPT/PBEF1) is associated with protection from obesity.
19300429	2009	Obesity (Silver Spring)	1930-7381	TITLE	0	0	10135	SYMBOL|DICTIONARY|EXTRACTED	pbef1	PBEF1	43#48		D009765	LONGTERM|DICTIONARY	obesity	obesity	85#92		A rare variant in the visfatin gene (NAMPT/PBEF1) is associated with protection from obesity.
9236417	1997	Circulation	0009-7322	CONCLUSIONS	3	10	5972	LONGTERM|DICTIONARY	renin	renin	31#36		D023903	LONGTERM|DICTIONARY	restenosis	restenosis	97#107		These results suggest that the renin-angiotensin system may be implicated in the pathogenesis of restenosis after coronary stenting.
19300429	2009	Obesity (Silver Spring)	1930-7381	ALL_TEXT_1/3	1	2	10135	SYMBOL|GENE|GN|DICTIONARY	visfatin	visfatin	108#116		D009765	LONGTERM|DICTIONARY	obesity	obesity	149#156		This study was aimed at investigation of the possibility that single-nucleotide polymorphisms (SNPs) in the visfatin gene are associated with either obesity or type 2 diabetes (T2D).
19300429	2009	Obesity (Silver Spring)	1930-7381	ALL_TEXT_1/3	1	2	10135	SYMBOL|GENE|GN|DICTIONARY	visfatin	visfatin	108#116		D003924	LONGTERM|DICTIONARY	type 2 diabetes	type 2 diabetes	160#175		This study was aimed at investigation of the possibility that single-nucleotide polymorphisms (SNPs) in the visfatin gene are associated with either obesity or type 2 diabetes (T2D).
19300429	2009	Obesity (Silver Spring)	1930-7381	ALL_TEXT_1/3	1	2	10135	SYMBOL|GENE|GN|DICTIONARY	visfatin	visfatin	108#116		D003924	SYMBOL|()|DICTIONARY|EXTRACTED	t2d	T2D	177#180	19300429-2-160-175	This study was aimed at investigation of the possibility that single-nucleotide polymorphisms (SNPs) in the visfatin gene are associated with either obesity or type 2 diabetes (T2D).
17492767	2007	Am. J. Med. Genet. B Neuropsychiatr. Genet.	1552-4841	ALL_TEXT_3/3	3	8	1610	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	dao	DAO	89#92	17492767-1-4-24	D012559	LONGTERM|DICTIONARY	schizophrenia	schizophrenia	118#131		We identified evidence for epistatic interaction between the associated SNPs at DAOA and DAO genes in contributing to schizophrenia risk (OR = 9.3 (1.4, 60.5).
20628598	2010	PLoS ONE	1932-6203	METHODOLOGY/PRINCIPAL FINDINGS	2	6	2646	SYMBOL|DICTIONARY|EXTRACTED	gckr	GCKR	14#18	20628598-1-162-192	D018149	LONGTERM|DICTIONARY	fpg	FPG	121#124	NaN	Together with GCKR rs780094, the risk alleles of these SNPs exhibited dosage effect in their associations with increased FPG (P=2.9x10(-9)) and reduced HOMA-B (P=1.1x10(-3)).
16797247	2006	Clin. Gastroenterol. Hepatol.	1542-3565	RESULTS	3	5	1559	SYMBOL|DICTIONARY	cyp2c9	CYP2C9	8#14		D015179	LONGTERM|DISEASE|DT|DICTIONARY	colorectal cancer	colorectal cancer	90#107		Variant CYP2C9 genotypes enhanced the protective effect of ibuprofen on the prevention of colorectal cancer, and a dose-response relationship with respect to increasing numbers of variant alleles was seen (P interaction = .02).
15057872	2004	Mol. Carcinog.	0899-1987	ALL_TEXT_3/3	3	7	3482	SYMBOL|GENE|GN|DICTIONARY	igf2r	Igf2r	50#55		D008107	LONGTERM|DICTIONARY	liver carcinogenesis	liver carcinogenesis	110#130		These results suggest that alterations of the M6p/Igf2r gene may be involved in both exogenous and endogenous liver carcinogenesis with the different patterns and frequencies.
22213154	2012	Hum. Mutat.	1098-1004	TITLE	0	0	5076	SYMBOL|DICTIONARY	pax2	PAX2	10#14		D007674	LONGTERM|DISEASE|DT|DICTIONARY	renal coloboma syndrome	renal coloboma syndrome	28#51		Update of PAX2 mutations in renal coloboma syndrome and establishment of a locus-specific database.
22213154	2012	Hum. Mutat.	1098-1004	ALL_TEXT_2/3	2	3	5076	SYMBOL|GENE|GN|DICTIONARY	pax2	PAX2	130#134		D007674	LONGTERM|DISEASE|DT|DICTIONARY	renal coloboma syndrome	renal coloboma syndrome	185#208		Prior to 2011, there was no actively maintained locus-specific database (LSDB) cataloguing the extent of genetic variation in the PAX2 gene and phenotypic variation in individuals with renal coloboma syndrome.
22213154	2012	Hum. Mutat.	1098-1004	ALL_TEXT_1/3	1	2	5076	SYMBOL|DICTIONARY	pax2	PAX2	34#38		D007674	LONGTERM|DICTIONARY	renal hypoplasia	renal hypoplasia	123#139		Mutations in the paired-box gene, PAX2, have been identified in approximately half of individuals with classic findings of renal hypoplasia/dysplasia and abnormalities of the optic nerve.
22213154	2012	Hum. Mutat.	1098-1004	ALL_TEXT_1/3	1	2	5076	SYMBOL|DICTIONARY	pax2	PAX2	34#38		D009901	LONGTERM|DICTIONARY	abnormalities of the optic nerve	abnormalities of the optic nerve	154#186		Mutations in the paired-box gene, PAX2, have been identified in approximately half of individuals with classic findings of renal hypoplasia/dysplasia and abnormalities of the optic nerve.
22213154	2012	Hum. Mutat.	1098-1004	ALL_TEXT_1/3	1	2	5076	SYMBOL|DICTIONARY	pax2	PAX2	34#38		C535662	LONGTERM|DICTIONARY	dysplasia	dysplasia	140#149	NaN	Mutations in the paired-box gene, PAX2, have been identified in approximately half of individuals with classic findings of renal hypoplasia/dysplasia and abnormalities of the optic nerve.
20183911	2010	Ann. Surg. Oncol.	1534-4681	RESULTS	3	6	2073	SYMBOL|NUMBER|DICTIONARY	ercc5	ERCC5	40#45		D001943	LONGTERM|DISEASE|DT|DICTIONARY	breast cancer	breast cancer	96#109		Of the nonsynonymous polymorphisms, the ERCC5 1104Asp variant was significantly associated with breast cancer (odds ratio = 1.42; 95% confidence interval = 1.08-1.97), and this association was more pronounced in women with lengthy estrogen exposure.
15571962	2005	Eur. J. Cancer	0959-8049	ALL_TEXT_3/3	3	9	675	SYMBOL|NUMBER|DICTIONARY	brca2	BRCA2	15#20		D010051	LONGTERM|DISEASE|DT|DICTIONARY	ovarian cancer	ovarian cancer	49#63		In conclusion, BRCA2 999del5 is present in 6% of ovarian cancer cases in Iceland and is associated with a 20-fold increase in the risk of the disease.
15675129	2005	Clin. Exp. Rheumatol.	0392-856X	CONCLUSIONS	4	9	3458	SYMBOL|EXTRACTED	ifn gamma	IFN-gamma	8#17	15675129-2-112-128	D013700	SYMBOL|DICTIONARY|EXTRACTED	gca	GCA	3#6	15675129-1-61-81	In GCA, IFN-gamma functional polymorphisms are associated with clinical manifestations of severity rather than susceptibility to this vasculitis.
15675129	2005	Clin. Exp. Rheumatol.	0392-856X	CONCLUSIONS	4	9	3458	SYMBOL|EXTRACTED	ifn gamma	IFN-gamma	8#17	15675129-2-112-128	D014657	LONGTERM|DICTIONARY	vasculitis	vasculitis	134#144		In GCA, IFN-gamma functional polymorphisms are associated with clinical manifestations of severity rather than susceptibility to this vasculitis.
20183911	2010	Ann. Surg. Oncol.	1534-4681	METHODS	2	5	7515	SYMBOL|DICTIONARY	xrcc1	XRCC1	31#36		D001943	LONGTERM|DISEASE|DT|DICTIONARY	breast cancer	breast cancer	186#199		Genotyping of polymorphisms of XRCC1 (Arg194Trp and Arg399Gln), OGG1 (Ser326Cys and Arg229Gln), ERCC2 Lys751Gln, ERCC4 Ser662Pro, and ERCC5 His1104Asp was performed and used to evaluate breast cancer susceptibility.
20183911	2010	Ann. Surg. Oncol.	1534-4681	METHODS	2	5	4968	SYMBOL|DICTIONARY	ogg1	OGG1	64#68		D001943	LONGTERM|DISEASE|DT|DICTIONARY	breast cancer	breast cancer	186#199		Genotyping of polymorphisms of XRCC1 (Arg194Trp and Arg399Gln), OGG1 (Ser326Cys and Arg229Gln), ERCC2 Lys751Gln, ERCC4 Ser662Pro, and ERCC5 His1104Asp was performed and used to evaluate breast cancer susceptibility.
20183911	2010	Ann. Surg. Oncol.	1534-4681	METHODS	2	5	2068	SYMBOL|DICTIONARY	ercc2	ERCC2	96#101		D001943	LONGTERM|DISEASE|DT|DICTIONARY	breast cancer	breast cancer	186#199		Genotyping of polymorphisms of XRCC1 (Arg194Trp and Arg399Gln), OGG1 (Ser326Cys and Arg229Gln), ERCC2 Lys751Gln, ERCC4 Ser662Pro, and ERCC5 His1104Asp was performed and used to evaluate breast cancer susceptibility.
20183911	2010	Ann. Surg. Oncol.	1534-4681	METHODS	2	5	2072	SYMBOL|DICTIONARY	ercc4	ERCC4	113#118		D001943	LONGTERM|DISEASE|DT|DICTIONARY	breast cancer	breast cancer	186#199		Genotyping of polymorphisms of XRCC1 (Arg194Trp and Arg399Gln), OGG1 (Ser326Cys and Arg229Gln), ERCC2 Lys751Gln, ERCC4 Ser662Pro, and ERCC5 His1104Asp was performed and used to evaluate breast cancer susceptibility.
20183911	2010	Ann. Surg. Oncol.	1534-4681	METHODS	2	5	2073	SYMBOL|DICTIONARY	ercc5	ERCC5	134#139		D001943	LONGTERM|DISEASE|DT|DICTIONARY	breast cancer	breast cancer	186#199		Genotyping of polymorphisms of XRCC1 (Arg194Trp and Arg399Gln), OGG1 (Ser326Cys and Arg229Gln), ERCC2 Lys751Gln, ERCC4 Ser662Pro, and ERCC5 His1104Asp was performed and used to evaluate breast cancer susceptibility.
9550468	1998	Arthritis Rheum.	0004-3591	RESULTS	3	4	596	SYMBOL|DICTIONARY	bcl 2	bcl-2	4#9		D008180	SYMBOL|DISEASE|DN|DICTIONARY|EXTRACTED	sle	SLE	88#91	9550468-1-158-186	The bcl-2, Fas-L, and IL-10 loci showed significantly different allelic distribution in SLE patients compared with controls, indicating an association between these genes and SLE.
9550468	1998	Arthritis Rheum.	0004-3591	RESULTS	3	4	596	SYMBOL|DICTIONARY	bcl 2	bcl-2	4#9		D008180	SYMBOL|DICTIONARY|EXTRACTED	sle	SLE	175#178	9550468-1-158-186	The bcl-2, Fas-L, and IL-10 loci showed significantly different allelic distribution in SLE patients compared with controls, indicating an association between these genes and SLE.
9550468	1998	Arthritis Rheum.	0004-3591	RESULTS	3	4	3586	SYMBOL|DICTIONARY	il 10	IL-10	22#27		D008180	SYMBOL|DISEASE|DN|DICTIONARY|EXTRACTED	sle	SLE	88#91	9550468-1-158-186	The bcl-2, Fas-L, and IL-10 loci showed significantly different allelic distribution in SLE patients compared with controls, indicating an association between these genes and SLE.
9550468	1998	Arthritis Rheum.	0004-3591	RESULTS	3	4	3586	SYMBOL|DICTIONARY	il 10	IL-10	22#27		D008180	SYMBOL|DICTIONARY|EXTRACTED	sle	SLE	175#178	9550468-1-158-186	The bcl-2, Fas-L, and IL-10 loci showed significantly different allelic distribution in SLE patients compared with controls, indicating an association between these genes and SLE.
9550468	1998	Arthritis Rheum.	0004-3591	RESULTS	3	4	356	LONGTERM|DICTIONARY	fas-l	Fas-L	11#16	NaN	D008180	SYMBOL|DISEASE|DN|DICTIONARY|EXTRACTED	sle	SLE	88#91	9550468-1-158-186	The bcl-2, Fas-L, and IL-10 loci showed significantly different allelic distribution in SLE patients compared with controls, indicating an association between these genes and SLE.
9550468	1998	Arthritis Rheum.	0004-3591	RESULTS	3	4	356	LONGTERM|DICTIONARY	fas-l	Fas-L	11#16	NaN	D008180	SYMBOL|DICTIONARY|EXTRACTED	sle	SLE	175#178	9550468-1-158-186	The bcl-2, Fas-L, and IL-10 loci showed significantly different allelic distribution in SLE patients compared with controls, indicating an association between these genes and SLE.
15973118	2005	Inflamm. Bowel Dis.	1078-0998	RESULTS	3	5	7099	SYMBOL|DICTIONARY|EXTRACTED	tlr4	TLR4	50#54	15973118-1-42-62	D003424	SYMBOL|EXTRACTED	cd	CD	105#107	15973118-1-133-148	An almost 2-fold increase in the frequency of the TLR4 Asp299Gly phenotype was observed in patients with CD (14.2%) compared with healthy controls (7.5%, P = 0.038, odds ratio = 2.03).
15973118	2005	Inflamm. Bowel Dis.	1078-0998	TITLE	0	0	7099	LONGTERM|DICTIONARY	toll like receptor 4	Toll-like receptor 4	12#32		D003424	LONGTERM|DISEASE|DT|DICTIONARY	crohn disease	Crohn's disease	136#151		The role of Toll-like receptor 4 Asp299Gly and Thr399Ile polymorphisms and CARD15/NOD2 mutations in the susceptibility and phenotype of Crohn's disease.
15973118	2005	Inflamm. Bowel Dis.	1078-0998	TITLE	0	0	64127	SYMBOL|DICTIONARY	card15	CARD15	75#81		D003424	LONGTERM|DISEASE|DT|DICTIONARY	crohn disease	Crohn's disease	136#151		The role of Toll-like receptor 4 Asp299Gly and Thr399Ile polymorphisms and CARD15/NOD2 mutations in the susceptibility and phenotype of Crohn's disease.
15973118	2005	Inflamm. Bowel Dis.	1078-0998	TITLE	0	0	64127	SYMBOL|DICTIONARY	nod2	NOD2	82#86		D003424	LONGTERM|DISEASE|DT|DICTIONARY	crohn disease	Crohn's disease	136#151		The role of Toll-like receptor 4 Asp299Gly and Thr399Ile polymorphisms and CARD15/NOD2 mutations in the susceptibility and phenotype of Crohn's disease.
15973118	2005	Inflamm. Bowel Dis.	1078-0998	BACKGROUND	1	1	7099	LONGTERM|DICTIONARY	toll like receptor 4	Toll-like receptor 4	42#62		D003424	LONGTERM|DISEASE|DT|DICTIONARY	crohn disease	Crohn's disease	133#148		We investigated the influence of 2 common Toll-like receptor 4 (TLR4) polymorphisms on susceptibility and disease characteristics of Crohn's disease (CD).
15973118	2005	Inflamm. Bowel Dis.	1078-0998	BACKGROUND	1	1	7099	LONGTERM|DICTIONARY	toll like receptor 4	Toll-like receptor 4	42#62		D003424	SYMBOL|EXTRACTED|()	cd	CD	150#152	15973118-1-133-148	We investigated the influence of 2 common Toll-like receptor 4 (TLR4) polymorphisms on susceptibility and disease characteristics of Crohn's disease (CD).
15973118	2005	Inflamm. Bowel Dis.	1078-0998	BACKGROUND	1	1	7099	SYMBOL|()|DICTIONARY|EXTRACTED	tlr4	TLR4	64#68	15973118-1-42-62	D003424	LONGTERM|DISEASE|DT|DICTIONARY	crohn disease	Crohn's disease	133#148		We investigated the influence of 2 common Toll-like receptor 4 (TLR4) polymorphisms on susceptibility and disease characteristics of Crohn's disease (CD).
15973118	2005	Inflamm. Bowel Dis.	1078-0998	BACKGROUND	1	1	7099	SYMBOL|()|DICTIONARY|EXTRACTED	tlr4	TLR4	64#68	15973118-1-42-62	D003424	SYMBOL|EXTRACTED|()	cd	CD	150#152	15973118-1-133-148	We investigated the influence of 2 common Toll-like receptor 4 (TLR4) polymorphisms on susceptibility and disease characteristics of Crohn's disease (CD).
15973118	2005	Inflamm. Bowel Dis.	1078-0998	METHODS	2	2	7099	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	tlr4	TLR4	139#143	15973118-1-42-62	D003424	SYMBOL|EXTRACTED	cd	CD	35#37	15973118-1-133-148	Genomic DNA from 204 patients with CD and 199 unrelated controls was analyzed for the presence of 2 single nucleotide polymorphisms in the TLR4 gene, resulting in the amino acid substitutions Asp299Gly and Thr399Ile.
15973118	2005	Inflamm. Bowel Dis.	1078-0998	METHODS	2	3	64127	SYMBOL|DICTIONARY	card15	CARD15	63#69		D003424	SYMBOL|EXTRACTED	cd	CD	49#51	15973118-1-133-148	In addition, the carrier status for the 3 common CD-associated CARD15/NOD2 gene mutations, Arg702Trp, Gly908Arg, and 1007fs, was determined.
15973118	2005	Inflamm. Bowel Dis.	1078-0998	METHODS	2	3	64127	SYMBOL|GENE|GN|DICTIONARY	nod2	NOD2	70#74		D003424	SYMBOL|EXTRACTED	cd	CD	49#51	15973118-1-133-148	In addition, the carrier status for the 3 common CD-associated CARD15/NOD2 gene mutations, Arg702Trp, Gly908Arg, and 1007fs, was determined.
18383527	2008	Head Neck	1097-0347	BACKGROUND	1	2	2052	SYMBOL|EXTRACTED	meh	mEH	60#63	18383527-1-0-28	D006258	LONGTERM|DICTIONARY	head and neck carcinogenesis	head and neck carcinogenesis	100#128		We investigated whether functional genetic polymorphisms in mEH may have a risk-modifying effect on head and neck carcinogenesis.
18383527	2008	Head Neck	1097-0347	METHODS	2	3	2052	SYMBOL|EXTRACTED	meh	mEH	117#120	18383527-1-0-28	D002277	LONGTERM|DISEASE|DT|DICTIONARY	laryngeal carcinoma	laryngeal carcinoma	51#70		Blood from 429 patients with oral, pharyngeal, and laryngeal carcinoma and 419 healthy subjects was investigated for mEH polymorphisms.
18383527	2008	Head Neck	1097-0347	TITLE	0	0	2052	LONGTERM|DICTIONARY	microsomal epoxide hydrolase	Microsomal epoxide hydrolase	0#28		D006258	LONGTERM|DISEASE|DT|DICTIONARY	head and neck cancer	head and neck cancer	56#76		Microsomal epoxide hydrolase genotypes and the risk for head and neck cancer.
18383527	2008	Head Neck	1097-0347	CONCLUSION	4	7	2052	SYMBOL|EXTRACTED	meh	mEH	109#112	18383527-1-0-28	D002277	LONGTERM|DISEASE|DT|DICTIONARY	hypopharyngeal carcinoma	hypopharyngeal carcinoma	210#234		In contrast to earlier reports, we could not demonstrate a risk-modifying effect of genetic polymorphisms in mEH on head and neck carcinogenesis, except for the predicted high activity variant in patients with hypopharyngeal carcinoma.
18383527	2008	Head Neck	1097-0347	CONCLUSION	4	7	2052	SYMBOL|EXTRACTED	meh	mEH	109#112	18383527-1-0-28	D006258	LONGTERM|DICTIONARY	head and neck carcinogenesis	head and neck carcinogenesis	116#144		In contrast to earlier reports, we could not demonstrate a risk-modifying effect of genetic polymorphisms in mEH on head and neck carcinogenesis, except for the predicted high activity variant in patients with hypopharyngeal carcinoma.
16797247	2006	Clin. Gastroenterol. Hepatol.	1542-3565	BACKGROUND AND AIMS	1	1	54578	SYMBOL|()|DICTIONARY	ugt1a6	UGT1A6	79#85		C563365	LONGTERM|DICTIONARY	colorectal adenomas	colorectal adenomas	221#240		Variant genotypes of uridine diphosphate glucuronsyltransferase isoenzyme 1A6 (UGT1A6) associated with decreased metabolic activity have been associated with an enhanced protective effect of aspirin on the development of colorectal adenomas.
16797247	2006	Clin. Gastroenterol. Hepatol.	1542-3565	BACKGROUND AND AIMS	1	2	54578	SYMBOL|DICTIONARY	ugt1a6	UGT1A6	30#36		D015179	LONGTERM|DISEASE|DT|DICTIONARY	colorectal cancer	colorectal cancer	201#218		However, interactions between UGT1A6 variants or variants of another enzyme that metabolizes nonsteroidal anti-inflammatory drugs (NSAIDs), cytochrome P4502C9 (CYP2C9), and NSAIDs in the prevention of colorectal cancer have not been studied extensively.
16797247	2006	Clin. Gastroenterol. Hepatol.	1542-3565	BACKGROUND AND AIMS	1	2	1559	SYMBOL|()|DICTIONARY	cyp2c9	CYP2C9	160#166		D015179	LONGTERM|DISEASE|DT|DICTIONARY	colorectal cancer	colorectal cancer	201#218		However, interactions between UGT1A6 variants or variants of another enzyme that metabolizes nonsteroidal anti-inflammatory drugs (NSAIDs), cytochrome P4502C9 (CYP2C9), and NSAIDs in the prevention of colorectal cancer have not been studied extensively.
20018409	2012	Neurobiol. Aging	1558-1497	ALL_TEXT_2/3	2	2	120892	SYMBOL|DICTIONARY|EXTRACTED	lrrk2	LRRK2	14#19	20018409-1-140-168	D010300	SYMBOL|EXTRACTED	pd	PD	20#22	20018409-1-101-120	We analyzed a LRRK2 PD (R1628P) risk variant in a group of 885 subjects comprising of AD and controls.
20018409	2012	Neurobiol. Aging	1558-1497	ALL_TEXT_2/3	2	2	120892	SYMBOL|DICTIONARY|EXTRACTED	lrrk2	LRRK2	14#19	20018409-1-140-168	D000544	LONGTERM|DICTIONARY	ad	AD	86#88	NaN	We analyzed a LRRK2 PD (R1628P) risk variant in a group of 885 subjects comprising of AD and controls.
16797247	2006	Clin. Gastroenterol. Hepatol.	1542-3565	METHODS	2	3	54578	SYMBOL|DICTIONARY	ugt1a6	UGT1A6	0#6		D015179	LONGTERM|DISEASE|DT|DICTIONARY	colorectal cancer	colorectal cancer	69#86		UGT1A6 and CYP2C9 genotypes were determined in 2295 individuals with colorectal cancer and 2903 controls.
16797247	2006	Clin. Gastroenterol. Hepatol.	1542-3565	METHODS	2	3	1559	SYMBOL|DICTIONARY	cyp2c9	CYP2C9	11#17		D015179	LONGTERM|DISEASE|DT|DICTIONARY	colorectal cancer	colorectal cancer	69#86		UGT1A6 and CYP2C9 genotypes were determined in 2295 individuals with colorectal cancer and 2903 controls.
20018409	2012	Neurobiol. Aging	1558-1497	ALL_TEXT_3/3	3	5	120892	SYMBOL|DICTIONARY|EXTRACTED	lrrk2	LRRK2	4#9	20018409-1-140-168	D000544	LONGTERM|DICTIONARY	ad	AD	47#49	NaN	The LRRK2 R1628P variant increases the risk of AD in our population and our in vitro findings suggest that it is a functional variant and predisposes to apoptosis.
16094257	2005	Psychiatr. Genet.	0955-8829	TITLE	0	0	57132	LONGTERM|DICTIONARY	chmp1.5	CHMP1.5	24#31	NaN	D001714	LONGTERM|DISEASE|DT|DICTIONARY	bipolar disorder	bipolar disorder	54#70		Association analysis of CHMP1.5 genetic variation and bipolar disorder.
15912506	2005	Ann. Neurol.	0364-5134	ALL_TEXT_3/3	3	10	5133	LONGTERM|DICTIONARY	pd-1	PD-1	37#41	NaN	D009103	SYMBOL|EXTRACTED	ms	MS	99#101	15912506-1-101-119	In conclusion, our data suggest that PD-1 polymorphism is a genetic modifier of the progression of MS, possibly through inducing a partial defect in PD-1-mediated inhibition of T-cell activation.
15912506	2005	Ann. Neurol.	0364-5134	ALL_TEXT_3/3	3	10	5133	LONGTERM|DICTIONARY	pd-1	PD-1	149#153	NaN	D009103	SYMBOL|EXTRACTED	ms	MS	99#101	15912506-1-101-119	In conclusion, our data suggest that PD-1 polymorphism is a genetic modifier of the progression of MS, possibly through inducing a partial defect in PD-1-mediated inhibition of T-cell activation.
12618866	2003	Genes Immun.	1466-4879	ALL_TEXT_3/3	3	3	5788	SYMBOL|DICTIONARY	ptprc	PTPRC	108#113		D012595	SYMBOL|EXTRACTED	ssc	SSc	88#91	12618866-2-116-134	The mutation was found with significantly enhanced frequency in patients suffering from SSc suggesting that PTPRC could play a role as susceptibility gene not only in MS but also in other autoimmune diseases.
12618866	2003	Genes Immun.	1466-4879	ALL_TEXT_3/3	3	3	5788	SYMBOL|DICTIONARY	ptprc	PTPRC	108#113		D009103	SYMBOL|EXTRACTED	ms	MS	167#169	12618866-1-139-157	The mutation was found with significantly enhanced frequency in patients suffering from SSc suggesting that PTPRC could play a role as susceptibility gene not only in MS but also in other autoimmune diseases.
12618866	2003	Genes Immun.	1466-4879	ALL_TEXT_3/3	3	3	5788	SYMBOL|DICTIONARY	ptprc	PTPRC	108#113		D001327	LONGTERM|DICTIONARY	autoimmune diseases	autoimmune diseases	188#207		The mutation was found with significantly enhanced frequency in patients suffering from SSc suggesting that PTPRC could play a role as susceptibility gene not only in MS but also in other autoimmune diseases.
12618866	2003	Genes Immun.	1466-4879	ALL_TEXT_1/3	1	1	5788	SYMBOL|DICTIONARY	ptprc	PTPRC	73#78		D009103	LONGTERM|DICTIONARY	multiple sclerosis	multiple sclerosis	139#157		A point mutation in exon A (C to G transversion at position 77) of human PTPRC (CD45) has recently been associated with the development of multiple sclerosis (MS) for at least a subgroup of patients.
12618866	2003	Genes Immun.	1466-4879	ALL_TEXT_1/3	1	1	5788	SYMBOL|DICTIONARY	ptprc	PTPRC	73#78		D009103	SYMBOL|EXTRACTED|()	ms	MS	159#161	12618866-1-139-157	A point mutation in exon A (C to G transversion at position 77) of human PTPRC (CD45) has recently been associated with the development of multiple sclerosis (MS) for at least a subgroup of patients.
12618866	2003	Genes Immun.	1466-4879	ALL_TEXT_1/3	1	1	5788	SYMBOL|()|DICTIONARY|EXTRACTED	cd45	CD45	80#84	12618866-0-24-29	D009103	LONGTERM|DICTIONARY	multiple sclerosis	multiple sclerosis	139#157		A point mutation in exon A (C to G transversion at position 77) of human PTPRC (CD45) has recently been associated with the development of multiple sclerosis (MS) for at least a subgroup of patients.
12618866	2003	Genes Immun.	1466-4879	ALL_TEXT_1/3	1	1	5788	SYMBOL|()|DICTIONARY|EXTRACTED	cd45	CD45	80#84	12618866-0-24-29	D009103	SYMBOL|EXTRACTED|()	ms	MS	159#161	12618866-1-139-157	A point mutation in exon A (C to G transversion at position 77) of human PTPRC (CD45) has recently been associated with the development of multiple sclerosis (MS) for at least a subgroup of patients.
12618866	2003	Genes Immun.	1466-4879	TITLE	0	0	5788	SYMBOL|DICTIONARY	ptprc	PTPRC	24#29		D012595	LONGTERM|DICTIONARY	systemic sclerosis	systemic sclerosis	66#84		Enhanced frequency of a PTPRC (CD45) exon A mutation (77C-->G) in systemic sclerosis.
12618866	2003	Genes Immun.	1466-4879	TITLE	0	0	5788	SYMBOL|()|DICTIONARY|EXTRACTED	cd45	CD45	31#35	12618866-0-24-29	D012595	LONGTERM|DICTIONARY	systemic sclerosis	systemic sclerosis	66#84		Enhanced frequency of a PTPRC (CD45) exon A mutation (77C-->G) in systemic sclerosis.
12618866	2003	Genes Immun.	1466-4879	ALL_TEXT_3/3	3	4	5788	SYMBOL|DICTIONARY	ptprc	PTPRC	59#64		D001327	LONGTERM|DICTIONARY	autoimmune disorders	autoimmune disorders	138#158		Further understanding of the mode of interaction of mutant PTPRC with other susceptibility genes may uncover mechanisms common in various autoimmune disorders.
20939760	2011	Exp. Lung Res.	1521-0499	ALL_TEXT_2/3	2	4	1956	SYMBOL|DICTIONARY|EXTRACTED	egfr	EGFR	36#40	20939760-0-0-32	D002289	LONGTERM|DICTIONARY|EXTRACTED	nsclc	NSCLC	57#62	20939760-1-26-52	In this study, mutation analysis of EGFR in 218 cases of NSCLC was performed.
18455351	2008	Int. J. Dev. Neurosci.	0736-5748	ALL_TEXT_3/3	3	9	958	SYMBOL|DICTIONARY	cd40	CD40	116#120		D013226	SYMBOL|EXTRACTED	se	SE	98#100	18455351-3-138-156	Our data provide evidence that rosiglitazone considerably attenuates inflammatory responses after SE by suppressing CD40 expression and microglial activation.
16086317	2006	Hum. Mutat.	1098-1004	ALL_TEXT_1/3	1	1	368	SYMBOL|GENE|GN|DICTIONARY	abcc6	ABCC6	157#162		D011561	LONGTERM|DICTIONARY	pseudoxanthoma elasticum	Pseudoxanthoma elasticum	0#24		Pseudoxanthoma elasticum (PXE) is a systemic heritable disorder that affects the elastic tissue in the skin, eye, and cardiovascular system.Mutations in the ABCC6 gene cause PXE.
16086317	2006	Hum. Mutat.	1098-1004	ALL_TEXT_1/3	1	1	368	SYMBOL|GENE|GN|DICTIONARY	abcc6	ABCC6	157#162		D011561	SYMBOL|()|DICTIONARY|EXTRACTED	pxe	PXE	26#29	16086317-1-0-24	Pseudoxanthoma elasticum (PXE) is a systemic heritable disorder that affects the elastic tissue in the skin, eye, and cardiovascular system.Mutations in the ABCC6 gene cause PXE.
16086317	2006	Hum. Mutat.	1098-1004	ALL_TEXT_1/3	1	1	368	SYMBOL|GENE|GN|DICTIONARY	abcc6	ABCC6	157#162		D011561	SYMBOL|DICTIONARY|EXTRACTED	pxe	PXE	174#177	16086317-1-0-24	Pseudoxanthoma elasticum (PXE) is a systemic heritable disorder that affects the elastic tissue in the skin, eye, and cardiovascular system.Mutations in the ABCC6 gene cause PXE.
16086317	2006	Hum. Mutat.	1098-1004	ALL_TEXT_1/3	1	1	368	SYMBOL|GENE|GN|DICTIONARY	abcc6	ABCC6	157#162		D030342	LONGTERM|DISEASE|DT|DICTIONARY	systemic heritable disorder	systemic heritable disorder	36#63		Pseudoxanthoma elasticum (PXE) is a systemic heritable disorder that affects the elastic tissue in the skin, eye, and cardiovascular system.Mutations in the ABCC6 gene cause PXE.
16086317	2006	Hum. Mutat.	1098-1004	ALL_TEXT_1/3	1	1	368	SYMBOL|GENE|GN|DICTIONARY	abcc6	ABCC6	157#162		D002318	LONGTERM|DICTIONARY	skin, eye, and cardiovascular system	skin, eye, and cardiovascular system	103#139	NaN	Pseudoxanthoma elasticum (PXE) is a systemic heritable disorder that affects the elastic tissue in the skin, eye, and cardiovascular system.Mutations in the ABCC6 gene cause PXE.
11357375	2001	Genetika	0016-6758	ALL_TEXT_1/3	1	1	847	LONGTERM|DICTIONARY	catalase	catalase	100#108		D003924	LONGTERM|DICTIONARY	non insulin dependent diabetes mellitus	non-insulin-dependent diabetes mellitus	194#233		Allelic and genotypic distributions of the polymorphic markers C1167T and Pro197Leu of the genes of catalase (CAT) and glutathione peroxidase (GPX1), respectively, were studied in patients with non-insulin-dependent diabetes mellitus (NIDDM) and hypertension without complications (the control group, n = 52) and with complications: myocardial infarction (MI, n = 53) or stroke (n = 50).
11357375	2001	Genetika	0016-6758	ALL_TEXT_1/3	1	1	847	LONGTERM|DICTIONARY	catalase	catalase	100#108		D003924	LONGTERM|()|DICTIONARY|EXTRACTED	niddm	NIDDM	235#240	11357375-1-194-233	Allelic and genotypic distributions of the polymorphic markers C1167T and Pro197Leu of the genes of catalase (CAT) and glutathione peroxidase (GPX1), respectively, were studied in patients with non-insulin-dependent diabetes mellitus (NIDDM) and hypertension without complications (the control group, n = 52) and with complications: myocardial infarction (MI, n = 53) or stroke (n = 50).
11357375	2001	Genetika	0016-6758	ALL_TEXT_1/3	1	1	847	LONGTERM|DICTIONARY	catalase	catalase	100#108		D006973	LONGTERM|DICTIONARY	hypertension	hypertension	246#258		Allelic and genotypic distributions of the polymorphic markers C1167T and Pro197Leu of the genes of catalase (CAT) and glutathione peroxidase (GPX1), respectively, were studied in patients with non-insulin-dependent diabetes mellitus (NIDDM) and hypertension without complications (the control group, n = 52) and with complications: myocardial infarction (MI, n = 53) or stroke (n = 50).
11357375	2001	Genetika	0016-6758	ALL_TEXT_1/3	1	1	847	LONGTERM|DICTIONARY	catalase	catalase	100#108		D009203	LONGTERM|DICTIONARY	myocardial infarction	myocardial infarction	333#354		Allelic and genotypic distributions of the polymorphic markers C1167T and Pro197Leu of the genes of catalase (CAT) and glutathione peroxidase (GPX1), respectively, were studied in patients with non-insulin-dependent diabetes mellitus (NIDDM) and hypertension without complications (the control group, n = 52) and with complications: myocardial infarction (MI, n = 53) or stroke (n = 50).
11357375	2001	Genetika	0016-6758	ALL_TEXT_1/3	1	1	847	LONGTERM|DICTIONARY	catalase	catalase	100#108		D009203	SYMBOL|EXTRACTED	mi	MI	356#358	11357375-1-333-354	Allelic and genotypic distributions of the polymorphic markers C1167T and Pro197Leu of the genes of catalase (CAT) and glutathione peroxidase (GPX1), respectively, were studied in patients with non-insulin-dependent diabetes mellitus (NIDDM) and hypertension without complications (the control group, n = 52) and with complications: myocardial infarction (MI, n = 53) or stroke (n = 50).
11357375	2001	Genetika	0016-6758	ALL_TEXT_1/3	1	1	847	LONGTERM|DICTIONARY	catalase	catalase	100#108		D020521	LONGTERM|DICTIONARY	stroke	stroke	371#377		Allelic and genotypic distributions of the polymorphic markers C1167T and Pro197Leu of the genes of catalase (CAT) and glutathione peroxidase (GPX1), respectively, were studied in patients with non-insulin-dependent diabetes mellitus (NIDDM) and hypertension without complications (the control group, n = 52) and with complications: myocardial infarction (MI, n = 53) or stroke (n = 50).
11357375	2001	Genetika	0016-6758	ALL_TEXT_1/3	1	1	847	SYMBOL|()|DICTIONARY|EXTRACTED	cat	CAT	110#113	11357375-1-100-108	D003924	LONGTERM|DICTIONARY	non insulin dependent diabetes mellitus	non-insulin-dependent diabetes mellitus	194#233		Allelic and genotypic distributions of the polymorphic markers C1167T and Pro197Leu of the genes of catalase (CAT) and glutathione peroxidase (GPX1), respectively, were studied in patients with non-insulin-dependent diabetes mellitus (NIDDM) and hypertension without complications (the control group, n = 52) and with complications: myocardial infarction (MI, n = 53) or stroke (n = 50).
11357375	2001	Genetika	0016-6758	ALL_TEXT_1/3	1	1	847	SYMBOL|()|DICTIONARY|EXTRACTED	cat	CAT	110#113	11357375-1-100-108	D003924	LONGTERM|()|DICTIONARY|EXTRACTED	niddm	NIDDM	235#240	11357375-1-194-233	Allelic and genotypic distributions of the polymorphic markers C1167T and Pro197Leu of the genes of catalase (CAT) and glutathione peroxidase (GPX1), respectively, were studied in patients with non-insulin-dependent diabetes mellitus (NIDDM) and hypertension without complications (the control group, n = 52) and with complications: myocardial infarction (MI, n = 53) or stroke (n = 50).
11357375	2001	Genetika	0016-6758	ALL_TEXT_1/3	1	1	847	SYMBOL|()|DICTIONARY|EXTRACTED	cat	CAT	110#113	11357375-1-100-108	D006973	LONGTERM|DICTIONARY	hypertension	hypertension	246#258		Allelic and genotypic distributions of the polymorphic markers C1167T and Pro197Leu of the genes of catalase (CAT) and glutathione peroxidase (GPX1), respectively, were studied in patients with non-insulin-dependent diabetes mellitus (NIDDM) and hypertension without complications (the control group, n = 52) and with complications: myocardial infarction (MI, n = 53) or stroke (n = 50).
11357375	2001	Genetika	0016-6758	ALL_TEXT_1/3	1	1	847	SYMBOL|()|DICTIONARY|EXTRACTED	cat	CAT	110#113	11357375-1-100-108	D009203	LONGTERM|DICTIONARY	myocardial infarction	myocardial infarction	333#354		Allelic and genotypic distributions of the polymorphic markers C1167T and Pro197Leu of the genes of catalase (CAT) and glutathione peroxidase (GPX1), respectively, were studied in patients with non-insulin-dependent diabetes mellitus (NIDDM) and hypertension without complications (the control group, n = 52) and with complications: myocardial infarction (MI, n = 53) or stroke (n = 50).
11357375	2001	Genetika	0016-6758	ALL_TEXT_1/3	1	1	847	SYMBOL|()|DICTIONARY|EXTRACTED	cat	CAT	110#113	11357375-1-100-108	D009203	SYMBOL|EXTRACTED	mi	MI	356#358	11357375-1-333-354	Allelic and genotypic distributions of the polymorphic markers C1167T and Pro197Leu of the genes of catalase (CAT) and glutathione peroxidase (GPX1), respectively, were studied in patients with non-insulin-dependent diabetes mellitus (NIDDM) and hypertension without complications (the control group, n = 52) and with complications: myocardial infarction (MI, n = 53) or stroke (n = 50).
11357375	2001	Genetika	0016-6758	ALL_TEXT_1/3	1	1	847	SYMBOL|()|DICTIONARY|EXTRACTED	cat	CAT	110#113	11357375-1-100-108	D020521	LONGTERM|DICTIONARY	stroke	stroke	371#377		Allelic and genotypic distributions of the polymorphic markers C1167T and Pro197Leu of the genes of catalase (CAT) and glutathione peroxidase (GPX1), respectively, were studied in patients with non-insulin-dependent diabetes mellitus (NIDDM) and hypertension without complications (the control group, n = 52) and with complications: myocardial infarction (MI, n = 53) or stroke (n = 50).
11357375	2001	Genetika	0016-6758	ALL_TEXT_1/3	1	1	2876	LONGTERM|DICTIONARY	gpx1	GPX1	143#147	NaN	D003924	LONGTERM|DICTIONARY	non insulin dependent diabetes mellitus	non-insulin-dependent diabetes mellitus	194#233		Allelic and genotypic distributions of the polymorphic markers C1167T and Pro197Leu of the genes of catalase (CAT) and glutathione peroxidase (GPX1), respectively, were studied in patients with non-insulin-dependent diabetes mellitus (NIDDM) and hypertension without complications (the control group, n = 52) and with complications: myocardial infarction (MI, n = 53) or stroke (n = 50).
11357375	2001	Genetika	0016-6758	ALL_TEXT_1/3	1	1	2876	LONGTERM|DICTIONARY	gpx1	GPX1	143#147	NaN	D003924	LONGTERM|()|DICTIONARY|EXTRACTED	niddm	NIDDM	235#240	11357375-1-194-233	Allelic and genotypic distributions of the polymorphic markers C1167T and Pro197Leu of the genes of catalase (CAT) and glutathione peroxidase (GPX1), respectively, were studied in patients with non-insulin-dependent diabetes mellitus (NIDDM) and hypertension without complications (the control group, n = 52) and with complications: myocardial infarction (MI, n = 53) or stroke (n = 50).
11357375	2001	Genetika	0016-6758	ALL_TEXT_1/3	1	1	2876	LONGTERM|DICTIONARY	gpx1	GPX1	143#147	NaN	D006973	LONGTERM|DICTIONARY	hypertension	hypertension	246#258		Allelic and genotypic distributions of the polymorphic markers C1167T and Pro197Leu of the genes of catalase (CAT) and glutathione peroxidase (GPX1), respectively, were studied in patients with non-insulin-dependent diabetes mellitus (NIDDM) and hypertension without complications (the control group, n = 52) and with complications: myocardial infarction (MI, n = 53) or stroke (n = 50).
11357375	2001	Genetika	0016-6758	ALL_TEXT_1/3	1	1	2876	LONGTERM|DICTIONARY	gpx1	GPX1	143#147	NaN	D009203	LONGTERM|DICTIONARY	myocardial infarction	myocardial infarction	333#354		Allelic and genotypic distributions of the polymorphic markers C1167T and Pro197Leu of the genes of catalase (CAT) and glutathione peroxidase (GPX1), respectively, were studied in patients with non-insulin-dependent diabetes mellitus (NIDDM) and hypertension without complications (the control group, n = 52) and with complications: myocardial infarction (MI, n = 53) or stroke (n = 50).
11357375	2001	Genetika	0016-6758	ALL_TEXT_1/3	1	1	2876	LONGTERM|DICTIONARY	gpx1	GPX1	143#147	NaN	D009203	SYMBOL|EXTRACTED	mi	MI	356#358	11357375-1-333-354	Allelic and genotypic distributions of the polymorphic markers C1167T and Pro197Leu of the genes of catalase (CAT) and glutathione peroxidase (GPX1), respectively, were studied in patients with non-insulin-dependent diabetes mellitus (NIDDM) and hypertension without complications (the control group, n = 52) and with complications: myocardial infarction (MI, n = 53) or stroke (n = 50).
11357375	2001	Genetika	0016-6758	ALL_TEXT_1/3	1	1	2876	LONGTERM|DICTIONARY	gpx1	GPX1	143#147	NaN	D020521	LONGTERM|DICTIONARY	stroke	stroke	371#377		Allelic and genotypic distributions of the polymorphic markers C1167T and Pro197Leu of the genes of catalase (CAT) and glutathione peroxidase (GPX1), respectively, were studied in patients with non-insulin-dependent diabetes mellitus (NIDDM) and hypertension without complications (the control group, n = 52) and with complications: myocardial infarction (MI, n = 53) or stroke (n = 50).
11357375	2001	Genetika	0016-6758	TITLE	0	0	847	LONGTERM|DICTIONARY	catalase	catalase	17#25		D003924	LONGTERM|DICTIONARY	non insulin dependent diabetes mellitus	non-insulin-dependent diabetes mellitus	107#146		[Polymorphism of catalase and glutathione peroxidase genes in macrovascular complications in patients with non-insulin-dependent diabetes mellitus and hypertension].
11357375	2001	Genetika	0016-6758	TITLE	0	0	847	LONGTERM|DICTIONARY	catalase	catalase	17#25		D006973	LONGTERM|DICTIONARY	hypertension	hypertension	151#163		[Polymorphism of catalase and glutathione peroxidase genes in macrovascular complications in patients with non-insulin-dependent diabetes mellitus and hypertension].
11357375	2001	Genetika	0016-6758	TITLE	0	0	847	LONGTERM|DICTIONARY	catalase	catalase	17#25		D003925	LONGTERM|DICTIONARY	macrovascular complications	macrovascular complications	62#89	NaN	[Polymorphism of catalase and glutathione peroxidase genes in macrovascular complications in patients with non-insulin-dependent diabetes mellitus and hypertension].
16086317	2006	Hum. Mutat.	1098-1004	ALL_TEXT_2/3	2	6	368	SYMBOL|DICTIONARY	abcc6	ABCC6	86#91		D011561	SYMBOL|DICTIONARY|EXTRACTED	pxe	PXE	164#167	16086317-1-0-24	Chromosomal haplotyping with two proximal and two distal polymorphic markers flanking ABCC6 demonstrated that most chromosomes that carry these relatively frequent PXE mutations have related haplotypes specific for these mutations, which suggests that these chromosomes originate from single founder mutations.
20484924	2010	Int. Arch. Allergy Immunol.	1423-0097	METHODS	2	5	3596	SYMBOL|DICTIONARY	il13	IL13	15#19		D012220	LONGTERM|DICTIONARY	rhinitis	rhinitis	58#66		Association of IL13 and IL4R polymorphisms in relation to rhinitis, asthma, serum IgE and skin test response was studied in: (1) 188 trios ascertained through a proband with rhinitis who were clinically not affected by asthma; (2) 407 trios with an asthmatic proband, and (3) 118 asthma cases and 102 unrelated healthy controls using family-based association testing, logistic regression, and analysis of variance as appropriate.
20484924	2010	Int. Arch. Allergy Immunol.	1423-0097	METHODS	2	5	3596	SYMBOL|DICTIONARY	il13	IL13	15#19		D001249	LONGTERM|DICTIONARY	asthma	asthma	68#74		Association of IL13 and IL4R polymorphisms in relation to rhinitis, asthma, serum IgE and skin test response was studied in: (1) 188 trios ascertained through a proband with rhinitis who were clinically not affected by asthma; (2) 407 trios with an asthmatic proband, and (3) 118 asthma cases and 102 unrelated healthy controls using family-based association testing, logistic regression, and analysis of variance as appropriate.
20484924	2010	Int. Arch. Allergy Immunol.	1423-0097	METHODS	2	5	3596	SYMBOL|DICTIONARY	il13	IL13	15#19		D012220	LONGTERM|DICTIONARY	rhinitis	rhinitis	174#182		Association of IL13 and IL4R polymorphisms in relation to rhinitis, asthma, serum IgE and skin test response was studied in: (1) 188 trios ascertained through a proband with rhinitis who were clinically not affected by asthma; (2) 407 trios with an asthmatic proband, and (3) 118 asthma cases and 102 unrelated healthy controls using family-based association testing, logistic regression, and analysis of variance as appropriate.
20484924	2010	Int. Arch. Allergy Immunol.	1423-0097	METHODS	2	5	3596	SYMBOL|DICTIONARY	il13	IL13	15#19		D001249	LONGTERM|DICTIONARY	asthma	asthma	219#225		Association of IL13 and IL4R polymorphisms in relation to rhinitis, asthma, serum IgE and skin test response was studied in: (1) 188 trios ascertained through a proband with rhinitis who were clinically not affected by asthma; (2) 407 trios with an asthmatic proband, and (3) 118 asthma cases and 102 unrelated healthy controls using family-based association testing, logistic regression, and analysis of variance as appropriate.
20484924	2010	Int. Arch. Allergy Immunol.	1423-0097	METHODS	2	5	3596	SYMBOL|DICTIONARY	il13	IL13	15#19		D013224	LONGTERM|DICTIONARY	asthmatic	asthmatic	249#258		Association of IL13 and IL4R polymorphisms in relation to rhinitis, asthma, serum IgE and skin test response was studied in: (1) 188 trios ascertained through a proband with rhinitis who were clinically not affected by asthma; (2) 407 trios with an asthmatic proband, and (3) 118 asthma cases and 102 unrelated healthy controls using family-based association testing, logistic regression, and analysis of variance as appropriate.
20484924	2010	Int. Arch. Allergy Immunol.	1423-0097	METHODS	2	5	3596	SYMBOL|DICTIONARY	il13	IL13	15#19		D001249	LONGTERM|DICTIONARY	asthma	asthma	280#286		Association of IL13 and IL4R polymorphisms in relation to rhinitis, asthma, serum IgE and skin test response was studied in: (1) 188 trios ascertained through a proband with rhinitis who were clinically not affected by asthma; (2) 407 trios with an asthmatic proband, and (3) 118 asthma cases and 102 unrelated healthy controls using family-based association testing, logistic regression, and analysis of variance as appropriate.
20484924	2010	Int. Arch. Allergy Immunol.	1423-0097	METHODS	2	5	3566	SYMBOL|DICTIONARY	il4r	IL4R	24#28		D012220	LONGTERM|DICTIONARY	rhinitis	rhinitis	58#66		Association of IL13 and IL4R polymorphisms in relation to rhinitis, asthma, serum IgE and skin test response was studied in: (1) 188 trios ascertained through a proband with rhinitis who were clinically not affected by asthma; (2) 407 trios with an asthmatic proband, and (3) 118 asthma cases and 102 unrelated healthy controls using family-based association testing, logistic regression, and analysis of variance as appropriate.
20484924	2010	Int. Arch. Allergy Immunol.	1423-0097	METHODS	2	5	3566	SYMBOL|DICTIONARY	il4r	IL4R	24#28		D001249	LONGTERM|DICTIONARY	asthma	asthma	68#74		Association of IL13 and IL4R polymorphisms in relation to rhinitis, asthma, serum IgE and skin test response was studied in: (1) 188 trios ascertained through a proband with rhinitis who were clinically not affected by asthma; (2) 407 trios with an asthmatic proband, and (3) 118 asthma cases and 102 unrelated healthy controls using family-based association testing, logistic regression, and analysis of variance as appropriate.
20484924	2010	Int. Arch. Allergy Immunol.	1423-0097	METHODS	2	5	3566	SYMBOL|DICTIONARY	il4r	IL4R	24#28		D012220	LONGTERM|DICTIONARY	rhinitis	rhinitis	174#182		Association of IL13 and IL4R polymorphisms in relation to rhinitis, asthma, serum IgE and skin test response was studied in: (1) 188 trios ascertained through a proband with rhinitis who were clinically not affected by asthma; (2) 407 trios with an asthmatic proband, and (3) 118 asthma cases and 102 unrelated healthy controls using family-based association testing, logistic regression, and analysis of variance as appropriate.
20484924	2010	Int. Arch. Allergy Immunol.	1423-0097	METHODS	2	5	3566	SYMBOL|DICTIONARY	il4r	IL4R	24#28		D001249	LONGTERM|DICTIONARY	asthma	asthma	219#225		Association of IL13 and IL4R polymorphisms in relation to rhinitis, asthma, serum IgE and skin test response was studied in: (1) 188 trios ascertained through a proband with rhinitis who were clinically not affected by asthma; (2) 407 trios with an asthmatic proband, and (3) 118 asthma cases and 102 unrelated healthy controls using family-based association testing, logistic regression, and analysis of variance as appropriate.
20484924	2010	Int. Arch. Allergy Immunol.	1423-0097	METHODS	2	5	3566	SYMBOL|DICTIONARY	il4r	IL4R	24#28		D013224	LONGTERM|DICTIONARY	asthmatic	asthmatic	249#258		Association of IL13 and IL4R polymorphisms in relation to rhinitis, asthma, serum IgE and skin test response was studied in: (1) 188 trios ascertained through a proband with rhinitis who were clinically not affected by asthma; (2) 407 trios with an asthmatic proband, and (3) 118 asthma cases and 102 unrelated healthy controls using family-based association testing, logistic regression, and analysis of variance as appropriate.
20484924	2010	Int. Arch. Allergy Immunol.	1423-0097	METHODS	2	5	3566	SYMBOL|DICTIONARY	il4r	IL4R	24#28		D001249	LONGTERM|DICTIONARY	asthma	asthma	280#286		Association of IL13 and IL4R polymorphisms in relation to rhinitis, asthma, serum IgE and skin test response was studied in: (1) 188 trios ascertained through a proband with rhinitis who were clinically not affected by asthma; (2) 407 trios with an asthmatic proband, and (3) 118 asthma cases and 102 unrelated healthy controls using family-based association testing, logistic regression, and analysis of variance as appropriate.
12939427	2004	Neurology	1526-632X	METHODS	3	5	4155	SYMBOL|DICTIONARY|EXTRACTED	mbp	MBP	66#69	12939427-1-4-24	D003711	LONGTERM|DICTIONARY	mbp	MBP	66#69	NaN	The phenotype, allele, and genotype frequencies for two groups of MBP alleles were determined.
20361264	2010	Fam. Cancer	1573-7292	ALL_TEXT_3/3	3	6	11186	SYMBOL|DICTIONARY	rassf1a	RASSF1A	11#18		D001943	LONGTERM|DISEASE|DT|DICTIONARY	familial breast cancer	familial breast cancer	98#120		Hence, the RASSF1A p.A331S polymorphism is not confirmed as a significant germline contributor to familial breast cancer susceptibility.
20361264	2010	Fam. Cancer	1573-7292	ALL_TEXT_2/3	2	4	11186	SYMBOL|DICTIONARY	rassf1a	RASSF1A	4#11		D001943	LONGTERM|DISEASE|DT|DICTIONARY	familial breast cancer	familial breast cancer	55#77		The RASSF1A p.A331S variant was not more common in the familial breast cancer cases than in the controls (P = 0.27).
20361264	2010	Fam. Cancer	1573-7292	ALL_TEXT_2/3	2	3	11186	SYMBOL|DICTIONARY	rassf1a	RASSF1A	21#28		D001943	LONGTERM|DISEASE|DN|DT|DICTIONARY	breast cancer	breast cancer	65#78		We genotyped p.A331S RASSF1A in 854 independent, familial, white breast cancer patients (645 BRCA mutation negative, 119 BRCA1 and 90 BRCA2 positive) and compared the genotype in 331 healthy women.
20361264	2010	Fam. Cancer	1573-7292	ALL_TEXT_2/3	2	3	672	SYMBOL|DICTIONARY	brca1	BRCA1	121#126		D001943	LONGTERM|DISEASE|DN|DT|DICTIONARY	breast cancer	breast cancer	65#78		We genotyped p.A331S RASSF1A in 854 independent, familial, white breast cancer patients (645 BRCA mutation negative, 119 BRCA1 and 90 BRCA2 positive) and compared the genotype in 331 healthy women.
20361264	2010	Fam. Cancer	1573-7292	ALL_TEXT_2/3	2	3	675	SYMBOL|DICTIONARY	brca2	BRCA2	134#139		D001943	LONGTERM|DISEASE|DN|DT|DICTIONARY	breast cancer	breast cancer	65#78		We genotyped p.A331S RASSF1A in 854 independent, familial, white breast cancer patients (645 BRCA mutation negative, 119 BRCA1 and 90 BRCA2 positive) and compared the genotype in 331 healthy women.
20361264	2010	Fam. Cancer	1573-7292	ALL_TEXT_1/3	1	2	11186	SYMBOL|DICTIONARY	rassf1a	RASSF1A	56#63		D001943	LONGTERM|DISEASE|DT|DICTIONARY	breast cancer	breast cancer	105#118		Recently, a missense polymorphism predicting p.A331S in RASSF1A was associated with an increased risk of breast cancer and early-onset breast cancer in BRCA1 and BRCA2 mutation carriers.
20361264	2010	Fam. Cancer	1573-7292	ALL_TEXT_1/3	1	2	11186	SYMBOL|DICTIONARY	rassf1a	RASSF1A	56#63		D001943	LONGTERM|DISEASE|DT|DICTIONARY	breast cancer	breast cancer	135#148		Recently, a missense polymorphism predicting p.A331S in RASSF1A was associated with an increased risk of breast cancer and early-onset breast cancer in BRCA1 and BRCA2 mutation carriers.
20361264	2010	Fam. Cancer	1573-7292	ALL_TEXT_1/3	1	2	672	SYMBOL|DICTIONARY	brca1	BRCA1	152#157		D001943	LONGTERM|DISEASE|DT|DICTIONARY	breast cancer	breast cancer	105#118		Recently, a missense polymorphism predicting p.A331S in RASSF1A was associated with an increased risk of breast cancer and early-onset breast cancer in BRCA1 and BRCA2 mutation carriers.
20361264	2010	Fam. Cancer	1573-7292	ALL_TEXT_1/3	1	2	672	SYMBOL|DICTIONARY	brca1	BRCA1	152#157		D001943	LONGTERM|DISEASE|DT|DICTIONARY	breast cancer	breast cancer	135#148		Recently, a missense polymorphism predicting p.A331S in RASSF1A was associated with an increased risk of breast cancer and early-onset breast cancer in BRCA1 and BRCA2 mutation carriers.
20361264	2010	Fam. Cancer	1573-7292	ALL_TEXT_1/3	1	2	675	SYMBOL|DICTIONARY	brca2	BRCA2	162#167		D001943	LONGTERM|DISEASE|DT|DICTIONARY	breast cancer	breast cancer	105#118		Recently, a missense polymorphism predicting p.A331S in RASSF1A was associated with an increased risk of breast cancer and early-onset breast cancer in BRCA1 and BRCA2 mutation carriers.
20361264	2010	Fam. Cancer	1573-7292	ALL_TEXT_1/3	1	2	675	SYMBOL|DICTIONARY	brca2	BRCA2	162#167		D001943	LONGTERM|DISEASE|DT|DICTIONARY	breast cancer	breast cancer	135#148		Recently, a missense polymorphism predicting p.A331S in RASSF1A was associated with an increased risk of breast cancer and early-onset breast cancer in BRCA1 and BRCA2 mutation carriers.
20361264	2010	Fam. Cancer	1573-7292	ALL_TEXT_1/3	1	1	11186	SYMBOL|()|DICTIONARY	rassf1a	RASSF1A	88#95		D001943	LONGTERM|DISEASE|DT|DICTIONARY	breast cancer	breast cancer	126#139		Inactivation or loss of the tumour suppressor Ras associated domain family 1 isoform A (RASSF1A) allele has been described in breast cancer.
20361264	2010	Fam. Cancer	1573-7292	TITLE	0	0	11186	SYMBOL|DICTIONARY	rassf1a	RASSF1A	0#7		D001943	LONGTERM|DISEASE|DT|DICTIONARY	familial breast cancer	familial breast cancer	24#46		RASSF1A polymorphism in familial breast cancer.
12150336	2003	J. Endocrinol. Invest.	0391-4097	ALL_TEXT_1/3	1	2	846	SYMBOL|EXTRACTED	car	CaR	88#91	12150336-1-4-28	D049950	SYMBOL|EXTRACTED	phpt	PHPT	143#147	12150336-1-345-372	The aim of the present study was to investigate the frequency of this and other 2 known CaR polymorphisms (R990G and Q1011 E) in patients with PHPT and their effect on its phenotype.
18573495	2009	Atherosclerosis	1879-1484	CONCLUSION	3	10	3553	SYMBOL|GENE|GN|DICTIONARY	il1b	IL1B	0#4		D009765	LONGTERM|DICTIONARY	obesity	obesity	103#110		IL1B genetic variation may have a role in CRP level regulation and this association may be modified by obesity.
18573495	2009	Atherosclerosis	1879-1484	CONCLUSION	3	10	1401	SYMBOL|DICTIONARY|EXTRACTED	crp	CRP	42#45	18573495-1-32-50	D009765	LONGTERM|DICTIONARY	obesity	obesity	103#110		IL1B genetic variation may have a role in CRP level regulation and this association may be modified by obesity.
12150336	2003	J. Endocrinol. Invest.	0391-4097	TITLE	0	0	846	LONGTERM|GENE|GN|GT|DICTIONARY	calcium sensing receptor	Calcium-sensing receptor	0#24		D049950	LONGTERM|DICTIONARY	primary hyperparathyroidism	primary hyperparathyroidism	47#74		Calcium-sensing receptor gene polymorphisms in primary hyperparathyroidism.
18498660	2008	BMC Med. Genet.	1471-2350	TITLE	0	0	60412	SYMBOL|DICTIONARY	exoc4	EXOC4	19#24		D003920	LONGTERM|DICTIONARY	diabetes	Diabetes	81#89		Polymorphisms near EXOC4 and LRGUK on chromosome 7q32 are associated with Type 2 Diabetes and fasting glucose; the NHLBI Family Heart Study.
18498660	2008	BMC Med. Genet.	1471-2350	TITLE	0	0	60412	SYMBOL|DICTIONARY	exoc4	EXOC4	19#24		D017827	LONGTERM|DICTIONARY	type	Type	74#78		Polymorphisms near EXOC4 and LRGUK on chromosome 7q32 are associated with Type 2 Diabetes and fasting glucose; the NHLBI Family Heart Study.
18498660	2008	BMC Med. Genet.	1471-2350	TITLE	0	0	136332	SYMBOL|DICTIONARY	lrguk	LRGUK	29#34		D003920	LONGTERM|DICTIONARY	diabetes	Diabetes	81#89		Polymorphisms near EXOC4 and LRGUK on chromosome 7q32 are associated with Type 2 Diabetes and fasting glucose; the NHLBI Family Heart Study.
18498660	2008	BMC Med. Genet.	1471-2350	TITLE	0	0	136332	SYMBOL|DICTIONARY	lrguk	LRGUK	29#34		D017827	LONGTERM|DICTIONARY	type	Type	74#78		Polymorphisms near EXOC4 and LRGUK on chromosome 7q32 are associated with Type 2 Diabetes and fasting glucose; the NHLBI Family Heart Study.
14697642	2004	Cancer Genet. Cytogenet.	0165-4608	ALL_TEXT_2/3	2	8	2064	SYMBOL|DICTIONARY	her 2 neu	HER-2/neu	188#197		D009369	LONGTERM|DICTIONARY	advanced-stage tumors	advanced-stage tumors	90#111		In addition, more profound chromosomal changes were consistently associated with the more advanced-stage tumors, and less expression of the estrogen and the progesterone receptors, and of HER-2/neu.
18498660	2008	BMC Med. Genet.	1471-2350	METHODS	2	4	6934	SYMBOL|DICTIONARY	tcf7l2	TCF7L2	66#72		C537770	LONGTERM|DICTIONARY	regression	Regression	0#10		Regression modeling, adjusting for BMI, age, sex, smoking and the TCF7L2 polymorphism, was used to evaluate the association of these polymorphisms with T2D and fasting glucoses levels.
16824064	2006	J. Gastroenterol. Hepatol.	0815-9319	TITLE	0	0	3576	LONGTERM|GENE|GN|DICTIONARY	interleukin 8	Interleukin-8	0#13		D013274	LONGTERM|DISEASE|DT|DICTIONARY	gastric carcinoma	gastric carcinoma	77#94		Interleukin-8 gene polymorphism associated with susceptibility to non-cardia gastric carcinoma with microsatellite instability.
16824064	2006	J. Gastroenterol. Hepatol.	0815-9319	TITLE	0	0	3576	LONGTERM|GENE|GN|DICTIONARY	interleukin 8	Interleukin-8	0#13		D053842	LONGTERM|DICTIONARY	microsatellite instability	microsatellite instability	100#126	NaN	Interleukin-8 gene polymorphism associated with susceptibility to non-cardia gastric carcinoma with microsatellite instability.
16824064	2006	J. Gastroenterol. Hepatol.	0815-9319	BACKGROUND AND AIM	1	1	5928	LONGTERM|DICTIONARY	msi	MSI	56#59	NaN	D013274	LONGTERM|DISEASE|DT|DICTIONARY	gastric carcinoma	Gastric carcinoma	0#17		Gastric carcinoma (GC) with microsatellite instability (MSI) exhibits clinicopathological characteristics distinct from microsatellite-stable (MSS) GC.
16824064	2006	J. Gastroenterol. Hepatol.	0815-9319	BACKGROUND AND AIM	1	1	5928	LONGTERM|DICTIONARY	msi	MSI	56#59	NaN	D013274	SYMBOL|EXTRACTED|()	gc	GC	19#21	16824064-1-0-17	Gastric carcinoma (GC) with microsatellite instability (MSI) exhibits clinicopathological characteristics distinct from microsatellite-stable (MSS) GC.
16824064	2006	J. Gastroenterol. Hepatol.	0815-9319	BACKGROUND AND AIM	1	1	5928	LONGTERM|DICTIONARY	msi	MSI	56#59	NaN	D013274	SYMBOL|EXTRACTED	gc	GC	148#150	16824064-1-0-17	Gastric carcinoma (GC) with microsatellite instability (MSI) exhibits clinicopathological characteristics distinct from microsatellite-stable (MSS) GC.
16824064	2006	J. Gastroenterol. Hepatol.	0815-9319	BACKGROUND AND AIM	1	1	5928	LONGTERM|DICTIONARY	msi	MSI	56#59	NaN	C536652	LONGTERM|DICTIONARY	msi	MSI	56#59	NaN	Gastric carcinoma (GC) with microsatellite instability (MSI) exhibits clinicopathological characteristics distinct from microsatellite-stable (MSS) GC.
16824064	2006	J. Gastroenterol. Hepatol.	0815-9319	BACKGROUND AND AIM	1	1	5928	LONGTERM|DICTIONARY	msi	MSI	56#59	NaN	D053842	LONGTERM|DICTIONARY	microsatellite instability	microsatellite instability	28#54	NaN	Gastric carcinoma (GC) with microsatellite instability (MSI) exhibits clinicopathological characteristics distinct from microsatellite-stable (MSS) GC.
16824064	2006	J. Gastroenterol. Hepatol.	0815-9319	BACKGROUND AND AIM	1	1	5928	LONGTERM|DICTIONARY	msi	MSI	56#59	NaN	D053842	LONGTERM|DICTIONARY	microsatellite-stable	microsatellite-stable	120#141	NaN	Gastric carcinoma (GC) with microsatellite instability (MSI) exhibits clinicopathological characteristics distinct from microsatellite-stable (MSS) GC.
14697642	2004	Cancer Genet. Cytogenet.	0165-4608	TITLE	0	0	7157	SYMBOL|DICTIONARY	tp53	TP53	148#152		D001943	LONGTERM|DICTIONARY	breast cancers	breast cancers	91#105		Chromosomal comparative genomic hybridization abnormalities in early- and late-onset human breast cancers: correlation with disease progression and TP53 mutations.
16824064	2006	J. Gastroenterol. Hepatol.	0815-9319	BACKGROUND AND AIM	1	5	5928	LONGTERM|DICTIONARY	msi	MSI	97#100	NaN	C536652	LONGTERM|DICTIONARY	msi	MSI	97#100	NaN	The objective of this study was to elucidate the relationship between cytokine polymorphisms and MSI phenotypes.
16824064	2006	J. Gastroenterol. Hepatol.	0815-9319	METHODS	2	6	3553	SYMBOL|NUMBER|DICTIONARY	il 1b	IL-1B	98#103		D013274	SYMBOL|EXTRACTED	gc	GC	69#71	16824064-1-0-17	In a case-control study including 482 controls and 181 patients with GC, interleukin (IL)-8 -251, IL-1B-511, IL-1RN, and tumor necrosis factor-A (TNFA) -857 polymorphisms were genotyped.
16824064	2006	J. Gastroenterol. Hepatol.	0815-9319	METHODS	2	6	3557	SYMBOL|DICTIONARY	il 1rn	IL-1RN	109#115		D013274	SYMBOL|EXTRACTED	gc	GC	69#71	16824064-1-0-17	In a case-control study including 482 controls and 181 patients with GC, interleukin (IL)-8 -251, IL-1B-511, IL-1RN, and tumor necrosis factor-A (TNFA) -857 polymorphisms were genotyped.
16824064	2006	J. Gastroenterol. Hepatol.	0815-9319	METHODS	2	6	7124	LONGTERM|GENE|GT|DICTIONARY	tumor necrosis factor-a	tumor necrosis factor-A	121#144		D013274	SYMBOL|EXTRACTED	gc	GC	69#71	16824064-1-0-17	In a case-control study including 482 controls and 181 patients with GC, interleukin (IL)-8 -251, IL-1B-511, IL-1RN, and tumor necrosis factor-A (TNFA) -857 polymorphisms were genotyped.
16824064	2006	J. Gastroenterol. Hepatol.	0815-9319	METHODS	2	7	7157	SYMBOL|GENE|GN|DICTIONARY	p53	p53	57#60		D013274	SYMBOL|EXTRACTED	gc	GC	83#85	16824064-1-0-17	The presence of MSI and mutations in exons 5 to 8 of the p53 gene were examined in GC cases.
16824064	2006	J. Gastroenterol. Hepatol.	0815-9319	METHODS	2	7	7157	SYMBOL|GENE|GN|DICTIONARY	p53	p53	57#60		C536652	LONGTERM|DICTIONARY	msi	MSI	16#19	NaN	The presence of MSI and mutations in exons 5 to 8 of the p53 gene were examined in GC cases.
16824064	2006	J. Gastroenterol. Hepatol.	0815-9319	METHODS	2	7	5928	LONGTERM|DICTIONARY	msi	MSI	16#19	NaN	D013274	SYMBOL|EXTRACTED	gc	GC	83#85	16824064-1-0-17	The presence of MSI and mutations in exons 5 to 8 of the p53 gene were examined in GC cases.
16824064	2006	J. Gastroenterol. Hepatol.	0815-9319	METHODS	2	7	5928	LONGTERM|DICTIONARY	msi	MSI	16#19	NaN	C536652	LONGTERM|DICTIONARY	msi	MSI	16#19	NaN	The presence of MSI and mutations in exons 5 to 8 of the p53 gene were examined in GC cases.
20010906	2010	Int J Obes (Lond)	1476-5497	OBJECTIVE	1	2	4828	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	nmb	NMB	3#6	20010906-1-0-12	D009765	LONGTERM|DICTIONARY	obesity	obesity	65#72		An NMB gene polymorphism (P73T) has been earlier associated with obesity and abnormal eating behaviour in adults.
20959826	2011	Br. J. Cancer	1532-1827	METHODS	2	5	3845	SYMBOL|DICTIONARY	kras	KRAS	24#28		D015179	SYMBOL|DICTIONARY|EXTRACTED	crc	CRC	42#45	20959826-2-120-137	The prognostic value of KRAS mutations in CRC was evaluated using survival analysis.
16774538	2006	Tissue Antigens	0001-2815	TITLE	0	0	4312	SYMBOL|GENE|GN|DICTIONARY	mmp 1	MMP-1	0#5		D055113	LONGTERM|DICTIONARY	chronic periodontitis	chronic periodontitis	55#76		MMP-1 promoter gene polymorphism and susceptibility to chronic periodontitis in a Chinese population.
16358723	2006	Genetika	0016-6758	ALL_TEXT_1/3	1	1	1234	SYMBOL|DICTIONARY	ccr5	CCR5	47#51		D015658	LONGTERM|DISEASE|DT|DICTIONARY|DA	human immunodeficiency virus (hiv-1) infection	human immunodeficiency virus (HIV-1) infection	183#229		The 32-bp deletion (CCR5del32 mutation) in the CCR5 (chemokine (C-C motif) receptor 5) gene, encoding CCR5 chemokine receptor, is one of the factors determining natural resistance to human immunodeficiency virus (HIV-1) infection.
16358723	2006	Genetika	0016-6758	ALL_TEXT_1/3	1	1	1234	SYMBOL|DICTIONARY	ccr5	CCR5	47#51		D015658	SYMBOL|EXTRACTED|()|DISEASE|DN	human immunodeficiency virus (hiv-1) infection	human immunodeficiency virus (HIV-1) infection	183#229	16358723-1-183-211	The 32-bp deletion (CCR5del32 mutation) in the CCR5 (chemokine (C-C motif) receptor 5) gene, encoding CCR5 chemokine receptor, is one of the factors determining natural resistance to human immunodeficiency virus (HIV-1) infection.
16358723	2006	Genetika	0016-6758	ALL_TEXT_1/3	1	1	1234	SYMBOL|DICTIONARY	ccr5	CCR5	102#106		D015658	LONGTERM|DISEASE|DT|DICTIONARY|DA	human immunodeficiency virus (hiv-1) infection	human immunodeficiency virus (HIV-1) infection	183#229		The 32-bp deletion (CCR5del32 mutation) in the CCR5 (chemokine (C-C motif) receptor 5) gene, encoding CCR5 chemokine receptor, is one of the factors determining natural resistance to human immunodeficiency virus (HIV-1) infection.
16358723	2006	Genetika	0016-6758	ALL_TEXT_1/3	1	1	1234	SYMBOL|DICTIONARY	ccr5	CCR5	102#106		D015658	SYMBOL|EXTRACTED|()|DISEASE|DN	human immunodeficiency virus (hiv-1) infection	human immunodeficiency virus (HIV-1) infection	183#229	16358723-1-183-211	The 32-bp deletion (CCR5del32 mutation) in the CCR5 (chemokine (C-C motif) receptor 5) gene, encoding CCR5 chemokine receptor, is one of the factors determining natural resistance to human immunodeficiency virus (HIV-1) infection.
20663522	2010	J. Urol.	1527-3792	MATERIALS AND METHODS	2	3	1113	LONGTERM|DICTIONARY	chromogranin a	Chromogranin A	0#14		D011471	LONGTERM|DISEASE|DT|DICTIONARY	prostate cancer	prostate cancer	119#134		Chromogranin A and endothelin-1 expression was evaluated by immunohistochemistry in prostate specimens of 114 men with prostate cancer who underwent radical retropubic prostatectomy and in 27 with bladder cancer who underwent radical cystectomy and served as controls.
20663522	2010	J. Urol.	1527-3792	MATERIALS AND METHODS	2	3	1113	LONGTERM|DICTIONARY	chromogranin a	Chromogranin A	0#14		D001749	LONGTERM|DISEASE|DT|DICTIONARY	bladder cancer	bladder cancer	197#211		Chromogranin A and endothelin-1 expression was evaluated by immunohistochemistry in prostate specimens of 114 men with prostate cancer who underwent radical retropubic prostatectomy and in 27 with bladder cancer who underwent radical cystectomy and served as controls.
20663522	2010	J. Urol.	1527-3792	MATERIALS AND METHODS	2	3	1906	LONGTERM|DICTIONARY	endothelin 1	endothelin-1	19#31		D011471	LONGTERM|DISEASE|DT|DICTIONARY	prostate cancer	prostate cancer	119#134		Chromogranin A and endothelin-1 expression was evaluated by immunohistochemistry in prostate specimens of 114 men with prostate cancer who underwent radical retropubic prostatectomy and in 27 with bladder cancer who underwent radical cystectomy and served as controls.
20663522	2010	J. Urol.	1527-3792	MATERIALS AND METHODS	2	3	1906	LONGTERM|DICTIONARY	endothelin 1	endothelin-1	19#31		D001749	LONGTERM|DISEASE|DT|DICTIONARY	bladder cancer	bladder cancer	197#211		Chromogranin A and endothelin-1 expression was evaluated by immunohistochemistry in prostate specimens of 114 men with prostate cancer who underwent radical retropubic prostatectomy and in 27 with bladder cancer who underwent radical cystectomy and served as controls.
16054149	2006	Atherosclerosis	0021-9150	ALL_TEXT_3/3	3	9	116519	SYMBOL|DICTIONARY	apoa5	APOA5	54#59		D003324	SYMBOL|DICTIONARY|EXTRACTED	cad	CAD	131#134	16054149-2-29-52	Notably, haplotype analysis further verified that the APOA5 -1131C and c.553T bi-loci haplotype was significantly overpresented in CAD, as compared to the controls.
20037740	2011	Comp. Funct. Genomics	1532-6268	ALL_TEXT_2/3	2	5	3576	SYMBOL|DICTIONARY	il 8	IL-8	20#24		D002100	LONGTERM|DICTIONARY	cachexia	cachexia	166#174		The serum levels of IL-8 were significantly elevated in patients with low-third gastric cancer compared with controls, and were further up-regulated in patients with cachexia than those without (Z = -3.134, P = .002).
20037740	2011	Comp. Funct. Genomics	1532-6268	ALL_TEXT_2/3	2	5	3576	SYMBOL|DICTIONARY	il 8	IL-8	20#24		D013274	LONGTERM|DISEASE|DT|DICTIONARY	low-third gastric cancer	low-third gastric cancer	70#94		The serum levels of IL-8 were significantly elevated in patients with low-third gastric cancer compared with controls, and were further up-regulated in patients with cachexia than those without (Z = -3.134, P = .002).
20037740	2011	Comp. Funct. Genomics	1532-6268	ALL_TEXT_1/3	1	2	3576	SYMBOL|GENE|GN|DICTIONARY	il 8	IL-8	20#24		D009369	LONGTERM|DISEASE|DT|DICTIONARY	cancer cachexia	cancer cachexia	101#116		The polymorphism of IL-8 gene, which may affect the production level of IL-8, may be associated with cancer cachexia.Methods.
20037740	2011	Comp. Funct. Genomics	1532-6268	ALL_TEXT_1/3	1	2	3576	SYMBOL|GENE|GN|DICTIONARY	il 8	IL-8	20#24		D009369	LONGTERM|DICTIONARY	cancer cachexia	cancer cachexia	101#116		The polymorphism of IL-8 gene, which may affect the production level of IL-8, may be associated with cancer cachexia.Methods.
20037740	2011	Comp. Funct. Genomics	1532-6268	ALL_TEXT_1/3	1	2	3576	SYMBOL|DICTIONARY	il 8	IL-8	72#76		D009369	LONGTERM|DISEASE|DT|DICTIONARY	cancer cachexia	cancer cachexia	101#116		The polymorphism of IL-8 gene, which may affect the production level of IL-8, may be associated with cancer cachexia.Methods.
20037740	2011	Comp. Funct. Genomics	1532-6268	ALL_TEXT_1/3	1	2	3576	SYMBOL|DICTIONARY	il 8	IL-8	72#76		D009369	LONGTERM|DICTIONARY	cancer cachexia	cancer cachexia	101#116		The polymorphism of IL-8 gene, which may affect the production level of IL-8, may be associated with cancer cachexia.Methods.
20037740	2011	Comp. Funct. Genomics	1532-6268	TITLE	0	0	3576	LONGTERM|DICTIONARY	interleukin 8	interleukin-8	15#28		D002100	LONGTERM|DICTIONARY	cachexia	cachexia	34#42		Association of interleukin-8 with cachexia from patients with low-third gastric cancer.
20037740	2011	Comp. Funct. Genomics	1532-6268	TITLE	0	0	3576	LONGTERM|DICTIONARY	interleukin 8	interleukin-8	15#28		D013274	LONGTERM|DISEASE|DT|DICTIONARY	low-third gastric cancer	low-third gastric cancer	62#86		Association of interleukin-8 with cachexia from patients with low-third gastric cancer.
20616199	2010	Am. J. Epidemiol.	1476-6256	ALL_TEXT_3/3	3	5	7916	SYMBOL|DICTIONARY	bat2	BAT2	88#92		D009765	LONGTERM|DICTIONARY	obesity	obesity	16#23		Odds ratios for obesity ranged from 1.46 (95% confidence interval (CI): 1.12, 1.92) for BAT2 to 2.16 (95% CI: 1.39, 3.37) for MC4R.
20616199	2010	Am. J. Epidemiol.	1476-6256	ALL_TEXT_3/3	3	5	4160	SYMBOL|DICTIONARY	mc4r	MC4R	126#130		D009765	LONGTERM|DICTIONARY	obesity	obesity	16#23		Odds ratios for obesity ranged from 1.46 (95% confidence interval (CI): 1.12, 1.92) for BAT2 to 2.16 (95% CI: 1.39, 3.37) for MC4R.
1980685	1991	J. Lipid Res.	0022-2275	TITLE	0	0	335	LONGTERM|GENE|GN|DICTIONARY	apolipoprotein a i	apolipoprotein A-I	6#24		C564591	LONGTERM|DICTIONARY	hyperalphalipoproteinemia	hyperalphalipoproteinemia	70#95		Human apolipoprotein A-I gene promoter polymorphism: association with hyperalphalipoproteinemia.
15956353	2005	J. Mol. Endocrinol.	0952-5041	ALL_TEXT_3/3	3	7	1594	SYMBOL|GENE|GN|DICTIONARY	cyp27b1	CYP27B1	21#28		D000224	LONGTERM|DISEASE|DT|DICTIONARY	autoimmune addison disease	autoimmune Addison's disease	122#150		Alleles at the three CYP27B1 markers were in tight linkage disequilibrium with each other and all showed association with autoimmune Addison's disease.
15956353	2005	J. Mol. Endocrinol.	0952-5041	TITLE	0	0	1594	SYMBOL|GENE|GN|DICTIONARY	cyp27b1	CYP27B1	19#26		D000224	LONGTERM|DISEASE|DT|DICTIONARY	autoimmune addison disease	autoimmune Addison's disease	55#83		A haplotype of the CYP27B1 promoter is associated with autoimmune Addison's disease but not with Graves' disease in a UK population.
15956353	2005	J. Mol. Endocrinol.	0952-5041	TITLE	0	0	1594	SYMBOL|GENE|GN|DICTIONARY	cyp27b1	CYP27B1	19#26		D006111	LONGTERM|DISEASE|DT|DICTIONARY	graves disease	Graves' disease	97#112		A haplotype of the CYP27B1 promoter is associated with autoimmune Addison's disease but not with Graves' disease in a UK population.
15956353	2005	J. Mol. Endocrinol.	0952-5041	ALL_TEXT_1/3	1	2	1594	SYMBOL|GENE|GN|DICTIONARY	cyp27b1	CYP27B1	116#123		D006111	LONGTERM|DISEASE|DT|DICTIONARY	graves disease	Graves' disease	160#175		We have examined three single nucleotide polymorphisms (SNPs) that are located in the 5' region and promoter of the CYP27B1 gene for association in a cohort of Graves' disease and autoimmune Addison's disease subjects from the UK.
15956353	2005	J. Mol. Endocrinol.	0952-5041	ALL_TEXT_1/3	1	2	1594	SYMBOL|GENE|GN|DICTIONARY	cyp27b1	CYP27B1	116#123		D000224	LONGTERM|DISEASE|DT|DICTIONARY	autoimmune addison disease	autoimmune Addison's disease	180#208		We have examined three single nucleotide polymorphisms (SNPs) that are located in the 5' region and promoter of the CYP27B1 gene for association in a cohort of Graves' disease and autoimmune Addison's disease subjects from the UK.
15956353	2005	J. Mol. Endocrinol.	0952-5041	ALL_TEXT_1/3	1	3	1594	SYMBOL|DICTIONARY	cyp27b1	CYP27B1	210#217		D000224	LONGTERM|DISEASE|DT|DICTIONARY	autoimmune addison disease	autoimmune Addison's disease	45#73		Genomic DNA samples from white patients with autoimmune Addison's disease (n = 104) and healthy controls (n = 464) were genotyped by PCR-RFLP analysis for the SNPs at positions -1260 and -1077 5' of the coding CYP27B1 sequences.
14691540	2006	PLoS Biol.	1545-7885	TITLE	0	0	2572	SYMBOL|DICTIONARY	gad2	GAD2	0#4		D009765	LONGTERM|DICTIONARY	obesity	obesity	55#62		GAD2 on chromosome 10p12 is a candidate gene for human obesity.
21285140	2011	Am J Psychiatry	1535-7228	CONCLUSIONS	4	9	9378	SYMBOL|DICTIONARY	nrxn1	NRXN1	138#143		D012559	LONGTERM|DICTIONARY	schizophrenia	schizophrenia	45#58		The data strongly confirm the association of schizophrenia with 1q21.1, 15q13.3, and 22q11.21 deletions, 16p11.2 duplications, and exonic NRXN1 deletions.
18043699	2009	Eur J Clin Nutr	1476-5640	ALL_TEXT_3/3	3	5	27087	LONGTERM|DICTIONARY	leu7	Leu7	110#114	NaN	D009765	LONGTERM|DICTIONARY	obesity	obesity	26#33		The results indicate that obesity may be a pivotal factor in multiplying the disease risk associated with the Leu7Pro polymorphism in preproNPY.
18043699	2009	Eur J Clin Nutr	1476-5640	ALL_TEXT_3/3	3	5	4852	LONGTERM|DICTIONARY	prepronpy	preproNPY	134#143	NaN	D009765	LONGTERM|DICTIONARY	obesity	obesity	26#33		The results indicate that obesity may be a pivotal factor in multiplying the disease risk associated with the Leu7Pro polymorphism in preproNPY.
15834927	2005	Hepatology	0270-9139	ALL_TEXT_2/3	2	7	4524	SYMBOL|DICTIONARY|EXTRACTED	mthfr	MTHFR	30#35	15834927-2-47-82	D005234	LONGTERM|DICTIONARY	steatosis	Steatosis	0#9		Steatosis correlated with the MTHFR polymorphism, homocysteinemia, HAI and fibrosis.
15834927	2005	Hepatology	0270-9139	ALL_TEXT_2/3	2	7	4524	SYMBOL|DICTIONARY|EXTRACTED	mthfr	MTHFR	30#35	15834927-2-47-82	C566403	LONGTERM|DICTIONARY	homocysteinemia	homocysteinemia	50#65		Steatosis correlated with the MTHFR polymorphism, homocysteinemia, HAI and fibrosis.
15834927	2005	Hepatology	0270-9139	ALL_TEXT_2/3	2	7	4524	SYMBOL|DICTIONARY|EXTRACTED	mthfr	MTHFR	30#35	15834927-2-47-82	D005355	LONGTERM|DICTIONARY	fibrosis	fibrosis	75#83	NaN	Steatosis correlated with the MTHFR polymorphism, homocysteinemia, HAI and fibrosis.
20514303	2010	J. Korean Med. Sci.	1598-6357	ALL_TEXT_1/3	1	1	2322	SYMBOL|DICTIONARY	flt3	FLT3	162#166		D015470	LONGTERM|DICTIONARY	acute myeloid leukemia	acute myeloid leukemia	115#137		Identification of prognostic factors and risk-based post-remission therapy was proposed to improve the outcomes of acute myeloid leukemia (AML) and a mutation of FLT3 has been reported to be a risk factor, especially for pediatric patients.
20514303	2010	J. Korean Med. Sci.	1598-6357	ALL_TEXT_1/3	1	1	2322	SYMBOL|DICTIONARY	flt3	FLT3	162#166		D015470	SYMBOL|()|DICTIONARY|EXTRACTED	aml	AML	139#142	20514303-1-115-137	Identification of prognostic factors and risk-based post-remission therapy was proposed to improve the outcomes of acute myeloid leukemia (AML) and a mutation of FLT3 has been reported to be a risk factor, especially for pediatric patients.
20514303	2010	J. Korean Med. Sci.	1598-6357	TITLE	0	0	2322	SYMBOL|DICTIONARY	flt3	FLT3	25#29		D015470	LONGTERM|DICTIONARY	pediatric acute myeloid leukemia	pediatric acute myeloid leukemia	70#102		High transcript level of FLT3 associated with high risk of relapse in pediatric acute myeloid leukemia.
20514303	2010	J. Korean Med. Sci.	1598-6357	ALL_TEXT_2/3	2	3	2322	SYMBOL|DICTIONARY	flt3	FLT3	59#63		D015470	LONGTERM|DISEASE|DN|DICTIONARY	pediatric aml	pediatric AML	83#96		To define the prognostic significance, transcript level of FLT3 was analyzed in 52 pediatric AML patients.
19892845	2010	Clin. Chem.	1530-8561	RESULTS	3	10	672	SYMBOL|DICTIONARY	brca1	BRCA1	114#119		D001943	LONGTERM|DISEASE|DT|DICTIONARY	breast cancer	breast cancer	48#61		c.591C>T was detected in B(O)C families (1.5%), breast cancer cases (0.3%), and controls (0.9%). c.591C>T induced BRCA1 exon 9 skipping and modified the relative expression of Delta(9,10), Delta(9,10,11B), Delta11B, and full-length isoforms.
18436884	2008	Stroke	1524-4628	BACKGROUND AND PURPOSE	1	3	1234	SYMBOL|DICTIONARY|EXTRACTED	ccr5	CCR5	66#70		D002318	LONGTERM|DISEASE|DT|DICTIONARY	cardiovascular disease	cardiovascular disease	190#212		The main aim of this study was to examine potential effect of the CCR5-del32 mutation on systemic inflammation, intima-media thickness in carotid and femoral arteries, and on the indices of cardiovascular disease.
18436884	2008	Stroke	1524-4628	BACKGROUND AND PURPOSE	1	3	1234	SYMBOL|DICTIONARY|EXTRACTED	ccr5	CCR5	66#70		D007249	LONGTERM|DICTIONARY	inflammation	inflammation	98#110	NaN	The main aim of this study was to examine potential effect of the CCR5-del32 mutation on systemic inflammation, intima-media thickness in carotid and femoral arteries, and on the indices of cardiovascular disease.
18436884	2008	Stroke	1524-4628	TITLE	0	0	1234	SYMBOL|DICTIONARY|EXTRACTED	ccr5	CCR5	7#11		D002318	LONGTERM|DISEASE|DT|DICTIONARY	cardiovascular disease	cardiovascular disease	95#117		Common CCR5-del32 frameshift mutation associated with serum levels of inflammatory markers and cardiovascular disease risk in the Bruneck population.
18384775	2009	Fertil. Steril.	1556-5653	OBJECTIVE	1	1	2332	SYMBOL|DICTIONARY	fmr1	FMR1	60#64		D016649	LONGTERM|DICTIONARY	premature ovarian failure	premature ovarian failure	191#216		To assess whether the number of triple CGG expansion of the FMR1 (fragile X) gene, known to correlate at premutation (55-200 repeats) and full mutation (>200 repeats) ranges with risk toward premature ovarian failure (POF), also correlates with milder forms of premature ovarian senescence.
18384775	2009	Fertil. Steril.	1556-5653	OBJECTIVE	1	1	2332	SYMBOL|DICTIONARY	fmr1	FMR1	60#64		D016649	SYMBOL|()|DICTIONARY|EXTRACTED	pof	POF	218#221	18384775-1-191-216	To assess whether the number of triple CGG expansion of the FMR1 (fragile X) gene, known to correlate at premutation (55-200 repeats) and full mutation (>200 repeats) ranges with risk toward premature ovarian failure (POF), also correlates with milder forms of premature ovarian senescence.
18384775	2009	Fertil. Steril.	1556-5653	OBJECTIVE	1	1	2332	SYMBOL|DICTIONARY	fmr1	FMR1	60#64		D005600	LONGTERM|DICTIONARY	fragile x	fragile X	66#75	NaN	To assess whether the number of triple CGG expansion of the FMR1 (fragile X) gene, known to correlate at premutation (55-200 repeats) and full mutation (>200 repeats) ranges with risk toward premature ovarian failure (POF), also correlates with milder forms of premature ovarian senescence.
18436884	2008	Stroke	1524-4628	METHODS	2	4	1234	SYMBOL|()|DICTIONARY|EXTRACTED	ccr5	CCR5	138#142	18436884-4-118-136	D050197	LONGTERM|DICTIONARY	atherosclerosis	atherosclerosis	176#191		In the present study, we have examined the association of a common functional 32-bp frameshift deletion mutation in a chemokine receptor (CCR5) in relation to inflammation and atherosclerosis.
18436884	2008	Stroke	1524-4628	METHODS	2	4	1234	SYMBOL|()|DICTIONARY|EXTRACTED	ccr5	CCR5	138#142	18436884-4-118-136	D007249	LONGTERM|DICTIONARY	inflammation	inflammation	159#171	NaN	In the present study, we have examined the association of a common functional 32-bp frameshift deletion mutation in a chemokine receptor (CCR5) in relation to inflammation and atherosclerosis.
16006970	2005	J. Urol.	0022-5347	RESULTS	3	5	3569	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	il 6	IL-6	40#44	16006970-1-2-15	D011471	LONGTERM|DISEASE|DT|DICTIONARY	advanced prostate cancer	advanced prostate cancer	99#123		: We found that the -174G>C genotype of IL-6 gene was associated with an overall increased risk of advanced prostate cancer.
19710694	2010	J Hum Hypertens	1476-5527	ALL_TEXT_1/3	1	2	5029	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	p2ry2	P2RY2	75#80	19710694-0-4-49	D006973	LONGTERM|DICTIONARY	hypertension	hypertension	100#112		The aim of this study was to investigate the association between the human P2RY2 gene and essential hypertension (EH) through a haplotype-based case-control study that included two gender groups.
19710694	2010	J Hum Hypertens	1476-5527	TITLE	0	0	5029	LONGTERM|DICTIONARY|GENE|GA	purinergic receptor p2y g protein coupled 2	purinergic receptor P2Y, G-protein coupled, 2	4#49		D006973	LONGTERM|DICTIONARY	hypertension	hypertension	89#101		The purinergic receptor P2Y, G-protein coupled, 2 (P2RY2) gene associated with essential hypertension in Japanese men.
19710694	2010	J Hum Hypertens	1476-5527	TITLE	0	0	5029	SYMBOL|()|GENE|GN|DICTIONARY|EXTRACTED	p2ry2	P2RY2	51#56	19710694-0-4-49	D006973	LONGTERM|DICTIONARY	hypertension	hypertension	89#101		The purinergic receptor P2Y, G-protein coupled, 2 (P2RY2) gene associated with essential hypertension in Japanese men.
11179016	2001	Am. J. Hum. Genet.	0002-9297	ALL_TEXT_1/3	1	4	3117	SYMBOL|DICTIONARY	hla dqa1	HLA-DQA1	78#86		D009290	LONGTERM|DICTIONARY	narcoleptic	narcoleptic	34#45	NaN	As reported elsewhere, almost all narcoleptic subjects were positive for both HLA-DQA1*0102 and -DQB1*0602.
11179016	2001	Am. J. Hum. Genet.	0002-9297	ALL_TEXT_1/3	1	4	3119	LONGTERM|DICTIONARY	dqb1	DQB1	97#101	NaN	D009290	LONGTERM|DICTIONARY	narcoleptic	narcoleptic	34#45	NaN	As reported elsewhere, almost all narcoleptic subjects were positive for both HLA-DQA1*0102 and -DQB1*0602.
18701098	2009	Fertil. Steril.	1556-5653	ALL_TEXT	1	2	11132	SYMBOL|GENE|GN|DICTIONARY	capn 10	CAPN-10	77#84		D011085	SYMBOL|DICTIONARY|EXTRACTED	pcos	PCOS	145#149	18701098-1-156-181	Our data showed that 111 haplotype and 111/121 and 111/111 diplotypes in the CAPN-10 gene were associated with a significantly increased risk of PCOS, and 112 haplotype and 121/121 and 112/122 diplotypes were associated with decreased risk of PCOS in the Korean population.
18701098	2009	Fertil. Steril.	1556-5653	ALL_TEXT	1	2	11132	SYMBOL|GENE|GN|DICTIONARY	capn 10	CAPN-10	77#84		D011085	SYMBOL|DICTIONARY|EXTRACTED	pcos	PCOS	243#247	18701098-1-156-181	Our data showed that 111 haplotype and 111/121 and 111/111 diplotypes in the CAPN-10 gene were associated with a significantly increased risk of PCOS, and 112 haplotype and 121/121 and 112/122 diplotypes were associated with decreased risk of PCOS in the Korean population.
18701098	2009	Fertil. Steril.	1556-5653	ALL_TEXT	1	1	11132	SYMBOL|DICTIONARY	capn 10	CAPN-10	28#35		D011085	LONGTERM|DISEASE|DT|DICTIONARY	polycystic ovary syndrome	polycystic ovary syndrome	156#181		We investigated whether the CAPN-10 polymorphism UCSNP-43, -19, and -63 contribute, either individually or as haplotype/diplotype, to the susceptibility of polycystic ovary syndrome (PCOS) or related quantitative traits in Korean women.
18701098	2009	Fertil. Steril.	1556-5653	ALL_TEXT	1	1	11132	SYMBOL|DICTIONARY	capn 10	CAPN-10	28#35		D011085	SYMBOL|()|DICTIONARY|EXTRACTED	pcos	PCOS	183#187	18701098-1-156-181	We investigated whether the CAPN-10 polymorphism UCSNP-43, -19, and -63 contribute, either individually or as haplotype/diplotype, to the susceptibility of polycystic ovary syndrome (PCOS) or related quantitative traits in Korean women.
18701098	2009	Fertil. Steril.	1556-5653	TITLE	0	0	11132	LONGTERM|DICTIONARY	calpain 10	Calpain-10	21#31		D011085	LONGTERM|DISEASE|DT|DICTIONARY	polycystic ovary syndrome	polycystic ovary syndrome	63#88		111/121 diplotype of Calpain-10 is associated with the risk of polycystic ovary syndrome in Korean women.
15191797	2004	Exp. Neurol.	0014-4886	TITLE	0	0	960	SYMBOL|DICTIONARY	cd44	CD44	22#26		D013226	LONGTERM|DICTIONARY	status epilepticus	status epilepticus	98#116		Reciprocal changes of CD44 and GAP-43 expression in the dentate gyrus inner molecular layer after status epilepticus in mice.
15191797	2004	Exp. Neurol.	0014-4886	TITLE	0	0	2596	SYMBOL|DICTIONARY	gap 43	GAP-43	31#37		D013226	LONGTERM|DICTIONARY	status epilepticus	status epilepticus	98#116		Reciprocal changes of CD44 and GAP-43 expression in the dentate gyrus inner molecular layer after status epilepticus in mice.
15191797	2004	Exp. Neurol.	0014-4886	ALL_TEXT_3/3	3	8	2596	SYMBOL|DICTIONARY	gap 43	GAP-43	38#44		D013226	SYMBOL|EXTRACTED	se	SE	12#14	15191797-4-26-44	Thus, after SE in mice, early loss of GAP-43 and strong CD44 induction in the IML correlated with hilar cell loss and subsequent MFS.
15191797	2004	Exp. Neurol.	0014-4886	ALL_TEXT_3/3	3	8	960	SYMBOL|DICTIONARY	cd44	CD44	56#60		D013226	SYMBOL|EXTRACTED	se	SE	12#14	15191797-4-26-44	Thus, after SE in mice, early loss of GAP-43 and strong CD44 induction in the IML correlated with hilar cell loss and subsequent MFS.
21966470	2012	PLoS ONE	1932-6203	ALL_TEXT_1/3	1	1	4204	SYMBOL|()|GENE|GN|DICTIONARY|EXTRACTED	mecp2	MECP2	131#136	21966470-1-101-129	D015518	LONGTERM|DISEASE|DT|DICTIONARY	rett syndrome	Rett syndrome	0#13		Rett syndrome (RTT) is an autism spectrum developmental disorder caused by mutations in the X-linked methyl-CpG binding protein 2 (MECP2) gene.
21966470	2012	PLoS ONE	1932-6203	ALL_TEXT_1/3	1	1	4204	SYMBOL|()|GENE|GN|DICTIONARY|EXTRACTED	mecp2	MECP2	131#136	21966470-1-101-129	D015518	SYMBOL|()|DICTIONARY|EXTRACTED	rtt	RTT	15#18	21966470-1-0-13	Rett syndrome (RTT) is an autism spectrum developmental disorder caused by mutations in the X-linked methyl-CpG binding protein 2 (MECP2) gene.
21966470	2012	PLoS ONE	1932-6203	ALL_TEXT_1/3	1	1	4204	SYMBOL|()|GENE|GN|DICTIONARY|EXTRACTED	mecp2	MECP2	131#136	21966470-1-101-129	D001321	LONGTERM|DICTIONARY	autism	autism	26#32		Rett syndrome (RTT) is an autism spectrum developmental disorder caused by mutations in the X-linked methyl-CpG binding protein 2 (MECP2) gene.
21966470	2012	PLoS ONE	1932-6203	ALL_TEXT_1/3	1	1	4204	SYMBOL|()|GENE|GN|DICTIONARY|EXTRACTED	mecp2	MECP2	131#136	21966470-1-101-129	D002658	LONGTERM|DISEASE|DT|DICTIONARY	developmental disorder	developmental disorder	42#64		Rett syndrome (RTT) is an autism spectrum developmental disorder caused by mutations in the X-linked methyl-CpG binding protein 2 (MECP2) gene.
16168297	2005	J. Am. Coll. Cardiol.	1558-3597	OBJECTIVES	1	1	4846	LONGTERM|DICTIONARY	endothelial nitric oxide synthase	endothelial nitric oxide synthase	74#107		D009203	LONGTERM|DICTIONARY	myocardial infarction	myocardial infarction	132#153		This study sought to evaluate the effect of genetic polymorphism G894T on endothelial nitric oxide synthase (eNOS); on the risk for myocardial infarction (MI); and on the release of von Willebrand factor (vWF), interleukin (IL)-6, IL-1b, and oxidized low-density lipoprotein (ox-LDL) levels during the acute phase of MI and one year after the event.
16168297	2005	J. Am. Coll. Cardiol.	1558-3597	OBJECTIVES	1	1	4846	LONGTERM|DICTIONARY	endothelial nitric oxide synthase	endothelial nitric oxide synthase	74#107		D009203	SYMBOL|EXTRACTED|()	mi	MI	155#157	16168297-1-132-153	This study sought to evaluate the effect of genetic polymorphism G894T on endothelial nitric oxide synthase (eNOS); on the risk for myocardial infarction (MI); and on the release of von Willebrand factor (vWF), interleukin (IL)-6, IL-1b, and oxidized low-density lipoprotein (ox-LDL) levels during the acute phase of MI and one year after the event.
16168297	2005	J. Am. Coll. Cardiol.	1558-3597	OBJECTIVES	1	1	4846	LONGTERM|DICTIONARY	endothelial nitric oxide synthase	endothelial nitric oxide synthase	74#107		D009203	SYMBOL|EXTRACTED	mi	MI	317#319	16168297-1-132-153	This study sought to evaluate the effect of genetic polymorphism G894T on endothelial nitric oxide synthase (eNOS); on the risk for myocardial infarction (MI); and on the release of von Willebrand factor (vWF), interleukin (IL)-6, IL-1b, and oxidized low-density lipoprotein (ox-LDL) levels during the acute phase of MI and one year after the event.
16168297	2005	J. Am. Coll. Cardiol.	1558-3597	OBJECTIVES	1	1	4846	SYMBOL|EXTRACTED|()	enos	eNOS	109#113	16168297-1-74-107	D009203	LONGTERM|DICTIONARY	myocardial infarction	myocardial infarction	132#153		This study sought to evaluate the effect of genetic polymorphism G894T on endothelial nitric oxide synthase (eNOS); on the risk for myocardial infarction (MI); and on the release of von Willebrand factor (vWF), interleukin (IL)-6, IL-1b, and oxidized low-density lipoprotein (ox-LDL) levels during the acute phase of MI and one year after the event.
16168297	2005	J. Am. Coll. Cardiol.	1558-3597	OBJECTIVES	1	1	4846	SYMBOL|EXTRACTED|()	enos	eNOS	109#113	16168297-1-74-107	D009203	SYMBOL|EXTRACTED|()	mi	MI	155#157	16168297-1-132-153	This study sought to evaluate the effect of genetic polymorphism G894T on endothelial nitric oxide synthase (eNOS); on the risk for myocardial infarction (MI); and on the release of von Willebrand factor (vWF), interleukin (IL)-6, IL-1b, and oxidized low-density lipoprotein (ox-LDL) levels during the acute phase of MI and one year after the event.
16168297	2005	J. Am. Coll. Cardiol.	1558-3597	OBJECTIVES	1	1	4846	SYMBOL|EXTRACTED|()	enos	eNOS	109#113	16168297-1-74-107	D009203	SYMBOL|EXTRACTED	mi	MI	317#319	16168297-1-132-153	This study sought to evaluate the effect of genetic polymorphism G894T on endothelial nitric oxide synthase (eNOS); on the risk for myocardial infarction (MI); and on the release of von Willebrand factor (vWF), interleukin (IL)-6, IL-1b, and oxidized low-density lipoprotein (ox-LDL) levels during the acute phase of MI and one year after the event.
16168297	2005	J. Am. Coll. Cardiol.	1558-3597	OBJECTIVES	1	1	7450	LONGTERM|GENE|GT|DICTIONARY	von willebrand factor	von Willebrand factor	182#203		D009203	LONGTERM|DICTIONARY	myocardial infarction	myocardial infarction	132#153		This study sought to evaluate the effect of genetic polymorphism G894T on endothelial nitric oxide synthase (eNOS); on the risk for myocardial infarction (MI); and on the release of von Willebrand factor (vWF), interleukin (IL)-6, IL-1b, and oxidized low-density lipoprotein (ox-LDL) levels during the acute phase of MI and one year after the event.
16168297	2005	J. Am. Coll. Cardiol.	1558-3597	OBJECTIVES	1	1	7450	LONGTERM|GENE|GT|DICTIONARY	von willebrand factor	von Willebrand factor	182#203		D009203	SYMBOL|EXTRACTED|()	mi	MI	155#157	16168297-1-132-153	This study sought to evaluate the effect of genetic polymorphism G894T on endothelial nitric oxide synthase (eNOS); on the risk for myocardial infarction (MI); and on the release of von Willebrand factor (vWF), interleukin (IL)-6, IL-1b, and oxidized low-density lipoprotein (ox-LDL) levels during the acute phase of MI and one year after the event.
16168297	2005	J. Am. Coll. Cardiol.	1558-3597	OBJECTIVES	1	1	7450	LONGTERM|GENE|GT|DICTIONARY	von willebrand factor	von Willebrand factor	182#203		D009203	SYMBOL|EXTRACTED	mi	MI	317#319	16168297-1-132-153	This study sought to evaluate the effect of genetic polymorphism G894T on endothelial nitric oxide synthase (eNOS); on the risk for myocardial infarction (MI); and on the release of von Willebrand factor (vWF), interleukin (IL)-6, IL-1b, and oxidized low-density lipoprotein (ox-LDL) levels during the acute phase of MI and one year after the event.
16168297	2005	J. Am. Coll. Cardiol.	1558-3597	OBJECTIVES	1	1	7450	SYMBOL|EXTRACTED|()	vwf	vWF	205#208	16168297-1-182-203	D009203	LONGTERM|DICTIONARY	myocardial infarction	myocardial infarction	132#153		This study sought to evaluate the effect of genetic polymorphism G894T on endothelial nitric oxide synthase (eNOS); on the risk for myocardial infarction (MI); and on the release of von Willebrand factor (vWF), interleukin (IL)-6, IL-1b, and oxidized low-density lipoprotein (ox-LDL) levels during the acute phase of MI and one year after the event.
16168297	2005	J. Am. Coll. Cardiol.	1558-3597	OBJECTIVES	1	1	7450	SYMBOL|EXTRACTED|()	vwf	vWF	205#208	16168297-1-182-203	D009203	SYMBOL|EXTRACTED|()	mi	MI	155#157	16168297-1-132-153	This study sought to evaluate the effect of genetic polymorphism G894T on endothelial nitric oxide synthase (eNOS); on the risk for myocardial infarction (MI); and on the release of von Willebrand factor (vWF), interleukin (IL)-6, IL-1b, and oxidized low-density lipoprotein (ox-LDL) levels during the acute phase of MI and one year after the event.
16168297	2005	J. Am. Coll. Cardiol.	1558-3597	OBJECTIVES	1	1	7450	SYMBOL|EXTRACTED|()	vwf	vWF	205#208	16168297-1-182-203	D009203	SYMBOL|EXTRACTED	mi	MI	317#319	16168297-1-132-153	This study sought to evaluate the effect of genetic polymorphism G894T on endothelial nitric oxide synthase (eNOS); on the risk for myocardial infarction (MI); and on the release of von Willebrand factor (vWF), interleukin (IL)-6, IL-1b, and oxidized low-density lipoprotein (ox-LDL) levels during the acute phase of MI and one year after the event.
16168297	2005	J. Am. Coll. Cardiol.	1558-3597	OBJECTIVES	1	1	3553	SYMBOL|DICTIONARY	il 1b	IL-1b	231#236		D009203	LONGTERM|DICTIONARY	myocardial infarction	myocardial infarction	132#153		This study sought to evaluate the effect of genetic polymorphism G894T on endothelial nitric oxide synthase (eNOS); on the risk for myocardial infarction (MI); and on the release of von Willebrand factor (vWF), interleukin (IL)-6, IL-1b, and oxidized low-density lipoprotein (ox-LDL) levels during the acute phase of MI and one year after the event.
16168297	2005	J. Am. Coll. Cardiol.	1558-3597	OBJECTIVES	1	1	3553	SYMBOL|DICTIONARY	il 1b	IL-1b	231#236		D009203	SYMBOL|EXTRACTED|()	mi	MI	155#157	16168297-1-132-153	This study sought to evaluate the effect of genetic polymorphism G894T on endothelial nitric oxide synthase (eNOS); on the risk for myocardial infarction (MI); and on the release of von Willebrand factor (vWF), interleukin (IL)-6, IL-1b, and oxidized low-density lipoprotein (ox-LDL) levels during the acute phase of MI and one year after the event.
16168297	2005	J. Am. Coll. Cardiol.	1558-3597	OBJECTIVES	1	1	3553	SYMBOL|DICTIONARY	il 1b	IL-1b	231#236		D009203	SYMBOL|EXTRACTED	mi	MI	317#319	16168297-1-132-153	This study sought to evaluate the effect of genetic polymorphism G894T on endothelial nitric oxide synthase (eNOS); on the risk for myocardial infarction (MI); and on the release of von Willebrand factor (vWF), interleukin (IL)-6, IL-1b, and oxidized low-density lipoprotein (ox-LDL) levels during the acute phase of MI and one year after the event.
16168297	2005	J. Am. Coll. Cardiol.	1558-3597	OBJECTIVES	1	1	3569	SYMBOL|DICTIONARY	interleukin (il)-6	interleukin (IL)-6	211#229		D009203	LONGTERM|DICTIONARY	myocardial infarction	myocardial infarction	132#153		This study sought to evaluate the effect of genetic polymorphism G894T on endothelial nitric oxide synthase (eNOS); on the risk for myocardial infarction (MI); and on the release of von Willebrand factor (vWF), interleukin (IL)-6, IL-1b, and oxidized low-density lipoprotein (ox-LDL) levels during the acute phase of MI and one year after the event.
16168297	2005	J. Am. Coll. Cardiol.	1558-3597	OBJECTIVES	1	1	3569	SYMBOL|DICTIONARY	interleukin (il)-6	interleukin (IL)-6	211#229		D009203	SYMBOL|EXTRACTED|()	mi	MI	155#157	16168297-1-132-153	This study sought to evaluate the effect of genetic polymorphism G894T on endothelial nitric oxide synthase (eNOS); on the risk for myocardial infarction (MI); and on the release of von Willebrand factor (vWF), interleukin (IL)-6, IL-1b, and oxidized low-density lipoprotein (ox-LDL) levels during the acute phase of MI and one year after the event.
16168297	2005	J. Am. Coll. Cardiol.	1558-3597	OBJECTIVES	1	1	3569	SYMBOL|DICTIONARY	interleukin (il)-6	interleukin (IL)-6	211#229		D009203	SYMBOL|EXTRACTED	mi	MI	317#319	16168297-1-132-153	This study sought to evaluate the effect of genetic polymorphism G894T on endothelial nitric oxide synthase (eNOS); on the risk for myocardial infarction (MI); and on the release of von Willebrand factor (vWF), interleukin (IL)-6, IL-1b, and oxidized low-density lipoprotein (ox-LDL) levels during the acute phase of MI and one year after the event.
20208132	2010	Cell. Oncol.	1875-8606	BACKGROUND	1	3	835	LONGTERM|DICTIONARY	caspase 2	caspase-2	133#142		D002292	LONGTERM|DICTIONARY	renal cell carcinomas	renal cell carcinomas	48#69		We, therefore, investigated their expression in renal cell carcinomas (RCCs) of the clear cell type in vivo and analysed the role of caspase-2 in chemotherapy-induced apoptosis in RCCs in vitro.
20208132	2010	Cell. Oncol.	1875-8606	BACKGROUND	1	3	835	LONGTERM|DICTIONARY	caspase 2	caspase-2	133#142		D002292	SYMBOL|PLURAL|()|DICTIONARY|EXTRACTED	rccs	RCCs	71#75	20208132-3-48-69	We, therefore, investigated their expression in renal cell carcinomas (RCCs) of the clear cell type in vivo and analysed the role of caspase-2 in chemotherapy-induced apoptosis in RCCs in vitro.
20208132	2010	Cell. Oncol.	1875-8606	BACKGROUND	1	3	835	LONGTERM|DICTIONARY	caspase 2	caspase-2	133#142		D002292	SYMBOL|PLURAL|DICTIONARY|EXTRACTED	rccs	RCCs	180#184	20208132-3-48-69	We, therefore, investigated their expression in renal cell carcinomas (RCCs) of the clear cell type in vivo and analysed the role of caspase-2 in chemotherapy-induced apoptosis in RCCs in vitro.
16909243	2006	Pediatr. Nephrol.	0931-041X	ALL_TEXT_1/3	1	4	7490	LONGTERM|DICTIONARY	wt1	WT1	94#97	NaN	D052159	LONGTERM|DISEASE|DT|DICTIONARY	frasier syndrome	Frasier syndrome	141#157		Three girls out of 32 of the group with steroid resistance under 18 years presented classical WT1 splice mutations (IVS9+5G>A, IVS9+4C>T) of Frasier syndrome.
11891618	2002	Am. J. Hum. Genet.	0002-9297	TITLE	0	0	11132	LONGTERM|DICTIONARY	calpain 10	calpain-10	95#105		D003920	LONGTERM|DICTIONARY	diabetes	diabetes	55#63		Geographic and haplotype structure of candidate type 2 diabetes susceptibility variants at the calpain-10 locus.
11891618	2002	Am. J. Hum. Genet.	0002-9297	ALL_TEXT_1/3	1	1	11132	LONGTERM|DICTIONARY	calpain 10	calpain-10	69#79		D003924	LONGTERM|DICTIONARY	non insulin dependent diabetes mellitus	non-insulin-dependent diabetes mellitus	153#192		Recently, a positional cloning study proposed that haplotypes at the calpain-10 locus (CAPN10) are associated with increased risk of type 2 diabetes, or non-insulin-dependent diabetes mellitus, in Mexican Americans, Finns, and Germans.
11891618	2002	Am. J. Hum. Genet.	0002-9297	ALL_TEXT_1/3	1	1	11132	LONGTERM|DICTIONARY	calpain 10	calpain-10	69#79		D003920	LONGTERM|DICTIONARY	diabetes	diabetes	140#148		Recently, a positional cloning study proposed that haplotypes at the calpain-10 locus (CAPN10) are associated with increased risk of type 2 diabetes, or non-insulin-dependent diabetes mellitus, in Mexican Americans, Finns, and Germans.
11891618	2002	Am. J. Hum. Genet.	0002-9297	ALL_TEXT_1/3	1	1	11132	SYMBOL|()|DICTIONARY	capn10	CAPN10	87#93		D003924	LONGTERM|DICTIONARY	non insulin dependent diabetes mellitus	non-insulin-dependent diabetes mellitus	153#192		Recently, a positional cloning study proposed that haplotypes at the calpain-10 locus (CAPN10) are associated with increased risk of type 2 diabetes, or non-insulin-dependent diabetes mellitus, in Mexican Americans, Finns, and Germans.
11891618	2002	Am. J. Hum. Genet.	0002-9297	ALL_TEXT_1/3	1	1	11132	SYMBOL|()|DICTIONARY	capn10	CAPN10	87#93		D003920	LONGTERM|DICTIONARY	diabetes	diabetes	140#148		Recently, a positional cloning study proposed that haplotypes at the calpain-10 locus (CAPN10) are associated with increased risk of type 2 diabetes, or non-insulin-dependent diabetes mellitus, in Mexican Americans, Finns, and Germans.
9550468	1998	Arthritis Rheum.	0004-3591	CONCLUSION	4	8	596	SYMBOL|DICTIONARY	bcl 2	bcl-2	73#78		D008180	SYMBOL|DICTIONARY|EXTRACTED	sle	SLE	127#130	9550468-1-158-186	The results suggest that individuals carrying specific genotypes of both bcl-2 and IL-10 are at significant risk of developing SLE.
9550468	1998	Arthritis Rheum.	0004-3591	CONCLUSION	4	8	3586	SYMBOL|DICTIONARY	il 10	IL-10	83#88		D008180	SYMBOL|DICTIONARY|EXTRACTED	sle	SLE	127#130	9550468-1-158-186	The results suggest that individuals carrying specific genotypes of both bcl-2 and IL-10 are at significant risk of developing SLE.
17260091	2008	Breast Cancer Res. Treat.	0167-6806	RESULTS	3	5	4524	SYMBOL|NUMBER|DICTIONARY|EXTRACTED	mthfr	MTHFR	4#9	17260091-0-0-35	D001943	LONGTERM|DISEASE|DT|DICTIONARY	breast cancer	breast cancer	53#66		The MTHFR 677 genotype frequencies for CC, CT, TT in breast cancer cases were 30%, 44% and 26%, respectively, and 35%, 51%, 14% in controls.
17666372	2008	Haematologica	1592-8721	INTERPRETATION AND CONCLUSIONS	4	10	4255	SYMBOL|DICTIONARY	mgmt	MGMT	39#43		D008228	SYMBOL|DICTIONARY|EXTRACTED	nhl	NHL	67#70	17666372-1-141-163	The association of genetic variants in MGMT with increased risk of NHL suggests that alkyl adducts may contribute to lymphomagenesis, and points to environmental and endogenous alkylating agents as possible risk factors for NHL.
17666372	2008	Haematologica	1592-8721	INTERPRETATION AND CONCLUSIONS	4	10	4255	SYMBOL|DICTIONARY	mgmt	MGMT	39#43		D008228	SYMBOL|DICTIONARY|EXTRACTED	nhl	NHL	224#227	17666372-1-141-163	The association of genetic variants in MGMT with increased risk of NHL suggests that alkyl adducts may contribute to lymphomagenesis, and points to environmental and endogenous alkylating agents as possible risk factors for NHL.
18067970	2008	Ophthalmology	1549-4713	TITLE	0	0	3075	LONGTERM|DICTIONARY	complement factor h	complement factor H	58#77		D008268	LONGTERM|DICTIONARY	age related macular degeneration	age-related macular degeneration	102#134		Peripheral reticular pigmentary change is associated with complement factor H polymorphism (Y402H) in age-related macular degeneration.
18234410	2008	Prog. Neuropsychopharmacol. Biol. Psychiatry	0278-5846	ALL_TEXT_2/3	2	6	4524	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	mthfr	MTHFR	21#26	18234410-4-4-39	D020138	LONGTERM|DICTIONARY	hyperhomocysteinemia	hyperhomocysteinemia	49#69		The C677T variant of MTHFR gene can also lead to hyperhomocysteinemia particularly when serum folate level is decreased.
18234410	2008	Prog. Neuropsychopharmacol. Biol. Psychiatry	0278-5846	TITLE	0	0	4524	LONGTERM|GENE|GN|DICTIONARY	methylenetetrahydrofolate reductase	methylenetetrahydrofolate reductase	57#92		D020138	LONGTERM|DICTIONARY	hyperhomocysteinemia	hyperhomocysteinemia	102#122		Evaluation of the relationship between C677T variants of methylenetetrahydrofolate reductase gene and hyperhomocysteinemia in children receiving antiepileptic drug therapy.
18067970	2008	Ophthalmology	1549-4713	METHODS	4	4	3075	SYMBOL|DICTIONARY|EXTRACTED	cfh	CFH	67#70	18067970-1-82-101	D008268	SYMBOL|DISEASE|DN|DICTIONARY|EXTRACTED	amd	AMD	108#111	18067970-1-25-57	Age-related macular degeneration phenotypes of 796 carriers of the CFH Y402H variant were compared with the AMD phenotypes of 160 noncarriers.
18067970	2008	Ophthalmology	1549-4713	METHODS	4	4	3075	SYMBOL|DICTIONARY|EXTRACTED	cfh	CFH	67#70	18067970-1-82-101	D008268	LONGTERM|DISEASE|DN|DICTIONARY	macular degeneration	macular degeneration	12#32		Age-related macular degeneration phenotypes of 796 carriers of the CFH Y402H variant were compared with the AMD phenotypes of 160 noncarriers.
18067970	2008	Ophthalmology	1549-4713	RESULTS	6	7	3075	SYMBOL|DICTIONARY|EXTRACTED	cfh	CFH	68#71	18067970-1-82-101	D008268	SYMBOL|DICTIONARY|EXTRACTED	amd	AMD	18#21	18067970-1-25-57	The proportion of AMD cases with PRPC correlated with the number of CFH risk C alleles in a dose-response fashion.
19698145	2009	J Neuroinflammation	1742-2094	TITLE	0	0	3569	SYMBOL|DICTIONARY	il 6	IL-6	78#82		D000544	LONGTERM|DISEASE|DT|DICTIONARY	alzheimer disease	Alzheimer's disease	108#127		Replication by the Epistasis Project of the interaction between the genes for IL-6 and IL-10 in the risk of Alzheimer's disease.
19698145	2009	J Neuroinflammation	1742-2094	TITLE	0	0	3586	SYMBOL|DICTIONARY	il 10	IL-10	87#92		D000544	LONGTERM|DISEASE|DT|DICTIONARY	alzheimer disease	Alzheimer's disease	108#127		Replication by the Epistasis Project of the interaction between the genes for IL-6 and IL-10 in the risk of Alzheimer's disease.
17459075	2007	Clin. Exp. Immunol.	0009-9104	ALL_TEXT_3/3	3	6	1493	SYMBOL|DICTIONARY|EXTRACTED	ctla 4	CTLA-4	34#40	17459075-0-48-66	D012595	SYMBOL|EXTRACTED|DISEASE|DN	ssc	SSc	17#20	17459075-1-0-18	Thus, in Italian SSc patients the CTLA-4 -318C/T promoter polymorphism appears to be associated with the susceptibility to develop SSc without thyroid involvement.
17459075	2007	Clin. Exp. Immunol.	0009-9104	ALL_TEXT_3/3	3	6	1493	SYMBOL|DICTIONARY|EXTRACTED	ctla 4	CTLA-4	34#40	17459075-0-48-66	D012595	SYMBOL|EXTRACTED	ssc	SSc	131#134	17459075-1-0-18	Thus, in Italian SSc patients the CTLA-4 -318C/T promoter polymorphism appears to be associated with the susceptibility to develop SSc without thyroid involvement.
19698145	2009	J Neuroinflammation	1742-2094	BACKGROUND	1	2	3569	LONGTERM|DICTIONARY	interleukin 6	interleukin-6	160#173		D000544	SYMBOL|EXTRACTED	ad	AD	43#45	19698145-1-44-63	An interaction associated with the risk of AD has been reported between polymorphisms in the regulatory regions of the genes for the pro-inflammatory cytokine, interleukin-6 (IL-6, gene: IL6), and the anti-inflammatory cytokine, interleukin-10 (IL-10, gene: IL10).
19698145	2009	J Neuroinflammation	1742-2094	BACKGROUND	1	2	3569	SYMBOL|GENE|GN|DICTIONARY	il 6	IL-6	175#179		D000544	SYMBOL|EXTRACTED	ad	AD	43#45	19698145-1-44-63	An interaction associated with the risk of AD has been reported between polymorphisms in the regulatory regions of the genes for the pro-inflammatory cytokine, interleukin-6 (IL-6, gene: IL6), and the anti-inflammatory cytokine, interleukin-10 (IL-10, gene: IL10).
19698145	2009	J Neuroinflammation	1742-2094	BACKGROUND	1	2	3569	SYMBOL|DICTIONARY	il6	IL6	187#190		D000544	SYMBOL|EXTRACTED	ad	AD	43#45	19698145-1-44-63	An interaction associated with the risk of AD has been reported between polymorphisms in the regulatory regions of the genes for the pro-inflammatory cytokine, interleukin-6 (IL-6, gene: IL6), and the anti-inflammatory cytokine, interleukin-10 (IL-10, gene: IL10).
19698145	2009	J Neuroinflammation	1742-2094	BACKGROUND	1	2	3586	LONGTERM|DICTIONARY	interleukin 10	interleukin-10	229#243		D000544	SYMBOL|EXTRACTED	ad	AD	43#45	19698145-1-44-63	An interaction associated with the risk of AD has been reported between polymorphisms in the regulatory regions of the genes for the pro-inflammatory cytokine, interleukin-6 (IL-6, gene: IL6), and the anti-inflammatory cytokine, interleukin-10 (IL-10, gene: IL10).
19698145	2009	J Neuroinflammation	1742-2094	BACKGROUND	1	2	3586	SYMBOL|GENE|GN|DICTIONARY	il 10	IL-10	245#250		D000544	SYMBOL|EXTRACTED	ad	AD	43#45	19698145-1-44-63	An interaction associated with the risk of AD has been reported between polymorphisms in the regulatory regions of the genes for the pro-inflammatory cytokine, interleukin-6 (IL-6, gene: IL6), and the anti-inflammatory cytokine, interleukin-10 (IL-10, gene: IL10).
19698145	2009	J Neuroinflammation	1742-2094	BACKGROUND	1	2	3586	SYMBOL|DICTIONARY	il10	IL10	258#262		D000544	SYMBOL|EXTRACTED	ad	AD	43#45	19698145-1-44-63	An interaction associated with the risk of AD has been reported between polymorphisms in the regulatory regions of the genes for the pro-inflammatory cytokine, interleukin-6 (IL-6, gene: IL6), and the anti-inflammatory cytokine, interleukin-10 (IL-10, gene: IL10).
17459075	2007	Clin. Exp. Immunol.	0009-9104	ALL_TEXT_2/3	2	4	6899	SYMBOL|()|DICTIONARY|EXTRACTED	tga	TGA	345#348	17459075-4-330-343	D012595	SYMBOL|EXTRACTED|DISEASE|DN	ssc	SSc	82#85	17459075-1-0-18	No significant association has been found with either polymorphisms.Nevertheless, SSc patients without concomitant Hashimoto's thyroiditis (HT) were carrying both the -318T allele (P = 0.031) and the +49 G allele (P = 0.076) more frequently than SSc patients with HT [defined by positivity for anti-thyroperoxidase (TPO) and anti-thyroglobulin (TGA) autoantibodies] than controls.
17459075	2007	Clin. Exp. Immunol.	0009-9104	ALL_TEXT_2/3	2	4	6899	SYMBOL|()|DICTIONARY|EXTRACTED	tga	TGA	345#348	17459075-4-330-343	D050031	SYMBOL|EXTRACTED|()	ht	HT	140#142	17459075-4-115-138	No significant association has been found with either polymorphisms.Nevertheless, SSc patients without concomitant Hashimoto's thyroiditis (HT) were carrying both the -318T allele (P = 0.031) and the +49 G allele (P = 0.076) more frequently than SSc patients with HT [defined by positivity for anti-thyroperoxidase (TPO) and anti-thyroglobulin (TGA) autoantibodies] than controls.
17459075	2007	Clin. Exp. Immunol.	0009-9104	ALL_TEXT_2/3	2	4	6899	SYMBOL|()|DICTIONARY|EXTRACTED	tga	TGA	345#348	17459075-4-330-343	D012595	SYMBOL|EXTRACTED|DISEASE|DN	ssc	SSc	246#249	17459075-1-0-18	No significant association has been found with either polymorphisms.Nevertheless, SSc patients without concomitant Hashimoto's thyroiditis (HT) were carrying both the -318T allele (P = 0.031) and the +49 G allele (P = 0.076) more frequently than SSc patients with HT [defined by positivity for anti-thyroperoxidase (TPO) and anti-thyroglobulin (TGA) autoantibodies] than controls.
17459075	2007	Clin. Exp. Immunol.	0009-9104	ALL_TEXT_2/3	2	4	6899	SYMBOL|()|DICTIONARY|EXTRACTED	tga	TGA	345#348	17459075-4-330-343	D050031	SYMBOL|EXTRACTED	ht	HT	264#266	17459075-4-115-138	No significant association has been found with either polymorphisms.Nevertheless, SSc patients without concomitant Hashimoto's thyroiditis (HT) were carrying both the -318T allele (P = 0.031) and the +49 G allele (P = 0.076) more frequently than SSc patients with HT [defined by positivity for anti-thyroperoxidase (TPO) and anti-thyroglobulin (TGA) autoantibodies] than controls.
17459075	2007	Clin. Exp. Immunol.	0009-9104	ALL_TEXT_2/3	2	3	1493	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	ctla 4	CTLA-4	0#6		D012595	SYMBOL|EXTRACTED	ssc	SSc	107#110	17459075-1-0-18	CTLA-4 promoter (-318C/T) and exon 1 (+49 A/G) polymorphisms have been analysed in 43 Italian females with SSc and in 93 unrelated matched healthy controls by a newly designed tetra-primer amplification refractory mutation system-polymerase chain reaction (T-ARMS-PCR) method.
17459075	2007	Clin. Exp. Immunol.	0009-9104	ALL_TEXT_1/3	1	2	1493	SYMBOL|()|GENE|GN|DICTIONARY|EXTRACTED	ctla 4	CTLA-4	97#103	17459075-0-48-66	D001327	LONGTERM|DICTIONARY	autoimmune disorders	autoimmune disorders	11#31		Like other autoimmune disorders, the possible role of specific cytotoxic T lymphocyte antigen-4 (CTLA-4) gene polymorphisms in predisposing to SSc has been hypothesized, but it remains controversial.
17459075	2007	Clin. Exp. Immunol.	0009-9104	ALL_TEXT_1/3	1	2	1493	SYMBOL|()|GENE|GN|DICTIONARY|EXTRACTED	ctla 4	CTLA-4	97#103	17459075-0-48-66	D012595	SYMBOL|EXTRACTED	ssc	SSc	143#146	17459075-1-0-18	Like other autoimmune disorders, the possible role of specific cytotoxic T lymphocyte antigen-4 (CTLA-4) gene polymorphisms in predisposing to SSc has been hypothesized, but it remains controversial.
17459075	2007	Clin. Exp. Immunol.	0009-9104	ALL_TEXT_1/3	1	2	1493	LONGTERM|NUMBER|DICTIONARY|GENE|GA	cytotoxic t lymphocyte antigen-4	cytotoxic T lymphocyte antigen-4	63#95		D001327	LONGTERM|DICTIONARY	autoimmune disorders	autoimmune disorders	11#31		Like other autoimmune disorders, the possible role of specific cytotoxic T lymphocyte antigen-4 (CTLA-4) gene polymorphisms in predisposing to SSc has been hypothesized, but it remains controversial.
17459075	2007	Clin. Exp. Immunol.	0009-9104	ALL_TEXT_1/3	1	2	1493	LONGTERM|NUMBER|DICTIONARY|GENE|GA	cytotoxic t lymphocyte antigen-4	cytotoxic T lymphocyte antigen-4	63#95		D012595	SYMBOL|EXTRACTED	ssc	SSc	143#146	17459075-1-0-18	Like other autoimmune disorders, the possible role of specific cytotoxic T lymphocyte antigen-4 (CTLA-4) gene polymorphisms in predisposing to SSc has been hypothesized, but it remains controversial.
17459075	2007	Clin. Exp. Immunol.	0009-9104	TITLE	0	0	1493	SYMBOL|()|GENE|GN|DICTIONARY|EXTRACTED	ctla 4	CTLA-4	70#76	17459075-0-48-66	D012595	LONGTERM|DICTIONARY	systemic sclerosis	systemic sclerosis	145#163		Association of -318 C/T and +49 A/G cytotoxic T lymphocyte antigen-4 (CTLA-4) gene polymorphisms with a clinical subset of Italian patients with systemic sclerosis.
17459075	2007	Clin. Exp. Immunol.	0009-9104	TITLE	0	0	1493	LONGTERM|NUMBER|DICTIONARY|GENE|GA	cytotoxic t lymphocyte antigen-4	cytotoxic T lymphocyte antigen-4	36#68		D012595	LONGTERM|DICTIONARY	systemic sclerosis	systemic sclerosis	145#163		Association of -318 C/T and +49 A/G cytotoxic T lymphocyte antigen-4 (CTLA-4) gene polymorphisms with a clinical subset of Italian patients with systemic sclerosis.
17168855	2007	Curr. Med. Chem.	0929-8673	ALL_TEXT_3/3	3	9	2056	LONGTERM|DICTIONARY	erythropoietin	erythropoietin	96#110		D000740	LONGTERM|DICTIONARY	anemia	anemia	52#58		The only proven effective prevention of RBV-induced anemia is the concomitant administration of erythropoietin.
17260091	2008	Breast Cancer Res. Treat.	0167-6806	BACKGROUND	1	1	4524	LONGTERM|DICTIONARY	methylenetetrahydrofolate reductase	methylenetetrahydrofolate reductase	22#57		D001943	LONGTERM|DISEASE|DT|DICTIONARY	breast cancer	breast cancer	172#185		A reduced activity of methylenetetrahydrofolate reductase (MTHFR) due to frequent C677T polymorphism affects DNA synthesis, repair and methylation and may be implicated in breast cancer risk.
17260091	2008	Breast Cancer Res. Treat.	0167-6806	BACKGROUND	1	1	4524	SYMBOL|()|DICTIONARY|EXTRACTED	mthfr	MTHFR	59#64	17260091-0-0-35	D001943	LONGTERM|DISEASE|DT|DICTIONARY	breast cancer	breast cancer	172#185		A reduced activity of methylenetetrahydrofolate reductase (MTHFR) due to frequent C677T polymorphism affects DNA synthesis, repair and methylation and may be implicated in breast cancer risk.
15191797	2004	Exp. Neurol.	0014-4886	ALL_TEXT_2/3	2	4	4852	LONGTERM|DICTIONARY	neuropeptide y	neuropeptide Y	86#100		D013226	LONGTERM|DICTIONARY	status epilepticus	status epilepticus	26#44		After pilocarpine-induced status epilepticus (SE) in mice most hilar neurons died and neuropeptide Y (NPY) immunoreactivity appeared in the dentate inner molecular layer (IML) after 10-31 days indicative of MFS.
15191797	2004	Exp. Neurol.	0014-4886	ALL_TEXT_2/3	2	4	4852	LONGTERM|DICTIONARY	neuropeptide y	neuropeptide Y	86#100		D013226	SYMBOL|EXTRACTED|()	se	SE	46#48	15191797-4-26-44	After pilocarpine-induced status epilepticus (SE) in mice most hilar neurons died and neuropeptide Y (NPY) immunoreactivity appeared in the dentate inner molecular layer (IML) after 10-31 days indicative of MFS.
20056646	2010	Cancer Epidemiol. Biomarkers Prev.	1538-7755	CONCLUSION	4	12	4292	SYMBOL|DICTIONARY	mlh1	MLH1	109#113		D011471	LONGTERM|DISEASE|DT|DICTIONARY	overall prostate cancer	overall prostate cancer	141#164		This population-based case-control study provides evidence for a possible association with a gene variant in MLH1 in relation to the risk of overall prostate cancer, more aggressive disease, and prostate cancer recurrence, which warrants replication.
20056646	2010	Cancer Epidemiol. Biomarkers Prev.	1538-7755	CONCLUSION	4	12	4292	SYMBOL|DICTIONARY	mlh1	MLH1	109#113		D011471	LONGTERM|DISEASE|DT|DICTIONARY	more aggressive disease, and prostate cancer	more aggressive disease, and prostate cancer	166#210		This population-based case-control study provides evidence for a possible association with a gene variant in MLH1 in relation to the risk of overall prostate cancer, more aggressive disease, and prostate cancer recurrence, which warrants replication.
15191797	2004	Exp. Neurol.	0014-4886	ALL_TEXT_3/3	3	7	960	SYMBOL|DICTIONARY	cd44	CD44	101#105		D013226	SYMBOL|EXTRACTED	se	SE	6#8	15191797-4-26-44	After SE induced by repeated kainate injections, mice did not show any hilar cell loss or changes in CD44 or GAP-43 expression in the IML, and MFS was absent at 20-35 days.
15191797	2004	Exp. Neurol.	0014-4886	ALL_TEXT_3/3	3	7	2596	SYMBOL|DICTIONARY	gap 43	GAP-43	109#115		D013226	SYMBOL|EXTRACTED	se	SE	6#8	15191797-4-26-44	After SE induced by repeated kainate injections, mice did not show any hilar cell loss or changes in CD44 or GAP-43 expression in the IML, and MFS was absent at 20-35 days.
14713779	2004	J. Urol.	0022-5347	TITLE	0	0	4953	LONGTERM|DICTIONARY	ornithine decarboxylase	ornithine decarboxylase	21#44		D011471	LONGTERM|DISEASE|DT|DICTIONARY	prostate cancer	prostate cancer	106#121		Association among an ornithine decarboxylase polymorphism, androgen receptor gene (CAG) repeat length and prostate cancer risk.
14713779	2004	J. Urol.	0022-5347	TITLE	0	0	367	LONGTERM|GENE|GN|GT|DICTIONARY	androgen receptor	androgen receptor	59#76		D011471	LONGTERM|DISEASE|DT|DICTIONARY	prostate cancer	prostate cancer	106#121		Association among an ornithine decarboxylase polymorphism, androgen receptor gene (CAG) repeat length and prostate cancer risk.
14713779	2004	J. Urol.	0022-5347	PURPOSE	1	1	4953	LONGTERM|DICTIONARY|GENE|GA	ornithine decarboxylase	ornithine decarboxylase	79#102		D009369	LONGTERM|DICTIONARY	tumor	tumor	174#179		A single nucleotide substitution of guanine to adenine (A) at base +316 in the ornithine decarboxylase (ODC) gene may be associated with greater ODC expression and increased tumor growth.
14713779	2004	J. Urol.	0022-5347	PURPOSE	1	1	4953	SYMBOL|()|GENE|GN|DICTIONARY|EXTRACTED	odc	ODC	104#107	14713779-1-79-102	D009369	LONGTERM|DICTIONARY	tumor	tumor	174#179		A single nucleotide substitution of guanine to adenine (A) at base +316 in the ornithine decarboxylase (ODC) gene may be associated with greater ODC expression and increased tumor growth.
14713779	2004	J. Urol.	0022-5347	PURPOSE	1	1	4953	SYMBOL|DICTIONARY|EXTRACTED	odc	ODC	145#148	14713779-1-79-102	D009369	LONGTERM|DICTIONARY	tumor	tumor	174#179		A single nucleotide substitution of guanine to adenine (A) at base +316 in the ornithine decarboxylase (ODC) gene may be associated with greater ODC expression and increased tumor growth.
15191797	2004	Exp. Neurol.	0014-4886	ALL_TEXT_2/3	2	6	2596	SYMBOL|DICTIONARY	gap 43	GAP-43	12#18		D013226	SYMBOL|EXTRACTED	se	SE	100#102	15191797-4-26-44	Conversely, GAP-43 immunoreactivity was decreased in the IML at 3-10 days after pilocarpine-induced SE.
20709820	2011	Am. J. Respir. Crit. Care Med.	1535-4970	CONCLUSIONS	5	7	636	SYMBOL|DICTIONARY	bicd1	BICD1	44#49		D004646	LONGTERM|DICTIONARY	emphysema	emphysema	82#91		our study suggests that genetic variants in BICD1 are associated with qualitative emphysema in COPD.
20709820	2011	Am. J. Respir. Crit. Care Med.	1535-4970	CONCLUSIONS	5	7	636	SYMBOL|DICTIONARY	bicd1	BICD1	44#49		D029424	SYMBOL|DICTIONARY|EXTRACTED	copd	COPD	95#99	20709820-1-0-37	our study suggests that genetic variants in BICD1 are associated with qualitative emphysema in COPD.
14713779	2004	J. Urol.	0022-5347	RESULTS	3	7	4953	SYMBOL|DICTIONARY|EXTRACTED	odc	ODC	20#23	14713779-1-79-102	D011471	LONGTERM|DISEASE|DT|DICTIONARY	prostate cancer	prostate cancer	92#107		The presence of the ODC A allele was not significantly associated with an increased risk of prostate cancer (OR 1.33, 95% CI 0.90 to 1.96).
15983957	2005	Am. J. Kidney Dis.	1523-6838	METHODS	2	4	7369	SYMBOL|GENE|GN|DICTIONARY	umod	UMOD	83#87		D007674	SYMBOL|DICTIONARY|EXTRACTED	fjhn	FJHN	125#129	15983957-1-67-110	We performed linkage analysis and sequencing of the entire codifying region of the UMOD gene in 4 Spanish families with MCKD/FJHN/GCKD.
15983957	2005	Am. J. Kidney Dis.	1523-6838	METHODS	2	4	7369	SYMBOL|GENE|GN|DICTIONARY	umod	UMOD	83#87		D007674	SYMBOL|EXTRACTED	gckd	GCKD	130#134	15983957-1-142-172	We performed linkage analysis and sequencing of the entire codifying region of the UMOD gene in 4 Spanish families with MCKD/FJHN/GCKD.
16606986	2006	Am. J. Trop. Med. Hyg.	0002-9637	TITLE	0	0	2212	SYMBOL|()|DICTIONARY	cd32	CD32	37#41		D018512	LONGTERM|DICTIONARY	parasitemia	parasitemia	94#105		Association of FCgamma receptor IIA (CD32) polymorphism with malarial anemia and high-density parasitemia in infants and young children.
16606986	2006	Am. J. Trop. Med. Hyg.	0002-9637	TITLE	0	0	2212	SYMBOL|()|DICTIONARY	cd32	CD32	37#41		D000740	LONGTERM|DICTIONARY	malarial anemia	malarial anemia	61#76		Association of FCgamma receptor IIA (CD32) polymorphism with malarial anemia and high-density parasitemia in infants and young children.
20959826	2011	Br. J. Cancer	1532-1827	CONCLUSIONS	4	10	3845	SYMBOL|DICTIONARY	kras	KRAS	4#8		D009369	LONGTERM|DISEASE|DT|DICTIONARY	rectal cancer	rectal cancer	87#100		The KRAS mutation came forward as a negative predictive factor for OS in patients with rectal cancer and for DFS in stage II colon cancer patients.
20959826	2011	Br. J. Cancer	1532-1827	CONCLUSIONS	4	10	3845	SYMBOL|DICTIONARY	kras	KRAS	4#8		D009369	LONGTERM|DISEASE|DN|DT|DICTIONARY	dfs in stage ii colon cancer	DFS in stage II colon cancer	109#137		The KRAS mutation came forward as a negative predictive factor for OS in patients with rectal cancer and for DFS in stage II colon cancer patients.
20959826	2011	Br. J. Cancer	1532-1827	CONCLUSIONS	4	10	3845	SYMBOL|DICTIONARY	kras	KRAS	4#8		C567932	LONGTERM|DICTIONARY	os	OS	67#69	NaN	The KRAS mutation came forward as a negative predictive factor for OS in patients with rectal cancer and for DFS in stage II colon cancer patients.
15983957	2005	Am. J. Kidney Dis.	1523-6838	BACKGROUND	1	1	7369	SYMBOL|GENE|GN|DICTIONARY	umod	UMOD	292#296		D007674	LONGTERM|DICTIONARY	familial juvenile hyperuricemic nephropathy	familial juvenile hyperuricemic nephropathy	67#110		Autosomal dominant medullary cystic kidney disease type 2 (MCKD2), familial juvenile hyperuricemic nephropathy (FJHN), and autosomal dominant glomerulocystic kidney disease (GCKD) constitute a hereditary renal disease group that may lead to end-stage renal failure caused by mutations of the UMOD gene and its product, uromodulin or Tamm-Horsfall protein.
15983957	2005	Am. J. Kidney Dis.	1523-6838	BACKGROUND	1	1	7369	SYMBOL|GENE|GN|DICTIONARY	umod	UMOD	292#296		D007674	SYMBOL|()|DICTIONARY|EXTRACTED	fjhn	FJHN	112#116	15983957-1-67-110	Autosomal dominant medullary cystic kidney disease type 2 (MCKD2), familial juvenile hyperuricemic nephropathy (FJHN), and autosomal dominant glomerulocystic kidney disease (GCKD) constitute a hereditary renal disease group that may lead to end-stage renal failure caused by mutations of the UMOD gene and its product, uromodulin or Tamm-Horsfall protein.
15983957	2005	Am. J. Kidney Dis.	1523-6838	BACKGROUND	1	1	7369	SYMBOL|GENE|GN|DICTIONARY	umod	UMOD	292#296		D007674	SYMBOL|EXTRACTED|()	gckd	GCKD	174#178	15983957-1-142-172	Autosomal dominant medullary cystic kidney disease type 2 (MCKD2), familial juvenile hyperuricemic nephropathy (FJHN), and autosomal dominant glomerulocystic kidney disease (GCKD) constitute a hereditary renal disease group that may lead to end-stage renal failure caused by mutations of the UMOD gene and its product, uromodulin or Tamm-Horsfall protein.
15983957	2005	Am. J. Kidney Dis.	1523-6838	BACKGROUND	1	1	7369	SYMBOL|GENE|GN|DICTIONARY	umod	UMOD	292#296		D007676	LONGTERM|DICTIONARY	end stage renal failure	end-stage renal failure	241#264		Autosomal dominant medullary cystic kidney disease type 2 (MCKD2), familial juvenile hyperuricemic nephropathy (FJHN), and autosomal dominant glomerulocystic kidney disease (GCKD) constitute a hereditary renal disease group that may lead to end-stage renal failure caused by mutations of the UMOD gene and its product, uromodulin or Tamm-Horsfall protein.
15983957	2005	Am. J. Kidney Dis.	1523-6838	BACKGROUND	1	1	7369	SYMBOL|GENE|GN|DICTIONARY	umod	UMOD	292#296		D007674	LONGTERM|DISEASE|DT|DICTIONARY	autosomal dominant glomerulocystic kidney disease	autosomal dominant glomerulocystic kidney disease	123#172		Autosomal dominant medullary cystic kidney disease type 2 (MCKD2), familial juvenile hyperuricemic nephropathy (FJHN), and autosomal dominant glomerulocystic kidney disease (GCKD) constitute a hereditary renal disease group that may lead to end-stage renal failure caused by mutations of the UMOD gene and its product, uromodulin or Tamm-Horsfall protein.
15983957	2005	Am. J. Kidney Dis.	1523-6838	BACKGROUND	1	1	7369	SYMBOL|GENE|GN|DICTIONARY	umod	UMOD	292#296		D007674	LONGTERM|DISEASE|DT|DICTIONARY	hereditary renal disease	hereditary renal disease	193#217		Autosomal dominant medullary cystic kidney disease type 2 (MCKD2), familial juvenile hyperuricemic nephropathy (FJHN), and autosomal dominant glomerulocystic kidney disease (GCKD) constitute a hereditary renal disease group that may lead to end-stage renal failure caused by mutations of the UMOD gene and its product, uromodulin or Tamm-Horsfall protein.
15983957	2005	Am. J. Kidney Dis.	1523-6838	BACKGROUND	1	1	7369	SYMBOL|GENE|GN|DICTIONARY	umod	UMOD	292#296		C537696	LONGTERM|DICTIONARY	medullary cystic kidney disease type 2	medullary cystic kidney disease type 2	19#57	NaN	Autosomal dominant medullary cystic kidney disease type 2 (MCKD2), familial juvenile hyperuricemic nephropathy (FJHN), and autosomal dominant glomerulocystic kidney disease (GCKD) constitute a hereditary renal disease group that may lead to end-stage renal failure caused by mutations of the UMOD gene and its product, uromodulin or Tamm-Horsfall protein.
20977478	2011	J. Neurochem.	1471-4159	ALL_TEXT_3/3	3	10	6470	SYMBOL|DICTIONARY|EXTRACTED	shmt1	SHMT1	4#9	20977478-0-70-75	D001927	LONGTERM|DICTIONARY	higher in schizophrenic brains	higher in schizophrenic brains	22#52	NaN	The SHMT1 levels were higher in schizophrenic brains compared to controls, but no changes in SRR levels.
18043699	2009	Eur J Clin Nutr	1476-5640	ALL_TEXT_1/3	1	1	4852	LONGTERM|DICTIONARY	preproneuropeptide y	preproneuropeptide Y	51#71	NaN	D050197	LONGTERM|DICTIONARY	atherosclerosis	atherosclerosis	121#136		The leucine7 to proline7 (Leu7Pro) polymorphism in preproneuropeptide Y (preproNPY) has been associated with accelerated atherosclerosis and type II diabetes, both of which are obesity-related diseases.
18043699	2009	Eur J Clin Nutr	1476-5640	ALL_TEXT_1/3	1	1	4852	LONGTERM|DICTIONARY	preproneuropeptide y	preproneuropeptide Y	51#71	NaN	D003924	LONGTERM|DICTIONARY	type ii diabetes	type II diabetes	141#157		The leucine7 to proline7 (Leu7Pro) polymorphism in preproneuropeptide Y (preproNPY) has been associated with accelerated atherosclerosis and type II diabetes, both of which are obesity-related diseases.
18043699	2009	Eur J Clin Nutr	1476-5640	ALL_TEXT_1/3	1	1	4852	LONGTERM|DICTIONARY	preproneuropeptide y	preproneuropeptide Y	51#71	NaN	D009765	LONGTERM|DICTIONARY	obesity	obesity	177#184		The leucine7 to proline7 (Leu7Pro) polymorphism in preproneuropeptide Y (preproNPY) has been associated with accelerated atherosclerosis and type II diabetes, both of which are obesity-related diseases.
18043699	2009	Eur J Clin Nutr	1476-5640	ALL_TEXT_1/3	1	1	4852	LONGTERM|DICTIONARY	prepronpy	preproNPY	73#82	NaN	D050197	LONGTERM|DICTIONARY	atherosclerosis	atherosclerosis	121#136		The leucine7 to proline7 (Leu7Pro) polymorphism in preproneuropeptide Y (preproNPY) has been associated with accelerated atherosclerosis and type II diabetes, both of which are obesity-related diseases.
18043699	2009	Eur J Clin Nutr	1476-5640	ALL_TEXT_1/3	1	1	4852	LONGTERM|DICTIONARY	prepronpy	preproNPY	73#82	NaN	D003924	LONGTERM|DICTIONARY	type ii diabetes	type II diabetes	141#157		The leucine7 to proline7 (Leu7Pro) polymorphism in preproneuropeptide Y (preproNPY) has been associated with accelerated atherosclerosis and type II diabetes, both of which are obesity-related diseases.
18043699	2009	Eur J Clin Nutr	1476-5640	ALL_TEXT_1/3	1	1	4852	LONGTERM|DICTIONARY	prepronpy	preproNPY	73#82	NaN	D009765	LONGTERM|DICTIONARY	obesity	obesity	177#184		The leucine7 to proline7 (Leu7Pro) polymorphism in preproneuropeptide Y (preproNPY) has been associated with accelerated atherosclerosis and type II diabetes, both of which are obesity-related diseases.
12165742	2003	Med. Sci. Monit.	1234-1010	BACKGROUND	1	1	10	SYMBOL|DICTIONARY	nat2	NAT2	6#10		D003110	LONGTERM|DISEASE|DT|DICTIONARY	colon cancer	colon cancer	75#87		Rapid NAT2 acetylation has been considered as a risk factor for developing colon cancer in a number of studies, however the overall results of such studies are inconsistent.
19164214	2009	J. Clin. Oncol.	1527-7755	TITLE	0	0	5290	SYMBOL|DICTIONARY	pi3k	PI3K	26#30		D004938	LONGTERM|DISEASE|DN|DT|DICTIONARY	esophageal cancer	esophageal cancer	94#111		Genetic variations in the PI3K/PTEN/AKT/mTOR pathway are associated with clinical outcomes in esophageal cancer patients treated with chemoradiotherapy.
19164214	2009	J. Clin. Oncol.	1527-7755	TITLE	0	0	5728	SYMBOL|DICTIONARY|EXTRACTED	pten	PTEN	31#35		D004938	LONGTERM|DISEASE|DN|DT|DICTIONARY	esophageal cancer	esophageal cancer	94#111		Genetic variations in the PI3K/PTEN/AKT/mTOR pathway are associated with clinical outcomes in esophageal cancer patients treated with chemoradiotherapy.
19164214	2009	J. Clin. Oncol.	1527-7755	TITLE	0	0	21977	LONGTERM|DICTIONARY	mtor	mTOR	40#44	NaN	D004938	LONGTERM|DISEASE|DN|DT|DICTIONARY	esophageal cancer	esophageal cancer	94#111		Genetic variations in the PI3K/PTEN/AKT/mTOR pathway are associated with clinical outcomes in esophageal cancer patients treated with chemoradiotherapy.
18436884	2008	Stroke	1524-4628	CONCLUSIONS	4	13	1234	LONGTERM|DICTIONARY	ccr5	CCR5	78#82		D050197	LONGTERM|DICTIONARY	atherosclerosis	atherosclerosis	176#191		These findings are consistent with the hypothesis that the chemokine receptor CCR5 is involved in the mediation of low-grade systemic inflammation and may play a role in human atherosclerosis and cardiovascular disease.
18436884	2008	Stroke	1524-4628	CONCLUSIONS	4	13	1234	LONGTERM|DICTIONARY	ccr5	CCR5	78#82		D002318	LONGTERM|DISEASE|DT|DICTIONARY	cardiovascular disease	cardiovascular disease	196#218		These findings are consistent with the hypothesis that the chemokine receptor CCR5 is involved in the mediation of low-grade systemic inflammation and may play a role in human atherosclerosis and cardiovascular disease.
18436884	2008	Stroke	1524-4628	CONCLUSIONS	4	13	1234	LONGTERM|DICTIONARY	ccr5	CCR5	78#82		D007249	LONGTERM|DICTIONARY	inflammation	inflammation	134#146	NaN	These findings are consistent with the hypothesis that the chemokine receptor CCR5 is involved in the mediation of low-grade systemic inflammation and may play a role in human atherosclerosis and cardiovascular disease.
18436884	2008	Stroke	1524-4628	CONCLUSIONS	4	12	1401	LONGTERM|GENE|GT|DICTIONARY	c reactive protein	C-reactive protein	87#105		D002318	LONGTERM|DISEASE|DT|DICTIONARY	cardiovascular disease	cardiovascular disease	145#167		The chemokine receptor CCR5-del32 frameshift mutation is associated with low levels of C-reactive protein, decreased intima-media thickness, and cardiovascular disease risk.
18436884	2008	Stroke	1524-4628	CONCLUSIONS	4	12	1234	LONGTERM|DICTIONARY	ccr5	CCR5	23#27		D002318	LONGTERM|DISEASE|DT|DICTIONARY	cardiovascular disease	cardiovascular disease	145#167		The chemokine receptor CCR5-del32 frameshift mutation is associated with low levels of C-reactive protein, decreased intima-media thickness, and cardiovascular disease risk.
12165742	2003	Med. Sci. Monit.	1234-1010	TITLE	0	0	10	LONGTERM|DICTIONARY	n acetyltransferase 2	N-acetyltransferase 2	48#69		D015179	LONGTERM|DISEASE|DT|DICTIONARY	colorectal cancer	colorectal cancer	93#110		Meta-analysis of 20 case-control studies on the N-acetyltransferase 2 acetylation status and colorectal cancer risk.
16386647	2006	Hum. Immunol.	0198-8859	ALL_TEXT_3/3	3	5	3106	LONGTERM|DICTIONARY	hla-b27	HLA-B27	71#78	NaN	D013167	SYMBOL|EXTRACTED	as	AS	64#66	16386647-3-129-151	Statistical analysis revealed: (1) a weaker association between AS and HLA-B27 in Algerians than in that reported for European patients (63% versus 80-90%), suggesting a possible influence of other genetic/environmental determinants in the studied population and (2) an association between MICA-129 met/met genotype and juvenile AS (p = 0.02) independent of HLA-B27 status.
16386647	2006	Hum. Immunol.	0198-8859	ALL_TEXT_3/3	3	5	3106	LONGTERM|DICTIONARY	hla-b27	HLA-B27	71#78	NaN	D013167	SYMBOL|EXTRACTED	as	AS	329#331	16386647-3-129-151	Statistical analysis revealed: (1) a weaker association between AS and HLA-B27 in Algerians than in that reported for European patients (63% versus 80-90%), suggesting a possible influence of other genetic/environmental determinants in the studied population and (2) an association between MICA-129 met/met genotype and juvenile AS (p = 0.02) independent of HLA-B27 status.
16386647	2006	Hum. Immunol.	0198-8859	ALL_TEXT_3/3	3	5	3106	LONGTERM|DICTIONARY	hla-b27	HLA-B27	358#365	NaN	D013167	SYMBOL|EXTRACTED	as	AS	64#66	16386647-3-129-151	Statistical analysis revealed: (1) a weaker association between AS and HLA-B27 in Algerians than in that reported for European patients (63% versus 80-90%), suggesting a possible influence of other genetic/environmental determinants in the studied population and (2) an association between MICA-129 met/met genotype and juvenile AS (p = 0.02) independent of HLA-B27 status.
16386647	2006	Hum. Immunol.	0198-8859	ALL_TEXT_3/3	3	5	3106	LONGTERM|DICTIONARY	hla-b27	HLA-B27	358#365	NaN	D013167	SYMBOL|EXTRACTED	as	AS	329#331	16386647-3-129-151	Statistical analysis revealed: (1) a weaker association between AS and HLA-B27 in Algerians than in that reported for European patients (63% versus 80-90%), suggesting a possible influence of other genetic/environmental determinants in the studied population and (2) an association between MICA-129 met/met genotype and juvenile AS (p = 0.02) independent of HLA-B27 status.
12579739	2004	Yan Ke Xue Bao	1000-4432	RESULTS	3	6	6010	LONGTERM|GENE|GN|DICTIONARY	rhodopsin	rhodopsin	33#42		D012174	LONGTERM|DICTIONARY	retinitis pigmentosa	retinitis pigmentosa	88#108		Three different mutations in the rhodopsin gene were found in 3 of the 83 patients with retinitis pigmentosa(Va1104Phe, Lys311Glu, Pro347Leu).
19164214	2009	J. Clin. Oncol.	1527-7755	RESULTS	3	9	2475	SYMBOL|DICTIONARY	frap1	FRAP1	38#43		D003643	LONGTERM|DICTIONARY	death	death	102#107	NaN	Patients homozygous for either of the FRAP1 SNPs assayed had a more than three-fold increased risk of death.
16630736	2006	Mol. Genet. Metab.	1096-7192	TITLE	0	0	79158	SYMBOL|GENE|GN|DICTIONARY	gnpta	GNPTA	47#52		D009081	LONGTERM|DICTIONARY	mucolipidosis iii	Mucolipidosis III	5#22		When Mucolipidosis III meets Mucolipidosis II: GNPTA gene mutations in 24 patients.
16630736	2006	Mol. Genet. Metab.	1096-7192	TITLE	0	0	79158	SYMBOL|GENE|GN|DICTIONARY	gnpta	GNPTA	47#52		D009081	LONGTERM|DICTIONARY	mucolipidosis ii	Mucolipidosis II	29#45		When Mucolipidosis III meets Mucolipidosis II: GNPTA gene mutations in 24 patients.
16630736	2006	Mol. Genet. Metab.	1096-7192	ALL_TEXT_1/3	1	3	79158	SYMBOL|DICTIONARY	gnpta	GNPTA	36#41		D009081	LONGTERM|DICTIONARY	ml ii	ML II	62#67	NaN	We report the molecular analysis of GNPTA in 21 families with ML II and 3 families with ML III.
16630736	2006	Mol. Genet. Metab.	1096-7192	ALL_TEXT_1/3	1	3	79158	SYMBOL|DICTIONARY	gnpta	GNPTA	36#41		D009081	LONGTERM|DICTIONARY	ml iii	ML III	88#94	NaN	We report the molecular analysis of GNPTA in 21 families with ML II and 3 families with ML III.
16630736	2006	Mol. Genet. Metab.	1096-7192	ALL_TEXT_3/3	3	7	79158	SYMBOL|DICTIONARY	gnpta	GNPTA	114#119		D009081	LONGTERM|DICTIONARY	ml ii	ML II	7#12	NaN	The 21 ML II patients were homozygous while the three ML III patients were compound heterozygous for mutations in GNPTA.
16630736	2006	Mol. Genet. Metab.	1096-7192	ALL_TEXT_3/3	3	7	79158	SYMBOL|DICTIONARY	gnpta	GNPTA	114#119		D009081	LONGTERM|DICTIONARY	ml iii	ML III	54#60	NaN	The 21 ML II patients were homozygous while the three ML III patients were compound heterozygous for mutations in GNPTA.
16630736	2006	Mol. Genet. Metab.	1096-7192	ALL_TEXT_3/3	3	9	79158	SYMBOL|DICTIONARY	gnpta	GNPTA	49#54		D009081	LONGTERM|DICTIONARY	ml iii	ML III	94#100	NaN	We suggest that the diseases due to mutations in GNPTA represent a clinical continuum between ML III and ML II, and the classification of these diseases should be based on the age of onset, clinical symptoms, and severity.
16630736	2006	Mol. Genet. Metab.	1096-7192	ALL_TEXT_3/3	3	9	79158	SYMBOL|DICTIONARY	gnpta	GNPTA	49#54		D009081	LONGTERM|DICTIONARY	ml ii	ML II	105#110	NaN	We suggest that the diseases due to mutations in GNPTA represent a clinical continuum between ML III and ML II, and the classification of these diseases should be based on the age of onset, clinical symptoms, and severity.
7981680	1995	Hum. Mol. Genet.	0964-6906	ALL_TEXT_2/3	2	4	3481	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	igf ii	IGF-II	44#50	7981680-1-0-29	D012208	LONGTERM|DICTIONARY	rhabdomyosarcomas	rhabdomyosarcomas	263#280		Here we show that monoallelic expression of IGF-II gene is conserved in normal adult muscle tissue whereas two or more copies of active IGF-II alleles, arising by either relaxation of imprinting or duplication of the active allele, are found in 9 out of 11 (82%) rhabdomyosarcomas retaining heterozygosity at 11p15, regardless of the histological subtype.
7981680	1995	Hum. Mol. Genet.	0964-6906	ALL_TEXT_2/3	2	4	3481	SYMBOL|DICTIONARY|EXTRACTED	igf ii	IGF-II	136#142	7981680-1-0-29	D012208	LONGTERM|DICTIONARY	rhabdomyosarcomas	rhabdomyosarcomas	263#280		Here we show that monoallelic expression of IGF-II gene is conserved in normal adult muscle tissue whereas two or more copies of active IGF-II alleles, arising by either relaxation of imprinting or duplication of the active allele, are found in 9 out of 11 (82%) rhabdomyosarcomas retaining heterozygosity at 11p15, regardless of the histological subtype.
12080485	2002	Am. J. Hum. Genet.	0002-9297	ALL_TEXT_3/3	3	5	7305	SYMBOL|DICTIONARY	tyrobp	TYROBP	154#160		C536329	SYMBOL|DICTIONARY|EXTRACTED	plosl	PLOSL	14#19	12080485-1-0-76	Patients with PLOSL have no defects in cell-mediated immunity, suggesting a remarkable capacity of the human immune system to compensate for the inactive TYROBP-mediated activation pathway.
18496208	2008	Psychiatr. Genet.	1473-5873	METHODS	2	3	10611	SYMBOL|GENE|GN|DICTIONARY	pdlim5	PDLIM5	44#50		D001714	SYMBOL|EXTRACTED	bp	BP	96#98	18496208-1-193-209	Five single nucleotide polymorphisms in the PDLIM5 gene were genotyped in 290 European-American BP families.
18496208	2008	Psychiatr. Genet.	1473-5873	OBJECTIVES	1	2	10611	SYMBOL|DICTIONARY	pdlim5	PDLIM5	86#92		D001714	SYMBOL|EXTRACTED	bp	BP	120#122	18496208-1-193-209	We performed a family-based association study to test the hypothesis that variants in PDLIM5 increase susceptibility to BP in European-Americans and a meta-analysis to clarify whether there is a single marker consistently contributing to risk for BP.
18496208	2008	Psychiatr. Genet.	1473-5873	OBJECTIVES	1	2	10611	SYMBOL|DICTIONARY	pdlim5	PDLIM5	86#92		D001714	SYMBOL|EXTRACTED	bp	BP	247#249	18496208-1-193-209	We performed a family-based association study to test the hypothesis that variants in PDLIM5 increase susceptibility to BP in European-Americans and a meta-analysis to clarify whether there is a single marker consistently contributing to risk for BP.
18496208	2008	Psychiatr. Genet.	1473-5873	OBJECTIVES	1	1	10611	SYMBOL|DICTIONARY	lim	LIM	74#77		D012559	LONGTERM|DICTIONARY	schizophrenia	schizophrenia	175#188		The postsynaptic density-95/discs large/zone occludens-1 (PDZ) domain and LIM (Lin-11, Isl-1, and Mec-3) domain 5 (PDLIM5) gene has been analyzed as a candidate gene for both schizophrenia and bipolar disorder (BP) in Japanese samples.
18496208	2008	Psychiatr. Genet.	1473-5873	OBJECTIVES	1	1	10611	SYMBOL|DICTIONARY	lim	LIM	74#77		D001714	LONGTERM|DISEASE|DT|DICTIONARY	bipolar disorder	bipolar disorder	193#209		The postsynaptic density-95/discs large/zone occludens-1 (PDZ) domain and LIM (Lin-11, Isl-1, and Mec-3) domain 5 (PDLIM5) gene has been analyzed as a candidate gene for both schizophrenia and bipolar disorder (BP) in Japanese samples.
18496208	2008	Psychiatr. Genet.	1473-5873	OBJECTIVES	1	1	10611	SYMBOL|DICTIONARY	lim	LIM	74#77		D001714	SYMBOL|EXTRACTED|()	bp	BP	211#213	18496208-1-193-209	The postsynaptic density-95/discs large/zone occludens-1 (PDZ) domain and LIM (Lin-11, Isl-1, and Mec-3) domain 5 (PDLIM5) gene has been analyzed as a candidate gene for both schizophrenia and bipolar disorder (BP) in Japanese samples.
18496208	2008	Psychiatr. Genet.	1473-5873	OBJECTIVES	1	1	3670	SYMBOL|DICTIONARY	isl 1	Isl-1	87#92		D012559	LONGTERM|DICTIONARY	schizophrenia	schizophrenia	175#188		The postsynaptic density-95/discs large/zone occludens-1 (PDZ) domain and LIM (Lin-11, Isl-1, and Mec-3) domain 5 (PDLIM5) gene has been analyzed as a candidate gene for both schizophrenia and bipolar disorder (BP) in Japanese samples.
18496208	2008	Psychiatr. Genet.	1473-5873	OBJECTIVES	1	1	3670	SYMBOL|DICTIONARY	isl 1	Isl-1	87#92		D001714	LONGTERM|DISEASE|DT|DICTIONARY	bipolar disorder	bipolar disorder	193#209		The postsynaptic density-95/discs large/zone occludens-1 (PDZ) domain and LIM (Lin-11, Isl-1, and Mec-3) domain 5 (PDLIM5) gene has been analyzed as a candidate gene for both schizophrenia and bipolar disorder (BP) in Japanese samples.
18496208	2008	Psychiatr. Genet.	1473-5873	OBJECTIVES	1	1	3670	SYMBOL|DICTIONARY	isl 1	Isl-1	87#92		D001714	SYMBOL|EXTRACTED|()	bp	BP	211#213	18496208-1-193-209	The postsynaptic density-95/discs large/zone occludens-1 (PDZ) domain and LIM (Lin-11, Isl-1, and Mec-3) domain 5 (PDLIM5) gene has been analyzed as a candidate gene for both schizophrenia and bipolar disorder (BP) in Japanese samples.
18496208	2008	Psychiatr. Genet.	1473-5873	OBJECTIVES	1	1	10611	SYMBOL|()|GENE|GN|DICTIONARY	pdlim5	PDLIM5	115#121		D012559	LONGTERM|DICTIONARY	schizophrenia	schizophrenia	175#188		The postsynaptic density-95/discs large/zone occludens-1 (PDZ) domain and LIM (Lin-11, Isl-1, and Mec-3) domain 5 (PDLIM5) gene has been analyzed as a candidate gene for both schizophrenia and bipolar disorder (BP) in Japanese samples.
18496208	2008	Psychiatr. Genet.	1473-5873	OBJECTIVES	1	1	10611	SYMBOL|()|GENE|GN|DICTIONARY	pdlim5	PDLIM5	115#121		D001714	LONGTERM|DISEASE|DT|DICTIONARY	bipolar disorder	bipolar disorder	193#209		The postsynaptic density-95/discs large/zone occludens-1 (PDZ) domain and LIM (Lin-11, Isl-1, and Mec-3) domain 5 (PDLIM5) gene has been analyzed as a candidate gene for both schizophrenia and bipolar disorder (BP) in Japanese samples.
18496208	2008	Psychiatr. Genet.	1473-5873	OBJECTIVES	1	1	10611	SYMBOL|()|GENE|GN|DICTIONARY	pdlim5	PDLIM5	115#121		D001714	SYMBOL|EXTRACTED|()	bp	BP	211#213	18496208-1-193-209	The postsynaptic density-95/discs large/zone occludens-1 (PDZ) domain and LIM (Lin-11, Isl-1, and Mec-3) domain 5 (PDLIM5) gene has been analyzed as a candidate gene for both schizophrenia and bipolar disorder (BP) in Japanese samples.
18496208	2008	Psychiatr. Genet.	1473-5873	CONCLUSION	4	9	10611	SYMBOL|DICTIONARY	pdlim5	PDLIM5	0#6		D001714	SYMBOL|EXTRACTED	bp	BP	52#54	18496208-1-193-209	PDLIM5 may have a minor effect on susceptibility to BP in Caucasians.
20373279	2011	Exp. Clin. Endocrinol. Diabetes	1439-3646	ALL_TEXT_3/3	3	11	79068	SYMBOL|DICTIONARY	fto	FTO	15#18		D009765	LONGTERM|DICTIONARY	obesity	obesity	39#46		In conclusion, FTO was associated with obesity, but not with weight gain in adults during 11 years of follow-up.
20373279	2011	Exp. Clin. Endocrinol. Diabetes	1439-3646	ALL_TEXT_3/3	3	11	79068	SYMBOL|DICTIONARY	fto	FTO	15#18		D015430	LONGTERM|DICTIONARY	weight gain	weight gain	61#72	NaN	In conclusion, FTO was associated with obesity, but not with weight gain in adults during 11 years of follow-up.
14713779	2004	J. Urol.	0022-5347	RESULTS	3	9	4953	SYMBOL|DICTIONARY|EXTRACTED	odc	ODC	75#78	14713779-1-79-102	D011471	LONGTERM|DISEASE|DT|DICTIONARY	prostate cancer	prostate cancer	28#43		Smoking was associated with prostate cancer only in men carrying a least 1 ODC A allele (p interaction = 0.02).
20064547	2010	Mech. Ageing Dev.	1872-6216	ALL_TEXT_3/3	3	9	4780	SYMBOL|DICTIONARY	nfe2l2	NFE2L2	28#34		D000544	SYMBOL|EXTRACTED	ad	AD	72#74	20064547-1-0-19	Our findings do not support NFE2L2 or KEAP1 as susceptibility genes for AD or cataract.
20064547	2010	Mech. Ageing Dev.	1872-6216	ALL_TEXT_3/3	3	9	4780	SYMBOL|DICTIONARY	nfe2l2	NFE2L2	28#34		D002386	LONGTERM|DICTIONARY	cataract	cataract	78#86		Our findings do not support NFE2L2 or KEAP1 as susceptibility genes for AD or cataract.
20064547	2010	Mech. Ageing Dev.	1872-6216	ALL_TEXT_3/3	3	9	9817	SYMBOL|DICTIONARY	keap1	KEAP1	38#43		D000544	SYMBOL|EXTRACTED	ad	AD	72#74	20064547-1-0-19	Our findings do not support NFE2L2 or KEAP1 as susceptibility genes for AD or cataract.
20064547	2010	Mech. Ageing Dev.	1872-6216	ALL_TEXT_3/3	3	9	9817	SYMBOL|DICTIONARY	keap1	KEAP1	38#43		D002386	LONGTERM|DICTIONARY	cataract	cataract	78#86		Our findings do not support NFE2L2 or KEAP1 as susceptibility genes for AD or cataract.
20064547	2010	Mech. Ageing Dev.	1872-6216	ALL_TEXT_3/3	3	8	4780	SYMBOL|DICTIONARY	nfe2l2	NFE2L2	21#27		D002386	LONGTERM|DICTIONARY	cataract	cataract	90#98		Another haplotype of NFE2L2 was associated with 4 years later age at surgery for cortical cataract (p(c)=0.009).
16490169	2006	Acta Pharmacol. Sin.	1671-4083	RESULTS	3	9	1565	SYMBOL|DICTIONARY	cyp2d6	CYP2D6	185#191		D004409	SYMBOL|EXTRACTED	td	TD	117#119	16490169-1-122-140	The results of logistic regression analysis demonstrated that mean age and duration of illness were risk factors for TD, but not sex, cumulative exposure to neuroleptic drugs in years, CYP2D6 or CYP1A2 genotype.
16490169	2006	Acta Pharmacol. Sin.	1671-4083	RESULTS	3	9	1544	SYMBOL|DICTIONARY	cyp1a2	CYP1A2	195#201		D004409	SYMBOL|EXTRACTED	td	TD	117#119	16490169-1-122-140	The results of logistic regression analysis demonstrated that mean age and duration of illness were risk factors for TD, but not sex, cumulative exposure to neuroleptic drugs in years, CYP2D6 or CYP1A2 genotype.
20546854	2010	Thromb. Res.	1879-2472	METHODS	2	8	80150	LONGTERM|DICTIONARY	l asparaginase	L-asparaginase	94#108		D019851	LONGTERM|DICTIONARY	thrombophilia	thrombophilia	265#278		LMWH was given once daily subcutaneously at a dose of 1mg/kg, starting with the first dose of L-asparaginase (day 12 of induction, day 8 of consolidation) until one week after the last dose (day 40 of induction, day 25 of consolidation), to patients with inherited thrombophilia stemming from either factor V Leiden or prothrombin gene mutation.
20546854	2010	Thromb. Res.	1879-2472	METHODS	2	8	2153	LONGTERM|DICTIONARY	factor v leiden	factor V Leiden	300#315		D019851	LONGTERM|DICTIONARY	thrombophilia	thrombophilia	265#278		LMWH was given once daily subcutaneously at a dose of 1mg/kg, starting with the first dose of L-asparaginase (day 12 of induction, day 8 of consolidation) until one week after the last dose (day 40 of induction, day 25 of consolidation), to patients with inherited thrombophilia stemming from either factor V Leiden or prothrombin gene mutation.
20546854	2010	Thromb. Res.	1879-2472	METHODS	2	8	2147	LONGTERM|GENE|GN|DICTIONARY	prothrombin	prothrombin	319#330		D019851	LONGTERM|DICTIONARY	thrombophilia	thrombophilia	265#278		LMWH was given once daily subcutaneously at a dose of 1mg/kg, starting with the first dose of L-asparaginase (day 12 of induction, day 8 of consolidation) until one week after the last dose (day 40 of induction, day 25 of consolidation), to patients with inherited thrombophilia stemming from either factor V Leiden or prothrombin gene mutation.
16386647	2006	Hum. Immunol.	0198-8859	ALL_TEXT_2/3	2	3	3106	LONGTERM|DICTIONARY	hlab27	HLAB27	220#226	NaN	D013167	LONGTERM|DICTIONARY	ankylosing spondylitis	ankylosing spondylitis	129#151		We investigated whether this dimorphism (MICA-129met [methionine] and MICA-129val [valine]) is associated with susceptibility to ankylosing spondylitis (AS) in a cohort of Algerian patients stratified according to their HLAB27 status and the age of onset of the disease.
16386647	2006	Hum. Immunol.	0198-8859	ALL_TEXT_2/3	2	3	3106	LONGTERM|DICTIONARY	hlab27	HLAB27	220#226	NaN	D013167	SYMBOL|EXTRACTED|()	as	AS	153#155	16386647-3-129-151	We investigated whether this dimorphism (MICA-129met [methionine] and MICA-129val [valine]) is associated with susceptibility to ankylosing spondylitis (AS) in a cohort of Algerian patients stratified according to their HLAB27 status and the age of onset of the disease.
12669197	2004	Diabetologia	0012-186X	CONCLUSION/INTERPRETATION	4	10	3172	LONGTERM|DICTIONARY	hnf-4alpha	HNF-4alpha	32#42	NaN	D003920	LONGTERM|DICTIONARY	diabetes	diabetes	149#157		Our findings suggest that T130I-HNF-4alpha is a loss-of-function mutation in hepatocytes and that this mutation is associated with late-onset Type 2 diabetes in Japanese subjects.
12669197	2004	Diabetologia	0012-186X	CONCLUSION/INTERPRETATION	4	10	3172	LONGTERM|DICTIONARY	hnf-4alpha	HNF-4alpha	32#42	NaN	D017827	LONGTERM|DICTIONARY	type	Type	142#146		Our findings suggest that T130I-HNF-4alpha is a loss-of-function mutation in hepatocytes and that this mutation is associated with late-onset Type 2 diabetes in Japanese subjects.
18179891	2008	Am. J. Hum. Genet.	1537-6605	TITLE	0	0	2103	SYMBOL|DICTIONARY	esrrb	ESRRB	13#18		C537845	LONGTERM|DICTIONARY	autosomal-recessive nonsyndromic hearing impairment dfnb35	autosomal-recessive nonsyndromic hearing impairment DFNB35	65#123		Mutations of ESRRB encoding estrogen-related receptor beta cause autosomal-recessive nonsyndromic hearing impairment DFNB35.
18179891	2008	Am. J. Hum. Genet.	1537-6605	TITLE	0	0	2103	LONGTERM|DICTIONARY	estrogen related receptor beta	estrogen-related receptor beta	28#58		C537845	LONGTERM|DICTIONARY	autosomal-recessive nonsyndromic hearing impairment dfnb35	autosomal-recessive nonsyndromic hearing impairment DFNB35	65#123		Mutations of ESRRB encoding estrogen-related receptor beta cause autosomal-recessive nonsyndromic hearing impairment DFNB35.
12669197	2004	Diabetologia	0012-186X	CONCLUSION/INTERPRETATION	4	11	3172	LONGTERM|DICTIONARY	hnf-4alpha	HNF-4alpha	26#36	NaN	D003920	LONGTERM|DICTIONARY	diabetes	diabetes	89#97		The T130I mutation in the HNF-4alpha gene might be involved in the development of Type 2 diabetes in the Japanese population.
12669197	2004	Diabetologia	0012-186X	CONCLUSION/INTERPRETATION	4	11	3172	LONGTERM|DICTIONARY	hnf-4alpha	HNF-4alpha	26#36	NaN	D017827	LONGTERM|DICTIONARY	type	Type	82#86		The T130I mutation in the HNF-4alpha gene might be involved in the development of Type 2 diabetes in the Japanese population.
17082176	2007	Carcinogenesis	0143-3334	ALL_TEXT_1/3	1	1	1728	SYMBOL|()|DICTIONARY|EXTRACTED	nqo1	NQO1	34#38	17082176-1-8-30	D015179	LONGTERM|DICTIONARY	colorectal neoplasia	colorectal neoplasia	145#165		NADP(H):quinone oxidoreductase 1 (NQO1) and microsomal epoxide hydrolase (EPHX1, also mEH) are attractive candidate enzymes for association with colorectal neoplasia because they metabolize a number of compounds including polycyclic aromatic hydrocarbons (PAHs) that have been linked with colorectal carcinogenesis.
17082176	2007	Carcinogenesis	0143-3334	ALL_TEXT_1/3	1	1	1728	SYMBOL|()|DICTIONARY|EXTRACTED	nqo1	NQO1	34#38	17082176-1-8-30	D015179	LONGTERM|DICTIONARY	colorectal carcinogenesis	colorectal carcinogenesis	289#314		NADP(H):quinone oxidoreductase 1 (NQO1) and microsomal epoxide hydrolase (EPHX1, also mEH) are attractive candidate enzymes for association with colorectal neoplasia because they metabolize a number of compounds including polycyclic aromatic hydrocarbons (PAHs) that have been linked with colorectal carcinogenesis.
17082176	2007	Carcinogenesis	0143-3334	ALL_TEXT_1/3	1	1	2052	SYMBOL|DICTIONARY	ephx1	EPHX1	74#79		D015179	LONGTERM|DICTIONARY	colorectal neoplasia	colorectal neoplasia	145#165		NADP(H):quinone oxidoreductase 1 (NQO1) and microsomal epoxide hydrolase (EPHX1, also mEH) are attractive candidate enzymes for association with colorectal neoplasia because they metabolize a number of compounds including polycyclic aromatic hydrocarbons (PAHs) that have been linked with colorectal carcinogenesis.
17082176	2007	Carcinogenesis	0143-3334	ALL_TEXT_1/3	1	1	2052	SYMBOL|DICTIONARY	ephx1	EPHX1	74#79		D015179	LONGTERM|DICTIONARY	colorectal carcinogenesis	colorectal carcinogenesis	289#314		NADP(H):quinone oxidoreductase 1 (NQO1) and microsomal epoxide hydrolase (EPHX1, also mEH) are attractive candidate enzymes for association with colorectal neoplasia because they metabolize a number of compounds including polycyclic aromatic hydrocarbons (PAHs) that have been linked with colorectal carcinogenesis.
17082176	2007	Carcinogenesis	0143-3334	ALL_TEXT_1/3	1	1	1728	LONGTERM|NUMBER|DICTIONARY	nadp(h):quinone oxidoreductase 1	NADP(H):quinone oxidoreductase 1	0#32		D015179	LONGTERM|DICTIONARY	colorectal neoplasia	colorectal neoplasia	145#165		NADP(H):quinone oxidoreductase 1 (NQO1) and microsomal epoxide hydrolase (EPHX1, also mEH) are attractive candidate enzymes for association with colorectal neoplasia because they metabolize a number of compounds including polycyclic aromatic hydrocarbons (PAHs) that have been linked with colorectal carcinogenesis.
17082176	2007	Carcinogenesis	0143-3334	ALL_TEXT_1/3	1	1	1728	LONGTERM|NUMBER|DICTIONARY	nadp(h):quinone oxidoreductase 1	NADP(H):quinone oxidoreductase 1	0#32		D015179	LONGTERM|DICTIONARY	colorectal carcinogenesis	colorectal carcinogenesis	289#314		NADP(H):quinone oxidoreductase 1 (NQO1) and microsomal epoxide hydrolase (EPHX1, also mEH) are attractive candidate enzymes for association with colorectal neoplasia because they metabolize a number of compounds including polycyclic aromatic hydrocarbons (PAHs) that have been linked with colorectal carcinogenesis.
17082176	2007	Carcinogenesis	0143-3334	TITLE	0	0	2052	SYMBOL|GENE|GN|DICTIONARY	ephx1	EPHX1	22#27		C563365	LONGTERM|DICTIONARY	colorectal adenomas	colorectal adenomas	110#129		Role of NQO1C609T and EPHX1 gene polymorphisms in the association of smoking and alcohol with sporadic distal colorectal adenomas: results from the UKFSS Study.
16004559	2006	Pharmacogenomics	1462-2416	TITLE	0	0	5243	SYMBOL|GENE|GN|DICTIONARY	abcb1	ABCB1	34#39		D004827	LONGTERM|DISEASE|DN|DICTIONARY	epilepsy	epilepsy	48#56		Complex haplotypic effects of the ABCB1 gene on epilepsy treatment response.
17082176	2007	Carcinogenesis	0143-3334	ALL_TEXT_2/3	2	4	1728	SYMBOL|NUMBER|DICTIONARY|EXTRACTED	nqo1	NQO1	4#8	17082176-1-8-30	D000236	LONGTERM|DICTIONARY	adenoma	adenoma	63#70		The NQO1 609*T allele was positively associated with high-risk adenoma in this population [odds ratio (OR), 1.36; 95% confidence interval (CI), 1.02-1.83].
16490169	2006	Acta Pharmacol. Sin.	1671-4083	RESULTS	3	6	1544	SYMBOL|DICTIONARY	cyp1a2	CYP1A2	31#37		D004409	SYMBOL|EXTRACTED	td	TD	64#66	16490169-1-122-140	Moreover, the frequency of the CYP1A2 C allele in patients with TD was significantly higher than that in those without TD (Chi2=6.38, P<0.05).
16490169	2006	Acta Pharmacol. Sin.	1671-4083	RESULTS	3	6	1544	SYMBOL|DICTIONARY	cyp1a2	CYP1A2	31#37		D004409	SYMBOL|EXTRACTED	td	TD	119#121	16490169-1-122-140	Moreover, the frequency of the CYP1A2 C allele in patients with TD was significantly higher than that in those without TD (Chi2=6.38, P<0.05).
18080216	2009	Fam. Cancer	1389-9600	ALL_TEXT_1/3	1	3	27306	SYMBOL|PLURAL|DICTIONARY	gsts	GSTs	91#95		D001943	LONGTERM|DISEASE|DT|DICTIONARY	sporadic breast cancer	sporadic breast cancer	112#134		In the present case-control study, undertaken to examine the influence of polymorphisms of GSTs in familial and sporadic breast cancer susceptibility, 597 women including 222 sporadic breast cancer patients, 125 familial breast cancer patients and 250 females with no history of cancer as controls were genotyped by PCR based methods.
18080216	2009	Fam. Cancer	1389-9600	ALL_TEXT_1/3	1	3	27306	SYMBOL|PLURAL|DICTIONARY	gsts	GSTs	91#95		D001943	LONGTERM|DISEASE|DN|DT|DICTIONARY	sporadic breast cancer	sporadic breast cancer	175#197		In the present case-control study, undertaken to examine the influence of polymorphisms of GSTs in familial and sporadic breast cancer susceptibility, 597 women including 222 sporadic breast cancer patients, 125 familial breast cancer patients and 250 females with no history of cancer as controls were genotyped by PCR based methods.
18080216	2009	Fam. Cancer	1389-9600	ALL_TEXT_1/3	1	3	27306	SYMBOL|PLURAL|DICTIONARY	gsts	GSTs	91#95		D001943	LONGTERM|DISEASE|DN|DT|DICTIONARY	familial breast cancer	familial breast cancer	212#234		In the present case-control study, undertaken to examine the influence of polymorphisms of GSTs in familial and sporadic breast cancer susceptibility, 597 women including 222 sporadic breast cancer patients, 125 familial breast cancer patients and 250 females with no history of cancer as controls were genotyped by PCR based methods.
18080216	2009	Fam. Cancer	1389-9600	ALL_TEXT_1/3	1	3	27306	SYMBOL|PLURAL|DICTIONARY	gsts	GSTs	91#95		D009369	LONGTERM|DISEASE|DT|DICTIONARY	cancer	cancer	279#285		In the present case-control study, undertaken to examine the influence of polymorphisms of GSTs in familial and sporadic breast cancer susceptibility, 597 women including 222 sporadic breast cancer patients, 125 familial breast cancer patients and 250 females with no history of cancer as controls were genotyped by PCR based methods.
12394840	2002	Transplantation	0041-1337	BACKGROUND	1	5	348	LONGTERM|DICTIONARY	apo e2	Apo E2	0#6	NaN	D003928	LONGTERM|DICTIONARY	diabetic nephropathy	diabetic nephropathy	47#67		Apo E2 has also been found to increase risk of diabetic nephropathy and so may be more prevalent in PTX candidates.
12586300	2003	J. Hepatol.	0168-8278	RESULTS	3	6	3077	SYMBOL|DICTIONARY	hfe	HFE	210#213		D008103	LONGTERM|DICTIONARY	liver cirrhosis	liver cirrhosis	52#67		By multivariate regression analysis odds ratios for liver cirrhosis were 5.9 (confidence interval (CI) 1.6-22.6; P<0.009) for C282Y heterozygotes and 2.9 (CI 1.0-8.4; P<0.05) for H63D heterozygotes compared to HFE wildtypes.
12586300	2003	J. Hepatol.	0168-8278	RESULTS	3	7	3077	SYMBOL|DICTIONARY	hfe	HFE	16#19		D005355	LONGTERM|DICTIONARY	cirrhosis	cirrhosis	92#101		Considering all HFE heterozygous HCV patients, odds ratios of 3.6 (CI 1.4-9.3; P<0.009) for cirrhosis and 3.1 (CI 1.3-7.3; P<0.009) for fibrosis were calculated.
12586300	2003	J. Hepatol.	0168-8278	RESULTS	3	5	3077	SYMBOL|DICTIONARY	hfe	HFE	0#3		C537248	LONGTERM|DICTIONARY	ts	TS	94#96	NaN	HFE heterozygous HCV patients had higher ferritin (349+/-37 vs. 193+/-15 microg/l; P<0.0005), TS (38+/-2 vs. 32+/-1%; P<0.0005), serum iron (144+/-6 vs. 121+/-3 microg/dl; P<0.0005), semiquantitative liver iron staining (0.26+/-0.07 vs. 0.09+/-0.03; P<0.006) and fibrosis scores (1.9+/-0.2 vs. 1.4+/-0.1; P<0.003) compared to HFE wildtypes.
12586300	2003	J. Hepatol.	0168-8278	RESULTS	3	5	3077	SYMBOL|DICTIONARY	hfe	HFE	0#3		D005355	LONGTERM|DICTIONARY	fibrosis	fibrosis	263#271	NaN	HFE heterozygous HCV patients had higher ferritin (349+/-37 vs. 193+/-15 microg/l; P<0.0005), TS (38+/-2 vs. 32+/-1%; P<0.0005), serum iron (144+/-6 vs. 121+/-3 microg/dl; P<0.0005), semiquantitative liver iron staining (0.26+/-0.07 vs. 0.09+/-0.03; P<0.006) and fibrosis scores (1.9+/-0.2 vs. 1.4+/-0.1; P<0.003) compared to HFE wildtypes.
12586300	2003	J. Hepatol.	0168-8278	RESULTS	3	5	3077	SYMBOL|DICTIONARY	hfe	HFE	326#329		C537248	LONGTERM|DICTIONARY	ts	TS	94#96	NaN	HFE heterozygous HCV patients had higher ferritin (349+/-37 vs. 193+/-15 microg/l; P<0.0005), TS (38+/-2 vs. 32+/-1%; P<0.0005), serum iron (144+/-6 vs. 121+/-3 microg/dl; P<0.0005), semiquantitative liver iron staining (0.26+/-0.07 vs. 0.09+/-0.03; P<0.006) and fibrosis scores (1.9+/-0.2 vs. 1.4+/-0.1; P<0.003) compared to HFE wildtypes.
12586300	2003	J. Hepatol.	0168-8278	RESULTS	3	5	3077	SYMBOL|DICTIONARY	hfe	HFE	326#329		D005355	LONGTERM|DICTIONARY	fibrosis	fibrosis	263#271	NaN	HFE heterozygous HCV patients had higher ferritin (349+/-37 vs. 193+/-15 microg/l; P<0.0005), TS (38+/-2 vs. 32+/-1%; P<0.0005), serum iron (144+/-6 vs. 121+/-3 microg/dl; P<0.0005), semiquantitative liver iron staining (0.26+/-0.07 vs. 0.09+/-0.03; P<0.006) and fibrosis scores (1.9+/-0.2 vs. 1.4+/-0.1; P<0.003) compared to HFE wildtypes.
9823305	1998	Cancer Res.	0008-5472	ALL_TEXT_1/3	1	2	1545	SYMBOL|DICTIONARY|EXTRACTED	cyp1b1	CYP1B1	34#40	9823305-0-15-34	D001943	LONGTERM|DISEASE|DT|DICTIONARY	breast cancer	breast cancer	202#215		Because of the preeminent role of CYP1B1 in mammary estrogen/carcinogen metabolism, we examined the CYP1B1 gene to determine whether genetic differences could account for interindividual differences in breast cancer risk.
9823305	1998	Cancer Res.	0008-5472	ALL_TEXT_1/3	1	2	1545	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	cyp1b1	CYP1B1	100#106	9823305-0-15-34	D001943	LONGTERM|DISEASE|DT|DICTIONARY	breast cancer	breast cancer	202#215		Because of the preeminent role of CYP1B1 in mammary estrogen/carcinogen metabolism, we examined the CYP1B1 gene to determine whether genetic differences could account for interindividual differences in breast cancer risk.
12586300	2003	J. Hepatol.	0168-8278	TITLE	0	0	3077	SYMBOL|DICTIONARY	hfe	HFE	0#3		D019698	LONGTERM|DICTIONARY	chronic hepatitis c	chronic hepatitis C	18#37		HFE mutations and chronic hepatitis C: H63D and C282Y heterozygosity are independent risk factors for liver fibrosis and cirrhosis.
12586300	2003	J. Hepatol.	0168-8278	TITLE	0	0	3077	SYMBOL|DICTIONARY	hfe	HFE	0#3		D005355	LONGTERM|DICTIONARY	cirrhosis	cirrhosis	121#130		HFE mutations and chronic hepatitis C: H63D and C282Y heterozygosity are independent risk factors for liver fibrosis and cirrhosis.
12586300	2003	J. Hepatol.	0168-8278	TITLE	0	0	3077	SYMBOL|DICTIONARY	hfe	HFE	0#3		D005355	LONGTERM|DICTIONARY	fibrosis	fibrosis	108#116		HFE mutations and chronic hepatitis C: H63D and C282Y heterozygosity are independent risk factors for liver fibrosis and cirrhosis.
12586300	2003	J. Hepatol.	0168-8278	BACKGROUND/AIMS	1	1	3077	SYMBOL|DICTIONARY	hfe	HFE	27#30		D019698	LONGTERM|DICTIONARY	chronic hepatitis c	chronic hepatitis C	58#77		The impact of heterozygous HFE mutations on the course of chronic hepatitis C and iron indices was studied.
16187919	2006	Thyroid	1050-7256	ALL_TEXT_1/3	1	1	7173	LONGTERM|DICTIONARY	thyroid peroxidase	Thyroid peroxidase	0#18		C564766	LONGTERM|DICTIONARY	total iodide organification defects	total iodide organification defects	62#97	NaN	Thyroid peroxidase (TPO) deficiency is frequently involved in total iodide organification defects (TIOD).
16187919	2006	Thyroid	1050-7256	ALL_TEXT_1/3	1	1	7173	LONGTERM|DICTIONARY	thyroid peroxidase	Thyroid peroxidase	0#18		C564766	LONGTERM|DICTIONARY	tiod	TIOD	99#103	NaN	Thyroid peroxidase (TPO) deficiency is frequently involved in total iodide organification defects (TIOD).
16187919	2006	Thyroid	1050-7256	ALL_TEXT_1/3	1	1	7173	SYMBOL|()|DICTIONARY|EXTRACTED	tpo	TPO	20#23	16187919-1-0-18	C564766	LONGTERM|DICTIONARY	total iodide organification defects	total iodide organification defects	62#97	NaN	Thyroid peroxidase (TPO) deficiency is frequently involved in total iodide organification defects (TIOD).
16187919	2006	Thyroid	1050-7256	ALL_TEXT_1/3	1	1	7173	SYMBOL|()|DICTIONARY|EXTRACTED	tpo	TPO	20#23	16187919-1-0-18	C564766	LONGTERM|DICTIONARY	tiod	TIOD	99#103	NaN	Thyroid peroxidase (TPO) deficiency is frequently involved in total iodide organification defects (TIOD).
16187919	2006	Thyroid	1050-7256	ALL_TEXT_1/3	1	3	7173	SYMBOL|DICTIONARY|EXTRACTED	tpo	TPO	31#34	16187919-1-0-18	C564766	LONGTERM|DICTIONARY	tiod	TIOD	122#126	NaN	However, a single heterozygous TPO mutation is reported in a high percentage (approximately 20%) of patients with typical TIOD phenotype.
12586300	2003	J. Hepatol.	0168-8278	CONCLUSIONS	4	9	3077	SYMBOL|DICTIONARY	hfe	HFE	14#17		D006526	SYMBOL|EXTRACTED|DISEASE|DN	hcv infection	HCV infection	52#65	12586300-2-113-132	Screening for HFE mutations should be considered in HCV infection.
17040410	2006	Neurogastroenterol. Motil.	1350-1925	ALL_TEXT_3/3	3	10	6532	SYMBOL|GENE|GN|DICTIONARY	sert	SERT	136#140		D043183	SYMBOL|DICTIONARY|EXTRACTED	ibs	IBS	73#76	17040410-1-149-173	A significant association was observed between the SERT polymorphism and IBS, especially diarrhoea-predominant IBS, suggesting that the SERT gene is a potential candidate gene involved in IBS in Korea.
17040410	2006	Neurogastroenterol. Motil.	1350-1925	ALL_TEXT_3/3	3	10	6532	SYMBOL|GENE|GN|DICTIONARY	sert	SERT	136#140		D003967	LONGTERM|DICTIONARY	diarrhoea	diarrhoea	89#98		A significant association was observed between the SERT polymorphism and IBS, especially diarrhoea-predominant IBS, suggesting that the SERT gene is a potential candidate gene involved in IBS in Korea.
17040410	2006	Neurogastroenterol. Motil.	1350-1925	ALL_TEXT_3/3	3	10	6532	SYMBOL|GENE|GN|DICTIONARY	sert	SERT	136#140		D043183	SYMBOL|DICTIONARY|EXTRACTED	ibs	IBS	111#114	17040410-1-149-173	A significant association was observed between the SERT polymorphism and IBS, especially diarrhoea-predominant IBS, suggesting that the SERT gene is a potential candidate gene involved in IBS in Korea.
17040410	2006	Neurogastroenterol. Motil.	1350-1925	ALL_TEXT_3/3	3	10	6532	SYMBOL|GENE|GN|DICTIONARY	sert	SERT	136#140		D043183	SYMBOL|DICTIONARY|EXTRACTED	ibs	IBS	188#191	17040410-1-149-173	A significant association was observed between the SERT polymorphism and IBS, especially diarrhoea-predominant IBS, suggesting that the SERT gene is a potential candidate gene involved in IBS in Korea.
12080485	2002	Am. J. Hum. Genet.	0002-9297	ALL_TEXT_2/3	2	3	54209	SYMBOL|DICTIONARY	trem2	TREM2	65#70		C536329	SYMBOL|DICTIONARY|EXTRACTED	plosl	PLOSL	44#49	12080485-1-0-76	Here we complete the molecular pathology of PLOSL by identifying TREM2 as the second PLOSL gene.
19395426	2010	J. Psychopharmacol. (Oxford)	1461-7285	TITLE	0	0	1576	SYMBOL|DICTIONARY	cyp3a4	CYP3A4	87#93		D012559	LONGTERM|DISEASE|DN|DICTIONARY	schizophrenia	schizophrenia	111#124		Relationship between response to risperidone, plasma concentrations of risperidone and CYP3A4 polymorphisms in schizophrenia patients.
16490169	2006	Acta Pharmacol. Sin.	1671-4083	AIM	1	1	1565	SYMBOL|GENE|GN|DICTIONARY	cyp2d6	CYP2D6	47#53		D004409	LONGTERM|DICTIONARY	tardive dyskinesia	tardive dyskinesia	122#140		To investigate the possible association of the CYP2D6 gene C100T polymorphism and the CYP1A2 gene C163A polymorphism with tardive dyskinesia (TD) in Chinese patients with schizophrenia.
16490169	2006	Acta Pharmacol. Sin.	1671-4083	AIM	1	1	1565	SYMBOL|GENE|GN|DICTIONARY	cyp2d6	CYP2D6	47#53		D004409	SYMBOL|EXTRACTED|()	td	TD	142#144	16490169-1-122-140	To investigate the possible association of the CYP2D6 gene C100T polymorphism and the CYP1A2 gene C163A polymorphism with tardive dyskinesia (TD) in Chinese patients with schizophrenia.
16490169	2006	Acta Pharmacol. Sin.	1671-4083	AIM	1	1	1565	SYMBOL|GENE|GN|DICTIONARY	cyp2d6	CYP2D6	47#53		D012559	LONGTERM|DICTIONARY	schizophrenia	schizophrenia	171#184		To investigate the possible association of the CYP2D6 gene C100T polymorphism and the CYP1A2 gene C163A polymorphism with tardive dyskinesia (TD) in Chinese patients with schizophrenia.
16490169	2006	Acta Pharmacol. Sin.	1671-4083	AIM	1	1	1544	SYMBOL|GENE|GN|DICTIONARY	cyp1a2	CYP1A2	86#92		D004409	LONGTERM|DICTIONARY	tardive dyskinesia	tardive dyskinesia	122#140		To investigate the possible association of the CYP2D6 gene C100T polymorphism and the CYP1A2 gene C163A polymorphism with tardive dyskinesia (TD) in Chinese patients with schizophrenia.
16490169	2006	Acta Pharmacol. Sin.	1671-4083	AIM	1	1	1544	SYMBOL|GENE|GN|DICTIONARY	cyp1a2	CYP1A2	86#92		D004409	SYMBOL|EXTRACTED|()	td	TD	142#144	16490169-1-122-140	To investigate the possible association of the CYP2D6 gene C100T polymorphism and the CYP1A2 gene C163A polymorphism with tardive dyskinesia (TD) in Chinese patients with schizophrenia.
16490169	2006	Acta Pharmacol. Sin.	1671-4083	AIM	1	1	1544	SYMBOL|GENE|GN|DICTIONARY	cyp1a2	CYP1A2	86#92		D012559	LONGTERM|DICTIONARY	schizophrenia	schizophrenia	171#184		To investigate the possible association of the CYP2D6 gene C100T polymorphism and the CYP1A2 gene C163A polymorphism with tardive dyskinesia (TD) in Chinese patients with schizophrenia.
12850481	2004	Blood Cells Mol. Dis.	1079-9796	TITLE	0	0	54658	SYMBOL|DICTIONARY	ugt1 a1	UGT1 A1	72#79		D000755	LONGTERM|DISEASE|DT|DICTIONARY	sickle cell disease	sickle cell disease	135#154		Analysis of the A(TA)(n)TAA configuration in the promoter region of the UGT1 A1 gene in Greek patients with thalassemia intermedia and sickle cell disease.
12850481	2004	Blood Cells Mol. Dis.	1079-9796	TITLE	0	0	54658	SYMBOL|DICTIONARY	ugt1 a1	UGT1 A1	72#79		D013789	LONGTERM|DICTIONARY	thalassemia	thalassemia	108#119		Analysis of the A(TA)(n)TAA configuration in the promoter region of the UGT1 A1 gene in Greek patients with thalassemia intermedia and sickle cell disease.
20674764	2011	Microbes Infect.	1769-714X	ALL_TEXT_2/3	2	5	51311	SYMBOL|DICTIONARY	tlr8	TLR8	29#33		D006479	SYMBOL|EXTRACTED|DISEASE|DN	cchf	CCHF	105#109	20674764-1-8-31	We investigated frequency of TLR8 Met1Val, TLR8 -129C/G, TLR9 -1486T/C and TLR9 2458G/A polymorphisms in CCHF patients and healthy controls.
20674764	2011	Microbes Infect.	1769-714X	ALL_TEXT_2/3	2	5	51311	SYMBOL|DICTIONARY	tlr8	TLR8	43#47		D006479	SYMBOL|EXTRACTED|DISEASE|DN	cchf	CCHF	105#109	20674764-1-8-31	We investigated frequency of TLR8 Met1Val, TLR8 -129C/G, TLR9 -1486T/C and TLR9 2458G/A polymorphisms in CCHF patients and healthy controls.
20674764	2011	Microbes Infect.	1769-714X	ALL_TEXT_2/3	2	5	54106	SYMBOL|DICTIONARY	tlr9	TLR9	57#61		D006479	SYMBOL|EXTRACTED|DISEASE|DN	cchf	CCHF	105#109	20674764-1-8-31	We investigated frequency of TLR8 Met1Val, TLR8 -129C/G, TLR9 -1486T/C and TLR9 2458G/A polymorphisms in CCHF patients and healthy controls.
20674764	2011	Microbes Infect.	1769-714X	ALL_TEXT_2/3	2	5	54106	SYMBOL|NUMBER|DICTIONARY	tlr9	TLR9	75#79		D006479	SYMBOL|EXTRACTED|DISEASE|DN	cchf	CCHF	105#109	20674764-1-8-31	We investigated frequency of TLR8 Met1Val, TLR8 -129C/G, TLR9 -1486T/C and TLR9 2458G/A polymorphisms in CCHF patients and healthy controls.
15048896	2004	Ann. Neurol.	0364-5134	ALL_TEXT_2/3	2	4	348	LONGTERM|DICTIONARY	apoe	ApoE	34#38	NaN	D009103	SYMBOL|DISEASE|DN|DICTIONARY|EXTRACTED	ms	MS	12#14	15048896-1-83-101	Ninety-nine MS patients underwent ApoE genotyping, clinical examination, and magnetic resonance imaging at baseline and after 2.7 +/- 1.1 years to assess lesion load (LL) and BVC.
15699697	2005	J. Pediatr. Gastroenterol. Nutr.	0277-2116	RESULTS	3	6	1990	LONGTERM|DICTIONARY	pancreatic elastase 1	pancreatic elastase-1	26#47		D003550	SYMBOL|DISEASE|DN|DICTIONARY|EXTRACTED	cf	CF	7#9	15699697-1-5-20	In all CF patients, fecal pancreatic elastase-1 concentrations of the first assay after diagnosis (3 to 4 months of age) were lower than the cut-off level for normals of <200 microg/g stool.
19111531	2009	Clin. Biochem.	1873-2933	OBJECTIVES	1	3	4846	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	nos3	NOS3	126#130	19111531-2-51-55	D006973	LONGTERM|DICTIONARY	hypertension	hypertension	140#152		In the present study, we examined a possible association between the 27-base pair (bp) repeat polymorphism in intron 4 of the NOS3 gene and hypertension in a sample of the Tunisian population.
19111531	2009	Clin. Biochem.	1873-2933	OBJECTIVES	1	2	4846	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	enos	eNOS	51#55	19111531-1-30-63	D006973	LONGTERM|DICTIONARY	hypertension	hypertension	87#99		Controversial results regarding the association of eNOS gene (NOS3) polymorphisms with hypertension have been reported.
19111531	2009	Clin. Biochem.	1873-2933	OBJECTIVES	1	2	4846	SYMBOL|()|DICTIONARY|EXTRACTED	nos3	NOS3	62#66	19111531-2-51-55	D006973	LONGTERM|DICTIONARY	hypertension	hypertension	87#99		Controversial results regarding the association of eNOS gene (NOS3) polymorphisms with hypertension have been reported.
19509271	2009	Mol. Cancer Ther.	1538-8514	ALL_TEXT_1/3	1	2	1268	SYMBOL|EXTRACTED	cb1	CB1	189#192	19509271-1-64-86	D009369	LONGTERM|DISEASE|DT|CLINE|CN|DICTIONARY	cancer	cancer	110#116		Because cannabinoid receptor agonists are capable of reducing proliferation and inducing apoptosis in diverse cancer cells such as glioma, breast cancer, and melanoma, we evaluated whether CB1 is a potential drug target in rhabdomyosarcoma.
19509271	2009	Mol. Cancer Ther.	1538-8514	ALL_TEXT_1/3	1	2	1268	SYMBOL|EXTRACTED	cb1	CB1	189#192	19509271-1-64-86	D005910	LONGTERM|DICTIONARY	glioma	glioma	131#137		Because cannabinoid receptor agonists are capable of reducing proliferation and inducing apoptosis in diverse cancer cells such as glioma, breast cancer, and melanoma, we evaluated whether CB1 is a potential drug target in rhabdomyosarcoma.
19509271	2009	Mol. Cancer Ther.	1538-8514	ALL_TEXT_1/3	1	2	1268	SYMBOL|EXTRACTED	cb1	CB1	189#192	19509271-1-64-86	D001943	LONGTERM|DISEASE|DT|DICTIONARY	breast cancer	breast cancer	139#152		Because cannabinoid receptor agonists are capable of reducing proliferation and inducing apoptosis in diverse cancer cells such as glioma, breast cancer, and melanoma, we evaluated whether CB1 is a potential drug target in rhabdomyosarcoma.
19509271	2009	Mol. Cancer Ther.	1538-8514	ALL_TEXT_1/3	1	2	1268	SYMBOL|EXTRACTED	cb1	CB1	189#192	19509271-1-64-86	D008545	LONGTERM|DICTIONARY	melanoma	melanoma	158#166		Because cannabinoid receptor agonists are capable of reducing proliferation and inducing apoptosis in diverse cancer cells such as glioma, breast cancer, and melanoma, we evaluated whether CB1 is a potential drug target in rhabdomyosarcoma.
19509271	2009	Mol. Cancer Ther.	1538-8514	ALL_TEXT_1/3	1	2	1268	SYMBOL|EXTRACTED	cb1	CB1	189#192	19509271-1-64-86	D012208	LONGTERM|DICTIONARY	rhabdomyosarcoma	rhabdomyosarcoma	223#239		Because cannabinoid receptor agonists are capable of reducing proliferation and inducing apoptosis in diverse cancer cells such as glioma, breast cancer, and melanoma, we evaluated whether CB1 is a potential drug target in rhabdomyosarcoma.
15699697	2005	J. Pediatr. Gastroenterol. Nutr.	0277-2116	RESULTS	3	8	1990	LONGTERM|DICTIONARY	pancreatic elastase 1	pancreatic elastase-1	59#80		D003550	SYMBOL|EXTRACTED	cf	CF	37#39	15699697-1-5-20	At the age of 6 months, all screened CF subjects had fecal pancreatic elastase-1 concentrations <100 microg/g and at the age of 12 months all were pancreatic insufficient.
12080485	2002	Am. J. Hum. Genet.	0002-9297	ALL_TEXT_1/3	1	2	7305	SYMBOL|DICTIONARY	tyrobp	TYROBP	49#55		C536329	SYMBOL|DICTIONARY|EXTRACTED	plosl	PLOSL	30#35	12080485-1-0-76	Elsewhere, we have identified PLOSL mutations in TYROBP (DAP12), which codes for a membrane receptor component in natural-killer and myeloid cells, and also have identified genetic heterogeneity in PLOSL, with some patients carrying no mutations in TYROBP.
12080485	2002	Am. J. Hum. Genet.	0002-9297	ALL_TEXT_1/3	1	2	7305	SYMBOL|DICTIONARY	tyrobp	TYROBP	49#55		C536329	SYMBOL|DICTIONARY|EXTRACTED	plosl	PLOSL	198#203	12080485-1-0-76	Elsewhere, we have identified PLOSL mutations in TYROBP (DAP12), which codes for a membrane receptor component in natural-killer and myeloid cells, and also have identified genetic heterogeneity in PLOSL, with some patients carrying no mutations in TYROBP.
12080485	2002	Am. J. Hum. Genet.	0002-9297	ALL_TEXT_1/3	1	2	7305	SYMBOL|()|DICTIONARY|EXTRACTED	dap12	DAP12	57#62	12080485-2-49-55	C536329	SYMBOL|DICTIONARY|EXTRACTED	plosl	PLOSL	30#35	12080485-1-0-76	Elsewhere, we have identified PLOSL mutations in TYROBP (DAP12), which codes for a membrane receptor component in natural-killer and myeloid cells, and also have identified genetic heterogeneity in PLOSL, with some patients carrying no mutations in TYROBP.
12080485	2002	Am. J. Hum. Genet.	0002-9297	ALL_TEXT_1/3	1	2	7305	SYMBOL|()|DICTIONARY|EXTRACTED	dap12	DAP12	57#62	12080485-2-49-55	C536329	SYMBOL|DICTIONARY|EXTRACTED	plosl	PLOSL	198#203	12080485-1-0-76	Elsewhere, we have identified PLOSL mutations in TYROBP (DAP12), which codes for a membrane receptor component in natural-killer and myeloid cells, and also have identified genetic heterogeneity in PLOSL, with some patients carrying no mutations in TYROBP.
12080485	2002	Am. J. Hum. Genet.	0002-9297	ALL_TEXT_1/3	1	2	7305	SYMBOL|DICTIONARY	tyrobp	TYROBP	249#255		C536329	SYMBOL|DICTIONARY|EXTRACTED	plosl	PLOSL	30#35	12080485-1-0-76	Elsewhere, we have identified PLOSL mutations in TYROBP (DAP12), which codes for a membrane receptor component in natural-killer and myeloid cells, and also have identified genetic heterogeneity in PLOSL, with some patients carrying no mutations in TYROBP.
12080485	2002	Am. J. Hum. Genet.	0002-9297	ALL_TEXT_1/3	1	2	7305	SYMBOL|DICTIONARY	tyrobp	TYROBP	249#255		C536329	SYMBOL|DICTIONARY|EXTRACTED	plosl	PLOSL	198#203	12080485-1-0-76	Elsewhere, we have identified PLOSL mutations in TYROBP (DAP12), which codes for a membrane receptor component in natural-killer and myeloid cells, and also have identified genetic heterogeneity in PLOSL, with some patients carrying no mutations in TYROBP.
23566200	2013	Immunology	1365-2567	ALL_TEXT_3/3	3	10	929	SYMBOL|DICTIONARY	cd14	CD14	22#26		D003424	SYMBOL|EXTRACTED	cd	CD	64#66	23566200-5-176-191	Among LPMCs, isolated CD14(+) intestinal Ms from patients with CD expressed TGR5.
23566200	2013	Immunology	1365-2567	ALL_TEXT_3/3	3	10	151306	SYMBOL|DICTIONARY	tgr5	TGR5	77#81		D003424	SYMBOL|EXTRACTED	cd	CD	64#66	23566200-5-176-191	Among LPMCs, isolated CD14(+) intestinal Ms from patients with CD expressed TGR5.
20197243	2010	Cancer Epidemiol	1877-783X	RESULTS	3	5	10	SYMBOL|DICTIONARY|EXTRACTED	nat2	NAT2	244#248	20197243-2-100-121	D001943	LONGTERM|DISEASE|DT|DICTIONARY	breast cancer	breast cancer	104#117		Among never-active smokers, a long duration of passive smoking was associated with an increased risk of breast cancer (odds ratio (OR) 1.86 (95% confidence interval (95% CI) 1.01-3.44) (test for trend (p=0.07)); that risk was more elevated for NAT2 slow acetylators (OR 2.76, 95% CI 1.16-6.59) (and highest in extremely slow acetylators), but not elevated for NAT2 fast acetylators (OR 1.17, 95% CI 0.42-3.23).
20197243	2010	Cancer Epidemiol	1877-783X	RESULTS	3	5	10	SYMBOL|DICTIONARY|EXTRACTED	nat2	NAT2	360#364	20197243-2-100-121	D001943	LONGTERM|DISEASE|DT|DICTIONARY	breast cancer	breast cancer	104#117		Among never-active smokers, a long duration of passive smoking was associated with an increased risk of breast cancer (odds ratio (OR) 1.86 (95% confidence interval (95% CI) 1.01-3.44) (test for trend (p=0.07)); that risk was more elevated for NAT2 slow acetylators (OR 2.76, 95% CI 1.16-6.59) (and highest in extremely slow acetylators), but not elevated for NAT2 fast acetylators (OR 1.17, 95% CI 0.42-3.23).
20196834	2010	BMC Med. Genet.	1471-2350	BACKGROUND	1	3	4780	SYMBOL|DICTIONARY	nfe2l2	NFE2L2	39#45		D010300	LONGTERM|DISEASE|DT|DICTIONARY	parkinson disease	Parkinson's disease	150#169		Here, we hypothesize that variation in NFE2L2 and KEAP1, the genes encoding the two major regulators of the phase II response, may affect the risk of Parkinson's disease.
20196834	2010	BMC Med. Genet.	1471-2350	BACKGROUND	1	3	9817	SYMBOL|DICTIONARY	keap1	KEAP1	50#55		D010300	LONGTERM|DISEASE|DT|DICTIONARY	parkinson disease	Parkinson's disease	150#169		Here, we hypothesize that variation in NFE2L2 and KEAP1, the genes encoding the two major regulators of the phase II response, may affect the risk of Parkinson's disease.
21966456	2012	PLoS ONE	1932-6203	METHODOLOGY/PRINCIPAL FINDINGS	2	7	5733	LONGTERM|DICTIONARY	ep3	EP3	0#3	NaN	D014456	LONGTERM|DICTIONARY	mooren ulcer	Mooren's ulcer	89#103		EP3 was expressed in the conjunctival epithelium of patients with chemical eye burns and Mooren's ulcer and in normal human conjunctival epithelium.
21966456	2012	PLoS ONE	1932-6203	METHODOLOGY/PRINCIPAL FINDINGS	2	7	5733	LONGTERM|DICTIONARY	ep3	EP3	0#3	NaN	D005126	LONGTERM|DICTIONARY	chemical eye burns	chemical eye burns	66#84	NaN	EP3 was expressed in the conjunctival epithelium of patients with chemical eye burns and Mooren's ulcer and in normal human conjunctival epithelium.
18067970	2008	Ophthalmology	1549-4713	OBJECTIVE	1	1	3075	LONGTERM|DICTIONARY	complement factor h	complement factor H	82#101		D008268	LONGTERM|DICTIONARY|DISEASE|DA	age related macular degeneration	age-related macular degeneration	25#57		To examine phenotypes of age-related macular degeneration (AMD) patients with the complement factor H (CFH) variant (Y402H, C allele at rs1061170).
18067970	2008	Ophthalmology	1549-4713	OBJECTIVE	1	1	3075	LONGTERM|DICTIONARY	complement factor h	complement factor H	82#101		D008268	SYMBOL|()|DISEASE|DN|DICTIONARY|EXTRACTED	amd	AMD	59#62	18067970-1-25-57	To examine phenotypes of age-related macular degeneration (AMD) patients with the complement factor H (CFH) variant (Y402H, C allele at rs1061170).
18067970	2008	Ophthalmology	1549-4713	OBJECTIVE	1	1	3075	SYMBOL|()|DICTIONARY|EXTRACTED	cfh	CFH	103#106	18067970-1-82-101	D008268	LONGTERM|DICTIONARY|DISEASE|DA	age related macular degeneration	age-related macular degeneration	25#57		To examine phenotypes of age-related macular degeneration (AMD) patients with the complement factor H (CFH) variant (Y402H, C allele at rs1061170).
18067970	2008	Ophthalmology	1549-4713	OBJECTIVE	1	1	3075	SYMBOL|()|DICTIONARY|EXTRACTED	cfh	CFH	103#106	18067970-1-82-101	D008268	SYMBOL|()|DISEASE|DN|DICTIONARY|EXTRACTED	amd	AMD	59#62	18067970-1-25-57	To examine phenotypes of age-related macular degeneration (AMD) patients with the complement factor H (CFH) variant (Y402H, C allele at rs1061170).
22302274	2013	J. Neurol.	1432-1459	ALL_TEXT_2/3	2	3	10558	SYMBOL|DICTIONARY	sptlc1	SPTLC1	221#227		D030342	LONGTERM|DICTIONARY	inherited neuropathy	inherited neuropathy	120#140		To study the frequency of mutations in these genes and the associated phenotypes, we screened 140 index patients in our inherited neuropathy cohort with a clinical diagnosis of HSAN for mutations in the coding regions of SPTLC1, RAB7, WNK1/HSN2, FAM134B, NTRK1 (TRKA) and NGFB.
22302274	2013	J. Neurol.	1432-1459	ALL_TEXT_2/3	2	3	338382	SYMBOL|DICTIONARY	rab7	RAB7	229#233		D030342	LONGTERM|DICTIONARY	inherited neuropathy	inherited neuropathy	120#140		To study the frequency of mutations in these genes and the associated phenotypes, we screened 140 index patients in our inherited neuropathy cohort with a clinical diagnosis of HSAN for mutations in the coding regions of SPTLC1, RAB7, WNK1/HSN2, FAM134B, NTRK1 (TRKA) and NGFB.
22302274	2013	J. Neurol.	1432-1459	ALL_TEXT_2/3	2	3	65125	SYMBOL|DICTIONARY	wnk1	WNK1	235#239		D030342	LONGTERM|DICTIONARY	inherited neuropathy	inherited neuropathy	120#140		To study the frequency of mutations in these genes and the associated phenotypes, we screened 140 index patients in our inherited neuropathy cohort with a clinical diagnosis of HSAN for mutations in the coding regions of SPTLC1, RAB7, WNK1/HSN2, FAM134B, NTRK1 (TRKA) and NGFB.
22302274	2013	J. Neurol.	1432-1459	ALL_TEXT_2/3	2	3	65125	SYMBOL|DICTIONARY	hsn2	HSN2	240#244		D030342	LONGTERM|DICTIONARY	inherited neuropathy	inherited neuropathy	120#140		To study the frequency of mutations in these genes and the associated phenotypes, we screened 140 index patients in our inherited neuropathy cohort with a clinical diagnosis of HSAN for mutations in the coding regions of SPTLC1, RAB7, WNK1/HSN2, FAM134B, NTRK1 (TRKA) and NGFB.
22302274	2013	J. Neurol.	1432-1459	ALL_TEXT_2/3	2	3	54463	SYMBOL|DICTIONARY	fam134b	FAM134B	246#253		D030342	LONGTERM|DICTIONARY	inherited neuropathy	inherited neuropathy	120#140		To study the frequency of mutations in these genes and the associated phenotypes, we screened 140 index patients in our inherited neuropathy cohort with a clinical diagnosis of HSAN for mutations in the coding regions of SPTLC1, RAB7, WNK1/HSN2, FAM134B, NTRK1 (TRKA) and NGFB.
22302274	2013	J. Neurol.	1432-1459	ALL_TEXT_2/3	2	3	4914	SYMBOL|DICTIONARY	ntrk1	NTRK1	255#260		D030342	LONGTERM|DICTIONARY	inherited neuropathy	inherited neuropathy	120#140		To study the frequency of mutations in these genes and the associated phenotypes, we screened 140 index patients in our inherited neuropathy cohort with a clinical diagnosis of HSAN for mutations in the coding regions of SPTLC1, RAB7, WNK1/HSN2, FAM134B, NTRK1 (TRKA) and NGFB.
22302274	2013	J. Neurol.	1432-1459	ALL_TEXT_2/3	2	3	4914	SYMBOL|()|DICTIONARY|EXTRACTED	trka	TRKA	262#266	22302274-3-255-260	D030342	LONGTERM|DICTIONARY	inherited neuropathy	inherited neuropathy	120#140		To study the frequency of mutations in these genes and the associated phenotypes, we screened 140 index patients in our inherited neuropathy cohort with a clinical diagnosis of HSAN for mutations in the coding regions of SPTLC1, RAB7, WNK1/HSN2, FAM134B, NTRK1 (TRKA) and NGFB.
22302274	2013	J. Neurol.	1432-1459	ALL_TEXT_2/3	2	3	4803	SYMBOL|DICTIONARY	ngfb	NGFB	272#276		D030342	LONGTERM|DICTIONARY	inherited neuropathy	inherited neuropathy	120#140		To study the frequency of mutations in these genes and the associated phenotypes, we screened 140 index patients in our inherited neuropathy cohort with a clinical diagnosis of HSAN for mutations in the coding regions of SPTLC1, RAB7, WNK1/HSN2, FAM134B, NTRK1 (TRKA) and NGFB.
20196834	2010	BMC Med. Genet.	1471-2350	TITLE	0	0	4780	SYMBOL|DICTIONARY	nrf2	Nrf2	15#19		D010300	LONGTERM|DISEASE|DT|DICTIONARY	parkinson disease	Parkinson's disease	52#71		Association of Nrf2-encoding NFE2L2 haplotypes with Parkinson's disease.
20196834	2010	BMC Med. Genet.	1471-2350	TITLE	0	0	4780	SYMBOL|DICTIONARY	nfe2l2	NFE2L2	29#35		D010300	LONGTERM|DISEASE|DT|DICTIONARY	parkinson disease	Parkinson's disease	52#71		Association of Nrf2-encoding NFE2L2 haplotypes with Parkinson's disease.
20196918	2010	Int. J. Neuropsychopharmacol.	1469-5111	ALL_TEXT_2/3	2	3	5020	SYMBOL|DICTIONARY|EXTRACTED	oxt	OXT	27#30	20196918-2-26-34	D012559	LONGTERM|DICTIONARY	schizophrenia	schizophrenia	139#152		Therefore, we evaluated if OXT and OXT receptor (OXTR) genes might play a role in the symptom severity and clozapine treatment response in schizophrenia subjects.
20196918	2010	Int. J. Neuropsychopharmacol.	1469-5111	ALL_TEXT_2/3	2	3	5020	SYMBOL|GENE|GN|DICTIONARY|GA|EXTRACTED	oxt	OXT	35#38	20196918-2-26-34	D012559	LONGTERM|DICTIONARY	schizophrenia	schizophrenia	139#152		Therefore, we evaluated if OXT and OXT receptor (OXTR) genes might play a role in the symptom severity and clozapine treatment response in schizophrenia subjects.
12181642	2002	J. Hum. Genet.	1434-5161	ALL_TEXT_1/3	1	3	7421	LONGTERM|GENE|GT|DICTIONARY	vitamin d receptor	vitamin D receptor	78#96		D011471	LONGTERM|DISEASE|DT|DICTIONARY	prostate cancer	prostate cancer	25#40		A three-fold increase in prostate cancer risk associated with the less active vitamin D receptor allele (the T allele from VDR TaqI polymorphism at codon 352) was reported.
12181642	2002	J. Hum. Genet.	1434-5161	ALL_TEXT_1/3	1	3	7421	SYMBOL|DICTIONARY|EXTRACTED	vdr	VDR	123#126	12181642-2-77-95	D011471	LONGTERM|DISEASE|DT|DICTIONARY	prostate cancer	prostate cancer	25#40		A three-fold increase in prostate cancer risk associated with the less active vitamin D receptor allele (the T allele from VDR TaqI polymorphism at codon 352) was reported.
15292102	2005	J. Androl.	0196-3635	ALL_TEXT_3/3	3	9	1636	SYMBOL|DICTIONARY	ace	ACE	33#36		D007172	SYMBOL|EXTRACTED	ed	ED	58#60	15292102-2-179-199	No association was found between ACE I/D polymorphism and ED in the population studied.
18234410	2008	Prog. Neuropsychopharmacol. Biol. Psychiatry	0278-5846	ALL_TEXT_2/3	2	7	4524	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	mthfr	MTHFR	243#248	18234410-4-4-39	D004827	LONGTERM|DISEASE|DN|DICTIONARY	epileptic	epileptic	83#92		In this study, we investigated the levels of serum folate, vitamin B-12 and Hcy in epileptic patients receiving carbamazepine (CBZ) or valproic acid (VPA) as monotherapy, and we also evaluated the probable contribution of the C677T variant of MTHFR gene in hyperhomocysteinemia.
18234410	2008	Prog. Neuropsychopharmacol. Biol. Psychiatry	0278-5846	ALL_TEXT_2/3	2	7	4524	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	mthfr	MTHFR	243#248	18234410-4-4-39	D020138	LONGTERM|DICTIONARY	hyperhomocysteinemia	hyperhomocysteinemia	257#277		In this study, we investigated the levels of serum folate, vitamin B-12 and Hcy in epileptic patients receiving carbamazepine (CBZ) or valproic acid (VPA) as monotherapy, and we also evaluated the probable contribution of the C677T variant of MTHFR gene in hyperhomocysteinemia.
15386943	2004	Biomed. Environ. Sci.	0895-3988	TITLE	0	0	1636	LONGTERM|GENE|GN|GT|DICTIONARY	angiotensin converting enzyme	angiotensin converting enzyme	37#66		D006973	LONGTERM|DICTIONARY	hypertension	hypertension	124#136		Interaction and relationship between angiotensin converting enzyme gene and environmental factors predisposing to essential hypertension in Mongolian population of China.
15386943	2004	Biomed. Environ. Sci.	0895-3988	OBJECTIVE	1	1	1636	SYMBOL|DICTIONARY	ace	ACE	59#62		D006973	LONGTERM|DICTIONARY	hypertension	hypertension	125#137		To investigate the association of specific functional gene ACE (I/D) variants of the renin-angiotensin system with essential hypertension (EH) and interaction between ACE (I/D) gene and risk factors for EH in a genetically homogenous Mongolia rural population of China.
15386943	2004	Biomed. Environ. Sci.	0895-3988	OBJECTIVE	1	1	1636	SYMBOL|DICTIONARY	ace	ACE	167#170		D006973	LONGTERM|DICTIONARY	hypertension	hypertension	125#137		To investigate the association of specific functional gene ACE (I/D) variants of the renin-angiotensin system with essential hypertension (EH) and interaction between ACE (I/D) gene and risk factors for EH in a genetically homogenous Mongolia rural population of China.
9217972	1997	Brain Pathol.	1015-6305	ALL_TEXT_3/3	3	9	1029	SYMBOL|DICTIONARY	cdkn2	CDKN2	0#5		D005909	SYMBOL|DICTIONARY|EXTRACTED	gbm	GBM	28#31	9217972-1-0-23	CDKN2 deletions occurred in GBM from patients somewhat older than those patients with GBM lacking CDKN2 deletion (mean age 53 vs. 48 years).
9217972	1997	Brain Pathol.	1015-6305	ALL_TEXT_3/3	3	9	1029	SYMBOL|DICTIONARY	cdkn2	CDKN2	0#5		D005909	SYMBOL|DICTIONARY|EXTRACTED	gbm	GBM	86#89	9217972-1-0-23	CDKN2 deletions occurred in GBM from patients somewhat older than those patients with GBM lacking CDKN2 deletion (mean age 53 vs. 48 years).
9217972	1997	Brain Pathol.	1015-6305	ALL_TEXT_3/3	3	9	1029	SYMBOL|DICTIONARY	cdkn2	CDKN2	98#103		D005909	SYMBOL|DICTIONARY|EXTRACTED	gbm	GBM	28#31	9217972-1-0-23	CDKN2 deletions occurred in GBM from patients somewhat older than those patients with GBM lacking CDKN2 deletion (mean age 53 vs. 48 years).
9217972	1997	Brain Pathol.	1015-6305	ALL_TEXT_3/3	3	9	1029	SYMBOL|DICTIONARY	cdkn2	CDKN2	98#103		D005909	SYMBOL|DICTIONARY|EXTRACTED	gbm	GBM	86#89	9217972-1-0-23	CDKN2 deletions occurred in GBM from patients somewhat older than those patients with GBM lacking CDKN2 deletion (mean age 53 vs. 48 years).
11948460	2002	Int. J. Cancer	0020-7136	ALL_TEXT_3/3	3	12	999	SYMBOL|GENE|GN|DICTIONARY	cdh1	CDH1	76#80		D011471	SYMBOL|GFAM|FN|DICTIONARY|EXTRACTED	hpc	HPC	181#184	11948460-3-17-43	We found several germline mutations of unknown clinical significance in the CDH1 gene that probably do not explain the association of prostate, gastric and/or breast cancers in the HPC-families.
11948460	2002	Int. J. Cancer	0020-7136	ALL_TEXT_3/3	3	12	999	SYMBOL|GENE|GN|DICTIONARY	cdh1	CDH1	76#80		D001943	LONGTERM|DICTIONARY	gastric and/or breast cancers	gastric and/or breast cancers	144#173		We found several germline mutations of unknown clinical significance in the CDH1 gene that probably do not explain the association of prostate, gastric and/or breast cancers in the HPC-families.
20683028	2010	Anticancer Res.	1791-7530	RESULTS AND CONCLUSION	3	10	1545	SYMBOL|NUMBER|DICTIONARY|EXTRACTED	cyp1b1	CYP1B1	23#29	20683028-2-0-19	D001943	LONGTERM|DISEASE|DT|DICTIONARY	breast cancer	breast cancer	116#129		The combined effect of CYP1B1*3 polymorphism and NAT2 slow acetylator genotype contributed to an increased risk for breast cancer in patients in this study (p=0.004).
20683028	2010	Anticancer Res.	1791-7530	RESULTS AND CONCLUSION	3	10	10	SYMBOL|DICTIONARY	nat2	NAT2	49#53		D001943	LONGTERM|DISEASE|DT|DICTIONARY	breast cancer	breast cancer	116#129		The combined effect of CYP1B1*3 polymorphism and NAT2 slow acetylator genotype contributed to an increased risk for breast cancer in patients in this study (p=0.004).
16230376	2005	Cancer Res.	0008-5472	TITLE	0	0	374	LONGTERM|DICTIONARY	amphiregulin	amphiregulin	13#25		D002289	LONGTERM|DICTIONARY	non-small cell lung cancers	non-small cell lung cancers	145#172		Increases of amphiregulin and transforming growth factor-alpha in serum as predictors of poor response to gefitinib among patients with advanced non-small cell lung cancers.
16230376	2005	Cancer Res.	0008-5472	TITLE	0	0	7124	LONGTERM|DICTIONARY	transforming growth factor alpha	transforming growth factor-alpha	30#62		D002289	LONGTERM|DICTIONARY	non-small cell lung cancers	non-small cell lung cancers	145#172		Increases of amphiregulin and transforming growth factor-alpha in serum as predictors of poor response to gefitinib among patients with advanced non-small cell lung cancers.
19191329	2009	Hum. Mutat.	1098-1004	ALL_TEXT_2/3	2	7	6261	SYMBOL|DICTIONARY	ryr1	RYR1	49#53		D008305	SYMBOL|()|DISEASE|DN|DICTIONARY	mhs	MHS	106#109		Performing an in-depth mutation screening of the RYR1 transcript sequence in 36 unrelated MH susceptible (MHS) patients, we identified 17 novel, five rare, and eight non-disease-causing variants in 23 patients.
19191329	2009	Hum. Mutat.	1098-1004	ALL_TEXT_2/3	2	7	6261	SYMBOL|DICTIONARY	ryr1	RYR1	49#53		D008305	SYMBOL|EXTRACTED	mh susceptible	MH susceptible	90#104	19191329-1-0-22	Performing an in-depth mutation screening of the RYR1 transcript sequence in 36 unrelated MH susceptible (MHS) patients, we identified 17 novel, five rare, and eight non-disease-causing variants in 23 patients.
11467490	2001	J Craniomaxillofac Surg	1010-5182	BACKGROUND	1	2	2261	LONGTERM|DICTIONARY	fibroblast growth factor receptor 3	fibroblast growth factor receptor 3	99#134		D003398	LONGTERM|DICTIONARY	craniosynostosis	craniosynostosis	195#211		The aim of the study is to determine whether the family has the pro250arg mutation in the gene for fibroblast growth factor receptor 3 (FGFR3), a mutation found in patients with various types of craniosynostosis.
11467490	2001	J Craniomaxillofac Surg	1010-5182	BACKGROUND	1	2	2261	SYMBOL|()|DICTIONARY|EXTRACTED	fgfr3	FGFR3	136#141	11467490-2-99-134	D003398	LONGTERM|DICTIONARY	craniosynostosis	craniosynostosis	195#211		The aim of the study is to determine whether the family has the pro250arg mutation in the gene for fibroblast growth factor receptor 3 (FGFR3), a mutation found in patients with various types of craniosynostosis.
11467490	2001	J Craniomaxillofac Surg	1010-5182	TITLE	0	0	2261	LONGTERM|DICTIONARY	fibroblast growth factor receptor 3	fibroblast growth factor receptor 3	44#79		D003398	LONGTERM|DICTIONARY	craniosynostosis	craniosynostosis	105#121		New Zealand Maori family with the pro250arg fibroblast growth factor receptor 3 mutation associated with craniosynostosis.
10459349	1999	Cancer Genet. Cytogenet.	0165-4608	ALL_TEXT_3/3	3	7	4763	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	nf1	NF1	99#102	10459349-1-0-19	D018318	LONGTERM|DICTIONARY	plexiform neurofibromas	plexiform neurofibromas	147#170		This finding suggests that loss of the second allele, and thus inactivation of both alleles of the NF1 gene, is associated with the development of plexiform neurofibromas.
10459349	1999	Cancer Genet. Cytogenet.	0165-4608	ALL_TEXT_2/3	2	5	4763	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	nf1	NF1	86#89	10459349-1-0-19	D009369	LONGTERM|DICTIONARY	tumors	tumors	35#41		In this study, we examined 14 such tumors from 10 NF1-patients for allele loss of the NF1 gene (LOH: loss of heterozygosity) using four intragenic polymorphic markers.
15075790	2004	Eur. J. Cancer Prev.	0959-8278	TITLE	0	0	1029	SYMBOL|DICTIONARY	ink4a	INK4A	55#60		D008545	LONGTERM|DICTIONARY	melanoma	melanoma	43#51		Estimating the relative risk of developing melanoma in INK4A carriers.
10459349	1999	Cancer Genet. Cytogenet.	0165-4608	TITLE	0	0	4763	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	nf1	NF1	20#23		D018318	LONGTERM|DICTIONARY	plexiform neurofibromas	plexiform neurofibromas	47#70		Allelic loss of the NF1 gene in NF1-associated plexiform neurofibromas.
18067970	2008	Ophthalmology	1549-4713	CONCLUSIONS	7	8	3075	SYMBOL|DICTIONARY|EXTRACTED	cfh	CFH	4#7	18067970-1-82-101	D008268	SYMBOL|DICTIONARY|EXTRACTED	amd	AMD	68#71	18067970-1-25-57	The CFH Y402H polymorphism is associated with PRPC, suggesting that AMD changes are not limited to the macula.
19228880	2009	FASEB J.	1530-6860	ALL_TEXT_2/3	2	5	2944	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	gstm1	GSTM1	60#65	19228880-1-113-141	D001943	LONGTERM|DISEASE|DT|DICTIONARY	breast cancer	breast cancer	98#111		Furthermore, we identified a functional polymorphism in the GSTM1 promoter region associated with breast cancer.
15124102	2004	Am. J. Hum. Genet.	0002-9297	ALL_TEXT_2/3	2	3	1947	SYMBOL|DICTIONARY	efnb1	Efnb1	6#11		D000014	LONGTERM|DICTIONARY	malformations	malformations	46#59		Since Efnb1 mutant mice display a spectrum of malformations and an unusual inheritance reminiscent of CFNS, we analyzed the EFNB1 gene in three families with CFNS.
15124102	2004	Am. J. Hum. Genet.	0002-9297	ALL_TEXT_2/3	2	3	1947	SYMBOL|DICTIONARY	efnb1	Efnb1	6#11		C536456	SYMBOL|DICTIONARY|EXTRACTED	cfns	CFNS	102#106	15124102-1-0-26	Since Efnb1 mutant mice display a spectrum of malformations and an unusual inheritance reminiscent of CFNS, we analyzed the EFNB1 gene in three families with CFNS.
15124102	2004	Am. J. Hum. Genet.	0002-9297	ALL_TEXT_2/3	2	3	1947	SYMBOL|DICTIONARY	efnb1	Efnb1	6#11		C536456	SYMBOL|DICTIONARY|EXTRACTED	cfns	CFNS	158#162	15124102-1-0-26	Since Efnb1 mutant mice display a spectrum of malformations and an unusual inheritance reminiscent of CFNS, we analyzed the EFNB1 gene in three families with CFNS.
15124102	2004	Am. J. Hum. Genet.	0002-9297	ALL_TEXT_2/3	2	3	1947	SYMBOL|GENE|GN|DICTIONARY	efnb1	EFNB1	124#129		D000014	LONGTERM|DICTIONARY	malformations	malformations	46#59		Since Efnb1 mutant mice display a spectrum of malformations and an unusual inheritance reminiscent of CFNS, we analyzed the EFNB1 gene in three families with CFNS.
15124102	2004	Am. J. Hum. Genet.	0002-9297	ALL_TEXT_2/3	2	3	1947	SYMBOL|GENE|GN|DICTIONARY	efnb1	EFNB1	124#129		C536456	SYMBOL|DICTIONARY|EXTRACTED	cfns	CFNS	102#106	15124102-1-0-26	Since Efnb1 mutant mice display a spectrum of malformations and an unusual inheritance reminiscent of CFNS, we analyzed the EFNB1 gene in three families with CFNS.
15124102	2004	Am. J. Hum. Genet.	0002-9297	ALL_TEXT_2/3	2	3	1947	SYMBOL|GENE|GN|DICTIONARY	efnb1	EFNB1	124#129		C536456	SYMBOL|DICTIONARY|EXTRACTED	cfns	CFNS	158#162	15124102-1-0-26	Since Efnb1 mutant mice display a spectrum of malformations and an unusual inheritance reminiscent of CFNS, we analyzed the EFNB1 gene in three families with CFNS.
20207535	2010	Eur. J. Cancer	1879-0852	ALL_TEXT_3/3	3	11	2938	SYMBOL|DICTIONARY	gsta1	GSTA1	0#5		D015179	LONGTERM|DISEASE|DT|DICTIONARY	colorectal cancer	colorectal cancer	49#66		GSTA1 *A/*B polymorphism was not associated with colorectal cancer risk.
20207535	2010	Eur. J. Cancer	1879-0852	ALL_TEXT_3/3	3	12	2944	SYMBOL|DICTIONARY	gstm1	GSTM1	0#5		D015179	LONGTERM|DISEASE|DT|DICTIONARY	colorectal cancer	colorectal cancer	58#75		GSTM1 and GSTT1 null genotypes confer additional risk for colorectal cancer in Caucasian populations.
20207535	2010	Eur. J. Cancer	1879-0852	ALL_TEXT_3/3	3	12	2952	SYMBOL|DICTIONARY	gstt1	GSTT1	10#15		D015179	LONGTERM|DISEASE|DT|DICTIONARY	colorectal cancer	colorectal cancer	58#75		GSTM1 and GSTT1 null genotypes confer additional risk for colorectal cancer in Caucasian populations.
20377893	2010	BMC Med. Genet.	1471-2350	TITLE	0	0	60314	SYMBOL|DICTIONARY|GENE|GA	myg1	MYG1	33#37		D014820	LONGTERM|DICTIONARY	vitiligo	vitiligo	68#76		Promoter polymorphism -119C/G in MYG1 (C12orf10) gene is related to vitiligo susceptibility and Arg4Gln affects mitochondrial entrance of Myg1.
20377893	2010	BMC Med. Genet.	1471-2350	TITLE	0	0	60314	SYMBOL|()|GENE|GN|DICTIONARY|EXTRACTED	c12orf10	C12orf10	39#47	20377893-0-33-37	D014820	LONGTERM|DICTIONARY	vitiligo	vitiligo	68#76		Promoter polymorphism -119C/G in MYG1 (C12orf10) gene is related to vitiligo susceptibility and Arg4Gln affects mitochondrial entrance of Myg1.
20377893	2010	BMC Med. Genet.	1471-2350	TITLE	0	0	60314	SYMBOL|DICTIONARY	myg1	Myg1	138#142		D014820	LONGTERM|DICTIONARY	vitiligo	vitiligo	68#76		Promoter polymorphism -119C/G in MYG1 (C12orf10) gene is related to vitiligo susceptibility and Arg4Gln affects mitochondrial entrance of Myg1.
9361298	1997	Neurobiol. Dis.	0969-9961	ALL_TEXT_2/3	2	4	2705	SYMBOL|DICTIONARY	cx32	Cx32	21#25		D003711	LONGTERM|DICTIONARY	myelin sheath	myelin sheath	107#120	NaN	In peripheral nerve, Cx32 is localized to incisures and paranodes, regions of noncompact myelin within the myelin sheath.
20724655	2011	J. Lipid Res.	1539-7262	ALL_TEXT_3/3	3	5	338	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	apob	APOB	21#25	20724655-3-47-63	C566031	LONGTERM|DICTIONARY	tg	TG	149#151	NaN	Associations of four APOB gene single nucleotide polymorphisms (SNP) (rs934197, rs693, rs676210, and rs1042031) were tested for association with the TG response to fenofibrate using a mixed growth curve model where the familial structure was modeled as a random effect and cardiovascular risk factors were included as covariates.
17186357	2008	Breast Cancer Res. Treat.	0167-6806	ALL_TEXT_3/3	3	7	2778	SYMBOL|DICTIONARY	gnas1	GNAS1	29#34		D001943	LONGTERM|DISEASE|DT|DICTIONARY	breast carcinoma	breast carcinoma	126#142		Our results suggest that the GNAS1 T393C SNP is a novel genetic host factor for disease progression in patients with invasive breast carcinoma.
18555606	2008	Neurosci. Lett.	0304-3940	ALL_TEXT_3/3	3	11	348	SYMBOL|EXTRACTED	apoe	ApoE	136#140	18555606-4-197-213	D000544	SYMBOL|EXTRACTED	ad	AD	125#127	18555606-1-0-19	The combination of t-tau and Abeta1-42 is a robust and reliable assay that may be useful in discriminating cases at risk for AD such as ApoE epsilon4 allele carriers from nAD patients or from age-matched control subjects.
18555606	2008	Neurosci. Lett.	0304-3940	ALL_TEXT_3/3	3	10	348	SYMBOL|EXTRACTED	apoe	ApoE	21#25	18555606-4-197-213	D000544	SYMBOL|DISEASE|DN|DICTIONARY|EXTRACTED	ad	AD	0#2		AD patients carrying ApoE epsilon4 allele had lower Abeta1-42 (p<0.001) levels than those without a epsilon4 allele.
15709194	2005	Clin. Cancer Res.	1078-0432	EXPERIMENTAL DESIGN	2	3	3558	SYMBOL|DICTIONARY	interleukin (il)-2	interleukin (IL)-2	138#156		D008545	LONGTERM|DICTIONARY	melanoma	melanoma	30#38		Ninety patients with stage IV melanoma were treated with biochemotherapy, including cisplatin, vinblastine, and dacarbazine combined with interleukin (IL)-2 and IFN-alpha either with or without tamoxifen.
15709194	2005	Clin. Cancer Res.	1078-0432	EXPERIMENTAL DESIGN	2	3	3439	LONGTERM|DICTIONARY	ifn-alpha	IFN-alpha	161#170	NaN	D008545	LONGTERM|DICTIONARY	melanoma	melanoma	30#38		Ninety patients with stage IV melanoma were treated with biochemotherapy, including cisplatin, vinblastine, and dacarbazine combined with interleukin (IL)-2 and IFN-alpha either with or without tamoxifen.
20377893	2010	BMC Med. Genet.	1471-2350	BACKGROUND	1	2	60314	SYMBOL|GFAM|FN|DICTIONARY	myg1	MYG1	24#28		D014820	LONGTERM|DISEASE|DN|DICTIONARY	vitiligo	vitiligo	72#80		We recently showed that MYG1 mRNA expression is elevated in the skin of vitiligo patients.
19228880	2009	FASEB J.	1530-6860	TITLE	0	0	2944	SYMBOL|DICTIONARY|EXTRACTED	gstm1	GSTM1	52#57		D001943	LONGTERM|DISEASE|DT|DICTIONARY	breast cancer	breast cancer	94#107		A functional polymorphism in the promoter region of GSTM1 implies a complex role for GSTM1 in breast cancer.
19228880	2009	FASEB J.	1530-6860	TITLE	0	0	2944	SYMBOL|DICTIONARY|EXTRACTED	gstm1	GSTM1	85#90		D001943	LONGTERM|DISEASE|DT|DICTIONARY	breast cancer	breast cancer	94#107		A functional polymorphism in the promoter region of GSTM1 implies a complex role for GSTM1 in breast cancer.
17138064	2007	Transpl. Immunol.	0966-3274	AG/GG	2	7	3586	SYMBOL|GENE|GN|DICTIONARY	il10	IL10	23#27		D003586	LONGTERM|DISEASE|DT|DICTIONARY	cmv infection	CMV infection	79#92		We conclude that donor IL10 gene polymorphisms may influence the likelihood of CMV infection in the high risk patients investigated.
17138064	2007	Transpl. Immunol.	0966-3274	UNLABELLED	1	4	3586	SYMBOL|DICTIONARY	il10	IL10	6#10		D003586	LONGTERM|DISEASE|DT|DICTIONARY	cmv infection	CMV infection	55#68		Donor IL10(-1082 AA) genotype reduced the incidence of CMV infection (p=0.031) and CMV episodes in these patients tended to occur later (AA: median 83 days,
20100586	2011	Biol. Blood Marrow Transplant.	1523-6536	ALL_TEXT_3/3	3	11	7124	SYMBOL|EXTRACTED	tnf-alpha	TNF-alpha	48#57	20100586-1-0-21	D006086	SYMBOL|EXTRACTED	agvhd	aGVHD	22#27	20100586-1-117-148	Severe (grade III-IV) aGVHD was associated with TNF-alpha -1031C allele (HR, 2.38; P = .03), -863A allele (HR, 3.18; P = .003), and d4/d4 genotype (HR, 2.82; P = .01).
14962090	2004	J. Invest. Dermatol.	0022-202X	ALL_TEXT_3/3	3	11	3660	SYMBOL|DICTIONARY|EXTRACTED	irf2	IRF2	18#22	14962090-2-132-162	D011565	LONGTERM|DICTIONARY	psoriasis	psoriasis	62#71		Our data identify IRF2 as a potential susceptibility gene for psoriasis.
17186357	2008	Breast Cancer Res. Treat.	0167-6806	ALL_TEXT_2/3	2	3	2778	SYMBOL|DICTIONARY	gnas1	GNAS1	100#105		D002292	LONGTERM|DISEASE|DT|DICTIONARY	bladder, renal cell and colorectal carcinoma	bladder, renal cell and colorectal carcinoma	162#206		We have recently shown that genotypes of the single nucleotide polymorphism (SNP) T393C in the gene GNAS1 are associated with survival of patients suffering from bladder, renal cell and colorectal carcinoma.
19546348	2009	Exp. Biol. Med. (Maywood)	1535-3699	ALL_TEXT_2/3	2	6	3091	LONGTERM|DICTIONARY	hif-1	HIF-1	143#148	NaN	D008175	LONGTERM|DISEASE|DT|DICTIONARY	lung cancer	lung cancer	48#59		There was no significant difference between the lung cancer cases and controls in terms of the distribution of genotyping frequencies of seven HIF-1alphapolymorphisms (P > 0.05).
18688140	2009	Neurol India	0028-3886	TITLE	0	0	6532	LONGTERM|DICTIONARY	serotonin transporter	Serotonin transporter	0#21	NaN	D018781	LONGTERM|DICTIONARY	tension-type headache	tension-type headache	66#87		Serotonin transporter gene polymorphisms in patients with chronic tension-type headache: a preliminary study.
17522430	2007	Cancer Biomark	1574-0153	ALL_TEXT_2/3	2	3	8743	SYMBOL|GENE|GN|DICTIONARY	trail	TRAIL	31#36		D001943	LONGTERM|DISEASE|DT|DICTIONARY	breast cancer	breast cancer	55#68		To evaluate the involvement of TRAIL receptor genes in breast cancer, we carried out a case-control study of eight selected polymorphisms in a large sample of Spanish women.
17522430	2007	Cancer Biomark	1574-0153	TITLE	0	0	8743	SYMBOL|GENE|GN|DICTIONARY	trail	TRAIL	17#22		D001943	LONGTERM|DISEASE|DT|DICTIONARY	breast cancer	breast cancer	50#63		Polymorphisms in TRAIL receptor genes and risk of breast cancer in Spanish women.
17522430	2007	Cancer Biomark	1574-0153	ALL_TEXT_3/3	3	6	8793	SYMBOL|DICTIONARY	dcr2	DcR2	50#54		D001943	LONGTERM|DISEASE|DT|DICTIONARY	breast cancer	breast cancer	87#100		Interestingly, allele 2699G in the decoy receptor DcR2 appears associated with reduced breast cancer risk (P=0.05).
17186357	2008	Breast Cancer Res. Treat.	0167-6806	TITLE	0	0	2778	SYMBOL|DICTIONARY	gnas1	GNAS1	35#40		D001943	LONGTERM|DISEASE|DT|DICTIONARY	breast carcinoma	breast carcinoma	108#124		The T393C polymorphism in the gene GNAS1 of G protein is associated with survival of patients with invasive breast carcinoma.
12932609	2003	J. Am. Coll. Cardiol.	0735-1097	RESULTS	4	11	136319	LONGTERM|DICTIONARY	myotrophin	myotrophin	44#54	NaN	D006333	SYMBOL|EXTRACTED	hf	HF	20#22	12932609-1-73-86	However, males with HF had higher levels of myotrophin than females (p < 0.001).
17121882	2007	Clin. Cancer Res.	1078-0432	PURPOSE	1	1	56475	LONGTERM|DICTIONARY	reprimo	Reprimo	0#7	NaN	D009369	LONGTERM|DISEASE|DT|DICTIONARY	tumor	tumor	21#26		Reprimo, a candidate tumor-suppressor gene, regulates p53-mediated cell cycle arrest at G2 phase, and tumor-suppressor gene methylation is involved in the pathogenesis and progression of esophageal cancer.
17121882	2007	Clin. Cancer Res.	1078-0432	PURPOSE	1	1	56475	LONGTERM|DICTIONARY	reprimo	Reprimo	0#7	NaN	D009369	LONGTERM|DISEASE|DT|DICTIONARY	tumor	tumor	102#107		Reprimo, a candidate tumor-suppressor gene, regulates p53-mediated cell cycle arrest at G2 phase, and tumor-suppressor gene methylation is involved in the pathogenesis and progression of esophageal cancer.
17121882	2007	Clin. Cancer Res.	1078-0432	PURPOSE	1	1	56475	LONGTERM|DICTIONARY	reprimo	Reprimo	0#7	NaN	D004938	LONGTERM|DISEASE|DT|DICTIONARY	esophageal cancer	esophageal cancer	187#204		Reprimo, a candidate tumor-suppressor gene, regulates p53-mediated cell cycle arrest at G2 phase, and tumor-suppressor gene methylation is involved in the pathogenesis and progression of esophageal cancer.
17121882	2007	Clin. Cancer Res.	1078-0432	PURPOSE	1	1	7157	LONGTERM|DICTIONARY	p53	p53	54#57	NaN	D009369	LONGTERM|DISEASE|DT|DICTIONARY	tumor	tumor	21#26		Reprimo, a candidate tumor-suppressor gene, regulates p53-mediated cell cycle arrest at G2 phase, and tumor-suppressor gene methylation is involved in the pathogenesis and progression of esophageal cancer.
17121882	2007	Clin. Cancer Res.	1078-0432	PURPOSE	1	1	7157	LONGTERM|DICTIONARY	p53	p53	54#57	NaN	D009369	LONGTERM|DISEASE|DT|DICTIONARY	tumor	tumor	102#107		Reprimo, a candidate tumor-suppressor gene, regulates p53-mediated cell cycle arrest at G2 phase, and tumor-suppressor gene methylation is involved in the pathogenesis and progression of esophageal cancer.
17121882	2007	Clin. Cancer Res.	1078-0432	PURPOSE	1	1	7157	LONGTERM|DICTIONARY	p53	p53	54#57	NaN	D004938	LONGTERM|DISEASE|DT|DICTIONARY	esophageal cancer	esophageal cancer	187#204		Reprimo, a candidate tumor-suppressor gene, regulates p53-mediated cell cycle arrest at G2 phase, and tumor-suppressor gene methylation is involved in the pathogenesis and progression of esophageal cancer.
12939427	2004	Neurology	1526-632X	CONCLUSION	5	10	4155	SYMBOL|DICTIONARY|EXTRACTED	mbp	MBP	20#23	12939427-1-4-24	D009103	SYMBOL|EXTRACTED	ms	MS	97#99	12939427-1-73-91	Polymorphism of the MBP or another gene in its vicinity appears to contribute to the etiology of MS for the subgroups of DR4- and DR5-positive Italians and Russians.
12939427	2004	Neurology	1526-632X	CONCLUSION	5	10	4155	SYMBOL|DICTIONARY|EXTRACTED	mbp	MBP	20#23	12939427-1-4-24	D003711	LONGTERM|DICTIONARY	mbp	MBP	20#23	NaN	Polymorphism of the MBP or another gene in its vicinity appears to contribute to the etiology of MS for the subgroups of DR4- and DR5-positive Italians and Russians.
12939427	2004	Neurology	1526-632X	CONCLUSION	5	10	3126	LONGTERM|DICTIONARY	dr4	DR4	121#124	NaN	D009103	SYMBOL|EXTRACTED	ms	MS	97#99	12939427-1-73-91	Polymorphism of the MBP or another gene in its vicinity appears to contribute to the etiology of MS for the subgroups of DR4- and DR5-positive Italians and Russians.
12939427	2004	Neurology	1526-632X	CONCLUSION	5	10	3126	LONGTERM|DICTIONARY	dr4	DR4	121#124	NaN	D003711	LONGTERM|DICTIONARY	mbp	MBP	20#23	NaN	Polymorphism of the MBP or another gene in its vicinity appears to contribute to the etiology of MS for the subgroups of DR4- and DR5-positive Italians and Russians.
12939427	2004	Neurology	1526-632X	CONCLUSION	5	10	8795	LONGTERM|DICTIONARY	dr5	DR5	130#133	NaN	D009103	SYMBOL|EXTRACTED	ms	MS	97#99	12939427-1-73-91	Polymorphism of the MBP or another gene in its vicinity appears to contribute to the etiology of MS for the subgroups of DR4- and DR5-positive Italians and Russians.
12939427	2004	Neurology	1526-632X	CONCLUSION	5	10	8795	LONGTERM|DICTIONARY	dr5	DR5	130#133	NaN	D003711	LONGTERM|DICTIONARY	mbp	MBP	20#23	NaN	Polymorphism of the MBP or another gene in its vicinity appears to contribute to the etiology of MS for the subgroups of DR4- and DR5-positive Italians and Russians.
20484924	2010	Int. Arch. Allergy Immunol.	1423-0097	RESULTS	3	7	3596	SYMBOL|DICTIONARY	il13	IL13	0#4		D012220	LONGTERM|DICTIONARY	rhinitis	rhinitis	59#67		IL13 C-1111T (rs1800925) was significantly associated with rhinitis and atopic phenotypes in rhinitis trios that were not affected by clinical asthma.
20484924	2010	Int. Arch. Allergy Immunol.	1423-0097	RESULTS	3	7	3596	SYMBOL|DICTIONARY	il13	IL13	0#4		D012220	LONGTERM|DICTIONARY	rhinitis	rhinitis	93#101		IL13 C-1111T (rs1800925) was significantly associated with rhinitis and atopic phenotypes in rhinitis trios that were not affected by clinical asthma.
20484924	2010	Int. Arch. Allergy Immunol.	1423-0097	RESULTS	3	7	3596	SYMBOL|DICTIONARY	il13	IL13	0#4		D001249	LONGTERM|DICTIONARY	asthma	asthma	143#149		IL13 C-1111T (rs1800925) was significantly associated with rhinitis and atopic phenotypes in rhinitis trios that were not affected by clinical asthma.
20484924	2010	Int. Arch. Allergy Immunol.	1423-0097	RESULTS	3	7	3596	SYMBOL|DICTIONARY	il13	IL13	0#4		C566404	LONGTERM|DICTIONARY	atopic	atopic	72#78	NaN	IL13 C-1111T (rs1800925) was significantly associated with rhinitis and atopic phenotypes in rhinitis trios that were not affected by clinical asthma.
17955208	2008	Diabetologia	0012-186X	CONCLUSIONS/INTERPRETATION	4	10	7275	SYMBOL|DICTIONARY	tub	TUB	35#38		D056128	LONGTERM|DICTIONARY	central obesity	central obesity	82#97		We have replicated associations of TUB SNP rs2272382 with measures of general and central obesity in normal postmenopausal women.
17955208	2008	Diabetologia	0012-186X	CONCLUSIONS/INTERPRETATION	4	11	7275	SYMBOL|DICTIONARY	tub	TUB	23#26		D009765	LONGTERM|DICTIONARY	obesity	obesity	62#69		These findings confirm TUB as a candidate gene for late-onset obesity in humans.
12104085	2002	Clin. Chim. Acta	0009-8981	METHODS	3	7	1071	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	cetp	CETP	129#133	12104085-2-0-34	D003327	SYMBOL|DISEASE|DN|DICTIONARY|EXTRACTED	chd	CHD	89#92	12104085-5-118-141	LDL particles sizes were analyzed by 2-16% nondenaturing polyacrylamide gradient gels in CHD patients with D442G mutation in the CETP gene.
20197243	2010	Cancer Epidemiol	1877-783X	TITLE	0	0	10	LONGTERM|DICTIONARY	n acetyltransferase 2	N-acetyltransferase 2	30#51		D001943	LONGTERM|DISEASE|DT|DICTIONARY	breast cancer	breast cancer	65#78		Smoking (active and passive), N-acetyltransferase 2, and risk of breast cancer.
15953084	2005	Clin. Exp. Dermatol.	0307-6938	ALL_TEXT_1/3	1	1	3107	SYMBOL|DICTIONARY	psors1	PSORS1	0#6		D011565	LONGTERM|DICTIONARY	psoriasis vulgaris	psoriasis vulgaris	89#107		PSORS1 on chromosome 6p21.3, which contains the MHC, is a major susceptibility locus for psoriasis vulgaris.
18318767	2008	Br. J. Haematol.	1365-2141	ALL_TEXT_3/3	3	7	56681	SYMBOL|DICTIONARY	sar1a	SAR1A	41#46		D000755	SYMBOL|DICTIONARY|EXTRACTED	scd	SCD	179#182	18318767-3-149-168	These data suggest that variation within SAR1A regulatory elements might contribute to inter-individual differences in regulation of HbF expression and patient responses to HC in SCD.
18318767	2008	Br. J. Haematol.	1365-2141	TITLE	0	0	56681	SYMBOL|GENE|GN|DICTIONARY	sar1a	sar1a	61#66		D000740	LONGTERM|DICTIONARY	anaemia	anaemia	105#112		Fetal haemoglobin response to hydroxycarbamide treatment and sar1a promoter polymorphisms in sickle cell anaemia.
18318767	2008	Br. J. Haematol.	1365-2141	ALL_TEXT_2/3	2	3	56681	SYMBOL|GENE|GN|DICTIONARY	sar1a	SAR1A	56#61		D000755	LONGTERM|DISEASE|DT|DICTIONARY|DA	sickle cell disease	sickle cell disease	149#168		This study aimed to assess whether polymorphisms in the SAR1A promoter are associated with differences Hb F levels or HC therapeutic responses among sickle cell disease (SCD) patients.
18318767	2008	Br. J. Haematol.	1365-2141	ALL_TEXT_2/3	2	3	56681	SYMBOL|GENE|GN|DICTIONARY	sar1a	SAR1A	56#61		D000755	SYMBOL|()|DISEASE|DN|DICTIONARY|EXTRACTED	scd	SCD	170#173	18318767-3-149-168	This study aimed to assess whether polymorphisms in the SAR1A promoter are associated with differences Hb F levels or HC therapeutic responses among sickle cell disease (SCD) patients.
15781196	2005	Mol. Genet. Metab.	1096-7192	ALL_TEXT_1/3	1	1	590	LONGTERM|DICTIONARY	butyrylcholinesterase	butyrylcholinesterase	31#52		D000544	LONGTERM|DISEASE|DT|DICTIONARY	alzheimer disease	Alzheimer's disease	103#122		The genetic variation of human butyrylcholinesterase has been associated with height, body mass index, Alzheimer's disease, and response to xenobiotic agents.
19811440	2009	Immunol. Invest.	1532-4311	ALL_TEXT_3/3	3	8	3606	SYMBOL|DICTIONARY	il 18	IL-18	30#35		D055113	LONGTERM|DICTIONARY	chronic periodontitis	chronic periodontitis	94#115		The results did not show that IL-18 and TLR4 variants have an effect on the susceptibility to chronic periodontitis.
19811440	2009	Immunol. Invest.	1532-4311	ALL_TEXT_3/3	3	8	7099	SYMBOL|DICTIONARY	tlr4	TLR4	40#44		D055113	LONGTERM|DICTIONARY	chronic periodontitis	chronic periodontitis	94#115		The results did not show that IL-18 and TLR4 variants have an effect on the susceptibility to chronic periodontitis.
17347480	2007	Circ. Res.	1524-4571	TITLE	0	0	7442	LONGTERM|DICTIONARY	transient receptor potential vanilloid type-1	transient receptor potential vanilloid type-1	14#59	NaN	D009765	LONGTERM|DICTIONARY	obesity	obesity	94#101		Activation of transient receptor potential vanilloid type-1 channel prevents adipogenesis and obesity.
19811440	2009	Immunol. Invest.	1532-4311	ALL_TEXT_2/3	2	4	7099	SYMBOL|DICTIONARY	tlr4	TLR4	40#44		D010518	LONGTERM|DICTIONARY	periodontitis	Periodontitis	0#13		Periodontitis severity in patients with TLR4 c.896AG/1196CT genotype was significantly higher than wildtype carriers.
19811440	2009	Immunol. Invest.	1532-4311	ALL_TEXT_1/3	1	1	7099	LONGTERM|GENE|GN|DICTIONARY	toll like receptor 4	Toll-like receptor 4	60#80		D055113	LONGTERM|DICTIONARY	chronic periodontitis	chronic periodontitis	175#196		The aim of the study was to assess whether genotypes in the Toll-like receptor 4 gene and in the promoter of the interleukin-18 gene are associated with the susceptibility to chronic periodontitis.
19811440	2009	Immunol. Invest.	1532-4311	ALL_TEXT_1/3	1	1	3606	LONGTERM|GENE|GN|DICTIONARY	interleukin 18	interleukin-18	113#127		D055113	LONGTERM|DICTIONARY	chronic periodontitis	chronic periodontitis	175#196		The aim of the study was to assess whether genotypes in the Toll-like receptor 4 gene and in the promoter of the interleukin-18 gene are associated with the susceptibility to chronic periodontitis.
19811440	2009	Immunol. Invest.	1532-4311	TITLE	0	0	7099	SYMBOL|DICTIONARY	tlr4	TLR4	0#4		D055113	LONGTERM|DICTIONARY	chronic periodontitis	chronic periodontitis	32#53		TLR4 and IL-18 gene variants in chronic periodontitis: impact on disease susceptibility and severity.
19811440	2009	Immunol. Invest.	1532-4311	TITLE	0	0	3606	SYMBOL|GENE|GN|DICTIONARY	il 18	IL-18	9#14		D055113	LONGTERM|DICTIONARY	chronic periodontitis	chronic periodontitis	32#53		TLR4 and IL-18 gene variants in chronic periodontitis: impact on disease susceptibility and severity.
19892845	2010	Clin. Chem.	1530-8561	CONCLUSIONS	4	15	672	SYMBOL|DICTIONARY	brca1	BRCA1	99#104		D001943	LONGTERM|DICTIONARY	brca1	BRCA1	99#104	NaN	Naturally occurring alternative splicing isoforms need to be considered when assessing the role of BRCA1 UVs on splicing.
12006918	2002	J Cardiovasc Risk	1350-6277	DESIGN AND METHODS	2	3	3990	LONGTERM|DICTIONARY	hl	HL	11#13	NaN	D003327	SYMBOL|DISEASE|DN|DICTIONARY|EXTRACTED	chd	CHD	40#43	12006918-2-28-50	We studied HL -514 C/T in 562 Caucasian CHD patients aged under 50 years and in 642 Caucasian community recruited subjects without historical evidence of CHD.
12006918	2002	J Cardiovasc Risk	1350-6277	DESIGN AND METHODS	2	3	3990	LONGTERM|DICTIONARY	hl	HL	11#13	NaN	D003327	SYMBOL|DICTIONARY|EXTRACTED	chd	CHD	154#157	12006918-2-28-50	We studied HL -514 C/T in 562 Caucasian CHD patients aged under 50 years and in 642 Caucasian community recruited subjects without historical evidence of CHD.
16194568	2006	Neuropeptides	0143-4179	ALL_TEXT_2/3	2	4	4852	SYMBOL|DICTIONARY|EXTRACTED	npy	NPY	14#17	16194568-1-8-22	D012640	LONGTERM|DICTIONARY	seizure	seizure	77#84		In SS gerbil, NPY immunoreactivity in the hippocampus was lower than that in seizure resistant gerbil.
16194568	2006	Neuropeptides	0143-4179	ALL_TEXT_1/3	1	1	4852	LONGTERM|DICTIONARY	neuropeptide y	neuropeptide Y	8#22		D004827	LONGTERM|DICTIONARY	epileptic	epileptic	97#106		Changed neuropeptide Y (NPY) system in the hippocampus has been reported in various experimental epileptic models.
16194568	2006	Neuropeptides	0143-4179	ALL_TEXT_1/3	1	1	4852	SYMBOL|()|DICTIONARY|EXTRACTED	npy	NPY	24#27	16194568-1-8-22	D004827	LONGTERM|DICTIONARY	epileptic	epileptic	97#106		Changed neuropeptide Y (NPY) system in the hippocampus has been reported in various experimental epileptic models.
16194568	2006	Neuropeptides	0143-4179	TITLE	0	0	4852	LONGTERM|DICTIONARY	neuropeptide y	neuropeptide Y	57#71		D012640	LONGTERM|DICTIONARY	seizure	seizure	101#108		Differential effects of vigabatrin and zonisamide on the neuropeptide Y system in the hippocampus of seizure prone gerbil.
16194568	2006	Neuropeptides	0143-4179	ALL_TEXT_2/3	2	3	4852	SYMBOL|DICTIONARY|EXTRACTED	npy	NPY	124#127	16194568-1-8-22	D012640	LONGTERM|DICTIONARY	seizure sensitive	seizure sensitive	161#178		In the present study, therefore, we performed analyses of effects of vigabatrin (VGB) and zonisamide (ZNS) treatment on the NPY system in the hippocampus of the seizure sensitive (SS) gerbils.
16194568	2006	Neuropeptides	0143-4179	ALL_TEXT_1/3	1	2	4852	SYMBOL|DICTIONARY|EXTRACTED	npy	NPY	70#73	16194568-1-8-22	D004827	LONGTERM|DICTIONARY	epileptic	epileptic	88#97		However, there have been little data concerning the alteration in the NPY system in the epileptic hippocampus following treatment of anti-epileptic drugs (AEDs).
16194568	2006	Neuropeptides	0143-4179	ALL_TEXT_1/3	1	2	4852	SYMBOL|DICTIONARY|EXTRACTED	npy	NPY	70#73	16194568-1-8-22	D004827	LONGTERM|DICTIONARY	epileptic	epileptic	138#147		However, there have been little data concerning the alteration in the NPY system in the epileptic hippocampus following treatment of anti-epileptic drugs (AEDs).
20100586	2011	Biol. Blood Marrow Transplant.	1523-6536	ALL_TEXT_3/3	3	14	7124	SYMBOL|EXTRACTED	tnf-alpha	TNF-alpha	90#99	20100586-1-0-21	D006086	SYMBOL|EXTRACTED	agvhd	aGVHD	120#125	20100586-1-117-148	Our findings indicate clinically important relationships between genetic polymorphisms in TNF-alpha and the severity of aGVHD in this cohort.
16194568	2006	Neuropeptides	0143-4179	ALL_TEXT_3/3	3	8	4852	SYMBOL|DICTIONARY|EXTRACTED	npy	NPY	70#73	16194568-1-8-22	D004827	LONGTERM|DICTIONARY	aeds	AEDs	28#32	NaN	These findings suggest that AEDs treatments may distinctly affect the NPY system in the SS gerbil hippocampus.
16194568	2006	Neuropeptides	0143-4179	ALL_TEXT_3/3	3	8	4852	SYMBOL|DICTIONARY|EXTRACTED	npy	NPY	70#73	16194568-1-8-22	D012640	LONGTERM|DICTIONARY	ss	SS	88#90	NaN	These findings suggest that AEDs treatments may distinctly affect the NPY system in the SS gerbil hippocampus.
15734955	2005	Cancer Epidemiol. Biomarkers Prev.	1055-9965	ALL_TEXT_3/3	3	10	7515	SYMBOL|NUMBER|DICTIONARY	xrcc1	XRCC1	38#43		D001943	LONGTERM|DISEASE|DT|DICTIONARY	breast cancer	breast cancer	355#368		In subjects with at least one copy of XRCC1 194Trp allele, there was a moderate interaction with high intake of fruits and vegetables (>/=35 half-cup servings per week of any fruits, fruit juices, and vegetables, OR, 0.58; 95% CI, 0.38-0.89; ICR, -0.49; 95% CI, -0.03 to -0.95), and dietary plus supplement antioxidant intake with 33% to 42% decreases in breast cancer risk compared with those with the Arg194Arg genotype and low-intake individuals.
16882462	2007	Ann Epidemiol	1047-2797	TITLE	0	0	348	LONGTERM|DICTIONARY	apolipoprotein e	Apolipoprotein E	0#16		D005705	LONGTERM|DISEASE|DT|DICTIONARY	gallbladder disease	gallbladder disease	30#49		Apolipoprotein E genotype and gallbladder disease risk in a large population-based cohort.
16882462	2007	Ann Epidemiol	1047-2797	PURPOSE	1	1	348	LONGTERM|DICTIONARY	apolipoprotein e	apolipoprotein E	60#76		D005705	LONGTERM|DISEASE|DT|DICTIONARY	gallbladder disease	gallbladder disease	97#116		The aim of the study is to describe the association between apolipoprotein E (apoE) genotype and gallbladder disease incidence.
16882462	2007	Ann Epidemiol	1047-2797	PURPOSE	1	1	348	SYMBOL|EXTRACTED|()	apoe	apoE	78#82	16882462-1-60-76	D005705	LONGTERM|DISEASE|DT|DICTIONARY	gallbladder disease	gallbladder disease	97#116		The aim of the study is to describe the association between apolipoprotein E (apoE) genotype and gallbladder disease incidence.
15182647	2004	Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi	1007-8738	AIM	1	1	57379	LONGTERM|DICTIONARY	activation induced cytidine deaminase	activation-induced cytidine deaminase	23#60		C565292	LONGTERM|DICTIONARY	atopic asthma	atopic asthma	115#128		To explore whether the activation-induced cytidine deaminase(AICDA) gene 8408 C/T polymorphism is related to adult atopic asthma and the level of plasma IgE.
15182647	2004	Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi	1007-8738	AIM	1	1	57379	SYMBOL|()|GENE|GN|DICTIONARY	aicda	AICDA	61#66		C565292	LONGTERM|DICTIONARY	atopic asthma	atopic asthma	115#128		To explore whether the activation-induced cytidine deaminase(AICDA) gene 8408 C/T polymorphism is related to adult atopic asthma and the level of plasma IgE.
18798262	2008	Int. J. Cancer	1097-0215	ALL_TEXT_3/3	3	7	4851	SYMBOL|DICTIONARY	notch1	Notch1	57#63		D009369	LONGTERM|DICTIONARY	tumors	tumors	86#92		Genetic alterations resulting in premature truncation of Notch1 were identified in 28 tumors, whereas 8 revealed alterations in the heterodimerization and 16 harbored deletions in the ligand-binding region.
20533278	2010	Zhonghua Yi Xue Yi Chuan Xue Za Zhi	1003-9406	CONCLUSION	4	8	100507436	SYMBOL|GENE|GN|DICTIONARY	mica	MICA	59#63		D015179	LONGTERM|DISEASE|DT|DICTIONARY	colorectal cancer	colorectal cancer	112#129		Although there was no genetic susceptibility attributed to MICA gene polymorphism with regard to development of colorectal cancer, serum levels of soluble MICA may be a diagnostic marker of advanced stages.
17329413	2007	J. Neurosci.	1529-2401	ALL_TEXT_3/3	3	7	494513	SYMBOL|()|DICTIONARY	dfnb59	DFNB59	126#132		D003638	LONGTERM|DICTIONARY	recessive deafness	recessive deafness	106#124	NaN	Previous studies have described two missense mutations in the human pejvakin gene that cause nonsyndromic recessive deafness (DFNB59) by affecting the function of auditory neurons.
17898867	2007	Neoplasia	1476-5586	ALL_TEXT_1/3	1	1	1636	LONGTERM|GENE|GT|DICTIONARY	angiotensin i converting enzyme	angiotensin I-converting enzyme	40#71		D015179	LONGTERM|DISEASE|DT|DICTIONARY	colorectal cancer	colorectal cancer	81#98		We studied the putative significance of angiotensin I-converting enzyme (ACE) in colorectal cancer (CRC) biology.
17898867	2007	Neoplasia	1476-5586	ALL_TEXT_1/3	1	1	1636	LONGTERM|GENE|GT|DICTIONARY	angiotensin i converting enzyme	angiotensin I-converting enzyme	40#71		D015179	SYMBOL|()|DICTIONARY|EXTRACTED	crc	CRC	100#103	17898867-1-81-98	We studied the putative significance of angiotensin I-converting enzyme (ACE) in colorectal cancer (CRC) biology.
17898867	2007	Neoplasia	1476-5586	ALL_TEXT_1/3	1	1	1636	SYMBOL|()|DICTIONARY|EXTRACTED	ace	ACE	73#76	17898867-1-40-71	D015179	LONGTERM|DISEASE|DT|DICTIONARY	colorectal cancer	colorectal cancer	81#98		We studied the putative significance of angiotensin I-converting enzyme (ACE) in colorectal cancer (CRC) biology.
17898867	2007	Neoplasia	1476-5586	ALL_TEXT_1/3	1	1	1636	SYMBOL|()|DICTIONARY|EXTRACTED	ace	ACE	73#76	17898867-1-40-71	D015179	SYMBOL|()|DICTIONARY|EXTRACTED	crc	CRC	100#103	17898867-1-81-98	We studied the putative significance of angiotensin I-converting enzyme (ACE) in colorectal cancer (CRC) biology.
17898867	2007	Neoplasia	1476-5586	TITLE	0	0	1636	LONGTERM|GENE|GT|DICTIONARY	angiotensin i converting enzyme	angiotensin I-converting enzyme	29#60		D009369	LONGTERM|DISEASE|DT|DICTIONARY	tumor	tumor	77#82		The gene polymorphism of the angiotensin I-converting enzyme correlates with tumor size and patient survival in colorectal cancer patients.
17898867	2007	Neoplasia	1476-5586	TITLE	0	0	1636	LONGTERM|GENE|GT|DICTIONARY	angiotensin i converting enzyme	angiotensin I-converting enzyme	29#60		D015179	LONGTERM|DISEASE|DN|DT|DICTIONARY	colorectal cancer	colorectal cancer	112#129		The gene polymorphism of the angiotensin I-converting enzyme correlates with tumor size and patient survival in colorectal cancer patients.
17898867	2007	Neoplasia	1476-5586	ALL_TEXT_1/3	1	3	1636	SYMBOL|DICTIONARY|EXTRACTED	ace	ACE	0#3		D015179	SYMBOL|DISEASE|DN|DICTIONARY|EXTRACTED	crc	CRC	63#66	17898867-1-81-98	ACE insertion (I)/deletion (D) polymorphism was studied in 141 CRC patients and 189 controls.
18026693	2008	Endocrine	1355-008X	ALL_TEXT_3/3	3	7	64135	SYMBOL|GENE|GN|DICTIONARY	ifih1	IFIH1	78#83		D006111	SYMBOL|EXTRACTED	gd	GD	113#115	18026693-1-61-76	Therefore we were unable to find the association of A946T polymorphism of the IFIH1 gene with the development of GD in a Chinese population.
17898867	2007	Neoplasia	1476-5586	ALL_TEXT_2/3	2	5	1636	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	ace	ACE	0#3		D000236	LONGTERM|DICTIONARY	adenomas	adenomas	43#51		ACE protein was more commonly expressed in adenomas [17 (81%)] and cancer epithelial cells [22 (100%)] than in corresponding non-neoplastic crypt and surface epithelium [2 (10%) and 2 (9%), respectively].
17898867	2007	Neoplasia	1476-5586	ALL_TEXT_2/3	2	5	1636	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	ace	ACE	0#3		D009369	LONGTERM|DISEASE|DT|DICTIONARY	cancer	cancer	67#73		ACE protein was more commonly expressed in adenomas [17 (81%)] and cancer epithelial cells [22 (100%)] than in corresponding non-neoplastic crypt and surface epithelium [2 (10%) and 2 (9%), respectively].
18026693	2008	Endocrine	1355-008X	ALL_TEXT_1/3	1	2	64135	SYMBOL|()|GENE|GN|DICTIONARY	ifih1	IFIH1	96#101		D006111	SYMBOL|EXTRACTED	gd	GD	136#138	18026693-1-61-76	A recent study revealed that the A946T polymorphism (rs1990760) in interferon induced helicase (IFIH1) gene was a susceptible locus for GD.
18026693	2008	Endocrine	1355-008X	ALL_TEXT_2/3	2	3	64135	SYMBOL|GENE|GN|DICTIONARY	ifih1	IFIH1	160#165		D006111	SYMBOL|EXTRACTED|DISEASE|DN	gd	GD	70#72	18026693-1-61-76	A case-control study in a Chinese population was undertaken, with 261 GD patients and 206 healthy subjects, to analyze the association of A946T polymorphism in IFIH1 gene with GD.
18026693	2008	Endocrine	1355-008X	ALL_TEXT_2/3	2	3	64135	SYMBOL|GENE|GN|DICTIONARY	ifih1	IFIH1	160#165		D006111	SYMBOL|EXTRACTED	gd	GD	176#178	18026693-1-61-76	A case-control study in a Chinese population was undertaken, with 261 GD patients and 206 healthy subjects, to analyze the association of A946T polymorphism in IFIH1 gene with GD.
17587429	2007	Respirology	1323-7799	TITLE	0	0	3586	LONGTERM|DICTIONARY	interleukin 10	interleukin-10	17#31		D014397	LONGTERM|DICTIONARY	pulmonary tuberculosis	pulmonary tuberculosis	121#143		Polymorphisms of interleukin-10 and tumour necrosis factor-alpha genes are associated with newly diagnosed and recurrent pulmonary tuberculosis.
14713779	2004	J. Urol.	0022-5347	RESULTS	3	8	4953	SYMBOL|DICTIONARY|EXTRACTED	odc	ODC	38#41	14713779-1-79-102	D011471	LONGTERM|DISEASE|DT|DICTIONARY	prostate cancer	prostate cancer	110#125		However, men who inherited at least 1 ODC A alleles and less than 22 AR CAG repeats were at twice the risk of prostate cancer compared with those with 2 guanine alleles and 22 or greater AR CAG repeats (OR 2.09, 95% CI 1.23 to 3.57).
14713779	2004	J. Urol.	0022-5347	RESULTS	3	8	367	SYMBOL|EXTRACTED	ar	AR	69#71	14713779-2-110-127	D011471	LONGTERM|DISEASE|DT|DICTIONARY	prostate cancer	prostate cancer	110#125		However, men who inherited at least 1 ODC A alleles and less than 22 AR CAG repeats were at twice the risk of prostate cancer compared with those with 2 guanine alleles and 22 or greater AR CAG repeats (OR 2.09, 95% CI 1.23 to 3.57).
14713779	2004	J. Urol.	0022-5347	RESULTS	3	8	367	SYMBOL|EXTRACTED	ar	AR	187#189	14713779-2-110-127	D011471	LONGTERM|DISEASE|DT|DICTIONARY	prostate cancer	prostate cancer	110#125		However, men who inherited at least 1 ODC A alleles and less than 22 AR CAG repeats were at twice the risk of prostate cancer compared with those with 2 guanine alleles and 22 or greater AR CAG repeats (OR 2.09, 95% CI 1.23 to 3.57).
17587429	2007	Respirology	1323-7799	BACKGROUND AND OBJECTIVES	1	2	7124	SYMBOL|EXTRACTED|()	tnf alpha	TNF-alpha	127#136	17587429-2-97-125	D014376	LONGTERM|DICTIONARY	tuberculosis	tuberculosis	74#86		The present study investigated the relationship between susceptibility to tuberculosis and human tumour necrosis factor-alpha (TNF-alpha) and interleukin-10 genes (IL-10).
17587429	2007	Respirology	1323-7799	BACKGROUND AND OBJECTIVES	1	2	3586	LONGTERM|GENE|GN|DICTIONARY	interleukin 10	interleukin-10	142#156		D014376	LONGTERM|DICTIONARY	tuberculosis	tuberculosis	74#86		The present study investigated the relationship between susceptibility to tuberculosis and human tumour necrosis factor-alpha (TNF-alpha) and interleukin-10 genes (IL-10).
19429005	2009	Neurosci. Lett.	0304-3940	TITLE	0	0	9749	SYMBOL|DICTIONARY	phactr2	Phactr2	0#7		D010300	LONGTERM|DISEASE|DT|DICTIONARY	parkinson disease	Parkinson's disease	12#31		Phactr2 and Parkinson's disease.
17587429	2007	Respirology	1323-7799	RESULTS	3	5	7124	SYMBOL|EXTRACTED	tnf alpha	TNF-alpha	43#52	17587429-2-97-125	D014390	SYMBOL|DISEASE|DN|DICTIONARY	tb	TB	82#84		There was no significant difference in the TNF-alpha-308 G/A genotype between the TB patient groups and the controls.
17587429	2007	Respirology	1323-7799	CONCLUSION	4	7	7124	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	tnf alpha	TNF-alpha	122#131	17587429-2-97-125	D014390	LONGTERM|DICTIONARY	tb	TB	86#88	NaN	The -1082A allele of the IL-10 gene may be important in determining susceptibility to TB, however, the -308 allele of the TNF-alpha gene does not affect differential TB susceptibility.
17587429	2007	Respirology	1323-7799	CONCLUSION	4	7	7124	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	tnf alpha	TNF-alpha	122#131	17587429-2-97-125	D014390	LONGTERM|DICTIONARY	tb	TB	166#168	NaN	The -1082A allele of the IL-10 gene may be important in determining susceptibility to TB, however, the -308 allele of the TNF-alpha gene does not affect differential TB susceptibility.
15973118	2005	Inflamm. Bowel Dis.	1078-0998	CONCLUSIONS	4	9	7099	SYMBOL|DICTIONARY|EXTRACTED	tlr4	TLR4	4#8	15973118-1-42-62	D003424	SYMBOL|EXTRACTED	cd	CD	53#55	15973118-1-133-148	The TLR4 Asp299Gly polymorphism is a risk factor for CD.
21966456	2012	PLoS ONE	1932-6203	CONCLUSIONS	3	9	5733	SYMBOL|EXTRACTED	ep3	EP3	55#58	21966456-1-249-275	D013262	SYMBOL|DICTIONARY|EXTRACTED	sjs	SJS	124#127	21966456-1-48-72	We posit an association between the down-regulation of EP3 in conjunctival epithelium and the pathogenesis and pathology of SJS/TEN and OCP, and suggest a common mechanism(s) in the pathology of these diseases.
21966456	2012	PLoS ONE	1932-6203	CONCLUSIONS	3	9	5733	SYMBOL|EXTRACTED	ep3	EP3	55#58	21966456-1-249-275	D064420	SYMBOL|EXTRACTED	ten	TEN	128#131	21966456-1-103-129	We posit an association between the down-regulation of EP3 in conjunctival epithelium and the pathogenesis and pathology of SJS/TEN and OCP, and suggest a common mechanism(s) in the pathology of these diseases.
21966456	2012	PLoS ONE	1932-6203	CONCLUSIONS	3	9	5733	SYMBOL|EXTRACTED	ep3	EP3	55#58	21966456-1-249-275	D010390	SYMBOL|DICTIONARY|EXTRACTED	ocp	OCP	136#139	21966456-3-193-222	We posit an association between the down-regulation of EP3 in conjunctival epithelium and the pathogenesis and pathology of SJS/TEN and OCP, and suggest a common mechanism(s) in the pathology of these diseases.
16614115	2006	Cancer Epidemiol. Biomarkers Prev.	1055-9965	TITLE	0	0	7124	SYMBOL|DICTIONARY	tnf a	TNF-A	61#66		D010190	LONGTERM|DICTIONARY	pancreatic adenocarcinoma	pancreatic adenocarcinoma	98#123		Inflammation, genetic polymorphisms in proinflammatory genes TNF-A, RANTES, and CCR5, and risk of pancreatic adenocarcinoma.
16614115	2006	Cancer Epidemiol. Biomarkers Prev.	1055-9965	TITLE	0	0	7124	SYMBOL|DICTIONARY	tnf a	TNF-A	61#66		D007249	LONGTERM|DICTIONARY	inflammation	Inflammation	0#12	NaN	Inflammation, genetic polymorphisms in proinflammatory genes TNF-A, RANTES, and CCR5, and risk of pancreatic adenocarcinoma.
16614115	2006	Cancer Epidemiol. Biomarkers Prev.	1055-9965	TITLE	0	0	6352	SYMBOL|DICTIONARY	rantes	RANTES	68#74		D010190	LONGTERM|DICTIONARY	pancreatic adenocarcinoma	pancreatic adenocarcinoma	98#123		Inflammation, genetic polymorphisms in proinflammatory genes TNF-A, RANTES, and CCR5, and risk of pancreatic adenocarcinoma.
16614115	2006	Cancer Epidemiol. Biomarkers Prev.	1055-9965	TITLE	0	0	6352	SYMBOL|DICTIONARY	rantes	RANTES	68#74		D007249	LONGTERM|DICTIONARY	inflammation	Inflammation	0#12	NaN	Inflammation, genetic polymorphisms in proinflammatory genes TNF-A, RANTES, and CCR5, and risk of pancreatic adenocarcinoma.
16614115	2006	Cancer Epidemiol. Biomarkers Prev.	1055-9965	TITLE	0	0	1234	SYMBOL|DICTIONARY	ccr5	CCR5	80#84		D010190	LONGTERM|DICTIONARY	pancreatic adenocarcinoma	pancreatic adenocarcinoma	98#123		Inflammation, genetic polymorphisms in proinflammatory genes TNF-A, RANTES, and CCR5, and risk of pancreatic adenocarcinoma.
16614115	2006	Cancer Epidemiol. Biomarkers Prev.	1055-9965	TITLE	0	0	1234	SYMBOL|DICTIONARY	ccr5	CCR5	80#84		D007249	LONGTERM|DICTIONARY	inflammation	Inflammation	0#12	NaN	Inflammation, genetic polymorphisms in proinflammatory genes TNF-A, RANTES, and CCR5, and risk of pancreatic adenocarcinoma.
19546348	2009	Exp. Biol. Med. (Maywood)	1535-3699	ALL_TEXT_3/3	3	9	3091	LONGTERM|DICTIONARY	hif-1	HIF-1	46#51	NaN	D008175	LONGTERM|DISEASE|DT|DICTIONARY	lung cancer	lung cancer	93#104		These findings show that polymorphisms in the HIF-1alphagene do not confer susceptibility to lung cancer.
15776395	2005	Am. J. Hum. Genet.	0002-9297	ALL_TEXT_3/3	3	4	3559	SYMBOL|DICTIONARY|EXTRACTED	cd25	CD25	106#110	15776395-1-147-152	D003922	SYMBOL|EXTRACTED	t1d	T1D	89#92	15776395-1-55-70	We found strong statistical evidence in the case-control collection (P=6.5x10(-8)) for a T1D locus in the CD25 region of chromosome 10p15 and replicated the association in the family collection (P=7.3x10(-3); combined P=1.3x10(-10)).
20709820	2011	Am. J. Respir. Crit. Care Med.	1535-4970	CONCLUSIONS	5	8	636	SYMBOL|DICTIONARY	bicd1	BICD1	12#17		D004646	LONGTERM|DICTIONARY	emphysema	emphysema	158#167		Variants in BICD1 are associated with length of telomeres, which suggests that a mechanism linked to accelerated aging may be involved in the pathogenesis of emphysema.
16614115	2006	Cancer Epidemiol. Biomarkers Prev.	1055-9965	ALL_TEXT_2/3	2	6	7124	LONGTERM|DICTIONARY	tumor necrosis factor alpha	tumor necrosis factor-alpha	68#95		D010190	LONGTERM|DISEASE|DT|DICTIONARY	pancreatic cancer	pancreatic cancer	41#58		There was no overall association between pancreatic cancer risk and tumor necrosis factor-alpha (TNF-A -308G/A), regulated upon activation, normally T cell-expressed, and presumably secreted (RANTES -403G/A), and CC chemokine receptor 5 (CCR5-Delta32) polymorphisms.
16614115	2006	Cancer Epidemiol. Biomarkers Prev.	1055-9965	ALL_TEXT_2/3	2	6	7124	SYMBOL|DICTIONARY	tnf a	TNF-A	97#102		D010190	LONGTERM|DISEASE|DT|DICTIONARY	pancreatic cancer	pancreatic cancer	41#58		There was no overall association between pancreatic cancer risk and tumor necrosis factor-alpha (TNF-A -308G/A), regulated upon activation, normally T cell-expressed, and presumably secreted (RANTES -403G/A), and CC chemokine receptor 5 (CCR5-Delta32) polymorphisms.
16614115	2006	Cancer Epidemiol. Biomarkers Prev.	1055-9965	ALL_TEXT_2/3	2	6	6352	SYMBOL|DICTIONARY	rantes	RANTES	192#198		D010190	LONGTERM|DISEASE|DT|DICTIONARY	pancreatic cancer	pancreatic cancer	41#58		There was no overall association between pancreatic cancer risk and tumor necrosis factor-alpha (TNF-A -308G/A), regulated upon activation, normally T cell-expressed, and presumably secreted (RANTES -403G/A), and CC chemokine receptor 5 (CCR5-Delta32) polymorphisms.
16614115	2006	Cancer Epidemiol. Biomarkers Prev.	1055-9965	ALL_TEXT_2/3	2	6	1234	LONGTERM|GENE|GT|NUMBER|DICTIONARY	cc chemokine receptor 5	CC chemokine receptor 5	213#236		D010190	LONGTERM|DISEASE|DT|DICTIONARY	pancreatic cancer	pancreatic cancer	41#58		There was no overall association between pancreatic cancer risk and tumor necrosis factor-alpha (TNF-A -308G/A), regulated upon activation, normally T cell-expressed, and presumably secreted (RANTES -403G/A), and CC chemokine receptor 5 (CCR5-Delta32) polymorphisms.
16614115	2006	Cancer Epidemiol. Biomarkers Prev.	1055-9965	ALL_TEXT_2/3	2	6	1234	SYMBOL|EXTRACTED|()	ccr5	CCR5	238#242	16614115-6-216-234	D010190	LONGTERM|DISEASE|DT|DICTIONARY	pancreatic cancer	pancreatic cancer	41#58		There was no overall association between pancreatic cancer risk and tumor necrosis factor-alpha (TNF-A -308G/A), regulated upon activation, normally T cell-expressed, and presumably secreted (RANTES -403G/A), and CC chemokine receptor 5 (CCR5-Delta32) polymorphisms.
15776395	2005	Am. J. Hum. Genet.	0002-9297	ALL_TEXT_1/3	1	1	3559	SYMBOL|DICTIONARY	il2ra	IL2RA	147#152		D003922	LONGTERM|DICTIONARY	type 1 diabetes	type 1 diabetes	55#70		As part of an ongoing search for genes associated with type 1 diabetes (T1D), a common autoimmune disease, we tested the biological candidate gene IL2RA (CD25), which encodes a subunit (IL-2R alpha) of the high-affinity interleukin-2 (IL-2) receptor complex.
15776395	2005	Am. J. Hum. Genet.	0002-9297	ALL_TEXT_1/3	1	1	3559	SYMBOL|DICTIONARY	il2ra	IL2RA	147#152		D003922	SYMBOL|EXTRACTED|()	t1d	T1D	72#75	15776395-1-55-70	As part of an ongoing search for genes associated with type 1 diabetes (T1D), a common autoimmune disease, we tested the biological candidate gene IL2RA (CD25), which encodes a subunit (IL-2R alpha) of the high-affinity interleukin-2 (IL-2) receptor complex.
15776395	2005	Am. J. Hum. Genet.	0002-9297	ALL_TEXT_1/3	1	1	3559	SYMBOL|DICTIONARY	il2ra	IL2RA	147#152		D001327	LONGTERM|DISEASE|DT|DICTIONARY	autoimmune disease	autoimmune disease	87#105		As part of an ongoing search for genes associated with type 1 diabetes (T1D), a common autoimmune disease, we tested the biological candidate gene IL2RA (CD25), which encodes a subunit (IL-2R alpha) of the high-affinity interleukin-2 (IL-2) receptor complex.
15776395	2005	Am. J. Hum. Genet.	0002-9297	ALL_TEXT_1/3	1	1	3559	SYMBOL|()|DICTIONARY|EXTRACTED	cd25	CD25	154#158	15776395-1-147-152	D003922	LONGTERM|DICTIONARY	type 1 diabetes	type 1 diabetes	55#70		As part of an ongoing search for genes associated with type 1 diabetes (T1D), a common autoimmune disease, we tested the biological candidate gene IL2RA (CD25), which encodes a subunit (IL-2R alpha) of the high-affinity interleukin-2 (IL-2) receptor complex.
15776395	2005	Am. J. Hum. Genet.	0002-9297	ALL_TEXT_1/3	1	1	3559	SYMBOL|()|DICTIONARY|EXTRACTED	cd25	CD25	154#158	15776395-1-147-152	D003922	SYMBOL|EXTRACTED|()	t1d	T1D	72#75	15776395-1-55-70	As part of an ongoing search for genes associated with type 1 diabetes (T1D), a common autoimmune disease, we tested the biological candidate gene IL2RA (CD25), which encodes a subunit (IL-2R alpha) of the high-affinity interleukin-2 (IL-2) receptor complex.
15776395	2005	Am. J. Hum. Genet.	0002-9297	ALL_TEXT_1/3	1	1	3559	SYMBOL|()|DICTIONARY|EXTRACTED	cd25	CD25	154#158	15776395-1-147-152	D001327	LONGTERM|DISEASE|DT|DICTIONARY	autoimmune disease	autoimmune disease	87#105		As part of an ongoing search for genes associated with type 1 diabetes (T1D), a common autoimmune disease, we tested the biological candidate gene IL2RA (CD25), which encodes a subunit (IL-2R alpha) of the high-affinity interleukin-2 (IL-2) receptor complex.
16614115	2006	Cancer Epidemiol. Biomarkers Prev.	1055-9965	ALL_TEXT_3/3	3	8	7124	SYMBOL|DICTIONARY	tnf a	TNF-A	86#91		D010190	LONGTERM|DISEASE|DT|DICTIONARY	pancreatic cancer	pancreatic cancer	20#37		Among patients with pancreatic cancer, pancreatitis was significantly associated with TNF-A -308 GA + AA (OR, 3.1; 95% CI, 1.3-7.4) and with RANTES -403 GA + AA (OR, 2.3; 95% CI, 1.0-5.4).
16614115	2006	Cancer Epidemiol. Biomarkers Prev.	1055-9965	ALL_TEXT_3/3	3	8	7124	SYMBOL|DICTIONARY	tnf a	TNF-A	86#91		D010190	LONGTERM|DICTIONARY	pancreatitis	pancreatitis	39#51		Among patients with pancreatic cancer, pancreatitis was significantly associated with TNF-A -308 GA + AA (OR, 3.1; 95% CI, 1.3-7.4) and with RANTES -403 GA + AA (OR, 2.3; 95% CI, 1.0-5.4).
16614115	2006	Cancer Epidemiol. Biomarkers Prev.	1055-9965	ALL_TEXT_3/3	3	8	6352	SYMBOL|DICTIONARY	rantes	RANTES	141#147		D010190	LONGTERM|DISEASE|DT|DICTIONARY	pancreatic cancer	pancreatic cancer	20#37		Among patients with pancreatic cancer, pancreatitis was significantly associated with TNF-A -308 GA + AA (OR, 3.1; 95% CI, 1.3-7.4) and with RANTES -403 GA + AA (OR, 2.3; 95% CI, 1.0-5.4).
16614115	2006	Cancer Epidemiol. Biomarkers Prev.	1055-9965	ALL_TEXT_3/3	3	8	6352	SYMBOL|DICTIONARY	rantes	RANTES	141#147		D010190	LONGTERM|DICTIONARY	pancreatitis	pancreatitis	39#51		Among patients with pancreatic cancer, pancreatitis was significantly associated with TNF-A -308 GA + AA (OR, 3.1; 95% CI, 1.3-7.4) and with RANTES -403 GA + AA (OR, 2.3; 95% CI, 1.0-5.4).
19892845	2010	Clin. Chem.	1530-8561	CONCLUSIONS	4	14	672	SYMBOL|DICTIONARY	brca1	BRCA1	46#51		D001943	LONGTERM|DICTIONARY	brca1	BRCA1	46#51	NaN	Our data support a nonpathogenic role for the BRCA1 c.591C>T variant.
16434832	2006	Tohoku J. Exp. Med.	0040-8727	ALL_TEXT_2/3	2	4	2261	LONGTERM|DICTIONARY|GFAM|FA	fibroblast growth factor receptor 3	fibroblast growth factor receptor 3	99#134		D000130	LONGTERM|DICTIONARY	achondroplasia	achondroplasia	35#49		The vast majority of patients with achondroplasia have a G-to-A transition at position 1138 of the fibroblast growth factor receptor 3 (FGFR3) cDNA sequence, resulting in the Gly-to-Arg substitution at position 380 of the FGFR3 protein.
16434832	2006	Tohoku J. Exp. Med.	0040-8727	ALL_TEXT_2/3	2	4	2261	SYMBOL|()|GFAM|FN|DICTIONARY|EXTRACTED	fgfr3	FGFR3	136#141	16434832-4-99-134	D000130	LONGTERM|DICTIONARY	achondroplasia	achondroplasia	35#49		The vast majority of patients with achondroplasia have a G-to-A transition at position 1138 of the fibroblast growth factor receptor 3 (FGFR3) cDNA sequence, resulting in the Gly-to-Arg substitution at position 380 of the FGFR3 protein.
16434832	2006	Tohoku J. Exp. Med.	0040-8727	ALL_TEXT_2/3	2	4	2261	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	fgfr3	FGFR3	222#227	16434832-4-99-134	D000130	LONGTERM|DICTIONARY	achondroplasia	achondroplasia	35#49		The vast majority of patients with achondroplasia have a G-to-A transition at position 1138 of the fibroblast growth factor receptor 3 (FGFR3) cDNA sequence, resulting in the Gly-to-Arg substitution at position 380 of the FGFR3 protein.
12963757	2004	Neurology	1526-632X	CONCLUSIONS	4	9	348	SYMBOL|DICTIONARY	apoe	APOE	82#86		D000544	LONGTERM|DISEASE|DT|DICTIONARY	alzheimer disease	Alzheimer's disease	47#66		Antihypertensive therapy decreases the risk of Alzheimer's disease exerted by the APOE-epsilon4 allele.
19052543	2009	Neuropsychopharmacology	1740-634X	ALL_TEXT_1/3	1	2	1268	SYMBOL|DICTIONARY|EXTRACTED	cnr1	CNR1	65#69	19052543-1-91-113	D019970	SYMBOL|EXTRACTED	cd	CD	74#76	19052543-1-200-218	This study aimed to investigate directly the association between CNR1 and CD in four independent samples.
19052543	2009	Neuropsychopharmacology	1740-634X	TITLE	0	0	1268	SYMBOL|DICTIONARY|EXTRACTED	cnr1	CNR1	36#40		D019970	LONGTERM|DICTIONARY	cocaine dependence	cocaine dependence	69#87		Interaction between two independent CNR1 variants increases risk for cocaine dependence in European Americans: a replication study in family-based sample and population-based sample.
19052543	2009	Neuropsychopharmacology	1740-634X	ALL_TEXT_1/3	1	1	1268	SYMBOL|()|DICTIONARY|EXTRACTED	cnr1	CNR1	120#124	19052543-1-91-113	D019966	LONGTERM|DICTIONARY	drug dependence	drug dependence	168#183		We recently reported that, in a European-American (EA) sample, the interaction between two cannabinoid receptor 1 gene (CNR1) variants significantly increased risk for drug dependence (DD), including cocaine dependence (CD).
19052543	2009	Neuropsychopharmacology	1740-634X	ALL_TEXT_1/3	1	1	1268	SYMBOL|()|DICTIONARY|EXTRACTED	cnr1	CNR1	120#124	19052543-1-91-113	D019966	SYMBOL|EXTRACTED|()	dd	DD	185#187	19052543-1-168-183	We recently reported that, in a European-American (EA) sample, the interaction between two cannabinoid receptor 1 gene (CNR1) variants significantly increased risk for drug dependence (DD), including cocaine dependence (CD).
19052543	2009	Neuropsychopharmacology	1740-634X	ALL_TEXT_1/3	1	1	1268	SYMBOL|()|DICTIONARY|EXTRACTED	cnr1	CNR1	120#124	19052543-1-91-113	D019970	LONGTERM|DICTIONARY	cocaine dependence	cocaine dependence	200#218		We recently reported that, in a European-American (EA) sample, the interaction between two cannabinoid receptor 1 gene (CNR1) variants significantly increased risk for drug dependence (DD), including cocaine dependence (CD).
19052543	2009	Neuropsychopharmacology	1740-634X	ALL_TEXT_1/3	1	1	1268	SYMBOL|()|DICTIONARY|EXTRACTED	cnr1	CNR1	120#124	19052543-1-91-113	D019970	SYMBOL|EXTRACTED|()	cd	CD	220#222	19052543-1-200-218	We recently reported that, in a European-American (EA) sample, the interaction between two cannabinoid receptor 1 gene (CNR1) variants significantly increased risk for drug dependence (DD), including cocaine dependence (CD).
12582029	2003	Cancer Epidemiol. Biomarkers Prev.	1055-9965	TITLE	0	0	4968	SYMBOL|DICTIONARY	ogg1	OGG1	23#27		D001943	LONGTERM|DISEASE|DT|DICTIONARY	breast cancer	breast cancer	55#68		No association between OGG1 Ser326Cys polymorphism and breast cancer risk.
19052543	2009	Neuropsychopharmacology	1740-634X	ALL_TEXT_2/3	2	5	1268	SYMBOL|DICTIONARY|EXTRACTED	cnr1	CNR1	40#44	19052543-1-91-113	D019970	SYMBOL|EXTRACTED	cd	CD	197#199	19052543-1-200-218	The interaction between two independent CNR1 variants, ie, the G allele-containing genotypes of rs6454674 (SNP3(G+)), and the T/T genotype of rs806368 (SNP8(T)/T), significantly increased risk for CD in the EA family (P(GEE)=0.015) and EA case-control (P(regression)=0.003) samples.
12104085	2002	Clin. Chim. Acta	0009-8981	TITLE	0	0	1071	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	cetp	CETP	0#4		D003327	LONGTERM|DISEASE|DT|DICTIONARY	coronary heart disease	coronary heart disease	92#114		CETP gene mutation (D442G) increases low-density lipoprotein particle size in patients with coronary heart disease.
18753723	2008	Int Heart J	1349-2365	ALL_TEXT_3/3	3	10	3569	SYMBOL|DICTIONARY|EXTRACTED	il 6	IL-6	34#38	18753723-1-19-32	D003324	SYMBOL|DICTIONARY|EXTRACTED	cad	CAD	62#65	18753723-2-161-184	A simple measurement of the serum IL-6 level in patients with CAD can potentially identify subjects with complex coronary lesions and provide the option of aggressive medical strategies in a clinical setting.
12104085	2002	Clin. Chim. Acta	0009-8981	OBJECTIVES	2	5	1071	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	cetp	CETP	55#59	12104085-2-0-34	D003327	LONGTERM|DICTIONARY	coronary heart diseases	coronary heart diseases	118#141		To investigate the effect of the D442G mutation in the CETP gene on major peak size of LDL particles in patients with coronary heart diseases (CHD).
12104085	2002	Clin. Chim. Acta	0009-8981	OBJECTIVES	2	5	1071	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	cetp	CETP	55#59	12104085-2-0-34	D003327	SYMBOL|()|DICTIONARY|EXTRACTED	chd	CHD	143#146	12104085-5-118-141	To investigate the effect of the D442G mutation in the CETP gene on major peak size of LDL particles in patients with coronary heart diseases (CHD).
20136773	2010	Tissue Antigens	1399-0039	ALL_TEXT_2/3	2	5	3123	SYMBOL|DICTIONARY	leukocyte antigen (hla)-drb1 and -dqb1	leukocyte antigen (HLA)-DRB1 and -DQB1	10#48		D002311	SYMBOL|DICTIONARY|EXTRACTED	dcm	DCM	99#102	20136773-4-188-218	The human leukocyte antigen (HLA)-DRB1 and -DQB1 alleles were analyzed in 76 patients with primary DCM and 111 ethnically matched healthy controls using polymerase chain reaction-sequence specific primers technique.
18726117	2009	J. Cancer Res. Clin. Oncol.	1432-1335	CONCLUSIONS	4	8	1956	SYMBOL|DICTIONARY|EXTRACTED	egfr	EGFR	0#4		D008175	LONGTERM|DICTIONARY	lung cancers	lung cancers	67#79		EGFR mutation status was not correlated with R497KEGFR genotype of lung cancers.
17870204	2008	Lung Cancer	0169-5002	ALL_TEXT_3/3	3	7	4292	SYMBOL|DICTIONARY	hmlh1	hMLH1	33#38		D008175	LONGTERM|DISEASE|DT|DICTIONARY	lung cancer	lung cancer	108#119		These findings indicate that the hMLH1 rs1799977 polymorphism may contribute to the etiology of early-onset lung cancer as well as some specific subtype of lung cancer.
17870204	2008	Lung Cancer	0169-5002	ALL_TEXT_3/3	3	7	4292	SYMBOL|DICTIONARY	hmlh1	hMLH1	33#38		D008175	LONGTERM|DISEASE|DT|DICTIONARY	lung cancer	lung cancer	156#167		These findings indicate that the hMLH1 rs1799977 polymorphism may contribute to the etiology of early-onset lung cancer as well as some specific subtype of lung cancer.
17870204	2008	Lung Cancer	0169-5002	TITLE	0	0	4292	SYMBOL|DICTIONARY	hmlh1	hMLH1	17#22		D008175	LONGTERM|DISEASE|DT|DICTIONARY	lung cancer	lung cancer	47#58		Polymorphisms in hMLH1 and risk of early-onset lung cancer in a southeast Chinese population.
17870204	2008	Lung Cancer	0169-5002	ALL_TEXT_1/3	1	2	4292	SYMBOL|DICTIONARY	hmlh1	hMLH1	93#98		D009369	LONGTERM|DICTIONARY	sporadic and hereditary cancers	sporadic and hereditary cancers	60#91		Defects in MMR genes have been involved in several types of sporadic and hereditary cancers. hMLH1 is considered one of central members of the MMR pathway.
17870204	2008	Lung Cancer	0169-5002	ALL_TEXT_2/3	2	3	4292	SYMBOL|GENE|GN|DICTIONARY	hmlh1	hMLH1	105#110		D008175	LONGTERM|DISEASE|DT|DICTIONARY	lung cancer	lung cancer	128#139		We conducted a hospital-based case-control study to investigate associations of common variations in the hMLH1 gene and risk of lung cancer.
18726117	2009	J. Cancer Res. Clin. Oncol.	1432-1335	INTRODUCTION	1	2	1956	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	egfr	EGFR	15#19	18726117-1-56-88	D002289	LONGTERM|DISEASE|DT|DICTIONARY	non small cell lung cancer	non-small cell lung cancer	55#81		On other hand, EGFR gene mutations at kinase domain in non-small cell lung cancer (NSCLC) have been examined for their ability to predict sensitivity to gefitinib or erlotinib.
18726117	2009	J. Cancer Res. Clin. Oncol.	1432-1335	INTRODUCTION	1	2	1956	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	egfr	EGFR	15#19	18726117-1-56-88	D002289	LONGTERM|()|DICTIONARY|EXTRACTED	nsclc	NSCLC	83#88	18726117-2-55-81	On other hand, EGFR gene mutations at kinase domain in non-small cell lung cancer (NSCLC) have been examined for their ability to predict sensitivity to gefitinib or erlotinib.
18726117	2009	J. Cancer Res. Clin. Oncol.	1432-1335	MATERIALS AND METHODS	2	3	1956	SYMBOL|DICTIONARY|EXTRACTED	egfr	EGFR	20#24	18726117-1-56-88	D002289	LONGTERM|DICTIONARY|EXTRACTED	nsclc	NSCLC	96#101	18726117-2-55-81	We investigated the EGFR mutations and/or R497K polymorphism statuses in 225 surgically treated NSCLC cases.192 adenocarcinoma cases were included.
18726117	2009	J. Cancer Res. Clin. Oncol.	1432-1335	MATERIALS AND METHODS	2	3	1956	SYMBOL|DICTIONARY|EXTRACTED	egfr	EGFR	20#24	18726117-1-56-88	D000230	LONGTERM|DICTIONARY	adenocarcinoma	adenocarcinoma	112#126		We investigated the EGFR mutations and/or R497K polymorphism statuses in 225 surgically treated NSCLC cases.192 adenocarcinoma cases were included.
18726117	2009	J. Cancer Res. Clin. Oncol.	1432-1335	TITLE	0	0	1956	SYMBOL|DICTIONARY|EXTRACTED	egfr	EGFR	0#4		D008175	LONGTERM|DISEASE|DT|DICTIONARY	lung cancer	lung cancer	70#81		EGFR R497K polymorphism is a favorable prognostic factor for advanced lung cancer.
20136773	2010	Tissue Antigens	1399-0039	ALL_TEXT_3/3	3	8	3123	SYMBOL|DICTIONARY	drb1	DRB1	67#71		D002311	SYMBOL|DICTIONARY|EXTRACTED	dcm	DCM	62#65	20136773-4-188-218	Two haplotypes were associated with increased risk of primary DCM: DRB1*0401/DQB1*0302 (OR = 4.53, P = 0.002) and DRB1*0401/DQB1*0401 (OR = 9.42, P = 0.004).
20136773	2010	Tissue Antigens	1399-0039	ALL_TEXT_3/3	3	8	3123	SYMBOL|DICTIONARY	drb1	DRB1	114#118		D002311	SYMBOL|DICTIONARY|EXTRACTED	dcm	DCM	62#65	20136773-4-188-218	Two haplotypes were associated with increased risk of primary DCM: DRB1*0401/DQB1*0302 (OR = 4.53, P = 0.002) and DRB1*0401/DQB1*0401 (OR = 9.42, P = 0.004).
18726117	2009	J. Cancer Res. Clin. Oncol.	1432-1335	RESULTS	3	5	1956	SYMBOL|DICTIONARY|EXTRACTED	egfr	EGFR	0#4		D008175	LONGTERM|DISEASE|DN|DT|DICTIONARY	lung cancer	lung cancer	58#69		EGFR mutations at kinase domain were found from 95 of 225 lung cancer patients.
11340230	2001	Stroke	1524-4628	RESULTS	3	8	348	SYMBOL|DICTIONARY	apoe	APOE	75#79		D013345	SYMBOL|DICTIONARY|EXTRACTED	aneurysmatic sah	aneurysmatic SAH	17#33	11340230-1-42-65	126 patients had aneurysmatic SAH, and detailed information on outcome and APOE genotype was available for 108 patients (86%).
16457697	2006	Breast Cancer Res.	1465-542X	CONCLUSION	4	14	7515	SYMBOL|DICTIONARY	xrcc1	XRCC1	35#40		D001943	LONGTERM|DISEASE|DT|DICTIONARY	breast cancer	breast cancer	71#84		In our study, genetic variation in XRCC1 Arg399Gln was associated with breast cancer risk only among women with a history of smoking cigarettes.
18985386	2009	Hum. Genet.	1432-1203	ALL_TEXT_3/3	3	10	2580	SYMBOL|DICTIONARY	gak	GAK	82#85		D010300	SYMBOL|EXTRACTED	pd	PD	72#74	18985386-1-70-87	These data suggest the identification of new susceptibility alleles for PD in the GAK/DGKQ region, and also provide further support for the role of SNCA and MAPT in PD susceptibility.
18985386	2009	Hum. Genet.	1432-1203	ALL_TEXT_3/3	3	10	2580	SYMBOL|DICTIONARY	gak	GAK	82#85		D010300	SYMBOL|EXTRACTED	pd	PD	165#167	18985386-1-70-87	These data suggest the identification of new susceptibility alleles for PD in the GAK/DGKQ region, and also provide further support for the role of SNCA and MAPT in PD susceptibility.
18985386	2009	Hum. Genet.	1432-1203	ALL_TEXT_3/3	3	10	1609	SYMBOL|DICTIONARY	dgkq	DGKQ	86#90		D010300	SYMBOL|EXTRACTED	pd	PD	72#74	18985386-1-70-87	These data suggest the identification of new susceptibility alleles for PD in the GAK/DGKQ region, and also provide further support for the role of SNCA and MAPT in PD susceptibility.
18985386	2009	Hum. Genet.	1432-1203	ALL_TEXT_3/3	3	10	1609	SYMBOL|DICTIONARY	dgkq	DGKQ	86#90		D010300	SYMBOL|EXTRACTED	pd	PD	165#167	18985386-1-70-87	These data suggest the identification of new susceptibility alleles for PD in the GAK/DGKQ region, and also provide further support for the role of SNCA and MAPT in PD susceptibility.
18985386	2009	Hum. Genet.	1432-1203	ALL_TEXT_3/3	3	10	6622	SYMBOL|DICTIONARY	snca	SNCA	148#152		D010300	SYMBOL|EXTRACTED	pd	PD	72#74	18985386-1-70-87	These data suggest the identification of new susceptibility alleles for PD in the GAK/DGKQ region, and also provide further support for the role of SNCA and MAPT in PD susceptibility.
18985386	2009	Hum. Genet.	1432-1203	ALL_TEXT_3/3	3	10	6622	SYMBOL|DICTIONARY	snca	SNCA	148#152		D010300	SYMBOL|EXTRACTED	pd	PD	165#167	18985386-1-70-87	These data suggest the identification of new susceptibility alleles for PD in the GAK/DGKQ region, and also provide further support for the role of SNCA and MAPT in PD susceptibility.
18985386	2009	Hum. Genet.	1432-1203	ALL_TEXT_3/3	3	10	4137	SYMBOL|DICTIONARY	mapt	MAPT	157#161		D010300	SYMBOL|EXTRACTED	pd	PD	72#74	18985386-1-70-87	These data suggest the identification of new susceptibility alleles for PD in the GAK/DGKQ region, and also provide further support for the role of SNCA and MAPT in PD susceptibility.
18985386	2009	Hum. Genet.	1432-1203	ALL_TEXT_3/3	3	10	4137	SYMBOL|DICTIONARY	mapt	MAPT	157#161		D010300	SYMBOL|EXTRACTED	pd	PD	165#167	18985386-1-70-87	These data suggest the identification of new susceptibility alleles for PD in the GAK/DGKQ region, and also provide further support for the role of SNCA and MAPT in PD susceptibility.
11340230	2001	Stroke	1524-4628	TITLE	0	0	348	LONGTERM|DICTIONARY	apolipoprotein e	apolipoprotein E	15#31		D013345	LONGTERM|DICTIONARY	aneurysmal subarachnoid hemorrhage	aneurysmal subarachnoid hemorrhage	64#98		Association of apolipoprotein E polymorphism with outcome after aneurysmal subarachnoid hemorrhage: a preliminary study.
16457697	2006	Breast Cancer Res.	1465-542X	RESULTS	3	12	7515	SYMBOL|DICTIONARY	xrcc1	XRCC1	58#63		D001943	LONGTERM|DISEASE|DT|DICTIONARY	breast cancer	breast cancer	82#95		No other factor examined modified the association between XRCC1 polymorphisms and breast cancer risk.
16457697	2006	Breast Cancer Res.	1465-542X	CONCLUSION	4	13	7515	SYMBOL|DICTIONARY	xrcc1	XRCC1	61#66		D001943	LONGTERM|DISEASE|DT|DICTIONARY	postmenopausal breast cancer	postmenopausal breast cancer	109#137		Our results support the hypothesis that genetic variation in XRCC1, particularly in Arg194Trp, may influence postmenopausal breast cancer risk.
14563640	2004	Blood	0006-4971	TITLE	0	0	11093	SYMBOL|GENE|GN|DICTIONARY	adamts13	ADAMTS13	30#38		D011697	LONGTERM|DISEASE|DT|DICTIONARY	upshaw schulman syndrome	Upshaw-Schulman syndrome	80#104		Molecular characterization of ADAMTS13 gene mutations in Japanese patients with Upshaw-Schulman syndrome.
12963757	2004	Neurology	1526-632X	TITLE	0	0	348	SYMBOL|DICTIONARY	apoe	APOE	20#24		D000544	LONGTERM|DICTIONARY	ad	AD	93#95	NaN	Combined effects of APOE genotype, blood pressure, and antihypertensive drug use on incident AD.
16167465	2005	Neuropsychopharmacol Hung	1419-8711	ALL_TEXT_1/3	1	1	1815	LONGTERM|GENE|GT|DICTIONARY	dopamine d4 receptor	Dopamine D4 receptor	0#20		D019966	LONGTERM|DICTIONARY	substance dependence	substance dependence	131#151		Dopamine D4 receptor (DRD4) and serotonin transporter (SERT) gene polymorphisms were studied, as possible genetic risk factors for substance dependence.
16167465	2005	Neuropsychopharmacol Hung	1419-8711	ALL_TEXT_1/3	1	1	1815	SYMBOL|()|DICTIONARY|EXTRACTED	drd4	DRD4	22#26	16167465-1-0-20	D019966	LONGTERM|DICTIONARY	substance dependence	substance dependence	131#151		Dopamine D4 receptor (DRD4) and serotonin transporter (SERT) gene polymorphisms were studied, as possible genetic risk factors for substance dependence.
16167465	2005	Neuropsychopharmacol Hung	1419-8711	ALL_TEXT_1/3	1	1	6532	SYMBOL|()|GENE|GN|DICTIONARY	sert	SERT	55#59		D019966	LONGTERM|DICTIONARY	substance dependence	substance dependence	131#151		Dopamine D4 receptor (DRD4) and serotonin transporter (SERT) gene polymorphisms were studied, as possible genetic risk factors for substance dependence.
16167465	2005	Neuropsychopharmacol Hung	1419-8711	TITLE	0	0	1815	LONGTERM|GENE|GT|DICTIONARY	dopamine d4 receptor	dopamine D4 receptor	49#69		D006556	LONGTERM|DICTIONARY	heroin dependence	heroin dependence	109#126		Combined effect of promoter polymorphisms in the dopamine D4 receptor and the serotonin transporter genes in heroin dependence.
16167465	2005	Neuropsychopharmacol Hung	1419-8711	TITLE	0	0	6532	LONGTERM|DICTIONARY	serotonin transporter	serotonin transporter	78#99	NaN	D006556	LONGTERM|DICTIONARY	heroin dependence	heroin dependence	109#126		Combined effect of promoter polymorphisms in the dopamine D4 receptor and the serotonin transporter genes in heroin dependence.
19131637	2009	Clin. Chem.	1530-8561	TITLE	0	0	1071	LONGTERM|GENE|GT|DICTIONARY	cholesteryl ester transfer protein	cholesteryl ester transfer protein	64#98		D050197	LONGTERM|DICTIONARY	atherosclerosis	atherosclerosis	170#185		Associations of genetic variants in ATP-binding cassette A1 and cholesteryl ester transfer protein and differences in lipoprotein subclasses in the multi-ethnic study of atherosclerosis.
19131637	2009	Clin. Chem.	1530-8561	TITLE	0	0	19	SYMBOL|DICTIONARY	atp-binding cassette a1	ATP-binding cassette A1	36#59		D050197	LONGTERM|DICTIONARY	atherosclerosis	atherosclerosis	170#185		Associations of genetic variants in ATP-binding cassette A1 and cholesteryl ester transfer protein and differences in lipoprotein subclasses in the multi-ethnic study of atherosclerosis.
19131637	2009	Clin. Chem.	1530-8561	METHODS	2	3	19	SYMBOL|DICTIONARY	abca1	ABCA1	15#20		D050197	LONGTERM|DICTIONARY	atherosclerosis	Atherosclerosis	95#110		We genotyped 2 ABCA1 and 5 CETP polymorphisms in 999 participants of the Multi-Ethnic Study of Atherosclerosis (MESA) and studied their associations with HDL and LDL subclass particle concentrations, measured by nuclear magnetic resonance spectroscopy.
19131637	2009	Clin. Chem.	1530-8561	METHODS	2	3	1071	SYMBOL|DICTIONARY|EXTRACTED	cetp	CETP	27#31	19131637-1-36-70	D050197	LONGTERM|DICTIONARY	atherosclerosis	Atherosclerosis	95#110		We genotyped 2 ABCA1 and 5 CETP polymorphisms in 999 participants of the Multi-Ethnic Study of Atherosclerosis (MESA) and studied their associations with HDL and LDL subclass particle concentrations, measured by nuclear magnetic resonance spectroscopy.
15075790	2004	Eur. J. Cancer Prev.	0959-8278	ALL_TEXT_2/3	2	4	1029	SYMBOL|DICTIONARY	ink4a	INK4A	90#95		D008545	LONGTERM|DICTIONARY	melanoma	melanoma	61#69		Subjects completed a questionnaire covering risk factors for melanoma and were tested for INK4A mutations.
12915675	2003	J. Clin. Endocrinol. Metab.	0021-972X	ALL_TEXT_2/3	2	6	4353	SYMBOL|DICTIONARY|EXTRACTED	mpo	MPO	125#128	12915675-1-0-15	D050197	LONGTERM|DICTIONARY	atherosclerosis	atherosclerosis	4#19		The atherosclerosis severity score (ASC) for abdominal aorta and carotid arteries was determined by ultrasonography, and the MPO genotype was analyzed.
17690944	2008	J Neural Transm (Vienna)	0300-9564	ALL_TEXT_3/3	3	7	6531	LONGTERM|DICTIONARY	dopamine transporter	dopamine transporter	53#73		D008881	LONGTERM|DICTIONARY	migraine	migraine	120#128		We conclude that functional genetic variation in the dopamine transporter does not act as a significant risk factor for migraine.
17690944	2008	J Neural Transm (Vienna)	0300-9564	ALL_TEXT_3/3	3	6	6531	LONGTERM|DICTIONARY	dopamine transporter	dopamine transporter	94#114		D008881	LONGTERM|DICTIONARY	migraine	migraine	20#28		Finally we examined migraine with and without aura, and likewise found no association between dopamine transporter VNTRs or their haplotypes and either classification of the disease.
17690944	2008	J Neural Transm (Vienna)	0300-9564	TITLE	0	0	6531	LONGTERM|GENE|GN|DICTIONARY	dopamine transporter	dopamine transporter	74#94		D008881	LONGTERM|DICTIONARY	migraine	migraine	103#111		Family-based association analysis of functional VNTR polymorphisms in the dopamine transporter gene in migraine with and without aura.
15635591	2005	Am. J. Med. Genet. B Neuropsychiatr. Genet.	1552-4841	ALL_TEXT_3/3	3	6	3569	SYMBOL|DICTIONARY|EXTRACTED	il 6	IL-6	29#33	15635591-1-29-42	D010300	SYMBOL|EXTRACTED	pd	PD	120#122	15635591-1-180-199	When the GG genotypes of the IL-6 and ERbeta SNPs were combined, the combination was much more robustly associated with PD, and especially with PD with an early age of onset, than respective GG genotype when analyzed separately.
15635591	2005	Am. J. Med. Genet. B Neuropsychiatr. Genet.	1552-4841	ALL_TEXT_3/3	3	6	3569	SYMBOL|DICTIONARY|EXTRACTED	il 6	IL-6	29#33	15635591-1-29-42	D010300	SYMBOL|EXTRACTED	pd	PD	144#146	15635591-1-180-199	When the GG genotypes of the IL-6 and ERbeta SNPs were combined, the combination was much more robustly associated with PD, and especially with PD with an early age of onset, than respective GG genotype when analyzed separately.
15635591	2005	Am. J. Med. Genet. B Neuropsychiatr. Genet.	1552-4841	ALL_TEXT_3/3	3	6	2100	SYMBOL|EXTRACTED	erbeta	ERbeta	38#44	15635591-3-139-161	D010300	SYMBOL|EXTRACTED	pd	PD	120#122	15635591-1-180-199	When the GG genotypes of the IL-6 and ERbeta SNPs were combined, the combination was much more robustly associated with PD, and especially with PD with an early age of onset, than respective GG genotype when analyzed separately.
15635591	2005	Am. J. Med. Genet. B Neuropsychiatr. Genet.	1552-4841	ALL_TEXT_3/3	3	6	2100	SYMBOL|EXTRACTED	erbeta	ERbeta	38#44	15635591-3-139-161	D010300	SYMBOL|EXTRACTED	pd	PD	144#146	15635591-1-180-199	When the GG genotypes of the IL-6 and ERbeta SNPs were combined, the combination was much more robustly associated with PD, and especially with PD with an early age of onset, than respective GG genotype when analyzed separately.
15635591	2005	Am. J. Med. Genet. B Neuropsychiatr. Genet.	1552-4841	ALL_TEXT_3/3	3	7	3569	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	il 6	IL-6	48#52	15635591-1-29-42	D010300	SYMBOL|EXTRACTED	pd	PD	100#102	15635591-1-180-199	Our results indicate that the G-174C SNP in the IL-6 promoter may influence the risk for developing PD, particularly regarding early age of onset PD, and that the effect is modified by interaction of the G-1730A SNP in the ERbeta gene.
15635591	2005	Am. J. Med. Genet. B Neuropsychiatr. Genet.	1552-4841	ALL_TEXT_3/3	3	7	3569	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	il 6	IL-6	48#52	15635591-1-29-42	D010300	SYMBOL|EXTRACTED	pd	PD	146#148	15635591-1-180-199	Our results indicate that the G-174C SNP in the IL-6 promoter may influence the risk for developing PD, particularly regarding early age of onset PD, and that the effect is modified by interaction of the G-1730A SNP in the ERbeta gene.
15635591	2005	Am. J. Med. Genet. B Neuropsychiatr. Genet.	1552-4841	ALL_TEXT_3/3	3	7	2100	SYMBOL|EXTRACTED|GENE|GN	erbeta	ERbeta	223#229	15635591-3-139-161	D010300	SYMBOL|EXTRACTED	pd	PD	100#102	15635591-1-180-199	Our results indicate that the G-174C SNP in the IL-6 promoter may influence the risk for developing PD, particularly regarding early age of onset PD, and that the effect is modified by interaction of the G-1730A SNP in the ERbeta gene.
15635591	2005	Am. J. Med. Genet. B Neuropsychiatr. Genet.	1552-4841	ALL_TEXT_3/3	3	7	2100	SYMBOL|EXTRACTED|GENE|GN	erbeta	ERbeta	223#229	15635591-3-139-161	D010300	SYMBOL|EXTRACTED	pd	PD	146#148	15635591-1-180-199	Our results indicate that the G-174C SNP in the IL-6 promoter may influence the risk for developing PD, particularly regarding early age of onset PD, and that the effect is modified by interaction of the G-1730A SNP in the ERbeta gene.
15635591	2005	Am. J. Med. Genet. B Neuropsychiatr. Genet.	1552-4841	ALL_TEXT_2/3	2	4	3569	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	il 6	IL-6	81#85	15635591-1-29-42	D010300	SYMBOL|EXTRACTED	pd	PD	176#178	15635591-1-180-199	To investigate the influence of a G/C SNP at position 174 in the promoter of the IL-6 gene, and the possible interaction of this SNP and the ERbeta G-1730A SNP on the risk for PD, the G-174C SNP was genotyped, by pyrosequencing, in 258 patients with PD and 308 controls.
15635591	2005	Am. J. Med. Genet. B Neuropsychiatr. Genet.	1552-4841	ALL_TEXT_2/3	2	4	3569	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	il 6	IL-6	81#85	15635591-1-29-42	D010300	SYMBOL|EXTRACTED	pd	PD	250#252	15635591-1-180-199	To investigate the influence of a G/C SNP at position 174 in the promoter of the IL-6 gene, and the possible interaction of this SNP and the ERbeta G-1730A SNP on the risk for PD, the G-174C SNP was genotyped, by pyrosequencing, in 258 patients with PD and 308 controls.
15635591	2005	Am. J. Med. Genet. B Neuropsychiatr. Genet.	1552-4841	ALL_TEXT_2/3	2	4	2100	SYMBOL|EXTRACTED	erbeta	ERbeta	141#147	15635591-3-139-161	D010300	SYMBOL|EXTRACTED	pd	PD	176#178	15635591-1-180-199	To investigate the influence of a G/C SNP at position 174 in the promoter of the IL-6 gene, and the possible interaction of this SNP and the ERbeta G-1730A SNP on the risk for PD, the G-174C SNP was genotyped, by pyrosequencing, in 258 patients with PD and 308 controls.
15635591	2005	Am. J. Med. Genet. B Neuropsychiatr. Genet.	1552-4841	ALL_TEXT_2/3	2	4	2100	SYMBOL|EXTRACTED	erbeta	ERbeta	141#147	15635591-3-139-161	D010300	SYMBOL|EXTRACTED	pd	PD	250#252	15635591-1-180-199	To investigate the influence of a G/C SNP at position 174 in the promoter of the IL-6 gene, and the possible interaction of this SNP and the ERbeta G-1730A SNP on the risk for PD, the G-174C SNP was genotyped, by pyrosequencing, in 258 patients with PD and 308 controls.
15635591	2005	Am. J. Med. Genet. B Neuropsychiatr. Genet.	1552-4841	ALL_TEXT_3/3	3	5	3569	SYMBOL|DICTIONARY|EXTRACTED	il 6	IL-6	61#65	15635591-1-29-42	D010300	SYMBOL|EXTRACTED	pd	PD	186#188	15635591-1-180-199	A significantly elevated frequency of the GG genotype of the IL-6 SNP was found in the patient group and this was most obvious among patients with an early age of onset (</=50 years) of PD.
15635591	2005	Am. J. Med. Genet. B Neuropsychiatr. Genet.	1552-4841	ALL_TEXT_2/3	2	3	2100	SYMBOL|EXTRACTED|()	erbeta	ERbeta	163#169	15635591-3-139-161	D010300	SYMBOL|EXTRACTED	pd	PD	191#193	15635591-1-180-199	In a previous study, we reported an association between a G/A single nucleotide polymorphism (SNP) at position 1730 in the gene coding for estrogen receptor beta (ERbeta) and age of onset of PD.
15635591	2005	Am. J. Med. Genet. B Neuropsychiatr. Genet.	1552-4841	TITLE	0	0	3569	LONGTERM|DICTIONARY	interleukin 6	interleukin-6	51#64		D010300	LONGTERM|DISEASE|DT|DICTIONARY	parkinson disease	Parkinson's disease	117#136		Interaction of polymorphisms in the genes encoding interleukin-6 and estrogen receptor beta on the susceptibility to Parkinson's disease.
15635591	2005	Am. J. Med. Genet. B Neuropsychiatr. Genet.	1552-4841	ALL_TEXT_1/3	1	1	3569	LONGTERM|DICTIONARY	interleukin 6	interleukin-6	29#42		D010300	LONGTERM|DICTIONARY	parkinson disease	Parkinson's disease	180#199		The multifunctional cytokine interleukin-6 (IL-6) is involved in inflammatory processes in the central nervous system and increased levels of IL-6 have been found in patients with Parkinson's disease (PD).
15635591	2005	Am. J. Med. Genet. B Neuropsychiatr. Genet.	1552-4841	ALL_TEXT_1/3	1	1	3569	LONGTERM|DICTIONARY	interleukin 6	interleukin-6	29#42		D010300	SYMBOL|EXTRACTED|()	pd	PD	201#203	15635591-1-180-199	The multifunctional cytokine interleukin-6 (IL-6) is involved in inflammatory processes in the central nervous system and increased levels of IL-6 have been found in patients with Parkinson's disease (PD).
15635591	2005	Am. J. Med. Genet. B Neuropsychiatr. Genet.	1552-4841	ALL_TEXT_1/3	1	1	3569	SYMBOL|()|DICTIONARY|EXTRACTED	il 6	IL-6	44#48	15635591-1-29-42	D010300	LONGTERM|DICTIONARY	parkinson disease	Parkinson's disease	180#199		The multifunctional cytokine interleukin-6 (IL-6) is involved in inflammatory processes in the central nervous system and increased levels of IL-6 have been found in patients with Parkinson's disease (PD).
15635591	2005	Am. J. Med. Genet. B Neuropsychiatr. Genet.	1552-4841	ALL_TEXT_1/3	1	1	3569	SYMBOL|()|DICTIONARY|EXTRACTED	il 6	IL-6	44#48	15635591-1-29-42	D010300	SYMBOL|EXTRACTED|()	pd	PD	201#203	15635591-1-180-199	The multifunctional cytokine interleukin-6 (IL-6) is involved in inflammatory processes in the central nervous system and increased levels of IL-6 have been found in patients with Parkinson's disease (PD).
15635591	2005	Am. J. Med. Genet. B Neuropsychiatr. Genet.	1552-4841	ALL_TEXT_1/3	1	1	3569	SYMBOL|DICTIONARY|EXTRACTED	il 6	IL-6	142#146	15635591-1-29-42	D010300	LONGTERM|DICTIONARY	parkinson disease	Parkinson's disease	180#199		The multifunctional cytokine interleukin-6 (IL-6) is involved in inflammatory processes in the central nervous system and increased levels of IL-6 have been found in patients with Parkinson's disease (PD).
15635591	2005	Am. J. Med. Genet. B Neuropsychiatr. Genet.	1552-4841	ALL_TEXT_1/3	1	1	3569	SYMBOL|DICTIONARY|EXTRACTED	il 6	IL-6	142#146	15635591-1-29-42	D010300	SYMBOL|EXTRACTED|()	pd	PD	201#203	15635591-1-180-199	The multifunctional cytokine interleukin-6 (IL-6) is involved in inflammatory processes in the central nervous system and increased levels of IL-6 have been found in patients with Parkinson's disease (PD).
19996333	2010	Thorax	1468-3296	BACKGROUND	1	2	4843	SYMBOL|DICTIONARY	nos2a	NOS2A	92#97		D001249	LONGTERM|DICTIONARY	asthma	asthma	118#124		Because nitrosative stress affects respiratory health, it was hypothesised that variants in NOS2A are associated with asthma incidence and lung function growth during adolescence.
12484521	2003	Hypertens. Res.	0916-9636	ALL_TEXT_3/3	3	7	5327	LONGTERM|DICTIONARY	t-pa	t-PA	61#65	NaN	D006973	LONGTERM|DICTIONARY	hypertension	hypertension	86#98		There was no evidence of an association between the level of t-PA antigen and risk of hypertension.
12484521	2003	Hypertens. Res.	0916-9636	ALL_TEXT_2/3	2	4	5327	SYMBOL|GENE|GN|DICTIONARY	t pa	t-PA	57#61		D006973	LONGTERM|DICTIONARY	hypertensive	hypertensive	70#82	NaN	The distributions of the II, ID, and DD genotypes of the t-PA gene in hypertensive patients (0.15, 0.49, 0.36) were similar to those in control subjects (0.11, 0.51, 0.38; p = 0.626).
12928685	2003	Eye (Lond)	0950-222X	CONCLUSION	4	11	2153	LONGTERM|DICTIONARY	factor v leiden	factor V Leiden	22#37		D015356	LONGTERM|DICTIONARY	retinal artery occlusion	retinal artery occlusion	103#127		Our data suggest that factor V Leiden and prothrombin 20210A do not play a major role in patients with retinal artery occlusion.
20237592	2010	Can. J. Physiol. Pharmacol.	1205-7541	ALL_TEXT_3/3	3	9	1392	LONGTERM|GENE|GT|DICTIONARY	corticotropin releasing factor	corticotropin-releasing factor	22#52		D007020	LONGTERM|DICTIONARY	corticotropin-releasing factor	corticotropin-releasing factor	22#52	NaN	Pretreatment with the corticotropin-releasing factor (CRF) blocker astressin and the extracellular signal-regulated kinase 1/2 (ERK1/2) pathway blocker PD98059 abolished these effects of Ucn.
20237592	2010	Can. J. Physiol. Pharmacol.	1205-7541	ALL_TEXT_3/3	3	9	1392	SYMBOL|()|DICTIONARY|EXTRACTED	crf	CRF	54#57	20237592-9-22-52	D007020	LONGTERM|DICTIONARY	corticotropin-releasing factor	corticotropin-releasing factor	22#52	NaN	Pretreatment with the corticotropin-releasing factor (CRF) blocker astressin and the extracellular signal-regulated kinase 1/2 (ERK1/2) pathway blocker PD98059 abolished these effects of Ucn.
20237592	2010	Can. J. Physiol. Pharmacol.	1205-7541	ALL_TEXT_3/3	3	9	7349	SYMBOL|EXTRACTED	ucn	Ucn	187#190	20237592-1-28-37	D007020	LONGTERM|DICTIONARY	corticotropin-releasing factor	corticotropin-releasing factor	22#52	NaN	Pretreatment with the corticotropin-releasing factor (CRF) blocker astressin and the extracellular signal-regulated kinase 1/2 (ERK1/2) pathway blocker PD98059 abolished these effects of Ucn.
20237592	2010	Can. J. Physiol. Pharmacol.	1205-7541	ALL_TEXT_3/3	3	9	5594	LONGTERM|NUMBER|DICTIONARY	extracellular signal-regulated kinase 1/2	extracellular signal-regulated kinase 1/2	85#126		D007020	LONGTERM|DICTIONARY	corticotropin-releasing factor	corticotropin-releasing factor	22#52	NaN	Pretreatment with the corticotropin-releasing factor (CRF) blocker astressin and the extracellular signal-regulated kinase 1/2 (ERK1/2) pathway blocker PD98059 abolished these effects of Ucn.
20237592	2010	Can. J. Physiol. Pharmacol.	1205-7541	ALL_TEXT_3/3	3	9	5595	LONGTERM|NUMBER|DICTIONARY	extracellular signal-regulated kinase 1/2	extracellular signal-regulated kinase 1/2	85#126		D007020	LONGTERM|DICTIONARY	corticotropin-releasing factor	corticotropin-releasing factor	22#52	NaN	Pretreatment with the corticotropin-releasing factor (CRF) blocker astressin and the extracellular signal-regulated kinase 1/2 (ERK1/2) pathway blocker PD98059 abolished these effects of Ucn.
20237592	2010	Can. J. Physiol. Pharmacol.	1205-7541	ALL_TEXT_3/3	3	9	5594	SYMBOL|NUMBER|DICTIONARY	erk1/2	ERK1/2	128#134		D007020	LONGTERM|DICTIONARY	corticotropin-releasing factor	corticotropin-releasing factor	22#52	NaN	Pretreatment with the corticotropin-releasing factor (CRF) blocker astressin and the extracellular signal-regulated kinase 1/2 (ERK1/2) pathway blocker PD98059 abolished these effects of Ucn.
20237592	2010	Can. J. Physiol. Pharmacol.	1205-7541	ALL_TEXT_3/3	3	9	5595	SYMBOL|NUMBER|DICTIONARY	erk1/2	ERK1/2	128#134		D007020	LONGTERM|DICTIONARY	corticotropin-releasing factor	corticotropin-releasing factor	22#52	NaN	Pretreatment with the corticotropin-releasing factor (CRF) blocker astressin and the extracellular signal-regulated kinase 1/2 (ERK1/2) pathway blocker PD98059 abolished these effects of Ucn.
20237592	2010	Can. J. Physiol. Pharmacol.	1205-7541	ALL_TEXT_3/3	3	8	7349	SYMBOL|EXTRACTED	ucn	Ucn	104#107	20237592-1-28-37	D007022	LONGTERM|DICTIONARY	decrease of the systolic blood pressure	decrease of the systolic blood pressure	25#64		Meanwhile, a significant decrease of the systolic blood pressure (SBP) was observed after the long-term Ucn administration, and there was a significant positive correlation (r2 = 0.6993) between serum ACE activity and SBP.
20237592	2010	Can. J. Physiol. Pharmacol.	1205-7541	ALL_TEXT_3/3	3	8	1636	SYMBOL|DICTIONARY|EXTRACTED	ace	ACE	201#204	20237592-1-91-120	D007022	LONGTERM|DICTIONARY	decrease of the systolic blood pressure	decrease of the systolic blood pressure	25#64		Meanwhile, a significant decrease of the systolic blood pressure (SBP) was observed after the long-term Ucn administration, and there was a significant positive correlation (r2 = 0.6993) between serum ACE activity and SBP.
18588668	2008	BMC Gastroenterol	1471-230X	CONCLUSION	4	7	10891	SYMBOL|DICTIONARY	ppargc1a	PPARGC1A	28#36		D065626	LONGTERM|DICTIONARY|EXTRACTED	nafld	NAFLD	154#159	18588668-0-65-97	This finding suggested that PPARGC1A polymorphism and lower expression of PPARGC1A mRNA in the liver are an important genetic contribution to etiology of NAFLD.
18588668	2008	BMC Gastroenterol	1471-230X	CONCLUSION	4	7	10891	SYMBOL|GFAM|FN|DICTIONARY	ppargc1a	PPARGC1A	74#82		D065626	LONGTERM|DICTIONARY|EXTRACTED	nafld	NAFLD	154#159	18588668-0-65-97	This finding suggested that PPARGC1A polymorphism and lower expression of PPARGC1A mRNA in the liver are an important genetic contribution to etiology of NAFLD.
18588668	2008	BMC Gastroenterol	1471-230X	CONCLUSION	4	6	10891	SYMBOL|DICTIONARY	ppargc1a	PPARGC1A	95#103		D065626	LONGTERM|DICTIONARY|EXTRACTED	nafld	NAFLD	108#113	18588668-0-65-97	This is the first study to demonstrate a significant association between genetic variations in PPARGC1A and NAFLD.
18588668	2008	BMC Gastroenterol	1471-230X	BACKGROUND	1	1	10891	SYMBOL|()|DICTIONARY	ppargc1a	PPARGC1A	246#254		D065626	LONGTERM|DICTIONARY|EXTRACTED	nafld	NAFLD	85#90	18588668-0-65-97	Genetic factors as well as environmental factors are important in the development of NAFLD and in this study we investigated associations between polymorphisms of peroxisome proliferators-activated receptor gamma coactivator 1alpha polymorphism (PPARGC1A) and NAFLD.
18588668	2008	BMC Gastroenterol	1471-230X	BACKGROUND	1	1	10891	SYMBOL|()|DICTIONARY	ppargc1a	PPARGC1A	246#254		D065626	LONGTERM|DICTIONARY|EXTRACTED	nafld	NAFLD	260#265	18588668-0-65-97	Genetic factors as well as environmental factors are important in the development of NAFLD and in this study we investigated associations between polymorphisms of peroxisome proliferators-activated receptor gamma coactivator 1alpha polymorphism (PPARGC1A) and NAFLD.
18588668	2008	BMC Gastroenterol	1471-230X	TITLE	0	0	10891	SYMBOL|DICTIONARY	ppargc1a	PPARGC1A	20#28		D065626	LONGTERM|DICTIONARY	nonalcoholic fatty liver disease	nonalcoholic fatty liver disease	65#97		Association between PPARGC1A polymorphisms and the occurrence of nonalcoholic fatty liver disease (NAFLD).
18588668	2008	BMC Gastroenterol	1471-230X	TITLE	0	0	10891	SYMBOL|DICTIONARY	ppargc1a	PPARGC1A	20#28		D065626	LONGTERM|()|DICTIONARY|EXTRACTED	nafld	NAFLD	99#104	18588668-0-65-97	Association between PPARGC1A polymorphisms and the occurrence of nonalcoholic fatty liver disease (NAFLD).
11463752	2001	Hypertension	1524-4563	ALL_TEXT_1/3	1	4	133	SYMBOL|EXTRACTED|GENE|GN	am	AM	73#75	11463752-1-0-14	D006973	LONGTERM|DICTIONARY	hypertension	hypertension	107#119		In this study, we investigated the association between DNA variations in AM gene and the predisposition to hypertension.
18588668	2008	BMC Gastroenterol	1471-230X	AIMS	2	2	10891	SYMBOL|DICTIONARY	ppargc1a	PPARGC1A	156#164		D065626	LONGTERM|NUMBER|DICTIONARY|EXTRACTED	nafld	NAFLD	45#50	18588668-0-65-97	We recruited 115 patients with biopsy-proven NAFLD, 65 with NASH and 50 with simple steatosis, and 441 healthy control subjects and investigated 15 SNPs of PPARGC1A.
18588668	2008	BMC Gastroenterol	1471-230X	AIMS	2	2	10891	SYMBOL|DICTIONARY	ppargc1a	PPARGC1A	156#164		D005234	LONGTERM|DICTIONARY	steatosis	steatosis	84#93		We recruited 115 patients with biopsy-proven NAFLD, 65 with NASH and 50 with simple steatosis, and 441 healthy control subjects and investigated 15 SNPs of PPARGC1A.
19753311	2009	Mol. Vis.	1090-0535	PURPOSE	1	3	1128	SYMBOL|()|DICTIONARY	chrm1	CHRM1	154#159		D009216	LONGTERM|DICTIONARY	high myopia	high myopia	70#81		Our specific aim in this study was to examine the association between high myopia and polymorphisms within the muscarinic acetylcholine receptors 1 gene (CHRM1).
17241880	2007	Gastroenterology	0016-5085	BACKGROUND &amp; AIMS	1	2	7036	SYMBOL|DICTIONARY|EXTRACTED	tfr2	TfR2	13#17	17241880-1-0-22	D006432	LONGTERM|DICTIONARY	hereditary hemochromatosis	hereditary hemochromatosis	41#67		Mutations of TfR2 in humans cause type 3 hereditary hemochromatosis.
10889552	2000	Mol. Psychiatry	1359-4184	ALL_TEXT_1/3	1	4	1544	SYMBOL|DICTIONARY|EXTRACTED	cyp1a2	CYP1A2	57#63	10889552-0-33-52	D004409	SYMBOL|EXTRACTED	td	TD	131#133	10889552-1-0-18	Therefore, person-to-person differences in the extent of CYP1A2 induction by smoking may contribute to risk for the development of TD.
16322490	2006	Stroke	1524-4628	CONCLUSIONS	4	10	7124	LONGTERM|DICTIONARY	tnf-alpha	TNF-alpha	2#11	NaN	D020300	SYMBOL|DICTIONARY|EXTRACTED	ich	ICH	58#61	16322490-1-95-118	A TNF-alpha SNP was associated with increased risk of new ICH in the natural course of BAVMs.
10889552	2000	Mol. Psychiatry	1359-4184	ALL_TEXT_2/3	2	7	1544	SYMBOL|DICTIONARY|EXTRACTED	cyp1a2	CYP1A2	190#196	10889552-0-33-52	D012559	LONGTERM|DICTIONARY	schizophrenia	schizophrenia	28#41		A total of 85 patients with schizophrenia were assessed for TD severity using the Abnormal Involuntary Movement Scale (AIMS), and were subsequently genotyped for the (C-->A) polymorphism in CYP1A2.
10889552	2000	Mol. Psychiatry	1359-4184	ALL_TEXT_2/3	2	7	1544	SYMBOL|DICTIONARY|EXTRACTED	cyp1a2	CYP1A2	190#196	10889552-0-33-52	D004409	SYMBOL|EXTRACTED	td	TD	60#62	10889552-1-0-18	A total of 85 patients with schizophrenia were assessed for TD severity using the Abnormal Involuntary Movement Scale (AIMS), and were subsequently genotyped for the (C-->A) polymorphism in CYP1A2.
10889552	2000	Mol. Psychiatry	1359-4184	ALL_TEXT_2/3	2	7	1544	SYMBOL|DICTIONARY|EXTRACTED	cyp1a2	CYP1A2	190#196	10889552-0-33-52	D004409	LONGTERM|DICTIONARY	abnormal involuntary movement	Abnormal Involuntary Movement	82#111		A total of 85 patients with schizophrenia were assessed for TD severity using the Abnormal Involuntary Movement Scale (AIMS), and were subsequently genotyped for the (C-->A) polymorphism in CYP1A2.
12800193	2003	Int. J. Cancer	0020-7136	ALL_TEXT_1/3	1	2	3845	LONGTERM|DICTIONARY	ki-ras	ki-ras	219#225	NaN	D003110	LONGTERM|DICTIONARY	colon carcinogenesis	colon carcinogenesis	181#201		To characterize the CC531 model at the molecular level, we screened for mutations in genes covering important signal-transduction pathways that are known to play major roles during colon carcinogenesis, the wnt and the ki-ras signaling pathways.
21110240	2011	Swiss Med Wkly	1424-3997	PRINCIPLES	1	4	348	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	apoe	APOE	91#95	21110240-2-4-8	D020528	SYMBOL|EXTRACTED	primary progressive ms	primary progressive MS	126#148	21110240-3-0-18	The aim of this study was to assess (multicentre assessment) the possible influence of the APOE gene on the susceptibility of primary progressive MS (PPMS) in Hungary.
16687442	2006	Hum. Mol. Genet.	0964-6906	ALL_TEXT_3/3	3	10	842	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	casp 9	CASP-9	27#33	16687442-1-0-9	D008175	LONGTERM|DISEASE|DT|DICTIONARY	lung cancer	lung cancer	126#137		These results suggest that CASP-9 promoter polymorphisms affect CASP-9 expression and contribute to genetic susceptibility to lung cancer.
16687442	2006	Hum. Mol. Genet.	0964-6906	ALL_TEXT_3/3	3	10	842	SYMBOL|DICTIONARY|EXTRACTED	casp 9	CASP-9	64#70	16687442-1-0-9	D008175	LONGTERM|DISEASE|DT|DICTIONARY	lung cancer	lung cancer	126#137		These results suggest that CASP-9 promoter polymorphisms affect CASP-9 expression and contribute to genetic susceptibility to lung cancer.
21966456	2012	PLoS ONE	1932-6203	BACKGROUND	1	2	5733	SYMBOL|EXTRACTED	ep3	EP3	22#25	21966456-1-249-275	D007249	LONGTERM|DICTIONARY	inflammation	inflammation	201#213	NaN	We also reported that EP3 is dominantly expressed in the ocular surface-, especially the conjunctival epithelium, and suggested that EP3 in the conjunctival epithelium may down-regulate ocular surface inflammation.
21966456	2012	PLoS ONE	1932-6203	BACKGROUND	1	2	5733	SYMBOL|EXTRACTED	ep3	EP3	133#136	21966456-1-249-275	D007249	LONGTERM|DICTIONARY	inflammation	inflammation	201#213	NaN	We also reported that EP3 is dominantly expressed in the ocular surface-, especially the conjunctival epithelium, and suggested that EP3 in the conjunctival epithelium may down-regulate ocular surface inflammation.
20350254	2010	Ann. Med.	1365-2060	CONCLUSIONS	4	9	3606	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	il 18	IL-18	50#55	20350254-1-0-14	D050197	LONGTERM|DICTIONARY	atherosclerosis	atherosclerosis	107#122		Among all study subjects, the polymorphism of the IL-18 gene is not associated with subclinical markers of atherosclerosis.
20564317	2010	Prostate	1097-0045	BACKGROUND	1	1	4524	LONGTERM|DICTIONARY|GENE|GA	methylenetetrahydrofolate reductase	methylenetetrahydrofolate reductase	46#81		D011471	LONGTERM|DISEASE|DT|DICTIONARY	prostate cancer	prostate cancer	115#130		We hypothesized that genetic polymorphisms in methylenetetrahydrofolate reductase (MTHFR) gene are associated with prostate cancer risk.
20564317	2010	Prostate	1097-0045	BACKGROUND	1	1	4524	SYMBOL|()|GENE|GN|DICTIONARY|EXTRACTED	mthfr	MTHFR	83#88	20564317-1-46-81	D011471	LONGTERM|DISEASE|DT|DICTIONARY	prostate cancer	prostate cancer	115#130		We hypothesized that genetic polymorphisms in methylenetetrahydrofolate reductase (MTHFR) gene are associated with prostate cancer risk.
19276544	2009	J. Alzheimers Dis.	1387-2877	ALL_TEXT_1/3	1	1	9846	SYMBOL|()|GENE|GN|DICTIONARY	gab2	GAB2	75#79		D000544	LONGTERM|DISEASE|DT|DICTIONARY	alzheimer disease	Alzheimer's disease	143#162		A common polymorphism (rs2373115) in the GRB-associated binding protein 2 (GAB2) gene has been recently associated with the risk of developing Alzheimer's disease (AD) in 644 apolipoprotein E (ApoE) epsilon4 carriers.
19276544	2009	J. Alzheimers Dis.	1387-2877	ALL_TEXT_1/3	1	1	9846	SYMBOL|()|GENE|GN|DICTIONARY	gab2	GAB2	75#79		D000544	SYMBOL|EXTRACTED|()	ad	AD	164#166	19276544-1-143-162	A common polymorphism (rs2373115) in the GRB-associated binding protein 2 (GAB2) gene has been recently associated with the risk of developing Alzheimer's disease (AD) in 644 apolipoprotein E (ApoE) epsilon4 carriers.
19276544	2009	J. Alzheimers Dis.	1387-2877	ALL_TEXT_1/3	1	1	348	LONGTERM|DICTIONARY	apolipoprotein e	apolipoprotein E	175#191		D000544	LONGTERM|DISEASE|DT|DICTIONARY	alzheimer disease	Alzheimer's disease	143#162		A common polymorphism (rs2373115) in the GRB-associated binding protein 2 (GAB2) gene has been recently associated with the risk of developing Alzheimer's disease (AD) in 644 apolipoprotein E (ApoE) epsilon4 carriers.
19276544	2009	J. Alzheimers Dis.	1387-2877	ALL_TEXT_1/3	1	1	348	LONGTERM|DICTIONARY	apolipoprotein e	apolipoprotein E	175#191		D000544	SYMBOL|EXTRACTED|()	ad	AD	164#166	19276544-1-143-162	A common polymorphism (rs2373115) in the GRB-associated binding protein 2 (GAB2) gene has been recently associated with the risk of developing Alzheimer's disease (AD) in 644 apolipoprotein E (ApoE) epsilon4 carriers.
19276544	2009	J. Alzheimers Dis.	1387-2877	ALL_TEXT_1/3	1	1	348	SYMBOL|EXTRACTED|()	apoe	ApoE	193#197	19276544-1-175-191	D000544	LONGTERM|DISEASE|DT|DICTIONARY	alzheimer disease	Alzheimer's disease	143#162		A common polymorphism (rs2373115) in the GRB-associated binding protein 2 (GAB2) gene has been recently associated with the risk of developing Alzheimer's disease (AD) in 644 apolipoprotein E (ApoE) epsilon4 carriers.
19276544	2009	J. Alzheimers Dis.	1387-2877	ALL_TEXT_1/3	1	1	348	SYMBOL|EXTRACTED|()	apoe	ApoE	193#197	19276544-1-175-191	D000544	SYMBOL|EXTRACTED|()	ad	AD	164#166	19276544-1-143-162	A common polymorphism (rs2373115) in the GRB-associated binding protein 2 (GAB2) gene has been recently associated with the risk of developing Alzheimer's disease (AD) in 644 apolipoprotein E (ApoE) epsilon4 carriers.
19276544	2009	J. Alzheimers Dis.	1387-2877	ALL_TEXT_1/3	1	1	9846	SYMBOL|DICTIONARY	grb-associated binding protein 2	GRB-associated binding protein 2	41#73		D000544	LONGTERM|DISEASE|DT|DICTIONARY	alzheimer disease	Alzheimer's disease	143#162		A common polymorphism (rs2373115) in the GRB-associated binding protein 2 (GAB2) gene has been recently associated with the risk of developing Alzheimer's disease (AD) in 644 apolipoprotein E (ApoE) epsilon4 carriers.
19276544	2009	J. Alzheimers Dis.	1387-2877	ALL_TEXT_1/3	1	1	9846	SYMBOL|DICTIONARY	grb-associated binding protein 2	GRB-associated binding protein 2	41#73		D000544	SYMBOL|EXTRACTED|()	ad	AD	164#166	19276544-1-143-162	A common polymorphism (rs2373115) in the GRB-associated binding protein 2 (GAB2) gene has been recently associated with the risk of developing Alzheimer's disease (AD) in 644 apolipoprotein E (ApoE) epsilon4 carriers.
16219118	2006	Psychol Med	0033-2917	TITLE	0	0	3084	LONGTERM|DICTIONARY	neuregulin 1	Neuregulin 1	0#12		D012559	LONGTERM|DICTIONARY	schizophrenia	schizophrenia	25#38		Neuregulin 1 (NRG1 ) and schizophrenia: analysis of a US family sample and the evidence in the balance.
16219118	2006	Psychol Med	0033-2917	TITLE	0	0	3084	SYMBOL|DICTIONARY	nrg1	NRG1	14#18		D012559	LONGTERM|DICTIONARY	schizophrenia	schizophrenia	25#38		Neuregulin 1 (NRG1 ) and schizophrenia: analysis of a US family sample and the evidence in the balance.
20485448	2010	J. Hum. Genet.	1435-232X	TITLE	0	0	4210	SYMBOL|DICTIONARY	mefv	MEFV	143#147		D010505	LONGTERM|DICTIONARY	familial mediterranean fever	familial Mediterranean fever	71#99		Genotype-phenotype studies in a large cohort of Armenian patients with familial Mediterranean fever suggest clinical disease with heterozygous MEFV mutations.
18340109	2008	Dement Geriatr Cogn Disord	1421-9824	ALL_TEXT_3/3	3	8	348	SYMBOL|DICTIONARY	apoe4	APOE4	89#94		D000544	LONGTERM|DICTIONARY	ad	AD	62#64	NaN	Also, the specific haplotypes with the A allele that increase AD risk differ between the APOE4-positive and APOE4-negative pools.
18340109	2008	Dement Geriatr Cogn Disord	1421-9824	ALL_TEXT_3/3	3	8	348	SYMBOL|DICTIONARY	apoe4	APOE4	108#113		D000544	LONGTERM|DICTIONARY	ad	AD	62#64	NaN	Also, the specific haplotypes with the A allele that increase AD risk differ between the APOE4-positive and APOE4-negative pools.
17932345	2008	Cancer Epidemiol. Biomarkers Prev.	1055-9965	METHODS	2	8	10333	SYMBOL|DICTIONARY	tlr6	TLR6	117#121		D011471	LONGTERM|DISEASE|DT|DICTIONARY	prostate cancer	prostate cancer	205#220		We genotyped 19 common (>5%) haplotype-tagging SNPs chosen from the SNPs discovered in a resequencing study spanning TLR6, TLR1, and TLR10 to test for the association between sequence variants cluster and prostate cancer.
17932345	2008	Cancer Epidemiol. Biomarkers Prev.	1055-9965	METHODS	2	8	7096	SYMBOL|DICTIONARY	tlr1	TLR1	123#127		D011471	LONGTERM|DISEASE|DT|DICTIONARY	prostate cancer	prostate cancer	205#220		We genotyped 19 common (>5%) haplotype-tagging SNPs chosen from the SNPs discovered in a resequencing study spanning TLR6, TLR1, and TLR10 to test for the association between sequence variants cluster and prostate cancer.
17932345	2008	Cancer Epidemiol. Biomarkers Prev.	1055-9965	METHODS	2	8	81793	SYMBOL|DICTIONARY	tlr10	TLR10	133#138		D011471	LONGTERM|DISEASE|DT|DICTIONARY	prostate cancer	prostate cancer	205#220		We genotyped 19 common (>5%) haplotype-tagging SNPs chosen from the SNPs discovered in a resequencing study spanning TLR6, TLR1, and TLR10 to test for the association between sequence variants cluster and prostate cancer.
17036313	2007	Am. J. Med. Genet. A	1552-4825	ALL_TEXT_3/3	3	10	2706	LONGTERM|DICTIONARY	connexin 26	connexin 26	253#264		D034381	LONGTERM|DICTIONARY	hearing loss	hearing loss	206#218	NaN	These results indicate that (1) the V37I allele is common in individuals of Chinese descent but rarely present in individuals of Caucasian decent; and (2) the V37I allele is pathogenic, but produces milder hearing loss compared to nonsense mutations of connexin 26 such as the 35delG mutation.
18340109	2008	Dement Geriatr Cogn Disord	1421-9824	TITLE	0	0	29979	SYMBOL|DICTIONARY|EXTRACTED	ubqln1	UBQLN1	12#18		D000544	LONGTERM|DISEASE|DN|DT|DICTIONARY	alzheimer disease	Alzheimer's disease	40#59		Analysis of UBQLN1 variants in a Polish Alzheimer's disease patient: control series.
20196834	2010	BMC Med. Genet.	1471-2350	CONCLUSION	4	10	4780	SYMBOL|DICTIONARY	nfe2l2	NFE2L2	37#43		D010300	LONGTERM|DISEASE|DT|DICTIONARY	parkinson disease	Parkinson's disease	57#76		These data suggest that variation in NFE2L2 modifies the Parkinson's disease process and provide another link between oxidative stress and neurodegeneration.
20196834	2010	BMC Med. Genet.	1471-2350	CONCLUSION	4	10	4780	SYMBOL|DICTIONARY	nfe2l2	NFE2L2	37#43		D019636	LONGTERM|DICTIONARY	neurodegeneration	neurodegeneration	139#156	NaN	These data suggest that variation in NFE2L2 modifies the Parkinson's disease process and provide another link between oxidative stress and neurodegeneration.
17932345	2008	Cancer Epidemiol. Biomarkers Prev.	1055-9965	TITLE	0	0	10333	SYMBOL|DICTIONARY	tlr6	TLR6	53#57		D011471	LONGTERM|DISEASE|DT|DICTIONARY	prostate cancer	prostate cancer	80#95		Association between Toll-like receptor gene cluster (TLR6, TLR1, and TLR10) and prostate cancer.
17932345	2008	Cancer Epidemiol. Biomarkers Prev.	1055-9965	TITLE	0	0	7096	SYMBOL|DICTIONARY	tlr1	TLR1	59#63		D011471	LONGTERM|DISEASE|DT|DICTIONARY	prostate cancer	prostate cancer	80#95		Association between Toll-like receptor gene cluster (TLR6, TLR1, and TLR10) and prostate cancer.
17932345	2008	Cancer Epidemiol. Biomarkers Prev.	1055-9965	TITLE	0	0	81793	SYMBOL|DICTIONARY	tlr10	TLR10	69#74		D011471	LONGTERM|DISEASE|DT|DICTIONARY	prostate cancer	prostate cancer	80#95		Association between Toll-like receptor gene cluster (TLR6, TLR1, and TLR10) and prostate cancer.
15258326	2004	Dis. Markers	0278-0240	ALL_TEXT_1/3	1	2	2952	SYMBOL|GENE|GN|DICTIONARY	gstt1	GSTT1	127#132		D008175	LONGTERM|DISEASE|DT|DICTIONARY	lung cancer	lung cancer	190#201		It catalyzes the reduction of glutathione to its thioester; thus, deficiency in GST activity due to homozygous deletion of the GSTT1 gene (null genotype) may play a role in the induction of lung cancer by smoking.
15258326	2004	Dis. Markers	0278-0240	ALL_TEXT_1/3	1	2	2952	SYMBOL|GENE|GN|DICTIONARY	gstt1	GSTT1	127#132		D018455	LONGTERM|DICTIONARY	deficiency in gst activity	deficiency in GST activity	66#92		It catalyzes the reduction of glutathione to its thioester; thus, deficiency in GST activity due to homozygous deletion of the GSTT1 gene (null genotype) may play a role in the induction of lung cancer by smoking.
12939326	2003	Invest. Ophthalmol. Vis. Sci.	0146-0404	CONCLUSIONS	4	7	1280	SYMBOL|DICTIONARY	col2a1	COL2A1	57#63		D012163	SYMBOL|EXTRACTED	rrd	RRD	27#30	12939326-1-61-113	In two large families with RRD, linkage was found at the COL2A1 locus.
18190611	2008	Clin. Exp. Immunol.	1365-2249	ALL_TEXT_3/3	3	6	7040	LONGTERM|DICTIONARY	tgf-beta1	TGF-beta1	47#56	NaN	D013967	LONGTERM|DISEASE|DT|DICTIONARY	autoimmune thyroid disease	autoimmune thyroid disease	116#142		In conclusion, the +869T/C polymorphism in the TGF-beta1 gene is associated with the severity and intractability of autoimmune thyroid disease.
19390641	2009	Mol. Vis.	1090-0535	CONCLUSIONS	4	15	6247	LONGTERM|DICTIONARY	xlrs	XLRS	38#42	NaN	D041441	SYMBOL|EXTRACTED	xlrs	XLRS	38#42	19390641-1-0-22	The genetic characteristics of Korean XLRS will be helpful for understanding the worldwide spectrum of RS1 mutation.
19390641	2009	Mol. Vis.	1090-0535	CONCLUSIONS	4	15	6247	LONGTERM|DICTIONARY	rs1	RS1	103#106	NaN	D041441	SYMBOL|EXTRACTED	xlrs	XLRS	38#42	19390641-1-0-22	The genetic characteristics of Korean XLRS will be helpful for understanding the worldwide spectrum of RS1 mutation.
18190611	2008	Clin. Exp. Immunol.	1365-2249	TITLE	0	0	7040	LONGTERM|DICTIONARY	transforming growth factor-beta1	transforming growth factor-beta1	32#64	NaN	D013967	LONGTERM|DISEASE|DT|DICTIONARY	autoimmune thyroid disease	autoimmune thyroid disease	124#150		The +869T/C polymorphism in the transforming growth factor-beta1 gene is associated with the severity and intractability of autoimmune thyroid disease.
18190611	2008	Clin. Exp. Immunol.	1365-2249	ALL_TEXT_1/3	1	2	7040	LONGTERM|DICTIONARY	transforming growth factor-beta1	transforming growth factor-beta1	51#83	NaN	D006111	SYMBOL|EXTRACTED	gd	GD	186#188	18190611-1-67-82	To clarify whether the +869T/C polymorphism in the transforming growth factor-beta1 (TGF-beta1) gene, which is associated with TGF-beta1 expression, is involved in the intractability of GD and severity of HD, we genotyped the TGF-beta1 +869T/C polymorphism by polymerase chain reaction-restriction fragment length polymorphism method in genomic DNA samples from 33 patients with HD who developed hypothyroidism before they were 50 years old (severe HD) and 30 untreated, euthyroid patients with HD who were older than 50 years (mild HD).
18190611	2008	Clin. Exp. Immunol.	1365-2249	ALL_TEXT_1/3	1	2	7040	LONGTERM|DICTIONARY	transforming growth factor-beta1	transforming growth factor-beta1	51#83	NaN	D050031	SYMBOL|EXTRACTED	hd	HD	205#207	18190611-1-16-35	To clarify whether the +869T/C polymorphism in the transforming growth factor-beta1 (TGF-beta1) gene, which is associated with TGF-beta1 expression, is involved in the intractability of GD and severity of HD, we genotyped the TGF-beta1 +869T/C polymorphism by polymerase chain reaction-restriction fragment length polymorphism method in genomic DNA samples from 33 patients with HD who developed hypothyroidism before they were 50 years old (severe HD) and 30 untreated, euthyroid patients with HD who were older than 50 years (mild HD).
18190611	2008	Clin. Exp. Immunol.	1365-2249	ALL_TEXT_1/3	1	2	7040	LONGTERM|DICTIONARY	transforming growth factor-beta1	transforming growth factor-beta1	51#83	NaN	D050031	SYMBOL|EXTRACTED	hd	HD	379#381	18190611-1-16-35	To clarify whether the +869T/C polymorphism in the transforming growth factor-beta1 (TGF-beta1) gene, which is associated with TGF-beta1 expression, is involved in the intractability of GD and severity of HD, we genotyped the TGF-beta1 +869T/C polymorphism by polymerase chain reaction-restriction fragment length polymorphism method in genomic DNA samples from 33 patients with HD who developed hypothyroidism before they were 50 years old (severe HD) and 30 untreated, euthyroid patients with HD who were older than 50 years (mild HD).
18190611	2008	Clin. Exp. Immunol.	1365-2249	ALL_TEXT_1/3	1	2	7040	LONGTERM|DICTIONARY	transforming growth factor-beta1	transforming growth factor-beta1	51#83	NaN	D007037	LONGTERM|DICTIONARY	hypothyroidism	hypothyroidism	396#410		To clarify whether the +869T/C polymorphism in the transforming growth factor-beta1 (TGF-beta1) gene, which is associated with TGF-beta1 expression, is involved in the intractability of GD and severity of HD, we genotyped the TGF-beta1 +869T/C polymorphism by polymerase chain reaction-restriction fragment length polymorphism method in genomic DNA samples from 33 patients with HD who developed hypothyroidism before they were 50 years old (severe HD) and 30 untreated, euthyroid patients with HD who were older than 50 years (mild HD).
18190611	2008	Clin. Exp. Immunol.	1365-2249	ALL_TEXT_1/3	1	2	7040	LONGTERM|DICTIONARY	transforming growth factor-beta1	transforming growth factor-beta1	51#83	NaN	D050031	SYMBOL|EXTRACTED	hd	HD	449#451	18190611-1-16-35	To clarify whether the +869T/C polymorphism in the transforming growth factor-beta1 (TGF-beta1) gene, which is associated with TGF-beta1 expression, is involved in the intractability of GD and severity of HD, we genotyped the TGF-beta1 +869T/C polymorphism by polymerase chain reaction-restriction fragment length polymorphism method in genomic DNA samples from 33 patients with HD who developed hypothyroidism before they were 50 years old (severe HD) and 30 untreated, euthyroid patients with HD who were older than 50 years (mild HD).
18190611	2008	Clin. Exp. Immunol.	1365-2249	ALL_TEXT_1/3	1	2	7040	LONGTERM|DICTIONARY	transforming growth factor-beta1	transforming growth factor-beta1	51#83	NaN	D050031	SYMBOL|EXTRACTED	hd	HD	495#497	18190611-1-16-35	To clarify whether the +869T/C polymorphism in the transforming growth factor-beta1 (TGF-beta1) gene, which is associated with TGF-beta1 expression, is involved in the intractability of GD and severity of HD, we genotyped the TGF-beta1 +869T/C polymorphism by polymerase chain reaction-restriction fragment length polymorphism method in genomic DNA samples from 33 patients with HD who developed hypothyroidism before they were 50 years old (severe HD) and 30 untreated, euthyroid patients with HD who were older than 50 years (mild HD).
18190611	2008	Clin. Exp. Immunol.	1365-2249	ALL_TEXT_1/3	1	2	7040	LONGTERM|DICTIONARY	transforming growth factor-beta1	transforming growth factor-beta1	51#83	NaN	D050031	SYMBOL|EXTRACTED	hd	HD	533#535	18190611-1-16-35	To clarify whether the +869T/C polymorphism in the transforming growth factor-beta1 (TGF-beta1) gene, which is associated with TGF-beta1 expression, is involved in the intractability of GD and severity of HD, we genotyped the TGF-beta1 +869T/C polymorphism by polymerase chain reaction-restriction fragment length polymorphism method in genomic DNA samples from 33 patients with HD who developed hypothyroidism before they were 50 years old (severe HD) and 30 untreated, euthyroid patients with HD who were older than 50 years (mild HD).
18190611	2008	Clin. Exp. Immunol.	1365-2249	ALL_TEXT_1/3	1	2	7040	LONGTERM|DICTIONARY	tgf-beta1	TGF-beta1	85#94	NaN	D006111	SYMBOL|EXTRACTED	gd	GD	186#188	18190611-1-67-82	To clarify whether the +869T/C polymorphism in the transforming growth factor-beta1 (TGF-beta1) gene, which is associated with TGF-beta1 expression, is involved in the intractability of GD and severity of HD, we genotyped the TGF-beta1 +869T/C polymorphism by polymerase chain reaction-restriction fragment length polymorphism method in genomic DNA samples from 33 patients with HD who developed hypothyroidism before they were 50 years old (severe HD) and 30 untreated, euthyroid patients with HD who were older than 50 years (mild HD).
18190611	2008	Clin. Exp. Immunol.	1365-2249	ALL_TEXT_1/3	1	2	7040	LONGTERM|DICTIONARY	tgf-beta1	TGF-beta1	85#94	NaN	D050031	SYMBOL|EXTRACTED	hd	HD	205#207	18190611-1-16-35	To clarify whether the +869T/C polymorphism in the transforming growth factor-beta1 (TGF-beta1) gene, which is associated with TGF-beta1 expression, is involved in the intractability of GD and severity of HD, we genotyped the TGF-beta1 +869T/C polymorphism by polymerase chain reaction-restriction fragment length polymorphism method in genomic DNA samples from 33 patients with HD who developed hypothyroidism before they were 50 years old (severe HD) and 30 untreated, euthyroid patients with HD who were older than 50 years (mild HD).
18190611	2008	Clin. Exp. Immunol.	1365-2249	ALL_TEXT_1/3	1	2	7040	LONGTERM|DICTIONARY	tgf-beta1	TGF-beta1	85#94	NaN	D050031	SYMBOL|EXTRACTED	hd	HD	379#381	18190611-1-16-35	To clarify whether the +869T/C polymorphism in the transforming growth factor-beta1 (TGF-beta1) gene, which is associated with TGF-beta1 expression, is involved in the intractability of GD and severity of HD, we genotyped the TGF-beta1 +869T/C polymorphism by polymerase chain reaction-restriction fragment length polymorphism method in genomic DNA samples from 33 patients with HD who developed hypothyroidism before they were 50 years old (severe HD) and 30 untreated, euthyroid patients with HD who were older than 50 years (mild HD).
18190611	2008	Clin. Exp. Immunol.	1365-2249	ALL_TEXT_1/3	1	2	7040	LONGTERM|DICTIONARY	tgf-beta1	TGF-beta1	85#94	NaN	D007037	LONGTERM|DICTIONARY	hypothyroidism	hypothyroidism	396#410		To clarify whether the +869T/C polymorphism in the transforming growth factor-beta1 (TGF-beta1) gene, which is associated with TGF-beta1 expression, is involved in the intractability of GD and severity of HD, we genotyped the TGF-beta1 +869T/C polymorphism by polymerase chain reaction-restriction fragment length polymorphism method in genomic DNA samples from 33 patients with HD who developed hypothyroidism before they were 50 years old (severe HD) and 30 untreated, euthyroid patients with HD who were older than 50 years (mild HD).
18190611	2008	Clin. Exp. Immunol.	1365-2249	ALL_TEXT_1/3	1	2	7040	LONGTERM|DICTIONARY	tgf-beta1	TGF-beta1	85#94	NaN	D050031	SYMBOL|EXTRACTED	hd	HD	449#451	18190611-1-16-35	To clarify whether the +869T/C polymorphism in the transforming growth factor-beta1 (TGF-beta1) gene, which is associated with TGF-beta1 expression, is involved in the intractability of GD and severity of HD, we genotyped the TGF-beta1 +869T/C polymorphism by polymerase chain reaction-restriction fragment length polymorphism method in genomic DNA samples from 33 patients with HD who developed hypothyroidism before they were 50 years old (severe HD) and 30 untreated, euthyroid patients with HD who were older than 50 years (mild HD).
18190611	2008	Clin. Exp. Immunol.	1365-2249	ALL_TEXT_1/3	1	2	7040	LONGTERM|DICTIONARY	tgf-beta1	TGF-beta1	85#94	NaN	D050031	SYMBOL|EXTRACTED	hd	HD	495#497	18190611-1-16-35	To clarify whether the +869T/C polymorphism in the transforming growth factor-beta1 (TGF-beta1) gene, which is associated with TGF-beta1 expression, is involved in the intractability of GD and severity of HD, we genotyped the TGF-beta1 +869T/C polymorphism by polymerase chain reaction-restriction fragment length polymorphism method in genomic DNA samples from 33 patients with HD who developed hypothyroidism before they were 50 years old (severe HD) and 30 untreated, euthyroid patients with HD who were older than 50 years (mild HD).
18190611	2008	Clin. Exp. Immunol.	1365-2249	ALL_TEXT_1/3	1	2	7040	LONGTERM|DICTIONARY	tgf-beta1	TGF-beta1	85#94	NaN	D050031	SYMBOL|EXTRACTED	hd	HD	533#535	18190611-1-16-35	To clarify whether the +869T/C polymorphism in the transforming growth factor-beta1 (TGF-beta1) gene, which is associated with TGF-beta1 expression, is involved in the intractability of GD and severity of HD, we genotyped the TGF-beta1 +869T/C polymorphism by polymerase chain reaction-restriction fragment length polymorphism method in genomic DNA samples from 33 patients with HD who developed hypothyroidism before they were 50 years old (severe HD) and 30 untreated, euthyroid patients with HD who were older than 50 years (mild HD).
18190611	2008	Clin. Exp. Immunol.	1365-2249	ALL_TEXT_1/3	1	2	7040	LONGTERM|DICTIONARY	tgf-beta1	TGF-beta1	127#136	NaN	D006111	SYMBOL|EXTRACTED	gd	GD	186#188	18190611-1-67-82	To clarify whether the +869T/C polymorphism in the transforming growth factor-beta1 (TGF-beta1) gene, which is associated with TGF-beta1 expression, is involved in the intractability of GD and severity of HD, we genotyped the TGF-beta1 +869T/C polymorphism by polymerase chain reaction-restriction fragment length polymorphism method in genomic DNA samples from 33 patients with HD who developed hypothyroidism before they were 50 years old (severe HD) and 30 untreated, euthyroid patients with HD who were older than 50 years (mild HD).
18190611	2008	Clin. Exp. Immunol.	1365-2249	ALL_TEXT_1/3	1	2	7040	LONGTERM|DICTIONARY	tgf-beta1	TGF-beta1	127#136	NaN	D050031	SYMBOL|EXTRACTED	hd	HD	205#207	18190611-1-16-35	To clarify whether the +869T/C polymorphism in the transforming growth factor-beta1 (TGF-beta1) gene, which is associated with TGF-beta1 expression, is involved in the intractability of GD and severity of HD, we genotyped the TGF-beta1 +869T/C polymorphism by polymerase chain reaction-restriction fragment length polymorphism method in genomic DNA samples from 33 patients with HD who developed hypothyroidism before they were 50 years old (severe HD) and 30 untreated, euthyroid patients with HD who were older than 50 years (mild HD).
18190611	2008	Clin. Exp. Immunol.	1365-2249	ALL_TEXT_1/3	1	2	7040	LONGTERM|DICTIONARY	tgf-beta1	TGF-beta1	127#136	NaN	D050031	SYMBOL|EXTRACTED	hd	HD	379#381	18190611-1-16-35	To clarify whether the +869T/C polymorphism in the transforming growth factor-beta1 (TGF-beta1) gene, which is associated with TGF-beta1 expression, is involved in the intractability of GD and severity of HD, we genotyped the TGF-beta1 +869T/C polymorphism by polymerase chain reaction-restriction fragment length polymorphism method in genomic DNA samples from 33 patients with HD who developed hypothyroidism before they were 50 years old (severe HD) and 30 untreated, euthyroid patients with HD who were older than 50 years (mild HD).
18190611	2008	Clin. Exp. Immunol.	1365-2249	ALL_TEXT_1/3	1	2	7040	LONGTERM|DICTIONARY	tgf-beta1	TGF-beta1	127#136	NaN	D007037	LONGTERM|DICTIONARY	hypothyroidism	hypothyroidism	396#410		To clarify whether the +869T/C polymorphism in the transforming growth factor-beta1 (TGF-beta1) gene, which is associated with TGF-beta1 expression, is involved in the intractability of GD and severity of HD, we genotyped the TGF-beta1 +869T/C polymorphism by polymerase chain reaction-restriction fragment length polymorphism method in genomic DNA samples from 33 patients with HD who developed hypothyroidism before they were 50 years old (severe HD) and 30 untreated, euthyroid patients with HD who were older than 50 years (mild HD).
18190611	2008	Clin. Exp. Immunol.	1365-2249	ALL_TEXT_1/3	1	2	7040	LONGTERM|DICTIONARY	tgf-beta1	TGF-beta1	127#136	NaN	D050031	SYMBOL|EXTRACTED	hd	HD	449#451	18190611-1-16-35	To clarify whether the +869T/C polymorphism in the transforming growth factor-beta1 (TGF-beta1) gene, which is associated with TGF-beta1 expression, is involved in the intractability of GD and severity of HD, we genotyped the TGF-beta1 +869T/C polymorphism by polymerase chain reaction-restriction fragment length polymorphism method in genomic DNA samples from 33 patients with HD who developed hypothyroidism before they were 50 years old (severe HD) and 30 untreated, euthyroid patients with HD who were older than 50 years (mild HD).
18190611	2008	Clin. Exp. Immunol.	1365-2249	ALL_TEXT_1/3	1	2	7040	LONGTERM|DICTIONARY	tgf-beta1	TGF-beta1	127#136	NaN	D050031	SYMBOL|EXTRACTED	hd	HD	495#497	18190611-1-16-35	To clarify whether the +869T/C polymorphism in the transforming growth factor-beta1 (TGF-beta1) gene, which is associated with TGF-beta1 expression, is involved in the intractability of GD and severity of HD, we genotyped the TGF-beta1 +869T/C polymorphism by polymerase chain reaction-restriction fragment length polymorphism method in genomic DNA samples from 33 patients with HD who developed hypothyroidism before they were 50 years old (severe HD) and 30 untreated, euthyroid patients with HD who were older than 50 years (mild HD).
18190611	2008	Clin. Exp. Immunol.	1365-2249	ALL_TEXT_1/3	1	2	7040	LONGTERM|DICTIONARY	tgf-beta1	TGF-beta1	127#136	NaN	D050031	SYMBOL|EXTRACTED	hd	HD	533#535	18190611-1-16-35	To clarify whether the +869T/C polymorphism in the transforming growth factor-beta1 (TGF-beta1) gene, which is associated with TGF-beta1 expression, is involved in the intractability of GD and severity of HD, we genotyped the TGF-beta1 +869T/C polymorphism by polymerase chain reaction-restriction fragment length polymorphism method in genomic DNA samples from 33 patients with HD who developed hypothyroidism before they were 50 years old (severe HD) and 30 untreated, euthyroid patients with HD who were older than 50 years (mild HD).
18190611	2008	Clin. Exp. Immunol.	1365-2249	ALL_TEXT_1/3	1	2	7040	LONGTERM|DICTIONARY	tgf-beta1	TGF-beta1	226#235	NaN	D006111	SYMBOL|EXTRACTED	gd	GD	186#188	18190611-1-67-82	To clarify whether the +869T/C polymorphism in the transforming growth factor-beta1 (TGF-beta1) gene, which is associated with TGF-beta1 expression, is involved in the intractability of GD and severity of HD, we genotyped the TGF-beta1 +869T/C polymorphism by polymerase chain reaction-restriction fragment length polymorphism method in genomic DNA samples from 33 patients with HD who developed hypothyroidism before they were 50 years old (severe HD) and 30 untreated, euthyroid patients with HD who were older than 50 years (mild HD).
18190611	2008	Clin. Exp. Immunol.	1365-2249	ALL_TEXT_1/3	1	2	7040	LONGTERM|DICTIONARY	tgf-beta1	TGF-beta1	226#235	NaN	D050031	SYMBOL|EXTRACTED	hd	HD	205#207	18190611-1-16-35	To clarify whether the +869T/C polymorphism in the transforming growth factor-beta1 (TGF-beta1) gene, which is associated with TGF-beta1 expression, is involved in the intractability of GD and severity of HD, we genotyped the TGF-beta1 +869T/C polymorphism by polymerase chain reaction-restriction fragment length polymorphism method in genomic DNA samples from 33 patients with HD who developed hypothyroidism before they were 50 years old (severe HD) and 30 untreated, euthyroid patients with HD who were older than 50 years (mild HD).
18190611	2008	Clin. Exp. Immunol.	1365-2249	ALL_TEXT_1/3	1	2	7040	LONGTERM|DICTIONARY	tgf-beta1	TGF-beta1	226#235	NaN	D050031	SYMBOL|EXTRACTED	hd	HD	379#381	18190611-1-16-35	To clarify whether the +869T/C polymorphism in the transforming growth factor-beta1 (TGF-beta1) gene, which is associated with TGF-beta1 expression, is involved in the intractability of GD and severity of HD, we genotyped the TGF-beta1 +869T/C polymorphism by polymerase chain reaction-restriction fragment length polymorphism method in genomic DNA samples from 33 patients with HD who developed hypothyroidism before they were 50 years old (severe HD) and 30 untreated, euthyroid patients with HD who were older than 50 years (mild HD).
18190611	2008	Clin. Exp. Immunol.	1365-2249	ALL_TEXT_1/3	1	2	7040	LONGTERM|DICTIONARY	tgf-beta1	TGF-beta1	226#235	NaN	D007037	LONGTERM|DICTIONARY	hypothyroidism	hypothyroidism	396#410		To clarify whether the +869T/C polymorphism in the transforming growth factor-beta1 (TGF-beta1) gene, which is associated with TGF-beta1 expression, is involved in the intractability of GD and severity of HD, we genotyped the TGF-beta1 +869T/C polymorphism by polymerase chain reaction-restriction fragment length polymorphism method in genomic DNA samples from 33 patients with HD who developed hypothyroidism before they were 50 years old (severe HD) and 30 untreated, euthyroid patients with HD who were older than 50 years (mild HD).
18190611	2008	Clin. Exp. Immunol.	1365-2249	ALL_TEXT_1/3	1	2	7040	LONGTERM|DICTIONARY	tgf-beta1	TGF-beta1	226#235	NaN	D050031	SYMBOL|EXTRACTED	hd	HD	449#451	18190611-1-16-35	To clarify whether the +869T/C polymorphism in the transforming growth factor-beta1 (TGF-beta1) gene, which is associated with TGF-beta1 expression, is involved in the intractability of GD and severity of HD, we genotyped the TGF-beta1 +869T/C polymorphism by polymerase chain reaction-restriction fragment length polymorphism method in genomic DNA samples from 33 patients with HD who developed hypothyroidism before they were 50 years old (severe HD) and 30 untreated, euthyroid patients with HD who were older than 50 years (mild HD).
18190611	2008	Clin. Exp. Immunol.	1365-2249	ALL_TEXT_1/3	1	2	7040	LONGTERM|DICTIONARY	tgf-beta1	TGF-beta1	226#235	NaN	D050031	SYMBOL|EXTRACTED	hd	HD	495#497	18190611-1-16-35	To clarify whether the +869T/C polymorphism in the transforming growth factor-beta1 (TGF-beta1) gene, which is associated with TGF-beta1 expression, is involved in the intractability of GD and severity of HD, we genotyped the TGF-beta1 +869T/C polymorphism by polymerase chain reaction-restriction fragment length polymorphism method in genomic DNA samples from 33 patients with HD who developed hypothyroidism before they were 50 years old (severe HD) and 30 untreated, euthyroid patients with HD who were older than 50 years (mild HD).
18190611	2008	Clin. Exp. Immunol.	1365-2249	ALL_TEXT_1/3	1	2	7040	LONGTERM|DICTIONARY	tgf-beta1	TGF-beta1	226#235	NaN	D050031	SYMBOL|EXTRACTED	hd	HD	533#535	18190611-1-16-35	To clarify whether the +869T/C polymorphism in the transforming growth factor-beta1 (TGF-beta1) gene, which is associated with TGF-beta1 expression, is involved in the intractability of GD and severity of HD, we genotyped the TGF-beta1 +869T/C polymorphism by polymerase chain reaction-restriction fragment length polymorphism method in genomic DNA samples from 33 patients with HD who developed hypothyroidism before they were 50 years old (severe HD) and 30 untreated, euthyroid patients with HD who were older than 50 years (mild HD).
18190611	2008	Clin. Exp. Immunol.	1365-2249	ALL_TEXT_2/3	2	3	7253	LONGTERM|GENE|GT|DICTIONARY	thyrotropin receptor	thyrotropin receptor	109#129		D006111	SYMBOL|EXTRACTED	gd	GD	44#46	18190611-1-67-82	We also examined 48 euthyroid patients with GD who had been under treatment and were still positive for anti-thyrotropin receptor antibodies (intractable GD), 20 euthyroid patients with GD in remission and 45 healthy controls.
18190611	2008	Clin. Exp. Immunol.	1365-2249	ALL_TEXT_2/3	2	3	7253	LONGTERM|GENE|GT|DICTIONARY	thyrotropin receptor	thyrotropin receptor	109#129		D006111	SYMBOL|EXTRACTED	gd	GD	154#156	18190611-1-67-82	We also examined 48 euthyroid patients with GD who had been under treatment and were still positive for anti-thyrotropin receptor antibodies (intractable GD), 20 euthyroid patients with GD in remission and 45 healthy controls.
18190611	2008	Clin. Exp. Immunol.	1365-2249	ALL_TEXT_2/3	2	3	7253	LONGTERM|GENE|GT|DICTIONARY	thyrotropin receptor	thyrotropin receptor	109#129		D006111	SYMBOL|EXTRACTED	gd	GD	186#188	18190611-1-67-82	We also examined 48 euthyroid patients with GD who had been under treatment and were still positive for anti-thyrotropin receptor antibodies (intractable GD), 20 euthyroid patients with GD in remission and 45 healthy controls.
14602139	2004	Eur. J. Cancer	0959-8049	ALL_TEXT_3/3	3	7	1588	SYMBOL|DICTIONARY	cyp19	CYP19	164#169		D001943	LONGTERM|DISEASE|DT|DICTIONARY	er-positive breast cancer	ER-positive breast cancer	96#121		The combination of these two polymorphisms was found to be more useful in the assessment of the ER-positive breast cancer risk (OR=3.00, 95% CI=1.56-5.74) than the CYP19 (TTTA)7(-3bp) polymorphism alone.
14602139	2004	Eur. J. Cancer	0959-8049	ALL_TEXT_3/3	3	6	1543	SYMBOL|NUMBER|DICTIONARY	cyp1a1	CYP1A1	0#6		D001943	LONGTERM|DICTIONARY	breast cancers	breast cancers	109#123		CYP1A1 6235C allele carriers showed a non-significant (P=0.06) trend towards a decreased risk of ER-positive breast cancers (OR=0.65, 95% CI 0.42-1.02), but not ER-negative breast cancers.
14602139	2004	Eur. J. Cancer	0959-8049	ALL_TEXT_3/3	3	6	1543	SYMBOL|NUMBER|DICTIONARY	cyp1a1	CYP1A1	0#6		D001943	LONGTERM|DICTIONARY	breast cancers	breast cancers	173#187		CYP1A1 6235C allele carriers showed a non-significant (P=0.06) trend towards a decreased risk of ER-positive breast cancers (OR=0.65, 95% CI 0.42-1.02), but not ER-negative breast cancers.
14602139	2004	Eur. J. Cancer	0959-8049	ALL_TEXT_3/3	3	5	1588	SYMBOL|DICTIONARY	cyp19	CYP19	0#5		D001943	LONGTERM|DICTIONARY	breast cancers	breast cancers	98#112		CYP19 (TTTA)7(-3bp) allele carriers showed a significantly (P<0.05) increased risk of ER-positive breast cancers (Odds Ratio (OR)=1.72, 95% Confidence Interval (CI) 1.10-2.69), but not ER-negative breast cancers.
14602139	2004	Eur. J. Cancer	0959-8049	ALL_TEXT_3/3	3	5	1588	SYMBOL|DICTIONARY	cyp19	CYP19	0#5		D001943	LONGTERM|DICTIONARY	breast cancers	breast cancers	197#211		CYP19 (TTTA)7(-3bp) allele carriers showed a significantly (P<0.05) increased risk of ER-positive breast cancers (Odds Ratio (OR)=1.72, 95% Confidence Interval (CI) 1.10-2.69), but not ER-negative breast cancers.
14602139	2004	Eur. J. Cancer	0959-8049	ALL_TEXT_2/3	2	4	1588	SYMBOL|DICTIONARY	cyp19	CYP19	19#24		D001943	LONGTERM|DISEASE|DT|DICTIONARY	breast cancer	breast cancer	131#144		Two polymorphisms, CYP19 (TTTA repeats) in intron 4 and CYP1A1 6235C/T in the 3' non-coding region, and their association with the breast cancer risk after adjustment for the other epidemiological risk factors were examined.
14602139	2004	Eur. J. Cancer	0959-8049	ALL_TEXT_2/3	2	4	1543	SYMBOL|NUMBER|DICTIONARY	cyp1a1	CYP1A1	56#62		D001943	LONGTERM|DISEASE|DT|DICTIONARY	breast cancer	breast cancer	131#144		Two polymorphisms, CYP19 (TTTA repeats) in intron 4 and CYP1A1 6235C/T in the 3' non-coding region, and their association with the breast cancer risk after adjustment for the other epidemiological risk factors were examined.
14602139	2004	Eur. J. Cancer	0959-8049	ALL_TEXT_1/3	1	2	1588	SYMBOL|()|DICTIONARY	cyp19	CYP19	93#98		D001943	LONGTERM|DICTIONARY	er-positive breast cancers	ER-positive breast cancers	145#171		Thus, the significance of genetic polymorphisms of genes involved in oestrogen biosynthesis (CYP19) and metabolism (CYP1A1) as a risk factor for ER-positive breast cancers was evaluated.
14602139	2004	Eur. J. Cancer	0959-8049	ALL_TEXT_1/3	1	2	1543	SYMBOL|()|DICTIONARY	cyp1a1	CYP1A1	116#122		D001943	LONGTERM|DICTIONARY	er-positive breast cancers	ER-positive breast cancers	145#171		Thus, the significance of genetic polymorphisms of genes involved in oestrogen biosynthesis (CYP19) and metabolism (CYP1A1) as a risk factor for ER-positive breast cancers was evaluated.
19892319	2010	Biol. Psychiatry	1873-2402	CONCLUSIONS	4	7	1312	SYMBOL|DICTIONARY|EXTRACTED	comt	COMT	134#138	19892319-1-54-82	D012559	LONGTERM|DICTIONARY	schizophrenia	schizophrenia	3#16		In schizophrenia, brain structures important for executive and affective processing show activity that is differentially predicted by COMT allelic variation in an opposing manner even at rest, providing evidence for the salience of prefrontal dopaminergic tone in task-independent, basal-level neural activity.
19892319	2010	Biol. Psychiatry	1873-2402	CONCLUSIONS	4	7	1312	SYMBOL|DICTIONARY|EXTRACTED	comt	COMT	134#138	19892319-1-54-82	D001927	LONGTERM|DICTIONARY	brain structures	brain structures	18#34	NaN	In schizophrenia, brain structures important for executive and affective processing show activity that is differentially predicted by COMT allelic variation in an opposing manner even at rest, providing evidence for the salience of prefrontal dopaminergic tone in task-independent, basal-level neural activity.
14602139	2004	Eur. J. Cancer	0959-8049	TITLE	0	0	1588	SYMBOL|DICTIONARY	cyp19	CYP19	40#45		D001943	LONGTERM|DISEASE|DT|DICTIONARY	breast cancer	breast cancer	94#107		Association of genetic polymorphisms in CYP19 and CYP1A1 with the oestrogen receptor-positive breast cancer risk.
14602139	2004	Eur. J. Cancer	0959-8049	TITLE	0	0	1543	SYMBOL|DICTIONARY	cyp1a1	CYP1A1	50#56		D001943	LONGTERM|DISEASE|DT|DICTIONARY	breast cancer	breast cancer	94#107		Association of genetic polymorphisms in CYP19 and CYP1A1 with the oestrogen receptor-positive breast cancer risk.
19360675	2009	Autism Res	1939-3806	ALL_TEXT_1/3	1	1	6532	SYMBOL|DICTIONARY	slc6a4	SLC6A4	70#76		D001321	LONGTERM|DICTIONARY	autism	autism	91#97		In the current study we explored the hypothesis that rare variants in SLC6A4 contribute to autism susceptibility and to rigid-compulsive behaviors in autism.
19360675	2009	Autism Res	1939-3806	ALL_TEXT_1/3	1	1	6532	SYMBOL|DICTIONARY	slc6a4	SLC6A4	70#76		D001321	LONGTERM|DICTIONARY	autism	autism	150#156		In the current study we explored the hypothesis that rare variants in SLC6A4 contribute to autism susceptibility and to rigid-compulsive behaviors in autism.
19360675	2009	Autism Res	1939-3806	ALL_TEXT_1/3	1	1	6532	SYMBOL|DICTIONARY	slc6a4	SLC6A4	70#76		D001523	LONGTERM|DICTIONARY	rigid-compulsive behaviors	rigid-compulsive behaviors	120#146		In the current study we explored the hypothesis that rare variants in SLC6A4 contribute to autism susceptibility and to rigid-compulsive behaviors in autism.
19360675	2009	Autism Res	1939-3806	ALL_TEXT_1/3	1	1	6532	SYMBOL|DICTIONARY	slc6a4	SLC6A4	70#76		D001523	LONGTERM|DICTIONARY	rigid-compulsive behaviors	rigid-compulsive behaviors	120#146		In the current study we explored the hypothesis that rare variants in SLC6A4 contribute to autism susceptibility and to rigid-compulsive behaviors in autism.
16945136	2006	BMC Cancer	1471-2407	RESULTS	3	11	2876	SYMBOL|DICTIONARY	gpx 1	GPX-1	241#246		D001943	LONGTERM|DISEASE|DT|DICTIONARY	breast cancer	breast cancer	47#60		While neither allele alone shows any change in breast cancer risk, an increase in the risk of breast cancer (OR 1.87, 95% CI 1.09 - 3.19) is observed in individuals who carry both the Ala16Ala genotype of MnSOD and the Leu198Leu genotype of GPX-1.
16945136	2006	BMC Cancer	1471-2407	RESULTS	3	11	2876	SYMBOL|DICTIONARY	gpx 1	GPX-1	241#246		D001943	LONGTERM|DISEASE|DT|DICTIONARY	breast cancer	breast cancer	94#107		While neither allele alone shows any change in breast cancer risk, an increase in the risk of breast cancer (OR 1.87, 95% CI 1.09 - 3.19) is observed in individuals who carry both the Ala16Ala genotype of MnSOD and the Leu198Leu genotype of GPX-1.
16945136	2006	BMC Cancer	1471-2407	CONCLUSION	4	12	2876	SYMBOL|DICTIONARY	gpx 1	GPX-1	21#26		D001943	LONGTERM|DISEASE|DT|DICTIONARY	breast cancer	breast cancer	84#97		Polymorphisms in the GPX-1 and MnSOD genes are associated with an increased risk of breast cancer.
16945136	2006	BMC Cancer	1471-2407	CONCLUSION	4	12	6648	SYMBOL|GENE|GN|DICTIONARY	mnsod	MnSOD	31#36		D001943	LONGTERM|DISEASE|DT|DICTIONARY	breast cancer	breast cancer	84#97		Polymorphisms in the GPX-1 and MnSOD genes are associated with an increased risk of breast cancer.
21110240	2011	Swiss Med Wkly	1424-3997	PRINCIPLES	1	2	348	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	apoe	APOE	4#8	21110240-2-4-8	D019636	LONGTERM|DICTIONARY	neurodegenerative diseases	neurodegenerative diseases	36#62		The APOE gene (APOE) is involved in neurodegenerative diseases, the best-known association being that between the APOE 4 allele and Alzheimer's disease.
21110240	2011	Swiss Med Wkly	1424-3997	PRINCIPLES	1	2	348	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	apoe	APOE	4#8	21110240-2-4-8	D000544	LONGTERM|DISEASE|DT|DICTIONARY	alzheimer disease	Alzheimer's disease	133#152		The APOE gene (APOE) is involved in neurodegenerative diseases, the best-known association being that between the APOE 4 allele and Alzheimer's disease.
21110240	2011	Swiss Med Wkly	1424-3997	PRINCIPLES	1	2	348	SYMBOL|()|DICTIONARY|EXTRACTED	apoe	APOE	15#19	21110240-2-4-8	D019636	LONGTERM|DICTIONARY	neurodegenerative diseases	neurodegenerative diseases	36#62		The APOE gene (APOE) is involved in neurodegenerative diseases, the best-known association being that between the APOE 4 allele and Alzheimer's disease.
21110240	2011	Swiss Med Wkly	1424-3997	PRINCIPLES	1	2	348	SYMBOL|()|DICTIONARY|EXTRACTED	apoe	APOE	15#19	21110240-2-4-8	D000544	LONGTERM|DISEASE|DT|DICTIONARY	alzheimer disease	Alzheimer's disease	133#152		The APOE gene (APOE) is involved in neurodegenerative diseases, the best-known association being that between the APOE 4 allele and Alzheimer's disease.
21110240	2011	Swiss Med Wkly	1424-3997	PRINCIPLES	1	2	348	SYMBOL|ALPHA|DICTIONARY|EXTRACTED	apoe	APOE	114#118	21110240-2-4-8	D019636	LONGTERM|DICTIONARY	neurodegenerative diseases	neurodegenerative diseases	36#62		The APOE gene (APOE) is involved in neurodegenerative diseases, the best-known association being that between the APOE 4 allele and Alzheimer's disease.
21110240	2011	Swiss Med Wkly	1424-3997	PRINCIPLES	1	2	348	SYMBOL|ALPHA|DICTIONARY|EXTRACTED	apoe	APOE	114#118	21110240-2-4-8	D000544	LONGTERM|DISEASE|DT|DICTIONARY	alzheimer disease	Alzheimer's disease	133#152		The APOE gene (APOE) is involved in neurodegenerative diseases, the best-known association being that between the APOE 4 allele and Alzheimer's disease.
12939326	2003	Invest. Ophthalmol. Vis. Sci.	0146-0404	TITLE	0	0	1280	SYMBOL|GENE|GN|DICTIONARY	col2a1	COL2A1	98#104		C563710	LONGTERM|DICTIONARY	autosomal dominant rhegmatogenous retinal detachment	Autosomal dominant rhegmatogenous retinal detachment	0#52		Autosomal dominant rhegmatogenous retinal detachment associated with an Arg453Ter mutation in the COL2A1 gene.
16702373	2006	Cancer Epidemiol. Biomarkers Prev.	1055-9965	ALL_TEXT_1/3	1	3	4683	SYMBOL|DICTIONARY	nbs1	NBS1	80#84		D011471	LONGTERM|DISEASE|DT|DICTIONARY	prostate cancer	prostate cancer	127#142		In this study, a number of analyses were done to determine whether mutations in NBS1 are associated with an increased risk for prostate cancer.
20644276	2010	Neurol India	0028-3886	ALL_TEXT_3/3	3	8	348	LONGTERM|DICTIONARY	apo-e	Apo-E	41#46	NaN	D009157	SYMBOL|EXTRACTED	mg	MG	108#110	20644276-1-11-28	Our results suggest that the presence of Apo-E4 allele might influence seropositive status in patients with MG and seems an associated susceptible factor in female patients.
11739440	2001	J. Clin. Endocrinol. Metab.	0021-972X	ALL_TEXT_3/3	3	8	5928	LONGTERM|DICTIONARY	msi	MSI	73#76	NaN	C567552	LONGTERM|DICTIONARY	precocious pubarche	precocious pubarche	3#22		In precocious pubarche girls, birth weight was also inversely related to MSI (r = -0.29; P < 0.0005), total cholesterol (r = -0.38; P < 0.0005), and low density lipoprotein cholesterol (r = -0.44; P < 0.0005).
17879560	2007	Neuropsychopharmacol Hung	1419-8711	ALL_TEXT_2/3	2	5	1815	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	drd4	DRD4	199#203	17879560-1-10-30	D001289	SYMBOL|DICTIONARY|EXTRACTED	adhd	ADHD	242#246	17879560-1-96-136	In this study we describe an association analysis of the 120 bp duplication and three sequence variations (SNPs, Single Nucleotide Polymorphism; -616 C/G, -615 A/G, -521 C/T) in the 5' region of the DRD4 gene is presented among children with ADHD.
17879560	2007	Neuropsychopharmacol Hung	1419-8711	TITLE	0	0	1815	LONGTERM|GENE|GN|GT|DICTIONARY	dopamine d4 receptor	dopamine D4 receptor	17#37		D001289	LONGTERM|DISEASE|DT|DICTIONARY	attention deficit hyperactivity disorder	attention deficit hyperactivity disorder	55#95		[Analysis of the dopamine D4 receptor gene variants in attention deficit hyperactivity disorder].
17879560	2007	Neuropsychopharmacol Hung	1419-8711	ALL_TEXT_1/3	1	1	1815	LONGTERM|GENE|GT|DICTIONARY|GA	dopamine d4 receptor	dopamine D4 receptor	10#30		D001289	LONGTERM|DICTIONARY	attention deficit hyperactivity disorder	attention deficit hyperactivity disorder	96#136		The human dopamine D4 receptor (DRD4) gene has been extensively studied as a candidate gene for attention deficit hyperactivity disorder (ADHD).
17879560	2007	Neuropsychopharmacol Hung	1419-8711	ALL_TEXT_1/3	1	1	1815	LONGTERM|GENE|GT|DICTIONARY|GA	dopamine d4 receptor	dopamine D4 receptor	10#30		D001289	SYMBOL|()|DICTIONARY|EXTRACTED	adhd	ADHD	138#142	17879560-1-96-136	The human dopamine D4 receptor (DRD4) gene has been extensively studied as a candidate gene for attention deficit hyperactivity disorder (ADHD).
17879560	2007	Neuropsychopharmacol Hung	1419-8711	ALL_TEXT_1/3	1	1	1815	SYMBOL|()|GENE|GN|DICTIONARY|EXTRACTED	drd4	DRD4	32#36	17879560-1-10-30	D001289	LONGTERM|DICTIONARY	attention deficit hyperactivity disorder	attention deficit hyperactivity disorder	96#136		The human dopamine D4 receptor (DRD4) gene has been extensively studied as a candidate gene for attention deficit hyperactivity disorder (ADHD).
17879560	2007	Neuropsychopharmacol Hung	1419-8711	ALL_TEXT_1/3	1	1	1815	SYMBOL|()|GENE|GN|DICTIONARY|EXTRACTED	drd4	DRD4	32#36	17879560-1-10-30	D001289	SYMBOL|()|DICTIONARY|EXTRACTED	adhd	ADHD	138#142	17879560-1-96-136	The human dopamine D4 receptor (DRD4) gene has been extensively studied as a candidate gene for attention deficit hyperactivity disorder (ADHD).
21153458	2011	Tumour Biol.	1423-0380	ALL_TEXT_2/3	2	6	5743	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	cox 2	COX-2	43#48	21153458-1-48-64	D009369	LONGTERM|DICTIONARY	smaller tumours	smaller tumours	121#136		On the other hand, hypermethylation of the COX-2 gene promoter was observed in 27% of cases and strongly associated with smaller tumours (<5 cm, p = 0.011).
21153458	2011	Tumour Biol.	1423-0380	ALL_TEXT_2/3	2	4	5743	SYMBOL|DICTIONARY|EXTRACTED	cox 2	COX-2	54#59	21153458-1-48-64	D009369	LONGTERM|DICTIONARY	tumours	tumours	15#22		We showed that tumours exhibiting moderate to intense COX-2 immunostaining were significantly more frequent in patients over 45 years old (p = 0.027).
18496208	2008	Psychiatr. Genet.	1473-5873	TITLE	0	0	10611	SYMBOL|DICTIONARY	pdlim5	PDLIM5	0#6		D001714	LONGTERM|DISEASE|DT|DICTIONARY	bipolar disorder	bipolar disorder	29#45		PDLIM5 and susceptibility to bipolar disorder: a family-based association study and meta-analysis.
21153458	2011	Tumour Biol.	1423-0380	ALL_TEXT_1/3	1	2	5743	SYMBOL|DICTIONARY|EXTRACTED	cox 2	COX-2	59#64	21153458-1-48-64	D001943	LONGTERM|DICTIONARY	infiltrating ductal breast carcinomas	infiltrating ductal breast carcinomas	218#255		The aim of this study was to investigate the expression of COX-2 and its association with clinical parameters, patient's survival, hormones receptors (oestrogen, progesterone), ERBB2 and TP53 expression in 83 cases of infiltrating ductal breast carcinomas.
21153458	2011	Tumour Biol.	1423-0380	ALL_TEXT_1/3	1	2	2064	SYMBOL|DICTIONARY	erbb2	ERBB2	177#182		D001943	LONGTERM|DICTIONARY	infiltrating ductal breast carcinomas	infiltrating ductal breast carcinomas	218#255		The aim of this study was to investigate the expression of COX-2 and its association with clinical parameters, patient's survival, hormones receptors (oestrogen, progesterone), ERBB2 and TP53 expression in 83 cases of infiltrating ductal breast carcinomas.
21153458	2011	Tumour Biol.	1423-0380	ALL_TEXT_1/3	1	2	7157	SYMBOL|DICTIONARY	tp53	TP53	187#191		D001943	LONGTERM|DICTIONARY	infiltrating ductal breast carcinomas	infiltrating ductal breast carcinomas	218#255		The aim of this study was to investigate the expression of COX-2 and its association with clinical parameters, patient's survival, hormones receptors (oestrogen, progesterone), ERBB2 and TP53 expression in 83 cases of infiltrating ductal breast carcinomas.
21153458	2011	Tumour Biol.	1423-0380	TITLE	0	0	5743	SYMBOL|DICTIONARY|EXTRACTED	cox 2	COX-2	41#46		D018270	LONGTERM|DISEASE|DT|DICTIONARY	ductal invasive breast carcinoma	ductal invasive breast carcinoma	73#105		Methylation status and overexpression of COX-2 in Tunisian patients with ductal invasive breast carcinoma.
17879560	2007	Neuropsychopharmacol Hung	1419-8711	ALL_TEXT_3/3	3	9	1815	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	drd4	DRD4	166#170	17879560-1-10-30	D009447	LONGTERM|DICTIONARY	neuroblastoma	neuroblastoma	184#197		The different 120 bp duplication alleles (1-repeat, 2-repeat and the newly identified 4-repeat allele) was found to have an effect on transcriptional activity of the DRD4 gene in both neuroblastoma and retinoblastoma cell lines in a dose-dependent manner.
17879560	2007	Neuropsychopharmacol Hung	1419-8711	ALL_TEXT_3/3	3	9	1815	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	drd4	DRD4	166#170	17879560-1-10-30	D012175	LONGTERM|CLINE|CN|DICTIONARY	retinoblastoma	retinoblastoma	202#216		The different 120 bp duplication alleles (1-repeat, 2-repeat and the newly identified 4-repeat allele) was found to have an effect on transcriptional activity of the DRD4 gene in both neuroblastoma and retinoblastoma cell lines in a dose-dependent manner.
17656222	2007	Urology	1527-9995	TITLE	0	0	999	SYMBOL|GENE|GN|DICTIONARY	e cadherin	E-cadherin	19#29		D011471	LONGTERM|DISEASE|DT|DICTIONARY	prostate cancer	prostate cancer	90#105		Significance of an E-cadherin gene promoter polymorphism for risk and disease severity of prostate cancer in a Japanese population.
17656222	2007	Urology	1527-9995	OBJECTIVES	1	1	999	SYMBOL|GENE|GN|DICTIONARY	e cadherin	E-cadherin	34#44		D011471	LONGTERM|DISEASE|DT|DICTIONARY	prostate cancer	prostate cancer	105#120		To explore the significance of an E-cadherin gene promoter polymorphism for risk and disease severity of prostate cancer in a Japanese population.
18001531	2008	Zhonghua Yi Xue Za Zhi	0376-2491	TITLE	0	0	3990	SYMBOL|GENE|GN|DICTIONARY	hepatic lipase	hepatic lipase	44#58		D002544	LONGTERM|DISEASE|DN|DICTIONARY	cerebral infarction	cerebral infarction	76#95		[The linkage disequilibrium of four loci in hepatic lipase promoter gene of cerebral infarction patients in Shanghai].
18001531	2008	Zhonghua Yi Xue Za Zhi	0376-2491	TITLE	0	0	3990	SYMBOL|GENE|GN|DICTIONARY	hepatic lipase	hepatic lipase	44#58		D056486	LONGTERM|DICTIONARY	hepatic lipase	hepatic lipase	44#58	NaN	[The linkage disequilibrium of four loci in hepatic lipase promoter gene of cerebral infarction patients in Shanghai].
17656222	2007	Urology	1527-9995	CONCLUSIONS	4	7	999	SYMBOL|GENE|GN|DICTIONARY	e cadherin	E-cadherin	64#74		D011471	LONGTERM|DISEASE|DT|DICTIONARY	prostate cancer	prostate cancer	105#120		The presence of the A allele of the -160C/A polymorphism in the E-cadherin gene may be a risk factor for prostate cancer in the Japanese population.
18001531	2008	Zhonghua Yi Xue Za Zhi	0376-2491	METHODS	2	3	3990	LONGTERM|DICTIONARY	hl	HL	4#6	NaN	D056486	LONGTERM|DICTIONARY	hl	HL	4#6	NaN	The HL gene polymorphism was analyzed by polymerase chain reaction- restriction fragment length polymorphism.
18001531	2008	Zhonghua Yi Xue Za Zhi	0376-2491	CONCLUSION	4	9	3990	LONGTERM|DICTIONARY	hl	HL	83#85	NaN	D002544	LONGTERM|DISEASE|DN|DICTIONARY	cerebral infarction	cerebral infarction	98#117		There are significant haplotypes and linkage disequilibrium among the four SNPs of HL gene in the cerebral infarction patients of Shanghai.
18001531	2008	Zhonghua Yi Xue Za Zhi	0376-2491	CONCLUSION	4	9	3990	LONGTERM|DICTIONARY	hl	HL	83#85	NaN	D056486	LONGTERM|DICTIONARY	hl	HL	83#85	NaN	There are significant haplotypes and linkage disequilibrium among the four SNPs of HL gene in the cerebral infarction patients of Shanghai.
19210888	2009	Clin. Exp. Rheumatol.	0392-856X	RESULTS	3	5	3123	SYMBOL|DICTIONARY	hla drb1	HLA-DRB1	46#54		D001171	SYMBOL|DICTIONARY|EXTRACTED	jia	JIA	22#25	19210888-1-0-29	In Hungarian patients JIA was associated with HLA-DRB1*01, DRB1*08, DRB1*13 (p=0.048, p=0.002, p=0.019, respectively) with marked differences between the disease subtypes classified according to the ILAR criteria.
19210888	2009	Clin. Exp. Rheumatol.	0392-856X	RESULTS	3	5	3123	SYMBOL|DICTIONARY	drb1	DRB1	59#63		D001171	SYMBOL|DICTIONARY|EXTRACTED	jia	JIA	22#25	19210888-1-0-29	In Hungarian patients JIA was associated with HLA-DRB1*01, DRB1*08, DRB1*13 (p=0.048, p=0.002, p=0.019, respectively) with marked differences between the disease subtypes classified according to the ILAR criteria.
19210888	2009	Clin. Exp. Rheumatol.	0392-856X	RESULTS	3	5	3123	SYMBOL|NUMBER|DICTIONARY	drb1	DRB1	68#72		D001171	SYMBOL|DICTIONARY|EXTRACTED	jia	JIA	22#25	19210888-1-0-29	In Hungarian patients JIA was associated with HLA-DRB1*01, DRB1*08, DRB1*13 (p=0.048, p=0.002, p=0.019, respectively) with marked differences between the disease subtypes classified according to the ILAR criteria.
19210888	2009	Clin. Exp. Rheumatol.	0392-856X	TITLE	0	0	3123	SYMBOL|DICTIONARY	hla drb1	HLA-DRB1	8#16		D001171	LONGTERM|DICTIONARY	juvenile idiopathic arthritis	juvenile idiopathic arthritis	55#84		Role of HLA-DRB1 and PTPN22 genes in susceptibility to juvenile idiopathic arthritis in Hungarian patients.
19210888	2009	Clin. Exp. Rheumatol.	0392-856X	TITLE	0	0	26191	SYMBOL|GENE|GN|DICTIONARY	ptpn22	PTPN22	21#27		D001171	LONGTERM|DICTIONARY	juvenile idiopathic arthritis	juvenile idiopathic arthritis	55#84		Role of HLA-DRB1 and PTPN22 genes in susceptibility to juvenile idiopathic arthritis in Hungarian patients.
19210888	2009	Clin. Exp. Rheumatol.	0392-856X	OBJECTIVE	1	2	26191	SYMBOL|()|DICTIONARY	ptpn22	PTPN22	195#201		D001327	LONGTERM|DICTIONARY	autoimmunity	autoimmunity	108#120		The present study was undertaken to investigate the association of polymorphisms in two candidate genes for autoimmunity, human leukocyte antigen (HLA) DRB1 and protein tyrosine phosphatase N22 (PTPN22) with JIA in Hungarian patients.
19210888	2009	Clin. Exp. Rheumatol.	0392-856X	OBJECTIVE	1	2	26191	SYMBOL|()|DICTIONARY	ptpn22	PTPN22	195#201		D001171	SYMBOL|DICTIONARY|EXTRACTED	jia	JIA	208#211	19210888-1-0-29	The present study was undertaken to investigate the association of polymorphisms in two candidate genes for autoimmunity, human leukocyte antigen (HLA) DRB1 and protein tyrosine phosphatase N22 (PTPN22) with JIA in Hungarian patients.
19210888	2009	Clin. Exp. Rheumatol.	0392-856X	OBJECTIVE	1	2	3123	SYMBOL|DICTIONARY	leukocyte antigen (hla) drb1	leukocyte antigen (HLA) DRB1	128#156		D001327	LONGTERM|DICTIONARY	autoimmunity	autoimmunity	108#120		The present study was undertaken to investigate the association of polymorphisms in two candidate genes for autoimmunity, human leukocyte antigen (HLA) DRB1 and protein tyrosine phosphatase N22 (PTPN22) with JIA in Hungarian patients.
19210888	2009	Clin. Exp. Rheumatol.	0392-856X	OBJECTIVE	1	2	3123	SYMBOL|DICTIONARY	leukocyte antigen (hla) drb1	leukocyte antigen (HLA) DRB1	128#156		D001171	SYMBOL|DICTIONARY|EXTRACTED	jia	JIA	208#211	19210888-1-0-29	The present study was undertaken to investigate the association of polymorphisms in two candidate genes for autoimmunity, human leukocyte antigen (HLA) DRB1 and protein tyrosine phosphatase N22 (PTPN22) with JIA in Hungarian patients.
19210888	2009	Clin. Exp. Rheumatol.	0392-856X	OBJECTIVE	1	2	26191	LONGTERM|DICTIONARY	protein tyrosine phosphatase n22	protein tyrosine phosphatase N22	161#193		D001327	LONGTERM|DICTIONARY	autoimmunity	autoimmunity	108#120		The present study was undertaken to investigate the association of polymorphisms in two candidate genes for autoimmunity, human leukocyte antigen (HLA) DRB1 and protein tyrosine phosphatase N22 (PTPN22) with JIA in Hungarian patients.
19210888	2009	Clin. Exp. Rheumatol.	0392-856X	OBJECTIVE	1	2	26191	LONGTERM|DICTIONARY	protein tyrosine phosphatase n22	protein tyrosine phosphatase N22	161#193		D001171	SYMBOL|DICTIONARY|EXTRACTED	jia	JIA	208#211	19210888-1-0-29	The present study was undertaken to investigate the association of polymorphisms in two candidate genes for autoimmunity, human leukocyte antigen (HLA) DRB1 and protein tyrosine phosphatase N22 (PTPN22) with JIA in Hungarian patients.
21094227	2011	Toxicol. Lett.	1879-3169	ALL_TEXT_3/3	3	12	9464	LONGTERM|DICTIONARY	th2	Th2	142#145	NaN	D056486	LONGTERM|DICTIONARY	liver injury	liver injury	112#124	NaN	In conclusion, to the best of our knowledge, this is the first report to demonstrate that dicloxacillin-induced liver injury is mediated by a Th2-type immune reaction and exacerbated by DK-PGD(2).
19210888	2009	Clin. Exp. Rheumatol.	0392-856X	CONCLUSIONS	4	8	3123	SYMBOL|DICTIONARY	hla drb1	HLA-DRB1	33#41		D001171	SYMBOL|DICTIONARY|EXTRACTED	jia	JIA	125#128	19210888-1-0-29	Our results confirm that certain HLA-DRB1 alleles reported previously as susceptibility factors are strongly associated with JIA in a Hungarian population.
16128377	2006	Acta Cardiol	0001-5385	RESULTS	3	14	1636	SYMBOL|DICTIONARY|EXTRACTED	ace	ACE	89#92	16128377-1-91-120	D006973	LONGTERM|DICTIONARY	hypertension	hypertension	17#29		The incidence of hypertension and cardiovascular events, was significantly higher in the ACE-DD (53 cases, 23%) than in the ACE-ID and ACE-II groups (20 and 3 cases, 5.9% and 2.4%, respectively), p = 0.0001.
16128377	2006	Acta Cardiol	0001-5385	RESULTS	3	14	1636	SYMBOL|DICTIONARY|EXTRACTED	ace	ACE	89#92	16128377-1-91-120	C536170	LONGTERM|DICTIONARY	dd	DD	93#95	NaN	The incidence of hypertension and cardiovascular events, was significantly higher in the ACE-DD (53 cases, 23%) than in the ACE-ID and ACE-II groups (20 and 3 cases, 5.9% and 2.4%, respectively), p = 0.0001.
16128377	2006	Acta Cardiol	0001-5385	RESULTS	3	14	1636	SYMBOL|DICTIONARY|EXTRACTED	ace	ACE	124#127	16128377-1-91-120	D006973	LONGTERM|DICTIONARY	hypertension	hypertension	17#29		The incidence of hypertension and cardiovascular events, was significantly higher in the ACE-DD (53 cases, 23%) than in the ACE-ID and ACE-II groups (20 and 3 cases, 5.9% and 2.4%, respectively), p = 0.0001.
16128377	2006	Acta Cardiol	0001-5385	RESULTS	3	14	1636	SYMBOL|DICTIONARY|EXTRACTED	ace	ACE	124#127	16128377-1-91-120	C536170	LONGTERM|DICTIONARY	dd	DD	93#95	NaN	The incidence of hypertension and cardiovascular events, was significantly higher in the ACE-DD (53 cases, 23%) than in the ACE-ID and ACE-II groups (20 and 3 cases, 5.9% and 2.4%, respectively), p = 0.0001.
16128377	2006	Acta Cardiol	0001-5385	RESULTS	3	14	1636	SYMBOL|DICTIONARY	ace	ACE	135#138		D006973	LONGTERM|DICTIONARY	hypertension	hypertension	17#29		The incidence of hypertension and cardiovascular events, was significantly higher in the ACE-DD (53 cases, 23%) than in the ACE-ID and ACE-II groups (20 and 3 cases, 5.9% and 2.4%, respectively), p = 0.0001.
16128377	2006	Acta Cardiol	0001-5385	RESULTS	3	14	1636	SYMBOL|DICTIONARY	ace	ACE	135#138		C536170	LONGTERM|DICTIONARY	dd	DD	93#95	NaN	The incidence of hypertension and cardiovascular events, was significantly higher in the ACE-DD (53 cases, 23%) than in the ACE-ID and ACE-II groups (20 and 3 cases, 5.9% and 2.4%, respectively), p = 0.0001.
19052543	2009	Neuropsychopharmacology	1740-634X	ALL_TEXT_3/3	3	10	1268	SYMBOL|DICTIONARY|EXTRACTED	cnr1	CNR1	33#37	19052543-1-91-113	D019970	SYMBOL|EXTRACTED	cd	CD	96#98	19052543-1-200-218	We conclude that two independent CNR1 variants have significant interaction effects on risk for CD in EAs; they may also have effects on risk for CD in AAs.
19052543	2009	Neuropsychopharmacology	1740-634X	ALL_TEXT_3/3	3	10	1268	SYMBOL|DICTIONARY|EXTRACTED	cnr1	CNR1	33#37	19052543-1-91-113	D019970	SYMBOL|EXTRACTED	cd	CD	146#148	19052543-1-200-218	We conclude that two independent CNR1 variants have significant interaction effects on risk for CD in EAs; they may also have effects on risk for CD in AAs.
10993992	2000	Neurology	0028-3878	TITLE	0	0	1471	LONGTERM|GENE|GN|DICTIONARY	cystatin c	cystatin C	22#32		D000544	LONGTERM|DISEASE|DT|DICTIONARY	alzheimer's disease	Alzheimer's disease	76#95		A polymorphism in the cystatin C gene is a novel risk factor for late-onset Alzheimer's disease.
10993992	2000	Neurology	0028-3878	RESULTS	3	3	1471	SYMBOL|DICTIONARY|EXTRACTED	cst3	CST3	69#73	10993992-1-59-69	D000544	LONGTERM|DICTIONARY	ad	AD	107#109	NaN	The authors find a signficant interaction between the GG genotype of CST3 and age/age of onset on risk for AD, such that in the over-80 age group the GG genotype contributes two-fold increased risk for the disease.
16128377	2006	Acta Cardiol	0001-5385	RESULTS	3	15	1636	SYMBOL|DICTIONARY|EXTRACTED	ace	ACE	103#106	16128377-1-91-120	D006973	LONGTERM|DICTIONARY	hypertension	hypertension	24#36		The higher incidence of hypertension was observed in the older age groups (36-45 and 46-55 years) with ACE-DD and ACE-ID genotypes.
16128377	2006	Acta Cardiol	0001-5385	RESULTS	3	15	1636	SYMBOL|DICTIONARY|EXTRACTED	ace	ACE	103#106	16128377-1-91-120	C536170	LONGTERM|DICTIONARY	dd	DD	107#109	NaN	The higher incidence of hypertension was observed in the older age groups (36-45 and 46-55 years) with ACE-DD and ACE-ID genotypes.
16128377	2006	Acta Cardiol	0001-5385	RESULTS	3	15	1636	SYMBOL|DICTIONARY|EXTRACTED	ace	ACE	114#117	16128377-1-91-120	D006973	LONGTERM|DICTIONARY	hypertension	hypertension	24#36		The higher incidence of hypertension was observed in the older age groups (36-45 and 46-55 years) with ACE-DD and ACE-ID genotypes.
16128377	2006	Acta Cardiol	0001-5385	RESULTS	3	15	1636	SYMBOL|DICTIONARY|EXTRACTED	ace	ACE	114#117	16128377-1-91-120	C536170	LONGTERM|DICTIONARY	dd	DD	107#109	NaN	The higher incidence of hypertension was observed in the older age groups (36-45 and 46-55 years) with ACE-DD and ACE-ID genotypes.
10993992	2000	Neurology	0028-3878	CONCLUSION	4	7	348	SYMBOL|DICTIONARY	apoe	APOE	48#52		D000544	LONGTERM|DICTIONARY	ad	AD	83#85	NaN	In the author's dataset the opposite effects of APOE and CST3 genotype on risk for AD with increasing age suggest that CST3 is one of the risk factors for later-onset AD.
10993992	2000	Neurology	0028-3878	CONCLUSION	4	7	348	SYMBOL|DICTIONARY	apoe	APOE	48#52		D000544	LONGTERM|DICTIONARY	ad	AD	167#169	NaN	In the author's dataset the opposite effects of APOE and CST3 genotype on risk for AD with increasing age suggest that CST3 is one of the risk factors for later-onset AD.
10993992	2000	Neurology	0028-3878	CONCLUSION	4	7	1471	SYMBOL|DICTIONARY|EXTRACTED	cst3	CST3	57#61	10993992-1-59-69	D000544	LONGTERM|DICTIONARY	ad	AD	83#85	NaN	In the author's dataset the opposite effects of APOE and CST3 genotype on risk for AD with increasing age suggest that CST3 is one of the risk factors for later-onset AD.
10993992	2000	Neurology	0028-3878	CONCLUSION	4	7	1471	SYMBOL|DICTIONARY|EXTRACTED	cst3	CST3	57#61	10993992-1-59-69	D000544	LONGTERM|DICTIONARY	ad	AD	167#169	NaN	In the author's dataset the opposite effects of APOE and CST3 genotype on risk for AD with increasing age suggest that CST3 is one of the risk factors for later-onset AD.
10993992	2000	Neurology	0028-3878	CONCLUSION	4	7	1471	SYMBOL|DICTIONARY|EXTRACTED	cst3	CST3	119#123	10993992-1-59-69	D000544	LONGTERM|DICTIONARY	ad	AD	83#85	NaN	In the author's dataset the opposite effects of APOE and CST3 genotype on risk for AD with increasing age suggest that CST3 is one of the risk factors for later-onset AD.
10993992	2000	Neurology	0028-3878	CONCLUSION	4	7	1471	SYMBOL|DICTIONARY|EXTRACTED	cst3	CST3	119#123	10993992-1-59-69	D000544	LONGTERM|DICTIONARY	ad	AD	167#169	NaN	In the author's dataset the opposite effects of APOE and CST3 genotype on risk for AD with increasing age suggest that CST3 is one of the risk factors for later-onset AD.
10993992	2000	Neurology	0028-3878	CONCLUSION	4	6	348	SYMBOL|DICTIONARY	apoe	APOE	47#51		D000544	LONGTERM|DICTIONARY	ad	AD	31#33	NaN	The reduced or absent risk for AD conferred by APOE in older populations has been well reported in the literature, prompting the suggestion that additional genetic risk factors confer risk for later-onset AD.
10993992	2000	Neurology	0028-3878	CONCLUSION	4	6	348	SYMBOL|DICTIONARY	apoe	APOE	47#51		D000544	LONGTERM|DICTIONARY	ad	AD	205#207	NaN	The reduced or absent risk for AD conferred by APOE in older populations has been well reported in the literature, prompting the suggestion that additional genetic risk factors confer risk for later-onset AD.
20939760	2011	Exp. Lung Res.	1521-0499	TITLE	0	0	1956	LONGTERM|GENE|GT|DICTIONARY	epidermal growth factor receptor	Epidermal growth factor receptor	0#32		D002289	LONGTERM|DISEASE|DT|DICTIONARY	non small cell lung cancer	non-small cell lung cancer	83#109		Epidermal growth factor receptor (EGFR) mutation and p-EGFR expression in resected non-small cell lung cancer.
20939760	2011	Exp. Lung Res.	1521-0499	TITLE	0	0	1956	SYMBOL|()|DICTIONARY|EXTRACTED	egfr	EGFR	34#38	20939760-0-0-32	D002289	LONGTERM|DISEASE|DT|DICTIONARY	non small cell lung cancer	non-small cell lung cancer	83#109		Epidermal growth factor receptor (EGFR) mutation and p-EGFR expression in resected non-small cell lung cancer.
20939760	2011	Exp. Lung Res.	1521-0499	TITLE	0	0	1956	SYMBOL|DICTIONARY|EXTRACTED	egfr	EGFR	55#59	20939760-0-0-32	D002289	LONGTERM|DISEASE|DT|DICTIONARY	non small cell lung cancer	non-small cell lung cancer	83#109		Epidermal growth factor receptor (EGFR) mutation and p-EGFR expression in resected non-small cell lung cancer.
23768946	2014	Neuromuscul. Disord.	1873-2364	TITLE	0	0	7148	SYMBOL|GENE|GN|DICTIONARY	tnxb	TNXB	39#43		D009135	LONGTERM|DICTIONARY	myopathy	myopathy	63#71		Compound heterozygous mutations of the TNXB gene cause primary myopathy.
12939326	2003	Invest. Ophthalmol. Vis. Sci.	0146-0404	METHODS	2	2	1280	SYMBOL|GENE|GN|DICTIONARY	col2a1	COL2A1	86#92		C537492	LONGTERM|DICTIONARY	stickler syndrome type 1	Stickler syndrome type 1	114#138		Clinical examination and linkage analysis of both families using markers flanking the COL2A1 gene associated with Stickler syndrome type 1, the loci for Wagner disease/erosive vitreoretinopathy (5q14.3), high myopia (18p11.31 and 12q21-q23), and nonsyndromic congenital retinal nonattachment (10q21).
12939326	2003	Invest. Ophthalmol. Vis. Sci.	0146-0404	METHODS	2	2	1280	SYMBOL|GENE|GN|DICTIONARY	col2a1	COL2A1	86#92		D009216	LONGTERM|DICTIONARY	high myopia	high myopia	204#215		Clinical examination and linkage analysis of both families using markers flanking the COL2A1 gene associated with Stickler syndrome type 1, the loci for Wagner disease/erosive vitreoretinopathy (5q14.3), high myopia (18p11.31 and 12q21-q23), and nonsyndromic congenital retinal nonattachment (10q21).
12939326	2003	Invest. Ophthalmol. Vis. Sci.	0146-0404	METHODS	2	2	1280	SYMBOL|GENE|GN|DICTIONARY	col2a1	COL2A1	86#92		C536075	LONGTERM|DISEASE|DT|DICTIONARY	wagner disease/erosive vitreoretinopathy	Wagner disease/erosive vitreoretinopathy	153#193		Clinical examination and linkage analysis of both families using markers flanking the COL2A1 gene associated with Stickler syndrome type 1, the loci for Wagner disease/erosive vitreoretinopathy (5q14.3), high myopia (18p11.31 and 12q21-q23), and nonsyndromic congenital retinal nonattachment (10q21).
12939326	2003	Invest. Ophthalmol. Vis. Sci.	0146-0404	METHODS	2	2	1280	SYMBOL|GENE|GN|DICTIONARY	col2a1	COL2A1	86#92		C536075	LONGTERM|DICTIONARY	wagner disease/erosive vitreoretinopathy	Wagner disease/erosive vitreoretinopathy	153#193		Clinical examination and linkage analysis of both families using markers flanking the COL2A1 gene associated with Stickler syndrome type 1, the loci for Wagner disease/erosive vitreoretinopathy (5q14.3), high myopia (18p11.31 and 12q21-q23), and nonsyndromic congenital retinal nonattachment (10q21).
19753311	2009	Mol. Vis.	1090-0535	PURPOSE	1	2	1134	LONGTERM|DICTIONARY	machr 1	mAChR 1	62#69	NaN	D005124	LONGTERM|DICTIONARY	myopic eye change	myopic eye change	112#129		Among all of the muscarinic acetylcholine receptors (mAChRs), mAChR 1 (M1) was the most effective in preventing myopic eye change.
19753311	2009	Mol. Vis.	1090-0535	PURPOSE	1	2	1134	LONGTERM|DICTIONARY	machr 1	mAChR 1	62#69	NaN	D005124	LONGTERM|DICTIONARY	myopic eye change	myopic eye change	112#129		Among all of the muscarinic acetylcholine receptors (mAChRs), mAChR 1 (M1) was the most effective in preventing myopic eye change.
23142968	2013	Psychiatr. Genet.	1473-5873	TITLE	0	0	55733	SYMBOL|DICTIONARY	hhat	HHAT	72#76		D012559	LONGTERM|DICTIONARY	schizophrenia	schizophrenia	80#93		Whole-genome-wide association study in the Bulgarian population reveals HHAT as schizophrenia susceptibility gene.
23142968	2013	Psychiatr. Genet.	1473-5873	RESULTS	3	6	55733	SYMBOL|GENE|GN|DICTIONARY	hhat	HHAT	95#99		D012559	LONGTERM|DICTIONARY	schizophrenia	schizophrenia	43#56		We found a significant association between schizophrenia and the intronic SNP rs7527939 in the HHAT gene (P-value of 6.4910 with an odds ratio of 2.63, 95% confidence interval of 1.89-3.66).
23142968	2013	Psychiatr. Genet.	1473-5873	CONCLUSION	4	8	55733	SYMBOL|DICTIONARY	hhat	HHAT	125#129		D012559	LONGTERM|DICTIONARY	schizophrenia	schizophrenia	72#85		We suggest rs7527939 to be the strongest indicator of susceptibility to schizophrenia in the Bulgarian population within the HHAT locus.
20237358	2010	Reprod Sci	1933-7205	ALL_TEXT_1/3	1	2	6347	SYMBOL|DICTIONARY|EXTRACTED	mcp 1	MCP-1	175#180	20237358-1-49-79	D000292	SYMBOL|DICTIONARY|EXTRACTED	pid	PID	257#260	20237358-1-131-158	The enzyme-linked immunosorbent assay (ELISA) and polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) were, respectively, used to measure the plasma MCP-1 level and MCP-1 polymorphism in 70 healthy controls and in 64 patients with PID before and after they received routine treatment protocols.
20237358	2010	Reprod Sci	1933-7205	ALL_TEXT_1/3	1	2	6347	SYMBOL|DICTIONARY|EXTRACTED	mcp 1	MCP-1	191#196	20237358-1-49-79	D000292	SYMBOL|DICTIONARY|EXTRACTED	pid	PID	257#260	20237358-1-131-158	The enzyme-linked immunosorbent assay (ELISA) and polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) were, respectively, used to measure the plasma MCP-1 level and MCP-1 polymorphism in 70 healthy controls and in 64 patients with PID before and after they received routine treatment protocols.
12355549	2002	Environ. Mol. Mutagen.	0893-6692	ALL_TEXT_3/3	3	7	9	SYMBOL|NUMBER|DICTIONARY|EXTRACTED	nat1	NAT1	124#128	12355549-1-0-21	D011471	LONGTERM|DISEASE|DT|DICTIONARY	prostate cancer	prostate cancer	74#89		The results of this small pilot study suggest increased susceptibility to prostate cancer for subjects with combinations of NAT1*10 and slow (particularly very slow) NAT2 acetylator genotypes.
12355549	2002	Environ. Mol. Mutagen.	0893-6692	ALL_TEXT_3/3	3	7	10	SYMBOL|DICTIONARY|EXTRACTED	nat2	NAT2	166#170	12355549-1-33-54	D011471	LONGTERM|DISEASE|DT|DICTIONARY	prostate cancer	prostate cancer	74#89		The results of this small pilot study suggest increased susceptibility to prostate cancer for subjects with combinations of NAT1*10 and slow (particularly very slow) NAT2 acetylator genotypes.
17404734	2008	Rheumatol. Int.	0172-8172	ALL_TEXT_1/3	1	2	6573	SYMBOL|GENE|GN|DICTIONARY	slc19a1	SLC19A1	40#47		D001172	LONGTERM|DICTIONARY|DISEASE|DA	rheumatoid arthritis	rheumatoid arthritis	80#100		In this respect, we investigate whether SLC19A1 genetic variations could affect rheumatoid arthritis (RA) patient response to antifolate treatment.
17404734	2008	Rheumatol. Int.	0172-8172	ALL_TEXT_1/3	1	2	6573	SYMBOL|GENE|GN|DICTIONARY	slc19a1	SLC19A1	40#47		D001172	SYMBOL|()|DISEASE|DN|DICTIONARY|EXTRACTED	ra	RA	102#104	17404734-2-80-100	In this respect, we investigate whether SLC19A1 genetic variations could affect rheumatoid arthritis (RA) patient response to antifolate treatment.
12355549	2002	Environ. Mol. Mutagen.	0893-6692	ALL_TEXT_3/3	3	5	9	SYMBOL|DICTIONARY|EXTRACTED	nat1	NAT1	42#46	12355549-1-0-21	D011471	LONGTERM|DISEASE|DT|DICTIONARY	prostate cancer	prostate cancer	139#154		In contrast, in comparison with all other NAT1 genotypes the putative rapid acetylator NAT1 genotype (NAT1*10) was significantly higher in prostate cancer cases than controls (OR, 2.17; 95% CI, 1.08-4.33; P = 0.03).
12355549	2002	Environ. Mol. Mutagen.	0893-6692	ALL_TEXT_3/3	3	5	9	SYMBOL|DICTIONARY|EXTRACTED	nat1	NAT1	87#91	12355549-1-0-21	D011471	LONGTERM|DISEASE|DT|DICTIONARY	prostate cancer	prostate cancer	139#154		In contrast, in comparison with all other NAT1 genotypes the putative rapid acetylator NAT1 genotype (NAT1*10) was significantly higher in prostate cancer cases than controls (OR, 2.17; 95% CI, 1.08-4.33; P = 0.03).
12355549	2002	Environ. Mol. Mutagen.	0893-6692	ALL_TEXT_3/3	3	5	9	SYMBOL|NUMBER|DICTIONARY|EXTRACTED	nat1	NAT1	102#106	12355549-1-0-21	D011471	LONGTERM|DISEASE|DT|DICTIONARY	prostate cancer	prostate cancer	139#154		In contrast, in comparison with all other NAT1 genotypes the putative rapid acetylator NAT1 genotype (NAT1*10) was significantly higher in prostate cancer cases than controls (OR, 2.17; 95% CI, 1.08-4.33; P = 0.03).
17404734	2008	Rheumatol. Int.	0172-8172	TITLE	0	0	6573	SYMBOL|GENE|GN|DICTIONARY	slc19a1	SLC19A1	74#81		D001172	LONGTERM|DISEASE|DN|DICTIONARY	rheumatoid arthritis	rheumatoid arthritis	100#120		Transcription regulatory polymorphism -43T>C in the 5'-flanking region of SLC19A1 gene could affect rheumatoid arthritis patient response to methotrexate therapy.
17131847	2007	Ann Acad Med Stetin	1427-440X	PURPOSE	1	1	5473	LONGTERM|DICTIONARY	beta thromboglobulin	beta-thromboglobulin	140#160		D017379	LONGTERM|DICTIONARY	left ventricular hypertrophy	left ventricular hypertrophy	347#375		1.The assessment in haemostasis system, fibrinogen, tissue plasminogen activator (t-PA) and its inhibitor type-1, von Willebrand factor and beta-thromboglobulin (beta-TG) levels and the changes in renin-angiotensin system (RAS), by determined angiotensin converting enzyme I (ACE) activity, in patients with essential hypertension (in relation to left ventricular hypertrophy) in comparison with normotension subjects.2.
17131847	2007	Ann Acad Med Stetin	1427-440X	PURPOSE	1	1	5473	LONGTERM|DICTIONARY	beta thromboglobulin	beta-thromboglobulin	140#160		D006973	LONGTERM|DICTIONARY	hypertension	hypertension	318#330		1.The assessment in haemostasis system, fibrinogen, tissue plasminogen activator (t-PA) and its inhibitor type-1, von Willebrand factor and beta-thromboglobulin (beta-TG) levels and the changes in renin-angiotensin system (RAS), by determined angiotensin converting enzyme I (ACE) activity, in patients with essential hypertension (in relation to left ventricular hypertrophy) in comparison with normotension subjects.2.
17131847	2007	Ann Acad Med Stetin	1427-440X	PURPOSE	1	1	5473	SYMBOL|EXTRACTED|()	beta tg	beta-TG	162#169	17131847-1-140-160	D017379	LONGTERM|DICTIONARY	left ventricular hypertrophy	left ventricular hypertrophy	347#375		1.The assessment in haemostasis system, fibrinogen, tissue plasminogen activator (t-PA) and its inhibitor type-1, von Willebrand factor and beta-thromboglobulin (beta-TG) levels and the changes in renin-angiotensin system (RAS), by determined angiotensin converting enzyme I (ACE) activity, in patients with essential hypertension (in relation to left ventricular hypertrophy) in comparison with normotension subjects.2.
17131847	2007	Ann Acad Med Stetin	1427-440X	PURPOSE	1	1	5473	SYMBOL|EXTRACTED|()	beta tg	beta-TG	162#169	17131847-1-140-160	D006973	LONGTERM|DICTIONARY	hypertension	hypertension	318#330		1.The assessment in haemostasis system, fibrinogen, tissue plasminogen activator (t-PA) and its inhibitor type-1, von Willebrand factor and beta-thromboglobulin (beta-TG) levels and the changes in renin-angiotensin system (RAS), by determined angiotensin converting enzyme I (ACE) activity, in patients with essential hypertension (in relation to left ventricular hypertrophy) in comparison with normotension subjects.2.
17131847	2007	Ann Acad Med Stetin	1427-440X	PURPOSE	1	1	5327	LONGTERM|DICTIONARY	tissue plasminogen activator (t-pa	tissue plasminogen activator (t-PA	52#86		D017379	LONGTERM|DICTIONARY	left ventricular hypertrophy	left ventricular hypertrophy	347#375		1.The assessment in haemostasis system, fibrinogen, tissue plasminogen activator (t-PA) and its inhibitor type-1, von Willebrand factor and beta-thromboglobulin (beta-TG) levels and the changes in renin-angiotensin system (RAS), by determined angiotensin converting enzyme I (ACE) activity, in patients with essential hypertension (in relation to left ventricular hypertrophy) in comparison with normotension subjects.2.
17131847	2007	Ann Acad Med Stetin	1427-440X	PURPOSE	1	1	5327	LONGTERM|DICTIONARY	tissue plasminogen activator (t-pa	tissue plasminogen activator (t-PA	52#86		D006973	LONGTERM|DICTIONARY	hypertension	hypertension	318#330		1.The assessment in haemostasis system, fibrinogen, tissue plasminogen activator (t-PA) and its inhibitor type-1, von Willebrand factor and beta-thromboglobulin (beta-TG) levels and the changes in renin-angiotensin system (RAS), by determined angiotensin converting enzyme I (ACE) activity, in patients with essential hypertension (in relation to left ventricular hypertrophy) in comparison with normotension subjects.2.
17131847	2007	Ann Acad Med Stetin	1427-440X	PURPOSE	1	1	5327	SYMBOL|EXTRACTED|()	tissue plasminogen activator (t-pa	tissue plasminogen activator (t-PA	52#86	17131847-1-52-80	D017379	LONGTERM|DICTIONARY	left ventricular hypertrophy	left ventricular hypertrophy	347#375		1.The assessment in haemostasis system, fibrinogen, tissue plasminogen activator (t-PA) and its inhibitor type-1, von Willebrand factor and beta-thromboglobulin (beta-TG) levels and the changes in renin-angiotensin system (RAS), by determined angiotensin converting enzyme I (ACE) activity, in patients with essential hypertension (in relation to left ventricular hypertrophy) in comparison with normotension subjects.2.
17131847	2007	Ann Acad Med Stetin	1427-440X	PURPOSE	1	1	5327	SYMBOL|EXTRACTED|()	tissue plasminogen activator (t-pa	tissue plasminogen activator (t-PA	52#86	17131847-1-52-80	D006973	LONGTERM|DICTIONARY	hypertension	hypertension	318#330		1.The assessment in haemostasis system, fibrinogen, tissue plasminogen activator (t-PA) and its inhibitor type-1, von Willebrand factor and beta-thromboglobulin (beta-TG) levels and the changes in renin-angiotensin system (RAS), by determined angiotensin converting enzyme I (ACE) activity, in patients with essential hypertension (in relation to left ventricular hypertrophy) in comparison with normotension subjects.2.
17131847	2007	Ann Acad Med Stetin	1427-440X	PURPOSE	1	1	7450	LONGTERM|GENE|GT|DICTIONARY	type-1, von willebrand factor	type-1, von Willebrand factor	106#135		D017379	LONGTERM|DICTIONARY	left ventricular hypertrophy	left ventricular hypertrophy	347#375		1.The assessment in haemostasis system, fibrinogen, tissue plasminogen activator (t-PA) and its inhibitor type-1, von Willebrand factor and beta-thromboglobulin (beta-TG) levels and the changes in renin-angiotensin system (RAS), by determined angiotensin converting enzyme I (ACE) activity, in patients with essential hypertension (in relation to left ventricular hypertrophy) in comparison with normotension subjects.2.
17131847	2007	Ann Acad Med Stetin	1427-440X	PURPOSE	1	1	7450	LONGTERM|GENE|GT|DICTIONARY	type-1, von willebrand factor	type-1, von Willebrand factor	106#135		D006973	LONGTERM|DICTIONARY	hypertension	hypertension	318#330		1.The assessment in haemostasis system, fibrinogen, tissue plasminogen activator (t-PA) and its inhibitor type-1, von Willebrand factor and beta-thromboglobulin (beta-TG) levels and the changes in renin-angiotensin system (RAS), by determined angiotensin converting enzyme I (ACE) activity, in patients with essential hypertension (in relation to left ventricular hypertrophy) in comparison with normotension subjects.2.
17131847	2007	Ann Acad Med Stetin	1427-440X	PURPOSE	1	1	1636	LONGTERM|GENE|GT|DICTIONARY	angiotensin converting enzyme i	angiotensin converting enzyme I	243#274		D017379	LONGTERM|DICTIONARY	left ventricular hypertrophy	left ventricular hypertrophy	347#375		1.The assessment in haemostasis system, fibrinogen, tissue plasminogen activator (t-PA) and its inhibitor type-1, von Willebrand factor and beta-thromboglobulin (beta-TG) levels and the changes in renin-angiotensin system (RAS), by determined angiotensin converting enzyme I (ACE) activity, in patients with essential hypertension (in relation to left ventricular hypertrophy) in comparison with normotension subjects.2.
17131847	2007	Ann Acad Med Stetin	1427-440X	PURPOSE	1	1	1636	LONGTERM|GENE|GT|DICTIONARY	angiotensin converting enzyme i	angiotensin converting enzyme I	243#274		D006973	LONGTERM|DICTIONARY	hypertension	hypertension	318#330		1.The assessment in haemostasis system, fibrinogen, tissue plasminogen activator (t-PA) and its inhibitor type-1, von Willebrand factor and beta-thromboglobulin (beta-TG) levels and the changes in renin-angiotensin system (RAS), by determined angiotensin converting enzyme I (ACE) activity, in patients with essential hypertension (in relation to left ventricular hypertrophy) in comparison with normotension subjects.2.
17131847	2007	Ann Acad Med Stetin	1427-440X	PURPOSE	1	1	2244	LONGTERM|DICTIONARY	fibrinogen	fibrinogen	40#50	NaN	D017379	LONGTERM|DICTIONARY	left ventricular hypertrophy	left ventricular hypertrophy	347#375		1.The assessment in haemostasis system, fibrinogen, tissue plasminogen activator (t-PA) and its inhibitor type-1, von Willebrand factor and beta-thromboglobulin (beta-TG) levels and the changes in renin-angiotensin system (RAS), by determined angiotensin converting enzyme I (ACE) activity, in patients with essential hypertension (in relation to left ventricular hypertrophy) in comparison with normotension subjects.2.
17131847	2007	Ann Acad Med Stetin	1427-440X	PURPOSE	1	1	2244	LONGTERM|DICTIONARY	fibrinogen	fibrinogen	40#50	NaN	D006973	LONGTERM|DICTIONARY	hypertension	hypertension	318#330		1.The assessment in haemostasis system, fibrinogen, tissue plasminogen activator (t-PA) and its inhibitor type-1, von Willebrand factor and beta-thromboglobulin (beta-TG) levels and the changes in renin-angiotensin system (RAS), by determined angiotensin converting enzyme I (ACE) activity, in patients with essential hypertension (in relation to left ventricular hypertrophy) in comparison with normotension subjects.2.
12355549	2002	Environ. Mol. Mutagen.	0893-6692	ALL_TEXT_1/3	1	1	10	SYMBOL|()|DICTIONARY|EXTRACTED	nat1	NAT1	23#27	12355549-1-0-21	D011471	LONGTERM|DICTIONARY	prostate tumors	prostate tumors	153#168		N-acetyltransferase-1 (NAT1) and N-acetyltransferase-2 (NAT2) are important in the metabolism of aromatic and heterocyclic amine carcinogens that induce prostate tumors in the rat.
12355549	2002	Environ. Mol. Mutagen.	0893-6692	ALL_TEXT_1/3	1	1	9	SYMBOL|()|DICTIONARY|EXTRACTED	nat2	NAT2	56#60	12355549-1-33-54	D011471	LONGTERM|DICTIONARY	prostate tumors	prostate tumors	153#168		N-acetyltransferase-1 (NAT1) and N-acetyltransferase-2 (NAT2) are important in the metabolism of aromatic and heterocyclic amine carcinogens that induce prostate tumors in the rat.
12355549	2002	Environ. Mol. Mutagen.	0893-6692	TITLE	0	0	9	SYMBOL|NUMBER|DICTIONARY|EXTRACTED	nat1	NAT1	65#69		D011471	LONGTERM|DISEASE|DT|DICTIONARY	prostate cancer	prostate cancer	15#30		Association of prostate cancer with rapid N-acetyltransferase 1 (NAT1*10) in combination with slow N-acetyltransferase 2 acetylator genotypes in a pilot case-control study.
12355549	2002	Environ. Mol. Mutagen.	0893-6692	TITLE	0	0	10	LONGTERM|DICTIONARY	n acetyltransferase 2	N-acetyltransferase 2	99#120		D011471	LONGTERM|DISEASE|DT|DICTIONARY	prostate cancer	prostate cancer	15#30		Association of prostate cancer with rapid N-acetyltransferase 1 (NAT1*10) in combination with slow N-acetyltransferase 2 acetylator genotypes in a pilot case-control study.
19450125	2009	Pharmacogenomics	1744-8042	CONCLUSION	4	9	54658	SYMBOL|DICTIONARY	ugt1a1	UGT1A1	27#33		D006402	LONGTERM|DICTIONARY	hematological toxicity	hematological toxicity	72#94	NaN	Our findings indicate that UGT1A1 genotyping is not a good predictor of hematological toxicity in patients treated with intermediate irinotecan doses.
20350254	2010	Ann. Med.	1365-2060	BACKGROUND AND AIM	1	2	3606	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	il 18	IL-18	30#35	20350254-1-0-14	D050197	LONGTERM|DICTIONARY	atherosclerosis	atherosclerosis	130#145		We wanted to evaluate whether IL-18 gene polymorphism associates independently of risk factors, with early subclinical markers of atherosclerosis (intima-media thickness (IMT), coronary artery compliance (CAC), and flow-mediated dilatation (FMD)) in a population of young healthy Caucasian adults.
20350254	2010	Ann. Med.	1365-2060	BACKGROUND AND AIM	1	2	3606	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	il 18	IL-18	30#35	20350254-1-0-14	D002311	LONGTERM|DICTIONARY	flow-mediated dilatation	flow-mediated dilatation	215#239	NaN	We wanted to evaluate whether IL-18 gene polymorphism associates independently of risk factors, with early subclinical markers of atherosclerosis (intima-media thickness (IMT), coronary artery compliance (CAC), and flow-mediated dilatation (FMD)) in a population of young healthy Caucasian adults.
20350254	2010	Ann. Med.	1365-2060	BACKGROUND AND AIM	1	2	3606	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	il 18	IL-18	30#35	20350254-1-0-14	D009135	LONGTERM|DICTIONARY	intima-media thickness	intima-media thickness	147#169	NaN	We wanted to evaluate whether IL-18 gene polymorphism associates independently of risk factors, with early subclinical markers of atherosclerosis (intima-media thickness (IMT), coronary artery compliance (CAC), and flow-mediated dilatation (FMD)) in a population of young healthy Caucasian adults.
19571538	2009	Cardiology	1421-9751	CONCLUSION	4	9	51085	SYMBOL|GENE|GN|DICTIONARY	mlxipl	MLXIPL	35#41		D003324	SYMBOL|DICTIONARY|EXTRACTED	cad	CAD	111#114	19571538-2-76-99	The gene sequence variation in the MLXIPL gene may serve as a novel genetic marker for the risk of significant CAD.
17434869	2007	Science	1095-9203	TITLE	0	0	79068	SYMBOL|GENE|GN|DICTIONARY	fto	FTO	24#27		D009765	LONGTERM|DICTIONARY	obesity	obesity	107#114		A common variant in the FTO gene is associated with body mass index and predisposes to childhood and adult obesity.
17434869	2007	Science	1095-9203	ALL_TEXT_2/3	2	3	79068	SYMBOL|DICTIONARY	fto	FTO	97#100		D003920	LONGTERM|DICTIONARY	diabetes	diabetes	160#168		A genome-wide search for type 2 diabetes-susceptibility genes identified a common variant in the FTO (fat mass and obesity associated) gene that predisposes to diabetes through an effect on body mass index (BMI).
17434869	2007	Science	1095-9203	ALL_TEXT_2/3	2	3	79068	SYMBOL|DICTIONARY	fto	FTO	97#100		D003920	LONGTERM|DICTIONARY	diabetes	diabetes	32#40		A genome-wide search for type 2 diabetes-susceptibility genes identified a common variant in the FTO (fat mass and obesity associated) gene that predisposes to diabetes through an effect on body mass index (BMI).
15562935	2005	Clin Cardiol	0160-9289	RESULTS	4	12	4973	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	lox 1	LOX-1	35#40	15562935-1-48-61	D003251	LONGTERM|DICTIONARY	stenosis	stenosis	115#123	NaN	Multivariate analysis demonstrated LOX-1 gene variants to be inversely associated with the presence of significant stenosis (odds ratio = 0.61; 95% confidence interval = 0.41-0.92).
19115972	2009	Clin. Infect. Dis.	1537-6591	ALL_TEXT_1/3	1	1	3106	SYMBOL|NUMBER|DICTIONARY	human leukocyte antigen allele (hla)-b	Human leukocyte antigen allele (HLA)-B	0#38		D004342	LONGTERM|DICTIONARY	hypersensitivity	hypersensitivity	72#88	NaN	Human leukocyte antigen allele (HLA)-B*5701 is associated with abacavir hypersensitivity.
20638926	2010	Cancer Epidemiol	1877-783X	CONCLUSIONS	4	5	4487	SYMBOL|GENE|GN|DICTIONARY	msx1	MSX1	59#63		D001943	LONGTERM|DISEASE|DT|DICTIONARY	breast cancer	breast cancer	114#127		The del/del genotype of the c.469+46_56del mutation in the MSX1 gene may be associated with the increased risk of breast cancer in Polish population and may be considered as an early marker in this disease.
20857490	2011	Int. J. Cancer	1097-0215	ALL_TEXT_3/3	3	10	9149	LONGTERM|DICTIONARY	mirk	Mirk	56#60	NaN	D034381	LONGTERM|DICTIONARY	loss of viability	loss of viability	102#119	NaN	In TOV21G cells, but not in normal diploid fibroblasts, Mirk depletion led to increased apoptosis and loss of viability.
12699434	2003	Clin. Endocrinol. (Oxf)	0300-0664	TITLE	0	0	1392	LONGTERM|DICTIONARY	corticotrophin-releasing hormone	corticotrophin-releasing hormone	30#62	NaN	D003480	LONGTERM|DISEASE|DT|DICTIONARY	cushing disease	Cushing's disease	81#98		Pituitary apoplexy induced by corticotrophin-releasing hormone in a patient with Cushing's disease.
18268124	2008	Cancer Epidemiol. Biomarkers Prev.	1055-9965	ALL_TEXT_1/3	1	1	4582	SYMBOL|DICTIONARY	muc1	MUC1	67#71		D010051	LONGTERM|DISEASE|DT|DICTIONARY	epithelial ovarian cancer	epithelial ovarian cancer	95#120		Studies suggest that underglycosylation of the cell membrane mucin MUC1 may be associated with epithelial ovarian cancer.
16528020	2006	Am. J. Respir. Crit. Care Med.	1073-449X	RATIONALE	1	1	3654	SYMBOL|()|DICTIONARY	irak 1	IRAK-1	37#43		D018805	LONGTERM|DICTIONARY	sepsis	sepsis	193#199		The IL-1 receptor-associated kinase (IRAK-1) plays a central role in TLR2- and TLR4-induced activation of nuclear factor (NF)-kappaB, a critical event in the transcriptional regulation of many sepsis-associated proinflammatory mediators.
16528020	2006	Am. J. Respir. Crit. Care Med.	1073-449X	RATIONALE	1	1	7097	SYMBOL|DICTIONARY	tlr2	TLR2	69#73		D018805	LONGTERM|DICTIONARY	sepsis	sepsis	193#199		The IL-1 receptor-associated kinase (IRAK-1) plays a central role in TLR2- and TLR4-induced activation of nuclear factor (NF)-kappaB, a critical event in the transcriptional regulation of many sepsis-associated proinflammatory mediators.
16528020	2006	Am. J. Respir. Crit. Care Med.	1073-449X	RATIONALE	1	1	7099	SYMBOL|DICTIONARY	tlr4	TLR4	79#83		D018805	LONGTERM|DICTIONARY	sepsis	sepsis	193#199		The IL-1 receptor-associated kinase (IRAK-1) plays a central role in TLR2- and TLR4-induced activation of nuclear factor (NF)-kappaB, a critical event in the transcriptional regulation of many sepsis-associated proinflammatory mediators.
16528020	2006	Am. J. Respir. Crit. Care Med.	1073-449X	RATIONALE	1	1	4790	LONGTERM|DICTIONARY	nuclear factor (nf)-kappab	nuclear factor (NF)-kappaB	106#132	NaN	D018805	LONGTERM|DICTIONARY	sepsis	sepsis	193#199		The IL-1 receptor-associated kinase (IRAK-1) plays a central role in TLR2- and TLR4-induced activation of nuclear factor (NF)-kappaB, a critical event in the transcriptional regulation of many sepsis-associated proinflammatory mediators.
16528020	2006	Am. J. Respir. Crit. Care Med.	1073-449X	TITLE	0	0	3654	SYMBOL|DICTIONARY	irak 1	IRAK-1	8#14		D018805	LONGTERM|DICTIONARY	sepsis	sepsis	109#115		Variant IRAK-1 haplotype is associated with increased nuclear factor-kappaB activation and worse outcomes in sepsis.
16528020	2006	Am. J. Respir. Crit. Care Med.	1073-449X	MEASUREMENTS AND MAIN RESULTS	3	6	3654	SYMBOL|DICTIONARY	irak 1	IRAK-1	4#10		D018805	LONGTERM|DICTIONARY	sepsis	sepsis	153#159		The IRAK-1 variant haplotype was associated with increased nuclear levels of NF-kappaB in LPS-stimulated peripheral blood neutrophils from patients with sepsis compared with that found in patients with wild-type IRAK-1 haplotype (p=0.0009).
16528020	2006	Am. J. Respir. Crit. Care Med.	1073-449X	MEASUREMENTS AND MAIN RESULTS	3	6	3654	SYMBOL|DICTIONARY	irak 1	IRAK-1	212#218		D018805	LONGTERM|DICTIONARY	sepsis	sepsis	153#159		The IRAK-1 variant haplotype was associated with increased nuclear levels of NF-kappaB in LPS-stimulated peripheral blood neutrophils from patients with sepsis compared with that found in patients with wild-type IRAK-1 haplotype (p=0.0009).
16528020	2006	Am. J. Respir. Crit. Care Med.	1073-449X	MEASUREMENTS AND MAIN RESULTS	3	6	4790	LONGTERM|DICTIONARY	nf-kappab	NF-kappaB	77#86	NaN	D018805	LONGTERM|DICTIONARY	sepsis	sepsis	153#159		The IRAK-1 variant haplotype was associated with increased nuclear levels of NF-kappaB in LPS-stimulated peripheral blood neutrophils from patients with sepsis compared with that found in patients with wild-type IRAK-1 haplotype (p=0.0009).
16690408	2006	Hum. Immunol.	0198-8859	ALL_TEXT_3/3	3	8	6891	SYMBOL|DICTIONARY	tap2	TAP2	7#11		D010392	SYMBOL|EXTRACTED	pv	PV	4#6	16690408-1-0-18	Two PV TAP2 risk alleles were identified (TAP2*C and TAP2*D), the frequency of which was estimated to be 37.8% in the patients and 5.3 % in the controls.
16690408	2006	Hum. Immunol.	0198-8859	ALL_TEXT_3/3	3	8	6891	SYMBOL|DICTIONARY	tap2	TAP2	42#46		D010392	SYMBOL|EXTRACTED	pv	PV	4#6	16690408-1-0-18	Two PV TAP2 risk alleles were identified (TAP2*C and TAP2*D), the frequency of which was estimated to be 37.8% in the patients and 5.3 % in the controls.
16690408	2006	Hum. Immunol.	0198-8859	ALL_TEXT_3/3	3	8	6891	SYMBOL|DICTIONARY	tap2	TAP2	53#57		D010392	SYMBOL|EXTRACTED	pv	PV	4#6	16690408-1-0-18	Two PV TAP2 risk alleles were identified (TAP2*C and TAP2*D), the frequency of which was estimated to be 37.8% in the patients and 5.3 % in the controls.
17131847	2007	Ann Acad Med Stetin	1427-440X	CONCLUSION	3	9	1636	SYMBOL|GENE|GN|DICTIONARY	ace	ACE	83#86		D017379	LONGTERM|DICTIONARY	left ventricular hypertrophy	left ventricular hypertrophy	109#137		The treatment with perindopril decreases blood pressure effectively independent of ACE gene I/D genotype and left ventricular hypertrophy.
19390641	2009	Mol. Vis.	1090-0535	TITLE	0	0	6247	LONGTERM|DICTIONARY	x-linked retinoschisis	X-linked retinoschisis	37#59	NaN	D041441	LONGTERM|DICTIONARY	x linked retinoschisis	X-linked retinoschisis	37#59		Molecular genetic characteristics of X-linked retinoschisis in Koreans.
16528020	2006	Am. J. Respir. Crit. Care Med.	1073-449X	CONCLUSIONS	4	8	3654	SYMBOL|DICTIONARY	irak 1	IRAK-1	32#38		D018805	LONGTERM|DICTIONARY	sepsis	sepsis	102#108		These results indicate that the IRAK-1 variant haplotype is functionally significant in patients with sepsis, being associated with increased nuclear translocation of NF-kappaB, more severe organ dysfunction, and higher mortality.
16528020	2006	Am. J. Respir. Crit. Care Med.	1073-449X	CONCLUSIONS	4	8	4790	LONGTERM|DICTIONARY	nf-kappab	NF-kappaB	167#176	NaN	D018805	LONGTERM|DICTIONARY	sepsis	sepsis	102#108		These results indicate that the IRAK-1 variant haplotype is functionally significant in patients with sepsis, being associated with increased nuclear translocation of NF-kappaB, more severe organ dysfunction, and higher mortality.
16690408	2006	Hum. Immunol.	0198-8859	TITLE	0	0	6890	LONGTERM|DICTIONARY	transporter associated with antigen processing	transporter associated with antigen processing	42#88		D010392	LONGTERM|DICTIONARY	pemphigus vulgaris	Pemphigus vulgaris	0#18		Pemphigus vulgaris is associated with the transporter associated with antigen processing (TAP) system.
17955230	2008	Eur. J. Clin. Pharmacol.	1432-1041	RESULTS	3	7	1559	SYMBOL|DICTIONARY	cyp2c9	CYP2C9	0#6		D006470	LONGTERM|DICTIONARY	bleeding	bleeding	81#89	NaN	CYP2C9 genotype was the only clinical feature associated with the risk of severe bleeding (one-sided P = 0.019, Fisher exact method), with an odds ratio of 4.8 (95% confidence interval of 1.4-16.6) for any variant genotype as compared to CYP2C9*1*1.
17955230	2008	Eur. J. Clin. Pharmacol.	1432-1041	RESULTS	3	7	1559	SYMBOL|NUMBER|DICTIONARY	cyp2c9	CYP2C9	238#244		D006470	LONGTERM|DICTIONARY	bleeding	bleeding	81#89	NaN	CYP2C9 genotype was the only clinical feature associated with the risk of severe bleeding (one-sided P = 0.019, Fisher exact method), with an odds ratio of 4.8 (95% confidence interval of 1.4-16.6) for any variant genotype as compared to CYP2C9*1*1.
17919375	2008	Zhonghua Yi Xue Za Zhi	0376-2491	RESULTS	3	4	7172	SYMBOL|NUMBER|DICTIONARY|EXTRACTED	tpmt	TPMT	72#76	17919375-1-52-80	D012216	LONGTERM|NUMBER|DICTIONARY	rheumatic diseases	rheumatic diseases	25#43		In the 200 patients with rheumatic diseases, 4 cases of heterozygote of TPMT*3C were detected, but no mutation of TPMT*2, TPMT*3B or TPMT*3A was found.
17919375	2008	Zhonghua Yi Xue Za Zhi	0376-2491	RESULTS	3	4	7172	SYMBOL|NUMBER|DICTIONARY|EXTRACTED	tpmt	TPMT	114#118	17919375-1-52-80	D012216	LONGTERM|NUMBER|DICTIONARY	rheumatic diseases	rheumatic diseases	25#43		In the 200 patients with rheumatic diseases, 4 cases of heterozygote of TPMT*3C were detected, but no mutation of TPMT*2, TPMT*3B or TPMT*3A was found.
17919375	2008	Zhonghua Yi Xue Za Zhi	0376-2491	RESULTS	3	4	7172	SYMBOL|NUMBER|DICTIONARY|EXTRACTED	tpmt	TPMT	122#126	17919375-1-52-80	D012216	LONGTERM|NUMBER|DICTIONARY	rheumatic diseases	rheumatic diseases	25#43		In the 200 patients with rheumatic diseases, 4 cases of heterozygote of TPMT*3C were detected, but no mutation of TPMT*2, TPMT*3B or TPMT*3A was found.
17919375	2008	Zhonghua Yi Xue Za Zhi	0376-2491	RESULTS	3	4	7172	SYMBOL|NUMBER|DICTIONARY|EXTRACTED	tpmt	TPMT	133#137	17919375-1-52-80	D012216	LONGTERM|NUMBER|DICTIONARY	rheumatic diseases	rheumatic diseases	25#43		In the 200 patients with rheumatic diseases, 4 cases of heterozygote of TPMT*3C were detected, but no mutation of TPMT*2, TPMT*3B or TPMT*3A was found.
17919375	2008	Zhonghua Yi Xue Za Zhi	0376-2491	METHODS	2	2	7172	SYMBOL|DICTIONARY|EXTRACTED	tpmt	TPMT	32#36	17919375-1-52-80	D012216	LONGTERM|DICTIONARY	rheumatic diseases	rheumatic diseases	58#76		Four common mutation alleles of TPMT in 200 patients with rheumatic diseases [TPMT*2 (G238C), TPMT*3A (A719G/G460A), TPMT*3B (G460A), TPMT*3C (A719G)] were detected by allele specific polymerase chain reaction (AS-PCR) and polymerase chain reaction-restriction fragment length polymorphism (PCR-PFLP).
17919375	2008	Zhonghua Yi Xue Za Zhi	0376-2491	METHODS	2	2	7172	SYMBOL|NUMBER|DICTIONARY|EXTRACTED	tpmt	TPMT	78#82	17919375-1-52-80	D012216	LONGTERM|DICTIONARY	rheumatic diseases	rheumatic diseases	58#76		Four common mutation alleles of TPMT in 200 patients with rheumatic diseases [TPMT*2 (G238C), TPMT*3A (A719G/G460A), TPMT*3B (G460A), TPMT*3C (A719G)] were detected by allele specific polymerase chain reaction (AS-PCR) and polymerase chain reaction-restriction fragment length polymorphism (PCR-PFLP).
17919375	2008	Zhonghua Yi Xue Za Zhi	0376-2491	METHODS	2	2	7172	SYMBOL|NUMBER|DICTIONARY|EXTRACTED	tpmt	TPMT	94#98	17919375-1-52-80	D012216	LONGTERM|DICTIONARY	rheumatic diseases	rheumatic diseases	58#76		Four common mutation alleles of TPMT in 200 patients with rheumatic diseases [TPMT*2 (G238C), TPMT*3A (A719G/G460A), TPMT*3B (G460A), TPMT*3C (A719G)] were detected by allele specific polymerase chain reaction (AS-PCR) and polymerase chain reaction-restriction fragment length polymorphism (PCR-PFLP).
17919375	2008	Zhonghua Yi Xue Za Zhi	0376-2491	METHODS	2	2	7172	SYMBOL|NUMBER|DICTIONARY|EXTRACTED	tpmt	TPMT	117#121	17919375-1-52-80	D012216	LONGTERM|DICTIONARY	rheumatic diseases	rheumatic diseases	58#76		Four common mutation alleles of TPMT in 200 patients with rheumatic diseases [TPMT*2 (G238C), TPMT*3A (A719G/G460A), TPMT*3B (G460A), TPMT*3C (A719G)] were detected by allele specific polymerase chain reaction (AS-PCR) and polymerase chain reaction-restriction fragment length polymorphism (PCR-PFLP).
17919375	2008	Zhonghua Yi Xue Za Zhi	0376-2491	METHODS	2	2	7172	SYMBOL|NUMBER|DICTIONARY|EXTRACTED	tpmt	TPMT	134#138	17919375-1-52-80	D012216	LONGTERM|DICTIONARY	rheumatic diseases	rheumatic diseases	58#76		Four common mutation alleles of TPMT in 200 patients with rheumatic diseases [TPMT*2 (G238C), TPMT*3A (A719G/G460A), TPMT*3B (G460A), TPMT*3C (A719G)] were detected by allele specific polymerase chain reaction (AS-PCR) and polymerase chain reaction-restriction fragment length polymorphism (PCR-PFLP).
14720258	2004	Clin. Exp. Allergy	0954-7894	TITLE	0	0	80332	SYMBOL|DICTIONARY	adam33	ADAM33	61#67		D001249	LONGTERM|DICTIONARY	asthma	Asthma	0#6		Asthma is associated with single-nucleotide polymorphisms in ADAM33.
14720258	2004	Clin. Exp. Allergy	0954-7894	BACKGROUND	1	1	80332	SYMBOL|GENE|GN|DICTIONARY	adam33	ADAM33	4#10		D001249	LONGTERM|DICTIONARY	asthma	asthma	50#56		The ADAM33 gene has recently been associated with asthma and bronchial hyper-reactivity.
16183801	2006	J. Med. Genet.	1468-6244	TITLE	0	0	4204	SYMBOL|GENE|GN|DICTIONARY	mecp2	MECP2	28#33		D015518	LONGTERM|DISEASE|DN|DT|DICTIONARY	rett syndrome	Rett syndrome	80#93		Gross rearrangements of the MECP2 gene are found in both classical and atypical Rett syndrome patients.
15059717	2004	Am. J. Ophthalmol.	0002-9394	PURPOSE	1	1	348	LONGTERM|DICTIONARY	apolipoprotein e	apolipoprotein E	49#65		D008268	LONGTERM|DICTIONARY	age related macular degeneration	age-related macular degeneration	114#146		To examine the relation among serum cholesterol, apolipoprotein E genotype (APOE), and the risk of early and late age-related macular degeneration (AMD).
15059717	2004	Am. J. Ophthalmol.	0002-9394	PURPOSE	1	1	348	LONGTERM|DICTIONARY	apolipoprotein e	apolipoprotein E	49#65		D008268	SYMBOL|()|DICTIONARY|EXTRACTED	amd	AMD	148#151	15059717-1-114-146	To examine the relation among serum cholesterol, apolipoprotein E genotype (APOE), and the risk of early and late age-related macular degeneration (AMD).
19526842	2009	Fiziol Zh	2522-9028	ALL_TEXT_3/3	3	5	5698	SYMBOL|DICTIONARY	lmp2	LMP2	26#30		D006973	LONGTERM|DICTIONARY	hypertension	hypertension	106#118		Obtained data suggest the LMP2 and PSMA6 gene polymorphisms significance as the risk factors of essential hypertension in adolescents.
19526842	2009	Fiziol Zh	2522-9028	ALL_TEXT_3/3	3	5	5687	SYMBOL|GENE|GN|DICTIONARY	psma6	PSMA6	35#40		D006973	LONGTERM|DICTIONARY	hypertension	hypertension	106#118		Obtained data suggest the LMP2 and PSMA6 gene polymorphisms significance as the risk factors of essential hypertension in adolescents.
19526842	2009	Fiziol Zh	2522-9028	ALL_TEXT_1/3	1	1	5698	SYMBOL|DICTIONARY	lmp2	LMP2	31#35		D006973	LONGTERM|DICTIONARY	hypertension	hypertension	157#169		Large multifunctional protease LMP2 (Arg60-->His), LMP7 (Lys145-->Gln) and PSMA6 (C(-8)-->G) gene allelic polymorphisms in 147 young patients with essential hypertension and in 208 practically healthy people were determinated.
19526842	2009	Fiziol Zh	2522-9028	ALL_TEXT_1/3	1	1	5696	SYMBOL|DICTIONARY	lmp7	LMP7	51#55		D006973	LONGTERM|DICTIONARY	hypertension	hypertension	157#169		Large multifunctional protease LMP2 (Arg60-->His), LMP7 (Lys145-->Gln) and PSMA6 (C(-8)-->G) gene allelic polymorphisms in 147 young patients with essential hypertension and in 208 practically healthy people were determinated.
19526842	2009	Fiziol Zh	2522-9028	ALL_TEXT_1/3	1	1	5687	SYMBOL|DICTIONARY	psma6	PSMA6	75#80		D006973	LONGTERM|DICTIONARY	hypertension	hypertension	157#169		Large multifunctional protease LMP2 (Arg60-->His), LMP7 (Lys145-->Gln) and PSMA6 (C(-8)-->G) gene allelic polymorphisms in 147 young patients with essential hypertension and in 208 practically healthy people were determinated.
15287851	2005	Liver Int.	1478-3223	BACKGROUND	1	3	3077	SYMBOL|DICTIONARY	hfe	HFE	53#56		D006526	LONGTERM|DISEASE|DN|DICTIONARY	hepatitis c	hepatitis C	124#135		Therefore our aim was to assess associations between HFE mutations and hepatic inflammation and stage of fibrosis in German hepatitis C patients.
15287851	2005	Liver Int.	1478-3223	BACKGROUND	1	3	3077	SYMBOL|DICTIONARY	hfe	HFE	53#56		D005355	LONGTERM|DICTIONARY	fibrosis	fibrosis	105#113	NaN	Therefore our aim was to assess associations between HFE mutations and hepatic inflammation and stage of fibrosis in German hepatitis C patients.
15287851	2005	Liver Int.	1478-3223	BACKGROUND	1	3	3077	SYMBOL|DICTIONARY	hfe	HFE	53#56		D007249	LONGTERM|DICTIONARY	inflammation	inflammation	79#91	NaN	Therefore our aim was to assess associations between HFE mutations and hepatic inflammation and stage of fibrosis in German hepatitis C patients.
17287556	2007	Indian J. Med. Res.	0971-5916	METHODS	2	4	4846	LONGTERM|DICTIONARY|GENE|GA	endothelial nitric oxide synthase	endothelial nitric oxide synthase	73#106		D003324	SYMBOL|DISEASE|DN|DICTIONARY|EXTRACTED	cad	CAD	136#139	17287556-2-192-215	We studied the 27 base pair tandem repeat polymorphism in intron4 of the endothelial nitric oxide synthase (eNOS) gene in 141 unrelated CAD patients with positive coronary angiograms and 159 age matched control subjects without a history of symptomatic CAD.
17287556	2007	Indian J. Med. Res.	0971-5916	METHODS	2	4	4846	LONGTERM|DICTIONARY|GENE|GA	endothelial nitric oxide synthase	endothelial nitric oxide synthase	73#106		D003324	SYMBOL|DICTIONARY|EXTRACTED	cad	CAD	253#256	17287556-2-192-215	We studied the 27 base pair tandem repeat polymorphism in intron4 of the endothelial nitric oxide synthase (eNOS) gene in 141 unrelated CAD patients with positive coronary angiograms and 159 age matched control subjects without a history of symptomatic CAD.
17287556	2007	Indian J. Med. Res.	0971-5916	METHODS	2	4	4846	SYMBOL|()|GENE|GN|DICTIONARY|EXTRACTED	enos	eNOS	108#112	17287556-4-73-106	D003324	SYMBOL|DISEASE|DN|DICTIONARY|EXTRACTED	cad	CAD	136#139	17287556-2-192-215	We studied the 27 base pair tandem repeat polymorphism in intron4 of the endothelial nitric oxide synthase (eNOS) gene in 141 unrelated CAD patients with positive coronary angiograms and 159 age matched control subjects without a history of symptomatic CAD.
17287556	2007	Indian J. Med. Res.	0971-5916	METHODS	2	4	4846	SYMBOL|()|GENE|GN|DICTIONARY|EXTRACTED	enos	eNOS	108#112	17287556-4-73-106	D003324	SYMBOL|DICTIONARY|EXTRACTED	cad	CAD	253#256	17287556-2-192-215	We studied the 27 base pair tandem repeat polymorphism in intron4 of the endothelial nitric oxide synthase (eNOS) gene in 141 unrelated CAD patients with positive coronary angiograms and 159 age matched control subjects without a history of symptomatic CAD.
20724655	2011	J. Lipid Res.	1539-7262	ALL_TEXT_3/3	3	7	338	SYMBOL|DICTIONARY|EXTRACTED	apob	APOB	61#65	20724655-3-47-63	C566031	LONGTERM|DICTIONARY	tg	TG	0#2	NaN	TG response to fenofibrate treatment was associated with one APOB SNP, rs676210 (Pro2739Leu), such that participants with the TT genotype of rs676210 had greater TG lowering than those with the CC genotype (additive model, P = 0.0017).
20724655	2011	J. Lipid Res.	1539-7262	ALL_TEXT_3/3	3	7	338	SYMBOL|DICTIONARY|EXTRACTED	apob	APOB	61#65	20724655-3-47-63	C566031	LONGTERM|DICTIONARY	tg	TG	162#164	NaN	TG response to fenofibrate treatment was associated with one APOB SNP, rs676210 (Pro2739Leu), such that participants with the TT genotype of rs676210 had greater TG lowering than those with the CC genotype (additive model, P = 0.0017).
20350254	2010	Ann. Med.	1365-2060	BACKGROUND AND AIM	1	1	3606	LONGTERM|DICTIONARY	interleukin 18	Interleukin-18	0#14		D050197	LONGTERM|DICTIONARY	atherosclerotic	atherosclerotic	32#47	NaN	Interleukin-18 (IL-18) is a pro-atherosclerotic cytokine.
20350254	2010	Ann. Med.	1365-2060	BACKGROUND AND AIM	1	1	3606	SYMBOL|()|DICTIONARY|EXTRACTED	il 18	IL-18	16#21	20350254-1-0-14	D050197	LONGTERM|DICTIONARY	atherosclerotic	atherosclerotic	32#47	NaN	Interleukin-18 (IL-18) is a pro-atherosclerotic cytokine.
19002671	2009	Psychopharmacology (Berl.)	1432-2072	TITLE	0	0	2166	SYMBOL|DICTIONARY|EXTRACTED	faah	FAAH	52#56		D002189	LONGTERM|DISEASE|DN|DICTIONARY	cannabis dependence	cannabis dependence	13#32		Intermediate cannabis dependence phenotypes and the FAAH C385A variant: an exploratory analysis.
12168876	2002	Anticancer Res.	0250-7005	ALL_TEXT_3/3	3	6	7157	LONGTERM|DICTIONARY	p53	p53	150#153	NaN	D009369	LONGTERM|DICTIONARY	tumors	tumors	74#80		At the time of diagnosis, the A-AA allele occurred more frequently in the tumors characterized by small tumor size, good to moderate differentiation, p53-negativity and low tumor proliferation activity.
12168876	2002	Anticancer Res.	0250-7005	ALL_TEXT_3/3	3	6	7157	LONGTERM|DICTIONARY	p53	p53	150#153	NaN	D009369	LONGTERM|DISEASE|DT|DICTIONARY	tumor	tumor	104#109		At the time of diagnosis, the A-AA allele occurred more frequently in the tumors characterized by small tumor size, good to moderate differentiation, p53-negativity and low tumor proliferation activity.
12168876	2002	Anticancer Res.	0250-7005	ALL_TEXT_3/3	3	6	7157	LONGTERM|DICTIONARY	p53	p53	150#153	NaN	D009369	LONGTERM|DISEASE|DT|DICTIONARY	tumor	tumor	173#178		At the time of diagnosis, the A-AA allele occurred more frequently in the tumors characterized by small tumor size, good to moderate differentiation, p53-negativity and low tumor proliferation activity.
14970845	2004	Eur. J. Hum. Genet.	1018-4813	TITLE	0	0	5621	LONGTERM|GENE|GN|GT|DICTIONARY	prion protein	prion protein	21#34		D007562	LONGTERM|DISEASE|DT|DICTIONARY	creutzfeldt jakob disease	Creutzfeldt-Jakob disease	91#116		Polymorphisms in the prion protein gene and in the doppel gene increase susceptibility for Creutzfeldt-Jakob disease.
14970845	2004	Eur. J. Hum. Genet.	1018-4813	TITLE	0	0	23627	SYMBOL|GENE|GN|DICTIONARY	doppel	doppel	51#57		D007562	LONGTERM|DISEASE|DT|DICTIONARY	creutzfeldt jakob disease	Creutzfeldt-Jakob disease	91#116		Polymorphisms in the prion protein gene and in the doppel gene increase susceptibility for Creutzfeldt-Jakob disease.
12168876	2002	Anticancer Res.	0250-7005	ALL_TEXT_3/3	3	7	354	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	psa	PSA	64#67	12168876-1-50-75	D001943	LONGTERM|DISEASE|DT|DICTIONARY	less aggressive forms of breast cancer	less aggressive forms of breast cancer	103#141		Our results suggest that the presence of the A-AA allele at the PSA promoter region is associated with less aggressive forms of breast cancer and could be looked on as a favorable prognostic factor.
16133961	2005	Dig. Dis. Sci.	0163-2116	ALL_TEXT_3/3	3	6	1557	SYMBOL|DICTIONARY	cyp2c19	CYP2C19	111#118		D014456	LONGTERM|DICTIONARY	ulcer	ulcer	30#35		The mean 2-week posttreatment ulcer size value by rabeprazole did not significantly differ among the different CYP2C19 genotypes, whereas the mean value in the homozygous extensive metabolizer patients treated with omeprazole was significantly (P = 0.0057) greater than in those with rabeprazole.
16133961	2005	Dig. Dis. Sci.	0163-2116	ALL_TEXT_3/3	3	5	1557	SYMBOL|DICTIONARY	cyp2c19	CYP2C19	157#164		D013276	LONGTERM|DICTIONARY	gastric ulcer	gastric ulcer	30#43		The endoscopic improvement of gastric ulcer size and ulcer healing rates using a thin rubber disc with a diameter of 6 mm, were evaluated in relation to the CYP2C19 genotypic status.
16133961	2005	Dig. Dis. Sci.	0163-2116	ALL_TEXT_3/3	3	5	1557	SYMBOL|DICTIONARY	cyp2c19	CYP2C19	157#164		D014456	LONGTERM|DICTIONARY	ulcer healing	ulcer healing	53#66		The endoscopic improvement of gastric ulcer size and ulcer healing rates using a thin rubber disc with a diameter of 6 mm, were evaluated in relation to the CYP2C19 genotypic status.
16222672	2006	Am. J. Med. Genet. A	1552-4825	TITLE	0	0	2697	SYMBOL|DICTIONARY	gja1	GJA1	28#32		C563160	LONGTERM|DICTIONARY	oculodentodigital dysplasia	oculodentodigital dysplasia	45#72		Letter to the editor: Novel GJA1 mutation in oculodentodigital dysplasia.
15018693	2004	J Geriatr Psychiatry Neurol	0891-9887	ALL_TEXT_3/3	3	7	348	SYMBOL|DICTIONARY	apoe	APOE	15#19		D000544	SYMBOL|EXTRACTED	ad	AD	93#95	15018693-1-47-66	In these data, APOE status was associated with the progression of sleep/wake disturbances in AD.
15018693	2004	J Geriatr Psychiatry Neurol	0891-9887	ALL_TEXT_3/3	3	7	348	SYMBOL|DICTIONARY	apoe	APOE	15#19		D012893	LONGTERM|DICTIONARY	sleep/wake disturbances	sleep/wake disturbances	66#89	NaN	In these data, APOE status was associated with the progression of sleep/wake disturbances in AD.
9545398	1998	Am. J. Hum. Genet.	0002-9297	ALL_TEXT_3/3	3	12	695	LONGTERM|DICTIONARY	btk	Btk	81#84	NaN	C537409	SYMBOL|DICTIONARY|EXTRACTED	xla	XLA	59#62	9545398-1-32-59	These studies indicate that 90%-95% of males with presumed XLA have mutations in Btk.
18080216	2009	Fam. Cancer	1389-9600	ALL_TEXT_3/3	3	8	2944	SYMBOL|DICTIONARY	gstm1	GSTM1	46#51		D001943	LONGTERM|DISEASE|DN|DT|DICTIONARY	familial breast cancer	familial breast cancer	9#31		However, familial breast cancer patients with GSTM1 null genotype had a relative risk of 0.42 (95%CI = 0.18-0.97) for an advanced disease stage.
18080216	2009	Fam. Cancer	1389-9600	ALL_TEXT_3/3	3	8	2944	SYMBOL|DICTIONARY	gstm1	GSTM1	46#51		D020178	LONGTERM|DICTIONARY	advanced disease	advanced disease	121#137	NaN	However, familial breast cancer patients with GSTM1 null genotype had a relative risk of 0.42 (95%CI = 0.18-0.97) for an advanced disease stage.
20631561	2010	J Clin Psychopharmacol	1533-712X	ALL_TEXT_3/3	3	8	2166	SYMBOL|GENE|GN|DICTIONARY	faah	FAAH	129#133		D015430	LONGTERM|DICTIONARY	weight gain	weight gain	194#205	NaN	Present findings, although obtained in a small population and in a naturalistic setting, suggest that the cDNA 385C/A SNP of the FAAH gene may predispose subjects to get a clinically meaningful weight gain after antipsychotic exposure.
18080216	2009	Fam. Cancer	1389-9600	ALL_TEXT_2/3	2	5	2944	SYMBOL|DICTIONARY	gstm1	GSTM1	15#20		D001943	LONGTERM|DISEASE|DT|DICTIONARY	familial breast cancer	familial breast cancer	81#103		Interestingly, GSTM1 deletion was found to be significantly associated only with familial breast cancer (OR = 2.0; 95%CI = 1.252-3.128) while GSTT1 was associated only with sporadic breast cancer (OR = 2.3; 95%CI = 1.336-3.970).
18080216	2009	Fam. Cancer	1389-9600	ALL_TEXT_2/3	2	5	2944	SYMBOL|DICTIONARY	gstm1	GSTM1	15#20		D001943	LONGTERM|DISEASE|DT|DICTIONARY	sporadic breast cancer	sporadic breast cancer	173#195		Interestingly, GSTM1 deletion was found to be significantly associated only with familial breast cancer (OR = 2.0; 95%CI = 1.252-3.128) while GSTT1 was associated only with sporadic breast cancer (OR = 2.3; 95%CI = 1.336-3.970).
18080216	2009	Fam. Cancer	1389-9600	ALL_TEXT_2/3	2	5	2952	SYMBOL|DICTIONARY	gstt1	GSTT1	142#147		D001943	LONGTERM|DISEASE|DT|DICTIONARY	familial breast cancer	familial breast cancer	81#103		Interestingly, GSTM1 deletion was found to be significantly associated only with familial breast cancer (OR = 2.0; 95%CI = 1.252-3.128) while GSTT1 was associated only with sporadic breast cancer (OR = 2.3; 95%CI = 1.336-3.970).
18080216	2009	Fam. Cancer	1389-9600	ALL_TEXT_2/3	2	5	2952	SYMBOL|DICTIONARY	gstt1	GSTT1	142#147		D001943	LONGTERM|DISEASE|DT|DICTIONARY	sporadic breast cancer	sporadic breast cancer	173#195		Interestingly, GSTM1 deletion was found to be significantly associated only with familial breast cancer (OR = 2.0; 95%CI = 1.252-3.128) while GSTT1 was associated only with sporadic breast cancer (OR = 2.3; 95%CI = 1.336-3.970).
15018693	2004	J Geriatr Psychiatry Neurol	0891-9887	TITLE	0	0	348	SYMBOL|DICTIONARY	apoe	APOE	46#50		D000544	LONGTERM|DISEASE|DT|DICTIONARY	alzheimer disease	Alzheimer's disease	25#44		Sleep/wake disruption in Alzheimer's disease: APOE status and longitudinal course.
18080216	2009	Fam. Cancer	1389-9600	ALL_TEXT_2/3	2	6	2950	SYMBOL|DICTIONARY	gstp1	GSTP1	0#5		D001943	LONGTERM|DISEASE|DT|DICTIONARY	familial breast cancer	familial breast cancer	70#92		GSTP1 Ile105Val polymorphism was associated neither with sporadic nor familial breast cancer susceptibility (P value > 0.05).
18080216	2009	Fam. Cancer	1389-9600	TITLE	0	0	2952	SYMBOL|DICTIONARY	gstt1	GSTT1	39#44		D001943	LONGTERM|DISEASE|DT|DICTIONARY	familial versus sporadic breast cancer	familial versus sporadic breast cancer	66#104		Influence of germline polymorphisms of GSTT1, GSTM1, and GSTP1 in familial versus sporadic breast cancer susceptibility and survival.
18080216	2009	Fam. Cancer	1389-9600	TITLE	0	0	2944	SYMBOL|DICTIONARY	gstm1	GSTM1	46#51		D001943	LONGTERM|DISEASE|DT|DICTIONARY	familial versus sporadic breast cancer	familial versus sporadic breast cancer	66#104		Influence of germline polymorphisms of GSTT1, GSTM1, and GSTP1 in familial versus sporadic breast cancer susceptibility and survival.
18080216	2009	Fam. Cancer	1389-9600	TITLE	0	0	2950	SYMBOL|DICTIONARY	gstp1	GSTP1	57#62		D001943	LONGTERM|DISEASE|DT|DICTIONARY	familial versus sporadic breast cancer	familial versus sporadic breast cancer	66#104		Influence of germline polymorphisms of GSTT1, GSTM1, and GSTP1 in familial versus sporadic breast cancer susceptibility and survival.
16702373	2006	Cancer Epidemiol. Biomarkers Prev.	1055-9965	ALL_TEXT_3/3	3	12	4683	SYMBOL|DICTIONARY	nbs1	NBS1	53#57		D011471	LONGTERM|DISEASE|DT|DICTIONARY	overall prostate cancer	overall prostate cancer	126#149		However, our data does suggest that mutations within NBS1, and in particular, 657del5, do not significantly contribute to the overall prostate cancer burden within our patient samples.
14508190	2004	J. Hypertens.	0263-6352	CONCLUSIONS	4	9	183	SYMBOL|DICTIONARY|EXTRACTED	agt	AGT	73#76	14508190-1-31-46	D006973	LONGTERM|DICTIONARY	hypertension	hypertension	205#217		These strategies appeared to yield a modest increase in precision at the AGT locus with respect to the physiological intermediate, but did not lead to significant association of the molecular markers with hypertension.
15562935	2005	Clin Cardiol	0160-9289	BACKGROUND	1	2	4973	SYMBOL|DICTIONARY|EXTRACTED	lox 1	LOX-1	18#23	15562935-1-48-61	D050197	LONGTERM|DICTIONARY	atherosclerotic lesions	atherosclerotic lesions	55#78	NaN	The expression of LOX-1 was shown to be upregulated in atherosclerotic lesions.
15018693	2004	J Geriatr Psychiatry Neurol	0891-9887	ALL_TEXT_1/3	1	2	348	SYMBOL|DICTIONARY	apoe	APOE	25#29		D000544	SYMBOL|EXTRACTED	ad	AD	76#78	15018693-1-47-66	Apolipoprotein epsilon4 (APOE epsilon4) carrier status may increase risk of AD, yet there are no data on relations between APOE status and progression of sleep disturbance in AD.
15018693	2004	J Geriatr Psychiatry Neurol	0891-9887	ALL_TEXT_1/3	1	2	348	SYMBOL|DICTIONARY	apoe	APOE	25#29		D012893	LONGTERM|DICTIONARY	sleep disturbance	sleep disturbance	154#171		Apolipoprotein epsilon4 (APOE epsilon4) carrier status may increase risk of AD, yet there are no data on relations between APOE status and progression of sleep disturbance in AD.
15018693	2004	J Geriatr Psychiatry Neurol	0891-9887	ALL_TEXT_1/3	1	2	348	SYMBOL|DICTIONARY	apoe	APOE	25#29		D000544	SYMBOL|EXTRACTED	ad	AD	175#177	15018693-1-47-66	Apolipoprotein epsilon4 (APOE epsilon4) carrier status may increase risk of AD, yet there are no data on relations between APOE status and progression of sleep disturbance in AD.
15018693	2004	J Geriatr Psychiatry Neurol	0891-9887	ALL_TEXT_1/3	1	2	348	SYMBOL|DICTIONARY	apoe	APOE	123#127		D000544	SYMBOL|EXTRACTED	ad	AD	76#78	15018693-1-47-66	Apolipoprotein epsilon4 (APOE epsilon4) carrier status may increase risk of AD, yet there are no data on relations between APOE status and progression of sleep disturbance in AD.
15018693	2004	J Geriatr Psychiatry Neurol	0891-9887	ALL_TEXT_1/3	1	2	348	SYMBOL|DICTIONARY	apoe	APOE	123#127		D012893	LONGTERM|DICTIONARY	sleep disturbance	sleep disturbance	154#171		Apolipoprotein epsilon4 (APOE epsilon4) carrier status may increase risk of AD, yet there are no data on relations between APOE status and progression of sleep disturbance in AD.
15018693	2004	J Geriatr Psychiatry Neurol	0891-9887	ALL_TEXT_1/3	1	2	348	SYMBOL|DICTIONARY	apoe	APOE	123#127		D000544	SYMBOL|EXTRACTED	ad	AD	175#177	15018693-1-47-66	Apolipoprotein epsilon4 (APOE epsilon4) carrier status may increase risk of AD, yet there are no data on relations between APOE status and progression of sleep disturbance in AD.
9498099	1998	Clin. Chim. Acta	0009-8981	ALL_TEXT_3/3	3	3	4023	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	lpl	LPL	23#26	9498099-2-23-41	D015228	LONGTERM|DICTIONARY	hypertriglyceridemia	hypertriglyceridemia	110#130		Here we report a novel LPL gene mutation (Glu421Lys), in a previously healthy primigravid woman who died from hypertriglyceridemia-induced pancreatitis during the last trimester of pregnancy.
9498099	1998	Clin. Chim. Acta	0009-8981	ALL_TEXT_3/3	3	3	4023	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	lpl	LPL	23#26	9498099-2-23-41	D010190	LONGTERM|DICTIONARY	pancreatitis	pancreatitis	139#151		Here we report a novel LPL gene mutation (Glu421Lys), in a previously healthy primigravid woman who died from hypertriglyceridemia-induced pancreatitis during the last trimester of pregnancy.
25466283	2015	Am. J. Hum. Genet.	1537-6605	TITLE	0	0	84942	SYMBOL|DICTIONARY	wdr73	WDR73	30#35		C537548	LONGTERM|DICTIONARY	galloway-mowat syndrome	Galloway-Mowat Syndrome	111#134	NaN	Loss-of-function mutations in WDR73 are responsible for microcephaly and steroid-resistant nephrotic syndrome: Galloway-Mowat syndrome.
25466283	2015	Am. J. Hum. Genet.	1537-6605	TITLE	0	0	84942	SYMBOL|DICTIONARY	wdr73	WDR73	30#35		D008831	LONGTERM|DICTIONARY	microcephaly	Microcephaly	56#68	NaN	Loss-of-function mutations in WDR73 are responsible for microcephaly and steroid-resistant nephrotic syndrome: Galloway-Mowat syndrome.
25466283	2015	Am. J. Hum. Genet.	1537-6605	TITLE	0	0	84942	SYMBOL|DICTIONARY	wdr73	WDR73	30#35		D009404	LONGTERM|DICTIONARY	nephrotic syndrome	Nephrotic Syndrome	91#109	NaN	Loss-of-function mutations in WDR73 are responsible for microcephaly and steroid-resistant nephrotic syndrome: Galloway-Mowat syndrome.
11450852	2001	J. Hum. Genet.	1434-5161	TITLE	0	0	2778	LONGTERM|DICTIONARY	gsalpha	Gsalpha	21#28	NaN	D011547	LONGTERM|DICTIONARY	sporadic pseudohypoparathyroidism type ia	sporadic pseudohypoparathyroidism type Ia	64#105		Two mutations of the Gsalpha gene in two Japanese patients with sporadic pseudohypoparathyroidism type Ia.
17785557	2007	Clin. Cancer Res.	1078-0432	RESULTS	3	12	7157	SYMBOL|DICTIONARY	p53	p53	111#114		D011471	SYMBOL|EXTRACTED	pc	PC	146#148	17785557-3-87-102	Although we did not find a significant relationship between the frequency of the Arg/Pro + Pro/Pro genotype of p53 Arg72Pro and susceptibility in PC, there was a combined effect of CXCL12 GA + AA genotype and the p53 72Arg/Pro + Pro/Pro genotype on the frequency of PC.
17785557	2007	Clin. Cancer Res.	1078-0432	RESULTS	3	12	7157	SYMBOL|DICTIONARY	p53	p53	111#114		D011471	SYMBOL|EXTRACTED	pc	PC	266#268	17785557-3-87-102	Although we did not find a significant relationship between the frequency of the Arg/Pro + Pro/Pro genotype of p53 Arg72Pro and susceptibility in PC, there was a combined effect of CXCL12 GA + AA genotype and the p53 72Arg/Pro + Pro/Pro genotype on the frequency of PC.
17785557	2007	Clin. Cancer Res.	1078-0432	RESULTS	3	12	6387	SYMBOL|DICTIONARY	cxcl12	CXCL12	181#187		D011471	SYMBOL|EXTRACTED	pc	PC	146#148	17785557-3-87-102	Although we did not find a significant relationship between the frequency of the Arg/Pro + Pro/Pro genotype of p53 Arg72Pro and susceptibility in PC, there was a combined effect of CXCL12 GA + AA genotype and the p53 72Arg/Pro + Pro/Pro genotype on the frequency of PC.
17785557	2007	Clin. Cancer Res.	1078-0432	RESULTS	3	12	6387	SYMBOL|DICTIONARY	cxcl12	CXCL12	181#187		D011471	SYMBOL|EXTRACTED	pc	PC	266#268	17785557-3-87-102	Although we did not find a significant relationship between the frequency of the Arg/Pro + Pro/Pro genotype of p53 Arg72Pro and susceptibility in PC, there was a combined effect of CXCL12 GA + AA genotype and the p53 72Arg/Pro + Pro/Pro genotype on the frequency of PC.
17785557	2007	Clin. Cancer Res.	1078-0432	RESULTS	3	12	7157	SYMBOL|NUMBER|DICTIONARY	p53	p53	213#216		D011471	SYMBOL|EXTRACTED	pc	PC	146#148	17785557-3-87-102	Although we did not find a significant relationship between the frequency of the Arg/Pro + Pro/Pro genotype of p53 Arg72Pro and susceptibility in PC, there was a combined effect of CXCL12 GA + AA genotype and the p53 72Arg/Pro + Pro/Pro genotype on the frequency of PC.
17785557	2007	Clin. Cancer Res.	1078-0432	RESULTS	3	12	7157	SYMBOL|NUMBER|DICTIONARY	p53	p53	213#216		D011471	SYMBOL|EXTRACTED	pc	PC	266#268	17785557-3-87-102	Although we did not find a significant relationship between the frequency of the Arg/Pro + Pro/Pro genotype of p53 Arg72Pro and susceptibility in PC, there was a combined effect of CXCL12 GA + AA genotype and the p53 72Arg/Pro + Pro/Pro genotype on the frequency of PC.
17785557	2007	Clin. Cancer Res.	1078-0432	CONCLUSIONS	4	14	6387	SYMBOL|DICTIONARY	cxcl12	CXCL12	38#44		D011471	SYMBOL|EXTRACTED	pc	PC	89#91	17785557-3-87-102	This is the first report showing that CXCL12 G801A polymorphism may be a risk factor for PC.
20610570	2010	Endocrinology	1945-7170	ALL_TEXT_1/3	1	1	3569	SYMBOL|DICTIONARY	il 6	IL-6	0#4		D007752	LONGTERM|DICTIONARY	infection-associated preterm labor	infection-associated preterm labor	89#123		IL-6 abundance in amniotic fluid and uterine tissues increases in late gestation or with infection-associated preterm labor.
15659127	2005	Clin Transplant	0902-0063	ALL_TEXT_3/3	3	9	183	SYMBOL|DICTIONARY|EXTRACTED	agt	AGT	17#20	15659127-4-47-62	D007674	LONGTERM|DICTIONARY	chronic renal transplant dysfunction	chronic renal transplant dysfunction	115#151		Determination of AGT M235T and PAI-1 genotypes prior to transplantation may help identify patients who at risk for chronic renal transplant dysfunction.
15659127	2005	Clin Transplant	0902-0063	ALL_TEXT_3/3	3	9	5054	SYMBOL|DICTIONARY|EXTRACTED	pai 1	PAI-1	31#36	15659127-3-19-52	D007674	LONGTERM|DICTIONARY	chronic renal transplant dysfunction	chronic renal transplant dysfunction	115#151		Determination of AGT M235T and PAI-1 genotypes prior to transplantation may help identify patients who at risk for chronic renal transplant dysfunction.
25356585	2015	PLoS ONE	1932-6203	TITLE	0	0	1513	LONGTERM|DICTIONARY	cathepsin k	cathepsin K	50#61		D005909	LONGTERM|DICTIONARY	glioblastoma	glioblastoma	85#97		Expression analysis of all protease genes reveals cathepsin K to be overexpressed in glioblastoma.
15659127	2005	Clin Transplant	0902-0063	ALL_TEXT_1/3	1	3	5054	LONGTERM|DICTIONARY	plasminogen activator inhibitor 1	plasminogen activator inhibitor-1	19#52		D005355	LONGTERM|DICTIONARY	fibrosis	fibrosis	133#141	NaN	It is thought that plasminogen activator inhibitor-1 (PAI-1) functions in the RAS, in addition to involvement in thrombotic risk and fibrosis.
15659127	2005	Clin Transplant	0902-0063	ALL_TEXT_1/3	1	3	5054	LONGTERM|DICTIONARY	plasminogen activator inhibitor 1	plasminogen activator inhibitor-1	19#52		D013927	LONGTERM|DICTIONARY	thrombotic risk	thrombotic risk	113#128	NaN	It is thought that plasminogen activator inhibitor-1 (PAI-1) functions in the RAS, in addition to involvement in thrombotic risk and fibrosis.
15659127	2005	Clin Transplant	0902-0063	ALL_TEXT_1/3	1	3	5054	SYMBOL|()|DICTIONARY|EXTRACTED	pai 1	PAI-1	54#59	15659127-3-19-52	D005355	LONGTERM|DICTIONARY	fibrosis	fibrosis	133#141	NaN	It is thought that plasminogen activator inhibitor-1 (PAI-1) functions in the RAS, in addition to involvement in thrombotic risk and fibrosis.
15659127	2005	Clin Transplant	0902-0063	ALL_TEXT_1/3	1	3	5054	SYMBOL|()|DICTIONARY|EXTRACTED	pai 1	PAI-1	54#59	15659127-3-19-52	D013927	LONGTERM|DICTIONARY	thrombotic risk	thrombotic risk	113#128	NaN	It is thought that plasminogen activator inhibitor-1 (PAI-1) functions in the RAS, in addition to involvement in thrombotic risk and fibrosis.
25356585	2015	PLoS ONE	1932-6203	RESULTS	3	8	1513	SYMBOL|DICTIONARY|EXTRACTED	ctsk	CTSK	0#4		D005909	SYMBOL|DICTIONARY|EXTRACTED	gbm	GBM	51#54	25356585-2-126-149	CTSK overexpression was validated using RT-qPCR in GBM tissues as well.
15201134	2004	Am. J. Respir. Crit. Care Med.	1073-449X	ALL_TEXT_2/3	2	4	81793	SYMBOL|DICTIONARY|EXTRACTED	tlr10	TLR10	0#5		D001249	LONGTERM|DICTIONARY	asthma	asthma	21#27		TLR10 is a potential asthma candidate gene because early life innate immune responses to ubiquitous inhaled allergens and PAMPs may influence asthma susceptibility.
15201134	2004	Am. J. Respir. Crit. Care Med.	1073-449X	ALL_TEXT_2/3	2	4	81793	SYMBOL|DICTIONARY|EXTRACTED	tlr10	TLR10	0#5		D001249	LONGTERM|DICTIONARY	asthma	asthma	142#148		TLR10 is a potential asthma candidate gene because early life innate immune responses to ubiquitous inhaled allergens and PAMPs may influence asthma susceptibility.
17094469	2006	Anticancer Res.	0250-7005	ALL_TEXT_2/3	2	3	4193	SYMBOL|GENE|GN|DICTIONARY	mdm2	MDM2	40#44		D001749	LONGTERM|DISEASE|DT|DICTIONARY	bladder cancer	bladder cancer	53#67		The effect of T309G polymorphism of the MDM2 gene on bladder cancer susceptibility was investigated in a case-control study of 75 bladder cancer patients and 103 controls from Turkey.
17094469	2006	Anticancer Res.	0250-7005	ALL_TEXT_2/3	2	3	4193	SYMBOL|GENE|GN|DICTIONARY	mdm2	MDM2	40#44		D001749	LONGTERM|DISEASE|DN|DT|DICTIONARY	bladder cancer	bladder cancer	130#144		The effect of T309G polymorphism of the MDM2 gene on bladder cancer susceptibility was investigated in a case-control study of 75 bladder cancer patients and 103 controls from Turkey.
20383754	2011	Obes Surg	1708-0428	BACKGROUND	1	2	7421	LONGTERM|GENE|GT|DICTIONARY	vitamin d receptor	vitamin D receptor	228#246		D006962	LONGTERM|DICTIONARY	secondary hyperparathyroidism	secondary hyperparathyroidism	63#92		Individual differences in calcium absorption determine chronic secondary hyperparathyroidism after biliopancreatic diversion in half of the patients who have normal levels of 25-hydroxyvitamin D. We aimed to evaluate if certain vitamin D receptor polymorphisms may be responsible for the latter.
17094469	2006	Anticancer Res.	0250-7005	ALL_TEXT_1/3	1	2	4193	SYMBOL|GENE|GN|DICTIONARY	mdm2	MDM2	57#61		D009369	LONGTERM|DISEASE|DT|DICTIONARY	tumor	tumor	109#114		This polymorphism has an impact on the expression of the MDM2 gene, which is a key negative regulator of the tumor suppressor molecule p53.
17094469	2006	Anticancer Res.	0250-7005	ALL_TEXT_1/3	1	2	7157	SYMBOL|DICTIONARY	p53	p53	135#138		D009369	LONGTERM|DISEASE|DT|DICTIONARY	tumor	tumor	109#114		This polymorphism has an impact on the expression of the MDM2 gene, which is a key negative regulator of the tumor suppressor molecule p53.
19450125	2009	Pharmacogenomics	1744-8042	TITLE	0	0	54658	SYMBOL|NUMBER|DICTIONARY	ugt1a1	UGT1A1	0#6		D005767	LONGTERM|DICTIONARY	gastrointestinal toxicity	gastrointestinal toxicity	28#53	NaN	UGT1A1*28 genotype predicts gastrointestinal toxicity in patients treated with intermediate-dose irinotecan.
19648156	2009	Br J Anaesth	1471-6771	METHODS	2	4	6261	SYMBOL|DICTIONARY	ryr1	RYR1	37#41		D008305	SYMBOL|EXTRACTED	mh	MH	76#78	19648156-1-0-22	We then undertook the most extensive RYR1 genotype-phenotype correlation in MH to date using 504 individuals from 204 MH families and 23 RYR1 variants.
19648156	2009	Br J Anaesth	1471-6771	METHODS	2	4	6261	SYMBOL|DICTIONARY	ryr1	RYR1	37#41		D008305	SYMBOL|EXTRACTED	mh	MH	118#120	19648156-1-0-22	We then undertook the most extensive RYR1 genotype-phenotype correlation in MH to date using 504 individuals from 204 MH families and 23 RYR1 variants.
19648156	2009	Br J Anaesth	1471-6771	METHODS	2	4	6261	SYMBOL|DICTIONARY	ryr1	RYR1	137#141		D008305	SYMBOL|EXTRACTED	mh	MH	76#78	19648156-1-0-22	We then undertook the most extensive RYR1 genotype-phenotype correlation in MH to date using 504 individuals from 204 MH families and 23 RYR1 variants.
19648156	2009	Br J Anaesth	1471-6771	METHODS	2	4	6261	SYMBOL|DICTIONARY	ryr1	RYR1	137#141		D008305	SYMBOL|EXTRACTED	mh	MH	118#120	19648156-1-0-22	We then undertook the most extensive RYR1 genotype-phenotype correlation in MH to date using 504 individuals from 204 MH families and 23 RYR1 variants.
17094469	2006	Anticancer Res.	0250-7005	TITLE	0	0	4193	SYMBOL|DICTIONARY	mdm2	MDM2	0#4		D001749	LONGTERM|DISEASE|DT|DICTIONARY	bladder cancer	bladder cancer	43#57		MDM2 T309G polymorphism is associated with bladder cancer.
19648156	2009	Br J Anaesth	1471-6771	BACKGROUND	1	1	6261	SYMBOL|DICTIONARY	ryr1	RYR1	87#91		D008305	LONGTERM|DICTIONARY	malignant hyperthermia	Malignant hyperthermia	0#22		Malignant hyperthermia (MH) is associated, in the majority of cases, with mutations in RYR1, the gene encoding the skeletal muscle ryanodine receptor.
19648156	2009	Br J Anaesth	1471-6771	BACKGROUND	1	1	6261	SYMBOL|DICTIONARY	ryr1	RYR1	87#91		D008305	SYMBOL|EXTRACTED|()	mh	MH	24#26	19648156-1-0-22	Malignant hyperthermia (MH) is associated, in the majority of cases, with mutations in RYR1, the gene encoding the skeletal muscle ryanodine receptor.
19648156	2009	Br J Anaesth	1471-6771	BACKGROUND	1	1	6261	LONGTERM|GENE|GT|DICTIONARY	skeletal muscle ryanodine receptor	skeletal muscle ryanodine receptor	115#149		D008305	LONGTERM|DICTIONARY	malignant hyperthermia	Malignant hyperthermia	0#22		Malignant hyperthermia (MH) is associated, in the majority of cases, with mutations in RYR1, the gene encoding the skeletal muscle ryanodine receptor.
19648156	2009	Br J Anaesth	1471-6771	BACKGROUND	1	1	6261	LONGTERM|GENE|GT|DICTIONARY	skeletal muscle ryanodine receptor	skeletal muscle ryanodine receptor	115#149		D008305	SYMBOL|EXTRACTED|()	mh	MH	24#26	19648156-1-0-22	Malignant hyperthermia (MH) is associated, in the majority of cases, with mutations in RYR1, the gene encoding the skeletal muscle ryanodine receptor.
19648156	2009	Br J Anaesth	1471-6771	TITLE	0	0	6261	SYMBOL|DICTIONARY	ryr1	RYR1	21#25		D008305	LONGTERM|DICTIONARY	malignant hyperthermia	Malignant hyperthermia	30#52	NaN	Genetic variation in RYR1 and malignant hyperthermia phenotypes.
21270338	2011	Sci Transl Med	1946-6242	ALL_TEXT_1/3	1	3	7389	LONGTERM|DICTIONARY	uroporphyrinogen decarboxylase	Uroporphyrinogen decarboxylase	0#30		D009369	LONGTERM|DISEASE|DT|DICTIONARY	tumor	tumor	151#156		Uroporphyrinogen decarboxylase (UROD), a key regulator of heme biosynthesis, was identified from an RNA interference-based high-throughput screen as a tumor-selective radiosensitizing target for HNC.
21270338	2011	Sci Transl Med	1946-6242	ALL_TEXT_1/3	1	3	7389	LONGTERM|DICTIONARY	uroporphyrinogen decarboxylase	Uroporphyrinogen decarboxylase	0#30		D006258	SYMBOL|EXTRACTED	hnc	HNC	195#198	21270338-1-0-20	Uroporphyrinogen decarboxylase (UROD), a key regulator of heme biosynthesis, was identified from an RNA interference-based high-throughput screen as a tumor-selective radiosensitizing target for HNC.
21270338	2011	Sci Transl Med	1946-6242	ALL_TEXT_1/3	1	3	7389	SYMBOL|()|DICTIONARY|EXTRACTED	urod	UROD	32#36	21270338-3-0-30	D009369	LONGTERM|DISEASE|DT|DICTIONARY	tumor	tumor	151#156		Uroporphyrinogen decarboxylase (UROD), a key regulator of heme biosynthesis, was identified from an RNA interference-based high-throughput screen as a tumor-selective radiosensitizing target for HNC.
21270338	2011	Sci Transl Med	1946-6242	ALL_TEXT_1/3	1	3	7389	SYMBOL|()|DICTIONARY|EXTRACTED	urod	UROD	32#36	21270338-3-0-30	D006258	SYMBOL|EXTRACTED	hnc	HNC	195#198	21270338-1-0-20	Uroporphyrinogen decarboxylase (UROD), a key regulator of heme biosynthesis, was identified from an RNA interference-based high-throughput screen as a tumor-selective radiosensitizing target for HNC.
19648156	2009	Br J Anaesth	1471-6771	BACKGROUND	1	2	6261	SYMBOL|DICTIONARY	ryr1	RYR1	48#52		D008305	SYMBOL|DISEASE|DN|DICTIONARY|EXTRACTED	mh	MH	110#112	19648156-1-0-22	Our primary aim was to assess whether different RYR1 variants are associated with quantitative differences in MH phenotype.
19648156	2009	Br J Anaesth	1471-6771	CONCLUSIONS	4	9	6261	SYMBOL|DICTIONARY	ryr1	RYR1	54#58		D008305	SYMBOL|DISEASE|DN|DICTIONARY|EXTRACTED	mh	MH	4#6	19648156-1-0-22	The MH phenotype differs significantly with different RYR1 variants.
12167522	2002	J Affect Disord	0165-0327	CONCLUSION	5	10	3356	SYMBOL|DICTIONARY	htr2a	HTR2A	78#83		D001289	SYMBOL|DICTIONARY|EXTRACTED	adhd	ADHD	95#99	12167522-0-71-121	These preliminary results suggest a possible association between variation in HTR2A, childhood ADHD, and the later development of SAD in women.
12167522	2002	J Affect Disord	0165-0327	CONCLUSION	5	10	3356	SYMBOL|DICTIONARY	htr2a	HTR2A	78#83		D016574	SYMBOL|DICTIONARY|EXTRACTED	sad	SAD	130#133	12167522-1-62-89	These preliminary results suggest a possible association between variation in HTR2A, childhood ADHD, and the later development of SAD in women.
15082902	2004	J. Korean Med. Sci.	1011-8934	TITLE	0	0	672	SYMBOL|DICTIONARY	brca1	BRCA1	14#19		D001943	LONGTERM|DISEASE|DN|DT|DICTIONARY	korean breast cancer	Korean breast cancer	43#63		Prevalence of BRCA1 and BRCA2 mutations in Korean breast cancer patients.
15082902	2004	J. Korean Med. Sci.	1011-8934	TITLE	0	0	675	SYMBOL|DICTIONARY	brca2	BRCA2	24#29		D001943	LONGTERM|DISEASE|DN|DT|DICTIONARY	korean breast cancer	Korean breast cancer	43#63		Prevalence of BRCA1 and BRCA2 mutations in Korean breast cancer patients.
19141695	2009	Am. J. Clin. Nutr.	1938-3207	OBJECTIVE	2	4	2695	SYMBOL|DICTIONARY|EXTRACTED	gip	GIP	12#15	19141695-2-0-44	D065626	SYMBOL|()|DICTIONARY|EXTRACTED	nash	NASH	156#160	19141695-4-139-154	We assessed GIP response to SFA ingestion and its effect on glucose and lipid metabolism and on liver injury in patients with nonalcoholic steatohepatitis (NASH).
19141695	2009	Am. J. Clin. Nutr.	1938-3207	OBJECTIVE	2	4	2695	SYMBOL|DICTIONARY|EXTRACTED	gip	GIP	12#15	19141695-2-0-44	D065626	LONGTERM|DICTIONARY	nonalcoholic steatohepatitis	nonalcoholic steatohepatitis	126#154		We assessed GIP response to SFA ingestion and its effect on glucose and lipid metabolism and on liver injury in patients with nonalcoholic steatohepatitis (NASH).
19141695	2009	Am. J. Clin. Nutr.	1938-3207	OBJECTIVE	2	4	2695	SYMBOL|DICTIONARY|EXTRACTED	gip	GIP	12#15	19141695-2-0-44	D056486	LONGTERM|DICTIONARY	liver injury	liver injury	96#108	NaN	We assessed GIP response to SFA ingestion and its effect on glucose and lipid metabolism and on liver injury in patients with nonalcoholic steatohepatitis (NASH).
16860143	2006	J. Pediatr.	0022-3476	TITLE	0	0	5551	SYMBOL|DICTIONARY|EXTRACTED	prf1	PRF1	97#101		D051359	LONGTERM|DICTIONARY	hemophagocytic lymphohistiocytosis	hemophagocytic lymphohistiocytosis	34#68		Patients of African ancestry with hemophagocytic lymphohistiocytosis share a common haplotype of PRF1 with a 50delT mutation.
19141695	2009	Am. J. Clin. Nutr.	1938-3207	BACKGROUND	1	2	2695	LONGTERM|DICTIONARY	glucose dependent insulinotropic polypeptide	Glucose-dependent insulinotropic polypeptide	0#44		D008659	LONGTERM|DICTIONARY	metabolic disorders	metabolic disorders	115#134		Glucose-dependent insulinotropic polypeptide (GIP) was recently linked to adipocyte metabolism and obesity-related metabolic disorders, including NAFLD, induced by an excess of saturated fatty acids (SFAs), but its role in vivo, as well as underlying mechanisms, is unknown.
19141695	2009	Am. J. Clin. Nutr.	1938-3207	BACKGROUND	1	2	2695	LONGTERM|DICTIONARY	glucose dependent insulinotropic polypeptide	Glucose-dependent insulinotropic polypeptide	0#44		D065626	LONGTERM|DICTIONARY|EXTRACTED	nafld	NAFLD	146#151	19141695-1-62-94	Glucose-dependent insulinotropic polypeptide (GIP) was recently linked to adipocyte metabolism and obesity-related metabolic disorders, including NAFLD, induced by an excess of saturated fatty acids (SFAs), but its role in vivo, as well as underlying mechanisms, is unknown.
19141695	2009	Am. J. Clin. Nutr.	1938-3207	BACKGROUND	1	2	2695	SYMBOL|()|DICTIONARY|EXTRACTED	gip	GIP	46#49	19141695-2-0-44	D008659	LONGTERM|DICTIONARY	metabolic disorders	metabolic disorders	115#134		Glucose-dependent insulinotropic polypeptide (GIP) was recently linked to adipocyte metabolism and obesity-related metabolic disorders, including NAFLD, induced by an excess of saturated fatty acids (SFAs), but its role in vivo, as well as underlying mechanisms, is unknown.
19141695	2009	Am. J. Clin. Nutr.	1938-3207	BACKGROUND	1	2	2695	SYMBOL|()|DICTIONARY|EXTRACTED	gip	GIP	46#49	19141695-2-0-44	D065626	LONGTERM|DICTIONARY|EXTRACTED	nafld	NAFLD	146#151	19141695-1-62-94	Glucose-dependent insulinotropic polypeptide (GIP) was recently linked to adipocyte metabolism and obesity-related metabolic disorders, including NAFLD, induced by an excess of saturated fatty acids (SFAs), but its role in vivo, as well as underlying mechanisms, is unknown.
16860143	2006	J. Pediatr.	0022-3476	ALL_TEXT_1/3	1	2	5551	SYMBOL|DICTIONARY|EXTRACTED	prf1	PRF1	106#110	16860143-1-17-25	D051359	SYMBOL|DICTIONARY|EXTRACTED	hlh	HLH	42#45	16860143-1-83-117	We found that all identified infants with HLH of African descent (17 from USA, 4 from Europe) have 50delT-PRF1 (16 homozygotes, 5 compound heterozygotes), accounting for the most frequently observed PRF1 mutation.
16860143	2006	J. Pediatr.	0022-3476	ALL_TEXT_1/3	1	2	5551	SYMBOL|DICTIONARY|EXTRACTED	prf1	PRF1	199#203	16860143-1-17-25	D051359	SYMBOL|DICTIONARY|EXTRACTED	hlh	HLH	42#45	16860143-1-83-117	We found that all identified infants with HLH of African descent (17 from USA, 4 from Europe) have 50delT-PRF1 (16 homozygotes, 5 compound heterozygotes), accounting for the most frequently observed PRF1 mutation.
19141695	2009	Am. J. Clin. Nutr.	1938-3207	TITLE	0	0	2695	LONGTERM|DICTIONARY	glucose dependent insulinotropic polypeptide	glucose-dependent insulinotropic polypeptide	33#77		D065626	LONGTERM|DICTIONARY	nonalcoholic steatohepatitis	nonalcoholic steatohepatitis	147#175		Prolonged saturated fat-induced, glucose-dependent insulinotropic polypeptide elevation is associated with adipokine imbalance and liver injury in nonalcoholic steatohepatitis: dysregulated enteroadipocyte axis as a novel feature of fatty liver.
19141695	2009	Am. J. Clin. Nutr.	1938-3207	TITLE	0	0	2695	LONGTERM|DICTIONARY	glucose dependent insulinotropic polypeptide	glucose-dependent insulinotropic polypeptide	33#77		D005234	LONGTERM|DICTIONARY	fatty liver	fatty liver	233#244		Prolonged saturated fat-induced, glucose-dependent insulinotropic polypeptide elevation is associated with adipokine imbalance and liver injury in nonalcoholic steatohepatitis: dysregulated enteroadipocyte axis as a novel feature of fatty liver.
19141695	2009	Am. J. Clin. Nutr.	1938-3207	TITLE	0	0	2695	LONGTERM|DICTIONARY	glucose dependent insulinotropic polypeptide	glucose-dependent insulinotropic polypeptide	33#77		C566610	LONGTERM|DICTIONARY	dysregulated enteroadipocyte axis	dysregulated enteroadipocyte axis	177#210	NaN	Prolonged saturated fat-induced, glucose-dependent insulinotropic polypeptide elevation is associated with adipokine imbalance and liver injury in nonalcoholic steatohepatitis: dysregulated enteroadipocyte axis as a novel feature of fatty liver.
19141695	2009	Am. J. Clin. Nutr.	1938-3207	TITLE	0	0	2695	LONGTERM|DICTIONARY	glucose dependent insulinotropic polypeptide	glucose-dependent insulinotropic polypeptide	33#77		D056486	LONGTERM|DICTIONARY	liver injury	liver injury	131#143	NaN	Prolonged saturated fat-induced, glucose-dependent insulinotropic polypeptide elevation is associated with adipokine imbalance and liver injury in nonalcoholic steatohepatitis: dysregulated enteroadipocyte axis as a novel feature of fatty liver.
19450125	2009	Pharmacogenomics	1744-8042	AIMS	1	1	54658	SYMBOL|DICTIONARY	ugt1a1	UGT1A1	12#18		D064420	LONGTERM|DICTIONARY	toxicity	toxicity	56#64	NaN	Variants in UGT1A1 have previously been associated with toxicity from irinotecan chemotherapy.
19141695	2009	Am. J. Clin. Nutr.	1938-3207	RESULTS	4	9	2695	SYMBOL|DICTIONARY|EXTRACTED	gip	GIP	0#3		D005234	LONGTERM|DICTIONARY	hepatic steatosis	hepatic steatosis	38#55		GIP response correlated directly with hepatic steatosis, postprandial resistin, and free fatty acid (FFA) increase and inversely with beta cell function and incretin effect.
19141695	2009	Am. J. Clin. Nutr.	1938-3207	RESULTS	4	8	2695	SYMBOL|DICTIONARY|EXTRACTED	gip	GIP	41#44	19141695-2-0-44	D065626	SYMBOL|DICTIONARY|EXTRACTED	nash	NASH	14#18	19141695-4-139-154	Patients with NASH exhibited a prolonged GIP elevation after fat ingestion.
16517578	2006	Thorax	0040-6376	CONCLUSIONS	4	13	7124	SYMBOL|EXTRACTED|GENE|GN	tnfalpha	TNFalpha	103#111	16517578-2-18-46	D001249	LONGTERM|DICTIONARY	asthma	asthma	140#146		A large scale case-control study is needed to clarify the functional effect of the polymorphism of the TNFalpha gene in the pathogenesis of asthma.
16490169	2006	Acta Pharmacol. Sin.	1671-4083	RESULTS	3	7	1565	SYMBOL|NUMBER|DICTIONARY	cyp2d6	CYP2D6	34#40		D004409	SYMBOL|EXTRACTED	td	TD	23#25	16490169-1-122-140	An association between TD and the CYP2D6 100T and CYP1A2 163C alleles was observed.
16490169	2006	Acta Pharmacol. Sin.	1671-4083	RESULTS	3	7	1544	SYMBOL|NUMBER|DICTIONARY	cyp1a2	CYP1A2	50#56		D004409	SYMBOL|EXTRACTED	td	TD	23#25	16490169-1-122-140	An association between TD and the CYP2D6 100T and CYP1A2 163C alleles was observed.
19141698	2009	J. Nutr.	1541-6100	ALL_TEXT_3/3	3	9	6934	SYMBOL|DICTIONARY|EXTRACTED	tcf7l2	TCF7L2	155#161	19141698-1-4-33	D008659	SYMBOL|EXTRACTED	mets	MetS	203#207	19141698-1-128-146	In summary, high (n-6) PUFA intakes (> or = 6.62% of energy intake) were associated with atherogenic dyslipidemia in carriers of the minor T allele at the TCF7L2 rs7903146 SNP and may predispose them to MetS, diabetes, and cardiovascular disease.
19141698	2009	J. Nutr.	1541-6100	ALL_TEXT_3/3	3	9	6934	SYMBOL|DICTIONARY|EXTRACTED	tcf7l2	TCF7L2	155#161	19141698-1-4-33	D003920	LONGTERM|DICTIONARY	diabetes	diabetes	209#217		In summary, high (n-6) PUFA intakes (> or = 6.62% of energy intake) were associated with atherogenic dyslipidemia in carriers of the minor T allele at the TCF7L2 rs7903146 SNP and may predispose them to MetS, diabetes, and cardiovascular disease.
19141698	2009	J. Nutr.	1541-6100	ALL_TEXT_3/3	3	9	6934	SYMBOL|DICTIONARY|EXTRACTED	tcf7l2	TCF7L2	155#161	19141698-1-4-33	D002318	LONGTERM|DISEASE|DT|DICTIONARY	cardiovascular disease	cardiovascular disease	223#245		In summary, high (n-6) PUFA intakes (> or = 6.62% of energy intake) were associated with atherogenic dyslipidemia in carriers of the minor T allele at the TCF7L2 rs7903146 SNP and may predispose them to MetS, diabetes, and cardiovascular disease.
19141698	2009	J. Nutr.	1541-6100	ALL_TEXT_3/3	3	9	6934	SYMBOL|DICTIONARY|EXTRACTED	tcf7l2	TCF7L2	155#161	19141698-1-4-33	D050171	LONGTERM|DICTIONARY	atherogenic dyslipidemia	atherogenic dyslipidemia	89#113		In summary, high (n-6) PUFA intakes (> or = 6.62% of energy intake) were associated with atherogenic dyslipidemia in carriers of the minor T allele at the TCF7L2 rs7903146 SNP and may predispose them to MetS, diabetes, and cardiovascular disease.
19141698	2009	J. Nutr.	1541-6100	ALL_TEXT_3/3	3	9	9933	LONGTERM|DICTIONARY	pufa	PUFA	23#27	NaN	D008659	SYMBOL|EXTRACTED	mets	MetS	203#207	19141698-1-128-146	In summary, high (n-6) PUFA intakes (> or = 6.62% of energy intake) were associated with atherogenic dyslipidemia in carriers of the minor T allele at the TCF7L2 rs7903146 SNP and may predispose them to MetS, diabetes, and cardiovascular disease.
19141698	2009	J. Nutr.	1541-6100	ALL_TEXT_3/3	3	9	9933	LONGTERM|DICTIONARY	pufa	PUFA	23#27	NaN	D003920	LONGTERM|DICTIONARY	diabetes	diabetes	209#217		In summary, high (n-6) PUFA intakes (> or = 6.62% of energy intake) were associated with atherogenic dyslipidemia in carriers of the minor T allele at the TCF7L2 rs7903146 SNP and may predispose them to MetS, diabetes, and cardiovascular disease.
19141698	2009	J. Nutr.	1541-6100	ALL_TEXT_3/3	3	9	9933	LONGTERM|DICTIONARY	pufa	PUFA	23#27	NaN	D002318	LONGTERM|DISEASE|DT|DICTIONARY	cardiovascular disease	cardiovascular disease	223#245		In summary, high (n-6) PUFA intakes (> or = 6.62% of energy intake) were associated with atherogenic dyslipidemia in carriers of the minor T allele at the TCF7L2 rs7903146 SNP and may predispose them to MetS, diabetes, and cardiovascular disease.
19141698	2009	J. Nutr.	1541-6100	ALL_TEXT_3/3	3	9	9933	LONGTERM|DICTIONARY	pufa	PUFA	23#27	NaN	D050171	LONGTERM|DICTIONARY	atherogenic dyslipidemia	atherogenic dyslipidemia	89#113		In summary, high (n-6) PUFA intakes (> or = 6.62% of energy intake) were associated with atherogenic dyslipidemia in carriers of the minor T allele at the TCF7L2 rs7903146 SNP and may predispose them to MetS, diabetes, and cardiovascular disease.
19350278	2009	Pediatr. Nephrol.	1432-198X	ALL_TEXT_2/3	2	4	9353	SYMBOL|DICTIONARY	slit2	SLIT2	76#81		D014718	SYMBOL|DICTIONARY|EXTRACTED	vur	VUR	124#127	19350278-1-23-45	In the study reported here, we investigated the genetic contribution of the SLIT2 and ROBO2 genes in non-syndromic familial VUR by mutation screening of 54 unrelated patients with primary VUR.
19350278	2009	Pediatr. Nephrol.	1432-198X	ALL_TEXT_2/3	2	4	9353	SYMBOL|DICTIONARY	slit2	SLIT2	76#81		D014718	SYMBOL|DICTIONARY|EXTRACTED	vur	VUR	188#191	19350278-1-23-45	In the study reported here, we investigated the genetic contribution of the SLIT2 and ROBO2 genes in non-syndromic familial VUR by mutation screening of 54 unrelated patients with primary VUR.
19350278	2009	Pediatr. Nephrol.	1432-198X	ALL_TEXT_2/3	2	4	6092	SYMBOL|GENE|GN|DICTIONARY	robo2	ROBO2	86#91		D014718	SYMBOL|DICTIONARY|EXTRACTED	vur	VUR	124#127	19350278-1-23-45	In the study reported here, we investigated the genetic contribution of the SLIT2 and ROBO2 genes in non-syndromic familial VUR by mutation screening of 54 unrelated patients with primary VUR.
19350278	2009	Pediatr. Nephrol.	1432-198X	ALL_TEXT_2/3	2	4	6092	SYMBOL|GENE|GN|DICTIONARY	robo2	ROBO2	86#91		D014718	SYMBOL|DICTIONARY|EXTRACTED	vur	VUR	188#191	19350278-1-23-45	In the study reported here, we investigated the genetic contribution of the SLIT2 and ROBO2 genes in non-syndromic familial VUR by mutation screening of 54 unrelated patients with primary VUR.
19141698	2009	J. Nutr.	1541-6100	ALL_TEXT_1/3	1	2	6934	SYMBOL|DICTIONARY|EXTRACTED	tcf7l2	TCF7L2	106#112	19141698-1-4-33	D008659	SYMBOL|EXTRACTED	mets	MetS	153#157	19141698-1-128-146	We investigated the effect of single nucleotide polymorphisms (SNP), rs7903146 and rs12255372, within the TCF7L2 locus on postprandial lipemia and other MetS-related traits and their modulation by dietary fat.
19141698	2009	J. Nutr.	1541-6100	ALL_TEXT_1/3	1	2	6934	SYMBOL|DICTIONARY|EXTRACTED	tcf7l2	TCF7L2	106#112	19141698-1-4-33	D006949	LONGTERM|DICTIONARY	lipemia	lipemia	135#142	NaN	We investigated the effect of single nucleotide polymorphisms (SNP), rs7903146 and rs12255372, within the TCF7L2 locus on postprandial lipemia and other MetS-related traits and their modulation by dietary fat.
19141698	2009	J. Nutr.	1541-6100	TITLE	0	0	6934	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	tcf7l2	TCF7L2	51#57		D006949	LONGTERM|DICTIONARY	lipemia	lipemia	88#95	NaN	Polyunsaturated fatty acids modulate the effect of TCF7L2 gene variants on postprandial lipemia.
19141698	2009	J. Nutr.	1541-6100	ALL_TEXT_1/3	1	1	6934	LONGTERM|DICTIONARY	transcription factor 7 like 2	transcription factor 7-like 2	4#33		D003920	LONGTERM|DICTIONARY	diabetes	diabetes	77#85		The transcription factor 7-like 2 (TCF7L2) has been recently associated with diabetes risk, and it may exert its effect through metabolic syndrome (MetS)-related traits and be subjected to modification by environmental factors.
19141698	2009	J. Nutr.	1541-6100	ALL_TEXT_1/3	1	1	6934	LONGTERM|DICTIONARY	transcription factor 7 like 2	transcription factor 7-like 2	4#33		D008659	LONGTERM|DISEASE|DT|DICTIONARY	metabolic syndrome	metabolic syndrome	128#146		The transcription factor 7-like 2 (TCF7L2) has been recently associated with diabetes risk, and it may exert its effect through metabolic syndrome (MetS)-related traits and be subjected to modification by environmental factors.
19141698	2009	J. Nutr.	1541-6100	ALL_TEXT_1/3	1	1	6934	LONGTERM|DICTIONARY	transcription factor 7 like 2	transcription factor 7-like 2	4#33		D008659	SYMBOL|EXTRACTED|()	mets	MetS	148#152	19141698-1-128-146	The transcription factor 7-like 2 (TCF7L2) has been recently associated with diabetes risk, and it may exert its effect through metabolic syndrome (MetS)-related traits and be subjected to modification by environmental factors.
19141698	2009	J. Nutr.	1541-6100	ALL_TEXT_1/3	1	1	6934	SYMBOL|()|DICTIONARY|EXTRACTED	tcf7l2	TCF7L2	35#41	19141698-1-4-33	D003920	LONGTERM|DICTIONARY	diabetes	diabetes	77#85		The transcription factor 7-like 2 (TCF7L2) has been recently associated with diabetes risk, and it may exert its effect through metabolic syndrome (MetS)-related traits and be subjected to modification by environmental factors.
19141698	2009	J. Nutr.	1541-6100	ALL_TEXT_1/3	1	1	6934	SYMBOL|()|DICTIONARY|EXTRACTED	tcf7l2	TCF7L2	35#41	19141698-1-4-33	D008659	LONGTERM|DISEASE|DT|DICTIONARY	metabolic syndrome	metabolic syndrome	128#146		The transcription factor 7-like 2 (TCF7L2) has been recently associated with diabetes risk, and it may exert its effect through metabolic syndrome (MetS)-related traits and be subjected to modification by environmental factors.
19141698	2009	J. Nutr.	1541-6100	ALL_TEXT_1/3	1	1	6934	SYMBOL|()|DICTIONARY|EXTRACTED	tcf7l2	TCF7L2	35#41	19141698-1-4-33	D008659	SYMBOL|EXTRACTED|()	mets	MetS	148#152	19141698-1-128-146	The transcription factor 7-like 2 (TCF7L2) has been recently associated with diabetes risk, and it may exert its effect through metabolic syndrome (MetS)-related traits and be subjected to modification by environmental factors.
9823305	1998	Cancer Res.	0008-5472	ALL_TEXT_2/3	2	6	1545	SYMBOL|DICTIONARY|EXTRACTED	cyp1b1	CYP1B1	37#43	9823305-0-15-34	D001943	LONGTERM|DISEASE|DT|DICTIONARY	breast cancer	breast cancer	83#96		To determine whether the polymorphic CYP1B1 alleles hold implications as potential breast cancer risk factors, we compared the CYP1B1 genotypes in 164 Caucasian and 59 African-American breast cancer cases with those in age-, race-, and frequency-matched controls.
9823305	1998	Cancer Res.	0008-5472	ALL_TEXT_2/3	2	6	1545	SYMBOL|DICTIONARY|EXTRACTED	cyp1b1	CYP1B1	37#43	9823305-0-15-34	D001943	LONGTERM|DISEASE|DT|DICTIONARY	breast cancer	breast cancer	185#198		To determine whether the polymorphic CYP1B1 alleles hold implications as potential breast cancer risk factors, we compared the CYP1B1 genotypes in 164 Caucasian and 59 African-American breast cancer cases with those in age-, race-, and frequency-matched controls.
9823305	1998	Cancer Res.	0008-5472	ALL_TEXT_2/3	2	6	1545	SYMBOL|DICTIONARY|EXTRACTED	cyp1b1	CYP1B1	127#133	9823305-0-15-34	D001943	LONGTERM|DISEASE|DT|DICTIONARY	breast cancer	breast cancer	83#96		To determine whether the polymorphic CYP1B1 alleles hold implications as potential breast cancer risk factors, we compared the CYP1B1 genotypes in 164 Caucasian and 59 African-American breast cancer cases with those in age-, race-, and frequency-matched controls.
9823305	1998	Cancer Res.	0008-5472	ALL_TEXT_2/3	2	6	1545	SYMBOL|DICTIONARY|EXTRACTED	cyp1b1	CYP1B1	127#133	9823305-0-15-34	D001943	LONGTERM|DISEASE|DT|DICTIONARY	breast cancer	breast cancer	185#198		To determine whether the polymorphic CYP1B1 alleles hold implications as potential breast cancer risk factors, we compared the CYP1B1 genotypes in 164 Caucasian and 59 African-American breast cancer cases with those in age-, race-, and frequency-matched controls.
18307574	2009	Allergy	1398-9995	RESULTS	3	8	2312	SYMBOL|DICTIONARY|EXTRACTED	flg	FLG	145#148	18307574-1-0-9	D001249	LONGTERM|DICTIONARY	asthma	asthma	94#100		There was also a 1.71-fold increased risk (42.6%vs 30%; P = 0.041) of school absence owing to asthma exacerbations in asthmatic individuals with FLG null mutation.
18307574	2009	Allergy	1398-9995	RESULTS	3	8	2312	SYMBOL|DICTIONARY|EXTRACTED	flg	FLG	145#148	18307574-1-0-9	D013224	LONGTERM|DICTIONARY	asthmatic	asthmatic	118#127		There was also a 1.71-fold increased risk (42.6%vs 30%; P = 0.041) of school absence owing to asthma exacerbations in asthmatic individuals with FLG null mutation.
18307574	2009	Allergy	1398-9995	RESULTS	3	9	2312	SYMBOL|DICTIONARY|EXTRACTED	flg	FLG	37#40	18307574-1-0-9	D001249	LONGTERM|DICTIONARY	asthma	asthma	54#60		On sub-group analysis, the effect of FLG mutations on asthma exacerbations is significant (P = 0.045) only for participants with relatively mild asthma controlled on inhaled steroids, with inhaled albuterol according to need.
18307574	2009	Allergy	1398-9995	RESULTS	3	9	2312	SYMBOL|DICTIONARY|EXTRACTED	flg	FLG	37#40	18307574-1-0-9	D001249	LONGTERM|DICTIONARY	asthma	asthma	145#151		On sub-group analysis, the effect of FLG mutations on asthma exacerbations is significant (P = 0.045) only for participants with relatively mild asthma controlled on inhaled steroids, with inhaled albuterol according to need.
19450125	2009	Pharmacogenomics	1744-8042	AIMS	1	2	54658	SYMBOL|DICTIONARY	ugt1a1	UGT1A1	80#86		D009503	LONGTERM|DICTIONARY	neutropenia	neutropenia	137#148		We conducted a pragmatic prospective cohort study to establish the relevance of UGT1A1 variants in the prediction of severe diarrhea and neutropenia in patients with colorectal cancer receiving irinotecan in a routine clinical setting.
19450125	2009	Pharmacogenomics	1744-8042	AIMS	1	2	54658	SYMBOL|DICTIONARY	ugt1a1	UGT1A1	80#86		D015179	LONGTERM|DISEASE|DT|DICTIONARY	colorectal cancer	colorectal cancer	166#183		We conducted a pragmatic prospective cohort study to establish the relevance of UGT1A1 variants in the prediction of severe diarrhea and neutropenia in patients with colorectal cancer receiving irinotecan in a routine clinical setting.
19450125	2009	Pharmacogenomics	1744-8042	AIMS	1	2	54658	SYMBOL|DICTIONARY	ugt1a1	UGT1A1	80#86		D003967	LONGTERM|DICTIONARY	diarrhea	diarrhea	124#132		We conducted a pragmatic prospective cohort study to establish the relevance of UGT1A1 variants in the prediction of severe diarrhea and neutropenia in patients with colorectal cancer receiving irinotecan in a routine clinical setting.
18307574	2009	Allergy	1398-9995	BACKGROUND	1	2	2312	SYMBOL|DICTIONARY|EXTRACTED	flg	FLG	39#42	18307574-1-0-9	D001249	LONGTERM|DICTIONARY	asthma	asthma	59#65		Our objective was to study the role of FLG null alleles in asthma exacerbations.
18307574	2009	Allergy	1398-9995	METHODS	2	3	2312	SYMBOL|DICTIONARY|EXTRACTED	flg	FLG	0#3		D001249	LONGTERM|DICTIONARY	asthma	asthma	102#108		FLG mutations R501X and 2282del4 were assayed in 1135 individuals ranging from 3 to 22 years old with asthma from Tayside and Dumfries, Scotland.
18307574	2009	Allergy	1398-9995	TITLE	0	0	2312	LONGTERM|DICTIONARY	filaggrin	Filaggrin	0#9		D001249	LONGTERM|DICTIONARY	asthma	asthma	55#61		Filaggrin null mutations are associated with increased asthma exacerbations in children and young adults.
18307574	2009	Allergy	1398-9995	BACKGROUND	1	1	2312	LONGTERM|DICTIONARY	filaggrin	Filaggrin	0#9		C565292	LONGTERM|DICTIONARY	atopic asthma	atopic asthma	78#91		Filaggrin (FLG) null mutations are important genetic predisposing factors for atopic asthma and have recently been shown to influence controller and reliever medication needs in asthmatic children.
18307574	2009	Allergy	1398-9995	BACKGROUND	1	1	2312	LONGTERM|DICTIONARY	filaggrin	Filaggrin	0#9		D013224	LONGTERM|DICTIONARY	asthmatic	asthmatic	178#187		Filaggrin (FLG) null mutations are important genetic predisposing factors for atopic asthma and have recently been shown to influence controller and reliever medication needs in asthmatic children.
18307574	2009	Allergy	1398-9995	BACKGROUND	1	1	2312	SYMBOL|()|DICTIONARY|EXTRACTED	flg	FLG	11#14	18307574-1-0-9	C565292	LONGTERM|DICTIONARY	atopic asthma	atopic asthma	78#91		Filaggrin (FLG) null mutations are important genetic predisposing factors for atopic asthma and have recently been shown to influence controller and reliever medication needs in asthmatic children.
18307574	2009	Allergy	1398-9995	BACKGROUND	1	1	2312	SYMBOL|()|DICTIONARY|EXTRACTED	flg	FLG	11#14	18307574-1-0-9	D013224	LONGTERM|DICTIONARY	asthmatic	asthmatic	178#187		Filaggrin (FLG) null mutations are important genetic predisposing factors for atopic asthma and have recently been shown to influence controller and reliever medication needs in asthmatic children.
15307921	2004	AIDS Res. Hum. Retroviruses	0889-2229	ALL_TEXT_1/3	1	1	1234	SYMBOL|DICTIONARY|EXTRACTED	ccr5	CCR5	0#4		D015658	LONGTERM|DISEASE|DT|DICTIONARY	human immunodeficiency virus	human immunodeficiency virus	83#111		CCR5 is a major coreceptor for cellular entry of macrophage-tropic isolates of the human immunodeficiency virus (HIV).
15307921	2004	AIDS Res. Hum. Retroviruses	0889-2229	ALL_TEXT_1/3	1	1	1234	SYMBOL|DICTIONARY|EXTRACTED	ccr5	CCR5	0#4		D015658	SYMBOL|()|DICTIONARY|EXTRACTED	hiv	HIV	113#116	15307921-1-83-111	CCR5 is a major coreceptor for cellular entry of macrophage-tropic isolates of the human immunodeficiency virus (HIV).
18307574	2009	Allergy	1398-9995	RESULTS	3	5	2312	SYMBOL|DICTIONARY|EXTRACTED	flg	FLG	4#7	18307574-1-0-9	D001249	LONGTERM|DICTIONARY	asthma	asthma	100#106		The FLG mutations were significantly associated with greater risk of exacerbations in children with asthma.
20973260	2010	Int. J. Gynecol. Cancer	1525-1438	CONCLUSIONS	4	9	7422	SYMBOL|DICTIONARY|EXTRACTED	vegf	VEGF	55#59	20973260-1-0-34	D010051	SYMBOL|EXTRACTED	eoc	EOC	105#108	20973260-2-114-139	The study suggested a possible association between the VEGF -1154G/A polymorphism with susceptibility to EOC, but there is no support for an association of the VEGF -460C/T, +936C/T, and -2578C/A polymorphisms with the risk for EOC.
20973260	2010	Int. J. Gynecol. Cancer	1525-1438	CONCLUSIONS	4	9	7422	SYMBOL|DICTIONARY|EXTRACTED	vegf	VEGF	55#59	20973260-1-0-34	D010051	SYMBOL|EXTRACTED	eoc	EOC	228#231	20973260-2-114-139	The study suggested a possible association between the VEGF -1154G/A polymorphism with susceptibility to EOC, but there is no support for an association of the VEGF -460C/T, +936C/T, and -2578C/A polymorphisms with the risk for EOC.
20973260	2010	Int. J. Gynecol. Cancer	1525-1438	CONCLUSIONS	4	9	7422	SYMBOL|DICTIONARY|EXTRACTED	vegf	VEGF	160#164	20973260-1-0-34	D010051	SYMBOL|EXTRACTED	eoc	EOC	105#108	20973260-2-114-139	The study suggested a possible association between the VEGF -1154G/A polymorphism with susceptibility to EOC, but there is no support for an association of the VEGF -460C/T, +936C/T, and -2578C/A polymorphisms with the risk for EOC.
20973260	2010	Int. J. Gynecol. Cancer	1525-1438	CONCLUSIONS	4	9	7422	SYMBOL|DICTIONARY|EXTRACTED	vegf	VEGF	160#164	20973260-1-0-34	D010051	SYMBOL|EXTRACTED	eoc	EOC	228#231	20973260-2-114-139	The study suggested a possible association between the VEGF -1154G/A polymorphism with susceptibility to EOC, but there is no support for an association of the VEGF -460C/T, +936C/T, and -2578C/A polymorphisms with the risk for EOC.
18614340	2009	Eur Neuropsychopharmacol	0924-977X	ALL_TEXT_3/3	3	8	2913	SYMBOL|DICTIONARY	grm3	GRM3	92#96		D012559	LONGTERM|DICTIONARY	schizophrenia	schizophrenia	100#113		Our results provide further evidence for the potential importance of the glutamate receptor GRM3 in schizophrenia, and indicate that the novel antipsychotic LY2140023 may actually be targeting a pathogenic pathway of schizophrenia.
18614340	2009	Eur Neuropsychopharmacol	0924-977X	ALL_TEXT_3/3	3	8	2913	SYMBOL|DICTIONARY	grm3	GRM3	92#96		D012559	LONGTERM|DICTIONARY	schizophrenia	schizophrenia	217#230		Our results provide further evidence for the potential importance of the glutamate receptor GRM3 in schizophrenia, and indicate that the novel antipsychotic LY2140023 may actually be targeting a pathogenic pathway of schizophrenia.
18614340	2009	Eur Neuropsychopharmacol	0924-977X	TITLE	0	0	2913	SYMBOL|DICTIONARY	grm3	GRM3	70#74		D012559	LONGTERM|DICTIONARY	schizophrenia	schizophrenia	78#91		Further evidence for a functional role of the glutamate receptor gene GRM3 in schizophrenia.
17603938	2007	Free Radic. Biol. Med.	0891-5849	ALL_TEXT_1/3	1	3	4313	SYMBOL|DICTIONARY	mmp-9 and -2	MMP-9 and -2	47#59		D013276	LONGTERM|DICTIONARY	acute gastric ulceration	acute gastric ulceration	79#103		We investigated the activity and expression of MMP-9 and -2 in ethanol-induced acute gastric ulceration in rats.
17603938	2007	Free Radic. Biol. Med.	0891-5849	ALL_TEXT_1/3	1	3	4318	SYMBOL|DICTIONARY	mmp-9 and -2	MMP-9 and -2	47#59		D013276	LONGTERM|DICTIONARY	acute gastric ulceration	acute gastric ulceration	79#103		We investigated the activity and expression of MMP-9 and -2 in ethanol-induced acute gastric ulceration in rats.
15886814	2005	Thromb. Haemost.	0340-6245	ALL_TEXT_1/3	1	4	1524	SYMBOL|DICTIONARY	cx3cr1	CX3CR1	64#70		D003324	LONGTERM|DISEASE|DT|DICTIONARY	coronary artery disease	coronary artery disease	76#99		We investigated the association of the alleles M280 and I249 of CX3CR1 with coronary artery disease (CAD) and with acute coronary syndrome (ACS).
15886814	2005	Thromb. Haemost.	0340-6245	ALL_TEXT_1/3	1	4	1524	SYMBOL|DICTIONARY	cx3cr1	CX3CR1	64#70		D003324	SYMBOL|()|DICTIONARY|EXTRACTED	cad	CAD	101#104	15886814-4-76-99	We investigated the association of the alleles M280 and I249 of CX3CR1 with coronary artery disease (CAD) and with acute coronary syndrome (ACS).
15886814	2005	Thromb. Haemost.	0340-6245	ALL_TEXT_1/3	1	4	1524	SYMBOL|DICTIONARY	cx3cr1	CX3CR1	64#70		D054058	LONGTERM|DISEASE|DT|DICTIONARY	acute coronary syndrome	acute coronary syndrome	115#138		We investigated the association of the alleles M280 and I249 of CX3CR1 with coronary artery disease (CAD) and with acute coronary syndrome (ACS).
15886814	2005	Thromb. Haemost.	0340-6245	ALL_TEXT_1/3	1	4	1524	SYMBOL|DICTIONARY	cx3cr1	CX3CR1	64#70		D054058	SYMBOL|EXTRACTED|()	acs	ACS	140#143	15886814-4-115-138	We investigated the association of the alleles M280 and I249 of CX3CR1 with coronary artery disease (CAD) and with acute coronary syndrome (ACS).
19152006	2009	Hum. Genet.	1432-1203	ALL_TEXT_3/3	3	6	1621	LONGTERM|DICTIONARY	dopamine beta hydroxylase	dopamine-beta hydroxylase	108#133		D020325	LONGTERM|DICTIONARY	migraine with aura	migraine with aura	188#206		Our data provide new evidence for an involvement of components of the dopaminergic system-in particular the dopamine-beta hydroxylase and dopamine transporter genes-to the pathogenesis of migraine with aura.
16168297	2005	J. Am. Coll. Cardiol.	1558-3597	RESULTS	4	9	3569	SYMBOL|DICTIONARY	il 6	IL-6	52#56		D013915	LONGTERM|DICTIONARY	gt	GT	24#26	NaN	During the acute phase, GT+TT had higher ox-LDL and IL-6 (131.2 +/- 6.4 IU/l and 8.5 +/- 0.7 pg/ml) compared with GG (101.7 +/- 9.64 IU/l and 6.2 +/- 0.8 pg/ml, p < 0.05 for both), but no difference was found at one year.
15886814	2005	Thromb. Haemost.	0340-6245	TITLE	0	0	1524	SYMBOL|GENE|GN|DICTIONARY	cx3cr1	CX3CR1	20#26		D054058	LONGTERM|DISEASE|DT|DICTIONARY	acute coronary syndrome	acute coronary syndrome	88#111		Opposite effects of CX3CR1 receptor polymorphisms V249I and T280M on the development of acute coronary syndrome. A possible implication of fractalkine in inflammatory activation.
15886814	2005	Thromb. Haemost.	0340-6245	TITLE	0	0	6376	LONGTERM|DICTIONARY	fractalkine	fractalkine	139#150	NaN	D054058	LONGTERM|DISEASE|DT|DICTIONARY	acute coronary syndrome	acute coronary syndrome	88#111		Opposite effects of CX3CR1 receptor polymorphisms V249I and T280M on the development of acute coronary syndrome. A possible implication of fractalkine in inflammatory activation.
19152006	2009	Hum. Genet.	1432-1203	ALL_TEXT_1/3	1	2	1621	SYMBOL|DICTIONARY	dbh	DBH	114#117		D020325	SYMBOL|EXTRACTED	ma	MA	75#77	19152006-1-130-148	Based on the genotyping results of 53 variants across the ten genes in 270 MA cases and 272 controls, three genes-DBH, DRD2 and SLC6A3-were chosen to proceed to additional genotyping of 380 MA cases and 378 controls.
19152006	2009	Hum. Genet.	1432-1203	ALL_TEXT_1/3	1	2	1621	SYMBOL|DICTIONARY	dbh	DBH	114#117		D020325	SYMBOL|EXTRACTED	ma	MA	190#192	19152006-1-130-148	Based on the genotyping results of 53 variants across the ten genes in 270 MA cases and 272 controls, three genes-DBH, DRD2 and SLC6A3-were chosen to proceed to additional genotyping of 380 MA cases and 378 controls.
19152006	2009	Hum. Genet.	1432-1203	ALL_TEXT_1/3	1	2	1813	SYMBOL|DICTIONARY	drd2	DRD2	119#123		D020325	SYMBOL|EXTRACTED	ma	MA	75#77	19152006-1-130-148	Based on the genotyping results of 53 variants across the ten genes in 270 MA cases and 272 controls, three genes-DBH, DRD2 and SLC6A3-were chosen to proceed to additional genotyping of 380 MA cases and 378 controls.
19152006	2009	Hum. Genet.	1432-1203	ALL_TEXT_1/3	1	2	1813	SYMBOL|DICTIONARY	drd2	DRD2	119#123		D020325	SYMBOL|EXTRACTED	ma	MA	190#192	19152006-1-130-148	Based on the genotyping results of 53 variants across the ten genes in 270 MA cases and 272 controls, three genes-DBH, DRD2 and SLC6A3-were chosen to proceed to additional genotyping of 380 MA cases and 378 controls.
19152006	2009	Hum. Genet.	1432-1203	ALL_TEXT_1/3	1	2	6531	SYMBOL|DICTIONARY	slc6a3	SLC6A3	128#134		D020325	SYMBOL|EXTRACTED	ma	MA	75#77	19152006-1-130-148	Based on the genotyping results of 53 variants across the ten genes in 270 MA cases and 272 controls, three genes-DBH, DRD2 and SLC6A3-were chosen to proceed to additional genotyping of 380 MA cases and 378 controls.
19152006	2009	Hum. Genet.	1432-1203	ALL_TEXT_1/3	1	2	6531	SYMBOL|DICTIONARY	slc6a3	SLC6A3	128#134		D020325	SYMBOL|EXTRACTED	ma	MA	190#192	19152006-1-130-148	Based on the genotyping results of 53 variants across the ten genes in 270 MA cases and 272 controls, three genes-DBH, DRD2 and SLC6A3-were chosen to proceed to additional genotyping of 380 MA cases and 378 controls.
20100586	2011	Biol. Blood Marrow Transplant.	1523-6536	ALL_TEXT_2/3	2	9	7124	SYMBOL|EXTRACTED	tnf-alpha	TNF-alpha	43#52	20100586-1-0-21	D006086	SYMBOL|EXTRACTED	agvhd	aGVHD	89#94	20100586-1-117-148	Significant associations were seen between TNF-alpha variant alleles and the severity of aGVHD (grade II-IV and grade III-IV), especially when analyzed in whites only (n = 165).
9823305	1998	Cancer Res.	0008-5472	ALL_TEXT_1/3	1	1	1545	LONGTERM|DICTIONARY	cytochrome p450 1b1	cytochrome P450 1B1	140#159		D001943	LONGTERM|DISEASE|DT|DICTIONARY	breast cancer	breast cancer	250#263		A key enzyme involved in the production of potentially carcinogenic estrogen metabolites and the activation of environmental carcinogens is cytochrome P450 1B1 (CYP1B1), the predominant member of the CYP1 family expressed in normal breast tissue and breast cancer.
9823305	1998	Cancer Res.	0008-5472	ALL_TEXT_1/3	1	1	1545	SYMBOL|()|DICTIONARY|EXTRACTED	cyp1b1	CYP1B1	161#167	9823305-0-15-34	D001943	LONGTERM|DISEASE|DT|DICTIONARY	breast cancer	breast cancer	250#263		A key enzyme involved in the production of potentially carcinogenic estrogen metabolites and the activation of environmental carcinogens is cytochrome P450 1B1 (CYP1B1), the predominant member of the CYP1 family expressed in normal breast tissue and breast cancer.
15886814	2005	Thromb. Haemost.	0340-6245	ALL_TEXT_3/3	3	9	1401	LONGTERM|GENE|GT|DICTIONARY	c reactive protein	C-reactive protein	127#145		D054058	SYMBOL|EXTRACTED	acs	ACS	7#10	15886814-4-115-138	During ACS these patients (carrying only I249) had significantly higher circulating concentrations of FKN and high sensitivity C-reactive protein (1.9- and 1.6-fold).
16255050	2005	Arthritis Rheum.	0004-3591	OBJECTIVE	1	3	6583	SYMBOL|DICTIONARY	slc22a4	SLC22A4	133#140		D003424	LONGTERM|DISEASE|DT|DICTIONARY	crohn disease	Crohn's disease	181#196		Recently, a functional haplotype of 2 single-nucleotide polymorphisms (SNPs) mapping to the organic cation transporter (OCTN) genes, SLC22A4 and SLC22A5, was identified as a second Crohn's disease susceptibility locus.
16255050	2005	Arthritis Rheum.	0004-3591	OBJECTIVE	1	3	6584	SYMBOL|DICTIONARY	slc22a5	SLC22A5	145#152		D003424	LONGTERM|DISEASE|DT|DICTIONARY	crohn disease	Crohn's disease	181#196		Recently, a functional haplotype of 2 single-nucleotide polymorphisms (SNPs) mapping to the organic cation transporter (OCTN) genes, SLC22A4 and SLC22A5, was identified as a second Crohn's disease susceptibility locus.
16255050	2005	Arthritis Rheum.	0004-3591	OBJECTIVE	1	2	64127	SYMBOL|DICTIONARY	card15	CARD15	45#51		D003424	LONGTERM|GENE|GN|DISEASE|DT|DICTIONARY	crohn disease	Crohn's disease	23#38		In a previous study, a Crohn's disease gene, CARD15, was demonstrated to be associated with psoriatic arthritis (PsA).
16255050	2005	Arthritis Rheum.	0004-3591	OBJECTIVE	1	2	64127	SYMBOL|DICTIONARY	card15	CARD15	45#51		D015535	LONGTERM|DICTIONARY	psoriatic arthritis	psoriatic arthritis	92#111		In a previous study, a Crohn's disease gene, CARD15, was demonstrated to be associated with psoriatic arthritis (PsA).
16255050	2005	Arthritis Rheum.	0004-3591	OBJECTIVE	1	2	64127	SYMBOL|DICTIONARY	card15	CARD15	45#51		D015535	SYMBOL|EXTRACTED|()	psa	PsA	113#116	16255050-2-92-111	In a previous study, a Crohn's disease gene, CARD15, was demonstrated to be associated with psoriatic arthritis (PsA).
16255050	2005	Arthritis Rheum.	0004-3591	METHODS	2	6	64127	SYMBOL|DICTIONARY	card15	CARD15	17#23		D015535	SYMBOL|EXTRACTED	psa	PsA	80#83	16255050-2-92-111	Association with CARD15 and OCTN was investigated in UK Caucasian patients with PsA (n = 472) and population controls (n = 594), using 5' allelic discrimination assays (TaqMan).
16255050	2005	Arthritis Rheum.	0004-3591	OBJECTIVE	1	4	6583	SYMBOL|GENE|GN|DICTIONARY	slc22a4	SLC22A4	4#11		D001172	LONGTERM|DICTIONARY	rheumatoid arthritis	rheumatoid arthritis	47#67		The SLC22A4 gene has also been associated with rheumatoid arthritis.
10800171	2000	Haematologica	0390-6078	RESULTS	3	7	2157	SYMBOL|GENE|GN|DICTIONARY	fviii	FVIII	4#9		D006467	LONGTERM|DICTIONARY	hemophilia a	hemophilia A	87#99		The FVIII gene inversion was present in 16 of the 32 patients (50%) affected by severe hemophilia A and was informative for 44 females.
16255050	2005	Arthritis Rheum.	0004-3591	RESULTS	3	9	64127	SYMBOL|DICTIONARY	card15	CARD15	27#33		D015535	SYMBOL|EXTRACTED	psa	PsA	18#21	16255050-2-92-111	No association of PsA with CARD15 was detected.
15257748	2004	J. Clin. Periodontol.	0303-6979	CONCLUSIONS	4	11	4312	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	mmp 1	MMP-1	54#59	15257748-1-0-26	D055113	LONGTERM|DICTIONARY	chronic periodontitis	chronic periodontitis	125#146		Our results demonstrate that the polymorphisms in the MMP-1 promoter may have only a small effect on the etiopathogenesis of chronic periodontitis.
15320482	2004	Orv Hetil	0030-6002	CONCLUSIONS	4	16	64127	SYMBOL|DICTIONARY	nod2	NOD2	60#64		D003424	LONGTERM|DISEASE|DT|DICTIONARY	crohn disease	Crohn's disease	128#143		In concordance with European data we found a high number of NOD2/CARD15 R702W and 3020insC mutations in Hungarian patients with Crohn's disease.
15320482	2004	Orv Hetil	0030-6002	CONCLUSIONS	4	16	64127	SYMBOL|DICTIONARY	card15	CARD15	65#71		D003424	LONGTERM|DISEASE|DT|DICTIONARY	crohn disease	Crohn's disease	128#143		In concordance with European data we found a high number of NOD2/CARD15 R702W and 3020insC mutations in Hungarian patients with Crohn's disease.
12793904	2003	Breast Cancer Res.	1465-542X	TITLE	0	0	4035	LONGTERM|DICTIONARY|GENE|GA	low density lipoprotein receptor related protein 1	low-density lipoprotein receptor-related protein 1	6#56		D001943	LONGTERM|DISEASE|DT|DICTIONARY	breast cancer	breast cancer	104#117		C766T low-density lipoprotein receptor-related protein 1 (LRP1) gene polymorphism and susceptibility to breast cancer.
12793904	2003	Breast Cancer Res.	1465-542X	TITLE	0	0	4035	SYMBOL|()|GENE|GN|DICTIONARY|EXTRACTED	lrp1	LRP1	58#62	12793904-0-6-56	D001943	LONGTERM|DISEASE|DT|DICTIONARY	breast cancer	breast cancer	104#117		C766T low-density lipoprotein receptor-related protein 1 (LRP1) gene polymorphism and susceptibility to breast cancer.
19363267	2009	J. Alzheimers Dis.	1875-8908	TITLE	0	0	5621	SYMBOL|DICTIONARY	prnp	PRNP	64#68		D000544	LONGTERM|DISEASE|DT|DICTIONARY	alzheimer disease	Alzheimer's disease	17#36		Earlier onset of Alzheimer's disease: risk polymorphisms within PRNP, PRND, CYP46, and APOE genes.
19363267	2009	J. Alzheimers Dis.	1875-8908	TITLE	0	0	23627	SYMBOL|DICTIONARY	prnd	PRND	70#74		D000544	LONGTERM|DISEASE|DT|DICTIONARY	alzheimer disease	Alzheimer's disease	17#36		Earlier onset of Alzheimer's disease: risk polymorphisms within PRNP, PRND, CYP46, and APOE genes.
19363267	2009	J. Alzheimers Dis.	1875-8908	TITLE	0	0	10858	SYMBOL|DICTIONARY	cyp46	CYP46	76#81		D000544	LONGTERM|DISEASE|DT|DICTIONARY	alzheimer disease	Alzheimer's disease	17#36		Earlier onset of Alzheimer's disease: risk polymorphisms within PRNP, PRND, CYP46, and APOE genes.
19363267	2009	J. Alzheimers Dis.	1875-8908	TITLE	0	0	348	SYMBOL|GENE|GN|DICTIONARY	apoe	APOE	87#91		D000544	LONGTERM|DISEASE|DT|DICTIONARY	alzheimer disease	Alzheimer's disease	17#36		Earlier onset of Alzheimer's disease: risk polymorphisms within PRNP, PRND, CYP46, and APOE genes.
12793904	2003	Breast Cancer Res.	1465-542X	BACKGROUND	1	3	4035	SYMBOL|DICTIONARY|EXTRACTED	lrp1	LRP1	47#51	12793904-0-6-56	D009369	LONGTERM|DISEASE|DT|CLINE|CN|DICTIONARY	cancer	cancer	82#88		Previous studies showed that the expression of LRP1 is related to invasiveness of cancer cells.
12793904	2003	Breast Cancer Res.	1465-542X	BACKGROUND	1	4	4035	SYMBOL|DICTIONARY|EXTRACTED	lrp1	LRP1	24#28	12793904-0-6-56	D009369	LONGTERM|DISEASE|DT|DICTIONARY	tumor	tumor	80#85		However, recent data on LRP1 suggest that this receptor can also be involved in tumor establishment and progression.
12793904	2003	Breast Cancer Res.	1465-542X	METHODS	2	5	4035	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	lrp1	LRP1	87#91	12793904-0-6-56	D001943	LONGTERM|DISEASE|DT|DICTIONARY	breast cancer	breast cancer	101#114		We investigated an association between the C766T polymorphism of the third exon of the LRP1 gene and breast cancer in a sample of women of Caucasian origin.
12793904	2003	Breast Cancer Res.	1465-542X	RESULTS	3	7	4035	SYMBOL|DICTIONARY|EXTRACTED	lrp1	LRP1	15#19	12793904-0-6-56	D001943	LONGTERM|DISEASE|DT|DICTIONARY	breast cancer	breast cancer	56#69		An increase in LRP1 T allele frequency in subjects with breast cancer was observed compared with controls (0.21 versus 0.15, P = 0.01963).
12793904	2003	Breast Cancer Res.	1465-542X	CONCLUSION	4	9	4035	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	lrp1	LRP1	46#50	12793904-0-6-56	D001943	LONGTERM|DISEASE|DT|DICTIONARY	breast cancer	breast cancer	96#109		The T allele of the C766T polymorphism in the LRP1 gene is associated with an increased risk of breast cancer development in women of Caucasian origin.
10800171	2000	Haematologica	0390-6078	DESIGN AND METHODS	2	4	2157	SYMBOL|DICTIONARY	fviii	FVIII	33#38		D006467	LONGTERM|DISEASE|DN|DICTIONARY	hemophilia a	hemophilia A	78#90		Following pedigree analysis, the FVIII inversion was first examined in severe hemophilia A patients by polymerase chain reaction (PCR) analysis.
11244459	2001	Int. J. Obes. Relat. Metab. Disord.	-	CONCLUSIONS	5	11	5443	SYMBOL|DICTIONARY|EXTRACTED	pomc	POMC	176#180	11244459-1-47-66	D009765	LONGTERM|DICTIONARY	obesity	obesity	164#171		Although further studies are required, the polymorphism between position 6997 and 6998 may represent one of the genetic variations that explain the linkage between obesity and POMC.
11244459	2001	Int. J. Obes. Relat. Metab. Disord.	-	CONCLUSIONS	5	10	5443	LONGTERM|DICTIONARY	proopiomelanocortin	proopiomelanocortin	89#108		D009765	LONGTERM|DICTIONARY	obesity	obesity	177#184		Mutations in codons 7 and 9 of the signal peptide may alter the translocation of the pre-proopiomelanocortin into the endoplasmic reticulum and, therefore, can be implicated in obesity.
19996333	2010	Thorax	1468-3296	CONCLUSION	4	10	4843	SYMBOL|GENE|GN|DICTIONARY	nos2a	NOS2A	25#30		D001249	LONGTERM|DICTIONARY	asthma	asthma	70#76		Common haplotypes in the NOS2A promoter are associated with new-onset asthma and lung function growth.
17405833	2007	Ann. Rheum. Dis.	0003-4967	TITLE	0	0	3458	LONGTERM|DICTIONARY	interferon gamma	Interferon-gamma	0#16		D009220	LONGTERM|DISEASE|DN|DICTIONARY	idiopathic inflammatory myopathy	idiopathic inflammatory myopathy	67#99		Interferon-gamma and interleukin-4 gene polymorphisms in Caucasian idiopathic inflammatory myopathy patients in UK.
17405833	2007	Ann. Rheum. Dis.	0003-4967	TITLE	0	0	3565	LONGTERM|GENE|GN|DICTIONARY	interleukin 4	interleukin-4	21#34		D009220	LONGTERM|DISEASE|DN|DICTIONARY	idiopathic inflammatory myopathy	idiopathic inflammatory myopathy	67#99		Interferon-gamma and interleukin-4 gene polymorphisms in Caucasian idiopathic inflammatory myopathy patients in UK.
16012724	2005	Oncol. Rep.	1021-335X	ALL_TEXT_3/3	3	5	2264	SYMBOL|DICTIONARY	fgfr4	FGFR4	10#15		D001943	LONGTERM|DISEASE|DT|DICTIONARY	breast cancer	breast cancer	84#97		Thus, the FGFR4 polymorphism may not be relevant in predicting nodal involvement of breast cancer or colon cancer patients.
16012724	2005	Oncol. Rep.	1021-335X	ALL_TEXT_3/3	3	5	2264	SYMBOL|DICTIONARY	fgfr4	FGFR4	10#15		D003110	LONGTERM|DISEASE|DN|DT|DICTIONARY	colon cancer	colon cancer	101#113		Thus, the FGFR4 polymorphism may not be relevant in predicting nodal involvement of breast cancer or colon cancer patients.
15705913	2005	Cancer Res.	0008-5472	ALL_TEXT_3/3	3	8	6648	SYMBOL|DICTIONARY	mnsod	MnSOD	88#93		D003643	LONGTERM|DICTIONARY	death	death	179#184	NaN	When we combined genotypes associated with higher levels of reactive oxygen species for MnSOD and MPO, women with MnSOD CC and MPO GG genotypes had a 3-fold decrease in hazard of death (hazard ratio, 0.33; 95% confidence interval, 0.13-0.80; P = 0.01).
15705913	2005	Cancer Res.	0008-5472	ALL_TEXT_3/3	3	8	4353	SYMBOL|DICTIONARY	mpo	MPO	98#101		D003643	LONGTERM|DICTIONARY	death	death	179#184	NaN	When we combined genotypes associated with higher levels of reactive oxygen species for MnSOD and MPO, women with MnSOD CC and MPO GG genotypes had a 3-fold decrease in hazard of death (hazard ratio, 0.33; 95% confidence interval, 0.13-0.80; P = 0.01).
15705913	2005	Cancer Res.	0008-5472	ALL_TEXT_3/3	3	8	6648	SYMBOL|DICTIONARY	mnsod	MnSOD	114#119		D003643	LONGTERM|DICTIONARY	death	death	179#184	NaN	When we combined genotypes associated with higher levels of reactive oxygen species for MnSOD and MPO, women with MnSOD CC and MPO GG genotypes had a 3-fold decrease in hazard of death (hazard ratio, 0.33; 95% confidence interval, 0.13-0.80; P = 0.01).
15705913	2005	Cancer Res.	0008-5472	ALL_TEXT_3/3	3	8	4353	SYMBOL|DICTIONARY	mpo	MPO	127#130		D003643	LONGTERM|DICTIONARY	death	death	179#184	NaN	When we combined genotypes associated with higher levels of reactive oxygen species for MnSOD and MPO, women with MnSOD CC and MPO GG genotypes had a 3-fold decrease in hazard of death (hazard ratio, 0.33; 95% confidence interval, 0.13-0.80; P = 0.01).
20628598	2010	PLoS ONE	1932-6203	TITLE	0	0	4544	SYMBOL|DICTIONARY|EXTRACTED	mtnr1b	MTNR1B	24#30		D018149	LONGTERM|DICTIONARY	fasting plasma glucose	fasting plasma glucose	76#98	NaN	Common polymorphisms in MTNR1B, G6PC2 and GCK are associated with increased fasting plasma glucose and impaired beta-cell function in Chinese subjects.
20628598	2010	PLoS ONE	1932-6203	TITLE	0	0	57818	SYMBOL|DICTIONARY|EXTRACTED	g6pc2	G6PC2	32#37		D018149	LONGTERM|DICTIONARY	fasting plasma glucose	fasting plasma glucose	76#98	NaN	Common polymorphisms in MTNR1B, G6PC2 and GCK are associated with increased fasting plasma glucose and impaired beta-cell function in Chinese subjects.
20628598	2010	PLoS ONE	1932-6203	TITLE	0	0	2645	SYMBOL|DICTIONARY|EXTRACTED	gck	GCK	42#45		D018149	LONGTERM|DICTIONARY	fasting plasma glucose	fasting plasma glucose	76#98	NaN	Common polymorphisms in MTNR1B, G6PC2 and GCK are associated with increased fasting plasma glucose and impaired beta-cell function in Chinese subjects.
10670188	2000	Minerva Cardioangiol	0026-4725	TITLE	0	0	185	SYMBOL|GENE|GN|DICTIONARY	at1r	AT1R	25#29		C536170	SYMBOL|DISEASE|DN|DICTIONARY	dd	DD	55#57		[The C1166 allele of the AT1R gene associated with ACE DD phenotype increases the risk for deep venous thrombosis].
10670188	2000	Minerva Cardioangiol	0026-4725	TITLE	0	0	185	SYMBOL|GENE|GN|DICTIONARY	at1r	AT1R	25#29		D020246	LONGTERM|DICTIONARY	deep venous thrombosis	deep venous thrombosis	91#113		[The C1166 allele of the AT1R gene associated with ACE DD phenotype increases the risk for deep venous thrombosis].
10670188	2000	Minerva Cardioangiol	0026-4725	TITLE	0	0	1636	SYMBOL|DICTIONARY	ace	ACE	51#54		C536170	SYMBOL|DISEASE|DN|DICTIONARY	dd	DD	55#57		[The C1166 allele of the AT1R gene associated with ACE DD phenotype increases the risk for deep venous thrombosis].
10670188	2000	Minerva Cardioangiol	0026-4725	TITLE	0	0	1636	SYMBOL|DICTIONARY	ace	ACE	51#54		D020246	LONGTERM|DICTIONARY	deep venous thrombosis	deep venous thrombosis	91#113		[The C1166 allele of the AT1R gene associated with ACE DD phenotype increases the risk for deep venous thrombosis].
17405833	2007	Ann. Rheum. Dis.	0003-4967	OBJECTIVE	1	1	3458	LONGTERM|DICTIONARY	interferon gamma	interferon-gamma	21#37		D009220	LONGTERM|DICTIONARY	idiopathic inflammatory myopathies	idiopathic inflammatory myopathies	111#145		To determine whether interferon-gamma (IFN-gamma) and interleukin-4 (IL-4) genes confer susceptibility for the idiopathic inflammatory myopathies (IIMs).
17405833	2007	Ann. Rheum. Dis.	0003-4967	OBJECTIVE	1	1	3458	LONGTERM|DICTIONARY	interferon gamma	interferon-gamma	21#37		D009220	SYMBOL|PLURAL|()|DICTIONARY|EXTRACTED	iims	IIMs	147#151	17405833-1-111-145	To determine whether interferon-gamma (IFN-gamma) and interleukin-4 (IL-4) genes confer susceptibility for the idiopathic inflammatory myopathies (IIMs).
17405833	2007	Ann. Rheum. Dis.	0003-4967	OBJECTIVE	1	1	3458	SYMBOL|EXTRACTED|()	ifn gamma	IFN-gamma	39#48	17405833-1-21-37	D009220	LONGTERM|DICTIONARY	idiopathic inflammatory myopathies	idiopathic inflammatory myopathies	111#145		To determine whether interferon-gamma (IFN-gamma) and interleukin-4 (IL-4) genes confer susceptibility for the idiopathic inflammatory myopathies (IIMs).
17405833	2007	Ann. Rheum. Dis.	0003-4967	OBJECTIVE	1	1	3458	SYMBOL|EXTRACTED|()	ifn gamma	IFN-gamma	39#48	17405833-1-21-37	D009220	SYMBOL|PLURAL|()|DICTIONARY|EXTRACTED	iims	IIMs	147#151	17405833-1-111-145	To determine whether interferon-gamma (IFN-gamma) and interleukin-4 (IL-4) genes confer susceptibility for the idiopathic inflammatory myopathies (IIMs).
17405833	2007	Ann. Rheum. Dis.	0003-4967	OBJECTIVE	1	1	3565	LONGTERM|DICTIONARY|GENE|GA	interleukin 4	interleukin-4	54#67		D009220	LONGTERM|DICTIONARY	idiopathic inflammatory myopathies	idiopathic inflammatory myopathies	111#145		To determine whether interferon-gamma (IFN-gamma) and interleukin-4 (IL-4) genes confer susceptibility for the idiopathic inflammatory myopathies (IIMs).
17405833	2007	Ann. Rheum. Dis.	0003-4967	OBJECTIVE	1	1	3565	LONGTERM|DICTIONARY|GENE|GA	interleukin 4	interleukin-4	54#67		D009220	SYMBOL|PLURAL|()|DICTIONARY|EXTRACTED	iims	IIMs	147#151	17405833-1-111-145	To determine whether interferon-gamma (IFN-gamma) and interleukin-4 (IL-4) genes confer susceptibility for the idiopathic inflammatory myopathies (IIMs).
17405833	2007	Ann. Rheum. Dis.	0003-4967	OBJECTIVE	1	1	3565	SYMBOL|()|GENE|GN|DICTIONARY|EXTRACTED	il 4	IL-4	69#73	17405833-1-54-67	D009220	LONGTERM|DICTIONARY	idiopathic inflammatory myopathies	idiopathic inflammatory myopathies	111#145		To determine whether interferon-gamma (IFN-gamma) and interleukin-4 (IL-4) genes confer susceptibility for the idiopathic inflammatory myopathies (IIMs).
17405833	2007	Ann. Rheum. Dis.	0003-4967	OBJECTIVE	1	1	3565	SYMBOL|()|GENE|GN|DICTIONARY|EXTRACTED	il 4	IL-4	69#73	17405833-1-54-67	D009220	SYMBOL|PLURAL|()|DICTIONARY|EXTRACTED	iims	IIMs	147#151	17405833-1-111-145	To determine whether interferon-gamma (IFN-gamma) and interleukin-4 (IL-4) genes confer susceptibility for the idiopathic inflammatory myopathies (IIMs).
15705913	2005	Cancer Res.	0008-5472	ALL_TEXT_3/3	3	7	847	SYMBOL|DICTIONARY	cat	CAT	5#8		D003643	LONGTERM|DICTIONARY	death	death	89#94	NaN	Both CAT TT and MnSOD CC genotypes were associated with nonsignificant reduced hazard of death.
15705913	2005	Cancer Res.	0008-5472	ALL_TEXT_3/3	3	7	6648	SYMBOL|DICTIONARY	mnsod	MnSOD	16#21		D003643	LONGTERM|DICTIONARY	death	death	89#94	NaN	Both CAT TT and MnSOD CC genotypes were associated with nonsignificant reduced hazard of death.
15705913	2005	Cancer Res.	0008-5472	TITLE	0	0	4353	SYMBOL|DICTIONARY	mpo	MPO	52#55		D001943	LONGTERM|DISEASE|DT|DICTIONARY	breast cancer	breast cancer	102#115		Polymorphisms in genes related to oxidative stress (MPO, MnSOD, CAT) and survival after treatment for breast cancer.
15705913	2005	Cancer Res.	0008-5472	TITLE	0	0	6648	SYMBOL|DICTIONARY	mnsod	MnSOD	57#62		D001943	LONGTERM|DISEASE|DT|DICTIONARY	breast cancer	breast cancer	102#115		Polymorphisms in genes related to oxidative stress (MPO, MnSOD, CAT) and survival after treatment for breast cancer.
15705913	2005	Cancer Res.	0008-5472	TITLE	0	0	847	SYMBOL|DICTIONARY	cat	CAT	64#67		D001943	LONGTERM|DISEASE|DT|DICTIONARY	breast cancer	breast cancer	102#115		Polymorphisms in genes related to oxidative stress (MPO, MnSOD, CAT) and survival after treatment for breast cancer.
19553609	2009	Invest. Ophthalmol. Vis. Sci.	1552-5783	CONCLUSIONS	4	9	10878	SYMBOL|DICTIONARY|EXTRACTED	cfhr3	CFHR3	12#17	19553609-1-79-108	D008268	SYMBOL|DICTIONARY|EXTRACTED	amd	AMD	65#68	19553609-1-234-266	Deletion of CFHR3 and CFHR1 protected against the development of AMD at least in part because the deletion tagged a protective haplotype and did not occur on the risk haplotype.
19553609	2009	Invest. Ophthalmol. Vis. Sci.	1552-5783	CONCLUSIONS	4	9	3078	SYMBOL|DICTIONARY	cfhr1	CFHR1	22#27		D008268	SYMBOL|DICTIONARY|EXTRACTED	amd	AMD	65#68	19553609-1-234-266	Deletion of CFHR3 and CFHR1 protected against the development of AMD at least in part because the deletion tagged a protective haplotype and did not occur on the risk haplotype.
15705913	2005	Cancer Res.	0008-5472	ALL_TEXT_1/3	1	2	4353	LONGTERM|DICTIONARY	myeloperoxidase	myeloperoxidase	150#165		D001943	LONGTERM|DISEASE|DT|DICTIONARY	breast cancer	breast cancer	302#315		Because mitochondrial manganese superoxide dismutase catalyzes conversion of superoxide radicals to H(2)O(2), with catalase neutralizing H(2)O(2) and myeloperoxidase converting H(2)O(2) to highly reactive hypochlorous acid, we hypothesized that gene variants could impact the efficacy of treatment for breast cancer and improve survival.
20810130	2011	J. Neurol. Sci.	1878-5883	BACKGROUND AND OBJECTIVE	1	3	3123	SYMBOL|DICTIONARY	hla drb1	HLA-DRB1	51#59		D009103	SYMBOL|EXTRACTED	ms	MS	87#89	20810130-1-0-18	This study investigated the frequencies of various HLA-DRB1 genotypes, their impact on MS susceptibility and their correlation with the clinical severity in a Spanish population.
9236417	1997	Circulation	0009-7322	METHODS AND RESULTS	2	4	1636	SYMBOL|DICTIONARY	ace	ACE	48#51		D023903	LONGTERM|DICTIONARY	restenosis	restenosis	73#83		We investigated a possible relation between the ACE I/D polymorphism and restenosis in 146 patients who underwent successful implantation of a Palmaz-Schatz stent and had 6-month follow-up angiography.
16187919	2006	Thyroid	1050-7256	ALL_TEXT_3/3	3	11	7173	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	tpo	TPO	33#36	16187919-1-0-18	C564766	LONGTERM|DICTIONARY	tiod	TIOD	84#88	NaN	Therefore, extensive analyses of TPO gene and 2p25 locus are needed in the frequent TIOD cases in whom conventional investigations disclosed only one mutant allele.
6889048	1983	Pediatrics	0031-4005	ALL_TEXT_3/3	3	5	462	LONGTERM|DICTIONARY	antithrombin	antithrombin	14#26	NaN	D013927	LONGTERM|DICTIONARY	thrombosis	thrombosis	79#89	NaN	Deficiency of antithrombin is known to be associated with an increased risk of thrombosis.
16187919	2006	Thyroid	1050-7256	ALL_TEXT_3/3	3	10	7173	SYMBOL|DICTIONARY|EXTRACTED	tpo	TPO	124#127	16187919-1-0-18	C564766	LONGTERM|DICTIONARY	tiod	TIOD	26#30	NaN	The results show that the TIOD phenotype in the propositus is associated to a compound heterozygous pattern, while a single TPO mutation does not significantly affect in vivo the efficiency of iodide organification.
15375002	2004	Cancer Res.	0008-5472	TITLE	0	0	9628	SYMBOL|DICTIONARY	rgs6	RGS6	29#33		D001749	LONGTERM|DISEASE|DT|DICTIONARY	bladder cancer	bladder cancer	56#70		A functional polymorphism in RGS6 modulates the risk of bladder cancer.
15375002	2004	Cancer Res.	0008-5472	ALL_TEXT_1/3	1	3	5997	SYMBOL|DICTIONARY	rgs2	RGS2	141#145		D001749	LONGTERM|DISEASE|DN|DT|DICTIONARY	bladder cancer	bladder cancer	33#47		In an epidemiologic study of 477 bladder cancer patients and 446 matched controls, three noncoding single-nucleotide polymorphisms (SNPs) in RGS2 and RGS6 were each associated with a statistically significant reduction in bladder cancer risk.
15375002	2004	Cancer Res.	0008-5472	ALL_TEXT_1/3	1	3	5997	SYMBOL|DICTIONARY	rgs2	RGS2	141#145		D001749	LONGTERM|DISEASE|DT|DICTIONARY	bladder cancer	bladder cancer	222#236		In an epidemiologic study of 477 bladder cancer patients and 446 matched controls, three noncoding single-nucleotide polymorphisms (SNPs) in RGS2 and RGS6 were each associated with a statistically significant reduction in bladder cancer risk.
15375002	2004	Cancer Res.	0008-5472	ALL_TEXT_1/3	1	3	9628	SYMBOL|DICTIONARY	rgs6	RGS6	150#154		D001749	LONGTERM|DISEASE|DN|DT|DICTIONARY	bladder cancer	bladder cancer	33#47		In an epidemiologic study of 477 bladder cancer patients and 446 matched controls, three noncoding single-nucleotide polymorphisms (SNPs) in RGS2 and RGS6 were each associated with a statistically significant reduction in bladder cancer risk.
15375002	2004	Cancer Res.	0008-5472	ALL_TEXT_1/3	1	3	9628	SYMBOL|DICTIONARY	rgs6	RGS6	150#154		D001749	LONGTERM|DISEASE|DT|DICTIONARY	bladder cancer	bladder cancer	222#236		In an epidemiologic study of 477 bladder cancer patients and 446 matched controls, three noncoding single-nucleotide polymorphisms (SNPs) in RGS2 and RGS6 were each associated with a statistically significant reduction in bladder cancer risk.
17405833	2007	Ann. Rheum. Dis.	0003-4967	RESULTS	3	6	3458	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	ifn gamma	IFN-gamma	7#16	17405833-1-21-37	D017285	LONGTERM|DICTIONARY	pm	PM	66#68	NaN	In the IFN-gamma gene, a weak allelic association was observed in PM versus controls at rs1861493 (odds ratio (OR) 1.6, 95% confidence interval (CI) 1.03 to 2.4).
17405833	2007	Ann. Rheum. Dis.	0003-4967	RESULTS	3	6	391109	LONGTERM|DICTIONARY	odds ratio (or) 1.6	odds ratio (OR) 1.6	99#118	NaN	D017285	LONGTERM|DICTIONARY	pm	PM	66#68	NaN	In the IFN-gamma gene, a weak allelic association was observed in PM versus controls at rs1861493 (odds ratio (OR) 1.6, 95% confidence interval (CI) 1.03 to 2.4).
15956634	2005	JAMA	1538-3598	MAIN OUTCOME MEASURES	4	5	348	SYMBOL|DICTIONARY|EXTRACTED	apoe	APOE	204#208	15956634-1-0-16	D051436	LONGTERM|DISEASE|DT|DICTIONARY	chronic kidney disease	chronic kidney disease	9#31		Incident chronic kidney disease progression, defined as hospitalization or death with kidney disease or increase in serum creatinine level of 0.4 mg/dL (35 micromol/L) or more above baseline, examined by APOE genotypes and alleles.
15956634	2005	JAMA	1538-3598	MAIN OUTCOME MEASURES	4	5	348	SYMBOL|DICTIONARY|EXTRACTED	apoe	APOE	204#208	15956634-1-0-16	D007674	LONGTERM|DISEASE|DT|DICTIONARY	death with kidney disease	death with kidney disease	75#100		Incident chronic kidney disease progression, defined as hospitalization or death with kidney disease or increase in serum creatinine level of 0.4 mg/dL (35 micromol/L) or more above baseline, examined by APOE genotypes and alleles.
15375002	2004	Cancer Res.	0008-5472	ALL_TEXT_3/3	3	8	5997	SYMBOL|DICTIONARY	rgs2	RGS2	29#33		D001749	LONGTERM|DISEASE|DT|CLINE|CN|DICTIONARY	bladder cancer	bladder cancer	99#113		Finally, we demonstrate that RGS2 transcripts and several splice variants of RGS6 are expressed in bladder cancer cells.
15375002	2004	Cancer Res.	0008-5472	ALL_TEXT_3/3	3	8	9628	SYMBOL|DICTIONARY	rgs6	RGS6	77#81		D001749	LONGTERM|DISEASE|DT|CLINE|CN|DICTIONARY	bladder cancer	bladder cancer	99#113		Finally, we demonstrate that RGS2 transcripts and several splice variants of RGS6 are expressed in bladder cancer cells.
15375002	2004	Cancer Res.	0008-5472	ALL_TEXT_3/3	3	9	5308	SYMBOL|GENE|GN|DICTIONARY	rgs	RGS	43#46		D009369	LONGTERM|DISEASE|DT|DICTIONARY	cancer	cancer	87#93		These data provide the first evidence that RGS proteins may be important modulators of cancer risk and validate RGS6 as a target for further study.
15375002	2004	Cancer Res.	0008-5472	ALL_TEXT_3/3	3	9	9628	SYMBOL|DICTIONARY	rgs6	RGS6	112#116		D009369	LONGTERM|DISEASE|DT|DICTIONARY	cancer	cancer	87#93		These data provide the first evidence that RGS proteins may be important modulators of cancer risk and validate RGS6 as a target for further study.
16254428	2006	Dement Geriatr Cogn Disord	1420-8008	RESULTS	3	7	348	SYMBOL|EXTRACTED	apoe	ApoE	152#156	16254428-1-33-49	D011605	LONGTERM|DICTIONARY	psychosis	psychosis	91#100		ApoE epsilon4 noncarriers showed better improvement in mean total BEHAVE-AD score and mean psychosis (delusions and hallucinations) subscale score than ApoE epsilon4 carriers.
16254428	2006	Dement Geriatr Cogn Disord	1420-8008	RESULTS	3	7	348	SYMBOL|EXTRACTED	apoe	ApoE	152#156	16254428-1-33-49	D006212	LONGTERM|DICTIONARY	hallucinations	hallucinations	116#130		ApoE epsilon4 noncarriers showed better improvement in mean total BEHAVE-AD score and mean psychosis (delusions and hallucinations) subscale score than ApoE epsilon4 carriers.
12932609	2003	J. Am. Coll. Cardiol.	0735-1097	OBJECTIVES	1	1	136319	LONGTERM|DICTIONARY	myotrophin	myotrophin	59#69	NaN	D006333	LONGTERM|DICTIONARY	heart failure	heart failure	73#86		The goal of this study was to investigate plasma levels of myotrophin in heart failure (HF) and their relationship to gender and disease severity.
12932609	2003	J. Am. Coll. Cardiol.	0735-1097	OBJECTIVES	1	1	136319	LONGTERM|DICTIONARY	myotrophin	myotrophin	59#69	NaN	D006333	SYMBOL|EXTRACTED|()	hf	HF	88#90	12932609-1-73-86	The goal of this study was to investigate plasma levels of myotrophin in heart failure (HF) and their relationship to gender and disease severity.
12932609	2003	J. Am. Coll. Cardiol.	0735-1097	TITLE	0	0	136319	LONGTERM|DICTIONARY	myotrophin	Myotrophin	0#10	NaN	D006333	LONGTERM|DICTIONARY	heart failure	heart failure	20#33		Myotrophin in human heart failure.
12932609	2003	J. Am. Coll. Cardiol.	0735-1097	BACKGROUND	2	3	4790	LONGTERM|DICTIONARY	nuclear factor kappa b	nuclear factor kappa B	70#92	NaN	D006333	SYMBOL|EXTRACTED	hf	HF	127#129	12932609-1-73-86	Recent evidence suggests an interaction with the transcription factor nuclear factor kappa B (NFkappaB), which is activated in HF and modulates myocardial protein expression.
12932609	2003	J. Am. Coll. Cardiol.	0735-1097	BACKGROUND	2	3	4790	LONGTERM|DICTIONARY	nfkappab	NFkappaB	94#102	NaN	D006333	SYMBOL|EXTRACTED	hf	HF	127#129	12932609-1-73-86	Recent evidence suggests an interaction with the transcription factor nuclear factor kappa B (NFkappaB), which is activated in HF and modulates myocardial protein expression.
12932609	2003	J. Am. Coll. Cardiol.	0735-1097	BACKGROUND	2	2	136319	LONGTERM|DICTIONARY	myotrophin	Myotrophin	0#10	NaN	D006332	LONGTERM|DICTIONARY	myocardial hypertrophy	myocardial hypertrophy	16#38	NaN	Myotrophin is a myocardial hypertrophy-inducing factor initially demonstrated in hypertrophied and cardiomyopathic hearts.
12932609	2003	J. Am. Coll. Cardiol.	0735-1097	BACKGROUND	2	2	136319	LONGTERM|DICTIONARY	myotrophin	Myotrophin	0#10	NaN	D006984	LONGTERM|DICTIONARY	hypertrophied	hypertrophied	81#94	NaN	Myotrophin is a myocardial hypertrophy-inducing factor initially demonstrated in hypertrophied and cardiomyopathic hearts.
12932609	2003	J. Am. Coll. Cardiol.	0735-1097	BACKGROUND	2	2	136319	LONGTERM|DICTIONARY	myotrophin	Myotrophin	0#10	NaN	D044542	LONGTERM|DICTIONARY	cardiomyopathic	cardiomyopathic	99#114	NaN	Myotrophin is a myocardial hypertrophy-inducing factor initially demonstrated in hypertrophied and cardiomyopathic hearts.
17300681	2007	Int. J. Gynecol. Cancer	1048-891X	ALL_TEXT_1/3	1	2	5243	SYMBOL|EXTRACTED	p gp	P-gp	31#35	17300681-1-4-18	D009369	LONGTERM|DISEASE|DT|DICTIONARY	cancer	cancer	78#84		Interindividual differences in P-gp activity could modulate susceptibility to cancer development.
17558308	2007	Pharmacogenet. Genomics	1744-6872	CONCLUSION	4	14	7515	SYMBOL|DICTIONARY	xrcc1	XRCC1	22#27		D001943	LONGTERM|DISEASE|DT|DICTIONARY	invasive breast cancer	invasive breast cancer	180#202		The DNA repair enzyme XRCC1 is a potential treatment predictor for the outcome and survival of anthracycline and cyclophosphamide/methotrexate/5-fluorouracil-based chemotherapy of invasive breast cancer.
17300681	2007	Int. J. Gynecol. Cancer	1048-891X	TITLE	0	0	5243	SYMBOL|GENE|GN|DICTIONARY	mdr1	MDR1	49#53		D016889	LONGTERM|DISEASE|DT|DICTIONARY	endometrial cancer	endometrial cancer	62#80		The significance of C3435T point mutation of the MDR1 gene in endometrial cancer.
12932609	2003	J. Am. Coll. Cardiol.	0735-1097	RESULTS	4	9	136319	LONGTERM|DICTIONARY	myotrophin	myotrophin	15#25	NaN	D006333	SYMBOL|EXTRACTED|DISEASE|DN	hf	HF	64#66	12932609-1-73-86	Log normalized myotrophin levels were significantly elevated in HF patients (mean +/- SEM [geometric mean, range], 2.402 +/- 0.021 [252, 72 to 933] vs. 2.268 +/- 0.021 [185, 28 to 501] fmol/ml, p < 0.0005).
17558308	2007	Pharmacogenet. Genomics	1744-6872	MAIN RESULTS	3	10	7515	SYMBOL|NUMBER|DICTIONARY	xrcc1	XRCC1	16#21		D003643	LONGTERM|DICTIONARY	death	death	73#78	NaN	Carriers of the XRCC1_1196_AA genotype had a reduced risk for recurrence/death (odds ratio adjusted 0.19; 95% confidence interval: 0.06-0.61), which was observed in survival analyses of all patients (P=0.003) and patients treated with chemotherapy but not radiotherapy (P=0.006).
17300681	2007	Int. J. Gynecol. Cancer	1048-891X	ALL_TEXT_2/3	2	4	5243	SYMBOL|DICTIONARY	mdr1	MDR1	34#38		D009369	LONGTERM|DISEASE|DT|DICTIONARY	cancer	cancer	67#73		Recently, association between the MDR1 C3435T polymorphism and the cancer susceptibility was shown.
17514530	2007	Curr. Eye Res.	0271-3683	ALL_TEXT_3/3	3	7	2944	SYMBOL|DICTIONARY|EXTRACTED	gstm1	GSTM1	0#5		D002386	LONGTERM|DICTIONARY	cataract	cataract	134#142		GSTM1-null genotype or combination of the GSTM1-null and GSTT1-positive genotypes in females may be associated with increased risk of cataract development in the Turkish population.
17514530	2007	Curr. Eye Res.	0271-3683	ALL_TEXT_3/3	3	7	2944	SYMBOL|DICTIONARY|EXTRACTED	gstm1	GSTM1	42#47	17514530-1-77-105	D002386	LONGTERM|DICTIONARY	cataract	cataract	134#142		GSTM1-null genotype or combination of the GSTM1-null and GSTT1-positive genotypes in females may be associated with increased risk of cataract development in the Turkish population.
17514530	2007	Curr. Eye Res.	0271-3683	ALL_TEXT_3/3	3	7	2952	SYMBOL|DICTIONARY	gstt1	GSTT1	57#62		D002386	LONGTERM|DICTIONARY	cataract	cataract	134#142		GSTM1-null genotype or combination of the GSTM1-null and GSTT1-positive genotypes in females may be associated with increased risk of cataract development in the Turkish population.
17514530	2007	Curr. Eye Res.	0271-3683	ALL_TEXT_3/3	3	5	2944	SYMBOL|DICTIONARY|EXTRACTED	gstm1	GSTM1	82#87	17514530-1-77-105	D002386	LONGTERM|DICTIONARY	cataract	cataract	138#146		There was also a statistically significant association between the combination of GSTM1-null and GSTT1-positive genotypes and the risk of cataract development in female subjects (p = 0.01; OR = 2.87; 95% CI = 1.25-6.69).
17514530	2007	Curr. Eye Res.	0271-3683	ALL_TEXT_3/3	3	5	2952	SYMBOL|DICTIONARY	gstt1	GSTT1	97#102		D002386	LONGTERM|DICTIONARY	cataract	cataract	138#146		There was also a statistically significant association between the combination of GSTM1-null and GSTT1-positive genotypes and the risk of cataract development in female subjects (p = 0.01; OR = 2.87; 95% CI = 1.25-6.69).
9535411	1998	Hypertension	0194-911X	ALL_TEXT_1/3	1	1	183	LONGTERM|GENE|GN|DICTIONARY	angiotensinogen	angiotensinogen	165#180		D007674	LONGTERM|DICTIONARY	nephropathy	nephropathy	63#74		This study examined the association between the development of nephropathy in non-insulin-dependent diabetes mellitus (NIDDM) patients and M235T polymorphism in the angiotensinogen gene.
9535411	1998	Hypertension	0194-911X	ALL_TEXT_1/3	1	1	183	LONGTERM|GENE|GN|DICTIONARY	angiotensinogen	angiotensinogen	165#180		D003924	LONGTERM|DICTIONARY|DISEASE|DA	non insulin dependent diabetes mellitus	non-insulin-dependent diabetes mellitus	78#117		This study examined the association between the development of nephropathy in non-insulin-dependent diabetes mellitus (NIDDM) patients and M235T polymorphism in the angiotensinogen gene.
9535411	1998	Hypertension	0194-911X	ALL_TEXT_1/3	1	1	183	LONGTERM|GENE|GN|DICTIONARY	angiotensinogen	angiotensinogen	165#180		D003924	LONGTERM|()|DISEASE|DN|DICTIONARY|EXTRACTED	niddm	NIDDM	119#124	9535411-1-78-117	This study examined the association between the development of nephropathy in non-insulin-dependent diabetes mellitus (NIDDM) patients and M235T polymorphism in the angiotensinogen gene.
17514530	2007	Curr. Eye Res.	0271-3683	ALL_TEXT_2/3	2	3	2944	SYMBOL|DICTIONARY|EXTRACTED	gstm1	GSTM1	0#5		D002386	LONGTERM|DICTIONARY	cataract	cataract	74#82		GSTM1 null genotype had a significant association with the development of cataract in female subjects (p < 0.0029; OR, 2.98; 95% CI, 1.41-6.34).
17514530	2007	Curr. Eye Res.	0271-3683	ALL_TEXT_1/3	1	2	2944	SYMBOL|DICTIONARY|EXTRACTED	gstm1	GSTM1	51#56	17514530-1-77-105	D002386	LONGTERM|DICTIONARY	cataract	cataract	133#141		Using a multiplex polymerase chain reaction (PCR), GSTM1 and GSTT1 gene polymorphisms were analyzed in 195 patients with age-related cataract (75 patients with cortical, 53 with nuclear, 37 with posterior subcapsular, and 30 with mixed type) and in 136 patients of an otherwise healthy control group of similar age.
17514530	2007	Curr. Eye Res.	0271-3683	ALL_TEXT_1/3	1	2	2952	SYMBOL|GENE|GN|DICTIONARY	gstt1	GSTT1	61#66		D002386	LONGTERM|DICTIONARY	cataract	cataract	133#141		Using a multiplex polymerase chain reaction (PCR), GSTM1 and GSTT1 gene polymorphisms were analyzed in 195 patients with age-related cataract (75 patients with cortical, 53 with nuclear, 37 with posterior subcapsular, and 30 with mixed type) and in 136 patients of an otherwise healthy control group of similar age.
17514530	2007	Curr. Eye Res.	0271-3683	ALL_TEXT_1/3	1	1	2944	LONGTERM|DICTIONARY	glutathione s transferase m1	glutathione-S-transferase M1	77#105		D002386	LONGTERM|DICTIONARY	cataract	cataract	211#219		In this study, we aimed to determine the effects of genetic polymorphisms of glutathione-S-transferase M1 (GSTM1) and glutathione-S-transferase T1 (GSTT1) on risk of developing different subtypes of age-related cataract in the Turkish population.
17514530	2007	Curr. Eye Res.	0271-3683	ALL_TEXT_1/3	1	1	2944	SYMBOL|()|DICTIONARY|EXTRACTED	gstm1	GSTM1	107#112	17514530-1-77-105	D002386	LONGTERM|DICTIONARY	cataract	cataract	211#219		In this study, we aimed to determine the effects of genetic polymorphisms of glutathione-S-transferase M1 (GSTM1) and glutathione-S-transferase T1 (GSTT1) on risk of developing different subtypes of age-related cataract in the Turkish population.
17514530	2007	Curr. Eye Res.	0271-3683	ALL_TEXT_1/3	1	1	2952	SYMBOL|()|DICTIONARY	gstt1	GSTT1	148#153		D002386	LONGTERM|DICTIONARY	cataract	cataract	211#219		In this study, we aimed to determine the effects of genetic polymorphisms of glutathione-S-transferase M1 (GSTM1) and glutathione-S-transferase T1 (GSTT1) on risk of developing different subtypes of age-related cataract in the Turkish population.
17514530	2007	Curr. Eye Res.	0271-3683	ALL_TEXT_1/3	1	1	2952	LONGTERM|DICTIONARY	glutathione-s-transferase t1	glutathione-S-transferase T1	118#146		D002386	LONGTERM|DICTIONARY	cataract	cataract	211#219		In this study, we aimed to determine the effects of genetic polymorphisms of glutathione-S-transferase M1 (GSTM1) and glutathione-S-transferase T1 (GSTT1) on risk of developing different subtypes of age-related cataract in the Turkish population.
17514530	2007	Curr. Eye Res.	0271-3683	TITLE	0	0	2944	LONGTERM|DICTIONARY	glutathione s transferase m1	Glutathione-S-transferase M1	0#28		D002386	LONGTERM|DICTIONARY	cataract	cataract	74#82		Glutathione-S-transferase M1 and T1 genetic polymorphisms and the risk of cataract development: a study in the Turkish population.
16352477	2006	Ophthalmic Genet.	1381-6810	TITLE	0	0	3859	LONGTERM|DICTIONARY|GENE|GA	keratin 12	keratin 12	100#110		D053559	LONGTERM|DISEASE|DT|DICTIONARY	meesmann corneal dystrophy	Meesmann corneal dystrophy	0#26		Meesmann corneal dystrophy (MECD): report of 2 families and a novel mutation in the cornea specific keratin 12 (KRT12) gene.
16352477	2006	Ophthalmic Genet.	1381-6810	TITLE	0	0	3859	LONGTERM|DICTIONARY|GENE|GA	keratin 12	keratin 12	100#110		D053559	SYMBOL|()|DICTIONARY|EXTRACTED	mecd	MECD	28#32	16352477-0-0-26	Meesmann corneal dystrophy (MECD): report of 2 families and a novel mutation in the cornea specific keratin 12 (KRT12) gene.
16352477	2006	Ophthalmic Genet.	1381-6810	TITLE	0	0	3859	SYMBOL|()|GENE|GN|DICTIONARY|EXTRACTED	krt12	KRT12	112#117	16352477-0-100-110	D053559	LONGTERM|DISEASE|DT|DICTIONARY	meesmann corneal dystrophy	Meesmann corneal dystrophy	0#26		Meesmann corneal dystrophy (MECD): report of 2 families and a novel mutation in the cornea specific keratin 12 (KRT12) gene.
16352477	2006	Ophthalmic Genet.	1381-6810	TITLE	0	0	3859	SYMBOL|()|GENE|GN|DICTIONARY|EXTRACTED	krt12	KRT12	112#117	16352477-0-100-110	D053559	SYMBOL|()|DICTIONARY|EXTRACTED	mecd	MECD	28#32	16352477-0-0-26	Meesmann corneal dystrophy (MECD): report of 2 families and a novel mutation in the cornea specific keratin 12 (KRT12) gene.
17701750	2007	Biomarkers	1354-750X	ALL_TEXT_1/3	1	3	7517	SYMBOL|GENE|GN|DICTIONARY	xrcc3	XRCC3	46#51		D001943	LONGTERM|DISEASE|DT|DICTIONARY	breast cancer	breast cancer	126#139		We examined the role of a polymorphism in the XRCC3 gene (rs861529; codon 241: threonine to methionine change) in determining breast cancer risk in Thai women.
17701750	2007	Biomarkers	1354-750X	TITLE	0	0	7517	SYMBOL|DICTIONARY	xrcc3	XRCC3	4#9		D001943	LONGTERM|DISEASE|DT|DICTIONARY	breast cancer	breast cancer	37#50		The XRCC3 Thr241Met polymorphism and breast cancer risk: a case-control study in a Thai population.
18162506	2008	Diabetes	1939-327X	TITLE	0	0	3630	LONGTERM|DICTIONARY	insulin	Insulin	0#7	NaN	D003920	LONGTERM|DICTIONARY	diabetes	diabetes	50#58		Insulin mutation screening in 1,044 patients with diabetes: mutations in the INS gene are a common cause of neonatal diabetes but a rare cause of diabetes diagnosed in childhood or adulthood.
18162506	2008	Diabetes	1939-327X	TITLE	0	0	3630	LONGTERM|DICTIONARY	insulin	Insulin	0#7	NaN	D003920	LONGTERM|DICTIONARY	neonatal diabetes	neonatal diabetes	108#125		Insulin mutation screening in 1,044 patients with diabetes: mutations in the INS gene are a common cause of neonatal diabetes but a rare cause of diabetes diagnosed in childhood or adulthood.
18162506	2008	Diabetes	1939-327X	TITLE	0	0	3630	LONGTERM|DICTIONARY	insulin	Insulin	0#7	NaN	D003920	LONGTERM|DICTIONARY	diabetes	diabetes	146#154		Insulin mutation screening in 1,044 patients with diabetes: mutations in the INS gene are a common cause of neonatal diabetes but a rare cause of diabetes diagnosed in childhood or adulthood.
18162506	2008	Diabetes	1939-327X	OBJECTIVE	1	1	3630	LONGTERM|DICTIONARY	insulin	Insulin	0#7	NaN	C563425	LONGTERM|DICTIONARY	permanent neonatal diabetes	permanent neonatal diabetes	72#99		Insulin gene (INS) mutations have recently been described as a cause of permanent neonatal diabetes (PND).
19380028	2009	Cancer Genet. Cytogenet.	1873-4456	ALL_TEXT_2/3	2	4	10	SYMBOL|DICTIONARY	nat2	NAT2	78#82		D001749	LONGTERM|DISEASE|DT|DICTIONARY	bladder cancer	bladder cancer	131#145		We have conducted this case-control study to assess the role of smoking, slow NAT2 variants, and GSTM1 and GSTT1 null genotypes in bladder cancer development in North Tunisia.
19380028	2009	Cancer Genet. Cytogenet.	1873-4456	ALL_TEXT_2/3	2	4	2944	SYMBOL|DICTIONARY	gstm1	GSTM1	97#102		D001749	LONGTERM|DISEASE|DT|DICTIONARY	bladder cancer	bladder cancer	131#145		We have conducted this case-control study to assess the role of smoking, slow NAT2 variants, and GSTM1 and GSTT1 null genotypes in bladder cancer development in North Tunisia.
19380028	2009	Cancer Genet. Cytogenet.	1873-4456	ALL_TEXT_2/3	2	4	2952	SYMBOL|DICTIONARY	gstt1	GSTT1	107#112		D001749	LONGTERM|DISEASE|DT|DICTIONARY	bladder cancer	bladder cancer	131#145		We have conducted this case-control study to assess the role of smoking, slow NAT2 variants, and GSTM1 and GSTT1 null genotypes in bladder cancer development in North Tunisia.
19380028	2009	Cancer Genet. Cytogenet.	1873-4456	ALL_TEXT_3/3	3	7	10	SYMBOL|DICTIONARY	nat2	NAT2	27#31		D001749	LONGTERM|DISEASE|DT|DICTIONARY	bladder cancer	bladder cancer	153#167		Furthermore, we found that NAT2 slow acetylator individuals temporarily carrying wild-type GSTT1 or GSTM1 null genotypes have a strong increased risk of bladder cancer (OR= 26 and 22.17, respectively).
19380028	2009	Cancer Genet. Cytogenet.	1873-4456	ALL_TEXT_3/3	3	7	2952	SYMBOL|DICTIONARY	gstt1	GSTT1	91#96		D001749	LONGTERM|DISEASE|DT|DICTIONARY	bladder cancer	bladder cancer	153#167		Furthermore, we found that NAT2 slow acetylator individuals temporarily carrying wild-type GSTT1 or GSTM1 null genotypes have a strong increased risk of bladder cancer (OR= 26 and 22.17, respectively).
19380028	2009	Cancer Genet. Cytogenet.	1873-4456	ALL_TEXT_3/3	3	7	2944	SYMBOL|DICTIONARY	gstm1	GSTM1	100#105		D001749	LONGTERM|DISEASE|DT|DICTIONARY	bladder cancer	bladder cancer	153#167		Furthermore, we found that NAT2 slow acetylator individuals temporarily carrying wild-type GSTT1 or GSTM1 null genotypes have a strong increased risk of bladder cancer (OR= 26 and 22.17, respectively).
10488956	1999	Atherosclerosis	0021-9150	TITLE	0	0	4524	LONGTERM|DICTIONARY	methylenetetrahydrofolate reductase	methylenetetrahydrofolate reductase	29#64		D009203	LONGTERM|DICTIONARY	myocardial infarction	myocardial infarction	120#141		The genotype interactions of methylenetetrahydrofolate reductase and renin-angiotensin system genes are associated with myocardial infarction.
12728975	2003	J Chin Med Assoc	1726-4901	RESULTS	3	7	183	SYMBOL|DICTIONARY|EXTRACTED	agt	AGT	26#29	12728975-1-78-93	D007674	LONGTERM|DICTIONARY	dm nephropathy	DM nephropathy	88#102		The allele frequencies of AGT point mutation at 235 (M235T) was significantly higher in DM nephropathy but the genotypic frequencies were not.
11935341	2002	Hum. Genet.	0340-6717	ALL_TEXT_3/3	3	6	23209	SYMBOL|GENE|GN|DICTIONARY	mlc1	MLC1	121#125		D012559	LONGTERM|DICTIONARY	schizophrenia	schizophrenia	74#87		The role, suggested by others, of a mutation in the MLC1gene in catatonic schizophrenia and the possible function of the MLC1 protein as a cation channel are discussed.
18034620	2008	Pharmacogenomics	1744-8042	METHODS	2	3	4524	SYMBOL|DICTIONARY|EXTRACTED	mthfr	MTHFR	54#59	18034620-2-0-35	D001172	SYMBOL|EXTRACTED	ra	RA	111#113	18034620-1-52-72	To examine the association between 677C>T and 1298A>C MTHFR polymorphisms and MTX efficacy in the treatment of RA, a total of 174 RA patients, treated with MTX plus methylprednisone 4 mg and folic acid 5 mg were analyzed.
18034620	2008	Pharmacogenomics	1744-8042	METHODS	2	3	4524	SYMBOL|DICTIONARY|EXTRACTED	mthfr	MTHFR	54#59	18034620-2-0-35	D001172	SYMBOL|DISEASE|DN|DICTIONARY|EXTRACTED	ra	RA	130#132	18034620-1-52-72	To examine the association between 677C>T and 1298A>C MTHFR polymorphisms and MTX efficacy in the treatment of RA, a total of 174 RA patients, treated with MTX plus methylprednisone 4 mg and folic acid 5 mg were analyzed.
11935341	2002	Hum. Genet.	0340-6717	TITLE	0	0	23209	SYMBOL|DICTIONARY	mlc1	MLC1	37#41		D010181	LONGTERM|DICTIONARY	subcortical cysts	subcortical cysts	99#116		Identification of novel mutations in MLC1 responsible for megalencephalic leukoencephalopathy with subcortical cysts.
11935341	2002	Hum. Genet.	0340-6717	TITLE	0	0	23209	SYMBOL|DICTIONARY	mlc1	MLC1	37#41		C536141	LONGTERM|DICTIONARY	megalencephalic leukoencephalopathy with subcortical cysts	Megalencephalic leukoencephalopathy with subcortical cysts	58#116	NaN	Identification of novel mutations in MLC1 responsible for megalencephalic leukoencephalopathy with subcortical cysts.
19846968	2009	Anticancer Res.	1791-7530	TITLE	0	0	7515	SYMBOL|DICTIONARY	xrcc1	XRCC1	20#25		D006258	LONGTERM|DISEASE|DT|DICTIONARY	head and neck cancer	head and neck cancer	44#64		Association between XRCC1 polymorphisms and head and neck cancer in a Hungarian population.
19022862	2009	Brain	1460-2156	ALL_TEXT_2/3	2	4	3123	SYMBOL|NUMBER|DICTIONARY	drb1	DRB1	26#30		D009103	SYMBOL|EXTRACTED	ms	MS	66#68	19022862-1-26-44	Our findings suggest that DRB1*1501 increases disease severity in MS by facilitating the development of more T2-foci, thereby increasing the potential for irreversible axonal compromise and subsequent neuronal degeneration, as suggested by the reduction of NAA concentrations in NAWM, ultimately leading to a decline in brain volume.
19022862	2009	Brain	1460-2156	ALL_TEXT_2/3	2	4	3123	SYMBOL|NUMBER|DICTIONARY	drb1	DRB1	26#30		D009410	LONGTERM|DICTIONARY	neuronal degeneration	neuronal degeneration	201#222	NaN	Our findings suggest that DRB1*1501 increases disease severity in MS by facilitating the development of more T2-foci, thereby increasing the potential for irreversible axonal compromise and subsequent neuronal degeneration, as suggested by the reduction of NAA concentrations in NAWM, ultimately leading to a decline in brain volume.
19022862	2009	Brain	1460-2156	ALL_TEXT_1/3	1	2	3123	SYMBOL|NUMBER|DICTIONARY	drb1	DRB1	41#45		D009103	SYMBOL|DISEASE|DN|DICTIONARY|EXTRACTED	ms	MS	203#205	19022862-1-26-44	Here we show a clear association between DRB1*1501 carrier status and four domains of disease severity in an investigation of genotype-phenotype associations in 505 robust, clinically well characterized MS patients evaluated cross-sectionally: (i) a reduction in the N-acetyl-aspartate (NAA) concentration within normal appearing white matter (NAWM) via (1)HMR spectroscopy (P = 0.025), (ii) an increase in the volume of white matter (WM) lesions utilizing conventional anatomical MRI techniques (1,127 mm(3); P = 0.031), (iii) a reduction in normalized brain parenchymal volume (nBPV) (P = 0.023), and (iv) impairments in cognitive function as measured by the Paced Auditory Serial Addition Test (PASAT-3) performance (Mean Z Score: DRB1*1501+: 0.110 versus DRB1*1501-: 0.048; P = 0.004).
19022862	2009	Brain	1460-2156	ALL_TEXT_1/3	1	2	3123	SYMBOL|NUMBER|DICTIONARY	drb1	DRB1	734#738		D009103	SYMBOL|DISEASE|DN|DICTIONARY|EXTRACTED	ms	MS	203#205	19022862-1-26-44	Here we show a clear association between DRB1*1501 carrier status and four domains of disease severity in an investigation of genotype-phenotype associations in 505 robust, clinically well characterized MS patients evaluated cross-sectionally: (i) a reduction in the N-acetyl-aspartate (NAA) concentration within normal appearing white matter (NAWM) via (1)HMR spectroscopy (P = 0.025), (ii) an increase in the volume of white matter (WM) lesions utilizing conventional anatomical MRI techniques (1,127 mm(3); P = 0.031), (iii) a reduction in normalized brain parenchymal volume (nBPV) (P = 0.023), and (iv) impairments in cognitive function as measured by the Paced Auditory Serial Addition Test (PASAT-3) performance (Mean Z Score: DRB1*1501+: 0.110 versus DRB1*1501-: 0.048; P = 0.004).
19022862	2009	Brain	1460-2156	ALL_TEXT_1/3	1	2	3123	SYMBOL|NUMBER|DICTIONARY	drb1	DRB1	759#763		D009103	SYMBOL|DISEASE|DN|DICTIONARY|EXTRACTED	ms	MS	203#205	19022862-1-26-44	Here we show a clear association between DRB1*1501 carrier status and four domains of disease severity in an investigation of genotype-phenotype associations in 505 robust, clinically well characterized MS patients evaluated cross-sectionally: (i) a reduction in the N-acetyl-aspartate (NAA) concentration within normal appearing white matter (NAWM) via (1)HMR spectroscopy (P = 0.025), (ii) an increase in the volume of white matter (WM) lesions utilizing conventional anatomical MRI techniques (1,127 mm(3); P = 0.031), (iii) a reduction in normalized brain parenchymal volume (nBPV) (P = 0.023), and (iv) impairments in cognitive function as measured by the Paced Auditory Serial Addition Test (PASAT-3) performance (Mean Z Score: DRB1*1501+: 0.110 versus DRB1*1501-: 0.048; P = 0.004).
19022862	2009	Brain	1460-2156	ALL_TEXT_1/3	1	1	3123	SYMBOL|NUMBER|DICTIONARY	leukocyte antigen (hla) drb1	leukocyte antigen (HLA) DRB1	79#107		D009103	LONGTERM|DICTIONARY	multiple sclerosis	multiple sclerosis	26#44		Genetic susceptibility to multiple sclerosis (MS) is associated with the human leukocyte antigen (HLA) DRB1*1501 allele.
19022862	2009	Brain	1460-2156	ALL_TEXT_1/3	1	1	3123	SYMBOL|NUMBER|DICTIONARY	leukocyte antigen (hla) drb1	leukocyte antigen (HLA) DRB1	79#107		D009103	SYMBOL|EXTRACTED|()	ms	MS	46#48	19022862-1-26-44	Genetic susceptibility to multiple sclerosis (MS) is associated with the human leukocyte antigen (HLA) DRB1*1501 allele.
20638924	2010	Cancer Epidemiol	1877-783X	RESULTS	2	3	7157	SYMBOL|DICTIONARY	p53	p53	19#22		D064420	LONGTERM|DICTIONARY	toxicity	toxicity	64#72	NaN	MTHFR allele T and p53 allele Pro were strongly associated with toxicity due to chemotherapy (odds ratio, 7.1 (95% confidence interval, 1.4-36.1; p=0.018) and 7.0 (95% confidence interval, 1.2-40.5; p=0.029), respectively).
14713779	2004	J. Urol.	0022-5347	PURPOSE	1	3	4953	SYMBOL|DICTIONARY|EXTRACTED	odc	ODC	77#80	14713779-1-79-102	D011471	LONGTERM|DISEASE|DT|DICTIONARY	prostate cancer	prostate cancer	94#109		A nested case-control study was done to examine the association between this ODC genotype and prostate cancer risk, and whether it varies by AR gene CAG repeat length and smoking.
14713779	2004	J. Urol.	0022-5347	PURPOSE	1	3	367	SYMBOL|EXTRACTED|GENE|GN	ar	AR	141#143	14713779-2-110-127	D011471	LONGTERM|DISEASE|DT|DICTIONARY	prostate cancer	prostate cancer	94#109		A nested case-control study was done to examine the association between this ODC genotype and prostate cancer risk, and whether it varies by AR gene CAG repeat length and smoking.
9158107	1997	Clin. Exp. Immunol.	0009-9104	TITLE	0	0	5196	SYMBOL|EXTRACTED|()	pf4	PF4	47#50	9158107-0-28-45	D013921	LONGTERM|DICTIONARY	thrombocytopenia	thrombocytopenia	123#139		Pathogenicity of human anti-platelet factor 4 (PF4)/heparin in vivo: generation of mouse anti-PF4/heparin and induction of thrombocytopenia by heparin.
9158107	1997	Clin. Exp. Immunol.	0009-9104	TITLE	0	0	5196	SYMBOL|EXTRACTED	pf4	PF4	94#97	9158107-0-28-45	D013921	LONGTERM|DICTIONARY	thrombocytopenia	thrombocytopenia	123#139		Pathogenicity of human anti-platelet factor 4 (PF4)/heparin in vivo: generation of mouse anti-PF4/heparin and induction of thrombocytopenia by heparin.
9158107	1997	Clin. Exp. Immunol.	0009-9104	TITLE	0	0	5196	LONGTERM|DICTIONARY	anti-platelet factor 4	anti-platelet factor 4	23#45		D013921	LONGTERM|DICTIONARY	thrombocytopenia	thrombocytopenia	123#139		Pathogenicity of human anti-platelet factor 4 (PF4)/heparin in vivo: generation of mouse anti-PF4/heparin and induction of thrombocytopenia by heparin.
12728975	2003	J Chin Med Assoc	1726-4901	TITLE	0	0	183	LONGTERM|DICTIONARY	angiotensinogen	angiotensinogen	29#44		D003924	LONGTERM|DICTIONARY	type ii diabetes	type II diabetes	105#121		Study of the polymorphism of angiotensinogen, anigiotensin-converting enzyme and angiotensin receptor in type II diabetes with end-stage renal disease in Taiwan.
12728975	2003	J Chin Med Assoc	1726-4901	TITLE	0	0	183	LONGTERM|DICTIONARY	angiotensinogen	angiotensinogen	29#44		D007676	SYMBOL|DISEASE|DT|DICTIONARY	end stage renal disease	end-stage renal disease	127#150		Study of the polymorphism of angiotensinogen, anigiotensin-converting enzyme and angiotensin receptor in type II diabetes with end-stage renal disease in Taiwan.
12081984	2002	Circulation	1524-4539	TITLE	0	0	6532	LONGTERM|DICTIONARY	serotonin transporter	Serotonin transporter	0#21	NaN	D009203	LONGTERM|DICTIONARY	myocardial infarction	myocardial infarction	44#65		Serotonin transporter gene polymorphism and myocardial infarction: Etude Cas-Tmoins de l'Infarctus du Myocarde (ECTIM).
19509271	2009	Mol. Cancer Ther.	1538-8514	ALL_TEXT_1/3	1	1	1268	LONGTERM|DICTIONARY	cannabinoid receptor 1	cannabinoid receptor 1	64#86		D012208	LONGTERM|DICTIONARY	rhabdomyosarcoma	rhabdomyosarcoma	119#135		Gene expression profiling has revealed that the gene coding for cannabinoid receptor 1 (CB1) is highly up-regulated in rhabdomyosarcoma biopsies bearing the typical chromosomal translocations PAX3/FKHR or PAX7/FKHR.
19509271	2009	Mol. Cancer Ther.	1538-8514	ALL_TEXT_1/3	1	1	1268	SYMBOL|EXTRACTED|()	cb1	CB1	88#91	19509271-1-64-86	D012208	LONGTERM|DICTIONARY	rhabdomyosarcoma	rhabdomyosarcoma	119#135		Gene expression profiling has revealed that the gene coding for cannabinoid receptor 1 (CB1) is highly up-regulated in rhabdomyosarcoma biopsies bearing the typical chromosomal translocations PAX3/FKHR or PAX7/FKHR.
19509271	2009	Mol. Cancer Ther.	1538-8514	ALL_TEXT_1/3	1	1	5077	SYMBOL|DICTIONARY	pax3	PAX3	192#196		D012208	LONGTERM|DICTIONARY	rhabdomyosarcoma	rhabdomyosarcoma	119#135		Gene expression profiling has revealed that the gene coding for cannabinoid receptor 1 (CB1) is highly up-regulated in rhabdomyosarcoma biopsies bearing the typical chromosomal translocations PAX3/FKHR or PAX7/FKHR.
19509271	2009	Mol. Cancer Ther.	1538-8514	ALL_TEXT_1/3	1	1	2308	SYMBOL|DICTIONARY	fkhr	FKHR	197#201		D012208	LONGTERM|DICTIONARY	rhabdomyosarcoma	rhabdomyosarcoma	119#135		Gene expression profiling has revealed that the gene coding for cannabinoid receptor 1 (CB1) is highly up-regulated in rhabdomyosarcoma biopsies bearing the typical chromosomal translocations PAX3/FKHR or PAX7/FKHR.
19509271	2009	Mol. Cancer Ther.	1538-8514	ALL_TEXT_1/3	1	1	5081	SYMBOL|DICTIONARY	pax7	PAX7	205#209		D012208	LONGTERM|DICTIONARY	rhabdomyosarcoma	rhabdomyosarcoma	119#135		Gene expression profiling has revealed that the gene coding for cannabinoid receptor 1 (CB1) is highly up-regulated in rhabdomyosarcoma biopsies bearing the typical chromosomal translocations PAX3/FKHR or PAX7/FKHR.
19509271	2009	Mol. Cancer Ther.	1538-8514	ALL_TEXT_1/3	1	1	2308	SYMBOL|DICTIONARY	fkhr	FKHR	210#214		D012208	LONGTERM|DICTIONARY	rhabdomyosarcoma	rhabdomyosarcoma	119#135		Gene expression profiling has revealed that the gene coding for cannabinoid receptor 1 (CB1) is highly up-regulated in rhabdomyosarcoma biopsies bearing the typical chromosomal translocations PAX3/FKHR or PAX7/FKHR.
12728975	2003	J Chin Med Assoc	1726-4901	BACKGROUND	1	1	1636	LONGTERM|GENE|GT|DICTIONARY	angiotensin converting enzyme	angiotensin-converting enzyme	41#70		D003924	LONGTERM|DICTIONARY	type ii diabetes	type II diabetes	155#171		This study compared the polymorphisms of angiotensin-converting enzyme (ACE), angiotensinogen (AGT) and angiotensin II type 1 receptor (AT1R) gene between type II diabetes with diabetic nephropathy (DN) in end-stage renal disease (ESRD) and those of the normal individuals in Taiwan.
12728975	2003	J Chin Med Assoc	1726-4901	BACKGROUND	1	1	1636	LONGTERM|GENE|GT|DICTIONARY	angiotensin converting enzyme	angiotensin-converting enzyme	41#70		D003928	LONGTERM|DICTIONARY	diabetic nephropathy	diabetic nephropathy	177#197		This study compared the polymorphisms of angiotensin-converting enzyme (ACE), angiotensinogen (AGT) and angiotensin II type 1 receptor (AT1R) gene between type II diabetes with diabetic nephropathy (DN) in end-stage renal disease (ESRD) and those of the normal individuals in Taiwan.
12728975	2003	J Chin Med Assoc	1726-4901	BACKGROUND	1	1	1636	LONGTERM|GENE|GT|DICTIONARY	angiotensin converting enzyme	angiotensin-converting enzyme	41#70		D003928	SYMBOL|EXTRACTED|()	dn	DN	199#201	12728975-1-177-197	This study compared the polymorphisms of angiotensin-converting enzyme (ACE), angiotensinogen (AGT) and angiotensin II type 1 receptor (AT1R) gene between type II diabetes with diabetic nephropathy (DN) in end-stage renal disease (ESRD) and those of the normal individuals in Taiwan.
12728975	2003	J Chin Med Assoc	1726-4901	BACKGROUND	1	1	1636	LONGTERM|GENE|GT|DICTIONARY	angiotensin converting enzyme	angiotensin-converting enzyme	41#70		D007676	LONGTERM|DICTIONARY	end stage renal disease	end-stage renal disease	206#229		This study compared the polymorphisms of angiotensin-converting enzyme (ACE), angiotensinogen (AGT) and angiotensin II type 1 receptor (AT1R) gene between type II diabetes with diabetic nephropathy (DN) in end-stage renal disease (ESRD) and those of the normal individuals in Taiwan.
12728975	2003	J Chin Med Assoc	1726-4901	BACKGROUND	1	1	1636	LONGTERM|GENE|GT|DICTIONARY	angiotensin converting enzyme	angiotensin-converting enzyme	41#70		D007676	SYMBOL|()|DICTIONARY|EXTRACTED	esrd	ESRD	231#235	12728975-1-206-229	This study compared the polymorphisms of angiotensin-converting enzyme (ACE), angiotensinogen (AGT) and angiotensin II type 1 receptor (AT1R) gene between type II diabetes with diabetic nephropathy (DN) in end-stage renal disease (ESRD) and those of the normal individuals in Taiwan.
12728975	2003	J Chin Med Assoc	1726-4901	BACKGROUND	1	1	1636	SYMBOL|()|DICTIONARY|EXTRACTED	ace	ACE	72#75	12728975-1-41-70	D003924	LONGTERM|DICTIONARY	type ii diabetes	type II diabetes	155#171		This study compared the polymorphisms of angiotensin-converting enzyme (ACE), angiotensinogen (AGT) and angiotensin II type 1 receptor (AT1R) gene between type II diabetes with diabetic nephropathy (DN) in end-stage renal disease (ESRD) and those of the normal individuals in Taiwan.
12728975	2003	J Chin Med Assoc	1726-4901	BACKGROUND	1	1	1636	SYMBOL|()|DICTIONARY|EXTRACTED	ace	ACE	72#75	12728975-1-41-70	D003928	LONGTERM|DICTIONARY	diabetic nephropathy	diabetic nephropathy	177#197		This study compared the polymorphisms of angiotensin-converting enzyme (ACE), angiotensinogen (AGT) and angiotensin II type 1 receptor (AT1R) gene between type II diabetes with diabetic nephropathy (DN) in end-stage renal disease (ESRD) and those of the normal individuals in Taiwan.
12728975	2003	J Chin Med Assoc	1726-4901	BACKGROUND	1	1	1636	SYMBOL|()|DICTIONARY|EXTRACTED	ace	ACE	72#75	12728975-1-41-70	D003928	SYMBOL|EXTRACTED|()	dn	DN	199#201	12728975-1-177-197	This study compared the polymorphisms of angiotensin-converting enzyme (ACE), angiotensinogen (AGT) and angiotensin II type 1 receptor (AT1R) gene between type II diabetes with diabetic nephropathy (DN) in end-stage renal disease (ESRD) and those of the normal individuals in Taiwan.
12728975	2003	J Chin Med Assoc	1726-4901	BACKGROUND	1	1	1636	SYMBOL|()|DICTIONARY|EXTRACTED	ace	ACE	72#75	12728975-1-41-70	D007676	LONGTERM|DICTIONARY	end stage renal disease	end-stage renal disease	206#229		This study compared the polymorphisms of angiotensin-converting enzyme (ACE), angiotensinogen (AGT) and angiotensin II type 1 receptor (AT1R) gene between type II diabetes with diabetic nephropathy (DN) in end-stage renal disease (ESRD) and those of the normal individuals in Taiwan.
12728975	2003	J Chin Med Assoc	1726-4901	BACKGROUND	1	1	1636	SYMBOL|()|DICTIONARY|EXTRACTED	ace	ACE	72#75	12728975-1-41-70	D007676	SYMBOL|()|DICTIONARY|EXTRACTED	esrd	ESRD	231#235	12728975-1-206-229	This study compared the polymorphisms of angiotensin-converting enzyme (ACE), angiotensinogen (AGT) and angiotensin II type 1 receptor (AT1R) gene between type II diabetes with diabetic nephropathy (DN) in end-stage renal disease (ESRD) and those of the normal individuals in Taiwan.
12728975	2003	J Chin Med Assoc	1726-4901	BACKGROUND	1	1	183	LONGTERM|DICTIONARY	angiotensinogen	angiotensinogen	78#93		D003924	LONGTERM|DICTIONARY	type ii diabetes	type II diabetes	155#171		This study compared the polymorphisms of angiotensin-converting enzyme (ACE), angiotensinogen (AGT) and angiotensin II type 1 receptor (AT1R) gene between type II diabetes with diabetic nephropathy (DN) in end-stage renal disease (ESRD) and those of the normal individuals in Taiwan.
12728975	2003	J Chin Med Assoc	1726-4901	BACKGROUND	1	1	183	LONGTERM|DICTIONARY	angiotensinogen	angiotensinogen	78#93		D003928	LONGTERM|DICTIONARY	diabetic nephropathy	diabetic nephropathy	177#197		This study compared the polymorphisms of angiotensin-converting enzyme (ACE), angiotensinogen (AGT) and angiotensin II type 1 receptor (AT1R) gene between type II diabetes with diabetic nephropathy (DN) in end-stage renal disease (ESRD) and those of the normal individuals in Taiwan.
12728975	2003	J Chin Med Assoc	1726-4901	BACKGROUND	1	1	183	LONGTERM|DICTIONARY	angiotensinogen	angiotensinogen	78#93		D003928	SYMBOL|EXTRACTED|()	dn	DN	199#201	12728975-1-177-197	This study compared the polymorphisms of angiotensin-converting enzyme (ACE), angiotensinogen (AGT) and angiotensin II type 1 receptor (AT1R) gene between type II diabetes with diabetic nephropathy (DN) in end-stage renal disease (ESRD) and those of the normal individuals in Taiwan.
12728975	2003	J Chin Med Assoc	1726-4901	BACKGROUND	1	1	183	LONGTERM|DICTIONARY	angiotensinogen	angiotensinogen	78#93		D007676	LONGTERM|DICTIONARY	end stage renal disease	end-stage renal disease	206#229		This study compared the polymorphisms of angiotensin-converting enzyme (ACE), angiotensinogen (AGT) and angiotensin II type 1 receptor (AT1R) gene between type II diabetes with diabetic nephropathy (DN) in end-stage renal disease (ESRD) and those of the normal individuals in Taiwan.
12728975	2003	J Chin Med Assoc	1726-4901	BACKGROUND	1	1	183	LONGTERM|DICTIONARY	angiotensinogen	angiotensinogen	78#93		D007676	SYMBOL|()|DICTIONARY|EXTRACTED	esrd	ESRD	231#235	12728975-1-206-229	This study compared the polymorphisms of angiotensin-converting enzyme (ACE), angiotensinogen (AGT) and angiotensin II type 1 receptor (AT1R) gene between type II diabetes with diabetic nephropathy (DN) in end-stage renal disease (ESRD) and those of the normal individuals in Taiwan.
12728975	2003	J Chin Med Assoc	1726-4901	BACKGROUND	1	1	183	SYMBOL|()|DICTIONARY|EXTRACTED	agt	AGT	95#98	12728975-1-78-93	D003924	LONGTERM|DICTIONARY	type ii diabetes	type II diabetes	155#171		This study compared the polymorphisms of angiotensin-converting enzyme (ACE), angiotensinogen (AGT) and angiotensin II type 1 receptor (AT1R) gene between type II diabetes with diabetic nephropathy (DN) in end-stage renal disease (ESRD) and those of the normal individuals in Taiwan.
12728975	2003	J Chin Med Assoc	1726-4901	BACKGROUND	1	1	183	SYMBOL|()|DICTIONARY|EXTRACTED	agt	AGT	95#98	12728975-1-78-93	D003928	LONGTERM|DICTIONARY	diabetic nephropathy	diabetic nephropathy	177#197		This study compared the polymorphisms of angiotensin-converting enzyme (ACE), angiotensinogen (AGT) and angiotensin II type 1 receptor (AT1R) gene between type II diabetes with diabetic nephropathy (DN) in end-stage renal disease (ESRD) and those of the normal individuals in Taiwan.
12728975	2003	J Chin Med Assoc	1726-4901	BACKGROUND	1	1	183	SYMBOL|()|DICTIONARY|EXTRACTED	agt	AGT	95#98	12728975-1-78-93	D003928	SYMBOL|EXTRACTED|()	dn	DN	199#201	12728975-1-177-197	This study compared the polymorphisms of angiotensin-converting enzyme (ACE), angiotensinogen (AGT) and angiotensin II type 1 receptor (AT1R) gene between type II diabetes with diabetic nephropathy (DN) in end-stage renal disease (ESRD) and those of the normal individuals in Taiwan.
12728975	2003	J Chin Med Assoc	1726-4901	BACKGROUND	1	1	183	SYMBOL|()|DICTIONARY|EXTRACTED	agt	AGT	95#98	12728975-1-78-93	D007676	LONGTERM|DICTIONARY	end stage renal disease	end-stage renal disease	206#229		This study compared the polymorphisms of angiotensin-converting enzyme (ACE), angiotensinogen (AGT) and angiotensin II type 1 receptor (AT1R) gene between type II diabetes with diabetic nephropathy (DN) in end-stage renal disease (ESRD) and those of the normal individuals in Taiwan.
12728975	2003	J Chin Med Assoc	1726-4901	BACKGROUND	1	1	183	SYMBOL|()|DICTIONARY|EXTRACTED	agt	AGT	95#98	12728975-1-78-93	D007676	SYMBOL|()|DICTIONARY|EXTRACTED	esrd	ESRD	231#235	12728975-1-206-229	This study compared the polymorphisms of angiotensin-converting enzyme (ACE), angiotensinogen (AGT) and angiotensin II type 1 receptor (AT1R) gene between type II diabetes with diabetic nephropathy (DN) in end-stage renal disease (ESRD) and those of the normal individuals in Taiwan.
12728975	2003	J Chin Med Assoc	1726-4901	BACKGROUND	1	1	185	LONGTERM|GENE|GT|DICTIONARY|GA	angiotensin ii type 1 receptor	angiotensin II type 1 receptor	104#134		D003924	LONGTERM|DICTIONARY	type ii diabetes	type II diabetes	155#171		This study compared the polymorphisms of angiotensin-converting enzyme (ACE), angiotensinogen (AGT) and angiotensin II type 1 receptor (AT1R) gene between type II diabetes with diabetic nephropathy (DN) in end-stage renal disease (ESRD) and those of the normal individuals in Taiwan.
12728975	2003	J Chin Med Assoc	1726-4901	BACKGROUND	1	1	185	LONGTERM|GENE|GT|DICTIONARY|GA	angiotensin ii type 1 receptor	angiotensin II type 1 receptor	104#134		D003928	LONGTERM|DICTIONARY	diabetic nephropathy	diabetic nephropathy	177#197		This study compared the polymorphisms of angiotensin-converting enzyme (ACE), angiotensinogen (AGT) and angiotensin II type 1 receptor (AT1R) gene between type II diabetes with diabetic nephropathy (DN) in end-stage renal disease (ESRD) and those of the normal individuals in Taiwan.
12728975	2003	J Chin Med Assoc	1726-4901	BACKGROUND	1	1	185	LONGTERM|GENE|GT|DICTIONARY|GA	angiotensin ii type 1 receptor	angiotensin II type 1 receptor	104#134		D003928	SYMBOL|EXTRACTED|()	dn	DN	199#201	12728975-1-177-197	This study compared the polymorphisms of angiotensin-converting enzyme (ACE), angiotensinogen (AGT) and angiotensin II type 1 receptor (AT1R) gene between type II diabetes with diabetic nephropathy (DN) in end-stage renal disease (ESRD) and those of the normal individuals in Taiwan.
12728975	2003	J Chin Med Assoc	1726-4901	BACKGROUND	1	1	185	LONGTERM|GENE|GT|DICTIONARY|GA	angiotensin ii type 1 receptor	angiotensin II type 1 receptor	104#134		D007676	LONGTERM|DICTIONARY	end stage renal disease	end-stage renal disease	206#229		This study compared the polymorphisms of angiotensin-converting enzyme (ACE), angiotensinogen (AGT) and angiotensin II type 1 receptor (AT1R) gene between type II diabetes with diabetic nephropathy (DN) in end-stage renal disease (ESRD) and those of the normal individuals in Taiwan.
12728975	2003	J Chin Med Assoc	1726-4901	BACKGROUND	1	1	185	LONGTERM|GENE|GT|DICTIONARY|GA	angiotensin ii type 1 receptor	angiotensin II type 1 receptor	104#134		D007676	SYMBOL|()|DICTIONARY|EXTRACTED	esrd	ESRD	231#235	12728975-1-206-229	This study compared the polymorphisms of angiotensin-converting enzyme (ACE), angiotensinogen (AGT) and angiotensin II type 1 receptor (AT1R) gene between type II diabetes with diabetic nephropathy (DN) in end-stage renal disease (ESRD) and those of the normal individuals in Taiwan.
12728975	2003	J Chin Med Assoc	1726-4901	BACKGROUND	1	1	185	SYMBOL|()|GENE|GN|DICTIONARY|EXTRACTED	at1r	AT1R	136#140	12728975-1-104-134	D003924	LONGTERM|DICTIONARY	type ii diabetes	type II diabetes	155#171		This study compared the polymorphisms of angiotensin-converting enzyme (ACE), angiotensinogen (AGT) and angiotensin II type 1 receptor (AT1R) gene between type II diabetes with diabetic nephropathy (DN) in end-stage renal disease (ESRD) and those of the normal individuals in Taiwan.
12728975	2003	J Chin Med Assoc	1726-4901	BACKGROUND	1	1	185	SYMBOL|()|GENE|GN|DICTIONARY|EXTRACTED	at1r	AT1R	136#140	12728975-1-104-134	D003928	LONGTERM|DICTIONARY	diabetic nephropathy	diabetic nephropathy	177#197		This study compared the polymorphisms of angiotensin-converting enzyme (ACE), angiotensinogen (AGT) and angiotensin II type 1 receptor (AT1R) gene between type II diabetes with diabetic nephropathy (DN) in end-stage renal disease (ESRD) and those of the normal individuals in Taiwan.
12728975	2003	J Chin Med Assoc	1726-4901	BACKGROUND	1	1	185	SYMBOL|()|GENE|GN|DICTIONARY|EXTRACTED	at1r	AT1R	136#140	12728975-1-104-134	D003928	SYMBOL|EXTRACTED|()	dn	DN	199#201	12728975-1-177-197	This study compared the polymorphisms of angiotensin-converting enzyme (ACE), angiotensinogen (AGT) and angiotensin II type 1 receptor (AT1R) gene between type II diabetes with diabetic nephropathy (DN) in end-stage renal disease (ESRD) and those of the normal individuals in Taiwan.
12728975	2003	J Chin Med Assoc	1726-4901	BACKGROUND	1	1	185	SYMBOL|()|GENE|GN|DICTIONARY|EXTRACTED	at1r	AT1R	136#140	12728975-1-104-134	D007676	LONGTERM|DICTIONARY	end stage renal disease	end-stage renal disease	206#229		This study compared the polymorphisms of angiotensin-converting enzyme (ACE), angiotensinogen (AGT) and angiotensin II type 1 receptor (AT1R) gene between type II diabetes with diabetic nephropathy (DN) in end-stage renal disease (ESRD) and those of the normal individuals in Taiwan.
12728975	2003	J Chin Med Assoc	1726-4901	BACKGROUND	1	1	185	SYMBOL|()|GENE|GN|DICTIONARY|EXTRACTED	at1r	AT1R	136#140	12728975-1-104-134	D007676	SYMBOL|()|DICTIONARY|EXTRACTED	esrd	ESRD	231#235	12728975-1-206-229	This study compared the polymorphisms of angiotensin-converting enzyme (ACE), angiotensinogen (AGT) and angiotensin II type 1 receptor (AT1R) gene between type II diabetes with diabetic nephropathy (DN) in end-stage renal disease (ESRD) and those of the normal individuals in Taiwan.
15699697	2005	J. Pediatr. Gastroenterol. Nutr.	0277-2116	TITLE	0	0	1080	SYMBOL|DICTIONARY	cftr	CFTR	83#87		D003550	LONGTERM|DISEASE|DN|DICTIONARY	cystic fibrosis	cystic fibrosis	40#55		Early decline of pancreatic function in cystic fibrosis patients with class 1 or 2 CFTR mutations.
14602139	2004	Eur. J. Cancer	0959-8049	ALL_TEXT_3/3	3	8	1588	SYMBOL|DICTIONARY	cyp19	CYP19	19#24		D001943	LONGTERM|DISEASE|DT|DICTIONARY	breast cancer	breast cancer	128#141		The combination of CYP19 (TTTA)7(-3bp) and CYP1A1 6235C/T polymorphisms is associated with an ER-positive, but not ER-negative, breast cancer risk, and, thus, would be useful in the selection of candidates for chemoprevention with tamoxifen.
14602139	2004	Eur. J. Cancer	0959-8049	ALL_TEXT_3/3	3	8	1543	SYMBOL|NUMBER|DICTIONARY	cyp1a1	CYP1A1	43#49		D001943	LONGTERM|DISEASE|DT|DICTIONARY	breast cancer	breast cancer	128#141		The combination of CYP19 (TTTA)7(-3bp) and CYP1A1 6235C/T polymorphisms is associated with an ER-positive, but not ER-negative, breast cancer risk, and, thus, would be useful in the selection of candidates for chemoprevention with tamoxifen.
15699697	2005	J. Pediatr. Gastroenterol. Nutr.	0277-2116	BACKGROUND	1	3	1080	SYMBOL|DICTIONARY	cftr	CFTR	83#87		D003550	SYMBOL|EXTRACTED	cf	CF	50#52	15699697-1-5-20	We assessed the decline of pancreatic function in CF infants carrying class 1 or 2 CFTR mutations who were diagnosed in a neonatal screening program.
21750109	2012	Hum. Mol. Genet.	1460-2083	TITLE	0	0	6563	SYMBOL|DICTIONARY	slc14a1	SLC14A1	50#57		D001749	LONGTERM|DISEASE|DT|DICTIONARY	urinary bladder cancer	urinary bladder cancer	67#89		European genome-wide association study identifies SLC14A1 as a new urinary bladder cancer susceptibility gene.
20659174	2011	Genes Brain Behav.	1601-183X	TITLE	0	0	8013	SYMBOL|GENE|GN|DICTIONARY	nr4a3	NR4A3	30#35		D012559	LONGTERM|DICTIONARY	schizophrenia	schizophrenia	67#80		Replicated association of the NR4A3 gene with smoking behaviour in schizophrenia and in bipolar disorder.
20659174	2011	Genes Brain Behav.	1601-183X	TITLE	0	0	8013	SYMBOL|GENE|GN|DICTIONARY	nr4a3	NR4A3	30#35		D001714	LONGTERM|DISEASE|DT|DICTIONARY	bipolar disorder	bipolar disorder	88#104		Replicated association of the NR4A3 gene with smoking behaviour in schizophrenia and in bipolar disorder.
20659174	2011	Genes Brain Behav.	1601-183X	ALL_TEXT_3/3	3	6	8013	SYMBOL|DICTIONARY	nr4a3	NR4A3	64#69		D008607	LONGTERM|DICTIONARY	mental health disease	mental health disease	222#243	NaN	We have replicated the positive association with smoking of the NR4A3 SNP rs1131339 in this group (P = 0.04), providing an important confirmation of the involvement of the NR4A3 gene in nicotine addiction in patients with mental health disease, a population significantly at risk for nicotine addiction.
20659174	2011	Genes Brain Behav.	1601-183X	ALL_TEXT_3/3	3	6	8013	SYMBOL|GENE|GN|DICTIONARY	nr4a3	NR4A3	172#177		D008607	LONGTERM|DICTIONARY	mental health disease	mental health disease	222#243	NaN	We have replicated the positive association with smoking of the NR4A3 SNP rs1131339 in this group (P = 0.04), providing an important confirmation of the involvement of the NR4A3 gene in nicotine addiction in patients with mental health disease, a population significantly at risk for nicotine addiction.
20659174	2011	Genes Brain Behav.	1601-183X	ALL_TEXT_3/3	3	5	8013	SYMBOL|GENE|GN|DICTIONARY	nr4a3	NR4A3	49#54		D001714	LONGTERM|DISEASE|DT|DICTIONARY	bipolar disorder	bipolar disorder	129#145		We then repeated the association analysis of the NR4A3 markers (rs1131339 and rs1405209) in a larger cohort of 319 patients with bipolar disorder, which included 167 smokers and 152 non-smokers.
11245417	2001	Cancer Res.	0008-5472	ALL_TEXT_1/3	1	1	10	LONGTERM|DICTIONARY	n acetyltransferase 2	N-acetyltransferase 2	13#34		D015179	LONGTERM|DISEASE|DT|DICTIONARY	colorectal cancer	colorectal cancer	150#167		Mutations in N-acetyltransferase 2 (NAT2), a highly polymorphic enzyme involved in the metabolism of xenobiotics and carcinogens, may affect risk for colorectal cancer (CRC), especially among individuals with germ-line mutations in DNA mismatch repair genes.
11245417	2001	Cancer Res.	0008-5472	ALL_TEXT_1/3	1	1	10	LONGTERM|DICTIONARY	n acetyltransferase 2	N-acetyltransferase 2	13#34		D015179	SYMBOL|()|DICTIONARY|EXTRACTED	crc	CRC	169#172	11245417-1-150-167	Mutations in N-acetyltransferase 2 (NAT2), a highly polymorphic enzyme involved in the metabolism of xenobiotics and carcinogens, may affect risk for colorectal cancer (CRC), especially among individuals with germ-line mutations in DNA mismatch repair genes.
11245417	2001	Cancer Res.	0008-5472	ALL_TEXT_1/3	1	1	10	SYMBOL|()|DICTIONARY|EXTRACTED	nat2	NAT2	36#40	11245417-0-53-74	D015179	LONGTERM|DISEASE|DT|DICTIONARY	colorectal cancer	colorectal cancer	150#167		Mutations in N-acetyltransferase 2 (NAT2), a highly polymorphic enzyme involved in the metabolism of xenobiotics and carcinogens, may affect risk for colorectal cancer (CRC), especially among individuals with germ-line mutations in DNA mismatch repair genes.
11245417	2001	Cancer Res.	0008-5472	ALL_TEXT_1/3	1	1	10	SYMBOL|()|DICTIONARY|EXTRACTED	nat2	NAT2	36#40	11245417-0-53-74	D015179	SYMBOL|()|DICTIONARY|EXTRACTED	crc	CRC	169#172	11245417-1-150-167	Mutations in N-acetyltransferase 2 (NAT2), a highly polymorphic enzyme involved in the metabolism of xenobiotics and carcinogens, may affect risk for colorectal cancer (CRC), especially among individuals with germ-line mutations in DNA mismatch repair genes.
21497595	2011	Eur. J. Pharmacol.	1879-0712	TITLE	0	0	2056	LONGTERM|DICTIONARY	erythropoietin	Erythropoietin	0#14		D007249	LONGTERM|DICTIONARY	inflammation	inflammation	36#48	NaN	Erythropoietin regulates apoptosis, inflammation and tissue remodelling via caspase-3 and IL-1 in isolated hemoperfused kidneys.
21497595	2011	Eur. J. Pharmacol.	1879-0712	TITLE	0	0	836	LONGTERM|DICTIONARY	caspase 3	caspase-3	76#85		D007249	LONGTERM|DICTIONARY	inflammation	inflammation	36#48	NaN	Erythropoietin regulates apoptosis, inflammation and tissue remodelling via caspase-3 and IL-1 in isolated hemoperfused kidneys.
21497595	2011	Eur. J. Pharmacol.	1879-0712	TITLE	0	0	3553	LONGTERM|DICTIONARY	il-1b	IL-1b	90#95	NaN	D007249	LONGTERM|DICTIONARY	inflammation	inflammation	36#48	NaN	Erythropoietin regulates apoptosis, inflammation and tissue remodelling via caspase-3 and IL-1 in isolated hemoperfused kidneys.
21497595	2011	Eur. J. Pharmacol.	1879-0712	ALL_TEXT_1/3	1	3	2056	LONGTERM|DICTIONARY	erythropoietin	erythropoietin	152#166		D007511	LONGTERM|DICTIONARY	ischemia	ischemia	42#50	NaN	Porcine kidneys, subjected to 10 min warm ischemia, underwent 16 h cold storage followed by 2 h normothermic hemoperfusion with or without 5000 units/L erythropoietin.
15476622	2004	Am. J. Cardiol.	0002-9149	TITLE	0	0	4312	LONGTERM|GENE|GN|DICTIONARY	matrix metalloproteinase 1	Matrix metalloproteinase-1	0#26		D009203	LONGTERM|DICTIONARY	myocardial infarction	myocardial infarction	105#126		Matrix metalloproteinase-1 promoter polymorphisms and changes in left ventricular volume following acute myocardial infarction.
16645213	2006	J Mol Diagn	1525-1578	ALL_TEXT_1/3	1	1	4869	SYMBOL|GENE|GN|DICTIONARY	npm1	NPM1	0#4		D015470	LONGTERM|DICTIONARY	acute myeloid leukemias	acute myeloid leukemias	77#100		NPM1 gene mutations are the most frequent genetic lesion in the 60% of adult acute myeloid leukemias (AMLs) with normal karyotype and no evidence of typical fusion genes (BCR/ABL1, PML/RARA, AML1/ETO, CBFB/MYH11, DEK/CAN).
16645213	2006	J Mol Diagn	1525-1578	ALL_TEXT_1/3	1	1	4869	SYMBOL|GENE|GN|DICTIONARY	npm1	NPM1	0#4		D015470	SYMBOL|PLURAL|()|DICTIONARY|EXTRACTED	amls	AMLs	102#106	16645213-1-77-100	NPM1 gene mutations are the most frequent genetic lesion in the 60% of adult acute myeloid leukemias (AMLs) with normal karyotype and no evidence of typical fusion genes (BCR/ABL1, PML/RARA, AML1/ETO, CBFB/MYH11, DEK/CAN).
16645213	2006	J Mol Diagn	1525-1578	ALL_TEXT_1/3	1	1	4869	SYMBOL|GENE|GN|DICTIONARY	npm1	NPM1	0#4		D030342	LONGTERM|DICTIONARY	genetic lesion	genetic lesion	42#56	NaN	NPM1 gene mutations are the most frequent genetic lesion in the 60% of adult acute myeloid leukemias (AMLs) with normal karyotype and no evidence of typical fusion genes (BCR/ABL1, PML/RARA, AML1/ETO, CBFB/MYH11, DEK/CAN).
16645213	2006	J Mol Diagn	1525-1578	ALL_TEXT_1/3	1	1	5371	SYMBOL|DICTIONARY	pml	PML	181#184		D015470	LONGTERM|DICTIONARY	acute myeloid leukemias	acute myeloid leukemias	77#100		NPM1 gene mutations are the most frequent genetic lesion in the 60% of adult acute myeloid leukemias (AMLs) with normal karyotype and no evidence of typical fusion genes (BCR/ABL1, PML/RARA, AML1/ETO, CBFB/MYH11, DEK/CAN).
16645213	2006	J Mol Diagn	1525-1578	ALL_TEXT_1/3	1	1	5371	SYMBOL|DICTIONARY	pml	PML	181#184		D015470	SYMBOL|PLURAL|()|DICTIONARY|EXTRACTED	amls	AMLs	102#106	16645213-1-77-100	NPM1 gene mutations are the most frequent genetic lesion in the 60% of adult acute myeloid leukemias (AMLs) with normal karyotype and no evidence of typical fusion genes (BCR/ABL1, PML/RARA, AML1/ETO, CBFB/MYH11, DEK/CAN).
16645213	2006	J Mol Diagn	1525-1578	ALL_TEXT_1/3	1	1	5371	SYMBOL|DICTIONARY	pml	PML	181#184		D030342	LONGTERM|DICTIONARY	genetic lesion	genetic lesion	42#56	NaN	NPM1 gene mutations are the most frequent genetic lesion in the 60% of adult acute myeloid leukemias (AMLs) with normal karyotype and no evidence of typical fusion genes (BCR/ABL1, PML/RARA, AML1/ETO, CBFB/MYH11, DEK/CAN).
16645213	2006	J Mol Diagn	1525-1578	ALL_TEXT_1/3	1	1	5914	SYMBOL|DICTIONARY	rara	RARA	185#189		D015470	LONGTERM|DICTIONARY	acute myeloid leukemias	acute myeloid leukemias	77#100		NPM1 gene mutations are the most frequent genetic lesion in the 60% of adult acute myeloid leukemias (AMLs) with normal karyotype and no evidence of typical fusion genes (BCR/ABL1, PML/RARA, AML1/ETO, CBFB/MYH11, DEK/CAN).
16645213	2006	J Mol Diagn	1525-1578	ALL_TEXT_1/3	1	1	5914	SYMBOL|DICTIONARY	rara	RARA	185#189		D015470	SYMBOL|PLURAL|()|DICTIONARY|EXTRACTED	amls	AMLs	102#106	16645213-1-77-100	NPM1 gene mutations are the most frequent genetic lesion in the 60% of adult acute myeloid leukemias (AMLs) with normal karyotype and no evidence of typical fusion genes (BCR/ABL1, PML/RARA, AML1/ETO, CBFB/MYH11, DEK/CAN).
16645213	2006	J Mol Diagn	1525-1578	ALL_TEXT_1/3	1	1	5914	SYMBOL|DICTIONARY	rara	RARA	185#189		D030342	LONGTERM|DICTIONARY	genetic lesion	genetic lesion	42#56	NaN	NPM1 gene mutations are the most frequent genetic lesion in the 60% of adult acute myeloid leukemias (AMLs) with normal karyotype and no evidence of typical fusion genes (BCR/ABL1, PML/RARA, AML1/ETO, CBFB/MYH11, DEK/CAN).
16645213	2006	J Mol Diagn	1525-1578	ALL_TEXT_1/3	1	1	861	SYMBOL|DICTIONARY	aml1	AML1	191#195		D015470	LONGTERM|DICTIONARY	acute myeloid leukemias	acute myeloid leukemias	77#100		NPM1 gene mutations are the most frequent genetic lesion in the 60% of adult acute myeloid leukemias (AMLs) with normal karyotype and no evidence of typical fusion genes (BCR/ABL1, PML/RARA, AML1/ETO, CBFB/MYH11, DEK/CAN).
16645213	2006	J Mol Diagn	1525-1578	ALL_TEXT_1/3	1	1	861	SYMBOL|DICTIONARY	aml1	AML1	191#195		D015470	SYMBOL|PLURAL|()|DICTIONARY|EXTRACTED	amls	AMLs	102#106	16645213-1-77-100	NPM1 gene mutations are the most frequent genetic lesion in the 60% of adult acute myeloid leukemias (AMLs) with normal karyotype and no evidence of typical fusion genes (BCR/ABL1, PML/RARA, AML1/ETO, CBFB/MYH11, DEK/CAN).
16645213	2006	J Mol Diagn	1525-1578	ALL_TEXT_1/3	1	1	861	SYMBOL|DICTIONARY	aml1	AML1	191#195		D030342	LONGTERM|DICTIONARY	genetic lesion	genetic lesion	42#56	NaN	NPM1 gene mutations are the most frequent genetic lesion in the 60% of adult acute myeloid leukemias (AMLs) with normal karyotype and no evidence of typical fusion genes (BCR/ABL1, PML/RARA, AML1/ETO, CBFB/MYH11, DEK/CAN).
16645213	2006	J Mol Diagn	1525-1578	ALL_TEXT_1/3	1	1	862	SYMBOL|DICTIONARY	eto	ETO	196#199		D015470	LONGTERM|DICTIONARY	acute myeloid leukemias	acute myeloid leukemias	77#100		NPM1 gene mutations are the most frequent genetic lesion in the 60% of adult acute myeloid leukemias (AMLs) with normal karyotype and no evidence of typical fusion genes (BCR/ABL1, PML/RARA, AML1/ETO, CBFB/MYH11, DEK/CAN).
16645213	2006	J Mol Diagn	1525-1578	ALL_TEXT_1/3	1	1	862	SYMBOL|DICTIONARY	eto	ETO	196#199		D015470	SYMBOL|PLURAL|()|DICTIONARY|EXTRACTED	amls	AMLs	102#106	16645213-1-77-100	NPM1 gene mutations are the most frequent genetic lesion in the 60% of adult acute myeloid leukemias (AMLs) with normal karyotype and no evidence of typical fusion genes (BCR/ABL1, PML/RARA, AML1/ETO, CBFB/MYH11, DEK/CAN).
16645213	2006	J Mol Diagn	1525-1578	ALL_TEXT_1/3	1	1	862	SYMBOL|DICTIONARY	eto	ETO	196#199		D030342	LONGTERM|DICTIONARY	genetic lesion	genetic lesion	42#56	NaN	NPM1 gene mutations are the most frequent genetic lesion in the 60% of adult acute myeloid leukemias (AMLs) with normal karyotype and no evidence of typical fusion genes (BCR/ABL1, PML/RARA, AML1/ETO, CBFB/MYH11, DEK/CAN).
16645213	2006	J Mol Diagn	1525-1578	ALL_TEXT_1/3	1	1	865	SYMBOL|DICTIONARY	cbfb	CBFB	201#205		D015470	LONGTERM|DICTIONARY	acute myeloid leukemias	acute myeloid leukemias	77#100		NPM1 gene mutations are the most frequent genetic lesion in the 60% of adult acute myeloid leukemias (AMLs) with normal karyotype and no evidence of typical fusion genes (BCR/ABL1, PML/RARA, AML1/ETO, CBFB/MYH11, DEK/CAN).
16645213	2006	J Mol Diagn	1525-1578	ALL_TEXT_1/3	1	1	865	SYMBOL|DICTIONARY	cbfb	CBFB	201#205		D015470	SYMBOL|PLURAL|()|DICTIONARY|EXTRACTED	amls	AMLs	102#106	16645213-1-77-100	NPM1 gene mutations are the most frequent genetic lesion in the 60% of adult acute myeloid leukemias (AMLs) with normal karyotype and no evidence of typical fusion genes (BCR/ABL1, PML/RARA, AML1/ETO, CBFB/MYH11, DEK/CAN).
16645213	2006	J Mol Diagn	1525-1578	ALL_TEXT_1/3	1	1	865	SYMBOL|DICTIONARY	cbfb	CBFB	201#205		D030342	LONGTERM|DICTIONARY	genetic lesion	genetic lesion	42#56	NaN	NPM1 gene mutations are the most frequent genetic lesion in the 60% of adult acute myeloid leukemias (AMLs) with normal karyotype and no evidence of typical fusion genes (BCR/ABL1, PML/RARA, AML1/ETO, CBFB/MYH11, DEK/CAN).
16645213	2006	J Mol Diagn	1525-1578	ALL_TEXT_1/3	1	1	4629	SYMBOL|DICTIONARY	myh11	MYH11	206#211		D015470	LONGTERM|DICTIONARY	acute myeloid leukemias	acute myeloid leukemias	77#100		NPM1 gene mutations are the most frequent genetic lesion in the 60% of adult acute myeloid leukemias (AMLs) with normal karyotype and no evidence of typical fusion genes (BCR/ABL1, PML/RARA, AML1/ETO, CBFB/MYH11, DEK/CAN).
16645213	2006	J Mol Diagn	1525-1578	ALL_TEXT_1/3	1	1	4629	SYMBOL|DICTIONARY	myh11	MYH11	206#211		D015470	SYMBOL|PLURAL|()|DICTIONARY|EXTRACTED	amls	AMLs	102#106	16645213-1-77-100	NPM1 gene mutations are the most frequent genetic lesion in the 60% of adult acute myeloid leukemias (AMLs) with normal karyotype and no evidence of typical fusion genes (BCR/ABL1, PML/RARA, AML1/ETO, CBFB/MYH11, DEK/CAN).
16645213	2006	J Mol Diagn	1525-1578	ALL_TEXT_1/3	1	1	4629	SYMBOL|DICTIONARY	myh11	MYH11	206#211		D030342	LONGTERM|DICTIONARY	genetic lesion	genetic lesion	42#56	NaN	NPM1 gene mutations are the most frequent genetic lesion in the 60% of adult acute myeloid leukemias (AMLs) with normal karyotype and no evidence of typical fusion genes (BCR/ABL1, PML/RARA, AML1/ETO, CBFB/MYH11, DEK/CAN).
16645213	2006	J Mol Diagn	1525-1578	ALL_TEXT_1/3	1	1	7913	SYMBOL|DICTIONARY	dek	DEK	213#216		D015470	LONGTERM|DICTIONARY	acute myeloid leukemias	acute myeloid leukemias	77#100		NPM1 gene mutations are the most frequent genetic lesion in the 60% of adult acute myeloid leukemias (AMLs) with normal karyotype and no evidence of typical fusion genes (BCR/ABL1, PML/RARA, AML1/ETO, CBFB/MYH11, DEK/CAN).
16645213	2006	J Mol Diagn	1525-1578	ALL_TEXT_1/3	1	1	7913	SYMBOL|DICTIONARY	dek	DEK	213#216		D015470	SYMBOL|PLURAL|()|DICTIONARY|EXTRACTED	amls	AMLs	102#106	16645213-1-77-100	NPM1 gene mutations are the most frequent genetic lesion in the 60% of adult acute myeloid leukemias (AMLs) with normal karyotype and no evidence of typical fusion genes (BCR/ABL1, PML/RARA, AML1/ETO, CBFB/MYH11, DEK/CAN).
16645213	2006	J Mol Diagn	1525-1578	ALL_TEXT_1/3	1	1	7913	SYMBOL|DICTIONARY	dek	DEK	213#216		D030342	LONGTERM|DICTIONARY	genetic lesion	genetic lesion	42#56	NaN	NPM1 gene mutations are the most frequent genetic lesion in the 60% of adult acute myeloid leukemias (AMLs) with normal karyotype and no evidence of typical fusion genes (BCR/ABL1, PML/RARA, AML1/ETO, CBFB/MYH11, DEK/CAN).
16645213	2006	J Mol Diagn	1525-1578	ALL_TEXT_1/3	1	1	25	SYMBOL|DICTIONARY	bcr/abl1	BCR/ABL1	171#179		D015470	LONGTERM|DICTIONARY	acute myeloid leukemias	acute myeloid leukemias	77#100		NPM1 gene mutations are the most frequent genetic lesion in the 60% of adult acute myeloid leukemias (AMLs) with normal karyotype and no evidence of typical fusion genes (BCR/ABL1, PML/RARA, AML1/ETO, CBFB/MYH11, DEK/CAN).
16645213	2006	J Mol Diagn	1525-1578	ALL_TEXT_1/3	1	1	25	SYMBOL|DICTIONARY	bcr/abl1	BCR/ABL1	171#179		D015470	SYMBOL|PLURAL|()|DICTIONARY|EXTRACTED	amls	AMLs	102#106	16645213-1-77-100	NPM1 gene mutations are the most frequent genetic lesion in the 60% of adult acute myeloid leukemias (AMLs) with normal karyotype and no evidence of typical fusion genes (BCR/ABL1, PML/RARA, AML1/ETO, CBFB/MYH11, DEK/CAN).
16645213	2006	J Mol Diagn	1525-1578	ALL_TEXT_1/3	1	1	25	SYMBOL|DICTIONARY	bcr/abl1	BCR/ABL1	171#179		D030342	LONGTERM|DICTIONARY	genetic lesion	genetic lesion	42#56	NaN	NPM1 gene mutations are the most frequent genetic lesion in the 60% of adult acute myeloid leukemias (AMLs) with normal karyotype and no evidence of typical fusion genes (BCR/ABL1, PML/RARA, AML1/ETO, CBFB/MYH11, DEK/CAN).
16645213	2006	J Mol Diagn	1525-1578	ALL_TEXT_1/3	1	1	613	SYMBOL|DICTIONARY	bcr/abl1	BCR/ABL1	171#179		D015470	LONGTERM|DICTIONARY	acute myeloid leukemias	acute myeloid leukemias	77#100		NPM1 gene mutations are the most frequent genetic lesion in the 60% of adult acute myeloid leukemias (AMLs) with normal karyotype and no evidence of typical fusion genes (BCR/ABL1, PML/RARA, AML1/ETO, CBFB/MYH11, DEK/CAN).
16645213	2006	J Mol Diagn	1525-1578	ALL_TEXT_1/3	1	1	613	SYMBOL|DICTIONARY	bcr/abl1	BCR/ABL1	171#179		D015470	SYMBOL|PLURAL|()|DICTIONARY|EXTRACTED	amls	AMLs	102#106	16645213-1-77-100	NPM1 gene mutations are the most frequent genetic lesion in the 60% of adult acute myeloid leukemias (AMLs) with normal karyotype and no evidence of typical fusion genes (BCR/ABL1, PML/RARA, AML1/ETO, CBFB/MYH11, DEK/CAN).
16645213	2006	J Mol Diagn	1525-1578	ALL_TEXT_1/3	1	1	613	SYMBOL|DICTIONARY	bcr/abl1	BCR/ABL1	171#179		D030342	LONGTERM|DICTIONARY	genetic lesion	genetic lesion	42#56	NaN	NPM1 gene mutations are the most frequent genetic lesion in the 60% of adult acute myeloid leukemias (AMLs) with normal karyotype and no evidence of typical fusion genes (BCR/ABL1, PML/RARA, AML1/ETO, CBFB/MYH11, DEK/CAN).
16645213	2006	J Mol Diagn	1525-1578	ALL_TEXT_1/3	1	1	25	SYMBOL|DICTIONARY	bcr/abl1	BCR/ABL1	171#179		D015470	LONGTERM|DICTIONARY	acute myeloid leukemias	acute myeloid leukemias	77#100		NPM1 gene mutations are the most frequent genetic lesion in the 60% of adult acute myeloid leukemias (AMLs) with normal karyotype and no evidence of typical fusion genes (BCR/ABL1, PML/RARA, AML1/ETO, CBFB/MYH11, DEK/CAN).
16645213	2006	J Mol Diagn	1525-1578	ALL_TEXT_1/3	1	1	25	SYMBOL|DICTIONARY	bcr/abl1	BCR/ABL1	171#179		D015470	SYMBOL|PLURAL|()|DICTIONARY|EXTRACTED	amls	AMLs	102#106	16645213-1-77-100	NPM1 gene mutations are the most frequent genetic lesion in the 60% of adult acute myeloid leukemias (AMLs) with normal karyotype and no evidence of typical fusion genes (BCR/ABL1, PML/RARA, AML1/ETO, CBFB/MYH11, DEK/CAN).
16645213	2006	J Mol Diagn	1525-1578	ALL_TEXT_1/3	1	1	25	SYMBOL|DICTIONARY	bcr/abl1	BCR/ABL1	171#179		D030342	LONGTERM|DICTIONARY	genetic lesion	genetic lesion	42#56	NaN	NPM1 gene mutations are the most frequent genetic lesion in the 60% of adult acute myeloid leukemias (AMLs) with normal karyotype and no evidence of typical fusion genes (BCR/ABL1, PML/RARA, AML1/ETO, CBFB/MYH11, DEK/CAN).
16645213	2006	J Mol Diagn	1525-1578	ALL_TEXT_1/3	1	1	613	SYMBOL|DICTIONARY	bcr/abl1	BCR/ABL1	171#179		D015470	LONGTERM|DICTIONARY	acute myeloid leukemias	acute myeloid leukemias	77#100		NPM1 gene mutations are the most frequent genetic lesion in the 60% of adult acute myeloid leukemias (AMLs) with normal karyotype and no evidence of typical fusion genes (BCR/ABL1, PML/RARA, AML1/ETO, CBFB/MYH11, DEK/CAN).
16645213	2006	J Mol Diagn	1525-1578	ALL_TEXT_1/3	1	1	613	SYMBOL|DICTIONARY	bcr/abl1	BCR/ABL1	171#179		D015470	SYMBOL|PLURAL|()|DICTIONARY|EXTRACTED	amls	AMLs	102#106	16645213-1-77-100	NPM1 gene mutations are the most frequent genetic lesion in the 60% of adult acute myeloid leukemias (AMLs) with normal karyotype and no evidence of typical fusion genes (BCR/ABL1, PML/RARA, AML1/ETO, CBFB/MYH11, DEK/CAN).
16645213	2006	J Mol Diagn	1525-1578	ALL_TEXT_1/3	1	1	613	SYMBOL|DICTIONARY	bcr/abl1	BCR/ABL1	171#179		D030342	LONGTERM|DICTIONARY	genetic lesion	genetic lesion	42#56	NaN	NPM1 gene mutations are the most frequent genetic lesion in the 60% of adult acute myeloid leukemias (AMLs) with normal karyotype and no evidence of typical fusion genes (BCR/ABL1, PML/RARA, AML1/ETO, CBFB/MYH11, DEK/CAN).
16006970	2005	J. Urol.	0022-5347	RESULTS	3	9	3569	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	il 6	IL-6	41#45	16006970-1-2-15	D011471	LONGTERM|DISEASE|DT|DICTIONARY	prostate cancer	prostate cancer	158#173		Furthermore, the -174G>C genotype of the IL-6 gene was significantly associated with increased serum prostate specific antigen (p = 0.004) and with recurrent prostate cancer compared with GG homozygotes (p = 0.027).
16006970	2005	J. Urol.	0022-5347	RESULTS	3	9	354	LONGTERM|DICTIONARY	prostate specific antigen	prostate specific antigen	101#126		D011471	LONGTERM|DISEASE|DT|DICTIONARY	prostate cancer	prostate cancer	158#173		Furthermore, the -174G>C genotype of the IL-6 gene was significantly associated with increased serum prostate specific antigen (p = 0.004) and with recurrent prostate cancer compared with GG homozygotes (p = 0.027).
16006970	2005	J. Urol.	0022-5347	MATERIALS AND METHODS	2	4	3569	SYMBOL|DICTIONARY|EXTRACTED	il 6	IL-6	33#37	16006970-1-2-15	D011471	LONGTERM|DISEASE|DT|DICTIONARY	prostate cancer	prostate cancer	125#140		: We examined the association of IL-6 polymorphism with the risk of advanced disease in 95 patients with different stages of prostate cancer using the tetra-primer polymerase chain reaction genotyping method.
16006970	2005	J. Urol.	0022-5347	MATERIALS AND METHODS	2	4	3569	SYMBOL|DICTIONARY|EXTRACTED	il 6	IL-6	33#37	16006970-1-2-15	D020178	LONGTERM|DICTIONARY	advanced disease	advanced disease	68#84	NaN	: We examined the association of IL-6 polymorphism with the risk of advanced disease in 95 patients with different stages of prostate cancer using the tetra-primer polymerase chain reaction genotyping method.
16645213	2006	J Mol Diagn	1525-1578	TITLE	0	0	4869	SYMBOL|DICTIONARY	npm1	NPM1	84#88		D015470	LONGTERM|DICTIONARY	acute myeloid leukemia	acute myeloid leukemia	102#124		Denaturing high-performance liquid chromatography: a valid approach for identifying NPM1 mutations in acute myeloid leukemia.
16006970	2005	J. Urol.	0022-5347	PURPOSE	1	3	3569	SYMBOL|DICTIONARY|EXTRACTED	il 6	IL-6	33#37	16006970-1-2-15	D011471	LONGTERM|DISEASE|DT|DICTIONARY	prostate cancer	prostate cancer	56#71		We determined the association of IL-6 polymorphism with prostate cancer progression.
16006970	2005	J. Urol.	0022-5347	TITLE	0	0	3569	LONGTERM|DICTIONARY	interleukin 6	Interleukin-6	0#13		D011471	LONGTERM|DISEASE|DT|DICTIONARY	aggressive prostate cancer	aggressive prostate cancer	51#77		Interleukin-6 polymorphism is associated with more aggressive prostate cancer.
16006970	2005	J. Urol.	0022-5347	PURPOSE	1	1	3569	LONGTERM|DICTIONARY	interleukin 6	Interleukin-6	2#15		D011471	LONGTERM|DISEASE|DT|DICTIONARY	prostate cancer	prostate cancer	52#67		: Interleukin-6 (IL-6) has an important role during prostate cancer progression and IL-6 levels in the serum of patients with hormone refractory and metastatic prostate cancer are significantly increased compared with those in patients with hormone sensitive and localized prostate cancer.
16006970	2005	J. Urol.	0022-5347	PURPOSE	1	1	3569	LONGTERM|DICTIONARY	interleukin 6	Interleukin-6	2#15		D011471	LONGTERM|DISEASE|DT|DICTIONARY	metastatic prostate cancer	metastatic prostate cancer	149#175		: Interleukin-6 (IL-6) has an important role during prostate cancer progression and IL-6 levels in the serum of patients with hormone refractory and metastatic prostate cancer are significantly increased compared with those in patients with hormone sensitive and localized prostate cancer.
16006970	2005	J. Urol.	0022-5347	PURPOSE	1	1	3569	LONGTERM|DICTIONARY	interleukin 6	Interleukin-6	2#15		D011471	LONGTERM|DISEASE|DT|DICTIONARY	prostate cancer	prostate cancer	273#288		: Interleukin-6 (IL-6) has an important role during prostate cancer progression and IL-6 levels in the serum of patients with hormone refractory and metastatic prostate cancer are significantly increased compared with those in patients with hormone sensitive and localized prostate cancer.
16006970	2005	J. Urol.	0022-5347	PURPOSE	1	1	3569	SYMBOL|()|DICTIONARY|EXTRACTED	il 6	IL-6	17#21	16006970-1-2-15	D011471	LONGTERM|DISEASE|DT|DICTIONARY	prostate cancer	prostate cancer	52#67		: Interleukin-6 (IL-6) has an important role during prostate cancer progression and IL-6 levels in the serum of patients with hormone refractory and metastatic prostate cancer are significantly increased compared with those in patients with hormone sensitive and localized prostate cancer.
16006970	2005	J. Urol.	0022-5347	PURPOSE	1	1	3569	SYMBOL|()|DICTIONARY|EXTRACTED	il 6	IL-6	17#21	16006970-1-2-15	D011471	LONGTERM|DISEASE|DT|DICTIONARY	metastatic prostate cancer	metastatic prostate cancer	149#175		: Interleukin-6 (IL-6) has an important role during prostate cancer progression and IL-6 levels in the serum of patients with hormone refractory and metastatic prostate cancer are significantly increased compared with those in patients with hormone sensitive and localized prostate cancer.
16006970	2005	J. Urol.	0022-5347	PURPOSE	1	1	3569	SYMBOL|()|DICTIONARY|EXTRACTED	il 6	IL-6	17#21	16006970-1-2-15	D011471	LONGTERM|DISEASE|DT|DICTIONARY	prostate cancer	prostate cancer	273#288		: Interleukin-6 (IL-6) has an important role during prostate cancer progression and IL-6 levels in the serum of patients with hormone refractory and metastatic prostate cancer are significantly increased compared with those in patients with hormone sensitive and localized prostate cancer.
16006970	2005	J. Urol.	0022-5347	PURPOSE	1	1	3569	SYMBOL|DICTIONARY|EXTRACTED	il 6	IL-6	84#88	16006970-1-2-15	D011471	LONGTERM|DISEASE|DT|DICTIONARY	prostate cancer	prostate cancer	52#67		: Interleukin-6 (IL-6) has an important role during prostate cancer progression and IL-6 levels in the serum of patients with hormone refractory and metastatic prostate cancer are significantly increased compared with those in patients with hormone sensitive and localized prostate cancer.
16006970	2005	J. Urol.	0022-5347	PURPOSE	1	1	3569	SYMBOL|DICTIONARY|EXTRACTED	il 6	IL-6	84#88	16006970-1-2-15	D011471	LONGTERM|DISEASE|DT|DICTIONARY	metastatic prostate cancer	metastatic prostate cancer	149#175		: Interleukin-6 (IL-6) has an important role during prostate cancer progression and IL-6 levels in the serum of patients with hormone refractory and metastatic prostate cancer are significantly increased compared with those in patients with hormone sensitive and localized prostate cancer.
16006970	2005	J. Urol.	0022-5347	PURPOSE	1	1	3569	SYMBOL|DICTIONARY|EXTRACTED	il 6	IL-6	84#88	16006970-1-2-15	D011471	LONGTERM|DISEASE|DT|DICTIONARY	prostate cancer	prostate cancer	273#288		: Interleukin-6 (IL-6) has an important role during prostate cancer progression and IL-6 levels in the serum of patients with hormone refractory and metastatic prostate cancer are significantly increased compared with those in patients with hormone sensitive and localized prostate cancer.
15993987	2006	Neurobiol. Aging	0197-4580	TITLE	0	0	348	SYMBOL|DICTIONARY	apoe	APOE	70#74		D000686	LONGTERM|DICTIONARY	amyloidosis	amyloidosis	22#33		Induction of vascular amyloidosis-beta by oxidative stress depends on APOE genotype.
15993987	2006	Neurobiol. Aging	0197-4580	ALL_TEXT_1/3	1	1	348	LONGTERM|DICTIONARY	apolipoprotein e epsilon4/epsilon4	apolipoprotein E epsilon4/epsilon4	35#69		D000686	LONGTERM|DICTIONARY	beta-amyloidosis	beta-amyloidosis	97#113		The reduced antioxidant defense in apolipoprotein E epsilon4/epsilon4 carriers may contribute to beta-amyloidosis.
16909243	2006	Pediatr. Nephrol.	0931-041X	ALL_TEXT_1/3	1	1	7490	LONGTERM|DICTIONARY	wt1	WT1	0#3	NaN	D009404	LONGTERM|DISEASE|DT|DICTIONARY	nephrotic syndrome	nephrotic syndrome	51#69		WT1 mutations have been considered a rare cause of nephrotic syndrome but recent reports challenge this assumption.
16909243	2006	Pediatr. Nephrol.	0931-041X	TITLE	0	0	7490	LONGTERM|DICTIONARY	wt1	WT1	0#3	NaN	D009404	LONGTERM|DISEASE|DT|DICTIONARY	nephrotic syndrome	nephrotic syndrome	17#35		WT1 mutations in nephrotic syndrome revisited. High prevalence in young girls, associations and renal phenotypes.
16909243	2006	Pediatr. Nephrol.	0931-041X	ALL_TEXT_1/3	1	3	7827	SYMBOL|DICTIONARY	nphs2	NPHS2	198#203		D009404	LONGTERM|DISEASE|DT|NUMBER|DICTIONARY	nephrotic syndrome	nephrotic syndrome	51#69		We screened for WT1 mutations in 200 patients with nephrotic syndrome: 114 with steroid resistance (SRNS) and 86 with steroid dependence (SDNS) for whom other inherited forms of nephrotic syndrome (NPHS2, CD2AP) had been previously excluded.
16909243	2006	Pediatr. Nephrol.	0931-041X	ALL_TEXT_1/3	1	3	7827	SYMBOL|DICTIONARY	nphs2	NPHS2	198#203		D009404	LONGTERM|DISEASE|DT|DICTIONARY	nephrotic syndrome	nephrotic syndrome	178#196		We screened for WT1 mutations in 200 patients with nephrotic syndrome: 114 with steroid resistance (SRNS) and 86 with steroid dependence (SDNS) for whom other inherited forms of nephrotic syndrome (NPHS2, CD2AP) had been previously excluded.
16909243	2006	Pediatr. Nephrol.	0931-041X	ALL_TEXT_1/3	1	3	23607	SYMBOL|DICTIONARY	cd2ap	CD2AP	205#210		D009404	LONGTERM|DISEASE|DT|NUMBER|DICTIONARY	nephrotic syndrome	nephrotic syndrome	51#69		We screened for WT1 mutations in 200 patients with nephrotic syndrome: 114 with steroid resistance (SRNS) and 86 with steroid dependence (SDNS) for whom other inherited forms of nephrotic syndrome (NPHS2, CD2AP) had been previously excluded.
16909243	2006	Pediatr. Nephrol.	0931-041X	ALL_TEXT_1/3	1	3	23607	SYMBOL|DICTIONARY	cd2ap	CD2AP	205#210		D009404	LONGTERM|DISEASE|DT|DICTIONARY	nephrotic syndrome	nephrotic syndrome	178#196		We screened for WT1 mutations in 200 patients with nephrotic syndrome: 114 with steroid resistance (SRNS) and 86 with steroid dependence (SDNS) for whom other inherited forms of nephrotic syndrome (NPHS2, CD2AP) had been previously excluded.
16909243	2006	Pediatr. Nephrol.	0931-041X	ALL_TEXT_1/3	1	3	7490	LONGTERM|DICTIONARY	wt1	WT1	16#19	NaN	D009404	LONGTERM|DISEASE|DT|NUMBER|DICTIONARY	nephrotic syndrome	nephrotic syndrome	51#69		We screened for WT1 mutations in 200 patients with nephrotic syndrome: 114 with steroid resistance (SRNS) and 86 with steroid dependence (SDNS) for whom other inherited forms of nephrotic syndrome (NPHS2, CD2AP) had been previously excluded.
16909243	2006	Pediatr. Nephrol.	0931-041X	ALL_TEXT_1/3	1	3	7490	LONGTERM|DICTIONARY	wt1	WT1	16#19	NaN	D009404	LONGTERM|DISEASE|DT|DICTIONARY	nephrotic syndrome	nephrotic syndrome	178#196		We screened for WT1 mutations in 200 patients with nephrotic syndrome: 114 with steroid resistance (SRNS) and 86 with steroid dependence (SDNS) for whom other inherited forms of nephrotic syndrome (NPHS2, CD2AP) had been previously excluded.
8942447	1997	Am J Psychiatry	0002-953X	CONCLUSIONS	4	9	3123	SYMBOL|DICTIONARY	drb1	DRB1	100#104		D012559	LONGTERM|DICTIONARY	schizophrenia	schizophrenia	224#237		Alternatively, it may be that maternal B lymphocytes that do not express the DR4 antigen encoded by DRB1*04 respond to influenza virus by producing antibodies that perturb neurodevelopment, thus underpinning a proportion of schizophrenia cases.
8942447	1997	Am J Psychiatry	0002-953X	CONCLUSIONS	4	9	3126	LONGTERM|DICTIONARY	dr4	DR4	77#80	NaN	D012559	LONGTERM|DICTIONARY	schizophrenia	schizophrenia	224#237		Alternatively, it may be that maternal B lymphocytes that do not express the DR4 antigen encoded by DRB1*04 respond to influenza virus by producing antibodies that perturb neurodevelopment, thus underpinning a proportion of schizophrenia cases.
16775186	2006	Cancer Epidemiol. Biomarkers Prev.	1055-9965	ALL_TEXT_1/3	1	2	5444	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	pon1	PON1	97#101	16775186-1-0-13	D001943	LONGTERM|DISEASE|DT|DICTIONARY	breast cancer	breast cancer	129#142		In this study, we investigated the association of two common, nonsynonymous polymorphisms in the PON1 gene (Q192R and L55M) with breast cancer risk in postmenopausal women through a nested case-control study within the American Cancer Society Cancer Prevention Study II Nutrition Cohort.
16775186	2006	Cancer Epidemiol. Biomarkers Prev.	1055-9965	ALL_TEXT_1/3	1	2	5444	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	pon1	PON1	97#101	16775186-1-0-13	D009369	LONGTERM|DISEASE|DT|DICTIONARY	cancer	Cancer	228#234		In this study, we investigated the association of two common, nonsynonymous polymorphisms in the PON1 gene (Q192R and L55M) with breast cancer risk in postmenopausal women through a nested case-control study within the American Cancer Society Cancer Prevention Study II Nutrition Cohort.
16775186	2006	Cancer Epidemiol. Biomarkers Prev.	1055-9965	ALL_TEXT_1/3	1	2	5444	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	pon1	PON1	97#101	16775186-1-0-13	D009369	LONGTERM|DISEASE|DT|DICTIONARY	cancer	Cancer	243#249		In this study, we investigated the association of two common, nonsynonymous polymorphisms in the PON1 gene (Q192R and L55M) with breast cancer risk in postmenopausal women through a nested case-control study within the American Cancer Society Cancer Prevention Study II Nutrition Cohort.
16775186	2006	Cancer Epidemiol. Biomarkers Prev.	1055-9965	TITLE	0	0	5444	LONGTERM|GENE|GN|DICTIONARY	paraoxonase 1	paraoxonase 1	36#49		D001943	LONGTERM|DISEASE|DT|DICTIONARY	breast cancer	breast cancer	60#73		Association of polymorphisms in the paraoxonase 1 gene with breast cancer incidence in the CPS-II Nutrition Cohort.
20842733	2011	Genes Chromosomes Cancer	1098-2264	ALL_TEXT_3/3	3	8	6470	SYMBOL|DICTIONARY	shmt	SHMT	63#67		D008175	LONGTERM|DISEASE|DN|DT|DICTIONARY	lung cancer	lung cancer	138#149		We observed that interactions between MTHFR677, MTHFR1298, and SHMT polymorphisms may have a significant impact on genetic instability in lung cancer patients.
20842733	2011	Genes Chromosomes Cancer	1098-2264	ALL_TEXT_3/3	3	8	4524	LONGTERM|DICTIONARY	mthfr	MTHFR	48#53	NaN	D008175	LONGTERM|DISEASE|DN|DT|DICTIONARY	lung cancer	lung cancer	138#149		We observed that interactions between MTHFR677, MTHFR1298, and SHMT polymorphisms may have a significant impact on genetic instability in lung cancer patients.
16775186	2006	Cancer Epidemiol. Biomarkers Prev.	1055-9965	ALL_TEXT_3/3	3	7	5444	SYMBOL|DICTIONARY|EXTRACTED	pon1	PON1	48#52	16775186-1-0-13	D001943	LONGTERM|DISEASE|DT|DICTIONARY	breast cancer	breast cancer	125#138		These results suggest that genetic variation in PON1, particularly at the L55M SNP, may be associated with increased risk of breast cancer in postmenopausal women.
16796743	2006	BMC Med. Genet.	1471-2350	BACKGROUND	1	3	6583	SYMBOL|DICTIONARY	slc22a4	SLC22A4	60#67		D001327	LONGTERM|DICTIONARY	autoimmune diseases	autoimmune diseases	137#156		Polymorphisms in the carnitine transporters, encoded by the SLC22A4 and SLC22A5 genes, have been involved in susceptibility to two other autoimmune diseases, rheumatoid arthritis and Crohn's disease.
16796743	2006	BMC Med. Genet.	1471-2350	BACKGROUND	1	3	6583	SYMBOL|DICTIONARY	slc22a4	SLC22A4	60#67		D001172	LONGTERM|DICTIONARY	rheumatoid arthritis	rheumatoid arthritis	158#178		Polymorphisms in the carnitine transporters, encoded by the SLC22A4 and SLC22A5 genes, have been involved in susceptibility to two other autoimmune diseases, rheumatoid arthritis and Crohn's disease.
16796743	2006	BMC Med. Genet.	1471-2350	BACKGROUND	1	3	6583	SYMBOL|DICTIONARY	slc22a4	SLC22A4	60#67		D003424	LONGTERM|DISEASE|DT|DICTIONARY	crohn disease	Crohn's disease	183#198		Polymorphisms in the carnitine transporters, encoded by the SLC22A4 and SLC22A5 genes, have been involved in susceptibility to two other autoimmune diseases, rheumatoid arthritis and Crohn's disease.
16796743	2006	BMC Med. Genet.	1471-2350	BACKGROUND	1	3	6584	SYMBOL|GENE|GN|DICTIONARY	slc22a5	SLC22A5	72#79		D001327	LONGTERM|DICTIONARY	autoimmune diseases	autoimmune diseases	137#156		Polymorphisms in the carnitine transporters, encoded by the SLC22A4 and SLC22A5 genes, have been involved in susceptibility to two other autoimmune diseases, rheumatoid arthritis and Crohn's disease.
16796743	2006	BMC Med. Genet.	1471-2350	BACKGROUND	1	3	6584	SYMBOL|GENE|GN|DICTIONARY	slc22a5	SLC22A5	72#79		D001172	LONGTERM|DICTIONARY	rheumatoid arthritis	rheumatoid arthritis	158#178		Polymorphisms in the carnitine transporters, encoded by the SLC22A4 and SLC22A5 genes, have been involved in susceptibility to two other autoimmune diseases, rheumatoid arthritis and Crohn's disease.
16796743	2006	BMC Med. Genet.	1471-2350	BACKGROUND	1	3	6584	SYMBOL|GENE|GN|DICTIONARY	slc22a5	SLC22A5	72#79		D003424	LONGTERM|DISEASE|DT|DICTIONARY	crohn disease	Crohn's disease	183#198		Polymorphisms in the carnitine transporters, encoded by the SLC22A4 and SLC22A5 genes, have been involved in susceptibility to two other autoimmune diseases, rheumatoid arthritis and Crohn's disease.
16796743	2006	BMC Med. Genet.	1471-2350	TITLE	0	0	6583	SYMBOL|DICTIONARY	slc22a4	SLC22A4	36#43		D003920	LONGTERM|DICTIONARY	diabetes	diabetes	74#82		Evidence for the association of the SLC22A4 and SLC22A5 genes with type 1 diabetes: a case control study.
16796743	2006	BMC Med. Genet.	1471-2350	TITLE	0	0	6584	SYMBOL|GENE|GN|DICTIONARY	slc22a5	SLC22A5	48#55		D003920	LONGTERM|DICTIONARY	diabetes	diabetes	74#82		Evidence for the association of the SLC22A4 and SLC22A5 genes with type 1 diabetes: a case control study.
16796743	2006	BMC Med. Genet.	1471-2350	RESULTS	3	7	6583	SYMBOL|GENE|GN|DICTIONARY	slc22a4	SLC22A4	68#75		D003922	SYMBOL|EXTRACTED	t1d	T1D	125#128	16796743-1-0-15	When independently analyzed, one of the tested polymorphisms in the SLC22A4 gene at 1672 showed significant association with T1D in our Spanish cohort.
16796743	2006	BMC Med. Genet.	1471-2350	BACKGROUND	1	4	6584	SYMBOL|GENE|GN|DICTIONARY	octn2	OCTN2	190#195		D003922	SYMBOL|EXTRACTED	t1d	T1D	75#78	16796743-1-0-15	For these reasons, we investigated for the first time the association with T1D of six single nucleotide polymorphisms (SNPs) mapping to these candidate genes: slc2F2, slc2F11, T306I, L503F, OCTN2-promoter and OCTN2-intron.
16796743	2006	BMC Med. Genet.	1471-2350	BACKGROUND	1	4	6584	SYMBOL|DICTIONARY	octn2	OCTN2	209#214		D003922	SYMBOL|EXTRACTED	t1d	T1D	75#78	16796743-1-0-15	For these reasons, we investigated for the first time the association with T1D of six single nucleotide polymorphisms (SNPs) mapping to these candidate genes: slc2F2, slc2F11, T306I, L503F, OCTN2-promoter and OCTN2-intron.
18820912	2009	Ann. Hematol.	1432-0584	TITLE	0	0	30061	SYMBOL|GENE|GN|DICTIONARY	slc40a1	SLC40A1	9#16		D006432	LONGTERM|DISEASE|DN|DICTIONARY	haemochromatosis	haemochromatosis	41#57		Does the SLC40A1 gene modify HFE-related haemochromatosis phenotypes?
18820912	2009	Ann. Hematol.	1432-0584	TITLE	0	0	3077	SYMBOL|DICTIONARY	hfe	HFE	29#32		D006432	LONGTERM|DISEASE|DN|DICTIONARY	haemochromatosis	haemochromatosis	41#57		Does the SLC40A1 gene modify HFE-related haemochromatosis phenotypes?
18820912	2009	Ann. Hematol.	1432-0584	ALL_TEXT_1/3	1	1	3077	SYMBOL|GENE|GN|DICTIONARY	hfe	HFE	87#90		D030342	LONGTERM|DISEASE|DN|DICTIONARY	hereditary haemochromatosis	hereditary haemochromatosis	5#32		Most hereditary haemochromatosis patients are homozygous for the C282Y mutation of the HFE gene.
16490169	2006	Acta Pharmacol. Sin.	1671-4083	RESULTS	3	5	1565	SYMBOL|DICTIONARY	cyp2d6	CYP2D6	59#65		D004409	SYMBOL|EXTRACTED	td	TD	121#123	16490169-1-122-140	No significant differences in genotypes frequencies of the CYP2D6 C100T polymorphism were observed between patients with TD and without TD (Chi2=4.078, P>0.05), but patients with TD had a significant excess of the T allele compared with those without TD (Chi2=4.28, P<0.05).
16490169	2006	Acta Pharmacol. Sin.	1671-4083	RESULTS	3	5	1565	SYMBOL|DICTIONARY	cyp2d6	CYP2D6	59#65		D004409	SYMBOL|EXTRACTED	td	TD	136#138	16490169-1-122-140	No significant differences in genotypes frequencies of the CYP2D6 C100T polymorphism were observed between patients with TD and without TD (Chi2=4.078, P>0.05), but patients with TD had a significant excess of the T allele compared with those without TD (Chi2=4.28, P<0.05).
16490169	2006	Acta Pharmacol. Sin.	1671-4083	RESULTS	3	5	1565	SYMBOL|DICTIONARY	cyp2d6	CYP2D6	59#65		D004409	SYMBOL|EXTRACTED	td	TD	179#181	16490169-1-122-140	No significant differences in genotypes frequencies of the CYP2D6 C100T polymorphism were observed between patients with TD and without TD (Chi2=4.078, P>0.05), but patients with TD had a significant excess of the T allele compared with those without TD (Chi2=4.28, P<0.05).
16490169	2006	Acta Pharmacol. Sin.	1671-4083	RESULTS	3	5	1565	SYMBOL|DICTIONARY	cyp2d6	CYP2D6	59#65		D004409	SYMBOL|EXTRACTED	td	TD	251#253	16490169-1-122-140	No significant differences in genotypes frequencies of the CYP2D6 C100T polymorphism were observed between patients with TD and without TD (Chi2=4.078, P>0.05), but patients with TD had a significant excess of the T allele compared with those without TD (Chi2=4.28, P<0.05).
18820912	2009	Ann. Hematol.	1432-0584	ALL_TEXT_1/3	1	3	30061	SYMBOL|GENE|GN|DICTIONARY	slc40a1	SLC40A1	73#80		D019190	LONGTERM|DICTIONARY	iron overload	iron overload	105#118		The main objective of this work was to study the role of variants in the SLC40A1 gene in the severity of iron overload and his clinical consequences in 100 Spanish probands homozygous for the C282Y mutation of the HFE gene.
18820912	2009	Ann. Hematol.	1432-0584	ALL_TEXT_1/3	1	3	3077	SYMBOL|GENE|GN|DICTIONARY	hfe	HFE	214#217		D019190	LONGTERM|DICTIONARY	iron overload	iron overload	105#118		The main objective of this work was to study the role of variants in the SLC40A1 gene in the severity of iron overload and his clinical consequences in 100 Spanish probands homozygous for the C282Y mutation of the HFE gene.
16490169	2006	Acta Pharmacol. Sin.	1671-4083	TITLE	0	0	1565	SYMBOL|DICTIONARY	cyp2d6	CYP2D6	15#21		D004409	LONGTERM|DICTIONARY	tardive dyskinesia	tardive dyskinesia	56#74		Association of CYP2D6 and CYP1A2 gene polymorphism with tardive dyskinesia in Chinese schizophrenic patients.
16490169	2006	Acta Pharmacol. Sin.	1671-4083	TITLE	0	0	1565	SYMBOL|DICTIONARY	cyp2d6	CYP2D6	15#21		D012559	LONGTERM|DICTIONARY	schizophrenic	schizophrenic	86#99	NaN	Association of CYP2D6 and CYP1A2 gene polymorphism with tardive dyskinesia in Chinese schizophrenic patients.
16490169	2006	Acta Pharmacol. Sin.	1671-4083	TITLE	0	0	1544	SYMBOL|GENE|GN|DICTIONARY	cyp1a2	CYP1A2	26#32		D004409	LONGTERM|DICTIONARY	tardive dyskinesia	tardive dyskinesia	56#74		Association of CYP2D6 and CYP1A2 gene polymorphism with tardive dyskinesia in Chinese schizophrenic patients.
16490169	2006	Acta Pharmacol. Sin.	1671-4083	TITLE	0	0	1544	SYMBOL|GENE|GN|DICTIONARY	cyp1a2	CYP1A2	26#32		D012559	LONGTERM|DICTIONARY	schizophrenic	schizophrenic	86#99	NaN	Association of CYP2D6 and CYP1A2 gene polymorphism with tardive dyskinesia in Chinese schizophrenic patients.
9217972	1997	Brain Pathol.	1015-6305	ALL_TEXT_1/3	1	3	1029	SYMBOL|DICTIONARY	cdkn2	CDKN2	38#43		D005909	SYMBOL|DICTIONARY|EXTRACTED	gbm	GBM	62#65	9217972-1-0-23	We evaluated the relationship between CDKN2 deletions and the GBM subsets as defined by EGFR amplification or TP53 mutation in 70 GBM.
9217972	1997	Brain Pathol.	1015-6305	ALL_TEXT_1/3	1	3	1029	SYMBOL|DICTIONARY	cdkn2	CDKN2	38#43		D005909	SYMBOL|DICTIONARY|EXTRACTED	gbm	GBM	130#133	9217972-1-0-23	We evaluated the relationship between CDKN2 deletions and the GBM subsets as defined by EGFR amplification or TP53 mutation in 70 GBM.
9217972	1997	Brain Pathol.	1015-6305	ALL_TEXT_1/3	1	3	1956	SYMBOL|DICTIONARY	egfr	EGFR	88#92		D005909	SYMBOL|DICTIONARY|EXTRACTED	gbm	GBM	62#65	9217972-1-0-23	We evaluated the relationship between CDKN2 deletions and the GBM subsets as defined by EGFR amplification or TP53 mutation in 70 GBM.
9217972	1997	Brain Pathol.	1015-6305	ALL_TEXT_1/3	1	3	1956	SYMBOL|DICTIONARY	egfr	EGFR	88#92		D005909	SYMBOL|DICTIONARY|EXTRACTED	gbm	GBM	130#133	9217972-1-0-23	We evaluated the relationship between CDKN2 deletions and the GBM subsets as defined by EGFR amplification or TP53 mutation in 70 GBM.
9217972	1997	Brain Pathol.	1015-6305	ALL_TEXT_1/3	1	3	7157	SYMBOL|DICTIONARY	tp53	TP53	110#114		D005909	SYMBOL|DICTIONARY|EXTRACTED	gbm	GBM	62#65	9217972-1-0-23	We evaluated the relationship between CDKN2 deletions and the GBM subsets as defined by EGFR amplification or TP53 mutation in 70 GBM.
9217972	1997	Brain Pathol.	1015-6305	ALL_TEXT_1/3	1	3	7157	SYMBOL|DICTIONARY	tp53	TP53	110#114		D005909	SYMBOL|DICTIONARY|EXTRACTED	gbm	GBM	130#133	9217972-1-0-23	We evaluated the relationship between CDKN2 deletions and the GBM subsets as defined by EGFR amplification or TP53 mutation in 70 GBM.
18806915	2009	Eur Arch Psychiatry Clin Neurosci	1433-8491	INTRODUCTION	1	2	6532	SYMBOL|DICTIONARY	5 httlpr	5-HTTLPR	125#133		C564323	LONGTERM|DICTIONARY	neuroticism	neuroticism	232#243		One of the most frequently studied genetic polymorphisms in the background of psychological and psychiatric phenomena is the 5-HTTLPR polymorphism of the serotonin transporter gene which has earlier been found to be associated with neuroticism and neuroticism-related traits and disorders.
18806915	2009	Eur Arch Psychiatry Clin Neurosci	1433-8491	INTRODUCTION	1	2	6532	SYMBOL|DICTIONARY	5 httlpr	5-HTTLPR	125#133		C564323	LONGTERM|DICTIONARY	neuroticism	neuroticism	248#259		One of the most frequently studied genetic polymorphisms in the background of psychological and psychiatric phenomena is the 5-HTTLPR polymorphism of the serotonin transporter gene which has earlier been found to be associated with neuroticism and neuroticism-related traits and disorders.
18806915	2009	Eur Arch Psychiatry Clin Neurosci	1433-8491	INTRODUCTION	1	2	6532	SYMBOL|DICTIONARY	5 httlpr	5-HTTLPR	125#133		D001523	LONGTERM|DICTIONARY	psychiatric	psychiatric	96#107	NaN	One of the most frequently studied genetic polymorphisms in the background of psychological and psychiatric phenomena is the 5-HTTLPR polymorphism of the serotonin transporter gene which has earlier been found to be associated with neuroticism and neuroticism-related traits and disorders.
9217972	1997	Brain Pathol.	1015-6305	ALL_TEXT_1/3	1	1	1956	SYMBOL|DICTIONARY	egfr	EGFR	131#135		D005909	LONGTERM|DICTIONARY	glioblastoma multiforme	Glioblastoma multiforme	0#23		Glioblastoma multiforme (GBM) can be divided into genetic subsets: approximately one-third of GBM, primarily in older adults, have EGFR amplification; another one-third, primarily in younger adults, have TP53 mutation.
9217972	1997	Brain Pathol.	1015-6305	ALL_TEXT_1/3	1	1	1956	SYMBOL|DICTIONARY	egfr	EGFR	131#135		D005909	SYMBOL|()|DICTIONARY|EXTRACTED	gbm	GBM	25#28	9217972-1-0-23	Glioblastoma multiforme (GBM) can be divided into genetic subsets: approximately one-third of GBM, primarily in older adults, have EGFR amplification; another one-third, primarily in younger adults, have TP53 mutation.
9217972	1997	Brain Pathol.	1015-6305	ALL_TEXT_1/3	1	1	1956	SYMBOL|DICTIONARY	egfr	EGFR	131#135		D005909	SYMBOL|DICTIONARY|EXTRACTED	gbm	GBM	94#97	9217972-1-0-23	Glioblastoma multiforme (GBM) can be divided into genetic subsets: approximately one-third of GBM, primarily in older adults, have EGFR amplification; another one-third, primarily in younger adults, have TP53 mutation.
9217972	1997	Brain Pathol.	1015-6305	ALL_TEXT_1/3	1	1	7157	SYMBOL|DICTIONARY	tp53	TP53	204#208		D005909	LONGTERM|DICTIONARY	glioblastoma multiforme	Glioblastoma multiforme	0#23		Glioblastoma multiforme (GBM) can be divided into genetic subsets: approximately one-third of GBM, primarily in older adults, have EGFR amplification; another one-third, primarily in younger adults, have TP53 mutation.
9217972	1997	Brain Pathol.	1015-6305	ALL_TEXT_1/3	1	1	7157	SYMBOL|DICTIONARY	tp53	TP53	204#208		D005909	SYMBOL|()|DICTIONARY|EXTRACTED	gbm	GBM	25#28	9217972-1-0-23	Glioblastoma multiforme (GBM) can be divided into genetic subsets: approximately one-third of GBM, primarily in older adults, have EGFR amplification; another one-third, primarily in younger adults, have TP53 mutation.
9217972	1997	Brain Pathol.	1015-6305	ALL_TEXT_1/3	1	1	7157	SYMBOL|DICTIONARY	tp53	TP53	204#208		D005909	SYMBOL|DICTIONARY|EXTRACTED	gbm	GBM	94#97	9217972-1-0-23	Glioblastoma multiforme (GBM) can be divided into genetic subsets: approximately one-third of GBM, primarily in older adults, have EGFR amplification; another one-third, primarily in younger adults, have TP53 mutation.
18806915	2009	Eur Arch Psychiatry Clin Neurosci	1433-8491	TITLE	0	0	6532	SYMBOL|DICTIONARY	5 httlpr	5-HTTLPR	35#43		C564323	LONGTERM|DICTIONARY	neuroticism	neuroticism	49#60		Association of the s allele of the 5-HTTLPR with neuroticism-related traits and temperaments in a psychiatrically healthy population.
9217972	1997	Brain Pathol.	1015-6305	ALL_TEXT_2/3	2	6	1956	SYMBOL|DICTIONARY	egfr	EGFR	19#23		D005909	SYMBOL|DICTIONARY|EXTRACTED	gbm	GBM	10#13	9217972-1-0-23	Of the 28 GBM with EGFR amplification, 20 (71%) had CDKN2 deletion (p = 0.0078).
9217972	1997	Brain Pathol.	1015-6305	ALL_TEXT_2/3	2	6	1029	SYMBOL|DICTIONARY	cdkn2	CDKN2	52#57		D005909	SYMBOL|DICTIONARY|EXTRACTED	gbm	GBM	10#13	9217972-1-0-23	Of the 28 GBM with EGFR amplification, 20 (71%) had CDKN2 deletion (p = 0.0078).
9217972	1997	Brain Pathol.	1015-6305	ALL_TEXT_2/3	2	5	1029	SYMBOL|DICTIONARY	cdkn2	CDKN2	0#5		D005909	SYMBOL|DICTIONARY|EXTRACTED	gbm	GBM	41#44	9217972-1-0-23	CDKN2 deletions were present in 36 (51%) GBM.
18806915	2009	Eur Arch Psychiatry Clin Neurosci	1433-8491	INTRODUCTION	1	4	6532	SYMBOL|DICTIONARY	5 httlpr	5-HTTLPR	63#71		C564323	LONGTERM|DICTIONARY	neuroticism	neuroticism	168#179		The aim of our study was to investigate the association of the 5-HTTLPR polymorphism with several smaller, distinct and better characterisable phenomena related to the neuroticism trait.
20703234	2011	Hypertens. Res.	1348-4214	ALL_TEXT_3/3	3	12	185	SYMBOL|DICTIONARY|EXTRACTED	at1r	AT1R	55#59	20703234-1-94-124	D006973	LONGTERM|DICTIONARY	hypertension	hypertension	106#118		Our study pooled previous findings and showed that the AT1R +1166 C allele conferred an increased risk of hypertension.
11843659	2002	Arch Dermatol	0003-987X	TITLE	0	0	1294	SYMBOL|DICTIONARY	col7a1	COL7A1	23#29		D016108	LONGTERM|DICTIONARY	dystrophic epidermolysis bullosa	dystrophic epidermolysis bullosa	122#154		Toenail dystrophy with COL7A1 glycine substitution mutations segregates as an autosomal dominant trait in 2 families with dystrophic epidermolysis bullosa.
11843659	2002	Arch Dermatol	0003-987X	TITLE	0	0	1294	SYMBOL|DICTIONARY	col7a1	COL7A1	23#29		C564384	LONGTERM|DICTIONARY	toenail dystrophy	Toenail dystrophy	0#17	NaN	Toenail dystrophy with COL7A1 glycine substitution mutations segregates as an autosomal dominant trait in 2 families with dystrophic epidermolysis bullosa.
9217972	1997	Brain Pathol.	1015-6305	ALL_TEXT_3/3	3	8	1029	SYMBOL|DICTIONARY	cdkn2	CDKN2	6#11		D005909	SYMBOL|DICTIONARY|EXTRACTED	gbm	GBM	49#52	9217972-1-0-23	Thus, CDKN2 deletions occur twice as commonly in GBM with EGFR amplification (71%) than in GBM with TP53 mutation (29%).
9217972	1997	Brain Pathol.	1015-6305	ALL_TEXT_3/3	3	8	1029	SYMBOL|DICTIONARY	cdkn2	CDKN2	6#11		D005909	SYMBOL|DICTIONARY|EXTRACTED	gbm	GBM	91#94	9217972-1-0-23	Thus, CDKN2 deletions occur twice as commonly in GBM with EGFR amplification (71%) than in GBM with TP53 mutation (29%).
9217972	1997	Brain Pathol.	1015-6305	ALL_TEXT_3/3	3	8	1956	SYMBOL|DICTIONARY	egfr	EGFR	58#62		D005909	SYMBOL|DICTIONARY|EXTRACTED	gbm	GBM	49#52	9217972-1-0-23	Thus, CDKN2 deletions occur twice as commonly in GBM with EGFR amplification (71%) than in GBM with TP53 mutation (29%).
9217972	1997	Brain Pathol.	1015-6305	ALL_TEXT_3/3	3	8	1956	SYMBOL|DICTIONARY	egfr	EGFR	58#62		D005909	SYMBOL|DICTIONARY|EXTRACTED	gbm	GBM	91#94	9217972-1-0-23	Thus, CDKN2 deletions occur twice as commonly in GBM with EGFR amplification (71%) than in GBM with TP53 mutation (29%).
9217972	1997	Brain Pathol.	1015-6305	ALL_TEXT_3/3	3	8	7157	SYMBOL|DICTIONARY	tp53	TP53	100#104		D005909	SYMBOL|DICTIONARY|EXTRACTED	gbm	GBM	49#52	9217972-1-0-23	Thus, CDKN2 deletions occur twice as commonly in GBM with EGFR amplification (71%) than in GBM with TP53 mutation (29%).
9217972	1997	Brain Pathol.	1015-6305	ALL_TEXT_3/3	3	8	7157	SYMBOL|DICTIONARY	tp53	TP53	100#104		D005909	SYMBOL|DICTIONARY|EXTRACTED	gbm	GBM	91#94	9217972-1-0-23	Thus, CDKN2 deletions occur twice as commonly in GBM with EGFR amplification (71%) than in GBM with TP53 mutation (29%).
17558308	2007	Pharmacogenet. Genomics	1744-6872	TITLE	0	0	7515	SYMBOL|DICTIONARY	xrcc1	XRCC1	38#43		D001943	LONGTERM|DISEASE|DT|DICTIONARY	invasive breast cancer	invasive breast cancer	194#216		Polymorphism of the DNA repair enzyme XRCC1 is associated with treatment prediction in anthracycline and cyclophosphamide/methotrexate/5-fluorouracil-based chemotherapy of patients with primary invasive breast cancer.
20662556	2010	DNA Cell Biol.	1557-7430	ALL_TEXT_2/3	2	3	3603	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	il 16	IL-16	63#68	20662556-1-0-14	D004715	LONGTERM|DICTIONARY	endometriosis	endometriosis	95#108		We analyzed rs4778889 T/C, rs11556218 T/G polymorphisms of the IL-16 gene in 230 patients with endometriosis and 203 controls in a Chinese population, using a polymerase chain reaction-high resolution melting analysis strategy and DNA sequencing methods.
8942447	1997	Am J Psychiatry	0002-953X	TITLE	0	0	3123	SYMBOL|GENE|GN|DICTIONARY	hla drb1	HLA DRB1	27#35		D012559	LONGTERM|DICTIONARY	schizophrenia	schizophrenia	73#86		Genetic association of the HLA DRB1 gene locus on chromosome 6p21.3 with schizophrenia.
20644276	2010	Neurol India	0028-3886	ALL_TEXT_2/3	2	3	348	LONGTERM|DICTIONARY	apolipoprotein e	apolipoprotein E	52#68		D009157	SYMBOL|EXTRACTED	mg	MG	90#92	20644276-1-11-28	This case-control study, studied the association of apolipoprotein E (Apo-E) alleles with MG. Anti-AChR antibody was measured using radio receptor immunoassay.
20644276	2010	Neurol India	0028-3886	ALL_TEXT_2/3	2	3	348	SYMBOL|()|DICTIONARY|EXTRACTED	apo e	Apo-E	70#75	20644276-3-52-68	D009157	SYMBOL|EXTRACTED	mg	MG	90#92	20644276-1-11-28	This case-control study, studied the association of apolipoprotein E (Apo-E) alleles with MG. Anti-AChR antibody was measured using radio receptor immunoassay.
9361298	1997	Neurobiol. Dis.	0969-9961	ALL_TEXT_3/3	3	5	2705	SYMBOL|DICTIONARY	cx32	Cx32	32#36		D003711	LONGTERM|DICTIONARY	myelin sheath	myelin sheath	136#149	NaN	"This localization suggests that Cx32 forms ""reflexive"" gap junctions that allow ions and small molecules to diffuse directly across the myelin sheath, which is a thousandfold shorter distance than the circumferential pathway through the Schwann cell cytoplasm."
9361298	1997	Neurobiol. Dis.	0969-9961	TITLE	0	0	2705	LONGTERM|DICTIONARY	connexin32	Connexin32	0#10	NaN	C535919	LONGTERM|DISEASE|DT|DICTIONARY	x-linked charcot-marie-tooth disease	X-linked Charcot-Marie-Tooth disease	15#51		Connexin32 and X-linked Charcot-Marie-Tooth disease.
9361298	1997	Neurobiol. Dis.	0969-9961	ALL_TEXT_1/3	1	1	2705	SYMBOL|()|DICTIONARY	cx32	Cx32	47#51		D002607	LONGTERM|DISEASE|DT|DICTIONARY	charcot marie tooth disease	Charcot-Marie-Tooth disease	80#107		Mutations in the gap junction gene connexin32 (Cx32) cause the X-linked form of Charcot-Marie-Tooth disease, an inherited demyelinating neuropathy.
9361298	1997	Neurobiol. Dis.	0969-9961	ALL_TEXT_1/3	1	1	2705	SYMBOL|()|DICTIONARY	cx32	Cx32	47#51		D003711	LONGTERM|DICTIONARY	inherited demyelinating neuropathy	inherited demyelinating neuropathy	112#146		Mutations in the gap junction gene connexin32 (Cx32) cause the X-linked form of Charcot-Marie-Tooth disease, an inherited demyelinating neuropathy.
17223007	2007	Biomed. Pharmacother.	0753-3322	ALL_TEXT_3/3	3	7	4318	SYMBOL|DICTIONARY	mmp 9	MMP-9	36#41		D017544	SYMBOL|DICTIONARY|EXTRACTED	aaa	AAA	76#79	17223007-1-0-25	We therefore found no evidence that MMP-9 is a marker of susceptibility for AAA.
17223007	2007	Biomed. Pharmacother.	0753-3322	ALL_TEXT_2/3	2	4	4318	SYMBOL|GENE|GN|DICTIONARY	mmp 9	MMP-9	121#126		D017544	SYMBOL|DICTIONARY|EXTRACTED	aaa	AAA	167#170	17223007-1-0-25	We evaluated two different polymorphisms, a CA repeat and a cytosine to thymidine transition in the promoter sequence of MMP-9 gene for frequency in 146 patients with AAA.
16168297	2005	J. Am. Coll. Cardiol.	1558-3597	RESULTS	4	8	7450	SYMBOL|EXTRACTED	vwf	vWF	24#27	16168297-1-182-203	D013915	LONGTERM|DICTIONARY	gt	GT	42#44	NaN	During the acute phase, vWF was higher in GT+TT (121.02 +/- 5.47%) versus GG (84.6 +/- 7.1%, p < 0.01), an effect persisting after one year (90.4 +/- 3.8 vs. 73.1 +/- 4.6%, p < 0.01).
17223007	2007	Biomed. Pharmacother.	0753-3322	TITLE	0	0	4318	LONGTERM|GENE|GN|DICTIONARY	matrix metalloproteinase 9	matrix metalloproteinase-9	28#54		D017544	LONGTERM|DICTIONARY	abdominal aortic aneurysm	abdominal aortic aneurysm	91#116		Polymorphic analysis of the matrix metalloproteinase-9 gene and susceptibility to sporadic abdominal aortic aneurysm.
19117570	2009	Atherosclerosis	1879-1484	CONCLUSIONS	4	8	5468	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	pparg	PPARg	48#53	19117570-1-0-9	D054058	SYMBOL|EXTRACTED	acs	ACS	66#69	19117570-3-124-147	The protective role of 93695C>T polymorphism in PPARg promoter in ACS suggests that PPARg genetic variants may affect the susceptibility to atherosclerotic diseases.
19117570	2009	Atherosclerosis	1879-1484	CONCLUSIONS	4	8	5468	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	pparg	PPARg	48#53	19117570-1-0-9	D050197	LONGTERM|DICTIONARY	atherosclerotic diseases	atherosclerotic diseases	140#164		The protective role of 93695C>T polymorphism in PPARg promoter in ACS suggests that PPARg genetic variants may affect the susceptibility to atherosclerotic diseases.
19117570	2009	Atherosclerosis	1879-1484	CONCLUSIONS	4	8	5468	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	pparg	PPARg	84#89	19117570-1-0-9	D054058	SYMBOL|EXTRACTED	acs	ACS	66#69	19117570-3-124-147	The protective role of 93695C>T polymorphism in PPARg promoter in ACS suggests that PPARg genetic variants may affect the susceptibility to atherosclerotic diseases.
19117570	2009	Atherosclerosis	1879-1484	CONCLUSIONS	4	8	5468	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	pparg	PPARg	84#89	19117570-1-0-9	D050197	LONGTERM|DICTIONARY	atherosclerotic diseases	atherosclerotic diseases	140#164		The protective role of 93695C>T polymorphism in PPARg promoter in ACS suggests that PPARg genetic variants may affect the susceptibility to atherosclerotic diseases.
19117570	2009	Atherosclerosis	1879-1484	TITLE	0	0	5468	SYMBOL|GENE|GN|DICTIONARY	ppargamma	PPARgamma	0#9		D054058	LONGTERM|DISEASE|DT|DICTIONARY	acute coronary syndrome	acute coronary syndrome	37#60		PPARgamma promoter polymorphisms and acute coronary syndrome.
19117570	2009	Atherosclerosis	1879-1484	BACKGROUND	1	2	5468	SYMBOL|DICTIONARY|EXTRACTED	pparg	PPARg	4#9	19117570-1-0-9	D002318	LONGTERM|DISEASE|DT|DICTIONARY	cardiovascular disease	cardiovascular disease	91#113		Two PPARg common polymorphisms, Pro12Ala and 161C>T, have been found to be associated with cardiovascular disease.
19117570	2009	Atherosclerosis	1879-1484	BACKGROUND	1	3	5468	SYMBOL|DICTIONARY|EXTRACTED	pparg	PPARg	30#35	19117570-1-0-9	D054058	LONGTERM|DISEASE|DT|DICTIONARY	acute coronary syndrome	acute coronary syndrome	124#147		In this study, in addition to PPARg coding region, we looked for genetic variations in promoters and their association with acute coronary syndrome (ACS).
19117570	2009	Atherosclerosis	1879-1484	BACKGROUND	1	3	5468	SYMBOL|DICTIONARY|EXTRACTED	pparg	PPARg	30#35	19117570-1-0-9	D054058	SYMBOL|EXTRACTED|()	acs	ACS	149#152	19117570-3-124-147	In this study, in addition to PPARg coding region, we looked for genetic variations in promoters and their association with acute coronary syndrome (ACS).
9886312	1999	Br. J. Haematol.	0007-1048	ALL_TEXT_2/3	2	4	2815	SYMBOL|DICTIONARY	gpix	GPIX	156#160		D006470	LONGTERM|DICTIONARY	bleeding	bleeding	112#120		Allele-specific restriction enzyme analysis showed that the propositus and one of his sisters. both with severe bleeding diathesis. were homozygous for the GPIX mutation: the members of the family with mild bleeding diathesis and/or giant platelets in the peripheral blood were heterozygous, whereas the healthy ones were homozygous for the normal allele.
9886312	1999	Br. J. Haematol.	0007-1048	ALL_TEXT_2/3	2	4	2815	SYMBOL|DICTIONARY	gpix	GPIX	156#160		D006470	LONGTERM|DICTIONARY	bleeding	bleeding	207#215		Allele-specific restriction enzyme analysis showed that the propositus and one of his sisters. both with severe bleeding diathesis. were homozygous for the GPIX mutation: the members of the family with mild bleeding diathesis and/or giant platelets in the peripheral blood were heterozygous, whereas the healthy ones were homozygous for the normal allele.
18922928	2008	Cancer Res.	1538-7445	ALL_TEXT_1/3	1	3	3845	SYMBOL|NUMBER|DICTIONARY	kras	KRAS	279#283		D002289	LONGTERM|DISEASE|DT|DICTIONARY	non small cell lung cancer	non-small cell lung cancer	189#215		The purpose of this study was to identify single nucleotide polymorphisms (SNP) that could modify let-7 binding and to assess the effect of such SNPs on target gene regulation and risk for non-small cell lung cancer (NSCLC). let-7 complementary sites (LCS) were sequenced in the KRAS 3' untranslated region from 74 NSCLC cases to identify mutations and SNPs that correlated with NSCLC.
18922928	2008	Cancer Res.	1538-7445	ALL_TEXT_1/3	1	3	3845	SYMBOL|NUMBER|DICTIONARY	kras	KRAS	279#283		D002289	LONGTERM|()|DICTIONARY|EXTRACTED	nsclc	NSCLC	217#222	18922928-3-189-215	The purpose of this study was to identify single nucleotide polymorphisms (SNP) that could modify let-7 binding and to assess the effect of such SNPs on target gene regulation and risk for non-small cell lung cancer (NSCLC). let-7 complementary sites (LCS) were sequenced in the KRAS 3' untranslated region from 74 NSCLC cases to identify mutations and SNPs that correlated with NSCLC.
18922928	2008	Cancer Res.	1538-7445	ALL_TEXT_1/3	1	3	3845	SYMBOL|NUMBER|DICTIONARY	kras	KRAS	279#283		D002289	LONGTERM|DICTIONARY|EXTRACTED	nsclc	NSCLC	315#320	18922928-3-189-215	The purpose of this study was to identify single nucleotide polymorphisms (SNP) that could modify let-7 binding and to assess the effect of such SNPs on target gene regulation and risk for non-small cell lung cancer (NSCLC). let-7 complementary sites (LCS) were sequenced in the KRAS 3' untranslated region from 74 NSCLC cases to identify mutations and SNPs that correlated with NSCLC.
18922928	2008	Cancer Res.	1538-7445	ALL_TEXT_1/3	1	3	3845	SYMBOL|NUMBER|DICTIONARY	kras	KRAS	279#283		D002289	LONGTERM|DICTIONARY|EXTRACTED	nsclc	NSCLC	379#384	18922928-3-189-215	The purpose of this study was to identify single nucleotide polymorphisms (SNP) that could modify let-7 binding and to assess the effect of such SNPs on target gene regulation and risk for non-small cell lung cancer (NSCLC). let-7 complementary sites (LCS) were sequenced in the KRAS 3' untranslated region from 74 NSCLC cases to identify mutations and SNPs that correlated with NSCLC.
18922928	2008	Cancer Res.	1538-7445	TITLE	0	0	3845	SYMBOL|NUMBER|DICTIONARY	kras	KRAS	52#56		D002289	LONGTERM|DISEASE|DT|DICTIONARY	non small cell lung cancer	non-small cell lung cancer	90#116		A SNP in a let-7 microRNA complementary site in the KRAS 3' untranslated region increases non-small cell lung cancer risk.
14521605	2004	J. Thromb. Haemost.	1538-7933	TITLE	0	0	2811	LONGTERM|DICTIONARY	glycoprotein ibalpha	glycoprotein Ibalpha	53#73	NaN	C536458	LONGTERM|DISEASE|DT|DICTIONARY	platelet type von willebrand disease	platelet-type von Willebrand disease	128#164		Identification of a novel point mutation in platelet glycoprotein Ibalpha, Gly to Ser at residue 233, in a Japanese family with platelet-type von Willebrand disease.
19360657	2009	Autism Res	1939-3806	ALL_TEXT_1/3	1	2	6505	SYMBOL|DICTIONARY	slc1a1	SLC1A1	243#249		D009771	LONGTERM|DICTIONARY	obsessions	obsessions	16#26		The presence of obsessions and compulsions similar to OCD in autism, the identification of this region in a genome-wide linkage analysis of individuals with autism spectrum disorders (ASDs), and the hypothesized role of glutamate in ASDs make SLC1A1 a candidate gene for ASD as well.
19360657	2009	Autism Res	1939-3806	ALL_TEXT_1/3	1	2	6505	SYMBOL|DICTIONARY	slc1a1	SLC1A1	243#249		D009771	SYMBOL|DICTIONARY|EXTRACTED	ocd	OCD	54#57	19360657-1-149-178	The presence of obsessions and compulsions similar to OCD in autism, the identification of this region in a genome-wide linkage analysis of individuals with autism spectrum disorders (ASDs), and the hypothesized role of glutamate in ASDs make SLC1A1 a candidate gene for ASD as well.
19360657	2009	Autism Res	1939-3806	ALL_TEXT_1/3	1	2	6505	SYMBOL|DICTIONARY	slc1a1	SLC1A1	243#249		D001321	LONGTERM|DICTIONARY	autism	autism	61#67		The presence of obsessions and compulsions similar to OCD in autism, the identification of this region in a genome-wide linkage analysis of individuals with autism spectrum disorders (ASDs), and the hypothesized role of glutamate in ASDs make SLC1A1 a candidate gene for ASD as well.
19360657	2009	Autism Res	1939-3806	ALL_TEXT_1/3	1	2	6505	SYMBOL|DICTIONARY	slc1a1	SLC1A1	243#249		D002659	LONGTERM|DICTIONARY	autism spectrum disorders	autism spectrum disorders	157#182		The presence of obsessions and compulsions similar to OCD in autism, the identification of this region in a genome-wide linkage analysis of individuals with autism spectrum disorders (ASDs), and the hypothesized role of glutamate in ASDs make SLC1A1 a candidate gene for ASD as well.
19360657	2009	Autism Res	1939-3806	ALL_TEXT_1/3	1	2	6505	SYMBOL|DICTIONARY	slc1a1	SLC1A1	243#249		D001321	SYMBOL|PLURAL|()|DICTIONARY|EXTRACTED	asd	ASD	184#187	19360657-2-157-182	The presence of obsessions and compulsions similar to OCD in autism, the identification of this region in a genome-wide linkage analysis of individuals with autism spectrum disorders (ASDs), and the hypothesized role of glutamate in ASDs make SLC1A1 a candidate gene for ASD as well.
19360657	2009	Autism Res	1939-3806	ALL_TEXT_1/3	1	2	6505	SYMBOL|DICTIONARY	slc1a1	SLC1A1	243#249		D001321	SYMBOL|PLURAL|DICTIONARY|EXTRACTED	asd	ASD	233#236	19360657-2-157-182	The presence of obsessions and compulsions similar to OCD in autism, the identification of this region in a genome-wide linkage analysis of individuals with autism spectrum disorders (ASDs), and the hypothesized role of glutamate in ASDs make SLC1A1 a candidate gene for ASD as well.
19360657	2009	Autism Res	1939-3806	ALL_TEXT_1/3	1	2	6505	SYMBOL|DICTIONARY	slc1a1	SLC1A1	243#249		D001321	SYMBOL|DICTIONARY|EXTRACTED	asd	ASD	271#274	19360657-2-157-182	The presence of obsessions and compulsions similar to OCD in autism, the identification of this region in a genome-wide linkage analysis of individuals with autism spectrum disorders (ASDs), and the hypothesized role of glutamate in ASDs make SLC1A1 a candidate gene for ASD as well.
19360657	2009	Autism Res	1939-3806	ALL_TEXT_1/3	1	3	6505	SYMBOL|DICTIONARY	slc1a1	SLC1A1	32#38		D001321	LONGTERM|DICTIONARY	autism	autism	43#49		To test for association between SLC1A1 and autism, we typed three single nucleotide polymorphisms (SNPs, rs301430, rs301979, rs301434) previously associated with OCD in 86 strictly defined trios with autism.
19360657	2009	Autism Res	1939-3806	ALL_TEXT_1/3	1	3	6505	SYMBOL|DICTIONARY	slc1a1	SLC1A1	32#38		D009771	SYMBOL|DICTIONARY|EXTRACTED	ocd	OCD	162#165	19360657-1-149-178	To test for association between SLC1A1 and autism, we typed three single nucleotide polymorphisms (SNPs, rs301430, rs301979, rs301434) previously associated with OCD in 86 strictly defined trios with autism.
19360657	2009	Autism Res	1939-3806	ALL_TEXT_1/3	1	3	6505	SYMBOL|DICTIONARY	slc1a1	SLC1A1	32#38		D001321	LONGTERM|DICTIONARY	autism	autism	200#206		To test for association between SLC1A1 and autism, we typed three single nucleotide polymorphisms (SNPs, rs301430, rs301979, rs301434) previously associated with OCD in 86 strictly defined trios with autism.
12963757	2004	Neurology	1526-632X	OBJECTIVE	1	1	348	SYMBOL|DICTIONARY	apoe	APOE	29#33		D000544	LONGTERM|DISEASE|DT|DICTIONARY	alzheimer disease	Alzheimer's disease	93#112		To study the hypotheses that APOE-epsilon4 allele may interact with blood pressure to affect Alzheimer's disease (AD) occurrence and that antihypertensive therapy could modify such an effect.
12963757	2004	Neurology	1526-632X	OBJECTIVE	1	1	348	SYMBOL|DICTIONARY	apoe	APOE	29#33		D000544	SYMBOL|EXTRACTED|()	ad	AD	114#116	12963757-1-93-112	To study the hypotheses that APOE-epsilon4 allele may interact with blood pressure to affect Alzheimer's disease (AD) occurrence and that antihypertensive therapy could modify such an effect.
12963757	2004	Neurology	1526-632X	RESULTS	3	7	348	SYMBOL|DICTIONARY	apoe	APOE	76#80		D000544	SYMBOL|EXTRACTED	ad	AD	59#61	12963757-1-93-112	Antihypertensive therapy significantly reduced the risk of AD regardless of APOE-epsilon4 status and counteracted the combined risk effect of the epsilon4 allele with high systolic pressure on the disease.
12963757	2004	Neurology	1526-632X	RESULTS	3	6	348	SYMBOL|DICTIONARY	apoe	APOE	0#4		D000544	SYMBOL|EXTRACTED	ad	AD	88#90	12963757-1-93-112	APOE-epsilon4 allele combined with low diastolic pressure greatly increased the risk of AD independent of antihypertensive drug use.
12963757	2004	Neurology	1526-632X	RESULTS	3	5	348	SYMBOL|DICTIONARY	apoe	APOE	0#4		D000544	SYMBOL|EXTRACTED	ad	AD	146#148	12963757-1-93-112	APOE-epsilon4 allele, high systolic pressure (> or = 140 mm Hg), and low diastolic pressure (<70 mm Hg) were associated with an increased risk of AD.
1976809	1990	J. Rheumatol.	0315-162X	ALL_TEXT_3/3	3	5	720	LONGTERM|DICTIONARY	c4a	C4A	52#55	NaN	D008180	SYMBOL|DICTIONARY|EXTRACTED	sle	SLE	103#106	1976809-1-73-101	Our results showed that the frequency of phenotypic C4A deficiency was 44.1% in Japanese patients with SLE and this value was comparable with that (43.2%) in Caucasian patients.
10889552	2000	Mol. Psychiatry	1359-4184	TITLE	0	0	1544	LONGTERM|DICTIONARY|GENE|GA	cytochrome p450 1a2	cytochrome P450 1A2	33#52		D004409	LONGTERM|DICTIONARY	tardive dyskinesia	tardive dyskinesia	85#103		A functional polymorphism of the cytochrome P450 1A2 (CYP1A2) gene: association with tardive dyskinesia in schizophrenia.
10889552	2000	Mol. Psychiatry	1359-4184	TITLE	0	0	1544	LONGTERM|DICTIONARY|GENE|GA	cytochrome p450 1a2	cytochrome P450 1A2	33#52		D012559	LONGTERM|DICTIONARY	schizophrenia	schizophrenia	107#120		A functional polymorphism of the cytochrome P450 1A2 (CYP1A2) gene: association with tardive dyskinesia in schizophrenia.
10889552	2000	Mol. Psychiatry	1359-4184	TITLE	0	0	1544	SYMBOL|()|GENE|GN|DICTIONARY|EXTRACTED	cyp1a2	CYP1A2	54#60	10889552-0-33-52	D004409	LONGTERM|DICTIONARY	tardive dyskinesia	tardive dyskinesia	85#103		A functional polymorphism of the cytochrome P450 1A2 (CYP1A2) gene: association with tardive dyskinesia in schizophrenia.
10889552	2000	Mol. Psychiatry	1359-4184	TITLE	0	0	1544	SYMBOL|()|GENE|GN|DICTIONARY|EXTRACTED	cyp1a2	CYP1A2	54#60	10889552-0-33-52	D012559	LONGTERM|DICTIONARY	schizophrenia	schizophrenia	107#120		A functional polymorphism of the cytochrome P450 1A2 (CYP1A2) gene: association with tardive dyskinesia in schizophrenia.
12800193	2003	Int. J. Cancer	0020-7136	TITLE	0	0	1499	SYMBOL|GENE|GN|DICTIONARY	beta catenin	beta-catenin	82#94		D003110	LONGTERM|DISEASE|DT|CLINE|CN|DICTIONARY	colon carcinoma	colon carcinoma	30#45		Expression profiling of CC531 colon carcinoma cells reveals similar regulation of beta-catenin target genes by both butyrate and aspirin.
10889552	2000	Mol. Psychiatry	1359-4184	ALL_TEXT_2/3	2	6	1544	SYMBOL|DICTIONARY|EXTRACTED	cyp1a2	CYP1A2	89#95	10889552-0-33-52	D004409	SYMBOL|EXTRACTED	td	TD	111#113	10889552-1-0-18	The aim of this study was to test the clinical importance of the (C-->A) polymorphism in CYP1A2 in relation to TD severity.
15258326	2004	Dis. Markers	0278-0240	ALL_TEXT_2/3	2	4	2952	SYMBOL|DICTIONARY	gstt1	GSTT1	104#109		D008175	LONGTERM|DISEASE|DT|DICTIONARY	increased lung cancer	increased lung cancer	52#73		Comparisons between groups showed that there was an increased lung cancer risk for individuals with the GSTT1 null genotype.
15258326	2004	Dis. Markers	0278-0240	ALL_TEXT_2/3	2	3	2952	SYMBOL|GENE|GN|DICTIONARY	gstt1	GSTT1	31#36		D008175	LONGTERM|DISEASE|DN|DT|DICTIONARY	lung cancer	lung cancer	167#178		We studied the distribution of GSTT1 gene deletion in peripheral blood DNA samples from 178 healthy controls (41 nonsmokers, 63 passive smokers and 74 smokers) and 52 lung cancer patients.
12373604	2002	Br. J. Cancer	0007-0920	ALL_TEXT_3/3	3	8	675	SYMBOL|GENE|GN|DICTIONARY	brca2	BRCA2	25#30		D009369	LONGTERM|DISEASE|DT|DICTIONARY	stomach cancer	stomach cancer	124#138		Our results confirm that BRCA2 gene mutations are also associated with familial aggregations of not only breast but also of stomach cancer.
15258326	2004	Dis. Markers	0278-0240	TITLE	0	0	2952	SYMBOL|GENE|GN|DICTIONARY	gstt1	GSTT1	0#5		D008175	LONGTERM|DISEASE|DT|DICTIONARY	lung cancer	lung cancer	39#50		GSTT1 gene deletion is associated with lung cancer in Mexican patients.
12373604	2002	Br. J. Cancer	0007-0920	ALL_TEXT_2/3	2	5	675	SYMBOL|GENE|GN|DICTIONARY	brca2	BRCA2	37#42		D001943	LONGTERM|DISEASE|DN|DT|DICTIONARY	breast cancer	breast cancer	54#67		We analysed by direct sequencing the BRCA2 gene in 29 breast cancer patients derived from 29 families with an aggregation of at least one female breast cancer diagnosed before the age of 50 years and one male stomach cancer diagnosed before the age of 55 years.
12373604	2002	Br. J. Cancer	0007-0920	ALL_TEXT_2/3	2	5	675	SYMBOL|GENE|GN|DICTIONARY	brca2	BRCA2	37#42		D009369	LONGTERM|DISEASE|DT|DICTIONARY	stomach cancer	stomach cancer	209#223		We analysed by direct sequencing the BRCA2 gene in 29 breast cancer patients derived from 29 families with an aggregation of at least one female breast cancer diagnosed before the age of 50 years and one male stomach cancer diagnosed before the age of 55 years.
12373604	2002	Br. J. Cancer	0007-0920	ALL_TEXT_2/3	2	5	675	SYMBOL|GENE|GN|DICTIONARY	brca2	BRCA2	37#42		D001943	LONGTERM|DISEASE|DT|DICTIONARY	breast cancer	breast cancer	145#158		We analysed by direct sequencing the BRCA2 gene in 29 breast cancer patients derived from 29 families with an aggregation of at least one female breast cancer diagnosed before the age of 50 years and one male stomach cancer diagnosed before the age of 55 years.
12373604	2002	Br. J. Cancer	0007-0920	ALL_TEXT_2/3	2	4	675	SYMBOL|GENE|GN|DICTIONARY	brca2	BRCA2	98#103		D009369	LONGTERM|DISEASE|DT|DICTIONARY	stomach cancer	stomach cancer	53#67		Recently, it has been reported that the incidence of stomach cancer is significantly increased in BRCA2 gene mutation carriers.
12373604	2002	Br. J. Cancer	0007-0920	TITLE	0	0	675	SYMBOL|GENE|GN|DICTIONARY	brca2	BRCA2	0#5		D001943	LONGTERM|DICTIONARY	breast and stomach cancers	breast and stomach cancers	54#80		BRCA2 gene mutations in families with aggregations of breast and stomach cancers.
19237575	2009	Proc. Natl. Acad. Sci. U.S.A.	1091-6490	ALL_TEXT_3/3	3	5	965	SYMBOL|DICTIONARY	cd58	CD58	35#39		D009103	SYMBOL|EXTRACTED	ms	MS	101#103	19237575-1-0-18	This protective effect of enhanced CD58 expression on circulating mononuclear cells in patients with MS is supported by finding that CD58 mRNA expression is higher in MS subjects during clinical remission.
19237575	2009	Proc. Natl. Acad. Sci. U.S.A.	1091-6490	ALL_TEXT_3/3	3	5	965	SYMBOL|DICTIONARY	cd58	CD58	35#39		D009103	SYMBOL|EXTRACTED	ms	MS	167#169	19237575-1-0-18	This protective effect of enhanced CD58 expression on circulating mononuclear cells in patients with MS is supported by finding that CD58 mRNA expression is higher in MS subjects during clinical remission.
19237575	2009	Proc. Natl. Acad. Sci. U.S.A.	1091-6490	ALL_TEXT_3/3	3	5	965	SYMBOL|GFAM|FN|DICTIONARY	cd58	CD58	133#137		D009103	SYMBOL|EXTRACTED	ms	MS	101#103	19237575-1-0-18	This protective effect of enhanced CD58 expression on circulating mononuclear cells in patients with MS is supported by finding that CD58 mRNA expression is higher in MS subjects during clinical remission.
19237575	2009	Proc. Natl. Acad. Sci. U.S.A.	1091-6490	ALL_TEXT_3/3	3	5	965	SYMBOL|GFAM|FN|DICTIONARY	cd58	CD58	133#137		D009103	SYMBOL|EXTRACTED	ms	MS	167#169	19237575-1-0-18	This protective effect of enhanced CD58 expression on circulating mononuclear cells in patients with MS is supported by finding that CD58 mRNA expression is higher in MS subjects during clinical remission.
12373604	2002	Br. J. Cancer	0007-0920	ALL_TEXT_1/3	1	2	999	SYMBOL|GENE|GN|DICTIONARY	e cadherin	E-cadherin	142#152		D013274	LONGTERM|DISEASE|DT|DICTIONARY	hereditary diffuse gastric carcinoma	hereditary diffuse gastric carcinoma	62#98		It is estimated that 25% of families meeting the criteria for hereditary diffuse gastric carcinoma (HDCG) will have germline mutations in the E-cadherin gene.
16230376	2005	Cancer Res.	0008-5472	ALL_TEXT_3/3	3	7	7039	LONGTERM|DICTIONARY|EXTRACTED	tgf alpha	TGF-alpha	79#88	16230376-1-33-65	D002289	LONGTERM|DISEASE|DN|DICTIONARY|EXTRACTED	nsclc	NSCLC	122#127	16230376-1-146-172	Multivariate analysis showed an independent association between positivity for TGF-alpha and shorter survival times among NSCLC patients treated with gefitinib (P = 0.034).
20674764	2011	Microbes Infect.	1769-714X	ALL_TEXT_3/3	3	11	51311	SYMBOL|DICTIONARY	tlr8	TLR8	26#30		D006479	SYMBOL|EXTRACTED|DISEASE|DN	cchf disease	CCHF disease	122#134	20674764-1-8-31	Our findings suggest that TLR8 Met1Val, TLR8 -129C/G, and TLR9 -1486T/C polymorphisms are important on clinical course of CCHF disease.
20674764	2011	Microbes Infect.	1769-714X	ALL_TEXT_3/3	3	11	51311	SYMBOL|DICTIONARY	tlr8	TLR8	40#44		D006479	SYMBOL|EXTRACTED|DISEASE|DN	cchf disease	CCHF disease	122#134	20674764-1-8-31	Our findings suggest that TLR8 Met1Val, TLR8 -129C/G, and TLR9 -1486T/C polymorphisms are important on clinical course of CCHF disease.
20674764	2011	Microbes Infect.	1769-714X	ALL_TEXT_3/3	3	11	54106	SYMBOL|DICTIONARY	tlr9	TLR9	58#62		D006479	SYMBOL|EXTRACTED|DISEASE|DN	cchf disease	CCHF disease	122#134	20674764-1-8-31	Our findings suggest that TLR8 Met1Val, TLR8 -129C/G, and TLR9 -1486T/C polymorphisms are important on clinical course of CCHF disease.
1976809	1990	J. Rheumatol.	0315-162X	ALL_TEXT_3/3	3	6	720	SYMBOL|GENE|GN|DICTIONARY	c4a	C4A	34#37		D008180	SYMBOL|DICTIONARY|EXTRACTED	sle	SLE	83#86	1976809-1-73-101	On the other hand the deletion of C4A gene was not found in Japanese patients with SLE (0%), or in healthy controls (0.6%).
16230376	2005	Cancer Res.	0008-5472	ALL_TEXT_1/3	1	1	374	LONGTERM|DICTIONARY	amphiregulin	amphiregulin	16#28		D002289	LONGTERM|DISEASE|DT|DICTIONARY	non small cell lung cancer	non-small cell lung cancer	146#172		Serum levels of amphiregulin and transforming growth factor-alpha (TGF-alpha), which were identified previously to be expressed at high levels in non-small cell lung cancer (NSCLC) with poor response to gefitinib, were examined by ELISA using blood samples taken from 50 patients with advanced NSCLCs.
16230376	2005	Cancer Res.	0008-5472	ALL_TEXT_1/3	1	1	374	LONGTERM|DICTIONARY	amphiregulin	amphiregulin	16#28		D002289	LONGTERM|()|DICTIONARY|EXTRACTED	nsclc	NSCLC	174#179	16230376-1-146-172	Serum levels of amphiregulin and transforming growth factor-alpha (TGF-alpha), which were identified previously to be expressed at high levels in non-small cell lung cancer (NSCLC) with poor response to gefitinib, were examined by ELISA using blood samples taken from 50 patients with advanced NSCLCs.
16230376	2005	Cancer Res.	0008-5472	ALL_TEXT_1/3	1	1	374	LONGTERM|DICTIONARY	amphiregulin	amphiregulin	16#28		D002289	LONGTERM|DICTIONARY|EXTRACTED|PLURAL	nsclc	NSCLC	294#299	16230376-1-146-172	Serum levels of amphiregulin and transforming growth factor-alpha (TGF-alpha), which were identified previously to be expressed at high levels in non-small cell lung cancer (NSCLC) with poor response to gefitinib, were examined by ELISA using blood samples taken from 50 patients with advanced NSCLCs.
16230376	2005	Cancer Res.	0008-5472	ALL_TEXT_1/3	1	1	7124	LONGTERM|DICTIONARY	transforming growth factor alpha	transforming growth factor-alpha	33#65		D002289	LONGTERM|DISEASE|DT|DICTIONARY	non small cell lung cancer	non-small cell lung cancer	146#172		Serum levels of amphiregulin and transforming growth factor-alpha (TGF-alpha), which were identified previously to be expressed at high levels in non-small cell lung cancer (NSCLC) with poor response to gefitinib, were examined by ELISA using blood samples taken from 50 patients with advanced NSCLCs.
16230376	2005	Cancer Res.	0008-5472	ALL_TEXT_1/3	1	1	7124	LONGTERM|DICTIONARY	transforming growth factor alpha	transforming growth factor-alpha	33#65		D002289	LONGTERM|()|DICTIONARY|EXTRACTED	nsclc	NSCLC	174#179	16230376-1-146-172	Serum levels of amphiregulin and transforming growth factor-alpha (TGF-alpha), which were identified previously to be expressed at high levels in non-small cell lung cancer (NSCLC) with poor response to gefitinib, were examined by ELISA using blood samples taken from 50 patients with advanced NSCLCs.
16230376	2005	Cancer Res.	0008-5472	ALL_TEXT_1/3	1	1	7124	LONGTERM|DICTIONARY	transforming growth factor alpha	transforming growth factor-alpha	33#65		D002289	LONGTERM|DICTIONARY|EXTRACTED|PLURAL	nsclc	NSCLC	294#299	16230376-1-146-172	Serum levels of amphiregulin and transforming growth factor-alpha (TGF-alpha), which were identified previously to be expressed at high levels in non-small cell lung cancer (NSCLC) with poor response to gefitinib, were examined by ELISA using blood samples taken from 50 patients with advanced NSCLCs.
16230376	2005	Cancer Res.	0008-5472	ALL_TEXT_1/3	1	1	7039	LONGTERM|()|DICTIONARY|EXTRACTED	tgf alpha	TGF-alpha	67#76	16230376-1-33-65	D002289	LONGTERM|DISEASE|DT|DICTIONARY	non small cell lung cancer	non-small cell lung cancer	146#172		Serum levels of amphiregulin and transforming growth factor-alpha (TGF-alpha), which were identified previously to be expressed at high levels in non-small cell lung cancer (NSCLC) with poor response to gefitinib, were examined by ELISA using blood samples taken from 50 patients with advanced NSCLCs.
16230376	2005	Cancer Res.	0008-5472	ALL_TEXT_1/3	1	1	7039	LONGTERM|()|DICTIONARY|EXTRACTED	tgf alpha	TGF-alpha	67#76	16230376-1-33-65	D002289	LONGTERM|()|DICTIONARY|EXTRACTED	nsclc	NSCLC	174#179	16230376-1-146-172	Serum levels of amphiregulin and transforming growth factor-alpha (TGF-alpha), which were identified previously to be expressed at high levels in non-small cell lung cancer (NSCLC) with poor response to gefitinib, were examined by ELISA using blood samples taken from 50 patients with advanced NSCLCs.
16230376	2005	Cancer Res.	0008-5472	ALL_TEXT_1/3	1	1	7039	LONGTERM|()|DICTIONARY|EXTRACTED	tgf alpha	TGF-alpha	67#76	16230376-1-33-65	D002289	LONGTERM|DICTIONARY|EXTRACTED|PLURAL	nsclc	NSCLC	294#299	16230376-1-146-172	Serum levels of amphiregulin and transforming growth factor-alpha (TGF-alpha), which were identified previously to be expressed at high levels in non-small cell lung cancer (NSCLC) with poor response to gefitinib, were examined by ELISA using blood samples taken from 50 patients with advanced NSCLCs.
18281036	2009	Fertil. Steril.	1556-5653	TITLE	0	0	367	LONGTERM|GENE|GN|GT|DICTIONARY	androgen receptor	androgen receptor	30#47		D016649	LONGTERM|DICTIONARY	premature ovarian failure	Premature ovarian failure	0#25		Premature ovarian failure and androgen receptor gene CAG repeat lengths weighted by X chromosome inactivation patterns.
17095747	2007	Am. J. Respir. Crit. Care Med.	1073-449X	TITLE	0	0	5027	SYMBOL|GENE|GN|DICTIONARY	p2x7	P2X7	22#26		D014376	LONGTERM|DICTIONARY	extrapulmonary tuberculosis	extrapulmonary tuberculosis	60#87		A polymorphism in the P2X7 gene increases susceptibility to extrapulmonary tuberculosis.
9047388	1997	Oncogene	0950-9232	ALL_TEXT_2/3	2	6	1029	SYMBOL|DICTIONARY	p16	p16	47#50		D009369	LONGTERM|DICTIONARY	tumors	tumors	6#12		Seven tumors (of 29, 24%) had an alteration of p16 and p53; five (of 33, 15%) had alterations of p16 and PRAD-1; three (of 29, 10%) had alterations of all three genes.
9047388	1997	Oncogene	0950-9232	ALL_TEXT_2/3	2	6	1029	SYMBOL|DICTIONARY	p16	p16	97#100		D009369	LONGTERM|DICTIONARY	tumors	tumors	6#12		Seven tumors (of 29, 24%) had an alteration of p16 and p53; five (of 33, 15%) had alterations of p16 and PRAD-1; three (of 29, 10%) had alterations of all three genes.
9047388	1997	Oncogene	0950-9232	ALL_TEXT_2/3	2	6	595	SYMBOL|DICTIONARY	prad 1	PRAD-1	105#111		D009369	LONGTERM|DICTIONARY	tumors	tumors	6#12		Seven tumors (of 29, 24%) had an alteration of p16 and p53; five (of 33, 15%) had alterations of p16 and PRAD-1; three (of 29, 10%) had alterations of all three genes.
9047388	1997	Oncogene	0950-9232	ALL_TEXT_2/3	2	6	7157	LONGTERM|DICTIONARY	p53	p53	55#58	NaN	D009369	LONGTERM|DICTIONARY	tumors	tumors	6#12		Seven tumors (of 29, 24%) had an alteration of p16 and p53; five (of 33, 15%) had alterations of p16 and PRAD-1; three (of 29, 10%) had alterations of all three genes.
17095747	2007	Am. J. Respir. Crit. Care Med.	1073-449X	OBJECTIVE	2	5	5027	LONGTERM|DICTIONARY	p2x(7)	P2X(7)	143#149	NaN	D014376	SYMBOL|EXTRACTED	tb	TB	53#55	17095747-1-56-68	The association of these polymorphisms with clinical TB was subsequently investigated in two separate case-control cohorts and the function of P2X(7) was assessed in subjects from one cohort.
17095747	2007	Am. J. Respir. Crit. Care Med.	1073-449X	OBJECTIVE	2	4	5027	SYMBOL|DICTIONARY	p2x7	P2X7	33#37		D014376	SYMBOL|EXTRACTED	tb	TB	76#78	17095747-1-56-68	To determine if polymorphisms in P2X7 are associated with increased risk of TB, the prevalence of four polymorphisms was assessed in individuals from Southeast Asia, where the majority of patients with TB in our study originate.
17095747	2007	Am. J. Respir. Crit. Care Med.	1073-449X	OBJECTIVE	2	4	5027	SYMBOL|DICTIONARY	p2x7	P2X7	33#37		D014376	SYMBOL|EXTRACTED	tb	TB	202#204	17095747-1-56-68	To determine if polymorphisms in P2X7 are associated with increased risk of TB, the prevalence of four polymorphisms was assessed in individuals from Southeast Asia, where the majority of patients with TB in our study originate.
18565259	2008	Clin. Exp. Rheumatol.	0392-856X	TITLE	0	0	7133	SYMBOL|DICTIONARY	tnfrsf1b	TNFRSF1B	30#38		D001172	LONGTERM|DISEASE|DN|DICTIONARY	rheumatoid arthritis	rheumatoid arthritis	72#92		Influence of FCGR3A-V212F and TNFRSF1B-M196R genotypes in patients with rheumatoid arthritis treated with infliximab therapy.
18565259	2008	Clin. Exp. Rheumatol.	0392-856X	TITLE	0	0	2214	SYMBOL|DICTIONARY	fcgr3a-v212f	FCGR3A-V212F	13#25		D001172	LONGTERM|DISEASE|DN|DICTIONARY	rheumatoid arthritis	rheumatoid arthritis	72#92		Influence of FCGR3A-V212F and TNFRSF1B-M196R genotypes in patients with rheumatoid arthritis treated with infliximab therapy.
18565259	2008	Clin. Exp. Rheumatol.	0392-856X	OBJECTIVE	1	3	2214	SYMBOL|DICTIONARY	fcgr3a	FCGR3A	107#113		D001172	LONGTERM|DICTIONARY	rheumatoid arthritis	rheumatoid arthritis	162#182		The aim of this study is to determine whether two functional single-nucleotide polymorphisms, V212F in the FCGR3A, and M196R in the TNFRSF1B genes correlate with rheumatoid arthritis susceptibility and response to anti-TNF-alpha therapy.
18565259	2008	Clin. Exp. Rheumatol.	0392-856X	OBJECTIVE	1	3	7133	SYMBOL|GENE|GN|DICTIONARY	tnfrsf1b	TNFRSF1B	132#140		D001172	LONGTERM|DICTIONARY	rheumatoid arthritis	rheumatoid arthritis	162#182		The aim of this study is to determine whether two functional single-nucleotide polymorphisms, V212F in the FCGR3A, and M196R in the TNFRSF1B genes correlate with rheumatoid arthritis susceptibility and response to anti-TNF-alpha therapy.
18565259	2008	Clin. Exp. Rheumatol.	0392-856X	OBJECTIVE	1	3	7124	LONGTERM|DICTIONARY	tnf-alpha	TNF-alpha	219#228	NaN	D001172	LONGTERM|DICTIONARY	rheumatoid arthritis	rheumatoid arthritis	162#182		The aim of this study is to determine whether two functional single-nucleotide polymorphisms, V212F in the FCGR3A, and M196R in the TNFRSF1B genes correlate with rheumatoid arthritis susceptibility and response to anti-TNF-alpha therapy.
10213916	1999	Neuroimmunomodulation	1021-7401	ALL_TEXT_2/3	2	6	7349	LONGTERM|DICTIONARY	urocortin	urocortin	47#56		D007022	LONGTERM|DICTIONARY	hypotension	hypotension	82#93	NaN	Therefore, we examined the parallel effects of urocortin- and hydralazine-induced hypotension on acute inflammation induced by carrageenin in the rat.
10213916	1999	Neuroimmunomodulation	1021-7401	ALL_TEXT_2/3	2	6	7349	LONGTERM|DICTIONARY	urocortin	urocortin	47#56		D007249	LONGTERM|DICTIONARY	inflammation	inflammation	103#115	NaN	Therefore, we examined the parallel effects of urocortin- and hydralazine-induced hypotension on acute inflammation induced by carrageenin in the rat.
20683028	2010	Anticancer Res.	1791-7530	TITLE	0	0	1545	SYMBOL|DICTIONARY|EXTRACTED	cyp1b1	CYP1B1	19#25		D001943	LONGTERM|DISEASE|DT|DICTIONARY	breast cancer	breast cancer	117#130		Combined effect of CYP1B1 codon 432 polymorphism and N-acetyltransferase 2 slow acetylator phenotypes in relation to breast cancer in the Turkish population.
20683028	2010	Anticancer Res.	1791-7530	TITLE	0	0	10	LONGTERM|DICTIONARY	n acetyltransferase 2	N-acetyltransferase 2	53#74		D001943	LONGTERM|DISEASE|DT|DICTIONARY	breast cancer	breast cancer	117#130		Combined effect of CYP1B1 codon 432 polymorphism and N-acetyltransferase 2 slow acetylator phenotypes in relation to breast cancer in the Turkish population.
10508521	1999	Nat. Genet.	1061-4036	ALL_TEXT_3/3	3	7	23418	SYMBOL|DICTIONARY	crb1	CRB1	206#210		D012174	SYMBOL|DISEASE|DN|DICTIONARY|EXTRACTED	rp	RP	17#19	10508521-1-0-20	In ten unrelated RP patients with preserved para-arteriolar RPE, we identified a homozygous AluY insertion disrupting the ORF, five homozygous missense mutations and four compound heterozygous mutations in CRB1.
15201134	2004	Am. J. Respir. Crit. Care Med.	1073-449X	ALL_TEXT_3/3	3	8	81793	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	tlr10	TLR10	125#130	15201134-1-0-21	D001249	LONGTERM|DICTIONARY	asthma	asthma	165#171		Consistent association in two independent samples and association with an intermediate phenotype provides strong support for TLR10 genetic variation contributing to asthma risk.
10213916	1999	Neuroimmunomodulation	1021-7401	TITLE	0	0	7349	LONGTERM|DICTIONARY	urocortin	Urocortin	0#9		D007022	LONGTERM|DICTIONARY	hypotension	hypotension	51#62	NaN	Urocortin and inflammation: confounding effects of hypotension on measures of inflammation.
10213916	1999	Neuroimmunomodulation	1021-7401	TITLE	0	0	7349	LONGTERM|DICTIONARY	urocortin	Urocortin	0#9		D007249	LONGTERM|DICTIONARY	inflammation	inflammation	14#26	NaN	Urocortin and inflammation: confounding effects of hypotension on measures of inflammation.
10213916	1999	Neuroimmunomodulation	1021-7401	TITLE	0	0	7349	LONGTERM|DICTIONARY	urocortin	Urocortin	0#9		D007249	LONGTERM|DICTIONARY	inflammation	inflammation	78#90	NaN	Urocortin and inflammation: confounding effects of hypotension on measures of inflammation.
10508521	1999	Nat. Genet.	1061-4036	ALL_TEXT_3/3	3	9	23418	SYMBOL|DICTIONARY	crb1	CRB1	70#74		C563999	SYMBOL|DISEASE|DN|DICTIONARY|EXTRACTED	rp12	RP12	43#47	10508521-0-58-78	The distinct RPE abnormalities observed in RP12 patients suggest that CRB1 mutations trigger a novel mechanism of photoreceptor degeneration.
10508521	1999	Nat. Genet.	1061-4036	ALL_TEXT_3/3	3	9	23418	SYMBOL|DICTIONARY	crb1	CRB1	70#74		D009410	LONGTERM|DICTIONARY	photoreceptor degeneration	photoreceptor degeneration	114#140		The distinct RPE abnormalities observed in RP12 patients suggest that CRB1 mutations trigger a novel mechanism of photoreceptor degeneration.
15201134	2004	Am. J. Respir. Crit. Care Med.	1073-449X	TITLE	0	0	81793	LONGTERM|GENE|GN|DICTIONARY	toll like receptor 10	TOLL-like receptor 10	0#21		D001249	LONGTERM|DICTIONARY	asthma	asthma	59#65		TOLL-like receptor 10 genetic variation is associated with asthma in two independent samples.
10213916	1999	Neuroimmunomodulation	1021-7401	ALL_TEXT_1/3	1	2	7349	LONGTERM|DICTIONARY	urocortin	Urocortin	0#9		D004487	LONGTERM|DICTIONARY	edema	edema	56#61	NaN	Urocortin given systemically inhibited heat-induced paw edema in the rat, and was therefore ascribed anti-inflammatory properties.
20393813	2010	J. Mol. Neurosci.	1559-1166	ALL_TEXT_2/3	2	6	3569	SYMBOL|DICTIONARY	il 6	IL-6	15#19		D012559	LONGTERM|DICTIONARY	schizophrenic	schizophrenic	144#157	NaN	Differences in IL-6 and IL-10 promoter haplotypes may play an important role in determining the transcription level for IL-6 and IL-10 genes in schizophrenic patients.
20393813	2010	J. Mol. Neurosci.	1559-1166	ALL_TEXT_2/3	2	6	3586	SYMBOL|GENE|GN|DICTIONARY	il 10	IL-10	24#29		D012559	LONGTERM|DICTIONARY	schizophrenic	schizophrenic	144#157	NaN	Differences in IL-6 and IL-10 promoter haplotypes may play an important role in determining the transcription level for IL-6 and IL-10 genes in schizophrenic patients.
20393813	2010	J. Mol. Neurosci.	1559-1166	ALL_TEXT_2/3	2	6	3569	SYMBOL|DICTIONARY	il 6	IL-6	120#124		D012559	LONGTERM|DICTIONARY	schizophrenic	schizophrenic	144#157	NaN	Differences in IL-6 and IL-10 promoter haplotypes may play an important role in determining the transcription level for IL-6 and IL-10 genes in schizophrenic patients.
20393813	2010	J. Mol. Neurosci.	1559-1166	ALL_TEXT_2/3	2	6	3586	SYMBOL|GENE|GN|DICTIONARY	il 10	IL-10	129#134		D012559	LONGTERM|DICTIONARY	schizophrenic	schizophrenic	144#157	NaN	Differences in IL-6 and IL-10 promoter haplotypes may play an important role in determining the transcription level for IL-6 and IL-10 genes in schizophrenic patients.
10213916	1999	Neuroimmunomodulation	1021-7401	ALL_TEXT_1/3	1	3	7349	LONGTERM|DICTIONARY	urocortin	urocortin	27#36		D007249	LONGTERM|DICTIONARY	inflammation	inflammation	77#89	NaN	We examined the effects of urocortin in the carrageenin-induced subcutaneous inflammation model.
20810130	2011	J. Neurol. Sci.	1878-5883	BACKGROUND AND OBJECTIVE	1	2	3123	SYMBOL|DICTIONARY	drb1	DRB1	60#64		D009103	SYMBOL|EXTRACTED	ms	MS	100#102	20810130-1-0-18	Epistatic interactions between both parental alleles in the DRB1 loci have been shown to modify the MS susceptibility risk.
15142050	2004	Clin Transplant	0902-0063	TITLE	0	0	348	LONGTERM|GENE|GN|DICTIONARY	apolipoprotein e	Apolipoprotein E	0#16		D050197	LONGTERM|DICTIONARY	atherosclerosis	atherosclerosis	96#111		Apolipoprotein E gene polymorphism in renal transplant recipients: effects on lipid metabolism, atherosclerosis and allograft function.
20810130	2011	J. Neurol. Sci.	1878-5883	TITLE	0	0	3123	SYMBOL|DICTIONARY	hla drb1	HLA-DRB1	18#26		D009103	LONGTERM|DICTIONARY	multiple sclerosis	multiple sclerosis	69#87		Epistasis between HLA-DRB1 parental alleles in a Spanish cohort with multiple sclerosis.
20810130	2011	J. Neurol. Sci.	1878-5883	BACKGROUND AND OBJECTIVE	1	1	3123	SYMBOL|NUMBER|DICTIONARY	hla drb1	HLA-DRB1	110#118		D009103	LONGTERM|DICTIONARY	multiple sclerosis	Multiple sclerosis	0#18		Multiple sclerosis (MS) has been consistently associated with the HLA-DR2 haplotype and particularly with the HLA-DRB1*15 allele.
20810130	2011	J. Neurol. Sci.	1878-5883	BACKGROUND AND OBJECTIVE	1	1	3123	SYMBOL|NUMBER|DICTIONARY	hla drb1	HLA-DRB1	110#118		D009103	SYMBOL|EXTRACTED|()	ms	MS	20#22	20810130-1-0-18	Multiple sclerosis (MS) has been consistently associated with the HLA-DR2 haplotype and particularly with the HLA-DRB1*15 allele.
20644276	2010	Neurol India	0028-3886	ALL_TEXT_2/3	2	4	348	SYMBOL|DICTIONARY|EXTRACTED	apo e	Apo-E	0#5		D009157	SYMBOL|EXTRACTED|DISEASE|DN	mg	MG	37#39	20644276-1-11-28	Apo-E genotypes were analyzed in 120 MG patients and 120 healthy subjects.
15123604	2004	J. Biol. Chem.	0021-9258	TITLE	0	0	387082	SYMBOL|()|DICTIONARY	sumo 4	SUMO-4	42#48		D003920	LONGTERM|DICTIONARY	type i diabetes mellitus	type I diabetes mellitus	149#173		A M55V polymorphism in a novel SUMO gene (SUMO-4) differentially activates heat shock transcription factors and is associated with susceptibility to type I diabetes mellitus.
15123604	2004	J. Biol. Chem.	0021-9258	TITLE	0	0	387082	SYMBOL|()|DICTIONARY	sumo 4	SUMO-4	42#48		D012769	LONGTERM|DICTIONARY	heat shock	heat shock	75#85	NaN	A M55V polymorphism in a novel SUMO gene (SUMO-4) differentially activates heat shock transcription factors and is associated with susceptibility to type I diabetes mellitus.
15123604	2004	J. Biol. Chem.	0021-9258	ALL_TEXT_3/3	3	5	387082	SYMBOL|DICTIONARY	sumo 4	SUMO-4	62#68		D008113	LONGTERM|()|DISEASE|DT|CLINE|CN|DICTIONARY	liver carcinoma	liver carcinoma	10#25		In HepG2 (liver carcinoma) cells transiently transfected with SUMO-4 expression vectors, Met-55 was associated with the elevated levels of activated heat shock factor transcription factors as compared with Val-55, whereas the levels of NF-kappaB were suppressed to an identical degree.
15123604	2004	J. Biol. Chem.	0021-9258	ALL_TEXT_3/3	3	5	387082	SYMBOL|DICTIONARY	sumo 4	SUMO-4	62#68		D012769	LONGTERM|DICTIONARY	heat shock	heat shock	149#159	NaN	In HepG2 (liver carcinoma) cells transiently transfected with SUMO-4 expression vectors, Met-55 was associated with the elevated levels of activated heat shock factor transcription factors as compared with Val-55, whereas the levels of NF-kappaB were suppressed to an identical degree.
19580347	2009	Neoplasma	0028-2685	TITLE	0	0	3091	SYMBOL|()|GENE|GN|DICTIONARY	hif 1alpha	HIF-1alpha	54#64		D001943	LONGTERM|DISEASE|DT|DICTIONARY	breast cancer	breast cancer	108#121		Associations between hypoxia-inducible factor-1alpha (HIF-1alpha) gene polymorphisms and risk of developing breast cancer.
17405833	2007	Ann. Rheum. Dis.	0003-4967	CONCLUSIONS	4	9	3565	SYMBOL|DICTIONARY|EXTRACTED	il 4	IL-4	59#63	17405833-1-54-67	D056728	SYMBOL|DISEASE|DN|DICTIONARY|EXTRACTED	iim disease	IIM disease	125#136	17405833-1-111-145	The SNPs tested in this study within the region coding for IL-4 fail to show significant associations with susceptibility to IIM disease.
19580347	2009	Neoplasma	0028-2685	ALL_TEXT_2/3	2	3	3091	SYMBOL|DICTIONARY	hif 1alpha	HIF-1alpha	40#50		D001943	LONGTERM|DISEASE|DT|DICTIONARY	breast cancer	breast cancer	69#82		We investigated the association between HIF-1alpha polymorphisms and breast cancer risk, and clinico-pathological parameters in the population.
17044097	2007	Am. J. Med. Genet. B Neuropsychiatr. Genet.	1552-4841	ALL_TEXT_3/3	3	7	627	SYMBOL|DICTIONARY|EXTRACTED	bdnf	BDNF	61#65	17044097-1-0-33	D001289	SYMBOL|DICTIONARY|EXTRACTED	adhd	ADHD	87#91	17044097-2-63-103	This study provides evidence for the possible involvement of BDNF in susceptibility to ADHD.
17044097	2007	Am. J. Med. Genet. B Neuropsychiatr. Genet.	1552-4841	TITLE	0	0	627	LONGTERM|GENE|GN|GT|DICTIONARY	brain derived neurotrophic factor	brain-derived neurotrophic factor	39#72		D001289	LONGTERM|DISEASE|DT|DICTIONARY	deficit hyperactivity disorder	deficit hyperactivity disorder	106#136		Family-based association study between brain-derived neurotrophic factor gene polymorphisms and attention deficit hyperactivity disorder in UK and Taiwanese samples.
17044097	2007	Am. J. Med. Genet. B Neuropsychiatr. Genet.	1552-4841	ALL_TEXT_2/3	2	3	627	SYMBOL|DICTIONARY|EXTRACTED	bdnf	BDNF	47#51	17044097-1-0-33	D001289	SYMBOL|DICTIONARY|EXTRACTED	adhd	ADHD	97#101	17044097-2-63-103	This study investigated the role of two common BDNF variants (Val66Met, C270T) in two samples of ADHD probands from the United Kingdom (n = 180) and Taiwan (n = 212).
17044097	2007	Am. J. Med. Genet. B Neuropsychiatr. Genet.	1552-4841	ALL_TEXT_1/3	1	2	627	SYMBOL|DICTIONARY|EXTRACTED	bdnf	BDNF	55#59	17044097-1-0-33	D001289	LONGTERM|DICTIONARY	attention deficit hyperactivity disorder	attention-deficit hyperactivity disorder	63#103		Several lines of evidence implicate the involvement of BDNF in attention-deficit hyperactivity disorder (ADHD).
17044097	2007	Am. J. Med. Genet. B Neuropsychiatr. Genet.	1552-4841	ALL_TEXT_1/3	1	2	627	SYMBOL|DICTIONARY|EXTRACTED	bdnf	BDNF	55#59	17044097-1-0-33	D001289	SYMBOL|()|DICTIONARY|EXTRACTED	adhd	ADHD	105#109	17044097-2-63-103	Several lines of evidence implicate the involvement of BDNF in attention-deficit hyperactivity disorder (ADHD).
1976809	1990	J. Rheumatol.	0315-162X	ALL_TEXT_1/3	1	1	720	SYMBOL|GENE|GN|DICTIONARY	c4a	C4A	17#20		D008180	LONGTERM|DICTIONARY	systemic lupus erythematosus	systemic lupus erythematosus	73#101		The frequency of C4A gene deletion was studied in Japanese patients with systemic lupus erythematosus (SLE) and was compared with healthy controls.
1976809	1990	J. Rheumatol.	0315-162X	ALL_TEXT_1/3	1	1	720	SYMBOL|GENE|GN|DICTIONARY	c4a	C4A	17#20		D008180	SYMBOL|()|DICTIONARY|EXTRACTED	sle	SLE	103#106	1976809-1-73-101	The frequency of C4A gene deletion was studied in Japanese patients with systemic lupus erythematosus (SLE) and was compared with healthy controls.
18449423	2008	Thromb. Haemost.	0340-6245	TITLE	0	0	2153	LONGTERM|DICTIONARY	factor v leiden	factor V Leiden	59#74		D012170	LONGTERM|DICTIONARY	retinal vein occlusion	retinal vein occlusion	116#138		The prevalence of activated protein C (APC) resistance and factor V Leiden is significantly higher in patients with retinal vein occlusion without general risk factors. Case-control study and meta-analysis.
18449423	2008	Thromb. Haemost.	0340-6245	TITLE	0	0	2153	LONGTERM|DICTIONARY	factor v leiden	factor V Leiden	59#74		D020016	LONGTERM|DICTIONARY	apc	APC	39#42		The prevalence of activated protein C (APC) resistance and factor V Leiden is significantly higher in patients with retinal vein occlusion without general risk factors. Case-control study and meta-analysis.
11579943	2002	Intern. Med.	0918-2918	OBJECTIVE	1	1	3077	SYMBOL|DICTIONARY	hfe	HFE	141#144		D006432	LONGTERM|DICTIONARY	hereditary hemochromatosis	hereditary hemochromatosis	25#51		The gene responsible for hereditary hemochromatosis close to the human leukocyte antigen A locus was previously identified and designated as HFE.
18449423	2008	Thromb. Haemost.	0340-6245	ALL_TEXT_1/3	1	1	2153	LONGTERM|DICTIONARY	factor v leiden	factor V Leiden	61#76		D012170	LONGTERM|DICTIONARY	retinal vein occlusion	retinal vein occlusion	104#126		Several small case-control studies have investigated whether factor V Leiden (FVL) is a risk factor for retinal vein occlusion (RVO) and generated conflicting data.
18449423	2008	Thromb. Haemost.	0340-6245	ALL_TEXT_1/3	1	1	2153	LONGTERM|DICTIONARY	factor v leiden	factor V Leiden	61#76		D012170	SYMBOL|EXTRACTED|()	rvo	RVO	128#131	18449423-1-104-126	Several small case-control studies have investigated whether factor V Leiden (FVL) is a risk factor for retinal vein occlusion (RVO) and generated conflicting data.
17385326	2007	Genetika	0016-6758	TITLE	0	0	142	SYMBOL|GENE|GN|DICTIONARY	adprt1	ADPRT1	51#57		D005921	LONGTERM|DICTIONARY	glomerulonephritis	glomerulonephritis	87#105		[Polymorphic markers Val762Ala and Leu54Phe of the ADPRT1 gene associated with chronic glomerulonephritis in Russian patients from the city of Moscow].
17385326	2007	Genetika	0016-6758	ALL_TEXT_1/3	1	1	142	SYMBOL|GENE|GN|DICTIONARY	adprt1	ADPRT1	109#115		D005921	LONGTERM|DISEASE|DN|DICTIONARY	glomerulonephritis	glomerulonephritis	189#207		A comparative analysis of allelic and genotype distribution of polymorphic markers Val762Ala and Leu54Phe of ADPRT1 gene encoding poly(ADP-ribose)polymerase I has been performed in chronic glomerulonephritis patients compared to normal controls.
8942447	1997	Am J Psychiatry	0002-953X	OBJECTIVE	1	2	3119	SYMBOL|DICTIONARY	hla dqb1	HLA DQB1	4#12		D012559	LONGTERM|DICTIONARY	schizophrenia	schizophrenia	108#121		The HLA DQB1*0602 allele was also studied because of previous reports of genetic association between it and schizophrenia.
8942447	1997	Am J Psychiatry	0002-953X	CONCLUSIONS	4	7	3123	SYMBOL|DICTIONARY	drb1	DRB1	0#4		D012559	LONGTERM|DICTIONARY	schizophrenia	schizophrenia	72#85		DRB1*04 alleles may partially account for the genetic predisposition to schizophrenia.
15988127	2005	J. Pharmacol. Sci.	1347-8613	ALL_TEXT_3/3	3	8	5337	SYMBOL|DICTIONARY	pld1	PLD1	15#19		D006332	LONGTERM|DICTIONARY	heart hypertrophy	heart hypertrophy	86#103	NaN	In conclusion, PLD1 and PLD2 expressions were strongly enhanced both in rat and human heart hypertrophy, which may be responsible for the coincident potentiation of the PLD activation by alpha-adrenoceptor and protein kinase C stimulation.
15988127	2005	J. Pharmacol. Sci.	1347-8613	ALL_TEXT_3/3	3	8	5338	SYMBOL|DICTIONARY	pld2	PLD2	24#28		D006332	LONGTERM|DICTIONARY	heart hypertrophy	heart hypertrophy	86#103	NaN	In conclusion, PLD1 and PLD2 expressions were strongly enhanced both in rat and human heart hypertrophy, which may be responsible for the coincident potentiation of the PLD activation by alpha-adrenoceptor and protein kinase C stimulation.
18650507	2008	N. Engl. J. Med.	1533-4406	TITLE	0	0	10599	SYMBOL|DICTIONARY	slco1b1	SLCO1B1	0#7		D009135	LONGTERM|DICTIONARY	myopathy	myopathy	36#44		SLCO1B1 variants and statin-induced myopathy--a genomewide study.
18650507	2008	N. Engl. J. Med.	1533-4406	RESULTS	3	5	10599	SYMBOL|DICTIONARY	slco1b1	SLCO1B1	139#146		D009135	LONGTERM|DICTIONARY	myopathy	myopathy	59#67		The genomewide scan yielded a single strong association of myopathy with the rs4363657 single-nucleotide polymorphism (SNP) located within SLCO1B1 on chromosome 12 (P=4x10(-9)).
20674764	2011	Microbes Infect.	1769-714X	ALL_TEXT_3/3	3	10	54106	SYMBOL|DICTIONARY	tlr9	TLR9	17#21		D006479	SYMBOL|EXTRACTED|DISEASE|DN	cchf	CCHF	74#78	20674764-1-8-31	The frequency of TLR9 -1486C/C genotype was significantly higher in fatal CCHF patients than in healthy controls (p=0.009) and in patients with severe disease compared to non-severe disease (p=0.044).
19145484	2009	Breast Cancer Res. Treat.	1573-7217	ALL_TEXT_1/3	1	1	7421	LONGTERM|GENE|GT|DICTIONARY|GA	vitamin d receptor	vitamin D receptor	29#47		D001943	LONGTERM|DISEASE|DT|DICTIONARY	breast cancer	breast cancer	91#104		Several polymorphisms in the vitamin D receptor (VDR) gene have been reported to influence breast cancer risk.
19145484	2009	Breast Cancer Res. Treat.	1573-7217	ALL_TEXT_1/3	1	1	7421	SYMBOL|()|GENE|GN|DICTIONARY|EXTRACTED	vdr	VDR	49#52	19145484-1-29-47	D001943	LONGTERM|DISEASE|DT|DICTIONARY	breast cancer	breast cancer	91#104		Several polymorphisms in the vitamin D receptor (VDR) gene have been reported to influence breast cancer risk.
19145484	2009	Breast Cancer Res. Treat.	1573-7217	TITLE	0	0	7421	LONGTERM|GENE|GN|GT|DICTIONARY	vitamin d receptor	vitamin D receptor	21#39		D001943	LONGTERM|DISEASE|DT|DICTIONARY	breast cancer	breast cancer	60#73		Fok1 polymorphism of vitamin D receptor gene contributes to breast cancer susceptibility: a meta-analysis.
19145484	2009	Breast Cancer Res. Treat.	1573-7217	ALL_TEXT_3/3	3	7	57862	SYMBOL|DICTIONARY	apa1	Apa1	60#64		D001943	LONGTERM|DISEASE|DT|DICTIONARY	breast cancer	breast cancer	87#100		No significant associations were observed between the Bsm1, Apa1 and Taq1 variants and breast cancer risk.
19210888	2009	Clin. Exp. Rheumatol.	0392-856X	RESULTS	3	6	26191	SYMBOL|DICTIONARY	ptpn22	PTPN22	32#38		D001171	SYMBOL|DICTIONARY|EXTRACTED	jia	JIA	55#58	19210888-1-0-29	There was no association of the PTPN22 C1858T SNP with JIA (p=0.66).
19546348	2009	Exp. Biol. Med. (Maywood)	1535-3699	TITLE	0	0	3091	LONGTERM|DICTIONARY	hypoxia-inducible factor-1alpha	hypoxia-inducible factor-1alpha	26#57	NaN	D008175	LONGTERM|DISEASE|DT|DICTIONARY	lung cancer	lung cancer	67#78		Genetic variations in the hypoxia-inducible factor-1alpha gene and lung cancer.
19892845	2010	Clin. Chem.	1530-8561	BACKGROUND	1	1	672	SYMBOL|DICTIONARY	brca1	BRCA1	25#30		D061325	LONGTERM|DISEASE|DT|DICTIONARY	breast and ovarian cancer	breast and ovarian cancer	83#108		Deleterious mutations in BRCA1 (breast cancer 1, early onset; MIM 113705) increase breast and ovarian cancer [B(O)C] risk; however, many variants cannot be readily classified as deleterious or neutral.
19892845	2010	Clin. Chem.	1530-8561	BACKGROUND	1	1	672	SYMBOL|DICTIONARY	brca1	BRCA1	25#30		D001943	LONGTERM|DICTIONARY	brca1	BRCA1	25#30	NaN	Deleterious mutations in BRCA1 (breast cancer 1, early onset; MIM 113705) increase breast and ovarian cancer [B(O)C] risk; however, many variants cannot be readily classified as deleterious or neutral.
19892845	2010	Clin. Chem.	1530-8561	BACKGROUND	1	1	672	LONGTERM|DICTIONARY	breast cancer 1	breast cancer 1	32#47		D061325	LONGTERM|DISEASE|DT|DICTIONARY	breast and ovarian cancer	breast and ovarian cancer	83#108		Deleterious mutations in BRCA1 (breast cancer 1, early onset; MIM 113705) increase breast and ovarian cancer [B(O)C] risk; however, many variants cannot be readily classified as deleterious or neutral.
19892845	2010	Clin. Chem.	1530-8561	BACKGROUND	1	1	672	LONGTERM|DICTIONARY	breast cancer 1	breast cancer 1	32#47		D001943	LONGTERM|DICTIONARY	brca1	BRCA1	25#30	NaN	Deleterious mutations in BRCA1 (breast cancer 1, early onset; MIM 113705) increase breast and ovarian cancer [B(O)C] risk; however, many variants cannot be readily classified as deleterious or neutral.
11244489	2001	Mol. Psychiatry	1359-4184	ALL_TEXT_3/3	3	11	7124	SYMBOL|EXTRACTED	tnfalpha	TNFalpha	39#47	11244489-4-14-41	D012559	LONGTERM|DICTIONARY	schizophrenia	schizophrenia	90#103		These data suggest a potential role of TNFalpha as a candidate gene for susceptibility to schizophrenia and suggest that immune dysregulation in schizophrenic patients could also have a genetic component.
11244489	2001	Mol. Psychiatry	1359-4184	ALL_TEXT_3/3	3	11	7124	SYMBOL|EXTRACTED	tnfalpha	TNFalpha	39#47	11244489-4-14-41	D007154	LONGTERM|DICTIONARY	immune dysregulation	immune dysregulation	121#141	NaN	These data suggest a potential role of TNFalpha as a candidate gene for susceptibility to schizophrenia and suggest that immune dysregulation in schizophrenic patients could also have a genetic component.
19773262	2010	Haematologica	1592-8721	DESIGN AND METHODS	2	7	6208	SYMBOL|DICTIONARY	rps14	RPS14	98#103		D029503	LONGTERM|DICTIONARY	diamond blackfan anemia	Diamond-Blackfan anemia	171#194		In this genotype-phenotype analysis we screened the coding sequence and intron-exon boundaries of RPS14, RPS16, RPS24, RPL5, RPL11, and RPL35A in 92 Italian patients with Diamond-Blackfan anemia who were negative for RPS19 mutations.
19773262	2010	Haematologica	1592-8721	DESIGN AND METHODS	2	7	6217	SYMBOL|DICTIONARY	rps16	RPS16	105#110		D029503	LONGTERM|DICTIONARY	diamond blackfan anemia	Diamond-Blackfan anemia	171#194		In this genotype-phenotype analysis we screened the coding sequence and intron-exon boundaries of RPS14, RPS16, RPS24, RPL5, RPL11, and RPL35A in 92 Italian patients with Diamond-Blackfan anemia who were negative for RPS19 mutations.
19773262	2010	Haematologica	1592-8721	DESIGN AND METHODS	2	7	6229	SYMBOL|DICTIONARY	rps24	RPS24	112#117		D029503	LONGTERM|DICTIONARY	diamond blackfan anemia	Diamond-Blackfan anemia	171#194		In this genotype-phenotype analysis we screened the coding sequence and intron-exon boundaries of RPS14, RPS16, RPS24, RPL5, RPL11, and RPL35A in 92 Italian patients with Diamond-Blackfan anemia who were negative for RPS19 mutations.
19773262	2010	Haematologica	1592-8721	DESIGN AND METHODS	2	7	6125	SYMBOL|DICTIONARY	rpl5	RPL5	119#123		D029503	LONGTERM|DICTIONARY	diamond blackfan anemia	Diamond-Blackfan anemia	171#194		In this genotype-phenotype analysis we screened the coding sequence and intron-exon boundaries of RPS14, RPS16, RPS24, RPL5, RPL11, and RPL35A in 92 Italian patients with Diamond-Blackfan anemia who were negative for RPS19 mutations.
19773262	2010	Haematologica	1592-8721	DESIGN AND METHODS	2	7	6135	SYMBOL|DICTIONARY	rpl11	RPL11	125#130		D029503	LONGTERM|DICTIONARY	diamond blackfan anemia	Diamond-Blackfan anemia	171#194		In this genotype-phenotype analysis we screened the coding sequence and intron-exon boundaries of RPS14, RPS16, RPS24, RPL5, RPL11, and RPL35A in 92 Italian patients with Diamond-Blackfan anemia who were negative for RPS19 mutations.
19773262	2010	Haematologica	1592-8721	DESIGN AND METHODS	2	7	6165	SYMBOL|DICTIONARY	rpl35a	RPL35A	136#142		D029503	LONGTERM|DICTIONARY	diamond blackfan anemia	Diamond-Blackfan anemia	171#194		In this genotype-phenotype analysis we screened the coding sequence and intron-exon boundaries of RPS14, RPS16, RPS24, RPL5, RPL11, and RPL35A in 92 Italian patients with Diamond-Blackfan anemia who were negative for RPS19 mutations.
19773262	2010	Haematologica	1592-8721	DESIGN AND METHODS	2	7	6223	SYMBOL|DICTIONARY	rps19	RPS19	217#222		D029503	LONGTERM|DICTIONARY	diamond blackfan anemia	Diamond-Blackfan anemia	171#194		In this genotype-phenotype analysis we screened the coding sequence and intron-exon boundaries of RPS14, RPS16, RPS24, RPL5, RPL11, and RPL35A in 92 Italian patients with Diamond-Blackfan anemia who were negative for RPS19 mutations.
19892845	2010	Clin. Chem.	1530-8561	TITLE	0	0	672	SYMBOL|DICTIONARY	brca1	BRCA1	77#82		D001943	LONGTERM|DICTIONARY	brca1	BRCA1	77#82	NaN	Alternative splicing and molecular characterization of splice site variants: BRCA1 c.591C>T as a case study.
7680712	1993	J. Acquir. Immune Defic. Syndr.	0894-9255	ALL_TEXT_3/3	3	5	1437	SYMBOL|DICTIONARY|EXTRACTED	gmcsf	GMCSF	112#117	7680712-2-174-222	D016483	LONGTERM|DICTIONARY	hiv associated lymphoma	HIV-associated lymphoma	55#78		We conclude that it is feasible to treat patients with HIV-associated lymphoma using standard dose m-BACOD plus GMCSF, but further study is needed to determine whether full-dose regimens improve survival when compared with reduced dose regimens in these individuals.
7680712	1993	J. Acquir. Immune Defic. Syndr.	0894-9255	ALL_TEXT_3/3	3	4	1437	SYMBOL|DICTIONARY|EXTRACTED	gmcsf	GMCSF	51#56	7680712-2-174-222	D064420	LONGTERM|DICTIONARY	toxicity	toxicity	104#112	NaN	Eight patients received standard dose m-BACOD plus GMCSF without experiencing dose-limiting hematologic toxicity, although significant nonhematologic toxicity was seen.
7680712	1993	J. Acquir. Immune Defic. Syndr.	0894-9255	ALL_TEXT_3/3	3	4	1437	SYMBOL|DICTIONARY|EXTRACTED	gmcsf	GMCSF	51#56	7680712-2-174-222	D064420	LONGTERM|DICTIONARY	toxicity	toxicity	150#158	NaN	Eight patients received standard dose m-BACOD plus GMCSF without experiencing dose-limiting hematologic toxicity, although significant nonhematologic toxicity was seen.
21685359	2011	J. Natl. Cancer Inst.	1460-2105	METHODS	2	5	6275	SYMBOL|GFAM|FN|DICTIONARY	s100a4	S100A4	126#132		D003110	LONGTERM|DISEASE|DT|CLINE|CN|DICTIONARY	colon cancer	Colon cancer	0#12		Colon cancer cell lines (HCT116, SW620, LS174T, SW480, and DLD-1) were treated with 1 M niclosamide to analyze the effect on S100A4 mRNA and protein expression by quantitative reverse transcription-polymerase chain reaction and immunoblot assays, and effects on cell migration, invasion, proliferation, and colony formation were also assessed in vitro.
8909447	1996	Neurology	0028-3878	TITLE	0	0	5621	LONGTERM|GENE|GN|GT|DICTIONARY	prion protein	prion protein	16#29		D007562	LONGTERM|DISEASE|DT|DICTIONARY	familial creutzfeldt jakob disease	familial Creutzfeldt-Jakob disease	51#85		Mutation of the prion protein gene at codon 208 in familial Creutzfeldt-Jakob disease.
16930377	2006	Eur. J. Neurol.	1468-1331	ALL_TEXT_2/3	2	4	7018	LONGTERM|DICTIONARY	transferrin	transferrin	98#109	NaN	D012148	SYMBOL|DICTIONARY|EXTRACTED	rls	RLS	28#31	16930377-1-23-45	Although most patients with RLS have normal serum ferritin levels, concentrations of ferritin and transferrin in the cerebrospinal fluid are reduced, suggesting iron deficiency within the central nervous system.
16930377	2006	Eur. J. Neurol.	1468-1331	ALL_TEXT_2/3	2	4	7018	LONGTERM|DICTIONARY	transferrin	transferrin	98#109	NaN	D020279	LONGTERM|DICTIONARY	iron deficiency within the central nervous system	iron deficiency within the central nervous system	161#210		Although most patients with RLS have normal serum ferritin levels, concentrations of ferritin and transferrin in the cerebrospinal fluid are reduced, suggesting iron deficiency within the central nervous system.
16930377	2006	Eur. J. Neurol.	1468-1331	ALL_TEXT_2/3	2	4	7018	LONGTERM|DICTIONARY	transferrin	transferrin	98#109	NaN	D020279	LONGTERM|DICTIONARY	iron deficiency within the central nervous system	iron deficiency within the central nervous system	161#210		Although most patients with RLS have normal serum ferritin levels, concentrations of ferritin and transferrin in the cerebrospinal fluid are reduced, suggesting iron deficiency within the central nervous system.
17503474	2007	Am. J. Med. Genet. B Neuropsychiatr. Genet.	1552-4841	ALL_TEXT_3/3	3	10	54715	SYMBOL|EXTRACTED	a2bp1	A2BP1	124#129	17503474-3-133-159	D001321	LONGTERM|DICTIONARY	autism	autism	165#171		Although only nominal association was observed, and no obvious causal mutations were identified, these results suggest that A2BP1 may affect susceptibility or cause autism in a subset of patients.
15571962	2005	Eur. J. Cancer	0959-8049	ALL_TEXT_3/3	3	8	675	SYMBOL|DICTIONARY	brca2	BRCA2	63#68		D061325	LONGTERM|DISEASE|DT|DICTIONARY	breast/ovarian cancer	breast/ovarian cancer	18#39		Family history of breast/ovarian cancer was present for 70% of BRCA2 carriers and approximately 14% for non-carriers with carcinoma.
15571962	2005	Eur. J. Cancer	0959-8049	ALL_TEXT_3/3	3	8	675	SYMBOL|DICTIONARY	brca2	BRCA2	63#68		D002277	LONGTERM|DICTIONARY	carcinoma	carcinoma	122#131	NaN	Family history of breast/ovarian cancer was present for 70% of BRCA2 carriers and approximately 14% for non-carriers with carcinoma.
16721725	2006	Int. J. Cancer	0020-7136	ALL_TEXT_2/3	2	3	5241	LONGTERM|GENE|GT|DICTIONARY	progesterone receptor	progesterone receptor	68#89		D009369	LONGTERM|DICTIONARY	tumors	tumors	105#111		We also evaluated differences in risk by estrogen receptor (ER) and progesterone receptor (PR) status in tumors, and the potential modification of the smoking association by N-acetyl transferase 2 (NAT2) genotype.
16721725	2006	Int. J. Cancer	0020-7136	ALL_TEXT_2/3	2	3	5241	SYMBOL|EXTRACTED|()	pr	PR	91#93	16721725-3-68-89	D009369	LONGTERM|DICTIONARY	tumors	tumors	105#111		We also evaluated differences in risk by estrogen receptor (ER) and progesterone receptor (PR) status in tumors, and the potential modification of the smoking association by N-acetyl transferase 2 (NAT2) genotype.
16721725	2006	Int. J. Cancer	0020-7136	ALL_TEXT_2/3	2	3	10	SYMBOL|()|DICTIONARY	nat2	NAT2	198#202		D009369	LONGTERM|DICTIONARY	tumors	tumors	105#111		We also evaluated differences in risk by estrogen receptor (ER) and progesterone receptor (PR) status in tumors, and the potential modification of the smoking association by N-acetyl transferase 2 (NAT2) genotype.
16721725	2006	Int. J. Cancer	0020-7136	ALL_TEXT_3/3	3	7	10	SYMBOL|DICTIONARY	nat2	NAT2	0#4		D001943	LONGTERM|DISEASE|DT|DICTIONARY	breast cancer	breast cancer	73#86		NAT2 slow vs. rapid/intermediate acetylation genotype was not related to breast cancer risk (0.99 (0.87-1.13)), and did not significantly modify the smoking relationships.
15571962	2005	Eur. J. Cancer	0959-8049	TITLE	0	0	675	SYMBOL|DICTIONARY	brca2	BRCA2	0#5		D010051	LONGTERM|DISEASE|DT|DICTIONARY	familial ovarian cancer	familial ovarian cancer	44#67		BRCA2, but not BRCA1, mutations account for familial ovarian cancer in Iceland: a population-based study.
15571962	2005	Eur. J. Cancer	0959-8049	TITLE	0	0	672	SYMBOL|DICTIONARY	brca1	BRCA1	15#20		D010051	LONGTERM|DISEASE|DT|DICTIONARY	familial ovarian cancer	familial ovarian cancer	44#67		BRCA2, but not BRCA1, mutations account for familial ovarian cancer in Iceland: a population-based study.
15571962	2005	Eur. J. Cancer	0959-8049	ALL_TEXT_1/3	1	2	672	SYMBOL|DICTIONARY	brca1	BRCA1	21#26		D010051	LONGTERM|DISEASE|DN|DT|DICTIONARY	ovarian cancer	ovarian cancer	69#83		The frequency of the BRCA1 G5193A and BRCA2 999del5 mutations in all ovarian cancer patients diagnosed over the period 1991-2000 was determined.
15571962	2005	Eur. J. Cancer	0959-8049	ALL_TEXT_1/3	1	2	675	SYMBOL|NUMBER|DICTIONARY	brca2	BRCA2	38#43		D010051	LONGTERM|DISEASE|DN|DT|DICTIONARY	ovarian cancer	ovarian cancer	69#83		The frequency of the BRCA1 G5193A and BRCA2 999del5 mutations in all ovarian cancer patients diagnosed over the period 1991-2000 was determined.
15571962	2005	Eur. J. Cancer	0959-8049	ALL_TEXT_2/3	2	5	672	SYMBOL|DICTIONARY	brca1	BRCA1	19#24		D002277	LONGTERM|DICTIONARY	carcinomas	carcinomas	7#17		In the carcinomas, BRCA1 and BRCA2 mutations were present in 1.2% and 6% of cases, respectively.
15571962	2005	Eur. J. Cancer	0959-8049	ALL_TEXT_2/3	2	5	675	SYMBOL|DICTIONARY	brca2	BRCA2	29#34		D002277	LONGTERM|DICTIONARY	carcinomas	carcinomas	7#17		In the carcinomas, BRCA1 and BRCA2 mutations were present in 1.2% and 6% of cases, respectively.
11793483	2002	Hum. Mutat.	1098-1004	TITLE	0	0	5009	LONGTERM|DICTIONARY	ornithine transcarbamylase	ornithine transcarbamylase	154#180		D020163	LONGTERM|DICTIONARY	otc deficiency	OTC deficiency	204#218		Identification of seven novel missense mutations, two splice-site mutations, two microdeletions and a polymorphic amino acid substitution in the gene for ornithine transcarbamylase (OTC) in patients with OTC deficiency.
11793483	2002	Hum. Mutat.	1098-1004	TITLE	0	0	5009	SYMBOL|()|DICTIONARY|EXTRACTED	otc	OTC	182#185	11793483-0-154-180	D020163	LONGTERM|DICTIONARY	otc deficiency	OTC deficiency	204#218		Identification of seven novel missense mutations, two splice-site mutations, two microdeletions and a polymorphic amino acid substitution in the gene for ornithine transcarbamylase (OTC) in patients with OTC deficiency.
12627470	2003	Am. J. Med. Genet. B Neuropsychiatr. Genet.	1552-4841	TITLE	0	0	2099	LONGTERM|GENE|GT|DICTIONARY	estrogen receptor alpha	estrogen receptor alpha	70#93		D001714	LONGTERM|DISEASE|DT|DICTIONARY	bipolar disorder	bipolar disorder	170#186		Variation in the coding sequence and flanking splice junctions of the estrogen receptor alpha (ERalpha) gene does not play an important role in genetic susceptibility to bipolar disorder or bipolar affective puerperal psychosis.
12627470	2003	Am. J. Med. Genet. B Neuropsychiatr. Genet.	1552-4841	TITLE	0	0	2099	LONGTERM|GENE|GT|DICTIONARY	estrogen receptor alpha	estrogen receptor alpha	70#93		D011605	LONGTERM|DICTIONARY	puerperal psychosis	puerperal psychosis	208#227		Variation in the coding sequence and flanking splice junctions of the estrogen receptor alpha (ERalpha) gene does not play an important role in genetic susceptibility to bipolar disorder or bipolar affective puerperal psychosis.
12627470	2003	Am. J. Med. Genet. B Neuropsychiatr. Genet.	1552-4841	ALL_TEXT_1/3	1	2	2099	LONGTERM|GENE|GT|DICTIONARY	estrogen receptor alpha	estrogen receptor alpha	4#27		D001523	LONGTERM|DICTIONARY	psychiatric disorders	psychiatric disorders	172#193		The estrogen receptor alpha (ERalpha) gene in particular has been a subject of interest and has recently been intensively screened for variations of potential relevance to psychiatric disorders, resulting in the identification of four mutations in individuals with bipolar disorder or puerperal psychosis.
12627470	2003	Am. J. Med. Genet. B Neuropsychiatr. Genet.	1552-4841	ALL_TEXT_1/3	1	2	2099	LONGTERM|GENE|GT|DICTIONARY	estrogen receptor alpha	estrogen receptor alpha	4#27		D001714	LONGTERM|DISEASE|DT|DICTIONARY	bipolar disorder	bipolar disorder	265#281		The estrogen receptor alpha (ERalpha) gene in particular has been a subject of interest and has recently been intensively screened for variations of potential relevance to psychiatric disorders, resulting in the identification of four mutations in individuals with bipolar disorder or puerperal psychosis.
12627470	2003	Am. J. Med. Genet. B Neuropsychiatr. Genet.	1552-4841	ALL_TEXT_1/3	1	2	2099	LONGTERM|GENE|GT|DICTIONARY	estrogen receptor alpha	estrogen receptor alpha	4#27		D011605	LONGTERM|DICTIONARY	puerperal psychosis	puerperal psychosis	285#304		The estrogen receptor alpha (ERalpha) gene in particular has been a subject of interest and has recently been intensively screened for variations of potential relevance to psychiatric disorders, resulting in the identification of four mutations in individuals with bipolar disorder or puerperal psychosis.
12627470	2003	Am. J. Med. Genet. B Neuropsychiatr. Genet.	1552-4841	ALL_TEXT_2/3	2	3	2099	LONGTERM|DICTIONARY	eralpha	ERalpha	45#52	NaN	D011605	LONGTERM|DICTIONARY	puerperal psychosis	puerperal psychosis	243#262		We have examined the frequency of these four ERalpha variations in a case control study using a group of mixed gender bipolar individuals (N = 231), further classified into subsets of parous bipolar females with (N = 112) and without (N = 50) puerperal psychosis, and a non-psychiatric comparison group (N = 110).
12627470	2003	Am. J. Med. Genet. B Neuropsychiatr. Genet.	1552-4841	ALL_TEXT_2/3	2	3	2099	LONGTERM|DICTIONARY	eralpha	ERalpha	45#52	NaN	D001714	LONGTERM|DICTIONARY	parous bipolar females	parous bipolar females	184#206	NaN	We have examined the frequency of these four ERalpha variations in a case control study using a group of mixed gender bipolar individuals (N = 231), further classified into subsets of parous bipolar females with (N = 112) and without (N = 50) puerperal psychosis, and a non-psychiatric comparison group (N = 110).
16211375	2006	Diabetologia	0012-186X	CONCLUSIONS/INTERPRETATION	4	9	59272	SYMBOL|DICTIONARY|EXTRACTED	ace2	ACE2	37#41	16211375-2-0-33	D003928	LONGTERM|DICTIONARY	diabetic nephropathy	diabetic nephropathy	80#100		In Finnish type 1 diabetic patients, ACE2 polymorphisms are not associated with diabetic nephropathy or any studied risk factor for this complication.
16211375	2006	Diabetologia	0012-186X	RESULTS	3	7	59272	SYMBOL|DICTIONARY|EXTRACTED	ace2	ACE2	12#16	16211375-2-0-33	D003928	LONGTERM|DICTIONARY	diabetic nephropathy	diabetic nephropathy	51#71		None of the ACE2 polymorphisms was associated with diabetic nephropathy, and this finding was supported by the haplotype analysis.
24640096	2014	Klin. Lab. Diagn.	0869-2084	ALL_TEXT_1/3	1	1	7077	SYMBOL|DICTIONARY	timp 2	TIMP-2	152#158		D010518	LONGTERM|DICTIONARY	periodontitis	periodontitis	335#348		Results of comparative immunoenzymatic study of matrix metalloproteinase (MMP) 2, 8 and 9, interleukins (IL) If and 6, tissue MMP inhibitors (TIMP-1and TIMP-2) and TNF-a in oral fluid of patients with different teeth and denture constructive materials show that MMP-9 content in oral fluid can serve as a marker of chronic generalized periodontitis because it is elevated in all patients irrespective of presence or absence of metallic tooth restorations.
24640096	2014	Klin. Lab. Diagn.	0869-2084	ALL_TEXT_1/3	1	1	7124	SYMBOL|DICTIONARY	tnf a	TNF-a	164#169		D010518	LONGTERM|DICTIONARY	periodontitis	periodontitis	335#348		Results of comparative immunoenzymatic study of matrix metalloproteinase (MMP) 2, 8 and 9, interleukins (IL) If and 6, tissue MMP inhibitors (TIMP-1and TIMP-2) and TNF-a in oral fluid of patients with different teeth and denture constructive materials show that MMP-9 content in oral fluid can serve as a marker of chronic generalized periodontitis because it is elevated in all patients irrespective of presence or absence of metallic tooth restorations.
24640096	2014	Klin. Lab. Diagn.	0869-2084	ALL_TEXT_1/3	1	1	4318	SYMBOL|DICTIONARY	mmp 9	MMP-9	262#267		D010518	LONGTERM|DICTIONARY	periodontitis	periodontitis	335#348		Results of comparative immunoenzymatic study of matrix metalloproteinase (MMP) 2, 8 and 9, interleukins (IL) If and 6, tissue MMP inhibitors (TIMP-1and TIMP-2) and TNF-a in oral fluid of patients with different teeth and denture constructive materials show that MMP-9 content in oral fluid can serve as a marker of chronic generalized periodontitis because it is elevated in all patients irrespective of presence or absence of metallic tooth restorations.
24640096	2014	Klin. Lab. Diagn.	0869-2084	ALL_TEXT_1/3	1	1	7076	SYMBOL|NUMBER|DICTIONARY	timp-1	TIMP-1	142#148		D010518	LONGTERM|DICTIONARY	periodontitis	periodontitis	335#348		Results of comparative immunoenzymatic study of matrix metalloproteinase (MMP) 2, 8 and 9, interleukins (IL) If and 6, tissue MMP inhibitors (TIMP-1and TIMP-2) and TNF-a in oral fluid of patients with different teeth and denture constructive materials show that MMP-9 content in oral fluid can serve as a marker of chronic generalized periodontitis because it is elevated in all patients irrespective of presence or absence of metallic tooth restorations.
24640096	2014	Klin. Lab. Diagn.	0869-2084	ALL_TEXT_1/3	1	2	4317	SYMBOL|DICTIONARY	mmp 8	MMP-8	0#5		D010518	LONGTERM|DISEASE|DN|DICTIONARY	periodontitis	periodontitis	55#68		MMP-8 level is elevated as compared to control only in periodontitis patients with metallic restorations.
16211375	2006	Diabetologia	0012-186X	AIMS/HYPOTHESIS	1	3	59272	SYMBOL|DICTIONARY|EXTRACTED	ace2	ACE2	82#86	16211375-2-0-33	D003928	LONGTERM|DICTIONARY	diabetic nephropathy	diabetic nephropathy	107#127		Based on this, the aim of the present study was to evaluate whether variations in ACE2 are associated with diabetic nephropathy.
16309832	2006	Neurosci. Lett.	0304-3940	TITLE	0	0	5743	LONGTERM|DICTIONARY	cyclooxygenase 2	cyclooxygenase 2	4#20		D000544	LONGTERM|DISEASE|DT|DICTIONARY	alzheimer disease	Alzheimer's disease	71#90		The cyclooxygenase 2 -765 C promoter allele is a protective factor for Alzheimer's disease.
15940757	2005	J. Rheumatol.	0315-162X	RESULTS	3	7	2944	SYMBOL|DICTIONARY	gstm1	GSTM1	31#36		D001172	SYMBOL|EXTRACTED	ra	RA	19#21	15940757-1-129-149	The OR for risk of RA with the GSTM1-null genotype was 1.40 (95% CI 1.02- 1.92, p = 0.04), and 1.86 (95% CI 1.12- 3.09, p = 0.005) among individuals without the shared epitope (SE).
15940757	2005	J. Rheumatol.	0315-162X	RESULTS	3	7	2944	SYMBOL|DICTIONARY	gstm1	GSTM1	31#36		D012753	LONGTERM|DICTIONARY	shared epitope	shared epitope	161#175	NaN	The OR for risk of RA with the GSTM1-null genotype was 1.40 (95% CI 1.02- 1.92, p = 0.04), and 1.86 (95% CI 1.12- 3.09, p = 0.005) among individuals without the shared epitope (SE).
15940757	2005	J. Rheumatol.	0315-162X	RESULTS	3	7	2944	SYMBOL|DICTIONARY	gstm1	GSTM1	31#36		D012753	LONGTERM|DICTIONARY	se	SE	177#179	NaN	The OR for risk of RA with the GSTM1-null genotype was 1.40 (95% CI 1.02- 1.92, p = 0.04), and 1.86 (95% CI 1.12- 3.09, p = 0.005) among individuals without the shared epitope (SE).
16277672	2006	Arthritis Res. Ther.	1478-6362	ALL_TEXT_3/3	3	11	26191	SYMBOL|DICTIONARY	ptpn22	PTPN22	43#49		D001172	SYMBOL|EXTRACTED	ra	RA	57#59	16277672-2-121-141	This study is the first to show linkage of PTPN22 to RF+ RA, consistent with PTPN22 as a new RA gene.
16277672	2006	Arthritis Res. Ther.	1478-6362	ALL_TEXT_3/3	3	11	26191	SYMBOL|DICTIONARY	ptpn22	PTPN22	77#83		D001172	SYMBOL|EXTRACTED	ra	RA	57#59	16277672-2-121-141	This study is the first to show linkage of PTPN22 to RF+ RA, consistent with PTPN22 as a new RA gene.
17955208	2008	Diabetologia	0012-186X	TITLE	0	0	7275	SYMBOL|DICTIONARY	tub	TUB	0#3		D009765	LONGTERM|DICTIONARY	obesity	obesity	39#46		TUB is a candidate gene for late-onset obesity in women.
15940757	2005	J. Rheumatol.	0315-162X	OBJECTIVE	1	1	2952	SYMBOL|DICTIONARY	gstt1	GSTT1	89#94		D001172	LONGTERM|DICTIONARY	rheumatoid arthritis	rheumatoid arthritis	129#149		To determine the effects of genetic polymorphisms of glutathione S-transferase (GST) M1, GSTT1, and GSTP on risk and severity of rheumatoid arthritis (RA) in a Korean population.
15940757	2005	J. Rheumatol.	0315-162X	OBJECTIVE	1	1	2952	SYMBOL|DICTIONARY	gstt1	GSTT1	89#94		D001172	SYMBOL|EXTRACTED|()	ra	RA	151#153	15940757-1-129-149	To determine the effects of genetic polymorphisms of glutathione S-transferase (GST) M1, GSTT1, and GSTP on risk and severity of rheumatoid arthritis (RA) in a Korean population.
15940757	2005	J. Rheumatol.	0315-162X	OBJECTIVE	1	1	2950	SYMBOL|DICTIONARY	gstp	GSTP	100#104		D001172	LONGTERM|DICTIONARY	rheumatoid arthritis	rheumatoid arthritis	129#149		To determine the effects of genetic polymorphisms of glutathione S-transferase (GST) M1, GSTT1, and GSTP on risk and severity of rheumatoid arthritis (RA) in a Korean population.
15940757	2005	J. Rheumatol.	0315-162X	OBJECTIVE	1	1	2950	SYMBOL|DICTIONARY	gstp	GSTP	100#104		D001172	SYMBOL|EXTRACTED|()	ra	RA	151#153	15940757-1-129-149	To determine the effects of genetic polymorphisms of glutathione S-transferase (GST) M1, GSTT1, and GSTP on risk and severity of rheumatoid arthritis (RA) in a Korean population.
15940757	2005	J. Rheumatol.	0315-162X	OBJECTIVE	1	1	2944	LONGTERM|DICTIONARY	glutathione s-transferase (gst) m1	glutathione S-transferase (GST) M1	53#87		D001172	LONGTERM|DICTIONARY	rheumatoid arthritis	rheumatoid arthritis	129#149		To determine the effects of genetic polymorphisms of glutathione S-transferase (GST) M1, GSTT1, and GSTP on risk and severity of rheumatoid arthritis (RA) in a Korean population.
15940757	2005	J. Rheumatol.	0315-162X	OBJECTIVE	1	1	2944	LONGTERM|DICTIONARY	glutathione s-transferase (gst) m1	glutathione S-transferase (GST) M1	53#87		D001172	SYMBOL|EXTRACTED|()	ra	RA	151#153	15940757-1-129-149	To determine the effects of genetic polymorphisms of glutathione S-transferase (GST) M1, GSTT1, and GSTP on risk and severity of rheumatoid arthritis (RA) in a Korean population.
15940757	2005	J. Rheumatol.	0315-162X	OBJECTIVE	1	1	2944	SYMBOL|()|DICTIONARY|EXTRACTED	glutathione s-transferase (gst) m1	glutathione S-transferase (GST) M1	53#87	15940757-1-53-78	D001172	LONGTERM|DICTIONARY	rheumatoid arthritis	rheumatoid arthritis	129#149		To determine the effects of genetic polymorphisms of glutathione S-transferase (GST) M1, GSTT1, and GSTP on risk and severity of rheumatoid arthritis (RA) in a Korean population.
15940757	2005	J. Rheumatol.	0315-162X	OBJECTIVE	1	1	2944	SYMBOL|()|DICTIONARY|EXTRACTED	glutathione s-transferase (gst) m1	glutathione S-transferase (GST) M1	53#87	15940757-1-53-78	D001172	SYMBOL|EXTRACTED|()	ra	RA	151#153	15940757-1-129-149	To determine the effects of genetic polymorphisms of glutathione S-transferase (GST) M1, GSTT1, and GSTP on risk and severity of rheumatoid arthritis (RA) in a Korean population.
16538170	2006	Pharmacogenet. Genomics	1744-6872	ALL_TEXT_3/3	3	9	196	SYMBOL|EXTRACTED	ahr	AhR	59#62	16538170-1-4-29	D001943	LONGTERM|DISEASE|DT|DICTIONARY	breast cancer	breast cancer	129#142		In conclusion, the results from our study suggest that the AhR Lys554Arg polymorphism may be a genetic susceptibility factor for breast cancer, whereas CYP1A2*1F, which is a potentially functional single nucleotide polymorphism, may not be related to breast cancer risk.
16538170	2006	Pharmacogenet. Genomics	1744-6872	ALL_TEXT_3/3	3	9	196	SYMBOL|EXTRACTED	ahr	AhR	59#62	16538170-1-4-29	D001943	LONGTERM|DISEASE|DT|DICTIONARY	breast cancer	breast cancer	251#264		In conclusion, the results from our study suggest that the AhR Lys554Arg polymorphism may be a genetic susceptibility factor for breast cancer, whereas CYP1A2*1F, which is a potentially functional single nucleotide polymorphism, may not be related to breast cancer risk.
16538170	2006	Pharmacogenet. Genomics	1744-6872	ALL_TEXT_3/3	3	9	1544	SYMBOL|NUMBER|DICTIONARY	cyp1a2	CYP1A2	152#158		D001943	LONGTERM|DISEASE|DT|DICTIONARY	breast cancer	breast cancer	129#142		In conclusion, the results from our study suggest that the AhR Lys554Arg polymorphism may be a genetic susceptibility factor for breast cancer, whereas CYP1A2*1F, which is a potentially functional single nucleotide polymorphism, may not be related to breast cancer risk.
16538170	2006	Pharmacogenet. Genomics	1744-6872	ALL_TEXT_3/3	3	9	1544	SYMBOL|NUMBER|DICTIONARY	cyp1a2	CYP1A2	152#158		D001943	LONGTERM|DISEASE|DT|DICTIONARY	breast cancer	breast cancer	251#264		In conclusion, the results from our study suggest that the AhR Lys554Arg polymorphism may be a genetic susceptibility factor for breast cancer, whereas CYP1A2*1F, which is a potentially functional single nucleotide polymorphism, may not be related to breast cancer risk.
14630904	2004	J. Dent. Res.	0022-0345	ALL_TEXT_1/3	1	2	5308	SYMBOL|DICTIONARY	pitx2	PITX2	17#22		C535679	LONGTERM|DISEASE|DT|DICTIONARY	rieger syndrome	Rieger syndrome	72#87		Mutations in the PITX2, FOXC1, and PAX6 genes have been associated with Rieger syndrome.
14630904	2004	J. Dent. Res.	0022-0345	ALL_TEXT_1/3	1	2	2296	SYMBOL|DICTIONARY	foxc1	FOXC1	24#29		C535679	LONGTERM|DISEASE|DT|DICTIONARY	rieger syndrome	Rieger syndrome	72#87		Mutations in the PITX2, FOXC1, and PAX6 genes have been associated with Rieger syndrome.
14630904	2004	J. Dent. Res.	0022-0345	ALL_TEXT_1/3	1	2	5080	SYMBOL|GENE|GN|DICTIONARY	pax6	PAX6	35#39		C535679	LONGTERM|DISEASE|DT|DICTIONARY	rieger syndrome	Rieger syndrome	72#87		Mutations in the PITX2, FOXC1, and PAX6 genes have been associated with Rieger syndrome.
19773262	2010	Haematologica	1592-8721	BACKGROUND	1	5	6229	SYMBOL|DICTIONARY	rps24	RPS24	13#18		D029503	LONGTERM|DICTIONARY	diamond blackfan anemia	Diamond-Blackfan anemia	84#107		Mutations in RPS24, RPS17, and RPL35A described in a minority of patients show that Diamond-Blackfan anemia is a disorder of ribosome biogenesis.
19773262	2010	Haematologica	1592-8721	BACKGROUND	1	5	6218	SYMBOL|DICTIONARY	rps17	RPS17	20#25		D029503	LONGTERM|DICTIONARY	diamond blackfan anemia	Diamond-Blackfan anemia	84#107		Mutations in RPS24, RPS17, and RPL35A described in a minority of patients show that Diamond-Blackfan anemia is a disorder of ribosome biogenesis.
19773262	2010	Haematologica	1592-8721	BACKGROUND	1	5	6165	SYMBOL|DICTIONARY	rpl35a	RPL35A	31#37		D029503	LONGTERM|DICTIONARY	diamond blackfan anemia	Diamond-Blackfan anemia	84#107		Mutations in RPS24, RPS17, and RPL35A described in a minority of patients show that Diamond-Blackfan anemia is a disorder of ribosome biogenesis.
14630904	2004	J. Dent. Res.	0022-0345	TITLE	0	0	5308	SYMBOL|DICTIONARY	pitx2	PITX2	62#67		C535679	LONGTERM|DISEASE|DT|GFAM|FN|DICTIONARY	rieger syndrome	Rieger syndrome	73#88		Novel identification of a four-base-pair deletion mutation in PITX2 in a Rieger syndrome family.
7680712	1993	J. Acquir. Immune Defic. Syndr.	0894-9255	ALL_TEXT_2/3	2	2	1437	LONGTERM|GENE|GT|DICTIONARY	granulocyte macrophage colony stimulating factor	granulocyte-macrophage colony stimulating factor	174#222		D064420	LONGTERM|DICTIONARY	toxicity	toxicity	45#53	NaN	We conducted a Phase I trial to evaluate the toxicity of the combination of m-BACOD (methotrexate, Bleomycin, doxorubicin, cyclophosphamide, vincristine, dexamethasone) with granulocyte-macrophage colony stimulating factor (GMCSF) in these patients.
7680712	1993	J. Acquir. Immune Defic. Syndr.	0894-9255	ALL_TEXT_2/3	2	2	1437	SYMBOL|()|DICTIONARY|EXTRACTED	gmcsf	GMCSF	224#229	7680712-2-174-222	D064420	LONGTERM|DICTIONARY	toxicity	toxicity	45#53	NaN	We conducted a Phase I trial to evaluate the toxicity of the combination of m-BACOD (methotrexate, Bleomycin, doxorubicin, cyclophosphamide, vincristine, dexamethasone) with granulocyte-macrophage colony stimulating factor (GMCSF) in these patients.
14630904	2004	J. Dent. Res.	0022-0345	ALL_TEXT_3/3	3	7	5308	SYMBOL|DICTIONARY	pitx2	PITX2	131#136		C538049	LONGTERM|DICTIONARY	oligodontia	oligodontia	39#50		Our novel discovery indicates that the oligodontia and other phenotypes of Rieger syndrome observed in this family are due to this PITX2 mutation, and these data further support the critical role of PIXT2 in tooth morphogenesis.
14630904	2004	J. Dent. Res.	0022-0345	ALL_TEXT_3/3	3	7	5308	SYMBOL|DICTIONARY	pitx2	PITX2	131#136		C535679	LONGTERM|DISEASE|DT|DICTIONARY	rieger syndrome	Rieger syndrome	75#90		Our novel discovery indicates that the oligodontia and other phenotypes of Rieger syndrome observed in this family are due to this PITX2 mutation, and these data further support the critical role of PIXT2 in tooth morphogenesis.
15940757	2005	J. Rheumatol.	0315-162X	RESULTS	3	9	2952	SYMBOL|DICTIONARY	gstt1	GSTT1	40#45		D001172	SYMBOL|EXTRACTED	ra	RA	96#98	15940757-1-129-149	No association was observed between the GSTT1 or GSTP1 genotypes and either risk or severity of RA.
15940757	2005	J. Rheumatol.	0315-162X	RESULTS	3	9	2950	SYMBOL|DICTIONARY	gstp1	GSTP1	49#54		D001172	SYMBOL|EXTRACTED	ra	RA	96#98	15940757-1-129-149	No association was observed between the GSTT1 or GSTP1 genotypes and either risk or severity of RA.
15940757	2005	J. Rheumatol.	0315-162X	RESULTS	3	8	2944	SYMBOL|DICTIONARY	gstm1	GSTM1	61#66		D001172	SYMBOL|EXTRACTED	ra	RA	20#22	15940757-1-129-149	Among patients with RA, the OR for risk of severe RA for the GSTM1-null genotype was 2.45 (95% CI 1.04- 5.77, p = 0.02).
15940757	2005	J. Rheumatol.	0315-162X	RESULTS	3	8	2944	SYMBOL|DICTIONARY	gstm1	GSTM1	61#66		D001172	SYMBOL|EXTRACTED	ra	RA	50#52	15940757-1-129-149	Among patients with RA, the OR for risk of severe RA for the GSTM1-null genotype was 2.45 (95% CI 1.04- 5.77, p = 0.02).
18396210	2008	Hum. Immunol.	0198-8859	ALL_TEXT_3/3	3	5	3553	SYMBOL|DICTIONARY	il 1 beta	IL-1 beta	9#18		D009369	LONGTERM|DISEASE|DT|DICTIONARY	tumor	tumor	134#139		However, IL-1 beta -511TT genotype and T1+ haplotype combination illustrated low risk for disease at the middle third location of the tumor (odds ratio [OR] = 0.27; 95% confidence interval [CI] = 0.11-0.62; p = 0.002; OR = 0.462; 95% CI = 0.253-0.845, p = 0.01).
18396210	2008	Hum. Immunol.	0198-8859	ALL_TEXT_3/3	3	6	3553	SYMBOL|DICTIONARY	il 1 beta	IL-1 beta	29#38		D009369	LONGTERM|DISEASE|DT|DICTIONARY	tumor	tumor	126#131		In conclusion, subjects with IL-1 beta -511TT genotype or IL-1 beta*T-IL-1RN*1 (T1) haplotype had lower risk for middle third tumor location of EC in a northern Indian population.
18396210	2008	Hum. Immunol.	0198-8859	ALL_TEXT_3/3	3	6	3553	SYMBOL|DICTIONARY	il 1 beta	IL-1 beta	29#38		D004938	SYMBOL|EXTRACTED	ec	EC	144#146	18396210-2-150-167	In conclusion, subjects with IL-1 beta -511TT genotype or IL-1 beta*T-IL-1RN*1 (T1) haplotype had lower risk for middle third tumor location of EC in a northern Indian population.
18396210	2008	Hum. Immunol.	0198-8859	ALL_TEXT_3/3	3	6	3553	SYMBOL|DICTIONARY	il 1 beta	IL-1 beta	58#67		D009369	LONGTERM|DISEASE|DT|DICTIONARY	tumor	tumor	126#131		In conclusion, subjects with IL-1 beta -511TT genotype or IL-1 beta*T-IL-1RN*1 (T1) haplotype had lower risk for middle third tumor location of EC in a northern Indian population.
18396210	2008	Hum. Immunol.	0198-8859	ALL_TEXT_3/3	3	6	3553	SYMBOL|DICTIONARY	il 1 beta	IL-1 beta	58#67		D004938	SYMBOL|EXTRACTED	ec	EC	144#146	18396210-2-150-167	In conclusion, subjects with IL-1 beta -511TT genotype or IL-1 beta*T-IL-1RN*1 (T1) haplotype had lower risk for middle third tumor location of EC in a northern Indian population.
18396210	2008	Hum. Immunol.	0198-8859	ALL_TEXT_3/3	3	6	3557	SYMBOL|NUMBER|DICTIONARY	il 1rn	IL-1RN	70#76		D009369	LONGTERM|DISEASE|DT|DICTIONARY	tumor	tumor	126#131		In conclusion, subjects with IL-1 beta -511TT genotype or IL-1 beta*T-IL-1RN*1 (T1) haplotype had lower risk for middle third tumor location of EC in a northern Indian population.
18396210	2008	Hum. Immunol.	0198-8859	ALL_TEXT_3/3	3	6	3557	SYMBOL|NUMBER|DICTIONARY	il 1rn	IL-1RN	70#76		D004938	SYMBOL|EXTRACTED	ec	EC	144#146	18396210-2-150-167	In conclusion, subjects with IL-1 beta -511TT genotype or IL-1 beta*T-IL-1RN*1 (T1) haplotype had lower risk for middle third tumor location of EC in a northern Indian population.
18396210	2008	Hum. Immunol.	0198-8859	ALL_TEXT_1/3	1	1	3553	SYMBOL|GENE|GN|DICTIONARY	interleukin (il)-1	Interleukin (IL)-1	0#18		D009369	LONGTERM|DISEASE|DT|DICTIONARY	cancer	cancer	86#92		Interleukin (IL)-1 gene polymorphisms affect several inflammatory diseases, including cancer.
18396210	2008	Hum. Immunol.	0198-8859	ALL_TEXT_1/3	1	1	3553	SYMBOL|GENE|GN|DICTIONARY	interleukin (il)-1	Interleukin (IL)-1	0#18		D007249	LONGTERM|DICTIONARY	inflammatory diseases	inflammatory diseases	53#74		Interleukin (IL)-1 gene polymorphisms affect several inflammatory diseases, including cancer.
18396210	2008	Hum. Immunol.	0198-8859	TITLE	0	0	3553	SYMBOL|NUMBER|DICTIONARY	il 1 beta	IL-1 beta	47#56		D004938	LONGTERM|DISEASE|DT|DICTIONARY	esophageal cancer	esophageal cancer	123#140		Potential influence of interleukin-1 haplotype IL-1 beta-511*T-IL-1RN*1 in conferring low risk to middle third location of esophageal cancer: a case-control study.
18396210	2008	Hum. Immunol.	0198-8859	TITLE	0	0	3557	SYMBOL|NUMBER|DICTIONARY	il 1rn	IL-1RN	63#69		D004938	LONGTERM|DISEASE|DT|DICTIONARY	esophageal cancer	esophageal cancer	123#140		Potential influence of interleukin-1 haplotype IL-1 beta-511*T-IL-1RN*1 in conferring low risk to middle third location of esophageal cancer: a case-control study.
18396210	2008	Hum. Immunol.	0198-8859	ALL_TEXT_1/3	1	2	3553	SYMBOL|DICTIONARY	il 1 beta	IL-1 beta	81#90		D004938	LONGTERM|DISEASE|DT|DICTIONARY	esophageal cancer	esophageal cancer	150#167		Therefore, we studied genetic association of biallelic (-511C>T) polymorphism of IL-1 beta and 86-bp VNTR polymorphism of IL-1RN in 159 patients with esophageal cancer (EC) and 194 age- and gender-matched healthy controls.
18396210	2008	Hum. Immunol.	0198-8859	ALL_TEXT_1/3	1	2	3553	SYMBOL|DICTIONARY	il 1 beta	IL-1 beta	81#90		D004938	SYMBOL|EXTRACTED|()	ec	EC	169#171	18396210-2-150-167	Therefore, we studied genetic association of biallelic (-511C>T) polymorphism of IL-1 beta and 86-bp VNTR polymorphism of IL-1RN in 159 patients with esophageal cancer (EC) and 194 age- and gender-matched healthy controls.
18396210	2008	Hum. Immunol.	0198-8859	ALL_TEXT_1/3	1	2	3557	SYMBOL|DICTIONARY	il 1rn	IL-1RN	122#128		D004938	LONGTERM|DISEASE|DT|DICTIONARY	esophageal cancer	esophageal cancer	150#167		Therefore, we studied genetic association of biallelic (-511C>T) polymorphism of IL-1 beta and 86-bp VNTR polymorphism of IL-1RN in 159 patients with esophageal cancer (EC) and 194 age- and gender-matched healthy controls.
18396210	2008	Hum. Immunol.	0198-8859	ALL_TEXT_1/3	1	2	3557	SYMBOL|DICTIONARY	il 1rn	IL-1RN	122#128		D004938	SYMBOL|EXTRACTED|()	ec	EC	169#171	18396210-2-150-167	Therefore, we studied genetic association of biallelic (-511C>T) polymorphism of IL-1 beta and 86-bp VNTR polymorphism of IL-1RN in 159 patients with esophageal cancer (EC) and 194 age- and gender-matched healthy controls.
17914947	2008	J. Gastroenterol. Hepatol.	0815-9319	CONCLUSIONS	4	7	7097	SYMBOL|DICTIONARY	tlr2	TLR2	53#57		D003424	SYMBOL|EXTRACTED	cd	CD	106#108	17914947-1-76-91	There was no evidence that the above variants of the TLR2, TLR4 and TLR9 genes are major risk factors for CD or influence disease phenotype in our New Zealand case-control study.
17914947	2008	J. Gastroenterol. Hepatol.	0815-9319	CONCLUSIONS	4	7	7099	SYMBOL|DICTIONARY	tlr4	TLR4	59#63		D003424	SYMBOL|EXTRACTED	cd	CD	106#108	17914947-1-76-91	There was no evidence that the above variants of the TLR2, TLR4 and TLR9 genes are major risk factors for CD or influence disease phenotype in our New Zealand case-control study.
17914947	2008	J. Gastroenterol. Hepatol.	0815-9319	CONCLUSIONS	4	7	54106	SYMBOL|GENE|GN|DICTIONARY	tlr9	TLR9	68#72		D003424	SYMBOL|EXTRACTED	cd	CD	106#108	17914947-1-76-91	There was no evidence that the above variants of the TLR2, TLR4 and TLR9 genes are major risk factors for CD or influence disease phenotype in our New Zealand case-control study.
17914947	2008	J. Gastroenterol. Hepatol.	0815-9319	RESULTS	3	6	7099	SYMBOL|DICTIONARY	tlr4	TLR4	94#98		D003424	SYMBOL|EXTRACTED	cd	CD	258#260	17914947-1-76-91	However, combination of the datasets of published studies with our dataset confirmed that the TLR4 polymorphism 299G (P = 0.0005; OR of 1.42 [95% CI 1.17-1.74]) and the TLR9 polymorphism -1237C (P = 0.0416; OR of 1.33 [95% CI 1.01-1.75]) are associated with CD.
17914947	2008	J. Gastroenterol. Hepatol.	0815-9319	RESULTS	3	6	54106	SYMBOL|DICTIONARY	tlr9	TLR9	169#173		D003424	SYMBOL|EXTRACTED	cd	CD	258#260	17914947-1-76-91	However, combination of the datasets of published studies with our dataset confirmed that the TLR4 polymorphism 299G (P = 0.0005; OR of 1.42 [95% CI 1.17-1.74]) and the TLR9 polymorphism -1237C (P = 0.0416; OR of 1.33 [95% CI 1.01-1.75]) are associated with CD.
17914947	2008	J. Gastroenterol. Hepatol.	0815-9319	TITLE	0	0	7097	SYMBOL|DICTIONARY	tlr2	TLR2	0#4		D003424	LONGTERM|DISEASE|DT|DICTIONARY	crohn disease	Crohn's disease	38#53		TLR2, TLR4 and TLR9 polymorphisms and Crohn's disease in a New Zealand Caucasian cohort.
17914947	2008	J. Gastroenterol. Hepatol.	0815-9319	TITLE	0	0	7099	SYMBOL|DICTIONARY	tlr4	TLR4	6#10		D003424	LONGTERM|DISEASE|DT|DICTIONARY	crohn disease	Crohn's disease	38#53		TLR2, TLR4 and TLR9 polymorphisms and Crohn's disease in a New Zealand Caucasian cohort.
17914947	2008	J. Gastroenterol. Hepatol.	0815-9319	TITLE	0	0	54106	SYMBOL|DICTIONARY	tlr9	TLR9	15#19		D003424	LONGTERM|DISEASE|DT|DICTIONARY	crohn disease	Crohn's disease	38#53		TLR2, TLR4 and TLR9 polymorphisms and Crohn's disease in a New Zealand Caucasian cohort.
17914947	2008	J. Gastroenterol. Hepatol.	0815-9319	BACKGROUND AND AIM	1	2	7097	SYMBOL|DICTIONARY	tlr2	TLR2	95#99		D003424	SYMBOL|EXTRACTED	cd	CD	125#127	17914947-1-76-91	Here we examined the association between candidate disease-susceptibility polymorphisms in the TLR2, TLR4 and TLR9 genes and CD in a New Zealand Caucasian population.
17914947	2008	J. Gastroenterol. Hepatol.	0815-9319	BACKGROUND AND AIM	1	2	7099	SYMBOL|DICTIONARY	tlr4	TLR4	101#105		D003424	SYMBOL|EXTRACTED	cd	CD	125#127	17914947-1-76-91	Here we examined the association between candidate disease-susceptibility polymorphisms in the TLR2, TLR4 and TLR9 genes and CD in a New Zealand Caucasian population.
17914947	2008	J. Gastroenterol. Hepatol.	0815-9319	BACKGROUND AND AIM	1	2	54106	SYMBOL|GENE|GN|DICTIONARY	tlr9	TLR9	110#114		D003424	SYMBOL|EXTRACTED	cd	CD	125#127	17914947-1-76-91	Here we examined the association between candidate disease-susceptibility polymorphisms in the TLR2, TLR4 and TLR9 genes and CD in a New Zealand Caucasian population.
18830229	2009	Eur. J. Hum. Genet.	1476-5438	ALL_TEXT_3/3	3	4	7248	SYMBOL|DICTIONARY	tsc1	TSC1	44#48		D014402	SYMBOL|DICTIONARY|EXTRACTED	tsc	TSC	124#127	18830229-1-0-26	Here we investigate the effects of putative TSC1 missense mutations identified in individuals with signs and/or symptoms of TSC on TSC1-TSC2 complex formation and mTOR signalling.
18830229	2009	Eur. J. Hum. Genet.	1476-5438	ALL_TEXT_3/3	3	4	7248	SYMBOL|DICTIONARY	tsc1	TSC1	131#135		D014402	SYMBOL|DICTIONARY|EXTRACTED	tsc	TSC	124#127	18830229-1-0-26	Here we investigate the effects of putative TSC1 missense mutations identified in individuals with signs and/or symptoms of TSC on TSC1-TSC2 complex formation and mTOR signalling.
18830229	2009	Eur. J. Hum. Genet.	1476-5438	ALL_TEXT_3/3	3	4	7249	SYMBOL|DICTIONARY	tsc2	TSC2	136#140		D014402	SYMBOL|DICTIONARY|EXTRACTED	tsc	TSC	124#127	18830229-1-0-26	Here we investigate the effects of putative TSC1 missense mutations identified in individuals with signs and/or symptoms of TSC on TSC1-TSC2 complex formation and mTOR signalling.
18830229	2009	Eur. J. Hum. Genet.	1476-5438	ALL_TEXT_3/3	3	5	7248	SYMBOL|DICTIONARY	tsc1	TSC1	74#78		D014402	SYMBOL|DICTIONARY|EXTRACTED	tsc	TSC	193#196	18830229-1-0-26	We show that specific amino-acid substitutions close to the N-terminal of TSC1 reduce steady-state levels of TSC1, resulting in the activation of mTOR signalling and leading to the symptoms of TSC.
18830229	2009	Eur. J. Hum. Genet.	1476-5438	ALL_TEXT_3/3	3	5	7248	SYMBOL|DICTIONARY	tsc1	TSC1	109#113		D014402	SYMBOL|DICTIONARY|EXTRACTED	tsc	TSC	193#196	18830229-1-0-26	We show that specific amino-acid substitutions close to the N-terminal of TSC1 reduce steady-state levels of TSC1, resulting in the activation of mTOR signalling and leading to the symptoms of TSC.
18830229	2009	Eur. J. Hum. Genet.	1476-5438	TITLE	0	0	7248	SYMBOL|GENE|GN|DICTIONARY	tsc1	TSC1	26#30		D014402	LONGTERM|DICTIONARY	tuberous sclerosis	tuberous sclerosis	42#60		Missense mutations to the TSC1 gene cause tuberous sclerosis complex.
19362357	2009	J. Allergy Clin. Immunol.	1097-6825	METHODS	3	6	30009	SYMBOL|DICTIONARY|EXTRACTED	tbx21	TBX21	43#48	19362357-1-20-46	D001249	LONGTERM|DICTIONARY	asthma	asthma	94#100		Furthermore, the impact of combinations of TBX21 and HLX1 polymorphisms on the development of asthma was assessed by using a risk score model.
19362357	2009	J. Allergy Clin. Immunol.	1097-6825	METHODS	3	6	3142	SYMBOL|DICTIONARY	hlx1	HLX1	53#57		D001249	LONGTERM|DICTIONARY	asthma	asthma	94#100		Furthermore, the impact of combinations of TBX21 and HLX1 polymorphisms on the development of asthma was assessed by using a risk score model.
19358091	2009	Exp. Clin. Endocrinol. Diabetes	1439-3646	INTRODUCTION	1	1	2645	LONGTERM|GENE|GN|DICTIONARY	glucokinase	glucokinase	17#28		D003924	LONGTERM|DICTIONARY	maturity onset diabetes in the young	Maturity onset diabetes in the young	61#97		Mutations in the glucokinase gene (GCK) produce a subtype of Maturity onset diabetes in the young (MODY), named MODY 2.
19358091	2009	Exp. Clin. Endocrinol. Diabetes	1439-3646	INTRODUCTION	1	1	2645	SYMBOL|DICTIONARY	mody 2	MODY 2	112#118		D003924	LONGTERM|DICTIONARY	maturity onset diabetes in the young	Maturity onset diabetes in the young	61#97		Mutations in the glucokinase gene (GCK) produce a subtype of Maturity onset diabetes in the young (MODY), named MODY 2.
19358091	2009	Exp. Clin. Endocrinol. Diabetes	1439-3646	TITLE	0	0	2645	LONGTERM|GENE|GN|DICTIONARY	glucokinase	Glucokinase	0#11		D003924	SYMBOL|DISEASE|DN|DICTIONARY	mody	MODY	76#80		Glucokinase gene mutation screening in Argentinean clinically characterized MODY patients.
9481718	1998	Nephrol. Dial. Transplant.	0931-0509	TITLE	0	0	348	LONGTERM|DICTIONARY	apoe	ApoE	0#4	NaN	D003920	LONGTERM|DICTIONARY	diabetes mellitus	diabetes mellitus	37#54		ApoE polymorphism and albuminuria in diabetes mellitus: a role for LDL in the development of nephropathy in NIDDM?
9481718	1998	Nephrol. Dial. Transplant.	0931-0509	TITLE	0	0	348	LONGTERM|DICTIONARY	apoe	ApoE	0#4	NaN	D007674	LONGTERM|DICTIONARY	nephropathy	nephropathy	93#104		ApoE polymorphism and albuminuria in diabetes mellitus: a role for LDL in the development of nephropathy in NIDDM?
9481718	1998	Nephrol. Dial. Transplant.	0931-0509	TITLE	0	0	348	LONGTERM|DICTIONARY	apoe	ApoE	0#4	NaN	D003924	LONGTERM|DICTIONARY|EXTRACTED	niddm	NIDDM	108#113		ApoE polymorphism and albuminuria in diabetes mellitus: a role for LDL in the development of nephropathy in NIDDM?
9481718	1998	Nephrol. Dial. Transplant.	0931-0509	TITLE	0	0	348	LONGTERM|DICTIONARY	apoe	ApoE	0#4	NaN	D000419	LONGTERM|DICTIONARY	albuminuria	albuminuria	22#33	NaN	ApoE polymorphism and albuminuria in diabetes mellitus: a role for LDL in the development of nephropathy in NIDDM?
1301936	1993	Hum. Mutat.	1059-7794	ALL_TEXT_2/3	2	3	4942	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	oat	OAT	137#140	1301936-0-34-60	D015799	LONGTERM|DICTIONARY	oat	OAT	137#140	NaN	In the present case, through sequencing of the PCR amplified cDNA products, we have detected a novel 15-bp deletion within exon 5 of the OAT gene which retains the original reading frame.
16721725	2006	Int. J. Cancer	0020-7136	TITLE	0	0	10	SYMBOL|DICTIONARY	nat2	NAT2	17#21		D001943	LONGTERM|DISEASE|DT|DICTIONARY	breast cancer	breast cancer	47#60		Tobacco smoking, NAT2 acetylation genotype and breast cancer risk.
16538170	2006	Pharmacogenet. Genomics	1744-6872	ALL_TEXT_1/3	1	3	1544	SYMBOL|NUMBER|DICTIONARY	cyp1a2	CYP1A2	84#90		D001943	LONGTERM|DISEASE|DT|DICTIONARY	breast cancer	breast cancer	134#147		In this study, we investigated whether two common polymorphisms in these two genes, CYP1A2*1F and AhR Lys554Arg, were associated with breast cancer risk in 1090 cases and 1183 controls, a subset of the population-based case-control study, the Shanghai Breast Cancer Study.
16538170	2006	Pharmacogenet. Genomics	1744-6872	ALL_TEXT_1/3	1	3	1544	SYMBOL|NUMBER|DICTIONARY	cyp1a2	CYP1A2	84#90		D001943	LONGTERM|DISEASE|DT|DICTIONARY	breast cancer	Breast Cancer	252#265		In this study, we investigated whether two common polymorphisms in these two genes, CYP1A2*1F and AhR Lys554Arg, were associated with breast cancer risk in 1090 cases and 1183 controls, a subset of the population-based case-control study, the Shanghai Breast Cancer Study.
16538170	2006	Pharmacogenet. Genomics	1744-6872	ALL_TEXT_1/3	1	3	196	SYMBOL|EXTRACTED	ahr	AhR	98#101	16538170-1-4-29	D001943	LONGTERM|DISEASE|DT|DICTIONARY	breast cancer	breast cancer	134#147		In this study, we investigated whether two common polymorphisms in these two genes, CYP1A2*1F and AhR Lys554Arg, were associated with breast cancer risk in 1090 cases and 1183 controls, a subset of the population-based case-control study, the Shanghai Breast Cancer Study.
16538170	2006	Pharmacogenet. Genomics	1744-6872	ALL_TEXT_1/3	1	3	196	SYMBOL|EXTRACTED	ahr	AhR	98#101	16538170-1-4-29	D001943	LONGTERM|DISEASE|DT|DICTIONARY	breast cancer	Breast Cancer	252#265		In this study, we investigated whether two common polymorphisms in these two genes, CYP1A2*1F and AhR Lys554Arg, were associated with breast cancer risk in 1090 cases and 1183 controls, a subset of the population-based case-control study, the Shanghai Breast Cancer Study.
14521605	2004	J. Thromb. Haemost.	1538-7933	CONCLUSIONS	5	13	7450	SYMBOL|DICTIONARY|EXTRACTED	vwf	VWF	94#97	14521605-1-58-79	C536458	SYMBOL|EXTRACTED	plt vwd	plt-VWD	34#41	14521605-2-0-36	The G233S is a molecular basis of plt-VWD, and residue 233 plays critical roles in regulating VWF binding.
18075470	2008	Pharmacogenet. Genomics	1744-6872	RESULTS	4	9	1544	SYMBOL|DICTIONARY	cyp1a2	CYP1A2	55#61		D010300	SYMBOL|EXTRACTED	pd	PD	79#81	18075470-4-52-71	No evidence existed to suggest any association between CYP1A2 and the onset of PD (P=0.08).
16538170	2006	Pharmacogenet. Genomics	1744-6872	ALL_TEXT_2/3	2	5	196	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	ahr	AhR	8#11	16538170-1-4-29	D001943	LONGTERM|DISEASE|DT|DICTIONARY	breast cancer	breast cancer	77#90		For the AhR gene, the A (Lys) allele was associated with a decreased risk of breast cancer.
21685359	2011	J. Natl. Cancer Inst.	1460-2105	METHODS	2	3	6275	SYMBOL|DICTIONARY	s100a4	S100A4	41#47		D003110	LONGTERM|DISEASE|DT|CLINE|CN|DICTIONARY	colon cancer	colon cancer	146#158		To identify a transcription inhibitor of S100A4, high-throughput screening of 1280 pharmacologically active compounds was performed using a human colon cancer cell line expressing a S100A4 promoter-driven luciferase (LUC) reporter gene construct (HCT116-S1004p-LUC).
21685359	2011	J. Natl. Cancer Inst.	1460-2105	METHODS	2	3	6275	SYMBOL|GENE|GN|DICTIONARY	s100a4	S100A4	182#188		D003110	LONGTERM|DISEASE|DT|CLINE|CN|DICTIONARY	colon cancer	colon cancer	146#158		To identify a transcription inhibitor of S100A4, high-throughput screening of 1280 pharmacologically active compounds was performed using a human colon cancer cell line expressing a S100A4 promoter-driven luciferase (LUC) reporter gene construct (HCT116-S1004p-LUC).
16517152	2006	Eur. J. Cancer	0959-8049	TITLE	0	0	4153	LONGTERM|DICTIONARY	mannose binding lectin	mannose-binding lectin	12#34		D009503	LONGTERM|DICTIONARY	febrile neutropenia	febrile neutropenia	78#97		The role of mannose-binding lectin (MBL) in paediatric oncology patients with febrile neutropenia.
16517152	2006	Eur. J. Cancer	0959-8049	TITLE	0	0	4153	SYMBOL|()|DICTIONARY|EXTRACTED	mbl	MBL	36#39	16517152-0-12-34	D009503	LONGTERM|DICTIONARY	febrile neutropenia	febrile neutropenia	78#97		The role of mannose-binding lectin (MBL) in paediatric oncology patients with febrile neutropenia.
17287556	2007	Indian J. Med. Res.	0971-5916	BACKGROUND &amp; OBJECTIVES	1	2	4843	SYMBOL|GENE|GN|DICTIONARY	nos	NOS	112#115		D003324	LONGTERM|DICTIONARY	coronary atherosclerosis	coronary atherosclerosis	69#93		Since reduced NO synthesis has been implicated in the development of coronary atherosclerosis; polymorphisms of NOS gene might be associated with increased susceptibility to this disorder and coronary artery disease (CAD).
17287556	2007	Indian J. Med. Res.	0971-5916	BACKGROUND &amp; OBJECTIVES	1	2	4843	SYMBOL|GENE|GN|DICTIONARY	nos	NOS	112#115		D003324	LONGTERM|DISEASE|DT|DICTIONARY	coronary artery disease	coronary artery disease	192#215		Since reduced NO synthesis has been implicated in the development of coronary atherosclerosis; polymorphisms of NOS gene might be associated with increased susceptibility to this disorder and coronary artery disease (CAD).
17287556	2007	Indian J. Med. Res.	0971-5916	BACKGROUND &amp; OBJECTIVES	1	2	4843	SYMBOL|GENE|GN|DICTIONARY	nos	NOS	112#115		D003324	SYMBOL|()|DICTIONARY|EXTRACTED	cad	CAD	217#220	17287556-2-192-215	Since reduced NO synthesis has been implicated in the development of coronary atherosclerosis; polymorphisms of NOS gene might be associated with increased susceptibility to this disorder and coronary artery disease (CAD).
17287556	2007	Indian J. Med. Res.	0971-5916	TITLE	0	0	4846	LONGTERM|GENE|GN|DICTIONARY	endothelial nitric oxide synthase	Endothelial nitric oxide synthase	0#33		D003324	LONGTERM|DISEASE|DT|DICTIONARY	coronary artery disease	coronary artery disease	82#105		Endothelial nitric oxide synthase gene intron4 VNTR polymorphism in patients with coronary artery disease in Iran.
19362357	2009	J. Allergy Clin. Immunol.	1097-6825	CONCLUSIONS	5	13	30009	SYMBOL|DICTIONARY|EXTRACTED	tbx21	TBX21	24#29	19362357-1-20-46	D001249	LONGTERM|DICTIONARY	asthma	asthma	77#83		These data suggest that TBX21 polymorphisms contribute to the development of asthma, potentially by altering TBX21 promoter activity.
19362357	2009	J. Allergy Clin. Immunol.	1097-6825	CONCLUSIONS	5	13	30009	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	tbx21	TBX21	109#114	19362357-1-20-46	D001249	LONGTERM|DICTIONARY	asthma	asthma	77#83		These data suggest that TBX21 polymorphisms contribute to the development of asthma, potentially by altering TBX21 promoter activity.
19773262	2010	Haematologica	1592-8721	TITLE	0	0	6125	SYMBOL|DICTIONARY	rpl5	RPL5	82#86		D029503	LONGTERM|DICTIONARY	diamond blackfan anemia	Diamond-Blackfan anemia	0#23		Diamond-Blackfan anemia: genotype-phenotype correlations in Italian patients with RPL5 and RPL11 mutations.
19773262	2010	Haematologica	1592-8721	TITLE	0	0	6135	SYMBOL|DICTIONARY	rpl11	RPL11	91#96		D029503	LONGTERM|DICTIONARY	diamond blackfan anemia	Diamond-Blackfan anemia	0#23		Diamond-Blackfan anemia: genotype-phenotype correlations in Italian patients with RPL5 and RPL11 mutations.
15738346	2005	Hypertension	1524-4563	ALL_TEXT_3/3	3	9	10891	SYMBOL|DICTIONARY	pgc 1alpha	PGC-1alpha	33#43		D006973	LONGTERM|DICTIONARY	hypertension	hypertension	94#106		In conclusion, the Ser allele of PGC-1alpha Gly482Ser confers a significantly reduced risk of hypertension in whites.
20812194	2010	Genet. Mol. Res.	1676-5680	ALL_TEXT_3/3	3	6	5444	SYMBOL|DICTIONARY|EXTRACTED	pon1	PON1	94#98	20812194-1-0-13	D001172	LONGTERM|DICTIONARY	rheumatoid arthritis	rheumatoid arthritis	107#127		There were no significant differences in the -107C/T polymorphism in the promoter sequence of PON1 between rheumatoid arthritis and normal subjects (chi(2) = 0.861, P = 0.650).
20812194	2010	Genet. Mol. Res.	1676-5680	ALL_TEXT_3/3	3	7	5444	SYMBOL|NUMBER|DICTIONARY|EXTRACTED	pon1	PON1	19#23	20812194-1-0-13	D001172	LONGTERM|DICTIONARY	rheumatoid arthritis	rheumatoid arthritis	59#79		In conclusion, the PON1 55MM genotype is a risk factor for rheumatoid arthritis.
20812194	2010	Genet. Mol. Res.	1676-5680	ALL_TEXT_2/3	2	4	5444	SYMBOL|NUMBER|DICTIONARY|EXTRACTED	pon1	PON1	22#26	20812194-1-0-13	D001172	LONGTERM|DISEASE|DN|DICTIONARY	rheumatoid arthritis	rheumatoid arthritis	73#93		The prevalence of the PON1 55MM genotype was significantly greater among rheumatoid arthritis patients (17%) when compared to control subjects (5.2%) (odds ratio (OR) = 3.75; 95% confidence interval (CI) = 1.87-11.8, P = 0.025).
20812194	2010	Genet. Mol. Res.	1676-5680	TITLE	0	0	5444	LONGTERM|DICTIONARY	paraoxonase 1	paraoxonase-1	25#38		D001172	LONGTERM|DICTIONARY	rheumatoid arthritis	rheumatoid arthritis	60#80		The L55M polymorphism of paraoxonase-1 is a risk factor for rheumatoid arthritis.
9047388	1997	Oncogene	0950-9232	TITLE	0	0	1029	SYMBOL|GENE|GN|DICTIONARY	p16	p16	19#22		D006258	LONGTERM|DISEASE|DT|DICTIONARY	head and neck cancer	head and neck cancer	31#51		Alterations of the p16 gene in head and neck cancer: frequency and association with p53, PRAD-1 and HPV.
9047388	1997	Oncogene	0950-9232	TITLE	0	0	595	SYMBOL|DICTIONARY	prad 1	PRAD-1	89#95		D006258	LONGTERM|DISEASE|DT|DICTIONARY	head and neck cancer	head and neck cancer	31#51		Alterations of the p16 gene in head and neck cancer: frequency and association with p53, PRAD-1 and HPV.
9047388	1997	Oncogene	0950-9232	TITLE	0	0	7157	LONGTERM|DICTIONARY	p53	p53	84#87	NaN	D006258	LONGTERM|DISEASE|DT|DICTIONARY	head and neck cancer	head and neck cancer	31#51		Alterations of the p16 gene in head and neck cancer: frequency and association with p53, PRAD-1 and HPV.
8942447	1997	Am J Psychiatry	0002-953X	OBJECTIVE	1	1	3123	SYMBOL|DICTIONARY	leukocyte antigen (hla) drb1	leukocyte antigen (HLA) DRB1	35#63		D001172	LONGTERM|DICTIONARY	rheumatoid arthritis	rheumatoid arthritis	139#159		The authors investigated the human leukocyte antigen (HLA) DRB1*04 gene in schizophrenic patients because it is positively associated with rheumatoid arthritis, an autoimmune disease that exhibits a strong negative association with schizophrenia.
8942447	1997	Am J Psychiatry	0002-953X	OBJECTIVE	1	1	3123	SYMBOL|DICTIONARY	leukocyte antigen (hla) drb1	leukocyte antigen (HLA) DRB1	35#63		D001327	LONGTERM|DISEASE|DT|DICTIONARY	autoimmune disease	autoimmune disease	164#182		The authors investigated the human leukocyte antigen (HLA) DRB1*04 gene in schizophrenic patients because it is positively associated with rheumatoid arthritis, an autoimmune disease that exhibits a strong negative association with schizophrenia.
8942447	1997	Am J Psychiatry	0002-953X	OBJECTIVE	1	1	3123	SYMBOL|DICTIONARY	leukocyte antigen (hla) drb1	leukocyte antigen (HLA) DRB1	35#63		D012559	LONGTERM|DICTIONARY	schizophrenia	schizophrenia	232#245		The authors investigated the human leukocyte antigen (HLA) DRB1*04 gene in schizophrenic patients because it is positively associated with rheumatoid arthritis, an autoimmune disease that exhibits a strong negative association with schizophrenia.
17898867	2007	Neoplasia	1476-5586	ALL_TEXT_3/3	3	11	1636	SYMBOL|DICTIONARY|EXTRACTED	ace	ACE	21#24	17898867-1-40-71	D009369	LONGTERM|DISEASE|DT|DICTIONARY	tumor	tumor	146#151		Our study shows that ACE is differentially expressed in CRCs and that gene polymorphism is associated with gender-specific differences in primary tumor size and patient survival.
19423162	2009	Leuk. Res.	1873-5835	TITLE	0	0	4193	SYMBOL|DICTIONARY	mdm2	MDM2	8#12		D015470	LONGTERM|DICTIONARY	acute myeloid leukemia	acute myeloid leukemia	82#104		Risk of MDM2 SNP309 alone or in combination with the p53 codon 72 polymorphism in acute myeloid leukemia.
19423162	2009	Leuk. Res.	1873-5835	TITLE	0	0	7157	SYMBOL|DICTIONARY	p53	p53	53#56		D015470	LONGTERM|DICTIONARY	acute myeloid leukemia	acute myeloid leukemia	82#104		Risk of MDM2 SNP309 alone or in combination with the p53 codon 72 polymorphism in acute myeloid leukemia.
18806915	2009	Eur Arch Psychiatry Clin Neurosci	1433-8491	CONCLUSIONS	4	12	6532	SYMBOL|DICTIONARY	5 httlpr	5-HTTLPR	60#68		C564323	LONGTERM|DICTIONARY	neuroticism	neuroticism	90#101		Our results thus yield further insight into the role of the 5-HTTLPR in the background of neuroticism and neuroticism-related psychiatric disorders.
18806915	2009	Eur Arch Psychiatry Clin Neurosci	1433-8491	CONCLUSIONS	4	12	6532	SYMBOL|DICTIONARY	5 httlpr	5-HTTLPR	60#68		C564323	LONGTERM|DICTIONARY	neuroticism	neuroticism	106#117		Our results thus yield further insight into the role of the 5-HTTLPR in the background of neuroticism and neuroticism-related psychiatric disorders.
18806915	2009	Eur Arch Psychiatry Clin Neurosci	1433-8491	CONCLUSIONS	4	12	6532	SYMBOL|DICTIONARY	5 httlpr	5-HTTLPR	60#68		D001523	LONGTERM|DICTIONARY	psychiatric disorders	psychiatric disorders	126#147		Our results thus yield further insight into the role of the 5-HTTLPR in the background of neuroticism and neuroticism-related psychiatric disorders.
18806915	2009	Eur Arch Psychiatry Clin Neurosci	1433-8491	CONCLUSIONS	4	10	6532	SYMBOL|DICTIONARY	5 httlpr	5-HTTLPR	308#316		C564323	LONGTERM|DICTIONARY	neuroticism	neuroticism	80#91		Our study is the first that confirms that traits and characteristics related to neuroticism, such as increased anxiety, depression, hopelessness, somatization, feeling of guilt, hostility, aggression, lack of self-directedness and affective temperament are consistently and independently associated with the 5-HTTLPR polymorphism of the serotonin transporter gene.
18806915	2009	Eur Arch Psychiatry Clin Neurosci	1433-8491	CONCLUSIONS	4	10	6532	SYMBOL|DICTIONARY	5 httlpr	5-HTTLPR	308#316		D001523	LONGTERM|DICTIONARY	aggression	aggression	189#199		Our study is the first that confirms that traits and characteristics related to neuroticism, such as increased anxiety, depression, hopelessness, somatization, feeling of guilt, hostility, aggression, lack of self-directedness and affective temperament are consistently and independently associated with the 5-HTTLPR polymorphism of the serotonin transporter gene.
18806915	2009	Eur Arch Psychiatry Clin Neurosci	1433-8491	CONCLUSIONS	4	10	6532	SYMBOL|DICTIONARY	5 httlpr	5-HTTLPR	308#316		D001008	LONGTERM|DICTIONARY	anxiety	anxiety	111#118		Our study is the first that confirms that traits and characteristics related to neuroticism, such as increased anxiety, depression, hopelessness, somatization, feeling of guilt, hostility, aggression, lack of self-directedness and affective temperament are consistently and independently associated with the 5-HTTLPR polymorphism of the serotonin transporter gene.
18806915	2009	Eur Arch Psychiatry Clin Neurosci	1433-8491	CONCLUSIONS	4	10	6532	SYMBOL|DICTIONARY	5 httlpr	5-HTTLPR	308#316		D003866	LONGTERM|DICTIONARY	depression	depression	120#130		Our study is the first that confirms that traits and characteristics related to neuroticism, such as increased anxiety, depression, hopelessness, somatization, feeling of guilt, hostility, aggression, lack of self-directedness and affective temperament are consistently and independently associated with the 5-HTTLPR polymorphism of the serotonin transporter gene.
15320482	2004	Orv Hetil	0030-6002	UNLABELLED	1	3	64127	SYMBOL|DICTIONARY	nod2	NOD2	63#67		D003424	LONGTERM|DICTIONARY	crohn's	Crohn's	98#105	NaN	The aim of this study was to determine the frequency of common NOD2/CARD15 mutations in Hungarian Crohn's patients.
15320482	2004	Orv Hetil	0030-6002	UNLABELLED	1	3	64127	SYMBOL|DICTIONARY	card15	CARD15	68#74		D003424	LONGTERM|DICTIONARY	crohn's	Crohn's	98#105	NaN	The aim of this study was to determine the frequency of common NOD2/CARD15 mutations in Hungarian Crohn's patients.
15320482	2004	Orv Hetil	0030-6002	UNLABELLED	1	1	64127	SYMBOL|DICTIONARY	nod2	NOD2	26#30		D003424	LONGTERM|DISEASE|DT|DICTIONARY	crohn disease	Crohn's disease	82#97		Recently mutations of the NOD2/CARD15 gene were identified as genetic markers for Crohn's disease (CD).
15320482	2004	Orv Hetil	0030-6002	UNLABELLED	1	1	64127	SYMBOL|DICTIONARY	nod2	NOD2	26#30		D003424	SYMBOL|EXTRACTED|()	cd	CD	99#101	15320482-1-82-97	Recently mutations of the NOD2/CARD15 gene were identified as genetic markers for Crohn's disease (CD).
15320482	2004	Orv Hetil	0030-6002	UNLABELLED	1	1	64127	SYMBOL|GENE|GN|DICTIONARY	card15	CARD15	31#37		D003424	LONGTERM|DISEASE|DT|DICTIONARY	crohn disease	Crohn's disease	82#97		Recently mutations of the NOD2/CARD15 gene were identified as genetic markers for Crohn's disease (CD).
15320482	2004	Orv Hetil	0030-6002	UNLABELLED	1	1	64127	SYMBOL|GENE|GN|DICTIONARY	card15	CARD15	31#37		D003424	SYMBOL|EXTRACTED|()	cd	CD	99#101	15320482-1-82-97	Recently mutations of the NOD2/CARD15 gene were identified as genetic markers for Crohn's disease (CD).
15048896	2004	Ann. Neurol.	0364-5134	TITLE	0	0	348	SYMBOL|DICTIONARY|EXTRACTED	apoe	APOE	77#81		D009103	SYMBOL|DISEASE|DN|DICTIONARY|EXTRACTED	ms	MS	60#62		"Accelerated evolution of brain atrophy and ""black holes"" in MS patients with APOE-epsilon 4."
15048896	2004	Ann. Neurol.	0364-5134	TITLE	0	0	348	SYMBOL|DICTIONARY|EXTRACTED	apoe	APOE	77#81		C566985	LONGTERM|DICTIONARY	"brain atrophy and ""black holes"	"brain atrophy and ""black holes"	25#55		"Accelerated evolution of brain atrophy and ""black holes"" in MS patients with APOE-epsilon 4."
19642078	2010	Musculoskeletal Care	1557-0681	OBJECTIVES	1	3	10599	SYMBOL|()|DICTIONARY	slco1b1	SLCO1B1	210#217		D009135	LONGTERM|DICTIONARY	myopathy	myopathy	63#71		Several factors increase the risk of developing statin-induced myopathy, including the single nucleotide polymorphism (SNP) rs4149056, located within the gene encoding solute carrier organic anion transporter (SLCO1B1).
19350278	2009	Pediatr. Nephrol.	1432-198X	TITLE	0	0	6092	SYMBOL|DICTIONARY	robo2	ROBO2	17#22		D014718	LONGTERM|DICTIONARY	familial vesico-ureteral reflux	familial vesico-ureteral reflux	58#89		Mutations in the ROBO2 and SLIT2 genes are rare causes of familial vesico-ureteral reflux.
19350278	2009	Pediatr. Nephrol.	1432-198X	TITLE	0	0	9353	SYMBOL|GENE|GN|DICTIONARY	slit2	SLIT2	27#32		D014718	LONGTERM|DICTIONARY	familial vesico-ureteral reflux	familial vesico-ureteral reflux	58#89		Mutations in the ROBO2 and SLIT2 genes are rare causes of familial vesico-ureteral reflux.
15571962	2005	Eur. J. Cancer	0959-8049	ALL_TEXT_3/3	3	7	675	SYMBOL|DICTIONARY	brca2	BRCA2	59#64		D010051	LONGTERM|DISEASE|DT|DICTIONARY	ovarian cancer	ovarian cancer	30#44		Odds Ratio (OR) of developing ovarian cancer was 20.65 for BRCA2 carriers.
7706461	1995	J. Clin. Invest.	0021-9738	ALL_TEXT_1/3	1	1	3674	SYMBOL|DICTIONARY	gpiib	GPIIb	44#49		D013915	LONGTERM|DICTIONARY	type ii glanzmann thrombasthenia	type II Glanzmann thrombasthenia	210#242		To gain insight into region of the platelet GPIIb-IIIa complex involved in receptor biogenesis and function, we examined the biochemical properties of a defective GPIIb-IIIa complex from patient suffering from type II Glanzmann thrombasthenia.
7706461	1995	J. Clin. Invest.	0021-9738	ALL_TEXT_1/3	1	1	3674	SYMBOL|DICTIONARY	gpiib	GPIIb	163#168		D013915	LONGTERM|DICTIONARY	type ii glanzmann thrombasthenia	type II Glanzmann thrombasthenia	210#242		To gain insight into region of the platelet GPIIb-IIIa complex involved in receptor biogenesis and function, we examined the biochemical properties of a defective GPIIb-IIIa complex from patient suffering from type II Glanzmann thrombasthenia.
20179607	2010	J. Cardiovasc. Pharmacol.	1533-4023	ALL_TEXT_1/3	1	3	1636	SYMBOL|DICTIONARY|EXTRACTED	ace	ACE	86#89	20179607-2-66-95	D002312	SYMBOL|DICTIONARY|EXTRACTED	hocm	HOCM	171#175	20179607-1-122-161	The aim of this study was to investigate the pharmacogenetic interactions between the ACE insertion/deletion polymorphism and the response to cibenzoline in patients with HOCM.
19018715	2009	Pharmacogenomics	1744-8042	ALL_TEXT_2/3	2	2	627	SYMBOL|DICTIONARY	bdnf	BDNF	131#135		D001714	LONGTERM|DICTIONARY	bipolar illness	bipolar illness	150#165		This paper describes a relationship between response to lithium prophylaxis and polymorphisms of two functionally connected genes: BDNF and NTRK2, in bipolar illness.
19018715	2009	Pharmacogenomics	1744-8042	ALL_TEXT_2/3	2	2	4915	SYMBOL|DICTIONARY	ntrk2	NTRK2	140#145		D001714	LONGTERM|DICTIONARY	bipolar illness	bipolar illness	150#165		This paper describes a relationship between response to lithium prophylaxis and polymorphisms of two functionally connected genes: BDNF and NTRK2, in bipolar illness.
19018715	2009	Pharmacogenomics	1744-8042	ALL_TEXT_1/3	1	1	627	SYMBOL|DICTIONARY	bdnf	BDNF	70#74		D001714	LONGTERM|DISEASE|DT|DICTIONARY	bipolar disorder	bipolar disorder	34#50		The neuroplasticity hypothesis of bipolar disorder indicates that the BDNF/Trk signaling pathway is associated with the pathogenesis of this illness and treatment with mood stabilizers, such as lithium.
19018715	2009	Pharmacogenomics	1744-8042	ALL_TEXT_1/3	1	1	4914	LONGTERM|DICTIONARY	trk	Trk	75#78	NaN	D001714	LONGTERM|DISEASE|DT|DICTIONARY	bipolar disorder	bipolar disorder	34#50		The neuroplasticity hypothesis of bipolar disorder indicates that the BDNF/Trk signaling pathway is associated with the pathogenesis of this illness and treatment with mood stabilizers, such as lithium.
15286153	2004	J. Med. Genet.	1468-6244	ALL_TEXT_3/3	3	5	83715	SYMBOL|DICTIONARY	espn	ESPN	50#54		D003638	LONGTERM|DICTIONARY	non-syndromic deafness	non-syndromic deafness	141#163	NaN	The abnormal vestibular phenotype associated with ESPN mutations will be a useful clinical marker for refining the differential diagnosis of non-syndromic deafness.
16359492	2006	Congenit Anom (Kyoto)	0914-3505	ALL_TEXT_1/3	1	1	1387	LONGTERM|GENE|GN|GT|DICTIONARY	creb-binding protein gene	CREB-binding protein gene	25#50		D012415	LONGTERM|DISEASE|DT|DICTIONARY	rubinstein taybi syndrome	Rubinstein-Taybi syndrome	58#83		Mutations in the CREBBP (CREB-binding protein gene) cause Rubinstein-Taybi syndrome (RSTS).
16359492	2006	Congenit Anom (Kyoto)	0914-3505	ALL_TEXT_1/3	1	1	1387	LONGTERM|GENE|GN|GT|DICTIONARY	creb-binding protein gene	CREB-binding protein gene	25#50		D012415	SYMBOL|EXTRACTED|()	rsts	RSTS	85#89	16359492-1-58-83	Mutations in the CREBBP (CREB-binding protein gene) cause Rubinstein-Taybi syndrome (RSTS).
18930330	2009	J. Hepatol.	0168-8278	BACKGROUND/AIMS	1	2	1493	SYMBOL|DICTIONARY	ctla 4	CTLA-4	90#96		D002779	LONGTERM|DICTIONARY	cholestasis	cholestasis	201#212		We investigated the impact of sequence diversity in candidate genes involved in immunity (CTLA-4 and TNFalpha), in bile formation (10 hepatobiliary transporter genes) and in the adaptative response to cholestasis (three nuclear receptor genes) on the susceptibility and severity of PBC.
18930330	2009	J. Hepatol.	0168-8278	BACKGROUND/AIMS	1	2	1493	SYMBOL|DICTIONARY	ctla 4	CTLA-4	90#96		D008105	SYMBOL|DICTIONARY|EXTRACTED	pbc	PBC	282#285	18930330-1-3-28	We investigated the impact of sequence diversity in candidate genes involved in immunity (CTLA-4 and TNFalpha), in bile formation (10 hepatobiliary transporter genes) and in the adaptative response to cholestasis (three nuclear receptor genes) on the susceptibility and severity of PBC.
18930330	2009	J. Hepatol.	0168-8278	BACKGROUND/AIMS	1	2	7124	LONGTERM|DICTIONARY	tnfalpha	TNFalpha	101#109	NaN	D002779	LONGTERM|DICTIONARY	cholestasis	cholestasis	201#212		We investigated the impact of sequence diversity in candidate genes involved in immunity (CTLA-4 and TNFalpha), in bile formation (10 hepatobiliary transporter genes) and in the adaptative response to cholestasis (three nuclear receptor genes) on the susceptibility and severity of PBC.
18930330	2009	J. Hepatol.	0168-8278	BACKGROUND/AIMS	1	2	7124	LONGTERM|DICTIONARY	tnfalpha	TNFalpha	101#109	NaN	D008105	SYMBOL|DICTIONARY|EXTRACTED	pbc	PBC	282#285	18930330-1-3-28	We investigated the impact of sequence diversity in candidate genes involved in immunity (CTLA-4 and TNFalpha), in bile formation (10 hepatobiliary transporter genes) and in the adaptative response to cholestasis (three nuclear receptor genes) on the susceptibility and severity of PBC.
15048896	2004	Ann. Neurol.	0364-5134	ALL_TEXT_1/3	1	1	348	LONGTERM|DICTIONARY	apolipoprotein e	Apolipoprotein E	0#16		D009103	LONGTERM|DICTIONARY	multiple sclerosis	multiple sclerosis	83#101		Apolipoprotein E (APOE)-epsilon4 has been associated with an unfavorable course of multiple sclerosis (MS).
15048896	2004	Ann. Neurol.	0364-5134	ALL_TEXT_1/3	1	1	348	LONGTERM|DICTIONARY	apolipoprotein e	Apolipoprotein E	0#16		D009103	SYMBOL|EXTRACTED|()	ms	MS	103#105	15048896-1-83-101	Apolipoprotein E (APOE)-epsilon4 has been associated with an unfavorable course of multiple sclerosis (MS).
15048896	2004	Ann. Neurol.	0364-5134	ALL_TEXT_1/3	1	1	348	SYMBOL|()|DICTIONARY|EXTRACTED	apoe	APOE	18#22	15048896-1-0-16	D009103	LONGTERM|DICTIONARY	multiple sclerosis	multiple sclerosis	83#101		Apolipoprotein E (APOE)-epsilon4 has been associated with an unfavorable course of multiple sclerosis (MS).
15048896	2004	Ann. Neurol.	0364-5134	ALL_TEXT_1/3	1	1	348	SYMBOL|()|DICTIONARY|EXTRACTED	apoe	APOE	18#22	15048896-1-0-16	D009103	SYMBOL|EXTRACTED|()	ms	MS	103#105	15048896-1-83-101	Apolipoprotein E (APOE)-epsilon4 has been associated with an unfavorable course of multiple sclerosis (MS).
18930330	2009	J. Hepatol.	0168-8278	RESULTS	3	5	1493	SYMBOL|DICTIONARY	ctla 4	CTLA-4	11#17		D008105	SYMBOL|DICTIONARY|EXTRACTED	pbc	PBC	90#93	18930330-1-3-28	Ht SNPs of CTLA-4 and TNFalpha genes were significantly associated with susceptibility to PBC.
18930330	2009	J. Hepatol.	0168-8278	RESULTS	3	5	7124	LONGTERM|DICTIONARY	tnfalpha	TNFalpha	22#30	NaN	D008105	SYMBOL|DICTIONARY|EXTRACTED	pbc	PBC	90#93	18930330-1-3-28	Ht SNPs of CTLA-4 and TNFalpha genes were significantly associated with susceptibility to PBC.
18930330	2009	J. Hepatol.	0168-8278	RESULTS	3	6	6522	SYMBOL|()|GENE|GN|DICTIONARY|EXTRACTED	ae2	AE2	155#158	18930330-6-136-153	D008107	LONGTERM|DISEASE|DT|DICTIONARY	liver disease	liver disease	24#37		The progression rate of liver disease under ursodeoxycholic acid (UDCA) therapy was significantly linked to SNPs of TNFalpha and SLC4A2/anion exchanger 2 (AE2) genes.
18930330	2009	J. Hepatol.	0168-8278	RESULTS	3	6	6522	SYMBOL|DICTIONARY	slc4a2/anion exchanger 2	SLC4A2/anion exchanger 2	129#153		D008107	LONGTERM|DISEASE|DT|DICTIONARY	liver disease	liver disease	24#37		The progression rate of liver disease under ursodeoxycholic acid (UDCA) therapy was significantly linked to SNPs of TNFalpha and SLC4A2/anion exchanger 2 (AE2) genes.
18930330	2009	J. Hepatol.	0168-8278	RESULTS	3	6	6522	SYMBOL|DICTIONARY|GENE|GA	slc4a2/anion exchanger 2	SLC4A2/anion exchanger 2	129#153		D008107	LONGTERM|DISEASE|DT|DICTIONARY	liver disease	liver disease	24#37		The progression rate of liver disease under ursodeoxycholic acid (UDCA) therapy was significantly linked to SNPs of TNFalpha and SLC4A2/anion exchanger 2 (AE2) genes.
18930330	2009	J. Hepatol.	0168-8278	RESULTS	3	6	7124	LONGTERM|DICTIONARY	tnfalpha	TNFalpha	116#124	NaN	D008107	LONGTERM|DISEASE|DT|DICTIONARY	liver disease	liver disease	24#37		The progression rate of liver disease under ursodeoxycholic acid (UDCA) therapy was significantly linked to SNPs of TNFalpha and SLC4A2/anion exchanger 2 (AE2) genes.
18191917	2008	Pathol. Biol.	0369-8114	ALL_TEXT_1/3	1	1	5621	LONGTERM|GENE|GN|GT|DICTIONARY	prion protein	prion protein	11#24		D017096	LONGTERM|DICTIONARY	prion diseases	prion diseases	104#118		The common prion protein gene (PRNP) codon 129 polymorphism is a strong susceptibility factor for human prion diseases.
9481718	1998	Nephrol. Dial. Transplant.	0931-0509	METHODS	2	4	348	LONGTERM|DICTIONARY	alipoprotein e	alipoprotein E	147#161	NaN	D007674	LONGTERM|DICTIONARY	nephropathy	nephropathy	29#40		We studied the prevalence of nephropathy (N+ = urinary albumin excretion rate (UAE) > 20 mg/d) in 134 Caucasian NIDDM patients ranked according to alipoprotein E (apoE) genotype (same distribution in 132 controls).
9481718	1998	Nephrol. Dial. Transplant.	0931-0509	METHODS	2	4	348	LONGTERM|DICTIONARY	alipoprotein e	alipoprotein E	147#161	NaN	D003924	LONGTERM|DISEASE|DN|DICTIONARY|EXTRACTED	niddm	NIDDM	112#117	9481718-2-28-67	We studied the prevalence of nephropathy (N+ = urinary albumin excretion rate (UAE) > 20 mg/d) in 134 Caucasian NIDDM patients ranked according to alipoprotein E (apoE) genotype (same distribution in 132 controls).
9481718	1998	Nephrol. Dial. Transplant.	0931-0509	METHODS	2	4	348	LONGTERM|DICTIONARY	apoe	apoE	163#167	NaN	D007674	LONGTERM|DICTIONARY	nephropathy	nephropathy	29#40		We studied the prevalence of nephropathy (N+ = urinary albumin excretion rate (UAE) > 20 mg/d) in 134 Caucasian NIDDM patients ranked according to alipoprotein E (apoE) genotype (same distribution in 132 controls).
9481718	1998	Nephrol. Dial. Transplant.	0931-0509	METHODS	2	4	348	LONGTERM|DICTIONARY	apoe	apoE	163#167	NaN	D003924	LONGTERM|DISEASE|DN|DICTIONARY|EXTRACTED	niddm	NIDDM	112#117	9481718-2-28-67	We studied the prevalence of nephropathy (N+ = urinary albumin excretion rate (UAE) > 20 mg/d) in 134 Caucasian NIDDM patients ranked according to alipoprotein E (apoE) genotype (same distribution in 132 controls).
11136712	2001	Hum. Mol. Genet.	0964-6906	ALL_TEXT_3/3	3	8	8820	SYMBOL|GENE|GN|DICTIONARY	hesx1	HESX1	171#176		D010900	LONGTERM|DICTIONARY	pituitary hypoplasia	pituitary hypoplasia	84#104		These results demonstrate that some sporadic cases of the more common mild forms of pituitary hypoplasia have a genetic basis, resulting from heterozygous mutation of the HESX1 gene.
9858366	1999	Neuroreport	0959-4965	TITLE	0	0	3782	LONGTERM|DICTIONARY	hskca3	hSKCa3	29#35	NaN	D012559	LONGTERM|DICTIONARY	schizophrenia	schizophrenia	57#70		Short CAG repeats within the hSKCa3 gene associated with schizophrenia: results of a family-based study.
11136712	2001	Hum. Mol. Genet.	0964-6906	ALL_TEXT_2/3	2	3	8820	SYMBOL|DICTIONARY	hesx1	Hesx1	63#68		D025962	SYMBOL|EXTRACTED	sod	SOD	95#98	11136712-1-39-60	Interestingly, a small proportion of mice heterozygous for the Hesx1 null allele show a milder SOD phenocopy, implying that heterozygous mutations in human HESX1 could underlie some cases of congenital pituitary hypoplasia with or without midline defects.
11136712	2001	Hum. Mol. Genet.	0964-6906	ALL_TEXT_2/3	2	3	8820	SYMBOL|DICTIONARY	hesx1	Hesx1	63#68		D009436	LONGTERM|DICTIONARY	congenital pituitary hypoplasia with or without midline defects	congenital pituitary hypoplasia with or without midline defects	191#254		Interestingly, a small proportion of mice heterozygous for the Hesx1 null allele show a milder SOD phenocopy, implying that heterozygous mutations in human HESX1 could underlie some cases of congenital pituitary hypoplasia with or without midline defects.
11136712	2001	Hum. Mol. Genet.	0964-6906	ALL_TEXT_2/3	2	3	8820	SYMBOL|DICTIONARY	hesx1	HESX1	156#161		D025962	SYMBOL|EXTRACTED	sod	SOD	95#98	11136712-1-39-60	Interestingly, a small proportion of mice heterozygous for the Hesx1 null allele show a milder SOD phenocopy, implying that heterozygous mutations in human HESX1 could underlie some cases of congenital pituitary hypoplasia with or without midline defects.
11136712	2001	Hum. Mol. Genet.	0964-6906	ALL_TEXT_2/3	2	3	8820	SYMBOL|DICTIONARY	hesx1	HESX1	156#161		D009436	LONGTERM|DICTIONARY	congenital pituitary hypoplasia with or without midline defects	congenital pituitary hypoplasia with or without midline defects	191#254		Interestingly, a small proportion of mice heterozygous for the Hesx1 null allele show a milder SOD phenocopy, implying that heterozygous mutations in human HESX1 could underlie some cases of congenital pituitary hypoplasia with or without midline defects.
11136712	2001	Hum. Mol. Genet.	0964-6906	ALL_TEXT_1/3	1	2	8820	SYMBOL|DICTIONARY	hesx1	HESX1	98#103		D025962	SYMBOL|EXTRACTED	sod	SOD	17#20	11136712-1-39-60	However, as most SOD/congenital hypopituitarism occurs sporadically, the possible contribution of HESX1 mutations to the aetiology of these cases is presently unclear.
11136712	2001	Hum. Mol. Genet.	0964-6906	ALL_TEXT_1/3	1	2	8820	SYMBOL|DICTIONARY	hesx1	HESX1	98#103		D007018	LONGTERM|DICTIONARY	congenital hypopituitarism	congenital hypopituitarism	21#47		However, as most SOD/congenital hypopituitarism occurs sporadically, the possible contribution of HESX1 mutations to the aetiology of these cases is presently unclear.
11136712	2001	Hum. Mol. Genet.	0964-6906	ALL_TEXT_1/3	1	1	8820	SYMBOL|DICTIONARY	hesx1	HESX1	272#277		D025962	SYMBOL|EXTRACTED|()	sod	SOD	62#65	11136712-1-39-60	We have previously shown that familial septo-optic dysplasia (SOD), a syndromic form of congenital hypopituitarism involving optic nerve hypoplasia and agenesis of midline brain structures, is associated with homozygosity for an inactivating mutation in the homeobox gene HESX1/Hesx1 in man and mouse.
11136712	2001	Hum. Mol. Genet.	0964-6906	ALL_TEXT_1/3	1	1	8820	SYMBOL|DICTIONARY	hesx1	HESX1	272#277		D009901	LONGTERM|DICTIONARY	optic nerve hypoplasia	optic nerve hypoplasia	125#147		We have previously shown that familial septo-optic dysplasia (SOD), a syndromic form of congenital hypopituitarism involving optic nerve hypoplasia and agenesis of midline brain structures, is associated with homozygosity for an inactivating mutation in the homeobox gene HESX1/Hesx1 in man and mouse.
11136712	2001	Hum. Mol. Genet.	0964-6906	ALL_TEXT_1/3	1	1	8820	SYMBOL|DICTIONARY	hesx1	HESX1	272#277		D025962	LONGTERM|DICTIONARY	familial septo-optic dysplasia	familial septo-optic dysplasia	30#60		We have previously shown that familial septo-optic dysplasia (SOD), a syndromic form of congenital hypopituitarism involving optic nerve hypoplasia and agenesis of midline brain structures, is associated with homozygosity for an inactivating mutation in the homeobox gene HESX1/Hesx1 in man and mouse.
11136712	2001	Hum. Mol. Genet.	0964-6906	ALL_TEXT_1/3	1	1	8820	SYMBOL|DICTIONARY	hesx1	HESX1	272#277		D007018	LONGTERM|DICTIONARY	congenital hypopituitarism	congenital hypopituitarism	88#114		We have previously shown that familial septo-optic dysplasia (SOD), a syndromic form of congenital hypopituitarism involving optic nerve hypoplasia and agenesis of midline brain structures, is associated with homozygosity for an inactivating mutation in the homeobox gene HESX1/Hesx1 in man and mouse.
11136712	2001	Hum. Mol. Genet.	0964-6906	ALL_TEXT_1/3	1	1	8820	SYMBOL|DICTIONARY	hesx1	Hesx1	278#283		D025962	SYMBOL|EXTRACTED|()	sod	SOD	62#65	11136712-1-39-60	We have previously shown that familial septo-optic dysplasia (SOD), a syndromic form of congenital hypopituitarism involving optic nerve hypoplasia and agenesis of midline brain structures, is associated with homozygosity for an inactivating mutation in the homeobox gene HESX1/Hesx1 in man and mouse.
11136712	2001	Hum. Mol. Genet.	0964-6906	ALL_TEXT_1/3	1	1	8820	SYMBOL|DICTIONARY	hesx1	Hesx1	278#283		D009901	LONGTERM|DICTIONARY	optic nerve hypoplasia	optic nerve hypoplasia	125#147		We have previously shown that familial septo-optic dysplasia (SOD), a syndromic form of congenital hypopituitarism involving optic nerve hypoplasia and agenesis of midline brain structures, is associated with homozygosity for an inactivating mutation in the homeobox gene HESX1/Hesx1 in man and mouse.
11136712	2001	Hum. Mol. Genet.	0964-6906	ALL_TEXT_1/3	1	1	8820	SYMBOL|DICTIONARY	hesx1	Hesx1	278#283		D025962	LONGTERM|DICTIONARY	familial septo-optic dysplasia	familial septo-optic dysplasia	30#60		We have previously shown that familial septo-optic dysplasia (SOD), a syndromic form of congenital hypopituitarism involving optic nerve hypoplasia and agenesis of midline brain structures, is associated with homozygosity for an inactivating mutation in the homeobox gene HESX1/Hesx1 in man and mouse.
11136712	2001	Hum. Mol. Genet.	0964-6906	ALL_TEXT_1/3	1	1	8820	SYMBOL|DICTIONARY	hesx1	Hesx1	278#283		D007018	LONGTERM|DICTIONARY	congenital hypopituitarism	congenital hypopituitarism	88#114		We have previously shown that familial septo-optic dysplasia (SOD), a syndromic form of congenital hypopituitarism involving optic nerve hypoplasia and agenesis of midline brain structures, is associated with homozygosity for an inactivating mutation in the homeobox gene HESX1/Hesx1 in man and mouse.
11136712	2001	Hum. Mol. Genet.	0964-6906	TITLE	0	0	8820	SYMBOL|DICTIONARY	hesx1	HESX1	13#18		D025962	LONGTERM|DICTIONARY	septo optic dysplasia	septo-optic dysplasia	90#111		Heterozygous HESX1 mutations associated with isolated congenital pituitary hypoplasia and septo-optic dysplasia.
11136712	2001	Hum. Mol. Genet.	0964-6906	TITLE	0	0	8820	SYMBOL|DICTIONARY	hesx1	HESX1	13#18		D010900	LONGTERM|DICTIONARY	congenital pituitary hypoplasia	congenital pituitary hypoplasia	54#85		Heterozygous HESX1 mutations associated with isolated congenital pituitary hypoplasia and septo-optic dysplasia.
11136712	2001	Hum. Mol. Genet.	0964-6906	ALL_TEXT_2/3	2	4	8820	SYMBOL|DICTIONARY	hesx1	HESX1	37#42		D004393	LONGTERM|DICTIONARY	isolated growth hormone deficiency	isolated growth hormone deficiency	149#183		Accordingly, we have now scanned for HESX1 mutations in 228 patients with a broad spectrum of congenital pituitary defects, ranging in severity from isolated growth hormone deficiency to SOD with panhypopituitarism.
11136712	2001	Hum. Mol. Genet.	0964-6906	ALL_TEXT_2/3	2	4	8820	SYMBOL|DICTIONARY	hesx1	HESX1	37#42		D025962	SYMBOL|EXTRACTED	sod	SOD	187#190	11136712-1-39-60	Accordingly, we have now scanned for HESX1 mutations in 228 patients with a broad spectrum of congenital pituitary defects, ranging in severity from isolated growth hormone deficiency to SOD with panhypopituitarism.
11136712	2001	Hum. Mol. Genet.	0964-6906	ALL_TEXT_2/3	2	4	8820	SYMBOL|DICTIONARY	hesx1	HESX1	37#42		C580003	LONGTERM|DICTIONARY	panhypopituitarism	panhypopituitarism	196#214		Accordingly, we have now scanned for HESX1 mutations in 228 patients with a broad spectrum of congenital pituitary defects, ranging in severity from isolated growth hormone deficiency to SOD with panhypopituitarism.
16259952	2006	Biochem. Biophys. Res. Commun.	0006-291X	ALL_TEXT_1/3	1	1	2353	LONGTERM|DICTIONARY	c-fos	c-fos	269#274	NaN	D006332	LONGTERM|DICTIONARY	cardiac hypertrophy	cardiac hypertrophy	67#86	NaN	We evaluated the effects of d-myo-inositol 1,4,5-tris-phosphate on cardiac hypertrophy. d-myo-inositol 1,4,5-tris-phosphate augmented cardiac hypertrophy as evidenced by its effects on DNA synthesis, protein synthesis, and expression of immediate-early genes c-myc and c-fos, beta-myosin heavy chain, and alpha-actin.
16259952	2006	Biochem. Biophys. Res. Commun.	0006-291X	ALL_TEXT_1/3	1	1	2353	LONGTERM|DICTIONARY	c-fos	c-fos	269#274	NaN	D006332	LONGTERM|DICTIONARY	cardiac hypertrophy	cardiac hypertrophy	134#153	NaN	We evaluated the effects of d-myo-inositol 1,4,5-tris-phosphate on cardiac hypertrophy. d-myo-inositol 1,4,5-tris-phosphate augmented cardiac hypertrophy as evidenced by its effects on DNA synthesis, protein synthesis, and expression of immediate-early genes c-myc and c-fos, beta-myosin heavy chain, and alpha-actin.
16259952	2006	Biochem. Biophys. Res. Commun.	0006-291X	ALL_TEXT_1/3	1	1	4609	LONGTERM|DICTIONARY	c-myc	c-myc	259#264	NaN	D006332	LONGTERM|DICTIONARY	cardiac hypertrophy	cardiac hypertrophy	67#86	NaN	We evaluated the effects of d-myo-inositol 1,4,5-tris-phosphate on cardiac hypertrophy. d-myo-inositol 1,4,5-tris-phosphate augmented cardiac hypertrophy as evidenced by its effects on DNA synthesis, protein synthesis, and expression of immediate-early genes c-myc and c-fos, beta-myosin heavy chain, and alpha-actin.
16259952	2006	Biochem. Biophys. Res. Commun.	0006-291X	ALL_TEXT_1/3	1	1	4609	LONGTERM|DICTIONARY	c-myc	c-myc	259#264	NaN	D006332	LONGTERM|DICTIONARY	cardiac hypertrophy	cardiac hypertrophy	134#153	NaN	We evaluated the effects of d-myo-inositol 1,4,5-tris-phosphate on cardiac hypertrophy. d-myo-inositol 1,4,5-tris-phosphate augmented cardiac hypertrophy as evidenced by its effects on DNA synthesis, protein synthesis, and expression of immediate-early genes c-myc and c-fos, beta-myosin heavy chain, and alpha-actin.
19079260	2009	Nat. Genet.	1546-1718	ALL_TEXT_3/3	3	5	79068	SYMBOL|DICTIONARY	fto	FTO	64#67		D009765	LONGTERM|DICTIONARY	obesity	obesity	165#172		This includes previously identified variants close to or in the FTO, MC4R, BDNF and SH2B1 genes, in addition to variants at seven loci not previously connected with obesity.
19079260	2009	Nat. Genet.	1546-1718	ALL_TEXT_3/3	3	5	4160	SYMBOL|DICTIONARY	mc4r	MC4R	69#73		D009765	LONGTERM|DICTIONARY	obesity	obesity	165#172		This includes previously identified variants close to or in the FTO, MC4R, BDNF and SH2B1 genes, in addition to variants at seven loci not previously connected with obesity.
19079260	2009	Nat. Genet.	1546-1718	ALL_TEXT_3/3	3	5	627	SYMBOL|DICTIONARY	bdnf	BDNF	75#79		D009765	LONGTERM|DICTIONARY	obesity	obesity	165#172		This includes previously identified variants close to or in the FTO, MC4R, BDNF and SH2B1 genes, in addition to variants at seven loci not previously connected with obesity.
19079260	2009	Nat. Genet.	1546-1718	ALL_TEXT_3/3	3	5	25970	SYMBOL|GENE|GN|DICTIONARY	sh2b1	SH2B1	84#89		D009765	LONGTERM|DICTIONARY	obesity	obesity	165#172		This includes previously identified variants close to or in the FTO, MC4R, BDNF and SH2B1 genes, in addition to variants at seven loci not previously connected with obesity.
9858366	1999	Neuroreport	0959-4965	ALL_TEXT_3/3	3	5	3782	LONGTERM|DICTIONARY	hskca3	hSKCa3	66#72	NaN	D012559	LONGTERM|DICTIONARY	schizophrenia	schizophrenia	103#116		Further studies using family-based designs should clarify whether hSKCa3 is a susceptibility factor to schizophrenia or co-segregates with a major disease gene in tight linkage.
12627470	2003	Am. J. Med. Genet. B Neuropsychiatr. Genet.	1552-4841	ALL_TEXT_3/3	3	7	2099	LONGTERM|DICTIONARY	eralpha	ERalpha	87#94	NaN	D001714	LONGTERM|DISEASE|DT|DICTIONARY	bipolar disorder	Bipolar Disorder	171#187		We conclude that variation in the coding sequence and flanking splice junctions of the ERalpha gene does not play an important pathogenic role in the majority of cases of Bipolar Disorder or Bipolar Affective Puerperal Psychosis.
12325071	2002	Ann. Neurol.	0364-5134	ALL_TEXT_1/3	1	1	2705	LONGTERM|DICTIONARY|GENE|GA	connexin 32	connexin 32	112#123		C535919	SYMBOL|()|DICTIONARY|EXTRACTED	cmtx	CMTX	38#42	12325071-1-9-36	X-linked Charcot-Marie-Tooth disease (CMTX) is a hereditary demyelinating neuropathy caused by mutations in the connexin 32 (Cx32) gene.
12325071	2002	Ann. Neurol.	0364-5134	ALL_TEXT_1/3	1	1	2705	LONGTERM|DICTIONARY|GENE|GA	connexin 32	connexin 32	112#123		C535919	LONGTERM|DISEASE|DT|DICTIONARY	x-linked charcot-marie-tooth disease	X-linked Charcot-Marie-Tooth disease	0#36		X-linked Charcot-Marie-Tooth disease (CMTX) is a hereditary demyelinating neuropathy caused by mutations in the connexin 32 (Cx32) gene.
12325071	2002	Ann. Neurol.	0364-5134	ALL_TEXT_1/3	1	1	2705	LONGTERM|DICTIONARY|GENE|GA	connexin 32	connexin 32	112#123		D020279	LONGTERM|DICTIONARY	hereditary demyelinating neuropathy	hereditary demyelinating neuropathy	49#84		X-linked Charcot-Marie-Tooth disease (CMTX) is a hereditary demyelinating neuropathy caused by mutations in the connexin 32 (Cx32) gene.
12325071	2002	Ann. Neurol.	0364-5134	ALL_TEXT_1/3	1	1	2705	SYMBOL|()|GENE|GN|DICTIONARY|EXTRACTED	cx32	Cx32	125#129	12325071-1-112-123	C535919	SYMBOL|()|DICTIONARY|EXTRACTED	cmtx	CMTX	38#42	12325071-1-9-36	X-linked Charcot-Marie-Tooth disease (CMTX) is a hereditary demyelinating neuropathy caused by mutations in the connexin 32 (Cx32) gene.
12325071	2002	Ann. Neurol.	0364-5134	ALL_TEXT_1/3	1	1	2705	SYMBOL|()|GENE|GN|DICTIONARY|EXTRACTED	cx32	Cx32	125#129	12325071-1-112-123	C535919	LONGTERM|DISEASE|DT|DICTIONARY	x-linked charcot-marie-tooth disease	X-linked Charcot-Marie-Tooth disease	0#36		X-linked Charcot-Marie-Tooth disease (CMTX) is a hereditary demyelinating neuropathy caused by mutations in the connexin 32 (Cx32) gene.
12325071	2002	Ann. Neurol.	0364-5134	ALL_TEXT_1/3	1	1	2705	SYMBOL|()|GENE|GN|DICTIONARY|EXTRACTED	cx32	Cx32	125#129	12325071-1-112-123	D020279	LONGTERM|DICTIONARY	hereditary demyelinating neuropathy	hereditary demyelinating neuropathy	49#84		X-linked Charcot-Marie-Tooth disease (CMTX) is a hereditary demyelinating neuropathy caused by mutations in the connexin 32 (Cx32) gene.
16757160	2007	Respir Med	0954-6111	BACKGROUND	1	2	3566	SYMBOL|GENE|GN|DICTIONARY	il-4 receptor	IL-4 receptor	12#25		D001249	LONGTERM|DICTIONARY	asthma	asthma	62#68		The gene of IL-4 receptor alpha chain is a candidate gene for asthma and atopy.
16507146	2006	Arthritis Res. Ther.	1478-6362	ALL_TEXT_2/3	2	7	7124	LONGTERM|DICTIONARY	tnfalpha	TNFalpha	54#62	NaN	D008180	SYMBOL|DICTIONARY|EXTRACTED	sle	SLE	77#80	16507146-1-103-131	Results showed a significantly higher amount of serum TNFalpha in the entire SLE population compared with controls.
9197423	1997	Cardiology	0008-6312	ALL_TEXT_1/3	1	1	1636	LONGTERM|GENE|GT|DICTIONARY|GA	angiotensin converting enzyme	angiotensin-converting enzyme	68#97		D017379	LONGTERM|DICTIONARY	left ventricular hypertrophy	left-ventricular hypertrophy	112#140		The relationship of an insertion/deletion (I/D) polymorphism of the angiotensin-converting enzyme (ACE) gene to left-ventricular hypertrophy in individuals with essential hypertension (EH) was investigated in a large population of Japanese men and women.
9197423	1997	Cardiology	0008-6312	ALL_TEXT_1/3	1	1	1636	LONGTERM|GENE|GT|DICTIONARY|GA	angiotensin converting enzyme	angiotensin-converting enzyme	68#97		D006973	LONGTERM|DICTIONARY	essential hypertension	essential hypertension	161#183		The relationship of an insertion/deletion (I/D) polymorphism of the angiotensin-converting enzyme (ACE) gene to left-ventricular hypertrophy in individuals with essential hypertension (EH) was investigated in a large population of Japanese men and women.
9197423	1997	Cardiology	0008-6312	ALL_TEXT_1/3	1	1	1636	LONGTERM|GENE|GT|DICTIONARY|GA	angiotensin converting enzyme	angiotensin-converting enzyme	68#97		D006973	SYMBOL|EXTRACTED|()	eh	EH	185#187	9197423-1-161-183	The relationship of an insertion/deletion (I/D) polymorphism of the angiotensin-converting enzyme (ACE) gene to left-ventricular hypertrophy in individuals with essential hypertension (EH) was investigated in a large population of Japanese men and women.
9197423	1997	Cardiology	0008-6312	ALL_TEXT_1/3	1	1	1636	SYMBOL|()|GENE|GN|DICTIONARY|EXTRACTED	ace	ACE	99#102	9197423-1-68-97	D017379	LONGTERM|DICTIONARY	left ventricular hypertrophy	left-ventricular hypertrophy	112#140		The relationship of an insertion/deletion (I/D) polymorphism of the angiotensin-converting enzyme (ACE) gene to left-ventricular hypertrophy in individuals with essential hypertension (EH) was investigated in a large population of Japanese men and women.
9197423	1997	Cardiology	0008-6312	ALL_TEXT_1/3	1	1	1636	SYMBOL|()|GENE|GN|DICTIONARY|EXTRACTED	ace	ACE	99#102	9197423-1-68-97	D006973	LONGTERM|DICTIONARY	essential hypertension	essential hypertension	161#183		The relationship of an insertion/deletion (I/D) polymorphism of the angiotensin-converting enzyme (ACE) gene to left-ventricular hypertrophy in individuals with essential hypertension (EH) was investigated in a large population of Japanese men and women.
9197423	1997	Cardiology	0008-6312	ALL_TEXT_1/3	1	1	1636	SYMBOL|()|GENE|GN|DICTIONARY|EXTRACTED	ace	ACE	99#102	9197423-1-68-97	D006973	SYMBOL|EXTRACTED|()	eh	EH	185#187	9197423-1-161-183	The relationship of an insertion/deletion (I/D) polymorphism of the angiotensin-converting enzyme (ACE) gene to left-ventricular hypertrophy in individuals with essential hypertension (EH) was investigated in a large population of Japanese men and women.
9197423	1997	Cardiology	0008-6312	TITLE	0	0	1636	LONGTERM|GENE|GN|GT|DICTIONARY	angiotensin converting enzyme	angiotensin-converting enzyme	46#75		D017379	LONGTERM|DICTIONARY	left ventricular hypertrophy	left-ventricular hypertrophy	86#114		Association of a deletion polymorphism of the angiotensin-converting enzyme gene with left-ventricular hypertrophy in Japanese women with essential hypertension; multicenter study of 1,919 subjects.
9197423	1997	Cardiology	0008-6312	TITLE	0	0	1636	LONGTERM|GENE|GN|GT|DICTIONARY	angiotensin converting enzyme	angiotensin-converting enzyme	46#75		D006973	LONGTERM|DICTIONARY	essential hypertension	essential hypertension	138#160		Association of a deletion polymorphism of the angiotensin-converting enzyme gene with left-ventricular hypertrophy in Japanese women with essential hypertension; multicenter study of 1,919 subjects.
9197423	1997	Cardiology	0008-6312	ALL_TEXT_2/3	2	3	1636	SYMBOL|DICTIONARY|EXTRACTED	ace	ACE	20#23	9197423-1-68-97	D006973	SYMBOL|EXTRACTED	eh	EH	85#87	9197423-1-161-183	The distribution of ACE genotypes did not differ significantly between patients with EH and control in both men and women.
9197423	1997	Cardiology	0008-6312	ALL_TEXT_1/3	1	2	1636	SYMBOL|DICTIONARY|EXTRACTED	ace	ACE	4#7	9197423-1-68-97	D006973	SYMBOL|EXTRACTED	eh	EH	38#40	9197423-1-161-183	The ACE genotype of 762 subjects with EH (425 men and 337 women) and 1,157 healthy controls (604 men and 553 women) was determined by polymerase chain reaction analysis.
16510718	2006	J. Neurosci.	1529-2401	ALL_TEXT_3/3	3	7	2332	SYMBOL|DICTIONARY|EXTRACTED	fmrp	FMRP	52#56	16510718-1-0-36	D014947	LONGTERM|DICTIONARY	injury discharge	injury discharge	13#29	NaN	Although the injury discharge subsided beyond 10 s, FMRP levels in polyribosomes and stress granules did not return to basal levels until 30 min after electrode penetration.
16510718	2006	J. Neurosci.	1529-2401	ALL_TEXT_3/3	3	5	2332	SYMBOL|DICTIONARY|EXTRACTED	fmrp	FMRP	17#21	16510718-1-0-36	D009410	LONGTERM|DICTIONARY	neuronal injury	neuronal injury	94#109	NaN	We then examined FMRP changes in subcellular localization resulting from mechanically induced neuronal injury by placement of electrodes into the dentate gyrus and the perforant path of the hippocampus in vivo.
16510718	2006	J. Neurosci.	1529-2401	TITLE	0	0	2332	LONGTERM|GENE|GT|DICTIONARY	fragile x mental retardation protein	Fragile X mental retardation protein	0#36		D009410	LONGTERM|DICTIONARY	neuronal injury	neuronal injury	92#107	NaN	Fragile X mental retardation protein shifts between polyribosomes and stress granules after neuronal injury by arsenite stress or in vivo hippocampal electrode insertion.
16510718	2006	J. Neurosci.	1529-2401	ALL_TEXT_1/3	1	1	2332	LONGTERM|GENE|GT|DICTIONARY	fragile x mental retardation protein	Fragile X mental retardation protein	0#36		D005600	LONGTERM|DISEASE|DT|DICTIONARY	fragile x syndrome	fragile X syndrome	70#88		Fragile X mental retardation protein (FMRP), the lack of which causes fragile X syndrome, is an RNA-binding protein encoded by the FMR1 gene.
16510718	2006	J. Neurosci.	1529-2401	ALL_TEXT_1/3	1	1	2332	SYMBOL|()|DICTIONARY|EXTRACTED	fmrp	FMRP	38#42	16510718-1-0-36	D005600	LONGTERM|DISEASE|DT|DICTIONARY	fragile x syndrome	fragile X syndrome	70#88		Fragile X mental retardation protein (FMRP), the lack of which causes fragile X syndrome, is an RNA-binding protein encoded by the FMR1 gene.
16510718	2006	J. Neurosci.	1529-2401	ALL_TEXT_1/3	1	1	2332	SYMBOL|GENE|GN|DICTIONARY	fmr1	FMR1	131#135		D005600	LONGTERM|DISEASE|DT|DICTIONARY	fragile x syndrome	fragile X syndrome	70#88		Fragile X mental retardation protein (FMRP), the lack of which causes fragile X syndrome, is an RNA-binding protein encoded by the FMR1 gene.
17680820	2007	Clin. Exp. Immunol.	0009-9104	ALL_TEXT_3/3	3	5	2220	LONGTERM|DICTIONARY	l ficolin	l-ficolin	48#57		D012141	LONGTERM|DICTIONARY	respiratory infections	respiratory infections	176#198		We selected groups possessing low or high serum l-ficolin concentrations (<or= 2.8 microg/ml or >or= 4.5 microg/ml, respectively) from Polish children suffering from recurrent respiratory infections (n = 146).
12656452	2003	J Natl Med Assoc	0027-9684	ALL_TEXT_1/3	1	1	348	SYMBOL|()|DICTIONARY	apoe4	ApoE4	63#68		D020521	LONGTERM|DICTIONARY	stroke	stroke	99#105		"Through its role in lipid metabolism, Apolipoprotein epsilon4 (ApoE4) may affect ""brain repair"" in stroke, brain hemorrhage, Alzheimer's disease, and other brain injury syndromes for which African Americans may have greater morbidity and mortality."
12656452	2003	J Natl Med Assoc	0027-9684	ALL_TEXT_1/3	1	1	348	SYMBOL|()|DICTIONARY	apoe4	ApoE4	63#68		D000544	LONGTERM|DISEASE|DT|DICTIONARY	alzheimer disease	Alzheimer's disease	125#144		"Through its role in lipid metabolism, Apolipoprotein epsilon4 (ApoE4) may affect ""brain repair"" in stroke, brain hemorrhage, Alzheimer's disease, and other brain injury syndromes for which African Americans may have greater morbidity and mortality."
12656452	2003	J Natl Med Assoc	0027-9684	ALL_TEXT_1/3	1	1	348	SYMBOL|()|DICTIONARY	apoe4	ApoE4	63#68		D001930	LONGTERM|DICTIONARY	brain injury syndromes	brain injury syndromes	156#178		"Through its role in lipid metabolism, Apolipoprotein epsilon4 (ApoE4) may affect ""brain repair"" in stroke, brain hemorrhage, Alzheimer's disease, and other brain injury syndromes for which African Americans may have greater morbidity and mortality."
12656452	2003	J Natl Med Assoc	0027-9684	ALL_TEXT_1/3	1	1	348	SYMBOL|()|DICTIONARY	apoe4	ApoE4	63#68		D020300	LONGTERM|DICTIONARY	brain hemorrhage	brain hemorrhage	107#123	NaN	"Through its role in lipid metabolism, Apolipoprotein epsilon4 (ApoE4) may affect ""brain repair"" in stroke, brain hemorrhage, Alzheimer's disease, and other brain injury syndromes for which African Americans may have greater morbidity and mortality."
17918232	2008	Am. J. Med. Genet. B Neuropsychiatr. Genet.	1552-485X	ALL_TEXT_3/3	3	8	6622	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	snca	SNCA	48#52	17918232-3-17-32	D003704	LONGTERM|DICTIONARY	dementia	dementia	85#93		Our data suggest the lack of involvement of the SNCA promoter in the pathogenesis of dementia in PD.
17918232	2008	Am. J. Med. Genet. B Neuropsychiatr. Genet.	1552-485X	ALL_TEXT_3/3	3	8	6622	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	snca	SNCA	48#52	17918232-3-17-32	D010300	SYMBOL|EXTRACTED	pd	PD	97#99	17918232-1-37-56	Our data suggest the lack of involvement of the SNCA promoter in the pathogenesis of dementia in PD.
17680820	2007	Clin. Exp. Immunol.	0009-9104	TITLE	0	0	2220	LONGTERM|DICTIONARY	l ficolin	L-ficolin	12#21		D007239	LONGTERM|DICTIONARY	infections	infections	63#73		Extremes of L-ficolin concentration in children with recurrent infections are associated with single nucleotide polymorphisms in the FCN2 gene.
17680820	2007	Clin. Exp. Immunol.	0009-9104	TITLE	0	0	2220	SYMBOL|GENE|GN|DICTIONARY	fcn2	FCN2	133#137		D007239	LONGTERM|DICTIONARY	infections	infections	63#73		Extremes of L-ficolin concentration in children with recurrent infections are associated with single nucleotide polymorphisms in the FCN2 gene.
17918232	2008	Am. J. Med. Genet. B Neuropsychiatr. Genet.	1552-485X	ALL_TEXT_1/3	1	3	6622	SYMBOL|GENE|GN|DICTIONARY	alpha synuclein	alpha-synuclein	17#32		D010300	SYMBOL|EXTRACTED	pd	PD	88#90	17918232-1-37-56	Mutations of the alpha-synuclein gene (SNCA) have been linked to rare familial forms of PD, while association studies on the promoter polymorphisms have given conflicting results in sporadic patients.
17918232	2008	Am. J. Med. Genet. B Neuropsychiatr. Genet.	1552-485X	ALL_TEXT_1/3	1	3	6622	SYMBOL|()|DICTIONARY|EXTRACTED	snca	SNCA	39#43	17918232-3-17-32	D010300	SYMBOL|EXTRACTED	pd	PD	88#90	17918232-1-37-56	Mutations of the alpha-synuclein gene (SNCA) have been linked to rare familial forms of PD, while association studies on the promoter polymorphisms have given conflicting results in sporadic patients.
17918232	2008	Am. J. Med. Genet. B Neuropsychiatr. Genet.	1552-485X	TITLE	0	0	6622	SYMBOL|GENE|GN|DICTIONARY	alpha synuclein	Alpha-synuclein	0#15		D003704	LONGTERM|DISEASE|DT|DICTIONARY	dementia	dementia	40#48		Alpha-synuclein promoter haplotypes and dementia in Parkinson's disease.
17918232	2008	Am. J. Med. Genet. B Neuropsychiatr. Genet.	1552-485X	TITLE	0	0	6622	SYMBOL|GENE|GN|DICTIONARY	alpha synuclein	Alpha-synuclein	0#15		D010300	LONGTERM|DISEASE|DT|DICTIONARY	parkinson's disease	Parkinson's disease	52#71		Alpha-synuclein promoter haplotypes and dementia in Parkinson's disease.
11933203	2002	Hum. Mutat.	1098-1004	TITLE	0	0	6696	LONGTERM|DICTIONARY	osteopontin	osteopontin	3#14		D008180	LONGTERM|DICTIONARY	systemic lupus erythematosus	systemic lupus erythematosus	54#82		An osteopontin (SPP1) polymorphism is associated with systemic lupus erythematosus.
11933203	2002	Hum. Mutat.	1098-1004	TITLE	0	0	6696	SYMBOL|()|DICTIONARY|EXTRACTED	spp1	SPP1	16#20	11933203-0-3-14	D008180	LONGTERM|DICTIONARY	systemic lupus erythematosus	systemic lupus erythematosus	54#82		An osteopontin (SPP1) polymorphism is associated with systemic lupus erythematosus.
17918232	2008	Am. J. Med. Genet. B Neuropsychiatr. Genet.	1552-485X	ALL_TEXT_2/3	2	4	6622	SYMBOL|GENE|GN|DICTIONARY	alpha synuclein	alpha-synuclein	105#120		D003704	LONGTERM|DICTIONARY	dementia	dementia	146#154		We have performed a case control study to investigate whether genetic variability in the promoter of the alpha-synuclein gene could predispose to dementia in PD.
17918232	2008	Am. J. Med. Genet. B Neuropsychiatr. Genet.	1552-485X	ALL_TEXT_2/3	2	4	6622	SYMBOL|GENE|GN|DICTIONARY	alpha synuclein	alpha-synuclein	105#120		D010300	SYMBOL|EXTRACTED	pd	PD	158#160	17918232-1-37-56	We have performed a case control study to investigate whether genetic variability in the promoter of the alpha-synuclein gene could predispose to dementia in PD.
19509271	2009	Mol. Cancer Ther.	1538-8514	TITLE	0	0	1268	LONGTERM|DICTIONARY	cannabinoid receptor 1	Cannabinoid receptor 1	0#22		D012208	LONGTERM|DICTIONARY	rhabdomyosarcoma	rhabdomyosarcoma	90#106		Cannabinoid receptor 1 is a potential drug target for treatment of translocation-positive rhabdomyosarcoma.
12574109	2003	Hypertension	1524-4563	ALL_TEXT_3/3	3	9	10891	SYMBOL|DICTIONARY	ppargc1	PPARGC1	46#53		D006973	LONGTERM|DICTIONARY	hypertension	hypertension	167#179		These results suggest, but do not prove, that PPARGC1 participates in blood pressure control, and sequence substitutions at its gene locus confer an increased risk of hypertension to a substantial proportion of men.
16043121	2005	Biochem. Biophys. Res. Commun.	0006-291X	TITLE	0	0	2833	SYMBOL|DICTIONARY|EXTRACTED	cxcr3	CXCR3	0#5		D001249	LONGTERM|DICTIONARY	asthma	asthma	44#50		CXCR3 polymorphisms associated with risk of asthma.
16043121	2005	Biochem. Biophys. Res. Commun.	0006-291X	ALL_TEXT_3/3	3	6	2833	SYMBOL|DICTIONARY|EXTRACTED	cxcr3	CXCR3	0#5		D001249	LONGTERM|DICTIONARY	asthma	asthma	144#150		CXCR3 variation/haplotype information identified in this study will provide valuable information and insight into strategies for the control of asthma and its subgroup, atopy.
16043121	2005	Biochem. Biophys. Res. Commun.	0006-291X	ALL_TEXT_3/3	3	5	2833	SYMBOL|DICTIONARY|EXTRACTED	cxcr3	CXCR3	43#48	16043121-1-4-38	D001249	LONGTERM|DICTIONARY	asthma	asthma	101#107		Our findings suggest that polymorphisms in CXCR3 might be one of the genetic factors for the risk of asthma development, especially in male atopic subjects.
12378512	2002	Hum. Pathol.	0046-8177	ALL_TEXT_1/3	1	3	7157	SYMBOL|DICTIONARY	p53	p53	40#43		D008113	LONGTERM|DICTIONARY	liver angiosarcoma	liver angiosarcoma	55#73		Alterations of p14(ARF), p16(INKa), and p53 in primary liver angiosarcoma from 19 patients were analyzed by methylation-specific polymerase chain reaction (MSP), restriction enzyme-related polymerase chain reaction (RE-PCR), microsatellite analysis, and DNA sequencing.
12378512	2002	Hum. Pathol.	0046-8177	ALL_TEXT_1/3	1	3	1029	LONGTERM|DICTIONARY	p14	p14	15#18	NaN	D008113	LONGTERM|DICTIONARY	liver angiosarcoma	liver angiosarcoma	55#73		Alterations of p14(ARF), p16(INKa), and p53 in primary liver angiosarcoma from 19 patients were analyzed by methylation-specific polymerase chain reaction (MSP), restriction enzyme-related polymerase chain reaction (RE-PCR), microsatellite analysis, and DNA sequencing.
12378512	2002	Hum. Pathol.	0046-8177	ALL_TEXT_1/3	1	3	1029	LONGTERM|DICTIONARY	p16	p16	25#28	NaN	D008113	LONGTERM|DICTIONARY	liver angiosarcoma	liver angiosarcoma	55#73		Alterations of p14(ARF), p16(INKa), and p53 in primary liver angiosarcoma from 19 patients were analyzed by methylation-specific polymerase chain reaction (MSP), restriction enzyme-related polymerase chain reaction (RE-PCR), microsatellite analysis, and DNA sequencing.
12574109	2003	Hypertension	1524-4563	ALL_TEXT_1/3	1	2	10891	SYMBOL|GENE|GN|DICTIONARY	ppargc1	PPARGC1	37#44		D006973	LONGTERM|DICTIONARY	hypertension	hypertension	75#87		We therefore ascertained whether the PPARGC1 gene locus is associated with hypertension.
12574109	2003	Hypertension	1524-4563	ALL_TEXT_1/3	1	3	10891	SYMBOL|DICTIONARY	ppargc1	PPARGC1	46#53		D006973	LONGTERM|DICTIONARY	hypertension	hypertension	71#83		We studied associations of 3 polymorphisms in PPARGC1 transcripts with hypertension in 683 middle-aged men and 530 middle-aged women of a cross-sectional Austrian population.
16128377	2006	Acta Cardiol	0001-5385	CONCLUSION	4	18	1636	SYMBOL|DICTIONARY|EXTRACTED	ace	ACE	22#25	16128377-1-91-120	D006973	LONGTERM|DICTIONARY	hypertension	hypertension	83#95		Our data suggest that ACE-DD polymorphism is associated with a higher incidence of hypertension in baseline healthy subjects, irrespective of other risk factors, and appears to affect the diastolic function.
16128377	2006	Acta Cardiol	0001-5385	CONCLUSION	4	18	1636	SYMBOL|DICTIONARY|EXTRACTED	ace	ACE	22#25	16128377-1-91-120	C536170	LONGTERM|DICTIONARY	dd	DD	26#28	NaN	Our data suggest that ACE-DD polymorphism is associated with a higher incidence of hypertension in baseline healthy subjects, irrespective of other risk factors, and appears to affect the diastolic function.
15939053	2005	Atherosclerosis	0021-9150	ALL_TEXT_1/3	1	1	1071	LONGTERM|GENE|GT|DICTIONARY	cholesteryl ester transfer protein	cholesteryl ester transfer protein	33#67		D002318	LONGTERM|DISEASE|DT|DICTIONARY	cardiovascular disease	cardiovascular disease	78#100		To better understand the role of cholesteryl ester transfer protein (CETP) in cardiovascular disease, nine polymorphisms spanning the gene from the upstream promoter region to beyond the 3'UTR were genotyped in 2553 individuals from multiple ethnic groups and with different cardiovascular disease profiles.
15939053	2005	Atherosclerosis	0021-9150	ALL_TEXT_1/3	1	1	1071	LONGTERM|GENE|GT|DICTIONARY	cholesteryl ester transfer protein	cholesteryl ester transfer protein	33#67		D002318	LONGTERM|DISEASE|DT|DICTIONARY	cardiovascular disease	cardiovascular disease	275#297		To better understand the role of cholesteryl ester transfer protein (CETP) in cardiovascular disease, nine polymorphisms spanning the gene from the upstream promoter region to beyond the 3'UTR were genotyped in 2553 individuals from multiple ethnic groups and with different cardiovascular disease profiles.
15939053	2005	Atherosclerosis	0021-9150	ALL_TEXT_1/3	1	1	1071	SYMBOL|()|DICTIONARY|EXTRACTED	cetp	CETP	69#73	15939053-1-33-67	D002318	LONGTERM|DISEASE|DT|DICTIONARY	cardiovascular disease	cardiovascular disease	78#100		To better understand the role of cholesteryl ester transfer protein (CETP) in cardiovascular disease, nine polymorphisms spanning the gene from the upstream promoter region to beyond the 3'UTR were genotyped in 2553 individuals from multiple ethnic groups and with different cardiovascular disease profiles.
15939053	2005	Atherosclerosis	0021-9150	ALL_TEXT_1/3	1	1	1071	SYMBOL|()|DICTIONARY|EXTRACTED	cetp	CETP	69#73	15939053-1-33-67	D002318	LONGTERM|DISEASE|DT|DICTIONARY	cardiovascular disease	cardiovascular disease	275#297		To better understand the role of cholesteryl ester transfer protein (CETP) in cardiovascular disease, nine polymorphisms spanning the gene from the upstream promoter region to beyond the 3'UTR were genotyped in 2553 individuals from multiple ethnic groups and with different cardiovascular disease profiles.
16133961	2005	Dig. Dis. Sci.	0163-2116	TITLE	0	0	1557	SYMBOL|DICTIONARY	cyp2c19	CYP2C19	97#104		D014456	LONGTERM|DICTIONARY	ulcer healing of omeprazole versus rabeprazole	ulcer healing of omeprazole versus rabeprazole	34#80		A comparative study on endoscopic ulcer healing of omeprazole versus rabeprazole with respect to CYP2C19 genotypic differences.
14650112	2004	Isr. Med. Assoc. J.	1565-1088	METHODS	3	4	154	LONGTERM|DICTIONARY	beta 2ar	beta 2AR	175#183	NaN	D013224	LONGTERM|DICTIONARY	asthmatics	asthmatics	34#44		Sixty-six Israeli Jewish and Arab asthmatics who had near-fatal asthma and/or severe nocturnal asthma and/or steroid-dependency were investigated for genetic polymorphisms of beta 2AR and compared to matched controls.
14650112	2004	Isr. Med. Assoc. J.	1565-1088	METHODS	3	4	154	LONGTERM|DICTIONARY	beta 2ar	beta 2AR	175#183	NaN	D001249	LONGTERM|DICTIONARY	asthma	asthma	64#70		Sixty-six Israeli Jewish and Arab asthmatics who had near-fatal asthma and/or severe nocturnal asthma and/or steroid-dependency were investigated for genetic polymorphisms of beta 2AR and compared to matched controls.
14650112	2004	Isr. Med. Assoc. J.	1565-1088	METHODS	3	4	154	LONGTERM|DICTIONARY	beta 2ar	beta 2AR	175#183	NaN	D001249	LONGTERM|DICTIONARY	asthma	asthma	95#101		Sixty-six Israeli Jewish and Arab asthmatics who had near-fatal asthma and/or severe nocturnal asthma and/or steroid-dependency were investigated for genetic polymorphisms of beta 2AR and compared to matched controls.
14763782	2004	Acta Odontol. Scand.	0001-6357	ALL_TEXT_2/3	2	3	3459	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	ifngr1	IFNGR1	69#75	14763782-2-178-187	D010518	LONGTERM|DICTIONARY	periodontitis	periodontitis	147#160		Using an intronic (CA)n polymorphic microsatellite marker within the IFNGR1 gene we investigated whether genetic polymorphisms are associated with periodontitis.
16734939	2007	Int. J. Neuropsychopharmacol.	1461-1457	ALL_TEXT_2/3	2	3	1312	SYMBOL|DICTIONARY|EXTRACTED	comt	COMT	104#108	16734939-2-4-32	D004062	SYMBOL|DICTIONARY|EXTRACTED	vcfs	VCFS	17#21	16734939-1-0-25	Individuals with VCFS carrying the low-activity allele (COMTL) are expected to have the lowest possible COMT activity since they have only a single copy of the gene.
16734939	2007	Int. J. Neuropsychopharmacol.	1461-1457	ALL_TEXT_1/3	1	2	1312	LONGTERM|DICTIONARY	catechol o methyltransferase	catechol-O-methyltransferase	4#32		D004062	SYMBOL|DICTIONARY|EXTRACTED	vcfs	VCFS	173#177	16734939-1-0-25	The catechol-O-methyltransferase (COMT), residing in the 22q11.2 microdeletion region, is a major candidate gene for genetic susceptibility to neuropsychiatric disorders in VCFS.
16734939	2007	Int. J. Neuropsychopharmacol.	1461-1457	ALL_TEXT_1/3	1	2	1312	LONGTERM|DICTIONARY	catechol o methyltransferase	catechol-O-methyltransferase	4#32		D001523	LONGTERM|DICTIONARY	neuropsychiatric disorders	neuropsychiatric disorders	143#169		The catechol-O-methyltransferase (COMT), residing in the 22q11.2 microdeletion region, is a major candidate gene for genetic susceptibility to neuropsychiatric disorders in VCFS.
16734939	2007	Int. J. Neuropsychopharmacol.	1461-1457	ALL_TEXT_1/3	1	2	1312	SYMBOL|()|DICTIONARY|EXTRACTED	comt	COMT	34#38	16734939-2-4-32	D004062	SYMBOL|DICTIONARY|EXTRACTED	vcfs	VCFS	173#177	16734939-1-0-25	The catechol-O-methyltransferase (COMT), residing in the 22q11.2 microdeletion region, is a major candidate gene for genetic susceptibility to neuropsychiatric disorders in VCFS.
16734939	2007	Int. J. Neuropsychopharmacol.	1461-1457	ALL_TEXT_1/3	1	2	1312	SYMBOL|()|DICTIONARY|EXTRACTED	comt	COMT	34#38	16734939-2-4-32	D001523	LONGTERM|DICTIONARY	neuropsychiatric disorders	neuropsychiatric disorders	143#169		The catechol-O-methyltransferase (COMT), residing in the 22q11.2 microdeletion region, is a major candidate gene for genetic susceptibility to neuropsychiatric disorders in VCFS.
16734939	2007	Int. J. Neuropsychopharmacol.	1461-1457	TITLE	0	0	1312	SYMBOL|NUMBER|DICTIONARY|EXTRACTED	comt	COMT	32#36		D001289	SYMBOL|DICTIONARY|EXTRACTED	adhd	ADHD	56#60		Association of the low-activity COMT 158Met allele with ADHD and OCD in subjects with velocardiofacial syndrome.
16734939	2007	Int. J. Neuropsychopharmacol.	1461-1457	TITLE	0	0	1312	SYMBOL|NUMBER|DICTIONARY|EXTRACTED	comt	COMT	32#36		D009771	SYMBOL|DICTIONARY|EXTRACTED	ocd	OCD	65#68		Association of the low-activity COMT 158Met allele with ADHD and OCD in subjects with velocardiofacial syndrome.
16734939	2007	Int. J. Neuropsychopharmacol.	1461-1457	TITLE	0	0	1312	SYMBOL|NUMBER|DICTIONARY|EXTRACTED	comt	COMT	32#36		D004062	LONGTERM|DISEASE|DT|DICTIONARY	velocardiofacial syndrome	velocardiofacial syndrome	86#111		Association of the low-activity COMT 158Met allele with ADHD and OCD in subjects with velocardiofacial syndrome.
16734939	2007	Int. J. Neuropsychopharmacol.	1461-1457	ALL_TEXT_3/3	3	7	1312	SYMBOL|DICTIONARY|EXTRACTED	comt	COMT	55#59	16734939-2-4-32	D004062	SYMBOL|DICTIONARY|EXTRACTED	vcfs	VCFS	85#89	16734939-1-0-25	The results of this study suggest that greatly reduced COMT activity, as expected in VCFS COMTL individuals may be a risk factor for psychiatric sequelae in this population.
16734939	2007	Int. J. Neuropsychopharmacol.	1461-1457	ALL_TEXT_3/3	3	7	1312	SYMBOL|DICTIONARY|EXTRACTED	comt	COMT	55#59	16734939-2-4-32	D001523	LONGTERM|DICTIONARY	psychiatric	psychiatric	133#144	NaN	The results of this study suggest that greatly reduced COMT activity, as expected in VCFS COMTL individuals may be a risk factor for psychiatric sequelae in this population.
16734939	2007	Int. J. Neuropsychopharmacol.	1461-1457	ALL_TEXT_3/3	3	5	1312	SYMBOL|NUMBER|DICTIONARY|EXTRACTED	comt	COMT	103#107	16734939-2-4-32	D004062	SYMBOL|DICTIONARY|EXTRACTED	vcfs	VCFS	38#42	16734939-1-0-25	Fifty-five unrelated individuals with VCFS underwent psychiatric evaluation and were genotyped for the COMT 158Val/Met polymorphism coding for COMT high/low-activity alleles.
16734939	2007	Int. J. Neuropsychopharmacol.	1461-1457	ALL_TEXT_3/3	3	5	1312	SYMBOL|NUMBER|DICTIONARY|EXTRACTED	comt	COMT	103#107	16734939-2-4-32	D001523	LONGTERM|DICTIONARY	psychiatric	psychiatric	53#64	NaN	Fifty-five unrelated individuals with VCFS underwent psychiatric evaluation and were genotyped for the COMT 158Val/Met polymorphism coding for COMT high/low-activity alleles.
16734939	2007	Int. J. Neuropsychopharmacol.	1461-1457	ALL_TEXT_3/3	3	5	1312	SYMBOL|DICTIONARY|EXTRACTED	comt	COMT	143#147	16734939-2-4-32	D004062	SYMBOL|DICTIONARY|EXTRACTED	vcfs	VCFS	38#42	16734939-1-0-25	Fifty-five unrelated individuals with VCFS underwent psychiatric evaluation and were genotyped for the COMT 158Val/Met polymorphism coding for COMT high/low-activity alleles.
16734939	2007	Int. J. Neuropsychopharmacol.	1461-1457	ALL_TEXT_3/3	3	5	1312	SYMBOL|DICTIONARY|EXTRACTED	comt	COMT	143#147	16734939-2-4-32	D001523	LONGTERM|DICTIONARY	psychiatric	psychiatric	53#64	NaN	Fifty-five unrelated individuals with VCFS underwent psychiatric evaluation and were genotyped for the COMT 158Val/Met polymorphism coding for COMT high/low-activity alleles.
17961231	2008	BMC Neurol	1471-2377	BACKGROUND	1	1	5274	LONGTERM|DICTIONARY	neuroserpin	Neuroserpin	0#11	NaN	D002544	LONGTERM|DICTIONARY	ischemic stroke	ischemic stroke	199#214		Neuroserpin, primarily localized to CNS neurons, inhibits the adverse effects of tissue-type plasminogen activator (tPA) on the neurovascular unit and has neuroprotective effects in animal models of ischemic stroke.
16734939	2007	Int. J. Neuropsychopharmacol.	1461-1457	ALL_TEXT_3/3	3	8	1312	SYMBOL|DICTIONARY|EXTRACTED	comt	COMT	51#55	16734939-2-4-32	D012559	LONGTERM|DICTIONARY	schizophrenia	schizophrenia	173#186		Future longitudinal studies focusing on additional COMT polymorphic sites and other candidate genes from the deleted region will elucidate the molecular pathways leading to schizophrenia and other psychiatric disorders in VCFS.
16734939	2007	Int. J. Neuropsychopharmacol.	1461-1457	ALL_TEXT_3/3	3	8	1312	SYMBOL|DICTIONARY|EXTRACTED	comt	COMT	51#55	16734939-2-4-32	D001523	LONGTERM|DICTIONARY	psychiatric disorders	psychiatric disorders	197#218		Future longitudinal studies focusing on additional COMT polymorphic sites and other candidate genes from the deleted region will elucidate the molecular pathways leading to schizophrenia and other psychiatric disorders in VCFS.
16734939	2007	Int. J. Neuropsychopharmacol.	1461-1457	ALL_TEXT_3/3	3	8	1312	SYMBOL|DICTIONARY|EXTRACTED	comt	COMT	51#55	16734939-2-4-32	D004062	SYMBOL|DICTIONARY|EXTRACTED	vcfs	VCFS	222#226	16734939-1-0-25	Future longitudinal studies focusing on additional COMT polymorphic sites and other candidate genes from the deleted region will elucidate the molecular pathways leading to schizophrenia and other psychiatric disorders in VCFS.
17961231	2008	BMC Neurol	1471-2377	METHODS	2	4	5274	LONGTERM|DICTIONARY	neuroserpin	Neuroserpin	0#11	NaN	D020521	LONGTERM|DICTIONARY	stroke	stroke	146#152		Neuroserpin single nucleotide polymorphisms (SNPs) chosen through HapMap were genotyped in the study population and assessed for association with stroke.
19420919	2009	Cerebrovasc. Dis.	1421-9786	ALL_TEXT_2/3	2	6	6401	LONGTERM|DICTIONARY	e selectin	E-selectin	36#46		D020521	LONGTERM|DISEASE|DN|DICTIONARY	stroke	stroke	182#188		Evaluation of genetic variation for E-selectin L554F polymorphisms revealed that the frequency of minor allele (F) and its heterozygous genotype (LF) is almost 4 times higher in the stroke patients than the controls (16.7 vs. 4.3 and 33.4 vs. 8.5, respectively).
16495393	2006	N. Engl. J. Med.	1533-4406	BACKGROUND	1	2	2064	SYMBOL|DICTIONARY	her2/neu	HER2/neu	37#45		D009369	LONGTERM|DICTIONARY	tumors	tumors	11#17		Women with tumors that overexpressed HER2/neu were also assigned to receive concomitant treatment with trastuzumab or no such treatment.
12918850	2003	J. Heart Valve Dis.	0966-8519	RESULTS	3	9	2200	SYMBOL|DICTIONARY|EXTRACTED	fbn1	FBN1	35#39	12918850-6-49-60	D008945	SYMBOL|DICTIONARY|EXTRACTED	mvp	MVP	15#18	12918850-3-50-71	OR for risk of MVP associated with FBN1 exon 15 T and exon 27 G alleles were 2.24 (95% CI 1.32-3.81) and 1.66 (95% CI 1.07-2.56), respectively.
16495393	2006	N. Engl. J. Med.	1533-4406	RESULTS	3	7	2064	SYMBOL|DICTIONARY	her2	HER2	40#44		D009369	LONGTERM|DISEASE|DT|DICTIONARY	cancer	cancer	58#64		Within the subgroup of patients who had HER2/neu-positive cancer, those who received trastuzumab had better three-year recurrence-free survival than those who did not receive the antibody (89 percent vs. 78 percent; hazard ratio for recurrence or death, 0.42; 95 percent confidence interval, 0.21 to 0.83; P=0.01).
16495393	2006	N. Engl. J. Med.	1533-4406	RESULTS	3	7	2064	SYMBOL|DICTIONARY	her2	HER2	40#44		D003643	LONGTERM|DICTIONARY	death	death	247#252	NaN	Within the subgroup of patients who had HER2/neu-positive cancer, those who received trastuzumab had better three-year recurrence-free survival than those who did not receive the antibody (89 percent vs. 78 percent; hazard ratio for recurrence or death, 0.42; 95 percent confidence interval, 0.21 to 0.83; P=0.01).
12918850	2003	J. Heart Valve Dis.	0966-8519	BACKGROUND AND AIM OF THE STUDY	1	4	2200	LONGTERM|GENE|GN|DICTIONARY	fibrillin 1	fibrillin-1	85#96		D008945	SYMBOL|DICTIONARY|EXTRACTED	mvp	MVP	128#131	12918850-3-50-71	Hence, a case-controlled study was performed to investigate the relationship between fibrillin-1 gene polymorphisms and risk of MVP in Taiwan Chinese.
12918850	2003	J. Heart Valve Dis.	0966-8519	RESULTS	3	7	2200	SYMBOL|DICTIONARY|EXTRACTED	fbn1	FBN1	122#126	12918850-6-49-60	D008945	SYMBOL|DICTIONARY|EXTRACTED	mvp	MVP	88#91	12918850-3-50-71	A significant difference was seen in genotype distribution or allelic frequency between MVP cases and controls for either FBN1 exon 15 polymorphism (p = 0.012 and 0.002, respectively) or exon 27 polymorphism (p = 0.04 and 0.02, respectively).
15287851	2005	Liver Int.	1478-3223	CONCLUSIONS	4	11	3077	SYMBOL|DICTIONARY	hfe	HFE	31#34		D019698	LONGTERM|DICTIONARY	chronic hepatitis c	chronic hepatitis C	113#132		Our findings support a role of HFE mutations as primary risk factors for fibrogenesis and disease progression in chronic hepatitis C.
12918850	2003	J. Heart Valve Dis.	0966-8519	TITLE	0	0	2200	LONGTERM|GENE|GN|DICTIONARY	fibrillin 1	fibrillin-1	20#31		D008945	LONGTERM|DICTIONARY	mitral valve prolapse	mitral valve prolapse	78#99		Association between fibrillin-1 gene exon 15 and 27 polymorphisms and risk of mitral valve prolapse.
7987717	1995	Zhonghua Yi Xue Za Zhi	0376-2491	ALL_TEXT_2/3	2	5	3123	SYMBOL|DICTIONARY	drb1	DRB1	4#8		D001172	LONGTERM|DICTIONARY	ra	RA	152#154	NaN	The DRB1 *0405 (Dw15) was the most common allele, accounting for 48% of DR4 positive normal individuals and also is a principal subtype associated with RA susceptibility (RR = 3.1, P < 0.005).
7987717	1995	Zhonghua Yi Xue Za Zhi	0376-2491	ALL_TEXT_2/3	2	5	3126	LONGTERM|DICTIONARY	dr4	DR4	72#75	NaN	D001172	LONGTERM|DICTIONARY	ra	RA	152#154	NaN	The DRB1 *0405 (Dw15) was the most common allele, accounting for 48% of DR4 positive normal individuals and also is a principal subtype associated with RA susceptibility (RR = 3.1, P < 0.005).
7987717	1995	Zhonghua Yi Xue Za Zhi	0376-2491	ALL_TEXT_3/3	3	7	3123	SYMBOL|DICTIONARY	drb1	DRB1	82#86		D001172	LONGTERM|DICTIONARY	ra	RA	50#52	NaN	All subtypes that were positively associated with RA susceptibility had the RRAA (DRB1* 0404, 0405.
7987717	1995	Zhonghua Yi Xue Za Zhi	0376-2491	ALL_TEXT_1/3	1	1	3126	SYMBOL|GENE|GN|DICTIONARY	dr4	DR4	4#7		D001172	LONGTERM|DICTIONARY	rheumatoid arthritis	rheumatoid arthritis	81#101		HLA-DR4 gene was studied by polymerase chain reaction method in 95 patients with rheumatoid arthritis(RA) and 130 normal controls in a Shanghai population.
7987717	1995	Zhonghua Yi Xue Za Zhi	0376-2491	ALL_TEXT_1/3	1	2	3126	LONGTERM|DICTIONARY	dr4	DR4	28#31	NaN	D001172	LONGTERM|DICTIONARY	ra	RA	66#68	NaN	The results showed that the DR4 was significantly associated with RA(RR = 3.1, chi 2 = 13.8, P < 0.005).
12631109	2004	Kidney Int.	0085-2538	BACKGROUND	1	3	1285	SYMBOL|DICTIONARY	col4a3	COL4A3	10#16		D009394	SYMBOL|EXTRACTED	as	AS	54#56	12631109-1-0-15	Using the COL4A3 -/- mouse, an animal model for human AS, we evaluated therapy with ramipril in mice.
20663522	2010	J. Urol.	1527-3792	CONCLUSIONS	4	10	1113	LONGTERM|DICTIONARY	chromogranin a	Chromogranin A	0#14		D011471	LONGTERM|DISEASE|DT|DICTIONARY	localized prostate cancer	localized prostate cancer	115#140		Chromogranin A expression was an independent predictor of biochemical failure after prostatectomy in patients with localized prostate cancer.
16821592	2006	Anticancer Res.	0250-7005	MATERIALS AND METHODS	2	3	5243	SYMBOL|DICTIONARY	mdr1	MDR1	23#27		D010051	LONGTERM|DISEASE|DN|DT|DICTIONARY	ovarian cancer	ovarian cancer	63#77		SNPs were analyzed for MDR1, MRP1, MRP2 and LRP in 60 advanced ovarian cancer patients.
16821592	2006	Anticancer Res.	0250-7005	MATERIALS AND METHODS	2	3	4363	SYMBOL|DICTIONARY	mrp1	MRP1	29#33		D010051	LONGTERM|DISEASE|DN|DT|DICTIONARY	ovarian cancer	ovarian cancer	63#77		SNPs were analyzed for MDR1, MRP1, MRP2 and LRP in 60 advanced ovarian cancer patients.
16821592	2006	Anticancer Res.	0250-7005	MATERIALS AND METHODS	2	3	1244	SYMBOL|DICTIONARY	mrp2	MRP2	35#39		D010051	LONGTERM|DISEASE|DN|DT|DICTIONARY	ovarian cancer	ovarian cancer	63#77		SNPs were analyzed for MDR1, MRP1, MRP2 and LRP in 60 advanced ovarian cancer patients.
16821592	2006	Anticancer Res.	0250-7005	MATERIALS AND METHODS	2	3	4035	SYMBOL|DICTIONARY	lrp	LRP	44#47		D010051	LONGTERM|DISEASE|DN|DT|DICTIONARY	ovarian cancer	ovarian cancer	63#77		SNPs were analyzed for MDR1, MRP1, MRP2 and LRP in 60 advanced ovarian cancer patients.
20096741	2010	Hum. Immunol.	1879-1166	TITLE	0	0	3305	SYMBOL|DICTIONARY	vegf/hsp70-hom	VEGF/HSP70-hom	23#37		D011471	LONGTERM|DISEASE|DT|DICTIONARY	prostate cancer	prostate cancer	74#89		Synergistic effect and VEGF/HSP70-hom haplotype analysis: relationship to prostate cancer risk and clinical outcome.
20096741	2010	Hum. Immunol.	1879-1166	TITLE	0	0	7422	SYMBOL|DICTIONARY	vegf/hsp70-hom	VEGF/HSP70-hom	23#37		D011471	LONGTERM|DISEASE|DT|DICTIONARY	prostate cancer	prostate cancer	74#89		Synergistic effect and VEGF/HSP70-hom haplotype analysis: relationship to prostate cancer risk and clinical outcome.
20096741	2010	Hum. Immunol.	1879-1166	TITLE	0	0	3305	SYMBOL|DICTIONARY	vegf/hsp70-hom	VEGF/HSP70-hom	23#37		D011471	LONGTERM|DISEASE|DT|DICTIONARY	prostate cancer	prostate cancer	74#89		Synergistic effect and VEGF/HSP70-hom haplotype analysis: relationship to prostate cancer risk and clinical outcome.
20096741	2010	Hum. Immunol.	1879-1166	TITLE	0	0	7422	SYMBOL|DICTIONARY	vegf/hsp70-hom	VEGF/HSP70-hom	23#37		D011471	LONGTERM|DISEASE|DT|DICTIONARY	prostate cancer	prostate cancer	74#89		Synergistic effect and VEGF/HSP70-hom haplotype analysis: relationship to prostate cancer risk and clinical outcome.
14521605	2004	J. Thromb. Haemost.	1538-7933	BACKGROUND	1	3	2811	LONGTERM|DICTIONARY	gpibalpha	GPIbalpha	26#35	NaN	C536458	SYMBOL|EXTRACTED	plt vwd	plt-VWD	105#112	14521605-2-0-36	To date, two mutations in GPIbalpha, G233V and M239V, have been reported in four unrelated families with plt-VWD.
9545398	1998	Am. J. Hum. Genet.	0002-9297	ALL_TEXT_2/3	2	7	695	LONGTERM|DICTIONARY	btk	Btk	188#191	NaN	C537409	SYMBOL|DICTIONARY|EXTRACTED	xla	XLA	146#149	9545398-1-32-59	Two of the three remaining patients had defects in other genes required for normal B cell development, and the third patient was unlikely to have XLA, on the basis of results of extensive Btk analysis.
12631109	2004	Kidney Int.	0085-2538	RESULTS	3	7	1285	SYMBOL|DICTIONARY	col4a3	COL4A3	10#16		D051437	LONGTERM|DICTIONARY	renal failure	renal failure	36#49		Untreated COL4A3 -/- mice died from renal failure after 71 +/- 6 days.
21074862	2011	J. Neuroimmunol.	1872-8421	ALL_TEXT_1/3	1	2	3123	SYMBOL|DICTIONARY	hla drb1	HLA-DRB1	39#47		D009157	SYMBOL|EXTRACTED|DISEASE|DN	mg	MG	75#77	21074862-1-33-50	We examined several autoantibodies and HLA-DRB1 genotyping in 260 Japanese MG patients.Sixty-two MG patients had thymoma.
21074862	2011	J. Neuroimmunol.	1872-8421	ALL_TEXT_1/3	1	2	3123	SYMBOL|DICTIONARY	hla drb1	HLA-DRB1	39#47		D009157	SYMBOL|EXTRACTED|DISEASE|DN	mg	MG	97#99	21074862-1-33-50	We examined several autoantibodies and HLA-DRB1 genotyping in 260 Japanese MG patients.Sixty-two MG patients had thymoma.
21074862	2011	J. Neuroimmunol.	1872-8421	ALL_TEXT_1/3	1	2	3123	SYMBOL|DICTIONARY	hla drb1	HLA-DRB1	39#47		D013945	LONGTERM|DICTIONARY	thymoma	thymoma	113#120		We examined several autoantibodies and HLA-DRB1 genotyping in 260 Japanese MG patients.Sixty-two MG patients had thymoma.
7581378	1995	Hum. Mol. Genet.	0964-6906	ALL_TEXT_3/3	3	8	2263	SYMBOL|DICTIONARY|EXTRACTED	fgfr2	FGFR2	47#52	7581378-1-26-61	D003398	LONGTERM|DICTIONARY	craniosynostosis syndromes	craniosynostosis syndromes	153#179		The data implies that second-site mutations in FGFR2 itself (outside of exon IIIc) or in other genes may determine specific aspects of the phenotypes of craniosynostosis syndromes.
20068450	2010	Anesthesiology	1528-1175	CONCLUSIONS	4	10	5173	LONGTERM|DICTIONARY	dynorphin a (1-17	dynorphin A (1-17	47#64		D010146	LONGTERM|DICTIONARY	pain	pain	129#133		These findings indicate that spinally released dynorphin A (1-17) by noxious stimuli leads to the direct activation of ascending pain transmission.
12960748	2004	Psychiatr. Genet.	0955-8829	RESULTS	3	6	1565	SYMBOL|NUMBER|DICTIONARY	cyp2d6	CYP2D6	76#82		D004409	LONGTERM|DICTIONARY	tardive dyskinesia	tardive dyskinesia	177#195		However, no significant difference was observed in the distribution of both CYP2D6*2 (C2938T) and CYP2D6*10 (C188T) polymorphisms between schizophrenic patients with or without tardive dyskinesia.
12960748	2004	Psychiatr. Genet.	0955-8829	RESULTS	3	6	1565	SYMBOL|NUMBER|DICTIONARY	cyp2d6	CYP2D6	76#82		D012559	LONGTERM|DICTIONARY	schizophrenic	schizophrenic	138#151	NaN	However, no significant difference was observed in the distribution of both CYP2D6*2 (C2938T) and CYP2D6*10 (C188T) polymorphisms between schizophrenic patients with or without tardive dyskinesia.
12960748	2004	Psychiatr. Genet.	0955-8829	RESULTS	3	6	1565	SYMBOL|NUMBER|DICTIONARY	cyp2d6	CYP2D6	98#104		D004409	LONGTERM|DICTIONARY	tardive dyskinesia	tardive dyskinesia	177#195		However, no significant difference was observed in the distribution of both CYP2D6*2 (C2938T) and CYP2D6*10 (C188T) polymorphisms between schizophrenic patients with or without tardive dyskinesia.
12960748	2004	Psychiatr. Genet.	0955-8829	RESULTS	3	6	1565	SYMBOL|NUMBER|DICTIONARY	cyp2d6	CYP2D6	98#104		D012559	LONGTERM|DICTIONARY	schizophrenic	schizophrenic	138#151	NaN	However, no significant difference was observed in the distribution of both CYP2D6*2 (C2938T) and CYP2D6*10 (C188T) polymorphisms between schizophrenic patients with or without tardive dyskinesia.
12960748	2004	Psychiatr. Genet.	0955-8829	CONCLUSION	4	7	1565	SYMBOL|NUMBER|DICTIONARY	cyp2d6	CYP2D6	52#58		D001480	SYMBOL|DICTIONARY|EXTRACTED	eps	EPS	133#136	12960748-3-41-64	The present results suggest that the homozygotes of CYP2D6*2 and CYP2D6*10 appear to be a susceptibility factor for developing acute EPS in schizophrenic patients and for impaired neuroleptic metabolism in Japanese schizophrenic patients.
12960748	2004	Psychiatr. Genet.	0955-8829	CONCLUSION	4	7	1565	SYMBOL|NUMBER|DICTIONARY	cyp2d6	CYP2D6	52#58		D012559	LONGTERM|DICTIONARY	schizophrenic	schizophrenic	140#153	NaN	The present results suggest that the homozygotes of CYP2D6*2 and CYP2D6*10 appear to be a susceptibility factor for developing acute EPS in schizophrenic patients and for impaired neuroleptic metabolism in Japanese schizophrenic patients.
12960748	2004	Psychiatr. Genet.	0955-8829	CONCLUSION	4	7	1565	SYMBOL|NUMBER|DICTIONARY	cyp2d6	CYP2D6	52#58		D012559	LONGTERM|DICTIONARY	schizophrenic	schizophrenic	215#228	NaN	The present results suggest that the homozygotes of CYP2D6*2 and CYP2D6*10 appear to be a susceptibility factor for developing acute EPS in schizophrenic patients and for impaired neuroleptic metabolism in Japanese schizophrenic patients.
12960748	2004	Psychiatr. Genet.	0955-8829	CONCLUSION	4	7	1565	SYMBOL|NUMBER|DICTIONARY	cyp2d6	CYP2D6	65#71		D001480	SYMBOL|DICTIONARY|EXTRACTED	eps	EPS	133#136	12960748-3-41-64	The present results suggest that the homozygotes of CYP2D6*2 and CYP2D6*10 appear to be a susceptibility factor for developing acute EPS in schizophrenic patients and for impaired neuroleptic metabolism in Japanese schizophrenic patients.
12960748	2004	Psychiatr. Genet.	0955-8829	CONCLUSION	4	7	1565	SYMBOL|NUMBER|DICTIONARY	cyp2d6	CYP2D6	65#71		D012559	LONGTERM|DICTIONARY	schizophrenic	schizophrenic	140#153	NaN	The present results suggest that the homozygotes of CYP2D6*2 and CYP2D6*10 appear to be a susceptibility factor for developing acute EPS in schizophrenic patients and for impaired neuroleptic metabolism in Japanese schizophrenic patients.
12960748	2004	Psychiatr. Genet.	0955-8829	CONCLUSION	4	7	1565	SYMBOL|NUMBER|DICTIONARY	cyp2d6	CYP2D6	65#71		D012559	LONGTERM|DICTIONARY	schizophrenic	schizophrenic	215#228	NaN	The present results suggest that the homozygotes of CYP2D6*2 and CYP2D6*10 appear to be a susceptibility factor for developing acute EPS in schizophrenic patients and for impaired neuroleptic metabolism in Japanese schizophrenic patients.
12960748	2004	Psychiatr. Genet.	0955-8829	RESULTS	3	4	1565	SYMBOL|NUMBER|DICTIONARY	cyp2d6	CYP2D6	24#30		D001480	SYMBOL|DICTIONARY|EXTRACTED	eps	EPS	154#157	12960748-3-41-64	The allele frequency of CYP2D6*2 was significantly higher, while that of CYP2D6*10 tended to be higher in the schizophrenic patients susceptible to acute EPS.
12960748	2004	Psychiatr. Genet.	0955-8829	RESULTS	3	4	1565	SYMBOL|NUMBER|DICTIONARY	cyp2d6	CYP2D6	24#30		D012559	LONGTERM|DICTIONARY	schizophrenic	schizophrenic	110#123	NaN	The allele frequency of CYP2D6*2 was significantly higher, while that of CYP2D6*10 tended to be higher in the schizophrenic patients susceptible to acute EPS.
12960748	2004	Psychiatr. Genet.	0955-8829	RESULTS	3	4	1565	SYMBOL|NUMBER|DICTIONARY	cyp2d6	CYP2D6	73#79		D001480	SYMBOL|DICTIONARY|EXTRACTED	eps	EPS	154#157	12960748-3-41-64	The allele frequency of CYP2D6*2 was significantly higher, while that of CYP2D6*10 tended to be higher in the schizophrenic patients susceptible to acute EPS.
12960748	2004	Psychiatr. Genet.	0955-8829	RESULTS	3	4	1565	SYMBOL|NUMBER|DICTIONARY	cyp2d6	CYP2D6	73#79		D012559	LONGTERM|DICTIONARY	schizophrenic	schizophrenic	110#123	NaN	The allele frequency of CYP2D6*2 was significantly higher, while that of CYP2D6*10 tended to be higher in the schizophrenic patients susceptible to acute EPS.
12960748	2004	Psychiatr. Genet.	0955-8829	RESULTS	3	5	1565	SYMBOL|NUMBER|DICTIONARY	cyp2d6	CYP2D6	161#167		D012559	LONGTERM|DICTIONARY	schizophrenic	schizophrenic	103#116	NaN	The steady-state serum haloperidol levels per daily dosage were observed to be significantly higher in schizophrenic patients with the mutant-type homozygote of CYP2D6*2, while this difference was trend level in those of CYP2D6*10.
12960748	2004	Psychiatr. Genet.	0955-8829	RESULTS	3	5	1565	SYMBOL|NUMBER|DICTIONARY	cyp2d6	CYP2D6	221#227		D012559	LONGTERM|DICTIONARY	schizophrenic	schizophrenic	103#116	NaN	The steady-state serum haloperidol levels per daily dosage were observed to be significantly higher in schizophrenic patients with the mutant-type homozygote of CYP2D6*2, while this difference was trend level in those of CYP2D6*10.
12960748	2004	Psychiatr. Genet.	0955-8829	METHODS	2	2	1565	SYMBOL|GENE|GN|DICTIONARY	cyp2d6	CYP2D6	4#10		D012559	LONGTERM|DICTIONARY	schizophrenic	schizophrenic	133#146	NaN	The CYP2D6 gene polymorphisms (CYP2D6*2, CYP2D6*3, CYP2D6*4, CYP2D6*10, and CYP2D6*12) were genotyped in 196 normal controls and 320 schizophrenic patients receiving neuroleptics.
12960748	2004	Psychiatr. Genet.	0955-8829	METHODS	2	2	1565	SYMBOL|NUMBER|DICTIONARY	cyp2d6	CYP2D6	31#37		D012559	LONGTERM|DICTIONARY	schizophrenic	schizophrenic	133#146	NaN	The CYP2D6 gene polymorphisms (CYP2D6*2, CYP2D6*3, CYP2D6*4, CYP2D6*10, and CYP2D6*12) were genotyped in 196 normal controls and 320 schizophrenic patients receiving neuroleptics.
12960748	2004	Psychiatr. Genet.	0955-8829	METHODS	2	2	1565	SYMBOL|NUMBER|DICTIONARY	cyp2d6	CYP2D6	41#47		D012559	LONGTERM|DICTIONARY	schizophrenic	schizophrenic	133#146	NaN	The CYP2D6 gene polymorphisms (CYP2D6*2, CYP2D6*3, CYP2D6*4, CYP2D6*10, and CYP2D6*12) were genotyped in 196 normal controls and 320 schizophrenic patients receiving neuroleptics.
12960748	2004	Psychiatr. Genet.	0955-8829	METHODS	2	2	1565	SYMBOL|NUMBER|DICTIONARY	cyp2d6	CYP2D6	51#57		D012559	LONGTERM|DICTIONARY	schizophrenic	schizophrenic	133#146	NaN	The CYP2D6 gene polymorphisms (CYP2D6*2, CYP2D6*3, CYP2D6*4, CYP2D6*10, and CYP2D6*12) were genotyped in 196 normal controls and 320 schizophrenic patients receiving neuroleptics.
12960748	2004	Psychiatr. Genet.	0955-8829	METHODS	2	2	1565	SYMBOL|NUMBER|DICTIONARY	cyp2d6	CYP2D6	61#67		D012559	LONGTERM|DICTIONARY	schizophrenic	schizophrenic	133#146	NaN	The CYP2D6 gene polymorphisms (CYP2D6*2, CYP2D6*3, CYP2D6*4, CYP2D6*10, and CYP2D6*12) were genotyped in 196 normal controls and 320 schizophrenic patients receiving neuroleptics.
12960748	2004	Psychiatr. Genet.	0955-8829	METHODS	2	2	1565	SYMBOL|NUMBER|DICTIONARY	cyp2d6	CYP2D6	76#82		D012559	LONGTERM|DICTIONARY	schizophrenic	schizophrenic	133#146	NaN	The CYP2D6 gene polymorphisms (CYP2D6*2, CYP2D6*3, CYP2D6*4, CYP2D6*10, and CYP2D6*12) were genotyped in 196 normal controls and 320 schizophrenic patients receiving neuroleptics.
19350382	2009	Cell. Mol. Neurobiol.	1573-6830	ALL_TEXT_1/3	1	3	5728	SYMBOL|GENE|GN|DICTIONARY	pten	PTEN	63#67		D005910	LONGTERM|DICTIONARY	gliomas	gliomas	29#36		We investigated 28 low grade gliomas for mutations of the MMAC/PTEN gene using single strand conformational polymorphism method followed by DNA sequencing.
19350382	2009	Cell. Mol. Neurobiol.	1573-6830	TITLE	0	0	5728	SYMBOL|GENE|GN|DICTIONARY	pten	PTEN	22#26		D005910	LONGTERM|DICTIONARY	gliomas	gliomas	78#85		Investigation of MMAC/PTEN gene mutations and protein expression in low grade gliomas.
11802810	2002	Jpn. J. Cancer Res.	0910-5050	ALL_TEXT_2/3	2	3	540	SYMBOL|DICTIONARY	atp7b	ATP7B	25#30		D001943	LONGTERM|DICTIONARY	breast carcinomas	breast carcinomas	80#97		To test this hypothesis, ATP7B expression and protein level were examined in 41 breast carcinomas using RT-PCR and immunohistochemistry.
19362357	2009	J. Allergy Clin. Immunol.	1097-6825	BACKGROUND	1	1	30009	SYMBOL|()|DICTIONARY|EXTRACTED	tbx21	TBX21	48#53	19362357-1-20-46	D006327	LONGTERM|DICTIONARY	blocks t	blocks T	176#184	NaN	The T cell-specific T-box transcription factor (TBX21) plays a crucial role in the regulation of the immune system because this factor induces the differentiation of T(H)1 and blocks T(H)2 commitment together with the homeobox transcription factor HLX1.
19362357	2009	J. Allergy Clin. Immunol.	1097-6825	BACKGROUND	1	1	3142	SYMBOL|DICTIONARY	hlx1	HLX1	248#252		D006327	LONGTERM|DICTIONARY	blocks t	blocks T	176#184	NaN	The T cell-specific T-box transcription factor (TBX21) plays a crucial role in the regulation of the immune system because this factor induces the differentiation of T(H)1 and blocks T(H)2 commitment together with the homeobox transcription factor HLX1.
19362357	2009	J. Allergy Clin. Immunol.	1097-6825	BACKGROUND	1	1	51497	LONGTERM|DICTIONARY	t(h)1	T(H)1	166#171	NaN	D006327	LONGTERM|DICTIONARY	blocks t	blocks T	176#184	NaN	The T cell-specific T-box transcription factor (TBX21) plays a crucial role in the regulation of the immune system because this factor induces the differentiation of T(H)1 and blocks T(H)2 commitment together with the homeobox transcription factor HLX1.
19350382	2009	Cell. Mol. Neurobiol.	1573-6830	ALL_TEXT_3/3	3	8	5728	SYMBOL|GENE|GN|DICTIONARY	pten	PTEN	36#40		D009369	LONGTERM|DICTIONARY	tumors	tumors	85#91		Moreover, it was observed that MMAC/PTEN protein expression was reduced to 73.08% of tumors.
17914947	2008	J. Gastroenterol. Hepatol.	0815-9319	CONCLUSIONS	4	8	7099	SYMBOL|NUMBER|DICTIONARY	tlr4	TLR4	38#42		D003424	SYMBOL|EXTRACTED	cd	CD	81#83	17914947-1-76-91	Nevertheless, the significance of the TLR4 299G and TLR9-1237C associations with CD worldwide was confirmed by a meta-analysis test using our datasets and datasets from previously published studies.
17914947	2008	J. Gastroenterol. Hepatol.	0815-9319	CONCLUSIONS	4	8	54106	SYMBOL|NUMBER|DICTIONARY	tlr9	TLR9	52#56		D003424	SYMBOL|EXTRACTED	cd	CD	81#83	17914947-1-76-91	Nevertheless, the significance of the TLR4 299G and TLR9-1237C associations with CD worldwide was confirmed by a meta-analysis test using our datasets and datasets from previously published studies.
12007670	2002	Eur Neuropsychopharmacol	0924-977X	TITLE	0	0	348	LONGTERM|DICTIONARY	apoe	ApoE	0#4	NaN	D000544	LONGTERM|DISEASE|DT|DICTIONARY	alzheimer disease	Alzheimer disease	81#98		ApoE genotype influences the biological effect of donepezil on APP metabolism in Alzheimer disease: evidence from a peripheral model.
12802709	2003	Am J Perinatol	0735-1631	ALL_TEXT_3/3	3	8	7124	SYMBOL|EXTRACTED	tnf alpha	TNF-alpha	4#13	12802709-1-64-91	D002581	LONGTERM|DICTIONARY	cervical incompetence	cervical incompetence	51#72	NaN	The TNF-alpha polymorphism was not associated with cervical incompetence or with delivery prior to 28 weeks in women who received an emergent cerclage.
12007670	2002	Eur Neuropsychopharmacol	0924-977X	ALL_TEXT_3/3	3	8	348	SYMBOL|EXTRACTED	apoe	ApoE	109#113	12007670-5-84-100	D000544	SYMBOL|EXTRACTED	ad	AD	190#192	12007670-2-0-17	The present study provides evidence that donepezil influences APP metabolism in platelets, and suggests that ApoE genotype might be an important modulating factor for drug responsiveness in AD.
20179607	2010	J. Cardiovasc. Pharmacol.	1533-4023	ALL_TEXT_3/3	3	12	1636	SYMBOL|DICTIONARY|EXTRACTED	ace	ACE	62#65	20179607-2-66-95	D002312	SYMBOL|DICTIONARY|EXTRACTED	hocm	HOCM	48#52	20179607-1-122-161	Cibenzoline was more effective in patients with HOCM with the ACE D allele.
16154235	2006	Neurobiol. Aging	1558-1497	ALL_TEXT_3/3	3	5	7422	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	vegf	VEGF	22#26	16154235-2-49-83	D000544	LONGTERM|DICTIONARY	ad	AD	77#79	NaN	No association of the VEGF promoter polymorphism with the risk of developing AD was observed.
22119709	2012	Toxicol. Appl. Pharmacol.	1096-0333	ALL_TEXT_3/3	3	9	1269	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	cb2	CB2	62#65	22119709-0-0-22	D003092	LONGTERM|DICTIONARY	colitis	colitis	100#107		Treatment with aminoalkylindole 6-iodo-pravadoline (AM630), a CB2 receptor antagonist, reversed the colitis protection provided by JWH-133 treatment.
11802810	2002	Jpn. J. Cancer Res.	0910-5050	ALL_TEXT_2/3	2	4	540	SYMBOL|GENE|GN|DICTIONARY	atp7b	ATP7B	0#5		D001943	LONGTERM|DICTIONARY	breast carcinomas	breast carcinomas	60#77		ATP7B gene / protein could be detected in 22.0% (9 / 41) of breast carcinomas and ATP7B gene expression was correlated well with the protein expression.
11802810	2002	Jpn. J. Cancer Res.	0910-5050	ALL_TEXT_2/3	2	4	540	SYMBOL|GENE|GN|DICTIONARY	atp7b	ATP7B	82#87		D001943	LONGTERM|DICTIONARY	breast carcinomas	breast carcinomas	60#77		ATP7B gene / protein could be detected in 22.0% (9 / 41) of breast carcinomas and ATP7B gene expression was correlated well with the protein expression.
14717782	2004	Br. J. Haematol.	0007-1048	TITLE	0	0	7450	LONGTERM|GENE|GT|DICTIONARY	von willebrand factor	von Willebrand factor	23#44		D003327	LONGTERM|DISEASE|DT|DICTIONARY	coronary heart disease	coronary heart disease	57#79		Genetic variability of von Willebrand factor and risk of coronary heart disease: the Rotterdam Study.
14717782	2004	Br. J. Haematol.	0007-1048	ALL_TEXT_1/3	1	1	7450	LONGTERM|GENE|GT|DICTIONARY	von willebrand factor	von Willebrand factor	4#25		D003327	LONGTERM|DISEASE|DT|DICTIONARY	coronary heart disease	coronary heart disease	64#86		The von Willebrand factor (VWF) may be causally associated with coronary heart disease (CHD) or merely be a marker of endothelial damage.
14717782	2004	Br. J. Haematol.	0007-1048	ALL_TEXT_1/3	1	1	7450	LONGTERM|GENE|GT|DICTIONARY	von willebrand factor	von Willebrand factor	4#25		D003327	SYMBOL|()|DICTIONARY|EXTRACTED	chd	CHD	88#91	14717782-1-64-86	The von Willebrand factor (VWF) may be causally associated with coronary heart disease (CHD) or merely be a marker of endothelial damage.
14717782	2004	Br. J. Haematol.	0007-1048	ALL_TEXT_1/3	1	1	7450	SYMBOL|()|DICTIONARY|EXTRACTED	vwf	VWF	27#30	14717782-1-4-25	D003327	LONGTERM|DISEASE|DT|DICTIONARY	coronary heart disease	coronary heart disease	64#86		The von Willebrand factor (VWF) may be causally associated with coronary heart disease (CHD) or merely be a marker of endothelial damage.
14717782	2004	Br. J. Haematol.	0007-1048	ALL_TEXT_1/3	1	1	7450	SYMBOL|()|DICTIONARY|EXTRACTED	vwf	VWF	27#30	14717782-1-4-25	D003327	SYMBOL|()|DICTIONARY|EXTRACTED	chd	CHD	88#91	14717782-1-64-86	The von Willebrand factor (VWF) may be causally associated with coronary heart disease (CHD) or merely be a marker of endothelial damage.
22119709	2012	Toxicol. Appl. Pharmacol.	1096-0333	TITLE	0	0	1269	LONGTERM|DICTIONARY	cannabinoid receptor 2	Cannabinoid receptor-2	0#22		D003092	LONGTERM|DICTIONARY	colitis	colitis	49#56		Cannabinoid receptor-2 (CB2) agonist ameliorates colitis in IL-10(-/-) mice by attenuating the activation of T cells and promoting their apoptosis.
22119709	2012	Toxicol. Appl. Pharmacol.	1096-0333	TITLE	0	0	1269	SYMBOL|EXTRACTED|()	cb2	CB2	24#27	22119709-0-0-22	D003092	LONGTERM|DICTIONARY	colitis	colitis	49#56		Cannabinoid receptor-2 (CB2) agonist ameliorates colitis in IL-10(-/-) mice by attenuating the activation of T cells and promoting their apoptosis.
22119709	2012	Toxicol. Appl. Pharmacol.	1096-0333	TITLE	0	0	3586	SYMBOL|DICTIONARY	il 10	IL-10	60#65		D003092	LONGTERM|DICTIONARY	colitis	colitis	49#56		Cannabinoid receptor-2 (CB2) agonist ameliorates colitis in IL-10(-/-) mice by attenuating the activation of T cells and promoting their apoptosis.
11802810	2002	Jpn. J. Cancer Res.	0910-5050	ALL_TEXT_3/3	3	5	540	SYMBOL|DICTIONARY	atp7b	ATP7B	8#13		D009369	LONGTERM|DICTIONARY	tumors	tumors	23#29		In nine ATP7B-positive tumors, adjacent normal breast tissue was similarly analyzed, revealing that ATP7B is upregulated in breast carcinoma.
11802810	2002	Jpn. J. Cancer Res.	0910-5050	ALL_TEXT_3/3	3	5	540	SYMBOL|DICTIONARY	atp7b	ATP7B	8#13		D001943	LONGTERM|DISEASE|DT|DICTIONARY	breast carcinoma	breast carcinoma	124#140		In nine ATP7B-positive tumors, adjacent normal breast tissue was similarly analyzed, revealing that ATP7B is upregulated in breast carcinoma.
11802810	2002	Jpn. J. Cancer Res.	0910-5050	ALL_TEXT_3/3	3	5	540	SYMBOL|DICTIONARY	atp7b	ATP7B	100#105		D009369	LONGTERM|DICTIONARY	tumors	tumors	23#29		In nine ATP7B-positive tumors, adjacent normal breast tissue was similarly analyzed, revealing that ATP7B is upregulated in breast carcinoma.
11802810	2002	Jpn. J. Cancer Res.	0910-5050	ALL_TEXT_3/3	3	5	540	SYMBOL|DICTIONARY	atp7b	ATP7B	100#105		D001943	LONGTERM|DISEASE|DT|DICTIONARY	breast carcinoma	breast carcinoma	124#140		In nine ATP7B-positive tumors, adjacent normal breast tissue was similarly analyzed, revealing that ATP7B is upregulated in breast carcinoma.
22119709	2012	Toxicol. Appl. Pharmacol.	1096-0333	ALL_TEXT_2/3	2	6	920	LONGTERM|DICTIONARY	cd4	CD4	43#46	NaN	D003092	LONGTERM|DICTIONARY	chronic colitis	chronic colitis	229#244		After JWH-133 treatment, the percentage of CD4(+) T cells, neutrophils, mast cells, natural killer (NK1.1) cells, and activated T cells declined in the intestinal lamina propria (LP) and mesenteric lymph nodes (MLN) of mice with chronic colitis.
20135361	2010	In Vitro Cell. Dev. Biol. Anim.	1543-706X	ALL_TEXT_1/3	1	1	1029	SYMBOL|DICTIONARY	p16	p16	23#26		D009369	LONGTERM|DICTIONARY	tumors	tumors	88#94		To investigate whether p16 inactivation is involved in the development of rat pulmonary tumors, we compared the p16 status and tumorigenicity of cell lines which indicated different p16 status.
20135361	2010	In Vitro Cell. Dev. Biol. Anim.	1543-706X	ALL_TEXT_1/3	1	1	1029	SYMBOL|DICTIONARY	p16	p16	23#26		D002471	LONGTERM|DICTIONARY	tumorigenicity	tumorigenicity	127#141	NaN	To investigate whether p16 inactivation is involved in the development of rat pulmonary tumors, we compared the p16 status and tumorigenicity of cell lines which indicated different p16 status.
20135361	2010	In Vitro Cell. Dev. Biol. Anim.	1543-706X	ALL_TEXT_1/3	1	1	1029	SYMBOL|DICTIONARY	p16	p16	112#115		D009369	LONGTERM|DICTIONARY	tumors	tumors	88#94		To investigate whether p16 inactivation is involved in the development of rat pulmonary tumors, we compared the p16 status and tumorigenicity of cell lines which indicated different p16 status.
20135361	2010	In Vitro Cell. Dev. Biol. Anim.	1543-706X	ALL_TEXT_1/3	1	1	1029	SYMBOL|DICTIONARY	p16	p16	112#115		D002471	LONGTERM|DICTIONARY	tumorigenicity	tumorigenicity	127#141	NaN	To investigate whether p16 inactivation is involved in the development of rat pulmonary tumors, we compared the p16 status and tumorigenicity of cell lines which indicated different p16 status.
20135361	2010	In Vitro Cell. Dev. Biol. Anim.	1543-706X	ALL_TEXT_1/3	1	1	1029	SYMBOL|DICTIONARY	p16	p16	182#185		D009369	LONGTERM|DICTIONARY	tumors	tumors	88#94		To investigate whether p16 inactivation is involved in the development of rat pulmonary tumors, we compared the p16 status and tumorigenicity of cell lines which indicated different p16 status.
20135361	2010	In Vitro Cell. Dev. Biol. Anim.	1543-706X	ALL_TEXT_1/3	1	1	1029	SYMBOL|DICTIONARY	p16	p16	182#185		D002471	LONGTERM|DICTIONARY	tumorigenicity	tumorigenicity	127#141	NaN	To investigate whether p16 inactivation is involved in the development of rat pulmonary tumors, we compared the p16 status and tumorigenicity of cell lines which indicated different p16 status.
22119709	2012	Toxicol. Appl. Pharmacol.	1096-0333	ALL_TEXT_1/3	1	4	1269	LONGTERM|DICTIONARY	cannabinoid receptor 2	cannabinoid receptor-2	35#57		D003092	LONGTERM|DICTIONARY	chronic colitis	chronic colitis	88#103		Here, we investigate the effect of cannabinoid receptor-2 (CB2) agonist, JWH-133, after chronic colitis in IL-10(-/-) mice.
22119709	2012	Toxicol. Appl. Pharmacol.	1096-0333	ALL_TEXT_1/3	1	4	1269	SYMBOL|EXTRACTED|()	cb2	CB2	59#62	22119709-0-0-22	D003092	LONGTERM|DICTIONARY	chronic colitis	chronic colitis	88#103		Here, we investigate the effect of cannabinoid receptor-2 (CB2) agonist, JWH-133, after chronic colitis in IL-10(-/-) mice.
22119709	2012	Toxicol. Appl. Pharmacol.	1096-0333	ALL_TEXT_1/3	1	4	3586	SYMBOL|DICTIONARY	il 10	IL-10	107#112		D003092	LONGTERM|DICTIONARY	chronic colitis	chronic colitis	88#103		Here, we investigate the effect of cannabinoid receptor-2 (CB2) agonist, JWH-133, after chronic colitis in IL-10(-/-) mice.
14717782	2004	Br. J. Haematol.	0007-1048	ALL_TEXT_3/3	3	9	7450	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	vwf	VWF	90#93	14717782-1-4-25	D003327	SYMBOL|DICTIONARY|EXTRACTED	chd	CHD	139#142	14717782-1-64-86	In conclusion, this study suggests that the G allele of the -1793 C/G polymorphism in the VWF gene is associated with an increased risk of CHD, but only in subjects with advanced atherosclerosis.
14717782	2004	Br. J. Haematol.	0007-1048	ALL_TEXT_3/3	3	9	7450	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	vwf	VWF	90#93	14717782-1-4-25	D050197	LONGTERM|DICTIONARY	atherosclerosis	atherosclerosis	179#194		In conclusion, this study suggests that the G allele of the -1793 C/G polymorphism in the VWF gene is associated with an increased risk of CHD, but only in subjects with advanced atherosclerosis.
17624340	2008	Fertil. Steril.	1556-5653	ALL_TEXT	1	2	26191	SYMBOL|DICTIONARY	ptpn22	PTPN22	42#48		D004715	LONGTERM|DICTIONARY	endometriosis	endometriosis	100#113		Our data show that female carriers of the PTPN22( *)T variant are significantly more susceptible to endometriosis than controls.
17624340	2008	Fertil. Steril.	1556-5653	TITLE	0	0	26191	SYMBOL|DICTIONARY	ptpn22	PTPN22	20#26		D004715	LONGTERM|DICTIONARY	endometriosis	endometriosis	31#44		Association between PTPN22 and endometriosis.
17624340	2008	Fertil. Steril.	1556-5653	ALL_TEXT	1	1	26191	SYMBOL|DICTIONARY	ptpn22	PTPN22	0#6		D004715	LONGTERM|DICTIONARY	endometriosis	endometriosis	107#120		PTPN22 is currently one of the few known shared-autoimmunity genes and is therefore a candidate marker for endometriosis.
15987458	2006	Breast Cancer Res.	1465-542X	METHODS	2	3	1586	SYMBOL|DICTIONARY	cyp17	CYP17	16#21		D001943	LONGTERM|DISEASE|DT|DICTIONARY	breast cancer	breast cancer	127#140		Risk factor and CYP17 genotyping data were derived from a large Australian population-based case-control-family study of 1,284 breast cancer cases and 679 controls.
17467628	2007	Heart Rhythm	1547-5271	RESULTS	4	7	3784	SYMBOL|DICTIONARY	kcnq1	KCNQ1	73#78		D008133	SYMBOL|EXTRACTED	lqts	LQTS	183#187	17467628-1-105-130	DNA samples were screened for the four common Finnish founder mutations (KCNQ1 G589D and IVS7-2A-->G, HERG L552S, and R176W), which are known to account for the majority of inherited LQTS in Finland.
17467628	2007	Heart Rhythm	1547-5271	RESULTS	4	7	3757	SYMBOL|DICTIONARY	herg	HERG	102#106		D008133	SYMBOL|EXTRACTED	lqts	LQTS	183#187	17467628-1-105-130	DNA samples were screened for the four common Finnish founder mutations (KCNQ1 G589D and IVS7-2A-->G, HERG L552S, and R176W), which are known to account for the majority of inherited LQTS in Finland.
14672398	2004	Breast Cancer Res. Treat.	0167-6806	TITLE	0	0	1869	SYMBOL|DICTIONARY	e2f1	E2F1	0#4		D001943	LONGTERM|DISEASE|DN|DT|DICTIONARY	node-positive breast cancer	node-positive breast cancer	59#86		E2F1 expression is related with the poor survival of lymph node-positive breast cancer patients treated with fluorouracil, doxorubicin and cyclophosphamide.
15987458	2006	Breast Cancer Res.	1465-542X	TITLE	0	0	1586	SYMBOL|GENE|GN|DICTIONARY	cyp17	CYP17	0#5		D001943	LONGTERM|DISEASE|DT|DICTIONARY	breast cancer	breast cancer	28#41		CYP17 genetic polymorphism, breast cancer, and breast cancer risk factors: Australian Breast Cancer Family Study.
15987458	2006	Breast Cancer Res.	1465-542X	TITLE	0	0	1586	SYMBOL|GENE|GN|DICTIONARY	cyp17	CYP17	0#5		D001943	LONGTERM|DISEASE|DT|DICTIONARY	breast cancer	breast cancer	47#60		CYP17 genetic polymorphism, breast cancer, and breast cancer risk factors: Australian Breast Cancer Family Study.
15987458	2006	Breast Cancer Res.	1465-542X	TITLE	0	0	1586	SYMBOL|GENE|GN|DICTIONARY	cyp17	CYP17	0#5		D001943	LONGTERM|DISEASE|DT|DICTIONARY	breast cancer	Breast Cancer	86#99		CYP17 genetic polymorphism, breast cancer, and breast cancer risk factors: Australian Breast Cancer Family Study.
12358323	2003	Eur. Respir. J.	0903-1936	ALL_TEXT_1/3	1	2	659	SYMBOL|DICTIONARY	bmpr2	BMPR2	0#5		D006976	SYMBOL|DICTIONARY|EXTRACTED	pah	PAH	72#75	12358323-1-52-83	BMPR2 was examined for mutations in 33 unrelated patients with sporadic PAH, and in two sisters with PAH, all of whom had taken fenfluramine derivatives, as well as in 130 normal controls.
12358323	2003	Eur. Respir. J.	0903-1936	ALL_TEXT_1/3	1	2	659	SYMBOL|DICTIONARY	bmpr2	BMPR2	0#5		D006976	SYMBOL|DICTIONARY|EXTRACTED	pah	PAH	101#104	12358323-1-52-83	BMPR2 was examined for mutations in 33 unrelated patients with sporadic PAH, and in two sisters with PAH, all of whom had taken fenfluramine derivatives, as well as in 130 normal controls.
12358323	2003	Eur. Respir. J.	0903-1936	TITLE	0	0	659	SYMBOL|DICTIONARY	bmpr2	BMPR2	0#5		D006976	LONGTERM|DICTIONARY	pulmonary hypertension	pulmonary hypertension	28#50		BMPR2 germline mutations in pulmonary hypertension associated with fenfluramine derivatives.
16277672	2006	Arthritis Res. Ther.	1478-6362	ALL_TEXT_3/3	3	8	26191	SYMBOL|NUMBER|DICTIONARY	ptpn22	PTPN22	44#50		D001172	SYMBOL|EXTRACTED	ra	RA	104#106	16277672-2-121-141	The transmission disequilibrium test of the PTPN22-620W allele revealed linkage and association for RF+ RA (61% of transmission, P = 0.037).
12358323	2003	Eur. Respir. J.	0903-1936	ALL_TEXT_3/3	3	8	659	LONGTERM|DICTIONARY	bone morphogenetic protein receptor 2	bone morphogenetic protein receptor 2	49#86	NaN	D006976	LONGTERM|DICTIONARY	pulmonary arterial hypertension	pulmonary arterial hypertension	254#285		In conclusion, the present authors have detected bone morphogenetic protein receptor 2 mutations that appear to be rare in the general population but may combine with exposure to fenfluramine derivatives to greatly increase the risk of developing severe pulmonary arterial hypertension.
18273796	2008	Genet. Mol. Res.	1676-5680	TITLE	0	0	3953	SYMBOL|DICTIONARY|EXTRACTED	lepr	LEPR	0#4		D009765	LONGTERM|DICTIONARY	obese	obese	66#71		LEPR p.Q223R, beta3-AR p.W64R and LEP c.-2548G>A gene variants in obese Brazilian subjects.
18273796	2008	Genet. Mol. Res.	1676-5680	TITLE	0	0	3952	SYMBOL|DICTIONARY|EXTRACTED	lep	LEP	34#37		D009765	LONGTERM|DICTIONARY	obese	obese	66#71		LEPR p.Q223R, beta3-AR p.W64R and LEP c.-2548G>A gene variants in obese Brazilian subjects.
15191797	2004	Exp. Neurol.	0014-4886	ALL_TEXT_3/3	3	10	960	SYMBOL|DICTIONARY	cd44	CD44	20#24		D009410	LONGTERM|DICTIONARY	terminal degeneration	terminal degeneration	61#82	NaN	We hypothesize that CD44 is involved in the response to axon terminal degeneration and/or neuronal reorganization preceding MFS.
18273796	2008	Genet. Mol. Res.	1676-5680	ALL_TEXT_1/3	1	2	3952	LONGTERM|DICTIONARY	leptin	leptin	42#48		D009765	LONGTERM|DICTIONARY	obesity	obesity	171#178		The adrenergic receptor beta3 (beta3-AR), leptin (LEP) and leptin receptor (LEPR) genes have been intensively evaluated in the search of variants that could be related to obesity and its cardiometabolic complications.
18273796	2008	Genet. Mol. Res.	1676-5680	ALL_TEXT_1/3	1	2	3952	SYMBOL|()|DICTIONARY|EXTRACTED	lep	LEP	50#53	18273796-2-42-48	D009765	LONGTERM|DICTIONARY	obesity	obesity	171#178		The adrenergic receptor beta3 (beta3-AR), leptin (LEP) and leptin receptor (LEPR) genes have been intensively evaluated in the search of variants that could be related to obesity and its cardiometabolic complications.
18273796	2008	Genet. Mol. Res.	1676-5680	ALL_TEXT_1/3	1	2	3953	LONGTERM|GENE|GT|DICTIONARY|GA	leptin receptor	leptin receptor	59#74		D009765	LONGTERM|DICTIONARY	obesity	obesity	171#178		The adrenergic receptor beta3 (beta3-AR), leptin (LEP) and leptin receptor (LEPR) genes have been intensively evaluated in the search of variants that could be related to obesity and its cardiometabolic complications.
18273796	2008	Genet. Mol. Res.	1676-5680	ALL_TEXT_1/3	1	2	3953	SYMBOL|()|GENE|GN|DICTIONARY|EXTRACTED	lepr	LEPR	76#80	18273796-2-59-74	D009765	LONGTERM|DICTIONARY	obesity	obesity	171#178		The adrenergic receptor beta3 (beta3-AR), leptin (LEP) and leptin receptor (LEPR) genes have been intensively evaluated in the search of variants that could be related to obesity and its cardiometabolic complications.
18273796	2008	Genet. Mol. Res.	1676-5680	ALL_TEXT_1/3	1	2	1934	SYMBOL|EXTRACTED|()	beta3	beta3	31#36	18273796-2-24-29	D009765	LONGTERM|DICTIONARY	obesity	obesity	171#178		The adrenergic receptor beta3 (beta3-AR), leptin (LEP) and leptin receptor (LEPR) genes have been intensively evaluated in the search of variants that could be related to obesity and its cardiometabolic complications.
18273796	2008	Genet. Mol. Res.	1676-5680	ALL_TEXT_2/3	2	8	155	SYMBOL|EXTRACTED	beta3 ar	beta3-AR	69#77	18273796-2-24-29	D009765	LONGTERM|DICTIONARY	obese	obese	140#145		There was no significant difference in the genotype frequency of the beta3-AR p.W64R and the LEP c.-2548G>A polymorphisms, between lean and obese subjects.
18273796	2008	Genet. Mol. Res.	1676-5680	ALL_TEXT_2/3	2	8	3952	SYMBOL|DICTIONARY|EXTRACTED	lep	LEP	93#96	18273796-2-42-48	D009765	LONGTERM|DICTIONARY	obese	obese	140#145		There was no significant difference in the genotype frequency of the beta3-AR p.W64R and the LEP c.-2548G>A polymorphisms, between lean and obese subjects.
18273796	2008	Genet. Mol. Res.	1676-5680	ALL_TEXT_3/3	3	9	3953	SYMBOL|DICTIONARY|EXTRACTED	lepr	LEPR	52#56	18273796-2-59-74	D009765	LONGTERM|DICTIONARY	obese	obese	132#137		However, the genotype and allele frequencies of the LEPR p.Q223R variant were significantly different between the normal weight and obese groups.
15956286	2005	Blood	0006-4971	ALL_TEXT_1/3	1	2	3779	LONGTERM|DICTIONARY	beta1	beta1	145#150		C564525	LONGTERM|DISEASE|DN|DICTIONARY	macrothrombocytopenia	macrothrombocytopenia	35#56		In 24.2% of 33 unrelated inherited macrothrombocytopenia patients and in 10.6% of 272 subjects of a healthy population a P for Q substitution in beta1-tubulin was found in the highly conserved residue 43.
15987458	2006	Breast Cancer Res.	1465-542X	RESULTS	3	5	1586	SYMBOL|DICTIONARY	cyp17	CYP17	37#42		D001943	LONGTERM|DISEASE|DT|DICTIONARY	breast cancer	breast cancer	56#69		We found no associations between the CYP17 genotype and breast cancer overall.
18281670	2008	J. Clin. Oncol.	1527-7755	TITLE	0	0	7184	SYMBOL|DICTIONARY	gp96	gp96	81#85		D009369	LONGTERM|DISEASE|DT|DICTIONARY	tumor	tumor	48#53		Phase III comparison of vitespen, an autologous tumor-derived heat shock protein gp96 peptide complex vaccine, with physician's choice of treatment for stage IV melanoma: the C-100-21 Study Group.
18281670	2008	J. Clin. Oncol.	1527-7755	TITLE	0	0	7184	SYMBOL|DICTIONARY	gp96	gp96	81#85		D008545	LONGTERM|DICTIONARY	stage iv melanoma	stage IV melanoma	152#169		Phase III comparison of vitespen, an autologous tumor-derived heat shock protein gp96 peptide complex vaccine, with physician's choice of treatment for stage IV melanoma: the C-100-21 Study Group.
18281670	2008	J. Clin. Oncol.	1527-7755	PURPOSE	1	1	7184	SYMBOL|DICTIONARY	gp96	gp96	92#96		D009369	LONGTERM|DISEASE|DT|DICTIONARY	tumor	tumor	58#63		To assess the antitumor activity of vitespen (autologous, tumor- derived heat shock protein gp96 peptide complexes) by determining whether patients with stage IV melanoma treated with vitespen experienced longer overall survival than patients treated with physician's choice.
18281670	2008	J. Clin. Oncol.	1527-7755	PURPOSE	1	1	7184	SYMBOL|DICTIONARY	gp96	gp96	92#96		D008545	LONGTERM|DISEASE|DN|DICTIONARY	stage iv melanoma	stage IV melanoma	153#170		To assess the antitumor activity of vitespen (autologous, tumor- derived heat shock protein gp96 peptide complexes) by determining whether patients with stage IV melanoma treated with vitespen experienced longer overall survival than patients treated with physician's choice.
18281670	2008	J. Clin. Oncol.	1527-7755	PATIENTS AND METHODS	2	2	3558	LONGTERM|DICTIONARY	interleukin 2	interleukin-2	176#189		D009369	LONGTERM|DISEASE|DT|DICTIONARY	tumor	tumor	203#208		Patients (N = 322) were randomly assigned 2:1 to receive vitespen or physician's choice (PC) of a treatment containing one or more of the following: dacarbazine, temozolomide, interleukin-2, or complete tumor resection.
20047977	2010	Am. J. Epidemiol.	1476-6256	ALL_TEXT_1/3	1	1	7124	LONGTERM|GENE|GT|DICTIONARY	tumor necrosis factor	tumor necrosis factor	118#139		D008228	LONGTERM|DICTIONARY	non hodgkin lymphoma	non-Hodgkin lymphoma	194#214		In an International Lymphoma Epidemiology Consortium pooled analysis, polymorphisms in 2 immune-system-related genes, tumor necrosis factor (TNF) and interleukin-10 (IL10), were associated with non-Hodgkin lymphoma (NHL) risk.
20047977	2010	Am. J. Epidemiol.	1476-6256	ALL_TEXT_1/3	1	1	7124	LONGTERM|GENE|GT|DICTIONARY	tumor necrosis factor	tumor necrosis factor	118#139		D008228	SYMBOL|()|DICTIONARY|EXTRACTED	nhl	NHL	216#219	20047977-1-194-214	In an International Lymphoma Epidemiology Consortium pooled analysis, polymorphisms in 2 immune-system-related genes, tumor necrosis factor (TNF) and interleukin-10 (IL10), were associated with non-Hodgkin lymphoma (NHL) risk.
20047977	2010	Am. J. Epidemiol.	1476-6256	ALL_TEXT_1/3	1	1	7124	SYMBOL|()|DICTIONARY|EXTRACTED	tnf	TNF	141#144	20047977-0-0-21	D008228	LONGTERM|DICTIONARY	non hodgkin lymphoma	non-Hodgkin lymphoma	194#214		In an International Lymphoma Epidemiology Consortium pooled analysis, polymorphisms in 2 immune-system-related genes, tumor necrosis factor (TNF) and interleukin-10 (IL10), were associated with non-Hodgkin lymphoma (NHL) risk.
20047977	2010	Am. J. Epidemiol.	1476-6256	ALL_TEXT_1/3	1	1	7124	SYMBOL|()|DICTIONARY|EXTRACTED	tnf	TNF	141#144	20047977-0-0-21	D008228	SYMBOL|()|DICTIONARY|EXTRACTED	nhl	NHL	216#219	20047977-1-194-214	In an International Lymphoma Epidemiology Consortium pooled analysis, polymorphisms in 2 immune-system-related genes, tumor necrosis factor (TNF) and interleukin-10 (IL10), were associated with non-Hodgkin lymphoma (NHL) risk.
20047977	2010	Am. J. Epidemiol.	1476-6256	ALL_TEXT_1/3	1	1	3586	LONGTERM|DICTIONARY	interleukin 10	interleukin-10	150#164		D008228	LONGTERM|DICTIONARY	non hodgkin lymphoma	non-Hodgkin lymphoma	194#214		In an International Lymphoma Epidemiology Consortium pooled analysis, polymorphisms in 2 immune-system-related genes, tumor necrosis factor (TNF) and interleukin-10 (IL10), were associated with non-Hodgkin lymphoma (NHL) risk.
20047977	2010	Am. J. Epidemiol.	1476-6256	ALL_TEXT_1/3	1	1	3586	LONGTERM|DICTIONARY	interleukin 10	interleukin-10	150#164		D008228	SYMBOL|()|DICTIONARY|EXTRACTED	nhl	NHL	216#219	20047977-1-194-214	In an International Lymphoma Epidemiology Consortium pooled analysis, polymorphisms in 2 immune-system-related genes, tumor necrosis factor (TNF) and interleukin-10 (IL10), were associated with non-Hodgkin lymphoma (NHL) risk.
20047977	2010	Am. J. Epidemiol.	1476-6256	ALL_TEXT_1/3	1	1	3586	SYMBOL|()|DICTIONARY|EXTRACTED	il10	IL10	166#170	20047977-1-150-164	D008228	LONGTERM|DICTIONARY	non hodgkin lymphoma	non-Hodgkin lymphoma	194#214		In an International Lymphoma Epidemiology Consortium pooled analysis, polymorphisms in 2 immune-system-related genes, tumor necrosis factor (TNF) and interleukin-10 (IL10), were associated with non-Hodgkin lymphoma (NHL) risk.
20047977	2010	Am. J. Epidemiol.	1476-6256	ALL_TEXT_1/3	1	1	3586	SYMBOL|()|DICTIONARY|EXTRACTED	il10	IL10	166#170	20047977-1-150-164	D008228	SYMBOL|()|DICTIONARY|EXTRACTED	nhl	NHL	216#219	20047977-1-194-214	In an International Lymphoma Epidemiology Consortium pooled analysis, polymorphisms in 2 immune-system-related genes, tumor necrosis factor (TNF) and interleukin-10 (IL10), were associated with non-Hodgkin lymphoma (NHL) risk.
16255050	2005	Arthritis Rheum.	0004-3591	RESULTS	3	10	6584	SYMBOL|DICTIONARY	slc22a5	SLC22A5	64#71		D015535	SYMBOL|EXTRACTED	psa	PsA	104#107	16255050-2-92-111	In contrast, a functional SNP mapping to the promoter region of SLC22A5 (rs2631367) was associated with PsA (for CC versus GG, odds ratio 1.65, 95% confidence interval 1.13-2.41, uncorrected P = 0.005).
20047977	2010	Am. J. Epidemiol.	1476-6256	ALL_TEXT_3/3	3	5	7124	SYMBOL|DICTIONARY|EXTRACTED	tnf	TNF	59#62	20047977-0-0-21	D008228	SYMBOL|DICTIONARY|EXTRACTED	nhl	NHL	79#82	20047977-1-194-214	In the combined population, odds ratios were increased for TNF -308A carriers (NHL: OR(allelic) = 1.13, P(trend) = 0.0001; DLBCL: OR(allelic) = 1.25, P(trend) = 3.7 x 10(-6); marginal zone lymphoma: OR(allelic) = 1.35, P(trend) = 0.004) and LTA 252G carriers (DLBCL: OR(allelic) = 1.12, P(trend) = 0.006; mycosis fungoides: OR(allelic) = 1.44, P(trend) = 0.015).
20047977	2010	Am. J. Epidemiol.	1476-6256	ALL_TEXT_3/3	3	5	7124	SYMBOL|DICTIONARY|EXTRACTED	tnf	TNF	59#62	20047977-0-0-21	D016393	SYMBOL|DICTIONARY|EXTRACTED	dlbcl	DLBCL	123#128	20047977-4-171-200	In the combined population, odds ratios were increased for TNF -308A carriers (NHL: OR(allelic) = 1.13, P(trend) = 0.0001; DLBCL: OR(allelic) = 1.25, P(trend) = 3.7 x 10(-6); marginal zone lymphoma: OR(allelic) = 1.35, P(trend) = 0.004) and LTA 252G carriers (DLBCL: OR(allelic) = 1.12, P(trend) = 0.006; mycosis fungoides: OR(allelic) = 1.44, P(trend) = 0.015).
20047977	2010	Am. J. Epidemiol.	1476-6256	ALL_TEXT_3/3	3	5	7124	SYMBOL|DICTIONARY|EXTRACTED	tnf	TNF	59#62	20047977-0-0-21	D018442	LONGTERM|DICTIONARY	marginal zone lymphoma	marginal zone lymphoma	175#197		In the combined population, odds ratios were increased for TNF -308A carriers (NHL: OR(allelic) = 1.13, P(trend) = 0.0001; DLBCL: OR(allelic) = 1.25, P(trend) = 3.7 x 10(-6); marginal zone lymphoma: OR(allelic) = 1.35, P(trend) = 0.004) and LTA 252G carriers (DLBCL: OR(allelic) = 1.12, P(trend) = 0.006; mycosis fungoides: OR(allelic) = 1.44, P(trend) = 0.015).
20047977	2010	Am. J. Epidemiol.	1476-6256	ALL_TEXT_3/3	3	5	7124	SYMBOL|DICTIONARY|EXTRACTED	tnf	TNF	59#62	20047977-0-0-21	D016393	SYMBOL|DICTIONARY|EXTRACTED	dlbcl	DLBCL	260#265	20047977-4-171-200	In the combined population, odds ratios were increased for TNF -308A carriers (NHL: OR(allelic) = 1.13, P(trend) = 0.0001; DLBCL: OR(allelic) = 1.25, P(trend) = 3.7 x 10(-6); marginal zone lymphoma: OR(allelic) = 1.35, P(trend) = 0.004) and LTA 252G carriers (DLBCL: OR(allelic) = 1.12, P(trend) = 0.006; mycosis fungoides: OR(allelic) = 1.44, P(trend) = 0.015).
20047977	2010	Am. J. Epidemiol.	1476-6256	ALL_TEXT_3/3	3	5	7124	SYMBOL|DICTIONARY|EXTRACTED	tnf	TNF	59#62	20047977-0-0-21	D015821	LONGTERM|DICTIONARY	mycosis	mycosis	305#312		In the combined population, odds ratios were increased for TNF -308A carriers (NHL: OR(allelic) = 1.13, P(trend) = 0.0001; DLBCL: OR(allelic) = 1.25, P(trend) = 3.7 x 10(-6); marginal zone lymphoma: OR(allelic) = 1.35, P(trend) = 0.004) and LTA 252G carriers (DLBCL: OR(allelic) = 1.12, P(trend) = 0.006; mycosis fungoides: OR(allelic) = 1.44, P(trend) = 0.015).
18798262	2008	Int. J. Cancer	1097-0215	ALL_TEXT_3/3	3	10	4851	SYMBOL|DICTIONARY	notch1	Notch1	23#29		D008223	LONGTERM|DICTIONARY	lymphoma	lymphoma	121#129		This report shows that Notch1 is a prevalent and major mutational target for 2',3'-dideoxycytidine and butadiene-induced lymphoma.
20047977	2010	Am. J. Epidemiol.	1476-6256	ALL_TEXT_3/3	3	7	3586	SYMBOL|DICTIONARY|EXTRACTED	il10	IL10	39#43	20047977-1-150-164	D016393	SYMBOL|DICTIONARY|EXTRACTED	dlbcl	DLBCL	57#62	20047977-4-171-200	Results suggested associations between IL10 -3575T>A and DLBCL (P(trend) = 0.02) and IL10 -1082A>G and mantle cell lymphoma (P(trend) = 0.04).
20047977	2010	Am. J. Epidemiol.	1476-6256	ALL_TEXT_3/3	3	7	3586	SYMBOL|DICTIONARY|EXTRACTED	il10	IL10	39#43	20047977-1-150-164	D020522	LONGTERM|DICTIONARY	mantle cell lymphoma	mantle cell lymphoma	103#123		Results suggested associations between IL10 -3575T>A and DLBCL (P(trend) = 0.02) and IL10 -1082A>G and mantle cell lymphoma (P(trend) = 0.04).
20047977	2010	Am. J. Epidemiol.	1476-6256	ALL_TEXT_3/3	3	7	3586	SYMBOL|DICTIONARY|EXTRACTED	il10	IL10	85#89	20047977-1-150-164	D016393	SYMBOL|DICTIONARY|EXTRACTED	dlbcl	DLBCL	57#62	20047977-4-171-200	Results suggested associations between IL10 -3575T>A and DLBCL (P(trend) = 0.02) and IL10 -1082A>G and mantle cell lymphoma (P(trend) = 0.04).
20047977	2010	Am. J. Epidemiol.	1476-6256	ALL_TEXT_3/3	3	7	3586	SYMBOL|DICTIONARY|EXTRACTED	il10	IL10	85#89	20047977-1-150-164	D020522	LONGTERM|DICTIONARY	mantle cell lymphoma	mantle cell lymphoma	103#123		Results suggested associations between IL10 -3575T>A and DLBCL (P(trend) = 0.02) and IL10 -1082A>G and mantle cell lymphoma (P(trend) = 0.04).
21151597	2011	Mol. Vis.	1090-0535	METHODS	2	2	149233	SYMBOL|DICTIONARY|EXTRACTED	il23r	IL23R	86#91	21151597-1-80-103	D005642	LONGTERM|DICTIONARY	fuchs' syndrome	Fuchs' syndrome	140#155	NaN	Three single-nucleotide polymorphisms (SNPs), rs7517847, rs11209032 and rs17375018 of IL23R were genotyped in 138 Chinese Han patients with Fuchs' syndrome and 407 healthy controls by using the polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) method.Data were analyzed by (2) analysis.
21151597	2011	Mol. Vis.	1090-0535	PURPOSE	1	1	149233	LONGTERM|GENE|GT|DICTIONARY|GA	interleukin 23 receptor	interleukin-23 receptor	80#103		D005642	LONGTERM|DICTIONARY	fuchs' syndrome	Fuchs' syndrome	122#137	NaN	The aim of the study was to investigate the association of polymorphisms of the interleukin-23 receptor (IL23R) gene with Fuchs' syndrome in a Chinese Han population.
21151597	2011	Mol. Vis.	1090-0535	PURPOSE	1	1	149233	SYMBOL|()|GENE|GN|DICTIONARY|EXTRACTED	il23r	IL23R	105#110	21151597-1-80-103	D005642	LONGTERM|DICTIONARY	fuchs' syndrome	Fuchs' syndrome	122#137	NaN	The aim of the study was to investigate the association of polymorphisms of the interleukin-23 receptor (IL23R) gene with Fuchs' syndrome in a Chinese Han population.
21151597	2011	Mol. Vis.	1090-0535	RESULTS	3	7	149233	SYMBOL|DICTIONARY|EXTRACTED	il23r	IL23R	99#104	21151597-1-80-103	D005642	LONGTERM|DICTIONARY	fuchs' syndrome	Fuchs' syndrome	110#125	NaN	Additionally, analysis according to gender did not show any influence of sex on the association of IL23R with Fuchs' syndrome.
16322490	2006	Stroke	1524-4628	RESULTS	3	8	7124	LONGTERM|DICTIONARY	tnf-alpha	TNF-alpha	120#129	NaN	D020300	SYMBOL|DICTIONARY|EXTRACTED	ich	ICH	84#87	16322490-1-95-118	After adjusting for age, race/ethnicity, and clinical presentation, the risk of new ICH was increased for patients with TNF-alpha-238 AG genotype (hazard ratio, 4.01; P=0.015).
16417222	2006	J. Invest. Dermatol.	0022-202X	ALL_TEXT_2/3	2	4	7299	LONGTERM|DICTIONARY	tyrosinase	tyrosinase	72#82		D016115	SYMBOL|EXTRACTED	oca	OCA	35#38	16417222-1-121-144	In Puerto Ricans with more typical OCA, the most common mutation of the tyrosinase (TYR) (human tyrosinase (OCA1) gene) gene was G47D.
16417222	2006	J. Invest. Dermatol.	0022-202X	ALL_TEXT_2/3	2	4	7299	SYMBOL|()|DICTIONARY|EXTRACTED	tyr	TYR	84#87	16417222-4-72-82	D016115	SYMBOL|EXTRACTED	oca	OCA	35#38	16417222-1-121-144	In Puerto Ricans with more typical OCA, the most common mutation of the tyrosinase (TYR) (human tyrosinase (OCA1) gene) gene was G47D.
16417222	2006	J. Invest. Dermatol.	0022-202X	ALL_TEXT_2/3	2	4	7299	LONGTERM|DICTIONARY|GENE|GA	tyrosinase	tyrosinase	96#106		D016115	SYMBOL|EXTRACTED	oca	OCA	35#38	16417222-1-121-144	In Puerto Ricans with more typical OCA, the most common mutation of the tyrosinase (TYR) (human tyrosinase (OCA1) gene) gene was G47D.
16417222	2006	J. Invest. Dermatol.	0022-202X	ALL_TEXT_2/3	2	4	7299	SYMBOL|()|GENE|GN|DICTIONARY|EXTRACTED	oca1	OCA1	108#112	16417222-4-96-106	D016115	SYMBOL|EXTRACTED	oca	OCA	35#38	16417222-1-121-144	In Puerto Ricans with more typical OCA, the most common mutation of the tyrosinase (TYR) (human tyrosinase (OCA1) gene) gene was G47D.
11462241	2001	Hum. Mutat.	1098-1004	TITLE	0	0	1536	SYMBOL|GENE|GN|DICTIONARY	cybb	CYBB	86#90		D006105	LONGTERM|DISEASE|DT|DICTIONARY	x linked chronic granulomatous disease	X-linked chronic granulomatous disease	46#84		Characterization of 11 novel mutations in the X-linked chronic granulomatous disease (CYBB gene).
11462241	2001	Hum. Mutat.	1098-1004	ALL_TEXT_1/3	1	1	1536	SYMBOL|GENE|GN|DICTIONARY	cybb	CYBB	95#99		D006105	LONGTERM|DISEASE|DT|DICTIONARY	chronic granulomatous disease	chronic granulomatous disease	26#55		The most frequent form of chronic granulomatous disease (CGD) is caused by inactivation of the CYBB gene, which encodes the gp91-phox subunit of phagocyte NADPH oxidase.
11462241	2001	Hum. Mutat.	1098-1004	ALL_TEXT_1/3	1	1	1536	SYMBOL|GENE|GN|DICTIONARY	cybb	CYBB	95#99		D006105	SYMBOL|()|DICTIONARY|EXTRACTED	cgd	CGD	57#60	11462241-1-26-55	The most frequent form of chronic granulomatous disease (CGD) is caused by inactivation of the CYBB gene, which encodes the gp91-phox subunit of phagocyte NADPH oxidase.
16322490	2006	Stroke	1524-4628	TITLE	0	0	7124	LONGTERM|NUMBER|DICTIONARY	tumor necrosis factor alpha	Tumor necrosis factor-alpha	0#27		D001165	LONGTERM|DICTIONARY	brain arteriovenous malformations	brain arteriovenous malformations	148#181		Tumor necrosis factor-alpha-238G>A promoter polymorphism is associated with increased risk of new hemorrhage in the natural course of patients with brain arteriovenous malformations.
16322490	2006	Stroke	1524-4628	TITLE	0	0	7124	LONGTERM|NUMBER|DICTIONARY	tumor necrosis factor alpha	Tumor necrosis factor-alpha	0#27		D006470	LONGTERM|DICTIONARY	hemorrhage	hemorrhage	98#108	NaN	Tumor necrosis factor-alpha-238G>A promoter polymorphism is associated with increased risk of new hemorrhage in the natural course of patients with brain arteriovenous malformations.
16417222	2006	J. Invest. Dermatol.	0022-202X	ALL_TEXT_2/3	2	5	4948	SYMBOL|GENE|GN|DICTIONARY	oca2	OCA2	98#102		D016115	SYMBOL|EXTRACTED|DISEASE|DN	oca	OCA	39#42	16417222-1-121-144	We describe screening 229 Puerto Rican OCA patients for these mutations, and for mutations in the OCA2 gene.
11474225	2001	Nephron	1660-8151	TITLE	0	0	1636	SYMBOL|DICTIONARY|EXTRACTED	ace	ACE	16#19		D005921	LONGTERM|DICTIONARY	glomerulosclerosis	glomerulosclerosis	72#90		Significance of ACE genotypes and medical treatments in childhood focal glomerulosclerosis.
11474225	2001	Nephron	1660-8151	METHODS	2	2	1636	SYMBOL|DICTIONARY|EXTRACTED	ace	ACE	63#66	11474225-1-51-80	D005923	SYMBOL|DICTIONARY|EXTRACTED	fsgs	FSGS	129#133	11474225-1-137-179	A multicenter retrospective study was performed on the role of ACE genotypes and medical treatments in 43 Japanese children with FSGS (20 males and 23 females), including 17 children who progressed to end-stage renal failure during the mean observation period of 6.9 +/- (SD) 5.0 years.
11474225	2001	Nephron	1660-8151	METHODS	2	2	1636	SYMBOL|DICTIONARY|EXTRACTED	ace	ACE	63#66	11474225-1-51-80	D007676	LONGTERM|DICTIONARY	end stage renal failure	end-stage renal failure	201#224		A multicenter retrospective study was performed on the role of ACE genotypes and medical treatments in 43 Japanese children with FSGS (20 males and 23 females), including 17 children who progressed to end-stage renal failure during the mean observation period of 6.9 +/- (SD) 5.0 years.
15734955	2005	Cancer Epidemiol. Biomarkers Prev.	1055-9965	ALL_TEXT_3/3	3	11	7515	SYMBOL|DICTIONARY	xrcc1	XRCC1	64#69		D001943	LONGTERM|DISEASE|DT|DICTIONARY	breast cancer	breast cancer	94#107		These results do not show that the two genetic polymorphisms of XRCC1 independently influence breast cancer risk.
20555002	2010	In Vivo	0258-851X	RESULTS	3	9	7422	SYMBOL|DICTIONARY|EXTRACTED	vegf	VEGF	58#62	20555002-2-8-42	D004715	LONGTERM|DICTIONARY	endometriosis	endometriosis	14#27		Patients with endometriosis had a higher incidence of the VEGF +405 CC genotype compared with the controls (p=0.027).
18563706	2009	Am. J. Med. Genet. B Neuropsychiatr. Genet.	1552-485X	ALL_TEXT_1/3	1	3	6531	SYMBOL|DICTIONARY	slc6a3	SLC6A3	199#205		D009139	LONGTERM|DICTIONARY	number tandem repeat variation	number tandem repeat variation	165#195	NaN	This study attempts to determine genetic influences on the relationship between the dopamine pathway and smoking cessation by examining associations with a variable number tandem repeat variation in SLC6A3 and the DRD2 variants TaqIA (A2 vs. A1), TaqIB (B2 vs. B1), C957T (C vs. T), and -141C Ins/Del (C vs. Del).
18563706	2009	Am. J. Med. Genet. B Neuropsychiatr. Genet.	1552-485X	ALL_TEXT_1/3	1	3	1813	SYMBOL|DICTIONARY	drd2	DRD2	214#218		D009139	LONGTERM|DICTIONARY	number tandem repeat variation	number tandem repeat variation	165#195	NaN	This study attempts to determine genetic influences on the relationship between the dopamine pathway and smoking cessation by examining associations with a variable number tandem repeat variation in SLC6A3 and the DRD2 variants TaqIA (A2 vs. A1), TaqIB (B2 vs. B1), C957T (C vs. T), and -141C Ins/Del (C vs. Del).
11313768	2001	Eur. J. Hum. Genet.	1018-4813	ALL_TEXT_1/3	1	1	4598	LONGTERM|DICTIONARY	mevalonate kinase	mevalonate kinase	188#205		D054078	SYMBOL|EXTRACTED|()	ma	MA	20#22	11313768-1-0-18	Mevalonic aciduria (MA) and hyperimmunoglobulinaemia D and periodic fever syndrome (HIDS) are two autosomal recessive inherited disorders both caused by a deficient activity of the enzyme mevalonate kinase (MK) resulting from mutations in the encoding MVK gene.
11313768	2001	Eur. J. Hum. Genet.	1018-4813	ALL_TEXT_1/3	1	1	4598	LONGTERM|DICTIONARY	mevalonate kinase	mevalonate kinase	188#205		D005334	LONGTERM|DISEASE|DT|DICTIONARY	periodic fever syndrome	periodic fever syndrome	59#82		Mevalonic aciduria (MA) and hyperimmunoglobulinaemia D and periodic fever syndrome (HIDS) are two autosomal recessive inherited disorders both caused by a deficient activity of the enzyme mevalonate kinase (MK) resulting from mutations in the encoding MVK gene.
11313768	2001	Eur. J. Hum. Genet.	1018-4813	ALL_TEXT_1/3	1	1	4598	LONGTERM|DICTIONARY	mevalonate kinase	mevalonate kinase	188#205		D030342	LONGTERM|DICTIONARY	inherited disorders	inherited disorders	118#137		Mevalonic aciduria (MA) and hyperimmunoglobulinaemia D and periodic fever syndrome (HIDS) are two autosomal recessive inherited disorders both caused by a deficient activity of the enzyme mevalonate kinase (MK) resulting from mutations in the encoding MVK gene.
11313768	2001	Eur. J. Hum. Genet.	1018-4813	ALL_TEXT_1/3	1	1	4598	SYMBOL|EXTRACTED|()	mk	MK	207#209	11313768-1-188-205	D054078	SYMBOL|EXTRACTED|()	ma	MA	20#22	11313768-1-0-18	Mevalonic aciduria (MA) and hyperimmunoglobulinaemia D and periodic fever syndrome (HIDS) are two autosomal recessive inherited disorders both caused by a deficient activity of the enzyme mevalonate kinase (MK) resulting from mutations in the encoding MVK gene.
11313768	2001	Eur. J. Hum. Genet.	1018-4813	ALL_TEXT_1/3	1	1	4598	SYMBOL|EXTRACTED|()	mk	MK	207#209	11313768-1-188-205	D005334	LONGTERM|DISEASE|DT|DICTIONARY	periodic fever syndrome	periodic fever syndrome	59#82		Mevalonic aciduria (MA) and hyperimmunoglobulinaemia D and periodic fever syndrome (HIDS) are two autosomal recessive inherited disorders both caused by a deficient activity of the enzyme mevalonate kinase (MK) resulting from mutations in the encoding MVK gene.
11313768	2001	Eur. J. Hum. Genet.	1018-4813	ALL_TEXT_1/3	1	1	4598	SYMBOL|EXTRACTED|()	mk	MK	207#209	11313768-1-188-205	D030342	LONGTERM|DICTIONARY	inherited disorders	inherited disorders	118#137		Mevalonic aciduria (MA) and hyperimmunoglobulinaemia D and periodic fever syndrome (HIDS) are two autosomal recessive inherited disorders both caused by a deficient activity of the enzyme mevalonate kinase (MK) resulting from mutations in the encoding MVK gene.
11313768	2001	Eur. J. Hum. Genet.	1018-4813	ALL_TEXT_1/3	1	1	4598	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	mvk	MVK	252#255	11313768-0-20-37	D054078	SYMBOL|EXTRACTED|()	ma	MA	20#22	11313768-1-0-18	Mevalonic aciduria (MA) and hyperimmunoglobulinaemia D and periodic fever syndrome (HIDS) are two autosomal recessive inherited disorders both caused by a deficient activity of the enzyme mevalonate kinase (MK) resulting from mutations in the encoding MVK gene.
11313768	2001	Eur. J. Hum. Genet.	1018-4813	ALL_TEXT_1/3	1	1	4598	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	mvk	MVK	252#255	11313768-0-20-37	D005334	LONGTERM|DISEASE|DT|DICTIONARY	periodic fever syndrome	periodic fever syndrome	59#82		Mevalonic aciduria (MA) and hyperimmunoglobulinaemia D and periodic fever syndrome (HIDS) are two autosomal recessive inherited disorders both caused by a deficient activity of the enzyme mevalonate kinase (MK) resulting from mutations in the encoding MVK gene.
11313768	2001	Eur. J. Hum. Genet.	1018-4813	ALL_TEXT_1/3	1	1	4598	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	mvk	MVK	252#255	11313768-0-20-37	D030342	LONGTERM|DICTIONARY	inherited disorders	inherited disorders	118#137		Mevalonic aciduria (MA) and hyperimmunoglobulinaemia D and periodic fever syndrome (HIDS) are two autosomal recessive inherited disorders both caused by a deficient activity of the enzyme mevalonate kinase (MK) resulting from mutations in the encoding MVK gene.
11313768	2001	Eur. J. Hum. Genet.	1018-4813	TITLE	0	0	4598	LONGTERM|DICTIONARY|GENE|GA	mevalonate kinase	mevalonate kinase	20#37		D054078	LONGTERM|DICTIONARY	mevalonic aciduria	mevalonic aciduria	95#113		Organization of the mevalonate kinase (MVK) gene and identification of novel mutations causing mevalonic aciduria and hyperimmunoglobulinaemia D and periodic fever syndrome.
11313768	2001	Eur. J. Hum. Genet.	1018-4813	TITLE	0	0	4598	LONGTERM|DICTIONARY|GENE|GA	mevalonate kinase	mevalonate kinase	20#37		D005334	LONGTERM|DISEASE|DT|DICTIONARY	periodic fever syndrome	periodic fever syndrome	149#172		Organization of the mevalonate kinase (MVK) gene and identification of novel mutations causing mevalonic aciduria and hyperimmunoglobulinaemia D and periodic fever syndrome.
11313768	2001	Eur. J. Hum. Genet.	1018-4813	TITLE	0	0	4598	SYMBOL|()|GENE|GN|DICTIONARY|EXTRACTED	mvk	MVK	39#42	11313768-0-20-37	D054078	LONGTERM|DICTIONARY	mevalonic aciduria	mevalonic aciduria	95#113		Organization of the mevalonate kinase (MVK) gene and identification of novel mutations causing mevalonic aciduria and hyperimmunoglobulinaemia D and periodic fever syndrome.
11313768	2001	Eur. J. Hum. Genet.	1018-4813	TITLE	0	0	4598	SYMBOL|()|GENE|GN|DICTIONARY|EXTRACTED	mvk	MVK	39#42	11313768-0-20-37	D005334	LONGTERM|DISEASE|DT|DICTIONARY	periodic fever syndrome	periodic fever syndrome	149#172		Organization of the mevalonate kinase (MVK) gene and identification of novel mutations causing mevalonic aciduria and hyperimmunoglobulinaemia D and periodic fever syndrome.
19563289	2009	J. Periodontol.	0022-3492	TITLE	0	0	3552	LONGTERM|DICTIONARY	interleukin-1	interleukin-1	26#39	NaN	D010518	LONGTERM|DICTIONARY	periodontitis	periodontitis	76#89		The role of the composite interleukin-1 genotype in the association between periodontitis and acute myocardial infarction.
19563289	2009	J. Periodontol.	0022-3492	TITLE	0	0	3552	LONGTERM|DICTIONARY	interleukin-1	interleukin-1	26#39	NaN	D009203	LONGTERM|DICTIONARY	acute myocardial infarction	acute myocardial infarction	94#121		The role of the composite interleukin-1 genotype in the association between periodontitis and acute myocardial infarction.
20816194	2010	J. Allergy Clin. Immunol.	1097-6825	BACKGROUND	1	1	3497	LONGTERM|DICTIONARY	ige	IgE	153#156	NaN	D007589	LONGTERM|DICTIONARY	hyper ige syndromes	Hyper-IgE syndromes	0#19		Hyper-IgE syndromes (HIES) are primary immunodeficiency disorders characterized by Staphylococcus aureus abscesses, recurrent pneumonia, increased serum IgE levels, and eczema.
20816194	2010	J. Allergy Clin. Immunol.	1097-6825	BACKGROUND	1	1	3497	LONGTERM|DICTIONARY	ige	IgE	153#156	NaN	D007589	SYMBOL|EXTRACTED|()	hies	HIES	21#25	20816194-1-0-19	Hyper-IgE syndromes (HIES) are primary immunodeficiency disorders characterized by Staphylococcus aureus abscesses, recurrent pneumonia, increased serum IgE levels, and eczema.
20816194	2010	J. Allergy Clin. Immunol.	1097-6825	BACKGROUND	1	1	3497	LONGTERM|DICTIONARY	ige	IgE	153#156	NaN	D004485	LONGTERM|DICTIONARY	eczema	eczema	169#175		Hyper-IgE syndromes (HIES) are primary immunodeficiency disorders characterized by Staphylococcus aureus abscesses, recurrent pneumonia, increased serum IgE levels, and eczema.
20816194	2010	J. Allergy Clin. Immunol.	1097-6825	BACKGROUND	1	1	3497	LONGTERM|DICTIONARY	ige	IgE	153#156	NaN	D007154	LONGTERM|DISEASE|DN|DICTIONARY	primary immunodeficiency disorders	primary immunodeficiency disorders	31#65		Hyper-IgE syndromes (HIES) are primary immunodeficiency disorders characterized by Staphylococcus aureus abscesses, recurrent pneumonia, increased serum IgE levels, and eczema.
20816194	2010	J. Allergy Clin. Immunol.	1097-6825	BACKGROUND	1	1	3497	LONGTERM|DICTIONARY	ige	IgE	153#156	NaN	D007154	LONGTERM|DICTIONARY	primary immunodeficiency disorders	primary immunodeficiency disorders	31#65		Hyper-IgE syndromes (HIES) are primary immunodeficiency disorders characterized by Staphylococcus aureus abscesses, recurrent pneumonia, increased serum IgE levels, and eczema.
20816194	2010	J. Allergy Clin. Immunol.	1097-6825	BACKGROUND	1	1	3497	LONGTERM|DICTIONARY	ige	IgE	153#156	NaN	D011014	LONGTERM|DICTIONARY	pneumonia	pneumonia	126#135		Hyper-IgE syndromes (HIES) are primary immunodeficiency disorders characterized by Staphylococcus aureus abscesses, recurrent pneumonia, increased serum IgE levels, and eczema.
20816194	2010	J. Allergy Clin. Immunol.	1097-6825	BACKGROUND	1	1	3497	LONGTERM|DICTIONARY	ige	IgE	153#156	NaN	D000038	LONGTERM|DICTIONARY	abscesses	abscesses	105#114	NaN	Hyper-IgE syndromes (HIES) are primary immunodeficiency disorders characterized by Staphylococcus aureus abscesses, recurrent pneumonia, increased serum IgE levels, and eczema.
18563706	2009	Am. J. Med. Genet. B Neuropsychiatr. Genet.	1552-485X	TITLE	0	0	1813	SYMBOL|DICTIONARY	drd2	DRD2	35#39		D008175	LONGTERM|DISEASE|DT|DICTIONARY	lung cancer	lung cancer	129#140		The impact of genetic variation in DRD2 and SLC6A3 on smoking cessation in a cohort of participants 1 year after enrollment in a lung cancer screening study.
18563706	2009	Am. J. Med. Genet. B Neuropsychiatr. Genet.	1552-485X	TITLE	0	0	6531	SYMBOL|DICTIONARY	slc6a3	SLC6A3	44#50		D008175	LONGTERM|DISEASE|DT|DICTIONARY	lung cancer	lung cancer	129#140		The impact of genetic variation in DRD2 and SLC6A3 on smoking cessation in a cohort of participants 1 year after enrollment in a lung cancer screening study.
12684755	2004	J. Mol. Med.	0946-2716	TITLE	0	0	4846	LONGTERM|DICTIONARY	endothelial nitric oxide synthase	endothelial nitric oxide synthase	45#78		D020138	LONGTERM|DICTIONARY	hyperhomocysteinemia	hyperhomocysteinemia	83#103		Interaction of CA repeat polymorphism of the endothelial nitric oxide synthase and hyperhomocysteinemia in acute coronary syndromes: evidence of gender-specific differences.
12684755	2004	J. Mol. Med.	0946-2716	TITLE	0	0	4846	LONGTERM|DICTIONARY	endothelial nitric oxide synthase	endothelial nitric oxide synthase	45#78		D054058	LONGTERM|DICTIONARY	acute coronary syndromes	acute coronary syndromes	107#131		Interaction of CA repeat polymorphism of the endothelial nitric oxide synthase and hyperhomocysteinemia in acute coronary syndromes: evidence of gender-specific differences.
9545398	1998	Am. J. Hum. Genet.	0002-9297	ALL_TEXT_3/3	3	9	695	LONGTERM|DICTIONARY	btk	Btk	96#99	NaN	D004194	LONGTERM|DICTIONARY	sporadic disease	sporadic disease	55#71	NaN	DNA samples from 41 of 49 of the mothers of males with sporadic disease and proven mutations in Btk were positive for the mutation found in their son.
19563289	2009	J. Periodontol.	0022-3492	BACKGROUND	1	1	3552	SYMBOL|DICTIONARY	interleukin (il)-1	interleukin (IL)-1	26#44		D010518	LONGTERM|DICTIONARY	periodontitis	periodontitis	94#107		Recent data indicate that interleukin (IL)-1 polymorphism may influence the susceptibility to periodontitis and coronary heart diseases.
19563289	2009	J. Periodontol.	0022-3492	BACKGROUND	1	1	3552	SYMBOL|DICTIONARY	interleukin (il)-1	interleukin (IL)-1	26#44		D003327	LONGTERM|DICTIONARY	coronary heart diseases	coronary heart diseases	112#135		Recent data indicate that interleukin (IL)-1 polymorphism may influence the susceptibility to periodontitis and coronary heart diseases.
9823305	1998	Cancer Res.	0008-5472	ALL_TEXT_3/3	3	11	1545	SYMBOL|DICTIONARY|EXTRACTED	cyp1b1	CYP1B1	28#34	9823305-0-15-34	D001943	LONGTERM|DISEASE|DT|DICTIONARY	breast cancer	breast cancer	93#106		These data suggest that the CYP1B1 polymorphisms in exon 3 are not associated with increased breast cancer risk but that the m1 polymorphism may be functionally important for steroid receptor expression in breast cancer of Caucasian patients.
9823305	1998	Cancer Res.	0008-5472	ALL_TEXT_3/3	3	11	1545	SYMBOL|DICTIONARY|EXTRACTED	cyp1b1	CYP1B1	28#34	9823305-0-15-34	D001943	LONGTERM|DISEASE|DT|DICTIONARY	breast cancer	breast cancer	206#219		These data suggest that the CYP1B1 polymorphisms in exon 3 are not associated with increased breast cancer risk but that the m1 polymorphism may be functionally important for steroid receptor expression in breast cancer of Caucasian patients.
10732801	2000	Neurogenetics	1364-6745	ALL_TEXT_1/3	1	1	7248	SYMBOL|()|DICTIONARY	tsc1	TSC1	129#133		D014402	LONGTERM|DICTIONARY	tuberous sclerosis complex	Tuberous sclerosis complex	0#26		Tuberous sclerosis complex (TSC) is an autosomal dominant multi-system disorder with two known disease loci on chromosomes 9q34 (TSC1) and 16p13.3 (TSC2).
10732801	2000	Neurogenetics	1364-6745	ALL_TEXT_1/3	1	1	7248	SYMBOL|()|DICTIONARY	tsc1	TSC1	129#133		D014402	SYMBOL|()|DICTIONARY|EXTRACTED	tsc	TSC	28#31	10732801-1-0-26	Tuberous sclerosis complex (TSC) is an autosomal dominant multi-system disorder with two known disease loci on chromosomes 9q34 (TSC1) and 16p13.3 (TSC2).
10732801	2000	Neurogenetics	1364-6745	ALL_TEXT_1/3	1	1	7248	SYMBOL|()|DICTIONARY	tsc1	TSC1	129#133		D030342	LONGTERM|DICTIONARY	autosomal dominant multi-system disorder	autosomal dominant multi-system disorder	39#79	NaN	Tuberous sclerosis complex (TSC) is an autosomal dominant multi-system disorder with two known disease loci on chromosomes 9q34 (TSC1) and 16p13.3 (TSC2).
16324400	2008	Zhonghua Yi Xue Za Zhi	0376-2491	CONCLUSION	4	10	675	SYMBOL|DICTIONARY	brca2	BRCA2	22#27		D001943	LONGTERM|DISEASE|DT|DICTIONARY	breast cancer	breast cancer	87#100		Germline mutations in BRCA2 may contribute less than mutations in BRCA1 to early-onset breast cancer in Shanghai.
16324400	2008	Zhonghua Yi Xue Za Zhi	0376-2491	CONCLUSION	4	10	672	SYMBOL|DICTIONARY	brca1	BRCA1	66#71		D001943	LONGTERM|DISEASE|DT|DICTIONARY	breast cancer	breast cancer	87#100		Germline mutations in BRCA2 may contribute less than mutations in BRCA1 to early-onset breast cancer in Shanghai.
17643058	2007	Int. Arch. Allergy Immunol.	1423-0097	METHODS	2	5	2950	SYMBOL|DICTIONARY	gstp1	GSTP1	58#63		D001249	LONGTERM|NUMBER|DICTIONARY	asthma	asthma	212#218		We screened single-nucleotide polymorphisms (SNPs) at the GSTP1 locus and performed an association study in the Japanese population using two independent case-control groups (group 1: 391 pediatric patients with asthma, 462 adult patients with asthma, and 639 controls, and group 2: 115 pediatric patients with asthma and 184 controls).
17643058	2007	Int. Arch. Allergy Immunol.	1423-0097	METHODS	2	5	2950	SYMBOL|DICTIONARY	gstp1	GSTP1	58#63		D001249	LONGTERM|DICTIONARY	asthma	asthma	244#250		We screened single-nucleotide polymorphisms (SNPs) at the GSTP1 locus and performed an association study in the Japanese population using two independent case-control groups (group 1: 391 pediatric patients with asthma, 462 adult patients with asthma, and 639 controls, and group 2: 115 pediatric patients with asthma and 184 controls).
17643058	2007	Int. Arch. Allergy Immunol.	1423-0097	METHODS	2	5	2950	SYMBOL|DICTIONARY	gstp1	GSTP1	58#63		D001249	LONGTERM|DICTIONARY	asthma	asthma	311#317		We screened single-nucleotide polymorphisms (SNPs) at the GSTP1 locus and performed an association study in the Japanese population using two independent case-control groups (group 1: 391 pediatric patients with asthma, 462 adult patients with asthma, and 639 controls, and group 2: 115 pediatric patients with asthma and 184 controls).
17643058	2007	Int. Arch. Allergy Immunol.	1423-0097	BACKGROUND	1	4	2950	SYMBOL|GENE|GN|DICTIONARY	gstp1	GSTP1	36#41		D001249	LONGTERM|DICTIONARY	asthma	asthma	81#87		Several studies have shown that the GSTP1 geneis involved in the pathogenesis of asthma and a gene-gene interaction may occur within the GST gene superfamily.
17643058	2007	Int. Arch. Allergy Immunol.	1423-0097	METHODS	2	6	2944	SYMBOL|DICTIONARY	gstm1	GSTM1	14#19		D001249	LONGTERM|DICTIONARY	asthma	asthma	89#95		The effect of GSTM1 null/present genotype on the association between GSTP1 Ile105Val and asthma was also investigated.
17643058	2007	Int. Arch. Allergy Immunol.	1423-0097	METHODS	2	6	2950	SYMBOL|DICTIONARY	gstp1	GSTP1	69#74		D001249	LONGTERM|DICTIONARY	asthma	asthma	89#95		The effect of GSTM1 null/present genotype on the association between GSTP1 Ile105Val and asthma was also investigated.
17643058	2007	Int. Arch. Allergy Immunol.	1423-0097	TITLE	0	0	2950	SYMBOL|GENE|GN|DICTIONARY	gstp1	GSTP1	4#9		D001249	LONGTERM|DICTIONARY	asthma	asthma	54#60		The GSTP1 gene is a susceptibility gene for childhood asthma and the GSTM1 gene is a modifier of the GSTP1 gene.
17643058	2007	Int. Arch. Allergy Immunol.	1423-0097	TITLE	0	0	2944	SYMBOL|GENE|GN|DICTIONARY	gstm1	GSTM1	69#74		D001249	LONGTERM|DICTIONARY	asthma	asthma	54#60		The GSTP1 gene is a susceptibility gene for childhood asthma and the GSTM1 gene is a modifier of the GSTP1 gene.
17643058	2007	Int. Arch. Allergy Immunol.	1423-0097	TITLE	0	0	2950	SYMBOL|GENE|GN|DICTIONARY	gstp1	GSTP1	101#106		D001249	LONGTERM|DICTIONARY	asthma	asthma	54#60		The GSTP1 gene is a susceptibility gene for childhood asthma and the GSTM1 gene is a modifier of the GSTP1 gene.
17643058	2007	Int. Arch. Allergy Immunol.	1423-0097	RESULTS	3	8	2950	SYMBOL|GENE|GN|DICTIONARY	gstp1	GSTP1	58#63		D001249	LONGTERM|DICTIONARY	asthma	asthma	83#89		The association between the Ile105Val polymorphism in the GSTP1 gene and childhood asthma was significant in both groups (p = 0.047 in group 1, and p = 0.021 in group 2).
18644122	2008	BMC Med. Genet.	1471-2350	BACKGROUND	1	4	6555	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	slc10a2	SLC10A2	41#48	18644122-3-112-156	D011127	LONGTERM|DICTIONARY	colorectal polyps	colorectal polyps	185#202		Here, we reconstructed haplotypes of the SLC10A2 gene locus and tested for association with non-syndromic familial and sporadic CRC compared to 'hyper-normal' controls who displayed no colorectal polyps on screening colonoscopy.
18644122	2008	BMC Med. Genet.	1471-2350	BACKGROUND	1	4	6555	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	slc10a2	SLC10A2	41#48	18644122-3-112-156	D015179	SYMBOL|DICTIONARY|EXTRACTED	non-syndromic familial and sporadic crc	non-syndromic familial and sporadic CRC	92#131	18644122-1-52-69	Here, we reconstructed haplotypes of the SLC10A2 gene locus and tested for association with non-syndromic familial and sporadic CRC compared to 'hyper-normal' controls who displayed no colorectal polyps on screening colonoscopy.
19624571	2009	Ann. Hum. Genet.	1469-1809	ALL_TEXT_1/3	1	2	9692	SYMBOL|DICTIONARY	kiaa0391	KIAA0391	163#171		D003324	LONGTERM|DISEASE|DT|DICTIONARY	coronary artery disease	coronary artery disease	198#221		We evaluated by molecular beacon-based genotyping assays the roles of five single nucleotide polymorphisms (SNPs) in the chromosomal region 14q13.2 harbouring the KIAA0391 and PSMA6 gene cluster in coronary artery disease (CAD) in the Saudi population.
19624571	2009	Ann. Hum. Genet.	1469-1809	ALL_TEXT_1/3	1	2	9692	SYMBOL|DICTIONARY	kiaa0391	KIAA0391	163#171		D003324	SYMBOL|()|DICTIONARY|EXTRACTED	cad	CAD	223#226	19624571-2-198-221	We evaluated by molecular beacon-based genotyping assays the roles of five single nucleotide polymorphisms (SNPs) in the chromosomal region 14q13.2 harbouring the KIAA0391 and PSMA6 gene cluster in coronary artery disease (CAD) in the Saudi population.
19624571	2009	Ann. Hum. Genet.	1469-1809	ALL_TEXT_1/3	1	2	5687	SYMBOL|GENE|GN|DICTIONARY	psma6	PSMA6	176#181		D003324	LONGTERM|DISEASE|DT|DICTIONARY	coronary artery disease	coronary artery disease	198#221		We evaluated by molecular beacon-based genotyping assays the roles of five single nucleotide polymorphisms (SNPs) in the chromosomal region 14q13.2 harbouring the KIAA0391 and PSMA6 gene cluster in coronary artery disease (CAD) in the Saudi population.
19624571	2009	Ann. Hum. Genet.	1469-1809	ALL_TEXT_1/3	1	2	5687	SYMBOL|GENE|GN|DICTIONARY	psma6	PSMA6	176#181		D003324	SYMBOL|()|DICTIONARY|EXTRACTED	cad	CAD	223#226	19624571-2-198-221	We evaluated by molecular beacon-based genotyping assays the roles of five single nucleotide polymorphisms (SNPs) in the chromosomal region 14q13.2 harbouring the KIAA0391 and PSMA6 gene cluster in coronary artery disease (CAD) in the Saudi population.
18644122	2008	BMC Med. Genet.	1471-2350	BACKGROUND	1	3	6555	SYMBOL|()|DICTIONARY|EXTRACTED	slc10a2	SLC10A2	163#170	18644122-3-112-156	C563365	LONGTERM|DICTIONARY	colorectal adenoma	colorectal adenoma	28#46		Recently, an association of colorectal adenoma with two variants (c.507C>T;p.L169L and c.511G>T;p.A171S) of the ileal sodium dependent bile acid transporter gene (SLC10A2) has been reported.
19624571	2009	Ann. Hum. Genet.	1469-1809	ALL_TEXT_3/3	3	8	9692	SYMBOL|DICTIONARY	kiaa0391	KIAA0391	75#83		D003324	SYMBOL|DICTIONARY|EXTRACTED	cad	CAD	135#138	19624571-2-198-221	Our study identified haplotypes in the chromosomal region encompassing the KIAA0391 and PSMA6 genes as a possible genetic link between CAD and MI.
19624571	2009	Ann. Hum. Genet.	1469-1809	ALL_TEXT_3/3	3	8	9692	SYMBOL|DICTIONARY	kiaa0391	KIAA0391	75#83		D009203	SYMBOL|EXTRACTED	mi	MI	143#145	19624571-6-110-131	Our study identified haplotypes in the chromosomal region encompassing the KIAA0391 and PSMA6 genes as a possible genetic link between CAD and MI.
19624571	2009	Ann. Hum. Genet.	1469-1809	ALL_TEXT_3/3	3	8	5687	SYMBOL|GENE|GN|DICTIONARY	psma6	PSMA6	88#93		D003324	SYMBOL|DICTIONARY|EXTRACTED	cad	CAD	135#138	19624571-2-198-221	Our study identified haplotypes in the chromosomal region encompassing the KIAA0391 and PSMA6 genes as a possible genetic link between CAD and MI.
19624571	2009	Ann. Hum. Genet.	1469-1809	ALL_TEXT_3/3	3	8	5687	SYMBOL|GENE|GN|DICTIONARY	psma6	PSMA6	88#93		D009203	SYMBOL|EXTRACTED	mi	MI	143#145	19624571-6-110-131	Our study identified haplotypes in the chromosomal region encompassing the KIAA0391 and PSMA6 genes as a possible genetic link between CAD and MI.
19300429	2009	Obesity (Silver Spring)	1930-7381	ALL_TEXT_2/3	2	6	10135	SYMBOL|DICTIONARY	nampt	NAMPT	49#54		D009765	LONGTERM|DICTIONARY	obese	obese	164#169		One rare SNP, rs10487818, located in intron 4 of NAMPT was associated with severe obesity, with a minor allele frequency of 1.6% in controls, 0.4% in the class III obese adults and, remarkably, 0% in the severely obese children.
19300429	2009	Obesity (Silver Spring)	1930-7381	ALL_TEXT_2/3	2	6	10135	SYMBOL|DICTIONARY	nampt	NAMPT	49#54		D009765	LONGTERM|DICTIONARY	obese	obese	213#218		One rare SNP, rs10487818, located in intron 4 of NAMPT was associated with severe obesity, with a minor allele frequency of 1.6% in controls, 0.4% in the class III obese adults and, remarkably, 0% in the severely obese children.
19300429	2009	Obesity (Silver Spring)	1930-7381	ALL_TEXT_2/3	2	6	10135	SYMBOL|DICTIONARY	nampt	NAMPT	49#54		D009765	LONGTERM|DICTIONARY	obesity	obesity	82#89		One rare SNP, rs10487818, located in intron 4 of NAMPT was associated with severe obesity, with a minor allele frequency of 1.6% in controls, 0.4% in the class III obese adults and, remarkably, 0% in the severely obese children.
11992567	2002	Am. J. Med. Genet.	0148-7299	ALL_TEXT_2/3	2	4	3569	LONGTERM|DICTIONARY	il-6	IL-6	40#44	NaN	D000544	SYMBOL|EXTRACTED	ad	AD	89#91	11992567-1-91-108	The results showed the frequency of the IL-6prom G allele was significantly increased in AD, although IL-6vntr polymorphism was not.
11992567	2002	Am. J. Med. Genet.	0148-7299	ALL_TEXT_2/3	2	4	3569	LONGTERM|DICTIONARY	il-6	IL-6	102#106	NaN	D000544	SYMBOL|EXTRACTED	ad	AD	89#91	11992567-1-91-108	The results showed the frequency of the IL-6prom G allele was significantly increased in AD, although IL-6vntr polymorphism was not.
11159940	2001	Hum. Mol. Genet.	0964-6906	ALL_TEXT_2/3	2	6	8626	SYMBOL|DICTIONARY	p63	p63	17#20		C535847	LONGTERM|DISEASE|DN|DT|DICTIONARY	aec syndrome	AEC syndrome	24#36		We have analysed p63 in AEC syndrome patients and identified missense mutations in eight families.
11159940	2001	Hum. Mol. Genet.	0964-6906	ALL_TEXT_2/3	2	4	8626	SYMBOL|GENE|GN|DICTIONARY	p63	p63	101#104		C538052	LONGTERM|DICTIONARY	adult syndromes	ADULT syndromes	49#64		Linkage studies suggest that the related LMS and ADULT syndromes are also caused by mutations in the p63 gene.
11159940	2001	Hum. Mol. Genet.	0964-6906	ALL_TEXT_1/3	1	3	8626	SYMBOL|GENE|GN|DICTIONARY	p63	p63	65#68		D002971	LONGTERM|DISEASE|DT|DICTIONARY	eec syndrome	EEC syndrome	97#109		We have recently demonstrated that heterozygous mutations in the p63 gene are the major cause of EEC syndrome.
11159940	2001	Hum. Mol. Genet.	0964-6906	ALL_TEXT_1/3	1	2	5818	SYMBOL|DICTIONARY	clped1	CLPED1	373#379		D004476	LONGTERM|DICTIONARY	ectodermal dysplasia syndromes	ectodermal dysplasia syndromes	94#124		This constellation of clinical signs is unique, but some overlap can be recognized with other ectodermal dysplasia syndromes, for example ectrodactyly--ectodermal dysplasia--cleft lip/palate (EEC; OMIM 604292), limb--mammary syndrome (LMS; OMIM 603543), acro-dermato-ungual-lacrimal-tooth syndrome (ADULT; OMIM 103285) and recessive cleft lip/palate--ectodermal dysplasia (CLPED1; OMIM 225060).
11159940	2001	Hum. Mol. Genet.	0964-6906	ALL_TEXT_1/3	1	2	5818	SYMBOL|DICTIONARY	clped1	CLPED1	373#379		C535903	LONGTERM|DISEASE|DT|DICTIONARY	limb mammary syndrome	limb--mammary syndrome	211#233		This constellation of clinical signs is unique, but some overlap can be recognized with other ectodermal dysplasia syndromes, for example ectrodactyly--ectodermal dysplasia--cleft lip/palate (EEC; OMIM 604292), limb--mammary syndrome (LMS; OMIM 603543), acro-dermato-ungual-lacrimal-tooth syndrome (ADULT; OMIM 103285) and recessive cleft lip/palate--ectodermal dysplasia (CLPED1; OMIM 225060).
11159940	2001	Hum. Mol. Genet.	0964-6906	ALL_TEXT_1/3	1	2	5818	SYMBOL|DICTIONARY	clped1	CLPED1	373#379		C538052	LONGTERM|DISEASE|DT|DICTIONARY	acro dermato ungual lacrimal tooth syndrome	acro-dermato-ungual-lacrimal-tooth syndrome	254#297		This constellation of clinical signs is unique, but some overlap can be recognized with other ectodermal dysplasia syndromes, for example ectrodactyly--ectodermal dysplasia--cleft lip/palate (EEC; OMIM 604292), limb--mammary syndrome (LMS; OMIM 603543), acro-dermato-ungual-lacrimal-tooth syndrome (ADULT; OMIM 103285) and recessive cleft lip/palate--ectodermal dysplasia (CLPED1; OMIM 225060).
11159940	2001	Hum. Mol. Genet.	0964-6906	ALL_TEXT_1/3	1	2	5818	SYMBOL|DICTIONARY	clped1	CLPED1	373#379		D002971	LONGTERM|DICTIONARY	dysplasia--cleft lip/palate	dysplasia--cleft lip/palate	163#190		This constellation of clinical signs is unique, but some overlap can be recognized with other ectodermal dysplasia syndromes, for example ectrodactyly--ectodermal dysplasia--cleft lip/palate (EEC; OMIM 604292), limb--mammary syndrome (LMS; OMIM 603543), acro-dermato-ungual-lacrimal-tooth syndrome (ADULT; OMIM 103285) and recessive cleft lip/palate--ectodermal dysplasia (CLPED1; OMIM 225060).
11159940	2001	Hum. Mol. Genet.	0964-6906	ALL_TEXT_1/3	1	2	5818	SYMBOL|DICTIONARY	clped1	CLPED1	373#379		D002971	LONGTERM|DICTIONARY	recessive cleft lip/palate--ectodermal dysplasia	recessive cleft lip/palate--ectodermal dysplasia	323#371		This constellation of clinical signs is unique, but some overlap can be recognized with other ectodermal dysplasia syndromes, for example ectrodactyly--ectodermal dysplasia--cleft lip/palate (EEC; OMIM 604292), limb--mammary syndrome (LMS; OMIM 603543), acro-dermato-ungual-lacrimal-tooth syndrome (ADULT; OMIM 103285) and recessive cleft lip/palate--ectodermal dysplasia (CLPED1; OMIM 225060).
11159940	2001	Hum. Mol. Genet.	0964-6906	ALL_TEXT_1/3	1	2	5818	SYMBOL|DICTIONARY	clped1	CLPED1	373#379		D002971	LONGTERM|DICTIONARY	recessive cleft lip/palate--ectodermal dysplasia	recessive cleft lip/palate--ectodermal dysplasia	323#371		This constellation of clinical signs is unique, but some overlap can be recognized with other ectodermal dysplasia syndromes, for example ectrodactyly--ectodermal dysplasia--cleft lip/palate (EEC; OMIM 604292), limb--mammary syndrome (LMS; OMIM 603543), acro-dermato-ungual-lacrimal-tooth syndrome (ADULT; OMIM 103285) and recessive cleft lip/palate--ectodermal dysplasia (CLPED1; OMIM 225060).
15660776	2005	Epilepsia	0013-9580	PURPOSE	1	1	348	LONGTERM|DICTIONARY	apoe	ApoE	60#64	NaN	D004833	LONGTERM|DICTIONARY	temporal lobe epilepsy	temporal lobe epilepsy	103#125		To clarify the possible role of other factors including the ApoE epsilon4 allele for memory decline in temporal lobe epilepsy (TLE).
15660776	2005	Epilepsia	0013-9580	PURPOSE	1	1	348	LONGTERM|DICTIONARY	apoe	ApoE	60#64	NaN	D004833	SYMBOL|()|DICTIONARY|EXTRACTED	tle	TLE	127#130	15660776-1-103-125	To clarify the possible role of other factors including the ApoE epsilon4 allele for memory decline in temporal lobe epilepsy (TLE).
16481299	2006	HBPD INT	1499-3872	CONCLUSIONS	4	8	3123	SYMBOL|DICTIONARY	drb1	DRB1	68#72		D008105	SYMBOL|DICTIONARY|EXTRACTED	pbc	PBC	22#25	16481299-1-39-64	The susceptibility to PBC in Chinese individuals is associated with DRB1*0701 allele.
16481299	2006	HBPD INT	1499-3872	RESULTS	3	5	3123	SYMBOL|DICTIONARY	drb1	DRB1	26#30		D008105	SYMBOL|DISEASE|DN|DICTIONARY|EXTRACTED	pbc	PBC	129#132	16481299-1-39-64	An increased frequency of DRB1*03 (18.4% vs. 7.2% in healthy controls) and a decreased frequency of DRB1*12 (16.9% vs. 28.8%) in PBC patients were statistically significant.
16481299	2006	HBPD INT	1499-3872	RESULTS	3	5	3123	SYMBOL|NUMBER|DICTIONARY	drb1	DRB1	100#104		D008105	SYMBOL|DISEASE|DN|DICTIONARY|EXTRACTED	pbc	PBC	129#132	16481299-1-39-64	An increased frequency of DRB1*03 (18.4% vs. 7.2% in healthy controls) and a decreased frequency of DRB1*12 (16.9% vs. 28.8%) in PBC patients were statistically significant.
16481299	2006	HBPD INT	1499-3872	RESULTS	3	4	3123	SYMBOL|DICTIONARY	hla drb1	HLA-DRB1	0#8		D008105	SYMBOL|DISEASE|DN|DICTIONARY|EXTRACTED	pbc	PBC	52#55	16481299-1-39-64	HLA-DRB1*07 allele detected in 19 of the 65 (29.2%) PBC patients was subtyped as DRB1*0701, as well as in 13.9% of controls (PC<0.05, OR=2.55, 95%CI: 1.4-4.6).
16481299	2006	HBPD INT	1499-3872	RESULTS	3	4	3123	SYMBOL|DICTIONARY	drb1	DRB1	81#85		D008105	SYMBOL|DISEASE|DN|DICTIONARY|EXTRACTED	pbc	PBC	52#55	16481299-1-39-64	HLA-DRB1*07 allele detected in 19 of the 65 (29.2%) PBC patients was subtyped as DRB1*0701, as well as in 13.9% of controls (PC<0.05, OR=2.55, 95%CI: 1.4-4.6).
16481299	2006	HBPD INT	1499-3872	BACKGROUND	1	2	3105	SYMBOL|DICTIONARY	hla-a, -b, and -drb1	HLA-A, -B, and -DRB1	85#105		D008105	SYMBOL|DICTIONARY|EXTRACTED	pbc	PBC	139#142	16481299-1-39-64	The aims of this study are to investigate the frequencies of human leukocyte antigen HLA-A, -B, and -DRB1 alleles in Chinese patients with PBC by polymerase chain reaction (PCR)-based techniques, and to assess the correlation of the above-mentioned HLA with some clinical and laboratory features.
16481299	2006	HBPD INT	1499-3872	BACKGROUND	1	2	3106	SYMBOL|DICTIONARY	hla-a, -b, and -drb1	HLA-A, -B, and -DRB1	85#105		D008105	SYMBOL|DICTIONARY|EXTRACTED	pbc	PBC	139#142	16481299-1-39-64	The aims of this study are to investigate the frequencies of human leukocyte antigen HLA-A, -B, and -DRB1 alleles in Chinese patients with PBC by polymerase chain reaction (PCR)-based techniques, and to assess the correlation of the above-mentioned HLA with some clinical and laboratory features.
16481299	2006	HBPD INT	1499-3872	BACKGROUND	1	2	3123	SYMBOL|DICTIONARY	hla-a, -b, and -drb1	HLA-A, -B, and -DRB1	85#105		D008105	SYMBOL|DICTIONARY|EXTRACTED	pbc	PBC	139#142	16481299-1-39-64	The aims of this study are to investigate the frequencies of human leukocyte antigen HLA-A, -B, and -DRB1 alleles in Chinese patients with PBC by polymerase chain reaction (PCR)-based techniques, and to assess the correlation of the above-mentioned HLA with some clinical and laboratory features.
16481299	2006	HBPD INT	1499-3872	BACKGROUND	1	2	3105	SYMBOL|DICTIONARY	hla-a, -b, and -drb1	HLA-A, -B, and -DRB1	85#105		D008105	SYMBOL|DICTIONARY|EXTRACTED	pbc	PBC	139#142	16481299-1-39-64	The aims of this study are to investigate the frequencies of human leukocyte antigen HLA-A, -B, and -DRB1 alleles in Chinese patients with PBC by polymerase chain reaction (PCR)-based techniques, and to assess the correlation of the above-mentioned HLA with some clinical and laboratory features.
16481299	2006	HBPD INT	1499-3872	BACKGROUND	1	2	3106	SYMBOL|DICTIONARY	hla-a, -b, and -drb1	HLA-A, -B, and -DRB1	85#105		D008105	SYMBOL|DICTIONARY|EXTRACTED	pbc	PBC	139#142	16481299-1-39-64	The aims of this study are to investigate the frequencies of human leukocyte antigen HLA-A, -B, and -DRB1 alleles in Chinese patients with PBC by polymerase chain reaction (PCR)-based techniques, and to assess the correlation of the above-mentioned HLA with some clinical and laboratory features.
16481299	2006	HBPD INT	1499-3872	BACKGROUND	1	2	3123	SYMBOL|DICTIONARY	hla-a, -b, and -drb1	HLA-A, -B, and -DRB1	85#105		D008105	SYMBOL|DICTIONARY|EXTRACTED	pbc	PBC	139#142	16481299-1-39-64	The aims of this study are to investigate the frequencies of human leukocyte antigen HLA-A, -B, and -DRB1 alleles in Chinese patients with PBC by polymerase chain reaction (PCR)-based techniques, and to assess the correlation of the above-mentioned HLA with some clinical and laboratory features.
15660776	2005	Epilepsia	0013-9580	CONCLUSIONS	4	8	348	LONGTERM|DICTIONARY	apoe	ApoE	111#115	NaN	D003072	LONGTERM|DICTIONARY	cognitive impairment	cognitive impairment	194#214		These results provide evidence for an alteration in cognitive performance as a function of the presence of the ApoE epsilon4 allele and point to the critical role of disease duration itself for cognitive impairment in TLE.
15660776	2005	Epilepsia	0013-9580	CONCLUSIONS	4	8	348	LONGTERM|DICTIONARY	apoe	ApoE	111#115	NaN	D004833	SYMBOL|DICTIONARY|EXTRACTED	tle	TLE	218#221	15660776-1-103-125	These results provide evidence for an alteration in cognitive performance as a function of the presence of the ApoE epsilon4 allele and point to the critical role of disease duration itself for cognitive impairment in TLE.
20191381	2011	Breast Cancer Res. Treat.	1573-7217	ALL_TEXT_3/3	3	8	4595	SYMBOL|DICTIONARY	mutyh	MUTYH	30#35		D015179	LONGTERM|GFAM|FN|DICTIONARY	non-polyposis families with breast and colorectal cancer	non-polyposis families with breast and colorectal cancer	68#124		Importantly, six heterozygous MUTYH mutations were identified among non-polyposis families with breast and colorectal cancer.
20191381	2011	Breast Cancer Res. Treat.	1573-7217	ALL_TEXT_3/3	3	8	4595	SYMBOL|DICTIONARY	mutyh	MUTYH	30#35		D015179	LONGTERM|DISEASE|DT|DICTIONARY	non-polyposis families with breast and colorectal cancer	non-polyposis families with breast and colorectal cancer	68#124		Importantly, six heterozygous MUTYH mutations were identified among non-polyposis families with breast and colorectal cancer.
18548239	2008	Eur. J. Clin. Pharmacol.	1432-1041	RESULTS	3	6	3458	LONGTERM|DICTIONARY	ifn-gamma	IFN-gamma	59#68	NaN	D006967	LONGTERM|DICTIONARY	allergy	allergy	117#124		There was no significant difference in the whole-allele of IFN-gamma distribution between patients with a penicillin allergy and control subjects.
18548239	2008	Eur. J. Clin. Pharmacol.	1432-1041	OBJECTIVE	1	2	3459	SYMBOL|DICTIONARY|GENE|GA	ifn gamma receptor 1	IFN-gamma receptor 1	71#91		D006967	LONGTERM|DICTIONARY	allergy	allergy	188#195		We studied the polymorphisms in the interferon (IFN)-gamma (gamma) and IFN-gamma receptor 1 (IFNR1) gene with the aim of clarifying the relationships among these polymorphisms, penicillin allergy and anti-penicillin antibodies.
18548239	2008	Eur. J. Clin. Pharmacol.	1432-1041	OBJECTIVE	1	2	3459	SYMBOL|EXTRACTED|()|GENE|GN	ifnr1	IFNR1	93#98	18548239-2-71-91	D006967	LONGTERM|DICTIONARY	allergy	allergy	188#195		We studied the polymorphisms in the interferon (IFN)-gamma (gamma) and IFN-gamma receptor 1 (IFNR1) gene with the aim of clarifying the relationships among these polymorphisms, penicillin allergy and anti-penicillin antibodies.
18548239	2008	Eur. J. Clin. Pharmacol.	1432-1041	OBJECTIVE	1	2	3458	LONGTERM|DICTIONARY	interferon (ifn)-gamma	interferon (IFN)-gamma	36#58	NaN	D006967	LONGTERM|DICTIONARY	allergy	allergy	188#195		We studied the polymorphisms in the interferon (IFN)-gamma (gamma) and IFN-gamma receptor 1 (IFNR1) gene with the aim of clarifying the relationships among these polymorphisms, penicillin allergy and anti-penicillin antibodies.
18548239	2008	Eur. J. Clin. Pharmacol.	1432-1041	TITLE	0	0	3458	LONGTERM|DICTIONARY	ifn-gamma	IFN-gamma	47#56	NaN	D006967	LONGTERM|DICTIONARY	allergy	allergy	126#133		Relationships between specific serum IgE, IgG, IFN-gamma level and IFN-gamma, IFNR1 polymorphisms in patients with penicillin allergy.
18548239	2008	Eur. J. Clin. Pharmacol.	1432-1041	TITLE	0	0	3458	LONGTERM|DICTIONARY	ifn-gamma	IFN-gamma	67#76	NaN	D006967	LONGTERM|DICTIONARY	allergy	allergy	126#133		Relationships between specific serum IgE, IgG, IFN-gamma level and IFN-gamma, IFNR1 polymorphisms in patients with penicillin allergy.
18548239	2008	Eur. J. Clin. Pharmacol.	1432-1041	TITLE	0	0	3459	LONGTERM|DICTIONARY	ifnr1	IFNR1	78#83	NaN	D006967	LONGTERM|DICTIONARY	allergy	allergy	126#133		Relationships between specific serum IgE, IgG, IFN-gamma level and IFN-gamma, IFNR1 polymorphisms in patients with penicillin allergy.
20191381	2011	Breast Cancer Res. Treat.	1573-7217	TITLE	0	0	4595	SYMBOL|DICTIONARY	mutyh	MUTYH	10#15		D001943	LONGTERM|DISEASE|DT|DICTIONARY	breast cancer	breast cancer	61#74		Increased MUTYH mutation frequency among Dutch families with breast cancer and colorectal cancer.
20191381	2011	Breast Cancer Res. Treat.	1573-7217	TITLE	0	0	4595	SYMBOL|DICTIONARY	mutyh	MUTYH	10#15		D015179	LONGTERM|DISEASE|DT|DICTIONARY	colorectal cancer	colorectal cancer	79#96		Increased MUTYH mutation frequency among Dutch families with breast cancer and colorectal cancer.
20191381	2011	Breast Cancer Res. Treat.	1573-7217	ALL_TEXT_1/3	1	1	4595	SYMBOL|DICTIONARY	mutyh	MUTYH	37#42		D011125	LONGTERM|DICTIONARY	mutyh associated polyposis	MUTYH-associated polyposis	68#94		Homozygous and compound heterozygous MUTYH mutations predispose for MUTYH-associated polyposis (MAP).
20191381	2011	Breast Cancer Res. Treat.	1573-7217	ALL_TEXT_1/3	1	1	4595	SYMBOL|DICTIONARY	mutyh	MUTYH	37#42		D011125	SYMBOL|()|DICTIONARY|EXTRACTED	map	MAP	96#99	20191381-1-68-94	Homozygous and compound heterozygous MUTYH mutations predispose for MUTYH-associated polyposis (MAP).
20191381	2011	Breast Cancer Res. Treat.	1573-7217	ALL_TEXT_2/3	2	4	4595	SYMBOL|DICTIONARY	mutyh	MUTYH	24#29		D001943	LONGTERM|DISEASE|DT|DICTIONARY	breast cancer	breast cancer	62#75		Yet, the involvement of MUTYH mutations in families with both breast cancer and colorectal cancer is unclear.
20191381	2011	Breast Cancer Res. Treat.	1573-7217	ALL_TEXT_2/3	2	4	4595	SYMBOL|DICTIONARY	mutyh	MUTYH	24#29		D015179	LONGTERM|DISEASE|DT|DICTIONARY	colorectal cancer	colorectal cancer	80#97		Yet, the involvement of MUTYH mutations in families with both breast cancer and colorectal cancer is unclear.
20191381	2011	Breast Cancer Res. Treat.	1573-7217	ALL_TEXT_2/3	2	5	4595	SYMBOL|DICTIONARY	mutyh	MUTYH	28#33		D001943	LONGTERM|DISEASE|DN|DT|DICTIONARY	breast cancer	breast cancer	120#133		Here, we have genotyped the MUTYH p.Tyr179Cys, p.Gly396Asp and p.Pro405Leu founder mutations in 153 Dutch families with breast cancer patients and colorectal cancer patients.
20191381	2011	Breast Cancer Res. Treat.	1573-7217	ALL_TEXT_2/3	2	5	4595	SYMBOL|DICTIONARY	mutyh	MUTYH	28#33		D015179	LONGTERM|DISEASE|DN|DT|DICTIONARY	colorectal cancer	colorectal cancer	147#164		Here, we have genotyped the MUTYH p.Tyr179Cys, p.Gly396Asp and p.Pro405Leu founder mutations in 153 Dutch families with breast cancer patients and colorectal cancer patients.
18548239	2008	Eur. J. Clin. Pharmacol.	1432-1041	RESULTS	3	9	3459	SYMBOL|EXTRACTED|GENE|GN	ifnr1	IFNR1	38#43	18548239-2-71-91	D004342	LONGTERM|DICTIONARY	allergic	allergic	52#60	NaN	The frequency of G/A (Val/Met) in the IFNR1 gene in allergic patients was significantly less than that in the controls (P < 0.05).
20191381	2011	Breast Cancer Res. Treat.	1573-7217	ALL_TEXT_3/3	3	7	4595	SYMBOL|DICTIONARY	mutyh	MUTYH	26#31		D011125	LONGTERM|GFAM|FN|DICTIONARY	polyposis	polyposis	74#83		As anticipated, biallelic MUTYH mutations were identified among 13% of 15 polyposis families, which was significantly increased compared to the absence of biallelic MUTYH mutations in the population (P = 0.0001).
20191381	2011	Breast Cancer Res. Treat.	1573-7217	ALL_TEXT_3/3	3	7	4595	SYMBOL|DICTIONARY	mutyh	MUTYH	165#170		D011125	LONGTERM|GFAM|FN|DICTIONARY	polyposis	polyposis	74#83		As anticipated, biallelic MUTYH mutations were identified among 13% of 15 polyposis families, which was significantly increased compared to the absence of biallelic MUTYH mutations in the population (P = 0.0001).
14567462	2004	Dig Liver Dis	1590-8658	METHODS	2	2	3123	SYMBOL|DICTIONARY	hla drb1	HLA-DRB1	162#170		D015209	SYMBOL|DISEASE|DN|DICTIONARY|EXTRACTED	psc	PSC	6#9	14567462-0-41-71	In 64 PSC patients and 183 normal controls of the same population (Northern Italy), allelic polymorphisms at the DNA level were investigated in MHC region genes: HLA-DRB1, HLA-DQB1 and HLA-B, tumour necrosis factor A (TNFA), and in CFTR gene, with polymerase chain reaction-based methodologies.
14567462	2004	Dig Liver Dis	1590-8658	METHODS	2	2	3119	SYMBOL|DICTIONARY	hla dqb1	HLA-DQB1	172#180		D015209	SYMBOL|DISEASE|DN|DICTIONARY|EXTRACTED	psc	PSC	6#9	14567462-0-41-71	In 64 PSC patients and 183 normal controls of the same population (Northern Italy), allelic polymorphisms at the DNA level were investigated in MHC region genes: HLA-DRB1, HLA-DQB1 and HLA-B, tumour necrosis factor A (TNFA), and in CFTR gene, with polymerase chain reaction-based methodologies.
14567462	2004	Dig Liver Dis	1590-8658	METHODS	2	2	1080	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	cftr	CFTR	232#236	14567462-1-139-190	D015209	SYMBOL|DISEASE|DN|DICTIONARY|EXTRACTED	psc	PSC	6#9	14567462-0-41-71	In 64 PSC patients and 183 normal controls of the same population (Northern Italy), allelic polymorphisms at the DNA level were investigated in MHC region genes: HLA-DRB1, HLA-DQB1 and HLA-B, tumour necrosis factor A (TNFA), and in CFTR gene, with polymerase chain reaction-based methodologies.
14567462	2004	Dig Liver Dis	1590-8658	METHODS	2	2	7124	LONGTERM|GENE|GT|DICTIONARY	tumour necrosis factor a	tumour necrosis factor A	192#216		D015209	SYMBOL|DISEASE|DN|DICTIONARY|EXTRACTED	psc	PSC	6#9	14567462-0-41-71	In 64 PSC patients and 183 normal controls of the same population (Northern Italy), allelic polymorphisms at the DNA level were investigated in MHC region genes: HLA-DRB1, HLA-DQB1 and HLA-B, tumour necrosis factor A (TNFA), and in CFTR gene, with polymerase chain reaction-based methodologies.
15007140	2004	Neurology	1526-632X	ALL_TEXT_1/3	1	1	348	SYMBOL|DICTIONARY	apoe	APOE	103#107		D009103	LONGTERM|DICTIONARY	multiple sclerosis	multiple sclerosis	183#201		The authors studied the association of an exon 4 (E4*epsilon2/3/4) and three promoter polymorphisms of APOE with disease course and severity stratified by gender in 221 patients with multiple sclerosis from two overlapping population-based prevalence cohorts.
15007140	2004	Neurology	1526-632X	TITLE	0	0	348	SYMBOL|DICTIONARY	apoe	APOE	15#19		D009103	LONGTERM|DICTIONARY	ms	MS	59#61	NaN	Association of APOE polymorphisms with disease severity in MS is limited to women.
22322133	2013	Blood Coagul. Fibrinolysis	1473-5733	TITLE	0	0	2160	LONGTERM|DICTIONARY	f11	F11	26#29	NaN	D005173	LONGTERM|DICTIONARY	congenital factor xi deficiency	congenital factor XI deficiency	77#108		Identification of a novel F11 missense mutation (Ile463Ser) in a family with congenital factor XI deficiency.
19524323	2011	Neurobiol. Aging	1558-1497	TITLE	0	0	64102	LONGTERM|DICTIONARY	tenomodulin	Tenomodulin	0#11		D000544	LONGTERM|DISEASE|DT|DICTIONARY	alzheimer disease	Alzheimer's disease	31#50		Tenomodulin variants, APOE and Alzheimer's disease in a Finnish case-control cohort.
19524323	2011	Neurobiol. Aging	1558-1497	TITLE	0	0	348	SYMBOL|DICTIONARY	apoe	APOE	22#26		D000544	LONGTERM|DISEASE|DT|DICTIONARY	alzheimer disease	Alzheimer's disease	31#50		Tenomodulin variants, APOE and Alzheimer's disease in a Finnish case-control cohort.
15386943	2004	Biomed. Environ. Sci.	0895-3988	CONCLUSION	4	10	1636	SYMBOL|DICTIONARY	ace	ACE	42#45		D003327	LONGTERM|DISEASE|DT|DICTIONARY	coronary heart disease	coronary heart disease	115#137		It is important for individuals who carry ACE D allele gene to prevent EH, and furthermore, to prevent and control coronary heart disease, in a view of population-based prevention.
19700865	2009	J. Genet.	0973-7731	TITLE	0	0	4313	LONGTERM|GENE|GN|DICTIONARY	matrix metalloproteinase 2	matrix metalloproteinase-2	15#41		D009203	LONGTERM|DICTIONARY	myocardial infarction	myocardial infarction	74#95		Association of matrix metalloproteinase-2 gene promoter polymorphism with myocardial infarction susceptibility in a Mexican population.
17471286	2008	Pharmacogenomics J.	1473-1150	ALL_TEXT_2/3	2	4	7124	SYMBOL|DICTIONARY	tnfa	TNFA	0#4		D006967	LONGTERM|DICTIONARY	allergy	allergy	91#98		TNFA GG genotype was a significant independent predictor of the primary risk of betalactam allergy, concurrently with total IgE level, with an age- and sex-adjusted odds ratio estimated at 2.45 (95% confidence interval: 1.18-5.08, P=0.0163).
17471286	2008	Pharmacogenomics J.	1473-1150	ALL_TEXT_2/3	2	4	3497	LONGTERM|DICTIONARY	ige	IgE	124#127	NaN	D006967	LONGTERM|DICTIONARY	allergy	allergy	91#98		TNFA GG genotype was a significant independent predictor of the primary risk of betalactam allergy, concurrently with total IgE level, with an age- and sex-adjusted odds ratio estimated at 2.45 (95% confidence interval: 1.18-5.08, P=0.0163).
17040410	2006	Neurogastroenterol. Motil.	1350-1925	TITLE	0	0	6532	LONGTERM|DICTIONARY	serotonin transporter	Serotonin transporter	0#21	NaN	D043183	LONGTERM|DISEASE|DT|DICTIONARY	irritable bowel syndrome	irritable bowel syndrome	44#68		Serotonin transporter gene polymorphism and irritable bowel syndrome.
17040410	2006	Neurogastroenterol. Motil.	1350-1925	ALL_TEXT_1/3	1	1	6532	SYMBOL|()|GENE|GN|DICTIONARY	sert	SERT	76#80		D043183	LONGTERM|DISEASE|DT|DICTIONARY	irritable bowel syndrome	irritable bowel syndrome	149#173		Polymorphisms in the promoter region of the serotonin reuptake transporter (SERT) gene may underlie the disturbance in gut function in patients with irritable bowel syndrome (IBS).
17040410	2006	Neurogastroenterol. Motil.	1350-1925	ALL_TEXT_1/3	1	1	6532	SYMBOL|()|GENE|GN|DICTIONARY	sert	SERT	76#80		D043183	SYMBOL|()|DICTIONARY|EXTRACTED	ibs	IBS	175#178	17040410-1-149-173	Polymorphisms in the promoter region of the serotonin reuptake transporter (SERT) gene may underlie the disturbance in gut function in patients with irritable bowel syndrome (IBS).
17471286	2008	Pharmacogenomics J.	1473-1150	TITLE	0	0	7124	LONGTERM|DICTIONARY	tumor necrosis factor alpha	tumor necrosis factor-alpha	15#42		D006967	LONGTERM|DICTIONARY	allergy	allergy	82#89		Association of tumor necrosis factor-alpha -308G>A polymorphism with IgE-mediated allergy to betalactams in an Italian population.
17471286	2008	Pharmacogenomics J.	1473-1150	TITLE	0	0	3497	LONGTERM|DICTIONARY	ige	IgE	69#72	NaN	D006967	LONGTERM|DICTIONARY	allergy	allergy	82#89		Association of tumor necrosis factor-alpha -308G>A polymorphism with IgE-mediated allergy to betalactams in an Italian population.
15476622	2004	Am. J. Cardiol.	0002-9149	ALL_TEXT	1	1	4312	LONGTERM|GENE|GN|DICTIONARY	matrix metalloproteinase 1	matrix metalloproteinase-1	21#47		D009203	LONGTERM|DICTIONARY	myocardial infarctions	myocardial infarctions	132#154		The relation between matrix metalloproteinase-1 promoter genotype and remodeling was studied in 42 patients after their first acute myocardial infarctions.
2533336	1990	Neurosci. Res.	0168-0102	ALL_TEXT_3/3	3	6	3350	SYMBOL|DICTIONARY	5 ht1a	5-HT1A	128#134		D012640	LONGTERM|DICTIONARY	seizures	seizures	85#93		In conclusion, the present study suggests that the inhibition of pilocarpine-induced seizures may be mediated by stimulation of 5-HT1A and by blockade of 5-HT1B receptors, located probably on the cholinergic terminals.
2533336	1990	Neurosci. Res.	0168-0102	ALL_TEXT_3/3	3	6	3351	SYMBOL|GENE|GN|DICTIONARY	5 ht1b	5-HT1B	154#160		D012640	LONGTERM|DICTIONARY	seizures	seizures	85#93		In conclusion, the present study suggests that the inhibition of pilocarpine-induced seizures may be mediated by stimulation of 5-HT1A and by blockade of 5-HT1B receptors, located probably on the cholinergic terminals.
2533336	1990	Neurosci. Res.	0168-0102	ALL_TEXT_2/3	2	3	3350	SYMBOL|GENE|GN|DICTIONARY	5 ht1a	5-HT1A	15#21		D012640	LONGTERM|DICTIONARY	seizure	seizure	150#157		Stimulation of 5-HT1A receptors with 8-hydroxy-di-N,N-propylaminotetralin (8-OH-DPAT) and blockade of 5-HT1B receptors with cyanopindolol resulted in seizure protection.
2533336	1990	Neurosci. Res.	0168-0102	ALL_TEXT_2/3	2	3	3351	SYMBOL|GENE|GN|DICTIONARY	5 ht1b	5-HT1B	102#108		D012640	LONGTERM|DICTIONARY	seizure	seizure	150#157		Stimulation of 5-HT1A receptors with 8-hydroxy-di-N,N-propylaminotetralin (8-OH-DPAT) and blockade of 5-HT1B receptors with cyanopindolol resulted in seizure protection.
19380028	2009	Cancer Genet. Cytogenet.	1873-4456	ALL_TEXT_3/3	3	5	2944	SYMBOL|DICTIONARY	gstm1	GSTM1	46#51		D001749	LONGTERM|DISEASE|DT|DICTIONARY	bladder cancer	bladder cancer	117#131		In all groups of patients, we have shown that GSTM1 and GSTT1 null genotypes did not appear to be a factor affecting bladder cancer susceptibility.
19380028	2009	Cancer Genet. Cytogenet.	1873-4456	ALL_TEXT_3/3	3	5	2952	SYMBOL|DICTIONARY	gstt1	GSTT1	56#61		D001749	LONGTERM|DISEASE|DT|DICTIONARY	bladder cancer	bladder cancer	117#131		In all groups of patients, we have shown that GSTM1 and GSTT1 null genotypes did not appear to be a factor affecting bladder cancer susceptibility.
17196936	2007	Biochem. Biophys. Res. Commun.	0006-291X	ALL_TEXT_1/3	1	2	627	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	bdnf	BDNF	53#57	17196936-1-0-33	D012559	LONGTERM|DICTIONARY	schizophrenia	schizophrenia	84#97		Previous studies have suggested that variants in the BDNF gene increase the risk of schizophrenia.
17196936	2007	Biochem. Biophys. Res. Commun.	0006-291X	TITLE	0	0	627	LONGTERM|GENE|GT|DICTIONARY	brain derived neurotrophic factor	Brain-derived neurotrophic factor	0#33		D012559	LONGTERM|DICTIONARY	schizophrenia	schizophrenia	46#59		Brain-derived neurotrophic factor and risk of schizophrenia: an association study and meta-analysis.
17192049	2007	Cancer Biomark	1574-0153	ALL_TEXT_1/3	1	1	1543	SYMBOL|DICTIONARY	cyp1a1	CYP1A1	0#6		D011471	LONGTERM|DISEASE|DT|DICTIONARY	prostate cancer	prostate cancer	153#168		CYP1A1 activates environmental procarcinogens and catalyzes oxidative metabolism of estrogens and is likely to play an important role in the etiology of prostate cancer.
17196936	2007	Biochem. Biophys. Res. Commun.	0006-291X	ALL_TEXT_3/3	3	5	627	SYMBOL|DICTIONARY|EXTRACTED	bdnf	BDNF	71#75	17196936-1-0-33	D012559	LONGTERM|DICTIONARY	schizophrenia	schizophrenia	94#107		In single-locus analysis, no significant association was found between BDNF polymorphisms and schizophrenia in our subjects.
17192049	2007	Cancer Biomark	1574-0153	ALL_TEXT_3/3	3	3	1543	SYMBOL|GENE|GN|DICTIONARY	cyp1a1	CYP1A1	99#105		D011471	LONGTERM|DISEASE|DT|DICTIONARY	prostate cancer	prostate cancer	258#273		The estimated relative risk was significantly high for individuals with w1/m1 genotype at 3'UTR of CYP1A1 gene (OR-4.64; 95%CI = 1.51-14.86; P < 0.01) whereas the CYP1A1 Ile/Val genotype (w2/m2) on exon 7 was found to be associated with a decreased risk for prostate cancer (OR-0.17; 95%CI = 0.02-0.89; P=0.03).
17192049	2007	Cancer Biomark	1574-0153	ALL_TEXT_3/3	3	3	1543	SYMBOL|DICTIONARY	cyp1a1	CYP1A1	163#169		D011471	LONGTERM|DISEASE|DT|DICTIONARY	prostate cancer	prostate cancer	258#273		The estimated relative risk was significantly high for individuals with w1/m1 genotype at 3'UTR of CYP1A1 gene (OR-4.64; 95%CI = 1.51-14.86; P < 0.01) whereas the CYP1A1 Ile/Val genotype (w2/m2) on exon 7 was found to be associated with a decreased risk for prostate cancer (OR-0.17; 95%CI = 0.02-0.89; P=0.03).
12034804	2002	Neurology	0028-3878	ALL_TEXT_2/3	2	2	3552	SYMBOL|DICTIONARY	il 1a	IL-1A	26#31		D000544	LONGTERM|DICTIONARY	ad	AD	146#148	NaN	The authors genotyped the IL-1A(-889) and IL-1B(-511) polymorphisms in large independent cohorts of 503 control individuals and 395 patients with AD, and a further 100 with brain Abeta load.
12034804	2002	Neurology	0028-3878	ALL_TEXT_2/3	2	2	3553	SYMBOL|DICTIONARY	il 1b	IL-1B	42#47		D000544	LONGTERM|DICTIONARY	ad	AD	146#148	NaN	The authors genotyped the IL-1A(-889) and IL-1B(-511) polymorphisms in large independent cohorts of 503 control individuals and 395 patients with AD, and a further 100 with brain Abeta load.
12034804	2002	Neurology	0028-3878	ALL_TEXT_1/3	1	1	3552	SYMBOL|DICTIONARY	il 1a	IL-1A	42#47		D000544	LONGTERM|DICTIONARY	ad	AD	85#87	NaN	Polymorphisms in the interleukin-1 genes, IL-1A and IL-1B, have been associated with AD, but not in all studies.
12034804	2002	Neurology	0028-3878	ALL_TEXT_1/3	1	1	3553	SYMBOL|DICTIONARY	il 1b	IL-1B	52#57		D000544	LONGTERM|DICTIONARY	ad	AD	85#87	NaN	Polymorphisms in the interleukin-1 genes, IL-1A and IL-1B, have been associated with AD, but not in all studies.
17196936	2007	Biochem. Biophys. Res. Commun.	0006-291X	ALL_TEXT_3/3	3	8	627	SYMBOL|DICTIONARY|EXTRACTED	bdnf	BDNF	32#36	17196936-1-0-33	D012559	LONGTERM|DICTIONARY	schizophrenia	schizophrenia	66#79		Our data provides evidence that BDNF is a susceptibility gene for schizophrenia in Chinese subjects.
9545398	1998	Am. J. Hum. Genet.	0002-9297	TITLE	0	0	695	LONGTERM|DICTIONARY	btk	btk	13#16	NaN	C537409	LONGTERM|DICTIONARY	x linked agammaglobulinemia	X-linked agammaglobulinemia	43#70		Mutations in btk in patients with presumed X-linked agammaglobulinemia.
12484521	2003	Hypertens. Res.	0916-9636	ALL_TEXT_1/3	1	2	5327	LONGTERM|DICTIONARY	t-pa	t-PA	140#144	NaN	D006973	LONGTERM|DICTIONARY	hypertension	hypertension	78#90		The present study examined whether there was an association between essential hypertension and either a polymorphism in the gene coding for t-PA or the plasma concentration of t-PA antigen.
12484521	2003	Hypertens. Res.	0916-9636	ALL_TEXT_1/3	1	2	5327	LONGTERM|DICTIONARY	t-pa	t-PA	176#180	NaN	D006973	LONGTERM|DICTIONARY	hypertension	hypertension	78#90		The present study examined whether there was an association between essential hypertension and either a polymorphism in the gene coding for t-PA or the plasma concentration of t-PA antigen.
17135225	2007	Rheumatology (Oxford)	1462-0324	CONCLUSION	4	9	26191	SYMBOL|DICTIONARY	ptpn22	PTPN22	36#42		D001172	SYMBOL|EXTRACTED	ra	RA	67#69	17135225-1-83-103	We conclude that C1858T is the sole PTPN22 variant predisposing to RA in our white Dutch sample set.
17135225	2007	Rheumatology (Oxford)	1462-0324	RESULTS	3	8	26191	SYMBOL|DICTIONARY	ptpn22	PTPN22	61#67		D001172	SYMBOL|EXTRACTED	ra	RA	89#91	17135225-1-83-103	No significant association of the haplotype tagged by the 3' PTPN22 SNP, rs3789604, with RA susceptibility (P = 0.134) was observed in our sample set.
24277619	2014	Am. J. Med. Genet. B Neuropsychiatr. Genet.	1552-485X	ALL_TEXT_3/3	3	7	217	SYMBOL|DICTIONARY	aldh2	ALDH2	0#5		D005483	LONGTERM|DICTIONARY	flushing	flushing	34#42		ALDH2 is strongly associated with flushing response, AD, and maximum drinks in males, with nonsynonymous SNP rs671 explaining 29.2%, 7.9%, and 22.9% of phenotypic variation, respectively, in this sample.
24277619	2014	Am. J. Med. Genet. B Neuropsychiatr. Genet.	1552-485X	ALL_TEXT_3/3	3	7	217	SYMBOL|DICTIONARY	aldh2	ALDH2	0#5		D000437	SYMBOL|EXTRACTED	ad	AD	53#55	24277619-1-0-18	ALDH2 is strongly associated with flushing response, AD, and maximum drinks in males, with nonsynonymous SNP rs671 explaining 29.2%, 7.9%, and 22.9% of phenotypic variation, respectively, in this sample.
17135225	2007	Rheumatology (Oxford)	1462-0324	RESULTS	3	6	26191	SYMBOL|NUMBER|DICTIONARY	ptpn22	PTPN22	83#89		D001172	SYMBOL|EXTRACTED	ra	RA	44#46	17135225-1-83-103	The sole haplotype strongly associated with RA in our Dutch population carries the PTPN22 1858T allele.
24277619	2014	Am. J. Med. Genet. B Neuropsychiatr. Genet.	1552-485X	ALL_TEXT_2/3	2	5	217	SYMBOL|DICTIONARY	aldh2	ALDH2	38#43		D000437	SYMBOL|EXTRACTED	ad	AD	55#57	24277619-1-0-18	Significant associations found in the ALDH2 region for AD (minimum P = 4.73  10(-8)) and two AD-related phenotypes: flushing response (minimum P = 4.75  10(-26)) and maximum drinks in a 24-hr period (minimum P = 1.54  10(-16)).
24277619	2014	Am. J. Med. Genet. B Neuropsychiatr. Genet.	1552-485X	ALL_TEXT_2/3	2	5	217	SYMBOL|DICTIONARY	aldh2	ALDH2	38#43		D000437	SYMBOL|EXTRACTED	ad	AD	94#96	24277619-1-0-18	Significant associations found in the ALDH2 region for AD (minimum P = 4.73  10(-8)) and two AD-related phenotypes: flushing response (minimum P = 4.75  10(-26)) and maximum drinks in a 24-hr period (minimum P = 1.54  10(-16)).
24277619	2014	Am. J. Med. Genet. B Neuropsychiatr. Genet.	1552-485X	ALL_TEXT_2/3	2	5	217	SYMBOL|DICTIONARY	aldh2	ALDH2	38#43		D005483	LONGTERM|DICTIONARY	flushing	flushing	117#125		Significant associations found in the ALDH2 region for AD (minimum P = 4.73  10(-8)) and two AD-related phenotypes: flushing response (minimum P = 4.75  10(-26)) and maximum drinks in a 24-hr period (minimum P = 1.54  10(-16)).
17135225	2007	Rheumatology (Oxford)	1462-0324	METHODS	2	4	26191	SYMBOL|DICTIONARY	ptpn22	PTPN22	66#72		D001172	SYMBOL|DISEASE|DN|DICTIONARY|EXTRACTED	ra	RA	15#17	17135225-1-83-103	A total of 667 RA patients and 286 controls were genotyped for 13 PTPN22 single nucleotide polymorphisms (SNPs) by allele-specific kinetic polymerase chain reaction. rs3789604 was genotyped in an additional 410 RA and 270 UA patients participating in the Leiden early arthritis inception cohort.
17135225	2007	Rheumatology (Oxford)	1462-0324	METHODS	2	4	26191	SYMBOL|DICTIONARY	ptpn22	PTPN22	66#72		D001172	SYMBOL|EXTRACTED	ra	RA	211#213	17135225-1-83-103	A total of 667 RA patients and 286 controls were genotyped for 13 PTPN22 single nucleotide polymorphisms (SNPs) by allele-specific kinetic polymerase chain reaction. rs3789604 was genotyped in an additional 410 RA and 270 UA patients participating in the Leiden early arthritis inception cohort.
17135225	2007	Rheumatology (Oxford)	1462-0324	METHODS	2	4	26191	SYMBOL|DICTIONARY	ptpn22	PTPN22	66#72		D001168	LONGTERM|DICTIONARY	leiden early arthritis	Leiden early arthritis	255#277		A total of 667 RA patients and 286 controls were genotyped for 13 PTPN22 single nucleotide polymorphisms (SNPs) by allele-specific kinetic polymerase chain reaction. rs3789604 was genotyped in an additional 410 RA and 270 UA patients participating in the Leiden early arthritis inception cohort.
19264732	2009	J. Med. Genet.	1468-6244	TITLE	0	0	79813	SYMBOL|DICTIONARY	ehmt1	EHMT1	117#122		C563043	LONGTERM|DISEASE|DT|DICTIONARY	subtelomeric deletion syndrome	subtelomeric deletion syndrome	53#83		Further clinical and molecular delineation of the 9q subtelomeric deletion syndrome supports a major contribution of EHMT1 haploinsufficiency to the core phenotype.
17135225	2007	Rheumatology (Oxford)	1462-0324	OBJECTIVES	1	1	26191	SYMBOL|DICTIONARY	ptpn22	PTPN22	27#33		D001172	LONGTERM|DICTIONARY	rheumatoid arthritis	rheumatoid arthritis	83#103		A missense SNP, C1858T, in PTPN22 has been identified as a genetic risk factor for rheumatoid arthritis (RA).
17135225	2007	Rheumatology (Oxford)	1462-0324	OBJECTIVES	1	1	26191	SYMBOL|DICTIONARY	ptpn22	PTPN22	27#33		D001172	SYMBOL|EXTRACTED|()	ra	RA	105#107	17135225-1-83-103	A missense SNP, C1858T, in PTPN22 has been identified as a genetic risk factor for rheumatoid arthritis (RA).
17135225	2007	Rheumatology (Oxford)	1462-0324	TITLE	0	0	26191	SYMBOL|GENE|GN|DICTIONARY	ptpn22	PTPN22	23#29		D001172	LONGTERM|DICTIONARY	ra	RA	75#77	NaN	The 620W allele is the PTPN22 genetic variant conferring susceptibility to RA in a Dutch population.
11992567	2002	Am. J. Med. Genet.	0148-7299	ALL_TEXT_3/3	3	7	3569	SYMBOL|DICTIONARY|EXTRACTED	il 6	IL-6	74#78	11992567-1-0-13	D000544	SYMBOL|EXTRACTED	ad	AD	129#131	11992567-1-91-108	These findings suggest that the IL-6prom G allele which may affect plasma IL-6 concentration might be a risk factor for sporadic AD in Japanese.
11992567	2002	Am. J. Med. Genet.	0148-7299	ALL_TEXT_3/3	3	6	3569	SYMBOL|DICTIONARY|EXTRACTED	il 6	IL-6	86#90	11992567-1-0-13	D000544	SYMBOL|DISEASE|DN|DICTIONARY|EXTRACTED	ad	AD	41#43	11992567-1-91-108	Moreover, the IL-6prom G allele-positive AD patients showed a tendency to have higher IL-6 concentration in the AD group.
11992567	2002	Am. J. Med. Genet.	0148-7299	ALL_TEXT_3/3	3	6	3569	SYMBOL|DICTIONARY|EXTRACTED	il 6	IL-6	86#90	11992567-1-0-13	D000544	SYMBOL|EXTRACTED	ad	AD	112#114	11992567-1-91-108	Moreover, the IL-6prom G allele-positive AD patients showed a tendency to have higher IL-6 concentration in the AD group.
11992567	2002	Am. J. Med. Genet.	0148-7299	ALL_TEXT_3/3	3	5	3569	SYMBOL|DICTIONARY|EXTRACTED	il 6	IL-6	7#11	11992567-1-0-13	D000544	SYMBOL|EXTRACTED	ad	AD	33#35	11992567-1-91-108	Plasma IL-6 concentration of the AD cases was also significantly higher than that of the control cases.
12771801	2003	J. Urol.	0022-5347	CONCLUSIONS	4	11	6716	SYMBOL|GENE|GN|DICTIONARY	srd5a2	SRD5A2	45#51		D011471	LONGTERM|DISEASE|DT|DICTIONARY	prostate cancer	prostate cancer	93#108		The V allele of the V89L polymorphism in the SRD5A2 gene may dominantly increase the risk of prostate cancer.
11992567	2002	Am. J. Med. Genet.	0148-7299	ALL_TEXT_2/3	2	3	3569	SYMBOL|DICTIONARY|EXTRACTED	il 6	IL-6	18#22	11992567-1-0-13	D000544	SYMBOL|EXTRACTED	ad	AD	53#55	11992567-1-91-108	We examined these IL-6 polymorphisms in 128 Japanese AD cases and 83 control cases using a PCR-RFLP method.
11992567	2002	Am. J. Med. Genet.	0148-7299	ALL_TEXT_1/3	1	1	3569	LONGTERM|DICTIONARY	interleukin 6	Interleukin-6	0#13		D000544	LONGTERM|DISEASE|DT|DICTIONARY	alzheimer disease	Alzheimer disease	91#108		"Interleukin-6 (IL-6), an inflammatory cytokine might be involved in the pathophysiology of Alzheimer disease (AD); several studies have reported that the ""C allele of IL-6 variable number of tandem repeat polymorphism"" (IL-6vntr) delayed initial onset of AD and also decreased its risk per se."
11992567	2002	Am. J. Med. Genet.	0148-7299	ALL_TEXT_1/3	1	1	3569	LONGTERM|DICTIONARY	interleukin 6	Interleukin-6	0#13		D000544	SYMBOL|EXTRACTED|()	ad	AD	110#112	11992567-1-91-108	"Interleukin-6 (IL-6), an inflammatory cytokine might be involved in the pathophysiology of Alzheimer disease (AD); several studies have reported that the ""C allele of IL-6 variable number of tandem repeat polymorphism"" (IL-6vntr) delayed initial onset of AD and also decreased its risk per se."
11992567	2002	Am. J. Med. Genet.	0148-7299	ALL_TEXT_1/3	1	1	3569	LONGTERM|DICTIONARY	interleukin 6	Interleukin-6	0#13		D000544	SYMBOL|EXTRACTED	ad	AD	255#257	11992567-1-91-108	"Interleukin-6 (IL-6), an inflammatory cytokine might be involved in the pathophysiology of Alzheimer disease (AD); several studies have reported that the ""C allele of IL-6 variable number of tandem repeat polymorphism"" (IL-6vntr) delayed initial onset of AD and also decreased its risk per se."
11992567	2002	Am. J. Med. Genet.	0148-7299	ALL_TEXT_1/3	1	1	3569	SYMBOL|()|DICTIONARY|EXTRACTED	il 6	IL-6	15#19	11992567-1-0-13	D000544	LONGTERM|DISEASE|DT|DICTIONARY	alzheimer disease	Alzheimer disease	91#108		"Interleukin-6 (IL-6), an inflammatory cytokine might be involved in the pathophysiology of Alzheimer disease (AD); several studies have reported that the ""C allele of IL-6 variable number of tandem repeat polymorphism"" (IL-6vntr) delayed initial onset of AD and also decreased its risk per se."
11992567	2002	Am. J. Med. Genet.	0148-7299	ALL_TEXT_1/3	1	1	3569	SYMBOL|()|DICTIONARY|EXTRACTED	il 6	IL-6	15#19	11992567-1-0-13	D000544	SYMBOL|EXTRACTED|()	ad	AD	110#112	11992567-1-91-108	"Interleukin-6 (IL-6), an inflammatory cytokine might be involved in the pathophysiology of Alzheimer disease (AD); several studies have reported that the ""C allele of IL-6 variable number of tandem repeat polymorphism"" (IL-6vntr) delayed initial onset of AD and also decreased its risk per se."
11992567	2002	Am. J. Med. Genet.	0148-7299	ALL_TEXT_1/3	1	1	3569	SYMBOL|()|DICTIONARY|EXTRACTED	il 6	IL-6	15#19	11992567-1-0-13	D000544	SYMBOL|EXTRACTED	ad	AD	255#257	11992567-1-91-108	"Interleukin-6 (IL-6), an inflammatory cytokine might be involved in the pathophysiology of Alzheimer disease (AD); several studies have reported that the ""C allele of IL-6 variable number of tandem repeat polymorphism"" (IL-6vntr) delayed initial onset of AD and also decreased its risk per se."
11992567	2002	Am. J. Med. Genet.	0148-7299	ALL_TEXT_1/3	1	1	3569	SYMBOL|DICTIONARY|EXTRACTED	il 6	IL-6	167#171	11992567-1-0-13	D000544	LONGTERM|DISEASE|DT|DICTIONARY	alzheimer disease	Alzheimer disease	91#108		"Interleukin-6 (IL-6), an inflammatory cytokine might be involved in the pathophysiology of Alzheimer disease (AD); several studies have reported that the ""C allele of IL-6 variable number of tandem repeat polymorphism"" (IL-6vntr) delayed initial onset of AD and also decreased its risk per se."
11992567	2002	Am. J. Med. Genet.	0148-7299	ALL_TEXT_1/3	1	1	3569	SYMBOL|DICTIONARY|EXTRACTED	il 6	IL-6	167#171	11992567-1-0-13	D000544	SYMBOL|EXTRACTED|()	ad	AD	110#112	11992567-1-91-108	"Interleukin-6 (IL-6), an inflammatory cytokine might be involved in the pathophysiology of Alzheimer disease (AD); several studies have reported that the ""C allele of IL-6 variable number of tandem repeat polymorphism"" (IL-6vntr) delayed initial onset of AD and also decreased its risk per se."
11992567	2002	Am. J. Med. Genet.	0148-7299	ALL_TEXT_1/3	1	1	3569	SYMBOL|DICTIONARY|EXTRACTED	il 6	IL-6	167#171	11992567-1-0-13	D000544	SYMBOL|EXTRACTED	ad	AD	255#257	11992567-1-91-108	"Interleukin-6 (IL-6), an inflammatory cytokine might be involved in the pathophysiology of Alzheimer disease (AD); several studies have reported that the ""C allele of IL-6 variable number of tandem repeat polymorphism"" (IL-6vntr) delayed initial onset of AD and also decreased its risk per se."
11992567	2002	Am. J. Med. Genet.	0148-7299	TITLE	0	0	3569	SYMBOL|DICTIONARY|EXTRACTED	il 6	IL-6	10#14		D000544	LONGTERM|DISEASE|DT|DICTIONARY	alzheimer disease	Alzheimer disease	39#56		Effect of IL-6 polymorphism on risk of Alzheimer disease: genotype-phenotype association study in Japanese cases.
19408338	2009	Inflamm. Bowel Dis.	1536-4844	RESULTS	3	9	2312	SYMBOL|DICTIONARY|EXTRACTED	flg	FLG	86#89	19408338-2-0-9	D015212	SYMBOL|DICTIONARY|EXTRACTED	ibd	IBD	32#35	19408338-1-10-36	Logistic regression analysis of IBD cases confirmed the association of carriage of an FLG null-allele with atopy (P = 0.01; OR 2.4, 95% CI 1.2-5.1) and co-occurrence of different forms of atopy (P = 0.003; OR 3.5, 95% CI 1.5-8.1).
19408338	2009	Inflamm. Bowel Dis.	1536-4844	RESULTS	3	9	2312	SYMBOL|DICTIONARY|EXTRACTED	flg	FLG	86#89	19408338-2-0-9	C564133	LONGTERM|DICTIONARY	atopy	atopy	107#112	NaN	Logistic regression analysis of IBD cases confirmed the association of carriage of an FLG null-allele with atopy (P = 0.01; OR 2.4, 95% CI 1.2-5.1) and co-occurrence of different forms of atopy (P = 0.003; OR 3.5, 95% CI 1.5-8.1).
19408338	2009	Inflamm. Bowel Dis.	1536-4844	RESULTS	3	9	2312	SYMBOL|DICTIONARY|EXTRACTED	flg	FLG	86#89	19408338-2-0-9	C564133	LONGTERM|DICTIONARY	atopy	atopy	188#193	NaN	Logistic regression analysis of IBD cases confirmed the association of carriage of an FLG null-allele with atopy (P = 0.01; OR 2.4, 95% CI 1.2-5.1) and co-occurrence of different forms of atopy (P = 0.003; OR 3.5, 95% CI 1.5-8.1).
20533278	2010	Zhonghua Yi Xue Yi Chuan Xue Za Zhi	1003-9406	RESULTS	3	5	100507436	SYMBOL|GENE|GN|DICTIONARY	mica	MICA	72#76		D015179	LONGTERM|DISEASE|DT|DICTIONARY	colorectal cancer	colorectal cancer	146#163		Neither the extracellular nor the transmembrane region polymorphisms of MICA gene were associated with the occurrence and the different stages of colorectal cancer.
20973260	2010	Int. J. Gynecol. Cancer	1525-1438	BACKGROUND	1	2	7422	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	vegf	VEGF	81#85	20973260-1-0-34	D010051	LONGTERM|DISEASE|DT|DICTIONARY	epithelial ovarian cancer	epithelial ovarian cancer	114#139		The aim of this study was to investigate the association of polymorphisms in the VEGF gene with susceptibility to epithelial ovarian cancer (EOC).
20973260	2010	Int. J. Gynecol. Cancer	1525-1438	BACKGROUND	1	2	7422	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	vegf	VEGF	81#85	20973260-1-0-34	D010051	SYMBOL|EXTRACTED|()	eoc	EOC	141#144	20973260-2-114-139	The aim of this study was to investigate the association of polymorphisms in the VEGF gene with susceptibility to epithelial ovarian cancer (EOC).
15060116	2004	J. Med. Genet.	1468-6244	TITLE	0	0	6899	SYMBOL|GENE|GN|DICTIONARY	tbx1	TBX1	75#79		D006330	LONGTERM|DICTIONARY	congenital heart defects	congenital heart defects	107#131		Assessment of association between variants and haplotypes of the remaining TBX1 gene and manifestations of congenital heart defects in 22q11.2 deletion patients.
8942447	1997	Am J Psychiatry	0002-953X	RESULTS	3	5	3123	SYMBOL|DICTIONARY	drb1	DRB1	17#21		D012559	LONGTERM|DICTIONARY	schizophrenic	schizophrenic	69#82	NaN	The frequency of DRB1*04 alleles was significantly lower in both the schizophrenic patients and the unrelated mothers of schizophrenic offspring than in the healthy comparison subjects.
8942447	1997	Am J Psychiatry	0002-953X	RESULTS	3	5	3123	SYMBOL|DICTIONARY	drb1	DRB1	17#21		D012559	LONGTERM|DICTIONARY	schizophrenic	schizophrenic	121#134	NaN	The frequency of DRB1*04 alleles was significantly lower in both the schizophrenic patients and the unrelated mothers of schizophrenic offspring than in the healthy comparison subjects.
15111581	2004	Invest. Ophthalmol. Vis. Sci.	0146-0404	PURPOSE	1	1	348	LONGTERM|DICTIONARY	apolipoprotein e	apolipoprotein E	25#41		D008268	LONGTERM|DICTIONARY	age related macular degeneration	age-related macular degeneration	60#92		To examine the effect of apolipoprotein E (APOE) alleles on age-related macular degeneration (AMD) risk and on age at diagnosis of AMD in a large patient cohort recruited from a single center.
15111581	2004	Invest. Ophthalmol. Vis. Sci.	0146-0404	PURPOSE	1	1	348	LONGTERM|DICTIONARY	apolipoprotein e	apolipoprotein E	25#41		D008268	SYMBOL|()|DICTIONARY|EXTRACTED	amd	AMD	94#97	15111581-1-60-92	To examine the effect of apolipoprotein E (APOE) alleles on age-related macular degeneration (AMD) risk and on age at diagnosis of AMD in a large patient cohort recruited from a single center.
15111581	2004	Invest. Ophthalmol. Vis. Sci.	0146-0404	PURPOSE	1	1	348	LONGTERM|DICTIONARY	apolipoprotein e	apolipoprotein E	25#41		D008268	SYMBOL|DICTIONARY|EXTRACTED	amd	AMD	131#134	15111581-1-60-92	To examine the effect of apolipoprotein E (APOE) alleles on age-related macular degeneration (AMD) risk and on age at diagnosis of AMD in a large patient cohort recruited from a single center.
15111581	2004	Invest. Ophthalmol. Vis. Sci.	0146-0404	PURPOSE	1	1	348	SYMBOL|()|DICTIONARY|EXTRACTED	apoe	APOE	43#47	15111581-1-25-41	D008268	LONGTERM|DICTIONARY	age related macular degeneration	age-related macular degeneration	60#92		To examine the effect of apolipoprotein E (APOE) alleles on age-related macular degeneration (AMD) risk and on age at diagnosis of AMD in a large patient cohort recruited from a single center.
15111581	2004	Invest. Ophthalmol. Vis. Sci.	0146-0404	PURPOSE	1	1	348	SYMBOL|()|DICTIONARY|EXTRACTED	apoe	APOE	43#47	15111581-1-25-41	D008268	SYMBOL|()|DICTIONARY|EXTRACTED	amd	AMD	94#97	15111581-1-60-92	To examine the effect of apolipoprotein E (APOE) alleles on age-related macular degeneration (AMD) risk and on age at diagnosis of AMD in a large patient cohort recruited from a single center.
15111581	2004	Invest. Ophthalmol. Vis. Sci.	0146-0404	PURPOSE	1	1	348	SYMBOL|()|DICTIONARY|EXTRACTED	apoe	APOE	43#47	15111581-1-25-41	D008268	SYMBOL|DICTIONARY|EXTRACTED	amd	AMD	131#134	15111581-1-60-92	To examine the effect of apolipoprotein E (APOE) alleles on age-related macular degeneration (AMD) risk and on age at diagnosis of AMD in a large patient cohort recruited from a single center.
21110240	2011	Swiss Med Wkly	1424-3997	TITLE	0	0	348	SYMBOL|DICTIONARY|EXTRACTED	apoe	APOE	0#4		D009103	LONGTERM|DICTIONARY	multiple sclerosis	multiple sclerosis	67#85		APOE epsilon status in Hungarian patients with primary progressive multiple sclerosis.
20137629	2010	Zhonghua Yi Xue Za Zhi	0376-2491	OBJECTIVE	1	1	3663	SYMBOL|DICTIONARY	irf5	IRF5	59#63		D008180	LONGTERM|DICTIONARY	sle	SLE	112#115		To investigate two single nucleotide polymorphism sites of IRF5 and TLR-9 and to detect their relationship with SLE (systemic lupus erythematosus) in a Han population from Shandong province.
20137629	2010	Zhonghua Yi Xue Za Zhi	0376-2491	OBJECTIVE	1	1	54106	SYMBOL|DICTIONARY	tlr 9	TLR-9	68#73		D008180	LONGTERM|DICTIONARY	sle	SLE	112#115		To investigate two single nucleotide polymorphism sites of IRF5 and TLR-9 and to detect their relationship with SLE (systemic lupus erythematosus) in a Han population from Shandong province.
20137629	2010	Zhonghua Yi Xue Za Zhi	0376-2491	TITLE	0	0	3663	SYMBOL|DICTIONARY	irf5	IRF5	44#48		D008180	SYMBOL|DISEASE|DN|DICTIONARY	sle	SLE	60#63		[Relationship between polymorphism sites of IRF5, TLR-9 and SLE patients in Shandong Han population].
20137629	2010	Zhonghua Yi Xue Za Zhi	0376-2491	TITLE	0	0	54106	SYMBOL|DICTIONARY	tlr 9	TLR-9	50#55		D008180	SYMBOL|DISEASE|DN|DICTIONARY	sle	SLE	60#63		[Relationship between polymorphism sites of IRF5, TLR-9 and SLE patients in Shandong Han population].
19027848	2009	Biochim. Biophys. Acta	0006-3002	TITLE	0	0	4641	SYMBOL|DICTIONARY	myo1c	MYO1C	4#9		D034381	LONGTERM|DICTIONARY	hearing loss	hearing loss	36#48	NaN	Are MYO1C and MYO1F associated with hearing loss?
19027848	2009	Biochim. Biophys. Acta	0006-3002	TITLE	0	0	4542	SYMBOL|DICTIONARY	myo1f	MYO1F	14#19		D034381	LONGTERM|DICTIONARY	hearing loss	hearing loss	36#48	NaN	Are MYO1C and MYO1F associated with hearing loss?
19235789	2010	Int J Geriatr Psychiatry	1099-1166	RESULTS	3	6	1814	SYMBOL|DICTIONARY	drd3	DRD3	35#39		D011595	LONGTERM|DICTIONARY	agitation	agitation	75#84		Associations were revealed between DRD3 and elation, and between DRD4 with agitation/aggression and with depression; however, these findings do not remain significant after correction for multiple testing.
19235789	2010	Int J Geriatr Psychiatry	1099-1166	RESULTS	3	6	1814	SYMBOL|DICTIONARY	drd3	DRD3	35#39		D001523	LONGTERM|DICTIONARY	aggression	aggression	85#95		Associations were revealed between DRD3 and elation, and between DRD4 with agitation/aggression and with depression; however, these findings do not remain significant after correction for multiple testing.
19235789	2010	Int J Geriatr Psychiatry	1099-1166	RESULTS	3	6	1814	SYMBOL|DICTIONARY	drd3	DRD3	35#39		D003866	LONGTERM|DICTIONARY	depression	depression	105#115		Associations were revealed between DRD3 and elation, and between DRD4 with agitation/aggression and with depression; however, these findings do not remain significant after correction for multiple testing.
19235789	2010	Int J Geriatr Psychiatry	1099-1166	RESULTS	3	6	1815	SYMBOL|DICTIONARY	drd4	DRD4	65#69		D011595	LONGTERM|DICTIONARY	agitation	agitation	75#84		Associations were revealed between DRD3 and elation, and between DRD4 with agitation/aggression and with depression; however, these findings do not remain significant after correction for multiple testing.
19235789	2010	Int J Geriatr Psychiatry	1099-1166	RESULTS	3	6	1815	SYMBOL|DICTIONARY	drd4	DRD4	65#69		D001523	LONGTERM|DICTIONARY	aggression	aggression	85#95		Associations were revealed between DRD3 and elation, and between DRD4 with agitation/aggression and with depression; however, these findings do not remain significant after correction for multiple testing.
19235789	2010	Int J Geriatr Psychiatry	1099-1166	RESULTS	3	6	1815	SYMBOL|DICTIONARY	drd4	DRD4	65#69		D003866	LONGTERM|DICTIONARY	depression	depression	105#115		Associations were revealed between DRD3 and elation, and between DRD4 with agitation/aggression and with depression; however, these findings do not remain significant after correction for multiple testing.
19027848	2009	Biochim. Biophys. Acta	0006-3002	ALL_TEXT_2/3	2	2	4641	SYMBOL|DICTIONARY	myo1c	MYO1C	110#115		D006319	LONGTERM|DICTIONARY	sensorineural hearing loss	sensorineural hearing loss	181#207		To better understand the role of this gene family we performed a mutational screening on two candidate genes, MYO1C and MYO1F, analyzing hundreds of patients, affected by bilateral sensorineural hearing loss and coming from different European countries.
19027848	2009	Biochim. Biophys. Acta	0006-3002	ALL_TEXT_2/3	2	2	4542	SYMBOL|DICTIONARY	myo1f	MYO1F	120#125		D006319	LONGTERM|DICTIONARY	sensorineural hearing loss	sensorineural hearing loss	181#207		To better understand the role of this gene family we performed a mutational screening on two candidate genes, MYO1C and MYO1F, analyzing hundreds of patients, affected by bilateral sensorineural hearing loss and coming from different European countries.
19027848	2009	Biochim. Biophys. Acta	0006-3002	ALL_TEXT_3/3	3	5	79784	SYMBOL|GENE|GN|DICTIONARY	myosin	myosin	50#56		D034381	LONGTERM|DICTIONARY	hearing loss	hearing loss	86#98	NaN	This study suggests a role of the above mentioned myosin genes in the pathogenesis of hearing loss.
18313024	2008	Am. J. Hum. Genet.	1537-6605	TITLE	0	0	10908	LONGTERM|GENE|GN|DICTIONARY	neuropathy target esterase	Neuropathy target esterase	0#26		D016472	LONGTERM|DISEASE|DT|DICTIONARY	motor neuron disease	motor neuron disease	48#68		Neuropathy target esterase gene mutations cause motor neuron disease.
9545398	1998	Am. J. Hum. Genet.	0002-9297	ALL_TEXT_2/3	2	8	695	LONGTERM|DICTIONARY	btk	Btk	53#56	NaN	C537409	SYMBOL|DICTIONARY|EXTRACTED	xla	XLA	134#137	9545398-1-32-59	Our techniques were unable to identify a mutation in Btk in one male with both a family history and laboratory findings suggestive of XLA.
15071492	2005	Genes Immun.	1466-4879	ALL_TEXT_1/3	1	3	7124	SYMBOL|DICTIONARY	tnf	TNF	29#32		D006526	SYMBOL|EXTRACTED|DISEASE|DN	hcv infection	HCV infection	83#96	15071492-1-109-120	We hypothesized that SNPs in TNF may be important in determining the outcome of an HCV infection.
17203304	2007	Hum. Genet.	0340-6717	ALL_TEXT_2/3	2	6	3361	SYMBOL|GENE|GN|DICTIONARY	htr5a	HTR5A	43#48		D001321	LONGTERM|DICTIONARY	autism	autism	57#63		We report a significant main effect of the HTR5A gene in autism (P = 0.0088), and a significant three-locus model comprising a synergistic interaction between the ITGB3 and SLC6A4 genes with an additive effect of HTR5A (P < 0.0010).
17203304	2007	Hum. Genet.	0340-6717	ALL_TEXT_2/3	2	6	3690	SYMBOL|DICTIONARY	itgb3	ITGB3	163#168		D001321	LONGTERM|DICTIONARY	autism	autism	57#63		We report a significant main effect of the HTR5A gene in autism (P = 0.0088), and a significant three-locus model comprising a synergistic interaction between the ITGB3 and SLC6A4 genes with an additive effect of HTR5A (P < 0.0010).
17203304	2007	Hum. Genet.	0340-6717	ALL_TEXT_2/3	2	6	6532	SYMBOL|GENE|GN|DICTIONARY	slc6a4	SLC6A4	173#179		D001321	LONGTERM|DICTIONARY	autism	autism	57#63		We report a significant main effect of the HTR5A gene in autism (P = 0.0088), and a significant three-locus model comprising a synergistic interaction between the ITGB3 and SLC6A4 genes with an additive effect of HTR5A (P < 0.0010).
17203304	2007	Hum. Genet.	0340-6717	ALL_TEXT_2/3	2	6	3361	SYMBOL|DICTIONARY	htr5a	HTR5A	213#218		D001321	LONGTERM|DICTIONARY	autism	autism	57#63		We report a significant main effect of the HTR5A gene in autism (P = 0.0088), and a significant three-locus model comprising a synergistic interaction between the ITGB3 and SLC6A4 genes with an additive effect of HTR5A (P < 0.0010).
17203304	2007	Hum. Genet.	0340-6717	TITLE	0	0	6532	SYMBOL|DICTIONARY	slc6a4	SLC6A4	31#37		D001321	LONGTERM|DICTIONARY	autism	autism	51#57		Evidence for epistasis between SLC6A4 and ITGB3 in autism etiology and in the determination of platelet serotonin levels.
17203304	2007	Hum. Genet.	0340-6717	TITLE	0	0	3690	SYMBOL|DICTIONARY	itgb3	ITGB3	42#47		D001321	LONGTERM|DICTIONARY	autism	autism	51#57		Evidence for epistasis between SLC6A4 and ITGB3 in autism etiology and in the determination of platelet serotonin levels.
17203304	2007	Hum. Genet.	0340-6717	ALL_TEXT_1/3	1	3	6532	SYMBOL|DICTIONARY	slc6a4	SLC6A4	150#156		D001321	LONGTERM|DICTIONARY	autism	autism	12#18		The role in autism etiology of seven candidate genes in the serotonin metabolic and neurotransmission pathways and mapping to autism linkage regions (SLC6A4, HTR1A, HTR1D, HTR2A, HTR5A, TPH1 and ITGB3) was analyzed in a sample of 186 nuclear families.
17203304	2007	Hum. Genet.	0340-6717	ALL_TEXT_1/3	1	3	6532	SYMBOL|DICTIONARY	slc6a4	SLC6A4	150#156		D001321	LONGTERM|DICTIONARY	autism	autism	126#132		The role in autism etiology of seven candidate genes in the serotonin metabolic and neurotransmission pathways and mapping to autism linkage regions (SLC6A4, HTR1A, HTR1D, HTR2A, HTR5A, TPH1 and ITGB3) was analyzed in a sample of 186 nuclear families.
17203304	2007	Hum. Genet.	0340-6717	ALL_TEXT_1/3	1	3	3350	SYMBOL|DICTIONARY	htr1a	HTR1A	158#163		D001321	LONGTERM|DICTIONARY	autism	autism	12#18		The role in autism etiology of seven candidate genes in the serotonin metabolic and neurotransmission pathways and mapping to autism linkage regions (SLC6A4, HTR1A, HTR1D, HTR2A, HTR5A, TPH1 and ITGB3) was analyzed in a sample of 186 nuclear families.
17203304	2007	Hum. Genet.	0340-6717	ALL_TEXT_1/3	1	3	3350	SYMBOL|DICTIONARY	htr1a	HTR1A	158#163		D001321	LONGTERM|DICTIONARY	autism	autism	126#132		The role in autism etiology of seven candidate genes in the serotonin metabolic and neurotransmission pathways and mapping to autism linkage regions (SLC6A4, HTR1A, HTR1D, HTR2A, HTR5A, TPH1 and ITGB3) was analyzed in a sample of 186 nuclear families.
17203304	2007	Hum. Genet.	0340-6717	ALL_TEXT_1/3	1	3	3352	SYMBOL|DICTIONARY	htr1d	HTR1D	165#170		D001321	LONGTERM|DICTIONARY	autism	autism	12#18		The role in autism etiology of seven candidate genes in the serotonin metabolic and neurotransmission pathways and mapping to autism linkage regions (SLC6A4, HTR1A, HTR1D, HTR2A, HTR5A, TPH1 and ITGB3) was analyzed in a sample of 186 nuclear families.
17203304	2007	Hum. Genet.	0340-6717	ALL_TEXT_1/3	1	3	3352	SYMBOL|DICTIONARY	htr1d	HTR1D	165#170		D001321	LONGTERM|DICTIONARY	autism	autism	126#132		The role in autism etiology of seven candidate genes in the serotonin metabolic and neurotransmission pathways and mapping to autism linkage regions (SLC6A4, HTR1A, HTR1D, HTR2A, HTR5A, TPH1 and ITGB3) was analyzed in a sample of 186 nuclear families.
17203304	2007	Hum. Genet.	0340-6717	ALL_TEXT_1/3	1	3	3356	SYMBOL|DICTIONARY	htr2a	HTR2A	172#177		D001321	LONGTERM|DICTIONARY	autism	autism	12#18		The role in autism etiology of seven candidate genes in the serotonin metabolic and neurotransmission pathways and mapping to autism linkage regions (SLC6A4, HTR1A, HTR1D, HTR2A, HTR5A, TPH1 and ITGB3) was analyzed in a sample of 186 nuclear families.
17203304	2007	Hum. Genet.	0340-6717	ALL_TEXT_1/3	1	3	3356	SYMBOL|DICTIONARY	htr2a	HTR2A	172#177		D001321	LONGTERM|DICTIONARY	autism	autism	126#132		The role in autism etiology of seven candidate genes in the serotonin metabolic and neurotransmission pathways and mapping to autism linkage regions (SLC6A4, HTR1A, HTR1D, HTR2A, HTR5A, TPH1 and ITGB3) was analyzed in a sample of 186 nuclear families.
17203304	2007	Hum. Genet.	0340-6717	ALL_TEXT_1/3	1	3	3361	SYMBOL|DICTIONARY	htr5a	HTR5A	179#184		D001321	LONGTERM|DICTIONARY	autism	autism	12#18		The role in autism etiology of seven candidate genes in the serotonin metabolic and neurotransmission pathways and mapping to autism linkage regions (SLC6A4, HTR1A, HTR1D, HTR2A, HTR5A, TPH1 and ITGB3) was analyzed in a sample of 186 nuclear families.
17203304	2007	Hum. Genet.	0340-6717	ALL_TEXT_1/3	1	3	3361	SYMBOL|DICTIONARY	htr5a	HTR5A	179#184		D001321	LONGTERM|DICTIONARY	autism	autism	126#132		The role in autism etiology of seven candidate genes in the serotonin metabolic and neurotransmission pathways and mapping to autism linkage regions (SLC6A4, HTR1A, HTR1D, HTR2A, HTR5A, TPH1 and ITGB3) was analyzed in a sample of 186 nuclear families.
17203304	2007	Hum. Genet.	0340-6717	ALL_TEXT_1/3	1	3	7166	SYMBOL|DICTIONARY	tph1	TPH1	186#190		D001321	LONGTERM|DICTIONARY	autism	autism	12#18		The role in autism etiology of seven candidate genes in the serotonin metabolic and neurotransmission pathways and mapping to autism linkage regions (SLC6A4, HTR1A, HTR1D, HTR2A, HTR5A, TPH1 and ITGB3) was analyzed in a sample of 186 nuclear families.
17203304	2007	Hum. Genet.	0340-6717	ALL_TEXT_1/3	1	3	7166	SYMBOL|DICTIONARY	tph1	TPH1	186#190		D001321	LONGTERM|DICTIONARY	autism	autism	126#132		The role in autism etiology of seven candidate genes in the serotonin metabolic and neurotransmission pathways and mapping to autism linkage regions (SLC6A4, HTR1A, HTR1D, HTR2A, HTR5A, TPH1 and ITGB3) was analyzed in a sample of 186 nuclear families.
17203304	2007	Hum. Genet.	0340-6717	ALL_TEXT_1/3	1	3	3690	SYMBOL|DICTIONARY	itgb3	ITGB3	195#200		D001321	LONGTERM|DICTIONARY	autism	autism	12#18		The role in autism etiology of seven candidate genes in the serotonin metabolic and neurotransmission pathways and mapping to autism linkage regions (SLC6A4, HTR1A, HTR1D, HTR2A, HTR5A, TPH1 and ITGB3) was analyzed in a sample of 186 nuclear families.
17203304	2007	Hum. Genet.	0340-6717	ALL_TEXT_1/3	1	3	3690	SYMBOL|DICTIONARY	itgb3	ITGB3	195#200		D001321	LONGTERM|DICTIONARY	autism	autism	126#132		The role in autism etiology of seven candidate genes in the serotonin metabolic and neurotransmission pathways and mapping to autism linkage regions (SLC6A4, HTR1A, HTR1D, HTR2A, HTR5A, TPH1 and ITGB3) was analyzed in a sample of 186 nuclear families.
9391065	1998	Proc. Natl. Acad. Sci. U.S.A.	0027-8424	ALL_TEXT_2/3	2	3	6010	LONGTERM|DICTIONARY	rhodopsin	rhodopsin	141#150		D012174	SYMBOL|EXTRACTED	adrp	ADRP	240#244	9391065-1-107-146	Previous work has highlighted the potential of retinylamine analogs as active-site directed inactivators of constitutively active mutants of rhodopsin with the idea that these or related compounds might be used therapeutically for cases of ADRP involving mutations of the active-site Lys.
16075239	2006	Eur Arch Otorhinolaryngol	0937-4477	ALL_TEXT_1/3	1	2	1080	SYMBOL|DICTIONARY	cftr	CFTR	196#200		D009298	LONGTERM|DICTIONARY	nasal polyps	nasal polyps	32#44		Forty-four patients affected by nasal polyps were admitted to the Department of Otolaryngology, Lublin University School of Medicine, Lublin, Poland, and screened for the most-commonly identified CFTR mutations [DeltaF508, G542X, N1303 K, 1717-1 (G to A), W1282X, G551D, R553X and DeltaI507] by applying the INNO-LIPA CF2 test strips.
16075239	2006	Eur Arch Otorhinolaryngol	0937-4477	ALL_TEXT_1/3	1	2	537	LONGTERM|DICTIONARY	cf2	CF2	318#321	NaN	D009298	LONGTERM|DICTIONARY	nasal polyps	nasal polyps	32#44		Forty-four patients affected by nasal polyps were admitted to the Department of Otolaryngology, Lublin University School of Medicine, Lublin, Poland, and screened for the most-commonly identified CFTR mutations [DeltaF508, G542X, N1303 K, 1717-1 (G to A), W1282X, G551D, R553X and DeltaI507] by applying the INNO-LIPA CF2 test strips.
16075239	2006	Eur Arch Otorhinolaryngol	0937-4477	TITLE	0	0	1080	SYMBOL|DICTIONARY	cftr	CFTR	24#28		D009298	LONGTERM|DICTIONARY	nasal polyps	nasal polyps	63#75		Analysis of most common CFTR mutations in patients affected by nasal polyps.
17050201	2006	Int. J. Hematol.	0925-5710	ALL_TEXT_1/3	1	1	2322	SYMBOL|DICTIONARY	flt3	Flt3	0#4		D015470	LONGTERM|DICTIONARY	acute myeloid leukemia	acute myeloid leukemia	71#93		Flt3 internal tandem duplication (Flt3-ITD) is a prevalent mutation in acute myeloid leukemia (AML).
17050201	2006	Int. J. Hematol.	0925-5710	ALL_TEXT_1/3	1	1	2322	SYMBOL|DICTIONARY	flt3	Flt3	0#4		D015470	SYMBOL|()|DICTIONARY|EXTRACTED	aml	AML	95#98	17050201-1-71-93	Flt3 internal tandem duplication (Flt3-ITD) is a prevalent mutation in acute myeloid leukemia (AML).
17050201	2006	Int. J. Hematol.	0925-5710	ALL_TEXT_1/3	1	1	2322	SYMBOL|DICTIONARY	flt3	Flt3	34#38		D015470	LONGTERM|DICTIONARY	acute myeloid leukemia	acute myeloid leukemia	71#93		Flt3 internal tandem duplication (Flt3-ITD) is a prevalent mutation in acute myeloid leukemia (AML).
17050201	2006	Int. J. Hematol.	0925-5710	ALL_TEXT_1/3	1	1	2322	SYMBOL|DICTIONARY	flt3	Flt3	34#38		D015470	SYMBOL|()|DICTIONARY|EXTRACTED	aml	AML	95#98	17050201-1-71-93	Flt3 internal tandem duplication (Flt3-ITD) is a prevalent mutation in acute myeloid leukemia (AML).
15111581	2004	Invest. Ophthalmol. Vis. Sci.	0146-0404	CONCLUSIONS	4	8	348	SYMBOL|DICTIONARY|EXTRACTED	apoe	APOE	28#32	15111581-1-25-41	D008268	SYMBOL|DICTIONARY|EXTRACTED	amd	AMD	71#74	15111581-1-60-92	The association between the APOE-epsilon4 allele and a reduced risk of AMD was established in a large cohort with sufficient statistical power.
16299685	2006	J. Nephrol.	1121-8428	ALL_TEXT_2/3	2	3	3569	SYMBOL|DICTIONARY|EXTRACTED	il 6	IL-6	70#74	16299685-0-0-13	D010505	SYMBOL|DICTIONARY|EXTRACTED	fmf	FMF	124#127	16299685-1-0-28	In this study, we investigated the role of the functionally important IL-6 -174 G/C polymorphism in the clinical outcome of FMF and amyloidosis.
16299685	2006	J. Nephrol.	1121-8428	ALL_TEXT_2/3	2	3	3569	SYMBOL|DICTIONARY|EXTRACTED	il 6	IL-6	70#74	16299685-0-0-13	D000686	LONGTERM|DICTIONARY	amyloidosis	amyloidosis	132#143		In this study, we investigated the role of the functionally important IL-6 -174 G/C polymorphism in the clinical outcome of FMF and amyloidosis.
16299685	2006	J. Nephrol.	1121-8428	TITLE	0	0	3569	LONGTERM|DICTIONARY	interleukin 6	Interleukin-6	0#13		D010505	LONGTERM|DISEASE|DN|DICTIONARY	familial mediterranean fever	familial Mediterranean fever	46#74		Interleukin-6 (IL-6) -174 G/C polymorphism in familial Mediterranean fever patients with and without amyloidosis.
16299685	2006	J. Nephrol.	1121-8428	TITLE	0	0	3569	LONGTERM|DICTIONARY	interleukin 6	Interleukin-6	0#13		D000686	LONGTERM|DICTIONARY	amyloidosis	amyloidosis	101#112		Interleukin-6 (IL-6) -174 G/C polymorphism in familial Mediterranean fever patients with and without amyloidosis.
16299685	2006	J. Nephrol.	1121-8428	TITLE	0	0	3569	SYMBOL|()|DICTIONARY|EXTRACTED	il 6	IL-6	15#19	16299685-0-0-13	D010505	LONGTERM|DISEASE|DN|DICTIONARY	familial mediterranean fever	familial Mediterranean fever	46#74		Interleukin-6 (IL-6) -174 G/C polymorphism in familial Mediterranean fever patients with and without amyloidosis.
16299685	2006	J. Nephrol.	1121-8428	TITLE	0	0	3569	SYMBOL|()|DICTIONARY|EXTRACTED	il 6	IL-6	15#19	16299685-0-0-13	D000686	LONGTERM|DICTIONARY	amyloidosis	amyloidosis	101#112		Interleukin-6 (IL-6) -174 G/C polymorphism in familial Mediterranean fever patients with and without amyloidosis.
16299685	2006	J. Nephrol.	1121-8428	ALL_TEXT_3/3	3	6	3569	SYMBOL|DICTIONARY|EXTRACTED	il 6	IL-6	22#26	16299685-0-0-13	D010505	SYMBOL|DICTIONARY|EXTRACTED	fmf	FMF	72#75	16299685-1-0-28	The results show that IL-6 -174 G/C polymorphism is not associated with FMF and amyloidosis.
16299685	2006	J. Nephrol.	1121-8428	ALL_TEXT_3/3	3	6	3569	SYMBOL|DICTIONARY|EXTRACTED	il 6	IL-6	22#26	16299685-0-0-13	D000686	LONGTERM|DICTIONARY	amyloidosis	amyloidosis	80#91		The results show that IL-6 -174 G/C polymorphism is not associated with FMF and amyloidosis.
19563289	2009	J. Periodontol.	0022-3492	RESULTS	3	9	3552	SYMBOL|DICTIONARY	il 1a	IL-1A	84#89		D009203	SYMBOL|DICTIONARY|EXTRACTED	ami	AMI	134#137	19563289-2-148-175	No significant differences were observed in the allele frequencies of the gene loci IL-1A -889 and IL-1B +C3954 between patients with AMI and controls.
19563289	2009	J. Periodontol.	0022-3492	RESULTS	3	9	3553	SYMBOL|DICTIONARY	il 1b	IL-1B	99#104		D009203	SYMBOL|DICTIONARY|EXTRACTED	ami	AMI	134#137	19563289-2-148-175	No significant differences were observed in the allele frequencies of the gene loci IL-1A -889 and IL-1B +C3954 between patients with AMI and controls.
20010906	2010	Int J Obes (Lond)	1476-5497	TITLE	0	0	4828	LONGTERM|GENE|GN|DICTIONARY	neuromedin b	neuromedin B	81#93		D009765	LONGTERM|DICTIONARY	obesity	obesity	128#135		Influence of maternal educational level on the association between the rs3809508 neuromedin B gene polymorphism and the risk of obesity in the HELENA study.
10200057	1999	Hum. Mutat.	1059-7794	TITLE	0	0	5053	SYMBOL|GENE|GN|DICTIONARY	pah	PAH	38#41		D010661	LONGTERM|DICTIONARY	phenylketonuria	phenylketonuria	120#135		Two novel mutations in exon 11 of the PAH gene (V1163del TG and P362T) associated with classic phenylketonuira and mild phenylketonuria. Mutations in brief no. 143. Online.
15300989	2004	Hum. Genet.	0340-6717	TITLE	0	0	3664	SYMBOL|DICTIONARY	irf6	IRF6	13#17		C536528	LONGTERM|DISEASE|DT|DICTIONARY	van der woude syndrome	Van der Woude syndrome	28#50		Gene symbol: IRF6. Disease: Van der Woude syndrome.
12170472	2002	Zhonghua Yi Xue Yi Chuan Xue Za Zhi	1003-9406	METHODS	2	2	54578	SYMBOL|DICTIONARY	ugt1f	UGT1F	21#26		D006528	SYMBOL|DICTIONARY|EXTRACTED	hcc	HCC	47#50	12170472-1-141-165	The polymorphisms of UGT1F of 84 patients with HCC and 144 healthy controls were detected by PCR-denaturation gradient gel electrophoresis-sequencing or PCR-single strain conformation polymorphsim-sequencing.
12170472	2002	Zhonghua Yi Xue Yi Chuan Xue Za Zhi	1003-9406	OBJECTIVE	1	1	54578	SYMBOL|()|DICTIONARY	ugt1f	UGT1F	69#74		D006528	LONGTERM|DISEASE|DT|DICTIONARY	hepatocellular carcinoma	hepatocellular carcinoma	141#165		To study the genetic polymorphisms of UDP-glucuronosyltransferase 1F(UGT1F) and the relationship between polymorphisms and susceptibility to hepatocellular carcinoma (HCC).
12170472	2002	Zhonghua Yi Xue Yi Chuan Xue Za Zhi	1003-9406	OBJECTIVE	1	1	54578	SYMBOL|()|DICTIONARY	ugt1f	UGT1F	69#74		D006528	SYMBOL|()|DICTIONARY|EXTRACTED	hcc	HCC	167#170	12170472-1-141-165	To study the genetic polymorphisms of UDP-glucuronosyltransferase 1F(UGT1F) and the relationship between polymorphisms and susceptibility to hepatocellular carcinoma (HCC).
12694583	2004	Tissue Antigens	0001-2815	ALL_TEXT_3/3	3	6	3123	SYMBOL|NUMBER|DICTIONARY	hla drb1	HLA-DRB1	9#17		D006111	LONGTERM|DICTIONARY	go	GO	74#76	NaN	Although HLA-DRB1*1405 showed an increased relative risk in patients with GO (Graves' opthalmopathy) (OR 4.61) when compared with patients without GO, the relative risk after adjusting for the number of comparisons was not significant.
12694583	2004	Tissue Antigens	0001-2815	ALL_TEXT_3/3	3	6	3123	SYMBOL|NUMBER|DICTIONARY	hla drb1	HLA-DRB1	9#17		D006111	LONGTERM|DICTIONARY	graves' opthalmopathy	Graves' opthalmopathy	78#99	NaN	Although HLA-DRB1*1405 showed an increased relative risk in patients with GO (Graves' opthalmopathy) (OR 4.61) when compared with patients without GO, the relative risk after adjusting for the number of comparisons was not significant.
12694583	2004	Tissue Antigens	0001-2815	ALL_TEXT_3/3	3	6	3123	SYMBOL|NUMBER|DICTIONARY	hla drb1	HLA-DRB1	9#17		D006111	LONGTERM|DICTIONARY	go	GO	147#149	NaN	Although HLA-DRB1*1405 showed an increased relative risk in patients with GO (Graves' opthalmopathy) (OR 4.61) when compared with patients without GO, the relative risk after adjusting for the number of comparisons was not significant.
19774492	2010	Mol. Biol. Rep.	1573-4978	ALL_TEXT_2/3	2	4	7128	SYMBOL|DICTIONARY	tnfaip3	TNFAIP3	28#35		D008180	SYMBOL|DICTIONARY|EXTRACTED	sle	SLE	55#58	19774492-1-0-28	In order to examine whether TNFAIP3 is associated with SLE in Chinese Han population, we genotyped one of its non-synonymous mutation SNP rs2230926, showing significant association evidence with SLE in European population, with 1,420 cases and 4,461 controls of Chinese Han by using Sequenom MassArray system.
19774492	2010	Mol. Biol. Rep.	1573-4978	ALL_TEXT_2/3	2	4	7128	SYMBOL|DICTIONARY	tnfaip3	TNFAIP3	28#35		D008180	SYMBOL|DICTIONARY|EXTRACTED	sle	SLE	195#198	19774492-1-0-28	In order to examine whether TNFAIP3 is associated with SLE in Chinese Han population, we genotyped one of its non-synonymous mutation SNP rs2230926, showing significant association evidence with SLE in European population, with 1,420 cases and 4,461 controls of Chinese Han by using Sequenom MassArray system.
15837080	2005	Int. J. Cardiol.	0167-5273	TITLE	0	0	7056	LONGTERM|DICTIONARY	thrombomodulin	thrombomodulin	25#39		D003324	LONGTERM|DISEASE|DT|DICTIONARY	coronary artery disease	coronary artery disease	65#88		Association study of the thrombomodulin -33G>A polymorphism with coronary artery disease and myocardial infarction in Chinese Han population.
15837080	2005	Int. J. Cardiol.	0167-5273	TITLE	0	0	7056	LONGTERM|DICTIONARY	thrombomodulin	thrombomodulin	25#39		D009203	LONGTERM|DICTIONARY	myocardial infarction	myocardial infarction	93#114		Association study of the thrombomodulin -33G>A polymorphism with coronary artery disease and myocardial infarction in Chinese Han population.
19774492	2010	Mol. Biol. Rep.	1573-4978	ALL_TEXT_3/3	3	6	7128	SYMBOL|DICTIONARY	tnfaip3	TNFAIP3	28#35		D001168	LONGTERM|DICTIONARY	arthritis	arthritis	61#70		Interestingly, rs2230926 of TNFAIP3 was also associated with arthritis, ANA and some other subphenotypes of the disease.
19774492	2010	Mol. Biol. Rep.	1573-4978	ALL_TEXT_3/3	3	7	7128	SYMBOL|DICTIONARY	tnfaip3	TNFAIP3	47#54		D008180	SYMBOL|DICTIONARY|EXTRACTED	sle	SLE	92#95	19774492-1-0-28	Our findings suggest that SNP rs2230926 in the TNFAIP3 might be a common genetic factor for SLE within different populations in terms of Chinese Han and European population.
17761687	2008	Hum. Mol. Genet.	0964-6906	ALL_TEXT_3/3	3	8	54970	SYMBOL|DICTIONARY	ttc12	TTC12	112#117		D000437	SYMBOL|EXTRACTED	ad	AD	26#28	17761687-1-91-109	We conclude that risk for AD is attributable in part to variants in four regions within this cluster: exon 3 of TTC12, exon 12/intron13 of NCAM1 and exons 2 and 5 of ANKK1.
17761687	2008	Hum. Mol. Genet.	0964-6906	ALL_TEXT_3/3	3	8	4684	SYMBOL|DICTIONARY	ncam1	NCAM1	139#144		D000437	SYMBOL|EXTRACTED	ad	AD	26#28	17761687-1-91-109	We conclude that risk for AD is attributable in part to variants in four regions within this cluster: exon 3 of TTC12, exon 12/intron13 of NCAM1 and exons 2 and 5 of ANKK1.
17761687	2008	Hum. Mol. Genet.	0964-6906	ALL_TEXT_3/3	3	8	255239	SYMBOL|DICTIONARY	ankk1	ANKK1	166#171		D000437	SYMBOL|EXTRACTED	ad	AD	26#28	17761687-1-91-109	We conclude that risk for AD is attributable in part to variants in four regions within this cluster: exon 3 of TTC12, exon 12/intron13 of NCAM1 and exons 2 and 5 of ANKK1.
19774492	2010	Mol. Biol. Rep.	1573-4978	ALL_TEXT_2/3	2	3	7128	SYMBOL|DICTIONARY	tnfaip3	TNFAIP3	140#147		D008180	SYMBOL|DICTIONARY|EXTRACTED	sle	SLE	126#129	19774492-1-0-28	Recently, several genome-wide association studies (GWA) in European population have found many novel susceptibility genes for SLE including TNFAIP3.
17761687	2008	Hum. Mol. Genet.	0964-6906	ALL_TEXT_2/3	2	5	4684	SYMBOL|DICTIONARY	ncam1	NCAM1	52#57		D000437	SYMBOL|EXTRACTED	ad	AD	11#13	17761687-1-91-109	Additional AD-associated haplotypes centered around NCAM1 exon 12 in the family sample (P(oihs) = 0.0032), and at exons 2 and 5 of ANKK1 in the case-control sample (P(oihs) = 0.00058).
17761687	2008	Hum. Mol. Genet.	0964-6906	ALL_TEXT_2/3	2	5	255239	SYMBOL|DICTIONARY	ankk1	ANKK1	131#136		D000437	SYMBOL|EXTRACTED	ad	AD	11#13	17761687-1-91-109	Additional AD-associated haplotypes centered around NCAM1 exon 12 in the family sample (P(oihs) = 0.0032), and at exons 2 and 5 of ANKK1 in the case-control sample (P(oihs) = 0.00058).
17761687	2008	Hum. Mol. Genet.	0964-6906	TITLE	0	0	1813	SYMBOL|DICTIONARY	drd2	DRD2	38#42		D000437	LONGTERM|DICTIONARY	alcohol dependence	alcohol dependence	70#88		Association of haplotypic variants in DRD2, ANKK1, TTC12 and NCAM1 to alcohol dependence in independent case control and family samples.
17761687	2008	Hum. Mol. Genet.	0964-6906	TITLE	0	0	255239	SYMBOL|DICTIONARY	ankk1	ANKK1	44#49		D000437	LONGTERM|DICTIONARY	alcohol dependence	alcohol dependence	70#88		Association of haplotypic variants in DRD2, ANKK1, TTC12 and NCAM1 to alcohol dependence in independent case control and family samples.
17761687	2008	Hum. Mol. Genet.	0964-6906	TITLE	0	0	54970	SYMBOL|DICTIONARY	ttc12	TTC12	51#56		D000437	LONGTERM|DICTIONARY	alcohol dependence	alcohol dependence	70#88		Association of haplotypic variants in DRD2, ANKK1, TTC12 and NCAM1 to alcohol dependence in independent case control and family samples.
17761687	2008	Hum. Mol. Genet.	0964-6906	TITLE	0	0	4684	SYMBOL|DICTIONARY	ncam1	NCAM1	61#66		D000437	LONGTERM|DICTIONARY	alcohol dependence	alcohol dependence	70#88		Association of haplotypic variants in DRD2, ANKK1, TTC12 and NCAM1 to alcohol dependence in independent case control and family samples.
17761687	2008	Hum. Mol. Genet.	0964-6906	ALL_TEXT_1/3	1	1	1813	SYMBOL|DICTIONARY	drd2	DRD2	75#79		D000437	LONGTERM|DICTIONARY	alcohol dependence	alcohol dependence	91#109		There have been many conflicting reports concerning the association of the DRD2 locus with alcohol dependence (AD).
17761687	2008	Hum. Mol. Genet.	0964-6906	ALL_TEXT_1/3	1	1	1813	SYMBOL|DICTIONARY	drd2	DRD2	75#79		D000437	SYMBOL|EXTRACTED|()	ad	AD	111#113	17761687-1-91-109	There have been many conflicting reports concerning the association of the DRD2 locus with alcohol dependence (AD).
17761687	2008	Hum. Mol. Genet.	0964-6906	ALL_TEXT_1/3	1	2	1813	SYMBOL|DICTIONARY	drd2	DRD2	95#99		D000437	SYMBOL|EXTRACTED	ad	AD	168#170	17761687-1-91-109	To investigate whether these findings could be reconciled by considering the genomic region of DRD2 in greater detail, we conducted two separate association studies of AD in 1220 European-American subjects using family-based (488 subjects) and case-control (318 cases and 414 controls) designs, and 43 single nucleotide polymorphisms mapped to the gene cluster of NCAM1, TTC12, ANKK1 and DRD2.
17761687	2008	Hum. Mol. Genet.	0964-6906	ALL_TEXT_1/3	1	2	4684	SYMBOL|DICTIONARY	ncam1	NCAM1	364#369		D000437	SYMBOL|EXTRACTED	ad	AD	168#170	17761687-1-91-109	To investigate whether these findings could be reconciled by considering the genomic region of DRD2 in greater detail, we conducted two separate association studies of AD in 1220 European-American subjects using family-based (488 subjects) and case-control (318 cases and 414 controls) designs, and 43 single nucleotide polymorphisms mapped to the gene cluster of NCAM1, TTC12, ANKK1 and DRD2.
17761687	2008	Hum. Mol. Genet.	0964-6906	ALL_TEXT_1/3	1	2	54970	SYMBOL|DICTIONARY	ttc12	TTC12	371#376		D000437	SYMBOL|EXTRACTED	ad	AD	168#170	17761687-1-91-109	To investigate whether these findings could be reconciled by considering the genomic region of DRD2 in greater detail, we conducted two separate association studies of AD in 1220 European-American subjects using family-based (488 subjects) and case-control (318 cases and 414 controls) designs, and 43 single nucleotide polymorphisms mapped to the gene cluster of NCAM1, TTC12, ANKK1 and DRD2.
17761687	2008	Hum. Mol. Genet.	0964-6906	ALL_TEXT_1/3	1	2	255239	SYMBOL|DICTIONARY	ankk1	ANKK1	378#383		D000437	SYMBOL|EXTRACTED	ad	AD	168#170	17761687-1-91-109	To investigate whether these findings could be reconciled by considering the genomic region of DRD2 in greater detail, we conducted two separate association studies of AD in 1220 European-American subjects using family-based (488 subjects) and case-control (318 cases and 414 controls) designs, and 43 single nucleotide polymorphisms mapped to the gene cluster of NCAM1, TTC12, ANKK1 and DRD2.
17761687	2008	Hum. Mol. Genet.	0964-6906	ALL_TEXT_1/3	1	2	1813	SYMBOL|DICTIONARY	drd2	DRD2	388#392		D000437	SYMBOL|EXTRACTED	ad	AD	168#170	17761687-1-91-109	To investigate whether these findings could be reconciled by considering the genomic region of DRD2 in greater detail, we conducted two separate association studies of AD in 1220 European-American subjects using family-based (488 subjects) and case-control (318 cases and 414 controls) designs, and 43 single nucleotide polymorphisms mapped to the gene cluster of NCAM1, TTC12, ANKK1 and DRD2.
15318030	2005	Psychiatr. Genet.	0955-8829	ALL_TEXT_1/3	1	1	151056	LONGTERM|DICTIONARY	phospholipase a2	phospholipase A2	46#62		D012559	LONGTERM|DICTIONARY	schizophrenic	schizophrenic	66#79	NaN	Several studies suggest increased activity of phospholipase A2 in schizophrenic patients.
15318030	2005	Psychiatr. Genet.	0955-8829	ALL_TEXT_3/3	3	6	8398	SYMBOL|DICTIONARY	ipla2	iPLA2	39#44		D012559	LONGTERM|DICTIONARY	schizophrenia	schizophrenia	90#103		In conclusion, our data suggested that iPLA2 may play a role as a susceptibility gene for schizophrenia in our sample; however, confirmatory studies in independent samples are needed.
20198856	2010	Mol. Biol. (Mosk.)	0026-8984	ALL_TEXT_1/3	1	2	5428	SYMBOL|DICTIONARY	polg1	POLG1	69#74		D006973	LONGTERM|DICTIONARY	arterial hypertension	arterial hypertension	121#142		We compared frequencies of polymorphisms in mitochondrial DNA and in POLG1 between healthy individuals and patients with arterial hypertension, as well as between patients with and without left ventricular hypertrophy.
20198856	2010	Mol. Biol. (Mosk.)	0026-8984	ALL_TEXT_1/3	1	2	5428	SYMBOL|DICTIONARY	polg1	POLG1	69#74		D017379	LONGTERM|DICTIONARY	left ventricular hypertrophy	left ventricular hypertrophy	189#217		We compared frequencies of polymorphisms in mitochondrial DNA and in POLG1 between healthy individuals and patients with arterial hypertension, as well as between patients with and without left ventricular hypertrophy.
16361298	2006	Br J Anaesth	0007-0912	ALL_TEXT_3/3	3	3	4524	SYMBOL|GENE|GN|DICTIONARY	mthfr	MTHFR	111#116		D013118	LONGTERM|DICTIONARY	myelopathy	myelopathy	247#257		Because of this uncommon clinical presentation, we analysed the patient's DNA, and found a polymorphism in the MTHFR gene that is associated with the thermolabile isoform of the 5,10-methylenetetrahydrofolate reductase enzyme, which explained the myelopathy experienced by the patient after being exposed to nitrous oxide.
11244489	2001	Mol. Psychiatry	1359-4184	ALL_TEXT_2/3	2	6	7124	SYMBOL|EXTRACTED|GENE|GN	tnfalpha	TNFalpha	38#46	11244489-4-14-41	D012559	LONGTERM|DICTIONARY	schizophrenic	schizophrenic	71#84	NaN	We studied the distribution of -G308A TNFalpha gene polymorphism in 84 schizophrenic patients and in 138 healthy volunteers.
14717963	2004	J. Thromb. Haemost.	1538-7933	ALL_TEXT_2/3	2	8	28938	LONGTERM|DICTIONARY	l-1	L-1	121#124	NaN	D009203	SYMBOL|EXTRACTED	mi	MI	27#29	14717963-1-62-83	A 2-fold increased risk of MI was found in women with the TT genotype who had folate levels below the median of 7.4 nmol L-1 compared with CC genotype and folate levels above the median (OR = 2.0; 95% CI 1.0, 3.7).
17186461	2007	Am. J. Hum. Genet.	0002-9297	ALL_TEXT_1/3	1	5	5663	LONGTERM|DICTIONARY	presenilin 1	presenilin 1	39#51		D000544	SYMBOL|EXTRACTED	familial ad	Familial AD	0#11	17186461-1-58-75	Familial AD is caused most commonly by presenilin 1 (PSEN1) or presenilin 2 (PSEN2) mutations, a discovery that has greatly advanced the field.
17186461	2007	Am. J. Hum. Genet.	0002-9297	ALL_TEXT_1/3	1	5	5663	SYMBOL|()|DICTIONARY|EXTRACTED	psen1	PSEN1	53#58	17186461-5-39-51	D000544	SYMBOL|EXTRACTED	familial ad	Familial AD	0#11	17186461-1-58-75	Familial AD is caused most commonly by presenilin 1 (PSEN1) or presenilin 2 (PSEN2) mutations, a discovery that has greatly advanced the field.
17186461	2007	Am. J. Hum. Genet.	0002-9297	ALL_TEXT_1/3	1	5	5664	LONGTERM|DICTIONARY	presenilin 2	presenilin 2	63#75		D000544	SYMBOL|EXTRACTED	familial ad	Familial AD	0#11	17186461-1-58-75	Familial AD is caused most commonly by presenilin 1 (PSEN1) or presenilin 2 (PSEN2) mutations, a discovery that has greatly advanced the field.
17186461	2007	Am. J. Hum. Genet.	0002-9297	ALL_TEXT_1/3	1	5	5664	SYMBOL|()|DICTIONARY|EXTRACTED	psen2	PSEN2	77#82	17186461-5-63-75	D000544	SYMBOL|EXTRACTED	familial ad	Familial AD	0#11	17186461-1-58-75	Familial AD is caused most commonly by presenilin 1 (PSEN1) or presenilin 2 (PSEN2) mutations, a discovery that has greatly advanced the field.
14717963	2004	J. Thromb. Haemost.	1538-7933	ALL_TEXT_1/3	1	3	4524	SYMBOL|NUMBER|DICTIONARY|EXTRACTED	mthfr	MTHFR	70#75	14717963-0-29-64	D020138	LONGTERM|DICTIONARY	hyperhomocysteinemia	hyperhomocysteinemia	36#56		We assessed the association between hyperhomocysteinemia, low folate, MTHFR 677TT mutation and risk of MI, and we investigated the effect of OC use on homocysteine levels in controls.
14717963	2004	J. Thromb. Haemost.	1538-7933	ALL_TEXT_1/3	1	3	4524	SYMBOL|NUMBER|DICTIONARY|EXTRACTED	mthfr	MTHFR	70#75	14717963-0-29-64	D009203	SYMBOL|EXTRACTED	mi	MI	103#105	14717963-1-62-83	We assessed the association between hyperhomocysteinemia, low folate, MTHFR 677TT mutation and risk of MI, and we investigated the effect of OC use on homocysteine levels in controls.
11739440	2001	J. Clin. Endocrinol. Metab.	0021-972X	ALL_TEXT_3/3	3	7	5928	LONGTERM|DICTIONARY	msi	MSI	168#171	NaN	C567552	LONGTERM|DICTIONARY	precocious pubarche	precocious pubarche	14#33		However among precocious pubarche girls, INS VNTR genotype was related to the severity of phenotype; I/I and I/III genotypes had lower birth weights (P < 0.01), higher MSI (P < 0.005), and lower insulin sensitivity (P < 0.005) than III/III girls.
11739440	2001	J. Clin. Endocrinol. Metab.	0021-972X	ALL_TEXT_3/3	3	7	5928	LONGTERM|DICTIONARY	msi	MSI	168#171	NaN	D007333	LONGTERM|DICTIONARY	lower insulin sensitivity (p < 0.005) than iii/iii girls	lower insulin sensitivity (P < 0.005) than III/III girls	189#245	NaN	However among precocious pubarche girls, INS VNTR genotype was related to the severity of phenotype; I/I and I/III genotypes had lower birth weights (P < 0.01), higher MSI (P < 0.005), and lower insulin sensitivity (P < 0.005) than III/III girls.
14720258	2004	Clin. Exp. Allergy	0954-7894	CONCLUSION	5	12	80332	SYMBOL|GENE|GN|DICTIONARY	adam33	ADAM33	76#82		D001249	LONGTERM|DICTIONARY	asthma	asthma	65#71		This study replicates the recently published association between asthma and ADAM33 gene variants.
17186461	2007	Am. J. Hum. Genet.	0002-9297	ALL_TEXT_2/3	2	8	5663	SYMBOL|DICTIONARY|EXTRACTED	psen1	PSEN1	80#85	17186461-5-39-51	D002311	SYMBOL|DICTIONARY|EXTRACTED	dcm	DCM	35#38	17186461-2-35-57	A total of 315 index patients with DCM were evaluated for sequence variation in PSEN1 and PSEN2.
17186461	2007	Am. J. Hum. Genet.	0002-9297	ALL_TEXT_2/3	2	8	5664	SYMBOL|DICTIONARY|EXTRACTED	psen2	PSEN2	90#95	17186461-5-63-75	D002311	SYMBOL|DICTIONARY|EXTRACTED	dcm	DCM	35#38	17186461-2-35-57	A total of 315 index patients with DCM were evaluated for sequence variation in PSEN1 and PSEN2.
14717963	2004	J. Thromb. Haemost.	1538-7933	ALL_TEXT_2/3	2	7	4524	SYMBOL|DICTIONARY|EXTRACTED	mthfr	MTHFR	8#13	14717963-0-29-64	D009203	SYMBOL|EXTRACTED	mi	MI	45#47	14717963-1-62-83	For all MTHFR genotypes combined, the OR for MI in the lowest quartile of folate (<5.4 nmol L-1) compared with the highest quartile (>10.4 nmol L-1) was 3.0 (95% CI 1.7, 5.1).
14717963	2004	J. Thromb. Haemost.	1538-7933	ALL_TEXT_2/3	2	7	28938	LONGTERM|DICTIONARY	l-1	L-1	92#95	NaN	D009203	SYMBOL|EXTRACTED	mi	MI	45#47	14717963-1-62-83	For all MTHFR genotypes combined, the OR for MI in the lowest quartile of folate (<5.4 nmol L-1) compared with the highest quartile (>10.4 nmol L-1) was 3.0 (95% CI 1.7, 5.1).
14717963	2004	J. Thromb. Haemost.	1538-7933	ALL_TEXT_2/3	2	7	28938	LONGTERM|DICTIONARY	l-1	L-1	144#147	NaN	D009203	SYMBOL|EXTRACTED	mi	MI	45#47	14717963-1-62-83	For all MTHFR genotypes combined, the OR for MI in the lowest quartile of folate (<5.4 nmol L-1) compared with the highest quartile (>10.4 nmol L-1) was 3.0 (95% CI 1.7, 5.1).
11739440	2001	J. Clin. Endocrinol. Metab.	0021-972X	ALL_TEXT_1/3	1	3	3630	LONGTERM|DICTIONARY	insulin	insulin	104#111	NaN	C567552	LONGTERM|DICTIONARY	precocious pubarche	precocious pubarche	43#62		In 141 Caucasian girls, who presented with precocious pubarche, hyperinsulinemia was assessed from mean insulin levels during an oral glucose load (MSI), and insulin sensitivity was determined from fasting glucose and insulin levels.
11739440	2001	J. Clin. Endocrinol. Metab.	0021-972X	ALL_TEXT_1/3	1	3	3630	LONGTERM|DICTIONARY	insulin	insulin	104#111	NaN	D006946	LONGTERM|DICTIONARY	hyperinsulinemia	hyperinsulinemia	64#80		In 141 Caucasian girls, who presented with precocious pubarche, hyperinsulinemia was assessed from mean insulin levels during an oral glucose load (MSI), and insulin sensitivity was determined from fasting glucose and insulin levels.
11739440	2001	J. Clin. Endocrinol. Metab.	0021-972X	ALL_TEXT_1/3	1	3	3630	LONGTERM|DICTIONARY	insulin	insulin	158#165	NaN	C567552	LONGTERM|DICTIONARY	precocious pubarche	precocious pubarche	43#62		In 141 Caucasian girls, who presented with precocious pubarche, hyperinsulinemia was assessed from mean insulin levels during an oral glucose load (MSI), and insulin sensitivity was determined from fasting glucose and insulin levels.
11739440	2001	J. Clin. Endocrinol. Metab.	0021-972X	ALL_TEXT_1/3	1	3	3630	LONGTERM|DICTIONARY	insulin	insulin	158#165	NaN	D006946	LONGTERM|DICTIONARY	hyperinsulinemia	hyperinsulinemia	64#80		In 141 Caucasian girls, who presented with precocious pubarche, hyperinsulinemia was assessed from mean insulin levels during an oral glucose load (MSI), and insulin sensitivity was determined from fasting glucose and insulin levels.
11739440	2001	J. Clin. Endocrinol. Metab.	0021-972X	ALL_TEXT_1/3	1	3	3630	LONGTERM|DICTIONARY	insulin	insulin	218#225	NaN	C567552	LONGTERM|DICTIONARY	precocious pubarche	precocious pubarche	43#62		In 141 Caucasian girls, who presented with precocious pubarche, hyperinsulinemia was assessed from mean insulin levels during an oral glucose load (MSI), and insulin sensitivity was determined from fasting glucose and insulin levels.
11739440	2001	J. Clin. Endocrinol. Metab.	0021-972X	ALL_TEXT_1/3	1	3	3630	LONGTERM|DICTIONARY	insulin	insulin	218#225	NaN	D006946	LONGTERM|DICTIONARY	hyperinsulinemia	hyperinsulinemia	64#80		In 141 Caucasian girls, who presented with precocious pubarche, hyperinsulinemia was assessed from mean insulin levels during an oral glucose load (MSI), and insulin sensitivity was determined from fasting glucose and insulin levels.
11739440	2001	J. Clin. Endocrinol. Metab.	0021-972X	ALL_TEXT_1/3	1	3	5928	LONGTERM|DICTIONARY	msi	MSI	148#151	NaN	C567552	LONGTERM|DICTIONARY	precocious pubarche	precocious pubarche	43#62		In 141 Caucasian girls, who presented with precocious pubarche, hyperinsulinemia was assessed from mean insulin levels during an oral glucose load (MSI), and insulin sensitivity was determined from fasting glucose and insulin levels.
11739440	2001	J. Clin. Endocrinol. Metab.	0021-972X	ALL_TEXT_1/3	1	3	5928	LONGTERM|DICTIONARY	msi	MSI	148#151	NaN	D006946	LONGTERM|DICTIONARY	hyperinsulinemia	hyperinsulinemia	64#80		In 141 Caucasian girls, who presented with precocious pubarche, hyperinsulinemia was assessed from mean insulin levels during an oral glucose load (MSI), and insulin sensitivity was determined from fasting glucose and insulin levels.
11739440	2001	J. Clin. Endocrinol. Metab.	0021-972X	TITLE	0	0	3630	LONGTERM|DICTIONARY	insulin	Insulin	0#7	NaN	C567552	LONGTERM|DICTIONARY	precocious pubarche	precocious pubarche	81#100		Insulin gene variable number of tandem repeat genotype and the low birth weight, precocious pubarche, and hyperinsulinism sequence.
11739440	2001	J. Clin. Endocrinol. Metab.	0021-972X	TITLE	0	0	3630	LONGTERM|DICTIONARY	insulin	Insulin	0#7	NaN	D006946	LONGTERM|DICTIONARY	hyperinsulinism	hyperinsulinism	106#121		Insulin gene variable number of tandem repeat genotype and the low birth weight, precocious pubarche, and hyperinsulinism sequence.
20042177	2010	Am. J. Ophthalmol.	1879-1891	CONCLUSION	5	15	5444	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	pon1	PON1	153#157	20042177-2-0-13	D008268	SYMBOL|DICTIONARY|EXTRACTED	amd	AMD	72#75	20042177-1-0-32	We believe that Met127Arg, His155Arg, and Ala252Gly play minor roles in AMD susceptibility because of their limited frequency and/or location within the PON1 gene.
9535412	1998	Hypertension	0194-911X	ALL_TEXT_3/3	3	5	966	SYMBOL|DICTIONARY	min 1	min(-1	264#270		C536170	LONGTERM|DICTIONARY	dd	DD	45#47	NaN	In the hypertensive group, the patients with DD genotype showed significantly less endothelium-dependent vasodilation compared with ID+II genotypes (at the highest dose of acetylcholine, forearm blood flow was 12.1+/-4.2 versus 17.0+/-4.1 mL x 100 mL tissue(-1) x min(-1)) (P<.005).
9535412	1998	Hypertension	0194-911X	ALL_TEXT_3/3	3	5	966	SYMBOL|DICTIONARY	min 1	min(-1	264#270		D006973	LONGTERM|DICTIONARY	hypertensive	hypertensive	7#19	NaN	In the hypertensive group, the patients with DD genotype showed significantly less endothelium-dependent vasodilation compared with ID+II genotypes (at the highest dose of acetylcholine, forearm blood flow was 12.1+/-4.2 versus 17.0+/-4.1 mL x 100 mL tissue(-1) x min(-1)) (P<.005).
20959826	2011	Br. J. Cancer	1532-1827	RESULTS	3	7	3845	SYMBOL|DICTIONARY	kras	KRAS	137#141		D015179	SYMBOL|DISEASE|DN|DICTIONARY|EXTRACTED	crc	CRC	111#114	20959826-2-120-137	Kaplan-Meier survival curves revealed a significantly shorter overall (OS) and disease-free survival (DFS) for CRC patients harbouring a KRAS mutation.
20959826	2011	Br. J. Cancer	1532-1827	RESULTS	3	7	3845	SYMBOL|DICTIONARY	kras	KRAS	137#141		C567932	LONGTERM|DICTIONARY	os	OS	71#73	NaN	Kaplan-Meier survival curves revealed a significantly shorter overall (OS) and disease-free survival (DFS) for CRC patients harbouring a KRAS mutation.
20959826	2011	Br. J. Cancer	1532-1827	RESULTS	3	7	3845	SYMBOL|DICTIONARY	kras	KRAS	137#141		D004194	LONGTERM|DICTIONARY	disease-free survival	disease-free survival	79#100	NaN	Kaplan-Meier survival curves revealed a significantly shorter overall (OS) and disease-free survival (DFS) for CRC patients harbouring a KRAS mutation.
20959826	2011	Br. J. Cancer	1532-1827	RESULTS	3	7	3845	SYMBOL|DICTIONARY	kras	KRAS	137#141		D004194	LONGTERM|DICTIONARY	dfs	DFS	102#105	NaN	Kaplan-Meier survival curves revealed a significantly shorter overall (OS) and disease-free survival (DFS) for CRC patients harbouring a KRAS mutation.
9535412	1998	Hypertension	0194-911X	ALL_TEXT_3/3	3	7	1636	SYMBOL|DICTIONARY|EXTRACTED	ace	ACE	37#40	9535412-3-108-137	D006973	LONGTERM|DICTIONARY	hypertensive	hypertensive	100#112	NaN	In conclusion, our data suggest that ACE polymorphism affects endothelium-dependent vasodilation in hypertensive patients and confirm that hypertensive patients had a blunted response to the endothelium-dependent agent acetylcholine.
9535412	1998	Hypertension	0194-911X	ALL_TEXT_3/3	3	7	1636	SYMBOL|DICTIONARY|EXTRACTED	ace	ACE	37#40	9535412-3-108-137	D006973	LONGTERM|DICTIONARY	hypertensive	hypertensive	139#151	NaN	In conclusion, our data suggest that ACE polymorphism affects endothelium-dependent vasodilation in hypertensive patients and confirm that hypertensive patients had a blunted response to the endothelium-dependent agent acetylcholine.
20959826	2011	Br. J. Cancer	1532-1827	BACKGROUND	1	2	3845	SYMBOL|DICTIONARY	kras	KRAS	163#167		D015179	LONGTERM|DISEASE|DT|DICTIONARY|DA	colorectal cancer	colorectal cancer	120#137		In this retrospective study, high-resolution melting analysis (HRMA) was validated and implemented for screening of 164 colorectal cancer (CRC) patients to detect KRAS hot-spot mutations and to evaluate its prognostic value.
20959826	2011	Br. J. Cancer	1532-1827	BACKGROUND	1	2	3845	SYMBOL|DICTIONARY	kras	KRAS	163#167		D015179	SYMBOL|()|DISEASE|DN|DICTIONARY|EXTRACTED	crc	CRC	139#142	20959826-2-120-137	In this retrospective study, high-resolution melting analysis (HRMA) was validated and implemented for screening of 164 colorectal cancer (CRC) patients to detect KRAS hot-spot mutations and to evaluate its prognostic value.
9535412	1998	Hypertension	0194-911X	TITLE	0	0	1636	LONGTERM|GENE|GN|GT|DICTIONARY	angiotensin converting enzyme	Angiotensin-converting enzyme	0#29		D006973	LONGTERM|DICTIONARY	hypertensive	hypertensive	119#131	NaN	Angiotensin-converting enzyme gene polymorphism is associated with endothelium-dependent vasodilation in never treated hypertensive patients.
20959826	2011	Br. J. Cancer	1532-1827	TITLE	0	0	3845	SYMBOL|DICTIONARY	kras	KRAS	0#4		D015179	LONGTERM|DISEASE|DT|DICTIONARY	colorectal cancer	colorectal cancer	61#78		KRAS mutation detection and prognostic potential in sporadic colorectal cancer using high-resolution melting analysis.
11401923	2001	Cancer Epidemiol. Biomarkers Prev.	1055-9965	ALL_TEXT_2/3	2	4	3115	SYMBOL|GFAM|FN|DICTIONARY	hla dpb1	HLA-DPB1	56#64		D003141	LONGTERM|DICTIONARY	infectious illness	infectious illness	11#29		History of infectious illness, EBV antibody titers, and HLA-DPB1 type have been compared in EBV(+ve) and EBV(-ve) cases.
11401923	2001	Cancer Epidemiol. Biomarkers Prev.	1055-9965	ALL_TEXT_2/3	2	4	3115	SYMBOL|GFAM|FN|DICTIONARY	hla dpb1	HLA-DPB1	56#64		D003141	LONGTERM|DICTIONARY	infectious illness	infectious illness	11#29		History of infectious illness, EBV antibody titers, and HLA-DPB1 type have been compared in EBV(+ve) and EBV(-ve) cases.
20350254	2010	Ann. Med.	1365-2060	TITLE	0	0	3606	LONGTERM|GENE|GN|DICTIONARY	interleukin 18	Interleukin-18	0#14		D050197	LONGTERM|DICTIONARY	atherosclerosis	atherosclerosis	60#75		Interleukin-18 gene polymorphism and markers of subclinical atherosclerosis. The Cardiovascular Risk in Young Finns Study.
11401923	2001	Cancer Epidemiol. Biomarkers Prev.	1055-9965	ALL_TEXT_3/3	3	7	3115	SYMBOL|DICTIONARY	hla dpb1	HLA-DPB1	82#90		D007244	LONGTERM|DICTIONARY	infectious mononucleosis	infectious mononucleosis	160#184		Higher proportions of EBV(+ve) (43%) than EBV(-ve) (31%) cases typed positive for HLA-DPB1*0301, but this was not statistically significant; the association of infectious mononucleosis with EBV(+ve) cases was stronger in this HLA subgroup (OR, 17.1; 95%CI, 1.06-1177) than in other cases (OR, 1.24; 95% CI, 0.02-15.4).
11401923	2001	Cancer Epidemiol. Biomarkers Prev.	1055-9965	TITLE	0	0	3115	SYMBOL|DICTIONARY	hla dpb1	HLA-DPB1	23#31		D020031	LONGTERM|DICTIONARY	epstein-barr virus	Epstein-Barr Virus	0#18		Epstein-Barr Virus and HLA-DPB1-*0301 in young adult Hodgkin's disease: evidence for inherited susceptibility to Epstein-Barr Virus in cases that are EBV(+ve).
11401923	2001	Cancer Epidemiol. Biomarkers Prev.	1055-9965	TITLE	0	0	3115	SYMBOL|DICTIONARY	hla dpb1	HLA-DPB1	23#31		D006689	LONGTERM|DISEASE|DT|DICTIONARY	hodgkin's disease	Hodgkin's disease	53#70		Epstein-Barr Virus and HLA-DPB1-*0301 in young adult Hodgkin's disease: evidence for inherited susceptibility to Epstein-Barr Virus in cases that are EBV(+ve).
11401923	2001	Cancer Epidemiol. Biomarkers Prev.	1055-9965	TITLE	0	0	3115	SYMBOL|DICTIONARY	hla dpb1	HLA-DPB1	23#31		D020031	LONGTERM|DICTIONARY	epstein-barr virus	Epstein-Barr Virus	113#131		Epstein-Barr Virus and HLA-DPB1-*0301 in young adult Hodgkin's disease: evidence for inherited susceptibility to Epstein-Barr Virus in cases that are EBV(+ve).
20663522	2010	J. Urol.	1527-3792	MATERIALS AND METHODS	2	2	1113	SYMBOL|DICTIONARY	chga	CHGA	14#18		D011471	LONGTERM|DISEASE|DT|DICTIONARY	prostate cancer	prostate cancer	139#154		We analyzed 2 CHGA polymorphisms by polymerase chain reaction-restriction fragment length polymorphism in DNA samples of 435 patients with prostate cancer and 316 age matched male controls.
16014697	2006	J. Med. Genet.	1468-6244	BACKGROUND	1	2	4938	SYMBOL|DICTIONARY	oas1	OAS1	33#37		D003922	LONGTERM|DICTIONARY	type 1 diabetes	type 1 diabetes	213#228		Recently, the minor allele of an OAS1 single nucleotide polymorphism (SNP) that alters splicing (rs10774671) was found to be associated with increased enzymatic activity and, in a case-sibling control study, with type 1 diabetes (T1D).
16014697	2006	J. Med. Genet.	1468-6244	BACKGROUND	1	2	4938	SYMBOL|DICTIONARY	oas1	OAS1	33#37		D003922	SYMBOL|EXTRACTED|()	t1d	T1D	230#233	16014697-2-213-228	Recently, the minor allele of an OAS1 single nucleotide polymorphism (SNP) that alters splicing (rs10774671) was found to be associated with increased enzymatic activity and, in a case-sibling control study, with type 1 diabetes (T1D).
16014697	2006	J. Med. Genet.	1468-6244	TITLE	0	0	64093	SYMBOL|GENE|GN|DICTIONARY	oas	OAS	24#27		D003922	LONGTERM|DICTIONARY	type 1 diabetes	type 1 diabetes	0#15	NaN	Type 1 diabetes and the OAS gene cluster: association with splicing polymorphism or haplotype?
15772682	2005	Genes Immun.	1466-4879	ALL_TEXT_2/3	2	3	3586	SYMBOL|DICTIONARY|EXTRACTED	il 10	IL-10	24#29	15772682-2-0-14	D012595	LONGTERM|DICTIONARY	ssc	SSc	80#83	NaN	To determine if certain IL-10 genotypes are risk factors for the development of SSc and influence disease-associated autoimmune responses, 248 Caucasian and 264 Japanese SSc patients and controls were genotyped for three loci: -3575, -2849, and -2763.
15772682	2005	Genes Immun.	1466-4879	ALL_TEXT_2/3	2	3	3586	SYMBOL|DICTIONARY|EXTRACTED	il 10	IL-10	24#29	15772682-2-0-14	D012595	LONGTERM|DICTIONARY	ssc	SSc	170#173	NaN	To determine if certain IL-10 genotypes are risk factors for the development of SSc and influence disease-associated autoimmune responses, 248 Caucasian and 264 Japanese SSc patients and controls were genotyped for three loci: -3575, -2849, and -2763.
20514303	2010	J. Korean Med. Sci.	1598-6357	ALL_TEXT_1/3	1	2	2322	SYMBOL|DICTIONARY	flt3	FLT3	10#14		D015470	LONGTERM|DICTIONARY	aml	AML	124#127		Recently, FLT3 expression level was implicated to have prognostic significance in adults, but little is known for childhood AML.
15772682	2005	Genes Immun.	1466-4879	TITLE	0	0	3586	LONGTERM|DICTIONARY	interleukin 10	Interleukin-10	0#14		D012595	LONGTERM|DICTIONARY	systemic sclerosis	systemic sclerosis	45#63		Interleukin-10 genotypes are associated with systemic sclerosis and influence disease-associated autoimmune responses.
15772682	2005	Genes Immun.	1466-4879	ALL_TEXT_3/3	3	7	3586	SYMBOL|DICTIONARY|EXTRACTED	il 10	IL-10	11#16	15772682-2-0-14	D012595	LONGTERM|DICTIONARY	ssc	SSc	48#51	NaN	Particular IL-10 genotypes were associated with SSc-related autoantibodies.
11951178	2002	Am. J. Hum. Genet.	0002-9297	ALL_TEXT_3/3	3	9	1270	SYMBOL|GENE|GN|DICTIONARY	cntf	CNTF	87#91		D000690	LONGTERM|DICTIONARY	amyotrophic lateral sclerosis	amyotrophic lateral sclerosis	36#65		In addition, patients with sporadic amyotrophic lateral sclerosis who had a homozygous CNTF gene defect showed significantly earlier disease onset but did not show a significant difference in disease duration.
15776585	2005	Dakar Med	0049-1101	ALL_TEXT_1/3	1	1	5166	LONGTERM|DICTIONARY	pyruvate dehydrogenase kinase 4	Pyruvate Dehydrogenase Kinase 4	122#153		D003924	LONGTERM|DICTIONARY	non insulin dependent diabetes mellitus	non-insulin dependent diabetes mellitus	73#112		We reported a study about three candidate genes which may be involved in non-insulin dependent diabetes mellitus (NIDDM): Pyruvate Dehydrogenase Kinase 4 (PDK4), Paraoxonase 2 (PON2) and Fatty Acid Binding Protein 2 (FABP2).
15776585	2005	Dakar Med	0049-1101	ALL_TEXT_1/3	1	1	5166	LONGTERM|DICTIONARY	pyruvate dehydrogenase kinase 4	Pyruvate Dehydrogenase Kinase 4	122#153		D003924	LONGTERM|()|DICTIONARY|EXTRACTED	niddm	NIDDM	114#119	15776585-1-73-112	We reported a study about three candidate genes which may be involved in non-insulin dependent diabetes mellitus (NIDDM): Pyruvate Dehydrogenase Kinase 4 (PDK4), Paraoxonase 2 (PON2) and Fatty Acid Binding Protein 2 (FABP2).
15776585	2005	Dakar Med	0049-1101	ALL_TEXT_1/3	1	1	5166	SYMBOL|()|DICTIONARY|EXTRACTED	pdk4	PDK4	155#159	15776585-0-25-56	D003924	LONGTERM|DICTIONARY	non insulin dependent diabetes mellitus	non-insulin dependent diabetes mellitus	73#112		We reported a study about three candidate genes which may be involved in non-insulin dependent diabetes mellitus (NIDDM): Pyruvate Dehydrogenase Kinase 4 (PDK4), Paraoxonase 2 (PON2) and Fatty Acid Binding Protein 2 (FABP2).
15776585	2005	Dakar Med	0049-1101	ALL_TEXT_1/3	1	1	5166	SYMBOL|()|DICTIONARY|EXTRACTED	pdk4	PDK4	155#159	15776585-0-25-56	D003924	LONGTERM|()|DICTIONARY|EXTRACTED	niddm	NIDDM	114#119	15776585-1-73-112	We reported a study about three candidate genes which may be involved in non-insulin dependent diabetes mellitus (NIDDM): Pyruvate Dehydrogenase Kinase 4 (PDK4), Paraoxonase 2 (PON2) and Fatty Acid Binding Protein 2 (FABP2).
15776585	2005	Dakar Med	0049-1101	ALL_TEXT_1/3	1	1	5445	LONGTERM|DICTIONARY	paraoxonase 2	Paraoxonase 2	162#175		D003924	LONGTERM|DICTIONARY	non insulin dependent diabetes mellitus	non-insulin dependent diabetes mellitus	73#112		We reported a study about three candidate genes which may be involved in non-insulin dependent diabetes mellitus (NIDDM): Pyruvate Dehydrogenase Kinase 4 (PDK4), Paraoxonase 2 (PON2) and Fatty Acid Binding Protein 2 (FABP2).
15776585	2005	Dakar Med	0049-1101	ALL_TEXT_1/3	1	1	5445	LONGTERM|DICTIONARY	paraoxonase 2	Paraoxonase 2	162#175		D003924	LONGTERM|()|DICTIONARY|EXTRACTED	niddm	NIDDM	114#119	15776585-1-73-112	We reported a study about three candidate genes which may be involved in non-insulin dependent diabetes mellitus (NIDDM): Pyruvate Dehydrogenase Kinase 4 (PDK4), Paraoxonase 2 (PON2) and Fatty Acid Binding Protein 2 (FABP2).
15776585	2005	Dakar Med	0049-1101	ALL_TEXT_1/3	1	1	5445	SYMBOL|()|DICTIONARY|EXTRACTED	pon2	PON2	177#181	15776585-0-65-78	D003924	LONGTERM|DICTIONARY	non insulin dependent diabetes mellitus	non-insulin dependent diabetes mellitus	73#112		We reported a study about three candidate genes which may be involved in non-insulin dependent diabetes mellitus (NIDDM): Pyruvate Dehydrogenase Kinase 4 (PDK4), Paraoxonase 2 (PON2) and Fatty Acid Binding Protein 2 (FABP2).
15776585	2005	Dakar Med	0049-1101	ALL_TEXT_1/3	1	1	5445	SYMBOL|()|DICTIONARY|EXTRACTED	pon2	PON2	177#181	15776585-0-65-78	D003924	LONGTERM|()|DICTIONARY|EXTRACTED	niddm	NIDDM	114#119	15776585-1-73-112	We reported a study about three candidate genes which may be involved in non-insulin dependent diabetes mellitus (NIDDM): Pyruvate Dehydrogenase Kinase 4 (PDK4), Paraoxonase 2 (PON2) and Fatty Acid Binding Protein 2 (FABP2).
15776585	2005	Dakar Med	0049-1101	ALL_TEXT_1/3	1	1	2169	LONGTERM|DICTIONARY	fatty acid binding protein 2	Fatty Acid Binding Protein 2	187#215		D003924	LONGTERM|DICTIONARY	non insulin dependent diabetes mellitus	non-insulin dependent diabetes mellitus	73#112		We reported a study about three candidate genes which may be involved in non-insulin dependent diabetes mellitus (NIDDM): Pyruvate Dehydrogenase Kinase 4 (PDK4), Paraoxonase 2 (PON2) and Fatty Acid Binding Protein 2 (FABP2).
15776585	2005	Dakar Med	0049-1101	ALL_TEXT_1/3	1	1	2169	LONGTERM|DICTIONARY	fatty acid binding protein 2	Fatty Acid Binding Protein 2	187#215		D003924	LONGTERM|()|DICTIONARY|EXTRACTED	niddm	NIDDM	114#119	15776585-1-73-112	We reported a study about three candidate genes which may be involved in non-insulin dependent diabetes mellitus (NIDDM): Pyruvate Dehydrogenase Kinase 4 (PDK4), Paraoxonase 2 (PON2) and Fatty Acid Binding Protein 2 (FABP2).
15776585	2005	Dakar Med	0049-1101	ALL_TEXT_1/3	1	1	2169	SYMBOL|()|DICTIONARY|EXTRACTED	fabp2	FABP2	217#222	15776585-0-91-119	D003924	LONGTERM|DICTIONARY	non insulin dependent diabetes mellitus	non-insulin dependent diabetes mellitus	73#112		We reported a study about three candidate genes which may be involved in non-insulin dependent diabetes mellitus (NIDDM): Pyruvate Dehydrogenase Kinase 4 (PDK4), Paraoxonase 2 (PON2) and Fatty Acid Binding Protein 2 (FABP2).
15776585	2005	Dakar Med	0049-1101	ALL_TEXT_1/3	1	1	2169	SYMBOL|()|DICTIONARY|EXTRACTED	fabp2	FABP2	217#222	15776585-0-91-119	D003924	LONGTERM|()|DICTIONARY|EXTRACTED	niddm	NIDDM	114#119	15776585-1-73-112	We reported a study about three candidate genes which may be involved in non-insulin dependent diabetes mellitus (NIDDM): Pyruvate Dehydrogenase Kinase 4 (PDK4), Paraoxonase 2 (PON2) and Fatty Acid Binding Protein 2 (FABP2).
15776585	2005	Dakar Med	0049-1101	TITLE	0	0	5166	LONGTERM|DICTIONARY	pyruvate dehydrogenase kinase 4	pyruvate dehydrogenase kinase 4	25#56		D003924	LONGTERM|DICTIONARY|EXTRACTED	niddm	NIDDM	135#140		[Genetic polymorphism of pyruvate dehydrogenase kinase 4 (PDK4), paraoxonase 2 (PON2), and fatty acid binding protein 2 (FABP2) in the NIDDM population of Senegal].
15776585	2005	Dakar Med	0049-1101	TITLE	0	0	5166	SYMBOL|()|DICTIONARY|EXTRACTED	pdk4	PDK4	58#62	15776585-0-25-56	D003924	LONGTERM|DICTIONARY|EXTRACTED	niddm	NIDDM	135#140		[Genetic polymorphism of pyruvate dehydrogenase kinase 4 (PDK4), paraoxonase 2 (PON2), and fatty acid binding protein 2 (FABP2) in the NIDDM population of Senegal].
15776585	2005	Dakar Med	0049-1101	TITLE	0	0	5445	LONGTERM|DICTIONARY	paraoxonase 2	paraoxonase 2	65#78		D003924	LONGTERM|DICTIONARY|EXTRACTED	niddm	NIDDM	135#140		[Genetic polymorphism of pyruvate dehydrogenase kinase 4 (PDK4), paraoxonase 2 (PON2), and fatty acid binding protein 2 (FABP2) in the NIDDM population of Senegal].
15776585	2005	Dakar Med	0049-1101	TITLE	0	0	5445	SYMBOL|()|DICTIONARY|EXTRACTED	pon2	PON2	80#84	15776585-0-65-78	D003924	LONGTERM|DICTIONARY|EXTRACTED	niddm	NIDDM	135#140		[Genetic polymorphism of pyruvate dehydrogenase kinase 4 (PDK4), paraoxonase 2 (PON2), and fatty acid binding protein 2 (FABP2) in the NIDDM population of Senegal].
15776585	2005	Dakar Med	0049-1101	TITLE	0	0	2169	LONGTERM|DICTIONARY	fatty acid binding protein 2	fatty acid binding protein 2	91#119		D003924	LONGTERM|DICTIONARY|EXTRACTED	niddm	NIDDM	135#140		[Genetic polymorphism of pyruvate dehydrogenase kinase 4 (PDK4), paraoxonase 2 (PON2), and fatty acid binding protein 2 (FABP2) in the NIDDM population of Senegal].
15776585	2005	Dakar Med	0049-1101	TITLE	0	0	2169	SYMBOL|()|DICTIONARY|EXTRACTED	fabp2	FABP2	121#126	15776585-0-91-119	D003924	LONGTERM|DICTIONARY|EXTRACTED	niddm	NIDDM	135#140		[Genetic polymorphism of pyruvate dehydrogenase kinase 4 (PDK4), paraoxonase 2 (PON2), and fatty acid binding protein 2 (FABP2) in the NIDDM population of Senegal].
18854826	2008	Br. J. Cancer	1532-1827	ALL_TEXT_2/3	2	3	5727	SYMBOL|DICTIONARY	ptch	PTCH	0#4		D009369	LONGTERM|DICTIONARY	tumours	tumours	31#38		PTCH was mutated in 55% of all tumours, independent of azathioprine treatment.
18854826	2008	Br. J. Cancer	1532-1827	ALL_TEXT_1/3	1	2	5727	SYMBOL|GENE|GN|DICTIONARY	ptch	PTCH	160#164		D012878	LONGTERM|DICTIONARY	skin tumours	skin tumours	96#108		To investigate whether azathioprine-associated mutagenesis contributes to the high incidence of skin tumours in organ transplant recipients (OTRs), we analysed PTCH gene mutations in 60 basal cell carcinomas (BCC); 39 from OTRs receiving azathioprine and 21 from individuals never exposed to azathioprine.
18854826	2008	Br. J. Cancer	1532-1827	ALL_TEXT_1/3	1	2	5727	SYMBOL|GENE|GN|DICTIONARY	ptch	PTCH	160#164		D002280	LONGTERM|DICTIONARY	basal cell carcinomas	basal cell carcinomas	186#207		To investigate whether azathioprine-associated mutagenesis contributes to the high incidence of skin tumours in organ transplant recipients (OTRs), we analysed PTCH gene mutations in 60 basal cell carcinomas (BCC); 39 from OTRs receiving azathioprine and 21 from individuals never exposed to azathioprine.
18854826	2008	Br. J. Cancer	1532-1827	ALL_TEXT_1/3	1	2	5727	SYMBOL|GENE|GN|DICTIONARY	ptch	PTCH	160#164		D002280	SYMBOL|()|DICTIONARY|EXTRACTED	bcc	BCC	209#212	18854826-2-186-207	To investigate whether azathioprine-associated mutagenesis contributes to the high incidence of skin tumours in organ transplant recipients (OTRs), we analysed PTCH gene mutations in 60 basal cell carcinomas (BCC); 39 from OTRs receiving azathioprine and 21 from individuals never exposed to azathioprine.
18512809	2008	Arthritis Rheum.	0004-3591	METHODS	2	5	3586	SYMBOL|GENE|GN|DICTIONARY	il10	IL10	84#88		D014890	SYMBOL|EXTRACTED	wg	WG	169#171	18512809-1-0-24	Three single-nucleotide polymorphisms (SNPs) tagging the promoter haplotypes of the IL10 gene (IL10 -3575, IL10 -1082, and IL10 -592) were analyzed in 403 patients with WG and 103 patients with CSS as well as 507 matched control subjects from Germany.
18512809	2008	Arthritis Rheum.	0004-3591	METHODS	2	5	3586	SYMBOL|GENE|GN|DICTIONARY	il10	IL10	84#88		D015267	SYMBOL|DICTIONARY|EXTRACTED	css	CSS	194#197	18512809-1-34-56	Three single-nucleotide polymorphisms (SNPs) tagging the promoter haplotypes of the IL10 gene (IL10 -3575, IL10 -1082, and IL10 -592) were analyzed in 403 patients with WG and 103 patients with CSS as well as 507 matched control subjects from Germany.
18512809	2008	Arthritis Rheum.	0004-3591	METHODS	2	5	3586	SYMBOL|DICTIONARY	il10	IL10	95#99		D014890	SYMBOL|EXTRACTED	wg	WG	169#171	18512809-1-0-24	Three single-nucleotide polymorphisms (SNPs) tagging the promoter haplotypes of the IL10 gene (IL10 -3575, IL10 -1082, and IL10 -592) were analyzed in 403 patients with WG and 103 patients with CSS as well as 507 matched control subjects from Germany.
18512809	2008	Arthritis Rheum.	0004-3591	METHODS	2	5	3586	SYMBOL|DICTIONARY	il10	IL10	95#99		D015267	SYMBOL|DICTIONARY|EXTRACTED	css	CSS	194#197	18512809-1-34-56	Three single-nucleotide polymorphisms (SNPs) tagging the promoter haplotypes of the IL10 gene (IL10 -3575, IL10 -1082, and IL10 -592) were analyzed in 403 patients with WG and 103 patients with CSS as well as 507 matched control subjects from Germany.
18512809	2008	Arthritis Rheum.	0004-3591	METHODS	2	5	3586	SYMBOL|DICTIONARY	il10	IL10	107#111		D014890	SYMBOL|EXTRACTED	wg	WG	169#171	18512809-1-0-24	Three single-nucleotide polymorphisms (SNPs) tagging the promoter haplotypes of the IL10 gene (IL10 -3575, IL10 -1082, and IL10 -592) were analyzed in 403 patients with WG and 103 patients with CSS as well as 507 matched control subjects from Germany.
18512809	2008	Arthritis Rheum.	0004-3591	METHODS	2	5	3586	SYMBOL|DICTIONARY	il10	IL10	107#111		D015267	SYMBOL|DICTIONARY|EXTRACTED	css	CSS	194#197	18512809-1-34-56	Three single-nucleotide polymorphisms (SNPs) tagging the promoter haplotypes of the IL10 gene (IL10 -3575, IL10 -1082, and IL10 -592) were analyzed in 403 patients with WG and 103 patients with CSS as well as 507 matched control subjects from Germany.
18512809	2008	Arthritis Rheum.	0004-3591	METHODS	2	5	3586	SYMBOL|DICTIONARY	il10	IL10	123#127		D014890	SYMBOL|EXTRACTED	wg	WG	169#171	18512809-1-0-24	Three single-nucleotide polymorphisms (SNPs) tagging the promoter haplotypes of the IL10 gene (IL10 -3575, IL10 -1082, and IL10 -592) were analyzed in 403 patients with WG and 103 patients with CSS as well as 507 matched control subjects from Germany.
18512809	2008	Arthritis Rheum.	0004-3591	METHODS	2	5	3586	SYMBOL|DICTIONARY	il10	IL10	123#127		D015267	SYMBOL|DICTIONARY|EXTRACTED	css	CSS	194#197	18512809-1-34-56	Three single-nucleotide polymorphisms (SNPs) tagging the promoter haplotypes of the IL10 gene (IL10 -3575, IL10 -1082, and IL10 -592) were analyzed in 403 patients with WG and 103 patients with CSS as well as 507 matched control subjects from Germany.
18854826	2008	Br. J. Cancer	1532-1827	TITLE	0	0	5727	SYMBOL|DICTIONARY	ptch	PTCH	0#4		D002280	LONGTERM|DICTIONARY	basal cell carcinomas	basal cell carcinomas	18#39		PTCH mutations in basal cell carcinomas from azathioprine-treated organ transplant recipients.
18512809	2008	Arthritis Rheum.	0004-3591	TITLE	0	0	3586	LONGTERM|GENE|GN|DICTIONARY	interleukin 10	interleukin-10	40#54		D015267	LONGTERM|DISEASE|DT|DICTIONARY	churg strauss syndrome	Churg-Strauss syndrome	121#143		Functionally relevant variations of the interleukin-10 gene associated with antineutrophil cytoplasmic antibody-negative Churg-Strauss syndrome, but not with Wegener's granulomatosis.
14623371	2004	Schizophr. Res.	0920-9964	TITLE	0	0	7124	LONGTERM|GENE|GN|DICTIONARY	tumor necrosis factor alpha	tumor necrosis factor alpha	18#45		D012559	LONGTERM|DICTIONARY	schizophrenia	schizophrenia	70#83		No association of tumor necrosis factor alpha gene polymorphisms with schizophrenia or response to clozapine.
14623371	2004	Schizophr. Res.	0920-9964	ALL_TEXT_1/3	1	1	7124	LONGTERM|DICTIONARY	tumor necrosis factor alpha	Tumor necrosis factor alpha	0#27		D012559	LONGTERM|DICTIONARY	schizophrenia	schizophrenia	119#132		Tumor necrosis factor alpha (TNF-alpha), a potent immunomodulator and proinflammatory cytokine, has been implicated in schizophrenia pathogenesis and clozapine response.
14623371	2004	Schizophr. Res.	0920-9964	ALL_TEXT_1/3	1	1	7124	SYMBOL|EXTRACTED|()	tnf alpha	TNF-alpha	29#38	14623371-1-0-27	D012559	LONGTERM|DICTIONARY	schizophrenia	schizophrenia	119#132		Tumor necrosis factor alpha (TNF-alpha), a potent immunomodulator and proinflammatory cytokine, has been implicated in schizophrenia pathogenesis and clozapine response.
14623371	2004	Schizophr. Res.	0920-9964	ALL_TEXT_2/3	2	2	7124	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	tnf alpha	TNF-alpha	74#83	14623371-1-0-27	D012559	LONGTERM|DICTIONARY	schizophrenia	schizophrenia	52#65		Two studies have established an association between schizophrenia and the TNF-alpha gene -308G/A polymorphism; however, both increased and decreased -308A allele frequency have been reported in two analogous investigations.
18854826	2008	Br. J. Cancer	1532-1827	ALL_TEXT_3/3	3	8	5727	SYMBOL|DICTIONARY	ptch	PTCH	114#118		D002280	SYMBOL|DICTIONARY|EXTRACTED	bcc	BCC	30#33	18854826-2-186-207	This study of post-transplant BCC provides the first indication that azathioprine exposure may be associated with PTCH mutations, particularly in tumours from non-sun-exposed skin.
18854826	2008	Br. J. Cancer	1532-1827	ALL_TEXT_3/3	3	8	5727	SYMBOL|DICTIONARY	ptch	PTCH	114#118		D009369	LONGTERM|DICTIONARY	tumours	tumours	146#153		This study of post-transplant BCC provides the first indication that azathioprine exposure may be associated with PTCH mutations, particularly in tumours from non-sun-exposed skin.
14623371	2004	Schizophr. Res.	0920-9964	ALL_TEXT_3/3	3	5	7124	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	tnf alpha	TNF-alpha	53#62	14623371-1-0-27	D012559	LONGTERM|DICTIONARY	schizophrenia	schizophrenia	187#200		The results of these investigations suggest that the TNF-alpha gene -308G/A variants do not play a major role in susceptibility to, clinical manifestations for, or clozapine response in, schizophrenia.
18512809	2008	Arthritis Rheum.	0004-3591	CONCLUSION	4	9	3586	SYMBOL|DICTIONARY	il10	IL10	56#60		D014890	SYMBOL|EXTRACTED	wg	WG	64#66	18512809-1-0-24	These findings challenge those from previous studies of IL10 in WG and provide further evidence that CSS and WG have distinct genetic backgrounds.
18512809	2008	Arthritis Rheum.	0004-3591	CONCLUSION	4	9	3586	SYMBOL|DICTIONARY	il10	IL10	56#60		D015267	SYMBOL|DICTIONARY|EXTRACTED	css	CSS	101#104	18512809-1-34-56	These findings challenge those from previous studies of IL10 in WG and provide further evidence that CSS and WG have distinct genetic backgrounds.
18512809	2008	Arthritis Rheum.	0004-3591	CONCLUSION	4	9	3586	SYMBOL|DICTIONARY	il10	IL10	56#60		D014890	SYMBOL|EXTRACTED	wg	WG	109#111	18512809-1-0-24	These findings challenge those from previous studies of IL10 in WG and provide further evidence that CSS and WG have distinct genetic backgrounds.
18512809	2008	Arthritis Rheum.	0004-3591	RESULTS	3	8	3586	SYMBOL|DICTIONARY	il10	IL10	17#21		D015267	SYMBOL|DICTIONARY|EXTRACTED	css	CSS	156#159	18512809-1-34-56	In contrast, the IL10 -3575/-1082/-592 TAC haplotype, part of the extended ancient haplotype IL10.2, was highly significantly associated with ANCA-negative CSS (chi2 = 19.14, P = 0.000012, corrected P = 0.0003, odds ratio 2.16, 95% confidence interval 1.52-3.06).
18077176	2008	Neurobiol. Dis.	1095-953X	ALL_TEXT_2/3	2	6	596	SYMBOL|DICTIONARY	bcl 2	Bcl-2	245#250		D000544	SYMBOL|EXTRACTED	ad	AD	137#139	18077176-1-32-49	The current investigation focused on detection of PtdSer on the outer leaflet of the bilayer in synaptosomes from brain of subjects with AD and amnestic mild cognitive impairment (MCI), as well as expression levels of apoptosis-related proteins Bcl-2, Bax, and caspase-3.
18077176	2008	Neurobiol. Dis.	1095-953X	ALL_TEXT_2/3	2	6	596	SYMBOL|DICTIONARY	bcl 2	Bcl-2	245#250		D003072	SYMBOL|()|DICTIONARY|EXTRACTED	mci	MCI	180#183	18077176-6-153-178	The current investigation focused on detection of PtdSer on the outer leaflet of the bilayer in synaptosomes from brain of subjects with AD and amnestic mild cognitive impairment (MCI), as well as expression levels of apoptosis-related proteins Bcl-2, Bax, and caspase-3.
18077176	2008	Neurobiol. Dis.	1095-953X	ALL_TEXT_2/3	2	6	596	SYMBOL|DICTIONARY	bcl 2	Bcl-2	245#250		D003072	LONGTERM|DICTIONARY	amnestic mild cognitive impairment	amnestic mild cognitive impairment	144#178		The current investigation focused on detection of PtdSer on the outer leaflet of the bilayer in synaptosomes from brain of subjects with AD and amnestic mild cognitive impairment (MCI), as well as expression levels of apoptosis-related proteins Bcl-2, Bax, and caspase-3.
18077176	2008	Neurobiol. Dis.	1095-953X	ALL_TEXT_2/3	2	6	836	LONGTERM|DICTIONARY	caspase 3	caspase-3	261#270		D000544	SYMBOL|EXTRACTED	ad	AD	137#139	18077176-1-32-49	The current investigation focused on detection of PtdSer on the outer leaflet of the bilayer in synaptosomes from brain of subjects with AD and amnestic mild cognitive impairment (MCI), as well as expression levels of apoptosis-related proteins Bcl-2, Bax, and caspase-3.
18077176	2008	Neurobiol. Dis.	1095-953X	ALL_TEXT_2/3	2	6	836	LONGTERM|DICTIONARY	caspase 3	caspase-3	261#270		D003072	SYMBOL|()|DICTIONARY|EXTRACTED	mci	MCI	180#183	18077176-6-153-178	The current investigation focused on detection of PtdSer on the outer leaflet of the bilayer in synaptosomes from brain of subjects with AD and amnestic mild cognitive impairment (MCI), as well as expression levels of apoptosis-related proteins Bcl-2, Bax, and caspase-3.
18077176	2008	Neurobiol. Dis.	1095-953X	ALL_TEXT_2/3	2	6	836	LONGTERM|DICTIONARY	caspase 3	caspase-3	261#270		D003072	LONGTERM|DICTIONARY	amnestic mild cognitive impairment	amnestic mild cognitive impairment	144#178		The current investigation focused on detection of PtdSer on the outer leaflet of the bilayer in synaptosomes from brain of subjects with AD and amnestic mild cognitive impairment (MCI), as well as expression levels of apoptosis-related proteins Bcl-2, Bax, and caspase-3.
18077176	2008	Neurobiol. Dis.	1095-953X	ALL_TEXT_2/3	2	6	581	LONGTERM|DICTIONARY	bax	Bax	252#255	NaN	D000544	SYMBOL|EXTRACTED	ad	AD	137#139	18077176-1-32-49	The current investigation focused on detection of PtdSer on the outer leaflet of the bilayer in synaptosomes from brain of subjects with AD and amnestic mild cognitive impairment (MCI), as well as expression levels of apoptosis-related proteins Bcl-2, Bax, and caspase-3.
18077176	2008	Neurobiol. Dis.	1095-953X	ALL_TEXT_2/3	2	6	581	LONGTERM|DICTIONARY	bax	Bax	252#255	NaN	D003072	SYMBOL|()|DICTIONARY|EXTRACTED	mci	MCI	180#183	18077176-6-153-178	The current investigation focused on detection of PtdSer on the outer leaflet of the bilayer in synaptosomes from brain of subjects with AD and amnestic mild cognitive impairment (MCI), as well as expression levels of apoptosis-related proteins Bcl-2, Bax, and caspase-3.
18077176	2008	Neurobiol. Dis.	1095-953X	ALL_TEXT_2/3	2	6	581	LONGTERM|DICTIONARY	bax	Bax	252#255	NaN	D003072	LONGTERM|DICTIONARY	amnestic mild cognitive impairment	amnestic mild cognitive impairment	144#178		The current investigation focused on detection of PtdSer on the outer leaflet of the bilayer in synaptosomes from brain of subjects with AD and amnestic mild cognitive impairment (MCI), as well as expression levels of apoptosis-related proteins Bcl-2, Bax, and caspase-3.
11948460	2002	Int. J. Cancer	0020-7136	TITLE	0	0	999	LONGTERM|DICTIONARY	e-cadherin	E-cadherin	22#32	NaN	D011471	LONGTERM|DISEASE|DT|DICTIONARY	hereditary prostate cancer	hereditary prostate cancer	63#89		Germline mutations in E-cadherin do not explain association of hereditary prostate cancer, gastric cancer and breast cancer.
11948460	2002	Int. J. Cancer	0020-7136	TITLE	0	0	999	LONGTERM|DICTIONARY	e-cadherin	E-cadherin	22#32	NaN	D013274	LONGTERM|DISEASE|DT|DICTIONARY	gastric cancer	gastric cancer	91#105		Germline mutations in E-cadherin do not explain association of hereditary prostate cancer, gastric cancer and breast cancer.
11948460	2002	Int. J. Cancer	0020-7136	TITLE	0	0	999	LONGTERM|DICTIONARY	e-cadherin	E-cadherin	22#32	NaN	D001943	LONGTERM|DISEASE|DT|DICTIONARY	breast cancer	breast cancer	110#123		Germline mutations in E-cadherin do not explain association of hereditary prostate cancer, gastric cancer and breast cancer.
21300947	2011	Arch. Gen. Psychiatry	1538-3636	OBJECTIVE	2	4	627	SYMBOL|DICTIONARY|EXTRACTED	bdnf	BDNF	25#29	21300947-1-4-37	D000544	SYMBOL|EXTRACTED	ad	AD	207#209	21300947-1-100-117	To determine whether the BDNF Val66Met gene variant interacts with age to predict brain and cognitive measures in healthy volunteers across the adult lifespan in an intermediate phenotype pattern related to AD by examining (1) cortical thickness, (2) fractional anisotropy of white matter tracts (ie, white matter integrity), and (3) episodic memory performance.
21300947	2011	Arch. Gen. Psychiatry	1538-3636	OBJECTIVE	2	4	627	SYMBOL|DICTIONARY|EXTRACTED	bdnf	BDNF	25#29	21300947-1-4-37	D009135	LONGTERM|DICTIONARY	thickness	thickness	236#245	NaN	To determine whether the BDNF Val66Met gene variant interacts with age to predict brain and cognitive measures in healthy volunteers across the adult lifespan in an intermediate phenotype pattern related to AD by examining (1) cortical thickness, (2) fractional anisotropy of white matter tracts (ie, white matter integrity), and (3) episodic memory performance.
20663522	2010	J. Urol.	1527-3792	RESULTS	3	4	1113	SYMBOL|DICTIONARY	chga	CHGA	8#12		D011471	LONGTERM|DISEASE|DT|DICTIONARY	prostate cancer	prostate cancer	96#111		For the CHGA Glu264Asp polymorphism men with the GG genotype were at 2.05 times higher risk for prostate cancer than men with the CC genotype (p = 0.014).
20020061	2010	PLoS ONE	1932-6203	CONCLUSIONS/SIGNIFICANCE	3	11	3845	SYMBOL|DICTIONARY	kras	KRAS	31#35		D015179	LONGTERM|DICTIONARY	colorectal tumors	colorectal tumors	75#92		Our results suggest a role for KRAS mutations in the propensity of primary colorectal tumors to metastasize to the lung.
25256182	2015	Stroke	1524-4628	RESULTS	3	6	100048912	SYMBOL|DICTIONARY	cdkn2bas	CDKN2BAS	90#98		D002532	SYMBOL|EXTRACTED	ia	IA	165#167	25256182-1-95-117	Genome-wide evidence of association was detected in the discovery sample on chromosome 9 (CDKN2BAS; rs10733376: P<1.010(-11)), in a gene previously associated with IA.
12824768	2003	Neuroreport	0959-4965	TITLE	0	0	23621	SYMBOL|GENE|GN|DICTIONARY	bace	BACE	20#24		D000544	LONGTERM|DISEASE|DT|DICTIONARY	alzheimer disease	Alzheimer's disease	54#73		Polymorphism in the BACE gene influences the risk for Alzheimer's disease.
12824768	2003	Neuroreport	0959-4965	ALL_TEXT_2/3	2	6	23621	SYMBOL|DICTIONARY	bace	BACE	0#4		D000544	SYMBOL|EXTRACTED	ad	AD	48#50	12824768-1-32-51	BACE exon 5 polymorphism influenced the risk of AD.
12824768	2003	Neuroreport	0959-4965	ALL_TEXT_2/3	2	5	23621	SYMBOL|DICTIONARY	bace	BACE	59#63		D000544	SYMBOL|EXTRACTED	ad	AD	83#85	12824768-1-32-51	Consequently, we investigated the association of different BACE polymorphisms with AD.
12824768	2003	Neuroreport	0959-4965	ALL_TEXT_2/3	2	4	23621	SYMBOL|GENE|GN|DICTIONARY	bace	BACE	18#22		D000544	SYMBOL|EXTRACTED	ad	AD	128#130	12824768-1-32-51	Variations of the BACE gene might influence activity and function of the protein and, thus, might influence the pathogenesis of AD.
12824768	2003	Neuroreport	0959-4965	ALL_TEXT_3/3	3	9	23621	SYMBOL|DICTIONARY	bace	BACE	16#20		D000544	SYMBOL|EXTRACTED	ad	AD	84#86	12824768-1-32-51	It appears that BACE polymorphism plays a more important role in the development of AD than previously assumed, possibly by influencing Abeta(42) levels.
21264219	2011	PLoS ONE	1932-6203	CONCLUSIONS/SIGNIFICANCE	3	9	79742	SYMBOL|DICTIONARY	dia1r	DIA1R	64#69		D038901	LONGTERM|DICTIONARY	x linked mental retardation	X-linked mental retardation	90#117		Examination of published literature revealed point mutations in DIA1R are associated with X-linked mental retardation (XLMR) and DIA1R deletion is associated with syndromes with ASD-like traits and/or XLMR.
21264219	2011	PLoS ONE	1932-6203	CONCLUSIONS/SIGNIFICANCE	3	9	79742	SYMBOL|DICTIONARY	dia1r	DIA1R	64#69		D038901	SYMBOL|EXTRACTED|()	xlmr	XLMR	119#123	21264219-9-90-117	Examination of published literature revealed point mutations in DIA1R are associated with X-linked mental retardation (XLMR) and DIA1R deletion is associated with syndromes with ASD-like traits and/or XLMR.
21264219	2011	PLoS ONE	1932-6203	CONCLUSIONS/SIGNIFICANCE	3	9	79742	SYMBOL|DICTIONARY	dia1r	DIA1R	64#69		D038901	SYMBOL|EXTRACTED	xlmr	XLMR	201#205	21264219-9-90-117	Examination of published literature revealed point mutations in DIA1R are associated with X-linked mental retardation (XLMR) and DIA1R deletion is associated with syndromes with ASD-like traits and/or XLMR.
21264219	2011	PLoS ONE	1932-6203	CONCLUSIONS/SIGNIFICANCE	3	9	79742	SYMBOL|DICTIONARY	dia1r	DIA1R	129#134		D038901	LONGTERM|DICTIONARY	x linked mental retardation	X-linked mental retardation	90#117		Examination of published literature revealed point mutations in DIA1R are associated with X-linked mental retardation (XLMR) and DIA1R deletion is associated with syndromes with ASD-like traits and/or XLMR.
21264219	2011	PLoS ONE	1932-6203	CONCLUSIONS/SIGNIFICANCE	3	9	79742	SYMBOL|DICTIONARY	dia1r	DIA1R	129#134		D038901	SYMBOL|EXTRACTED|()	xlmr	XLMR	119#123	21264219-9-90-117	Examination of published literature revealed point mutations in DIA1R are associated with X-linked mental retardation (XLMR) and DIA1R deletion is associated with syndromes with ASD-like traits and/or XLMR.
21264219	2011	PLoS ONE	1932-6203	CONCLUSIONS/SIGNIFICANCE	3	9	79742	SYMBOL|DICTIONARY	dia1r	DIA1R	129#134		D038901	SYMBOL|EXTRACTED	xlmr	XLMR	201#205	21264219-9-90-117	Examination of published literature revealed point mutations in DIA1R are associated with X-linked mental retardation (XLMR) and DIA1R deletion is associated with syndromes with ASD-like traits and/or XLMR.
14962090	2004	J. Invest. Dermatol.	0022-202X	ALL_TEXT_1/3	1	2	3660	LONGTERM|DICTIONARY	interferon regulatory factor 2	interferon regulatory factor 2	132#162		D011565	LONGTERM|DICTIONARY	psoriasis	psoriasis	57#66		Hypersensitivity to type 1 interferon signaling causes a psoriasis-like skin disease in mice deficient for the transcription factor interferon regulatory factor 2 (IRF2).
14962090	2004	J. Invest. Dermatol.	0022-202X	ALL_TEXT_1/3	1	2	3660	LONGTERM|DICTIONARY	interferon regulatory factor 2	interferon regulatory factor 2	132#162		D012871	LONGTERM|DISEASE|DT|DICTIONARY	skin disease	skin disease	72#84		Hypersensitivity to type 1 interferon signaling causes a psoriasis-like skin disease in mice deficient for the transcription factor interferon regulatory factor 2 (IRF2).
14962090	2004	J. Invest. Dermatol.	0022-202X	ALL_TEXT_1/3	1	2	3660	LONGTERM|DICTIONARY	interferon regulatory factor 2	interferon regulatory factor 2	132#162		D004342	LONGTERM|DICTIONARY	hypersensitivity	Hypersensitivity	0#16	NaN	Hypersensitivity to type 1 interferon signaling causes a psoriasis-like skin disease in mice deficient for the transcription factor interferon regulatory factor 2 (IRF2).
14962090	2004	J. Invest. Dermatol.	0022-202X	ALL_TEXT_1/3	1	2	3660	SYMBOL|()|DICTIONARY|EXTRACTED	irf2	IRF2	164#168	14962090-2-132-162	D011565	LONGTERM|DICTIONARY	psoriasis	psoriasis	57#66		Hypersensitivity to type 1 interferon signaling causes a psoriasis-like skin disease in mice deficient for the transcription factor interferon regulatory factor 2 (IRF2).
14962090	2004	J. Invest. Dermatol.	0022-202X	ALL_TEXT_1/3	1	2	3660	SYMBOL|()|DICTIONARY|EXTRACTED	irf2	IRF2	164#168	14962090-2-132-162	D012871	LONGTERM|DISEASE|DT|DICTIONARY	skin disease	skin disease	72#84		Hypersensitivity to type 1 interferon signaling causes a psoriasis-like skin disease in mice deficient for the transcription factor interferon regulatory factor 2 (IRF2).
14962090	2004	J. Invest. Dermatol.	0022-202X	ALL_TEXT_1/3	1	2	3660	SYMBOL|()|DICTIONARY|EXTRACTED	irf2	IRF2	164#168	14962090-2-132-162	D004342	LONGTERM|DICTIONARY	hypersensitivity	Hypersensitivity	0#16	NaN	Hypersensitivity to type 1 interferon signaling causes a psoriasis-like skin disease in mice deficient for the transcription factor interferon regulatory factor 2 (IRF2).
14962090	2004	J. Invest. Dermatol.	0022-202X	ALL_TEXT_1/3	1	3	3660	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	irf2	IRF2	10#14	14962090-2-132-162	D011565	LONGTERM|DICTIONARY	psoriasis	psoriasis	68#77		The human IRF2 gene is located at a previously identified candidate psoriasis susceptibility locus on chromosome 4q (PSORS3 at D4S1535).
14962090	2004	J. Invest. Dermatol.	0022-202X	ALL_TEXT_1/3	1	3	7889	SYMBOL|DICTIONARY	psors3	PSORS3	117#123		D011565	LONGTERM|DICTIONARY	psoriasis	psoriasis	68#77		The human IRF2 gene is located at a previously identified candidate psoriasis susceptibility locus on chromosome 4q (PSORS3 at D4S1535).
17121882	2007	Clin. Cancer Res.	1078-0432	RESULTS	3	6	56475	LONGTERM|DICTIONARY	reprimo	Reprimo	150#157	NaN	D001471	LONGTERM|DICTIONARY	barrett esophagus	Barrett's esophagus	3#22		In Barrett's esophagus (BE; P=0.001), high-grade dysplasia (HGD; P=0.001), and esophageal adenocarcinoma (EAC; P=0.00003), the level and frequency of Reprimo methylation were significantly higher than in normal esophagus (NE).
17121882	2007	Clin. Cancer Res.	1078-0432	RESULTS	3	6	56475	LONGTERM|DICTIONARY	reprimo	Reprimo	150#157	NaN	D000230	LONGTERM|DICTIONARY	esophageal adenocarcinoma	esophageal adenocarcinoma	79#104		In Barrett's esophagus (BE; P=0.001), high-grade dysplasia (HGD; P=0.001), and esophageal adenocarcinoma (EAC; P=0.00003), the level and frequency of Reprimo methylation were significantly higher than in normal esophagus (NE).
17121882	2007	Clin. Cancer Res.	1078-0432	RESULTS	3	6	56475	LONGTERM|DICTIONARY	reprimo	Reprimo	150#157	NaN	D008228	LONGTERM|DICTIONARY	high-grade dysplasia	high-grade dysplasia	38#58	NaN	In Barrett's esophagus (BE; P=0.001), high-grade dysplasia (HGD; P=0.001), and esophageal adenocarcinoma (EAC; P=0.00003), the level and frequency of Reprimo methylation were significantly higher than in normal esophagus (NE).
17121882	2007	Clin. Cancer Res.	1078-0432	RESULTS	3	6	56475	LONGTERM|DICTIONARY	reprimo	Reprimo	150#157	NaN	D008228	LONGTERM|DICTIONARY	hgd	HGD	60#63	NaN	In Barrett's esophagus (BE; P=0.001), high-grade dysplasia (HGD; P=0.001), and esophageal adenocarcinoma (EAC; P=0.00003), the level and frequency of Reprimo methylation were significantly higher than in normal esophagus (NE).
14962090	2004	J. Invest. Dermatol.	0022-202X	ALL_TEXT_3/3	3	7	3660	SYMBOL|DICTIONARY|EXTRACTED	irf2	IRF2	27#31	14962090-2-132-162	D011565	LONGTERM|DICTIONARY	psoriasis	psoriasis	44#53		We detected association of IRF2 with type 1 psoriasis at two markers in the IRF2 gene.
14962090	2004	J. Invest. Dermatol.	0022-202X	ALL_TEXT_3/3	3	7	3660	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	irf2	IRF2	76#80	14962090-2-132-162	D011565	LONGTERM|DICTIONARY	psoriasis	psoriasis	44#53		We detected association of IRF2 with type 1 psoriasis at two markers in the IRF2 gene.
14962090	2004	J. Invest. Dermatol.	0022-202X	ALL_TEXT_2/3	2	4	3660	SYMBOL|DICTIONARY|EXTRACTED	irf2	IRF2	51#55	14962090-2-132-162	D011565	LONGTERM|DICTIONARY	psoriasis	psoriasis	36#45		Therefore, we tested association of psoriasis with IRF2.
16025228	2005	Cardiovasc Drugs Ther	0920-3206	CONCLUSIONS	4	19	186	SYMBOL|GENE|GN|DICTIONARY	at2	AT2	235#238		D058065	LONGTERM|DICTIONARY	diabetic cardiomyopathy	diabetic cardiomyopathy	122#145		A high expression of AT2 may accelerate the apoptosis of cardiomyocytes in diabetic rats and play a role in precipitating diabetic cardiomyopathy; taurine may protect diabetic rats from developing cardiomyopathy also by downregulating AT2 receptors.
16025228	2005	Cardiovasc Drugs Ther	0920-3206	CONCLUSIONS	4	19	186	SYMBOL|GENE|GN|DICTIONARY	at2	AT2	235#238		D009202	LONGTERM|DICTIONARY	cardiomyopathy	cardiomyopathy	197#211		A high expression of AT2 may accelerate the apoptosis of cardiomyocytes in diabetic rats and play a role in precipitating diabetic cardiomyopathy; taurine may protect diabetic rats from developing cardiomyopathy also by downregulating AT2 receptors.
14962090	2004	J. Invest. Dermatol.	0022-202X	ALL_TEXT_3/3	3	8	3660	SYMBOL|DICTIONARY|EXTRACTED	irf2	IRF2	52#56	14962090-2-132-162	D011565	LONGTERM|DICTIONARY	psoriasis	psoriasis	69#78		Haplotype sharing analysis confirmed association of IRF2 with type 1 psoriasis (p=0.0017; pcorr=0.03).
17121882	2007	Clin. Cancer Res.	1078-0432	RESULTS	3	8	56475	LONGTERM|DICTIONARY	reprimo	Reprimo	0#7	NaN	C562729	SYMBOL|NUMBER|DICTIONARY|EXTRACTED	escc	ESCC	66#70	17121882-7-93-127	Reprimo methylation occurred in 0 of 19 NE samples, 6 (13%) of 45 ESCC, 9 (36%) of 25 BE, 7 (64%) of 11 HGD, and 47 (63%) of 75 EAC.
17121882	2007	Clin. Cancer Res.	1078-0432	RESULTS	3	8	56475	LONGTERM|DICTIONARY	reprimo	Reprimo	0#7	NaN	D001471	LONGTERM|DICTIONARY	be	BE	86#88	NaN	Reprimo methylation occurred in 0 of 19 NE samples, 6 (13%) of 45 ESCC, 9 (36%) of 25 BE, 7 (64%) of 11 HGD, and 47 (63%) of 75 EAC.
17121882	2007	Clin. Cancer Res.	1078-0432	RESULTS	3	8	56475	LONGTERM|DICTIONARY	reprimo	Reprimo	0#7	NaN	D008228	LONGTERM|DICTIONARY	hgd	HGD	104#107	NaN	Reprimo methylation occurred in 0 of 19 NE samples, 6 (13%) of 45 ESCC, 9 (36%) of 25 BE, 7 (64%) of 11 HGD, and 47 (63%) of 75 EAC.
19298594	2009	Br. J. Haematol.	1365-2141	TITLE	0	0	10456	SYMBOL|GENE|GN|DICTIONARY	hax1	HAX1	25#29		D009190	LONGTERM|DISEASE|DT|DICTIONARY	childhood myelodysplastic syndrome	childhood myelodysplastic syndrome	38#72		Mutation analysis of the HAX1 gene in childhood myelodysplastic syndrome.
8837968	1996	Acta Psychiatr Scand	0001-690X	ALL_TEXT_2/3	2	2	4908	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	nt 3	NT-3	89#93	8837968-0-26-40	D012559	LONGTERM|DICTIONARY	schizophrenics	schizophrenics	170#184		The A3/147 bp allele of a dinucleotide repeat polymorphism in the promoter region of the NT-3 gene has been reported as occurring more frequently in a sample of Japanese schizophrenics compared to controls.
8837968	1996	Acta Psychiatr Scand	0001-690X	ALL_TEXT_1/3	1	1	4908	LONGTERM|DICTIONARY	neurotrophin 3	neurotrophin-3	154#168		D012559	LONGTERM|DICTIONARY	schizophrenia	schizophrenia	73#86		Since abnormalities of brain development play a role in the aetiology of schizophrenia, growth factors, known to play a role in neurodevelopment, such as neurotrophin-3 (NT-3), are therefore candidate genes for this disorder.
8837968	1996	Acta Psychiatr Scand	0001-690X	ALL_TEXT_1/3	1	1	4908	LONGTERM|DICTIONARY	neurotrophin 3	neurotrophin-3	154#168		D001927	LONGTERM|DICTIONARY	abnormalities of brain	abnormalities of brain	6#28		Since abnormalities of brain development play a role in the aetiology of schizophrenia, growth factors, known to play a role in neurodevelopment, such as neurotrophin-3 (NT-3), are therefore candidate genes for this disorder.
8837968	1996	Acta Psychiatr Scand	0001-690X	ALL_TEXT_1/3	1	1	4908	SYMBOL|EXTRACTED|()	nt 3	NT-3	170#174	8837968-0-26-40	D012559	LONGTERM|DICTIONARY	schizophrenia	schizophrenia	73#86		Since abnormalities of brain development play a role in the aetiology of schizophrenia, growth factors, known to play a role in neurodevelopment, such as neurotrophin-3 (NT-3), are therefore candidate genes for this disorder.
8837968	1996	Acta Psychiatr Scand	0001-690X	ALL_TEXT_1/3	1	1	4908	SYMBOL|EXTRACTED|()	nt 3	NT-3	170#174	8837968-0-26-40	D001927	LONGTERM|DICTIONARY	abnormalities of brain	abnormalities of brain	6#28		Since abnormalities of brain development play a role in the aetiology of schizophrenia, growth factors, known to play a role in neurodevelopment, such as neurotrophin-3 (NT-3), are therefore candidate genes for this disorder.
10889552	2000	Mol. Psychiatry	1359-4184	ALL_TEXT_3/3	3	12	1544	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	cyp1a2	CYP1A2	64#70	10889552-0-33-52	D004409	SYMBOL|EXTRACTED	td	TD	134#136	10889552-1-0-18	These data suggest that the (C-->A) genetic polymorphism in the CYP1A2 gene may serve as a genetic risk factor for the development of TD in patients with schizophrenia.
10889552	2000	Mol. Psychiatry	1359-4184	ALL_TEXT_3/3	3	12	1544	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	cyp1a2	CYP1A2	64#70	10889552-0-33-52	D012559	LONGTERM|DICTIONARY	schizophrenia	schizophrenia	154#167		These data suggest that the (C-->A) genetic polymorphism in the CYP1A2 gene may serve as a genetic risk factor for the development of TD in patients with schizophrenia.
15057872	2004	Mol. Carcinog.	0899-1987	ALL_TEXT_1/3	1	1	3482	SYMBOL|()|GENE|GN|DICTIONARY	igf2r	Igf2r	48#53		D008107	LONGTERM|DICTIONARY	liver carcinogenesis	liver carcinogenesis	106#126		To elucidate whether the M6p/Igf2 receptor (M6p/Igf2r) gene might be involved in exogenous and endogenous liver carcinogenesis, we investigated its alteration in hepatocellular carcinomas (HCCs) induced by N-nitrosodiethylamine (DEN) and by a choline-deficient L-amino acid-defined (CDAA) diet in rats.
15057872	2004	Mol. Carcinog.	0899-1987	ALL_TEXT_1/3	1	1	3482	SYMBOL|()|GENE|GN|DICTIONARY	igf2r	Igf2r	48#53		D006528	LONGTERM|DICTIONARY	hepatocellular carcinomas	hepatocellular carcinomas	162#187		To elucidate whether the M6p/Igf2 receptor (M6p/Igf2r) gene might be involved in exogenous and endogenous liver carcinogenesis, we investigated its alteration in hepatocellular carcinomas (HCCs) induced by N-nitrosodiethylamine (DEN) and by a choline-deficient L-amino acid-defined (CDAA) diet in rats.
15057872	2004	Mol. Carcinog.	0899-1987	ALL_TEXT_1/3	1	1	3482	SYMBOL|()|GENE|GN|DICTIONARY	igf2r	Igf2r	48#53		D006528	SYMBOL|PLURAL|()|DICTIONARY|EXTRACTED	hccs	HCCs	189#193	15057872-1-162-187	To elucidate whether the M6p/Igf2 receptor (M6p/Igf2r) gene might be involved in exogenous and endogenous liver carcinogenesis, we investigated its alteration in hepatocellular carcinomas (HCCs) induced by N-nitrosodiethylamine (DEN) and by a choline-deficient L-amino acid-defined (CDAA) diet in rats.
17203290	2007	Immunogenetics	0093-7711	ALL_TEXT_1/3	1	2	3558	SYMBOL|DICTIONARY	interleukins (il)-2, -4, and -6	interleukins (IL)-2, -4, and -6	34#65		D007676	SYMBOL|DICTIONARY|EXTRACTED	esrd	ESRD	125#129	17203290-1-29-52	This study speculated the role of interleukins (IL)-2, -4, and -6 cytokines gene polymorphism with risk of susceptibility to ESRD.
17203290	2007	Immunogenetics	0093-7711	ALL_TEXT_1/3	1	2	3565	SYMBOL|DICTIONARY	interleukins (il)-2, -4, and -6	interleukins (IL)-2, -4, and -6	34#65		D007676	SYMBOL|DICTIONARY|EXTRACTED	esrd	ESRD	125#129	17203290-1-29-52	This study speculated the role of interleukins (IL)-2, -4, and -6 cytokines gene polymorphism with risk of susceptibility to ESRD.
17203290	2007	Immunogenetics	0093-7711	ALL_TEXT_1/3	1	2	3569	SYMBOL|DICTIONARY	interleukins (il)-2, -4, and -6	interleukins (IL)-2, -4, and -6	34#65		D007676	SYMBOL|DICTIONARY|EXTRACTED	esrd	ESRD	125#129	17203290-1-29-52	This study speculated the role of interleukins (IL)-2, -4, and -6 cytokines gene polymorphism with risk of susceptibility to ESRD.
16053028	2005	Sarcoidosis Vasc Diffuse Lung Dis	1124-0490	BACKGROUND AND AIM	1	1	3119	LONGTERM|DICTIONARY	dqb1	DQB1	81#85	NaN	D012507	LONGTERM|DICTIONARY	sarcoidosis	Sarcoidosis	0#11		Sarcoidosis has been reported to be associated with the HLA genes, in particular DQB1.
18407370	2009	Lung Cancer	0169-5002	ALL_TEXT_3/3	3	8	7515	SYMBOL|DICTIONARY	xrcc1	XRCC1	15#20		D008175	LONGTERM|DISEASE|DT|DICTIONARY	lung cancer	lung cancer	77#88		In conclusion, XRCC1 Arg399Gln and T-77C polymorphisms may alter the risk of lung cancer in women nonsmokers in China.
16741941	2006	Am. J. Med. Genet. B Neuropsychiatr. Genet.	1552-4841	TITLE	0	0	627	SYMBOL|DICTIONARY|EXTRACTED	bdnf	BDNF	27#31		D001714	LONGTERM|DISEASE|DT|GFAM|FN|DICTIONARY	bipolar disorder	bipolar disorder	44#60		Transmission distortion of BDNF variants to bipolar disorder type I patients from a South American population isolate.
16741941	2006	Am. J. Med. Genet. B Neuropsychiatr. Genet.	1552-4841	ALL_TEXT_1/3	1	1	627	LONGTERM|GENE|GT|DICTIONARY|GA	brain derived neurotrophic factor	brain derived neurotrophic factor	52#85		D001714	LONGTERM|DISEASE|DT|DICTIONARY	bipolar disorder	bipolar disorder	166#182		Recent reports have implicated polymorphisms in the brain derived neurotrophic factor (BDNF) gene region in the etiology of several psychiatric phenotypes, including bipolar disorder.
16741941	2006	Am. J. Med. Genet. B Neuropsychiatr. Genet.	1552-4841	ALL_TEXT_1/3	1	1	627	LONGTERM|GENE|GT|DICTIONARY|GA	brain derived neurotrophic factor	brain derived neurotrophic factor	52#85		D001523	LONGTERM|DICTIONARY	psychiatric	psychiatric	132#143	NaN	Recent reports have implicated polymorphisms in the brain derived neurotrophic factor (BDNF) gene region in the etiology of several psychiatric phenotypes, including bipolar disorder.
16741941	2006	Am. J. Med. Genet. B Neuropsychiatr. Genet.	1552-4841	ALL_TEXT_1/3	1	1	627	SYMBOL|()|GENE|GN|DICTIONARY|EXTRACTED	bdnf	BDNF	87#91	16741941-1-52-85	D001714	LONGTERM|DISEASE|DT|DICTIONARY	bipolar disorder	bipolar disorder	166#182		Recent reports have implicated polymorphisms in the brain derived neurotrophic factor (BDNF) gene region in the etiology of several psychiatric phenotypes, including bipolar disorder.
16741941	2006	Am. J. Med. Genet. B Neuropsychiatr. Genet.	1552-4841	ALL_TEXT_1/3	1	1	627	SYMBOL|()|GENE|GN|DICTIONARY|EXTRACTED	bdnf	BDNF	87#91	16741941-1-52-85	D001523	LONGTERM|DICTIONARY	psychiatric	psychiatric	132#143	NaN	Recent reports have implicated polymorphisms in the brain derived neurotrophic factor (BDNF) gene region in the etiology of several psychiatric phenotypes, including bipolar disorder.
18407370	2009	Lung Cancer	0169-5002	ALL_TEXT_3/3	3	5	7515	SYMBOL|NUMBER|DICTIONARY	xrcc1	XRCC1	28#33		D008175	LONGTERM|DISEASE|DT|DICTIONARY	lung cancer	lung cancer	190#201		Individuals with homozygous XRCC1 399Gln/Gln genotype (OR=1.75, 95% CI [1.02-3.01]) and XRCC1 -77 combined TC and CC genotype (OR=1.66, 95% CI [1.13-2.42]) showed a slightly higher risk for lung cancer overall.
18407370	2009	Lung Cancer	0169-5002	ALL_TEXT_3/3	3	5	7515	SYMBOL|DICTIONARY	xrcc1	XRCC1	88#93		D008175	LONGTERM|DISEASE|DT|DICTIONARY	lung cancer	lung cancer	190#201		Individuals with homozygous XRCC1 399Gln/Gln genotype (OR=1.75, 95% CI [1.02-3.01]) and XRCC1 -77 combined TC and CC genotype (OR=1.66, 95% CI [1.13-2.42]) showed a slightly higher risk for lung cancer overall.
19874431	2010	J Eur Acad Dermatol Venereol	1468-3083	TITLE	0	0	2312	LONGTERM|DICTIONARY	filaggrin	filaggrin	27#36		D003876	LONGTERM|DICTIONARY	atopic dermatitis	atopic dermatitis	121#138		Analysis of four prevalent filaggrin mutations (R501X, 2282del4, R2447X and S3247X) in Austrian and German patients with atopic dermatitis.
18407370	2009	Lung Cancer	0169-5002	ALL_TEXT_3/3	3	6	7515	SYMBOL|NUMBER|DICTIONARY	xrcc1	XRCC1	101#106		D000230	LONGTERM|DICTIONARY	adenocarcinoma	adenocarcinoma	19#33		In the subgroup of adenocarcinoma cases, adjusted ORs were increased for individuals with homozygous XRCC1 399Gln/Gln genotype (OR=2.62, 95% CI [1.44-4.79]) and XRCC1 -77 combined TC and CC genotype (OR=1.85, 95% CI [1.19-2.86]).
18407370	2009	Lung Cancer	0169-5002	ALL_TEXT_3/3	3	6	7515	SYMBOL|DICTIONARY	xrcc1	XRCC1	161#166		D000230	LONGTERM|DICTIONARY	adenocarcinoma	adenocarcinoma	19#33		In the subgroup of adenocarcinoma cases, adjusted ORs were increased for individuals with homozygous XRCC1 399Gln/Gln genotype (OR=2.62, 95% CI [1.44-4.79]) and XRCC1 -77 combined TC and CC genotype (OR=1.85, 95% CI [1.19-2.86]).
18407370	2009	Lung Cancer	0169-5002	TITLE	0	0	7515	SYMBOL|DICTIONARY	xrcc1	XRCC1	0#5		D008175	LONGTERM|DISEASE|DT|DICTIONARY	lung cancer	lung cancer	42#53		XRCC1 polymorphisms, cooking oil fume and lung cancer in Chinese women nonsmokers.
18407370	2009	Lung Cancer	0169-5002	ALL_TEXT_2/3	2	3	7515	SYMBOL|DICTIONARY	xrcc1	XRCC1	65#70		D008175	LONGTERM|DISEASE|DT|DICTIONARY	lung cancer	lung cancer	162#173		To establish our understanding of possible relationships between XRCC1 polymorphisms (5'UTR -77T>C, Arg194Trp, Arg280His and Arg399Gln) and the susceptibility to lung cancer among women nonsmokers, we performed a hospital-based case-control study of 350 patients with newly diagnosed lung cancer and 350 cancer-free controls, frequency matched by age.
18407370	2009	Lung Cancer	0169-5002	ALL_TEXT_2/3	2	3	7515	SYMBOL|DICTIONARY	xrcc1	XRCC1	65#70		D008175	LONGTERM|DISEASE|DT|DICTIONARY	lung cancer	lung cancer	284#295		To establish our understanding of possible relationships between XRCC1 polymorphisms (5'UTR -77T>C, Arg194Trp, Arg280His and Arg399Gln) and the susceptibility to lung cancer among women nonsmokers, we performed a hospital-based case-control study of 350 patients with newly diagnosed lung cancer and 350 cancer-free controls, frequency matched by age.
18407370	2009	Lung Cancer	0169-5002	ALL_TEXT_2/3	2	3	7515	SYMBOL|DICTIONARY	xrcc1	XRCC1	65#70		D009369	LONGTERM|DISEASE|DT|DICTIONARY	cancer	cancer	304#310		To establish our understanding of possible relationships between XRCC1 polymorphisms (5'UTR -77T>C, Arg194Trp, Arg280His and Arg399Gln) and the susceptibility to lung cancer among women nonsmokers, we performed a hospital-based case-control study of 350 patients with newly diagnosed lung cancer and 350 cancer-free controls, frequency matched by age.
18407370	2009	Lung Cancer	0169-5002	ALL_TEXT_1/3	1	2	7515	SYMBOL|DICTIONARY	xrcc1	XRCC1	42#47		D063646	LONGTERM|DICTIONARY	carcinogenesis	carcinogenesis	133#147		Single nucleotide polymorphisms (SNPs) in XRCC1 may alter protein function and repair capacity, thus lead to genetic instability and carcinogenesis.
18455351	2008	Int. J. Dev. Neurosci.	0736-5748	ALL_TEXT_2/3	2	4	5468	LONGTERM|DICTIONARY	peroxisome proliferator activated receptor gamma	peroxisome proliferator-activated receptor gamma	6#54		D020279	LONGTERM|DICTIONARY	cns diseases	CNS diseases	163#175		Since peroxisome proliferator-activated receptor gamma (PPARgamma) acts as a regulator of CNS inflammation and a powerful pharmacological target for counteracting CNS diseases, we investigated the role of the PPARgamma agonist, rosiglitazone, in the modulation of CD40 expression and in the pathological processes of inflammation after SE.
18455351	2008	Int. J. Dev. Neurosci.	0736-5748	ALL_TEXT_2/3	2	4	5468	LONGTERM|DICTIONARY	peroxisome proliferator activated receptor gamma	peroxisome proliferator-activated receptor gamma	6#54		D013226	SYMBOL|EXTRACTED	se	SE	336#338	18455351-3-138-156	Since peroxisome proliferator-activated receptor gamma (PPARgamma) acts as a regulator of CNS inflammation and a powerful pharmacological target for counteracting CNS diseases, we investigated the role of the PPARgamma agonist, rosiglitazone, in the modulation of CD40 expression and in the pathological processes of inflammation after SE.
18455351	2008	Int. J. Dev. Neurosci.	0736-5748	ALL_TEXT_2/3	2	4	5468	LONGTERM|DICTIONARY	peroxisome proliferator activated receptor gamma	peroxisome proliferator-activated receptor gamma	6#54		D007249	LONGTERM|DICTIONARY	inflammation	inflammation	94#106	NaN	Since peroxisome proliferator-activated receptor gamma (PPARgamma) acts as a regulator of CNS inflammation and a powerful pharmacological target for counteracting CNS diseases, we investigated the role of the PPARgamma agonist, rosiglitazone, in the modulation of CD40 expression and in the pathological processes of inflammation after SE.
18455351	2008	Int. J. Dev. Neurosci.	0736-5748	ALL_TEXT_2/3	2	4	5468	LONGTERM|DICTIONARY	peroxisome proliferator activated receptor gamma	peroxisome proliferator-activated receptor gamma	6#54		D007249	LONGTERM|DICTIONARY	processes of inflammation	processes of inflammation	304#329	NaN	Since peroxisome proliferator-activated receptor gamma (PPARgamma) acts as a regulator of CNS inflammation and a powerful pharmacological target for counteracting CNS diseases, we investigated the role of the PPARgamma agonist, rosiglitazone, in the modulation of CD40 expression and in the pathological processes of inflammation after SE.
18455351	2008	Int. J. Dev. Neurosci.	0736-5748	ALL_TEXT_2/3	2	4	5468	SYMBOL|()|DICTIONARY|EXTRACTED	ppargamma	PPARgamma	56#65	18455351-4-6-54	D020279	LONGTERM|DICTIONARY	cns diseases	CNS diseases	163#175		Since peroxisome proliferator-activated receptor gamma (PPARgamma) acts as a regulator of CNS inflammation and a powerful pharmacological target for counteracting CNS diseases, we investigated the role of the PPARgamma agonist, rosiglitazone, in the modulation of CD40 expression and in the pathological processes of inflammation after SE.
18455351	2008	Int. J. Dev. Neurosci.	0736-5748	ALL_TEXT_2/3	2	4	5468	SYMBOL|()|DICTIONARY|EXTRACTED	ppargamma	PPARgamma	56#65	18455351-4-6-54	D013226	SYMBOL|EXTRACTED	se	SE	336#338	18455351-3-138-156	Since peroxisome proliferator-activated receptor gamma (PPARgamma) acts as a regulator of CNS inflammation and a powerful pharmacological target for counteracting CNS diseases, we investigated the role of the PPARgamma agonist, rosiglitazone, in the modulation of CD40 expression and in the pathological processes of inflammation after SE.
18455351	2008	Int. J. Dev. Neurosci.	0736-5748	ALL_TEXT_2/3	2	4	5468	SYMBOL|()|DICTIONARY|EXTRACTED	ppargamma	PPARgamma	56#65	18455351-4-6-54	D007249	LONGTERM|DICTIONARY	inflammation	inflammation	94#106	NaN	Since peroxisome proliferator-activated receptor gamma (PPARgamma) acts as a regulator of CNS inflammation and a powerful pharmacological target for counteracting CNS diseases, we investigated the role of the PPARgamma agonist, rosiglitazone, in the modulation of CD40 expression and in the pathological processes of inflammation after SE.
18455351	2008	Int. J. Dev. Neurosci.	0736-5748	ALL_TEXT_2/3	2	4	5468	SYMBOL|()|DICTIONARY|EXTRACTED	ppargamma	PPARgamma	56#65	18455351-4-6-54	D007249	LONGTERM|DICTIONARY	processes of inflammation	processes of inflammation	304#329	NaN	Since peroxisome proliferator-activated receptor gamma (PPARgamma) acts as a regulator of CNS inflammation and a powerful pharmacological target for counteracting CNS diseases, we investigated the role of the PPARgamma agonist, rosiglitazone, in the modulation of CD40 expression and in the pathological processes of inflammation after SE.
18455351	2008	Int. J. Dev. Neurosci.	0736-5748	ALL_TEXT_2/3	2	4	5468	SYMBOL|DICTIONARY|EXTRACTED	ppargamma	PPARgamma	209#218	18455351-4-6-54	D020279	LONGTERM|DICTIONARY	cns diseases	CNS diseases	163#175		Since peroxisome proliferator-activated receptor gamma (PPARgamma) acts as a regulator of CNS inflammation and a powerful pharmacological target for counteracting CNS diseases, we investigated the role of the PPARgamma agonist, rosiglitazone, in the modulation of CD40 expression and in the pathological processes of inflammation after SE.
18455351	2008	Int. J. Dev. Neurosci.	0736-5748	ALL_TEXT_2/3	2	4	5468	SYMBOL|DICTIONARY|EXTRACTED	ppargamma	PPARgamma	209#218	18455351-4-6-54	D013226	SYMBOL|EXTRACTED	se	SE	336#338	18455351-3-138-156	Since peroxisome proliferator-activated receptor gamma (PPARgamma) acts as a regulator of CNS inflammation and a powerful pharmacological target for counteracting CNS diseases, we investigated the role of the PPARgamma agonist, rosiglitazone, in the modulation of CD40 expression and in the pathological processes of inflammation after SE.
18455351	2008	Int. J. Dev. Neurosci.	0736-5748	ALL_TEXT_2/3	2	4	5468	SYMBOL|DICTIONARY|EXTRACTED	ppargamma	PPARgamma	209#218	18455351-4-6-54	D007249	LONGTERM|DICTIONARY	inflammation	inflammation	94#106	NaN	Since peroxisome proliferator-activated receptor gamma (PPARgamma) acts as a regulator of CNS inflammation and a powerful pharmacological target for counteracting CNS diseases, we investigated the role of the PPARgamma agonist, rosiglitazone, in the modulation of CD40 expression and in the pathological processes of inflammation after SE.
18455351	2008	Int. J. Dev. Neurosci.	0736-5748	ALL_TEXT_2/3	2	4	5468	SYMBOL|DICTIONARY|EXTRACTED	ppargamma	PPARgamma	209#218	18455351-4-6-54	D007249	LONGTERM|DICTIONARY	processes of inflammation	processes of inflammation	304#329	NaN	Since peroxisome proliferator-activated receptor gamma (PPARgamma) acts as a regulator of CNS inflammation and a powerful pharmacological target for counteracting CNS diseases, we investigated the role of the PPARgamma agonist, rosiglitazone, in the modulation of CD40 expression and in the pathological processes of inflammation after SE.
18455351	2008	Int. J. Dev. Neurosci.	0736-5748	ALL_TEXT_2/3	2	4	958	SYMBOL|DICTIONARY	cd40	CD40	264#268		D020279	LONGTERM|DICTIONARY	cns diseases	CNS diseases	163#175		Since peroxisome proliferator-activated receptor gamma (PPARgamma) acts as a regulator of CNS inflammation and a powerful pharmacological target for counteracting CNS diseases, we investigated the role of the PPARgamma agonist, rosiglitazone, in the modulation of CD40 expression and in the pathological processes of inflammation after SE.
18455351	2008	Int. J. Dev. Neurosci.	0736-5748	ALL_TEXT_2/3	2	4	958	SYMBOL|DICTIONARY	cd40	CD40	264#268		D013226	SYMBOL|EXTRACTED	se	SE	336#338	18455351-3-138-156	Since peroxisome proliferator-activated receptor gamma (PPARgamma) acts as a regulator of CNS inflammation and a powerful pharmacological target for counteracting CNS diseases, we investigated the role of the PPARgamma agonist, rosiglitazone, in the modulation of CD40 expression and in the pathological processes of inflammation after SE.
18455351	2008	Int. J. Dev. Neurosci.	0736-5748	ALL_TEXT_2/3	2	4	958	SYMBOL|DICTIONARY	cd40	CD40	264#268		D007249	LONGTERM|DICTIONARY	inflammation	inflammation	94#106	NaN	Since peroxisome proliferator-activated receptor gamma (PPARgamma) acts as a regulator of CNS inflammation and a powerful pharmacological target for counteracting CNS diseases, we investigated the role of the PPARgamma agonist, rosiglitazone, in the modulation of CD40 expression and in the pathological processes of inflammation after SE.
18455351	2008	Int. J. Dev. Neurosci.	0736-5748	ALL_TEXT_2/3	2	4	958	SYMBOL|DICTIONARY	cd40	CD40	264#268		D007249	LONGTERM|DICTIONARY	processes of inflammation	processes of inflammation	304#329	NaN	Since peroxisome proliferator-activated receptor gamma (PPARgamma) acts as a regulator of CNS inflammation and a powerful pharmacological target for counteracting CNS diseases, we investigated the role of the PPARgamma agonist, rosiglitazone, in the modulation of CD40 expression and in the pathological processes of inflammation after SE.
16797247	2006	Clin. Gastroenterol. Hepatol.	1542-3565	RESULTS	3	7	1559	SYMBOL|DICTIONARY	cyp2c9	CYP2C9	8#14		D015179	LONGTERM|DISEASE|DT|DICTIONARY	colorectal cancer	colorectal cancer	152#169		Variant CYP2C9 genotypes showed no interaction with aspirin usage, and variant UGT1A6 genotypes showed no interaction with either NSAID with respect to colorectal cancer protection.
16797247	2006	Clin. Gastroenterol. Hepatol.	1542-3565	RESULTS	3	7	54578	SYMBOL|DICTIONARY	ugt1a6	UGT1A6	79#85		D015179	LONGTERM|DISEASE|DT|DICTIONARY	colorectal cancer	colorectal cancer	152#169		Variant CYP2C9 genotypes showed no interaction with aspirin usage, and variant UGT1A6 genotypes showed no interaction with either NSAID with respect to colorectal cancer protection.
16797247	2006	Clin. Gastroenterol. Hepatol.	1542-3565	TITLE	0	0	1559	SYMBOL|DICTIONARY	cyp2c9	CYP2C9	21#27		D015179	LONGTERM|DISEASE|DT|DICTIONARY	colorectal cancer	colorectal cancer	97#114		Interactions between CYP2C9 and UGT1A6 polymorphisms and nonsteroidal anti-inflammatory drugs in colorectal cancer prevention.
16797247	2006	Clin. Gastroenterol. Hepatol.	1542-3565	TITLE	0	0	54578	SYMBOL|DICTIONARY	ugt1a6	UGT1A6	32#38		D015179	LONGTERM|DISEASE|DT|DICTIONARY	colorectal cancer	colorectal cancer	97#114		Interactions between CYP2C9 and UGT1A6 polymorphisms and nonsteroidal anti-inflammatory drugs in colorectal cancer prevention.
18455351	2008	Int. J. Dev. Neurosci.	0736-5748	TITLE	0	0	5468	LONGTERM|DICTIONARY	peroxisome proliferator activated receptor gamma	Peroxisome proliferator-activated receptor gamma	0#48		D013226	LONGTERM|DICTIONARY	status epilepticus	status epilepticus	172#190		Peroxisome proliferator-activated receptor gamma agonist, rosiglitazone, suppresses CD40 expression and attenuates inflammatory responses after lithium pilocarpine-induced status epilepticus in rats.
18455351	2008	Int. J. Dev. Neurosci.	0736-5748	TITLE	0	0	958	SYMBOL|DICTIONARY	cd40	CD40	84#88		D013226	LONGTERM|DICTIONARY	status epilepticus	status epilepticus	172#190		Peroxisome proliferator-activated receptor gamma agonist, rosiglitazone, suppresses CD40 expression and attenuates inflammatory responses after lithium pilocarpine-induced status epilepticus in rats.
18455351	2008	Int. J. Dev. Neurosci.	0736-5748	ALL_TEXT_1/3	1	3	958	SYMBOL|DICTIONARY	cd40	CD40	45#49		D013226	LONGTERM|DICTIONARY	status epilepticus	status epilepticus	138#156		Our study showed that there was an increased CD40 expression on activated microglia in the brain injury after lithium pilocarpine-induced status epilepticus (SE) in rats.
18455351	2008	Int. J. Dev. Neurosci.	0736-5748	ALL_TEXT_1/3	1	3	958	SYMBOL|DICTIONARY	cd40	CD40	45#49		D013226	SYMBOL|EXTRACTED|()	se	SE	158#160	18455351-3-138-156	Our study showed that there was an increased CD40 expression on activated microglia in the brain injury after lithium pilocarpine-induced status epilepticus (SE) in rats.
18455351	2008	Int. J. Dev. Neurosci.	0736-5748	ALL_TEXT_1/3	1	3	958	SYMBOL|DICTIONARY	cd40	CD40	45#49		D020214	LONGTERM|DICTIONARY	brain injury	brain injury	91#103	NaN	Our study showed that there was an increased CD40 expression on activated microglia in the brain injury after lithium pilocarpine-induced status epilepticus (SE) in rats.
18455351	2008	Int. J. Dev. Neurosci.	0736-5748	ALL_TEXT_1/3	1	2	958	SYMBOL|DICTIONARY	cd40	CD40	23#27		D002493	LONGTERM|DICTIONARY	inflammatory responses in the central nervous system	inflammatory responses in the central nervous system	63#115		Ligation of microglial CD40 plays a role in the development of inflammatory responses in the central nervous system (CNS).
17492767	2007	Am. J. Med. Genet. B Neuropsychiatr. Genet.	1552-4841	TITLE	0	0	1610	LONGTERM|DICTIONARY	d amino acid oxidase	D-amino acid oxidase	59#79		D012559	LONGTERM|DICTIONARY	schizophrenia	schizophrenia	97#110		Evidence for association and epistasis at the DAOA/G30 and D-amino acid oxidase loci in an Irish schizophrenia sample.
17492767	2007	Am. J. Med. Genet. B Neuropsychiatr. Genet.	1552-4841	TITLE	0	0	282706	LONGTERM|DICTIONARY	g30	G30	51#54	NaN	D012559	LONGTERM|DICTIONARY	schizophrenia	schizophrenia	97#110		Evidence for association and epistasis at the DAOA/G30 and D-amino acid oxidase loci in an Irish schizophrenia sample.
17492767	2007	Am. J. Med. Genet. B Neuropsychiatr. Genet.	1552-4841	ALL_TEXT_1/3	1	3	1610	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	dao	DAO	196#199	17492767-1-4-24	D012559	LONGTERM|DICTIONARY	schizophrenia	schizophrenia	52#65		(2002); PNAS 99: 13675-13680, identifying the novel schizophrenia susceptibility gene DAOA/G30 and a number of independent studies have since reported evidence of association between the DAOA and DAO genes and schizophrenia.
17492767	2007	Am. J. Med. Genet. B Neuropsychiatr. Genet.	1552-4841	ALL_TEXT_1/3	1	3	1610	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	dao	DAO	196#199	17492767-1-4-24	D012559	LONGTERM|DICTIONARY	schizophrenia	schizophrenia	210#223		(2002); PNAS 99: 13675-13680, identifying the novel schizophrenia susceptibility gene DAOA/G30 and a number of independent studies have since reported evidence of association between the DAOA and DAO genes and schizophrenia.
17492767	2007	Am. J. Med. Genet. B Neuropsychiatr. Genet.	1552-4841	ALL_TEXT_1/3	1	3	282706	LONGTERM|DICTIONARY	g30	G30	91#94	NaN	D012559	LONGTERM|DICTIONARY	schizophrenia	schizophrenia	52#65		(2002); PNAS 99: 13675-13680, identifying the novel schizophrenia susceptibility gene DAOA/G30 and a number of independent studies have since reported evidence of association between the DAOA and DAO genes and schizophrenia.
17492767	2007	Am. J. Med. Genet. B Neuropsychiatr. Genet.	1552-4841	ALL_TEXT_1/3	1	3	282706	LONGTERM|DICTIONARY	g30	G30	91#94	NaN	D012559	LONGTERM|DICTIONARY	schizophrenia	schizophrenia	210#223		(2002); PNAS 99: 13675-13680, identifying the novel schizophrenia susceptibility gene DAOA/G30 and a number of independent studies have since reported evidence of association between the DAOA and DAO genes and schizophrenia.
16797247	2006	Clin. Gastroenterol. Hepatol.	1542-3565	CONCLUSIONS	4	8	1559	SYMBOL|DICTIONARY	cyp2c9	CYP2C9	79#85		D015179	LONGTERM|DISEASE|DT|DICTIONARY	colorectal cancer	colorectal cancer	148#165		In this study, the major effect seen was an enhancement by slower-metabolizing CYP2C9 variants of the chemopreventive activity of ibuprofen against colorectal cancer.
17492767	2007	Am. J. Med. Genet. B Neuropsychiatr. Genet.	1552-4841	ALL_TEXT_2/3	2	5	1610	SYMBOL|DICTIONARY|EXTRACTED	dao	DAO	83#86	17492767-1-4-24	D012559	LONGTERM|DICTIONARY	schizophrenia	schizophrenia	129#142		In this study, we performed association and epistasis analyses of the DAOA/G30 and DAO loci in a sample of 373 cases with DSM-IV schizophrenia/schizoaffective disorder and 812 controls from the Republic of Ireland.
17492767	2007	Am. J. Med. Genet. B Neuropsychiatr. Genet.	1552-4841	ALL_TEXT_2/3	2	5	1610	SYMBOL|DICTIONARY|EXTRACTED	dao	DAO	83#86	17492767-1-4-24	D011618	LONGTERM|DISEASE|DT|DICTIONARY	schizoaffective disorder	schizoaffective disorder	143#167		In this study, we performed association and epistasis analyses of the DAOA/G30 and DAO loci in a sample of 373 cases with DSM-IV schizophrenia/schizoaffective disorder and 812 controls from the Republic of Ireland.
17492767	2007	Am. J. Med. Genet. B Neuropsychiatr. Genet.	1552-4841	ALL_TEXT_2/3	2	5	282706	LONGTERM|DICTIONARY	g30	G30	75#78	NaN	D012559	LONGTERM|DICTIONARY	schizophrenia	schizophrenia	129#142		In this study, we performed association and epistasis analyses of the DAOA/G30 and DAO loci in a sample of 373 cases with DSM-IV schizophrenia/schizoaffective disorder and 812 controls from the Republic of Ireland.
17492767	2007	Am. J. Med. Genet. B Neuropsychiatr. Genet.	1552-4841	ALL_TEXT_2/3	2	5	282706	LONGTERM|DICTIONARY	g30	G30	75#78	NaN	D011618	LONGTERM|DISEASE|DT|DICTIONARY	schizoaffective disorder	schizoaffective disorder	143#167		In this study, we performed association and epistasis analyses of the DAOA/G30 and DAO loci in a sample of 373 cases with DSM-IV schizophrenia/schizoaffective disorder and 812 controls from the Republic of Ireland.
17492767	2007	Am. J. Med. Genet. B Neuropsychiatr. Genet.	1552-4841	ALL_TEXT_2/3	2	6	1610	SYMBOL|DICTIONARY|EXTRACTED	dao	DAO	177#180	17492767-1-4-24	D012559	LONGTERM|DICTIONARY	schizophrenia	schizophrenia	113#126		Corrected for the number of tests performed, we found evidence for association between markers at both genes and schizophrenia: DAOA/G30 (P = 0.005, OR = 1.34 (1.09, 1.65)) and DAO (P = 0.003, OR = 1.43 (1.12, 1.84).
17492767	2007	Am. J. Med. Genet. B Neuropsychiatr. Genet.	1552-4841	ALL_TEXT_2/3	2	6	282706	LONGTERM|DICTIONARY	g30	G30	133#136	NaN	D012559	LONGTERM|DICTIONARY	schizophrenia	schizophrenia	113#126		Corrected for the number of tests performed, we found evidence for association between markers at both genes and schizophrenia: DAOA/G30 (P = 0.005, OR = 1.34 (1.09, 1.65)) and DAO (P = 0.003, OR = 1.43 (1.12, 1.84).
17492767	2007	Am. J. Med. Genet. B Neuropsychiatr. Genet.	1552-4841	ALL_TEXT_3/3	3	7	1610	SYMBOL|DICTIONARY|EXTRACTED	dao	DAO	50#53	17492767-1-4-24	D012559	LONGTERM|DICTIONARY	schizophrenia	schizophrenia	144#157		The data suggest that evidence for association at DAO (marker rs2111902) is more consistent than previously realized, particularly in Caucasian schizophrenia populations.
9865924	1999	Clin. Cancer Res.	1078-0432	ALL_TEXT_1/3	1	1	1728	SYMBOL|DICTIONARY|EXTRACTED	nqo1	NQO1	32#36	9865924-0-35-57	D009369	LONGTERM|DICTIONARY	tumors	tumors	76#82		NAD(P)H:quinone oxidoreductase (NQO1; DT-diaphorase) is elevated in certain tumors, such as non-small cell lung cancer (NSCLC).
9865924	1999	Clin. Cancer Res.	1078-0432	ALL_TEXT_1/3	1	1	1728	SYMBOL|DICTIONARY|EXTRACTED	nqo1	NQO1	32#36	9865924-0-35-57	D002289	LONGTERM|DISEASE|DT|DICTIONARY	non small cell lung cancer	non-small cell lung cancer	92#118		NAD(P)H:quinone oxidoreductase (NQO1; DT-diaphorase) is elevated in certain tumors, such as non-small cell lung cancer (NSCLC).
9865924	1999	Clin. Cancer Res.	1078-0432	ALL_TEXT_1/3	1	1	1728	SYMBOL|DICTIONARY|EXTRACTED	nqo1	NQO1	32#36	9865924-0-35-57	D002289	LONGTERM|()|DICTIONARY|EXTRACTED	nsclc	NSCLC	120#125	9865924-1-92-118	NAD(P)H:quinone oxidoreductase (NQO1; DT-diaphorase) is elevated in certain tumors, such as non-small cell lung cancer (NSCLC).
9865924	1999	Clin. Cancer Res.	1078-0432	ALL_TEXT_1/3	1	1	1728	LONGTERM|DICTIONARY	dt diaphorase	DT-diaphorase	38#51		D009369	LONGTERM|DICTIONARY	tumors	tumors	76#82		NAD(P)H:quinone oxidoreductase (NQO1; DT-diaphorase) is elevated in certain tumors, such as non-small cell lung cancer (NSCLC).
9865924	1999	Clin. Cancer Res.	1078-0432	ALL_TEXT_1/3	1	1	1728	LONGTERM|DICTIONARY	dt diaphorase	DT-diaphorase	38#51		D002289	LONGTERM|DISEASE|DT|DICTIONARY	non small cell lung cancer	non-small cell lung cancer	92#118		NAD(P)H:quinone oxidoreductase (NQO1; DT-diaphorase) is elevated in certain tumors, such as non-small cell lung cancer (NSCLC).
9865924	1999	Clin. Cancer Res.	1078-0432	ALL_TEXT_1/3	1	1	1728	LONGTERM|DICTIONARY	dt diaphorase	DT-diaphorase	38#51		D002289	LONGTERM|()|DICTIONARY|EXTRACTED	nsclc	NSCLC	120#125	9865924-1-92-118	NAD(P)H:quinone oxidoreductase (NQO1; DT-diaphorase) is elevated in certain tumors, such as non-small cell lung cancer (NSCLC).
15939053	2005	Atherosclerosis	0021-9150	ALL_TEXT_3/3	3	8	1071	SYMBOL|DICTIONARY|EXTRACTED	cetp	CETP	149#153	15939053-1-33-67	D002318	LONGTERM|DISEASE|DT|DICTIONARY	cardiovascular disease	cardiovascular disease	178#200		These results replicate some earlier findings and also help to explain some of the apparent contradictions in the literature surrounding the role of CETP in modulating HDL-C and cardiovascular disease.
9865924	1999	Clin. Cancer Res.	1078-0432	ALL_TEXT_2/3	2	5	1728	SYMBOL|DICTIONARY|EXTRACTED	nqo1	NQO1	82#86	9865924-0-35-57	D009369	LONGTERM|DISEASE|DT|CLINE|CN|DICTIONARY	tumor	tumor	50#55		RH1 was, correspondingly, more cytotoxic to human tumor cells expressing elevated NQO1 activity (H460 NSCLC and HT29 human colon carcinoma), as measured by 3-(4,5-dimethylthiazol-2,5-diphenyl)tetrazolium assay, than it was to cells deficient in NQO1 activity (H596 NSCLC and BE human colon carcinoma).
9865924	1999	Clin. Cancer Res.	1078-0432	ALL_TEXT_2/3	2	5	1728	SYMBOL|DICTIONARY|EXTRACTED	nqo1	NQO1	82#86	9865924-0-35-57	D002289	LONGTERM|DICTIONARY|EXTRACTED	nsclc	NSCLC	102#107	9865924-1-92-118	RH1 was, correspondingly, more cytotoxic to human tumor cells expressing elevated NQO1 activity (H460 NSCLC and HT29 human colon carcinoma), as measured by 3-(4,5-dimethylthiazol-2,5-diphenyl)tetrazolium assay, than it was to cells deficient in NQO1 activity (H596 NSCLC and BE human colon carcinoma).
9865924	1999	Clin. Cancer Res.	1078-0432	ALL_TEXT_2/3	2	5	1728	SYMBOL|DICTIONARY|EXTRACTED	nqo1	NQO1	82#86	9865924-0-35-57	D003110	LONGTERM|DISEASE|DT|DICTIONARY	colon carcinoma	colon carcinoma	123#138		RH1 was, correspondingly, more cytotoxic to human tumor cells expressing elevated NQO1 activity (H460 NSCLC and HT29 human colon carcinoma), as measured by 3-(4,5-dimethylthiazol-2,5-diphenyl)tetrazolium assay, than it was to cells deficient in NQO1 activity (H596 NSCLC and BE human colon carcinoma).
9865924	1999	Clin. Cancer Res.	1078-0432	ALL_TEXT_2/3	2	5	1728	SYMBOL|DICTIONARY|EXTRACTED	nqo1	NQO1	82#86	9865924-0-35-57	D002289	LONGTERM|DICTIONARY|EXTRACTED	nsclc	NSCLC	265#270	9865924-1-92-118	RH1 was, correspondingly, more cytotoxic to human tumor cells expressing elevated NQO1 activity (H460 NSCLC and HT29 human colon carcinoma), as measured by 3-(4,5-dimethylthiazol-2,5-diphenyl)tetrazolium assay, than it was to cells deficient in NQO1 activity (H596 NSCLC and BE human colon carcinoma).
9865924	1999	Clin. Cancer Res.	1078-0432	ALL_TEXT_2/3	2	5	1728	SYMBOL|DICTIONARY|EXTRACTED	nqo1	NQO1	82#86	9865924-0-35-57	D003110	LONGTERM|DISEASE|DT|DICTIONARY	colon carcinoma	colon carcinoma	284#299		RH1 was, correspondingly, more cytotoxic to human tumor cells expressing elevated NQO1 activity (H460 NSCLC and HT29 human colon carcinoma), as measured by 3-(4,5-dimethylthiazol-2,5-diphenyl)tetrazolium assay, than it was to cells deficient in NQO1 activity (H596 NSCLC and BE human colon carcinoma).
9865924	1999	Clin. Cancer Res.	1078-0432	ALL_TEXT_2/3	2	5	1728	SYMBOL|DICTIONARY|EXTRACTED	nqo1	NQO1	245#249	9865924-0-35-57	D009369	LONGTERM|DISEASE|DT|CLINE|CN|DICTIONARY	tumor	tumor	50#55		RH1 was, correspondingly, more cytotoxic to human tumor cells expressing elevated NQO1 activity (H460 NSCLC and HT29 human colon carcinoma), as measured by 3-(4,5-dimethylthiazol-2,5-diphenyl)tetrazolium assay, than it was to cells deficient in NQO1 activity (H596 NSCLC and BE human colon carcinoma).
9865924	1999	Clin. Cancer Res.	1078-0432	ALL_TEXT_2/3	2	5	1728	SYMBOL|DICTIONARY|EXTRACTED	nqo1	NQO1	245#249	9865924-0-35-57	D002289	LONGTERM|DICTIONARY|EXTRACTED	nsclc	NSCLC	102#107	9865924-1-92-118	RH1 was, correspondingly, more cytotoxic to human tumor cells expressing elevated NQO1 activity (H460 NSCLC and HT29 human colon carcinoma), as measured by 3-(4,5-dimethylthiazol-2,5-diphenyl)tetrazolium assay, than it was to cells deficient in NQO1 activity (H596 NSCLC and BE human colon carcinoma).
9865924	1999	Clin. Cancer Res.	1078-0432	ALL_TEXT_2/3	2	5	1728	SYMBOL|DICTIONARY|EXTRACTED	nqo1	NQO1	245#249	9865924-0-35-57	D003110	LONGTERM|DISEASE|DT|DICTIONARY	colon carcinoma	colon carcinoma	123#138		RH1 was, correspondingly, more cytotoxic to human tumor cells expressing elevated NQO1 activity (H460 NSCLC and HT29 human colon carcinoma), as measured by 3-(4,5-dimethylthiazol-2,5-diphenyl)tetrazolium assay, than it was to cells deficient in NQO1 activity (H596 NSCLC and BE human colon carcinoma).
9865924	1999	Clin. Cancer Res.	1078-0432	ALL_TEXT_2/3	2	5	1728	SYMBOL|DICTIONARY|EXTRACTED	nqo1	NQO1	245#249	9865924-0-35-57	D002289	LONGTERM|DICTIONARY|EXTRACTED	nsclc	NSCLC	265#270	9865924-1-92-118	RH1 was, correspondingly, more cytotoxic to human tumor cells expressing elevated NQO1 activity (H460 NSCLC and HT29 human colon carcinoma), as measured by 3-(4,5-dimethylthiazol-2,5-diphenyl)tetrazolium assay, than it was to cells deficient in NQO1 activity (H596 NSCLC and BE human colon carcinoma).
9865924	1999	Clin. Cancer Res.	1078-0432	ALL_TEXT_2/3	2	5	1728	SYMBOL|DICTIONARY|EXTRACTED	nqo1	NQO1	245#249	9865924-0-35-57	D003110	LONGTERM|DISEASE|DT|DICTIONARY	colon carcinoma	colon carcinoma	284#299		RH1 was, correspondingly, more cytotoxic to human tumor cells expressing elevated NQO1 activity (H460 NSCLC and HT29 human colon carcinoma), as measured by 3-(4,5-dimethylthiazol-2,5-diphenyl)tetrazolium assay, than it was to cells deficient in NQO1 activity (H596 NSCLC and BE human colon carcinoma).
19383228	2009	J. Int. Med. Res.	0300-0605	ALL_TEXT_1/3	1	1	1636	LONGTERM|GENE|GT|DICTIONARY|GA	angiotensin converting enzyme	angiotensin-converting enzyme	52#81		D001249	LONGTERM|DICTIONARY	asthma	asthma	230#236		This study aimed to clarify the association between angiotensin-converting enzyme (ACE) gene polymorphisms and infant wheezing, and to determine whether an association may contribute to early prediction of persistent wheezing and asthma.
19383228	2009	J. Int. Med. Res.	0300-0605	ALL_TEXT_1/3	1	1	1636	SYMBOL|()|GENE|GN|DICTIONARY|EXTRACTED	ace	ACE	83#86	19383228-1-52-81	D001249	LONGTERM|DICTIONARY	asthma	asthma	230#236		This study aimed to clarify the association between angiotensin-converting enzyme (ACE) gene polymorphisms and infant wheezing, and to determine whether an association may contribute to early prediction of persistent wheezing and asthma.
20638926	2010	Cancer Epidemiol	1877-783X	PURPOSE	1	1	4487	SYMBOL|GENE|GN|DICTIONARY	msx1	MSX1	145#149		D001943	LONGTERM|DISEASE|DT|DICTIONARY	breast cancer	breast cancer	159#172		The aim of this study was to investigate the association of a 11 nucleotide deletion, the c.469+46_56del mutation, in the intron of the homeobox MSX1 gene and breast cancer occurrence and characteristics.
20638926	2010	Cancer Epidemiol	1877-783X	TITLE	0	0	4487	SYMBOL|GENE|GN|DICTIONARY	msx1	MSX1	44#48		D001943	LONGTERM|DISEASE|DT|DICTIONARY	breast cancer	breast cancer	78#91		The c.469+46_56del mutation in the homeobox MSX1 gene--a novel risk factor in breast cancer?
18200512	2008	Inflamm. Bowel Dis.	1078-0998	TITLE	0	0	4292	SYMBOL|DICTIONARY	mlh1	MLH1	18#22		D003093	LONGTERM|DICTIONARY	ulcerative colitis	ulcerative colitis	76#94		Evaluation of the MLH1 I219V alteration in DNA mismatch repair activity and ulcerative colitis.
18200512	2008	Inflamm. Bowel Dis.	1078-0998	BACKGROUND	1	3	4292	SYMBOL|DICTIONARY	mlh1	MLH1	8#12		C535541	SYMBOL|DISEASE|DN|DICTIONARY	ibd	IBD	131#134		Loss of MLH1 confers the characteristic microsatellite instability (MSI) phenotype which is also frequently found in the mucosa of IBD patients.
18200512	2008	Inflamm. Bowel Dis.	1078-0998	BACKGROUND	1	3	4292	SYMBOL|DICTIONARY	mlh1	MLH1	8#12		D053842	LONGTERM|DICTIONARY	microsatellite instability	microsatellite instability	40#66	NaN	Loss of MLH1 confers the characteristic microsatellite instability (MSI) phenotype which is also frequently found in the mucosa of IBD patients.
18200512	2008	Inflamm. Bowel Dis.	1078-0998	BACKGROUND	1	3	4292	SYMBOL|DICTIONARY	mlh1	MLH1	8#12		D053842	LONGTERM|DICTIONARY	msi	MSI	68#71	NaN	Loss of MLH1 confers the characteristic microsatellite instability (MSI) phenotype which is also frequently found in the mucosa of IBD patients.
18996923	2009	Hum. Mol. Genet.	1460-2083	ALL_TEXT_2/3	2	5	125	SYMBOL|DICTIONARY	adh1b	ADH1B	72#77		D005483	LONGTERM|DICTIONARY	flushing	flushing	103#111		There were study-wide significant associations (P<2.3 x 10(-4)) between ADH1B-Arg48His (rs1229984) and flushing and consumption, but only nominally significant associations (P<0.01) with dependence.
18996923	2009	Hum. Mol. Genet.	1460-2083	ALL_TEXT_2/3	2	5	125	SYMBOL|DICTIONARY	adh1b	ADH1B	72#77		D019966	LONGTERM|DICTIONARY	dependence	dependence	187#197		There were study-wide significant associations (P<2.3 x 10(-4)) between ADH1B-Arg48His (rs1229984) and flushing and consumption, but only nominally significant associations (P<0.01) with dependence.
18996923	2009	Hum. Mol. Genet.	1460-2083	ALL_TEXT_1/3	1	2	217	SYMBOL|DICTIONARY	aldh2	ALDH2	36#41		D000437	SYMBOL|EXTRACTED	ad	AD	55#57	18996923-1-0-18	The role of two genetic variants in ALDH2 and ADH1B in AD risk has been extensively investigated.
18996923	2009	Hum. Mol. Genet.	1460-2083	ALL_TEXT_1/3	1	2	125	SYMBOL|DICTIONARY	adh1b	ADH1B	46#51		D000437	SYMBOL|EXTRACTED	ad	AD	55#57	18996923-1-0-18	The role of two genetic variants in ALDH2 and ADH1B in AD risk has been extensively investigated.
18996923	2009	Hum. Mol. Genet.	1460-2083	ALL_TEXT_1/3	1	3	217	SYMBOL|DICTIONARY	aldh2	ALDH2	65#70		D005483	LONGTERM|DICTIONARY	flushing	flushing	122#130		This study tested for associations between nine polymorphisms in ALDH2 and 41 in the seven ADH genes, and alcohol-related flushing, alcohol use and dependence symptom scores in 4597 Australian twins.
18996923	2009	Hum. Mol. Genet.	1460-2083	ALL_TEXT_1/3	1	3	217	SYMBOL|DICTIONARY	aldh2	ALDH2	65#70		D019966	LONGTERM|DISEASE|DN|DICTIONARY	dependence	dependence	148#158		This study tested for associations between nine polymorphisms in ALDH2 and 41 in the seven ADH genes, and alcohol-related flushing, alcohol use and dependence symptom scores in 4597 Australian twins.
18996923	2009	Hum. Mol. Genet.	1460-2083	TITLE	0	0	217	SYMBOL|GENE|GN|DICTIONARY	aldh2	ALDH2	24#29		D019966	LONGTERM|DICTIONARY	dependence	dependence	97#107		Associations of ADH and ALDH2 gene variation with self report alcohol reactions, consumption and dependence: an integrated analysis.
16168297	2005	J. Am. Coll. Cardiol.	1558-3597	TITLE	0	0	4846	LONGTERM|DICTIONARY	endothelial nitric oxide synthase	endothelial nitric oxide synthase	24#57		D009203	LONGTERM|DICTIONARY	myocardial infarction	myocardial infarction	141#162		Genetic polymorphism on endothelial nitric oxide synthase affects endothelial activation and inflammatory response during the acute phase of myocardial infarction.
9550468	1998	Arthritis Rheum.	0004-3591	RESULTS	3	5	1493	SYMBOL|GENE|GN|DICTIONARY	ctla 4	CTLA-4	45#51		D008180	SYMBOL|DICTIONARY|EXTRACTED	sle	SLE	33#36	9550468-1-158-186	No association was found between SLE and the CTLA-4 gene.
11895223	2002	Clin. Endocrinol. (Oxf)	0300-0664	CONCLUSIONS	4	9	3126	SYMBOL|DICTIONARY	drb4	DRB4	87#91		D006111	LONGTERM|DISEASE|DT|DICTIONARY	graves disease	Graves' disease	23#38		Jamaican patients with Graves' disease share the DRB3 *0101 susceptible allele and the DRB4 *01 protective allele but not the susceptible haplotype DRB1 *0301, DRB3*0101, DQA1*0501 with Caucasians.
11895223	2002	Clin. Endocrinol. (Oxf)	0300-0664	CONCLUSIONS	4	9	3123	SYMBOL|DICTIONARY	drb1	DRB1	148#152		D006111	LONGTERM|DISEASE|DT|DICTIONARY	graves disease	Graves' disease	23#38		Jamaican patients with Graves' disease share the DRB3 *0101 susceptible allele and the DRB4 *01 protective allele but not the susceptible haplotype DRB1 *0301, DRB3*0101, DQA1*0501 with Caucasians.
11895223	2002	Clin. Endocrinol. (Oxf)	0300-0664	CONCLUSIONS	4	9	3117	LONGTERM|DICTIONARY	dqa1	DQA1	171#175	NaN	D006111	LONGTERM|DISEASE|DT|DICTIONARY	graves disease	Graves' disease	23#38		Jamaican patients with Graves' disease share the DRB3 *0101 susceptible allele and the DRB4 *01 protective allele but not the susceptible haplotype DRB1 *0301, DRB3*0101, DQA1*0501 with Caucasians.
18996923	2009	Hum. Mol. Genet.	1460-2083	ALL_TEXT_3/3	3	8	217	SYMBOL|DICTIONARY	aldh2	ALDH2	0#5		D005483	LONGTERM|DICTIONARY	flushing	flushing	40#48		ALDH2 variation was not associated with flushing or alcohol consumption, but was weakly associated with AD measures.
18996923	2009	Hum. Mol. Genet.	1460-2083	ALL_TEXT_3/3	3	8	217	SYMBOL|DICTIONARY	aldh2	ALDH2	0#5		D000437	SYMBOL|EXTRACTED	ad	AD	104#106	18996923-1-0-18	ALDH2 variation was not associated with flushing or alcohol consumption, but was weakly associated with AD measures.
18996923	2009	Hum. Mol. Genet.	1460-2083	ALL_TEXT_3/3	3	9	125	SYMBOL|DICTIONARY	adh1b	ADH1B	110#115		D005483	LONGTERM|DICTIONARY	flushing	flushing	167#175		These results bridge the gap between DNA sequence variation and alcohol-related behavior, confirming that the ADH1B-Arg48His polymorphism affects both alcohol-related flushing in Europeans and alcohol intake.
16359492	2006	Congenit Anom (Kyoto)	0914-3505	TITLE	0	0	1387	LONGTERM|GENE|GN|GT|DICTIONARY	creb binding protein	CREB-binding protein	27#47		D012415	LONGTERM|DISEASE|DT|DICTIONARY	rubinstein taybi syndrome	Rubinstein-Taybi syndrome	83#108		Comprehensive screening of CREB-binding protein gene mutations among patients with Rubinstein-Taybi syndrome using denaturing high-performance liquid chromatography.
20191381	2011	Breast Cancer Res. Treat.	1573-7217	ALL_TEXT_3/3	3	11	4595	SYMBOL|DICTIONARY	mutyh	MUTYH	49#54		D001943	LONGTERM|DISEASE|DN|DT|DICTIONARY	breast cancer	breast cancer	112#125		Together, our results indicate that heterozygous MUTYH mutations are associated with families that include both breast cancer patients and colorectal cancer patients, independent of which tumour type is more prevalent in the family.
20191381	2011	Breast Cancer Res. Treat.	1573-7217	ALL_TEXT_3/3	3	11	4595	SYMBOL|DICTIONARY	mutyh	MUTYH	49#54		D015179	LONGTERM|DISEASE|DN|DT|DICTIONARY	colorectal cancer	colorectal cancer	139#156		Together, our results indicate that heterozygous MUTYH mutations are associated with families that include both breast cancer patients and colorectal cancer patients, independent of which tumour type is more prevalent in the family.
20191381	2011	Breast Cancer Res. Treat.	1573-7217	ALL_TEXT_3/3	3	11	4595	SYMBOL|DICTIONARY	mutyh	MUTYH	49#54		D009369	LONGTERM|DISEASE|DT|GFAM|FN|DICTIONARY	tumour	tumour	188#194		Together, our results indicate that heterozygous MUTYH mutations are associated with families that include both breast cancer patients and colorectal cancer patients, independent of which tumour type is more prevalent in the family.
12579739	2004	Yan Ke Xue Bao	1000-4432	TITLE	0	0	6010	LONGTERM|DICTIONARY	rhodopsin	rhodopsin	13#22		D012174	LONGTERM|DICTIONARY	retinitis pigmentosa	retinitis pigmentosa	73#93		[Analysis of rhodopsin and peripherin/RDS genes in Chinese patients with retinitis pigmentosa].
12579739	2004	Yan Ke Xue Bao	1000-4432	TITLE	0	0	5630	LONGTERM|DICTIONARY	peripherin	peripherin	27#37		D012174	LONGTERM|DICTIONARY	retinitis pigmentosa	retinitis pigmentosa	73#93		[Analysis of rhodopsin and peripherin/RDS genes in Chinese patients with retinitis pigmentosa].
12579739	2004	Yan Ke Xue Bao	1000-4432	TITLE	0	0	5961	SYMBOL|GENE|GN|DICTIONARY	rds	RDS	38#41		D012174	LONGTERM|DICTIONARY	retinitis pigmentosa	retinitis pigmentosa	73#93		[Analysis of rhodopsin and peripherin/RDS genes in Chinese patients with retinitis pigmentosa].
12579739	2004	Yan Ke Xue Bao	1000-4432	PURPOSE	1	1	6010	LONGTERM|DICTIONARY	rhodopsin	rhodopsin	28#37		D012174	LONGTERM|DICTIONARY	retinitis pigmentosa	retinitis pigmentosa	91#111		To disclose the mutation of rhodopsin and peripherin/RDS genes among Chinese patients with retinitis pigmentosa as there was no identified mutation through sequencing reported in Chinese.
12579739	2004	Yan Ke Xue Bao	1000-4432	PURPOSE	1	1	5630	LONGTERM|DICTIONARY	peripherin	peripherin	42#52		D012174	LONGTERM|DICTIONARY	retinitis pigmentosa	retinitis pigmentosa	91#111		To disclose the mutation of rhodopsin and peripherin/RDS genes among Chinese patients with retinitis pigmentosa as there was no identified mutation through sequencing reported in Chinese.
12579739	2004	Yan Ke Xue Bao	1000-4432	PURPOSE	1	1	5961	SYMBOL|GENE|GN|DICTIONARY	rds	RDS	53#56		D012174	LONGTERM|DICTIONARY	retinitis pigmentosa	retinitis pigmentosa	91#111		To disclose the mutation of rhodopsin and peripherin/RDS genes among Chinese patients with retinitis pigmentosa as there was no identified mutation through sequencing reported in Chinese.
16154235	2006	Neurobiol. Aging	1558-1497	ALL_TEXT_2/3	2	3	7422	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	vegf	VEGF	4#8	16154235-2-49-83	D000544	LONGTERM|DICTIONARY	ad	AD	103#105	NaN	The VEGF gene is located at 6p21.3, a site several studies have shown to have significant linkage with AD, and a functional polymorphism within the VEGF promoter may alter the risk of developing AD.
16154235	2006	Neurobiol. Aging	1558-1497	ALL_TEXT_2/3	2	3	7422	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	vegf	VEGF	4#8	16154235-2-49-83	D000544	LONGTERM|DICTIONARY	ad	AD	195#197	NaN	The VEGF gene is located at 6p21.3, a site several studies have shown to have significant linkage with AD, and a functional polymorphism within the VEGF promoter may alter the risk of developing AD.
16154235	2006	Neurobiol. Aging	1558-1497	ALL_TEXT_2/3	2	3	7422	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	vegf	VEGF	148#152	16154235-2-49-83	D000544	LONGTERM|DICTIONARY	ad	AD	103#105	NaN	The VEGF gene is located at 6p21.3, a site several studies have shown to have significant linkage with AD, and a functional polymorphism within the VEGF promoter may alter the risk of developing AD.
16154235	2006	Neurobiol. Aging	1558-1497	ALL_TEXT_2/3	2	3	7422	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	vegf	VEGF	148#152	16154235-2-49-83	D000544	LONGTERM|DICTIONARY	ad	AD	195#197	NaN	The VEGF gene is located at 6p21.3, a site several studies have shown to have significant linkage with AD, and a functional polymorphism within the VEGF promoter may alter the risk of developing AD.
11556548	2001	J. Neuropathol. Exp. Neurol.	0022-3069	ALL_TEXT_3/3	3	8	4763	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	nf1	NF1	129#132	11556548-2-14-33	D001254	LONGTERM|DICTIONARY	pilocytic astrocytomas	pilocytic astrocytomas	51#73		The high rate of NF1 allele loss in NF1-associated pilocytic astrocytomas suggests a tumor initiating or promoting action of the NF1 gene in these patients.
11556548	2001	J. Neuropathol. Exp. Neurol.	0022-3069	ALL_TEXT_3/3	3	8	4763	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	nf1	NF1	129#132	11556548-2-14-33	D009369	LONGTERM|DISEASE|DT|DICTIONARY	tumor	tumor	85#90		The high rate of NF1 allele loss in NF1-associated pilocytic astrocytomas suggests a tumor initiating or promoting action of the NF1 gene in these patients.
12815595	2003	Hum. Mutat.	1098-1004	ALL_TEXT_3/3	3	8	10841	SYMBOL|DICTIONARY|EXTRACTED	ftcd	FTCD	120#124	12815595-1-207-242	C537425	LONGTERM|DICTIONARY	glutamate formiminotransferase deficiency	glutamate formiminotransferase deficiency	44#85		These mutations are the first identified in glutamate formiminotransferase deficiency and demonstrate that mutations in FTCD represent the molecular basis for the mild phenotype of this disease.
12815595	2003	Hum. Mutat.	1098-1004	ALL_TEXT_2/3	2	4	10841	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	ftcd	FTCD	32#36	12815595-1-207-242	C537425	LONGTERM|DICTIONARY	glutamate formiminotransferase deficiency	glutamate formiminotransferase deficiency	74#115		We found mutations in the human FTCD gene in three patients with putative glutamate formiminotransferase deficiency.
11556548	2001	J. Neuropathol. Exp. Neurol.	0022-3069	TITLE	0	0	4763	LONGTERM|DICTIONARY	nf1	NF1	8#11	NaN	D001254	LONGTERM|DICTIONARY	pilocytic astrocytomas	pilocytic astrocytomas	61#83		Loss of NF1 alleles distinguish sporadic from NF1-associated pilocytic astrocytomas.
11556548	2001	J. Neuropathol. Exp. Neurol.	0022-3069	TITLE	0	0	4763	LONGTERM|DICTIONARY	nf1	NF1	46#49	NaN	D001254	LONGTERM|DICTIONARY	pilocytic astrocytomas	pilocytic astrocytomas	61#83		Loss of NF1 alleles distinguish sporadic from NF1-associated pilocytic astrocytomas.
18026693	2008	Endocrine	1355-008X	ALL_TEXT_2/3	2	4	64135	SYMBOL|DICTIONARY	ifih1	IFIH1	33#38		D049970	LONGTERM|DICTIONARY	graves ophthalmopathy	Graves' ophthalmopathy	114#136		In addition, the distribution of IFIH1 genotypes was investigated in subgroups according to the onset age and the Graves' ophthalmopathy (GO).
18026693	2008	Endocrine	1355-008X	ALL_TEXT_2/3	2	4	64135	SYMBOL|DICTIONARY	ifih1	IFIH1	33#38		D049970	SYMBOL|EXTRACTED|()	go	GO	138#140	18026693-4-114-136	In addition, the distribution of IFIH1 genotypes was investigated in subgroups according to the onset age and the Graves' ophthalmopathy (GO).
12815595	2003	Hum. Mutat.	1098-1004	ALL_TEXT_1/3	1	1	10841	SYMBOL|()|DICTIONARY|EXTRACTED	ftcd	FTCD	244#248	12815595-1-207-242	C537425	LONGTERM|DICTIONARY	glutamate formiminotransferase deficiency	Glutamate formiminotransferase deficiency	0#41		Glutamate formiminotransferase deficiency, an autosomal recessive disorder and the second most common inborn error of folate metabolism, is presumed to be due to defects in the bifunctional enzyme glutamate formiminotransferase-cyclodeaminase (FTCD).
12815595	2003	Hum. Mutat.	1098-1004	ALL_TEXT_1/3	1	1	10841	SYMBOL|()|DICTIONARY|EXTRACTED	ftcd	FTCD	244#248	12815595-1-207-242	D030342	LONGTERM|DISEASE|DT|DICTIONARY	autosomal recessive disorder	autosomal recessive disorder	46#74		Glutamate formiminotransferase deficiency, an autosomal recessive disorder and the second most common inborn error of folate metabolism, is presumed to be due to defects in the bifunctional enzyme glutamate formiminotransferase-cyclodeaminase (FTCD).
12815595	2003	Hum. Mutat.	1098-1004	ALL_TEXT_1/3	1	1	10841	SYMBOL|()|DICTIONARY|EXTRACTED	ftcd	FTCD	244#248	12815595-1-207-242	D008661	LONGTERM|DICTIONARY	inborn error of folate metabolism	inborn error of folate metabolism	102#135	NaN	Glutamate formiminotransferase deficiency, an autosomal recessive disorder and the second most common inborn error of folate metabolism, is presumed to be due to defects in the bifunctional enzyme glutamate formiminotransferase-cyclodeaminase (FTCD).
15320482	2004	Orv Hetil	0030-6002	TITLE	0	0	64127	SYMBOL|DICTIONARY	nod2	NOD2	1#5		D003424	LONGTERM|DISEASE|DT|DICTIONARY	crohn disease	Crohn's disease	76#91		[NOD2/CARD15 mutations and genotype-phenotype correlations in patients with Crohn's disease. Hungarian multicenter study].
15320482	2004	Orv Hetil	0030-6002	TITLE	0	0	64127	SYMBOL|DICTIONARY	card15	CARD15	6#12		D003424	LONGTERM|DISEASE|DT|DICTIONARY	crohn disease	Crohn's disease	76#91		[NOD2/CARD15 mutations and genotype-phenotype correlations in patients with Crohn's disease. Hungarian multicenter study].
11556548	2001	J. Neuropathol. Exp. Neurol.	0022-3069	ALL_TEXT_2/3	2	4	7157	SYMBOL|GENE|GN|DICTIONARY	tp53	TP53	4#8		D009369	LONGTERM|DICTIONARY	tumors	tumors	82#88		The TP53 gene region on the short arm of chromosome 17 was also examined in these tumors using 3 markers.
16882462	2007	Ann Epidemiol	1047-2797	CONCLUSIONS	4	7	348	SYMBOL|EXTRACTED	apoe	apoE	68#72	16882462-1-60-76	D005705	LONGTERM|DISEASE|DT|DICTIONARY	gallbladder disease	gallbladder disease	96#115		These results suggest that independent of traditional risk factors, apoE genotype may influence gallbladder disease risk, particularly in whites.
20130978	2010	Cancer Causes Control	1573-7225	CONCLUSION	4	10	672	SYMBOL|NUMBER|DICTIONARY	brca1/2	BRCA1/2	115#122		D001943	SYMBOL|EXTRACTED	cbc	CBC	68#71	20130978-2-79-106	For two reproductive factors previously shown to be associated with CBC risk, we observed similar associations for BRCA1/2 carriers.
20130978	2010	Cancer Causes Control	1573-7225	CONCLUSION	4	10	675	SYMBOL|NUMBER|DICTIONARY	brca1/2	BRCA1/2	115#122		D001943	SYMBOL|EXTRACTED	cbc	CBC	68#71	20130978-2-79-106	For two reproductive factors previously shown to be associated with CBC risk, we observed similar associations for BRCA1/2 carriers.
18753723	2008	Int Heart J	1349-2365	TITLE	0	0	3569	LONGTERM|DICTIONARY	interleukin 6	interleukin-6	6#19		D003327	LONGTERM|DICTIONARY	coronary plaque complexity	coronary plaque complexity	57#83		Serum interleukin-6 levels, not genotype, correlate with coronary plaque complexity.
11762699	2002	Endocrine	1355-008X	ALL_TEXT_1/3	1	1	846	LONGTERM|GENE|GT|DICTIONARY|GA	calcium sensing receptor	calcium-sensing receptor	26#50		C537145	LONGTERM|DICTIONARY	familial hypocalciuric hypercalcemia	familial hypocalciuric hypercalcemia	112#148		Missense mutations in the calcium-sensing receptor (CaSR) gene have previously been identified in patients with familial hypocalciuric hypercalcemia (FHH) and neonatal severe hyperparathyroidism.
11762699	2002	Endocrine	1355-008X	ALL_TEXT_1/3	1	1	846	LONGTERM|GENE|GT|DICTIONARY|GA	calcium sensing receptor	calcium-sensing receptor	26#50		C537145	SYMBOL|EXTRACTED|()	fhh	FHH	150#153	11762699-1-112-148	Missense mutations in the calcium-sensing receptor (CaSR) gene have previously been identified in patients with familial hypocalciuric hypercalcemia (FHH) and neonatal severe hyperparathyroidism.
11762699	2002	Endocrine	1355-008X	ALL_TEXT_1/3	1	1	846	LONGTERM|GENE|GT|DICTIONARY|GA	calcium sensing receptor	calcium-sensing receptor	26#50		D006961	LONGTERM|DICTIONARY	hyperparathyroidism	hyperparathyroidism	175#194		Missense mutations in the calcium-sensing receptor (CaSR) gene have previously been identified in patients with familial hypocalciuric hypercalcemia (FHH) and neonatal severe hyperparathyroidism.
11762699	2002	Endocrine	1355-008X	ALL_TEXT_1/3	1	1	846	SYMBOL|()|GENE|GN|DICTIONARY|EXTRACTED	casr	CaSR	52#56	11762699-1-26-50	C537145	LONGTERM|DICTIONARY	familial hypocalciuric hypercalcemia	familial hypocalciuric hypercalcemia	112#148		Missense mutations in the calcium-sensing receptor (CaSR) gene have previously been identified in patients with familial hypocalciuric hypercalcemia (FHH) and neonatal severe hyperparathyroidism.
11762699	2002	Endocrine	1355-008X	ALL_TEXT_1/3	1	1	846	SYMBOL|()|GENE|GN|DICTIONARY|EXTRACTED	casr	CaSR	52#56	11762699-1-26-50	C537145	SYMBOL|EXTRACTED|()	fhh	FHH	150#153	11762699-1-112-148	Missense mutations in the calcium-sensing receptor (CaSR) gene have previously been identified in patients with familial hypocalciuric hypercalcemia (FHH) and neonatal severe hyperparathyroidism.
11762699	2002	Endocrine	1355-008X	ALL_TEXT_1/3	1	1	846	SYMBOL|()|GENE|GN|DICTIONARY|EXTRACTED	casr	CaSR	52#56	11762699-1-26-50	D006961	LONGTERM|DICTIONARY	hyperparathyroidism	hyperparathyroidism	175#194		Missense mutations in the calcium-sensing receptor (CaSR) gene have previously been identified in patients with familial hypocalciuric hypercalcemia (FHH) and neonatal severe hyperparathyroidism.
18753723	2008	Int Heart J	1349-2365	ALL_TEXT_1/3	1	2	3569	SYMBOL|DICTIONARY|EXTRACTED	il 6	IL-6	50#54	18753723-1-19-32	D003324	LONGTERM|DISEASE|DT|DICTIONARY	coronary artery disease	coronary artery disease	161#184		However, it is unknown whether the level of serum IL-6 or genetic IL-6 polymorphism is correlated with the complexity of coronary plaque in patients with stable coronary artery disease (CAD).
18753723	2008	Int Heart J	1349-2365	ALL_TEXT_1/3	1	2	3569	SYMBOL|DICTIONARY|EXTRACTED	il 6	IL-6	50#54	18753723-1-19-32	D003324	SYMBOL|()|DICTIONARY|EXTRACTED	cad	CAD	186#189	18753723-2-161-184	However, it is unknown whether the level of serum IL-6 or genetic IL-6 polymorphism is correlated with the complexity of coronary plaque in patients with stable coronary artery disease (CAD).
18753723	2008	Int Heart J	1349-2365	ALL_TEXT_1/3	1	2	3569	SYMBOL|DICTIONARY|EXTRACTED	il 6	IL-6	66#70	18753723-1-19-32	D003324	LONGTERM|DISEASE|DT|DICTIONARY	coronary artery disease	coronary artery disease	161#184		However, it is unknown whether the level of serum IL-6 or genetic IL-6 polymorphism is correlated with the complexity of coronary plaque in patients with stable coronary artery disease (CAD).
18753723	2008	Int Heart J	1349-2365	ALL_TEXT_1/3	1	2	3569	SYMBOL|DICTIONARY|EXTRACTED	il 6	IL-6	66#70	18753723-1-19-32	D003324	SYMBOL|()|DICTIONARY|EXTRACTED	cad	CAD	186#189	18753723-2-161-184	However, it is unknown whether the level of serum IL-6 or genetic IL-6 polymorphism is correlated with the complexity of coronary plaque in patients with stable coronary artery disease (CAD).
18698679	2008	World J. Gastroenterol.	1007-9327	METHODS	2	2	7124	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	tnf alpha	TNF-alpha	229#238	18698679-1-91-119	D003424	LONGTERM|DISEASE|DT|DICTIONARY	crohn disease	Crohn's disease	35#50		DNA samples from 388 patients with Crohn's disease (CD), 405 ulcerative colitis (UC), 27 indeterminate colitis (IC) and 201 randomly selected controls, from Canterbury, New Zealand were screened for 3 common polymorphisms in the TNF-alpha receptor: -238 G-->A, -308 G-->A and -857C-->T, using a Taqman assay.
18698679	2008	World J. Gastroenterol.	1007-9327	METHODS	2	2	7124	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	tnf alpha	TNF-alpha	229#238	18698679-1-91-119	D003424	SYMBOL|EXTRACTED|()	cd	CD	52#54	18698679-2-35-50	DNA samples from 388 patients with Crohn's disease (CD), 405 ulcerative colitis (UC), 27 indeterminate colitis (IC) and 201 randomly selected controls, from Canterbury, New Zealand were screened for 3 common polymorphisms in the TNF-alpha receptor: -238 G-->A, -308 G-->A and -857C-->T, using a Taqman assay.
18698679	2008	World J. Gastroenterol.	1007-9327	METHODS	2	2	7124	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	tnf alpha	TNF-alpha	229#238	18698679-1-91-119	D003093	LONGTERM|DICTIONARY	ulcerative colitis	ulcerative colitis	61#79		DNA samples from 388 patients with Crohn's disease (CD), 405 ulcerative colitis (UC), 27 indeterminate colitis (IC) and 201 randomly selected controls, from Canterbury, New Zealand were screened for 3 common polymorphisms in the TNF-alpha receptor: -238 G-->A, -308 G-->A and -857C-->T, using a Taqman assay.
18698679	2008	World J. Gastroenterol.	1007-9327	METHODS	2	2	7124	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	tnf alpha	TNF-alpha	229#238	18698679-1-91-119	D003093	SYMBOL|EXTRACTED|()	uc	UC	81#83	18698679-2-61-79	DNA samples from 388 patients with Crohn's disease (CD), 405 ulcerative colitis (UC), 27 indeterminate colitis (IC) and 201 randomly selected controls, from Canterbury, New Zealand were screened for 3 common polymorphisms in the TNF-alpha receptor: -238 G-->A, -308 G-->A and -857C-->T, using a Taqman assay.
18698679	2008	World J. Gastroenterol.	1007-9327	METHODS	2	2	7124	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	tnf alpha	TNF-alpha	229#238	18698679-1-91-119	D003092	LONGTERM|DICTIONARY	colitis	colitis	103#110		DNA samples from 388 patients with Crohn's disease (CD), 405 ulcerative colitis (UC), 27 indeterminate colitis (IC) and 201 randomly selected controls, from Canterbury, New Zealand were screened for 3 common polymorphisms in the TNF-alpha receptor: -238 G-->A, -308 G-->A and -857C-->T, using a Taqman assay.
18698679	2008	World J. Gastroenterol.	1007-9327	AIM	1	1	7124	SYMBOL|()|GENE|GN|DICTIONARY|EXTRACTED	tnf alpha	TNF-alpha	121#130	18698679-1-91-119	D015212	LONGTERM|DICTIONARY	inflammatory bowel diseases	inflammatory bowel diseases	157#184		To investigate the role that single nucleotide polymorphisms (SNPs) in the promoter of the tumour necrosis factor-alpha (TNF-alpha) gene play in the risk of inflammatory bowel diseases (IBDs) in a New Zealand population, in the context of international studies.
18698679	2008	World J. Gastroenterol.	1007-9327	AIM	1	1	7124	SYMBOL|()|GENE|GN|DICTIONARY|EXTRACTED	tnf alpha	TNF-alpha	121#130	18698679-1-91-119	D015212	SYMBOL|PLURAL|()|DICTIONARY|EXTRACTED	ibds	IBDs	186#190	18698679-1-157-184	To investigate the role that single nucleotide polymorphisms (SNPs) in the promoter of the tumour necrosis factor-alpha (TNF-alpha) gene play in the risk of inflammatory bowel diseases (IBDs) in a New Zealand population, in the context of international studies.
18698679	2008	World J. Gastroenterol.	1007-9327	TITLE	0	0	7124	LONGTERM|GENE|GN|DICTIONARY	tumor necrosis factor alpha	tumor necrosis factor-alpha	38#65		D015212	LONGTERM|DICTIONARY	inflammatory bowel diseases	inflammatory bowel diseases	79#106		Single nucleotide polymorphism in the tumor necrosis factor-alpha gene affects inflammatory bowel diseases risk.
18698679	2008	World J. Gastroenterol.	1007-9327	CONCLUSION	4	7	30829	SYMBOL|DICTIONARY	ibd3	IBD3	118#122		C535541	SYMBOL|DICTIONARY|EXTRACTED	ibd	IBD	200#203	18698679-1-157-184	TNF-alpha is a key cytokine known to play a role in inflammatory response, and the locus for the gene is found in the IBD3 region on chromosome 6p21, known to be associated with an increased risk for IBD.
18698679	2008	World J. Gastroenterol.	1007-9327	CONCLUSION	4	7	7124	LONGTERM|DICTIONARY	tnf-alpha	TNF-alpha	0#9	NaN	C535541	SYMBOL|DICTIONARY|EXTRACTED	ibd	IBD	200#203	18698679-1-157-184	TNF-alpha is a key cytokine known to play a role in inflammatory response, and the locus for the gene is found in the IBD3 region on chromosome 6p21, known to be associated with an increased risk for IBD.
12032588	2002	J. Hum. Genet.	1434-5161	TITLE	0	0	4000	LONGTERM|DICTIONARY	lamin a c	lamin A/C	18#27		D020389	LONGTERM|DISEASE|DT|DICTIONARY	autosomal dominant emery dreifuss muscular dystrophy	autosomal dominant Emery-Dreifuss muscular dystrophy	75#127		Identification of lamin A/C ( LMNA) gene mutations in Korean patients with autosomal dominant Emery-Dreifuss muscular dystrophy and limb-girdle muscular dystrophy 1B.
12032588	2002	J. Hum. Genet.	1434-5161	TITLE	0	0	4000	LONGTERM|DICTIONARY	lamin a c	lamin A/C	18#27		D049288	LONGTERM|DISEASE|DT|NUMBER|DICTIONARY	limb girdle muscular dystrophy	limb-girdle muscular dystrophy	132#162		Identification of lamin A/C ( LMNA) gene mutations in Korean patients with autosomal dominant Emery-Dreifuss muscular dystrophy and limb-girdle muscular dystrophy 1B.
12032588	2002	J. Hum. Genet.	1434-5161	TITLE	0	0	4000	SYMBOL|GENE|GN|DICTIONARY	lmna	LMNA	30#34		D020389	LONGTERM|DISEASE|DT|DICTIONARY	autosomal dominant emery dreifuss muscular dystrophy	autosomal dominant Emery-Dreifuss muscular dystrophy	75#127		Identification of lamin A/C ( LMNA) gene mutations in Korean patients with autosomal dominant Emery-Dreifuss muscular dystrophy and limb-girdle muscular dystrophy 1B.
12032588	2002	J. Hum. Genet.	1434-5161	TITLE	0	0	4000	SYMBOL|GENE|GN|DICTIONARY	lmna	LMNA	30#34		D049288	LONGTERM|DISEASE|DT|NUMBER|DICTIONARY	limb girdle muscular dystrophy	limb-girdle muscular dystrophy	132#162		Identification of lamin A/C ( LMNA) gene mutations in Korean patients with autosomal dominant Emery-Dreifuss muscular dystrophy and limb-girdle muscular dystrophy 1B.
18568133	2008	J Gastrointestin Liver Dis	1841-8724	BACKGROUND AND AIMS	1	1	3938	LONGTERM|DICTIONARY	lactase	Lactase	0#7	NaN	D005767	LONGTERM|DICTIONARY	gastrointestinal symptoms	gastrointestinal symptoms	31#56		Lactase non-persistence causes gastrointestinal symptoms after milk ingestion.
20208132	2010	Cell. Oncol.	1875-8606	RESULTS	3	7	596	SYMBOL|DICTIONARY	bcl 2	BCL-2	27#32		D009369	LONGTERM|DISEASE|DT|DICTIONARY	tumour	tumour	72#78		In contrast, antiapoptotic BCL-2 expression increased only during early tumour stages, whereas expression decreased in pT3 RCCs.
20208132	2010	Cell. Oncol.	1875-8606	RESULTS	3	7	596	SYMBOL|DICTIONARY	bcl 2	BCL-2	27#32		D002292	SYMBOL|PLURAL|DICTIONARY|EXTRACTED	rccs	RCCs	123#127	20208132-3-48-69	In contrast, antiapoptotic BCL-2 expression increased only during early tumour stages, whereas expression decreased in pT3 RCCs.
18698679	2008	World J. Gastroenterol.	1007-9327	CONCLUSION	4	8	7124	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	tnf alpha	TNF-alpha	24#33	18698679-1-91-119	D003093	SYMBOL|EXTRACTED	uc	UC	100#102	18698679-2-61-79	The -308 G/A SNP in the TNF-alpha promoter is functional, and may account in part for the increased UC risk associated with the IBD3 genomic region.
18698679	2008	World J. Gastroenterol.	1007-9327	CONCLUSION	4	8	30829	SYMBOL|DICTIONARY	ibd3	IBD3	128#132		D003093	SYMBOL|EXTRACTED	uc	UC	100#102	18698679-2-61-79	The -308 G/A SNP in the TNF-alpha promoter is functional, and may account in part for the increased UC risk associated with the IBD3 genomic region.
19408338	2009	Inflamm. Bowel Dis.	1536-4844	BACKGROUND	1	2	2312	LONGTERM|DICTIONARY	filaggrin	Filaggrin	0#9		D004485	LONGTERM|DICTIONARY	eczema	eczema	77#83		Filaggrin (FLG) loss-of-function variants (null-alleles) are associated with eczema and asthma in association with eczema.
19408338	2009	Inflamm. Bowel Dis.	1536-4844	BACKGROUND	1	2	2312	LONGTERM|DICTIONARY	filaggrin	Filaggrin	0#9		D001249	LONGTERM|DICTIONARY	asthma	asthma	88#94		Filaggrin (FLG) loss-of-function variants (null-alleles) are associated with eczema and asthma in association with eczema.
19408338	2009	Inflamm. Bowel Dis.	1536-4844	BACKGROUND	1	2	2312	LONGTERM|DICTIONARY	filaggrin	Filaggrin	0#9		D004485	LONGTERM|DICTIONARY	eczema	eczema	115#121		Filaggrin (FLG) loss-of-function variants (null-alleles) are associated with eczema and asthma in association with eczema.
19408338	2009	Inflamm. Bowel Dis.	1536-4844	BACKGROUND	1	2	2312	SYMBOL|()|DICTIONARY|EXTRACTED	flg	FLG	11#14	19408338-2-0-9	D004485	LONGTERM|DICTIONARY	eczema	eczema	77#83		Filaggrin (FLG) loss-of-function variants (null-alleles) are associated with eczema and asthma in association with eczema.
19408338	2009	Inflamm. Bowel Dis.	1536-4844	BACKGROUND	1	2	2312	SYMBOL|()|DICTIONARY|EXTRACTED	flg	FLG	11#14	19408338-2-0-9	D001249	LONGTERM|DICTIONARY	asthma	asthma	88#94		Filaggrin (FLG) loss-of-function variants (null-alleles) are associated with eczema and asthma in association with eczema.
19408338	2009	Inflamm. Bowel Dis.	1536-4844	BACKGROUND	1	2	2312	SYMBOL|()|DICTIONARY|EXTRACTED	flg	FLG	11#14	19408338-2-0-9	D004485	LONGTERM|DICTIONARY	eczema	eczema	115#121		Filaggrin (FLG) loss-of-function variants (null-alleles) are associated with eczema and asthma in association with eczema.
19350278	2009	Pediatr. Nephrol.	1432-198X	ALL_TEXT_3/3	3	9	6092	SYMBOL|DICTIONARY	robo2	ROBO2	34#39		D014718	SYMBOL|DICTIONARY|EXTRACTED	vur	VUR	69#72	19350278-1-23-45	We conclude that gene variants in ROBO2 and SLIT2 are rare causes of VUR in humans.
19350278	2009	Pediatr. Nephrol.	1432-198X	ALL_TEXT_3/3	3	9	9353	SYMBOL|DICTIONARY	slit2	SLIT2	44#49		D014718	SYMBOL|DICTIONARY|EXTRACTED	vur	VUR	69#72	19350278-1-23-45	We conclude that gene variants in ROBO2 and SLIT2 are rare causes of VUR in humans.
15279649	2004	Eur. J. Oral Sci.	0909-8836	ALL_TEXT_3/3	3	5	64127	SYMBOL|DICTIONARY	nod2	NOD2	47#51		D010518	LONGTERM|DICTIONARY	periodontitis	periodontitis	84#97		The prevalence of the 3020insC mutation of the NOD2/CARD15 protein in patients with periodontitis was 1.9% (three of 160) and that for the control group was 2.0% (five of 244) (P = 0.942).
15279649	2004	Eur. J. Oral Sci.	0909-8836	ALL_TEXT_3/3	3	5	64127	SYMBOL|GENE|GN|DICTIONARY	card15	CARD15	52#58		D010518	LONGTERM|DICTIONARY	periodontitis	periodontitis	84#97		The prevalence of the 3020insC mutation of the NOD2/CARD15 protein in patients with periodontitis was 1.9% (three of 160) and that for the control group was 2.0% (five of 244) (P = 0.942).
15956634	2005	JAMA	1538-3598	CONTEXT	1	1	348	LONGTERM|DICTIONARY|GENE|GA	apolipoprotein e	Apolipoprotein E	0#16		D003928	LONGTERM|DICTIONARY	diabetic nephropathy	diabetic nephropathy	65#85		Apolipoprotein E (APOE) genetic variation has been implicated in diabetic nephropathy with the epsilon2 allele increasing and the epsilon4 allele decreasing risk.
15956634	2005	JAMA	1538-3598	CONTEXT	1	1	348	SYMBOL|()|GENE|GN|DICTIONARY|EXTRACTED	apoe	APOE	18#22	15956634-1-0-16	D003928	LONGTERM|DICTIONARY	diabetic nephropathy	diabetic nephropathy	65#85		Apolipoprotein E (APOE) genetic variation has been implicated in diabetic nephropathy with the epsilon2 allele increasing and the epsilon4 allele decreasing risk.
14563640	2004	Blood	0006-4971	ALL_TEXT_1/3	1	1	11093	SYMBOL|GENE|GN|DICTIONARY	adamts13	ADAMTS13	38#46		D011697	LONGTERM|DISEASE|DT|DICTIONARY	upshaw schulman syndrome	Upshaw-Schulman syndrome	68#92		We report here 7 new mutations in the ADAMTS13 gene responsible for Upshaw-Schulman syndrome (USS), a catastrophic phenotype of congenital thrombotic thrombocytopenic purpura, by analyzing 5 Japanese families.
14563640	2004	Blood	0006-4971	ALL_TEXT_1/3	1	1	11093	SYMBOL|GENE|GN|DICTIONARY	adamts13	ADAMTS13	38#46		D011697	SYMBOL|()|DICTIONARY|EXTRACTED	uss	USS	94#97	14563640-1-68-92	We report here 7 new mutations in the ADAMTS13 gene responsible for Upshaw-Schulman syndrome (USS), a catastrophic phenotype of congenital thrombotic thrombocytopenic purpura, by analyzing 5 Japanese families.
14563640	2004	Blood	0006-4971	ALL_TEXT_1/3	1	1	11093	SYMBOL|GENE|GN|DICTIONARY	adamts13	ADAMTS13	38#46		D011697	LONGTERM|DICTIONARY	congenital thrombotic thrombocytopenic purpura	congenital thrombotic thrombocytopenic purpura	128#174		We report here 7 new mutations in the ADAMTS13 gene responsible for Upshaw-Schulman syndrome (USS), a catastrophic phenotype of congenital thrombotic thrombocytopenic purpura, by analyzing 5 Japanese families.
14563640	2004	Blood	0006-4971	ALL_TEXT_1/3	1	1	11093	SYMBOL|GENE|GN|DICTIONARY	adamts13	ADAMTS13	38#46		D002388	LONGTERM|DICTIONARY	catastrophic	catastrophic	102#114	NaN	We report here 7 new mutations in the ADAMTS13 gene responsible for Upshaw-Schulman syndrome (USS), a catastrophic phenotype of congenital thrombotic thrombocytopenic purpura, by analyzing 5 Japanese families.
11159742	2001	Carcinogenesis	0143-3334	ALL_TEXT_3/3	3	9	2944	SYMBOL|DICTIONARY	gstm1	GSTM1	76#81		D010051	LONGTERM|DICTIONARY	ovarian cancers	ovarian cancers	195#210		When stratified according to histological subtype a significantly increased GSTM1 null genotype was only observed for the endometrioid (65.4%, P = 0.013) and the combined endometrioid/clear cell ovarian cancers (67.0%, P = 0.004).
11159742	2001	Carcinogenesis	0143-3334	ALL_TEXT_3/3	3	8	2944	SYMBOL|DICTIONARY	gstm1	GSTM1	32#37		D010051	LONGTERM|DISEASE|DT|DICTIONARY	ovarian cancer	ovarian cancer	7#21		In the ovarian cancer group the GSTM1 null genotype was significantly elevated compared with controls (59.0 versus 48.9%, P = 0.025).
14563640	2004	Blood	0006-4971	ALL_TEXT_3/3	3	5	11093	SYMBOL|GENE|GN|DICTIONARY	adamts13	ADAMTS13	246#254		D011697	SYMBOL|DICTIONARY|EXTRACTED	uss	USS	133#136	14563640-1-68-92	Taken together with the findings in our recent report we determined the responsible mutations in a total of 7 Japanese patients with USS with a uniform clinical picture of severe neonatal hyperbilirubinemia, and in their family members, based on ADAMTS13 gene analysis.
14563640	2004	Blood	0006-4971	ALL_TEXT_3/3	3	5	11093	SYMBOL|GENE|GN|DICTIONARY	adamts13	ADAMTS13	246#254		D051556	LONGTERM|DICTIONARY	neonatal hyperbilirubinemia	neonatal hyperbilirubinemia	179#206		Taken together with the findings in our recent report we determined the responsible mutations in a total of 7 Japanese patients with USS with a uniform clinical picture of severe neonatal hyperbilirubinemia, and in their family members, based on ADAMTS13 gene analysis.
11159742	2001	Carcinogenesis	0143-3334	TITLE	0	0	2944	SYMBOL|DICTIONARY	gstm1	GSTM1	0#5		D010051	LONGTERM|DICTIONARY	endometriosis and ovarian cancer	endometriosis and ovarian cancer	46#78		GSTM1 null polymorphism and susceptibility to endometriosis and ovarian cancer.
11159742	2001	Carcinogenesis	0143-3334	TITLE	0	0	2944	SYMBOL|DICTIONARY	gstm1	GSTM1	0#5		D010051	LONGTERM|DISEASE|DT|DICTIONARY	endometriosis and ovarian cancer	endometriosis and ovarian cancer	46#78		GSTM1 null polymorphism and susceptibility to endometriosis and ovarian cancer.
11159742	2001	Carcinogenesis	0143-3334	ALL_TEXT_3/3	3	7	2944	SYMBOL|DICTIONARY	gstm1	GSTM1	21#26		D004715	LONGTERM|DISEASE|DN|DICTIONARY	endometriosis	endometriosis	71#84		The frequency of the GSTM1 null allele was not over-represented in the endometriosis patients (47.6%) compared with the controls (48.9%) (P = 0.898).
11159742	2001	Carcinogenesis	0143-3334	ALL_TEXT_2/3	2	5	2944	SYMBOL|DICTIONARY	gstm1	GSTM1	35#40		D004715	LONGTERM|NUMBER|DICTIONARY	endometriosis	endometriosis	87#100		In this study the frequency of the GSTM1 null genotype was investigated in 84 cases of endometriosis, 293 cases of ovarian cancer and 219 controls.
11159742	2001	Carcinogenesis	0143-3334	ALL_TEXT_2/3	2	5	2944	SYMBOL|DICTIONARY	gstm1	GSTM1	35#40		D010051	LONGTERM|DISEASE|DT|DICTIONARY	ovarian cancer	ovarian cancer	115#129		In this study the frequency of the GSTM1 null genotype was investigated in 84 cases of endometriosis, 293 cases of ovarian cancer and 219 controls.
11159742	2001	Carcinogenesis	0143-3334	ALL_TEXT_2/3	2	4	2944	SYMBOL|()|GENE|GN|DICTIONARY	gstm1	GSTM1	69#74		D004715	LONGTERM|DISEASE|DN|DICTIONARY	endometriosis	endometriosis	133#146		The null genetic polymorphism in the gene encoding the GST class mu (GSTM1) enzyme has been reported to be significantly elevated in endometriosis patients and may represent an endometriosis susceptibility allele.
11159742	2001	Carcinogenesis	0143-3334	ALL_TEXT_2/3	2	4	2944	SYMBOL|()|GENE|GN|DICTIONARY	gstm1	GSTM1	69#74		D004715	LONGTERM|DICTIONARY	endometriosis	endometriosis	177#190		The null genetic polymorphism in the gene encoding the GST class mu (GSTM1) enzyme has been reported to be significantly elevated in endometriosis patients and may represent an endometriosis susceptibility allele.
11719088	2002	Mutat. Res.	0027-5107	TITLE	0	0	3845	LONGTERM|DICTIONARY	k-ras	K-ras	40#45	NaN	D010190	LONGTERM|DISEASE|DT|DICTIONARY	pancreatic cancer	pancreatic cancer	64#81		DNA adducts, genetic polymorphisms, and K-ras mutation in human pancreatic cancer.
20208132	2010	Cell. Oncol.	1875-8606	RESULTS	3	8	835	LONGTERM|DICTIONARY	caspase 2	caspase-2	10#19		D002292	SYMBOL|CLINE|CN|DICTIONARY|EXTRACTED	rcc	RCC	34#37	20208132-3-48-69	In vitro, caspase-2 activation in RCC cell lines coincidenced with sensitivity of tumour cells towards Topotecan-induced apoptosis.
20208132	2010	Cell. Oncol.	1875-8606	RESULTS	3	8	835	LONGTERM|DICTIONARY	caspase 2	caspase-2	10#19		D009369	LONGTERM|DISEASE|DT|CLINE|CN|DICTIONARY	tumour	tumour	82#88		In vitro, caspase-2 activation in RCC cell lines coincidenced with sensitivity of tumour cells towards Topotecan-induced apoptosis.
17203290	2007	Immunogenetics	0093-7711	ALL_TEXT_3/3	3	12	3565	SYMBOL|DICTIONARY	il 4	IL-4	78#82		D007676	SYMBOL|DISEASE|DN|DICTIONARY|EXTRACTED	esrd	ESRD	55#59	17203290-1-29-52	Further, combined analysis implicated a higher risk in ESRD patients with low IL-4 and high IL-6 producing genotypes.
17203290	2007	Immunogenetics	0093-7711	ALL_TEXT_3/3	3	12	3569	SYMBOL|DICTIONARY	il 6	IL-6	92#96		D007676	SYMBOL|DISEASE|DN|DICTIONARY|EXTRACTED	esrd	ESRD	55#59	17203290-1-29-52	Further, combined analysis implicated a higher risk in ESRD patients with low IL-4 and high IL-6 producing genotypes.
17203290	2007	Immunogenetics	0093-7711	ALL_TEXT_3/3	3	11	3565	SYMBOL|DICTIONARY	il 4	IL-4	40#44		D007676	SYMBOL|DICTIONARY|EXTRACTED	esrd	ESRD	95#99	17203290-1-29-52	Our study suggests that polymorphism in IL-4 and IL-6 may be associated with susceptibility to ESRD.
17203290	2007	Immunogenetics	0093-7711	ALL_TEXT_3/3	3	11	3569	SYMBOL|DICTIONARY	il 6	IL-6	49#53		D007676	SYMBOL|DICTIONARY|EXTRACTED	esrd	ESRD	95#99	17203290-1-29-52	Our study suggests that polymorphism in IL-4 and IL-6 may be associated with susceptibility to ESRD.
17203290	2007	Immunogenetics	0093-7711	ALL_TEXT_3/3	3	10	3565	SYMBOL|DICTIONARY	il 4	IL-4	112#116		D009100	LONGTERM|DICTIONARY	combinations	combinations	87#99	NaN	>threefolds risk (odds ratio=3.48, 95%CI=1.88-6.42; p < 0.001) among the four possible combinations taking high IL-4 and low IL-6 as reference.
17203290	2007	Immunogenetics	0093-7711	ALL_TEXT_3/3	3	10	3569	SYMBOL|DICTIONARY	il 6	IL-6	125#129		D009100	LONGTERM|DICTIONARY	combinations	combinations	87#99	NaN	>threefolds risk (odds ratio=3.48, 95%CI=1.88-6.42; p < 0.001) among the four possible combinations taking high IL-4 and low IL-6 as reference.
19390641	2009	Mol. Vis.	1090-0535	CONCLUSIONS	4	13	6247	LONGTERM|DICTIONARY	xlrs	XLRS	141#145	NaN	D041441	SYMBOL|EXTRACTED	xlrs	XLRS	141#145	19390641-1-0-22	A missense mutation was the predominant type, and common or founder mutations were not observed in the Korean patients in this study who had XLRS.
7769500	1995	J Hypertens Suppl	0952-1178	OBJECTIVE	1	1	3643	LONGTERM|GENE|GN|GT|DICTIONARY	insulin receptor	insulin receptor	58#74		D006973	LONGTERM|DICTIONARY	hypertension	hypertension	116#128		To determine whether a microsatellite polymorphism of the insulin receptor gene (INSR) is associated with essential hypertension, as has been demonstrated previously for an RsaI restriction fragment length polymorphism (RFLP), and to examine blood pressure and plasma lipid profiles in relation to genotype.
14695540	2004	Hum. Mutat.	1098-1004	ALL_TEXT_3/3	3	8	2200	SYMBOL|DICTIONARY|EXTRACTED	fbn1	FBN1	70#74	14695540-1-105-116	D004479	LONGTERM|DICTIONARY	ectopia lentis	ectopia lentis	109#123		Genotype-phenotype analysis revealed that patients with an identified FBN1 mutation were more likely to have ectopia lentis and cardiovascular complications compared to those without an identifiable mutation (relative risks of 4.6 and 1.9, respectively).
14695540	2004	Hum. Mutat.	1098-1004	ALL_TEXT_3/3	3	8	2200	SYMBOL|DICTIONARY|EXTRACTED	fbn1	FBN1	70#74	14695540-1-105-116	D002318	LONGTERM|DICTIONARY	cardiovascular complications	cardiovascular complications	128#156	NaN	Genotype-phenotype analysis revealed that patients with an identified FBN1 mutation were more likely to have ectopia lentis and cardiovascular complications compared to those without an identifiable mutation (relative risks of 4.6 and 1.9, respectively).
16313808	2007	Zhonghua Yi Xue Za Zhi	0376-2491	CONCLUSION	4	9	3586	LONGTERM|DICTIONARY	il-10a	IL-10A	4#10	NaN	D001161	SYMBOL|EXTRACTED	as	AS	82#84	16313808-1-218-234	The IL-10A/A genotype is a predictable factor of microinflammatory state and high AS incidence rate in ESRD patients.
16313808	2007	Zhonghua Yi Xue Za Zhi	0376-2491	CONCLUSION	4	9	3586	LONGTERM|DICTIONARY	il-10a	IL-10A	4#10	NaN	D007676	SYMBOL|DISEASE|DN|DICTIONARY|EXTRACTED	esrd	ESRD	103#107	16313808-1-150-173	The IL-10A/A genotype is a predictable factor of microinflammatory state and high AS incidence rate in ESRD patients.
16181776	2006	Prostaglandins Leukot. Essent. Fatty Acids	0952-3278	ALL_TEXT_2/3	2	3	5321	SYMBOL|GENE|GN|DICTIONARY	pla2g4a	PLA2G4A	105#112		D012559	LONGTERM|DICTIONARY	schizophrenia	schizophrenia	138#151		The transmission disequilibrium test (TDT) showed that BanI-SNP located in the 5'-flanking region of the PLA2G4A gene was associated with schizophrenia (chi(2) = 5.16, P = 0.023) although the others failed to show such allelic associations.
7706461	1995	J. Clin. Invest.	0021-9738	TITLE	0	0	3674	SYMBOL|DICTIONARY	gpiib	GPIIb	129#134		D013915	LONGTERM|DICTIONARY	glanzmann thrombasthenia	Glanzmann thrombasthenia	0#24		Glanzmann thrombasthenia resulting from a single amino acid substitution between the second and third calcium-binding domains of GPIIb. Role of the GPIIb amino terminus in integrin subunit association.
7706461	1995	J. Clin. Invest.	0021-9738	TITLE	0	0	3674	SYMBOL|DICTIONARY	gpiib	GPIIb	148#153		D013915	LONGTERM|DICTIONARY	glanzmann thrombasthenia	Glanzmann thrombasthenia	0#24		Glanzmann thrombasthenia resulting from a single amino acid substitution between the second and third calcium-binding domains of GPIIb. Role of the GPIIb amino terminus in integrin subunit association.
18362425	2008	Circ. J.	1346-9843	CONCLUSIONS	3	9	2778	SYMBOL|DICTIONARY	gnas1	GNAS1	72#77		D019462	LONGTERM|DICTIONARY	vasovagal syncope	vasovagal syncope	22#39		The predisposition to vasovagal syncope seems to be associated with the GNAS1 FokI+ allele.
12168876	2002	Anticancer Res.	0250-7005	ALL_TEXT_2/3	2	4	354	SYMBOL|DICTIONARY|EXTRACTED	psa	PSA	40#43	12168876-1-50-75	D001943	LONGTERM|DISEASE|DT|DICTIONARY	breast cancer	breast cancer	61#74		To test this hypothesis, we assayed the PSA genotype for 101 breast cancer cases.
12168876	2002	Anticancer Res.	0250-7005	ALL_TEXT_3/3	3	5	57534	SYMBOL|DICTIONARY	mib 1	MIB-1	70#75		D009369	LONGTERM|DICTIONARY	tumors	tumors	100#106		We also performed immunostaining analysis for estrogen receptor, p53, MIB-1 and c-erbB-2 on all the tumors.
12168876	2002	Anticancer Res.	0250-7005	ALL_TEXT_3/3	3	5	2064	SYMBOL|DICTIONARY	c-erbb-2	c-erbB-2	80#88		D009369	LONGTERM|DICTIONARY	tumors	tumors	100#106		We also performed immunostaining analysis for estrogen receptor, p53, MIB-1 and c-erbB-2 on all the tumors.
12168876	2002	Anticancer Res.	0250-7005	ALL_TEXT_3/3	3	5	7157	LONGTERM|DICTIONARY	p53	p53	65#68	NaN	D009369	LONGTERM|DICTIONARY	tumors	tumors	100#106		We also performed immunostaining analysis for estrogen receptor, p53, MIB-1 and c-erbB-2 on all the tumors.
12168876	2002	Anticancer Res.	0250-7005	ALL_TEXT_1/3	1	2	354	SYMBOL|DICTIONARY|EXTRACTED	psa	PSA	79#82	12168876-1-50-75	D009369	LONGTERM|DICTIONARY	tumors	tumors	60#66		Furthermore, we have found that A-AA occurred frequently in tumors with higher PSA expressions.
12168876	2002	Anticancer Res.	0250-7005	TITLE	0	0	354	LONGTERM|GENE|GN|DICTIONARY	prostate specific antigen	prostate-specific antigen	15#40		D001943	LONGTERM|DISEASE|DT|DICTIONARY	breast cancer	breast cancer	108#121		Correlation of prostate-specific antigen promoter polymorphisms with clinicopathological characteristics in breast cancer.
15018693	2004	J Geriatr Psychiatry Neurol	0891-9887	ALL_TEXT_2/3	2	3	348	SYMBOL|DICTIONARY	apoe	APOE	114#118		D000544	SYMBOL|DISEASE|DN|DICTIONARY|EXTRACTED	ad	AD	68#70	15018693-1-47-66	The objective of this study was to determine if sleep parameters in AD patients change over time as a function of APOE carrier status.
18362425	2008	Circ. J.	1346-9843	BACKGROUND	1	2	2778	SYMBOL|DICTIONARY	gnas1	GNAS1	45#50		D006258	LONGTERM|DICTIONARY	head-up tilt test	head-up tilt test	119#136	NaN	The aim of the present study was to evaluate GNAS1 T/C,Ile 131 mutation's manifestation in syncopal patients regarding head-up tilt test (HUTT) results.
18362425	2008	Circ. J.	1346-9843	BACKGROUND	1	2	2778	SYMBOL|DICTIONARY	gnas1	GNAS1	45#50		D006258	LONGTERM|DICTIONARY	hutt	HUTT	138#142	NaN	The aim of the present study was to evaluate GNAS1 T/C,Ile 131 mutation's manifestation in syncopal patients regarding head-up tilt test (HUTT) results.
18362425	2008	Circ. J.	1346-9843	BACKGROUND	1	2	2778	SYMBOL|DICTIONARY	gnas1	GNAS1	45#50		D013575	LONGTERM|DICTIONARY	syncopal	syncopal	91#99	NaN	The aim of the present study was to evaluate GNAS1 T/C,Ile 131 mutation's manifestation in syncopal patients regarding head-up tilt test (HUTT) results.
18362425	2008	Circ. J.	1346-9843	METHODS AND RESULTS	2	3	2778	SYMBOL|DICTIONARY	gnas1	GNAS1	97#102		D013575	LONGTERM|DICTIONARY	syncopal	syncopal	7#15	NaN	In 137 syncopal patients (without any other diseases) the silent T/C,Ile 131 mutation within the GNAS1 codon on chromosome 20 q was identified.
9070496	1997	Cancer	0008-543X	BACKGROUND	1	3	355	LONGTERM|DICTIONARY	fas antigen	Fas antigen	0#11	NaN	D064420	LONGTERM|DICTIONARY	cytotoxicity	cytotoxicity	48#60	NaN	Fas antigen (Fas) and Fas ligand participate in cytotoxicity mediated by T lymphocytes and natural killer cells.
9070496	1997	Cancer	0008-543X	BACKGROUND	1	3	356	LONGTERM|DICTIONARY	fas ligand	Fas ligand	22#32	NaN	D064420	LONGTERM|DICTIONARY	cytotoxicity	cytotoxicity	48#60	NaN	Fas antigen (Fas) and Fas ligand participate in cytotoxicity mediated by T lymphocytes and natural killer cells.
17898867	2007	Neoplasia	1476-5586	ALL_TEXT_1/3	1	2	1636	SYMBOL|DICTIONARY|EXTRACTED	ace	ACE	20#23	17898867-1-40-71	D000236	LONGTERM|DICTIONARY	adenomas	adenomas	145#153		Local expression of ACE was investigated by quantitative reverse transcription-polymerase chain reaction and by immunohistochemistry in CRCs and adenomas.
21300947	2011	Arch. Gen. Psychiatry	1538-3636	CONTEXT	1	3	627	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	bdnf	BDNF	60#64	21300947-1-4-37	D000544	SYMBOL|EXTRACTED	ad	AD	101#103	21300947-1-100-117	Imaging-genetics strategies may clarify the manner in which BDNF gene variation predicts the risk of AD via characterization of its effects on at-risk structures or neural networks susceptible in this disorder.
7581378	1995	Hum. Mol. Genet.	0964-6906	ALL_TEXT_1/3	1	1	2263	LONGTERM|DICTIONARY|GENE|GA	fibroblast growth factor receptor 2	fibroblast growth factor receptor 2	26#61		D003398	LONGTERM|DICTIONARY	craniosynostosis syndromes	craniosynostosis syndromes	147#173		Dominant mutations in the fibroblast growth factor receptor 2 (FGFR2) gene have been recently identified as causes of four phenotypically distinct craniosynostosis syndromes, including Crouzon, Jackson-Weiss, Pfeiffer, and Apert syndromes.
7581378	1995	Hum. Mol. Genet.	0964-6906	ALL_TEXT_1/3	1	1	2263	LONGTERM|DICTIONARY|GENE|GA	fibroblast growth factor receptor 2	fibroblast growth factor receptor 2	26#61		C538582	LONGTERM|DICTIONARY	pfeiffer, and apert syndromes	Pfeiffer, and Apert syndromes	209#238		Dominant mutations in the fibroblast growth factor receptor 2 (FGFR2) gene have been recently identified as causes of four phenotypically distinct craniosynostosis syndromes, including Crouzon, Jackson-Weiss, Pfeiffer, and Apert syndromes.
7581378	1995	Hum. Mol. Genet.	0964-6906	ALL_TEXT_1/3	1	1	2263	SYMBOL|()|GENE|GN|DICTIONARY|EXTRACTED	fgfr2	FGFR2	63#68	7581378-1-26-61	D003398	LONGTERM|DICTIONARY	craniosynostosis syndromes	craniosynostosis syndromes	147#173		Dominant mutations in the fibroblast growth factor receptor 2 (FGFR2) gene have been recently identified as causes of four phenotypically distinct craniosynostosis syndromes, including Crouzon, Jackson-Weiss, Pfeiffer, and Apert syndromes.
7581378	1995	Hum. Mol. Genet.	0964-6906	ALL_TEXT_1/3	1	1	2263	SYMBOL|()|GENE|GN|DICTIONARY|EXTRACTED	fgfr2	FGFR2	63#68	7581378-1-26-61	C538582	LONGTERM|DICTIONARY	pfeiffer, and apert syndromes	Pfeiffer, and Apert syndromes	209#238		Dominant mutations in the fibroblast growth factor receptor 2 (FGFR2) gene have been recently identified as causes of four phenotypically distinct craniosynostosis syndromes, including Crouzon, Jackson-Weiss, Pfeiffer, and Apert syndromes.
18930330	2009	J. Hepatol.	0168-8278	CONCLUSIONS	4	9	6522	SYMBOL|DICTIONARY	slc4a2	SLC4A2	62#68		D008105	SYMBOL|DICTIONARY|EXTRACTED	pbc	PBC	127#130	18930330-1-3-28	They also demonstrate that allelic variations in TNFalpha and SLC4A2/AE2 have a significant impact on the evolutive profile of PBC under UDCA therapy.
18930330	2009	J. Hepatol.	0168-8278	CONCLUSIONS	4	9	6522	SYMBOL|EXTRACTED	ae2	AE2	69#72	18930330-6-136-153	D008105	SYMBOL|DICTIONARY|EXTRACTED	pbc	PBC	127#130	18930330-1-3-28	They also demonstrate that allelic variations in TNFalpha and SLC4A2/AE2 have a significant impact on the evolutive profile of PBC under UDCA therapy.
18930330	2009	J. Hepatol.	0168-8278	CONCLUSIONS	4	9	7124	LONGTERM|DICTIONARY	tnfalpha	TNFalpha	49#57	NaN	D008105	SYMBOL|DICTIONARY|EXTRACTED	pbc	PBC	127#130	18930330-1-3-28	They also demonstrate that allelic variations in TNFalpha and SLC4A2/AE2 have a significant impact on the evolutive profile of PBC under UDCA therapy.
20037740	2011	Comp. Funct. Genomics	1532-6268	ALL_TEXT_3/3	3	9	3576	SYMBOL|DICTIONARY	il 8	IL-8	0#4		D002100	LONGTERM|DICTIONARY	cachexia	cachexia	35#43		IL-8 appears to be associated with cachexia from patients with low-third gastric cancer.
20037740	2011	Comp. Funct. Genomics	1532-6268	ALL_TEXT_3/3	3	9	3576	SYMBOL|DICTIONARY	il 8	IL-8	0#4		D013274	LONGTERM|DISEASE|DT|DICTIONARY	low-third gastric cancer	low-third gastric cancer	63#87		IL-8 appears to be associated with cachexia from patients with low-third gastric cancer.
22119709	2012	Toxicol. Appl. Pharmacol.	1096-0333	ALL_TEXT_3/3	3	12	1269	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	cb2	CB2	40#43	22119709-0-0-22	D015212	SYMBOL|DICTIONARY|EXTRACTED	ibd	IBD	106#109	22119709-1-0-26	These results support the idea that the CB2 receptor agonists may serve as a therapeutic modality against IBD.
11583755	2001	Lancet	0140-6736	TITLE	0	0	1493	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	ctla4	CTLA4	21#26		D049970	LONGTERM|DICTIONARY	ophthalmopathy	ophthalmopathy	37#51		MHC class II region, CTLA4 gene, and ophthalmopathy in patients with Graves' disease.
11583755	2001	Lancet	0140-6736	TITLE	0	0	1493	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	ctla4	CTLA4	21#26		D006111	LONGTERM|DISEASE|DT|DICTIONARY	graves disease	Graves' disease	69#84		MHC class II region, CTLA4 gene, and ophthalmopathy in patients with Graves' disease.
16687442	2006	Hum. Mol. Genet.	0964-6906	ALL_TEXT_2/3	2	4	842	SYMBOL|DICTIONARY|EXTRACTED	casp 9	CASP-9	4#10	16687442-1-0-9	D008175	LONGTERM|DISEASE|DN|DT|DICTIONARY	lung cancer	lung cancer	44#55		The CASP-9 genotypes were determined in 432 lung cancer patients and 432 healthy controls that were frequency-matched for age and gender.
19553609	2009	Invest. Ophthalmol. Vis. Sci.	1552-5783	PURPOSE	1	1	10878	SYMBOL|()|DICTIONARY|EXTRACTED	cfhr3	CFHR3	110#115	19553609-1-79-108	D008268	LONGTERM|DICTIONARY	age related macular degeneration	age-related macular degeneration	234#266		To develop an assay for determining the number of copies of the genes encoding complement factor H related 3 (CFHR3) and 1 (CFHR1) and determine the contribution of copy number variation (CNV) at CFHR3 and CFHR1 to the development of age-related macular degeneration (AMD).
19553609	2009	Invest. Ophthalmol. Vis. Sci.	1552-5783	PURPOSE	1	1	10878	SYMBOL|()|DICTIONARY|EXTRACTED	cfhr3	CFHR3	110#115	19553609-1-79-108	D008268	SYMBOL|()|DICTIONARY|EXTRACTED	amd	AMD	268#271	19553609-1-234-266	To develop an assay for determining the number of copies of the genes encoding complement factor H related 3 (CFHR3) and 1 (CFHR1) and determine the contribution of copy number variation (CNV) at CFHR3 and CFHR1 to the development of age-related macular degeneration (AMD).
19553609	2009	Invest. Ophthalmol. Vis. Sci.	1552-5783	PURPOSE	1	1	3078	SYMBOL|()|DICTIONARY	cfhr1	CFHR1	124#129		D008268	LONGTERM|DICTIONARY	age related macular degeneration	age-related macular degeneration	234#266		To develop an assay for determining the number of copies of the genes encoding complement factor H related 3 (CFHR3) and 1 (CFHR1) and determine the contribution of copy number variation (CNV) at CFHR3 and CFHR1 to the development of age-related macular degeneration (AMD).
19553609	2009	Invest. Ophthalmol. Vis. Sci.	1552-5783	PURPOSE	1	1	3078	SYMBOL|()|DICTIONARY	cfhr1	CFHR1	124#129		D008268	SYMBOL|()|DICTIONARY|EXTRACTED	amd	AMD	268#271	19553609-1-234-266	To develop an assay for determining the number of copies of the genes encoding complement factor H related 3 (CFHR3) and 1 (CFHR1) and determine the contribution of copy number variation (CNV) at CFHR3 and CFHR1 to the development of age-related macular degeneration (AMD).
19553609	2009	Invest. Ophthalmol. Vis. Sci.	1552-5783	PURPOSE	1	1	10878	SYMBOL|DICTIONARY|EXTRACTED	cfhr3	CFHR3	196#201	19553609-1-79-108	D008268	LONGTERM|DICTIONARY	age related macular degeneration	age-related macular degeneration	234#266		To develop an assay for determining the number of copies of the genes encoding complement factor H related 3 (CFHR3) and 1 (CFHR1) and determine the contribution of copy number variation (CNV) at CFHR3 and CFHR1 to the development of age-related macular degeneration (AMD).
19553609	2009	Invest. Ophthalmol. Vis. Sci.	1552-5783	PURPOSE	1	1	10878	SYMBOL|DICTIONARY|EXTRACTED	cfhr3	CFHR3	196#201	19553609-1-79-108	D008268	SYMBOL|()|DICTIONARY|EXTRACTED	amd	AMD	268#271	19553609-1-234-266	To develop an assay for determining the number of copies of the genes encoding complement factor H related 3 (CFHR3) and 1 (CFHR1) and determine the contribution of copy number variation (CNV) at CFHR3 and CFHR1 to the development of age-related macular degeneration (AMD).
19553609	2009	Invest. Ophthalmol. Vis. Sci.	1552-5783	PURPOSE	1	1	3078	SYMBOL|DICTIONARY	cfhr1	CFHR1	206#211		D008268	LONGTERM|DICTIONARY	age related macular degeneration	age-related macular degeneration	234#266		To develop an assay for determining the number of copies of the genes encoding complement factor H related 3 (CFHR3) and 1 (CFHR1) and determine the contribution of copy number variation (CNV) at CFHR3 and CFHR1 to the development of age-related macular degeneration (AMD).
19553609	2009	Invest. Ophthalmol. Vis. Sci.	1552-5783	PURPOSE	1	1	3078	SYMBOL|DICTIONARY	cfhr1	CFHR1	206#211		D008268	SYMBOL|()|DICTIONARY|EXTRACTED	amd	AMD	268#271	19553609-1-234-266	To develop an assay for determining the number of copies of the genes encoding complement factor H related 3 (CFHR3) and 1 (CFHR1) and determine the contribution of copy number variation (CNV) at CFHR3 and CFHR1 to the development of age-related macular degeneration (AMD).
16687442	2006	Hum. Mol. Genet.	0964-6906	ALL_TEXT_1/3	1	1	842	LONGTERM|DICTIONARY	caspase 9	Caspase-9	0#9		D009369	LONGTERM|DISEASE|DT|DICTIONARY	cancer	cancer	149#155		Caspase-9 (CASP-9) is an initiator CASP in the apoptosome-driven apoptosis pathway and plays an important role in the development and progression of cancer.
16687442	2006	Hum. Mol. Genet.	0964-6906	ALL_TEXT_1/3	1	1	842	SYMBOL|()|DICTIONARY|EXTRACTED	casp 9	CASP-9	11#17	16687442-1-0-9	D009369	LONGTERM|DISEASE|DT|DICTIONARY	cancer	cancer	149#155		Caspase-9 (CASP-9) is an initiator CASP in the apoptosome-driven apoptosis pathway and plays an important role in the development and progression of cancer.
16687442	2006	Hum. Mol. Genet.	0964-6906	ALL_TEXT_1/3	1	1	1523	SYMBOL|DICTIONARY	casp	CASP	35#39		D009369	LONGTERM|DISEASE|DT|DICTIONARY	cancer	cancer	149#155		Caspase-9 (CASP-9) is an initiator CASP in the apoptosome-driven apoptosis pathway and plays an important role in the development and progression of cancer.
16687442	2006	Hum. Mol. Genet.	0964-6906	TITLE	0	0	842	LONGTERM|GENE|GN|DICTIONARY	caspase 9	Caspase 9	0#9		D008175	LONGTERM|DISEASE|DT|DICTIONARY	lung cancer	lung cancer	53#64		Caspase 9 promoter polymorphisms and risk of primary lung cancer.
16687442	2006	Hum. Mol. Genet.	0964-6906	ALL_TEXT_1/3	1	3	842	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	casp 9	CASP-9	157#163	16687442-1-0-9	D008175	LONGTERM|DISEASE|DT|DICTIONARY	lung cancer	lung cancer	190#201		To test this hypothesis, we examined the association of four polymorphisms [-1263A>G, -905T>G, -712C>T and -293_-275delCGTGAGGTCAGTGCGGGGA (-293del)] in the CASP-9 promoter with the risk of lung cancer in a Korean population.
16687442	2006	Hum. Mol. Genet.	0964-6906	ALL_TEXT_1/3	1	2	842	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	casp 9	CASP-9	44#50	16687442-1-0-9	D008175	LONGTERM|DISEASE|DT|DICTIONARY	lung cancer	lung cancer	143#154		Polymorphisms in the promoter region of the CASP-9 gene may influence the promoter activity of this gene, thereby modulating susceptibility to lung cancer.
11157139	2001	Rheumatology (Oxford)	1462-0324	METHODS	2	2	3123	SYMBOL|DICTIONARY	hla drb1	HLA DRB1	0#8		D016736	SYMBOL|DICTIONARY|EXTRACTED	aps	APS	153#156	11157139-1-68-93	HLA DRB1, DQB1 and DQA1 genotypes were determined by the polymerase chain reaction using sequence-specific primers in 83 Caucasoid British patients with APS.
11157139	2001	Rheumatology (Oxford)	1462-0324	METHODS	2	2	3117	LONGTERM|DICTIONARY	dqa1	DQA1	19#23	NaN	D016736	SYMBOL|DICTIONARY|EXTRACTED	aps	APS	153#156	11157139-1-68-93	HLA DRB1, DQB1 and DQA1 genotypes were determined by the polymerase chain reaction using sequence-specific primers in 83 Caucasoid British patients with APS.
11157139	2001	Rheumatology (Oxford)	1462-0324	METHODS	2	2	3119	LONGTERM|DICTIONARY	dqb1	DQB1	10#14	NaN	D016736	SYMBOL|DICTIONARY|EXTRACTED	aps	APS	153#156	11157139-1-68-93	HLA DRB1, DQB1 and DQA1 genotypes were determined by the polymerase chain reaction using sequence-specific primers in 83 Caucasoid British patients with APS.
11157139	2001	Rheumatology (Oxford)	1462-0324	RESULTS	3	5	350	LONGTERM|DICTIONARY	beta 2gpi	beta 2GPI	116#125	NaN	D016736	SYMBOL|DISEASE|DN|DICTIONARY|EXTRACTED	aps	APS	54#57	11157139-1-68-93	The association of the former was enhanced in primary APS patients with anti-beta 2-glycoprotein I antibodies (anti-beta 2GPI) [odds ratio 6.2, 95% confidence interval (2.2-17.6), P=0.0014, corrected P=0.042].
10213916	1999	Neuroimmunomodulation	1021-7401	ALL_TEXT_3/3	3	13	7349	LONGTERM|DICTIONARY	urocortin	urocortin	24#33		D007022	LONGTERM|DICTIONARY	hypotension	hypotension	210#221	NaN	As both hydralazine and urocortin lowered blood pressure and inflammatory exudate volume, we suggest that the anti-inflammatory effects of urocortin and related neuropeptides may be nonspecific, acting through hypotension rather than through direct anti-inflammatory mechanisms.
10213916	1999	Neuroimmunomodulation	1021-7401	ALL_TEXT_3/3	3	13	7349	LONGTERM|DICTIONARY	urocortin	urocortin	139#148		D007022	LONGTERM|DICTIONARY	hypotension	hypotension	210#221	NaN	As both hydralazine and urocortin lowered blood pressure and inflammatory exudate volume, we suggest that the anti-inflammatory effects of urocortin and related neuropeptides may be nonspecific, acting through hypotension rather than through direct anti-inflammatory mechanisms.
10213916	1999	Neuroimmunomodulation	1021-7401	ALL_TEXT_3/3	3	11	7349	LONGTERM|DICTIONARY	urocortin	Urocortin	0#9		D007022	LONGTERM|DICTIONARY	fall in blood pressure	fall in blood pressure	54#76		Urocortin and hydralazine both produced a significant fall in blood pressure compared to controls, with mean arterial pressure 2 h after carrageenin injection falling to 51.0 +/- 4.1 (p < 0.001) and 34.6 +/- 4.6 (p < 0.001) vs. 92.9 +/- 3.7 mm Hg in controls, respectively.
18508830	2009	Eur. Respir. J.	1399-3003	ALL_TEXT_3/3	3	8	183	LONGTERM|GENE|GN|DICTIONARY	angiotensinogen	angiotensinogen	25#40		D054990	LONGTERM|DICTIONARY	idiopathic pulmonary fibrosis progression	idiopathic pulmonary fibrosis progression	65#106		G-6A polymorphism of the angiotensinogen gene is associated with idiopathic pulmonary fibrosis progression but not with disease predisposition.
18508830	2009	Eur. Respir. J.	1399-3003	ALL_TEXT_3/3	3	8	23564	LONGTERM|DICTIONARY	g-6a	G-6A	0#4	NaN	D054990	LONGTERM|DICTIONARY	idiopathic pulmonary fibrosis progression	idiopathic pulmonary fibrosis progression	65#106		G-6A polymorphism of the angiotensinogen gene is associated with idiopathic pulmonary fibrosis progression but not with disease predisposition.
21966456	2012	PLoS ONE	1932-6203	BACKGROUND	1	1	5733	SYMBOL|()|DICTIONARY|EXTRACTED	ptger3	PTGER3	288#294	21966456-1-277-280	D013262	LONGTERM|DISEASE|DT|DICTIONARY	stevens johnson syndrome	Stevens-Johnson Syndrome	48#72		In our earlier genome-wide association study on Stevens-Johnson Syndrome (SJS) and its severe variant, toxic epidermal necrolysis (TEN), we found that in Japanese patients with these severe ocular surface complications there was an association with prostaglandin E receptor 3 (EP3) gene (PTGER3) polymorphisms.
21966456	2012	PLoS ONE	1932-6203	BACKGROUND	1	1	5733	SYMBOL|()|DICTIONARY|EXTRACTED	ptger3	PTGER3	288#294	21966456-1-277-280	D013262	SYMBOL|()|DICTIONARY|EXTRACTED	sjs	SJS	74#77	21966456-1-48-72	In our earlier genome-wide association study on Stevens-Johnson Syndrome (SJS) and its severe variant, toxic epidermal necrolysis (TEN), we found that in Japanese patients with these severe ocular surface complications there was an association with prostaglandin E receptor 3 (EP3) gene (PTGER3) polymorphisms.
21966456	2012	PLoS ONE	1932-6203	BACKGROUND	1	1	5733	SYMBOL|()|DICTIONARY|EXTRACTED	ptger3	PTGER3	288#294	21966456-1-277-280	D064420	LONGTERM|DICTIONARY	toxic epidermal necrolysis	toxic epidermal necrolysis	103#129		In our earlier genome-wide association study on Stevens-Johnson Syndrome (SJS) and its severe variant, toxic epidermal necrolysis (TEN), we found that in Japanese patients with these severe ocular surface complications there was an association with prostaglandin E receptor 3 (EP3) gene (PTGER3) polymorphisms.
21966456	2012	PLoS ONE	1932-6203	BACKGROUND	1	1	5733	SYMBOL|()|DICTIONARY|EXTRACTED	ptger3	PTGER3	288#294	21966456-1-277-280	D064420	SYMBOL|EXTRACTED|()	ten	TEN	131#134	21966456-1-103-129	In our earlier genome-wide association study on Stevens-Johnson Syndrome (SJS) and its severe variant, toxic epidermal necrolysis (TEN), we found that in Japanese patients with these severe ocular surface complications there was an association with prostaglandin E receptor 3 (EP3) gene (PTGER3) polymorphisms.
21966456	2012	PLoS ONE	1932-6203	BACKGROUND	1	1	5733	SYMBOL|()|GENE|GN|DICTIONARY|EXTRACTED	e receptor 3 (ep3)	E receptor 3 (EP3)	263#281	21966456-1-249-275	D013262	LONGTERM|DISEASE|DT|DICTIONARY	stevens johnson syndrome	Stevens-Johnson Syndrome	48#72		In our earlier genome-wide association study on Stevens-Johnson Syndrome (SJS) and its severe variant, toxic epidermal necrolysis (TEN), we found that in Japanese patients with these severe ocular surface complications there was an association with prostaglandin E receptor 3 (EP3) gene (PTGER3) polymorphisms.
21966456	2012	PLoS ONE	1932-6203	BACKGROUND	1	1	5733	SYMBOL|()|GENE|GN|DICTIONARY|EXTRACTED	e receptor 3 (ep3)	E receptor 3 (EP3)	263#281	21966456-1-249-275	D013262	SYMBOL|()|DICTIONARY|EXTRACTED	sjs	SJS	74#77	21966456-1-48-72	In our earlier genome-wide association study on Stevens-Johnson Syndrome (SJS) and its severe variant, toxic epidermal necrolysis (TEN), we found that in Japanese patients with these severe ocular surface complications there was an association with prostaglandin E receptor 3 (EP3) gene (PTGER3) polymorphisms.
21966456	2012	PLoS ONE	1932-6203	BACKGROUND	1	1	5733	SYMBOL|()|GENE|GN|DICTIONARY|EXTRACTED	e receptor 3 (ep3)	E receptor 3 (EP3)	263#281	21966456-1-249-275	D064420	LONGTERM|DICTIONARY	toxic epidermal necrolysis	toxic epidermal necrolysis	103#129		In our earlier genome-wide association study on Stevens-Johnson Syndrome (SJS) and its severe variant, toxic epidermal necrolysis (TEN), we found that in Japanese patients with these severe ocular surface complications there was an association with prostaglandin E receptor 3 (EP3) gene (PTGER3) polymorphisms.
21966456	2012	PLoS ONE	1932-6203	BACKGROUND	1	1	5733	SYMBOL|()|GENE|GN|DICTIONARY|EXTRACTED	e receptor 3 (ep3)	E receptor 3 (EP3)	263#281	21966456-1-249-275	D064420	SYMBOL|EXTRACTED|()	ten	TEN	131#134	21966456-1-103-129	In our earlier genome-wide association study on Stevens-Johnson Syndrome (SJS) and its severe variant, toxic epidermal necrolysis (TEN), we found that in Japanese patients with these severe ocular surface complications there was an association with prostaglandin E receptor 3 (EP3) gene (PTGER3) polymorphisms.
12728975	2003	J Chin Med Assoc	1726-4901	RESULTS	3	8	183	SYMBOL|DICTIONARY|EXTRACTED	agt	AGT	7#10	12728975-1-78-93	D007674	LONGTERM|DISEASE|DN|DICTIONARY	dm nephropathy	DM nephropathy	124#138		In the AGT point mutation at 174 (T174M), the frequencies of both of alleles and genotypes were significantly higher in the DM nephropathy patients.
18555221	2009	Fertil. Steril.	1556-5653	ALL_TEXT	1	2	23305	SYMBOL|()|GENE|GN|DICTIONARY	acsl6	ACSL6	59#64		D016649	LONGTERM|DICTIONARY	premature ovarian failure	premature ovarian failure	110#135		The acyl-coenzyme A synthetase long-chain family member 6 (ACSL6) gene on chromosome 5q31 was associated with premature ovarian failure and identified disease-susceptibility haplotypes.
18555221	2009	Fertil. Steril.	1556-5653	TITLE	0	0	23305	LONGTERM|DICTIONARY	acyl coa synthetase long chain family member 6	Acyl-CoA synthetase long-chain family member 6	0#46		D016649	LONGTERM|DICTIONARY	premature ovarian failure	premature ovarian failure	66#91		Acyl-CoA synthetase long-chain family member 6 is associated with premature ovarian failure.
18508830	2009	Eur. Respir. J.	1399-3003	TITLE	0	0	183	LONGTERM|GENE|GN|DICTIONARY	angiotensinogen	Angiotensinogen	0#15		D054990	LONGTERM|DISEASE|DN|DICTIONARY	idiopathic pulmonary fibrosis disease	idiopathic pulmonary fibrosis disease	50#87		Angiotensinogen gene G-6A polymorphism influences idiopathic pulmonary fibrosis disease progression.
18508830	2009	Eur. Respir. J.	1399-3003	TITLE	0	0	23564	LONGTERM|DICTIONARY	g-6a	G-6A	21#25	NaN	D054990	LONGTERM|DISEASE|DN|DICTIONARY	idiopathic pulmonary fibrosis disease	idiopathic pulmonary fibrosis disease	50#87		Angiotensinogen gene G-6A polymorphism influences idiopathic pulmonary fibrosis disease progression.
18508830	2009	Eur. Respir. J.	1399-3003	ALL_TEXT_1/3	1	1	183	LONGTERM|DICTIONARY	angiotensin ii	Angiotensin II	0#14		D054990	LONGTERM|DICTIONARY	idiopathic pulmonary fibrosis	idiopathic pulmonary fibrosis	82#111		Angiotensin II is a growth factor that plays a key role in the physiopathology of idiopathic pulmonary fibrosis (IPF).
18508830	2009	Eur. Respir. J.	1399-3003	ALL_TEXT_1/3	1	1	183	LONGTERM|DICTIONARY	angiotensin ii	Angiotensin II	0#14		D054990	SYMBOL|()|DICTIONARY|EXTRACTED	ipf	IPF	113#116	18508830-1-82-111	Angiotensin II is a growth factor that plays a key role in the physiopathology of idiopathic pulmonary fibrosis (IPF).
18508830	2009	Eur. Respir. J.	1399-3003	ALL_TEXT_1/3	1	3	183	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	agt	AGT	61#64	18508830-2-103-118	D054990	SYMBOL|DICTIONARY|EXTRACTED	ipf	IPF	89#92	18508830-1-82-111	In order to investigate whether the G-6A polymorphism of the AGT gene is associated with IPF development, severity and progression, the present study utilised a case-control study design and genotyped G-6A in 219 patients with IPF and 224 control subjects.
18508830	2009	Eur. Respir. J.	1399-3003	ALL_TEXT_1/3	1	3	183	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	agt	AGT	61#64	18508830-2-103-118	D054990	SYMBOL|DICTIONARY|EXTRACTED	ipf	IPF	227#230	18508830-1-82-111	In order to investigate whether the G-6A polymorphism of the AGT gene is associated with IPF development, severity and progression, the present study utilised a case-control study design and genotyped G-6A in 219 patients with IPF and 224 control subjects.
18508830	2009	Eur. Respir. J.	1399-3003	ALL_TEXT_1/3	1	3	23564	LONGTERM|DICTIONARY	g-6a	G-6A	36#40	NaN	D054990	SYMBOL|DICTIONARY|EXTRACTED	ipf	IPF	89#92	18508830-1-82-111	In order to investigate whether the G-6A polymorphism of the AGT gene is associated with IPF development, severity and progression, the present study utilised a case-control study design and genotyped G-6A in 219 patients with IPF and 224 control subjects.
18508830	2009	Eur. Respir. J.	1399-3003	ALL_TEXT_1/3	1	3	23564	LONGTERM|DICTIONARY	g-6a	G-6A	36#40	NaN	D054990	SYMBOL|DICTIONARY|EXTRACTED	ipf	IPF	227#230	18508830-1-82-111	In order to investigate whether the G-6A polymorphism of the AGT gene is associated with IPF development, severity and progression, the present study utilised a case-control study design and genotyped G-6A in 219 patients with IPF and 224 control subjects.
18508830	2009	Eur. Respir. J.	1399-3003	ALL_TEXT_1/3	1	3	23564	LONGTERM|DICTIONARY	g-6a	G-6A	201#205	NaN	D054990	SYMBOL|DICTIONARY|EXTRACTED	ipf	IPF	89#92	18508830-1-82-111	In order to investigate whether the G-6A polymorphism of the AGT gene is associated with IPF development, severity and progression, the present study utilised a case-control study design and genotyped G-6A in 219 patients with IPF and 224 control subjects.
18508830	2009	Eur. Respir. J.	1399-3003	ALL_TEXT_1/3	1	3	23564	LONGTERM|DICTIONARY	g-6a	G-6A	201#205	NaN	D054990	SYMBOL|DICTIONARY|EXTRACTED	ipf	IPF	227#230	18508830-1-82-111	In order to investigate whether the G-6A polymorphism of the AGT gene is associated with IPF development, severity and progression, the present study utilised a case-control study design and genotyped G-6A in 219 patients with IPF and 224 control subjects.
16182378	2006	J. Neuroimmunol.	0165-5728	ALL_TEXT_3/3	3	12	1234	SYMBOL|DICTIONARY	ccr5*delta32	CCR5*Delta32	23#35		D009103	SYMBOL|EXTRACTED	ms	MS	100#102	16182378-1-63-81	Carrier status for the CCR5*Delta32 mutation was not associated with patterns of immunopathology in MS.
19276544	2009	J. Alzheimers Dis.	1387-2877	ALL_TEXT_2/3	2	2	9846	SYMBOL|DICTIONARY	gab2	GAB2	42#46		D000544	SYMBOL|EXTRACTED	ad	AD	86#88	19276544-1-143-162	In order to assess the involvement of the GAB2 polymorphism in the risk of developing AD, we analyzed the genotype and allele distributions of the GAB2 rs2373115 polymorphism in 579 Italian subjects.
19276544	2009	J. Alzheimers Dis.	1387-2877	ALL_TEXT_2/3	2	2	9846	SYMBOL|DICTIONARY	gab2	GAB2	147#151		D000544	SYMBOL|EXTRACTED	ad	AD	86#88	19276544-1-143-162	In order to assess the involvement of the GAB2 polymorphism in the risk of developing AD, we analyzed the genotype and allele distributions of the GAB2 rs2373115 polymorphism in 579 Italian subjects.
17300681	2007	Int. J. Gynecol. Cancer	1048-891X	ALL_TEXT_3/3	3	11	5243	SYMBOL|DICTIONARY	mdr1	MDR1	30#34		D016889	LONGTERM|DISEASE|DT|DICTIONARY	endometrial cancer	endometrial cancer	74#92		Our observation suggests that MDR1 C3435T polymorphism is correlated with endometrial cancer susceptibility.
15523642	2005	Hum. Mutat.	1098-1004	ALL_TEXT_3/3	3	9	4763	LONGTERM|DICTIONARY	nf1	NF1	165#168	NaN	D009456	SYMBOL|DISEASE|DN|DICTIONARY|EXTRACTED	nf1	NF1	165#168	15523642-3-167-191	Our results suggest that the wild-type sequences function as ESE elements, whose disruption is responsible for the mutation-associated exon skipping observed in the NF1 patients.
20042177	2010	Am. J. Ophthalmol.	1879-1891	PURPOSE	1	3	5444	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	pon1	PON1	32#36	20042177-2-0-13	D008268	SYMBOL|DICTIONARY|EXTRACTED	amd	AMD	71#74	20042177-1-0-32	This study investigated whether PON1 gene polymorphisms associate with AMD.
18063422	2008	Clin. Gastroenterol. Hepatol.	1542-7714	BACKGROUND &amp; AIMS	1	1	5644	SYMBOL|DICTIONARY	prss1	PRSS1	103#108		C537262	LONGTERM|DICTIONARY	hereditary pancreatitis	hereditary pancreatitis	195#218		We have recently reported that the triplication of a approximately 605 kilobase segment containing the PRSS1 (encoding cationic trypsinogen) and PRSS2 (encoding anionic trypsinogen) genes causes hereditary pancreatitis.
18063422	2008	Clin. Gastroenterol. Hepatol.	1542-7714	BACKGROUND &amp; AIMS	1	1	5644	LONGTERM|DICTIONARY	cationic trypsinogen	cationic trypsinogen	119#139		C537262	LONGTERM|DICTIONARY	hereditary pancreatitis	hereditary pancreatitis	195#218		We have recently reported that the triplication of a approximately 605 kilobase segment containing the PRSS1 (encoding cationic trypsinogen) and PRSS2 (encoding anionic trypsinogen) genes causes hereditary pancreatitis.
18063422	2008	Clin. Gastroenterol. Hepatol.	1542-7714	BACKGROUND &amp; AIMS	1	1	5645	SYMBOL|DICTIONARY	prss2	PRSS2	145#150		C537262	LONGTERM|DICTIONARY	hereditary pancreatitis	hereditary pancreatitis	195#218		We have recently reported that the triplication of a approximately 605 kilobase segment containing the PRSS1 (encoding cationic trypsinogen) and PRSS2 (encoding anionic trypsinogen) genes causes hereditary pancreatitis.
18063422	2008	Clin. Gastroenterol. Hepatol.	1542-7714	BACKGROUND &amp; AIMS	1	1	5645	LONGTERM|GENE|GN|DICTIONARY	anionic trypsinogen	anionic trypsinogen	161#180		C537262	LONGTERM|DICTIONARY	hereditary pancreatitis	hereditary pancreatitis	195#218		We have recently reported that the triplication of a approximately 605 kilobase segment containing the PRSS1 (encoding cationic trypsinogen) and PRSS2 (encoding anionic trypsinogen) genes causes hereditary pancreatitis.
16361275	2006	Ann. Rheum. Dis.	0003-4967	RESULTS	3	4	3557	SYMBOL|DICTIONARY	il1rn	IL1RN	75#80		D013167	SYMBOL|EXTRACTED	as	AS	104#106	16361275-1-72-94	Association of alleles and genotypes of the markers IL1F10.3, IL1RN.4, and IL1RN.VNTR was observed with AS (p<0.05).
16361275	2006	Ann. Rheum. Dis.	0003-4967	RESULTS	3	4	84639	LONGTERM|DICTIONARY	il1f10	IL1F10	52#58	NaN	D013167	SYMBOL|EXTRACTED	as	AS	104#106	16361275-1-72-94	Association of alleles and genotypes of the markers IL1F10.3, IL1RN.4, and IL1RN.VNTR was observed with AS (p<0.05).
16361275	2006	Ann. Rheum. Dis.	0003-4967	RESULTS	3	5	3557	LONGTERM|DICTIONARY	il1rn	IL1RN	56#61	NaN	D013167	SYMBOL|EXTRACTED	as	AS	120#122	16361275-1-72-94	Haplotypes of pairs of these markers and of the markers IL1RN.6/1 and IL1RN.6/2 were also significantly associated with AS.
16361275	2006	Ann. Rheum. Dis.	0003-4967	RESULTS	3	5	3557	LONGTERM|DICTIONARY	il1rn	IL1RN	70#75	NaN	D013167	SYMBOL|EXTRACTED	as	AS	120#122	16361275-1-72-94	Haplotypes of pairs of these markers and of the markers IL1RN.6/1 and IL1RN.6/2 were also significantly associated with AS.
16361275	2006	Ann. Rheum. Dis.	0003-4967	METHODS	2	2	3557	SYMBOL|DICTIONARY	il1rn	IL1RN	149#154		D013167	SYMBOL|EXTRACTED|DISEASE|DN	as	AS	22#24	16361275-1-72-94	200 Taiwanese Chinese AS patients and 200 ethnically matched healthy controls were genotyped for five single nucleotide polymorphisms (SNPs) and the IL1RN.VNTR, markers previously associated with AS.
16361275	2006	Ann. Rheum. Dis.	0003-4967	METHODS	2	2	3557	SYMBOL|DICTIONARY	il1rn	IL1RN	149#154		D013167	SYMBOL|EXTRACTED	as	AS	196#198	16361275-1-72-94	200 Taiwanese Chinese AS patients and 200 ethnically matched healthy controls were genotyped for five single nucleotide polymorphisms (SNPs) and the IL1RN.VNTR, markers previously associated with AS.
20393813	2010	J. Mol. Neurosci.	1559-1166	ALL_TEXT_3/3	3	7	3569	SYMBOL|GENE|GN|DICTIONARY	il 6	IL-6	45#49		D012559	LONGTERM|DICTIONARY	schizophrenia	schizophrenia	115#128		The presence of allele C at position -174 of IL-6 promoter sequence may correlate with increasing risk of paranoid schizophrenia in the Polish population, but research on a broadened group of people is needed.
16361275	2006	Ann. Rheum. Dis.	0003-4967	TITLE	0	0	3552	SYMBOL|GENE|GN|DICTIONARY	il1	IL1	30#33		D013167	LONGTERM|DICTIONARY	ankylosing spondylitis	ankylosing spondylitis	60#82		Replication of association of IL1 gene complex members with ankylosing spondylitis in Taiwanese Chinese.
16361275	2006	Ann. Rheum. Dis.	0003-4967	OBJECTIVE	1	1	3552	SYMBOL|()|GENE|GN|DICTIONARY	il1	IL1	42#45		D013167	LONGTERM|DICTIONARY	ankylosing spondylitis	ankylosing spondylitis	72#94		To test the association of interleukin 1 (IL1) gene family members with ankylosing spondylitis (AS), previously reported in Europid subjects, in an ethnically remote population.
16361275	2006	Ann. Rheum. Dis.	0003-4967	OBJECTIVE	1	1	3552	SYMBOL|()|GENE|GN|DICTIONARY	il1	IL1	42#45		D013167	SYMBOL|EXTRACTED|()	as	AS	96#98	16361275-1-72-94	To test the association of interleukin 1 (IL1) gene family members with ankylosing spondylitis (AS), previously reported in Europid subjects, in an ethnically remote population.
11579943	2002	Intern. Med.	0918-2918	TITLE	0	0	3077	SYMBOL|GENE|GN|DICTIONARY	hfe	HFE	32#35		D019190	LONGTERM|DISEASE|DN|DICTIONARY	iron overload disorders	iron overload disorders	59#82		C282Y and H63D mutations in the HFE gene have no effect on iron overload disorders in Japan.
11579943	2002	Intern. Med.	0918-2918	TITLE	0	0	3077	SYMBOL|GENE|GN|DICTIONARY	hfe	HFE	32#35		D019190	LONGTERM|DICTIONARY	iron overload disorders	iron overload disorders	59#82		C282Y and H63D mutations in the HFE gene have no effect on iron overload disorders in Japan.
16361275	2006	Ann. Rheum. Dis.	0003-4967	CONCLUSIONS	4	8	3552	SYMBOL|GENE|GN|DICTIONARY	il1	IL1	4#7		D013167	SYMBOL|EXTRACTED	as	AS	40#42	16361275-1-72-94	The IL1 gene cluster is associated with AS in Taiwanese Chinese.
15459589	2005	Am. Heart J.	1097-6744	CONCLUSIONS	4	12	6404	SYMBOL|DICTIONARY	psgl 1	PSGL-1	44#50		D009203	SYMBOL|EXTRACTED	premature mi	premature MI	81#93	15459589-7-65-86	According to our results, the short B and C PSGL-1 alleles might protect against premature MI, probably because of their lesser adhesive capacity.
20211941	2010	Toxicol. Sci.	1096-0929	ALL_TEXT_3/3	3	8	4780	SYMBOL|DICTIONARY	nrf2	Nrf2	78#82		D064420	LONGTERM|DICTIONARY	toxicity	toxicity	169#177	NaN	Furthermore, striatal transplantation of neuroprogenitor cells overexpressing Nrf2 that differentiate into astrocytes after grafting also significantly reduced malonate toxicity.
17179858	2007	Neuroreport	0959-4965	TITLE	0	0	120892	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	lrrk2	LRRK2	26#31		D010300	LONGTERM|DISEASE|DT|DICTIONARY	parkinson disease	Parkinson's disease	53#72		A novel P755L mutation in LRRK2 gene associated with Parkinson's disease.
17179858	2007	Neuroreport	0959-4965	ALL_TEXT_1/3	1	2	120892	LONGTERM|DICTIONARY|GENE|GA	leucine rich repeat kinase 2	leucine-rich repeat kinase 2	22#50		D010300	LONGTERM|DISEASE|DT|DICTIONARY	parkinson disease	Parkinson's disease	88#107		The identification of leucine-rich repeat kinase 2 (LRRK2) gene mutations as a cause of Parkinson's disease has greatly expanded our knowledge of the genetic and molecular pathogenesis of this disorder.
17179858	2007	Neuroreport	0959-4965	ALL_TEXT_1/3	1	2	120892	SYMBOL|()|GENE|GN|DICTIONARY|EXTRACTED	lrrk2	LRRK2	52#57	17179858-2-22-50	D010300	LONGTERM|DISEASE|DT|DICTIONARY	parkinson disease	Parkinson's disease	88#107		The identification of leucine-rich repeat kinase 2 (LRRK2) gene mutations as a cause of Parkinson's disease has greatly expanded our knowledge of the genetic and molecular pathogenesis of this disorder.
8281141	1994	Hum. Mol. Genet.	0964-6906	ALL_TEXT_1/3	1	2	2200	LONGTERM|GENE|GN|DICTIONARY	fibrillin 1	fibrillin-1	29#40		D008382	SYMBOL|DICTIONARY|EXTRACTED	mfs	MFS	98#101	8281141-1-0-15	Previously, mutations in the fibrillin-1 gene on chromosome 15 (FBN1) have been reported to cause MFS.
8281141	1994	Hum. Mol. Genet.	0964-6906	ALL_TEXT_1/3	1	2	2200	SYMBOL|()|DICTIONARY	fbn1	FBN1	64#68		D008382	SYMBOL|DICTIONARY|EXTRACTED	mfs	MFS	98#101	8281141-1-0-15	Previously, mutations in the fibrillin-1 gene on chromosome 15 (FBN1) have been reported to cause MFS.
11186891	2001	Am. J. Med. Genet.	0148-7299	ALL_TEXT_1/3	1	1	1080	LONGTERM|DICTIONARY|GENE|GA	cystic fibrosis transmembrane conductance regulator	cystic fibrosis transmembrane conductance regulator	31#82		D003550	LONGTERM|DICTIONARY	cystic fibrosis	cystic fibrosis	121#136		More than 900 mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene have been reported to the cystic fibrosis (CF) consortium.
11186891	2001	Am. J. Med. Genet.	0148-7299	ALL_TEXT_1/3	1	1	1080	LONGTERM|DICTIONARY|GENE|GA	cystic fibrosis transmembrane conductance regulator	cystic fibrosis transmembrane conductance regulator	31#82		D003550	SYMBOL|EXTRACTED|()	cf	CF	138#140	11186891-1-121-136	More than 900 mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene have been reported to the cystic fibrosis (CF) consortium.
11186891	2001	Am. J. Med. Genet.	0148-7299	ALL_TEXT_1/3	1	1	1080	SYMBOL|()|GENE|GN|DICTIONARY|EXTRACTED	cftr	CFTR	84#88	11186891-1-31-82	D003550	LONGTERM|DICTIONARY	cystic fibrosis	cystic fibrosis	121#136		More than 900 mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene have been reported to the cystic fibrosis (CF) consortium.
11186891	2001	Am. J. Med. Genet.	0148-7299	ALL_TEXT_1/3	1	1	1080	SYMBOL|()|GENE|GN|DICTIONARY|EXTRACTED	cftr	CFTR	84#88	11186891-1-31-82	D003550	SYMBOL|EXTRACTED|()	cf	CF	138#140	11186891-1-121-136	More than 900 mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene have been reported to the cystic fibrosis (CF) consortium.
18576360	2008	Arthritis Rheum.	0004-3591	OBJECTIVE	1	1	26191	SYMBOL|GENE|GN|DICTIONARY	ptpn22	PTPN22	45#51		D012595	LONGTERM|DICTIONARY	systemic sclerosis	systemic sclerosis	155#173		To determine whether genetic variants of the PTPN22 gene, including the R620W (1858C>T) missense single-nucleotide polymorphism (SNP), are associated with systemic sclerosis (SSc).
18576360	2008	Arthritis Rheum.	0004-3591	OBJECTIVE	1	1	26191	SYMBOL|GENE|GN|DICTIONARY	ptpn22	PTPN22	45#51		D012595	SYMBOL|EXTRACTED|()	ssc	SSc	175#178	18576360-1-155-173	To determine whether genetic variants of the PTPN22 gene, including the R620W (1858C>T) missense single-nucleotide polymorphism (SNP), are associated with systemic sclerosis (SSc).
18576360	2008	Arthritis Rheum.	0004-3591	TITLE	0	0	26191	SYMBOL|NUMBER|DICTIONARY	ptpn22	PTPN22	4#10		D012595	LONGTERM|DICTIONARY	systemic sclerosis	systemic sclerosis	49#67		The PTPN22 620W allele confers susceptibility to systemic sclerosis: findings of a large case-control study of European Caucasians and a meta-analysis.
18576360	2008	Arthritis Rheum.	0004-3591	OBJECTIVE	1	3	26191	SYMBOL|NUMBER|DICTIONARY	ptpn22	PTPN22	138#144		D012595	SYMBOL|EXTRACTED	ssc	SSc	64#67	18576360-1-155-173	We then conducted a meta-analysis of the most recent studies of SSc in order to verify the association or lack of association between the PTPN22 1858C>T variant and SSc.
18576360	2008	Arthritis Rheum.	0004-3591	OBJECTIVE	1	3	26191	SYMBOL|NUMBER|DICTIONARY	ptpn22	PTPN22	138#144		D012595	SYMBOL|EXTRACTED	ssc	SSc	165#168	18576360-1-155-173	We then conducted a meta-analysis of the most recent studies of SSc in order to verify the association or lack of association between the PTPN22 1858C>T variant and SSc.
18576360	2008	Arthritis Rheum.	0004-3591	OBJECTIVE	1	2	26191	SYMBOL|DICTIONARY	ptpn22	PTPN22	6#12		D001327	LONGTERM|DICTIONARY	autoimmune diseases	autoimmune diseases	37#56		Since PTPN22 is involved in multiple autoimmune diseases, we also examined the occurrence of a concomitant autoimmune disease.
18576360	2008	Arthritis Rheum.	0004-3591	OBJECTIVE	1	2	26191	SYMBOL|DICTIONARY	ptpn22	PTPN22	6#12		D001327	LONGTERM|DISEASE|DT|DICTIONARY	autoimmune disease	autoimmune disease	107#125		Since PTPN22 is involved in multiple autoimmune diseases, we also examined the occurrence of a concomitant autoimmune disease.
18576360	2008	Arthritis Rheum.	0004-3591	METHODS	2	4	26191	SYMBOL|DICTIONARY	ptpn22	PTPN22	6#12		D012595	SYMBOL|EXTRACTED|DISEASE|DN	ssc	SSc	68#71	18576360-1-155-173	Seven PTPN22 SNPs were analyzed in a French Caucasian cohort of 659 SSc patients and 504 healthy controls.
18576360	2008	Arthritis Rheum.	0004-3591	RESULTS	3	7	26191	SYMBOL|NUMBER|DICTIONARY	ptpn22	PTPN22	99#105		D001327	LONGTERM|DISEASE|DT|DICTIONARY	autoimmune disease	autoimmune disease	48#66		In 33 of the 416 patients (8%), the concomitant autoimmune disease was known to be associated with PTPN22 1858T; these patients were excluded prior to analysis.
18576360	2008	Arthritis Rheum.	0004-3591	RESULTS	3	9	26191	SYMBOL|DICTIONARY	ptpn22	PTPN22	0#6		D012595	SYMBOL|EXTRACTED	ssc	SSc	66#69	18576360-1-155-173	PTPN22 haplotype analysis identified a strong association between SSc and the presence of a risk haplotype carrying the 1858T allele (P = 1.52 x 10(-7)) and a protective haplotype carrying the 1858C allele (P = 2.20 x 10(-16)) in our French Caucasian population.
19553609	2009	Invest. Ophthalmol. Vis. Sci.	1552-5783	RESULTS	3	6	10878	SYMBOL|DICTIONARY|EXTRACTED	cfhr3	CFHR3	27#32	19553609-1-79-108	D008268	SYMBOL|DICTIONARY|EXTRACTED	amd	AMD	72#75	19553609-1-234-266	Deletion of both copies of CFHR3 and CFHR1 decreased the odds of having AMD eightfold (95% CI 2-36) and always occurred on a protective haplotype, never on the risk haplotype tagged by the Y402H risk allele in CFH.
19553609	2009	Invest. Ophthalmol. Vis. Sci.	1552-5783	RESULTS	3	6	3078	SYMBOL|DICTIONARY	cfhr1	CFHR1	37#42		D008268	SYMBOL|DICTIONARY|EXTRACTED	amd	AMD	72#75	19553609-1-234-266	Deletion of both copies of CFHR3 and CFHR1 decreased the odds of having AMD eightfold (95% CI 2-36) and always occurred on a protective haplotype, never on the risk haplotype tagged by the Y402H risk allele in CFH.
19553609	2009	Invest. Ophthalmol. Vis. Sci.	1552-5783	RESULTS	3	6	3075	SYMBOL|DICTIONARY	cfh	CFH	210#213		D008268	SYMBOL|DICTIONARY|EXTRACTED	amd	AMD	72#75	19553609-1-234-266	Deletion of both copies of CFHR3 and CFHR1 decreased the odds of having AMD eightfold (95% CI 2-36) and always occurred on a protective haplotype, never on the risk haplotype tagged by the Y402H risk allele in CFH.
25466283	2015	Am. J. Hum. Genet.	1537-6605	ALL_TEXT_1/3	1	2	84942	SYMBOL|DICTIONARY	wdr73	WDR73	88#93		C537548	LONGTERM|DISEASE|DT|DICTIONARY	galloway mowat syndrome	Galloway-Mowat syndrome	129#152		Through a combination of autozygosity mapping and whole-exome sequencing, we identified WDR73 as a gene in which mutations cause Galloway-Mowat syndrome in two unrelated families.
16855621	2007	Genes Immun.	1466-4879	ALL_TEXT_2/3	2	3	3123	SYMBOL|DICTIONARY	drb1	DRB1	322#326		D001172	SYMBOL|DISEASE|DN|DICTIONARY	ra	RA	186#188		We have used a panel of three microsatellite markers in the class II region (D6S2666, D6S2665 and D6S2446) for genotyping and haplotype reconstruction in a total of 1687 Caucasian (1313 RA patients and 374 controls) and 1364 Korean individuals (744 RA patients and 620 controls), all of whom were previously genotyped for DRB1.
16855621	2007	Genes Immun.	1466-4879	ALL_TEXT_2/3	2	3	3123	SYMBOL|DICTIONARY	drb1	DRB1	322#326		D001172	SYMBOL|DISEASE|DN|DICTIONARY	ra	RA	249#251		We have used a panel of three microsatellite markers in the class II region (D6S2666, D6S2665 and D6S2446) for genotyping and haplotype reconstruction in a total of 1687 Caucasian (1313 RA patients and 374 controls) and 1364 Korean individuals (744 RA patients and 620 controls), all of whom were previously genotyped for DRB1.
16855621	2007	Genes Immun.	1466-4879	TITLE	0	0	3123	SYMBOL|DICTIONARY	drb1	DRB1	26#30		D001172	LONGTERM|DICTIONARY	rheumatoid arthritis	rheumatoid arthritis	93#113		Microsatellite typing for DRB1 alleles: application to the analysis of HLA associations with rheumatoid arthritis.
16517152	2006	Eur. J. Cancer	0959-8049	ALL_TEXT_2/3	2	7	4153	SYMBOL|DICTIONARY|EXTRACTED	mbl	MBL	25#28	16517152-0-12-34	D009503	LONGTERM|DICTIONARY	febrile neutropenia	febrile neutropenia	51#70		The capacity to increase MBL concentrations during febrile neutropenia was associated with MBL2 genotype.
16517152	2006	Eur. J. Cancer	0959-8049	ALL_TEXT_2/3	2	7	4153	SYMBOL|DICTIONARY	mbl2	MBL2	91#95		D009503	LONGTERM|DICTIONARY	febrile neutropenia	febrile neutropenia	51#70		The capacity to increase MBL concentrations during febrile neutropenia was associated with MBL2 genotype.
16517152	2006	Eur. J. Cancer	0959-8049	ALL_TEXT_1/3	1	4	4153	SYMBOL|DICTIONARY|EXTRACTED	mbl	MBL	28#31	16517152-0-12-34	D009503	LONGTERM|DICTIONARY	febrile neutropenia	febrile neutropenia	7#26		During febrile neutropenia, MBL concentrations were measured longitudinally in time.
16517152	2006	Eur. J. Cancer	0959-8049	ALL_TEXT_2/3	2	8	4153	SYMBOL|DICTIONARY|EXTRACTED	mbl	MBL	45#48	16517152-0-12-34	D009503	LONGTERM|DICTIONARY	neutropenic	neutropenic	78#89	NaN	Infectious parameters did not differ between MBL-deficient and MBL-sufficient neutropenic children (n = 66).
16517152	2006	Eur. J. Cancer	0959-8049	ALL_TEXT_2/3	2	8	4153	SYMBOL|DICTIONARY|EXTRACTED	mbl	MBL	63#66	16517152-0-12-34	D009503	LONGTERM|DICTIONARY	neutropenic	neutropenic	78#89	NaN	Infectious parameters did not differ between MBL-deficient and MBL-sufficient neutropenic children (n = 66).
7581378	1995	Hum. Mol. Genet.	0964-6906	TITLE	0	0	2263	SYMBOL|DICTIONARY|EXTRACTED	fgfr2	FGFR2	51#56		D003394	LONGTERM|DISEASE|DT|DICTIONARY	crouzon syndrome	Crouzon syndrome	0#16		Crouzon syndrome: mutations in two spliceoforms of FGFR2 and a common point mutation shared with Jackson-Weiss syndrome.
7581378	1995	Hum. Mol. Genet.	0964-6906	TITLE	0	0	2263	SYMBOL|DICTIONARY|EXTRACTED	fgfr2	FGFR2	51#56		C537559	LONGTERM|DISEASE|DT|DICTIONARY	jackson weiss syndrome	Jackson-Weiss syndrome	97#119		Crouzon syndrome: mutations in two spliceoforms of FGFR2 and a common point mutation shared with Jackson-Weiss syndrome.
11730829	2002	Atherosclerosis	0021-9150	ALL_TEXT_3/3	3	8	338	LONGTERM|DICTIONARY	apob	apoB	15#19	NaN	D006949	LONGTERM|DICTIONARY	hyperlipidemia	hyperlipidemia	39#53		In conclusion, apoB is associated with hyperlipidemia and apoE polymorphism is associated with later onset of hyperlipidemia in FCHL.
11730829	2002	Atherosclerosis	0021-9150	ALL_TEXT_3/3	3	8	338	LONGTERM|DICTIONARY	apob	apoB	15#19	NaN	D006949	LONGTERM|DICTIONARY	hyperlipidemia	hyperlipidemia	110#124		In conclusion, apoB is associated with hyperlipidemia and apoE polymorphism is associated with later onset of hyperlipidemia in FCHL.
11730829	2002	Atherosclerosis	0021-9150	ALL_TEXT_3/3	3	8	338	LONGTERM|DICTIONARY	apob	apoB	15#19	NaN	D006950	SYMBOL|DICTIONARY|EXTRACTED	fchl	FCHL	128#132	11730829-1-58-90	In conclusion, apoB is associated with hyperlipidemia and apoE polymorphism is associated with later onset of hyperlipidemia in FCHL.
11730829	2002	Atherosclerosis	0021-9150	ALL_TEXT_3/3	3	8	348	LONGTERM|DICTIONARY	apoe	apoE	58#62	NaN	D006949	LONGTERM|DICTIONARY	hyperlipidemia	hyperlipidemia	39#53		In conclusion, apoB is associated with hyperlipidemia and apoE polymorphism is associated with later onset of hyperlipidemia in FCHL.
11730829	2002	Atherosclerosis	0021-9150	ALL_TEXT_3/3	3	8	348	LONGTERM|DICTIONARY	apoe	apoE	58#62	NaN	D006949	LONGTERM|DICTIONARY	hyperlipidemia	hyperlipidemia	110#124		In conclusion, apoB is associated with hyperlipidemia and apoE polymorphism is associated with later onset of hyperlipidemia in FCHL.
11730829	2002	Atherosclerosis	0021-9150	ALL_TEXT_3/3	3	8	348	LONGTERM|DICTIONARY	apoe	apoE	58#62	NaN	D006950	SYMBOL|DICTIONARY|EXTRACTED	fchl	FCHL	128#132	11730829-1-58-90	In conclusion, apoB is associated with hyperlipidemia and apoE polymorphism is associated with later onset of hyperlipidemia in FCHL.
11802810	2002	Jpn. J. Cancer Res.	0910-5050	ALL_TEXT_3/3	3	8	540	SYMBOL|GENE|GN|DICTIONARY	atp7b	ATP7B	30#35		D001943	LONGTERM|DISEASE|DT|DICTIONARY	breast carcinoma	breast carcinoma	139#155		These findings suggested that ATP7B gene expression might be a chemoresistance marker for cisplatin in patients with poorly differentiated breast carcinoma.
15776395	2005	Am. J. Hum. Genet.	0002-9297	TITLE	0	0	3559	SYMBOL|DICTIONARY	il2ra	IL2RA	47#52		D003922	LONGTERM|DICTIONARY	type 1 diabetes	type 1 diabetes	18#33		Localization of a type 1 diabetes locus in the IL2RA/CD25 region by use of tag single-nucleotide polymorphisms.
15776395	2005	Am. J. Hum. Genet.	0002-9297	TITLE	0	0	3559	SYMBOL|DICTIONARY|EXTRACTED	cd25	CD25	53#57		D003922	LONGTERM|DICTIONARY	type 1 diabetes	type 1 diabetes	18#33		Localization of a type 1 diabetes locus in the IL2RA/CD25 region by use of tag single-nucleotide polymorphisms.
8822954	1996	Blood	0006-4971	ALL_TEXT_1/3	1	1	2821	SYMBOL|DICTIONARY|EXTRACTED	gpi	GPI	177#180	8822954-1-32-59	D000743	LONGTERM|DICTIONARY	hemolytic anemia	hemolytic anemia	93#109		We report here two new cases of glucose phosphate isomerase (GPI) deficiency associated with hemolytic anemia and present the results of molecular analysis of the five Japanese GPI variants.
8822954	1996	Blood	0006-4971	ALL_TEXT_1/3	1	1	2821	SYMBOL|DICTIONARY|EXTRACTED	gpi	GPI	177#180	8822954-1-32-59	D005955	LONGTERM|DICTIONARY	glucose phosphate isomerase (gpi) deficiency	glucose phosphate isomerase (GPI) deficiency	32#76		We report here two new cases of glucose phosphate isomerase (GPI) deficiency associated with hemolytic anemia and present the results of molecular analysis of the five Japanese GPI variants.
11802810	2002	Jpn. J. Cancer Res.	0910-5050	ALL_TEXT_1/3	1	2	540	SYMBOL|DICTIONARY	atp7b	ATP7B	36#41		D001943	LONGTERM|DICTIONARY	breast carcinomas	breast carcinomas	136#153		We investigated the hypothesis that ATP7B, which was shown to be associated with cisplatin resistance in vitro, is expressed in certain breast carcinomas.
18173548	2008	Eur. J. Clin. Invest.	1365-2362	CONCLUSIONS	4	7	4318	SYMBOL|DICTIONARY|EXTRACTED	mmp 9	MMP-9	52#57	18173548-1-46-58	D002340	LONGTERM|DICTIONARY	carotid atherosclerosis	carotid atherosclerosis	93#116		In summary, our results demonstrate associations of MMP-9 genotypes with different stages of carotid atherosclerosis.
11802810	2002	Jpn. J. Cancer Res.	0910-5050	TITLE	0	0	540	SYMBOL|()|DICTIONARY	atp7b	ATP7B	53#58		D001943	LONGTERM|DISEASE|DT|DICTIONARY	breast carcinoma	breast carcinoma	82#98		Copper-transporting P-type adenosine triphosphatase (ATP7B) is expressed in human breast carcinoma.
11802810	2002	Jpn. J. Cancer Res.	0910-5050	ALL_TEXT_1/3	1	1	540	SYMBOL|DICTIONARY	atp7b	ATP7B	93#98		D001943	LONGTERM|DICTIONARY	breast carcinomas	breast carcinomas	124#141		This is the first report to show that a copper-transporting P-type adenosine triphosphatase, ATP7B, is expressed in certain breast carcinomas, and a priori knowledge of its expression is important for the choice of therapy.
18173548	2008	Eur. J. Clin. Invest.	1365-2362	TITLE	0	0	4318	SYMBOL|DICTIONARY|EXTRACTED	mmp 9	MMP-9	0#5		D050197	LONGTERM|DICTIONARY	atherosclerosis	atherosclerosis	36#51		MMP-9 haplotypes and carotid artery atherosclerosis: an association study introducing a novel multicolour multiplex RealTime PCR protocol.
18173548	2008	Eur. J. Clin. Invest.	1365-2362	BACKGROUND	1	1	4318	SYMBOL|()|DICTIONARY|EXTRACTED	mmp 9	MMP-9	60#65	18173548-1-46-58	D014652	LONGTERM|DICTIONARY	vascular diseases	vascular diseases	122#139		Among other matrix metalloproteinases (MMPs), gelatinase B (MMP-9) is discussed to be associated with the pathogenesis of vascular diseases.
16434832	2006	Tohoku J. Exp. Med.	0040-8727	TITLE	0	0	2261	LONGTERM|GENE|GN|DICTIONARY	fibroblast growth factor receptor 3	fibroblast growth factor receptor 3	58#93		D000130	LONGTERM|DICTIONARY	achondroplasia	achondroplasia	115#129		Accurate diagnosis of a homozygous G1138A mutation in the fibroblast growth factor receptor 3 gene responsible for achondroplasia.
1982251	1991	Dis. Markers	0278-0240	TITLE	0	0	28695	SYMBOL|DICTIONARY	tcra	TCRA	81#85		D003922	LONGTERM|DICTIONARY	insulin dependent diabetes mellitus	insulin dependent diabetes mellitus	28#63		Non-HLA genetic factors and insulin dependent diabetes mellitus in the Japanese: TCRA, TCRB and TCRG, INS, THY1, CD3D and ETS1.
1982251	1991	Dis. Markers	0278-0240	TITLE	0	0	6957	SYMBOL|DICTIONARY	tcrb	TCRB	87#91		D003922	LONGTERM|DICTIONARY	insulin dependent diabetes mellitus	insulin dependent diabetes mellitus	28#63		Non-HLA genetic factors and insulin dependent diabetes mellitus in the Japanese: TCRA, TCRB and TCRG, INS, THY1, CD3D and ETS1.
1982251	1991	Dis. Markers	0278-0240	TITLE	0	0	6965	SYMBOL|DICTIONARY	tcrg	TCRG	96#100		D003922	LONGTERM|DICTIONARY	insulin dependent diabetes mellitus	insulin dependent diabetes mellitus	28#63		Non-HLA genetic factors and insulin dependent diabetes mellitus in the Japanese: TCRA, TCRB and TCRG, INS, THY1, CD3D and ETS1.
1982251	1991	Dis. Markers	0278-0240	TITLE	0	0	7070	SYMBOL|DICTIONARY|EXTRACTED	thy1	THY1	107#111		D003922	LONGTERM|DICTIONARY	insulin dependent diabetes mellitus	insulin dependent diabetes mellitus	28#63		Non-HLA genetic factors and insulin dependent diabetes mellitus in the Japanese: TCRA, TCRB and TCRG, INS, THY1, CD3D and ETS1.
1982251	1991	Dis. Markers	0278-0240	TITLE	0	0	915	SYMBOL|DICTIONARY	cd3d	CD3D	113#117		D003922	LONGTERM|DICTIONARY	insulin dependent diabetes mellitus	insulin dependent diabetes mellitus	28#63		Non-HLA genetic factors and insulin dependent diabetes mellitus in the Japanese: TCRA, TCRB and TCRG, INS, THY1, CD3D and ETS1.
1982251	1991	Dis. Markers	0278-0240	TITLE	0	0	2113	SYMBOL|DICTIONARY	ets1	ETS1	122#126		D003922	LONGTERM|DICTIONARY	insulin dependent diabetes mellitus	insulin dependent diabetes mellitus	28#63		Non-HLA genetic factors and insulin dependent diabetes mellitus in the Japanese: TCRA, TCRB and TCRG, INS, THY1, CD3D and ETS1.
1982251	1991	Dis. Markers	0278-0240	ALL_TEXT_1/3	1	1	28695	SYMBOL|DICTIONARY	tcra	TCRA	99#103		D003922	LONGTERM|DICTIONARY	insulin dependent diabetes mellitus	insulin-dependent diabetes mellitus	316#351		Polymorphism of the genes encoding the alpha, beta, and gamma chains of the human T-cell receptor (TCRA, TCRB, and TCRG), insulin gene (INS), and three closely linked polymorphic genes on chromosome 11q23, Thy-1 (THY1), T3-D (CD3D), and c-ets proto oncogene (ETS1) were investigated among 56 unrelated patients with insulin-dependent diabetes mellitus (IDDM) and 48 healthy controls.
1982251	1991	Dis. Markers	0278-0240	ALL_TEXT_1/3	1	1	28695	SYMBOL|DICTIONARY	tcra	TCRA	99#103		D003922	SYMBOL|()|DICTIONARY|EXTRACTED	iddm	IDDM	353#357	1982251-1-316-351	Polymorphism of the genes encoding the alpha, beta, and gamma chains of the human T-cell receptor (TCRA, TCRB, and TCRG), insulin gene (INS), and three closely linked polymorphic genes on chromosome 11q23, Thy-1 (THY1), T3-D (CD3D), and c-ets proto oncogene (ETS1) were investigated among 56 unrelated patients with insulin-dependent diabetes mellitus (IDDM) and 48 healthy controls.
1982251	1991	Dis. Markers	0278-0240	ALL_TEXT_1/3	1	1	6957	SYMBOL|DICTIONARY	tcrb	TCRB	105#109		D003922	LONGTERM|DICTIONARY	insulin dependent diabetes mellitus	insulin-dependent diabetes mellitus	316#351		Polymorphism of the genes encoding the alpha, beta, and gamma chains of the human T-cell receptor (TCRA, TCRB, and TCRG), insulin gene (INS), and three closely linked polymorphic genes on chromosome 11q23, Thy-1 (THY1), T3-D (CD3D), and c-ets proto oncogene (ETS1) were investigated among 56 unrelated patients with insulin-dependent diabetes mellitus (IDDM) and 48 healthy controls.
1982251	1991	Dis. Markers	0278-0240	ALL_TEXT_1/3	1	1	6957	SYMBOL|DICTIONARY	tcrb	TCRB	105#109		D003922	SYMBOL|()|DICTIONARY|EXTRACTED	iddm	IDDM	353#357	1982251-1-316-351	Polymorphism of the genes encoding the alpha, beta, and gamma chains of the human T-cell receptor (TCRA, TCRB, and TCRG), insulin gene (INS), and three closely linked polymorphic genes on chromosome 11q23, Thy-1 (THY1), T3-D (CD3D), and c-ets proto oncogene (ETS1) were investigated among 56 unrelated patients with insulin-dependent diabetes mellitus (IDDM) and 48 healthy controls.
1982251	1991	Dis. Markers	0278-0240	ALL_TEXT_1/3	1	1	6965	SYMBOL|DICTIONARY	tcrg	TCRG	115#119		D003922	LONGTERM|DICTIONARY	insulin dependent diabetes mellitus	insulin-dependent diabetes mellitus	316#351		Polymorphism of the genes encoding the alpha, beta, and gamma chains of the human T-cell receptor (TCRA, TCRB, and TCRG), insulin gene (INS), and three closely linked polymorphic genes on chromosome 11q23, Thy-1 (THY1), T3-D (CD3D), and c-ets proto oncogene (ETS1) were investigated among 56 unrelated patients with insulin-dependent diabetes mellitus (IDDM) and 48 healthy controls.
1982251	1991	Dis. Markers	0278-0240	ALL_TEXT_1/3	1	1	6965	SYMBOL|DICTIONARY	tcrg	TCRG	115#119		D003922	SYMBOL|()|DICTIONARY|EXTRACTED	iddm	IDDM	353#357	1982251-1-316-351	Polymorphism of the genes encoding the alpha, beta, and gamma chains of the human T-cell receptor (TCRA, TCRB, and TCRG), insulin gene (INS), and three closely linked polymorphic genes on chromosome 11q23, Thy-1 (THY1), T3-D (CD3D), and c-ets proto oncogene (ETS1) were investigated among 56 unrelated patients with insulin-dependent diabetes mellitus (IDDM) and 48 healthy controls.
1982251	1991	Dis. Markers	0278-0240	ALL_TEXT_1/3	1	1	7070	SYMBOL|DICTIONARY	thy 1	Thy-1	206#211		D003922	LONGTERM|DICTIONARY	insulin dependent diabetes mellitus	insulin-dependent diabetes mellitus	316#351		Polymorphism of the genes encoding the alpha, beta, and gamma chains of the human T-cell receptor (TCRA, TCRB, and TCRG), insulin gene (INS), and three closely linked polymorphic genes on chromosome 11q23, Thy-1 (THY1), T3-D (CD3D), and c-ets proto oncogene (ETS1) were investigated among 56 unrelated patients with insulin-dependent diabetes mellitus (IDDM) and 48 healthy controls.
1982251	1991	Dis. Markers	0278-0240	ALL_TEXT_1/3	1	1	7070	SYMBOL|DICTIONARY	thy 1	Thy-1	206#211		D003922	SYMBOL|()|DICTIONARY|EXTRACTED	iddm	IDDM	353#357	1982251-1-316-351	Polymorphism of the genes encoding the alpha, beta, and gamma chains of the human T-cell receptor (TCRA, TCRB, and TCRG), insulin gene (INS), and three closely linked polymorphic genes on chromosome 11q23, Thy-1 (THY1), T3-D (CD3D), and c-ets proto oncogene (ETS1) were investigated among 56 unrelated patients with insulin-dependent diabetes mellitus (IDDM) and 48 healthy controls.
1982251	1991	Dis. Markers	0278-0240	ALL_TEXT_1/3	1	1	7070	SYMBOL|()|DICTIONARY|EXTRACTED	thy1	THY1	213#217	1982251-1-206-211	D003922	LONGTERM|DICTIONARY	insulin dependent diabetes mellitus	insulin-dependent diabetes mellitus	316#351		Polymorphism of the genes encoding the alpha, beta, and gamma chains of the human T-cell receptor (TCRA, TCRB, and TCRG), insulin gene (INS), and three closely linked polymorphic genes on chromosome 11q23, Thy-1 (THY1), T3-D (CD3D), and c-ets proto oncogene (ETS1) were investigated among 56 unrelated patients with insulin-dependent diabetes mellitus (IDDM) and 48 healthy controls.
1982251	1991	Dis. Markers	0278-0240	ALL_TEXT_1/3	1	1	7070	SYMBOL|()|DICTIONARY|EXTRACTED	thy1	THY1	213#217	1982251-1-206-211	D003922	SYMBOL|()|DICTIONARY|EXTRACTED	iddm	IDDM	353#357	1982251-1-316-351	Polymorphism of the genes encoding the alpha, beta, and gamma chains of the human T-cell receptor (TCRA, TCRB, and TCRG), insulin gene (INS), and three closely linked polymorphic genes on chromosome 11q23, Thy-1 (THY1), T3-D (CD3D), and c-ets proto oncogene (ETS1) were investigated among 56 unrelated patients with insulin-dependent diabetes mellitus (IDDM) and 48 healthy controls.
1982251	1991	Dis. Markers	0278-0240	ALL_TEXT_1/3	1	1	915	SYMBOL|()|DICTIONARY	cd3d	CD3D	226#230		D003922	LONGTERM|DICTIONARY	insulin dependent diabetes mellitus	insulin-dependent diabetes mellitus	316#351		Polymorphism of the genes encoding the alpha, beta, and gamma chains of the human T-cell receptor (TCRA, TCRB, and TCRG), insulin gene (INS), and three closely linked polymorphic genes on chromosome 11q23, Thy-1 (THY1), T3-D (CD3D), and c-ets proto oncogene (ETS1) were investigated among 56 unrelated patients with insulin-dependent diabetes mellitus (IDDM) and 48 healthy controls.
1982251	1991	Dis. Markers	0278-0240	ALL_TEXT_1/3	1	1	915	SYMBOL|()|DICTIONARY	cd3d	CD3D	226#230		D003922	SYMBOL|()|DICTIONARY|EXTRACTED	iddm	IDDM	353#357	1982251-1-316-351	Polymorphism of the genes encoding the alpha, beta, and gamma chains of the human T-cell receptor (TCRA, TCRB, and TCRG), insulin gene (INS), and three closely linked polymorphic genes on chromosome 11q23, Thy-1 (THY1), T3-D (CD3D), and c-ets proto oncogene (ETS1) were investigated among 56 unrelated patients with insulin-dependent diabetes mellitus (IDDM) and 48 healthy controls.
1982251	1991	Dis. Markers	0278-0240	ALL_TEXT_1/3	1	1	2113	SYMBOL|()|DICTIONARY	ets1	ETS1	259#263		D003922	LONGTERM|DICTIONARY	insulin dependent diabetes mellitus	insulin-dependent diabetes mellitus	316#351		Polymorphism of the genes encoding the alpha, beta, and gamma chains of the human T-cell receptor (TCRA, TCRB, and TCRG), insulin gene (INS), and three closely linked polymorphic genes on chromosome 11q23, Thy-1 (THY1), T3-D (CD3D), and c-ets proto oncogene (ETS1) were investigated among 56 unrelated patients with insulin-dependent diabetes mellitus (IDDM) and 48 healthy controls.
1982251	1991	Dis. Markers	0278-0240	ALL_TEXT_1/3	1	1	2113	SYMBOL|()|DICTIONARY	ets1	ETS1	259#263		D003922	SYMBOL|()|DICTIONARY|EXTRACTED	iddm	IDDM	353#357	1982251-1-316-351	Polymorphism of the genes encoding the alpha, beta, and gamma chains of the human T-cell receptor (TCRA, TCRB, and TCRG), insulin gene (INS), and three closely linked polymorphic genes on chromosome 11q23, Thy-1 (THY1), T3-D (CD3D), and c-ets proto oncogene (ETS1) were investigated among 56 unrelated patients with insulin-dependent diabetes mellitus (IDDM) and 48 healthy controls.
1982251	1991	Dis. Markers	0278-0240	ALL_TEXT_1/3	1	1	3630	LONGTERM|DICTIONARY	insulin	insulin	122#129	NaN	D003922	LONGTERM|DICTIONARY	insulin dependent diabetes mellitus	insulin-dependent diabetes mellitus	316#351		Polymorphism of the genes encoding the alpha, beta, and gamma chains of the human T-cell receptor (TCRA, TCRB, and TCRG), insulin gene (INS), and three closely linked polymorphic genes on chromosome 11q23, Thy-1 (THY1), T3-D (CD3D), and c-ets proto oncogene (ETS1) were investigated among 56 unrelated patients with insulin-dependent diabetes mellitus (IDDM) and 48 healthy controls.
1982251	1991	Dis. Markers	0278-0240	ALL_TEXT_1/3	1	1	3630	LONGTERM|DICTIONARY	insulin	insulin	122#129	NaN	D003922	SYMBOL|()|DICTIONARY|EXTRACTED	iddm	IDDM	353#357	1982251-1-316-351	Polymorphism of the genes encoding the alpha, beta, and gamma chains of the human T-cell receptor (TCRA, TCRB, and TCRG), insulin gene (INS), and three closely linked polymorphic genes on chromosome 11q23, Thy-1 (THY1), T3-D (CD3D), and c-ets proto oncogene (ETS1) were investigated among 56 unrelated patients with insulin-dependent diabetes mellitus (IDDM) and 48 healthy controls.
20854105	2011	Genet Test Mol Biomarkers	1945-0257	BACKGROUND AND AIM	1	4	9156	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	exo1	EXO1	109#113	20854105-1-65-78	D015179	SYMBOL|DICTIONARY|EXTRACTED	crc	CRC	135#138	20854105-1-23-40	The aim of the present study was to examine the association between the L757P polymorphism at exon 13 of the EXO1 gene and the risk of CRC in Iranian patients.
21300947	2011	Arch. Gen. Psychiatry	1538-3636	RESULTS	7	9	627	SYMBOL|DICTIONARY|EXTRACTED	bdnf	BDNF	4#8	21300947-1-4-37	D009135	LONGTERM|DICTIONARY	thickness	thickness	75#84	NaN	The BDNF Val66Met polymorphism interacted with age to predict (1) cortical thickness (prominently at the entorhinal cortex and temporal gyri), (2) fractional anisotropy of white matter tracts (prominently at white matter tracts connecting to the medial temporal lobe), and (3) episodic memory performance.
11157139	2001	Rheumatology (Oxford)	1462-0324	RESULTS	3	4	3117	LONGTERM|DICTIONARY	dqa1	DQA1	18#22	NaN	D016736	SYMBOL|DICTIONARY|EXTRACTED	aps	APS	131#134	11157139-1-68-93	DQB1*0604/5/6/7/9-DQA1*0102-DRB1*1302 and DQB1*0303-DQA1*0201-DRB1*0701 haplotypes showed significantly positive correlations with APS [P=0.0087 and P=0.0012, respectively].
11157139	2001	Rheumatology (Oxford)	1462-0324	RESULTS	3	4	3117	LONGTERM|DICTIONARY	dqa1	DQA1	52#56	NaN	D016736	SYMBOL|DICTIONARY|EXTRACTED	aps	APS	131#134	11157139-1-68-93	DQB1*0604/5/6/7/9-DQA1*0102-DRB1*1302 and DQB1*0303-DQA1*0201-DRB1*0701 haplotypes showed significantly positive correlations with APS [P=0.0087 and P=0.0012, respectively].
11157139	2001	Rheumatology (Oxford)	1462-0324	RESULTS	3	4	3119	LONGTERM|DICTIONARY	dqb1	DQB1	0#4	NaN	D016736	SYMBOL|DICTIONARY|EXTRACTED	aps	APS	131#134	11157139-1-68-93	DQB1*0604/5/6/7/9-DQA1*0102-DRB1*1302 and DQB1*0303-DQA1*0201-DRB1*0701 haplotypes showed significantly positive correlations with APS [P=0.0087 and P=0.0012, respectively].
11157139	2001	Rheumatology (Oxford)	1462-0324	RESULTS	3	4	3119	LONGTERM|DICTIONARY	dqb1	DQB1	42#46	NaN	D016736	SYMBOL|DICTIONARY|EXTRACTED	aps	APS	131#134	11157139-1-68-93	DQB1*0604/5/6/7/9-DQA1*0102-DRB1*1302 and DQB1*0303-DQA1*0201-DRB1*0701 haplotypes showed significantly positive correlations with APS [P=0.0087 and P=0.0012, respectively].
19415413	2009	J. Neurol.	1432-1459	ALL_TEXT_3/3	3	4	6355	SYMBOL|DICTIONARY	ccl8	CCL8	20#24		D000544	SYMBOL|EXTRACTED	ad	AD	93#95	19415413-3-180-199	The distribution of CCL8/MCP-2 rs1133763 was not significantly different among patients with AD or FTLD and controls, even stratifying according to gender.
19415413	2009	J. Neurol.	1432-1459	ALL_TEXT_3/3	3	4	6355	SYMBOL|DICTIONARY	ccl8	CCL8	20#24		D057174	SYMBOL|DICTIONARY|EXTRACTED	ftld	FTLD	99#103	19415413-3-218-251	The distribution of CCL8/MCP-2 rs1133763 was not significantly different among patients with AD or FTLD and controls, even stratifying according to gender.
19415413	2009	J. Neurol.	1432-1459	ALL_TEXT_3/3	3	4	6355	SYMBOL|DICTIONARY	mcp 2	MCP-2	25#30		D000544	SYMBOL|EXTRACTED	ad	AD	93#95	19415413-3-180-199	The distribution of CCL8/MCP-2 rs1133763 was not significantly different among patients with AD or FTLD and controls, even stratifying according to gender.
19415413	2009	J. Neurol.	1432-1459	ALL_TEXT_3/3	3	4	6355	SYMBOL|DICTIONARY	mcp 2	MCP-2	25#30		D057174	SYMBOL|DICTIONARY|EXTRACTED	ftld	FTLD	99#103	19415413-3-218-251	The distribution of CCL8/MCP-2 rs1133763 was not significantly different among patients with AD or FTLD and controls, even stratifying according to gender.
19080705	2009	Zhonghua Yi Xue Za Zhi	0376-2491	OBJECTIVE	1	1	5075	SYMBOL|GENE|GN|DICTIONARY	pax1	PAX1	51#55		D012600	LONGTERM|DICTIONARY	congenital scoliosis	congenital scoliosis	66#86		To investigate the association of polymorphisms of PAX1 gene with congenital scoliosis (CS) in Chinese Han population and the relationship between the PAX1 gene polymorphisms and the clinical phenotypes of CS.
19080705	2009	Zhonghua Yi Xue Za Zhi	0376-2491	OBJECTIVE	1	1	5075	SYMBOL|GENE|GN|DICTIONARY	pax1	PAX1	51#55		D012600	SYMBOL|EXTRACTED|()	cs	CS	88#90	19080705-1-66-86	To investigate the association of polymorphisms of PAX1 gene with congenital scoliosis (CS) in Chinese Han population and the relationship between the PAX1 gene polymorphisms and the clinical phenotypes of CS.
19080705	2009	Zhonghua Yi Xue Za Zhi	0376-2491	OBJECTIVE	1	1	5075	SYMBOL|GENE|GN|DICTIONARY	pax1	PAX1	51#55		D012600	SYMBOL|EXTRACTED	cs	CS	206#208	19080705-1-66-86	To investigate the association of polymorphisms of PAX1 gene with congenital scoliosis (CS) in Chinese Han population and the relationship between the PAX1 gene polymorphisms and the clinical phenotypes of CS.
19080705	2009	Zhonghua Yi Xue Za Zhi	0376-2491	OBJECTIVE	1	1	5075	SYMBOL|GENE|GN|DICTIONARY	pax1	PAX1	151#155		D012600	LONGTERM|DICTIONARY	congenital scoliosis	congenital scoliosis	66#86		To investigate the association of polymorphisms of PAX1 gene with congenital scoliosis (CS) in Chinese Han population and the relationship between the PAX1 gene polymorphisms and the clinical phenotypes of CS.
19080705	2009	Zhonghua Yi Xue Za Zhi	0376-2491	OBJECTIVE	1	1	5075	SYMBOL|GENE|GN|DICTIONARY	pax1	PAX1	151#155		D012600	SYMBOL|EXTRACTED|()	cs	CS	88#90	19080705-1-66-86	To investigate the association of polymorphisms of PAX1 gene with congenital scoliosis (CS) in Chinese Han population and the relationship between the PAX1 gene polymorphisms and the clinical phenotypes of CS.
19080705	2009	Zhonghua Yi Xue Za Zhi	0376-2491	OBJECTIVE	1	1	5075	SYMBOL|GENE|GN|DICTIONARY	pax1	PAX1	151#155		D012600	SYMBOL|EXTRACTED	cs	CS	206#208	19080705-1-66-86	To investigate the association of polymorphisms of PAX1 gene with congenital scoliosis (CS) in Chinese Han population and the relationship between the PAX1 gene polymorphisms and the clinical phenotypes of CS.
19080705	2009	Zhonghua Yi Xue Za Zhi	0376-2491	TITLE	0	0	5075	SYMBOL|GENE|GN|DICTIONARY	pax1	PAX1	16#20		D012600	LONGTERM|DICTIONARY	congenital scoliosis	congenital scoliosis	63#83		[Association of PAX1 gene polymorphisms with susceptibility to congenital scoliosis in Chinese Han population].
16645213	2006	J Mol Diagn	1525-1578	ALL_TEXT_3/3	3	10	4869	LONGTERM|DICTIONARY	npm1	NPM1	39#43	NaN	D015470	SYMBOL|DICTIONARY|EXTRACTED	npmc+ aml	NPMc+ AML	157#166	16645213-1-77-100	Our results suggest that DHPLC detects NPM1mutations as well as direct sequencing and immunohistochemistry, providing a helpful approach in the diagnosis of NPMc+ AML.
16111806	2006	Cancer Lett.	0304-3835	ALL_TEXT_3/3	3	6	7037	SYMBOL|DICTIONARY|EXTRACTED	tfr1	TfR1	40#44	16111806-1-45-65	D009362	LONGTERM|DICTIONARY	metastasis	metastasis	204#214		In comparison, weak or no expression of TfR1 was observed in carcinoma samples of Dukes C or D grade with poorly differentiated cells and in carcinoma samples that had lymph node infiltration and distant metastasis.
16111806	2006	Cancer Lett.	0304-3835	ALL_TEXT_3/3	3	6	7037	SYMBOL|DICTIONARY|EXTRACTED	tfr1	TfR1	40#44	16111806-1-45-65	D002277	LONGTERM|DICTIONARY	carcinoma	carcinoma	61#70	NaN	In comparison, weak or no expression of TfR1 was observed in carcinoma samples of Dukes C or D grade with poorly differentiated cells and in carcinoma samples that had lymph node infiltration and distant metastasis.
16111806	2006	Cancer Lett.	0304-3835	ALL_TEXT_3/3	3	6	7037	SYMBOL|DICTIONARY|EXTRACTED	tfr1	TfR1	40#44	16111806-1-45-65	D002277	LONGTERM|DICTIONARY	carcinoma	carcinoma	141#150	NaN	In comparison, weak or no expression of TfR1 was observed in carcinoma samples of Dukes C or D grade with poorly differentiated cells and in carcinoma samples that had lymph node infiltration and distant metastasis.
16111806	2006	Cancer Lett.	0304-3835	ALL_TEXT_3/3	3	5	7037	SYMBOL|DICTIONARY|EXTRACTED	tfr1	TfR1	32#36	16111806-1-45-65	D015179	LONGTERM|DISEASE|DT|DICTIONARY	colorectal carcinoma	colorectal carcinoma	50#70		In this case high expression of TfR1 was found in colorectal carcinoma samples of Dukes A or B grade, and well differentiated colorectal carcinoma cells.
16111806	2006	Cancer Lett.	0304-3835	ALL_TEXT_3/3	3	5	7037	SYMBOL|DICTIONARY|EXTRACTED	tfr1	TfR1	32#36	16111806-1-45-65	D015179	LONGTERM|DISEASE|DT|CLINE|CN|DICTIONARY	colorectal carcinoma	colorectal carcinoma	126#146		In this case high expression of TfR1 was found in colorectal carcinoma samples of Dukes A or B grade, and well differentiated colorectal carcinoma cells.
16111806	2006	Cancer Lett.	0304-3835	ALL_TEXT_2/3	2	4	7037	SYMBOL|DICTIONARY|EXTRACTED	tfr1	TfR1	50#54	16111806-1-45-65	D015179	LONGTERM|DISEASE|DT|DICTIONARY	colorectal carcinoma	colorectal carcinoma	72#92		However, a relationship between the expression of TfR1 and the grade of colorectal carcinoma was observed.
16111806	2006	Cancer Lett.	0304-3835	ALL_TEXT_1/3	1	2	7037	SYMBOL|DICTIONARY|EXTRACTED	tfr1	TfR1	117#121	16111806-1-45-65	D002277	LONGTERM|DICTIONARY	carcinoma	carcinoma	22#31	NaN	While the majority of carcinoma patients were anemic, no relationship between the level of colon tissue ferritin and TfR1 and the systemic parameters of iron metabolism was evident.
16111806	2006	Cancer Lett.	0304-3835	ALL_TEXT_1/3	1	1	7037	SYMBOL|()|DICTIONARY|EXTRACTED	tfr1	TfR1	69#73	16111806-1-45-65	D015179	LONGTERM|DISEASE|DT|DICTIONARY	colorectal carcinoma	colorectal carcinoma	91#111		In this study, the level and distribution of transferrin receptor 1 (TfR1) and ferritin in colorectal carcinoma and in normal colon epithelium has been determined relative to the tumor stage and iron status of patients using immunohistochemical staining methods.
16111806	2006	Cancer Lett.	0304-3835	ALL_TEXT_1/3	1	1	7037	SYMBOL|()|DICTIONARY|EXTRACTED	tfr1	TfR1	69#73	16111806-1-45-65	D009369	LONGTERM|DISEASE|DT|DICTIONARY	tumor	tumor	179#184		In this study, the level and distribution of transferrin receptor 1 (TfR1) and ferritin in colorectal carcinoma and in normal colon epithelium has been determined relative to the tumor stage and iron status of patients using immunohistochemical staining methods.
16111806	2006	Cancer Lett.	0304-3835	ALL_TEXT_1/3	1	1	7037	LONGTERM|GENE|GT|NUMBER|DICTIONARY	transferrin receptor 1	transferrin receptor 1	45#67		D015179	LONGTERM|DISEASE|DT|DICTIONARY	colorectal carcinoma	colorectal carcinoma	91#111		In this study, the level and distribution of transferrin receptor 1 (TfR1) and ferritin in colorectal carcinoma and in normal colon epithelium has been determined relative to the tumor stage and iron status of patients using immunohistochemical staining methods.
16111806	2006	Cancer Lett.	0304-3835	ALL_TEXT_1/3	1	1	7037	LONGTERM|GENE|GT|NUMBER|DICTIONARY	transferrin receptor 1	transferrin receptor 1	45#67		D009369	LONGTERM|DISEASE|DT|DICTIONARY	tumor	tumor	179#184		In this study, the level and distribution of transferrin receptor 1 (TfR1) and ferritin in colorectal carcinoma and in normal colon epithelium has been determined relative to the tumor stage and iron status of patients using immunohistochemical staining methods.
16111806	2006	Cancer Lett.	0304-3835	TITLE	0	0	7037	LONGTERM|GENE|GT|NUMBER|DICTIONARY	transferrin receptor 1	transferrin receptor 1	25#47		D003110	LONGTERM|DISEASE|DT|DICTIONARY	colon cancer	colon cancer	78#90		Altered iron metabolism, transferrin receptor 1 and ferritin in patients with colon cancer.
17640379	2007	BMC Cancer	1471-2407	RESULTS	3	5	675	SYMBOL|DICTIONARY	brca2	BRCA2	264#269		D001943	LONGTERM|DISEASE|DT|DICTIONARY	breast cancer	breast cancer	39#52		Among families with high recurrence of breast cancer (> or = 3 cases in first-degree relatives), those from North Sardinia shared the same haplotype whereas the families from French Canadian and Jewish-Yemenite populations presented distinct genetic assets at the BRCA2 locus.
17640379	2007	BMC Cancer	1471-2407	RESULTS	3	6	675	SYMBOL|NUMBER|DICTIONARY	brca2	BRCA2	18#23		D001943	LONGTERM|DISEASE|DN|DT|DICTIONARY	breast cancer	breast cancer	87#100		Screening for the BRCA2-8765delAG variant among unselected and consecutively-collected breast cancer patients originating from the entire Sardinia revealed that such a mutation is present in the northern part of the island only [9/648 (1.4%) among cases from North Sardinia versus 0/493 among cases from South Sardinia].
17640379	2007	BMC Cancer	1471-2407	TITLE	0	0	675	SYMBOL|NUMBER|DICTIONARY	brca2	BRCA2	31#36		D001943	LONGTERM|DISEASE|DT|DICTIONARY	breast cancer	breast cancer	59#72		Origin and distribution of the BRCA2-8765delAG mutation in breast cancer.
17640379	2007	BMC Cancer	1471-2407	BACKGROUND	1	1	675	SYMBOL|NUMBER|DICTIONARY	brca2	BRCA2	4#9		D001943	LONGTERM|DISEASE|DT|GFAM|FN|DICTIONARY	breast cancer	breast cancer	54#67		The BRCA2-8765delAG mutation was firstly described in breast cancer families from French-Canadian and Jewish-Yemenite populations; it was then reported as a founder mutation in Sardinian families.
17640379	2007	BMC Cancer	1471-2407	BACKGROUND	1	2	675	SYMBOL|NUMBER|DICTIONARY	brca2	BRCA2	40#45		D001943	LONGTERM|DISEASE|DT|GFAM|FN|DICTIONARY	breast cancer	breast cancer	164#177		We evaluated both the prevalence of the BRCA2-8765delAG variant in Sardinia and the putative existence of a common ancestral origin through a haplotype analysis of breast cancer family members carrying such a mutation.
19141225	2009	Zhonghua Yu Fang Yi Xue Za Zhi	0253-9624	RESULTS	3	8	10332	SYMBOL|NUMBER|DICTIONARY	dc signr	DC-SIGNR	67#75		D006526	LONGTERM|DICTIONARY	hcv	HCV	219#222	NaN	Among HIV + DUs, there was a higher proportion of patient with the DC-SIGNR 5/6 and 5/8 (Fisher's exact, P = 0.043 and P = 0.034) with statistical significance; there was no statistically significant difference between HCV + and HCV-DUs and no significant difference between IDUs and other DUs for the DC-SIGNR polymorphism.
19141225	2009	Zhonghua Yu Fang Yi Xue Za Zhi	0253-9624	RESULTS	3	8	10332	SYMBOL|NUMBER|DICTIONARY	dc signr	DC-SIGNR	67#75		D006526	LONGTERM|DICTIONARY	hcv	HCV	229#232	NaN	Among HIV + DUs, there was a higher proportion of patient with the DC-SIGNR 5/6 and 5/8 (Fisher's exact, P = 0.043 and P = 0.034) with statistical significance; there was no statistically significant difference between HCV + and HCV-DUs and no significant difference between IDUs and other DUs for the DC-SIGNR polymorphism.
19141225	2009	Zhonghua Yu Fang Yi Xue Za Zhi	0253-9624	RESULTS	3	8	10332	SYMBOL|DICTIONARY	dc signr	DC-SIGNR	302#310		D006526	LONGTERM|DICTIONARY	hcv	HCV	219#222	NaN	Among HIV + DUs, there was a higher proportion of patient with the DC-SIGNR 5/6 and 5/8 (Fisher's exact, P = 0.043 and P = 0.034) with statistical significance; there was no statistically significant difference between HCV + and HCV-DUs and no significant difference between IDUs and other DUs for the DC-SIGNR polymorphism.
19141225	2009	Zhonghua Yu Fang Yi Xue Za Zhi	0253-9624	RESULTS	3	8	10332	SYMBOL|DICTIONARY	dc signr	DC-SIGNR	302#310		D006526	LONGTERM|DICTIONARY	hcv	HCV	229#232	NaN	Among HIV + DUs, there was a higher proportion of patient with the DC-SIGNR 5/6 and 5/8 (Fisher's exact, P = 0.043 and P = 0.034) with statistical significance; there was no statistically significant difference between HCV + and HCV-DUs and no significant difference between IDUs and other DUs for the DC-SIGNR polymorphism.
18313024	2008	Am. J. Hum. Genet.	1537-6605	ALL_TEXT_3/3	3	5	10908	SYMBOL|DICTIONARY|EXTRACTED	nte	NTE	0#3		D009422	LONGTERM|DICTIONARY	nte	NTE	0#3	NaN	NTE was a candidate because of its role in OPIDN and the similarity of our patients to those with OPIDN.
18313024	2008	Am. J. Hum. Genet.	1537-6605	ALL_TEXT_2/3	2	4	10908	SYMBOL|DICTIONARY|EXTRACTED	nte	NTE	152#155	18313024-1-280-306	D009422	LONGTERM|DICTIONARY	nte	NTE	152#155	NaN	Genome-wide analysis suggested linkage to a 22 cM homozygous locus (D19S565 to D19S884, maximum multipoint LOD score 3.28) on chromosome 19p13 to which NTE had been mapped (GenBank AJ004832).
18313024	2008	Am. J. Hum. Genet.	1537-6605	ALL_TEXT_3/3	3	7	10908	SYMBOL|DICTIONARY|EXTRACTED	nte	NTE	168#171	18313024-1-280-306	D009422	LONGTERM|DICTIONARY	nte	NTE	168#171	NaN	Affected subjects in the nonconsanguineous family were compound heterozygotes: one allele had c.2669G-->A mutation, which disrupts an interspecies conserved residue in NTE's catalytic domain (R890H), and the other allele had an insertion (c.2946_2947insCAGC) causing frameshift and protein truncation (p.S982fs1019).
18313024	2008	Am. J. Hum. Genet.	1537-6605	ALL_TEXT_3/3	3	6	10908	SYMBOL|DICTIONARY|EXTRACTED	nte	NTE	85#88	18313024-1-280-306	D009422	LONGTERM|DICTIONARY	nte	NTE	85#88	NaN	Affected subjects in the consanguineous kindred were homozygous for disease-specific NTE mutation c.3034A-->G that disrupted an interspecies conserved residue (M1012V) in NTE's catalytic domain.
18313024	2008	Am. J. Hum. Genet.	1537-6605	ALL_TEXT_3/3	3	6	10908	SYMBOL|DICTIONARY|EXTRACTED	nte	NTE	85#88	18313024-1-280-306	D009422	LONGTERM|DICTIONARY	nte	NTE	171#174	NaN	Affected subjects in the consanguineous kindred were homozygous for disease-specific NTE mutation c.3034A-->G that disrupted an interspecies conserved residue (M1012V) in NTE's catalytic domain.
18313024	2008	Am. J. Hum. Genet.	1537-6605	ALL_TEXT_3/3	3	6	10908	SYMBOL|DICTIONARY|EXTRACTED	nte	NTE	171#174	18313024-1-280-306	D009422	LONGTERM|DICTIONARY	nte	NTE	85#88	NaN	Affected subjects in the consanguineous kindred were homozygous for disease-specific NTE mutation c.3034A-->G that disrupted an interspecies conserved residue (M1012V) in NTE's catalytic domain.
18313024	2008	Am. J. Hum. Genet.	1537-6605	ALL_TEXT_3/3	3	6	10908	SYMBOL|DICTIONARY|EXTRACTED	nte	NTE	171#174	18313024-1-280-306	D009422	LONGTERM|DICTIONARY	nte	NTE	171#174	NaN	Affected subjects in the consanguineous kindred were homozygous for disease-specific NTE mutation c.3034A-->G that disrupted an interspecies conserved residue (M1012V) in NTE's catalytic domain.
18313024	2008	Am. J. Hum. Genet.	1537-6605	ALL_TEXT_1/3	1	1	5444	LONGTERM|DICTIONARY	paraoxonase 1	paraoxonase 1	125#138		D016472	LONGTERM|DISEASE|DT|DICTIONARY	motor neuron disease	motor neuron disease	67#87		The possibility that organophosphorus (OP) compounds contribute to motor neuron disease (MND) is supported by association of paraoxonase 1 polymorphisms with amyotrophic lateral sclerosis (ALS) and the occurrence of MND in OP compound-induced delayed neuropathy (OPIDN), in which neuropathy target esterase (NTE) is inhibited by organophosphorylation.
18313024	2008	Am. J. Hum. Genet.	1537-6605	ALL_TEXT_1/3	1	1	5444	LONGTERM|DICTIONARY	paraoxonase 1	paraoxonase 1	125#138		D016472	SYMBOL|EXTRACTED|()	mnd	MND	89#92	18313024-1-67-87	The possibility that organophosphorus (OP) compounds contribute to motor neuron disease (MND) is supported by association of paraoxonase 1 polymorphisms with amyotrophic lateral sclerosis (ALS) and the occurrence of MND in OP compound-induced delayed neuropathy (OPIDN), in which neuropathy target esterase (NTE) is inhibited by organophosphorylation.
18313024	2008	Am. J. Hum. Genet.	1537-6605	ALL_TEXT_1/3	1	1	5444	LONGTERM|DICTIONARY	paraoxonase 1	paraoxonase 1	125#138		D000690	LONGTERM|DICTIONARY	amyotrophic lateral sclerosis	amyotrophic lateral sclerosis	158#187		The possibility that organophosphorus (OP) compounds contribute to motor neuron disease (MND) is supported by association of paraoxonase 1 polymorphisms with amyotrophic lateral sclerosis (ALS) and the occurrence of MND in OP compound-induced delayed neuropathy (OPIDN), in which neuropathy target esterase (NTE) is inhibited by organophosphorylation.
18313024	2008	Am. J. Hum. Genet.	1537-6605	ALL_TEXT_1/3	1	1	5444	LONGTERM|DICTIONARY	paraoxonase 1	paraoxonase 1	125#138		D000690	SYMBOL|()|DICTIONARY|EXTRACTED	als	ALS	189#192	18313024-1-158-187	The possibility that organophosphorus (OP) compounds contribute to motor neuron disease (MND) is supported by association of paraoxonase 1 polymorphisms with amyotrophic lateral sclerosis (ALS) and the occurrence of MND in OP compound-induced delayed neuropathy (OPIDN), in which neuropathy target esterase (NTE) is inhibited by organophosphorylation.
18313024	2008	Am. J. Hum. Genet.	1537-6605	ALL_TEXT_1/3	1	1	5444	LONGTERM|DICTIONARY	paraoxonase 1	paraoxonase 1	125#138		D016472	SYMBOL|EXTRACTED	mnd	MND	216#219	18313024-1-67-87	The possibility that organophosphorus (OP) compounds contribute to motor neuron disease (MND) is supported by association of paraoxonase 1 polymorphisms with amyotrophic lateral sclerosis (ALS) and the occurrence of MND in OP compound-induced delayed neuropathy (OPIDN), in which neuropathy target esterase (NTE) is inhibited by organophosphorylation.
18313024	2008	Am. J. Hum. Genet.	1537-6605	ALL_TEXT_1/3	1	1	5444	LONGTERM|DICTIONARY	paraoxonase 1	paraoxonase 1	125#138		D009422	LONGTERM|DICTIONARY	neuropathy	neuropathy	251#261		The possibility that organophosphorus (OP) compounds contribute to motor neuron disease (MND) is supported by association of paraoxonase 1 polymorphisms with amyotrophic lateral sclerosis (ALS) and the occurrence of MND in OP compound-induced delayed neuropathy (OPIDN), in which neuropathy target esterase (NTE) is inhibited by organophosphorylation.
18313024	2008	Am. J. Hum. Genet.	1537-6605	ALL_TEXT_1/3	1	1	10908	LONGTERM|DICTIONARY	neuropathy target esterase	neuropathy target esterase	280#306		D016472	LONGTERM|DISEASE|DT|DICTIONARY	motor neuron disease	motor neuron disease	67#87		The possibility that organophosphorus (OP) compounds contribute to motor neuron disease (MND) is supported by association of paraoxonase 1 polymorphisms with amyotrophic lateral sclerosis (ALS) and the occurrence of MND in OP compound-induced delayed neuropathy (OPIDN), in which neuropathy target esterase (NTE) is inhibited by organophosphorylation.
18313024	2008	Am. J. Hum. Genet.	1537-6605	ALL_TEXT_1/3	1	1	10908	LONGTERM|DICTIONARY	neuropathy target esterase	neuropathy target esterase	280#306		D016472	SYMBOL|EXTRACTED|()	mnd	MND	89#92	18313024-1-67-87	The possibility that organophosphorus (OP) compounds contribute to motor neuron disease (MND) is supported by association of paraoxonase 1 polymorphisms with amyotrophic lateral sclerosis (ALS) and the occurrence of MND in OP compound-induced delayed neuropathy (OPIDN), in which neuropathy target esterase (NTE) is inhibited by organophosphorylation.
18313024	2008	Am. J. Hum. Genet.	1537-6605	ALL_TEXT_1/3	1	1	10908	LONGTERM|DICTIONARY	neuropathy target esterase	neuropathy target esterase	280#306		D000690	LONGTERM|DICTIONARY	amyotrophic lateral sclerosis	amyotrophic lateral sclerosis	158#187		The possibility that organophosphorus (OP) compounds contribute to motor neuron disease (MND) is supported by association of paraoxonase 1 polymorphisms with amyotrophic lateral sclerosis (ALS) and the occurrence of MND in OP compound-induced delayed neuropathy (OPIDN), in which neuropathy target esterase (NTE) is inhibited by organophosphorylation.
18313024	2008	Am. J. Hum. Genet.	1537-6605	ALL_TEXT_1/3	1	1	10908	LONGTERM|DICTIONARY	neuropathy target esterase	neuropathy target esterase	280#306		D000690	SYMBOL|()|DICTIONARY|EXTRACTED	als	ALS	189#192	18313024-1-158-187	The possibility that organophosphorus (OP) compounds contribute to motor neuron disease (MND) is supported by association of paraoxonase 1 polymorphisms with amyotrophic lateral sclerosis (ALS) and the occurrence of MND in OP compound-induced delayed neuropathy (OPIDN), in which neuropathy target esterase (NTE) is inhibited by organophosphorylation.
18313024	2008	Am. J. Hum. Genet.	1537-6605	ALL_TEXT_1/3	1	1	10908	LONGTERM|DICTIONARY	neuropathy target esterase	neuropathy target esterase	280#306		D016472	SYMBOL|EXTRACTED	mnd	MND	216#219	18313024-1-67-87	The possibility that organophosphorus (OP) compounds contribute to motor neuron disease (MND) is supported by association of paraoxonase 1 polymorphisms with amyotrophic lateral sclerosis (ALS) and the occurrence of MND in OP compound-induced delayed neuropathy (OPIDN), in which neuropathy target esterase (NTE) is inhibited by organophosphorylation.
18313024	2008	Am. J. Hum. Genet.	1537-6605	ALL_TEXT_1/3	1	1	10908	LONGTERM|DICTIONARY	neuropathy target esterase	neuropathy target esterase	280#306		D009422	LONGTERM|DICTIONARY	neuropathy	neuropathy	251#261		The possibility that organophosphorus (OP) compounds contribute to motor neuron disease (MND) is supported by association of paraoxonase 1 polymorphisms with amyotrophic lateral sclerosis (ALS) and the occurrence of MND in OP compound-induced delayed neuropathy (OPIDN), in which neuropathy target esterase (NTE) is inhibited by organophosphorylation.
18313024	2008	Am. J. Hum. Genet.	1537-6605	ALL_TEXT_1/3	1	1	10908	SYMBOL|()|DICTIONARY|EXTRACTED	nte	NTE	308#311	18313024-1-280-306	D016472	LONGTERM|DISEASE|DT|DICTIONARY	motor neuron disease	motor neuron disease	67#87		The possibility that organophosphorus (OP) compounds contribute to motor neuron disease (MND) is supported by association of paraoxonase 1 polymorphisms with amyotrophic lateral sclerosis (ALS) and the occurrence of MND in OP compound-induced delayed neuropathy (OPIDN), in which neuropathy target esterase (NTE) is inhibited by organophosphorylation.
18313024	2008	Am. J. Hum. Genet.	1537-6605	ALL_TEXT_1/3	1	1	10908	SYMBOL|()|DICTIONARY|EXTRACTED	nte	NTE	308#311	18313024-1-280-306	D016472	SYMBOL|EXTRACTED|()	mnd	MND	89#92	18313024-1-67-87	The possibility that organophosphorus (OP) compounds contribute to motor neuron disease (MND) is supported by association of paraoxonase 1 polymorphisms with amyotrophic lateral sclerosis (ALS) and the occurrence of MND in OP compound-induced delayed neuropathy (OPIDN), in which neuropathy target esterase (NTE) is inhibited by organophosphorylation.
18313024	2008	Am. J. Hum. Genet.	1537-6605	ALL_TEXT_1/3	1	1	10908	SYMBOL|()|DICTIONARY|EXTRACTED	nte	NTE	308#311	18313024-1-280-306	D000690	LONGTERM|DICTIONARY	amyotrophic lateral sclerosis	amyotrophic lateral sclerosis	158#187		The possibility that organophosphorus (OP) compounds contribute to motor neuron disease (MND) is supported by association of paraoxonase 1 polymorphisms with amyotrophic lateral sclerosis (ALS) and the occurrence of MND in OP compound-induced delayed neuropathy (OPIDN), in which neuropathy target esterase (NTE) is inhibited by organophosphorylation.
18313024	2008	Am. J. Hum. Genet.	1537-6605	ALL_TEXT_1/3	1	1	10908	SYMBOL|()|DICTIONARY|EXTRACTED	nte	NTE	308#311	18313024-1-280-306	D000690	SYMBOL|()|DICTIONARY|EXTRACTED	als	ALS	189#192	18313024-1-158-187	The possibility that organophosphorus (OP) compounds contribute to motor neuron disease (MND) is supported by association of paraoxonase 1 polymorphisms with amyotrophic lateral sclerosis (ALS) and the occurrence of MND in OP compound-induced delayed neuropathy (OPIDN), in which neuropathy target esterase (NTE) is inhibited by organophosphorylation.
18313024	2008	Am. J. Hum. Genet.	1537-6605	ALL_TEXT_1/3	1	1	10908	SYMBOL|()|DICTIONARY|EXTRACTED	nte	NTE	308#311	18313024-1-280-306	D016472	SYMBOL|EXTRACTED	mnd	MND	216#219	18313024-1-67-87	The possibility that organophosphorus (OP) compounds contribute to motor neuron disease (MND) is supported by association of paraoxonase 1 polymorphisms with amyotrophic lateral sclerosis (ALS) and the occurrence of MND in OP compound-induced delayed neuropathy (OPIDN), in which neuropathy target esterase (NTE) is inhibited by organophosphorylation.
18313024	2008	Am. J. Hum. Genet.	1537-6605	ALL_TEXT_1/3	1	1	10908	SYMBOL|()|DICTIONARY|EXTRACTED	nte	NTE	308#311	18313024-1-280-306	D009422	LONGTERM|DICTIONARY	neuropathy	neuropathy	251#261		The possibility that organophosphorus (OP) compounds contribute to motor neuron disease (MND) is supported by association of paraoxonase 1 polymorphisms with amyotrophic lateral sclerosis (ALS) and the occurrence of MND in OP compound-induced delayed neuropathy (OPIDN), in which neuropathy target esterase (NTE) is inhibited by organophosphorylation.
18313024	2008	Am. J. Hum. Genet.	1537-6605	ALL_TEXT_2/3	2	3	23111	SYMBOL|DICTIONARY	spg20	SPG20	83#88		C536858	LONGTERM|DISEASE|DT|DICTIONARY	troyer syndrome	Troyer Syndrome	60#75		Affected subjects resembled those with OPIDN and those with Troyer Syndrome due to SPG20/spartin gene mutation (excluded by genetic linkage and SPG20/spartin sequence analysis).
18313024	2008	Am. J. Hum. Genet.	1537-6605	ALL_TEXT_2/3	2	3	23111	SYMBOL|GENE|GN|DICTIONARY	spartin	spartin	89#96		C536858	LONGTERM|DISEASE|DT|DICTIONARY	troyer syndrome	Troyer Syndrome	60#75		Affected subjects resembled those with OPIDN and those with Troyer Syndrome due to SPG20/spartin gene mutation (excluded by genetic linkage and SPG20/spartin sequence analysis).
18313024	2008	Am. J. Hum. Genet.	1537-6605	ALL_TEXT_2/3	2	3	23111	SYMBOL|DICTIONARY	spg20	SPG20	144#149		C536858	LONGTERM|DISEASE|DT|DICTIONARY	troyer syndrome	Troyer Syndrome	60#75		Affected subjects resembled those with OPIDN and those with Troyer Syndrome due to SPG20/spartin gene mutation (excluded by genetic linkage and SPG20/spartin sequence analysis).
20543710	2011	J. Glaucoma	1536-481X	PURPOSE	1	5	348	SYMBOL|GENE|GN|DICTIONARY	apoe	APOE	17#21		D003327	LONGTERM|DISEASE|DT|DICTIONARY	coronary heart disease	coronary heart disease	86#108		The 4 allele of APOE gene was shown to be associated both with an increased risk for coronary heart disease and late-onset Alzheimer disease.
20543710	2011	J. Glaucoma	1536-481X	PURPOSE	1	5	348	SYMBOL|GENE|GN|DICTIONARY	apoe	APOE	17#21		D000544	LONGTERM|DISEASE|DT|DICTIONARY	alzheimer disease	Alzheimer disease	124#141		The 4 allele of APOE gene was shown to be associated both with an increased risk for coronary heart disease and late-onset Alzheimer disease.
18313024	2008	Am. J. Hum. Genet.	1537-6605	ALL_TEXT_3/3	3	8	10908	SYMBOL|DICTIONARY|EXTRACTED	nte	NTE	31#34	18313024-1-280-306	D016472	SYMBOL|EXTRACTED|DISEASE|DN	mnd	MND	58#61	18313024-1-67-87	Disease-specific, nonconserved NTE mutations in unrelated MND patients indicates NTE's importance in maintaining axonal integrity, raises the possibility that NTE pathway disturbances contribute to other MNDs including ALS, and supports the role of NTE abnormalities in axonopathy produced by neuropathic OP compounds.
18313024	2008	Am. J. Hum. Genet.	1537-6605	ALL_TEXT_3/3	3	8	10908	SYMBOL|DICTIONARY|EXTRACTED	nte	NTE	31#34	18313024-1-280-306	D016472	SYMBOL|EXTRACTED|PLURAL	mnd	MND	204#207	18313024-1-67-87	Disease-specific, nonconserved NTE mutations in unrelated MND patients indicates NTE's importance in maintaining axonal integrity, raises the possibility that NTE pathway disturbances contribute to other MNDs including ALS, and supports the role of NTE abnormalities in axonopathy produced by neuropathic OP compounds.
18313024	2008	Am. J. Hum. Genet.	1537-6605	ALL_TEXT_3/3	3	8	10908	SYMBOL|DICTIONARY|EXTRACTED	nte	NTE	31#34	18313024-1-280-306	D000690	SYMBOL|DICTIONARY|EXTRACTED	als	ALS	219#222	18313024-1-158-187	Disease-specific, nonconserved NTE mutations in unrelated MND patients indicates NTE's importance in maintaining axonal integrity, raises the possibility that NTE pathway disturbances contribute to other MNDs including ALS, and supports the role of NTE abnormalities in axonopathy produced by neuropathic OP compounds.
18313024	2008	Am. J. Hum. Genet.	1537-6605	ALL_TEXT_3/3	3	8	10908	SYMBOL|DICTIONARY|EXTRACTED	nte	NTE	31#34	18313024-1-280-306	D009422	LONGTERM|DICTIONARY	nte abnormalities	NTE abnormalities	249#266		Disease-specific, nonconserved NTE mutations in unrelated MND patients indicates NTE's importance in maintaining axonal integrity, raises the possibility that NTE pathway disturbances contribute to other MNDs including ALS, and supports the role of NTE abnormalities in axonopathy produced by neuropathic OP compounds.
18313024	2008	Am. J. Hum. Genet.	1537-6605	ALL_TEXT_3/3	3	8	10908	SYMBOL|DICTIONARY|EXTRACTED	nte	NTE	31#34	18313024-1-280-306	D012678	LONGTERM|DICTIONARY	neuropathic op compounds	neuropathic OP compounds	293#317	NaN	Disease-specific, nonconserved NTE mutations in unrelated MND patients indicates NTE's importance in maintaining axonal integrity, raises the possibility that NTE pathway disturbances contribute to other MNDs including ALS, and supports the role of NTE abnormalities in axonopathy produced by neuropathic OP compounds.
18313024	2008	Am. J. Hum. Genet.	1537-6605	ALL_TEXT_3/3	3	8	10908	SYMBOL|DICTIONARY|EXTRACTED	nte	NTE	81#84	18313024-1-280-306	D016472	SYMBOL|EXTRACTED|DISEASE|DN	mnd	MND	58#61	18313024-1-67-87	Disease-specific, nonconserved NTE mutations in unrelated MND patients indicates NTE's importance in maintaining axonal integrity, raises the possibility that NTE pathway disturbances contribute to other MNDs including ALS, and supports the role of NTE abnormalities in axonopathy produced by neuropathic OP compounds.
18313024	2008	Am. J. Hum. Genet.	1537-6605	ALL_TEXT_3/3	3	8	10908	SYMBOL|DICTIONARY|EXTRACTED	nte	NTE	81#84	18313024-1-280-306	D016472	SYMBOL|EXTRACTED|PLURAL	mnd	MND	204#207	18313024-1-67-87	Disease-specific, nonconserved NTE mutations in unrelated MND patients indicates NTE's importance in maintaining axonal integrity, raises the possibility that NTE pathway disturbances contribute to other MNDs including ALS, and supports the role of NTE abnormalities in axonopathy produced by neuropathic OP compounds.
18313024	2008	Am. J. Hum. Genet.	1537-6605	ALL_TEXT_3/3	3	8	10908	SYMBOL|DICTIONARY|EXTRACTED	nte	NTE	81#84	18313024-1-280-306	D000690	SYMBOL|DICTIONARY|EXTRACTED	als	ALS	219#222	18313024-1-158-187	Disease-specific, nonconserved NTE mutations in unrelated MND patients indicates NTE's importance in maintaining axonal integrity, raises the possibility that NTE pathway disturbances contribute to other MNDs including ALS, and supports the role of NTE abnormalities in axonopathy produced by neuropathic OP compounds.
18313024	2008	Am. J. Hum. Genet.	1537-6605	ALL_TEXT_3/3	3	8	10908	SYMBOL|DICTIONARY|EXTRACTED	nte	NTE	81#84	18313024-1-280-306	D009422	LONGTERM|DICTIONARY	nte abnormalities	NTE abnormalities	249#266		Disease-specific, nonconserved NTE mutations in unrelated MND patients indicates NTE's importance in maintaining axonal integrity, raises the possibility that NTE pathway disturbances contribute to other MNDs including ALS, and supports the role of NTE abnormalities in axonopathy produced by neuropathic OP compounds.
18313024	2008	Am. J. Hum. Genet.	1537-6605	ALL_TEXT_3/3	3	8	10908	SYMBOL|DICTIONARY|EXTRACTED	nte	NTE	81#84	18313024-1-280-306	D012678	LONGTERM|DICTIONARY	neuropathic op compounds	neuropathic OP compounds	293#317	NaN	Disease-specific, nonconserved NTE mutations in unrelated MND patients indicates NTE's importance in maintaining axonal integrity, raises the possibility that NTE pathway disturbances contribute to other MNDs including ALS, and supports the role of NTE abnormalities in axonopathy produced by neuropathic OP compounds.
18313024	2008	Am. J. Hum. Genet.	1537-6605	ALL_TEXT_3/3	3	8	10908	SYMBOL|DICTIONARY|EXTRACTED	nte	NTE	159#162	18313024-1-280-306	D016472	SYMBOL|EXTRACTED|DISEASE|DN	mnd	MND	58#61	18313024-1-67-87	Disease-specific, nonconserved NTE mutations in unrelated MND patients indicates NTE's importance in maintaining axonal integrity, raises the possibility that NTE pathway disturbances contribute to other MNDs including ALS, and supports the role of NTE abnormalities in axonopathy produced by neuropathic OP compounds.
18313024	2008	Am. J. Hum. Genet.	1537-6605	ALL_TEXT_3/3	3	8	10908	SYMBOL|DICTIONARY|EXTRACTED	nte	NTE	159#162	18313024-1-280-306	D016472	SYMBOL|EXTRACTED|PLURAL	mnd	MND	204#207	18313024-1-67-87	Disease-specific, nonconserved NTE mutations in unrelated MND patients indicates NTE's importance in maintaining axonal integrity, raises the possibility that NTE pathway disturbances contribute to other MNDs including ALS, and supports the role of NTE abnormalities in axonopathy produced by neuropathic OP compounds.
18313024	2008	Am. J. Hum. Genet.	1537-6605	ALL_TEXT_3/3	3	8	10908	SYMBOL|DICTIONARY|EXTRACTED	nte	NTE	159#162	18313024-1-280-306	D000690	SYMBOL|DICTIONARY|EXTRACTED	als	ALS	219#222	18313024-1-158-187	Disease-specific, nonconserved NTE mutations in unrelated MND patients indicates NTE's importance in maintaining axonal integrity, raises the possibility that NTE pathway disturbances contribute to other MNDs including ALS, and supports the role of NTE abnormalities in axonopathy produced by neuropathic OP compounds.
18313024	2008	Am. J. Hum. Genet.	1537-6605	ALL_TEXT_3/3	3	8	10908	SYMBOL|DICTIONARY|EXTRACTED	nte	NTE	159#162	18313024-1-280-306	D009422	LONGTERM|DICTIONARY	nte abnormalities	NTE abnormalities	249#266		Disease-specific, nonconserved NTE mutations in unrelated MND patients indicates NTE's importance in maintaining axonal integrity, raises the possibility that NTE pathway disturbances contribute to other MNDs including ALS, and supports the role of NTE abnormalities in axonopathy produced by neuropathic OP compounds.
18313024	2008	Am. J. Hum. Genet.	1537-6605	ALL_TEXT_3/3	3	8	10908	SYMBOL|DICTIONARY|EXTRACTED	nte	NTE	159#162	18313024-1-280-306	D012678	LONGTERM|DICTIONARY	neuropathic op compounds	neuropathic OP compounds	293#317	NaN	Disease-specific, nonconserved NTE mutations in unrelated MND patients indicates NTE's importance in maintaining axonal integrity, raises the possibility that NTE pathway disturbances contribute to other MNDs including ALS, and supports the role of NTE abnormalities in axonopathy produced by neuropathic OP compounds.
18313024	2008	Am. J. Hum. Genet.	1537-6605	ALL_TEXT_3/3	3	8	10908	SYMBOL|DICTIONARY|EXTRACTED	nte	NTE	249#252	18313024-1-280-306	D016472	SYMBOL|EXTRACTED|DISEASE|DN	mnd	MND	58#61	18313024-1-67-87	Disease-specific, nonconserved NTE mutations in unrelated MND patients indicates NTE's importance in maintaining axonal integrity, raises the possibility that NTE pathway disturbances contribute to other MNDs including ALS, and supports the role of NTE abnormalities in axonopathy produced by neuropathic OP compounds.
18313024	2008	Am. J. Hum. Genet.	1537-6605	ALL_TEXT_3/3	3	8	10908	SYMBOL|DICTIONARY|EXTRACTED	nte	NTE	249#252	18313024-1-280-306	D016472	SYMBOL|EXTRACTED|PLURAL	mnd	MND	204#207	18313024-1-67-87	Disease-specific, nonconserved NTE mutations in unrelated MND patients indicates NTE's importance in maintaining axonal integrity, raises the possibility that NTE pathway disturbances contribute to other MNDs including ALS, and supports the role of NTE abnormalities in axonopathy produced by neuropathic OP compounds.
18313024	2008	Am. J. Hum. Genet.	1537-6605	ALL_TEXT_3/3	3	8	10908	SYMBOL|DICTIONARY|EXTRACTED	nte	NTE	249#252	18313024-1-280-306	D000690	SYMBOL|DICTIONARY|EXTRACTED	als	ALS	219#222	18313024-1-158-187	Disease-specific, nonconserved NTE mutations in unrelated MND patients indicates NTE's importance in maintaining axonal integrity, raises the possibility that NTE pathway disturbances contribute to other MNDs including ALS, and supports the role of NTE abnormalities in axonopathy produced by neuropathic OP compounds.
18313024	2008	Am. J. Hum. Genet.	1537-6605	ALL_TEXT_3/3	3	8	10908	SYMBOL|DICTIONARY|EXTRACTED	nte	NTE	249#252	18313024-1-280-306	D009422	LONGTERM|DICTIONARY	nte abnormalities	NTE abnormalities	249#266		Disease-specific, nonconserved NTE mutations in unrelated MND patients indicates NTE's importance in maintaining axonal integrity, raises the possibility that NTE pathway disturbances contribute to other MNDs including ALS, and supports the role of NTE abnormalities in axonopathy produced by neuropathic OP compounds.
18313024	2008	Am. J. Hum. Genet.	1537-6605	ALL_TEXT_3/3	3	8	10908	SYMBOL|DICTIONARY|EXTRACTED	nte	NTE	249#252	18313024-1-280-306	D012678	LONGTERM|DICTIONARY	neuropathic op compounds	neuropathic OP compounds	293#317	NaN	Disease-specific, nonconserved NTE mutations in unrelated MND patients indicates NTE's importance in maintaining axonal integrity, raises the possibility that NTE pathway disturbances contribute to other MNDs including ALS, and supports the role of NTE abnormalities in axonopathy produced by neuropathic OP compounds.
15571962	2005	Eur. J. Cancer	0959-8049	ALL_TEXT_3/3	3	10	672	SYMBOL|DICTIONARY	brca1	BRCA1	4#9		D010051	LONGTERM|DISEASE|DT|DICTIONARY	ovarian cancer	ovarian cancer	69#83		The BRCA1 G5193A mutation is too rare to contribute significantly to ovarian cancer in Iceland.
16699517	2006	Nat. Genet.	1061-4036	ALL_TEXT_1/3	1	1	64135	SYMBOL|DICTIONARY	ifih1	IFIH1	149#154		D003922	LONGTERM|DICTIONARY	type 1 diabetes	type 1 diabetes	67#82		In this study we report convincing statistical support for a sixth type 1 diabetes (T1D) locus in the innate immunity viral RNA receptor gene region IFIH1 (also known as mda-5 or Helicard) on chromosome 2q24.3.
16699517	2006	Nat. Genet.	1061-4036	ALL_TEXT_1/3	1	1	64135	SYMBOL|DICTIONARY	ifih1	IFIH1	149#154		D003922	SYMBOL|EXTRACTED|()	t1d	T1D	84#87	16699517-1-67-82	In this study we report convincing statistical support for a sixth type 1 diabetes (T1D) locus in the innate immunity viral RNA receptor gene region IFIH1 (also known as mda-5 or Helicard) on chromosome 2q24.3.
16699517	2006	Nat. Genet.	1061-4036	ALL_TEXT_1/3	1	1	64135	SYMBOL|DICTIONARY	mda 5	mda-5	170#175		D003922	LONGTERM|DICTIONARY	type 1 diabetes	type 1 diabetes	67#82		In this study we report convincing statistical support for a sixth type 1 diabetes (T1D) locus in the innate immunity viral RNA receptor gene region IFIH1 (also known as mda-5 or Helicard) on chromosome 2q24.3.
16699517	2006	Nat. Genet.	1061-4036	ALL_TEXT_1/3	1	1	64135	SYMBOL|DICTIONARY	mda 5	mda-5	170#175		D003922	SYMBOL|EXTRACTED|()	t1d	T1D	84#87	16699517-1-67-82	In this study we report convincing statistical support for a sixth type 1 diabetes (T1D) locus in the innate immunity viral RNA receptor gene region IFIH1 (also known as mda-5 or Helicard) on chromosome 2q24.3.
16699517	2006	Nat. Genet.	1061-4036	TITLE	0	0	64135	SYMBOL|()|DICTIONARY	ifih1	IFIH1	125#130		D003922	LONGTERM|DICTIONARY	type 1 diabetes	type 1 diabetes	67#82		A genome-wide association study of nonsynonymous SNPs identifies a type 1 diabetes locus in the interferon-induced helicase (IFIH1) region.
18307574	2009	Allergy	1398-9995	CONCLUSION	4	10	2312	SYMBOL|DICTIONARY|EXTRACTED	flg	FLG	131#134	18307574-1-0-9	D001249	LONGTERM|DICTIONARY	asthma	asthma	31#37		In addition to their effect on asthma medication requirements reported previously, there is an association between the presence of FLG null mutations and the risk of asthma exacerbations in asthmatic children and young adults.
18307574	2009	Allergy	1398-9995	CONCLUSION	4	10	2312	SYMBOL|DICTIONARY|EXTRACTED	flg	FLG	131#134	18307574-1-0-9	D001249	LONGTERM|DICTIONARY	asthma	asthma	166#172		In addition to their effect on asthma medication requirements reported previously, there is an association between the presence of FLG null mutations and the risk of asthma exacerbations in asthmatic children and young adults.
18307574	2009	Allergy	1398-9995	CONCLUSION	4	10	2312	SYMBOL|DICTIONARY|EXTRACTED	flg	FLG	131#134	18307574-1-0-9	D013224	LONGTERM|DICTIONARY	asthmatic	asthmatic	190#199		In addition to their effect on asthma medication requirements reported previously, there is an association between the presence of FLG null mutations and the risk of asthma exacerbations in asthmatic children and young adults.
20037740	2011	Comp. Funct. Genomics	1532-6268	ALL_TEXT_1/3	1	1	3576	SYMBOL|DICTIONARY	interleukin (il)-8	Interleukin (IL)-8	11#29		D009369	LONGTERM|DISEASE|DT|DICTIONARY	cancer cachexia	cancer cachexia	72#87		Background.Interleukin (IL)-8 has been implicated in the development of cancer cachexia.
20037740	2011	Comp. Funct. Genomics	1532-6268	ALL_TEXT_1/3	1	1	3576	SYMBOL|DICTIONARY	interleukin (il)-8	Interleukin (IL)-8	11#29		D009369	LONGTERM|DICTIONARY	cancer cachexia	cancer cachexia	72#87		Background.Interleukin (IL)-8 has been implicated in the development of cancer cachexia.
12930688	2004	Zhonghua Yi Xue Za Zhi	0376-2491	OBJECTIVE	1	1	4436	SYMBOL|DICTIONARY	msh2	MSH2	101#105		D015179	LONGTERM|DICTIONARY	colorectal cancers	colorectal cancers	140#158		To investigate the etiological role of function and construction alteration in mismatch repair genes MSH2 and MLH1 in the patients onset of colorectal cancers (CRC) at early ages.
12930688	2004	Zhonghua Yi Xue Za Zhi	0376-2491	OBJECTIVE	1	1	4436	SYMBOL|DICTIONARY	msh2	MSH2	101#105		D015179	SYMBOL|()|DICTIONARY|EXTRACTED	crc	CRC	160#163	12930688-1-140-158	To investigate the etiological role of function and construction alteration in mismatch repair genes MSH2 and MLH1 in the patients onset of colorectal cancers (CRC) at early ages.
12930688	2004	Zhonghua Yi Xue Za Zhi	0376-2491	OBJECTIVE	1	1	4292	SYMBOL|DICTIONARY	mlh1	MLH1	110#114		D015179	LONGTERM|DICTIONARY	colorectal cancers	colorectal cancers	140#158		To investigate the etiological role of function and construction alteration in mismatch repair genes MSH2 and MLH1 in the patients onset of colorectal cancers (CRC) at early ages.
12930688	2004	Zhonghua Yi Xue Za Zhi	0376-2491	OBJECTIVE	1	1	4292	SYMBOL|DICTIONARY	mlh1	MLH1	110#114		D015179	SYMBOL|()|DICTIONARY|EXTRACTED	crc	CRC	160#163	12930688-1-140-158	To investigate the etiological role of function and construction alteration in mismatch repair genes MSH2 and MLH1 in the patients onset of colorectal cancers (CRC) at early ages.
16234515	2005	J. Clin. Oncol.	0732-183X	CONCLUSION	4	7	672	SYMBOL|DICTIONARY	brca1	BRCA1	88#93		D001943	LONGTERM|DISEASE|DT|DICTIONARY	breast cancer	breast cancer	59#72		Oophorectomy is an effective means of reducing the risk of breast cancer in carriers of BRCA1 mutations.
9217972	1997	Brain Pathol.	1015-6305	ALL_TEXT_1/3	1	2	1029	SYMBOL|DICTIONARY	cdkn2	CDKN2	58#63		D005909	SYMBOL|DICTIONARY|EXTRACTED	gbm	GBM	16#19	9217972-1-0-23	The majority of GBM also have homozygous deletions of the CDKN2 (p16/MTS1) gene, resulting in cell cycle deregulation and elevated proliferation indices.
9217972	1997	Brain Pathol.	1015-6305	ALL_TEXT_1/3	1	2	1029	SYMBOL|GENE|GN|DICTIONARY	mts1	MTS1	69#73		D005909	SYMBOL|DICTIONARY|EXTRACTED	gbm	GBM	16#19	9217972-1-0-23	The majority of GBM also have homozygous deletions of the CDKN2 (p16/MTS1) gene, resulting in cell cycle deregulation and elevated proliferation indices.
20543710	2011	J. Glaucoma	1536-481X	PURPOSE	1	4	348	LONGTERM|DICTIONARY	apolipoprotein e	Apolipoprotein E	0#16		D058225	LONGTERM|DICTIONARY	amyloid deposition	amyloid deposition	55#73		Apolipoprotein E (Apo-E) is directly involved in these amyloid deposition and fibrils formation.
20543710	2011	J. Glaucoma	1536-481X	PURPOSE	1	4	348	SYMBOL|()|DICTIONARY|EXTRACTED	apo e	Apo-E	18#23	20543710-4-0-16	D058225	LONGTERM|DICTIONARY	amyloid deposition	amyloid deposition	55#73		Apolipoprotein E (Apo-E) is directly involved in these amyloid deposition and fibrils formation.
11951178	2002	Am. J. Hum. Genet.	0002-9297	ALL_TEXT_3/3	3	10	1270	SYMBOL|DICTIONARY	cntf	CNTF	23#27		D000690	LONGTERM|DICTIONARY	amyotrophic lateral sclerosis	amyotrophic lateral sclerosis	163#192		Thus, we conclude that CNTF acts as a modifier gene that leads to early onset of disease in patients with FALS who have SOD-1 mutations, in patients with sporadic amyotrophic lateral sclerosis, and in the hSOD-1G93A mouse model.
11951178	2002	Am. J. Hum. Genet.	0002-9297	ALL_TEXT_3/3	3	10	6647	SYMBOL|DICTIONARY|EXTRACTED	sod 1	SOD-1	120#125	11951178-1-29-51	D000690	LONGTERM|DICTIONARY	amyotrophic lateral sclerosis	amyotrophic lateral sclerosis	163#192		Thus, we conclude that CNTF acts as a modifier gene that leads to early onset of disease in patients with FALS who have SOD-1 mutations, in patients with sporadic amyotrophic lateral sclerosis, and in the hSOD-1G93A mouse model.
10822820	2000	Genetika	0016-6758	TITLE	0	0	3578	SYMBOL|GENE|GN|DICTIONARY	il 9	il-9	73#77		D001249	LONGTERM|DICTIONARY	bronchial asthma	bronchial asthma	87#103		[Analysis of the association between the T113M polymorphism of the human il-9 gene and bronchial asthma].
1301936	1993	Hum. Mutat.	1059-7794	ALL_TEXT_1/3	1	2	4942	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	oat	OAT	97#100	1301936-0-34-60	D015799	LONGTERM|DICTIONARY	oat	OAT	97#100	NaN	Previously, we and others have reported a number of missense mutations and splice defects in the OAT gene associated with GA.
17199794	2007	Nephrology (Carlton)	1320-5358	RESULTS	3	10	1636	SYMBOL|DICTIONARY|EXTRACTED	ace	ACE	90#93	17199794-1-51-82	D007676	SYMBOL|DISEASE|DT|DICTIONARY	end stage renal disease	end stage renal disease	65#88		Six patients with steroid-resistant nephrotic syndrome went into end stage renal disease; ACE genotype was I/I in one and I/D in five, but none were D/D.
17199794	2007	Nephrology (Carlton)	1320-5358	RESULTS	3	10	1636	SYMBOL|DICTIONARY|EXTRACTED	ace	ACE	90#93	17199794-1-51-82	D009404	LONGTERM|DISEASE|DT|DICTIONARY	nephrotic syndrome	nephrotic syndrome	36#54		Six patients with steroid-resistant nephrotic syndrome went into end stage renal disease; ACE genotype was I/I in one and I/D in five, but none were D/D.
17199794	2007	Nephrology (Carlton)	1320-5358	CONCLUSION	4	11	1636	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	ace	ACE	33#36	17199794-1-51-82	C535761	SYMBOL|DICTIONARY|EXTRACTED	ins	INS	151#154	17199794-1-126-155	In contrast to previous reports, ACE gene polymorphism is irrelevant for clinical outcome, steroid responsiveness or morphology in Swiss children with INS.
11730829	2002	Atherosclerosis	0021-9150	ALL_TEXT_3/3	3	7	348	LONGTERM|DICTIONARY	apoe	apoE	238#242	NaN	D006949	LONGTERM|DICTIONARY	hyperlipidemia	hyperlipidemia	129#143		Among individuals who were normolipidemic at baseline, the following variables were independently associated with development of hyperlipidemia over 20 years: older age at baseline, male sex, greater increase in BMI during follow-up, and apoE alleles epsilon 2 or epsilon 4.
20208132	2010	Cell. Oncol.	1875-8606	BACKGROUND	1	2	835	LONGTERM|DICTIONARY	caspase 2	caspase-2	75#84		D009369	LONGTERM|DICTIONARY	tumours	tumours	209#216		Furthermore, only few data have been obtained concerning the expression of caspase-2, which can be alternatively spliced into caspase-2L and caspase-2S, and the other PIDDosome members PIDD and RAIDD in human tumours in vivo.
20208132	2010	Cell. Oncol.	1875-8606	BACKGROUND	1	2	55367	SYMBOL|DICTIONARY	pidd	PIDD	185#189		D009369	LONGTERM|DICTIONARY	tumours	tumours	209#216		Furthermore, only few data have been obtained concerning the expression of caspase-2, which can be alternatively spliced into caspase-2L and caspase-2S, and the other PIDDosome members PIDD and RAIDD in human tumours in vivo.
20208132	2010	Cell. Oncol.	1875-8606	BACKGROUND	1	2	8738	SYMBOL|DICTIONARY	raidd	RAIDD	194#199		D009369	LONGTERM|DICTIONARY	tumours	tumours	209#216		Furthermore, only few data have been obtained concerning the expression of caspase-2, which can be alternatively spliced into caspase-2L and caspase-2S, and the other PIDDosome members PIDD and RAIDD in human tumours in vivo.
20208132	2010	Cell. Oncol.	1875-8606	BACKGROUND	1	1	835	LONGTERM|DICTIONARY	caspase 2	caspase-2	18#27		D009369	LONGTERM|DISEASE|DT|DICTIONARY	cancer	cancer	66#72		The importance of caspase-2 activation for mediating apoptosis in cancer is not clear and seems to differ between different tumour types.
20208132	2010	Cell. Oncol.	1875-8606	BACKGROUND	1	1	835	LONGTERM|DICTIONARY	caspase 2	caspase-2	18#27		D009369	LONGTERM|DISEASE|DT|GFAM|FN|DICTIONARY	tumour	tumour	124#130		The importance of caspase-2 activation for mediating apoptosis in cancer is not clear and seems to differ between different tumour types.
20208132	2010	Cell. Oncol.	1875-8606	TITLE	0	0	835	LONGTERM|DICTIONARY	caspase 2	caspase-2	37#46		D002292	SYMBOL|PLURAL|DICTIONARY|EXTRACTED	rccs	RCCs	96#100		PIDDosome expression and the role of caspase-2 activation for chemotherapy-induced apoptosis in RCCs.
12081984	2002	Circulation	1524-4539	CONCLUSIONS	3	10	6532	SYMBOL|DICTIONARY	slc6a4	SLC6A4	23#29		D009203	SYMBOL|EXTRACTED	mi	MI	79#81	12081984-1-32-53	The LL genotype of the SLC6A4 polymorphism is associated with a higher risk of MI.
20208132	2010	Cell. Oncol.	1875-8606	RESULTS	3	5	835	LONGTERM|GFAM|FN|DICTIONARY	caspase 2	caspase-2	180#189		D009369	LONGTERM|DISEASE|DT|DICTIONARY	tumour	tumour	92#98		Our in vivo results showed an overall decrease in proapoptotic caspase-2L expression during tumour progression due to an increase in the relative share of caspase-2S mRNA in total caspase-2 mRNA expression.
16352452	2006	Mol. Genet. Metab.	1096-7192	TITLE	0	0	3074	SYMBOL|DICTIONARY	hexb	HEXB	7#11		D013661	LONGTERM|DISEASE|DT|DICTIONARY	tay sachs disease	Tay-Sachs disease	95#112		Common HEXB polymorphisms reduce serum HexA and HexB enzymatic activities, potentially masking Tay-Sachs disease carrier identification.
16352452	2006	Mol. Genet. Metab.	1096-7192	TITLE	0	0	3073	LONGTERM|DICTIONARY	hexa	HexA	39#43	NaN	D013661	LONGTERM|DISEASE|DT|DICTIONARY	tay sachs disease	Tay-Sachs disease	95#112		Common HEXB polymorphisms reduce serum HexA and HexB enzymatic activities, potentially masking Tay-Sachs disease carrier identification.
7769500	1995	J Hypertens Suppl	0952-1178	TITLE	0	0	3643	LONGTERM|GENE|GN|GT|DICTIONARY	insulin receptor	insulin receptor	74#90		D006973	LONGTERM|DICTIONARY	hypertension	hypertension	125#137		Insertion variant in intron 9, but not microsatellite in intron 2, of the insulin receptor gene is associated with essential hypertension.
20064547	2010	Mech. Ageing Dev.	1872-6216	ALL_TEXT_1/3	1	2	4780	SYMBOL|DICTIONARY	nfe2l2	NFE2L2	39#45		D000544	SYMBOL|EXTRACTED	ad	AD	192#194	20064547-1-0-19	We hypothesize that common variants of NFE2L2 and KEAP1, the genes encoding the main regulators of the Nrf2 system, an important defence system against oxidative stress, may influence risk of AD and/or age-related cataract.
20064547	2010	Mech. Ageing Dev.	1872-6216	ALL_TEXT_1/3	1	2	4780	SYMBOL|DICTIONARY	nfe2l2	NFE2L2	39#45		D002386	LONGTERM|DICTIONARY	cataract	cataract	214#222		We hypothesize that common variants of NFE2L2 and KEAP1, the genes encoding the main regulators of the Nrf2 system, an important defence system against oxidative stress, may influence risk of AD and/or age-related cataract.
20064547	2010	Mech. Ageing Dev.	1872-6216	ALL_TEXT_1/3	1	2	9817	SYMBOL|DICTIONARY	keap1	KEAP1	50#55		D000544	SYMBOL|EXTRACTED	ad	AD	192#194	20064547-1-0-19	We hypothesize that common variants of NFE2L2 and KEAP1, the genes encoding the main regulators of the Nrf2 system, an important defence system against oxidative stress, may influence risk of AD and/or age-related cataract.
20064547	2010	Mech. Ageing Dev.	1872-6216	ALL_TEXT_1/3	1	2	9817	SYMBOL|DICTIONARY	keap1	KEAP1	50#55		D002386	LONGTERM|DICTIONARY	cataract	cataract	214#222		We hypothesize that common variants of NFE2L2 and KEAP1, the genes encoding the main regulators of the Nrf2 system, an important defence system against oxidative stress, may influence risk of AD and/or age-related cataract.
20064547	2010	Mech. Ageing Dev.	1872-6216	ALL_TEXT_1/3	1	2	4780	SYMBOL|DICTIONARY	nrf2	Nrf2	103#107		D000544	SYMBOL|EXTRACTED	ad	AD	192#194	20064547-1-0-19	We hypothesize that common variants of NFE2L2 and KEAP1, the genes encoding the main regulators of the Nrf2 system, an important defence system against oxidative stress, may influence risk of AD and/or age-related cataract.
20064547	2010	Mech. Ageing Dev.	1872-6216	ALL_TEXT_1/3	1	2	4780	SYMBOL|DICTIONARY	nrf2	Nrf2	103#107		D002386	LONGTERM|DICTIONARY	cataract	cataract	214#222		We hypothesize that common variants of NFE2L2 and KEAP1, the genes encoding the main regulators of the Nrf2 system, an important defence system against oxidative stress, may influence risk of AD and/or age-related cataract.
16352452	2006	Mol. Genet. Metab.	1096-7192	ALL_TEXT_2/3	2	5	3073	LONGTERM|DICTIONARY	hexa	HexA	92#96	NaN	D013661	SYMBOL|DICTIONARY|EXTRACTED	tsd	TSD	26#29	16352452-1-13-30	Further, three additional TSD carriers ascertained by the atypical pattern of normal serum %HexA but carrier leukocyte %HexA, were found to have the [delTG (+) 619A>G] genotype.
16352452	2006	Mol. Genet. Metab.	1096-7192	ALL_TEXT_2/3	2	5	3073	LONGTERM|DICTIONARY	hexa	HexA	120#124	NaN	D013661	SYMBOL|DICTIONARY|EXTRACTED	tsd	TSD	26#29	16352452-1-13-30	Further, three additional TSD carriers ascertained by the atypical pattern of normal serum %HexA but carrier leukocyte %HexA, were found to have the [delTG (+) 619A>G] genotype.
16352452	2006	Mol. Genet. Metab.	1096-7192	ALL_TEXT_2/3	2	4	3074	SYMBOL|DICTIONARY	hexb	HEXB	22#26		D013661	SYMBOL|DICTIONARY|EXTRACTED	tsd	TSD	180#183	16352452-1-13-30	To determine if these HEXB polymorphisms reduce HexA and HexB enzymatic activities, 69 DNA samples from subjects previously screened enzymatically in both serum and leukocytes for TSD carrier status were selected for either high, mid-range or low serum Total Hex (defined as the sum of HexA and HexB) activities and were tested for the HEXB mutations.
16352452	2006	Mol. Genet. Metab.	1096-7192	ALL_TEXT_2/3	2	4	3074	SYMBOL|DICTIONARY	hexb	HEXB	336#340		D013661	SYMBOL|DICTIONARY|EXTRACTED	tsd	TSD	180#183	16352452-1-13-30	To determine if these HEXB polymorphisms reduce HexA and HexB enzymatic activities, 69 DNA samples from subjects previously screened enzymatically in both serum and leukocytes for TSD carrier status were selected for either high, mid-range or low serum Total Hex (defined as the sum of HexA and HexB) activities and were tested for the HEXB mutations.
16352452	2006	Mol. Genet. Metab.	1096-7192	ALL_TEXT_2/3	2	4	3073	LONGTERM|DICTIONARY	hexa	HexA	48#52	NaN	D013661	SYMBOL|DICTIONARY|EXTRACTED	tsd	TSD	180#183	16352452-1-13-30	To determine if these HEXB polymorphisms reduce HexA and HexB enzymatic activities, 69 DNA samples from subjects previously screened enzymatically in both serum and leukocytes for TSD carrier status were selected for either high, mid-range or low serum Total Hex (defined as the sum of HexA and HexB) activities and were tested for the HEXB mutations.
16352452	2006	Mol. Genet. Metab.	1096-7192	ALL_TEXT_2/3	2	4	3073	LONGTERM|DICTIONARY	hexa	HexA	286#290	NaN	D013661	SYMBOL|DICTIONARY|EXTRACTED	tsd	TSD	180#183	16352452-1-13-30	To determine if these HEXB polymorphisms reduce HexA and HexB enzymatic activities, 69 DNA samples from subjects previously screened enzymatically in both serum and leukocytes for TSD carrier status were selected for either high, mid-range or low serum Total Hex (defined as the sum of HexA and HexB) activities and were tested for the HEXB mutations.
16313808	2007	Zhonghua Yi Xue Za Zhi	0376-2491	RESULTS	3	8	3586	SYMBOL|DICTIONARY	il 10	IL-10	75#80		D001161	SYMBOL|EXTRACTED	as	AS	13#15	16313808-1-218-234	The raise of AS incidence rate was correspondent with the decline of serum IL-10 and raise of serum CRP and Fib.
16313808	2007	Zhonghua Yi Xue Za Zhi	0376-2491	RESULTS	3	8	1401	SYMBOL|DICTIONARY	crp	CRP	100#103		D001161	SYMBOL|EXTRACTED	as	AS	13#15	16313808-1-218-234	The raise of AS incidence rate was correspondent with the decline of serum IL-10 and raise of serum CRP and Fib.
19190538	2009	Pediatr. Res.	1530-0447	ALL_TEXT_1/3	1	1	4204	SYMBOL|GENE|GN|DICTIONARY	mecp2	MECP2	85#90		D015518	LONGTERM|DISEASE|DT|DICTIONARY	rett syndrome	Rett Syndrome	0#13		Rett Syndrome (RTT) is caused in more than 60% of cases by nonsense mutations in the MECP2 gene.
19190538	2009	Pediatr. Res.	1530-0447	ALL_TEXT_1/3	1	1	4204	SYMBOL|GENE|GN|DICTIONARY	mecp2	MECP2	85#90		D015518	SYMBOL|()|DICTIONARY|EXTRACTED	rtt	RTT	15#18	19190538-1-0-13	Rett Syndrome (RTT) is caused in more than 60% of cases by nonsense mutations in the MECP2 gene.
16313808	2007	Zhonghua Yi Xue Za Zhi	0376-2491	OBJECTIVE	1	1	3586	LONGTERM|GENE|GN|DICTIONARY	interleukin 10	interleukin-10	116#130		D007676	LONGTERM|DISEASE|DN|DICTIONARY	end stage renal disease	end stage renal disease	150#173		We do this investigation in order to reveal the relationship between the polymorphism of 1082A/G, anti-inflammatory interleukin-10 gene promoter, and end stage renal disease (ESRD) patients microinflammatory state and arteriosclerosis (AS).
16313808	2007	Zhonghua Yi Xue Za Zhi	0376-2491	OBJECTIVE	1	1	3586	LONGTERM|GENE|GN|DICTIONARY	interleukin 10	interleukin-10	116#130		D007676	SYMBOL|()|DISEASE|DN|DICTIONARY|EXTRACTED	esrd	ESRD	175#179	16313808-1-150-173	We do this investigation in order to reveal the relationship between the polymorphism of 1082A/G, anti-inflammatory interleukin-10 gene promoter, and end stage renal disease (ESRD) patients microinflammatory state and arteriosclerosis (AS).
16313808	2007	Zhonghua Yi Xue Za Zhi	0376-2491	OBJECTIVE	1	1	3586	LONGTERM|GENE|GN|DICTIONARY	interleukin 10	interleukin-10	116#130		D001161	SYMBOL|EXTRACTED|()	as	AS	236#238	16313808-1-218-234	We do this investigation in order to reveal the relationship between the polymorphism of 1082A/G, anti-inflammatory interleukin-10 gene promoter, and end stage renal disease (ESRD) patients microinflammatory state and arteriosclerosis (AS).
16313808	2007	Zhonghua Yi Xue Za Zhi	0376-2491	OBJECTIVE	1	1	3586	LONGTERM|GENE|GN|DICTIONARY	interleukin 10	interleukin-10	116#130		D001161	LONGTERM|DICTIONARY	microinflammatory state and arteriosclerosis	microinflammatory state and arteriosclerosis	190#234		We do this investigation in order to reveal the relationship between the polymorphism of 1082A/G, anti-inflammatory interleukin-10 gene promoter, and end stage renal disease (ESRD) patients microinflammatory state and arteriosclerosis (AS).
16313808	2007	Zhonghua Yi Xue Za Zhi	0376-2491	TITLE	0	0	3586	LONGTERM|GENE|GN|DICTIONARY	interleukin 10	interleukin-10	89#103		D007676	SYMBOL|DISEASE|DN|DICTIONARY|EXTRACTED	esrd	ESRD	148#152		[The research on the relationship between the polymorphism of 1082A/G, anti-inflammatory interleukin-10 gene promoter with its effect of preventing ESRD patients from microinflammation and arteriosclerosis].
16313808	2007	Zhonghua Yi Xue Za Zhi	0376-2491	TITLE	0	0	3586	LONGTERM|GENE|GN|DICTIONARY	interleukin 10	interleukin-10	89#103		D001161	LONGTERM|DICTIONARY	arteriosclerosis	arteriosclerosis	189#205		[The research on the relationship between the polymorphism of 1082A/G, anti-inflammatory interleukin-10 gene promoter with its effect of preventing ESRD patients from microinflammation and arteriosclerosis].
16313808	2007	Zhonghua Yi Xue Za Zhi	0376-2491	RESULTS	3	3	1401	SYMBOL|DICTIONARY	crp	CRP	33#36		D007676	SYMBOL|DICTIONARY|EXTRACTED	esrd	ESRD	76#80	16313808-1-150-173	Compared with the control group, CRP, TNF-alpha, CH50, C3, IL-10 and Alb of ESRD group were in the normal range, but still significantly higher than those of the control group, while IL-10, Alb were significant lower (P < 0.05).
16313808	2007	Zhonghua Yi Xue Za Zhi	0376-2491	RESULTS	3	3	3586	SYMBOL|DICTIONARY	il 10	IL-10	59#64		D007676	SYMBOL|DICTIONARY|EXTRACTED	esrd	ESRD	76#80	16313808-1-150-173	Compared with the control group, CRP, TNF-alpha, CH50, C3, IL-10 and Alb of ESRD group were in the normal range, but still significantly higher than those of the control group, while IL-10, Alb were significant lower (P < 0.05).
16313808	2007	Zhonghua Yi Xue Za Zhi	0376-2491	RESULTS	3	3	3586	SYMBOL|DICTIONARY	il 10	IL-10	183#188		D007676	SYMBOL|DICTIONARY|EXTRACTED	esrd	ESRD	76#80	16313808-1-150-173	Compared with the control group, CRP, TNF-alpha, CH50, C3, IL-10 and Alb of ESRD group were in the normal range, but still significantly higher than those of the control group, while IL-10, Alb were significant lower (P < 0.05).
16313808	2007	Zhonghua Yi Xue Za Zhi	0376-2491	RESULTS	3	3	213	LONGTERM|DICTIONARY	alb	Alb	69#72	NaN	D007676	SYMBOL|DICTIONARY|EXTRACTED	esrd	ESRD	76#80	16313808-1-150-173	Compared with the control group, CRP, TNF-alpha, CH50, C3, IL-10 and Alb of ESRD group were in the normal range, but still significantly higher than those of the control group, while IL-10, Alb were significant lower (P < 0.05).
16313808	2007	Zhonghua Yi Xue Za Zhi	0376-2491	RESULTS	3	3	213	LONGTERM|DICTIONARY	alb	Alb	190#193	NaN	D007676	SYMBOL|DICTIONARY|EXTRACTED	esrd	ESRD	76#80	16313808-1-150-173	Compared with the control group, CRP, TNF-alpha, CH50, C3, IL-10 and Alb of ESRD group were in the normal range, but still significantly higher than those of the control group, while IL-10, Alb were significant lower (P < 0.05).
16313808	2007	Zhonghua Yi Xue Za Zhi	0376-2491	RESULTS	3	3	7124	LONGTERM|DICTIONARY	tnf-alpha	TNF-alpha	38#47	NaN	D007676	SYMBOL|DICTIONARY|EXTRACTED	esrd	ESRD	76#80	16313808-1-150-173	Compared with the control group, CRP, TNF-alpha, CH50, C3, IL-10 and Alb of ESRD group were in the normal range, but still significantly higher than those of the control group, while IL-10, Alb were significant lower (P < 0.05).
16313808	2007	Zhonghua Yi Xue Za Zhi	0376-2491	METHODS	2	2	3586	SYMBOL|GENE|GN|DICTIONARY	il 10	IL-10	65#70		D001161	SYMBOL|EXTRACTED	as	AS	145#147	16313808-1-218-234	We used PCR-RFLP to measure the various kinds of distribution of IL-10 gene-1082A/G genotype and relevant indexes of microinflammatory state and AS of 870 ESRD patients and 1000 healthy persons of control group and to analyze the mechanism of its protection effect keeping ESRD patients away from microinflammation and arteriosclerosis.
16313808	2007	Zhonghua Yi Xue Za Zhi	0376-2491	METHODS	2	2	3586	SYMBOL|GENE|GN|DICTIONARY	il 10	IL-10	65#70		D007676	SYMBOL|DISEASE|DN|DICTIONARY|EXTRACTED	esrd	ESRD	155#159	16313808-1-150-173	We used PCR-RFLP to measure the various kinds of distribution of IL-10 gene-1082A/G genotype and relevant indexes of microinflammatory state and AS of 870 ESRD patients and 1000 healthy persons of control group and to analyze the mechanism of its protection effect keeping ESRD patients away from microinflammation and arteriosclerosis.
16313808	2007	Zhonghua Yi Xue Za Zhi	0376-2491	METHODS	2	2	3586	SYMBOL|GENE|GN|DICTIONARY	il 10	IL-10	65#70		D007676	SYMBOL|DISEASE|DN|DICTIONARY|EXTRACTED	esrd	ESRD	273#277	16313808-1-150-173	We used PCR-RFLP to measure the various kinds of distribution of IL-10 gene-1082A/G genotype and relevant indexes of microinflammatory state and AS of 870 ESRD patients and 1000 healthy persons of control group and to analyze the mechanism of its protection effect keeping ESRD patients away from microinflammation and arteriosclerosis.
16313808	2007	Zhonghua Yi Xue Za Zhi	0376-2491	METHODS	2	2	3586	SYMBOL|GENE|GN|DICTIONARY	il 10	IL-10	65#70		D001161	LONGTERM|DICTIONARY	arteriosclerosis	arteriosclerosis	319#335		We used PCR-RFLP to measure the various kinds of distribution of IL-10 gene-1082A/G genotype and relevant indexes of microinflammatory state and AS of 870 ESRD patients and 1000 healthy persons of control group and to analyze the mechanism of its protection effect keeping ESRD patients away from microinflammation and arteriosclerosis.
16313808	2007	Zhonghua Yi Xue Za Zhi	0376-2491	RESULTS	3	5	1401	SYMBOL|DICTIONARY	crp	CRP	10#13		D007676	SYMBOL|DISEASE|DN|DICTIONARY|EXTRACTED	esrd	ESRD	41#45	16313808-1-150-173	Levels of CRP, TNF-alpha, CH50 and C3 of ESRD patients with IL-10A/A genotype were significantly higher than those of ESRD patients with G/G and G/A genotype (P < 0.05), while IL-10 and Alb were significantly lower (P < 0.01).
16313808	2007	Zhonghua Yi Xue Za Zhi	0376-2491	RESULTS	3	5	1401	SYMBOL|DICTIONARY	crp	CRP	10#13		D007676	SYMBOL|DISEASE|DN|DICTIONARY|EXTRACTED	esrd	ESRD	118#122	16313808-1-150-173	Levels of CRP, TNF-alpha, CH50 and C3 of ESRD patients with IL-10A/A genotype were significantly higher than those of ESRD patients with G/G and G/A genotype (P < 0.05), while IL-10 and Alb were significantly lower (P < 0.01).
16313808	2007	Zhonghua Yi Xue Za Zhi	0376-2491	RESULTS	3	5	3586	SYMBOL|DICTIONARY	il 10	IL-10	176#181		D007676	SYMBOL|DISEASE|DN|DICTIONARY|EXTRACTED	esrd	ESRD	41#45	16313808-1-150-173	Levels of CRP, TNF-alpha, CH50 and C3 of ESRD patients with IL-10A/A genotype were significantly higher than those of ESRD patients with G/G and G/A genotype (P < 0.05), while IL-10 and Alb were significantly lower (P < 0.01).
16313808	2007	Zhonghua Yi Xue Za Zhi	0376-2491	RESULTS	3	5	3586	SYMBOL|DICTIONARY	il 10	IL-10	176#181		D007676	SYMBOL|DISEASE|DN|DICTIONARY|EXTRACTED	esrd	ESRD	118#122	16313808-1-150-173	Levels of CRP, TNF-alpha, CH50 and C3 of ESRD patients with IL-10A/A genotype were significantly higher than those of ESRD patients with G/G and G/A genotype (P < 0.05), while IL-10 and Alb were significantly lower (P < 0.01).
16313808	2007	Zhonghua Yi Xue Za Zhi	0376-2491	RESULTS	3	5	213	LONGTERM|DICTIONARY	alb	Alb	186#189	NaN	D007676	SYMBOL|DISEASE|DN|DICTIONARY|EXTRACTED	esrd	ESRD	41#45	16313808-1-150-173	Levels of CRP, TNF-alpha, CH50 and C3 of ESRD patients with IL-10A/A genotype were significantly higher than those of ESRD patients with G/G and G/A genotype (P < 0.05), while IL-10 and Alb were significantly lower (P < 0.01).
16313808	2007	Zhonghua Yi Xue Za Zhi	0376-2491	RESULTS	3	5	213	LONGTERM|DICTIONARY	alb	Alb	186#189	NaN	D007676	SYMBOL|DISEASE|DN|DICTIONARY|EXTRACTED	esrd	ESRD	118#122	16313808-1-150-173	Levels of CRP, TNF-alpha, CH50 and C3 of ESRD patients with IL-10A/A genotype were significantly higher than those of ESRD patients with G/G and G/A genotype (P < 0.05), while IL-10 and Alb were significantly lower (P < 0.01).
16313808	2007	Zhonghua Yi Xue Za Zhi	0376-2491	RESULTS	3	5	7124	LONGTERM|DICTIONARY	tnf-alpha	TNF-alpha	15#24	NaN	D007676	SYMBOL|DISEASE|DN|DICTIONARY|EXTRACTED	esrd	ESRD	41#45	16313808-1-150-173	Levels of CRP, TNF-alpha, CH50 and C3 of ESRD patients with IL-10A/A genotype were significantly higher than those of ESRD patients with G/G and G/A genotype (P < 0.05), while IL-10 and Alb were significantly lower (P < 0.01).
16313808	2007	Zhonghua Yi Xue Za Zhi	0376-2491	RESULTS	3	5	7124	LONGTERM|DICTIONARY	tnf-alpha	TNF-alpha	15#24	NaN	D007676	SYMBOL|DISEASE|DN|DICTIONARY|EXTRACTED	esrd	ESRD	118#122	16313808-1-150-173	Levels of CRP, TNF-alpha, CH50 and C3 of ESRD patients with IL-10A/A genotype were significantly higher than those of ESRD patients with G/G and G/A genotype (P < 0.05), while IL-10 and Alb were significantly lower (P < 0.01).
16313808	2007	Zhonghua Yi Xue Za Zhi	0376-2491	RESULTS	3	7	3586	SYMBOL|NUMBER|DICTIONARY	il 10	IL-10	42#47		D001161	SYMBOL|EXTRACTED	as	AS	22#24	16313808-1-218-234	The incidence rate of AS of patients with IL-10-1082A/A genotype was significantly higher than that of patients with G/G and G/A genotype (P < 0.01).
20136773	2010	Tissue Antigens	1399-0039	ALL_TEXT_2/3	2	4	3123	SYMBOL|DICTIONARY	hla drb1	HLA-DRB1	131#139		D002311	LONGTERM|DICTIONARY	primary dilated cardiomyopathy	primary dilated cardiomyopathy	188#218		The present study was the first report to evaluate the relationship between class II major histocompatibility complex (MHC) genes (HLA-DRB1 and HLA-DQB1) and the genetic susceptibility to primary dilated cardiomyopathy (DCM) in Tunisian patients.
20136773	2010	Tissue Antigens	1399-0039	ALL_TEXT_2/3	2	4	3123	SYMBOL|DICTIONARY	hla drb1	HLA-DRB1	131#139		D002311	SYMBOL|()|DICTIONARY|EXTRACTED	dcm	DCM	220#223	20136773-4-188-218	The present study was the first report to evaluate the relationship between class II major histocompatibility complex (MHC) genes (HLA-DRB1 and HLA-DQB1) and the genetic susceptibility to primary dilated cardiomyopathy (DCM) in Tunisian patients.
20136773	2010	Tissue Antigens	1399-0039	ALL_TEXT_2/3	2	4	3119	SYMBOL|DICTIONARY	hla dqb1	HLA-DQB1	144#152		D002311	LONGTERM|DICTIONARY	primary dilated cardiomyopathy	primary dilated cardiomyopathy	188#218		The present study was the first report to evaluate the relationship between class II major histocompatibility complex (MHC) genes (HLA-DRB1 and HLA-DQB1) and the genetic susceptibility to primary dilated cardiomyopathy (DCM) in Tunisian patients.
20136773	2010	Tissue Antigens	1399-0039	ALL_TEXT_2/3	2	4	3119	SYMBOL|DICTIONARY	hla dqb1	HLA-DQB1	144#152		D002311	SYMBOL|()|DICTIONARY|EXTRACTED	dcm	DCM	220#223	20136773-4-188-218	The present study was the first report to evaluate the relationship between class II major histocompatibility complex (MHC) genes (HLA-DRB1 and HLA-DQB1) and the genetic susceptibility to primary dilated cardiomyopathy (DCM) in Tunisian patients.
19034705	2009	Endocrine	1355-008X	CONCLUSION	4	8	7038	SYMBOL|EXTRACTED	tg	Tg	72#74	19034705-1-73-86	D050031	SYMBOL|EXTRACTED	ht	HT	55#57	19034705-5-85-108	In addition, the association of one SNP haplotype with HT suggests that Tg may be an AITD susceptibility gene.
17341859	2007	Dermatology (Basel)	1018-8665	METHODS	2	2	6256	SYMBOL|DICTIONARY	rxra	RXRA	165#169		D011565	LONGTERM|NUMBER|DICTIONARY	plaque psoriasis	plaque psoriasis	29#45		A total of 293 patients with plaque psoriasis, 82 patients with psoriasis guttata and 202 control subjects were enrolled in this study focused on 3 polymorphisms in RXRA and RXRB gene associations.
17341859	2007	Dermatology (Basel)	1018-8665	METHODS	2	2	6256	SYMBOL|DICTIONARY	rxra	RXRA	165#169		D011565	LONGTERM|DICTIONARY	psoriasis	psoriasis	64#73		A total of 293 patients with plaque psoriasis, 82 patients with psoriasis guttata and 202 control subjects were enrolled in this study focused on 3 polymorphisms in RXRA and RXRB gene associations.
17341859	2007	Dermatology (Basel)	1018-8665	METHODS	2	2	6257	SYMBOL|GENE|GN|DICTIONARY	rxrb	RXRB	174#178		D011565	LONGTERM|NUMBER|DICTIONARY	plaque psoriasis	plaque psoriasis	29#45		A total of 293 patients with plaque psoriasis, 82 patients with psoriasis guttata and 202 control subjects were enrolled in this study focused on 3 polymorphisms in RXRA and RXRB gene associations.
17341859	2007	Dermatology (Basel)	1018-8665	METHODS	2	2	6257	SYMBOL|GENE|GN|DICTIONARY	rxrb	RXRB	174#178		D011565	LONGTERM|DICTIONARY	psoriasis	psoriasis	64#73		A total of 293 patients with plaque psoriasis, 82 patients with psoriasis guttata and 202 control subjects were enrolled in this study focused on 3 polymorphisms in RXRA and RXRB gene associations.
17341859	2007	Dermatology (Basel)	1018-8665	RESULTS	3	4	6257	SYMBOL|NUMBER|DICTIONARY	rxrb	RXRB	80#84		D011565	LONGTERM|DICTIONARY	psoriasis	psoriasis	14#23		In women with psoriasis guttata, the higher risk for genotypes AA and TT in the RXRB 3'+140A/T polymorphism compared to healthy women was identified (p(corr) = 0.01).
17341859	2007	Dermatology (Basel)	1018-8665	RESULTS	3	7	6257	SYMBOL|DICTIONARY	rxrb	RXRB	7#11		D011565	LONGTERM|DICTIONARY	psoriasis	psoriasis	70#79		In the RXRB polymorphism, no genotype TT is observed in patients with psoriasis guttata with a positive personal history of repeated tonsillitis (p(corr) = 0.001).
17341859	2007	Dermatology (Basel)	1018-8665	RESULTS	3	7	6257	SYMBOL|DICTIONARY	rxrb	RXRB	7#11		D014069	LONGTERM|DICTIONARY	repeated tonsillitis	repeated tonsillitis	124#144		In the RXRB polymorphism, no genotype TT is observed in patients with psoriasis guttata with a positive personal history of repeated tonsillitis (p(corr) = 0.001).
25466283	2015	Am. J. Hum. Genet.	1537-6605	ALL_TEXT_3/3	3	7	84942	SYMBOL|DICTIONARY	wdr73	WDR73	12#17		C537548	LONGTERM|DISEASE|DT|DICTIONARY	galloway mowat syndrome	Galloway-Mowat syndrome	34#57		Altogether, WDR73 mutations cause Galloway-Mowat syndrome in a particular subset of individuals presenting with late-onset nephrotic syndrome, postnatal microcephaly, severe intellectual disability, and homogenous brain MRI features.
25466283	2015	Am. J. Hum. Genet.	1537-6605	ALL_TEXT_3/3	3	7	84942	SYMBOL|DICTIONARY	wdr73	WDR73	12#17		D009404	LONGTERM|DISEASE|DT|DICTIONARY	nephrotic syndrome	nephrotic syndrome	123#141		Altogether, WDR73 mutations cause Galloway-Mowat syndrome in a particular subset of individuals presenting with late-onset nephrotic syndrome, postnatal microcephaly, severe intellectual disability, and homogenous brain MRI features.
25466283	2015	Am. J. Hum. Genet.	1537-6605	ALL_TEXT_3/3	3	7	84942	SYMBOL|DICTIONARY	wdr73	WDR73	12#17		D008831	LONGTERM|DICTIONARY	microcephaly	microcephaly	153#165		Altogether, WDR73 mutations cause Galloway-Mowat syndrome in a particular subset of individuals presenting with late-onset nephrotic syndrome, postnatal microcephaly, severe intellectual disability, and homogenous brain MRI features.
25466283	2015	Am. J. Hum. Genet.	1537-6605	ALL_TEXT_3/3	3	7	84942	SYMBOL|DICTIONARY	wdr73	WDR73	12#17		D009069	LONGTERM|DICTIONARY	intellectual disability	intellectual disability	174#197		Altogether, WDR73 mutations cause Galloway-Mowat syndrome in a particular subset of individuals presenting with late-onset nephrotic syndrome, postnatal microcephaly, severe intellectual disability, and homogenous brain MRI features.
19034705	2009	Endocrine	1355-008X	TITLE	0	0	7038	LONGTERM|GENE|GN|DICTIONARY	thyroglobulin	thyroglobulin	19#32		D013967	LONGTERM|DISEASE|DT|DICTIONARY	autoimmune thyroid disease	autoimmune thyroid disease	56#82		Association of the thyroglobulin gene polymorphism with autoimmune thyroid disease in Chinese population.
19034705	2009	Endocrine	1355-008X	OBJECTIVE	1	1	7038	LONGTERM|DICTIONARY|GENE|GA	thyroglobulin	thyroglobulin	73#86		D013967	LONGTERM|DISEASE|DT|DICTIONARY	autoimmune thyroid disease	autoimmune thyroid disease	206#232		This study was performed to identify the presence of previously reported thyroglobulin (Tg) gene single nucleotide polymorphisms (SNPs) in Han Chinese Asians, and to investigate their potential relation to autoimmune thyroid disease (AITD).
19034705	2009	Endocrine	1355-008X	OBJECTIVE	1	1	7038	SYMBOL|EXTRACTED|()|GENE|GN	tg	Tg	88#90	19034705-1-73-86	D013967	LONGTERM|DISEASE|DT|DICTIONARY	autoimmune thyroid disease	autoimmune thyroid disease	206#232		This study was performed to identify the presence of previously reported thyroglobulin (Tg) gene single nucleotide polymorphisms (SNPs) in Han Chinese Asians, and to investigate their potential relation to autoimmune thyroid disease (AITD).
19034705	2009	Endocrine	1355-008X	RESULTS	3	6	7038	SYMBOL|EXTRACTED	tg	Tg	182#184	19034705-1-73-86	D050031	SYMBOL|EXTRACTED	ht	HT	112#114	19034705-5-85-108	(2) Haplotype analysis of these four SNPs revealed that the G-C-A-C haplotype was significantly associated with HT (P < 0.01, OR = 3.06, OR 95% CI [1.326-7.089]) and with serum anti-Tg antibody (Tg-Ab) positive AITD patients (P = 0.028, OR = 3.34).
19034705	2009	Endocrine	1355-008X	RESULTS	3	6	7038	SYMBOL|EXTRACTED	tg	Tg	182#184	19034705-1-73-86	D013967	SYMBOL|EXTRACTED|DISEASE|DN	aitd	AITD	211#215	19034705-1-206-232	(2) Haplotype analysis of these four SNPs revealed that the G-C-A-C haplotype was significantly associated with HT (P < 0.01, OR = 3.06, OR 95% CI [1.326-7.089]) and with serum anti-Tg antibody (Tg-Ab) positive AITD patients (P = 0.028, OR = 3.34).
19034705	2009	Endocrine	1355-008X	RESULTS	3	6	7038	SYMBOL|EXTRACTED	tg	Tg	195#197	19034705-1-73-86	D050031	SYMBOL|EXTRACTED	ht	HT	112#114	19034705-5-85-108	(2) Haplotype analysis of these four SNPs revealed that the G-C-A-C haplotype was significantly associated with HT (P < 0.01, OR = 3.06, OR 95% CI [1.326-7.089]) and with serum anti-Tg antibody (Tg-Ab) positive AITD patients (P = 0.028, OR = 3.34).
19034705	2009	Endocrine	1355-008X	RESULTS	3	6	7038	SYMBOL|EXTRACTED	tg	Tg	195#197	19034705-1-73-86	D013967	SYMBOL|EXTRACTED|DISEASE|DN	aitd	AITD	211#215	19034705-1-206-232	(2) Haplotype analysis of these four SNPs revealed that the G-C-A-C haplotype was significantly associated with HT (P < 0.01, OR = 3.06, OR 95% CI [1.326-7.089]) and with serum anti-Tg antibody (Tg-Ab) positive AITD patients (P = 0.028, OR = 3.34).
20136773	2010	Tissue Antigens	1399-0039	ALL_TEXT_2/3	2	6	3123	SYMBOL|DICTIONARY	hla drb1	HLA-DRB1	28#36		D002311	SYMBOL|DICTIONARY|EXTRACTED	dcm	DCM	192#195	20136773-4-188-218	An increased frequencies of HLA-DRB1*0401 (OR = 2.67, P < 0.001), HLA-DQB1*0302 (OR = 3.28, P = 0.001) and HLA-DQB1*0401 (OR = 6.26, P = 0.005) alleles were found in the patients with primary DCM compared with healthy controls.
20136773	2010	Tissue Antigens	1399-0039	ALL_TEXT_2/3	2	6	3119	SYMBOL|DICTIONARY	hla dqb1	HLA-DQB1	66#74		D002311	SYMBOL|DICTIONARY|EXTRACTED	dcm	DCM	192#195	20136773-4-188-218	An increased frequencies of HLA-DRB1*0401 (OR = 2.67, P < 0.001), HLA-DQB1*0302 (OR = 3.28, P = 0.001) and HLA-DQB1*0401 (OR = 6.26, P = 0.005) alleles were found in the patients with primary DCM compared with healthy controls.
20136773	2010	Tissue Antigens	1399-0039	ALL_TEXT_2/3	2	6	3119	SYMBOL|DICTIONARY	hla dqb1	HLA-DQB1	107#115		D002311	SYMBOL|DICTIONARY|EXTRACTED	dcm	DCM	192#195	20136773-4-188-218	An increased frequencies of HLA-DRB1*0401 (OR = 2.67, P < 0.001), HLA-DQB1*0302 (OR = 3.28, P = 0.001) and HLA-DQB1*0401 (OR = 6.26, P = 0.005) alleles were found in the patients with primary DCM compared with healthy controls.
1301936	1993	Hum. Mutat.	1059-7794	TITLE	0	0	4942	LONGTERM|DICTIONARY	ornithine aminotransferase	ornithine aminotransferase	34#60		D001284	LONGTERM|DICTIONARY	atrophy	atrophy	96#103		A 15-bp deletion in exon 5 of the ornithine aminotransferase (OAT) locus associated with gyrate atrophy.
1301936	1993	Hum. Mutat.	1059-7794	TITLE	0	0	4942	LONGTERM|DICTIONARY	ornithine aminotransferase	ornithine aminotransferase	34#60		D015799	LONGTERM|DICTIONARY	ornithine aminotransferase	ornithine aminotransferase	34#60	NaN	A 15-bp deletion in exon 5 of the ornithine aminotransferase (OAT) locus associated with gyrate atrophy.
1301936	1993	Hum. Mutat.	1059-7794	TITLE	0	0	4942	LONGTERM|DICTIONARY	ornithine aminotransferase	ornithine aminotransferase	34#60		D015799	LONGTERM|DICTIONARY	oat	OAT	62#65	NaN	A 15-bp deletion in exon 5 of the ornithine aminotransferase (OAT) locus associated with gyrate atrophy.
1301936	1993	Hum. Mutat.	1059-7794	TITLE	0	0	4942	SYMBOL|()|DICTIONARY|EXTRACTED	oat	OAT	62#65	1301936-0-34-60	D001284	LONGTERM|DICTIONARY	atrophy	atrophy	96#103		A 15-bp deletion in exon 5 of the ornithine aminotransferase (OAT) locus associated with gyrate atrophy.
1301936	1993	Hum. Mutat.	1059-7794	TITLE	0	0	4942	SYMBOL|()|DICTIONARY|EXTRACTED	oat	OAT	62#65	1301936-0-34-60	D015799	LONGTERM|DICTIONARY	ornithine aminotransferase	ornithine aminotransferase	34#60	NaN	A 15-bp deletion in exon 5 of the ornithine aminotransferase (OAT) locus associated with gyrate atrophy.
1301936	1993	Hum. Mutat.	1059-7794	TITLE	0	0	4942	SYMBOL|()|DICTIONARY|EXTRACTED	oat	OAT	62#65	1301936-0-34-60	D015799	LONGTERM|DICTIONARY	oat	OAT	62#65	NaN	A 15-bp deletion in exon 5 of the ornithine aminotransferase (OAT) locus associated with gyrate atrophy.
12058348	2002	Am. J. Hum. Genet.	0002-9297	ALL_TEXT_3/3	3	3	5781	SYMBOL|DICTIONARY	ptpn11	PTPN11	26#32		D009634	SYMBOL|EXTRACTED	ns	NS	102#104	12058348-1-390-405	Both mutations affect the PTPN11 phosphotyrosine phosphatase domain, which is involved in <30% of the NS PTPN11 mutations.
12058348	2002	Am. J. Hum. Genet.	0002-9297	ALL_TEXT_3/3	3	3	5781	SYMBOL|DICTIONARY	ptpn11	PTPN11	105#111		D009634	SYMBOL|EXTRACTED	ns	NS	102#104	12058348-1-390-405	Both mutations affect the PTPN11 phosphotyrosine phosphatase domain, which is involved in <30% of the NS PTPN11 mutations.
19415413	2009	J. Neurol.	1432-1459	ALL_TEXT_1/3	1	1	6355	SYMBOL|DICTIONARY	ccl8	CCL8	105#109		D019636	LONGTERM|DICTIONARY	neurodegeneration	neurodegeneration	133#150	NaN	CCL2/Monocyte Chemoattractant Protein (MCP)-1 and other chemokines sharing a similar sequence, including CCL8/MCP-2, are involved in neurodegeneration.
19415413	2009	J. Neurol.	1432-1459	ALL_TEXT_1/3	1	1	6355	SYMBOL|DICTIONARY	mcp 2	MCP-2	110#115		D019636	LONGTERM|DICTIONARY	neurodegeneration	neurodegeneration	133#150	NaN	CCL2/Monocyte Chemoattractant Protein (MCP)-1 and other chemokines sharing a similar sequence, including CCL8/MCP-2, are involved in neurodegeneration.
19415413	2009	J. Neurol.	1432-1459	ALL_TEXT_1/3	1	1	6347	SYMBOL|DICTIONARY	ccl2/monocyte chemoattractant protein (mcp)-1	CCL2/Monocyte Chemoattractant Protein (MCP)-1	0#45		D019636	LONGTERM|DICTIONARY	neurodegeneration	neurodegeneration	133#150	NaN	CCL2/Monocyte Chemoattractant Protein (MCP)-1 and other chemokines sharing a similar sequence, including CCL8/MCP-2, are involved in neurodegeneration.
19415413	2009	J. Neurol.	1432-1459	ALL_TEXT_1/3	1	1	6347	SYMBOL|DICTIONARY	ccl2/monocyte chemoattractant protein (mcp)-1	CCL2/Monocyte Chemoattractant Protein (MCP)-1	0#45		D019636	LONGTERM|DICTIONARY	neurodegeneration	neurodegeneration	133#150	NaN	CCL2/Monocyte Chemoattractant Protein (MCP)-1 and other chemokines sharing a similar sequence, including CCL8/MCP-2, are involved in neurodegeneration.
19415413	2009	J. Neurol.	1432-1459	TITLE	0	0	6355	SYMBOL|DICTIONARY	ccl8	CCL8	0#4		D000544	LONGTERM|DISEASE|DT|DICTIONARY	alzheimer disease	Alzheimer's disease	49#68		CCL8/MCP-2 association analysis in patients with Alzheimer's disease and frontotemporal lobar degeneration.
19415413	2009	J. Neurol.	1432-1459	TITLE	0	0	6355	SYMBOL|DICTIONARY	ccl8	CCL8	0#4		D057174	LONGTERM|DICTIONARY	frontotemporal lobar degeneration	frontotemporal lobar degeneration	73#106		CCL8/MCP-2 association analysis in patients with Alzheimer's disease and frontotemporal lobar degeneration.
19415413	2009	J. Neurol.	1432-1459	TITLE	0	0	6355	SYMBOL|DICTIONARY	mcp 2	MCP-2	5#10		D000544	LONGTERM|DISEASE|DT|DICTIONARY	alzheimer disease	Alzheimer's disease	49#68		CCL8/MCP-2 association analysis in patients with Alzheimer's disease and frontotemporal lobar degeneration.
19415413	2009	J. Neurol.	1432-1459	TITLE	0	0	6355	SYMBOL|DICTIONARY	mcp 2	MCP-2	5#10		D057174	LONGTERM|DICTIONARY	frontotemporal lobar degeneration	frontotemporal lobar degeneration	73#106		CCL8/MCP-2 association analysis in patients with Alzheimer's disease and frontotemporal lobar degeneration.
20136773	2010	Tissue Antigens	1399-0039	ALL_TEXT_3/3	3	7	3123	SYMBOL|NUMBER|DICTIONARY	hla drb1	HLA-DRB1	17#25		D002311	SYMBOL|DICTIONARY|EXTRACTED	dcm	DCM	144#147	20136773-4-188-218	Individuals with HLA-DRB1*1301 (OR = 0.24, P < 0.001) and HLA-DQB1*0201 (OR = 0.49, P = 0.002) alleles have a protective effect against primary DCM.
20136773	2010	Tissue Antigens	1399-0039	ALL_TEXT_3/3	3	7	3119	SYMBOL|DICTIONARY	hla dqb1	HLA-DQB1	58#66		D002311	SYMBOL|DICTIONARY|EXTRACTED	dcm	DCM	144#147	20136773-4-188-218	Individuals with HLA-DRB1*1301 (OR = 0.24, P < 0.001) and HLA-DQB1*0201 (OR = 0.49, P = 0.002) alleles have a protective effect against primary DCM.
19415413	2009	J. Neurol.	1432-1459	ALL_TEXT_3/3	3	5	6355	SYMBOL|DICTIONARY	ccl8	CCL8	0#4		D000544	SYMBOL|EXTRACTED	ad	AD	133#135	19415413-3-180-199	CCL8/MCP rs1133763 SNP, or other variants in linkage disequilibrium with this variant, likely do not influence the susceptibility to AD or FTLD in Caucasians.
19415413	2009	J. Neurol.	1432-1459	ALL_TEXT_3/3	3	5	6355	SYMBOL|DICTIONARY	ccl8	CCL8	0#4		D057174	SYMBOL|DICTIONARY|EXTRACTED	ftld	FTLD	139#143	19415413-3-218-251	CCL8/MCP rs1133763 SNP, or other variants in linkage disequilibrium with this variant, likely do not influence the susceptibility to AD or FTLD in Caucasians.
19484476	2009	J. Cancer Res. Clin. Oncol.	1432-1335	RESULTS	3	6	59348	SYMBOL|DICTIONARY|EXTRACTED	znf350	ZNF350	66#72	19484476-1-60-83	D001943	LONGTERM|DISEASE|DT|DICTIONARY	breast cancer	breast cancer	111#124		Joint effect analyses indicated that all the variant genotypes of ZNF350 polymorphisms accounted for increased breast cancer risk among subjects carrying variant homozygote of BRCA1 rs799917, particularly for ZNF350 rs4986773 (OR = 2.03, 95%CI = 1.02-4.05, the test for gene-gene interaction P (int) = 0.059).
19484476	2009	J. Cancer Res. Clin. Oncol.	1432-1335	RESULTS	3	6	672	SYMBOL|DICTIONARY	brca1	BRCA1	176#181		D001943	LONGTERM|DISEASE|DT|DICTIONARY	breast cancer	breast cancer	111#124		Joint effect analyses indicated that all the variant genotypes of ZNF350 polymorphisms accounted for increased breast cancer risk among subjects carrying variant homozygote of BRCA1 rs799917, particularly for ZNF350 rs4986773 (OR = 2.03, 95%CI = 1.02-4.05, the test for gene-gene interaction P (int) = 0.059).
19484476	2009	J. Cancer Res. Clin. Oncol.	1432-1335	RESULTS	3	6	59348	SYMBOL|DICTIONARY|EXTRACTED	znf350	ZNF350	209#215	19484476-1-60-83	D001943	LONGTERM|DISEASE|DT|DICTIONARY	breast cancer	breast cancer	111#124		Joint effect analyses indicated that all the variant genotypes of ZNF350 polymorphisms accounted for increased breast cancer risk among subjects carrying variant homozygote of BRCA1 rs799917, particularly for ZNF350 rs4986773 (OR = 2.03, 95%CI = 1.02-4.05, the test for gene-gene interaction P (int) = 0.059).
9217972	1997	Brain Pathol.	1015-6305	ALL_TEXT_3/3	3	7	1029	SYMBOL|DICTIONARY	cdkn2	CDKN2	28#33		D005909	SYMBOL|DICTIONARY|EXTRACTED	gbm	GBM	60#63	9217972-1-0-23	The remaining 16 cases with CDKN2 loss were divided between GBM with TP53 mutations (6 cases) and GBM with neither EGFR amplification nor TP53 mutation (10 cases).
9217972	1997	Brain Pathol.	1015-6305	ALL_TEXT_3/3	3	7	1029	SYMBOL|DICTIONARY	cdkn2	CDKN2	28#33		D005909	SYMBOL|DICTIONARY|EXTRACTED	gbm	GBM	98#101	9217972-1-0-23	The remaining 16 cases with CDKN2 loss were divided between GBM with TP53 mutations (6 cases) and GBM with neither EGFR amplification nor TP53 mutation (10 cases).
9217972	1997	Brain Pathol.	1015-6305	ALL_TEXT_3/3	3	7	7157	SYMBOL|DICTIONARY	tp53	TP53	69#73		D005909	SYMBOL|DICTIONARY|EXTRACTED	gbm	GBM	60#63	9217972-1-0-23	The remaining 16 cases with CDKN2 loss were divided between GBM with TP53 mutations (6 cases) and GBM with neither EGFR amplification nor TP53 mutation (10 cases).
9217972	1997	Brain Pathol.	1015-6305	ALL_TEXT_3/3	3	7	7157	SYMBOL|DICTIONARY	tp53	TP53	69#73		D005909	SYMBOL|DICTIONARY|EXTRACTED	gbm	GBM	98#101	9217972-1-0-23	The remaining 16 cases with CDKN2 loss were divided between GBM with TP53 mutations (6 cases) and GBM with neither EGFR amplification nor TP53 mutation (10 cases).
9217972	1997	Brain Pathol.	1015-6305	ALL_TEXT_3/3	3	7	1956	SYMBOL|DICTIONARY	egfr	EGFR	115#119		D005909	SYMBOL|DICTIONARY|EXTRACTED	gbm	GBM	60#63	9217972-1-0-23	The remaining 16 cases with CDKN2 loss were divided between GBM with TP53 mutations (6 cases) and GBM with neither EGFR amplification nor TP53 mutation (10 cases).
9217972	1997	Brain Pathol.	1015-6305	ALL_TEXT_3/3	3	7	1956	SYMBOL|DICTIONARY	egfr	EGFR	115#119		D005909	SYMBOL|DICTIONARY|EXTRACTED	gbm	GBM	98#101	9217972-1-0-23	The remaining 16 cases with CDKN2 loss were divided between GBM with TP53 mutations (6 cases) and GBM with neither EGFR amplification nor TP53 mutation (10 cases).
9217972	1997	Brain Pathol.	1015-6305	ALL_TEXT_3/3	3	7	7157	SYMBOL|DICTIONARY	tp53	TP53	138#142		D005909	SYMBOL|DICTIONARY|EXTRACTED	gbm	GBM	60#63	9217972-1-0-23	The remaining 16 cases with CDKN2 loss were divided between GBM with TP53 mutations (6 cases) and GBM with neither EGFR amplification nor TP53 mutation (10 cases).
9217972	1997	Brain Pathol.	1015-6305	ALL_TEXT_3/3	3	7	7157	SYMBOL|DICTIONARY	tp53	TP53	138#142		D005909	SYMBOL|DICTIONARY|EXTRACTED	gbm	GBM	98#101	9217972-1-0-23	The remaining 16 cases with CDKN2 loss were divided between GBM with TP53 mutations (6 cases) and GBM with neither EGFR amplification nor TP53 mutation (10 cases).
21440839	2011	Biomed. Environ. Sci.	0895-3988	OBJECTIVE	1	4	164045	LONGTERM|DICTIONARY	helicase	helicase	124#132	NaN	D064420	LONGTERM|DICTIONARY	toxicity	toxicity	193#201	NaN	The current study was conducted to elucidate the effects of Hg(2+) on the structure and activity of BLM642-1290 recombinant helicase, and to further explore the molecular mechanisms of mercury toxicity to the DNA helicase.
21440839	2011	Biomed. Environ. Sci.	0895-3988	OBJECTIVE	1	4	164045	LONGTERM|DICTIONARY	helicase	helicase	213#221	NaN	D064420	LONGTERM|DICTIONARY	toxicity	toxicity	193#201	NaN	The current study was conducted to elucidate the effects of Hg(2+) on the structure and activity of BLM642-1290 recombinant helicase, and to further explore the molecular mechanisms of mercury toxicity to the DNA helicase.
15308875	2004	Am. J. Nephrol.	0250-8095	CONCLUSION	4	10	7124	SYMBOL|GENE|GN|DICTIONARY	tnf alpha	TNF alpha	58#67		D005923	LONGTERM|DICTIONARY	focal segmental glomerulosclerosis	focal segmental glomerulosclerosis	165#199		Our results indicate that TGF-beta(1) gene Arg(25)-->Pro, TNF alpha gene G-308A and IL-6 gene G-174C polymorphisms are not risk factors or markers of progression in focal segmental glomerulosclerosis.
15308875	2004	Am. J. Nephrol.	0250-8095	CONCLUSION	4	10	3569	SYMBOL|GENE|GN|DICTIONARY	il 6	IL-6	84#88		D005923	LONGTERM|DICTIONARY	focal segmental glomerulosclerosis	focal segmental glomerulosclerosis	165#199		Our results indicate that TGF-beta(1) gene Arg(25)-->Pro, TNF alpha gene G-308A and IL-6 gene G-174C polymorphisms are not risk factors or markers of progression in focal segmental glomerulosclerosis.
15308875	2004	Am. J. Nephrol.	0250-8095	CONCLUSION	4	10	7040	SYMBOL|GENE|GN|DICTIONARY	tgf-beta(1)	TGF-beta(1)	26#37		D005923	LONGTERM|DICTIONARY	focal segmental glomerulosclerosis	focal segmental glomerulosclerosis	165#199		Our results indicate that TGF-beta(1) gene Arg(25)-->Pro, TNF alpha gene G-308A and IL-6 gene G-174C polymorphisms are not risk factors or markers of progression in focal segmental glomerulosclerosis.
17713436	2007	Transplantation	0041-1337	BACKGROUND	1	1	7099	SYMBOL|DICTIONARY	tlr4	TLR4	119#123		D006526	LONGTERM|DISEASE|DN|DICTIONARY	immune cells recognize hepatitis c virus	immune cells recognize hepatitis C virus	33#73		Experimental models suggest that immune cells recognize hepatitis C virus (HCV) through toll-like receptor (TLR)-2 and TLR4.
7581378	1995	Hum. Mol. Genet.	0964-6906	ALL_TEXT_2/3	2	4	2263	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	fgfr2	FGFR2	60#65	7581378-1-26-61	D003394	LONGTERM|DISEASE|DT|DICTIONARY	crouzon syndrome	Crouzon syndrome	98#114		We now report the finding of a mutation in exon IIIc of the FGFR2 gene in a kindred affected with Crouzon syndrome (C1043 to G; Ala344Gly) that is identical to the mutation previously associated with Jackson-Weiss syndrome.
7581378	1995	Hum. Mol. Genet.	0964-6906	ALL_TEXT_2/3	2	4	2263	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	fgfr2	FGFR2	60#65	7581378-1-26-61	C537559	LONGTERM|DISEASE|DT|DICTIONARY	jackson weiss syndrome	Jackson-Weiss syndrome	200#222		We now report the finding of a mutation in exon IIIc of the FGFR2 gene in a kindred affected with Crouzon syndrome (C1043 to G; Ala344Gly) that is identical to the mutation previously associated with Jackson-Weiss syndrome.
20064547	2010	Mech. Ageing Dev.	1872-6216	TITLE	0	0	4780	SYMBOL|DICTIONARY	nrf2	Nrf2	0#4		D000544	LONGTERM|DISEASE|DT|DICTIONARY	alzheimer disease	Alzheimer's disease	78#97		Nrf2-encoding NFE2L2 haplotypes influence disease progression but not risk in Alzheimer's disease and age-related cataract.
20064547	2010	Mech. Ageing Dev.	1872-6216	TITLE	0	0	4780	SYMBOL|DICTIONARY	nrf2	Nrf2	0#4		D002386	LONGTERM|DICTIONARY	cataract	cataract	114#122		Nrf2-encoding NFE2L2 haplotypes influence disease progression but not risk in Alzheimer's disease and age-related cataract.
20064547	2010	Mech. Ageing Dev.	1872-6216	TITLE	0	0	4780	SYMBOL|DICTIONARY	nfe2l2	NFE2L2	14#20		D000544	LONGTERM|DISEASE|DT|DICTIONARY	alzheimer disease	Alzheimer's disease	78#97		Nrf2-encoding NFE2L2 haplotypes influence disease progression but not risk in Alzheimer's disease and age-related cataract.
20064547	2010	Mech. Ageing Dev.	1872-6216	TITLE	0	0	4780	SYMBOL|DICTIONARY	nfe2l2	NFE2L2	14#20		D002386	LONGTERM|DICTIONARY	cataract	cataract	114#122		Nrf2-encoding NFE2L2 haplotypes influence disease progression but not risk in Alzheimer's disease and age-related cataract.
12939427	2004	Neurology	1526-632X	RESULTS	4	8	4155	SYMBOL|DICTIONARY|EXTRACTED	mbp	MBP	133#136	12939427-1-4-24	D009103	SYMBOL|DISEASE|DN|DICTIONARY|EXTRACTED	ms	MS	5#7	12939427-1-73-91	When MS patients and healthy control subjects were stratified according to HLA-DRB1 phenotypes, a significant association of MS with MBP alleles was found only in the DR4- and DR5-positive subgroups.
12939427	2004	Neurology	1526-632X	RESULTS	4	8	4155	SYMBOL|DICTIONARY|EXTRACTED	mbp	MBP	133#136	12939427-1-4-24	D009103	SYMBOL|EXTRACTED	ms	MS	125#127	12939427-1-73-91	When MS patients and healthy control subjects were stratified according to HLA-DRB1 phenotypes, a significant association of MS with MBP alleles was found only in the DR4- and DR5-positive subgroups.
12939427	2004	Neurology	1526-632X	RESULTS	4	8	4155	SYMBOL|DICTIONARY|EXTRACTED	mbp	MBP	133#136	12939427-1-4-24	D003711	LONGTERM|DICTIONARY	mbp	MBP	133#136	NaN	When MS patients and healthy control subjects were stratified according to HLA-DRB1 phenotypes, a significant association of MS with MBP alleles was found only in the DR4- and DR5-positive subgroups.
12939427	2004	Neurology	1526-632X	RESULTS	4	8	3126	LONGTERM|DICTIONARY	dr4	DR4	167#170	NaN	D009103	SYMBOL|DISEASE|DN|DICTIONARY|EXTRACTED	ms	MS	5#7	12939427-1-73-91	When MS patients and healthy control subjects were stratified according to HLA-DRB1 phenotypes, a significant association of MS with MBP alleles was found only in the DR4- and DR5-positive subgroups.
12939427	2004	Neurology	1526-632X	RESULTS	4	8	3126	LONGTERM|DICTIONARY	dr4	DR4	167#170	NaN	D009103	SYMBOL|EXTRACTED	ms	MS	125#127	12939427-1-73-91	When MS patients and healthy control subjects were stratified according to HLA-DRB1 phenotypes, a significant association of MS with MBP alleles was found only in the DR4- and DR5-positive subgroups.
12939427	2004	Neurology	1526-632X	RESULTS	4	8	3126	LONGTERM|DICTIONARY	dr4	DR4	167#170	NaN	D003711	LONGTERM|DICTIONARY	mbp	MBP	133#136	NaN	When MS patients and healthy control subjects were stratified according to HLA-DRB1 phenotypes, a significant association of MS with MBP alleles was found only in the DR4- and DR5-positive subgroups.
12939427	2004	Neurology	1526-632X	RESULTS	4	8	8795	LONGTERM|DICTIONARY	dr5	DR5	176#179	NaN	D009103	SYMBOL|DISEASE|DN|DICTIONARY|EXTRACTED	ms	MS	5#7	12939427-1-73-91	When MS patients and healthy control subjects were stratified according to HLA-DRB1 phenotypes, a significant association of MS with MBP alleles was found only in the DR4- and DR5-positive subgroups.
12939427	2004	Neurology	1526-632X	RESULTS	4	8	8795	LONGTERM|DICTIONARY	dr5	DR5	176#179	NaN	D009103	SYMBOL|EXTRACTED	ms	MS	125#127	12939427-1-73-91	When MS patients and healthy control subjects were stratified according to HLA-DRB1 phenotypes, a significant association of MS with MBP alleles was found only in the DR4- and DR5-positive subgroups.
12939427	2004	Neurology	1526-632X	RESULTS	4	8	8795	LONGTERM|DICTIONARY	dr5	DR5	176#179	NaN	D003711	LONGTERM|DICTIONARY	mbp	MBP	133#136	NaN	When MS patients and healthy control subjects were stratified according to HLA-DRB1 phenotypes, a significant association of MS with MBP alleles was found only in the DR4- and DR5-positive subgroups.
26437028	2016	Nat. Genet.	1546-1718	TITLE	0	0	118856	SYMBOL|DICTIONARY	mmp21	MMP21	0#5		D059446	LONGTERM|DICTIONARY	heterotaxy	heterotaxy	26#36		MMP21 is mutated in human heterotaxy and is required for normal left-right asymmetry in vertebrates.
17922187	2008	Breast Cancer Res. Treat.	0167-6806	TITLE	0	0	1545	SYMBOL|NUMBER|DICTIONARY|EXTRACTED	cyp1b1	CYP1B1	4#10		D001943	LONGTERM|DISEASE|DT|DICTIONARY	breast cancer	breast cancer	74#87		The CYP1B1_1358_GG genotype is associated with estrogen receptor-negative breast cancer.
17922187	2008	Breast Cancer Res. Treat.	0167-6806	ALL_TEXT_2/3	2	3	1545	SYMBOL|DICTIONARY|EXTRACTED	cyp1b1	CYP1B1	29#35	17922187-1-0-19	D001943	LONGTERM|DISEASE|DT|DICTIONARY	breast tumor	breast tumor	40#52		Given a relationship between CYP1B1 and breast tumor E2 level as well as E2 level and breast tumor ERalpha expression it is of interest to know whether CYP1B1 polymorphisms have an impact on the ERalpha status of breast cancer.
17922187	2008	Breast Cancer Res. Treat.	0167-6806	ALL_TEXT_2/3	2	3	1545	SYMBOL|DICTIONARY|EXTRACTED	cyp1b1	CYP1B1	29#35	17922187-1-0-19	D001943	LONGTERM|DISEASE|DT|DICTIONARY	breast tumor	breast tumor	86#98		Given a relationship between CYP1B1 and breast tumor E2 level as well as E2 level and breast tumor ERalpha expression it is of interest to know whether CYP1B1 polymorphisms have an impact on the ERalpha status of breast cancer.
17922187	2008	Breast Cancer Res. Treat.	0167-6806	ALL_TEXT_2/3	2	3	1545	SYMBOL|DICTIONARY|EXTRACTED	cyp1b1	CYP1B1	29#35	17922187-1-0-19	D001943	LONGTERM|DISEASE|DT|DICTIONARY	breast cancer	breast cancer	213#226		Given a relationship between CYP1B1 and breast tumor E2 level as well as E2 level and breast tumor ERalpha expression it is of interest to know whether CYP1B1 polymorphisms have an impact on the ERalpha status of breast cancer.
17922187	2008	Breast Cancer Res. Treat.	0167-6806	ALL_TEXT_2/3	2	3	1545	SYMBOL|DICTIONARY|EXTRACTED	cyp1b1	CYP1B1	152#158	17922187-1-0-19	D001943	LONGTERM|DISEASE|DT|DICTIONARY	breast tumor	breast tumor	40#52		Given a relationship between CYP1B1 and breast tumor E2 level as well as E2 level and breast tumor ERalpha expression it is of interest to know whether CYP1B1 polymorphisms have an impact on the ERalpha status of breast cancer.
17922187	2008	Breast Cancer Res. Treat.	0167-6806	ALL_TEXT_2/3	2	3	1545	SYMBOL|DICTIONARY|EXTRACTED	cyp1b1	CYP1B1	152#158	17922187-1-0-19	D001943	LONGTERM|DISEASE|DT|DICTIONARY	breast tumor	breast tumor	86#98		Given a relationship between CYP1B1 and breast tumor E2 level as well as E2 level and breast tumor ERalpha expression it is of interest to know whether CYP1B1 polymorphisms have an impact on the ERalpha status of breast cancer.
17922187	2008	Breast Cancer Res. Treat.	0167-6806	ALL_TEXT_2/3	2	3	1545	SYMBOL|DICTIONARY|EXTRACTED	cyp1b1	CYP1B1	152#158	17922187-1-0-19	D001943	LONGTERM|DISEASE|DT|DICTIONARY	breast cancer	breast cancer	213#226		Given a relationship between CYP1B1 and breast tumor E2 level as well as E2 level and breast tumor ERalpha expression it is of interest to know whether CYP1B1 polymorphisms have an impact on the ERalpha status of breast cancer.
17922187	2008	Breast Cancer Res. Treat.	0167-6806	ALL_TEXT_2/3	2	3	2099	LONGTERM|DICTIONARY	eralpha	ERalpha	99#106	NaN	D001943	LONGTERM|DISEASE|DT|DICTIONARY	breast tumor	breast tumor	40#52		Given a relationship between CYP1B1 and breast tumor E2 level as well as E2 level and breast tumor ERalpha expression it is of interest to know whether CYP1B1 polymorphisms have an impact on the ERalpha status of breast cancer.
17922187	2008	Breast Cancer Res. Treat.	0167-6806	ALL_TEXT_2/3	2	3	2099	LONGTERM|DICTIONARY	eralpha	ERalpha	99#106	NaN	D001943	LONGTERM|DISEASE|DT|DICTIONARY	breast tumor	breast tumor	86#98		Given a relationship between CYP1B1 and breast tumor E2 level as well as E2 level and breast tumor ERalpha expression it is of interest to know whether CYP1B1 polymorphisms have an impact on the ERalpha status of breast cancer.
17922187	2008	Breast Cancer Res. Treat.	0167-6806	ALL_TEXT_2/3	2	3	2099	LONGTERM|DICTIONARY	eralpha	ERalpha	99#106	NaN	D001943	LONGTERM|DISEASE|DT|DICTIONARY	breast cancer	breast cancer	213#226		Given a relationship between CYP1B1 and breast tumor E2 level as well as E2 level and breast tumor ERalpha expression it is of interest to know whether CYP1B1 polymorphisms have an impact on the ERalpha status of breast cancer.
17922187	2008	Breast Cancer Res. Treat.	0167-6806	ALL_TEXT_2/3	2	3	2099	LONGTERM|DICTIONARY	eralpha	ERalpha	195#202	NaN	D001943	LONGTERM|DISEASE|DT|DICTIONARY	breast tumor	breast tumor	40#52		Given a relationship between CYP1B1 and breast tumor E2 level as well as E2 level and breast tumor ERalpha expression it is of interest to know whether CYP1B1 polymorphisms have an impact on the ERalpha status of breast cancer.
17922187	2008	Breast Cancer Res. Treat.	0167-6806	ALL_TEXT_2/3	2	3	2099	LONGTERM|DICTIONARY	eralpha	ERalpha	195#202	NaN	D001943	LONGTERM|DISEASE|DT|DICTIONARY	breast tumor	breast tumor	86#98		Given a relationship between CYP1B1 and breast tumor E2 level as well as E2 level and breast tumor ERalpha expression it is of interest to know whether CYP1B1 polymorphisms have an impact on the ERalpha status of breast cancer.
17922187	2008	Breast Cancer Res. Treat.	0167-6806	ALL_TEXT_2/3	2	3	2099	LONGTERM|DICTIONARY	eralpha	ERalpha	195#202	NaN	D001943	LONGTERM|DISEASE|DT|DICTIONARY	breast cancer	breast cancer	213#226		Given a relationship between CYP1B1 and breast tumor E2 level as well as E2 level and breast tumor ERalpha expression it is of interest to know whether CYP1B1 polymorphisms have an impact on the ERalpha status of breast cancer.
17922187	2008	Breast Cancer Res. Treat.	0167-6806	ALL_TEXT_2/3	2	4	2099	LONGTERM|DICTIONARY	eralpha	ERalpha	274#281	NaN	D001943	LONGTERM|DISEASE|DT|DICTIONARY	breast cancer	breast cancer	41#54		We genotyped the GENICA population-based breast cancer case-control collection (1,021 cases, 1,015 controls) by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF MS) and investigated in cases the association between genotypes and tumor ERalpha status (739 ERalpha positive cases; 212 ERalpha negative cases) by logistic regression.
17922187	2008	Breast Cancer Res. Treat.	0167-6806	ALL_TEXT_2/3	2	4	2099	LONGTERM|DICTIONARY	eralpha	ERalpha	274#281	NaN	D009369	LONGTERM|DISEASE|DT|DICTIONARY	tumor	tumor	268#273		We genotyped the GENICA population-based breast cancer case-control collection (1,021 cases, 1,015 controls) by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF MS) and investigated in cases the association between genotypes and tumor ERalpha status (739 ERalpha positive cases; 212 ERalpha negative cases) by logistic regression.
17922187	2008	Breast Cancer Res. Treat.	0167-6806	ALL_TEXT_2/3	2	4	2099	LONGTERM|DICTIONARY	eralpha	ERalpha	294#301	NaN	D001943	LONGTERM|DISEASE|DT|DICTIONARY	breast cancer	breast cancer	41#54		We genotyped the GENICA population-based breast cancer case-control collection (1,021 cases, 1,015 controls) by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF MS) and investigated in cases the association between genotypes and tumor ERalpha status (739 ERalpha positive cases; 212 ERalpha negative cases) by logistic regression.
17922187	2008	Breast Cancer Res. Treat.	0167-6806	ALL_TEXT_2/3	2	4	2099	LONGTERM|DICTIONARY	eralpha	ERalpha	294#301	NaN	D009369	LONGTERM|DISEASE|DT|DICTIONARY	tumor	tumor	268#273		We genotyped the GENICA population-based breast cancer case-control collection (1,021 cases, 1,015 controls) by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF MS) and investigated in cases the association between genotypes and tumor ERalpha status (739 ERalpha positive cases; 212 ERalpha negative cases) by logistic regression.
17922187	2008	Breast Cancer Res. Treat.	0167-6806	ALL_TEXT_2/3	2	4	2099	LONGTERM|DICTIONARY	eralpha	ERalpha	322#329	NaN	D001943	LONGTERM|DISEASE|DT|DICTIONARY	breast cancer	breast cancer	41#54		We genotyped the GENICA population-based breast cancer case-control collection (1,021 cases, 1,015 controls) by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF MS) and investigated in cases the association between genotypes and tumor ERalpha status (739 ERalpha positive cases; 212 ERalpha negative cases) by logistic regression.
17922187	2008	Breast Cancer Res. Treat.	0167-6806	ALL_TEXT_2/3	2	4	2099	LONGTERM|DICTIONARY	eralpha	ERalpha	322#329	NaN	D009369	LONGTERM|DISEASE|DT|DICTIONARY	tumor	tumor	268#273		We genotyped the GENICA population-based breast cancer case-control collection (1,021 cases, 1,015 controls) by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF MS) and investigated in cases the association between genotypes and tumor ERalpha status (739 ERalpha positive cases; 212 ERalpha negative cases) by logistic regression.
17922187	2008	Breast Cancer Res. Treat.	0167-6806	ALL_TEXT_3/3	3	7	1545	SYMBOL|NUMBER|DICTIONARY|EXTRACTED	cyp1b1	CYP1B1	21#27	17922187-1-0-19	D001943	LONGTERM|DISEASE|DT|DICTIONARY	breast cancer	breast cancer	85#98		We conclude that the CYP1B1_1358_A>G polymorphism has an impact on ERalpha status in breast cancer in that the CYP1B1_1358_GG genotype known to encode higher CYP1B1 activity is associated with ERalpha negativity.
17922187	2008	Breast Cancer Res. Treat.	0167-6806	ALL_TEXT_3/3	3	7	1545	SYMBOL|NUMBER|DICTIONARY|EXTRACTED	cyp1b1	CYP1B1	111#117	17922187-1-0-19	D001943	LONGTERM|DISEASE|DT|DICTIONARY	breast cancer	breast cancer	85#98		We conclude that the CYP1B1_1358_A>G polymorphism has an impact on ERalpha status in breast cancer in that the CYP1B1_1358_GG genotype known to encode higher CYP1B1 activity is associated with ERalpha negativity.
17922187	2008	Breast Cancer Res. Treat.	0167-6806	ALL_TEXT_3/3	3	7	1545	SYMBOL|DICTIONARY|EXTRACTED	cyp1b1	CYP1B1	158#164	17922187-1-0-19	D001943	LONGTERM|DISEASE|DT|DICTIONARY	breast cancer	breast cancer	85#98		We conclude that the CYP1B1_1358_A>G polymorphism has an impact on ERalpha status in breast cancer in that the CYP1B1_1358_GG genotype known to encode higher CYP1B1 activity is associated with ERalpha negativity.
17922187	2008	Breast Cancer Res. Treat.	0167-6806	ALL_TEXT_3/3	3	7	2099	LONGTERM|DICTIONARY	eralpha	ERalpha	67#74	NaN	D001943	LONGTERM|DISEASE|DT|DICTIONARY	breast cancer	breast cancer	85#98		We conclude that the CYP1B1_1358_A>G polymorphism has an impact on ERalpha status in breast cancer in that the CYP1B1_1358_GG genotype known to encode higher CYP1B1 activity is associated with ERalpha negativity.
17922187	2008	Breast Cancer Res. Treat.	0167-6806	ALL_TEXT_3/3	3	7	2099	LONGTERM|DICTIONARY	eralpha	ERalpha	193#200	NaN	D001943	LONGTERM|DISEASE|DT|DICTIONARY	breast cancer	breast cancer	85#98		We conclude that the CYP1B1_1358_A>G polymorphism has an impact on ERalpha status in breast cancer in that the CYP1B1_1358_GG genotype known to encode higher CYP1B1 activity is associated with ERalpha negativity.
12939427	2004	Neurology	1526-632X	BACKGROUND	1	2	4155	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	mbp	MBP	97#100	12939427-1-4-24	D009103	SYMBOL|EXTRACTED	ms	MS	19#21	12939427-1-73-91	The association of MS with alleles of the (TGGA)n variable number tandem repeat (VNTR) 5' to the MBP gene is the subject of conflicting reports.
12939427	2004	Neurology	1526-632X	BACKGROUND	1	2	4155	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	mbp	MBP	97#100	12939427-1-4-24	C537362	LONGTERM|DICTIONARY	variable number tandem repeat	variable number tandem repeat	50#79	NaN	The association of MS with alleles of the (TGGA)n variable number tandem repeat (VNTR) 5' to the MBP gene is the subject of conflicting reports.
12939427	2004	Neurology	1526-632X	BACKGROUND	1	2	4155	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	mbp	MBP	97#100	12939427-1-4-24	C537362	LONGTERM|DICTIONARY	vntr	VNTR	81#85	NaN	The association of MS with alleles of the (TGGA)n variable number tandem repeat (VNTR) 5' to the MBP gene is the subject of conflicting reports.
12939427	2004	Neurology	1526-632X	BACKGROUND	1	2	4155	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	mbp	MBP	97#100	12939427-1-4-24	D003711	LONGTERM|DICTIONARY	mbp	MBP	97#100	NaN	The association of MS with alleles of the (TGGA)n variable number tandem repeat (VNTR) 5' to the MBP gene is the subject of conflicting reports.
12939427	2004	Neurology	1526-632X	OBJECTIVE	2	3	4155	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	mbp	MBP	54#57	12939427-1-4-24	D009103	SYMBOL|EXTRACTED	ms	MS	18#20	12939427-1-73-91	To study possible MS association with VNTR alleles of MBP gene in ethnic Italians and ethnic Russians.
12939427	2004	Neurology	1526-632X	OBJECTIVE	2	3	4155	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	mbp	MBP	54#57	12939427-1-4-24	C537362	LONGTERM|DICTIONARY	vntr	VNTR	38#42	NaN	To study possible MS association with VNTR alleles of MBP gene in ethnic Italians and ethnic Russians.
12939427	2004	Neurology	1526-632X	OBJECTIVE	2	3	4155	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	mbp	MBP	54#57	12939427-1-4-24	D003711	LONGTERM|DICTIONARY	mbp	MBP	54#57	NaN	To study possible MS association with VNTR alleles of MBP gene in ethnic Italians and ethnic Russians.
12939427	2004	Neurology	1526-632X	TITLE	0	0	4155	LONGTERM|GENE|GN|GT|DICTIONARY	myelin basic protein	Myelin basic protein	0#20		D009103	LONGTERM|DICTIONARY	ms	MS	45#47	NaN	Myelin basic protein gene is associated with MS in DR4- and DR5-positive Italians and Russians.
12939427	2004	Neurology	1526-632X	TITLE	0	0	3126	LONGTERM|DICTIONARY	dr4	DR4	51#54	NaN	D009103	LONGTERM|DICTIONARY	ms	MS	45#47	NaN	Myelin basic protein gene is associated with MS in DR4- and DR5-positive Italians and Russians.
12939427	2004	Neurology	1526-632X	TITLE	0	0	8795	LONGTERM|DICTIONARY	dr5	DR5	60#63	NaN	D009103	LONGTERM|DICTIONARY	ms	MS	45#47	NaN	Myelin basic protein gene is associated with MS in DR4- and DR5-positive Italians and Russians.
12939427	2004	Neurology	1526-632X	BACKGROUND	1	1	4155	LONGTERM|GENE|GT|DICTIONARY|GA	myelin basic protein	myelin basic protein	4#24		D009103	LONGTERM|DICTIONARY	multiple sclerosis	multiple sclerosis	73#91		The myelin basic protein (MBP) gene may confer genetic susceptibility to multiple sclerosis (MS).
12939427	2004	Neurology	1526-632X	BACKGROUND	1	1	4155	LONGTERM|GENE|GT|DICTIONARY|GA	myelin basic protein	myelin basic protein	4#24		D009103	SYMBOL|EXTRACTED|()	ms	MS	93#95	12939427-1-73-91	The myelin basic protein (MBP) gene may confer genetic susceptibility to multiple sclerosis (MS).
12939427	2004	Neurology	1526-632X	BACKGROUND	1	1	4155	LONGTERM|GENE|GT|DICTIONARY|GA	myelin basic protein	myelin basic protein	4#24		D003711	LONGTERM|DICTIONARY	myelin basic protein	myelin basic protein	4#24	NaN	The myelin basic protein (MBP) gene may confer genetic susceptibility to multiple sclerosis (MS).
12939427	2004	Neurology	1526-632X	BACKGROUND	1	1	4155	LONGTERM|GENE|GT|DICTIONARY|GA	myelin basic protein	myelin basic protein	4#24		D003711	LONGTERM|DICTIONARY	mbp	MBP	26#29	NaN	The myelin basic protein (MBP) gene may confer genetic susceptibility to multiple sclerosis (MS).
12939427	2004	Neurology	1526-632X	BACKGROUND	1	1	4155	SYMBOL|()|GENE|GN|DICTIONARY|EXTRACTED	mbp	MBP	26#29	12939427-1-4-24	D009103	LONGTERM|DICTIONARY	multiple sclerosis	multiple sclerosis	73#91		The myelin basic protein (MBP) gene may confer genetic susceptibility to multiple sclerosis (MS).
12939427	2004	Neurology	1526-632X	BACKGROUND	1	1	4155	SYMBOL|()|GENE|GN|DICTIONARY|EXTRACTED	mbp	MBP	26#29	12939427-1-4-24	D009103	SYMBOL|EXTRACTED|()	ms	MS	93#95	12939427-1-73-91	The myelin basic protein (MBP) gene may confer genetic susceptibility to multiple sclerosis (MS).
12939427	2004	Neurology	1526-632X	BACKGROUND	1	1	4155	SYMBOL|()|GENE|GN|DICTIONARY|EXTRACTED	mbp	MBP	26#29	12939427-1-4-24	D003711	LONGTERM|DICTIONARY	myelin basic protein	myelin basic protein	4#24	NaN	The myelin basic protein (MBP) gene may confer genetic susceptibility to multiple sclerosis (MS).
12939427	2004	Neurology	1526-632X	BACKGROUND	1	1	4155	SYMBOL|()|GENE|GN|DICTIONARY|EXTRACTED	mbp	MBP	26#29	12939427-1-4-24	D003711	LONGTERM|DICTIONARY	mbp	MBP	26#29	NaN	The myelin basic protein (MBP) gene may confer genetic susceptibility to multiple sclerosis (MS).
12939427	2004	Neurology	1526-632X	RESULTS	4	7	4155	SYMBOL|DICTIONARY|EXTRACTED	mbp	MBP	20#23	12939427-1-4-24	D009103	SYMBOL|DISEASE|DN|DICTIONARY|EXTRACTED	ms	MS	87#89	12939427-1-73-91	The distribution of MBP alleles and genotypes in the two ethnic groups, including both MS patients and control subjects, was very similar.
12939427	2004	Neurology	1526-632X	RESULTS	4	7	4155	SYMBOL|DICTIONARY|EXTRACTED	mbp	MBP	20#23	12939427-1-4-24	D003711	LONGTERM|DICTIONARY	mbp	MBP	20#23	NaN	The distribution of MBP alleles and genotypes in the two ethnic groups, including both MS patients and control subjects, was very similar.
12939427	2004	Neurology	1526-632X	METHODS	3	4	4155	SYMBOL|DICTIONARY|EXTRACTED	mbp	MBP	147#150	12939427-1-4-24	D009103	SYMBOL|EXTRACTED	ms	MS	56#58	12939427-1-73-91	Two hundred sixty-nine unrelated patients with definite MS and 385 unrelated healthy control subjects from Italy and Russia were genotyped for the MBP VNTR region and for the human leukocyte antigen (HLA) class II DRB1 gene.
12939427	2004	Neurology	1526-632X	METHODS	3	4	4155	SYMBOL|DICTIONARY|EXTRACTED	mbp	MBP	147#150	12939427-1-4-24	C537362	LONGTERM|DICTIONARY	vntr	VNTR	151#155	NaN	Two hundred sixty-nine unrelated patients with definite MS and 385 unrelated healthy control subjects from Italy and Russia were genotyped for the MBP VNTR region and for the human leukocyte antigen (HLA) class II DRB1 gene.
12939427	2004	Neurology	1526-632X	METHODS	3	4	4155	SYMBOL|DICTIONARY|EXTRACTED	mbp	MBP	147#150	12939427-1-4-24	D003711	LONGTERM|DICTIONARY	mbp	MBP	147#150	NaN	Two hundred sixty-nine unrelated patients with definite MS and 385 unrelated healthy control subjects from Italy and Russia were genotyped for the MBP VNTR region and for the human leukocyte antigen (HLA) class II DRB1 gene.
12939427	2004	Neurology	1526-632X	METHODS	3	4	3126	SYMBOL|GENE|GN|DICTIONARY	leukocyte antigen (hla) class ii drb1	leukocyte antigen (HLA) class II DRB1	181#218		D009103	SYMBOL|EXTRACTED	ms	MS	56#58	12939427-1-73-91	Two hundred sixty-nine unrelated patients with definite MS and 385 unrelated healthy control subjects from Italy and Russia were genotyped for the MBP VNTR region and for the human leukocyte antigen (HLA) class II DRB1 gene.
12939427	2004	Neurology	1526-632X	METHODS	3	4	3126	SYMBOL|GENE|GN|DICTIONARY	leukocyte antigen (hla) class ii drb1	leukocyte antigen (HLA) class II DRB1	181#218		C537362	LONGTERM|DICTIONARY	vntr	VNTR	151#155	NaN	Two hundred sixty-nine unrelated patients with definite MS and 385 unrelated healthy control subjects from Italy and Russia were genotyped for the MBP VNTR region and for the human leukocyte antigen (HLA) class II DRB1 gene.
12939427	2004	Neurology	1526-632X	METHODS	3	4	3126	SYMBOL|GENE|GN|DICTIONARY	leukocyte antigen (hla) class ii drb1	leukocyte antigen (HLA) class II DRB1	181#218		D003711	LONGTERM|DICTIONARY	mbp	MBP	147#150	NaN	Two hundred sixty-nine unrelated patients with definite MS and 385 unrelated healthy control subjects from Italy and Russia were genotyped for the MBP VNTR region and for the human leukocyte antigen (HLA) class II DRB1 gene.
12181642	2002	J. Hum. Genet.	1434-5161	TITLE	0	0	7421	LONGTERM|GENE|GN|GT|DICTIONARY	vitamin d receptor	vitamin D receptor	12#30		D011471	LONGTERM|DISEASE|DT|DICTIONARY	prostate cancer	prostate cancer	75#90		The role of vitamin D receptor gene polymorphisms in the susceptibility to prostate cancer of a southern European population.
12181642	2002	J. Hum. Genet.	1434-5161	ALL_TEXT_2/3	2	4	7421	SYMBOL|DICTIONARY|EXTRACTED	vdr	VDR	12#15	12181642-2-77-95	D011471	LONGTERM|DISEASE|DT|DICTIONARY	prostate cancer	prostate cancer	51#66		The role of VDR genotypes in the susceptibility to prostate cancer has not yet been studied in populations of southern Europe.
12631109	2004	Kidney Int.	0085-2538	CONCLUSIONS	4	15	1285	SYMBOL|DICTIONARY	col4a3	COL4A3	12#18		D009394	LONGTERM|DISEASE|DT|DICTIONARY	alport syndrome	Alport syndrome	51#66		The data in COL4A3 -/- mice as an animal-model for Alport syndrome suggest that ramipril might as well delay renal failure in humans with AS.
12631109	2004	Kidney Int.	0085-2538	CONCLUSIONS	4	15	1285	SYMBOL|DICTIONARY	col4a3	COL4A3	12#18		D051437	LONGTERM|DICTIONARY	renal failure	renal failure	109#122		The data in COL4A3 -/- mice as an animal-model for Alport syndrome suggest that ramipril might as well delay renal failure in humans with AS.
12631109	2004	Kidney Int.	0085-2538	CONCLUSIONS	4	15	1285	SYMBOL|DICTIONARY	col4a3	COL4A3	12#18		D009394	SYMBOL|EXTRACTED	as	AS	138#140	12631109-1-0-15	The data in COL4A3 -/- mice as an animal-model for Alport syndrome suggest that ramipril might as well delay renal failure in humans with AS.
12181642	2002	J. Hum. Genet.	1434-5161	ALL_TEXT_2/3	2	6	7421	SYMBOL|DICTIONARY|EXTRACTED	vdr	VDR	67#70	12181642-2-77-95	D011471	LONGTERM|DISEASE|DT|DICTIONARY	prostate cancer	prostate cancer	85#100		When cases were compared with controls, we found an association of VDR T allele with prostate cancer risk (odds ratio [OR] = 1.87, 95% confidence interval [CI] 1.02-3.37; P = 0.035).
12181642	2002	J. Hum. Genet.	1434-5161	ALL_TEXT_3/3	3	9	7421	SYMBOL|DICTIONARY|EXTRACTED	vdr	VDR	46#49	12181642-2-77-95	D011471	LONGTERM|DISEASE|DT|DICTIONARY	prostate cancer	prostate cancer	63#78		Our results indicate that the contribution of VDR genotypes to prostate cancer susceptibility might depend on the population studied and its geographic localization, and that VDR genotypes are important in the definition of the genetic risk profile of populations of southern Europe.
12181642	2002	J. Hum. Genet.	1434-5161	ALL_TEXT_3/3	3	9	7421	SYMBOL|DICTIONARY|EXTRACTED	vdr	VDR	175#178	12181642-2-77-95	D011471	LONGTERM|DISEASE|DT|DICTIONARY	prostate cancer	prostate cancer	63#78		Our results indicate that the contribution of VDR genotypes to prostate cancer susceptibility might depend on the population studied and its geographic localization, and that VDR genotypes are important in the definition of the genetic risk profile of populations of southern Europe.
10702401	2000	Am. J. Pathol.	0002-9440	ALL_TEXT_1/3	1	1	2130	SYMBOL|GENE|GN|DICTIONARY	ews	EWS	183#186		D012512	LONGTERM|DICTIONARY|GFAM|FA	ewing sarcoma	Ewing's sarcoma	4#19		The Ewing's sarcoma (ES) family of tumors, including peripheral neuroectodermal tumor (PNET), is defined genetically by specific chromosomal translocations resulting in fusion of the EWS gene with a member of the ETS family of transcription factors, either FLI1 (90-95%) or ERG (5-10%).
10702401	2000	Am. J. Pathol.	0002-9440	ALL_TEXT_1/3	1	1	2130	SYMBOL|GENE|GN|DICTIONARY	ews	EWS	183#186		D012512	SYMBOL|EXTRACTED|()	es	ES	21#23	10702401-1-4-19	The Ewing's sarcoma (ES) family of tumors, including peripheral neuroectodermal tumor (PNET), is defined genetically by specific chromosomal translocations resulting in fusion of the EWS gene with a member of the ETS family of transcription factors, either FLI1 (90-95%) or ERG (5-10%).
10702401	2000	Am. J. Pathol.	0002-9440	ALL_TEXT_1/3	1	1	2130	SYMBOL|GENE|GN|DICTIONARY	ews	EWS	183#186		D009369	LONGTERM|DICTIONARY	tumors	tumors	35#41		The Ewing's sarcoma (ES) family of tumors, including peripheral neuroectodermal tumor (PNET), is defined genetically by specific chromosomal translocations resulting in fusion of the EWS gene with a member of the ETS family of transcription factors, either FLI1 (90-95%) or ERG (5-10%).
10702401	2000	Am. J. Pathol.	0002-9440	ALL_TEXT_1/3	1	1	2130	SYMBOL|GENE|GN|DICTIONARY	ews	EWS	183#186		D017599	LONGTERM|DICTIONARY	neuroectodermal tumor	neuroectodermal tumor	64#85		The Ewing's sarcoma (ES) family of tumors, including peripheral neuroectodermal tumor (PNET), is defined genetically by specific chromosomal translocations resulting in fusion of the EWS gene with a member of the ETS family of transcription factors, either FLI1 (90-95%) or ERG (5-10%).
10702401	2000	Am. J. Pathol.	0002-9440	ALL_TEXT_1/3	1	1	2313	SYMBOL|DICTIONARY	fli1	FLI1	257#261		D012512	LONGTERM|DICTIONARY|GFAM|FA	ewing sarcoma	Ewing's sarcoma	4#19		The Ewing's sarcoma (ES) family of tumors, including peripheral neuroectodermal tumor (PNET), is defined genetically by specific chromosomal translocations resulting in fusion of the EWS gene with a member of the ETS family of transcription factors, either FLI1 (90-95%) or ERG (5-10%).
10702401	2000	Am. J. Pathol.	0002-9440	ALL_TEXT_1/3	1	1	2313	SYMBOL|DICTIONARY	fli1	FLI1	257#261		D012512	SYMBOL|EXTRACTED|()	es	ES	21#23	10702401-1-4-19	The Ewing's sarcoma (ES) family of tumors, including peripheral neuroectodermal tumor (PNET), is defined genetically by specific chromosomal translocations resulting in fusion of the EWS gene with a member of the ETS family of transcription factors, either FLI1 (90-95%) or ERG (5-10%).
10702401	2000	Am. J. Pathol.	0002-9440	ALL_TEXT_1/3	1	1	2313	SYMBOL|DICTIONARY	fli1	FLI1	257#261		D009369	LONGTERM|DICTIONARY	tumors	tumors	35#41		The Ewing's sarcoma (ES) family of tumors, including peripheral neuroectodermal tumor (PNET), is defined genetically by specific chromosomal translocations resulting in fusion of the EWS gene with a member of the ETS family of transcription factors, either FLI1 (90-95%) or ERG (5-10%).
10702401	2000	Am. J. Pathol.	0002-9440	ALL_TEXT_1/3	1	1	2313	SYMBOL|DICTIONARY	fli1	FLI1	257#261		D017599	LONGTERM|DICTIONARY	neuroectodermal tumor	neuroectodermal tumor	64#85		The Ewing's sarcoma (ES) family of tumors, including peripheral neuroectodermal tumor (PNET), is defined genetically by specific chromosomal translocations resulting in fusion of the EWS gene with a member of the ETS family of transcription factors, either FLI1 (90-95%) or ERG (5-10%).
16182378	2006	J. Neuroimmunol.	0165-5728	ALL_TEXT_1/3	1	3	1234	SYMBOL|DICTIONARY	ccr5	CCR5	91#95		D001927	LONGTERM|DICTIONARY	pattern ii lesions	pattern II lesions	12#30	NaN	However, in pattern II lesions, the number of CCR1 cells is decreased, while the number of CCR5 expressing cells is increased in late active versus early active regions.
16182378	2006	J. Neuroimmunol.	0165-5728	ALL_TEXT_1/3	1	3	1230	LONGTERM|DICTIONARY	ccr1	CCR1	46#50	NaN	D001927	LONGTERM|DICTIONARY	pattern ii lesions	pattern II lesions	12#30	NaN	However, in pattern II lesions, the number of CCR1 cells is decreased, while the number of CCR5 expressing cells is increased in late active versus early active regions.
19070929	2009	J. Hepatol.	0168-8278	CONCLUSIONS	4	10	1116	SYMBOL|DICTIONARY	ykl 40	YKL-40	43#49		D005355	LONGTERM|DICTIONARY	fibrosis	fibrosis	141#149	NaN	These results suggest a functional role of YKL-40 in liver fibrogenesis and should be taken into account when using YKL-40 as a non-invasive fibrosis marker.
19070929	2009	J. Hepatol.	0168-8278	CONCLUSIONS	4	10	1116	SYMBOL|DICTIONARY	ykl 40	YKL-40	116#122		D005355	LONGTERM|DICTIONARY	fibrosis	fibrosis	141#149	NaN	These results suggest a functional role of YKL-40 in liver fibrogenesis and should be taken into account when using YKL-40 as a non-invasive fibrosis marker.
17438526	2007	Oncogene	0950-9232	ALL_TEXT_3/3	3	9	1381	SYMBOL|DICTIONARY|EXTRACTED	crabp1	CRABP1	28#34	17438526-3-111-151	D009369	LONGTERM|DISEASE|DT|DICTIONARY	tumor	tumor	53#58		These results indicate that CRABP1 appears to have a tumor-suppressor function in esophageal epithelium, and its epigenetic silencing may play a pivotal role during esophageal carcinogenesis.
17438526	2007	Oncogene	0950-9232	ALL_TEXT_3/3	3	8	1381	SYMBOL|DICTIONARY|EXTRACTED	crabp1	CRABP1	61#67	17438526-3-111-151	D009369	LONGTERM|DISEASE|DT|CLINE|CN|DICTIONARY	cancer	cancer	124#130		Among 113 primary ESCC tumors, the absence of immunoreactive CRABP1 was significantly associated with de-differentiation of cancer cells and with distant lymph-node metastases in the patients.
17438526	2007	Oncogene	0950-9232	ALL_TEXT_3/3	3	8	1381	SYMBOL|DICTIONARY|EXTRACTED	crabp1	CRABP1	61#67	17438526-3-111-151	C562729	SYMBOL|DISEASE|DN|DICTIONARY|EXTRACTED	escc tumors	ESCC tumors	18#29	17438526-2-77-111	Among 113 primary ESCC tumors, the absence of immunoreactive CRABP1 was significantly associated with de-differentiation of cancer cells and with distant lymph-node metastases in the patients.
17438526	2007	Oncogene	0950-9232	ALL_TEXT_3/3	3	8	1381	SYMBOL|DICTIONARY|EXTRACTED	crabp1	CRABP1	61#67	17438526-3-111-151	C562729	LONGTERM|DICTIONARY	escc tumors	ESCC tumors	18#29		Among 113 primary ESCC tumors, the absence of immunoreactive CRABP1 was significantly associated with de-differentiation of cancer cells and with distant lymph-node metastases in the patients.
17438526	2007	Oncogene	0950-9232	ALL_TEXT_3/3	3	7	1381	SYMBOL|DICTIONARY|EXTRACTED	crabp1	CRABP1	15#21	17438526-3-111-151	C562729	SYMBOL|CLINE|CN|DICTIONARY|EXTRACTED	escc	ESCC	36#40	17438526-2-77-111	Restoration of CRABP1 expression in ESCC cells lacking the protein reduced cell growth by inducing arrest at G(0)-G(1), whereas knockdown of the gene in cells expressing CRABP1 promoted cell growth.
17438526	2007	Oncogene	0950-9232	ALL_TEXT_3/3	3	7	1381	SYMBOL|DICTIONARY|EXTRACTED	crabp1	CRABP1	170#176	17438526-3-111-151	C562729	SYMBOL|CLINE|CN|DICTIONARY|EXTRACTED	escc	ESCC	36#40	17438526-2-77-111	Restoration of CRABP1 expression in ESCC cells lacking the protein reduced cell growth by inducing arrest at G(0)-G(1), whereas knockdown of the gene in cells expressing CRABP1 promoted cell growth.
17438526	2007	Oncogene	0950-9232	ALL_TEXT_2/3	2	6	1381	SYMBOL|DICTIONARY|EXTRACTED	crabp1	CRABP1	19#25	17438526-3-111-151	C562729	SYMBOL|DICTIONARY|EXTRACTED	escc	ESCC	61#65	17438526-2-77-111	CpG methylation of CRABP1 was frequently observed in primary ESCC tissues as well.
17438526	2007	Oncogene	0950-9232	ALL_TEXT_2/3	2	4	1381	SYMBOL|GFAM|FN|DICTIONARY|EXTRACTED	crabp1	CRABP1	14#20	17438526-3-111-151	C562729	SYMBOL|CLINE|CN|DICTIONARY|EXTRACTED	escc	ESCC	56#60	17438526-2-77-111	Expression of CRABP1 mRNA was restored in gene-silenced ESCC cells after treatment with 5-aza 2'-deoxycytidine.
17438526	2007	Oncogene	0950-9232	ALL_TEXT_1/3	1	3	1381	LONGTERM|DICTIONARY	cellular retinoic acid binding protein 1	cellular retinoic acid binding protein 1	111#151		C562729	SYMBOL|CLINE|CN|DICTIONARY|EXTRACTED	escc	ESCC	177#181	17438526-2-77-111	In the course of this program, we identified frequent CpG methylation-dependent silencing of the gene encoding cellular retinoic acid binding protein 1 (CRABP1) in our panel of ESCC cell lines.
17438526	2007	Oncogene	0950-9232	ALL_TEXT_1/3	1	3	1381	SYMBOL|()|DICTIONARY|EXTRACTED	crabp1	CRABP1	153#159	17438526-3-111-151	C562729	SYMBOL|CLINE|CN|DICTIONARY|EXTRACTED	escc	ESCC	177#181	17438526-2-77-111	In the course of this program, we identified frequent CpG methylation-dependent silencing of the gene encoding cellular retinoic acid binding protein 1 (CRABP1) in our panel of ESCC cell lines.
19773262	2010	Haematologica	1592-8721	BACKGROUND	1	4	6223	SYMBOL|GENE|GN|DICTIONARY	rps19	RPS19	15#20		D029503	LONGTERM|DICTIONARY	diamond blackfan anemia	Diamond-Blackfan anemia	91#114		Defects in the RPS19 gene, encoding the ribosomal protein S19, are the main known cause of Diamond-Blackfan anemia and account for more than 25% of cases.
19773262	2010	Haematologica	1592-8721	BACKGROUND	1	4	6223	LONGTERM|DICTIONARY	ribosomal protein s19	ribosomal protein S19	40#61		D029503	LONGTERM|DICTIONARY	diamond blackfan anemia	Diamond-Blackfan anemia	91#114		Defects in the RPS19 gene, encoding the ribosomal protein S19, are the main known cause of Diamond-Blackfan anemia and account for more than 25% of cases.
9149321	1997	Psychiatr. Genet.	0955-8829	TITLE	0	0	6532	LONGTERM|DICTIONARY	serotonin transporter	serotonin transporter	52#73	NaN	D019964	LONGTERM|DISEASE|DT|DICTIONARY	affective disorder	affective disorder	100#118		Structure of a variable number tandem repeat of the serotonin transporter gene and association with affective disorder.
17438526	2007	Oncogene	0950-9232	TITLE	0	0	1381	SYMBOL|DICTIONARY|EXTRACTED	crabp1	CRABP1	75#81		D009369	LONGTERM|DISEASE|DT|DICTIONARY	tumor	tumor	57#62		Frequent methylation-associated silencing of a candidate tumor-suppressor, CRABP1, in esophageal squamous-cell carcinoma.
17438526	2007	Oncogene	0950-9232	TITLE	0	0	1381	SYMBOL|DICTIONARY|EXTRACTED	crabp1	CRABP1	75#81		C562729	LONGTERM|DISEASE|DT|DICTIONARY	esophageal squamous cell carcinoma	esophageal squamous-cell carcinoma	86#120		Frequent methylation-associated silencing of a candidate tumor-suppressor, CRABP1, in esophageal squamous-cell carcinoma.
15824176	2005	Cancer Epidemiol. Biomarkers Prev.	1055-9965	ALL_TEXT_1/3	1	2	367	SYMBOL|EXTRACTED	ar	AR	51#53	15824176-1-4-21	D011471	LONGTERM|DISEASE|DT|DICTIONARY	prostate cancer	Prostate cancer	0#15		Prostate cancer is androgen dependent, implicating AR in susceptibility to this male condition.
15824176	2005	Cancer Epidemiol. Biomarkers Prev.	1055-9965	TITLE	0	0	367	LONGTERM|GENE|GT|DICTIONARY	androgen receptor	androgen receptor	13#30		D011471	LONGTERM|DISEASE|DT|DICTIONARY	metastatic prostate cancer	metastatic prostate cancer	83#109		The E211 G>A androgen receptor polymorphism is associated with a decreased risk of metastatic prostate cancer and androgenetic alopecia.
15824176	2005	Cancer Epidemiol. Biomarkers Prev.	1055-9965	TITLE	0	0	367	LONGTERM|GENE|GT|DICTIONARY	androgen receptor	androgen receptor	13#30		D000505	LONGTERM|DICTIONARY	androgenetic alopecia	androgenetic alopecia	114#135		The E211 G>A androgen receptor polymorphism is associated with a decreased risk of metastatic prostate cancer and androgenetic alopecia.
15824176	2005	Cancer Epidemiol. Biomarkers Prev.	1055-9965	ALL_TEXT_2/3	2	4	79017	SYMBOL|DICTIONARY	ggc	GGC	12#15		D011471	LONGTERM|DISEASE|DT|DICTIONARY	prostate cancer	prostate cancer	78#93		The CAG and GGC repeats in the AR have been studied extensively as markers of prostate cancer susceptibility, with inconclusive findings, whereas the AR-E211 G>A polymorphism has been associated with androgenetic alopecia.
15824176	2005	Cancer Epidemiol. Biomarkers Prev.	1055-9965	ALL_TEXT_2/3	2	4	79017	SYMBOL|DICTIONARY	ggc	GGC	12#15		D000505	LONGTERM|DICTIONARY	androgenetic alopecia	androgenetic alopecia	200#221		The CAG and GGC repeats in the AR have been studied extensively as markers of prostate cancer susceptibility, with inconclusive findings, whereas the AR-E211 G>A polymorphism has been associated with androgenetic alopecia.
15824176	2005	Cancer Epidemiol. Biomarkers Prev.	1055-9965	ALL_TEXT_2/3	2	4	367	SYMBOL|EXTRACTED	ar	AR	31#33	15824176-1-4-21	D011471	LONGTERM|DISEASE|DT|DICTIONARY	prostate cancer	prostate cancer	78#93		The CAG and GGC repeats in the AR have been studied extensively as markers of prostate cancer susceptibility, with inconclusive findings, whereas the AR-E211 G>A polymorphism has been associated with androgenetic alopecia.
15824176	2005	Cancer Epidemiol. Biomarkers Prev.	1055-9965	ALL_TEXT_2/3	2	4	367	SYMBOL|EXTRACTED	ar	AR	31#33	15824176-1-4-21	D000505	LONGTERM|DICTIONARY	androgenetic alopecia	androgenetic alopecia	200#221		The CAG and GGC repeats in the AR have been studied extensively as markers of prostate cancer susceptibility, with inconclusive findings, whereas the AR-E211 G>A polymorphism has been associated with androgenetic alopecia.
15824176	2005	Cancer Epidemiol. Biomarkers Prev.	1055-9965	ALL_TEXT_2/3	2	4	367	SYMBOL|EXTRACTED	ar	AR	150#152	15824176-1-4-21	D011471	LONGTERM|DISEASE|DT|DICTIONARY	prostate cancer	prostate cancer	78#93		The CAG and GGC repeats in the AR have been studied extensively as markers of prostate cancer susceptibility, with inconclusive findings, whereas the AR-E211 G>A polymorphism has been associated with androgenetic alopecia.
15824176	2005	Cancer Epidemiol. Biomarkers Prev.	1055-9965	ALL_TEXT_2/3	2	4	367	SYMBOL|EXTRACTED	ar	AR	150#152	15824176-1-4-21	D000505	LONGTERM|DICTIONARY	androgenetic alopecia	androgenetic alopecia	200#221		The CAG and GGC repeats in the AR have been studied extensively as markers of prostate cancer susceptibility, with inconclusive findings, whereas the AR-E211 G>A polymorphism has been associated with androgenetic alopecia.
1301936	1993	Hum. Mutat.	1059-7794	ALL_TEXT_3/3	3	5	4942	SYMBOL|DICTIONARY|EXTRACTED	oat	OAT	40#43	1301936-0-34-60	D015799	LONGTERM|DICTIONARY	oat	OAT	40#43	NaN	The alternate, apparently nonexpressing OAT allele in this patient was inherited from the father, who displays only the normal length PCR product.
19546348	2009	Exp. Biol. Med. (Maywood)	1535-3699	ALL_TEXT_1/3	1	3	3091	LONGTERM|DICTIONARY	hif-1	HIF-1	67#72	NaN	D008175	LONGTERM|DISEASE|DN|DT|DICTIONARY	lung cancer	lung cancer	319#330		In this study, we have investigated the relationship between seven HIF-1alphapolymorphisms [C > T substitution in intron 8 (rs10873142), T418I (rs41508050) in exon 10, P564P (rs41492849), L580L (rs34005929), P582S (rs11549465), A588T (rs11549467) in exon 12 and dinucleotide GT repeats in intron 13 (rs10645014)] among lung cancer patients in the Turkish population.
16507928	2007	Obstet Gynecol	1873-233X	TITLE	0	0	355	SYMBOL|()|GENE|GN|DICTIONARY	tnfrsf6	TNFRSF6	5#12		D006461	LONGTERM|DICTIONARY	hemolysis	hemolysis	55#64	NaN	Fas (TNFRSF6) gene polymorphism in pregnant women with hemolysis, elevated liver enzymes, and low platelets and in their neonates.
18787519	2009	Am. J. Hypertens.	1941-7225	METHODS	2	4	8529	SYMBOL|GENE|GN|DICTIONARY	cyp4f2	CYP4F2	128#134		D002544	SYMBOL|EXTRACTED|DISEASE|DN	ci	CI	15#17	18787519-3-86-105	A total of 175 CI patients and 246 control subjects were genotyped for five single-nucleotide polymorphisms (SNPs) of the human CYP4F2 gene (rs3093105, rs3093135, rs1558139, rs2108622, rs3093200).
15718509	2005	Stroke	1524-4628	RESULTS	3	9	12	SYMBOL|DICTIONARY	serpina3	SERPINA3	205#213		D013345	SYMBOL|DICTIONARY|EXTRACTED	sah	SAH	249#252	15718509-3-38-61	A logistic regression model showed that the presence of genotype with T allele (AT+TT; odds ratio [OR], 2.01; 95% CI, 1.19 to 3.38; P=0.009) or AA genotype (OR, 0.49; 95% CI, 0.30 to 0.84; P=0.009) of the SERPINA3 influences the risk for aneurysmal SAH independently from smoking, excessive alcohol consumption, and hypertension.
15718509	2005	Stroke	1524-4628	RESULTS	3	9	12	SYMBOL|DICTIONARY	serpina3	SERPINA3	205#213		D006973	LONGTERM|DICTIONARY	hypertension	hypertension	316#328		A logistic regression model showed that the presence of genotype with T allele (AT+TT; odds ratio [OR], 2.01; 95% CI, 1.19 to 3.38; P=0.009) or AA genotype (OR, 0.49; 95% CI, 0.30 to 0.84; P=0.009) of the SERPINA3 influences the risk for aneurysmal SAH independently from smoking, excessive alcohol consumption, and hypertension.
15718509	2005	Stroke	1524-4628	RESULTS	3	9	12	SYMBOL|DICTIONARY	serpina3	SERPINA3	205#213		D000435	LONGTERM|DICTIONARY	excessive alcohol consumption	excessive alcohol consumption	281#310		A logistic regression model showed that the presence of genotype with T allele (AT+TT; odds ratio [OR], 2.01; 95% CI, 1.19 to 3.38; P=0.009) or AA genotype (OR, 0.49; 95% CI, 0.30 to 0.84; P=0.009) of the SERPINA3 influences the risk for aneurysmal SAH independently from smoking, excessive alcohol consumption, and hypertension.
15718509	2005	Stroke	1524-4628	RESULTS	3	9	12	SYMBOL|DICTIONARY	serpina3	SERPINA3	205#213		D000783	LONGTERM|DICTIONARY	aneurysmal	aneurysmal	238#248	NaN	A logistic regression model showed that the presence of genotype with T allele (AT+TT; odds ratio [OR], 2.01; 95% CI, 1.19 to 3.38; P=0.009) or AA genotype (OR, 0.49; 95% CI, 0.30 to 0.84; P=0.009) of the SERPINA3 influences the risk for aneurysmal SAH independently from smoking, excessive alcohol consumption, and hypertension.
15718509	2005	Stroke	1524-4628	RESULTS	3	8	12	SYMBOL|DICTIONARY	serpina3	SERPINA3	4#12		D013345	SYMBOL|DICTIONARY|EXTRACTED	sah	SAH	63#66	15718509-3-38-61	The SERPINA3 genotype distribution in patients with aneurysmal SAH (AA-29 16.1%; AT-108 60.0%; TT-43 23.9%) differed significantly from controls (AA-70 26.6%; AT-123 46.8%; TT-70 26.6%; P=0.009).
15718509	2005	Stroke	1524-4628	RESULTS	3	8	12	SYMBOL|DICTIONARY	serpina3	SERPINA3	4#12		D000783	LONGTERM|DICTIONARY	aneurysmal	aneurysmal	52#62	NaN	The SERPINA3 genotype distribution in patients with aneurysmal SAH (AA-29 16.1%; AT-108 60.0%; TT-43 23.9%) differed significantly from controls (AA-70 26.6%; AT-123 46.8%; TT-70 26.6%; P=0.009).
18787519	2009	Am. J. Hypertens.	1941-7225	TITLE	0	0	8529	SYMBOL|GENE|GN|DICTIONARY	cyp4f2	CYP4F2	19#25		D002544	LONGTERM|DICTIONARY	cerebral infarction	cerebral infarction	50#69		A haplotype of the CYP4F2 gene is associated with cerebral infarction in Japanese men.
18787519	2009	Am. J. Hypertens.	1941-7225	BACKGROUND	1	3	8529	SYMBOL|GENE|GN|DICTIONARY	cyp4f2	CYP4F2	70#76		D002544	LONGTERM|DICTIONARY	cerebral infarction	cerebral infarction	86#105		The aim of this study was to assess the association between the human CYP4F2 gene and cerebral infarction (CI), using a haplotype-based case-control study with separate analyses of data from the gender groups.
18787519	2009	Am. J. Hypertens.	1941-7225	BACKGROUND	1	3	8529	SYMBOL|GENE|GN|DICTIONARY	cyp4f2	CYP4F2	70#76		D002544	SYMBOL|EXTRACTED|()	ci	CI	107#109	18787519-3-86-105	The aim of this study was to assess the association between the human CYP4F2 gene and cerebral infarction (CI), using a haplotype-based case-control study with separate analyses of data from the gender groups.
15718509	2005	Stroke	1524-4628	BACKGROUND AND PURPOSE	1	3	12	SYMBOL|DICTIONARY	serpina3	SERPINA3	0#8		D013345	SYMBOL|()|DICTIONARY|EXTRACTED	sah	SAH	63#66	15718509-3-38-61	SERPINA3 can be related to aneurysmal subarachnoid hemorrhage (SAH) by influencing inflammation or by regulating cathepsin G activity.
15718509	2005	Stroke	1524-4628	BACKGROUND AND PURPOSE	1	3	12	SYMBOL|DICTIONARY	serpina3	SERPINA3	0#8		D013345	LONGTERM|DICTIONARY	aneurysmal subarachnoid hemorrhage	aneurysmal subarachnoid hemorrhage	27#61		SERPINA3 can be related to aneurysmal subarachnoid hemorrhage (SAH) by influencing inflammation or by regulating cathepsin G activity.
15718509	2005	Stroke	1524-4628	BACKGROUND AND PURPOSE	1	3	12	SYMBOL|DICTIONARY	serpina3	SERPINA3	0#8		D007249	LONGTERM|DICTIONARY	inflammation	inflammation	83#95	NaN	SERPINA3 can be related to aneurysmal subarachnoid hemorrhage (SAH) by influencing inflammation or by regulating cathepsin G activity.
15718509	2005	Stroke	1524-4628	BACKGROUND AND PURPOSE	1	1	12	SYMBOL|()|DICTIONARY	serpina3	SERPINA3	57#65		D007249	LONGTERM|DICTIONARY	acute and chronic inflammation	acute and chronic inflammation	176#206	NaN	The member 3 of clade A of serine proteinase inhibitors (SERPINA3), known previously as the alpha1-antichymotrypsin, is an acute phase protein, the levels of which increase in acute and chronic inflammation.
16507928	2007	Obstet Gynecol	1873-233X	METHODS	2	2	355	SYMBOL|NUMBER|DICTIONARY	tnfrsf6	TNFRSF6	233#240		D017359	LONGTERM|DISEASE|DT|DICTIONARY	hellp syndrome	HELLP syndrome	79#93		In a retrospective study, buccal swabs from 81 women with the complete form of HELLP syndrome and 83 normotensive control women with uncomplicated full-term pregnancy, and 110 of their neonates, were analyzed for the presence of the TNFRSF6-670 polymorphism.
15718509	2005	Stroke	1524-4628	METHODS	2	5	12	SYMBOL|DICTIONARY	serpina3	SERPINA3	92#100		D013345	SYMBOL|DICTIONARY|EXTRACTED	sah	SAH	40#43	15718509-3-38-61	A total of 180 patients with aneurysmal SAH and 263 healthy controls were genotyped for the SERPINA3 A/T polymorphism.
15718509	2005	Stroke	1524-4628	METHODS	2	5	12	SYMBOL|DICTIONARY	serpina3	SERPINA3	92#100		D000783	LONGTERM|DICTIONARY	aneurysmal	aneurysmal	29#39	NaN	A total of 180 patients with aneurysmal SAH and 263 healthy controls were genotyped for the SERPINA3 A/T polymorphism.
15718509	2005	Stroke	1524-4628	BACKGROUND AND PURPOSE	1	4	12	SYMBOL|DICTIONARY	serpina3	SERPINA3	31#39		D013345	SYMBOL|DICTIONARY|EXTRACTED	sah	SAH	85#88	15718509-3-38-61	We studied the significance of SERPINA3 A/T polymorphism in patients with aneurysmal SAH compared with healthy controls.
15718509	2005	Stroke	1524-4628	BACKGROUND AND PURPOSE	1	4	12	SYMBOL|DICTIONARY	serpina3	SERPINA3	31#39		D000783	LONGTERM|DICTIONARY	aneurysmal	aneurysmal	74#84	NaN	We studied the significance of SERPINA3 A/T polymorphism in patients with aneurysmal SAH compared with healthy controls.
21265945	2011	Psychiatry Clin. Neurosci.	1440-1819	ALL_TEXT_1/3	1	1	410	LONGTERM|DICTIONARY	arylsulfatase a	arylsulfatase A	113#128		D007966	LONGTERM|DICTIONARY	metachromatic leukodystrophy	Metachromatic leukodystrophy	0#28		Metachromatic leukodystrophy (MLD) is an autosomal recessive lysosomal storage disease caused by a deficiency of arylsulfatase A. MLD is a heterogeneous disease with variable age at onset and variable clinical features.
21265945	2011	Psychiatry Clin. Neurosci.	1440-1819	ALL_TEXT_1/3	1	1	410	LONGTERM|DICTIONARY	arylsulfatase a	arylsulfatase A	113#128		D007966	SYMBOL|()|DICTIONARY|EXTRACTED	mld	MLD	30#33	21265945-1-0-28	Metachromatic leukodystrophy (MLD) is an autosomal recessive lysosomal storage disease caused by a deficiency of arylsulfatase A. MLD is a heterogeneous disease with variable age at onset and variable clinical features.
21265945	2011	Psychiatry Clin. Neurosci.	1440-1819	ALL_TEXT_1/3	1	1	410	LONGTERM|DICTIONARY	arylsulfatase a	arylsulfatase A	113#128		D007966	SYMBOL|DICTIONARY|EXTRACTED	mld	MLD	130#133	21265945-1-0-28	Metachromatic leukodystrophy (MLD) is an autosomal recessive lysosomal storage disease caused by a deficiency of arylsulfatase A. MLD is a heterogeneous disease with variable age at onset and variable clinical features.
21265945	2011	Psychiatry Clin. Neurosci.	1440-1819	ALL_TEXT_1/3	1	1	410	LONGTERM|DICTIONARY	arylsulfatase a	arylsulfatase A	113#128		D016464	LONGTERM|DISEASE|DT|DICTIONARY	autosomal recessive lysosomal storage disease	autosomal recessive lysosomal storage disease	41#86		Metachromatic leukodystrophy (MLD) is an autosomal recessive lysosomal storage disease caused by a deficiency of arylsulfatase A. MLD is a heterogeneous disease with variable age at onset and variable clinical features.
21265945	2011	Psychiatry Clin. Neurosci.	1440-1819	TITLE	0	0	410	SYMBOL|DICTIONARY	arsa	ARSA	67#71		D007966	LONGTERM|DICTIONARY	adult type metachromatic leukodystrophy	Adult-type metachromatic leukodystrophy	0#39		Adult-type metachromatic leukodystrophy with compound heterozygous ARSA mutations: a case report and phenotypic comparison with a previously reported case.
21265945	2011	Psychiatry Clin. Neurosci.	1440-1819	ALL_TEXT_2/3	2	3	410	SYMBOL|DICTIONARY	arsa	ARSA	85#89		D007966	SYMBOL|DICTIONARY|EXTRACTED	mld	MLD	23#26	21265945-1-0-28	She was diagnosed with MLD by genetic analysis, which revealed compound heterozygous ARSA missense mutations (p.G99D and p.T409I).
12631109	2004	Kidney Int.	0085-2538	RESULTS	3	11	7040	LONGTERM|DICTIONARY	transforming growth factor-beta1	transforming growth factor-beta1	129#161	NaN	D005355	LONGTERM|DICTIONARY	interstitial fibrosis	interstitial fibrosis	71#92		In parallel, decreased deposition of extracellular matrix and lessened interstitial fibrosis as well as reduced amounts of renal transforming growth factor-beta1 (TGF-beta1) could be demonstrated.
12631109	2004	Kidney Int.	0085-2538	RESULTS	3	11	7040	LONGTERM|DICTIONARY	tgf-beta1	TGF-beta1	163#172	NaN	D005355	LONGTERM|DICTIONARY	interstitial fibrosis	interstitial fibrosis	71#92		In parallel, decreased deposition of extracellular matrix and lessened interstitial fibrosis as well as reduced amounts of renal transforming growth factor-beta1 (TGF-beta1) could be demonstrated.
12476417	2003	Zhonghua Yi Xue Yi Chuan Xue Za Zhi	1003-9406	OBJECTIVE	1	1	4846	LONGTERM|DICTIONARY|GENE|GA	endothelial nitric oxide synthase	endothelial nitric oxide synthase	38#71		D003324	LONGTERM|DISEASE|DT|DICTIONARY	coronary atherosclerotic heart disease	coronary atherosclerotic heart disease	102#140		To investigate the association of the endothelial nitric oxide synthase (eNOS) gene polymorphism with coronary atherosclerotic heart disease (CHD) in Chinese Han nationality.
21685359	2011	J. Natl. Cancer Inst.	1460-2105	RESULTS	3	8	6275	SYMBOL|GFAM|FN|DICTIONARY	s100a4	S100A4	8#14		D003110	LONGTERM|DISEASE|DT|CLINE|CN|DICTIONARY	colon cancer	colon cancer	157#169		Reduced S100A4 mRNA and protein expression, and inhibited cell migration, invasion, proliferation, and colony formation were observed in niclosamide-treated colon cancer cells in vitro.
12476417	2003	Zhonghua Yi Xue Yi Chuan Xue Za Zhi	1003-9406	TITLE	0	0	4846	LONGTERM|GENE|GN|DICTIONARY	endothelial nitric oxide synthase	endothelial nitric oxide synthase	27#60		D003324	LONGTERM|DISEASE|DT|DICTIONARY	coronary atherosclerotic heart disease	coronary atherosclerotic heart disease	85#123		[The G894T mutation of the endothelial nitric oxide synthase gene is associated with coronary atherosclerotic heart disease in Chinese].
15308875	2004	Am. J. Nephrol.	0250-8095	BACKGROUND	1	2	7124	SYMBOL|GENE|GN|DICTIONARY	tnf alpha	TNF alpha	62#71		D005923	LONGTERM|DICTIONARY	focal segmental glomerulosclerosis	focal segmental glomerulosclerosis	153#187		We evaluated the influence of TGF-beta(1) gene Arg(25)-->Pro, TNF alpha gene G-308A and IL-6 gene G-174C polymorphisms on the clinical manifestations of focal segmental glomerulosclerosis (FSGS).
15308875	2004	Am. J. Nephrol.	0250-8095	BACKGROUND	1	2	7124	SYMBOL|GENE|GN|DICTIONARY	tnf alpha	TNF alpha	62#71		D005923	SYMBOL|()|DICTIONARY|EXTRACTED	fsgs	FSGS	189#193	15308875-2-153-187	We evaluated the influence of TGF-beta(1) gene Arg(25)-->Pro, TNF alpha gene G-308A and IL-6 gene G-174C polymorphisms on the clinical manifestations of focal segmental glomerulosclerosis (FSGS).
15308875	2004	Am. J. Nephrol.	0250-8095	BACKGROUND	1	2	3569	SYMBOL|GENE|GN|DICTIONARY	il 6	IL-6	88#92		D005923	LONGTERM|DICTIONARY	focal segmental glomerulosclerosis	focal segmental glomerulosclerosis	153#187		We evaluated the influence of TGF-beta(1) gene Arg(25)-->Pro, TNF alpha gene G-308A and IL-6 gene G-174C polymorphisms on the clinical manifestations of focal segmental glomerulosclerosis (FSGS).
15308875	2004	Am. J. Nephrol.	0250-8095	BACKGROUND	1	2	3569	SYMBOL|GENE|GN|DICTIONARY	il 6	IL-6	88#92		D005923	SYMBOL|()|DICTIONARY|EXTRACTED	fsgs	FSGS	189#193	15308875-2-153-187	We evaluated the influence of TGF-beta(1) gene Arg(25)-->Pro, TNF alpha gene G-308A and IL-6 gene G-174C polymorphisms on the clinical manifestations of focal segmental glomerulosclerosis (FSGS).
15308875	2004	Am. J. Nephrol.	0250-8095	BACKGROUND	1	2	7040	SYMBOL|GENE|GN|DICTIONARY	tgf-beta(1)	TGF-beta(1)	30#41		D005923	LONGTERM|DICTIONARY	focal segmental glomerulosclerosis	focal segmental glomerulosclerosis	153#187		We evaluated the influence of TGF-beta(1) gene Arg(25)-->Pro, TNF alpha gene G-308A and IL-6 gene G-174C polymorphisms on the clinical manifestations of focal segmental glomerulosclerosis (FSGS).
15308875	2004	Am. J. Nephrol.	0250-8095	BACKGROUND	1	2	7040	SYMBOL|GENE|GN|DICTIONARY	tgf-beta(1)	TGF-beta(1)	30#41		D005923	SYMBOL|()|DICTIONARY|EXTRACTED	fsgs	FSGS	189#193	15308875-2-153-187	We evaluated the influence of TGF-beta(1) gene Arg(25)-->Pro, TNF alpha gene G-308A and IL-6 gene G-174C polymorphisms on the clinical manifestations of focal segmental glomerulosclerosis (FSGS).
20555002	2010	In Vivo	0258-851X	CONCLUSION	4	16	7422	SYMBOL|DICTIONARY|EXTRACTED	vegf	VEGF	41#45	20555002-2-8-42	D004715	LONGTERM|DICTIONARY	endometriosis	endometriosis	119#132		Our data suggest that the CC genotype of VEGF +405 and 460T/405C haplotypes of VEGF may be associated with the risk of endometriosis, but the G allele of VEGF +405 appears to be protective against endometriosis.
20555002	2010	In Vivo	0258-851X	CONCLUSION	4	16	7422	SYMBOL|DICTIONARY|EXTRACTED	vegf	VEGF	41#45	20555002-2-8-42	D004715	LONGTERM|DICTIONARY	endometriosis	endometriosis	197#210		Our data suggest that the CC genotype of VEGF +405 and 460T/405C haplotypes of VEGF may be associated with the risk of endometriosis, but the G allele of VEGF +405 appears to be protective against endometriosis.
20555002	2010	In Vivo	0258-851X	CONCLUSION	4	16	7422	SYMBOL|DICTIONARY|EXTRACTED	vegf	VEGF	79#83	20555002-2-8-42	D004715	LONGTERM|DICTIONARY	endometriosis	endometriosis	119#132		Our data suggest that the CC genotype of VEGF +405 and 460T/405C haplotypes of VEGF may be associated with the risk of endometriosis, but the G allele of VEGF +405 appears to be protective against endometriosis.
20555002	2010	In Vivo	0258-851X	CONCLUSION	4	16	7422	SYMBOL|DICTIONARY|EXTRACTED	vegf	VEGF	79#83	20555002-2-8-42	D004715	LONGTERM|DICTIONARY	endometriosis	endometriosis	197#210		Our data suggest that the CC genotype of VEGF +405 and 460T/405C haplotypes of VEGF may be associated with the risk of endometriosis, but the G allele of VEGF +405 appears to be protective against endometriosis.
20555002	2010	In Vivo	0258-851X	CONCLUSION	4	16	7422	SYMBOL|DICTIONARY|EXTRACTED	vegf	VEGF	154#158	20555002-2-8-42	D004715	LONGTERM|DICTIONARY	endometriosis	endometriosis	119#132		Our data suggest that the CC genotype of VEGF +405 and 460T/405C haplotypes of VEGF may be associated with the risk of endometriosis, but the G allele of VEGF +405 appears to be protective against endometriosis.
20555002	2010	In Vivo	0258-851X	CONCLUSION	4	16	7422	SYMBOL|DICTIONARY|EXTRACTED	vegf	VEGF	154#158	20555002-2-8-42	D004715	LONGTERM|DICTIONARY	endometriosis	endometriosis	197#210		Our data suggest that the CC genotype of VEGF +405 and 460T/405C haplotypes of VEGF may be associated with the risk of endometriosis, but the G allele of VEGF +405 appears to be protective against endometriosis.
17257320	2007	Tissue Antigens	0001-2815	ALL_TEXT_3/3	3	10	3123	SYMBOL|NUMBER|DICTIONARY	drb1	DRB1	117#121		D006509	SYMBOL|DISEASE|DN|DICTIONARY|EXTRACTED	hbv infection	HBV infection	98#111	17257320-1-0-11	The above data indicate that HLA-DRB1*03 and HLA-DRB1*07 are related to susceptibility to chronic HBV infection, and DRB1*15 is negatively related to persistence to chronic HBV infection among people in northwestern China.
17257320	2007	Tissue Antigens	0001-2815	ALL_TEXT_3/3	3	10	3123	SYMBOL|NUMBER|DICTIONARY	drb1	DRB1	117#121		D006509	SYMBOL|DISEASE|DN|DICTIONARY|EXTRACTED	hbv infection	HBV infection	173#186	17257320-1-0-11	The above data indicate that HLA-DRB1*03 and HLA-DRB1*07 are related to susceptibility to chronic HBV infection, and DRB1*15 is negatively related to persistence to chronic HBV infection among people in northwestern China.
17257320	2007	Tissue Antigens	0001-2815	ALL_TEXT_3/3	3	10	3123	SYMBOL|DICTIONARY	drb1	DRB1	33#37		D006509	SYMBOL|DISEASE|DN|DICTIONARY|EXTRACTED	hbv infection	HBV infection	98#111	17257320-1-0-11	The above data indicate that HLA-DRB1*03 and HLA-DRB1*07 are related to susceptibility to chronic HBV infection, and DRB1*15 is negatively related to persistence to chronic HBV infection among people in northwestern China.
17257320	2007	Tissue Antigens	0001-2815	ALL_TEXT_3/3	3	10	3123	SYMBOL|DICTIONARY	drb1	DRB1	33#37		D006509	SYMBOL|DISEASE|DN|DICTIONARY|EXTRACTED	hbv infection	HBV infection	173#186	17257320-1-0-11	The above data indicate that HLA-DRB1*03 and HLA-DRB1*07 are related to susceptibility to chronic HBV infection, and DRB1*15 is negatively related to persistence to chronic HBV infection among people in northwestern China.
17257320	2007	Tissue Antigens	0001-2815	ALL_TEXT_3/3	3	10	3123	SYMBOL|DICTIONARY	drb1	DRB1	49#53		D006509	SYMBOL|DISEASE|DN|DICTIONARY|EXTRACTED	hbv infection	HBV infection	98#111	17257320-1-0-11	The above data indicate that HLA-DRB1*03 and HLA-DRB1*07 are related to susceptibility to chronic HBV infection, and DRB1*15 is negatively related to persistence to chronic HBV infection among people in northwestern China.
17257320	2007	Tissue Antigens	0001-2815	ALL_TEXT_3/3	3	10	3123	SYMBOL|DICTIONARY	drb1	DRB1	49#53		D006509	SYMBOL|DISEASE|DN|DICTIONARY|EXTRACTED	hbv infection	HBV infection	173#186	17257320-1-0-11	The above data indicate that HLA-DRB1*03 and HLA-DRB1*07 are related to susceptibility to chronic HBV infection, and DRB1*15 is negatively related to persistence to chronic HBV infection among people in northwestern China.
17257320	2007	Tissue Antigens	0001-2815	ALL_TEXT_3/3	3	11	3123	SYMBOL|DICTIONARY	drb1	DRB1	29#33		D006509	SYMBOL|DISEASE|DN|DICTIONARY|EXTRACTED	hbv	HBV	135#138	17257320-1-0-11	Similar results were got for DRB1*03 and 15 alleles between the HBV-infected patients (n = 108) and 46 HBV seronegative spouses of the HBV patients, who were high-risk group for HBV infection.
17257320	2007	Tissue Antigens	0001-2815	ALL_TEXT_3/3	3	11	3123	SYMBOL|DICTIONARY	drb1	DRB1	29#33		D006509	SYMBOL|DISEASE|DN|DICTIONARY|EXTRACTED	hbv	HBV	178#181	17257320-1-0-11	Similar results were got for DRB1*03 and 15 alleles between the HBV-infected patients (n = 108) and 46 HBV seronegative spouses of the HBV patients, who were high-risk group for HBV infection.
18922923	2008	Cancer Res.	1538-7445	ALL_TEXT_1/3	1	1	5743	LONGTERM|DICTIONARY	cyclooxygenase 2	cyclooxygenase-2	31#47		D009062	LONGTERM|DISEASE|DT|CLINE|CN|DICTIONARY	oral epithelial carcinoma	oral epithelial carcinoma	243#268		Because the mRNA expression of cyclooxygenase-2 (COX-2) is up-regulated by arecoline in human gingival fibroblasts, as shown in our previous study, we further investigated the mRNA expression level of COX-2 and its upstream effectors in three oral epithelial carcinoma cell lines (KB, SAS, and Ca9-22) by using areca nut extract (ANE) and saliva-reacted ANE (sANE).
18922923	2008	Cancer Res.	1538-7445	ALL_TEXT_1/3	1	1	5743	SYMBOL|()|DICTIONARY|EXTRACTED	cox 2	COX-2	49#54	18922923-1-31-47	D009062	LONGTERM|DISEASE|DT|CLINE|CN|DICTIONARY	oral epithelial carcinoma	oral epithelial carcinoma	243#268		Because the mRNA expression of cyclooxygenase-2 (COX-2) is up-regulated by arecoline in human gingival fibroblasts, as shown in our previous study, we further investigated the mRNA expression level of COX-2 and its upstream effectors in three oral epithelial carcinoma cell lines (KB, SAS, and Ca9-22) by using areca nut extract (ANE) and saliva-reacted ANE (sANE).
18922923	2008	Cancer Res.	1538-7445	ALL_TEXT_1/3	1	1	5743	SYMBOL|DICTIONARY|EXTRACTED	cox 2	COX-2	201#206	18922923-1-31-47	D009062	LONGTERM|DISEASE|DT|CLINE|CN|DICTIONARY	oral epithelial carcinoma	oral epithelial carcinoma	243#268		Because the mRNA expression of cyclooxygenase-2 (COX-2) is up-regulated by arecoline in human gingival fibroblasts, as shown in our previous study, we further investigated the mRNA expression level of COX-2 and its upstream effectors in three oral epithelial carcinoma cell lines (KB, SAS, and Ca9-22) by using areca nut extract (ANE) and saliva-reacted ANE (sANE).
18922923	2008	Cancer Res.	1538-7445	TITLE	0	0	5743	LONGTERM|DICTIONARY	cyclooxygenase 2	cyclooxygenase-2	74#90		D009369	LONGTERM|DISEASE|DT|DICTIONARY	oral cancer	oral cancer	128#139		Up-regulation of inflammatory signalings by areca nut extract and role of cyclooxygenase-2 -1195G>a polymorphism reveal risk of oral cancer.
16816977	2007	Neurogenetics	1364-6745	ALL_TEXT_2/3	2	3	1812	SYMBOL|DICTIONARY	drd1	DRD1	249#253		D010300	SYMBOL|EXTRACTED	pd	PD	308#310	16816977-1-141-160	We present in this paper an extensive association analysis of a total of 20 markers including single nucleotide polymorphism/short tandem repeat/variable number tandem repeat/duplication markers from five candidate genes (namely, dopamine receptors DRD1, DRD2, DRD3, and DRD4, and dopamine transporter) with PD among two independent sample sets.
16816977	2007	Neurogenetics	1364-6745	ALL_TEXT_2/3	2	3	1813	SYMBOL|DICTIONARY	drd2	DRD2	255#259		D010300	SYMBOL|EXTRACTED	pd	PD	308#310	16816977-1-141-160	We present in this paper an extensive association analysis of a total of 20 markers including single nucleotide polymorphism/short tandem repeat/variable number tandem repeat/duplication markers from five candidate genes (namely, dopamine receptors DRD1, DRD2, DRD3, and DRD4, and dopamine transporter) with PD among two independent sample sets.
16816977	2007	Neurogenetics	1364-6745	ALL_TEXT_2/3	2	3	1814	SYMBOL|DICTIONARY	drd3	DRD3	261#265		D010300	SYMBOL|EXTRACTED	pd	PD	308#310	16816977-1-141-160	We present in this paper an extensive association analysis of a total of 20 markers including single nucleotide polymorphism/short tandem repeat/variable number tandem repeat/duplication markers from five candidate genes (namely, dopamine receptors DRD1, DRD2, DRD3, and DRD4, and dopamine transporter) with PD among two independent sample sets.
16816977	2007	Neurogenetics	1364-6745	ALL_TEXT_2/3	2	3	1815	SYMBOL|DICTIONARY	drd4	DRD4	271#275		D010300	SYMBOL|EXTRACTED	pd	PD	308#310	16816977-1-141-160	We present in this paper an extensive association analysis of a total of 20 markers including single nucleotide polymorphism/short tandem repeat/variable number tandem repeat/duplication markers from five candidate genes (namely, dopamine receptors DRD1, DRD2, DRD3, and DRD4, and dopamine transporter) with PD among two independent sample sets.
16816977	2007	Neurogenetics	1364-6745	ALL_TEXT_2/3	2	3	6531	LONGTERM|DICTIONARY	dopamine transporter	dopamine transporter	281#301		D010300	SYMBOL|EXTRACTED	pd	PD	308#310	16816977-1-141-160	We present in this paper an extensive association analysis of a total of 20 markers including single nucleotide polymorphism/short tandem repeat/variable number tandem repeat/duplication markers from five candidate genes (namely, dopamine receptors DRD1, DRD2, DRD3, and DRD4, and dopamine transporter) with PD among two independent sample sets.
16182378	2006	J. Neuroimmunol.	0165-5728	TITLE	0	0	1234	SYMBOL|DICTIONARY	ccr5	CCR5	36#40		D009103	LONGTERM|DICTIONARY	multiple sclerosis	multiple sclerosis	103#121		CCR5Delta32 polymorphism effects on CCR5 expression, patterns of immunopathology and disease course in multiple sclerosis.
16182378	2006	J. Neuroimmunol.	0165-5728	TITLE	0	0	1234	SYMBOL|DICTIONARY	ccr5	CCR5	36#40		D004194	LONGTERM|DICTIONARY	disease course	disease course	85#99	NaN	CCR5Delta32 polymorphism effects on CCR5 expression, patterns of immunopathology and disease course in multiple sclerosis.
8757534	1996	Br. J. Haematol.	0007-1048	ALL_TEXT_1/3	1	2	2235	LONGTERM|DICTIONARY	ferrochelatase	ferrochelatase	95#109		D046351	LONGTERM|DICTIONARY	erythropoietic protoporphyria	erythropoietic protoporphyria	59#88		We investigated a Japanese patient with a dominant form of erythropoietic protoporphyria for a ferrochelatase mutation.
19478460	2009	J. Clin. Invest.	1558-8238	ALL_TEXT_1/3	1	1	6531	SYMBOL|GENE|GN|DICTIONARY	slc6a3	SLC6A3	24#30		D001523	LONGTERM|DICTIONARY	neuropsychiatric disorders	neuropsychiatric disorders	119#145		Genetic variants of the SLC6A3 gene that encodes the human dopamine transporter (DAT) have been linked to a variety of neuropsychiatric disorders, particularly attention deficit hyperactivity disorder.
19478460	2009	J. Clin. Invest.	1558-8238	ALL_TEXT_1/3	1	1	6531	SYMBOL|GENE|GN|DICTIONARY	slc6a3	SLC6A3	24#30		D001289	LONGTERM|DISEASE|DT|DICTIONARY	deficit hyperactivity disorder	deficit hyperactivity disorder	170#200		Genetic variants of the SLC6A3 gene that encodes the human dopamine transporter (DAT) have been linked to a variety of neuropsychiatric disorders, particularly attention deficit hyperactivity disorder.
19478460	2009	J. Clin. Invest.	1558-8238	ALL_TEXT_1/3	1	1	6531	LONGTERM|DICTIONARY	dopamine transporter	dopamine transporter	59#79		D001523	LONGTERM|DICTIONARY	neuropsychiatric disorders	neuropsychiatric disorders	119#145		Genetic variants of the SLC6A3 gene that encodes the human dopamine transporter (DAT) have been linked to a variety of neuropsychiatric disorders, particularly attention deficit hyperactivity disorder.
19478460	2009	J. Clin. Invest.	1558-8238	ALL_TEXT_1/3	1	1	6531	LONGTERM|DICTIONARY	dopamine transporter	dopamine transporter	59#79		D001289	LONGTERM|DISEASE|DT|DICTIONARY	deficit hyperactivity disorder	deficit hyperactivity disorder	170#200		Genetic variants of the SLC6A3 gene that encodes the human dopamine transporter (DAT) have been linked to a variety of neuropsychiatric disorders, particularly attention deficit hyperactivity disorder.
19478460	2009	J. Clin. Invest.	1558-8238	ALL_TEXT_1/3	1	1	6531	SYMBOL|()|DICTIONARY|EXTRACTED	dat	DAT	81#84	19478460-1-59-79	D001523	LONGTERM|DICTIONARY	neuropsychiatric disorders	neuropsychiatric disorders	119#145		Genetic variants of the SLC6A3 gene that encodes the human dopamine transporter (DAT) have been linked to a variety of neuropsychiatric disorders, particularly attention deficit hyperactivity disorder.
19478460	2009	J. Clin. Invest.	1558-8238	ALL_TEXT_1/3	1	1	6531	SYMBOL|()|DICTIONARY|EXTRACTED	dat	DAT	81#84	19478460-1-59-79	D001289	LONGTERM|DISEASE|DT|DICTIONARY	deficit hyperactivity disorder	deficit hyperactivity disorder	170#200		Genetic variants of the SLC6A3 gene that encodes the human dopamine transporter (DAT) have been linked to a variety of neuropsychiatric disorders, particularly attention deficit hyperactivity disorder.
9747038	1998	J. Hum. Genet.	1434-5161	TITLE	0	0	5354	SYMBOL|()|GENE|GN|DICTIONARY	plp	PLP	97#100		D020371	LONGTERM|DISEASE|DT|DICTIONARY	pelizaeus merzbacher disease	Pelizaeus-Merzbacher disease	9#37		Connatal Pelizaeus-Merzbacher disease: a missense mutation in exon 4 of the proteolipid protein (PLP) gene.
21966456	2012	PLoS ONE	1932-6203	BACKGROUND	1	3	5733	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	ep3	EP3	55#58	21966456-1-249-275	D013262	SYMBOL|DICTIONARY|EXTRACTED	sjs	SJS	143#146	21966456-1-48-72	In the current study we investigated the expression of EP3 protein in the conjunctiva of patients with various ocular surface diseases such as SJS/TEN, chemical eye burns, Mooren's ulcers, and ocular cicatricial pemphigoid (OCP).
21966456	2012	PLoS ONE	1932-6203	BACKGROUND	1	3	5733	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	ep3	EP3	55#58	21966456-1-249-275	D064420	SYMBOL|EXTRACTED	ten	TEN	147#150	21966456-1-103-129	In the current study we investigated the expression of EP3 protein in the conjunctiva of patients with various ocular surface diseases such as SJS/TEN, chemical eye burns, Mooren's ulcers, and ocular cicatricial pemphigoid (OCP).
21966456	2012	PLoS ONE	1932-6203	BACKGROUND	1	3	5733	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	ep3	EP3	55#58	21966456-1-249-275	D010390	LONGTERM|DICTIONARY	ocular cicatricial pemphigoid	ocular cicatricial pemphigoid	193#222		In the current study we investigated the expression of EP3 protein in the conjunctiva of patients with various ocular surface diseases such as SJS/TEN, chemical eye burns, Mooren's ulcers, and ocular cicatricial pemphigoid (OCP).
21966456	2012	PLoS ONE	1932-6203	BACKGROUND	1	3	5733	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	ep3	EP3	55#58	21966456-1-249-275	D010390	SYMBOL|()|DICTIONARY|EXTRACTED	ocp	OCP	224#227	21966456-3-193-222	In the current study we investigated the expression of EP3 protein in the conjunctiva of patients with various ocular surface diseases such as SJS/TEN, chemical eye burns, Mooren's ulcers, and ocular cicatricial pemphigoid (OCP).
21966456	2012	PLoS ONE	1932-6203	BACKGROUND	1	3	5733	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	ep3	EP3	55#58	21966456-1-249-275	D014456	LONGTERM|DICTIONARY	mooren's ulcers	Mooren's ulcers	172#187		In the current study we investigated the expression of EP3 protein in the conjunctiva of patients with various ocular surface diseases such as SJS/TEN, chemical eye burns, Mooren's ulcers, and ocular cicatricial pemphigoid (OCP).
21966456	2012	PLoS ONE	1932-6203	BACKGROUND	1	3	5733	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	ep3	EP3	55#58	21966456-1-249-275	D005126	LONGTERM|DICTIONARY	chemical eye burns	chemical eye burns	152#170	NaN	In the current study we investigated the expression of EP3 protein in the conjunctiva of patients with various ocular surface diseases such as SJS/TEN, chemical eye burns, Mooren's ulcers, and ocular cicatricial pemphigoid (OCP).
11340230	2001	Stroke	1524-4628	BACKGROUND AND PURPOSE	1	3	348	LONGTERM|DICTIONARY	apolipoprotein e	apolipoprotein E	30#46		D013345	SYMBOL|DICTIONARY|EXTRACTED	sah	SAH	94#97	11340230-1-42-65	We studied the association of apolipoprotein E polymorphism with the outcome after aneurysmal SAH.
11340230	2001	Stroke	1524-4628	BACKGROUND AND PURPOSE	1	3	348	LONGTERM|DICTIONARY	apolipoprotein e	apolipoprotein E	30#46		D000783	LONGTERM|DICTIONARY	aneurysmal	aneurysmal	83#93	NaN	We studied the association of apolipoprotein E polymorphism with the outcome after aneurysmal SAH.
20638924	2010	Cancer Epidemiol	1877-783X	TITLE	0	0	7157	SYMBOL|DICTIONARY	p53	p53	29#32		D001943	LONGTERM|DISEASE|DN|DT|DICTIONARY	breast cancer	breast cancer	78#91		Distribution of TYMS, MTHFR, p53 and MDR1 gene polymorphisms in patients with breast cancer treated with neoadjuvant chemotherapy.
20638924	2010	Cancer Epidemiol	1877-783X	TITLE	0	0	5243	SYMBOL|GENE|GN|DICTIONARY	mdr1	MDR1	37#41		D001943	LONGTERM|DISEASE|DN|DT|DICTIONARY	breast cancer	breast cancer	78#91		Distribution of TYMS, MTHFR, p53 and MDR1 gene polymorphisms in patients with breast cancer treated with neoadjuvant chemotherapy.
11340230	2001	Stroke	1524-4628	BACKGROUND AND PURPOSE	1	2	348	SYMBOL|DICTIONARY	apoe	APOE	0#4		D000544	LONGTERM|DISEASE|DT|DICTIONARY	alzheimer disease	Alzheimer's disease	77#96		APOE genotype is the most important genetic determinant of susceptibility to Alzheimer's disease, and it is also shown to be associated with the outcome after traumatic brain injury.
11340230	2001	Stroke	1524-4628	BACKGROUND AND PURPOSE	1	2	348	SYMBOL|DICTIONARY	apoe	APOE	0#4		D001930	LONGTERM|DICTIONARY	traumatic brain injury	traumatic brain injury	159#181	NaN	APOE genotype is the most important genetic determinant of susceptibility to Alzheimer's disease, and it is also shown to be associated with the outcome after traumatic brain injury.
15956286	2005	Blood	0006-4971	ALL_TEXT_3/3	3	7	3779	LONGTERM|DICTIONARY	beta1	beta1	27#32		D002318	LONGTERM|DISEASE|DT|DICTIONARY	cardiovascular disease	cardiovascular disease	186#208		The prevalence of the Q43P beta1-tubulin variant was also 2 times higher (odds ratio, [OR] = 2.1;95% confidence interval [CI], 1.22-3.59) among control subjects than among patients with cardiovascular disease (10.4% versus 5.2%, P < .001).
20483145	2010	J. Neurol. Sci.	1878-5883	PURPOSE	1	2	4210	SYMBOL|GENE|GN|DICTIONARY	mefv	MEFV	0#4		D010505	LONGTERM|DICTIONARY	familial mediterranean fever	familial Mediterranean fever	39#67		MEFV gene, which is the main factor in familial Mediterranean fever, is an intracellular regulator of inflammation.
20483145	2010	J. Neurol. Sci.	1878-5883	PURPOSE	1	2	4210	SYMBOL|GENE|GN|DICTIONARY	mefv	MEFV	0#4		D007249	LONGTERM|DICTIONARY	inflammation	inflammation	102#114	NaN	MEFV gene, which is the main factor in familial Mediterranean fever, is an intracellular regulator of inflammation.
20483145	2010	J. Neurol. Sci.	1878-5883	PURPOSE	1	3	4210	SYMBOL|GENE|GN|DICTIONARY	mefv	MEFV	75#79		D009103	SYMBOL|EXTRACTED	ms	MS	101#103	20483145-1-0-18	This study was designed to determine if known mutations in pyrin domain of MEFV gene are involved in MS and associated with MS morbidity.
20483145	2010	J. Neurol. Sci.	1878-5883	PURPOSE	1	3	4210	SYMBOL|GENE|GN|DICTIONARY	mefv	MEFV	75#79		D009103	SYMBOL|EXTRACTED	ms	MS	124#126	20483145-1-0-18	This study was designed to determine if known mutations in pyrin domain of MEFV gene are involved in MS and associated with MS morbidity.
16457697	2006	Breast Cancer Res.	1465-542X	INTRODUCTION	1	4	7515	SYMBOL|DICTIONARY	xrcc1	XRCC1	53#58		D001943	LONGTERM|DISEASE|DT|DICTIONARY	breast cancer	breast cancer	63#76		We examined the association between polymorphisms in XRCC1 and breast cancer in the American Cancer Society Cancer Prevention Study II (CPS-II) Nutrition Cohort, a large prospective study of cancer incidence in the USA.
16457697	2006	Breast Cancer Res.	1465-542X	INTRODUCTION	1	4	7515	SYMBOL|DICTIONARY	xrcc1	XRCC1	53#58		D009369	LONGTERM|DISEASE|DT|DICTIONARY	cancer	Cancer	93#99		We examined the association between polymorphisms in XRCC1 and breast cancer in the American Cancer Society Cancer Prevention Study II (CPS-II) Nutrition Cohort, a large prospective study of cancer incidence in the USA.
16457697	2006	Breast Cancer Res.	1465-542X	INTRODUCTION	1	4	7515	SYMBOL|DICTIONARY	xrcc1	XRCC1	53#58		D009369	LONGTERM|DISEASE|DT|DICTIONARY	cancer	Cancer	108#114		We examined the association between polymorphisms in XRCC1 and breast cancer in the American Cancer Society Cancer Prevention Study II (CPS-II) Nutrition Cohort, a large prospective study of cancer incidence in the USA.
16457697	2006	Breast Cancer Res.	1465-542X	INTRODUCTION	1	4	7515	SYMBOL|DICTIONARY	xrcc1	XRCC1	53#58		D009369	LONGTERM|DISEASE|DT|DICTIONARY	cancer	cancer	191#197		We examined the association between polymorphisms in XRCC1 and breast cancer in the American Cancer Society Cancer Prevention Study II (CPS-II) Nutrition Cohort, a large prospective study of cancer incidence in the USA.
21300947	2011	Arch. Gen. Psychiatry	1538-3636	CONCLUSIONS	8	12	627	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	bdnf	BDNF	61#65	21300947-1-4-37	D000544	SYMBOL|EXTRACTED	ad	AD	142#144	21300947-1-100-117	Our novel findings provide convergent evidence in vivo for a BDNF genetic mechanism of susceptibility in an intermediate phenotype related to AD.
16457697	2006	Breast Cancer Res.	1465-542X	INTRODUCTION	1	3	7515	SYMBOL|DICTIONARY	xrcc1	XRCC1	62#67		D001943	LONGTERM|DISEASE|DT|DICTIONARY	breast cancer	breast cancer	81#94		However, results of previous association studies of these two XRCC1 variants and breast cancer have been inconsistent.
16457697	2006	Breast Cancer Res.	1465-542X	TITLE	0	0	7515	SYMBOL|DICTIONARY	xrcc1	XRCC1	23#28		D001943	LONGTERM|DISEASE|DT|DICTIONARY	breast cancer	breast cancer	83#96		A prospective study of XRCC1 (X-ray cross-complementing group 1) polymorphisms and breast cancer risk.
20483145	2010	J. Neurol. Sci.	1878-5883	RESULTS	3	9	4210	SYMBOL|GENE|GN|DICTIONARY	mefv	MEFV	71#75		D009103	SYMBOL|DISEASE|DN|DICTIONARY|EXTRACTED	ms	MS	150#152	20483145-1-0-18	The mean time to reach EDSS score 3.0 was earlier in the patients with MEFV gene mutation (p=0.02) and the relapse rate was slightly higher among the MS patients carrying MEFV gene mutation (p=0.04).
20483145	2010	J. Neurol. Sci.	1878-5883	RESULTS	3	9	4210	SYMBOL|GENE|GN|DICTIONARY	mefv	MEFV	171#175		D009103	SYMBOL|DISEASE|DN|DICTIONARY|EXTRACTED	ms	MS	150#152	20483145-1-0-18	The mean time to reach EDSS score 3.0 was earlier in the patients with MEFV gene mutation (p=0.02) and the relapse rate was slightly higher among the MS patients carrying MEFV gene mutation (p=0.04).
16457697	2006	Breast Cancer Res.	1465-542X	METHODS	2	8	7515	SYMBOL|DICTIONARY	xrcc1	XRCC1	134#139		D001943	LONGTERM|DISEASE|DT|DICTIONARY	breast cancer	breast cancer	158#171		We also examined whether factors associated with DNA damage, such as smoking and antioxidant intake, modified the association between XRCC1 polymorphisms and breast cancer.
19470260	2009	Zhongguo Dang Dai Er Ke Za Zhi	1008-8830	METHODS	2	4	28	SYMBOL|GENE|GN|DICTIONARY	abo	ABO	152#155		D001289	SYMBOL|DICTIONARY|EXTRACTED	adhd	ADHD	165#169	19470260-1-63-103	Haplotype-based haplotype relative risk (HHRR), transmission-disequilibrium test (TDT) and Chi-square test were used to examine the association between ABO gene and ADHD.
11933203	2002	Hum. Mutat.	1098-1004	ALL_TEXT_2/3	2	3	6696	LONGTERM|DICTIONARY	osteopontin	osteopontin	30#41		D008180	SYMBOL|DISEASE|DN|DICTIONARY|EXTRACTED	sle	SLE	249#252	11933203-2-94-122	We examined a polymorphism of osteopontin for an association with lupus in humans in an effort to determine whether there is any evidence that a genetic predisposition to altered osteopontin expression might explain the overexpression seen in human SLE patients.
11933203	2002	Hum. Mutat.	1098-1004	ALL_TEXT_2/3	2	3	6696	LONGTERM|DICTIONARY	osteopontin	osteopontin	179#190		D008180	SYMBOL|DISEASE|DN|DICTIONARY|EXTRACTED	sle	SLE	249#252	11933203-2-94-122	We examined a polymorphism of osteopontin for an association with lupus in humans in an effort to determine whether there is any evidence that a genetic predisposition to altered osteopontin expression might explain the overexpression seen in human SLE patients.
16167465	2005	Neuropsychopharmacol Hung	1419-8711	ALL_TEXT_2/3	2	4	1815	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	drd4	DRD4	44#48	16167465-1-0-20	D019966	LONGTERM|DICTIONARY	substance dependence	substance dependence	69#89		Association between the -521 C/T SNP of the DRD4 promoter region and substance dependence was significant in the subgroup of heroin dependents (p = 0.044).
19470260	2009	Zhongguo Dang Dai Er Ke Za Zhi	1008-8830	TITLE	0	0	28	SYMBOL|DICTIONARY	abo	ABO	21#24		D001289	LONGTERM|DISEASE|DT|DICTIONARY	attention deficit hyperactivity disorder	attention-deficit hyperactivity disorder	45#85		[Correlation between ABO blood type gene and attention-deficit hyperactivity disorder in children].
19470260	2009	Zhongguo Dang Dai Er Ke Za Zhi	1008-8830	OBJECTIVE	1	1	28	SYMBOL|DICTIONARY	abo	ABO	39#42		D001289	LONGTERM|DICTIONARY	attention deficit hyperactivity disorder	attention-deficit hyperactivity disorder	63#103		To investigate the correlation between ABO blood type gene and attention-deficit hyperactivity disorder (ADHD) in children.
19470260	2009	Zhongguo Dang Dai Er Ke Za Zhi	1008-8830	OBJECTIVE	1	1	28	SYMBOL|DICTIONARY	abo	ABO	39#42		D001289	SYMBOL|()|DICTIONARY|EXTRACTED	adhd	ADHD	105#109	19470260-1-63-103	To investigate the correlation between ABO blood type gene and attention-deficit hyperactivity disorder (ADHD) in children.
19470260	2009	Zhongguo Dang Dai Er Ke Za Zhi	1008-8830	METHODS	2	2	28	SYMBOL|DICTIONARY	abo	ABO	0#3		D001289	SYMBOL|DICTIONARY|EXTRACTED	adhd	ADHD	77#81	19470260-1-63-103	ABO blood types were determined using glass sheet method in 96 children with ADHD and their parents.
19470260	2009	Zhongguo Dang Dai Er Ke Za Zhi	1008-8830	CONCLUSIONS	4	8	28	SYMBOL|DICTIONARY	abo	ABO	30#33		D001289	SYMBOL|DICTIONARY|EXTRACTED	adhd	ADHD	54#58	19470260-1-63-103	There was correlation between ABO blood type gene and ADHD in children.
20553853	2011	J. Neurol. Sci.	1878-5883	TITLE	0	0	7515	SYMBOL|DICTIONARY	xrcc1	XRCC1	47#52		D000544	LONGTERM|DISEASE|DT|DICTIONARY	alzheimer's disease	Alzheimer's disease	78#97		Association of polymorphism of DNA repair gene XRCC1 with sporadic late-onset Alzheimer's disease and age of onset in elderly Han Chinese.
18368408	2008	Rheumatol. Int.	0172-8172	ALL_TEXT_3/3	3	8	847	SYMBOL|DICTIONARY|EXTRACTED	cat	CAT	30#33	18368408-2-0-8	D008180	SYMBOL|DICTIONARY|EXTRACTED	sle	SLE	114#117	18368408-1-80-108	Our findings suggest that the CAT -330CC genotype may contribute to some clinical manifestations in patients with SLE.
20553853	2011	J. Neurol. Sci.	1878-5883	ALL_TEXT_2/3	2	4	7515	SYMBOL|()|GENE|GN|DICTIONARY	xrcc1	XRCC1	83#88		D000544	SYMBOL|EXTRACTED	ad	AD	179#181	20553853-1-0-19	A functional polymorphism (Arg194Trp) of X-ray repair cross-complementing group 1 (XRCC1) gene may be associated with the repair efficiency of DNA damage which may have a role in AD.
20553853	2011	J. Neurol. Sci.	1878-5883	ALL_TEXT_2/3	2	5	7515	SYMBOL|DICTIONARY	xrcc1	XRCC1	11#16		D000544	SYMBOL|EXTRACTED	ad	AD	93#95	20553853-1-0-19	Therefore, XRCC1 Arg194Trp polymorphism may be a good candidate for genetic risk analysis in AD.
20553853	2011	J. Neurol. Sci.	1878-5883	ALL_TEXT_2/3	2	6	7515	SYMBOL|NUMBER|DICTIONARY	xrcc1	XRCC1	44#49		D000544	SYMBOL|EXTRACTED	ad	AD	88#90	20553853-1-0-19	A case-control study from Turkey found that XRCC1 194Trp was associated with late-onset AD (LOAD).
20484924	2010	Int. Arch. Allergy Immunol.	1423-0097	CONCLUSION	4	11	3596	SYMBOL|DICTIONARY	il13	IL13	0#4		D001249	LONGTERM|DICTIONARY	asthma	asthma	40#46		IL13 polymorphisms were associated with asthma and rhinitis without clinical asthma; thus, these polymorphisms may constitute a common etiologic pathway for their development.
20484924	2010	Int. Arch. Allergy Immunol.	1423-0097	CONCLUSION	4	11	3596	SYMBOL|DICTIONARY	il13	IL13	0#4		D012220	LONGTERM|DICTIONARY	rhinitis	rhinitis	51#59		IL13 polymorphisms were associated with asthma and rhinitis without clinical asthma; thus, these polymorphisms may constitute a common etiologic pathway for their development.
20484924	2010	Int. Arch. Allergy Immunol.	1423-0097	CONCLUSION	4	11	3596	SYMBOL|DICTIONARY	il13	IL13	0#4		D001249	LONGTERM|DICTIONARY	asthma	asthma	77#83		IL13 polymorphisms were associated with asthma and rhinitis without clinical asthma; thus, these polymorphisms may constitute a common etiologic pathway for their development.
14691540	2006	PLoS Biol.	1545-7885	ALL_TEXT_1/3	1	3	2572	SYMBOL|DICTIONARY	gad2	GAD2	77#81		D009767	LONGTERM|DICTIONARY	morbid obesity	morbid obesity	315#329		A case-control study (575 morbidly obese and 646 control subjects) analyzing GAD2 variants identified both a protective haplotype, including the most frequent alleles of single nucleotide polymorphisms (SNPs) +61450 C>A and +83897 T>A (OR = 0.81, 95% CI [0.681-0.972], p = 0.0049) and an at-risk SNP (-243 A>G) for morbid obesity (OR = 1.3, 95% CI [1.053-1.585], p = 0.014).
18368408	2008	Rheumatol. Int.	0172-8172	TITLE	0	0	847	LONGTERM|DICTIONARY	catalase	Catalase	0#8		D008180	LONGTERM|DICTIONARY	systemic lupus erythematosus	systemic lupus erythematosus	33#61		Catalase -262C>T polymorphism in systemic lupus erythematosus in Poland.
18368408	2008	Rheumatol. Int.	0172-8172	ALL_TEXT_3/3	3	5	847	SYMBOL|DICTIONARY|EXTRACTED	cat	CAT	64#67	18368408-2-0-8	D008180	SYMBOL|DISEASE|DN|DICTIONARY|EXTRACTED	sle	SLE	100#103	18368408-1-80-108	We did not observe significant differences in the prevalence of CAT -330C>T polymorphic variants in SLE patients and controls.
18368408	2008	Rheumatol. Int.	0172-8172	ALL_TEXT_2/3	2	4	847	SYMBOL|DICTIONARY|EXTRACTED	cat	CAT	99#102	18368408-2-0-8	D008180	SYMBOL|DISEASE|DN|DICTIONARY|EXTRACTED	sle	SLE	140#143	18368408-1-80-108	Therefore, using restriction length fragment polymorphism analysis, we compared the frequencies of CAT -330C>T polymorphic variants between SLE patients (n = 102) and controls (n = 199).
18368408	2008	Rheumatol. Int.	0172-8172	ALL_TEXT_3/3	3	7	847	SYMBOL|DICTIONARY|EXTRACTED	cat	CAT	26#29	18368408-2-0-8	D007970	LONGTERM|DICTIONARY	leukopenia	leukopenia	79#89		We also observed that the CAT -330CC genotype (recessive model) is linked with leukopenia OR = 3.232 (1.361-7.676, P = 0.0118), renal manifestations OR = 2.403 (1.085-5.321, P = 0.0471) and presence of anti-snRNP Ab OR = 4.206 (95% CI = 1.405-12.590, P = 0.0131), and anti-Scl-70 Ab, OR = 3.143 (95% CI = 1.171-8.433, P = 0.0343) in SLE patients.
18368408	2008	Rheumatol. Int.	0172-8172	ALL_TEXT_3/3	3	7	847	SYMBOL|DICTIONARY|EXTRACTED	cat	CAT	26#29	18368408-2-0-8	D008180	SYMBOL|DISEASE|DN|DICTIONARY|EXTRACTED	sle	SLE	333#336	18368408-1-80-108	We also observed that the CAT -330CC genotype (recessive model) is linked with leukopenia OR = 3.232 (1.361-7.676, P = 0.0118), renal manifestations OR = 2.403 (1.085-5.321, P = 0.0471) and presence of anti-snRNP Ab OR = 4.206 (95% CI = 1.405-12.590, P = 0.0131), and anti-Scl-70 Ab, OR = 3.143 (95% CI = 1.171-8.433, P = 0.0343) in SLE patients.
18368408	2008	Rheumatol. Int.	0172-8172	ALL_TEXT_3/3	3	7	57819	SYMBOL|DICTIONARY	snrnp	snRNP	207#212		D007970	LONGTERM|DICTIONARY	leukopenia	leukopenia	79#89		We also observed that the CAT -330CC genotype (recessive model) is linked with leukopenia OR = 3.232 (1.361-7.676, P = 0.0118), renal manifestations OR = 2.403 (1.085-5.321, P = 0.0471) and presence of anti-snRNP Ab OR = 4.206 (95% CI = 1.405-12.590, P = 0.0131), and anti-Scl-70 Ab, OR = 3.143 (95% CI = 1.171-8.433, P = 0.0343) in SLE patients.
18368408	2008	Rheumatol. Int.	0172-8172	ALL_TEXT_3/3	3	7	57819	SYMBOL|DICTIONARY	snrnp	snRNP	207#212		D008180	SYMBOL|DISEASE|DN|DICTIONARY|EXTRACTED	sle	SLE	333#336	18368408-1-80-108	We also observed that the CAT -330CC genotype (recessive model) is linked with leukopenia OR = 3.232 (1.361-7.676, P = 0.0118), renal manifestations OR = 2.403 (1.085-5.321, P = 0.0471) and presence of anti-snRNP Ab OR = 4.206 (95% CI = 1.405-12.590, P = 0.0131), and anti-Scl-70 Ab, OR = 3.143 (95% CI = 1.171-8.433, P = 0.0343) in SLE patients.
18368408	2008	Rheumatol. Int.	0172-8172	ALL_TEXT_3/3	3	6	847	SYMBOL|DICTIONARY|EXTRACTED	cat	CAT	27#30	18368408-2-0-8	D013921	LONGTERM|DICTIONARY	thrombocytopenia	thrombocytopenia	103#119		However, we found that the CAT -330CC genotype (recessive model) showed a significant association with thrombocytopenia OR = 7.314 (1.977-27.057, P = 0.0017).
19478460	2009	J. Clin. Invest.	1558-8238	ALL_TEXT_2/3	2	3	6531	SYMBOL|DICTIONARY	slc6a3	SLC6A3	141#147		C567730	SYMBOL|EXTRACTED|()|DISEASE|DN	parkinsonism-dystonia (ipd) syndrome	parkinsonism-dystonia (IPD) syndrome	69#105	19478460-3-59-90	Here, we analyzed 2 unrelated consanguineous families with infantile parkinsonism-dystonia (IPD) syndrome and identified homozygous missense SLC6A3 mutations (p.L368Q and p.P395L) in both families.
20020061	2010	PLoS ONE	1932-6203	TITLE	0	0	3845	SYMBOL|DICTIONARY	kras	KRAS	0#4		D009362	LONGTERM|DICTIONARY	metastases	metastases	63#73		KRAS mutations in primary colorectal cancer tumors and related metastases: a potential role in prediction of lung metastasis.
20020061	2010	PLoS ONE	1932-6203	TITLE	0	0	3845	SYMBOL|DICTIONARY	kras	KRAS	0#4		D015179	LONGTERM|DISEASE|DN|DT|DICTIONARY	colorectal cancer tumors	colorectal cancer tumors	26#50		KRAS mutations in primary colorectal cancer tumors and related metastases: a potential role in prediction of lung metastasis.
20020061	2010	PLoS ONE	1932-6203	TITLE	0	0	3845	SYMBOL|DICTIONARY	kras	KRAS	0#4		D015179	LONGTERM|DICTIONARY	colorectal cancer tumors	colorectal cancer tumors	26#50		KRAS mutations in primary colorectal cancer tumors and related metastases: a potential role in prediction of lung metastasis.
19360657	2009	Autism Res	1939-3806	TITLE	0	0	6505	SYMBOL|DICTIONARY	slc1a1	SLC1A1	59#65		D009771	SYMBOL|DICTIONARY|EXTRACTED	ocd	OCD	36#39		Family-Based Association Testing of OCD-associated SNPs of SLC1A1 in an autism sample.
19360657	2009	Autism Res	1939-3806	TITLE	0	0	6505	SYMBOL|DICTIONARY	slc1a1	SLC1A1	59#65		D001321	LONGTERM|DICTIONARY	autism	autism	72#78		Family-Based Association Testing of OCD-associated SNPs of SLC1A1 in an autism sample.
16219118	2006	Psychol Med	0033-2917	CONCLUSIONS	4	7	3084	SYMBOL|DICTIONARY	nrg1	NRG1	43#47		D012559	LONGTERM|DICTIONARY	schizophrenia	schizophrenia	52#65		Our failure to find an association between NRG1 and schizophrenia might reflect different linkage disequilibrium (LD) patterns found in different populations, disease allelic heterogeneity, clinical heterogeneity of schizophrenia, or inadequate statistical power deriving from moderate sample size.
16219118	2006	Psychol Med	0033-2917	CONCLUSIONS	4	7	3084	SYMBOL|DICTIONARY	nrg1	NRG1	43#47		D012559	LONGTERM|DICTIONARY	schizophrenia	schizophrenia	216#229		Our failure to find an association between NRG1 and schizophrenia might reflect different linkage disequilibrium (LD) patterns found in different populations, disease allelic heterogeneity, clinical heterogeneity of schizophrenia, or inadequate statistical power deriving from moderate sample size.
11933203	2002	Hum. Mutat.	1098-1004	ALL_TEXT_2/3	2	4	6696	LONGTERM|DICTIONARY	osteopontin	osteopontin	45#56		D008180	SYMBOL|DICTIONARY|EXTRACTED	sle	SLE	91#94	11933203-2-94-122	A silent polymorphism (707C>T, rs1126616) of osteopontin was significantly associated with SLE.
16219118	2006	Psychol Med	0033-2917	METHOD	2	4	3084	SYMBOL|DICTIONARY	nrg1	NRG1	58#62		D012559	LONGTERM|DICTIONARY	schizophrenia	schizophrenia	100#113		We genotyped 14 single nucleotide polymorphisms (SNPs) in NRG1 including those reported to comprise schizophrenia-associated haplotypes in Icelandic, Scottish, Irish, and Chinese Han populations.
10702401	2000	Am. J. Pathol.	0002-9440	ALL_TEXT_2/3	2	6	2130	SYMBOL|GFAM|FN|DICTIONARY	ews	EWS	51#54		D009369	LONGTERM|DICTIONARY	tumors	tumors	39#45		Ki-67 proliferative index was lower in tumors with EWS-FLI1 type 1 than those with non-type 1 EWS-FLI1, whether analyzed as a continuous (P = 0.049) or categorical (P = 0.047) variable.
10702401	2000	Am. J. Pathol.	0002-9440	ALL_TEXT_2/3	2	6	2313	SYMBOL|GFAM|FN|DICTIONARY	fli1	FLI1	55#59		D009369	LONGTERM|DICTIONARY	tumors	tumors	39#45		Ki-67 proliferative index was lower in tumors with EWS-FLI1 type 1 than those with non-type 1 EWS-FLI1, whether analyzed as a continuous (P = 0.049) or categorical (P = 0.047) variable.
10702401	2000	Am. J. Pathol.	0002-9440	ALL_TEXT_2/3	2	6	2130	SYMBOL|DICTIONARY	ews	EWS	94#97		D009369	LONGTERM|DICTIONARY	tumors	tumors	39#45		Ki-67 proliferative index was lower in tumors with EWS-FLI1 type 1 than those with non-type 1 EWS-FLI1, whether analyzed as a continuous (P = 0.049) or categorical (P = 0.047) variable.
10702401	2000	Am. J. Pathol.	0002-9440	ALL_TEXT_2/3	2	6	2313	SYMBOL|DICTIONARY	fli1	FLI1	98#102		D009369	LONGTERM|DICTIONARY	tumors	tumors	39#45		Ki-67 proliferative index was lower in tumors with EWS-FLI1 type 1 than those with non-type 1 EWS-FLI1, whether analyzed as a continuous (P = 0.049) or categorical (P = 0.047) variable.
10702401	2000	Am. J. Pathol.	0002-9440	TITLE	0	0	2130	SYMBOL|GFAM|FN|DICTIONARY	ews	EWS	15#18		D012512	LONGTERM|DICTIONARY	ewing sarcoma	Ewing's sarcoma	71#86		Association of EWS-FLI1 type 1 fusion with lower proliferative rate in Ewing's sarcoma.
10702401	2000	Am. J. Pathol.	0002-9440	TITLE	0	0	2313	SYMBOL|GFAM|FN|DICTIONARY	fli1	FLI1	19#23		D012512	LONGTERM|DICTIONARY	ewing sarcoma	Ewing's sarcoma	71#86		Association of EWS-FLI1 type 1 fusion with lower proliferative rate in Ewing's sarcoma.
16043121	2005	Biochem. Biophys. Res. Commun.	0006-291X	ALL_TEXT_1/3	1	2	2833	SYMBOL|DICTIONARY|EXTRACTED	cxcr3	CXCR3	116#121	16043121-1-4-38	D001249	LONGTERM|DICTIONARY	asthma	asthma	63#69		In an effort to discover polymorphisms have been implicated in asthma, we investigated the genetic polymorphisms in CXCR3 to evaluate it as a potential candidate gene for a host genetic study of asthma.
16043121	2005	Biochem. Biophys. Res. Commun.	0006-291X	ALL_TEXT_1/3	1	2	2833	SYMBOL|DICTIONARY|EXTRACTED	cxcr3	CXCR3	116#121	16043121-1-4-38	D001249	LONGTERM|DICTIONARY	asthma	asthma	195#201		In an effort to discover polymorphisms have been implicated in asthma, we investigated the genetic polymorphisms in CXCR3 to evaluate it as a potential candidate gene for a host genetic study of asthma.
20513754	2010	Toxicol. Sci.	1096-0929	ALL_TEXT_2/3	2	4	3665	SYMBOL|DICTIONARY	irf 7	IRF-7	56#61		D011014	LONGTERM|DICTIONARY	less pulmonary inflammation	less pulmonary inflammation	100#127		Two months after silica administration, both IFNAR- and IRF-7-deficient mice produced significantly less pulmonary inflammation and chemokines (KC and CCL2) than competent mice but developed similar lung fibrosis.
20513754	2010	Toxicol. Sci.	1096-0929	ALL_TEXT_2/3	2	4	3665	SYMBOL|DICTIONARY	irf 7	IRF-7	56#61		D005355	LONGTERM|DICTIONARY	fibrosis	fibrosis	204#212		Two months after silica administration, both IFNAR- and IRF-7-deficient mice produced significantly less pulmonary inflammation and chemokines (KC and CCL2) than competent mice but developed similar lung fibrosis.
20513754	2010	Toxicol. Sci.	1096-0929	ALL_TEXT_2/3	2	4	6357	SYMBOL|DICTIONARY	ccl2	CCL2	151#155		D011014	LONGTERM|DICTIONARY	less pulmonary inflammation	less pulmonary inflammation	100#127		Two months after silica administration, both IFNAR- and IRF-7-deficient mice produced significantly less pulmonary inflammation and chemokines (KC and CCL2) than competent mice but developed similar lung fibrosis.
20513754	2010	Toxicol. Sci.	1096-0929	ALL_TEXT_2/3	2	4	6357	SYMBOL|DICTIONARY	ccl2	CCL2	151#155		D005355	LONGTERM|DICTIONARY	fibrosis	fibrosis	204#212		Two months after silica administration, both IFNAR- and IRF-7-deficient mice produced significantly less pulmonary inflammation and chemokines (KC and CCL2) than competent mice but developed similar lung fibrosis.
20513754	2010	Toxicol. Sci.	1096-0929	ALL_TEXT_2/3	2	4	3454	SYMBOL|DICTIONARY	ifnar-	IFNAR-	45#51		D011014	LONGTERM|DICTIONARY	less pulmonary inflammation	less pulmonary inflammation	100#127		Two months after silica administration, both IFNAR- and IRF-7-deficient mice produced significantly less pulmonary inflammation and chemokines (KC and CCL2) than competent mice but developed similar lung fibrosis.
20513754	2010	Toxicol. Sci.	1096-0929	ALL_TEXT_2/3	2	4	3454	SYMBOL|DICTIONARY	ifnar-	IFNAR-	45#51		D005355	LONGTERM|DICTIONARY	fibrosis	fibrosis	204#212		Two months after silica administration, both IFNAR- and IRF-7-deficient mice produced significantly less pulmonary inflammation and chemokines (KC and CCL2) than competent mice but developed similar lung fibrosis.
12828656	2003	J. Periodont. Res.	0022-3484	RESULTS	3	5	4049	SYMBOL|EXTRACTED	lt alpha	LT-alpha	136#144	12828656-3-338-355	D055113	LONGTERM|DICTIONARY	chronic periodontitis	chronic periodontitis	71#92		The TNF-alpha (-308G/A) polymorphism itself showed no association with chronic periodontitis, whereas the frequency distribution of the LT-alpha (+252A/G) genotypes showed statistically significant differences between patients and the reference group.
12828656	2003	J. Periodont. Res.	0022-3484	RESULTS	3	5	7124	SYMBOL|EXTRACTED	tnf-alpha	TNF-alpha	4#13	12828656-2-0-21	D055113	LONGTERM|DICTIONARY	chronic periodontitis	chronic periodontitis	71#92		The TNF-alpha (-308G/A) polymorphism itself showed no association with chronic periodontitis, whereas the frequency distribution of the LT-alpha (+252A/G) genotypes showed statistically significant differences between patients and the reference group.
19237575	2009	Proc. Natl. Acad. Sci. U.S.A.	1091-6490	ALL_TEXT_1/3	1	2	965	SYMBOL|GENE|GN|DICTIONARY	cd58	CD58	71#75		D009103	SYMBOL|EXTRACTED	ms	MS	171#173	19237575-1-0-18	A whole genome association scan suggested that allelic variants in the CD58 gene region, encoding the costimulatory molecule LFA-3, are associated with risk of developing MS. We now report additional genetic evidence, as well as resequencing and fine mapping of the CD58 locus in patients with MS and control subjects.
19237575	2009	Proc. Natl. Acad. Sci. U.S.A.	1091-6490	ALL_TEXT_1/3	1	2	965	SYMBOL|GENE|GN|DICTIONARY	cd58	CD58	71#75		D009103	SYMBOL|EXTRACTED	ms	MS	294#296	19237575-1-0-18	A whole genome association scan suggested that allelic variants in the CD58 gene region, encoding the costimulatory molecule LFA-3, are associated with risk of developing MS. We now report additional genetic evidence, as well as resequencing and fine mapping of the CD58 locus in patients with MS and control subjects.
19237575	2009	Proc. Natl. Acad. Sci. U.S.A.	1091-6490	ALL_TEXT_1/3	1	2	965	SYMBOL|DICTIONARY	lfa 3	LFA-3	125#130		D009103	SYMBOL|EXTRACTED	ms	MS	171#173	19237575-1-0-18	A whole genome association scan suggested that allelic variants in the CD58 gene region, encoding the costimulatory molecule LFA-3, are associated with risk of developing MS. We now report additional genetic evidence, as well as resequencing and fine mapping of the CD58 locus in patients with MS and control subjects.
19237575	2009	Proc. Natl. Acad. Sci. U.S.A.	1091-6490	ALL_TEXT_1/3	1	2	965	SYMBOL|DICTIONARY	lfa 3	LFA-3	125#130		D009103	SYMBOL|EXTRACTED	ms	MS	294#296	19237575-1-0-18	A whole genome association scan suggested that allelic variants in the CD58 gene region, encoding the costimulatory molecule LFA-3, are associated with risk of developing MS. We now report additional genetic evidence, as well as resequencing and fine mapping of the CD58 locus in patients with MS and control subjects.
19237575	2009	Proc. Natl. Acad. Sci. U.S.A.	1091-6490	ALL_TEXT_1/3	1	2	965	SYMBOL|DICTIONARY	cd58	CD58	266#270		D009103	SYMBOL|EXTRACTED	ms	MS	171#173	19237575-1-0-18	A whole genome association scan suggested that allelic variants in the CD58 gene region, encoding the costimulatory molecule LFA-3, are associated with risk of developing MS. We now report additional genetic evidence, as well as resequencing and fine mapping of the CD58 locus in patients with MS and control subjects.
19237575	2009	Proc. Natl. Acad. Sci. U.S.A.	1091-6490	ALL_TEXT_1/3	1	2	965	SYMBOL|DICTIONARY	cd58	CD58	266#270		D009103	SYMBOL|EXTRACTED	ms	MS	294#296	19237575-1-0-18	A whole genome association scan suggested that allelic variants in the CD58 gene region, encoding the costimulatory molecule LFA-3, are associated with risk of developing MS. We now report additional genetic evidence, as well as resequencing and fine mapping of the CD58 locus in patients with MS and control subjects.
12010932	2002	Heart	1468-201X	CONCLUSIONS	5	8	4846	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	enos	eNOS	33#37	12010932-1-20-53	D003324	LONGTERM|DISEASE|DT|DICTIONARY	coronary artery disease	coronary artery disease	137#160		Glu298-->Asp polymorphism of the eNOS gene appears to be associated with the presence, extent, and severity of angiographically assessed coronary artery disease.
12828656	2003	J. Periodont. Res.	0022-3484	TITLE	0	0	4049	LONGTERM|DICTIONARY	lymphotoxin alpha	lymphotoxin-alpha	31#48		D055113	LONGTERM|DICTIONARY	chronic periodontitis	chronic periodontitis	123#144		Polymorphisms in the +252(A/G) lymphotoxin-alpha and the -308(A/G) tumor necrosis factor-alpha genes and susceptibility to chronic periodontitis in a Czech population.
12828656	2003	J. Periodont. Res.	0022-3484	TITLE	0	0	7124	LONGTERM|GENE|GN|DICTIONARY	tumor necrosis factor	tumor necrosis factor	67#88		D055113	LONGTERM|DICTIONARY	chronic periodontitis	chronic periodontitis	123#144		Polymorphisms in the +252(A/G) lymphotoxin-alpha and the -308(A/G) tumor necrosis factor-alpha genes and susceptibility to chronic periodontitis in a Czech population.
12828656	2003	J. Periodont. Res.	0022-3484	METHODS	2	3	7124	SYMBOL|DICTIONARY|EXTRACTED	tnf	TNF	137#140	12828656-2-0-21	D055113	LONGTERM|DICTIONARY	chronic periodontitis	chronic periodontitis	54#75		In this study, we investigated an association between chronic periodontitis and two previously described bi-allelic polymorphisms in the TNF locus: a G to A transition at position -308 in the 5'promoter region of the TNF-alpha gene and an NcoI restriction fragment length polymorphism (RFLP) in the first intron (position +252A/G) of the lymphotoxin alpha (LT-alpha) gene.
12828656	2003	J. Periodont. Res.	0022-3484	METHODS	2	3	7124	SYMBOL|GENE|GN|DICTIONARY	tnf alpha	TNF-alpha	217#226		D055113	LONGTERM|DICTIONARY	chronic periodontitis	chronic periodontitis	54#75		In this study, we investigated an association between chronic periodontitis and two previously described bi-allelic polymorphisms in the TNF locus: a G to A transition at position -308 in the 5'promoter region of the TNF-alpha gene and an NcoI restriction fragment length polymorphism (RFLP) in the first intron (position +252A/G) of the lymphotoxin alpha (LT-alpha) gene.
12828656	2003	J. Periodont. Res.	0022-3484	METHODS	2	3	4049	LONGTERM|DICTIONARY|GENE|GA	lymphotoxin alpha	lymphotoxin alpha	338#355		D055113	LONGTERM|DICTIONARY	chronic periodontitis	chronic periodontitis	54#75		In this study, we investigated an association between chronic periodontitis and two previously described bi-allelic polymorphisms in the TNF locus: a G to A transition at position -308 in the 5'promoter region of the TNF-alpha gene and an NcoI restriction fragment length polymorphism (RFLP) in the first intron (position +252A/G) of the lymphotoxin alpha (LT-alpha) gene.
12828656	2003	J. Periodont. Res.	0022-3484	METHODS	2	3	4049	SYMBOL|()|GENE|GN|DICTIONARY|EXTRACTED	lt alpha	LT-alpha	357#365	12828656-3-338-355	D055113	LONGTERM|DICTIONARY	chronic periodontitis	chronic periodontitis	54#75		In this study, we investigated an association between chronic periodontitis and two previously described bi-allelic polymorphisms in the TNF locus: a G to A transition at position -308 in the 5'promoter region of the TNF-alpha gene and an NcoI restriction fragment length polymorphism (RFLP) in the first intron (position +252A/G) of the lymphotoxin alpha (LT-alpha) gene.
11472373	2001	Br. J. Haematol.	0007-1048	TITLE	0	0	540	SYMBOL|DICTIONARY	atp7b	ATP7B	78#83		D006527	LONGTERM|DISEASE|DT|DICTIONARY	wilson disease	Wilson disease	20#34		Haemolytic onset of Wilson disease in a patient with homozygous truncation of ATP7B at Arg1319.
11472373	2001	Br. J. Haematol.	0007-1048	TITLE	0	0	540	SYMBOL|DICTIONARY	atp7b	ATP7B	78#83		D006461	LONGTERM|DICTIONARY	haemolytic	Haemolytic	0#10	NaN	Haemolytic onset of Wilson disease in a patient with homozygous truncation of ATP7B at Arg1319.
12010932	2002	Heart	1468-201X	METHODS	3	3	4846	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	enos	eNOS	127#131	12010932-1-20-53	D003324	LONGTERM|DISEASE|DT|DICTIONARY	coronary artery disease	coronary artery disease	158#181		Polymerase chain reaction/restriction fragment length polymorphism analysis was done to detect the Glu298-->Asp variant of the eNOS gene in 201 patients with coronary artery disease and 114 controls.
12010932	2002	Heart	1468-201X	BACKGROUND	1	1	4846	LONGTERM|DICTIONARY	endothelial nitric oxide synthase	endothelial nitric oxide synthase	20#53		D003324	LONGTERM|DISEASE|DT|DICTIONARY	coronary artery disease	coronary artery disease	106#129		Genetic variants of endothelial nitric oxide synthase (eNOS) could influence individual susceptibility to coronary artery disease.
12010932	2002	Heart	1468-201X	BACKGROUND	1	1	4846	SYMBOL|EXTRACTED|()	enos	eNOS	55#59	12010932-1-20-53	D003324	LONGTERM|DISEASE|DT|DICTIONARY	coronary artery disease	coronary artery disease	106#129		Genetic variants of endothelial nitric oxide synthase (eNOS) could influence individual susceptibility to coronary artery disease.
12010932	2002	Heart	1468-201X	RESULTS	4	6	4846	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	enos	eNOS	59#63	12010932-1-20-53	D003324	LONGTERM|DISEASE|DT|DICTIONARY	coronary artery disease	coronary artery disease	82#105		In comparison with subjects who had a Glu298 allele in the eNOS gene, the risk of coronary artery disease was increased among Asp/Asp carriers (odds ratio 2.9, 95% confidence interval 1.2 to 6.8, p = 0.01) and was independent of the other common risk factors (p = 0.04).
18327256	2008	Nat. Genet.	1546-1718	ALL_TEXT_3/3	3	5	56606	SYMBOL|DICTIONARY	slc2a9	SLC2A9	4#10		D006073	LONGTERM|DICTIONARY	gout	gout	76#80	NaN	The SLC2A9 genotypes also showed significant association with self-reported gout.
16320352	2006	Arthritis Rheum.	0004-3591	OBJECTIVE	1	1	26191	SYMBOL|DICTIONARY	ptpn22	PTPN22	150#156		D001327	LONGTERM|DICTIONARY	autoimmune disorders	autoimmune disorders	35#55		Analyses of families with multiple autoimmune disorders have revealed a functional polymorphism, 620W, in the intracellular tyrosine phosphatase gene PTPN22 as a predisposing factor for type 1 diabetes, seropositive rheumatoid arthritis, systemic lupus erythematosus, and Hashimoto thyroiditis, and the presence of the PTPN22 protein appears to herald the development of autoantibodies in these disorders.
16320352	2006	Arthritis Rheum.	0004-3591	OBJECTIVE	1	1	26191	SYMBOL|DICTIONARY	ptpn22	PTPN22	150#156		D001172	LONGTERM|DICTIONARY	seropositive rheumatoid arthritis	seropositive rheumatoid arthritis	203#236		Analyses of families with multiple autoimmune disorders have revealed a functional polymorphism, 620W, in the intracellular tyrosine phosphatase gene PTPN22 as a predisposing factor for type 1 diabetes, seropositive rheumatoid arthritis, systemic lupus erythematosus, and Hashimoto thyroiditis, and the presence of the PTPN22 protein appears to herald the development of autoantibodies in these disorders.
16320352	2006	Arthritis Rheum.	0004-3591	OBJECTIVE	1	1	26191	SYMBOL|DICTIONARY	ptpn22	PTPN22	150#156		D008180	LONGTERM|DICTIONARY	systemic lupus erythematosus	systemic lupus erythematosus	238#266		Analyses of families with multiple autoimmune disorders have revealed a functional polymorphism, 620W, in the intracellular tyrosine phosphatase gene PTPN22 as a predisposing factor for type 1 diabetes, seropositive rheumatoid arthritis, systemic lupus erythematosus, and Hashimoto thyroiditis, and the presence of the PTPN22 protein appears to herald the development of autoantibodies in these disorders.
16320352	2006	Arthritis Rheum.	0004-3591	OBJECTIVE	1	1	26191	SYMBOL|DICTIONARY	ptpn22	PTPN22	150#156		D003920	LONGTERM|DICTIONARY	diabetes	diabetes	193#201		Analyses of families with multiple autoimmune disorders have revealed a functional polymorphism, 620W, in the intracellular tyrosine phosphatase gene PTPN22 as a predisposing factor for type 1 diabetes, seropositive rheumatoid arthritis, systemic lupus erythematosus, and Hashimoto thyroiditis, and the presence of the PTPN22 protein appears to herald the development of autoantibodies in these disorders.
16320352	2006	Arthritis Rheum.	0004-3591	OBJECTIVE	1	1	26191	SYMBOL|GENE|GN|DICTIONARY	ptpn22	PTPN22	319#325		D001327	LONGTERM|DICTIONARY	autoimmune disorders	autoimmune disorders	35#55		Analyses of families with multiple autoimmune disorders have revealed a functional polymorphism, 620W, in the intracellular tyrosine phosphatase gene PTPN22 as a predisposing factor for type 1 diabetes, seropositive rheumatoid arthritis, systemic lupus erythematosus, and Hashimoto thyroiditis, and the presence of the PTPN22 protein appears to herald the development of autoantibodies in these disorders.
16320352	2006	Arthritis Rheum.	0004-3591	OBJECTIVE	1	1	26191	SYMBOL|GENE|GN|DICTIONARY	ptpn22	PTPN22	319#325		D001172	LONGTERM|DICTIONARY	seropositive rheumatoid arthritis	seropositive rheumatoid arthritis	203#236		Analyses of families with multiple autoimmune disorders have revealed a functional polymorphism, 620W, in the intracellular tyrosine phosphatase gene PTPN22 as a predisposing factor for type 1 diabetes, seropositive rheumatoid arthritis, systemic lupus erythematosus, and Hashimoto thyroiditis, and the presence of the PTPN22 protein appears to herald the development of autoantibodies in these disorders.
16320352	2006	Arthritis Rheum.	0004-3591	OBJECTIVE	1	1	26191	SYMBOL|GENE|GN|DICTIONARY	ptpn22	PTPN22	319#325		D008180	LONGTERM|DICTIONARY	systemic lupus erythematosus	systemic lupus erythematosus	238#266		Analyses of families with multiple autoimmune disorders have revealed a functional polymorphism, 620W, in the intracellular tyrosine phosphatase gene PTPN22 as a predisposing factor for type 1 diabetes, seropositive rheumatoid arthritis, systemic lupus erythematosus, and Hashimoto thyroiditis, and the presence of the PTPN22 protein appears to herald the development of autoantibodies in these disorders.
16320352	2006	Arthritis Rheum.	0004-3591	OBJECTIVE	1	1	26191	SYMBOL|GENE|GN|DICTIONARY	ptpn22	PTPN22	319#325		D003920	LONGTERM|DICTIONARY	diabetes	diabetes	193#201		Analyses of families with multiple autoimmune disorders have revealed a functional polymorphism, 620W, in the intracellular tyrosine phosphatase gene PTPN22 as a predisposing factor for type 1 diabetes, seropositive rheumatoid arthritis, systemic lupus erythematosus, and Hashimoto thyroiditis, and the presence of the PTPN22 protein appears to herald the development of autoantibodies in these disorders.
16320352	2006	Arthritis Rheum.	0004-3591	METHODS	2	3	26191	SYMBOL|DICTIONARY	ptpn22	PTPN22	47#53		D014890	SYMBOL|EXTRACTED	wg	WG	88#90	16320352-2-103-127	A population-based study was performed for the PTPN22 polymorphism in 199 patients with WG and in 399 healthy individuals.
16320352	2006	Arthritis Rheum.	0004-3591	OBJECTIVE	1	2	26191	SYMBOL|DICTIONARY	ptpn22	PTPN22	64#70		D014890	SYMBOL|EXTRACTED|()	wg	WG	129#131	16320352-2-103-127	This study therefore examined whether the functionally relevant PTPN22 polymorphism is associated with Wegener's granulomatosis (WG).
16320352	2006	Arthritis Rheum.	0004-3591	RESULTS	3	5	26191	SYMBOL|NUMBER|DICTIONARY	ptpn22	PTPN22	4#10		D014890	SYMBOL|DISEASE|DN|DICTIONARY|EXTRACTED	wg	WG	116#118	16320352-2-103-127	The PTPN22 620W allele frequency was significantly increased in antineutrophil cytoplasmic antibody (ANCA)-positive WG patients compared with healthy controls (P < 0.001).
11422615	2001	J. Gastroenterol. Hepatol.	0815-9319	RESULTS	3	6	2952	SYMBOL|DICTIONARY	gstt1	GSTT1	19#24		D009369	LONGTERM|DISEASE|DT|DICTIONARY	cancer	cancer	67#73		Inheritance of the GSTT1 null genotype conferred a twofold risk of cancer that was statistically significant with crude data (OR 2.18; 95% CI 1.38-3.43), but not after adjustment for age (OR 1.91; 95% CI 0.99-3.70).
16320352	2006	Arthritis Rheum.	0004-3591	CONCLUSION	4	7	26191	SYMBOL|NUMBER|DICTIONARY	ptpn22	PTPN22	4#10		D014890	SYMBOL|EXTRACTED	wg	WG	69#71	16320352-2-103-127	The PTPN22 620W allele appears to be involved in the pathogenesis of WG, and ANCA positivity seems to be the hallmark.
24211273	2014	Toxicol. Appl. Pharmacol.	1096-0333	ALL_TEXT_3/3	3	7	836	LONGTERM|DICTIONARY	caspase 3	caspase-3	58#67		D064420	LONGTERM|DICTIONARY	cytotoxicity	cytotoxicity	143#155	NaN	Synthetic cannabinoid treatment induced the activation of caspase-3, and preincubation with a caspase-3 inhibitor significantly suppressed the cytotoxicity.
24211273	2014	Toxicol. Appl. Pharmacol.	1096-0333	ALL_TEXT_3/3	3	7	836	LONGTERM|DICTIONARY	caspase 3	caspase-3	94#103		D064420	LONGTERM|DICTIONARY	cytotoxicity	cytotoxicity	143#155	NaN	Synthetic cannabinoid treatment induced the activation of caspase-3, and preincubation with a caspase-3 inhibitor significantly suppressed the cytotoxicity.
19723304	2009	BMC Med. Genet.	1471-2350	BACKGROUND	1	2	64127	SYMBOL|DICTIONARY	nod2	Nod2	111#115		D003424	LONGTERM|DISEASE|DT|DICTIONARY	crohn disease	Crohn's disease	201#216		The most significant finding in the IBD research has been identification of mutations in the gene that encodes Nod2 (nucleotide-binding oligomerization domain 2) protein in a subgroup of patients with Crohn's disease.
19723304	2009	BMC Med. Genet.	1471-2350	BACKGROUND	1	2	64127	LONGTERM|()|GENE|GN|DICTIONARY	nucleotide binding oligomerization domain 2	nucleotide-binding oligomerization domain 2	117#160		D003424	LONGTERM|DISEASE|DT|DICTIONARY	crohn disease	Crohn's disease	201#216		The most significant finding in the IBD research has been identification of mutations in the gene that encodes Nod2 (nucleotide-binding oligomerization domain 2) protein in a subgroup of patients with Crohn's disease.
11425413	2001	Lancet	0140-6736	ALL_TEXT_3/3	3	9	64127	SYMBOL|GENE|GN|DICTIONARY	nod2	NOD2	45#49		D003424	LONGTERM|DISEASE|DT|DICTIONARY	crohn disease	Crohn's disease	107#122		Interpretation The insertion mutation in the NOD2 gene confers a substantially increased susceptibility to Crohn's disease but not to ulcerative colitis.
11425413	2001	Lancet	0140-6736	ALL_TEXT_3/3	3	9	64127	SYMBOL|GENE|GN|DICTIONARY	nod2	NOD2	45#49		D003093	LONGTERM|DICTIONARY	ulcerative colitis	ulcerative colitis	134#152		Interpretation The insertion mutation in the NOD2 gene confers a substantially increased susceptibility to Crohn's disease but not to ulcerative colitis.
19723304	2009	BMC Med. Genet.	1471-2350	TITLE	0	0	10392	SYMBOL|GENE|GN|DICTIONARY	nod1	NOD1	48#52		D003093	LONGTERM|DISEASE|DN|DICTIONARY	ulcerative colitis	ulcerative colitis	61#79		Frequency of single nucleotide polymorphisms in NOD1 gene of ulcerative colitis patients: a case-control study in the Indian population.
16802107	2007	J. Inherit. Metab. Dis.	1573-2665	ALL_TEXT_1/3	1	3	256933	SYMBOL|DICTIONARY	npb	NPB	191#194		C535727	LONGTERM|DICTIONARY	hepatosplenomegaly	hepatosplenomegaly	20#38		Autopsy findings of hepatosplenomegaly, lymphadenopathy and ceroid-rich foam cells raised the suspicion of the visceral form of acid sphingomyelinase deficiency (Niemann-Pick disease type B; NPB) or a much rarer disorder, variant adult visceral form of Niemann-Pick disease type C (NPC).
16802107	2007	J. Inherit. Metab. Dis.	1573-2665	ALL_TEXT_1/3	1	3	256933	SYMBOL|DICTIONARY	npb	NPB	191#194		D052537	LONGTERM|DISEASE|DT|GFAM|FN|DICTIONARY	niemann-pick disease type b	Niemann-Pick disease type B	162#189		Autopsy findings of hepatosplenomegaly, lymphadenopathy and ceroid-rich foam cells raised the suspicion of the visceral form of acid sphingomyelinase deficiency (Niemann-Pick disease type B; NPB) or a much rarer disorder, variant adult visceral form of Niemann-Pick disease type C (NPC).
16802107	2007	J. Inherit. Metab. Dis.	1573-2665	ALL_TEXT_1/3	1	3	256933	SYMBOL|DICTIONARY	npb	NPB	191#194		D052556	LONGTERM|DISEASE|DT|GFAM|FN|DICTIONARY	niemann-pick disease type c	Niemann-Pick disease type C	253#280		Autopsy findings of hepatosplenomegaly, lymphadenopathy and ceroid-rich foam cells raised the suspicion of the visceral form of acid sphingomyelinase deficiency (Niemann-Pick disease type B; NPB) or a much rarer disorder, variant adult visceral form of Niemann-Pick disease type C (NPC).
16802107	2007	J. Inherit. Metab. Dis.	1573-2665	ALL_TEXT_1/3	1	3	256933	SYMBOL|DICTIONARY	npb	NPB	191#194		D008206	LONGTERM|DICTIONARY	lymphadenopathy	lymphadenopathy	40#55	NaN	Autopsy findings of hepatosplenomegaly, lymphadenopathy and ceroid-rich foam cells raised the suspicion of the visceral form of acid sphingomyelinase deficiency (Niemann-Pick disease type B; NPB) or a much rarer disorder, variant adult visceral form of Niemann-Pick disease type C (NPC).
16802107	2007	J. Inherit. Metab. Dis.	1573-2665	ALL_TEXT_1/3	1	3	256933	SYMBOL|DICTIONARY	npb	NPB	191#194		D030342	LONGTERM|DICTIONARY	rarer disorder	rarer disorder	206#220	NaN	Autopsy findings of hepatosplenomegaly, lymphadenopathy and ceroid-rich foam cells raised the suspicion of the visceral form of acid sphingomyelinase deficiency (Niemann-Pick disease type B; NPB) or a much rarer disorder, variant adult visceral form of Niemann-Pick disease type C (NPC).
20570322	2010	Gynecol. Oncol.	1095-6859	CONCLUSIONS	4	13	672	SYMBOL|DICTIONARY	brca1	BRCA1	73#78		D005185	LONGTERM|DISEASE|DT|DICTIONARY	fallopian tube cancer	fallopian tube cancer	32#53		Approximately 30% of women with fallopian tube cancer have a mutation in BRCA1 or BRCA2.
20570322	2010	Gynecol. Oncol.	1095-6859	CONCLUSIONS	4	13	675	SYMBOL|DICTIONARY	brca2	BRCA2	82#87		D005185	LONGTERM|DISEASE|DT|DICTIONARY	fallopian tube cancer	fallopian tube cancer	32#53		Approximately 30% of women with fallopian tube cancer have a mutation in BRCA1 or BRCA2.
20522430	2010	J. Med. Genet.	1468-6244	ALL_TEXT_1/3	1	1	6323	SYMBOL|DICTIONARY	scn1a	SCN1A	24#29		D012640	LONGTERM|DICTIONARY	febrile seizures	febrile seizures	62#78		BACKGROUND Mutations in SCN1A can cause genetic epilepsy with febrile seizures plus (GEFS+, inherited missense mutations) or Dravet syndrome (DS, de novo mutations of all types).
20522430	2010	J. Med. Genet.	1468-6244	ALL_TEXT_1/3	1	1	6323	SYMBOL|DICTIONARY	scn1a	SCN1A	24#29		D004831	LONGTERM|DISEASE|DT|DICTIONARY	dravet syndrome	Dravet syndrome	125#140		BACKGROUND Mutations in SCN1A can cause genetic epilepsy with febrile seizures plus (GEFS+, inherited missense mutations) or Dravet syndrome (DS, de novo mutations of all types).
20522430	2010	J. Med. Genet.	1468-6244	ALL_TEXT_1/3	1	1	6323	SYMBOL|DICTIONARY	scn1a	SCN1A	24#29		D030342	LONGTERM|DICTIONARY	genetic epilepsy	genetic epilepsy	40#56		BACKGROUND Mutations in SCN1A can cause genetic epilepsy with febrile seizures plus (GEFS+, inherited missense mutations) or Dravet syndrome (DS, de novo mutations of all types).
20522430	2010	J. Med. Genet.	1468-6244	TITLE	0	0	6323	SYMBOL|DICTIONARY	scn1a	SCN1A	50#55		D004831	LONGTERM|DISEASE|DT|DICTIONARY	dravet syndrome	Dravet syndrome	74#89		Mechanisms for variable expressivity of inherited SCN1A mutations causing Dravet syndrome.
21966470	2012	PLoS ONE	1932-6203	ALL_TEXT_2/3	2	3	4204	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	mecp2	MeCP2	41#46		D015518	SYMBOL|DICTIONARY|EXTRACTED	rtt	RTT	177#180	21966470-1-0-13	These include the identification of many MeCP2 target genes, better understanding of the neurobiological consequences of the loss- or mis-function of MeCP2, and drug testing in RTT mice and clinical trials in human RTT patients.
21966470	2012	PLoS ONE	1932-6203	ALL_TEXT_2/3	2	3	4204	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	mecp2	MeCP2	41#46		D015518	SYMBOL|DISEASE|DN|DICTIONARY|EXTRACTED	rtt	RTT	215#218	21966470-1-0-13	These include the identification of many MeCP2 target genes, better understanding of the neurobiological consequences of the loss- or mis-function of MeCP2, and drug testing in RTT mice and clinical trials in human RTT patients.
21966470	2012	PLoS ONE	1932-6203	ALL_TEXT_2/3	2	3	4204	SYMBOL|DICTIONARY|EXTRACTED	mecp2	MeCP2	150#155		D015518	SYMBOL|DICTIONARY|EXTRACTED	rtt	RTT	177#180	21966470-1-0-13	These include the identification of many MeCP2 target genes, better understanding of the neurobiological consequences of the loss- or mis-function of MeCP2, and drug testing in RTT mice and clinical trials in human RTT patients.
21966470	2012	PLoS ONE	1932-6203	ALL_TEXT_2/3	2	3	4204	SYMBOL|DICTIONARY|EXTRACTED	mecp2	MeCP2	150#155		D015518	SYMBOL|DISEASE|DN|DICTIONARY|EXTRACTED	rtt	RTT	215#218	21966470-1-0-13	These include the identification of many MeCP2 target genes, better understanding of the neurobiological consequences of the loss- or mis-function of MeCP2, and drug testing in RTT mice and clinical trials in human RTT patients.
20522430	2010	J. Med. Genet.	1468-6244	ALL_TEXT_1/3	1	2	6323	SYMBOL|DICTIONARY	scn1a	SCN1A	124#129		D004831	SYMBOL|DISEASE|DN|DICTIONARY	ds	DS	94#96		Although the mutational spectra are distinct, these disorders share major features and 10% of DS patients have an inherited SCN1A mutation.
12498973	2003	Neurobiol. Aging	0197-4580	ALL_TEXT_3/3	3	7	3383	SYMBOL|DICTIONARY|EXTRACTED	icam 1	ICAM-1	59#65	12498973-2-0-33	D000544	SYMBOL|EXTRACTED	ad	AD	92#94	12498973-1-71-90	This study shows for the first time an association between ICAM-1 E/K gene polymorphism and AD, suggesting that polymorphisms of the ICAM-1 gene may be clinically important and confirming that inflammatory mechanisms may be crucial in the pathophysiology of neuro-degenerative diseases.
12498973	2003	Neurobiol. Aging	0197-4580	ALL_TEXT_3/3	3	7	3383	SYMBOL|DICTIONARY|EXTRACTED	icam 1	ICAM-1	59#65	12498973-2-0-33	D019636	LONGTERM|DICTIONARY	neuro-degenerative diseases	neuro-degenerative diseases	258#285		This study shows for the first time an association between ICAM-1 E/K gene polymorphism and AD, suggesting that polymorphisms of the ICAM-1 gene may be clinically important and confirming that inflammatory mechanisms may be crucial in the pathophysiology of neuro-degenerative diseases.
12498973	2003	Neurobiol. Aging	0197-4580	ALL_TEXT_3/3	3	7	3383	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	icam 1	ICAM-1	133#139	12498973-2-0-33	D000544	SYMBOL|EXTRACTED	ad	AD	92#94	12498973-1-71-90	This study shows for the first time an association between ICAM-1 E/K gene polymorphism and AD, suggesting that polymorphisms of the ICAM-1 gene may be clinically important and confirming that inflammatory mechanisms may be crucial in the pathophysiology of neuro-degenerative diseases.
12498973	2003	Neurobiol. Aging	0197-4580	ALL_TEXT_3/3	3	7	3383	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	icam 1	ICAM-1	133#139	12498973-2-0-33	D019636	LONGTERM|DICTIONARY	neuro-degenerative diseases	neuro-degenerative diseases	258#285		This study shows for the first time an association between ICAM-1 E/K gene polymorphism and AD, suggesting that polymorphisms of the ICAM-1 gene may be clinically important and confirming that inflammatory mechanisms may be crucial in the pathophysiology of neuro-degenerative diseases.
12498973	2003	Neurobiol. Aging	0197-4580	ALL_TEXT_2/3	2	4	3383	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	icam 1	ICAM-1	94#100	12498973-2-0-33	D000544	SYMBOL|EXTRACTED	ad	AD	142#144	12498973-1-71-90	In this case-control study, we evaluated the distribution of E/K alleles and genotypes of the ICAM-1 gene in 98 patients affected by sporadic AD and 115 age- and sex-matched controls.
12498973	2003	Neurobiol. Aging	0197-4580	ALL_TEXT_1/3	1	2	3383	LONGTERM|DICTIONARY	intercellular adhesion molecule 1	Intercellular adhesion molecule-1	0#33		D058225	LONGTERM|DICTIONARY	neuritic plaques	neuritic plaques	169#185		Intercellular adhesion molecule-1 (ICAM-1) is an important mediator of inflammatory response and immune cell activation, is expressed on cerebrovascular endothelium and neuritic plaques in brain of AD patients, and seems to be implicated in the process of neuro-degeneration.
12498973	2003	Neurobiol. Aging	0197-4580	ALL_TEXT_1/3	1	2	3383	LONGTERM|DICTIONARY	intercellular adhesion molecule 1	Intercellular adhesion molecule-1	0#33		D000544	SYMBOL|DISEASE|DN|DICTIONARY|EXTRACTED	ad	AD	198#200	12498973-1-71-90	Intercellular adhesion molecule-1 (ICAM-1) is an important mediator of inflammatory response and immune cell activation, is expressed on cerebrovascular endothelium and neuritic plaques in brain of AD patients, and seems to be implicated in the process of neuro-degeneration.
12498973	2003	Neurobiol. Aging	0197-4580	ALL_TEXT_1/3	1	2	3383	LONGTERM|DICTIONARY	intercellular adhesion molecule 1	Intercellular adhesion molecule-1	0#33		D009410	LONGTERM|DICTIONARY	neuro-degeneration	neuro-degeneration	256#274	NaN	Intercellular adhesion molecule-1 (ICAM-1) is an important mediator of inflammatory response and immune cell activation, is expressed on cerebrovascular endothelium and neuritic plaques in brain of AD patients, and seems to be implicated in the process of neuro-degeneration.
12498973	2003	Neurobiol. Aging	0197-4580	ALL_TEXT_1/3	1	2	3383	SYMBOL|()|DICTIONARY|EXTRACTED	icam 1	ICAM-1	35#41	12498973-2-0-33	D058225	LONGTERM|DICTIONARY	neuritic plaques	neuritic plaques	169#185		Intercellular adhesion molecule-1 (ICAM-1) is an important mediator of inflammatory response and immune cell activation, is expressed on cerebrovascular endothelium and neuritic plaques in brain of AD patients, and seems to be implicated in the process of neuro-degeneration.
12498973	2003	Neurobiol. Aging	0197-4580	ALL_TEXT_1/3	1	2	3383	SYMBOL|()|DICTIONARY|EXTRACTED	icam 1	ICAM-1	35#41	12498973-2-0-33	D000544	SYMBOL|DISEASE|DN|DICTIONARY|EXTRACTED	ad	AD	198#200	12498973-1-71-90	Intercellular adhesion molecule-1 (ICAM-1) is an important mediator of inflammatory response and immune cell activation, is expressed on cerebrovascular endothelium and neuritic plaques in brain of AD patients, and seems to be implicated in the process of neuro-degeneration.
12498973	2003	Neurobiol. Aging	0197-4580	ALL_TEXT_1/3	1	2	3383	SYMBOL|()|DICTIONARY|EXTRACTED	icam 1	ICAM-1	35#41	12498973-2-0-33	D009410	LONGTERM|DICTIONARY	neuro-degeneration	neuro-degeneration	256#274	NaN	Intercellular adhesion molecule-1 (ICAM-1) is an important mediator of inflammatory response and immune cell activation, is expressed on cerebrovascular endothelium and neuritic plaques in brain of AD patients, and seems to be implicated in the process of neuro-degeneration.
12498973	2003	Neurobiol. Aging	0197-4580	TITLE	0	0	3383	LONGTERM|DICTIONARY	intercellular adhesion molecule 1	Intercellular adhesion molecule-1	0#33		D000544	LONGTERM|DISEASE|DT|DICTIONARY	alzheimer disease	Alzheimer's disease	62#81		Intercellular adhesion molecule-1 K469E gene polymorphism and Alzheimer's disease.
14974362	2004	Pol. Merkur. Lekarski	1426-9686	ALL_TEXT_3/3	3	6	1636	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	ace	ACE	113#116	14974362-3-275-304	D005921	SYMBOL|EXTRACTED	gn	GN	38#40	14974362-3-143-161	Among 50 patients with early stage of GN the distribution of genotypes and alleles depending on the polymorphism ACE gene was significantly different from 100 healthy controls.
15939053	2005	Atherosclerosis	0021-9150	TITLE	0	0	1071	SYMBOL|DICTIONARY|EXTRACTED	cetp	CETP	0#4		D002318	LONGTERM|DISEASE|DT|DICTIONARY	cardiovascular disease	cardiovascular disease	89#111		CETP polymorphisms associated with HDL cholesterol may differ from those associated with cardiovascular disease.
15189946	2004	Chest	0012-3692	STUDY OBJECTIVES	1	1	7124	LONGTERM|GENE|GT|DICTIONARY	tumor necrosis factor	Tumor necrosis factor	0#21		D006333	LONGTERM|DICTIONARY	heart failure	heart failure	80#93		Tumor necrosis factor (TNF)-alpha has been implicated in the pathophysiology of heart failure.
15189946	2004	Chest	0012-3692	STUDY OBJECTIVES	1	1	7124	SYMBOL|EXTRACTED|()	tnf)-alpha	TNF)-alpha	23#33	15189946-1-0-21	D006333	LONGTERM|DICTIONARY	heart failure	heart failure	80#93		Tumor necrosis factor (TNF)-alpha has been implicated in the pathophysiology of heart failure.
15189946	2004	Chest	0012-3692	STUDY OBJECTIVES	1	2	3586	SYMBOL|DICTIONARY	il 10	IL-10	74#79		D012770	LONGTERM|DICTIONARY	cardiogenic shock	cardiogenic shock	216#233	NaN	We explored a possible association between TNF-alpha, interleukin (IL)-6, IL-10, transforming growth factor (TGF)-beta, and interferon (IFN)-gamma cytokine polymorphisms, their in vivo production, and mortality from cardiogenic shock.
15189946	2004	Chest	0012-3692	STUDY OBJECTIVES	1	2	7124	SYMBOL|EXTRACTED	tnf-alpha	TNF-alpha	43#52	15189946-1-0-21	D012770	LONGTERM|DICTIONARY	cardiogenic shock	cardiogenic shock	216#233	NaN	We explored a possible association between TNF-alpha, interleukin (IL)-6, IL-10, transforming growth factor (TGF)-beta, and interferon (IFN)-gamma cytokine polymorphisms, their in vivo production, and mortality from cardiogenic shock.
15189946	2004	Chest	0012-3692	STUDY OBJECTIVES	1	2	3569	SYMBOL|DICTIONARY	interleukin (il)-6	interleukin (IL)-6	54#72		D012770	LONGTERM|DICTIONARY	cardiogenic shock	cardiogenic shock	216#233	NaN	We explored a possible association between TNF-alpha, interleukin (IL)-6, IL-10, transforming growth factor (TGF)-beta, and interferon (IFN)-gamma cytokine polymorphisms, their in vivo production, and mortality from cardiogenic shock.
15189946	2004	Chest	0012-3692	STUDY OBJECTIVES	1	2	3458	LONGTERM|DICTIONARY	interferon (ifn)-gamma	interferon (IFN)-gamma	124#146	NaN	D012770	LONGTERM|DICTIONARY	cardiogenic shock	cardiogenic shock	216#233	NaN	We explored a possible association between TNF-alpha, interleukin (IL)-6, IL-10, transforming growth factor (TGF)-beta, and interferon (IFN)-gamma cytokine polymorphisms, their in vivo production, and mortality from cardiogenic shock.
20020061	2010	PLoS ONE	1932-6203	METHODOLOGY/PRINCIPAL FINDINGS	2	7	3845	SYMBOL|DICTIONARY	kras	KRAS	23#27		D009369	LONGTERM|DICTIONARY	primary tumors	primary tumors	54#68		A higher percentage of KRAS mutations was detected in primary tumors of patiens with lung metastases than in patients with liver metastases (59% vs 32%; p = 0.054).
20020061	2010	PLoS ONE	1932-6203	METHODOLOGY/PRINCIPAL FINDINGS	2	7	3845	SYMBOL|DICTIONARY	kras	KRAS	23#27		D009362	LONGTERM|DICTIONARY	metastases	metastases	90#100		A higher percentage of KRAS mutations was detected in primary tumors of patiens with lung metastases than in patients with liver metastases (59% vs 32%; p = 0.054).
20020061	2010	PLoS ONE	1932-6203	METHODOLOGY/PRINCIPAL FINDINGS	2	7	3845	SYMBOL|DICTIONARY	kras	KRAS	23#27		D009362	LONGTERM|DICTIONARY	metastases	metastases	129#139		A higher percentage of KRAS mutations was detected in primary tumors of patiens with lung metastases than in patients with liver metastases (59% vs 32%; p = 0.054).
16416283	2007	J. Cancer Res. Clin. Oncol.	0171-5216	RESULTS	3	6	1543	SYMBOL|NUMBER|DICTIONARY|EXTRACTED	cyp1a1	CYP1A1	0#6		D002294	SYMBOL|EXTRACTED|DISEASE|DN	scc	SCC	68#71	16416283-2-180-203	CYP1A1*2(+)/GSTM1(-) combined genotypes were overrepresented in the SCC patients (14/70, 20.0%) and underrepresented in the ED (19/246, 7.7%) as compared to the intermediate prevalence in the HD (26/204, 12.7%); the adjusted OR for SCC versus ED reached 3.85 (95% CI=1.43-10.33).
16416283	2007	J. Cancer Res. Clin. Oncol.	0171-5216	RESULTS	3	6	1543	SYMBOL|NUMBER|DICTIONARY|EXTRACTED	cyp1a1	CYP1A1	0#6		D002294	SYMBOL|EXTRACTED	scc	SCC	232#235	16416283-2-180-203	CYP1A1*2(+)/GSTM1(-) combined genotypes were overrepresented in the SCC patients (14/70, 20.0%) and underrepresented in the ED (19/246, 7.7%) as compared to the intermediate prevalence in the HD (26/204, 12.7%); the adjusted OR for SCC versus ED reached 3.85 (95% CI=1.43-10.33).
16416283	2007	J. Cancer Res. Clin. Oncol.	0171-5216	RESULTS	3	6	1543	SYMBOL|NUMBER|DICTIONARY|EXTRACTED	cyp1a1	CYP1A1	0#6		C536181	LONGTERM|DICTIONARY	ed	ED	124#126	NaN	CYP1A1*2(+)/GSTM1(-) combined genotypes were overrepresented in the SCC patients (14/70, 20.0%) and underrepresented in the ED (19/246, 7.7%) as compared to the intermediate prevalence in the HD (26/204, 12.7%); the adjusted OR for SCC versus ED reached 3.85 (95% CI=1.43-10.33).
16416283	2007	J. Cancer Res. Clin. Oncol.	0171-5216	RESULTS	3	6	1543	SYMBOL|NUMBER|DICTIONARY|EXTRACTED	cyp1a1	CYP1A1	0#6		C536181	LONGTERM|DICTIONARY	ed	ED	243#245	NaN	CYP1A1*2(+)/GSTM1(-) combined genotypes were overrepresented in the SCC patients (14/70, 20.0%) and underrepresented in the ED (19/246, 7.7%) as compared to the intermediate prevalence in the HD (26/204, 12.7%); the adjusted OR for SCC versus ED reached 3.85 (95% CI=1.43-10.33).
16416283	2007	J. Cancer Res. Clin. Oncol.	0171-5216	RESULTS	3	6	2944	SYMBOL|DICTIONARY	gstm1	GSTM1	12#17		D002294	SYMBOL|EXTRACTED|DISEASE|DN	scc	SCC	68#71	16416283-2-180-203	CYP1A1*2(+)/GSTM1(-) combined genotypes were overrepresented in the SCC patients (14/70, 20.0%) and underrepresented in the ED (19/246, 7.7%) as compared to the intermediate prevalence in the HD (26/204, 12.7%); the adjusted OR for SCC versus ED reached 3.85 (95% CI=1.43-10.33).
16416283	2007	J. Cancer Res. Clin. Oncol.	0171-5216	RESULTS	3	6	2944	SYMBOL|DICTIONARY	gstm1	GSTM1	12#17		D002294	SYMBOL|EXTRACTED	scc	SCC	232#235	16416283-2-180-203	CYP1A1*2(+)/GSTM1(-) combined genotypes were overrepresented in the SCC patients (14/70, 20.0%) and underrepresented in the ED (19/246, 7.7%) as compared to the intermediate prevalence in the HD (26/204, 12.7%); the adjusted OR for SCC versus ED reached 3.85 (95% CI=1.43-10.33).
16416283	2007	J. Cancer Res. Clin. Oncol.	0171-5216	RESULTS	3	6	2944	SYMBOL|DICTIONARY	gstm1	GSTM1	12#17		C536181	LONGTERM|DICTIONARY	ed	ED	124#126	NaN	CYP1A1*2(+)/GSTM1(-) combined genotypes were overrepresented in the SCC patients (14/70, 20.0%) and underrepresented in the ED (19/246, 7.7%) as compared to the intermediate prevalence in the HD (26/204, 12.7%); the adjusted OR for SCC versus ED reached 3.85 (95% CI=1.43-10.33).
16416283	2007	J. Cancer Res. Clin. Oncol.	0171-5216	RESULTS	3	6	2944	SYMBOL|DICTIONARY	gstm1	GSTM1	12#17		C536181	LONGTERM|DICTIONARY	ed	ED	243#245	NaN	CYP1A1*2(+)/GSTM1(-) combined genotypes were overrepresented in the SCC patients (14/70, 20.0%) and underrepresented in the ED (19/246, 7.7%) as compared to the intermediate prevalence in the HD (26/204, 12.7%); the adjusted OR for SCC versus ED reached 3.85 (95% CI=1.43-10.33).
16416283	2007	J. Cancer Res. Clin. Oncol.	0171-5216	CONCLUSIONS	4	7	1543	SYMBOL|DICTIONARY|EXTRACTED	cyp1a1	CYP1A1	82#88	16416283-1-50-69	D002294	SYMBOL|EXTRACTED	scc	SCC	120#123	16416283-2-180-203	In agreement with some literature data, our results support the concerted role of CYP1A1 and GSTM1 at-risk genotypes in SCC predisposition.
16416283	2007	J. Cancer Res. Clin. Oncol.	0171-5216	CONCLUSIONS	4	7	2944	SYMBOL|DICTIONARY	gstm1	GSTM1	93#98		D002294	SYMBOL|EXTRACTED	scc	SCC	120#123	16416283-2-180-203	In agreement with some literature data, our results support the concerted role of CYP1A1 and GSTM1 at-risk genotypes in SCC predisposition.
16416283	2007	J. Cancer Res. Clin. Oncol.	0171-5216	METHODS	2	4	1543	SYMBOL|DICTIONARY|EXTRACTED	cyp1a1	CYP1A1	32#38	16416283-1-50-69	D008175	SYMBOL|EXTRACTED|DISEASE|DN	lc	LC	62#64	16416283-2-142-153	We compared the distribution of CYP1A1 and GSTM1 genotypes in LC patients (n=141), healthy donors (HD, n=204), and elderly tumor-free smokers and non-smokers (ED, n=246).
16416283	2007	J. Cancer Res. Clin. Oncol.	0171-5216	METHODS	2	4	1543	SYMBOL|DICTIONARY|EXTRACTED	cyp1a1	CYP1A1	32#38	16416283-1-50-69	D009369	LONGTERM|DISEASE|DT|DICTIONARY	tumor	tumor	123#128		We compared the distribution of CYP1A1 and GSTM1 genotypes in LC patients (n=141), healthy donors (HD, n=204), and elderly tumor-free smokers and non-smokers (ED, n=246).
16416283	2007	J. Cancer Res. Clin. Oncol.	0171-5216	METHODS	2	4	1543	SYMBOL|DICTIONARY|EXTRACTED	cyp1a1	CYP1A1	32#38	16416283-1-50-69	C536181	LONGTERM|DICTIONARY	ed	ED	159#161	NaN	We compared the distribution of CYP1A1 and GSTM1 genotypes in LC patients (n=141), healthy donors (HD, n=204), and elderly tumor-free smokers and non-smokers (ED, n=246).
16416283	2007	J. Cancer Res. Clin. Oncol.	0171-5216	METHODS	2	4	2944	SYMBOL|DICTIONARY	gstm1	GSTM1	43#48		D008175	SYMBOL|EXTRACTED|DISEASE|DN	lc	LC	62#64	16416283-2-142-153	We compared the distribution of CYP1A1 and GSTM1 genotypes in LC patients (n=141), healthy donors (HD, n=204), and elderly tumor-free smokers and non-smokers (ED, n=246).
16416283	2007	J. Cancer Res. Clin. Oncol.	0171-5216	METHODS	2	4	2944	SYMBOL|DICTIONARY	gstm1	GSTM1	43#48		D009369	LONGTERM|DISEASE|DT|DICTIONARY	tumor	tumor	123#128		We compared the distribution of CYP1A1 and GSTM1 genotypes in LC patients (n=141), healthy donors (HD, n=204), and elderly tumor-free smokers and non-smokers (ED, n=246).
16416283	2007	J. Cancer Res. Clin. Oncol.	0171-5216	METHODS	2	4	2944	SYMBOL|DICTIONARY	gstm1	GSTM1	43#48		C536181	LONGTERM|DICTIONARY	ed	ED	159#161	NaN	We compared the distribution of CYP1A1 and GSTM1 genotypes in LC patients (n=141), healthy donors (HD, n=204), and elderly tumor-free smokers and non-smokers (ED, n=246).
16416283	2007	J. Cancer Res. Clin. Oncol.	0171-5216	RESULTS	3	5	1543	SYMBOL|NUMBER|DICTIONARY|EXTRACTED	cyp1a1	CYP1A1	0#6		D002294	SYMBOL|EXTRACTED	scc	SCC	67#70	16416283-2-180-203	CYP1A1*2 allele carriers demonstrated a clear-cut association with SCC: the adjusted odds ratios (OR) were 2.22 (95% CI=1.06-4.63) and 2.27 (95% CI=1.14-4.52) when HD and ED were used as referents, respectively.
16416283	2007	J. Cancer Res. Clin. Oncol.	0171-5216	RESULTS	3	5	1543	SYMBOL|NUMBER|DICTIONARY|EXTRACTED	cyp1a1	CYP1A1	0#6		C536181	LONGTERM|DICTIONARY	ed	ED	171#173	NaN	CYP1A1*2 allele carriers demonstrated a clear-cut association with SCC: the adjusted odds ratios (OR) were 2.22 (95% CI=1.06-4.63) and 2.27 (95% CI=1.14-4.52) when HD and ED were used as referents, respectively.
16416283	2007	J. Cancer Res. Clin. Oncol.	0171-5216	PURPOSE	1	2	1543	SYMBOL|DICTIONARY|EXTRACTED	cyp1a1	CYP1A1	59#65	16416283-1-50-69	D008175	LONGTERM|DISEASE|DT|DICTIONARY	lung cancer	lung cancer	142#153		Therefore, it is expected that a combination of proficient CYP1A1 genotype with deficient GSTM1 variant would result in particularly elevated lung cancer (LC) risk, especially for squamous cell carcinoma (SCC).
16416283	2007	J. Cancer Res. Clin. Oncol.	0171-5216	PURPOSE	1	2	1543	SYMBOL|DICTIONARY|EXTRACTED	cyp1a1	CYP1A1	59#65	16416283-1-50-69	D008175	SYMBOL|EXTRACTED|()	lc	LC	155#157	16416283-2-142-153	Therefore, it is expected that a combination of proficient CYP1A1 genotype with deficient GSTM1 variant would result in particularly elevated lung cancer (LC) risk, especially for squamous cell carcinoma (SCC).
16416283	2007	J. Cancer Res. Clin. Oncol.	0171-5216	PURPOSE	1	2	1543	SYMBOL|DICTIONARY|EXTRACTED	cyp1a1	CYP1A1	59#65	16416283-1-50-69	D002294	LONGTERM|DISEASE|DT|DICTIONARY	squamous cell carcinoma	squamous cell carcinoma	180#203		Therefore, it is expected that a combination of proficient CYP1A1 genotype with deficient GSTM1 variant would result in particularly elevated lung cancer (LC) risk, especially for squamous cell carcinoma (SCC).
16416283	2007	J. Cancer Res. Clin. Oncol.	0171-5216	PURPOSE	1	2	1543	SYMBOL|DICTIONARY|EXTRACTED	cyp1a1	CYP1A1	59#65	16416283-1-50-69	D002294	SYMBOL|EXTRACTED|()	scc	SCC	205#208	16416283-2-180-203	Therefore, it is expected that a combination of proficient CYP1A1 genotype with deficient GSTM1 variant would result in particularly elevated lung cancer (LC) risk, especially for squamous cell carcinoma (SCC).
16416283	2007	J. Cancer Res. Clin. Oncol.	0171-5216	PURPOSE	1	2	2944	SYMBOL|DICTIONARY	gstm1	GSTM1	90#95		D008175	LONGTERM|DISEASE|DT|DICTIONARY	lung cancer	lung cancer	142#153		Therefore, it is expected that a combination of proficient CYP1A1 genotype with deficient GSTM1 variant would result in particularly elevated lung cancer (LC) risk, especially for squamous cell carcinoma (SCC).
16416283	2007	J. Cancer Res. Clin. Oncol.	0171-5216	PURPOSE	1	2	2944	SYMBOL|DICTIONARY	gstm1	GSTM1	90#95		D008175	SYMBOL|EXTRACTED|()	lc	LC	155#157	16416283-2-142-153	Therefore, it is expected that a combination of proficient CYP1A1 genotype with deficient GSTM1 variant would result in particularly elevated lung cancer (LC) risk, especially for squamous cell carcinoma (SCC).
16416283	2007	J. Cancer Res. Clin. Oncol.	0171-5216	PURPOSE	1	2	2944	SYMBOL|DICTIONARY	gstm1	GSTM1	90#95		D002294	LONGTERM|DISEASE|DT|DICTIONARY	squamous cell carcinoma	squamous cell carcinoma	180#203		Therefore, it is expected that a combination of proficient CYP1A1 genotype with deficient GSTM1 variant would result in particularly elevated lung cancer (LC) risk, especially for squamous cell carcinoma (SCC).
16416283	2007	J. Cancer Res. Clin. Oncol.	0171-5216	PURPOSE	1	2	2944	SYMBOL|DICTIONARY	gstm1	GSTM1	90#95		D002294	SYMBOL|EXTRACTED|()	scc	SCC	205#208	16416283-2-180-203	Therefore, it is expected that a combination of proficient CYP1A1 genotype with deficient GSTM1 variant would result in particularly elevated lung cancer (LC) risk, especially for squamous cell carcinoma (SCC).
16416283	2007	J. Cancer Res. Clin. Oncol.	0171-5216	TITLE	0	0	1543	SYMBOL|DICTIONARY|EXTRACTED	cyp1a1	CYP1A1	9#15		D002294	LONGTERM|DISEASE|DN|DT|DICTIONARY	squamous cell lung carcinoma	squamous cell lung carcinoma	63#91		Combined CYP1A1/GSTM1 at-risk genotypes are overrepresented in squamous cell lung carcinoma patients but underrepresented in elderly tumor-free subjects.
16416283	2007	J. Cancer Res. Clin. Oncol.	0171-5216	TITLE	0	0	1543	SYMBOL|DICTIONARY|EXTRACTED	cyp1a1	CYP1A1	9#15		D009369	LONGTERM|DISEASE|DT|DICTIONARY	tumor	tumor	133#138		Combined CYP1A1/GSTM1 at-risk genotypes are overrepresented in squamous cell lung carcinoma patients but underrepresented in elderly tumor-free subjects.
16416283	2007	J. Cancer Res. Clin. Oncol.	0171-5216	TITLE	0	0	2944	SYMBOL|DICTIONARY	gstm1	GSTM1	16#21		D002294	LONGTERM|DISEASE|DN|DT|DICTIONARY	squamous cell lung carcinoma	squamous cell lung carcinoma	63#91		Combined CYP1A1/GSTM1 at-risk genotypes are overrepresented in squamous cell lung carcinoma patients but underrepresented in elderly tumor-free subjects.
16416283	2007	J. Cancer Res. Clin. Oncol.	0171-5216	TITLE	0	0	2944	SYMBOL|DICTIONARY	gstm1	GSTM1	16#21		D009369	LONGTERM|DISEASE|DT|DICTIONARY	tumor	tumor	133#138		Combined CYP1A1/GSTM1 at-risk genotypes are overrepresented in squamous cell lung carcinoma patients but underrepresented in elderly tumor-free subjects.
15048896	2004	Ann. Neurol.	0364-5134	ALL_TEXT_3/3	3	9	348	SYMBOL|DICTIONARY|EXTRACTED	apoe	APOE	195#199	15048896-1-0-16	D009103	SYMBOL|DISEASE|DN|DICTIONARY|EXTRACTED	ms	MS	178#180	15048896-1-83-101	Accelerated brain tissue loss and a higher proportion of lesions evolving into BH therefore provide magnetic resonance imaging evidence for more pronounced tissue destruction in MS patients with APOE-epsilon4.
15958759	2005	Ann. Rheum. Dis.	0003-4967	RESULTS	4	6	4210	SYMBOL|DICTIONARY	mefv	MEFV	70#74		D001172	SYMBOL|EXTRACTED	ra	RA	26#28	15958759-2-60-80	17/98 (17%) patients with RA (all women) were heterozygous for common MEFV mutations, predominantly E148Q (12 patients), and one patient was homozygous for the V726A mutation.
18803945	2008	Metab. Clin. Exp.	1532-8600	ALL_TEXT_1/3	1	1	19	SYMBOL|()|GENE|GN|DICTIONARY	abca1	ABCA1	71#76		D050197	LONGTERM|DICTIONARY	atherosclerosis	atherosclerosis	188#203		Variants in the adenosine triphosphate-binding-cassette transporter 1 (ABCA1) gene are known to affect high-density lipoprotein cholesterol and plasma triglycerides and the development of atherosclerosis.
15958759	2005	Ann. Rheum. Dis.	0003-4967	METHODS	3	3	4210	SYMBOL|DICTIONARY	mefv	MEFV	39#43		D001172	SYMBOL|EXTRACTED	ra	RA	123#125	15958759-2-60-80	The frequency of the three most common MEFV mutations: M694V, V726A, and E148Q, was determined in 98 Israeli patients with RA (74 women, 24 men) and compared with that in 100 healthy subjects matched for origin.
16318816	2007	Zhonghua Wai Ke Za Zhi	0529-5815	CONCLUSIONS	4	9	2944	SYMBOL|DICTIONARY	gstm1	GSTM1	0#5		D011471	SYMBOL|EXTRACTED	pc	PC	140#142	16318816-1-183-198	GSTM1 [null] genotype was also related to the stage and grade, which may be helpful in determining the risk of locally disease and advanced PC.
16318816	2007	Zhonghua Wai Ke Za Zhi	0529-5815	CONCLUSIONS	4	8	2944	SYMBOL|DICTIONARY	gstm1	GSTM1	0#5		D011471	LONGTERM|DISEASE|DT|DICTIONARY	prostate cancer	prostate cancer	39#54		GSTM1 [null] genotype may be linked to prostate cancer risk in Chinese population.
20467232	2010	Tohoku J. Exp. Med.	1349-3329	ALL_TEXT_1/3	1	2	217	SYMBOL|GENE|GN|DICTIONARY	aldh2	ALDH2	42#47		D009203	LONGTERM|DICTIONARY	acute myocardial infarction	acute myocardial infarction	157#184		The G-to-A polymorphism in exon 12 of the ALDH2 gene, which causes Glu-to-Lys substitution at codon 504, has been shown to be an independent risk factor for acute myocardial infarction (AMI).
20467232	2010	Tohoku J. Exp. Med.	1349-3329	ALL_TEXT_1/3	1	2	217	SYMBOL|GENE|GN|DICTIONARY	aldh2	ALDH2	42#47		D009203	SYMBOL|()|DICTIONARY|EXTRACTED	ami	AMI	186#189	20467232-2-157-184	The G-to-A polymorphism in exon 12 of the ALDH2 gene, which causes Glu-to-Lys substitution at codon 504, has been shown to be an independent risk factor for acute myocardial infarction (AMI).
20207535	2010	Eur. J. Cancer	1879-0852	ALL_TEXT_1/3	1	4	2944	SYMBOL|DICTIONARY	gstm1	GSTM1	37#42		D015179	LONGTERM|DISEASE|DT|DICTIONARY	colorectal cancer	colorectal cancer	51#68		Forty-four studies were eligible for GSTM1 (11,998 colorectal cancer cases, 17,552 controls), 34 studies for GSTT1 (8596 cases, 13,589 controls), 19 studies for GSTP1 (5421 cases, 7671 controls) and four studies for GSTA1 polymorphism (1648 cases, 2039 controls).
20207535	2010	Eur. J. Cancer	1879-0852	ALL_TEXT_1/3	1	4	2952	SYMBOL|DICTIONARY	gstt1	GSTT1	109#114		D015179	LONGTERM|DISEASE|DT|DICTIONARY	colorectal cancer	colorectal cancer	51#68		Forty-four studies were eligible for GSTM1 (11,998 colorectal cancer cases, 17,552 controls), 34 studies for GSTT1 (8596 cases, 13,589 controls), 19 studies for GSTP1 (5421 cases, 7671 controls) and four studies for GSTA1 polymorphism (1648 cases, 2039 controls).
20207535	2010	Eur. J. Cancer	1879-0852	ALL_TEXT_1/3	1	4	2950	SYMBOL|DICTIONARY	gstp1	GSTP1	161#166		D015179	LONGTERM|DISEASE|DT|DICTIONARY	colorectal cancer	colorectal cancer	51#68		Forty-four studies were eligible for GSTM1 (11,998 colorectal cancer cases, 17,552 controls), 34 studies for GSTT1 (8596 cases, 13,589 controls), 19 studies for GSTP1 (5421 cases, 7671 controls) and four studies for GSTA1 polymorphism (1648 cases, 2039 controls).
20207535	2010	Eur. J. Cancer	1879-0852	ALL_TEXT_1/3	1	4	2938	SYMBOL|DICTIONARY	gsta1	GSTA1	216#221		D015179	LONGTERM|DISEASE|DT|DICTIONARY	colorectal cancer	colorectal cancer	51#68		Forty-four studies were eligible for GSTM1 (11,998 colorectal cancer cases, 17,552 controls), 34 studies for GSTT1 (8596 cases, 13,589 controls), 19 studies for GSTP1 (5421 cases, 7671 controls) and four studies for GSTA1 polymorphism (1648 cases, 2039 controls).
16932953	2007	Eur. J. Clin. Pharmacol.	0031-6970	OBJECTIVE	1	5	5243	SYMBOL|GENE|GN|DICTIONARY	mdr1	MDR1	63#67		D001172	SYMBOL|DISEASE|DN|DICTIONARY|EXTRACTED	ra	RA	105#107	16932953-1-0-20	The aim of this study was to examine the effect of the 3435C>T MDR1 gene polymorphism on the efficacy of RA treatment with disease-modifying antirheumatic drugs, i.e.
16318816	2007	Zhonghua Wai Ke Za Zhi	0529-5815	OBJECTIVE	1	1	1543	SYMBOL|DICTIONARY|EXTRACTED	cyp1a1	CYP1A1	104#110	16318816-1-104-110	D011471	LONGTERM|DISEASE|DT|DICTIONARY	prostate cancer	prostate cancer	183#198		To study the possible relationship between the single nucleotide polymorphism (SNP) of cytochrome P-450 CYP1A1 (CYP1A1) m1, m2 and GSTM1 [null] genotype and genetic susceptibility to prostate cancer (PC).
16318816	2007	Zhonghua Wai Ke Za Zhi	0529-5815	OBJECTIVE	1	1	1543	SYMBOL|DICTIONARY|EXTRACTED	cyp1a1	CYP1A1	104#110	16318816-1-104-110	D011471	SYMBOL|EXTRACTED|()	pc	PC	200#202	16318816-1-183-198	To study the possible relationship between the single nucleotide polymorphism (SNP) of cytochrome P-450 CYP1A1 (CYP1A1) m1, m2 and GSTM1 [null] genotype and genetic susceptibility to prostate cancer (PC).
16318816	2007	Zhonghua Wai Ke Za Zhi	0529-5815	OBJECTIVE	1	1	1543	SYMBOL|()|DICTIONARY|EXTRACTED	cyp1a1	CYP1A1	112#118	16318816-1-104-110	D011471	LONGTERM|DISEASE|DT|DICTIONARY	prostate cancer	prostate cancer	183#198		To study the possible relationship between the single nucleotide polymorphism (SNP) of cytochrome P-450 CYP1A1 (CYP1A1) m1, m2 and GSTM1 [null] genotype and genetic susceptibility to prostate cancer (PC).
16318816	2007	Zhonghua Wai Ke Za Zhi	0529-5815	OBJECTIVE	1	1	1543	SYMBOL|()|DICTIONARY|EXTRACTED	cyp1a1	CYP1A1	112#118	16318816-1-104-110	D011471	SYMBOL|EXTRACTED|()	pc	PC	200#202	16318816-1-183-198	To study the possible relationship between the single nucleotide polymorphism (SNP) of cytochrome P-450 CYP1A1 (CYP1A1) m1, m2 and GSTM1 [null] genotype and genetic susceptibility to prostate cancer (PC).
16318816	2007	Zhonghua Wai Ke Za Zhi	0529-5815	OBJECTIVE	1	1	2944	SYMBOL|DICTIONARY	gstm1	GSTM1	131#136		D011471	LONGTERM|DISEASE|DT|DICTIONARY	prostate cancer	prostate cancer	183#198		To study the possible relationship between the single nucleotide polymorphism (SNP) of cytochrome P-450 CYP1A1 (CYP1A1) m1, m2 and GSTM1 [null] genotype and genetic susceptibility to prostate cancer (PC).
16318816	2007	Zhonghua Wai Ke Za Zhi	0529-5815	OBJECTIVE	1	1	2944	SYMBOL|DICTIONARY	gstm1	GSTM1	131#136		D011471	SYMBOL|EXTRACTED|()	pc	PC	200#202	16318816-1-183-198	To study the possible relationship between the single nucleotide polymorphism (SNP) of cytochrome P-450 CYP1A1 (CYP1A1) m1, m2 and GSTM1 [null] genotype and genetic susceptibility to prostate cancer (PC).
16318816	2007	Zhonghua Wai Ke Za Zhi	0529-5815	OBJECTIVE	1	1	1543	LONGTERM|DICTIONARY	cytochrome p-450 cyp1a1	cytochrome P-450 CYP1A1	87#110		D011471	LONGTERM|DISEASE|DT|DICTIONARY	prostate cancer	prostate cancer	183#198		To study the possible relationship between the single nucleotide polymorphism (SNP) of cytochrome P-450 CYP1A1 (CYP1A1) m1, m2 and GSTM1 [null] genotype and genetic susceptibility to prostate cancer (PC).
16318816	2007	Zhonghua Wai Ke Za Zhi	0529-5815	OBJECTIVE	1	1	1543	LONGTERM|DICTIONARY	cytochrome p-450 cyp1a1	cytochrome P-450 CYP1A1	87#110		D011471	SYMBOL|EXTRACTED|()	pc	PC	200#202	16318816-1-183-198	To study the possible relationship between the single nucleotide polymorphism (SNP) of cytochrome P-450 CYP1A1 (CYP1A1) m1, m2 and GSTM1 [null] genotype and genetic susceptibility to prostate cancer (PC).
20467232	2010	Tohoku J. Exp. Med.	1349-3329	ALL_TEXT_3/3	3	8	217	SYMBOL|GENE|GN|DICTIONARY	aldh2	ALDH2	22#27		D009203	SYMBOL|DICTIONARY|EXTRACTED	ami	AMI	108#111	20467232-2-157-184	Thus, the A allele in ALDH2 gene is associated with the elevated plasma levels of hs-CRP after the onset of AMI, suggesting a higher susceptibility of the myocardium to ischemic injuries.
20467232	2010	Tohoku J. Exp. Med.	1349-3329	ALL_TEXT_3/3	3	8	217	SYMBOL|GENE|GN|DICTIONARY	aldh2	ALDH2	22#27		D007511	LONGTERM|DICTIONARY	ischemic injuries	ischemic injuries	169#186	NaN	Thus, the A allele in ALDH2 gene is associated with the elevated plasma levels of hs-CRP after the onset of AMI, suggesting a higher susceptibility of the myocardium to ischemic injuries.
20020061	2010	PLoS ONE	1932-6203	BACKGROUND	1	1	3845	SYMBOL|DICTIONARY	kras	KRAS	0#4		D015179	LONGTERM|DISEASE|DT|DICTIONARY	colorectal cancer	colorectal cancer	18#35		KRAS mutations in colorectal cancer primary tumors predict resistance to anti-Epidermal Growth Factor Receptor (EGFR) monoclonal antibody therapy in patients with metastatic colorectal cancer, and thus represent a true indicator of EGFR pathway activation status.
20020061	2010	PLoS ONE	1932-6203	BACKGROUND	1	1	3845	SYMBOL|DICTIONARY	kras	KRAS	0#4		D015179	LONGTERM|DICTIONARY	colorectal cancer primary tumors	colorectal cancer primary tumors	18#50		KRAS mutations in colorectal cancer primary tumors predict resistance to anti-Epidermal Growth Factor Receptor (EGFR) monoclonal antibody therapy in patients with metastatic colorectal cancer, and thus represent a true indicator of EGFR pathway activation status.
20020061	2010	PLoS ONE	1932-6203	BACKGROUND	1	1	3845	SYMBOL|DICTIONARY	kras	KRAS	0#4		D015179	LONGTERM|DISEASE|DT|DICTIONARY	colorectal cancer	colorectal cancer	174#191		KRAS mutations in colorectal cancer primary tumors predict resistance to anti-Epidermal Growth Factor Receptor (EGFR) monoclonal antibody therapy in patients with metastatic colorectal cancer, and thus represent a true indicator of EGFR pathway activation status.
20020061	2010	PLoS ONE	1932-6203	BACKGROUND	1	1	1956	LONGTERM|GENE|GT|DICTIONARY	epidermal growth factor receptor	Epidermal Growth Factor Receptor	78#110		D015179	LONGTERM|DISEASE|DT|DICTIONARY	colorectal cancer	colorectal cancer	18#35		KRAS mutations in colorectal cancer primary tumors predict resistance to anti-Epidermal Growth Factor Receptor (EGFR) monoclonal antibody therapy in patients with metastatic colorectal cancer, and thus represent a true indicator of EGFR pathway activation status.
20020061	2010	PLoS ONE	1932-6203	BACKGROUND	1	1	1956	LONGTERM|GENE|GT|DICTIONARY	epidermal growth factor receptor	Epidermal Growth Factor Receptor	78#110		D015179	LONGTERM|DICTIONARY	colorectal cancer primary tumors	colorectal cancer primary tumors	18#50		KRAS mutations in colorectal cancer primary tumors predict resistance to anti-Epidermal Growth Factor Receptor (EGFR) monoclonal antibody therapy in patients with metastatic colorectal cancer, and thus represent a true indicator of EGFR pathway activation status.
20020061	2010	PLoS ONE	1932-6203	BACKGROUND	1	1	1956	LONGTERM|GENE|GT|DICTIONARY	epidermal growth factor receptor	Epidermal Growth Factor Receptor	78#110		D015179	LONGTERM|DISEASE|DT|DICTIONARY	colorectal cancer	colorectal cancer	174#191		KRAS mutations in colorectal cancer primary tumors predict resistance to anti-Epidermal Growth Factor Receptor (EGFR) monoclonal antibody therapy in patients with metastatic colorectal cancer, and thus represent a true indicator of EGFR pathway activation status.
16318816	2007	Zhonghua Wai Ke Za Zhi	0529-5815	RESULTS	3	7	1543	SYMBOL|DICTIONARY|EXTRACTED	cyp1a1	CYP1A1	84#90	16318816-1-104-110	D011471	LONGTERM|DISEASE|DN|DT|DICTIONARY	prostate cancer	prostate cancer	113#128		There were no significant differences in the frequent distribution of two locate of CYP1A1 polymorphisms between prostate cancer patients and healthy controls (P > 0.05).
11799476	2002	Am. J. Hum. Genet.	0002-9297	ALL_TEXT_3/3	3	3	55997	SYMBOL|GENE|GN|DICTIONARY	cfc1	CFC1	20#24		D006331	LONGTERM|DICTIONARY	cardiac disorders	cardiac disorders	53#70		Our analysis of the CFC1 gene in patients with these cardiac disorders identified two disease-related mutations in 86 patients.
11799476	2002	Am. J. Hum. Genet.	0002-9297	ALL_TEXT_2/3	2	2	55997	SYMBOL|DICTIONARY	cfc1	CFC1	225#229		D006331	LONGTERM|DISEASE|DT|DICTIONARY	congenital heart disease	congenital heart disease	64#88		We hypothesized that a subset of patients with similar types of congenital heart disease---namely, transposition of the great arteries and double-outlet right ventricle, in the absence of laterality defects---would also have CFC1 mutations.
11799476	2002	Am. J. Hum. Genet.	0002-9297	ALL_TEXT_2/3	2	2	55997	SYMBOL|DICTIONARY	cfc1	CFC1	225#229		D014188	LONGTERM|DICTIONARY	transposition of the great arteries	transposition of the great arteries	99#134		We hypothesized that a subset of patients with similar types of congenital heart disease---namely, transposition of the great arteries and double-outlet right ventricle, in the absence of laterality defects---would also have CFC1 mutations.
11799476	2002	Am. J. Hum. Genet.	0002-9297	ALL_TEXT_2/3	2	2	55997	SYMBOL|DICTIONARY	cfc1	CFC1	225#229		D004310	LONGTERM|DICTIONARY	double-outlet	double-outlet	139#152		We hypothesized that a subset of patients with similar types of congenital heart disease---namely, transposition of the great arteries and double-outlet right ventricle, in the absence of laterality defects---would also have CFC1 mutations.
11799476	2002	Am. J. Hum. Genet.	0002-9297	ALL_TEXT_1/3	1	1	55997	SYMBOL|DICTIONARY	cfc1	CFC1	46#50		D059446	LONGTERM|DISEASE|DT|DICTIONARY	heterotaxy syndrome	heterotaxy syndrome	78#97		Recent investigations identified heterozygous CFC1 mutations in subjects with heterotaxy syndrome, all of whom had congenital cardiac malformations, including malposition of the great arteries.
11799476	2002	Am. J. Hum. Genet.	0002-9297	ALL_TEXT_1/3	1	1	55997	SYMBOL|DICTIONARY	cfc1	CFC1	46#50		D006331	LONGTERM|DICTIONARY	congenital cardiac malformations	congenital cardiac malformations	115#147		Recent investigations identified heterozygous CFC1 mutations in subjects with heterotaxy syndrome, all of whom had congenital cardiac malformations, including malposition of the great arteries.
11799476	2002	Am. J. Hum. Genet.	0002-9297	TITLE	0	0	55997	SYMBOL|DICTIONARY	cfc1	CFC1	0#4		D014188	LONGTERM|DICTIONARY	transposition of the great arteries	transposition of the great arteries	32#67		CFC1 mutations in patients with transposition of the great arteries and double-outlet right ventricle.
11799476	2002	Am. J. Hum. Genet.	0002-9297	TITLE	0	0	55997	SYMBOL|DICTIONARY	cfc1	CFC1	0#4		D004310	LONGTERM|DICTIONARY	double-outlet	double-outlet	72#85		CFC1 mutations in patients with transposition of the great arteries and double-outlet right ventricle.
14650112	2004	Isr. Med. Assoc. J.	1565-1088	OBJECTIVES	2	3	154	LONGTERM|DICTIONARY	beta 2ar	beta 2AR	51#59	NaN	D001249	LONGTERM|DICTIONARY	asthma	asthma	98#104		To investigate non-anglosaxic ethnic influences on beta 2AR polymorphisms and its correlations to asthma severity.
12355549	2002	Environ. Mol. Mutagen.	0893-6692	ALL_TEXT_1/3	1	2	9	SYMBOL|DICTIONARY|EXTRACTED	nat1	NAT1	60#64	12355549-1-0-21	D011471	LONGTERM|DISEASE|DT|DICTIONARY	prostate cancer	prostate cancer	112#127		We investigated the association of genetic polymorphisms in NAT1 and NAT2, alone and in combination, with human prostate cancer.
12355549	2002	Environ. Mol. Mutagen.	0893-6692	ALL_TEXT_1/3	1	2	10	SYMBOL|DICTIONARY|EXTRACTED	nat2	NAT2	69#73	12355549-1-33-54	D011471	LONGTERM|DISEASE|DT|DICTIONARY	prostate cancer	prostate cancer	112#127		We investigated the association of genetic polymorphisms in NAT1 and NAT2, alone and in combination, with human prostate cancer.
15228651	2004	Zhongguo Shi Yan Xue Ye Xue Za Zhi	1009-2137	ALL_TEXT_1/3	1	1	3105	SYMBOL|DICTIONARY	hla-a, -b, -drb1	HLA-A, -B, -DRB1	129#145		D006086	LONGTERM|DISEASE|DT|DICTIONARY	acute graft versus host disease	acute graft versus host disease	34#65		To explore a method of predicting acute graft versus host disease (aGVHD) after unrelated cord blood transplantation (UCBT), the HLA-A, -B, -DRB1 molecular three-dimensional structures in 25 patients with blood disorder who underwent UCBT and their donors were modeled by using molecular modeling technique.
15228651	2004	Zhongguo Shi Yan Xue Ye Xue Za Zhi	1009-2137	ALL_TEXT_1/3	1	1	3105	SYMBOL|DICTIONARY	hla-a, -b, -drb1	HLA-A, -B, -DRB1	129#145		D006086	SYMBOL|EXTRACTED|()	agvhd	aGVHD	67#72	15228651-1-34-65	To explore a method of predicting acute graft versus host disease (aGVHD) after unrelated cord blood transplantation (UCBT), the HLA-A, -B, -DRB1 molecular three-dimensional structures in 25 patients with blood disorder who underwent UCBT and their donors were modeled by using molecular modeling technique.
15228651	2004	Zhongguo Shi Yan Xue Ye Xue Za Zhi	1009-2137	ALL_TEXT_1/3	1	1	3105	SYMBOL|DICTIONARY	hla-a, -b, -drb1	HLA-A, -B, -DRB1	129#145		D025861	LONGTERM|DISEASE|DT|DICTIONARY	blood disorder	blood disorder	205#219		To explore a method of predicting acute graft versus host disease (aGVHD) after unrelated cord blood transplantation (UCBT), the HLA-A, -B, -DRB1 molecular three-dimensional structures in 25 patients with blood disorder who underwent UCBT and their donors were modeled by using molecular modeling technique.
15228651	2004	Zhongguo Shi Yan Xue Ye Xue Za Zhi	1009-2137	ALL_TEXT_1/3	1	1	3106	SYMBOL|DICTIONARY	hla-a, -b, -drb1	HLA-A, -B, -DRB1	129#145		D006086	LONGTERM|DISEASE|DT|DICTIONARY	acute graft versus host disease	acute graft versus host disease	34#65		To explore a method of predicting acute graft versus host disease (aGVHD) after unrelated cord blood transplantation (UCBT), the HLA-A, -B, -DRB1 molecular three-dimensional structures in 25 patients with blood disorder who underwent UCBT and their donors were modeled by using molecular modeling technique.
15228651	2004	Zhongguo Shi Yan Xue Ye Xue Za Zhi	1009-2137	ALL_TEXT_1/3	1	1	3106	SYMBOL|DICTIONARY	hla-a, -b, -drb1	HLA-A, -B, -DRB1	129#145		D006086	SYMBOL|EXTRACTED|()	agvhd	aGVHD	67#72	15228651-1-34-65	To explore a method of predicting acute graft versus host disease (aGVHD) after unrelated cord blood transplantation (UCBT), the HLA-A, -B, -DRB1 molecular three-dimensional structures in 25 patients with blood disorder who underwent UCBT and their donors were modeled by using molecular modeling technique.
15228651	2004	Zhongguo Shi Yan Xue Ye Xue Za Zhi	1009-2137	ALL_TEXT_1/3	1	1	3106	SYMBOL|DICTIONARY	hla-a, -b, -drb1	HLA-A, -B, -DRB1	129#145		D025861	LONGTERM|DISEASE|DT|DICTIONARY	blood disorder	blood disorder	205#219		To explore a method of predicting acute graft versus host disease (aGVHD) after unrelated cord blood transplantation (UCBT), the HLA-A, -B, -DRB1 molecular three-dimensional structures in 25 patients with blood disorder who underwent UCBT and their donors were modeled by using molecular modeling technique.
15228651	2004	Zhongguo Shi Yan Xue Ye Xue Za Zhi	1009-2137	ALL_TEXT_1/3	1	1	3123	SYMBOL|DICTIONARY	hla-a, -b, -drb1	HLA-A, -B, -DRB1	129#145		D006086	LONGTERM|DISEASE|DT|DICTIONARY	acute graft versus host disease	acute graft versus host disease	34#65		To explore a method of predicting acute graft versus host disease (aGVHD) after unrelated cord blood transplantation (UCBT), the HLA-A, -B, -DRB1 molecular three-dimensional structures in 25 patients with blood disorder who underwent UCBT and their donors were modeled by using molecular modeling technique.
15228651	2004	Zhongguo Shi Yan Xue Ye Xue Za Zhi	1009-2137	ALL_TEXT_1/3	1	1	3123	SYMBOL|DICTIONARY	hla-a, -b, -drb1	HLA-A, -B, -DRB1	129#145		D006086	SYMBOL|EXTRACTED|()	agvhd	aGVHD	67#72	15228651-1-34-65	To explore a method of predicting acute graft versus host disease (aGVHD) after unrelated cord blood transplantation (UCBT), the HLA-A, -B, -DRB1 molecular three-dimensional structures in 25 patients with blood disorder who underwent UCBT and their donors were modeled by using molecular modeling technique.
15228651	2004	Zhongguo Shi Yan Xue Ye Xue Za Zhi	1009-2137	ALL_TEXT_1/3	1	1	3123	SYMBOL|DICTIONARY	hla-a, -b, -drb1	HLA-A, -B, -DRB1	129#145		D025861	LONGTERM|DISEASE|DT|DICTIONARY	blood disorder	blood disorder	205#219		To explore a method of predicting acute graft versus host disease (aGVHD) after unrelated cord blood transplantation (UCBT), the HLA-A, -B, -DRB1 molecular three-dimensional structures in 25 patients with blood disorder who underwent UCBT and their donors were modeled by using molecular modeling technique.
15228651	2004	Zhongguo Shi Yan Xue Ye Xue Za Zhi	1009-2137	ALL_TEXT_1/3	1	1	3105	SYMBOL|DICTIONARY	hla-a, -b, -drb1	HLA-A, -B, -DRB1	129#145		D006086	LONGTERM|DISEASE|DT|DICTIONARY	acute graft versus host disease	acute graft versus host disease	34#65		To explore a method of predicting acute graft versus host disease (aGVHD) after unrelated cord blood transplantation (UCBT), the HLA-A, -B, -DRB1 molecular three-dimensional structures in 25 patients with blood disorder who underwent UCBT and their donors were modeled by using molecular modeling technique.
15228651	2004	Zhongguo Shi Yan Xue Ye Xue Za Zhi	1009-2137	ALL_TEXT_1/3	1	1	3105	SYMBOL|DICTIONARY	hla-a, -b, -drb1	HLA-A, -B, -DRB1	129#145		D006086	SYMBOL|EXTRACTED|()	agvhd	aGVHD	67#72	15228651-1-34-65	To explore a method of predicting acute graft versus host disease (aGVHD) after unrelated cord blood transplantation (UCBT), the HLA-A, -B, -DRB1 molecular three-dimensional structures in 25 patients with blood disorder who underwent UCBT and their donors were modeled by using molecular modeling technique.
15228651	2004	Zhongguo Shi Yan Xue Ye Xue Za Zhi	1009-2137	ALL_TEXT_1/3	1	1	3105	SYMBOL|DICTIONARY	hla-a, -b, -drb1	HLA-A, -B, -DRB1	129#145		D025861	LONGTERM|DISEASE|DT|DICTIONARY	blood disorder	blood disorder	205#219		To explore a method of predicting acute graft versus host disease (aGVHD) after unrelated cord blood transplantation (UCBT), the HLA-A, -B, -DRB1 molecular three-dimensional structures in 25 patients with blood disorder who underwent UCBT and their donors were modeled by using molecular modeling technique.
15228651	2004	Zhongguo Shi Yan Xue Ye Xue Za Zhi	1009-2137	ALL_TEXT_1/3	1	1	3106	SYMBOL|DICTIONARY	hla-a, -b, -drb1	HLA-A, -B, -DRB1	129#145		D006086	LONGTERM|DISEASE|DT|DICTIONARY	acute graft versus host disease	acute graft versus host disease	34#65		To explore a method of predicting acute graft versus host disease (aGVHD) after unrelated cord blood transplantation (UCBT), the HLA-A, -B, -DRB1 molecular three-dimensional structures in 25 patients with blood disorder who underwent UCBT and their donors were modeled by using molecular modeling technique.
15228651	2004	Zhongguo Shi Yan Xue Ye Xue Za Zhi	1009-2137	ALL_TEXT_1/3	1	1	3106	SYMBOL|DICTIONARY	hla-a, -b, -drb1	HLA-A, -B, -DRB1	129#145		D006086	SYMBOL|EXTRACTED|()	agvhd	aGVHD	67#72	15228651-1-34-65	To explore a method of predicting acute graft versus host disease (aGVHD) after unrelated cord blood transplantation (UCBT), the HLA-A, -B, -DRB1 molecular three-dimensional structures in 25 patients with blood disorder who underwent UCBT and their donors were modeled by using molecular modeling technique.
15228651	2004	Zhongguo Shi Yan Xue Ye Xue Za Zhi	1009-2137	ALL_TEXT_1/3	1	1	3106	SYMBOL|DICTIONARY	hla-a, -b, -drb1	HLA-A, -B, -DRB1	129#145		D025861	LONGTERM|DISEASE|DT|DICTIONARY	blood disorder	blood disorder	205#219		To explore a method of predicting acute graft versus host disease (aGVHD) after unrelated cord blood transplantation (UCBT), the HLA-A, -B, -DRB1 molecular three-dimensional structures in 25 patients with blood disorder who underwent UCBT and their donors were modeled by using molecular modeling technique.
15228651	2004	Zhongguo Shi Yan Xue Ye Xue Za Zhi	1009-2137	ALL_TEXT_1/3	1	1	3123	SYMBOL|DICTIONARY	hla-a, -b, -drb1	HLA-A, -B, -DRB1	129#145		D006086	LONGTERM|DISEASE|DT|DICTIONARY	acute graft versus host disease	acute graft versus host disease	34#65		To explore a method of predicting acute graft versus host disease (aGVHD) after unrelated cord blood transplantation (UCBT), the HLA-A, -B, -DRB1 molecular three-dimensional structures in 25 patients with blood disorder who underwent UCBT and their donors were modeled by using molecular modeling technique.
15228651	2004	Zhongguo Shi Yan Xue Ye Xue Za Zhi	1009-2137	ALL_TEXT_1/3	1	1	3123	SYMBOL|DICTIONARY	hla-a, -b, -drb1	HLA-A, -B, -DRB1	129#145		D006086	SYMBOL|EXTRACTED|()	agvhd	aGVHD	67#72	15228651-1-34-65	To explore a method of predicting acute graft versus host disease (aGVHD) after unrelated cord blood transplantation (UCBT), the HLA-A, -B, -DRB1 molecular three-dimensional structures in 25 patients with blood disorder who underwent UCBT and their donors were modeled by using molecular modeling technique.
15228651	2004	Zhongguo Shi Yan Xue Ye Xue Za Zhi	1009-2137	ALL_TEXT_1/3	1	1	3123	SYMBOL|DICTIONARY	hla-a, -b, -drb1	HLA-A, -B, -DRB1	129#145		D025861	LONGTERM|DISEASE|DT|DICTIONARY	blood disorder	blood disorder	205#219		To explore a method of predicting acute graft versus host disease (aGVHD) after unrelated cord blood transplantation (UCBT), the HLA-A, -B, -DRB1 molecular three-dimensional structures in 25 patients with blood disorder who underwent UCBT and their donors were modeled by using molecular modeling technique.
20020061	2010	PLoS ONE	1932-6203	METHODOLOGY/PRINCIPAL FINDINGS	2	5	3845	SYMBOL|DICTIONARY	kras	KRAS	13#17		D009369	LONGTERM|DICTIONARY	primary tumors	primary tumors	47#61		Mutations in KRAS were observed in 37 (34%) of primary tumors and in 40 (36%) of related metastases, yielding a 94% level of concordance (kappa index 0.86).
20020061	2010	PLoS ONE	1932-6203	METHODOLOGY/PRINCIPAL FINDINGS	2	5	3845	SYMBOL|DICTIONARY	kras	KRAS	13#17		D009362	LONGTERM|DICTIONARY	metastases	metastases	89#99		Mutations in KRAS were observed in 37 (34%) of primary tumors and in 40 (36%) of related metastases, yielding a 94% level of concordance (kappa index 0.86).
11709213	2002	J. Inorg. Biochem.	0162-0134	ALL_TEXT_3/3	3	3	4852	SYMBOL|DICTIONARY|EXTRACTED	npy	NPY	29#32	11709213-1-0-14	D000544	LONGTERM|DISEASE|DT|DICTIONARY	alzheimer disease	Alzheimer's disease	152#171		During the last two decades, NPY body fluid concentrations and NPY/PYY brain receptor numbers have been demonstrated to be altered during the course of Alzheimer's disease.
11709213	2002	J. Inorg. Biochem.	0162-0134	ALL_TEXT_3/3	3	3	4852	SYMBOL|DICTIONARY|EXTRACTED	npy	NPY	63#66	11709213-1-0-14	D000544	LONGTERM|DISEASE|DT|DICTIONARY	alzheimer disease	Alzheimer's disease	152#171		During the last two decades, NPY body fluid concentrations and NPY/PYY brain receptor numbers have been demonstrated to be altered during the course of Alzheimer's disease.
11709213	2002	J. Inorg. Biochem.	0162-0134	ALL_TEXT_3/3	3	3	5697	SYMBOL|DICTIONARY|EXTRACTED	pyy	PYY	67#70	11709213-1-25-35	D000544	LONGTERM|DISEASE|DT|DICTIONARY	alzheimer disease	Alzheimer's disease	152#171		During the last two decades, NPY body fluid concentrations and NPY/PYY brain receptor numbers have been demonstrated to be altered during the course of Alzheimer's disease.
15375002	2004	Cancer Res.	0008-5472	ALL_TEXT_2/3	2	5	9628	SYMBOL|DICTIONARY	rgs6	RGS6	44#48		D001749	LONGTERM|DISEASE|DT|DICTIONARY	bladder cancer	bladder cancer	132#146		When the SNPs were analyzed separately, the RGS6-rs2074647 (C-->T) polymorphism conferred the greatest overall reduction in risk of bladder cancer (odds ratio, 0.66; 95% confidence interval, 0.46-0.95).
11709213	2002	J. Inorg. Biochem.	0162-0134	TITLE	0	0	5697	LONGTERM|DICTIONARY	peptide yy	peptide YY	16#26		D000544	LONGTERM|DISEASE|DT|DICTIONARY	alzheimer disease	Alzheimer's disease	43#62		Neuropeptide Y, peptide YY and aluminum in Alzheimer's disease: is there an etiological relationship?
14695540	2004	Hum. Mutat.	1098-1004	ALL_TEXT_1/3	1	1	2200	LONGTERM|DICTIONARY	fibrillin 1	fibrillin-1	105#116		D008382	LONGTERM|DISEASE|DT|DICTIONARY	marfan syndrome	Marfan syndrome	0#15		Marfan syndrome (MFS) is a disorder of the extracellular matrix caused by mutations in the gene encoding fibrillin-1 (FBN1).
14695540	2004	Hum. Mutat.	1098-1004	ALL_TEXT_1/3	1	1	2200	LONGTERM|DICTIONARY	fibrillin 1	fibrillin-1	105#116		D008382	SYMBOL|()|DICTIONARY|EXTRACTED	mfs	MFS	17#20	14695540-1-0-15	Marfan syndrome (MFS) is a disorder of the extracellular matrix caused by mutations in the gene encoding fibrillin-1 (FBN1).
14695540	2004	Hum. Mutat.	1098-1004	ALL_TEXT_1/3	1	1	2200	SYMBOL|()|DICTIONARY|EXTRACTED	fbn1	FBN1	118#122	14695540-1-105-116	D008382	LONGTERM|DISEASE|DT|DICTIONARY	marfan syndrome	Marfan syndrome	0#15		Marfan syndrome (MFS) is a disorder of the extracellular matrix caused by mutations in the gene encoding fibrillin-1 (FBN1).
14695540	2004	Hum. Mutat.	1098-1004	ALL_TEXT_1/3	1	1	2200	SYMBOL|()|DICTIONARY|EXTRACTED	fbn1	FBN1	118#122	14695540-1-105-116	D008382	SYMBOL|()|DICTIONARY|EXTRACTED	mfs	MFS	17#20	14695540-1-0-15	Marfan syndrome (MFS) is a disorder of the extracellular matrix caused by mutations in the gene encoding fibrillin-1 (FBN1).
17961231	2008	BMC Neurol	1471-2377	BACKGROUND	1	2	5274	LONGTERM|DICTIONARY	neuroserpin	neuroserpin	41#52	NaN	D002544	LONGTERM|DICTIONARY	ischemic stroke	ischemic stroke	81#96		We sought to evaluate the association of neuroserpin polymorphisms with risk for ischemic stroke among young women.
15110323	2004	Mol. Genet. Metab.	1096-7192	TITLE	0	0	1374	SYMBOL|NUMBER|DICTIONARY	cpt 1a	CPT 1A	19#25		C535588	LONGTERM|DICTIONARY	carnitine palmitoyltransferase i deficiency	carnitine palmitoyltransferase I deficiency	68#111		Novel mutations in CPT 1A define molecular heterogeneity of hepatic carnitine palmitoyltransferase I deficiency.
14695540	2004	Hum. Mutat.	1098-1004	TITLE	0	0	2200	SYMBOL|DICTIONARY|EXTRACTED	fbn1	FBN1	26#30		D008382	LONGTERM|DISEASE|DT|DICTIONARY	marfan syndrome	Marfan syndrome	58#73		Detection of thirty novel FBN1 mutations in patients with Marfan syndrome or a related fibrillinopathy.
19225526	2009	Genes Immun.	1476-5470	TITLE	0	0	6775	SYMBOL|DICTIONARY	stat4	STAT4	52#57		D008180	SYMBOL|DICTIONARY|EXTRACTED	sle	SLE	26#29		Population differences in SLE susceptibility genes: STAT4 and BLK, but not PXK, are associated with systemic lupus erythematosus in Hong Kong Chinese.
19225526	2009	Genes Immun.	1476-5470	TITLE	0	0	6775	SYMBOL|DICTIONARY	stat4	STAT4	52#57		D008180	LONGTERM|DICTIONARY	systemic lupus erythematosus	systemic lupus erythematosus	100#128		Population differences in SLE susceptibility genes: STAT4 and BLK, but not PXK, are associated with systemic lupus erythematosus in Hong Kong Chinese.
19225526	2009	Genes Immun.	1476-5470	TITLE	0	0	640	SYMBOL|DICTIONARY	blk	BLK	62#65		D008180	SYMBOL|DICTIONARY|EXTRACTED	sle	SLE	26#29		Population differences in SLE susceptibility genes: STAT4 and BLK, but not PXK, are associated with systemic lupus erythematosus in Hong Kong Chinese.
19225526	2009	Genes Immun.	1476-5470	TITLE	0	0	640	SYMBOL|DICTIONARY	blk	BLK	62#65		D008180	LONGTERM|DICTIONARY	systemic lupus erythematosus	systemic lupus erythematosus	100#128		Population differences in SLE susceptibility genes: STAT4 and BLK, but not PXK, are associated with systemic lupus erythematosus in Hong Kong Chinese.
19225526	2009	Genes Immun.	1476-5470	TITLE	0	0	54899	SYMBOL|DICTIONARY	pxk	PXK	75#78		D008180	SYMBOL|DICTIONARY|EXTRACTED	sle	SLE	26#29		Population differences in SLE susceptibility genes: STAT4 and BLK, but not PXK, are associated with systemic lupus erythematosus in Hong Kong Chinese.
19225526	2009	Genes Immun.	1476-5470	TITLE	0	0	54899	SYMBOL|DICTIONARY	pxk	PXK	75#78		D008180	LONGTERM|DICTIONARY	systemic lupus erythematosus	systemic lupus erythematosus	100#128		Population differences in SLE susceptibility genes: STAT4 and BLK, but not PXK, are associated with systemic lupus erythematosus in Hong Kong Chinese.
9217972	1997	Brain Pathol.	1015-6305	ALL_TEXT_3/3	3	10	1956	SYMBOL|DICTIONARY	egfr	EGFR	28#32		D005909	SYMBOL|DICTIONARY|EXTRACTED	gbm	GBM	19#22	9217972-1-0-23	Specifically among GBM with EGFR amplification, those with CDKN2 deletions also occurred in patients slightly older than those few GBM without CDKN2 deletions (mean age 55 vs. 51 years).
9217972	1997	Brain Pathol.	1015-6305	ALL_TEXT_3/3	3	10	1956	SYMBOL|DICTIONARY	egfr	EGFR	28#32		D005909	SYMBOL|DICTIONARY|EXTRACTED	gbm	GBM	131#134	9217972-1-0-23	Specifically among GBM with EGFR amplification, those with CDKN2 deletions also occurred in patients slightly older than those few GBM without CDKN2 deletions (mean age 55 vs. 51 years).
9217972	1997	Brain Pathol.	1015-6305	ALL_TEXT_3/3	3	10	1029	SYMBOL|DICTIONARY	cdkn2	CDKN2	59#64		D005909	SYMBOL|DICTIONARY|EXTRACTED	gbm	GBM	19#22	9217972-1-0-23	Specifically among GBM with EGFR amplification, those with CDKN2 deletions also occurred in patients slightly older than those few GBM without CDKN2 deletions (mean age 55 vs. 51 years).
9217972	1997	Brain Pathol.	1015-6305	ALL_TEXT_3/3	3	10	1029	SYMBOL|DICTIONARY	cdkn2	CDKN2	59#64		D005909	SYMBOL|DICTIONARY|EXTRACTED	gbm	GBM	131#134	9217972-1-0-23	Specifically among GBM with EGFR amplification, those with CDKN2 deletions also occurred in patients slightly older than those few GBM without CDKN2 deletions (mean age 55 vs. 51 years).
9217972	1997	Brain Pathol.	1015-6305	ALL_TEXT_3/3	3	10	1029	SYMBOL|DICTIONARY	cdkn2	CDKN2	143#148		D005909	SYMBOL|DICTIONARY|EXTRACTED	gbm	GBM	19#22	9217972-1-0-23	Specifically among GBM with EGFR amplification, those with CDKN2 deletions also occurred in patients slightly older than those few GBM without CDKN2 deletions (mean age 55 vs. 51 years).
9217972	1997	Brain Pathol.	1015-6305	ALL_TEXT_3/3	3	10	1029	SYMBOL|DICTIONARY	cdkn2	CDKN2	143#148		D005909	SYMBOL|DICTIONARY|EXTRACTED	gbm	GBM	131#134	9217972-1-0-23	Specifically among GBM with EGFR amplification, those with CDKN2 deletions also occurred in patients slightly older than those few GBM without CDKN2 deletions (mean age 55 vs. 51 years).
11263767	2001	Arthritis Rheum.	0004-3591	CONCLUSION	4	12	3123	SYMBOL|DICTIONARY	drb1	DRB1	76#80		D001172	SYMBOL|EXTRACTED	ra	RA	174#176	11263767-1-19-39	Alleles that have a neutral or negative electric charge in their P4 pocket (DRB1*XP4n), such as DRB1*0103, *0402, *07, *08, *11 (except *1107), *12, and *13, protect against RA.
11263767	2001	Arthritis Rheum.	0004-3591	CONCLUSION	4	12	3123	SYMBOL|DICTIONARY	drb1	DRB1	96#100		D001172	SYMBOL|EXTRACTED	ra	RA	174#176	11263767-1-19-39	Alleles that have a neutral or negative electric charge in their P4 pocket (DRB1*XP4n), such as DRB1*0103, *0402, *07, *08, *11 (except *1107), *12, and *13, protect against RA.
11263767	2001	Arthritis Rheum.	0004-3591	CONCLUSION	4	13	3123	SYMBOL|DICTIONARY	drb1	DRB1	65#69		D001172	SYMBOL|EXTRACTED	ra	RA	191#193	11263767-1-19-39	Alleles that have a positive electric charge in their P4 pocket (DRB1*XP4p), such as DRB1*03, *0403, *0406, *0407, *0901, *1107, *14, *15, and *16, have no influence on the predisposition to RA.
11263767	2001	Arthritis Rheum.	0004-3591	CONCLUSION	4	13	3123	SYMBOL|DICTIONARY	drb1	DRB1	85#89		D001172	SYMBOL|EXTRACTED	ra	RA	191#193	11263767-1-19-39	Alleles that have a positive electric charge in their P4 pocket (DRB1*XP4p), such as DRB1*03, *0403, *0406, *0407, *0901, *1107, *14, *15, and *16, have no influence on the predisposition to RA.
19811440	2009	Immunol. Invest.	1532-4311	ALL_TEXT_3/3	3	9	7099	SYMBOL|DICTIONARY	tlr4	TLR4	62#66		D010518	LONGTERM|DISEASE|DN|DICTIONARY	periodontitis	periodontitis	30#43		Considering the low number of periodontitis patients carrying TLR4 variants (11%), a comparison of the periodontitis severity depending on the genotype has to be interpreted cautiously.
19811440	2009	Immunol. Invest.	1532-4311	ALL_TEXT_3/3	3	9	7099	SYMBOL|DICTIONARY	tlr4	TLR4	62#66		D010518	LONGTERM|DICTIONARY	periodontitis	periodontitis	103#116		Considering the low number of periodontitis patients carrying TLR4 variants (11%), a comparison of the periodontitis severity depending on the genotype has to be interpreted cautiously.
11263767	2001	Arthritis Rheum.	0004-3591	CONCLUSION	4	11	3123	SYMBOL|DICTIONARY	drb1	DRB1	4#8		D001172	SYMBOL|EXTRACTED	ra	RA	60#62	11263767-1-19-39	The DRB1*X allele polymorphism influences susceptibility to RA.
20564317	2010	Prostate	1097-0045	TITLE	0	0	4524	LONGTERM|DICTIONARY	methylenetetrahydrofolate reductase	methylenetetrahydrofolate reductase	44#79		D011471	LONGTERM|DISEASE|DT|DICTIONARY	prostate cancer	prostate cancer	131#146		Relationship between three polymorphisms of methylenetetrahydrofolate reductase (MTHFR C677T, A1298C, and G1793A) gene and risk of prostate cancer: a case-control study.
20564317	2010	Prostate	1097-0045	TITLE	0	0	4524	SYMBOL|DICTIONARY|EXTRACTED	mthfr	MTHFR	81#86		D011471	LONGTERM|DISEASE|DT|DICTIONARY	prostate cancer	prostate cancer	131#146		Relationship between three polymorphisms of methylenetetrahydrofolate reductase (MTHFR C677T, A1298C, and G1793A) gene and risk of prostate cancer: a case-control study.
17961231	2008	BMC Neurol	1471-2377	CONCLUSION	4	8	5274	LONGTERM|DICTIONARY	neuroserpin	neuroserpin	44#55	NaN	D002544	LONGTERM|DICTIONARY	ischemic stroke	ischemic stroke	87#102		This study provides the first evidence that neuroserpin is associated with early-onset ischemic stroke among Caucasian women.
19937159	2011	Neuromolecular Med.	1559-1174	ALL_TEXT_1/3	1	1	3356	SYMBOL|()|DICTIONARY	htr2a	HTR2A	76#81		D003866	LONGTERM|DISEASE|DT|DICTIONARY	depressive disorder	depressive disorder	160#179		Several recent investigations reported that the serotonin 2A receptor gene (HTR2A) was associated with selective serotonin reuptake inhibitors (SSRIs) in major depressive disorder.
19937159	2011	Neuromolecular Med.	1559-1174	TITLE	0	0	3356	SYMBOL|DICTIONARY	htr2a	HTR2A	0#5		D003866	LONGTERM|DISEASE|DT|DICTIONARY	depressive disorder	depressive disorder	48#67		HTR2A is associated with SSRI response in major depressive disorder in a Japanese cohort.
19937159	2011	Neuromolecular Med.	1559-1174	ALL_TEXT_2/3	2	3	3356	SYMBOL|DICTIONARY	htr2a	HTR2A	270#275		D003865	SYMBOL|DISEASE|DN|DICTIONARY	mdd	MDD	131#134		Therefore, we conducted a replication association study using a sample larger than those in the two original Japanese studies (265 MDD patients), and found that four SNPs, two functional SNPs (-A1438G: rs6311 and T102C: rs6313) and two SNPs (rs7997012 and rs1928040) in HTR2A, were associated with the therapeutic response to SSRIs.
19937159	2011	Neuromolecular Med.	1559-1174	ALL_TEXT_1/3	1	2	3356	SYMBOL|DICTIONARY	htr2a	HTR2A	58#63		D003865	SYMBOL|DISEASE|DN|DICTIONARY	mdd	MDD	95#98		There have also been two reported association analyses of HTR2A with SSRI response in Japanese MDD patients, but the results were rather inconsistent and both studies had the problem of small sample sizes.
19937159	2011	Neuromolecular Med.	1559-1174	ALL_TEXT_2/3	2	4	3356	SYMBOL|DICTIONARY	htr2a	HTR2A	0#5		D003865	SYMBOL|DISEASE|DN|DICTIONARY	mdd	MDD	69#72		HTR2A was associated with the therapeutic response SSRIs in Japanese MDD patients in a haplotype-wise analysis (P(all markers) = 0.0136), and a significant association between rs1928040 in HTR2A and SSRI response was detected in MDD (P(allele-wise analysis) = 0.0252).
19937159	2011	Neuromolecular Med.	1559-1174	ALL_TEXT_2/3	2	4	3356	SYMBOL|DICTIONARY	htr2a	HTR2A	189#194		D003865	SYMBOL|DISEASE|DN|DICTIONARY	mdd	MDD	69#72		HTR2A was associated with the therapeutic response SSRIs in Japanese MDD patients in a haplotype-wise analysis (P(all markers) = 0.0136), and a significant association between rs1928040 in HTR2A and SSRI response was detected in MDD (P(allele-wise analysis) = 0.0252).
19937159	2011	Neuromolecular Med.	1559-1174	ALL_TEXT_3/3	3	6	3356	SYMBOL|DICTIONARY	htr2a	HTR2A	31#36		D003865	SYMBOL|DISEASE|DN|DICTIONARY	mdd	MDD	136#139		In conclusion, we suggest that HTR2A may play an important role in the pathophysiology of the therapeutic response to SSRIs in Japanese MDD patients.
15459589	2005	Am. Heart J.	1097-6744	TITLE	0	0	6404	LONGTERM|DICTIONARY	p-selectin glycoprotein ligand	P-selectin glycoprotein ligand	17#47		D009203	LONGTERM|DICTIONARY	myocardial infarction	myocardial infarction	76#97		Short alleles of P-selectin glycoprotein ligand-1 protect against premature myocardial infarction.
20854105	2011	Genet Test Mol Biomarkers	1945-0257	BACKGROUND AND AIM	1	1	9156	LONGTERM|DICTIONARY	exonuclease 1	exonuclease 1	65#78		D015179	LONGTERM|DISEASE|DT|DICTIONARY	colorectal cancer	colorectal cancer	23#40		One candidate gene for colorectal cancer (CRC) susceptibility is exonuclease 1 (EXO1).
20854105	2011	Genet Test Mol Biomarkers	1945-0257	BACKGROUND AND AIM	1	1	9156	LONGTERM|DICTIONARY	exonuclease 1	exonuclease 1	65#78		D015179	SYMBOL|()|DICTIONARY|EXTRACTED	crc	CRC	42#45	20854105-1-23-40	One candidate gene for colorectal cancer (CRC) susceptibility is exonuclease 1 (EXO1).
20854105	2011	Genet Test Mol Biomarkers	1945-0257	BACKGROUND AND AIM	1	1	9156	SYMBOL|()|DICTIONARY|EXTRACTED	exo1	EXO1	80#84	20854105-1-65-78	D015179	LONGTERM|DISEASE|DT|DICTIONARY	colorectal cancer	colorectal cancer	23#40		One candidate gene for colorectal cancer (CRC) susceptibility is exonuclease 1 (EXO1).
20854105	2011	Genet Test Mol Biomarkers	1945-0257	BACKGROUND AND AIM	1	1	9156	SYMBOL|()|DICTIONARY|EXTRACTED	exo1	EXO1	80#84	20854105-1-65-78	D015179	SYMBOL|()|DICTIONARY|EXTRACTED	crc	CRC	42#45	20854105-1-23-40	One candidate gene for colorectal cancer (CRC) susceptibility is exonuclease 1 (EXO1).
15459589	2005	Am. Heart J.	1097-6744	METHODS	2	8	6404	SYMBOL|DICTIONARY	psgl 1	PSGL-1	16#22		D006973	LONGTERM|DICTIONARY	hypertension	hypertension	126#138		The role of the PSGL-1 polymorphism was also evaluated according to the additional risk factors of age, sex, smoking history, hypertension, hypercholesterolemia, and diabetes.
15459589	2005	Am. Heart J.	1097-6744	METHODS	2	8	6404	SYMBOL|DICTIONARY	psgl 1	PSGL-1	16#22		D006937	LONGTERM|DICTIONARY	hypercholesterolemia	hypercholesterolemia	140#160		The role of the PSGL-1 polymorphism was also evaluated according to the additional risk factors of age, sex, smoking history, hypertension, hypercholesterolemia, and diabetes.
15459589	2005	Am. Heart J.	1097-6744	METHODS	2	8	6404	SYMBOL|DICTIONARY	psgl 1	PSGL-1	16#22		D003920	LONGTERM|DICTIONARY	diabetes	diabetes	166#174		The role of the PSGL-1 polymorphism was also evaluated according to the additional risk factors of age, sex, smoking history, hypertension, hypercholesterolemia, and diabetes.
18779298	2008	Am. J. Clin. Nutr.	1938-3207	CONCLUSIONS	5	7	4160	SYMBOL|NUMBER|DICTIONARY|EXTRACTED	mc4r	MC4R	78#82	18779298-1-70-93	D009765	LONGTERM|DICTIONARY	obese	obese	55#60		The higher dietary intake of carbohydrates in severely obese persons with the MC4R 103I variant is in line with previous findings.
18779298	2008	Am. J. Clin. Nutr.	1938-3207	DESIGN	3	4	4160	SYMBOL|DICTIONARY|EXTRACTED	mc4r	MC4R	4#8	18779298-1-70-93	D009765	LONGTERM|DICTIONARY	obese	obese	70#75		The MC4R V103I polymorphism was genotyped in a group of 1029 severely obese white subjects with an average body mass index (BMI; in kg/m(2)) of 46.0 (range: 33-92).
15718509	2005	Stroke	1524-4628	TITLE	0	0	12	SYMBOL|()|DICTIONARY	serpina3	SERPINA3	30#38		D013345	LONGTERM|DICTIONARY	aneurysmal subarachnoid hemorrhage	aneurysmal subarachnoid hemorrhage	78#112		Alpha1-antichymotrypsin gene (SERPINA3) A/T polymorphism as a risk factor for aneurysmal subarachnoid hemorrhage.
18779298	2008	Am. J. Clin. Nutr.	1938-3207	OBJECTIVE	2	3	4160	SYMBOL|DICTIONARY|EXTRACTED	mc4r	MC4R	72#76	18779298-1-70-93	D009765	LONGTERM|DICTIONARY	obesity	obesity	142#149		The purpose of the study was to investigate the association between the MC4R V103I polymorphism and the dietary intake of persons with severe obesity, which was derived by using the Willett food-frequency questionnaire.
18779298	2008	Am. J. Clin. Nutr.	1938-3207	TITLE	0	0	4160	LONGTERM|GENE|GT|DICTIONARY	melanocortin 4 receptor	melanocortin-4 receptor	19#42		D009765	LONGTERM|DICTIONARY	obese	obese	94#99		Association of the melanocortin-4 receptor V103I polymorphism with dietary intake in severely obese persons.
17961231	2008	BMC Neurol	1471-2377	TITLE	0	0	5274	LONGTERM|DICTIONARY	neuroserpin	Neuroserpin	0#11	NaN	D020521	LONGTERM|DICTIONARY	stroke	stroke	30#36		Neuroserpin polymorphisms and stroke risk in a biracial population: the stroke prevention in young women study.
17961231	2008	BMC Neurol	1471-2377	TITLE	0	0	5274	LONGTERM|DICTIONARY	neuroserpin	Neuroserpin	0#11	NaN	D020521	LONGTERM|DICTIONARY	stroke	stroke	72#78		Neuroserpin polymorphisms and stroke risk in a biracial population: the stroke prevention in young women study.
19360675	2009	Autism Res	1939-3806	ALL_TEXT_3/3	3	4	6532	SYMBOL|DICTIONARY	slc6a4	SLC6A4	74#80		D009127	LONGTERM|DICTIONARY	rigid-compulsive traits scores	rigid-compulsive traits scores	86#116		Furthermore, we did not observe an association of rare coding variants in SLC6A4 with rigid-compulsive traits scores in the cases.
19360675	2009	Autism Res	1939-3806	ALL_TEXT_3/3	3	5	6532	SYMBOL|DICTIONARY	slc6a4	SLC6A4	76#82		D002659	LONGTERM|DICTIONARY	autism spectrum disorders	autism spectrum disorders	86#111		These results do not support a significant role for rare coding variants in SLC6A4 in autism spectrum disorders, nor do they support a significant role for SLC6A4 in rigid-compulsive traits in these disorders.
19360675	2009	Autism Res	1939-3806	ALL_TEXT_3/3	3	5	6532	SYMBOL|DICTIONARY	slc6a4	SLC6A4	156#162		D002659	LONGTERM|DICTIONARY	autism spectrum disorders	autism spectrum disorders	86#111		These results do not support a significant role for rare coding variants in SLC6A4 in autism spectrum disorders, nor do they support a significant role for SLC6A4 in rigid-compulsive traits in these disorders.
19360675	2009	Autism Res	1939-3806	ALL_TEXT_2/3	2	2	6532	SYMBOL|DICTIONARY	slc6a4	SLC6A4	174#180		D002659	LONGTERM|DICTIONARY	autism spectrum disorders	autism spectrum disorders	54#79		We made use of a large number of unrelated cases with autism spectrum disorders (approximately 350) and controls (approximately 420) and screened for rare exonic variants in SLC6A4 by a high-throughput method followed by sequencing.
19360675	2009	Autism Res	1939-3806	TITLE	0	0	6532	SYMBOL|DICTIONARY	sert	SERT	44#48		D002659	LONGTERM|DICTIONARY	autism spectrum disorders	autism spectrum disorders	59#84		A large-scale screen for coding variants in SERT/SLC6A4 in autism spectrum disorders.
19360675	2009	Autism Res	1939-3806	TITLE	0	0	6532	SYMBOL|DICTIONARY	slc6a4	SLC6A4	49#55		D002659	LONGTERM|DICTIONARY	autism spectrum disorders	autism spectrum disorders	59#84		A large-scale screen for coding variants in SERT/SLC6A4 in autism spectrum disorders.
12728975	2003	J Chin Med Assoc	1726-4901	CONCLUSIONS	4	11	183	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	agt	AGT	29#32	12728975-1-78-93	D003928	LONGTERM|DICTIONARY	diabetic nephropathy	diabetic nephropathy	65#85		Our study suggested that the AGT gene plays an important role in diabetic nephropathy.
20939760	2011	Exp. Lung Res.	1521-0499	ALL_TEXT_3/3	3	9	1956	SYMBOL|DICTIONARY|EXTRACTED	egfr	EGFR	23#27	20939760-0-0-32	D002289	LONGTERM|DICTIONARY|EXTRACTED	nsclc	NSCLC	72#77	20939760-1-26-52	This study correlating EGFR mutation with p-EGFR expression in resected NSCLC is one of the largest to date, although TKI response could not be assessed.
20939760	2011	Exp. Lung Res.	1521-0499	ALL_TEXT_3/3	3	9	1956	SYMBOL|DICTIONARY|EXTRACTED	egfr	EGFR	44#48	20939760-0-0-32	D002289	LONGTERM|DICTIONARY|EXTRACTED	nsclc	NSCLC	72#77	20939760-1-26-52	This study correlating EGFR mutation with p-EGFR expression in resected NSCLC is one of the largest to date, although TKI response could not be assessed.
9554754	1998	Hum. Mutat.	1059-7794	ALL_TEXT_1/3	1	1	367	LONGTERM|GENE|GN|GT|DICTIONARY	androgen receptor	androgen receptor	51#68		D013734	LONGTERM|DISEASE|DT|DICTIONARY	androgen insensitivity syndrome	androgen insensitivity syndrome	112#143		Several mutations have been described in the human androgen receptor gene including constitutional mutations in androgen insensitivity syndrome, somatic mutations in prostate cancer and triplet expansions in Kennedy's disease (Gottlieb et al.1997).
9554754	1998	Hum. Mutat.	1059-7794	ALL_TEXT_1/3	1	1	367	LONGTERM|GENE|GN|GT|DICTIONARY	androgen receptor	androgen receptor	51#68		D011471	LONGTERM|DISEASE|DT|DICTIONARY	prostate cancer	prostate cancer	166#181		Several mutations have been described in the human androgen receptor gene including constitutional mutations in androgen insensitivity syndrome, somatic mutations in prostate cancer and triplet expansions in Kennedy's disease (Gottlieb et al.1997).
9554754	1998	Hum. Mutat.	1059-7794	ALL_TEXT_1/3	1	1	367	LONGTERM|GENE|GN|GT|DICTIONARY	androgen receptor	androgen receptor	51#68		D055534	LONGTERM|DISEASE|DT|DICTIONARY	kennedy disease	Kennedy's disease	208#225		Several mutations have been described in the human androgen receptor gene including constitutional mutations in androgen insensitivity syndrome, somatic mutations in prostate cancer and triplet expansions in Kennedy's disease (Gottlieb et al.1997).
23505205	2013	Hum. Mutat.	1098-1004	ALL_TEXT_3/3	3	9	2294	SYMBOL|DICTIONARY	foxf1	FOXF1	100#105		C535474	LONGTERM|DICTIONARY	acd	ACD	109#112		These results corroborate and extend our previous observations and further establish involvement of FOXF1 in ACD/MPV and lung organogenesis.
17203304	2007	Hum. Genet.	0340-6717	ALL_TEXT_3/3	3	10	6532	SYMBOL|DICTIONARY	slc6a4	SLC6A4	30#36		D001321	LONGTERM|DICTIONARY	autism	autism	68#74		The overall results implicate SLC6A4 and ITGB3 gene interactions in autism etiology and in serotonin level determination, providing evidence for a common underlying genetic mechanism and a molecular explanation for the association of platelet hyperserotonemia with autism.
17203304	2007	Hum. Genet.	0340-6717	ALL_TEXT_3/3	3	10	6532	SYMBOL|DICTIONARY	slc6a4	SLC6A4	30#36		D001321	LONGTERM|DICTIONARY	autism	autism	265#271		The overall results implicate SLC6A4 and ITGB3 gene interactions in autism etiology and in serotonin level determination, providing evidence for a common underlying genetic mechanism and a molecular explanation for the association of platelet hyperserotonemia with autism.
17203304	2007	Hum. Genet.	0340-6717	ALL_TEXT_3/3	3	10	6532	SYMBOL|DICTIONARY	slc6a4	SLC6A4	30#36		D001791	LONGTERM|DICTIONARY	platelet hyperserotonemia	platelet hyperserotonemia	234#259	NaN	The overall results implicate SLC6A4 and ITGB3 gene interactions in autism etiology and in serotonin level determination, providing evidence for a common underlying genetic mechanism and a molecular explanation for the association of platelet hyperserotonemia with autism.
17203304	2007	Hum. Genet.	0340-6717	ALL_TEXT_3/3	3	10	3690	SYMBOL|GENE|GN|DICTIONARY	itgb3	ITGB3	41#46		D001321	LONGTERM|DICTIONARY	autism	autism	68#74		The overall results implicate SLC6A4 and ITGB3 gene interactions in autism etiology and in serotonin level determination, providing evidence for a common underlying genetic mechanism and a molecular explanation for the association of platelet hyperserotonemia with autism.
17203304	2007	Hum. Genet.	0340-6717	ALL_TEXT_3/3	3	10	3690	SYMBOL|GENE|GN|DICTIONARY	itgb3	ITGB3	41#46		D001321	LONGTERM|DICTIONARY	autism	autism	265#271		The overall results implicate SLC6A4 and ITGB3 gene interactions in autism etiology and in serotonin level determination, providing evidence for a common underlying genetic mechanism and a molecular explanation for the association of platelet hyperserotonemia with autism.
17203304	2007	Hum. Genet.	0340-6717	ALL_TEXT_3/3	3	10	3690	SYMBOL|GENE|GN|DICTIONARY	itgb3	ITGB3	41#46		D001791	LONGTERM|DICTIONARY	platelet hyperserotonemia	platelet hyperserotonemia	234#259	NaN	The overall results implicate SLC6A4 and ITGB3 gene interactions in autism etiology and in serotonin level determination, providing evidence for a common underlying genetic mechanism and a molecular explanation for the association of platelet hyperserotonemia with autism.
23505205	2013	Hum. Mutat.	1098-1004	TITLE	0	0	2294	SYMBOL|DICTIONARY	foxf1	FOXF1	6#11		C536590	LONGTERM|DICTIONARY	capillary dysplasia	capillary dysplasia	65#84		Novel FOXF1 mutations in sporadic and familial cases of alveolar capillary dysplasia with misaligned pulmonary veins imply a role for its DNA binding domain.
19571538	2009	Cardiology	1421-9751	METHODS	2	4	51085	SYMBOL|GENE|GN|DICTIONARY	mlxipl	MLXIPL	40#46		D003324	SYMBOL|DISEASE|DN|DICTIONARY|EXTRACTED	cad	CAD	74#77	19571538-2-76-99	The genotype of the polymorphism in the MLXIPL gene was determined in 352 CAD patients and 152 CAD-free subjects.
19571538	2009	Cardiology	1421-9751	METHODS	2	4	51085	SYMBOL|GENE|GN|DICTIONARY	mlxipl	MLXIPL	40#46		D003324	SYMBOL|DICTIONARY|EXTRACTED	cad	CAD	95#98	19571538-2-76-99	The genotype of the polymorphism in the MLXIPL gene was determined in 352 CAD patients and 152 CAD-free subjects.
9554754	1998	Hum. Mutat.	1059-7794	ALL_TEXT_1/3	1	2	367	LONGTERM|GENE|GN|GT|DICTIONARY	androgen receptor	androgen receptor	115#132		D013734	LONGTERM|DICTIONARY	complete androgen insensitivity	complete androgen insensitivity	36#67		Here we report on two siblings with complete androgen insensitivity and a novel missense mutation, D695V, in their androgen receptor gene.
19571538	2009	Cardiology	1421-9751	TITLE	0	0	51085	SYMBOL|DICTIONARY	mlxipl	MLXIPL	26#32		D003324	LONGTERM|DISEASE|DT|DICTIONARY	coronary artery disease	Coronary Artery Disease	67#90		G771C Polymorphism in the MLXIPL Gene Is Associated with a Risk of Coronary Artery Disease in the Chinese: A Case-Control Study.
17932345	2008	Cancer Epidemiol. Biomarkers Prev.	1055-9965	CONCLUSION	4	11	10333	SYMBOL|DICTIONARY	tlr6	TLR6	62#66		D011471	LONGTERM|DISEASE|DT|DICTIONARY	prostate cancer	prostate cancer	127#142		Inherited sequence variants of the innate immune gene cluster TLR6-TLR1-TLR10 were not appreciably associated with the risk of prostate cancer in this cohort.
17932345	2008	Cancer Epidemiol. Biomarkers Prev.	1055-9965	CONCLUSION	4	11	7096	SYMBOL|DICTIONARY	tlr1	TLR1	67#71		D011471	LONGTERM|DISEASE|DT|DICTIONARY	prostate cancer	prostate cancer	127#142		Inherited sequence variants of the innate immune gene cluster TLR6-TLR1-TLR10 were not appreciably associated with the risk of prostate cancer in this cohort.
17932345	2008	Cancer Epidemiol. Biomarkers Prev.	1055-9965	CONCLUSION	4	11	81793	SYMBOL|DICTIONARY	tlr10	TLR10	72#77		D011471	LONGTERM|DISEASE|DT|DICTIONARY	prostate cancer	prostate cancer	127#142		Inherited sequence variants of the innate immune gene cluster TLR6-TLR1-TLR10 were not appreciably associated with the risk of prostate cancer in this cohort.
17932345	2008	Cancer Epidemiol. Biomarkers Prev.	1055-9965	RESULTS	3	10	10333	SYMBOL|NUMBER|DICTIONARY	tlr6	TLR6	112#116		D011471	LONGTERM|DISEASE|DT|DICTIONARY	prostate cancer	prostate cancer	83#98		No effect modification was observed for age, body mass index, or family history of prostate cancer, except that TLR6_3649 showed nominally significant interaction with family history at the P < 0.05 level.
16757160	2007	Respir Med	0954-6111	CONCLUSION	5	13	3566	SYMBOL|GENE|GN|DICTIONARY	il 4ra	IL-4RA	24#30		D001249	LONGTERM|DICTIONARY	asthma	asthma	70#76		The association between IL-4RA gene polymorphisms, its haplotypes and asthma differed from ethnicities.
19264732	2009	J. Med. Genet.	1468-6244	CONCLUSIONS	3	11	79813	SYMBOL|DICTIONARY	ehmt1	EHMT1	130#135		D001523	LONGTERM|DICTIONARY	psychiatric	psychiatric	83#94	NaN	Interestingly, five of six patients who had reached adulthood had developed severe psychiatric pathology, which may indicate that EHMT1 haploinsufficiency is associated with neurodegeneration in addition to neurodevelopmental defect.
19264732	2009	J. Med. Genet.	1468-6244	CONCLUSIONS	3	11	79813	SYMBOL|DICTIONARY	ehmt1	EHMT1	130#135		D009422	LONGTERM|DICTIONARY	neurodevelopmental defect	neurodevelopmental defect	207#232	NaN	Interestingly, five of six patients who had reached adulthood had developed severe psychiatric pathology, which may indicate that EHMT1 haploinsufficiency is associated with neurodegeneration in addition to neurodevelopmental defect.
19264732	2009	J. Med. Genet.	1468-6244	CONCLUSIONS	3	11	79813	SYMBOL|DICTIONARY	ehmt1	EHMT1	130#135		D019636	LONGTERM|DICTIONARY	neurodegeneration	neurodegeneration	174#191	NaN	Interestingly, five of six patients who had reached adulthood had developed severe psychiatric pathology, which may indicate that EHMT1 haploinsufficiency is associated with neurodegeneration in addition to neurodevelopmental defect.
17121882	2007	Clin. Cancer Res.	1078-0432	CONCLUSIONS	4	11	56475	LONGTERM|DICTIONARY	reprimo	Reprimo	0#7	NaN	C562729	SYMBOL|DICTIONARY|EXTRACTED	escc	ESCC	91#95	17121882-7-93-127	Reprimo methylation occurs significantly more frequently in BE, HGD, and EAC than in NE or ESCC, suggesting that this epigenetic alteration is a specialized columnar, cell-specific early event with potential as a biomarker for the early detection of esophageal neoplasia.
17121882	2007	Clin. Cancer Res.	1078-0432	CONCLUSIONS	4	11	56475	LONGTERM|DICTIONARY	reprimo	Reprimo	0#7	NaN	D009369	LONGTERM|DICTIONARY	neoplasia	neoplasia	261#270		Reprimo methylation occurs significantly more frequently in BE, HGD, and EAC than in NE or ESCC, suggesting that this epigenetic alteration is a specialized columnar, cell-specific early event with potential as a biomarker for the early detection of esophageal neoplasia.
17121882	2007	Clin. Cancer Res.	1078-0432	CONCLUSIONS	4	11	56475	LONGTERM|DICTIONARY	reprimo	Reprimo	0#7	NaN	D001471	LONGTERM|DICTIONARY	be	BE	60#62	NaN	Reprimo methylation occurs significantly more frequently in BE, HGD, and EAC than in NE or ESCC, suggesting that this epigenetic alteration is a specialized columnar, cell-specific early event with potential as a biomarker for the early detection of esophageal neoplasia.
17121882	2007	Clin. Cancer Res.	1078-0432	CONCLUSIONS	4	11	56475	LONGTERM|DICTIONARY	reprimo	Reprimo	0#7	NaN	D008228	LONGTERM|DICTIONARY	hgd	HGD	64#67	NaN	Reprimo methylation occurs significantly more frequently in BE, HGD, and EAC than in NE or ESCC, suggesting that this epigenetic alteration is a specialized columnar, cell-specific early event with potential as a biomarker for the early detection of esophageal neoplasia.
9236417	1997	Circulation	0009-7322	BACKGROUND	1	2	5972	LONGTERM|DICTIONARY	renin	renin	38#43		D006965	LONGTERM|DICTIONARY	hyperplasia	hyperplasia	89#100	NaN	Experimental studies suggest that the renin-angiotensin system is involved in neointimal hyperplasia after arterial injury.
9236417	1997	Circulation	0009-7322	BACKGROUND	1	2	5972	LONGTERM|DICTIONARY	renin	renin	38#43		D057772	LONGTERM|DICTIONARY	arterial injury	arterial injury	107#122	NaN	Experimental studies suggest that the renin-angiotensin system is involved in neointimal hyperplasia after arterial injury.
9236417	1997	Circulation	0009-7322	BACKGROUND	1	3	1636	SYMBOL|DICTIONARY	ace	ACE	45#48		C536170	SYMBOL|DISEASE|DN|DICTIONARY	dd	DD	114#116		In humans, the plasma and cellular levels of ACE are associated with an I/D genetic polymorphism in the ACE gene, DD patients having higher levels.
9236417	1997	Circulation	0009-7322	BACKGROUND	1	3	1636	SYMBOL|GENE|GN|DICTIONARY	ace	ACE	104#107		C536170	SYMBOL|DISEASE|DN|DICTIONARY	dd	DD	114#116		In humans, the plasma and cellular levels of ACE are associated with an I/D genetic polymorphism in the ACE gene, DD patients having higher levels.
17666372	2008	Haematologica	1592-8721	RESULTS	3	7	4255	SYMBOL|DICTIONARY	mgmt	MGMT	11#15		D008228	SYMBOL|DICTIONARY|EXTRACTED	nhl	NHL	120#123	17666372-1-141-163	Two SNP in MGMT (Ile143Val and Lys178Arg) were in complete linkage disequilibrium and associated with increased risk of NHL (Ile143Val, Ile/Val vs. Ile/Ile, OR: 1.26; 95% CI: 0.93-1.70; Val/Val vs. Ile/Ile, OR: 2.55; 95% CI: 0.98-6.63; p trend: 0.024).
12928282	2003	Br J Ophthalmol	0007-1161	TITLE	0	0	6247	SYMBOL|GENE|GN|DICTIONARY	xlrs1	XLRS1	90#95		D041441	LONGTERM|DICTIONARY	x linked juvenile retinoschisis	X linked juvenile retinoschisis	21#52		Clinical features of X linked juvenile retinoschisis associated with new mutations in the XLRS1 gene in Italian families.
12189593	2002	Am. J. Hum. Genet.	0002-9297	TITLE	0	0	6309	LONGTERM|DICTIONARY	3beta hydroxysteroid delta5 desaturase	3beta-hydroxysteroid-delta5-desaturase	96#134		C537880	LONGTERM|DICTIONARY	lathosterolosis	Lathosterolosis	0#15		Lathosterolosis, a novel multiple-malformation/mental retardation syndrome due to deficiency of 3beta-hydroxysteroid-delta5-desaturase.
12189593	2002	Am. J. Hum. Genet.	0002-9297	TITLE	0	0	6309	LONGTERM|DICTIONARY	3beta hydroxysteroid delta5 desaturase	3beta-hydroxysteroid-delta5-desaturase	96#134		D000014	LONGTERM|DICTIONARY	malformation	malformation	34#46		Lathosterolosis, a novel multiple-malformation/mental retardation syndrome due to deficiency of 3beta-hydroxysteroid-delta5-desaturase.
12189593	2002	Am. J. Hum. Genet.	0002-9297	TITLE	0	0	6309	LONGTERM|DICTIONARY	3beta hydroxysteroid delta5 desaturase	3beta-hydroxysteroid-delta5-desaturase	96#134		D008607	LONGTERM|DISEASE|DN|DICTIONARY	mental retardation syndrome	mental retardation syndrome	47#74		Lathosterolosis, a novel multiple-malformation/mental retardation syndrome due to deficiency of 3beta-hydroxysteroid-delta5-desaturase.
12189593	2002	Am. J. Hum. Genet.	0002-9297	TITLE	0	0	6309	LONGTERM|DICTIONARY	3beta hydroxysteroid delta5 desaturase	3beta-hydroxysteroid-delta5-desaturase	96#134		C579862	LONGTERM|DICTIONARY	deficiency of 3beta	deficiency of 3beta	82#101		Lathosterolosis, a novel multiple-malformation/mental retardation syndrome due to deficiency of 3beta-hydroxysteroid-delta5-desaturase.
20179607	2010	J. Cardiovasc. Pharmacol.	1533-4023	ALL_TEXT_3/3	3	11	1636	SYMBOL|DICTIONARY|EXTRACTED	ace	ACE	28#31	20179607-2-66-95	D002312	SYMBOL|DICTIONARY|EXTRACTED	hocm	HOCM	14#18	20179607-1-122-161	Patients with HOCM with the ACE D allele had a high LVPG.
17666372	2008	Haematologica	1592-8721	RESULTS	3	9	7515	SYMBOL|DICTIONARY	xrcc1	XRCC1	17#22		D008228	SYMBOL|DICTIONARY|EXTRACTED	nhl	NHL	76#79	17666372-1-141-163	In addition, the XRCC1 Arg194Trp polymorphism was associated with decreased NHL risk (Arg/Trp vs. Arg/Arg, OR: 0.72; 95% CI: 0.49-1.07; Trp/Trp vs. Arg/Arg, OR: 0.45; 95% CI: 0.10-1.99; p trend: 0.059), mainly in diffuse large B-cell lymphoma.
17666372	2008	Haematologica	1592-8721	RESULTS	3	9	7515	SYMBOL|DICTIONARY	xrcc1	XRCC1	17#22		D016393	LONGTERM|DICTIONARY	b-cell lymphoma	B-cell lymphoma	227#242		In addition, the XRCC1 Arg194Trp polymorphism was associated with decreased NHL risk (Arg/Trp vs. Arg/Arg, OR: 0.72; 95% CI: 0.49-1.07; Trp/Trp vs. Arg/Arg, OR: 0.45; 95% CI: 0.10-1.99; p trend: 0.059), mainly in diffuse large B-cell lymphoma.
18562701	2009	Reprod Sci	1933-7205	INTRODUCTION	1	3	183	LONGTERM|DICTIONARY	angiotensinogen	angiotensinogen	22#37		D006973	LONGTERM|DICTIONARY	hypertension	hypertension	113#125		A polymorphism in the angiotensinogen basal promoter region of AGT -217 is more common in African Americans with hypertension.
18562701	2009	Reprod Sci	1933-7205	INTRODUCTION	1	3	183	SYMBOL|DICTIONARY	agt	AGT	63#66		D006973	LONGTERM|DICTIONARY	hypertension	hypertension	113#125		A polymorphism in the angiotensinogen basal promoter region of AGT -217 is more common in African Americans with hypertension.
17473385	2007	Dis. Markers	0278-0240	TITLE	0	0	4023	LONGTERM|GENE|GN|DICTIONARY	lipoprotein lipase	Lipoprotein lipase	0#18		D003324	LONGTERM|DISEASE|DT|DICTIONARY	coronary artery disease	coronary artery disease	69#92		Lipoprotein lipase gene PvuII polymorphism serum lipids and risk for coronary artery disease: meta-analysis.
18562701	2009	Reprod Sci	1933-7205	INTRODUCTION	1	1	183	LONGTERM|GENE|GN|DICTIONARY	angiotensinogen	angiotensinogen	24#39		D006973	LONGTERM|DICTIONARY	hypertension	hypertension	70#82		Genetic variants of the angiotensinogen gene have been linked to both hypertension and preeclampsia.
18562701	2009	Reprod Sci	1933-7205	INTRODUCTION	1	1	183	LONGTERM|GENE|GN|DICTIONARY	angiotensinogen	angiotensinogen	24#39		D011225	LONGTERM|DICTIONARY	preeclampsia	preeclampsia	87#99	NaN	Genetic variants of the angiotensinogen gene have been linked to both hypertension and preeclampsia.
18562701	2009	Reprod Sci	1933-7205	RESULTS	3	7	183	SYMBOL|DICTIONARY	agt	AGT	14#17		D011225	LONGTERM|DICTIONARY	preeclampsia	preeclampsia	132#144	NaN	The M235T and AGT -217 polymorphisms were both more common in African American women; however, the variants were not more common in preeclampsia.
18562701	2009	Reprod Sci	1933-7205	INTRODUCTION	1	4	183	SYMBOL|DICTIONARY	agt	AGT	52#55		D011225	LONGTERM|DICTIONARY	preeclampsia	preeclampsia	118#130	NaN	The authors investigated the frequency of M235T and AGT -217 in Caucasian and African American women with and without preeclampsia.
18562701	2009	Reprod Sci	1933-7205	CONCLUSION	4	8	183	LONGTERM|DICTIONARY	angiotensinogen	angiotensinogen	17#32		D011225	LONGTERM|DICTIONARY	preeclampsia	preeclampsia	162#174	NaN	The frequency of angiotensinogen polymorphisms M235T and AGT -217 is different by race; however, these polymorphisms are not associated with an increased risk of preeclampsia.
18562701	2009	Reprod Sci	1933-7205	CONCLUSION	4	8	183	SYMBOL|DICTIONARY	agt	AGT	57#60		D011225	LONGTERM|DICTIONARY	preeclampsia	preeclampsia	162#174	NaN	The frequency of angiotensinogen polymorphisms M235T and AGT -217 is different by race; however, these polymorphisms are not associated with an increased risk of preeclampsia.
16324400	2008	Zhonghua Yi Xue Za Zhi	0376-2491	OBJECTIVE	1	1	672	SYMBOL|DICTIONARY	brca1	BRCA1	33#38		D001943	LONGTERM|DISEASE|DN|DT|DICTIONARY	breast cancer	breast cancer	77#90		To investigate the prevalence of BRCA1 and BRCA2 mutations among early-onset breast cancer patients in Shanghai.
16324400	2008	Zhonghua Yi Xue Za Zhi	0376-2491	OBJECTIVE	1	1	675	SYMBOL|DICTIONARY	brca2	BRCA2	43#48		D001943	LONGTERM|DISEASE|DN|DT|DICTIONARY	breast cancer	breast cancer	77#90		To investigate the prevalence of BRCA1 and BRCA2 mutations among early-onset breast cancer patients in Shanghai.
16324400	2008	Zhonghua Yi Xue Za Zhi	0376-2491	TITLE	0	0	672	SYMBOL|DICTIONARY	brca1	BRCA1	24#29		D001943	LONGTERM|DISEASE|DN|DT|DICTIONARY	breast cancer	breast cancer	61#74		[Mutational analysis of BRCA1 and BRCA2 genes in early-onset breast cancer patients in Shanghai].
16324400	2008	Zhonghua Yi Xue Za Zhi	0376-2491	TITLE	0	0	675	SYMBOL|GENE|GN|DICTIONARY	brca2	BRCA2	34#39		D001943	LONGTERM|DISEASE|DN|DT|DICTIONARY	breast cancer	breast cancer	61#74		[Mutational analysis of BRCA1 and BRCA2 genes in early-onset breast cancer patients in Shanghai].
12747597	2003	Clin. Chem. Lab. Med.	1434-6621	TITLE	0	0	185	LONGTERM|GENE|GN|GT|DICTIONARY	angiotensin ii type 1 receptor	angiotensin-II type 1 receptor	95#125		D003324	LONGTERM|DISEASE|DT|DICTIONARY	coronary artery disease	coronary artery disease	162#185		Left ventricular size, mass and function in relation to angiotensin-converting enzyme gene and angiotensin-II type 1 receptor gene polymorphisms in patients with coronary artery disease.
17826416	2007	Am. J. Obstet. Gynecol.	1097-6868	CONCLUSION	4	7	7422	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	vegf	VEGF	36#40	17826416-1-73-107	D011225	LONGTERM|DICTIONARY	preeclampsia	preeclampsia	116#128	NaN	Carriage of the +936T allele of the VEGF gene may be associated with increased susceptibility to the development of preeclampsia and may be an independent risk factor for preeclampsia.
17826416	2007	Am. J. Obstet. Gynecol.	1097-6868	CONCLUSION	4	7	7422	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	vegf	VEGF	36#40	17826416-1-73-107	D011225	LONGTERM|DICTIONARY	preeclampsia	preeclampsia	171#183	NaN	Carriage of the +936T allele of the VEGF gene may be associated with increased susceptibility to the development of preeclampsia and may be an independent risk factor for preeclampsia.
17826416	2007	Am. J. Obstet. Gynecol.	1097-6868	TITLE	0	0	7422	LONGTERM|GENE|GN|GT|DICTIONARY	vascular endothelial growth factor	Vascular endothelial growth factor	0#34		D011225	LONGTERM|DICTIONARY	preeclampsia	preeclampsia	81#93	NaN	Vascular endothelial growth factor gene +936 C/T polymorphism is associated with preeclampsia in Korean women.
17826416	2007	Am. J. Obstet. Gynecol.	1097-6868	OBJECTIVE	1	1	7422	LONGTERM|GENE|GT|DICTIONARY|GA	vascular endothelial growth factor	vascular endothelial growth factor	73#107		D011225	LONGTERM|DICTIONARY	preeclampsia	preeclampsia	138#150	NaN	The purpose of this study was to evaluate potential associations between vascular endothelial growth factor (VEGF) gene polymorphisms and preeclampsia.
17826416	2007	Am. J. Obstet. Gynecol.	1097-6868	OBJECTIVE	1	1	7422	SYMBOL|()|GENE|GN|DICTIONARY|EXTRACTED	vegf	VEGF	109#113	17826416-1-73-107	D011225	LONGTERM|DICTIONARY	preeclampsia	preeclampsia	138#150	NaN	The purpose of this study was to evaluate potential associations between vascular endothelial growth factor (VEGF) gene polymorphisms and preeclampsia.
16324400	2008	Zhonghua Yi Xue Za Zhi	0376-2491	CONCLUSION	4	9	672	SYMBOL|DICTIONARY	brca1	BRCA1	24#29		D001943	LONGTERM|DISEASE|DT|DICTIONARY	breast cancer	breast cancer	108#121		Four novel mutations in BRCA1 and one novel mutation in BRCA2 may be mutations characterized of early-onset breast cancer in Chinese population.
16324400	2008	Zhonghua Yi Xue Za Zhi	0376-2491	CONCLUSION	4	9	675	SYMBOL|DICTIONARY	brca2	BRCA2	56#61		D001943	LONGTERM|DISEASE|DT|DICTIONARY	breast cancer	breast cancer	108#121		Four novel mutations in BRCA1 and one novel mutation in BRCA2 may be mutations characterized of early-onset breast cancer in Chinese population.
18714564	2008	Eur. J. Gynaecol. Oncol.	0392-2936	CONCLUSIONS	4	9	7422	SYMBOL|DICTIONARY|EXTRACTED	vegf	VEGF	82#86	18714564-1-0-34	D016889	LONGTERM|DICTIONARY	endometrial carcinomas	endometrial carcinomas	175#197		Although limited by sample size, our study did not demonstrated any evidence that VEGF -460 C/T, +405 G/C, and +936 C/T polymorphisms are associated with an increased risk of endometrial carcinomas in Japanese women.
18714564	2008	Eur. J. Gynaecol. Oncol.	0392-2936	RESULTS	3	8	7422	SYMBOL|DICTIONARY|EXTRACTED	vegf	VEGF	12#16	18714564-1-0-34	D016889	LONGTERM|DISEASE|DN|DT|DICTIONARY	endometrial carcinoma	endometrial carcinoma	125#146		Futhermore, VEGF -460 C/T, +405 G/C, and +936 C/T polymorphisms were not associated with three-year disease-free survival of endometrial carcinoma patients.
18798262	2008	Int. J. Cancer	1097-0215	ALL_TEXT_3/3	3	8	4851	SYMBOL|DICTIONARY	notch1	Notch1	69#75		D008223	LONGTERM|DICTIONARY	lymphomas	lymphomas	24#33		Dideoxycytidine-induced lymphomas displayed the highest frequency of Notch1 mutations (49%), whereas in butadiene- and phenolphthalein-induced tumors showed lower frequencies (26 and 10%, respectively).
18798262	2008	Int. J. Cancer	1097-0215	ALL_TEXT_3/3	3	8	4851	SYMBOL|DICTIONARY	notch1	Notch1	69#75		D009369	LONGTERM|DICTIONARY	tumors	tumors	143#149		Dideoxycytidine-induced lymphomas displayed the highest frequency of Notch1 mutations (49%), whereas in butadiene- and phenolphthalein-induced tumors showed lower frequencies (26 and 10%, respectively).
18714564	2008	Eur. J. Gynaecol. Oncol.	0392-2936	OBJECTIVE	1	1	7422	LONGTERM|GENE|GT|DICTIONARY	vascular endothelial growth factor	Vascular endothelial growth factor	0#34		D016889	LONGTERM|DICTIONARY	endometrial carcinomas	endometrial carcinomas	139#161		Vascular endothelial growth factor (VEGF) is one of the most potent endothelial cell mitogens and plays a critical role in angiogenesis of endometrial carcinomas.
18714564	2008	Eur. J. Gynaecol. Oncol.	0392-2936	OBJECTIVE	1	1	7422	SYMBOL|()|DICTIONARY|EXTRACTED	vegf	VEGF	36#40	18714564-1-0-34	D016889	LONGTERM|DICTIONARY	endometrial carcinomas	endometrial carcinomas	139#161		Vascular endothelial growth factor (VEGF) is one of the most potent endothelial cell mitogens and plays a critical role in angiogenesis of endometrial carcinomas.
18714564	2008	Eur. J. Gynaecol. Oncol.	0392-2936	TITLE	0	0	7422	LONGTERM|GENE|GN|GT|DICTIONARY	vascular endothelial growth factor	vascular endothelial growth factor	21#55		D016889	LONGTERM|DICTIONARY	endometrial carcinomas	endometrial carcinomas	78#100		Association study of vascular endothelial growth factor gene polymorphisms in endometrial carcinomas in a Japanese population.
18714564	2008	Eur. J. Gynaecol. Oncol.	0392-2936	OBJECTIVE	1	3	7422	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	vegf	VEGF	38#42	18714564-1-0-34	D016889	LONGTERM|DICTIONARY	endometrial carcinomas	endometrial carcinomas	82#104		In this study we investigated whether VEGF gene polymorphisms are associated with endometrial carcinomas in a Japanese population.
18714564	2008	Eur. J. Gynaecol. Oncol.	0392-2936	OBJECTIVE	1	2	7422	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	vegf	VEGF	64#68	18714564-1-0-34	D002277	LONGTERM|DICTIONARY	carcinomas	carcinomas	100#110		Several studies have demonstrated positive associations between VEGF gene polymorphisms and several carcinomas.
18798262	2008	Int. J. Cancer	1097-0215	TITLE	0	0	4851	SYMBOL|DICTIONARY	notch1	Notch1	0#6		D008223	LONGTERM|DICTIONARY	lymphoma	lymphoma	61#69		Notch1 is a frequent mutational target in chemically induced lymphoma in mouse.
18714564	2008	Eur. J. Gynaecol. Oncol.	0392-2936	METHODS	2	4	7422	SYMBOL|DICTIONARY|EXTRACTED	vegf	VEGF	53#57	18714564-1-0-34	D016889	LONGTERM|DICTIONARY	endometrial carcinomas	endometrial carcinomas	126#148		The allele frequencies and genotype distributions of VEGF -460 C/T, +405 G/C, and +936 C/T polymorphisms were examined in 105 endometrial carcinomas and 179 controls using PCR-RFLP analysis.
18798262	2008	Int. J. Cancer	1097-0215	ALL_TEXT_1/3	1	2	4851	SYMBOL|DICTIONARY	notch1	Notch1	15#21		D008223	LONGTERM|DICTIONARY	mouse lymphoma	mouse lymphoma	87#101		We report that Notch1 is a prevalent and major mutational target in chemically induced mouse lymphoma.
18714564	2008	Eur. J. Gynaecol. Oncol.	0392-2936	RESULTS	3	6	7422	SYMBOL|DICTIONARY|EXTRACTED	vegf	VEGF	83#87	18714564-1-0-34	D016889	LONGTERM|DISEASE|DN|DT|DICTIONARY	endometrial carcinoma	endometrial carcinoma	208#229		No significant differences in the allele frequencies and genotype distributions of VEGF -460 C/T (p = 0.54, 0.90), +405 G/C (p = 0.31, 0.17), and +936 C/T polymorphisms (p = 0.46, 0.24) were observed between endometrial carcinoma patients and controls.
23698071	2013	J. Invest. Dermatol.	1523-1747	ALL_TEXT_2/3	2	3	1387	SYMBOL|DICTIONARY	cbp	CBP	53#56		D009369	LONGTERM|DISEASE|DT|DICTIONARY	tumor	tumor	146#151		We have used a potent and specific inhibitor of p300/CBP HAT activity, C646, in order to evaluate the functional contributions of p300/CBP HAT to tumor development and progression.
23698071	2013	J. Invest. Dermatol.	1523-1747	ALL_TEXT_2/3	2	3	1387	SYMBOL|DICTIONARY	cbp	CBP	135#138		D009369	LONGTERM|DISEASE|DT|DICTIONARY	tumor	tumor	146#151		We have used a potent and specific inhibitor of p300/CBP HAT activity, C646, in order to evaluate the functional contributions of p300/CBP HAT to tumor development and progression.
23698071	2013	J. Invest. Dermatol.	1523-1747	ALL_TEXT_2/3	2	3	2033	LONGTERM|DICTIONARY	p300	p300	48#52	NaN	D009369	LONGTERM|DISEASE|DT|DICTIONARY	tumor	tumor	146#151		We have used a potent and specific inhibitor of p300/CBP HAT activity, C646, in order to evaluate the functional contributions of p300/CBP HAT to tumor development and progression.
23698071	2013	J. Invest. Dermatol.	1523-1747	ALL_TEXT_2/3	2	3	2033	LONGTERM|DICTIONARY	p300	p300	130#134	NaN	D009369	LONGTERM|DISEASE|DT|DICTIONARY	tumor	tumor	146#151		We have used a potent and specific inhibitor of p300/CBP HAT activity, C646, in order to evaluate the functional contributions of p300/CBP HAT to tumor development and progression.
23698071	2013	J. Invest. Dermatol.	1523-1747	TITLE	0	0	2033	SYMBOL|DICTIONARY	p300 hat	p300 HAT	24#32		D008545	LONGTERM|CLINE|CN|DICTIONARY	melanoma	melanoma	133#141		Selective inhibition of p300 HAT blocks cell cycle progression, induces cellular senescence, and inhibits the DNA damage response in melanoma cells.
23698071	2013	J. Invest. Dermatol.	1523-1747	ALL_TEXT_3/3	3	7	2033	SYMBOL|DICTIONARY	p300 hat	p300 HAT	32#40		D009369	LONGTERM|DISEASE|DT|CLINE|CN|DICTIONARY	tumor	tumor	98#103		Together, our data suggest that p300 HAT activity mediates critical growth regulatory pathways in tumor cells and may serve as a potential therapeutic target for melanoma and other malignancies by promoting cellular responses to DNA damaging agents that are currently ineffective against specific cancers.
23698071	2013	J. Invest. Dermatol.	1523-1747	ALL_TEXT_3/3	3	7	2033	SYMBOL|DICTIONARY	p300 hat	p300 HAT	32#40		D008545	LONGTERM|DICTIONARY	melanoma	melanoma	162#170		Together, our data suggest that p300 HAT activity mediates critical growth regulatory pathways in tumor cells and may serve as a potential therapeutic target for melanoma and other malignancies by promoting cellular responses to DNA damaging agents that are currently ineffective against specific cancers.
23698071	2013	J. Invest. Dermatol.	1523-1747	ALL_TEXT_3/3	3	7	2033	SYMBOL|DICTIONARY	p300 hat	p300 HAT	32#40		D009369	LONGTERM|DICTIONARY	malignancies	malignancies	181#193		Together, our data suggest that p300 HAT activity mediates critical growth regulatory pathways in tumor cells and may serve as a potential therapeutic target for melanoma and other malignancies by promoting cellular responses to DNA damaging agents that are currently ineffective against specific cancers.
23698071	2013	J. Invest. Dermatol.	1523-1747	ALL_TEXT_3/3	3	7	2033	SYMBOL|DICTIONARY	p300 hat	p300 HAT	32#40		D009369	LONGTERM|DICTIONARY	cancers	cancers	297#304		Together, our data suggest that p300 HAT activity mediates critical growth regulatory pathways in tumor cells and may serve as a potential therapeutic target for melanoma and other malignancies by promoting cellular responses to DNA damaging agents that are currently ineffective against specific cancers.
23698071	2013	J. Invest. Dermatol.	1523-1747	ALL_TEXT_3/3	3	5	2033	SYMBOL|DICTIONARY	p300 hat	p300 HAT	25#33		D008545	LONGTERM|DICTIONARY	melanoma	melanoma	57#65		Global assessment of the p300 HAT transcriptome in human melanoma identified functional roles in promoting cell cycle progression, chromatin assembly, and activation of DNA repair pathways through direct transcriptional regulatory mechanisms.
12828656	2003	J. Periodont. Res.	0022-3484	CONCLUSION	4	8	4049	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	lt alpha	LT-alpha	71#79	12828656-3-338-355	D055113	LONGTERM|DICTIONARY	chronic periodontitis	chronic periodontitis	135#156		Our data suggest that combined genotypes composed of the TNF-alpha and LT-alpha gene polymorphisms may influence the susceptibility to chronic periodontitis.
12828656	2003	J. Periodont. Res.	0022-3484	CONCLUSION	4	8	7124	SYMBOL|EXTRACTED	tnf-alpha	TNF-alpha	57#66	12828656-2-0-21	D055113	LONGTERM|DICTIONARY	chronic periodontitis	chronic periodontitis	135#156		Our data suggest that combined genotypes composed of the TNF-alpha and LT-alpha gene polymorphisms may influence the susceptibility to chronic periodontitis.
16082623	2005	Br J Surg	0007-1323	BACKGROUND	1	1	4314	SYMBOL|DICTIONARY	mmp 3	MMP-3	129#134		D017544	LONGTERM|DICTIONARY	abdominal aortic aneurysms	abdominal aortic aneurysms	228#254		The aim of the study was to investigate the effect of functional polymorphisms in promoters of matrix metalloproteinase (MMP) 2, MMP-3, MMP-9, MMP-12 and plasminogen activator inhibitor (PAI) 1 genes on the growth rate of small abdominal aortic aneurysms (AAA).
16082623	2005	Br J Surg	0007-1323	BACKGROUND	1	1	4314	SYMBOL|DICTIONARY	mmp 3	MMP-3	129#134		D017544	SYMBOL|()|DICTIONARY|EXTRACTED	aaa	AAA	256#259	16082623-1-228-254	The aim of the study was to investigate the effect of functional polymorphisms in promoters of matrix metalloproteinase (MMP) 2, MMP-3, MMP-9, MMP-12 and plasminogen activator inhibitor (PAI) 1 genes on the growth rate of small abdominal aortic aneurysms (AAA).
16082623	2005	Br J Surg	0007-1323	BACKGROUND	1	1	4318	SYMBOL|DICTIONARY	mmp 9	MMP-9	136#141		D017544	LONGTERM|DICTIONARY	abdominal aortic aneurysms	abdominal aortic aneurysms	228#254		The aim of the study was to investigate the effect of functional polymorphisms in promoters of matrix metalloproteinase (MMP) 2, MMP-3, MMP-9, MMP-12 and plasminogen activator inhibitor (PAI) 1 genes on the growth rate of small abdominal aortic aneurysms (AAA).
16082623	2005	Br J Surg	0007-1323	BACKGROUND	1	1	4318	SYMBOL|DICTIONARY	mmp 9	MMP-9	136#141		D017544	SYMBOL|()|DICTIONARY|EXTRACTED	aaa	AAA	256#259	16082623-1-228-254	The aim of the study was to investigate the effect of functional polymorphisms in promoters of matrix metalloproteinase (MMP) 2, MMP-3, MMP-9, MMP-12 and plasminogen activator inhibitor (PAI) 1 genes on the growth rate of small abdominal aortic aneurysms (AAA).
16082623	2005	Br J Surg	0007-1323	BACKGROUND	1	1	4321	SYMBOL|DICTIONARY	mmp 12	MMP-12	143#149		D017544	LONGTERM|DICTIONARY	abdominal aortic aneurysms	abdominal aortic aneurysms	228#254		The aim of the study was to investigate the effect of functional polymorphisms in promoters of matrix metalloproteinase (MMP) 2, MMP-3, MMP-9, MMP-12 and plasminogen activator inhibitor (PAI) 1 genes on the growth rate of small abdominal aortic aneurysms (AAA).
16082623	2005	Br J Surg	0007-1323	BACKGROUND	1	1	4321	SYMBOL|DICTIONARY	mmp 12	MMP-12	143#149		D017544	SYMBOL|()|DICTIONARY|EXTRACTED	aaa	AAA	256#259	16082623-1-228-254	The aim of the study was to investigate the effect of functional polymorphisms in promoters of matrix metalloproteinase (MMP) 2, MMP-3, MMP-9, MMP-12 and plasminogen activator inhibitor (PAI) 1 genes on the growth rate of small abdominal aortic aneurysms (AAA).
16082623	2005	Br J Surg	0007-1323	BACKGROUND	1	1	4313	SYMBOL|DICTIONARY	matrix metalloproteinase (mmp) 2	matrix metalloproteinase (MMP) 2	95#127		D017544	LONGTERM|DICTIONARY	abdominal aortic aneurysms	abdominal aortic aneurysms	228#254		The aim of the study was to investigate the effect of functional polymorphisms in promoters of matrix metalloproteinase (MMP) 2, MMP-3, MMP-9, MMP-12 and plasminogen activator inhibitor (PAI) 1 genes on the growth rate of small abdominal aortic aneurysms (AAA).
16082623	2005	Br J Surg	0007-1323	BACKGROUND	1	1	4313	SYMBOL|DICTIONARY	matrix metalloproteinase (mmp) 2	matrix metalloproteinase (MMP) 2	95#127		D017544	SYMBOL|()|DICTIONARY|EXTRACTED	aaa	AAA	256#259	16082623-1-228-254	The aim of the study was to investigate the effect of functional polymorphisms in promoters of matrix metalloproteinase (MMP) 2, MMP-3, MMP-9, MMP-12 and plasminogen activator inhibitor (PAI) 1 genes on the growth rate of small abdominal aortic aneurysms (AAA).
16082623	2005	Br J Surg	0007-1323	BACKGROUND	1	1	5054	LONGTERM|DICTIONARY	plasminogen activator inhibitor (pai) 1	plasminogen activator inhibitor (PAI) 1	154#193		D017544	LONGTERM|DICTIONARY	abdominal aortic aneurysms	abdominal aortic aneurysms	228#254		The aim of the study was to investigate the effect of functional polymorphisms in promoters of matrix metalloproteinase (MMP) 2, MMP-3, MMP-9, MMP-12 and plasminogen activator inhibitor (PAI) 1 genes on the growth rate of small abdominal aortic aneurysms (AAA).
16082623	2005	Br J Surg	0007-1323	BACKGROUND	1	1	5054	LONGTERM|DICTIONARY	plasminogen activator inhibitor (pai) 1	plasminogen activator inhibitor (PAI) 1	154#193		D017544	SYMBOL|()|DICTIONARY|EXTRACTED	aaa	AAA	256#259	16082623-1-228-254	The aim of the study was to investigate the effect of functional polymorphisms in promoters of matrix metalloproteinase (MMP) 2, MMP-3, MMP-9, MMP-12 and plasminogen activator inhibitor (PAI) 1 genes on the growth rate of small abdominal aortic aneurysms (AAA).
16082623	2005	Br J Surg	0007-1323	BACKGROUND	1	1	5054	SYMBOL|GENE|GN|DICTIONARY	plasminogen activator inhibitor (pai) 1	plasminogen activator inhibitor (PAI) 1	154#193		D017544	LONGTERM|DICTIONARY	abdominal aortic aneurysms	abdominal aortic aneurysms	228#254		The aim of the study was to investigate the effect of functional polymorphisms in promoters of matrix metalloproteinase (MMP) 2, MMP-3, MMP-9, MMP-12 and plasminogen activator inhibitor (PAI) 1 genes on the growth rate of small abdominal aortic aneurysms (AAA).
16082623	2005	Br J Surg	0007-1323	BACKGROUND	1	1	5054	SYMBOL|GENE|GN|DICTIONARY	plasminogen activator inhibitor (pai) 1	plasminogen activator inhibitor (PAI) 1	154#193		D017544	SYMBOL|()|DICTIONARY|EXTRACTED	aaa	AAA	256#259	16082623-1-228-254	The aim of the study was to investigate the effect of functional polymorphisms in promoters of matrix metalloproteinase (MMP) 2, MMP-3, MMP-9, MMP-12 and plasminogen activator inhibitor (PAI) 1 genes on the growth rate of small abdominal aortic aneurysms (AAA).
20646601	2010	Zhonghua Yi Xue Za Zhi	0376-2491	METHODS	2	5	3845	LONGTERM|DICTIONARY	k-ras	K-ras	30#35	NaN	D015179	LONGTERM|DISEASE|DT|DICTIONARY	colorectal cancer	colorectal cancer	95#112		Then the associations between K-ras mutation status and clinicopathological characteristics in colorectal cancer were analyzed.
20646601	2010	Zhonghua Yi Xue Za Zhi	0376-2491	TITLE	0	0	3845	LONGTERM|DICTIONARY	k-ras	K-ras	17#22	NaN	D015179	LONGTERM|DISEASE|DT|DICTIONARY	colorectal cancer	colorectal cancer	36#53		[Significance of K-ras detection in colorectal cancer].
20646601	2010	Zhonghua Yi Xue Za Zhi	0376-2491	OBJECTIVE	1	1	3845	LONGTERM|DICTIONARY	k-ras	K-ras	36#41	NaN	D015179	LONGTERM|DISEASE|DT|DICTIONARY	colorectal cancer	colorectal cancer	50#67		To determine the mutation status of K-ras gene in colorectal cancer and analyze the associations between its mutation status and clinicopathological characteristics in colorectal cancer so as to select the patients likely to benefit from a targeted therapy.
20646601	2010	Zhonghua Yi Xue Za Zhi	0376-2491	OBJECTIVE	1	1	3845	LONGTERM|DICTIONARY	k-ras	K-ras	36#41	NaN	D015179	LONGTERM|DISEASE|DT|DICTIONARY	colorectal cancer	colorectal cancer	168#185		To determine the mutation status of K-ras gene in colorectal cancer and analyze the associations between its mutation status and clinicopathological characteristics in colorectal cancer so as to select the patients likely to benefit from a targeted therapy.
12209087	2002	J. Allergy Clin. Immunol.	0091-6749	ALL_TEXT_1/3	1	2	3458	SYMBOL|DICTIONARY	ifng	IFNG	16#20		D001249	LONGTERM|DICTIONARY	asthma	asthma	60#66		We selected the IFNG locus on 12q21 as a candidate gene for asthma on the basis of its role in pathophysiology and positive linkage demonstrated in other populations.
12209087	2002	J. Allergy Clin. Immunol.	0091-6749	ALL_TEXT_1/3	1	3	3497	LONGTERM|DICTIONARY	ige	IgE	116#119	NaN	D001249	LONGTERM|DICTIONARY	asthma	asthma	93#99		The aim of this study was to investigate association of a CA-repeat marker in this gene with asthma and total serum IgE levels in the North Indian population.
12209087	2002	J. Allergy Clin. Immunol.	0091-6749	TITLE	0	0	3458	SYMBOL|GENE|GN|DICTIONARY	ifng	IFNG	15#19		D001249	LONGTERM|DICTIONARY	asthma	asthma	43#49		Association of IFNG gene polymorphism with asthma in the Indian population.
11043512	2000	J. Hum. Genet.	1434-5161	ALL_TEXT_3/3	3	5	1636	SYMBOL|DICTIONARY|EXTRACTED	ace	ACE	49#52	11043512-0-87-116	D006973	LONGTERM|DICTIONARY	hypertension	hypertension	249#261		These data suggest that genetic variation at the ACE locus may be associated with some determinants for blood pressure in elderly persons, and imply the involvement of the ACE insertion/deletion polymorphism in the etiology of age-related essential hypertension in the Japanese population.
11043512	2000	J. Hum. Genet.	1434-5161	ALL_TEXT_3/3	3	5	1636	SYMBOL|DICTIONARY|EXTRACTED	ace	ACE	172#175	11043512-0-87-116	D006973	LONGTERM|DICTIONARY	hypertension	hypertension	249#261		These data suggest that genetic variation at the ACE locus may be associated with some determinants for blood pressure in elderly persons, and imply the involvement of the ACE insertion/deletion polymorphism in the etiology of age-related essential hypertension in the Japanese population.
11043512	2000	J. Hum. Genet.	1434-5161	ALL_TEXT_2/3	2	2	1636	SYMBOL|DICTIONARY|EXTRACTED	ace	ACE	46#49	11043512-0-87-116	D006973	LONGTERM|DICTIONARY	hypertension	hypertension	78#90		We investigated a possible association of the ACE polymorphism with essential hypertension in a total of 263 cases/controls from among the elderly (age, over 70 years) and middle-aged (age between 30 and 60 years) Japanese population.
11043512	2000	J. Hum. Genet.	1434-5161	TITLE	0	0	1636	LONGTERM|GENE|GT|DICTIONARY|GA	angiotensin converting enzyme	angiotensin-converting enzyme	87#116		D006973	LONGTERM|DICTIONARY	hypertension	hypertension	25#37		Association of essential hypertension in elderly Japanese with I/D polymorphism of the angiotensin-converting enzyme (ACE) gene.
11043512	2000	J. Hum. Genet.	1434-5161	TITLE	0	0	1636	SYMBOL|()|GENE|GN|DICTIONARY|EXTRACTED	ace	ACE	118#121	11043512-0-87-116	D006973	LONGTERM|DICTIONARY	hypertension	hypertension	25#37		Association of essential hypertension in elderly Japanese with I/D polymorphism of the angiotensin-converting enzyme (ACE) gene.
11043512	2000	J. Hum. Genet.	1434-5161	ALL_TEXT_1/3	1	1	1636	LONGTERM|GENE|GT|DICTIONARY	angiotensin converting enzyme	angiotensin-converting enzyme	92#121		D009203	LONGTERM|DICTIONARY	myocardial infarction	myocardial infarction	147#168		Recent evidence suggests that an insertion/deletion (I/D) polymorphism of the gene encoding angiotensin-converting enzyme (ACE) is associated with myocardial infarction and related cardiovascular diseases.
11043512	2000	J. Hum. Genet.	1434-5161	ALL_TEXT_1/3	1	1	1636	LONGTERM|GENE|GT|DICTIONARY	angiotensin converting enzyme	angiotensin-converting enzyme	92#121		D002318	LONGTERM|DICTIONARY	cardiovascular diseases	cardiovascular diseases	181#204		Recent evidence suggests that an insertion/deletion (I/D) polymorphism of the gene encoding angiotensin-converting enzyme (ACE) is associated with myocardial infarction and related cardiovascular diseases.
11043512	2000	J. Hum. Genet.	1434-5161	ALL_TEXT_1/3	1	1	1636	SYMBOL|()|DICTIONARY|EXTRACTED	ace	ACE	123#126	11043512-0-87-116	D009203	LONGTERM|DICTIONARY	myocardial infarction	myocardial infarction	147#168		Recent evidence suggests that an insertion/deletion (I/D) polymorphism of the gene encoding angiotensin-converting enzyme (ACE) is associated with myocardial infarction and related cardiovascular diseases.
11043512	2000	J. Hum. Genet.	1434-5161	ALL_TEXT_1/3	1	1	1636	SYMBOL|()|DICTIONARY|EXTRACTED	ace	ACE	123#126	11043512-0-87-116	D002318	LONGTERM|DICTIONARY	cardiovascular diseases	cardiovascular diseases	181#204		Recent evidence suggests that an insertion/deletion (I/D) polymorphism of the gene encoding angiotensin-converting enzyme (ACE) is associated with myocardial infarction and related cardiovascular diseases.
12484521	2003	Hypertens. Res.	0916-9636	ALL_TEXT_3/3	3	8	5327	LONGTERM|DICTIONARY	t-pa	t-PA	117#121	NaN	D006973	LONGTERM|DICTIONARY	hypertension	hypertension	195#207		Thus, in this case control study, neither the presence of the insertion allele of the Alu-repeat polymorphism of the t-PA nor the level of t-PA antigen were associated with the risk of essential hypertension.
12484521	2003	Hypertens. Res.	0916-9636	ALL_TEXT_3/3	3	8	5327	LONGTERM|DICTIONARY	t-pa	t-PA	139#143	NaN	D006973	LONGTERM|DICTIONARY	hypertension	hypertension	195#207		Thus, in this case control study, neither the presence of the insertion allele of the Alu-repeat polymorphism of the t-PA nor the level of t-PA antigen were associated with the risk of essential hypertension.
11263767	2001	Arthritis Rheum.	0004-3591	RESULTS	3	8	3123	SYMBOL|DICTIONARY	drb1	DRB1	32#36		D001172	SYMBOL|DISEASE|DN|DICTIONARY|EXTRACTED	ra	RA	154#156	11263767-1-19-39	Among the SE-negative subjects, DRB1 genotypes with 1 or 2 DRB1*XP4n alleles were significantly overrepresented in the control subjects compared with the RA patients, whereas DRB1*XP4p/XP4p genotypes were equally represented in the patients and controls.
11263767	2001	Arthritis Rheum.	0004-3591	RESULTS	3	8	3123	SYMBOL|DICTIONARY	drb1	DRB1	32#36		D012753	LONGTERM|DICTIONARY	se	SE	10#12	NaN	Among the SE-negative subjects, DRB1 genotypes with 1 or 2 DRB1*XP4n alleles were significantly overrepresented in the control subjects compared with the RA patients, whereas DRB1*XP4p/XP4p genotypes were equally represented in the patients and controls.
11263767	2001	Arthritis Rheum.	0004-3591	RESULTS	3	8	3123	SYMBOL|DICTIONARY	drb1	DRB1	59#63		D001172	SYMBOL|DISEASE|DN|DICTIONARY|EXTRACTED	ra	RA	154#156	11263767-1-19-39	Among the SE-negative subjects, DRB1 genotypes with 1 or 2 DRB1*XP4n alleles were significantly overrepresented in the control subjects compared with the RA patients, whereas DRB1*XP4p/XP4p genotypes were equally represented in the patients and controls.
11263767	2001	Arthritis Rheum.	0004-3591	RESULTS	3	8	3123	SYMBOL|DICTIONARY	drb1	DRB1	59#63		D012753	LONGTERM|DICTIONARY	se	SE	10#12	NaN	Among the SE-negative subjects, DRB1 genotypes with 1 or 2 DRB1*XP4n alleles were significantly overrepresented in the control subjects compared with the RA patients, whereas DRB1*XP4p/XP4p genotypes were equally represented in the patients and controls.
11263767	2001	Arthritis Rheum.	0004-3591	RESULTS	3	8	3123	SYMBOL|DICTIONARY	drb1	DRB1	175#179		D001172	SYMBOL|DISEASE|DN|DICTIONARY|EXTRACTED	ra	RA	154#156	11263767-1-19-39	Among the SE-negative subjects, DRB1 genotypes with 1 or 2 DRB1*XP4n alleles were significantly overrepresented in the control subjects compared with the RA patients, whereas DRB1*XP4p/XP4p genotypes were equally represented in the patients and controls.
11263767	2001	Arthritis Rheum.	0004-3591	RESULTS	3	8	3123	SYMBOL|DICTIONARY	drb1	DRB1	175#179		D012753	LONGTERM|DICTIONARY	se	SE	10#12	NaN	Among the SE-negative subjects, DRB1 genotypes with 1 or 2 DRB1*XP4n alleles were significantly overrepresented in the control subjects compared with the RA patients, whereas DRB1*XP4p/XP4p genotypes were equally represented in the patients and controls.
16226919	2006	Mol. Ther.	1525-0016	ALL_TEXT_3/3	3	11	6121	SYMBOL|DICTIONARY	rpe65	RPE65	194#199		D057130	LONGTERM|DICTIONARY	leber congenital amaurosis	Leber congenital amaurosis	157#183		Successful, stable restoration of rod and cone photoreceptor function in these dogs has important implications for treatment of human patients affected with Leber congenital amaurosis caused by RPE65 mutations.
11263767	2001	Arthritis Rheum.	0004-3591	TITLE	0	0	3123	SYMBOL|DICTIONARY	hla drb1	HLA-DRB1	37#45		D001172	LONGTERM|DICTIONARY	rheumatoid arthritis	rheumatoid arthritis	83#103		Influence of shared epitope-negative HLA-DRB1 alleles on genetic susceptibility to rheumatoid arthritis.
11263767	2001	Arthritis Rheum.	0004-3591	TITLE	0	0	3123	SYMBOL|DICTIONARY	hla drb1	HLA-DRB1	37#45		D012753	LONGTERM|DICTIONARY	shared epitope	shared epitope	13#27	NaN	Influence of shared epitope-negative HLA-DRB1 alleles on genetic susceptibility to rheumatoid arthritis.
11263767	2001	Arthritis Rheum.	0004-3591	OBJECTIVE	1	2	3123	SYMBOL|DICTIONARY	hla drb1	HLA-DRB1	36#44		D001172	SYMBOL|EXTRACTED	ra	RA	82#84	11263767-1-19-39	It is not known whether SE-negative HLA-DRB1 alleles influence the development of RA.
11263767	2001	Arthritis Rheum.	0004-3591	OBJECTIVE	1	2	3123	SYMBOL|DICTIONARY	hla drb1	HLA-DRB1	36#44		D012753	LONGTERM|DICTIONARY	se	SE	24#26	NaN	It is not known whether SE-negative HLA-DRB1 alleles influence the development of RA.
11263767	2001	Arthritis Rheum.	0004-3591	OBJECTIVE	1	3	3123	SYMBOL|DICTIONARY	drb1	DRB1	65#69		D001172	SYMBOL|EXTRACTED	ra	RA	95#97	11263767-1-19-39	This study examined the influence of SE-negative HLA-DR alleles (DRB1*X) on the development of RA in 3 different French populations.
11263767	2001	Arthritis Rheum.	0004-3591	OBJECTIVE	1	3	3123	SYMBOL|DICTIONARY	drb1	DRB1	65#69		D012753	LONGTERM|DICTIONARY	se	SE	37#39	NaN	This study examined the influence of SE-negative HLA-DR alleles (DRB1*X) on the development of RA in 3 different French populations.
21285140	2011	Am J Psychiatry	1535-7228	RESULTS	3	7	7037	SYMBOL|DICTIONARY	tfrc	TFRC	129#133		D008607	LONGTERM|DICTIONARY	mental retardation syndrome	mental retardation syndrome	192#219	NaN	The most consistently supported candidate associations across data sets included a 1.6-Mb deletion in chromosome 3q29 (21 genes, TFRC to BDH1) that was previously described in a mild-moderate mental retardation syndrome, exonic duplications in the gene for vasoactive intestinal peptide receptor 2 (VIPR2), and exonic duplications in C16orf72.
21285140	2011	Am J Psychiatry	1535-7228	RESULTS	3	7	622	SYMBOL|DICTIONARY	bdh1	BDH1	137#141		D008607	LONGTERM|DICTIONARY	mental retardation syndrome	mental retardation syndrome	192#219	NaN	The most consistently supported candidate associations across data sets included a 1.6-Mb deletion in chromosome 3q29 (21 genes, TFRC to BDH1) that was previously described in a mild-moderate mental retardation syndrome, exonic duplications in the gene for vasoactive intestinal peptide receptor 2 (VIPR2), and exonic duplications in C16orf72.
21285140	2011	Am J Psychiatry	1535-7228	RESULTS	3	7	7434	LONGTERM|DICTIONARY	vasoactive intestinal peptide receptor 2	vasoactive intestinal peptide receptor 2	257#297		D008607	LONGTERM|DICTIONARY	mental retardation syndrome	mental retardation syndrome	192#219	NaN	The most consistently supported candidate associations across data sets included a 1.6-Mb deletion in chromosome 3q29 (21 genes, TFRC to BDH1) that was previously described in a mild-moderate mental retardation syndrome, exonic duplications in the gene for vasoactive intestinal peptide receptor 2 (VIPR2), and exonic duplications in C16orf72.
21285140	2011	Am J Psychiatry	1535-7228	RESULTS	3	7	7434	SYMBOL|()|DICTIONARY|EXTRACTED	vipr2	VIPR2	299#304	21285140-7-257-297	D008607	LONGTERM|DICTIONARY	mental retardation syndrome	mental retardation syndrome	192#219	NaN	The most consistently supported candidate associations across data sets included a 1.6-Mb deletion in chromosome 3q29 (21 genes, TFRC to BDH1) that was previously described in a mild-moderate mental retardation syndrome, exonic duplications in the gene for vasoactive intestinal peptide receptor 2 (VIPR2), and exonic duplications in C16orf72.
21285140	2011	Am J Psychiatry	1535-7228	RESULTS	3	7	29035	SYMBOL|DICTIONARY	c16orf72	C16orf72	334#342		D008607	LONGTERM|DICTIONARY	mental retardation syndrome	mental retardation syndrome	192#219	NaN	The most consistently supported candidate associations across data sets included a 1.6-Mb deletion in chromosome 3q29 (21 genes, TFRC to BDH1) that was previously described in a mild-moderate mental retardation syndrome, exonic duplications in the gene for vasoactive intestinal peptide receptor 2 (VIPR2), and exonic duplications in C16orf72.
16917940	2007	Am. J. Med. Genet. B Neuropsychiatr. Genet.	1552-4841	TITLE	0	0	1815	LONGTERM|GENE|GT|DICTIONARY|GA	dopamine d4 receptor	dopamine D4 receptor	24#44		D001289	LONGTERM|DISEASE|DT|DICTIONARY	attention deficit hyperactivity disorder	attention deficit hyperactivity disorder	61#101		Exon 3 polymorphisms of dopamine D4 receptor (DRD4) gene and attention deficit hyperactivity disorder in Chinese children.
16917940	2007	Am. J. Med. Genet. B Neuropsychiatr. Genet.	1552-4841	TITLE	0	0	1815	SYMBOL|()|GENE|GN|DICTIONARY|EXTRACTED	drd4	DRD4	46#50	16917940-0-24-44	D001289	LONGTERM|DISEASE|DT|DICTIONARY	attention deficit hyperactivity disorder	attention deficit hyperactivity disorder	61#101		Exon 3 polymorphisms of dopamine D4 receptor (DRD4) gene and attention deficit hyperactivity disorder in Chinese children.
16917940	2007	Am. J. Med. Genet. B Neuropsychiatr. Genet.	1552-4841	ALL_TEXT_1/3	1	1	1815	LONGTERM|GENE|GT|DICTIONARY|GA	dopamine d4 receptor	Dopamine D4 receptor	0#20		D001289	LONGTERM|DICTIONARY	attention deficit hyperactivity disorder	attention deficit hyperactivity disorder	70#110		Dopamine D4 receptor (DRD4) gene is implicated in the pathogenesis of attention deficit hyperactivity disorder (ADHD).
16917940	2007	Am. J. Med. Genet. B Neuropsychiatr. Genet.	1552-4841	ALL_TEXT_1/3	1	1	1815	LONGTERM|GENE|GT|DICTIONARY|GA	dopamine d4 receptor	Dopamine D4 receptor	0#20		D001289	SYMBOL|()|DICTIONARY|EXTRACTED	adhd	ADHD	112#116	16917940-1-70-110	Dopamine D4 receptor (DRD4) gene is implicated in the pathogenesis of attention deficit hyperactivity disorder (ADHD).
16917940	2007	Am. J. Med. Genet. B Neuropsychiatr. Genet.	1552-4841	ALL_TEXT_1/3	1	1	1815	SYMBOL|()|GENE|GN|DICTIONARY|EXTRACTED	drd4	DRD4	22#26	16917940-0-24-44	D001289	LONGTERM|DICTIONARY	attention deficit hyperactivity disorder	attention deficit hyperactivity disorder	70#110		Dopamine D4 receptor (DRD4) gene is implicated in the pathogenesis of attention deficit hyperactivity disorder (ADHD).
16917940	2007	Am. J. Med. Genet. B Neuropsychiatr. Genet.	1552-4841	ALL_TEXT_1/3	1	1	1815	SYMBOL|()|GENE|GN|DICTIONARY|EXTRACTED	drd4	DRD4	22#26	16917940-0-24-44	D001289	SYMBOL|()|DICTIONARY|EXTRACTED	adhd	ADHD	112#116	16917940-1-70-110	Dopamine D4 receptor (DRD4) gene is implicated in the pathogenesis of attention deficit hyperactivity disorder (ADHD).
15583997	2005	Zhonghua Yi Xue Yi Chuan Xue Za Zhi	1003-9406	CONCLUSION	4	9	1585	SYMBOL|GENE|GN|DICTIONARY	cyp11b2	CYP11B2	56#63		D006973	LONGTERM|DICTIONARY	hypertension	hypertension	92#104		The results suggested that the T(-344)C polymorphism of CYP11B2 gene may be associated with hypertension in female Kazakh population of Xinjiang Barlikun area.
16917940	2007	Am. J. Med. Genet. B Neuropsychiatr. Genet.	1552-4841	ALL_TEXT_1/3	1	4	1815	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	drd4	DRD4	83#87	16917940-0-24-44	D001289	SYMBOL|DICTIONARY|EXTRACTED	adhd	ADHD	74#78	16917940-1-70-110	We therefore perform another study to investigate the association between ADHD and DRD4 gene polymorphism in Chinese children in Hong Kong.
15583997	2005	Zhonghua Yi Xue Yi Chuan Xue Za Zhi	1003-9406	RESULTS	3	6	1585	SYMBOL|DICTIONARY	cyp11b2	CYP11B2	19#26		D006973	LONGTERM|DICTIONARY	hypertensives	hypertensives	82#95	NaN	The frequencies of CYP11B2 genotypes of CC, CT and TT were 0.20, 0.50 and 0.30 in hypertensives respectively, and 0.12, 0.61 and 0.27 in controls respectively.
16917940	2007	Am. J. Med. Genet. B Neuropsychiatr. Genet.	1552-4841	ALL_TEXT_3/3	3	9	1815	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	drd4	DRD4	83#87	16917940-0-24-44	D001289	SYMBOL|DICTIONARY|EXTRACTED	adhd	ADHD	74#78	16917940-1-70-110	Both family-based and case-control analyses showed no association between ADHD and DRD4 gene polymorphisms (transmission dysequilibrium test (TDT): P = 0.91 and P = 0.33 for the 7-repeat and 4-repeat alleles, respectively; OR for the 7-repeat allele = 2.01 (95% CI 0.07-60.4, P = 0.66), OR for the 4-repeat allele = 1.51 (95% CI 0.80-2.85, P = 0.2)).
15583997	2005	Zhonghua Yi Xue Yi Chuan Xue Za Zhi	1003-9406	OBJECTIVE	1	1	1585	LONGTERM|GENE|GN|DICTIONARY	aldosterone synthase	aldosterone synthase	63#83		D006973	LONGTERM|DICTIONARY	hypertension	hypertension	112#124		To investigate the association of the T(-344)C polymorphism of aldosterone synthase gene CYP11B2 with essential hypertension in Xinjiang Kazakh isolated population.
15583997	2005	Zhonghua Yi Xue Yi Chuan Xue Za Zhi	1003-9406	OBJECTIVE	1	1	1585	SYMBOL|DICTIONARY	cyp11b2	CYP11B2	89#96		D006973	LONGTERM|DICTIONARY	hypertension	hypertension	112#124		To investigate the association of the T(-344)C polymorphism of aldosterone synthase gene CYP11B2 with essential hypertension in Xinjiang Kazakh isolated population.
11553050	2001	Clin. Genet.	0009-9163	ALL_TEXT_1/3	1	1	5080	SYMBOL|GENE|GN|DICTIONARY	pax6	PAX6	67#71		D015783	LONGTERM|DICTIONARY	congenital aniridia	Congenital aniridia	0#19		Congenital aniridia is due to deletions and point mutations in the PAX6 gene.
11553050	2001	Clin. Genet.	0009-9163	TITLE	0	0	5080	SYMBOL|DICTIONARY	pax6	PAX6	0#4		D015783	LONGTERM|DICTIONARY	aniridia	aniridia	31#39		PAX6 mutation in a family with aniridia, congenital ptosis, and mental retardation.
11553050	2001	Clin. Genet.	0009-9163	TITLE	0	0	5080	SYMBOL|DICTIONARY	pax6	PAX6	0#4		C566737	LONGTERM|DICTIONARY	congenital ptosis	congenital ptosis	41#58		PAX6 mutation in a family with aniridia, congenital ptosis, and mental retardation.
11553050	2001	Clin. Genet.	0009-9163	TITLE	0	0	5080	SYMBOL|DICTIONARY	pax6	PAX6	0#4		D008607	LONGTERM|DICTIONARY	mental retardation	mental retardation	64#82		PAX6 mutation in a family with aniridia, congenital ptosis, and mental retardation.
19173862	2009	Zhonghua Liu Xing Bing Xue Za Zhi	0254-6450	TITLE	0	0	7507	SYMBOL|GENE|GN|DICTIONARY	xpa	XPA	52#55		D004938	LONGTERM|DISEASE|DT|DICTIONARY	esophageal cancer	esophageal cancer	83#100		[Study on the relationship between polymorphisms of XPA gene and susceptibility of esophageal cancer].
11245417	2001	Cancer Res.	0008-5472	ALL_TEXT_2/3	2	2	10	SYMBOL|DICTIONARY|EXTRACTED	nat2	NAT2	18#22	11245417-0-53-74	D015179	SYMBOL|DICTIONARY|EXTRACTED	crc	CRC	80#83	11245417-1-150-167	We determined the NAT2 genotypes and allele frequencies for 86 individuals with CRC who had mutations in hMLH1, hMSH2, or hPMS1.
11245417	2001	Cancer Res.	0008-5472	ALL_TEXT_2/3	2	2	4292	SYMBOL|DICTIONARY	hmlh1	hMLH1	105#110		D015179	SYMBOL|DICTIONARY|EXTRACTED	crc	CRC	80#83	11245417-1-150-167	We determined the NAT2 genotypes and allele frequencies for 86 individuals with CRC who had mutations in hMLH1, hMSH2, or hPMS1.
11245417	2001	Cancer Res.	0008-5472	ALL_TEXT_2/3	2	2	4436	SYMBOL|DICTIONARY	hmsh2	hMSH2	112#117		D015179	SYMBOL|DICTIONARY|EXTRACTED	crc	CRC	80#83	11245417-1-150-167	We determined the NAT2 genotypes and allele frequencies for 86 individuals with CRC who had mutations in hMLH1, hMSH2, or hPMS1.
11245417	2001	Cancer Res.	0008-5472	ALL_TEXT_2/3	2	2	5378	SYMBOL|DICTIONARY	hpms1	hPMS1	122#127		D015179	SYMBOL|DICTIONARY|EXTRACTED	crc	CRC	80#83	11245417-1-150-167	We determined the NAT2 genotypes and allele frequencies for 86 individuals with CRC who had mutations in hMLH1, hMSH2, or hPMS1.
18596619	2008	Neuroreport	0959-4965	ALL_TEXT_2/3	2	2	627	SYMBOL|DICTIONARY	bdnf	BDNF	25#29		D012559	LONGTERM|DICTIONARY	schizophrenia	schizophrenia	95#108		We hypothesized that the BDNF-COMT gene interaction would affect the symptoms and cognition in schizophrenia.
18596619	2008	Neuroreport	0959-4965	ALL_TEXT_2/3	2	2	1312	SYMBOL|GENE|GN|DICTIONARY	comt	COMT	30#34		D012559	LONGTERM|DICTIONARY	schizophrenia	schizophrenia	95#108		We hypothesized that the BDNF-COMT gene interaction would affect the symptoms and cognition in schizophrenia.
11245417	2001	Cancer Res.	0008-5472	ALL_TEXT_3/3	3	4	10	SYMBOL|DICTIONARY|EXTRACTED	nat2	NAT2	56#60	11245417-0-53-74	D015179	SYMBOL|DICTIONARY|EXTRACTED	crc	CRC	254#257	11245417-1-150-167	However, when individuals were stratified separately by NAT2 polymorphism (NAT2*5, NAT2*6, and NAT2*7), those who were heterozygous at the mutant locus NAT2*7 after adjustment for the NAT2 mutant loci NAT2*5 and NAT2*6 had a significantly higher risk of CRC (hazard ratio, 2.96; P = 0.012) and all of the cancers (hazard ratio, 3.37; P = 0.00004) than individuals homozygous for wild type at the NAT2*7 allele.
11245417	2001	Cancer Res.	0008-5472	ALL_TEXT_3/3	3	4	10	SYMBOL|DICTIONARY|EXTRACTED	nat2	NAT2	56#60	11245417-0-53-74	D009369	LONGTERM|DICTIONARY	cancers	cancers	305#312		However, when individuals were stratified separately by NAT2 polymorphism (NAT2*5, NAT2*6, and NAT2*7), those who were heterozygous at the mutant locus NAT2*7 after adjustment for the NAT2 mutant loci NAT2*5 and NAT2*6 had a significantly higher risk of CRC (hazard ratio, 2.96; P = 0.012) and all of the cancers (hazard ratio, 3.37; P = 0.00004) than individuals homozygous for wild type at the NAT2*7 allele.
11245417	2001	Cancer Res.	0008-5472	ALL_TEXT_3/3	3	4	10	SYMBOL|NUMBER|DICTIONARY|EXTRACTED	nat2	NAT2	75#79	11245417-0-53-74	D015179	SYMBOL|DICTIONARY|EXTRACTED	crc	CRC	254#257	11245417-1-150-167	However, when individuals were stratified separately by NAT2 polymorphism (NAT2*5, NAT2*6, and NAT2*7), those who were heterozygous at the mutant locus NAT2*7 after adjustment for the NAT2 mutant loci NAT2*5 and NAT2*6 had a significantly higher risk of CRC (hazard ratio, 2.96; P = 0.012) and all of the cancers (hazard ratio, 3.37; P = 0.00004) than individuals homozygous for wild type at the NAT2*7 allele.
11245417	2001	Cancer Res.	0008-5472	ALL_TEXT_3/3	3	4	10	SYMBOL|NUMBER|DICTIONARY|EXTRACTED	nat2	NAT2	75#79	11245417-0-53-74	D009369	LONGTERM|DICTIONARY	cancers	cancers	305#312		However, when individuals were stratified separately by NAT2 polymorphism (NAT2*5, NAT2*6, and NAT2*7), those who were heterozygous at the mutant locus NAT2*7 after adjustment for the NAT2 mutant loci NAT2*5 and NAT2*6 had a significantly higher risk of CRC (hazard ratio, 2.96; P = 0.012) and all of the cancers (hazard ratio, 3.37; P = 0.00004) than individuals homozygous for wild type at the NAT2*7 allele.
11245417	2001	Cancer Res.	0008-5472	ALL_TEXT_3/3	3	4	10	SYMBOL|NUMBER|DICTIONARY|EXTRACTED	nat2	NAT2	83#87	11245417-0-53-74	D015179	SYMBOL|DICTIONARY|EXTRACTED	crc	CRC	254#257	11245417-1-150-167	However, when individuals were stratified separately by NAT2 polymorphism (NAT2*5, NAT2*6, and NAT2*7), those who were heterozygous at the mutant locus NAT2*7 after adjustment for the NAT2 mutant loci NAT2*5 and NAT2*6 had a significantly higher risk of CRC (hazard ratio, 2.96; P = 0.012) and all of the cancers (hazard ratio, 3.37; P = 0.00004) than individuals homozygous for wild type at the NAT2*7 allele.
11245417	2001	Cancer Res.	0008-5472	ALL_TEXT_3/3	3	4	10	SYMBOL|NUMBER|DICTIONARY|EXTRACTED	nat2	NAT2	83#87	11245417-0-53-74	D009369	LONGTERM|DICTIONARY	cancers	cancers	305#312		However, when individuals were stratified separately by NAT2 polymorphism (NAT2*5, NAT2*6, and NAT2*7), those who were heterozygous at the mutant locus NAT2*7 after adjustment for the NAT2 mutant loci NAT2*5 and NAT2*6 had a significantly higher risk of CRC (hazard ratio, 2.96; P = 0.012) and all of the cancers (hazard ratio, 3.37; P = 0.00004) than individuals homozygous for wild type at the NAT2*7 allele.
11245417	2001	Cancer Res.	0008-5472	ALL_TEXT_3/3	3	4	10	SYMBOL|NUMBER|DICTIONARY|EXTRACTED	nat2	NAT2	95#99	11245417-0-53-74	D015179	SYMBOL|DICTIONARY|EXTRACTED	crc	CRC	254#257	11245417-1-150-167	However, when individuals were stratified separately by NAT2 polymorphism (NAT2*5, NAT2*6, and NAT2*7), those who were heterozygous at the mutant locus NAT2*7 after adjustment for the NAT2 mutant loci NAT2*5 and NAT2*6 had a significantly higher risk of CRC (hazard ratio, 2.96; P = 0.012) and all of the cancers (hazard ratio, 3.37; P = 0.00004) than individuals homozygous for wild type at the NAT2*7 allele.
11245417	2001	Cancer Res.	0008-5472	ALL_TEXT_3/3	3	4	10	SYMBOL|NUMBER|DICTIONARY|EXTRACTED	nat2	NAT2	95#99	11245417-0-53-74	D009369	LONGTERM|DICTIONARY	cancers	cancers	305#312		However, when individuals were stratified separately by NAT2 polymorphism (NAT2*5, NAT2*6, and NAT2*7), those who were heterozygous at the mutant locus NAT2*7 after adjustment for the NAT2 mutant loci NAT2*5 and NAT2*6 had a significantly higher risk of CRC (hazard ratio, 2.96; P = 0.012) and all of the cancers (hazard ratio, 3.37; P = 0.00004) than individuals homozygous for wild type at the NAT2*7 allele.
11245417	2001	Cancer Res.	0008-5472	ALL_TEXT_3/3	3	4	10	SYMBOL|NUMBER|DICTIONARY|EXTRACTED	nat2	NAT2	152#156	11245417-0-53-74	D015179	SYMBOL|DICTIONARY|EXTRACTED	crc	CRC	254#257	11245417-1-150-167	However, when individuals were stratified separately by NAT2 polymorphism (NAT2*5, NAT2*6, and NAT2*7), those who were heterozygous at the mutant locus NAT2*7 after adjustment for the NAT2 mutant loci NAT2*5 and NAT2*6 had a significantly higher risk of CRC (hazard ratio, 2.96; P = 0.012) and all of the cancers (hazard ratio, 3.37; P = 0.00004) than individuals homozygous for wild type at the NAT2*7 allele.
11245417	2001	Cancer Res.	0008-5472	ALL_TEXT_3/3	3	4	10	SYMBOL|NUMBER|DICTIONARY|EXTRACTED	nat2	NAT2	152#156	11245417-0-53-74	D009369	LONGTERM|DICTIONARY	cancers	cancers	305#312		However, when individuals were stratified separately by NAT2 polymorphism (NAT2*5, NAT2*6, and NAT2*7), those who were heterozygous at the mutant locus NAT2*7 after adjustment for the NAT2 mutant loci NAT2*5 and NAT2*6 had a significantly higher risk of CRC (hazard ratio, 2.96; P = 0.012) and all of the cancers (hazard ratio, 3.37; P = 0.00004) than individuals homozygous for wild type at the NAT2*7 allele.
11245417	2001	Cancer Res.	0008-5472	ALL_TEXT_3/3	3	4	10	SYMBOL|DICTIONARY|EXTRACTED	nat2	NAT2	184#188	11245417-0-53-74	D015179	SYMBOL|DICTIONARY|EXTRACTED	crc	CRC	254#257	11245417-1-150-167	However, when individuals were stratified separately by NAT2 polymorphism (NAT2*5, NAT2*6, and NAT2*7), those who were heterozygous at the mutant locus NAT2*7 after adjustment for the NAT2 mutant loci NAT2*5 and NAT2*6 had a significantly higher risk of CRC (hazard ratio, 2.96; P = 0.012) and all of the cancers (hazard ratio, 3.37; P = 0.00004) than individuals homozygous for wild type at the NAT2*7 allele.
11245417	2001	Cancer Res.	0008-5472	ALL_TEXT_3/3	3	4	10	SYMBOL|DICTIONARY|EXTRACTED	nat2	NAT2	184#188	11245417-0-53-74	D009369	LONGTERM|DICTIONARY	cancers	cancers	305#312		However, when individuals were stratified separately by NAT2 polymorphism (NAT2*5, NAT2*6, and NAT2*7), those who were heterozygous at the mutant locus NAT2*7 after adjustment for the NAT2 mutant loci NAT2*5 and NAT2*6 had a significantly higher risk of CRC (hazard ratio, 2.96; P = 0.012) and all of the cancers (hazard ratio, 3.37; P = 0.00004) than individuals homozygous for wild type at the NAT2*7 allele.
11245417	2001	Cancer Res.	0008-5472	ALL_TEXT_3/3	3	4	10	SYMBOL|NUMBER|DICTIONARY|EXTRACTED	nat2	NAT2	201#205	11245417-0-53-74	D015179	SYMBOL|DICTIONARY|EXTRACTED	crc	CRC	254#257	11245417-1-150-167	However, when individuals were stratified separately by NAT2 polymorphism (NAT2*5, NAT2*6, and NAT2*7), those who were heterozygous at the mutant locus NAT2*7 after adjustment for the NAT2 mutant loci NAT2*5 and NAT2*6 had a significantly higher risk of CRC (hazard ratio, 2.96; P = 0.012) and all of the cancers (hazard ratio, 3.37; P = 0.00004) than individuals homozygous for wild type at the NAT2*7 allele.
11245417	2001	Cancer Res.	0008-5472	ALL_TEXT_3/3	3	4	10	SYMBOL|NUMBER|DICTIONARY|EXTRACTED	nat2	NAT2	201#205	11245417-0-53-74	D009369	LONGTERM|DICTIONARY	cancers	cancers	305#312		However, when individuals were stratified separately by NAT2 polymorphism (NAT2*5, NAT2*6, and NAT2*7), those who were heterozygous at the mutant locus NAT2*7 after adjustment for the NAT2 mutant loci NAT2*5 and NAT2*6 had a significantly higher risk of CRC (hazard ratio, 2.96; P = 0.012) and all of the cancers (hazard ratio, 3.37; P = 0.00004) than individuals homozygous for wild type at the NAT2*7 allele.
11245417	2001	Cancer Res.	0008-5472	ALL_TEXT_3/3	3	4	10	SYMBOL|NUMBER|DICTIONARY|EXTRACTED	nat2	NAT2	212#216	11245417-0-53-74	D015179	SYMBOL|DICTIONARY|EXTRACTED	crc	CRC	254#257	11245417-1-150-167	However, when individuals were stratified separately by NAT2 polymorphism (NAT2*5, NAT2*6, and NAT2*7), those who were heterozygous at the mutant locus NAT2*7 after adjustment for the NAT2 mutant loci NAT2*5 and NAT2*6 had a significantly higher risk of CRC (hazard ratio, 2.96; P = 0.012) and all of the cancers (hazard ratio, 3.37; P = 0.00004) than individuals homozygous for wild type at the NAT2*7 allele.
11245417	2001	Cancer Res.	0008-5472	ALL_TEXT_3/3	3	4	10	SYMBOL|NUMBER|DICTIONARY|EXTRACTED	nat2	NAT2	212#216	11245417-0-53-74	D009369	LONGTERM|DICTIONARY	cancers	cancers	305#312		However, when individuals were stratified separately by NAT2 polymorphism (NAT2*5, NAT2*6, and NAT2*7), those who were heterozygous at the mutant locus NAT2*7 after adjustment for the NAT2 mutant loci NAT2*5 and NAT2*6 had a significantly higher risk of CRC (hazard ratio, 2.96; P = 0.012) and all of the cancers (hazard ratio, 3.37; P = 0.00004) than individuals homozygous for wild type at the NAT2*7 allele.
11245417	2001	Cancer Res.	0008-5472	ALL_TEXT_3/3	3	4	10	SYMBOL|NUMBER|DICTIONARY|EXTRACTED	nat2	NAT2	396#400	11245417-0-53-74	D015179	SYMBOL|DICTIONARY|EXTRACTED	crc	CRC	254#257	11245417-1-150-167	However, when individuals were stratified separately by NAT2 polymorphism (NAT2*5, NAT2*6, and NAT2*7), those who were heterozygous at the mutant locus NAT2*7 after adjustment for the NAT2 mutant loci NAT2*5 and NAT2*6 had a significantly higher risk of CRC (hazard ratio, 2.96; P = 0.012) and all of the cancers (hazard ratio, 3.37; P = 0.00004) than individuals homozygous for wild type at the NAT2*7 allele.
11245417	2001	Cancer Res.	0008-5472	ALL_TEXT_3/3	3	4	10	SYMBOL|NUMBER|DICTIONARY|EXTRACTED	nat2	NAT2	396#400	11245417-0-53-74	D009369	LONGTERM|DICTIONARY	cancers	cancers	305#312		However, when individuals were stratified separately by NAT2 polymorphism (NAT2*5, NAT2*6, and NAT2*7), those who were heterozygous at the mutant locus NAT2*7 after adjustment for the NAT2 mutant loci NAT2*5 and NAT2*6 had a significantly higher risk of CRC (hazard ratio, 2.96; P = 0.012) and all of the cancers (hazard ratio, 3.37; P = 0.00004) than individuals homozygous for wild type at the NAT2*7 allele.
18596619	2008	Neuroreport	0959-4965	ALL_TEXT_1/3	1	1	627	SYMBOL|DICTIONARY	bdnf	BDNF	69#73		D012559	LONGTERM|DICTIONARY	schizophrenia	schizophrenia	199#212		The methionine variant of Val66Met brain-derived neurotrophic factor BDNF met and catecholamine-O-methyltransferase (COMT L) is associated with a deficit in attention and aggravation of delusions in schizophrenia.
18596619	2008	Neuroreport	0959-4965	ALL_TEXT_1/3	1	1	627	SYMBOL|DICTIONARY	bdnf	BDNF	69#73		D001289	LONGTERM|DICTIONARY	deficit in attention and aggravation of delusions	deficit in attention and aggravation of delusions	146#195		The methionine variant of Val66Met brain-derived neurotrophic factor BDNF met and catecholamine-O-methyltransferase (COMT L) is associated with a deficit in attention and aggravation of delusions in schizophrenia.
18596619	2008	Neuroreport	0959-4965	ALL_TEXT_1/3	1	1	1312	SYMBOL|DICTIONARY	comt	COMT	117#121		D012559	LONGTERM|DICTIONARY	schizophrenia	schizophrenia	199#212		The methionine variant of Val66Met brain-derived neurotrophic factor BDNF met and catecholamine-O-methyltransferase (COMT L) is associated with a deficit in attention and aggravation of delusions in schizophrenia.
18596619	2008	Neuroreport	0959-4965	ALL_TEXT_1/3	1	1	1312	SYMBOL|DICTIONARY	comt	COMT	117#121		D001289	LONGTERM|DICTIONARY	deficit in attention and aggravation of delusions	deficit in attention and aggravation of delusions	146#195		The methionine variant of Val66Met brain-derived neurotrophic factor BDNF met and catecholamine-O-methyltransferase (COMT L) is associated with a deficit in attention and aggravation of delusions in schizophrenia.
17039310	2007	Mod Rheumatol	1439-7595	ALL_TEXT_1/3	1	1	6288	SYMBOL|GENE|GN|DICTIONARY	saa1	SAA1	59#63		D000686	LONGTERM|DICTIONARY	aa amyloidosis	AA amyloidosis	106#120		To investigate the precise modality of association between SAA1 gene polymorphisms and the development of AA amyloidosis in patients with rheumatoid arthritis (RA), Japanese patients with RA (n=153), among whom 29 were histologically diagnosed as having amyloidosis, were genotyped for three single nucleotide polymorphisms (SNPs), C-13T, C2995T, and C3010T, in the SAA gene.
17039310	2007	Mod Rheumatol	1439-7595	ALL_TEXT_1/3	1	1	6288	SYMBOL|GENE|GN|DICTIONARY	saa1	SAA1	59#63		D001172	LONGTERM|DICTIONARY	rheumatoid arthritis	rheumatoid arthritis	138#158		To investigate the precise modality of association between SAA1 gene polymorphisms and the development of AA amyloidosis in patients with rheumatoid arthritis (RA), Japanese patients with RA (n=153), among whom 29 were histologically diagnosed as having amyloidosis, were genotyped for three single nucleotide polymorphisms (SNPs), C-13T, C2995T, and C3010T, in the SAA gene.
17039310	2007	Mod Rheumatol	1439-7595	ALL_TEXT_1/3	1	1	6288	SYMBOL|GENE|GN|DICTIONARY	saa1	SAA1	59#63		D001172	SYMBOL|EXTRACTED|()	ra	RA	160#162	17039310-1-138-158	To investigate the precise modality of association between SAA1 gene polymorphisms and the development of AA amyloidosis in patients with rheumatoid arthritis (RA), Japanese patients with RA (n=153), among whom 29 were histologically diagnosed as having amyloidosis, were genotyped for three single nucleotide polymorphisms (SNPs), C-13T, C2995T, and C3010T, in the SAA gene.
17039310	2007	Mod Rheumatol	1439-7595	ALL_TEXT_1/3	1	1	6288	SYMBOL|GENE|GN|DICTIONARY	saa1	SAA1	59#63		D001172	SYMBOL|EXTRACTED	ra	RA	188#190	17039310-1-138-158	To investigate the precise modality of association between SAA1 gene polymorphisms and the development of AA amyloidosis in patients with rheumatoid arthritis (RA), Japanese patients with RA (n=153), among whom 29 were histologically diagnosed as having amyloidosis, were genotyped for three single nucleotide polymorphisms (SNPs), C-13T, C2995T, and C3010T, in the SAA gene.
17039310	2007	Mod Rheumatol	1439-7595	ALL_TEXT_1/3	1	1	6288	SYMBOL|GENE|GN|DICTIONARY	saa1	SAA1	59#63		D000686	LONGTERM|DICTIONARY	amyloidosis	amyloidosis	254#265		To investigate the precise modality of association between SAA1 gene polymorphisms and the development of AA amyloidosis in patients with rheumatoid arthritis (RA), Japanese patients with RA (n=153), among whom 29 were histologically diagnosed as having amyloidosis, were genotyped for three single nucleotide polymorphisms (SNPs), C-13T, C2995T, and C3010T, in the SAA gene.
17039310	2007	Mod Rheumatol	1439-7595	ALL_TEXT_1/3	1	1	6287	SYMBOL|GENE|GN|DICTIONARY	saa	SAA	366#369		D000686	LONGTERM|DICTIONARY	aa amyloidosis	AA amyloidosis	106#120		To investigate the precise modality of association between SAA1 gene polymorphisms and the development of AA amyloidosis in patients with rheumatoid arthritis (RA), Japanese patients with RA (n=153), among whom 29 were histologically diagnosed as having amyloidosis, were genotyped for three single nucleotide polymorphisms (SNPs), C-13T, C2995T, and C3010T, in the SAA gene.
17039310	2007	Mod Rheumatol	1439-7595	ALL_TEXT_1/3	1	1	6287	SYMBOL|GENE|GN|DICTIONARY	saa	SAA	366#369		D001172	LONGTERM|DICTIONARY	rheumatoid arthritis	rheumatoid arthritis	138#158		To investigate the precise modality of association between SAA1 gene polymorphisms and the development of AA amyloidosis in patients with rheumatoid arthritis (RA), Japanese patients with RA (n=153), among whom 29 were histologically diagnosed as having amyloidosis, were genotyped for three single nucleotide polymorphisms (SNPs), C-13T, C2995T, and C3010T, in the SAA gene.
17039310	2007	Mod Rheumatol	1439-7595	ALL_TEXT_1/3	1	1	6287	SYMBOL|GENE|GN|DICTIONARY	saa	SAA	366#369		D001172	SYMBOL|EXTRACTED|()	ra	RA	160#162	17039310-1-138-158	To investigate the precise modality of association between SAA1 gene polymorphisms and the development of AA amyloidosis in patients with rheumatoid arthritis (RA), Japanese patients with RA (n=153), among whom 29 were histologically diagnosed as having amyloidosis, were genotyped for three single nucleotide polymorphisms (SNPs), C-13T, C2995T, and C3010T, in the SAA gene.
17039310	2007	Mod Rheumatol	1439-7595	ALL_TEXT_1/3	1	1	6287	SYMBOL|GENE|GN|DICTIONARY	saa	SAA	366#369		D001172	SYMBOL|EXTRACTED	ra	RA	188#190	17039310-1-138-158	To investigate the precise modality of association between SAA1 gene polymorphisms and the development of AA amyloidosis in patients with rheumatoid arthritis (RA), Japanese patients with RA (n=153), among whom 29 were histologically diagnosed as having amyloidosis, were genotyped for three single nucleotide polymorphisms (SNPs), C-13T, C2995T, and C3010T, in the SAA gene.
17039310	2007	Mod Rheumatol	1439-7595	ALL_TEXT_1/3	1	1	6287	SYMBOL|GENE|GN|DICTIONARY	saa	SAA	366#369		D000686	LONGTERM|DICTIONARY	amyloidosis	amyloidosis	254#265		To investigate the precise modality of association between SAA1 gene polymorphisms and the development of AA amyloidosis in patients with rheumatoid arthritis (RA), Japanese patients with RA (n=153), among whom 29 were histologically diagnosed as having amyloidosis, were genotyped for three single nucleotide polymorphisms (SNPs), C-13T, C2995T, and C3010T, in the SAA gene.
16816977	2007	Neurogenetics	1364-6745	TITLE	0	0	1815	SYMBOL|NUMBER|DICTIONARY	drd4	DRD4	164#168		D010300	LONGTERM|DISEASE|DT|DICTIONARY	parkinson disease	Parkinson's disease	26#45		Genetic susceptibility to Parkinson's disease among South and North Indians: I. Role of polymorphisms in dopamine receptor and transporter genes and association of DRD4 120-bp duplication marker.
14567462	2004	Dig Liver Dis	1590-8658	RESULTS	3	3	3123	SYMBOL|DICTIONARY	drb1	DRB1	15#19		D015209	SYMBOL|DISEASE|DN|DICTIONARY|EXTRACTED	psc	PSC	202#205	14567462-0-41-71	Frequencies of DRB1*01, DQA1*0101, DQB1*0102 (14 vs. 8%, p<0.05), DRB1*16, DQA1*0102, DQB1*0502 (8 vs. 3%, p<0.025) and DRB1*04, DQA1*03, DQB1*0301 (10 vs. 4%, p<0.005) haplotypes were more elevated in PSC patients.
14567462	2004	Dig Liver Dis	1590-8658	RESULTS	3	3	3123	SYMBOL|NUMBER|DICTIONARY	drb1	DRB1	66#70		D015209	SYMBOL|DISEASE|DN|DICTIONARY|EXTRACTED	psc	PSC	202#205	14567462-0-41-71	Frequencies of DRB1*01, DQA1*0101, DQB1*0102 (14 vs. 8%, p<0.05), DRB1*16, DQA1*0102, DQB1*0502 (8 vs. 3%, p<0.025) and DRB1*04, DQA1*03, DQB1*0301 (10 vs. 4%, p<0.005) haplotypes were more elevated in PSC patients.
14567462	2004	Dig Liver Dis	1590-8658	RESULTS	3	3	3123	SYMBOL|DICTIONARY	drb1	DRB1	120#124		D015209	SYMBOL|DISEASE|DN|DICTIONARY|EXTRACTED	psc	PSC	202#205	14567462-0-41-71	Frequencies of DRB1*01, DQA1*0101, DQB1*0102 (14 vs. 8%, p<0.05), DRB1*16, DQA1*0102, DQB1*0502 (8 vs. 3%, p<0.025) and DRB1*04, DQA1*03, DQB1*0301 (10 vs. 4%, p<0.005) haplotypes were more elevated in PSC patients.
14567462	2004	Dig Liver Dis	1590-8658	RESULTS	3	3	3117	LONGTERM|DICTIONARY	dqa1	DQA1	24#28	NaN	D015209	SYMBOL|DISEASE|DN|DICTIONARY|EXTRACTED	psc	PSC	202#205	14567462-0-41-71	Frequencies of DRB1*01, DQA1*0101, DQB1*0102 (14 vs. 8%, p<0.05), DRB1*16, DQA1*0102, DQB1*0502 (8 vs. 3%, p<0.025) and DRB1*04, DQA1*03, DQB1*0301 (10 vs. 4%, p<0.005) haplotypes were more elevated in PSC patients.
14567462	2004	Dig Liver Dis	1590-8658	RESULTS	3	3	3117	LONGTERM|DICTIONARY	dqa1	DQA1	75#79	NaN	D015209	SYMBOL|DISEASE|DN|DICTIONARY|EXTRACTED	psc	PSC	202#205	14567462-0-41-71	Frequencies of DRB1*01, DQA1*0101, DQB1*0102 (14 vs. 8%, p<0.05), DRB1*16, DQA1*0102, DQB1*0502 (8 vs. 3%, p<0.025) and DRB1*04, DQA1*03, DQB1*0301 (10 vs. 4%, p<0.005) haplotypes were more elevated in PSC patients.
14567462	2004	Dig Liver Dis	1590-8658	RESULTS	3	3	3117	LONGTERM|DICTIONARY	dqa1	DQA1	129#133	NaN	D015209	SYMBOL|DISEASE|DN|DICTIONARY|EXTRACTED	psc	PSC	202#205	14567462-0-41-71	Frequencies of DRB1*01, DQA1*0101, DQB1*0102 (14 vs. 8%, p<0.05), DRB1*16, DQA1*0102, DQB1*0502 (8 vs. 3%, p<0.025) and DRB1*04, DQA1*03, DQB1*0301 (10 vs. 4%, p<0.005) haplotypes were more elevated in PSC patients.
14567462	2004	Dig Liver Dis	1590-8658	RESULTS	3	3	3119	LONGTERM|DICTIONARY	dqb1	DQB1	35#39	NaN	D015209	SYMBOL|DISEASE|DN|DICTIONARY|EXTRACTED	psc	PSC	202#205	14567462-0-41-71	Frequencies of DRB1*01, DQA1*0101, DQB1*0102 (14 vs. 8%, p<0.05), DRB1*16, DQA1*0102, DQB1*0502 (8 vs. 3%, p<0.025) and DRB1*04, DQA1*03, DQB1*0301 (10 vs. 4%, p<0.005) haplotypes were more elevated in PSC patients.
14567462	2004	Dig Liver Dis	1590-8658	RESULTS	3	3	3119	LONGTERM|DICTIONARY	dqb1	DQB1	86#90	NaN	D015209	SYMBOL|DISEASE|DN|DICTIONARY|EXTRACTED	psc	PSC	202#205	14567462-0-41-71	Frequencies of DRB1*01, DQA1*0101, DQB1*0102 (14 vs. 8%, p<0.05), DRB1*16, DQA1*0102, DQB1*0502 (8 vs. 3%, p<0.025) and DRB1*04, DQA1*03, DQB1*0301 (10 vs. 4%, p<0.005) haplotypes were more elevated in PSC patients.
14567462	2004	Dig Liver Dis	1590-8658	RESULTS	3	3	3119	LONGTERM|DICTIONARY	dqb1	DQB1	138#142	NaN	D015209	SYMBOL|DISEASE|DN|DICTIONARY|EXTRACTED	psc	PSC	202#205	14567462-0-41-71	Frequencies of DRB1*01, DQA1*0101, DQB1*0102 (14 vs. 8%, p<0.05), DRB1*16, DQA1*0102, DQB1*0502 (8 vs. 3%, p<0.025) and DRB1*04, DQA1*03, DQB1*0301 (10 vs. 4%, p<0.005) haplotypes were more elevated in PSC patients.
18061279	2008	J. Neuroimmunol.	0165-5728	ALL_TEXT_1/3	1	1	627	SYMBOL|GENE|GN|DICTIONARY	bdnf	BDNF	49#53		D009103	LONGTERM|DICTIONARY	ms	MS	119#121	NaN	Two single nucleotide polymorphisms of the human BDNF gene, G196A and C270T, and their impact on the susceptibility to MS and disease progression in the Polish population were investigated.
17855693	2007	Cancer Epidemiol. Biomarkers Prev.	1055-9965	TITLE	0	0	4524	LONGTERM|GENE|GN|DICTIONARY	methylenetetrahydrofolate reductase	methylenetetrahydrofolate reductase	13#48		D015179	LONGTERM|DISEASE|DT|DICTIONARY	colorectal cancer	colorectal cancer	112#129		Influence of methylenetetrahydrofolate reductase gene polymorphisms C677T and A1298C on age-associated risk for colorectal cancer in a caucasian lynch syndrome population.
17855693	2007	Cancer Epidemiol. Biomarkers Prev.	1055-9965	TITLE	0	0	4524	LONGTERM|GENE|GN|DICTIONARY	methylenetetrahydrofolate reductase	methylenetetrahydrofolate reductase	13#48		D003123	LONGTERM|DISEASE|DT|DICTIONARY	lynch syndrome	lynch syndrome	145#159		Influence of methylenetetrahydrofolate reductase gene polymorphisms C677T and A1298C on age-associated risk for colorectal cancer in a caucasian lynch syndrome population.
19996333	2010	Thorax	1468-3296	METHODS	2	5	4843	SYMBOL|DICTIONARY	nos2a	NOS2A	24#29		D001249	LONGTERM|DICTIONARY	asthma	asthma	41#47		Association between the NOS2A region and asthma or lung function growth was tested using genetic block-specific principal component and haplotype analyses.
17855693	2007	Cancer Epidemiol. Biomarkers Prev.	1055-9965	ALL_TEXT_2/3	2	5	4524	LONGTERM|GENE|GN|DICTIONARY	methylenetetrahydrofolate reductase	methylenetetrahydrofolate reductase	85#120		D015179	LONGTERM|DISEASE|DT|DICTIONARY	colorectal cancer	colorectal cancer	153#170		We investigated the association of C677T and A1298C, two common polymorphisms in the methylenetetrahydrofolate reductase gene, with risk for early onset colorectal cancer in Lynch syndrome.
17855693	2007	Cancer Epidemiol. Biomarkers Prev.	1055-9965	ALL_TEXT_2/3	2	5	4524	LONGTERM|GENE|GN|DICTIONARY	methylenetetrahydrofolate reductase	methylenetetrahydrofolate reductase	85#120		D003123	LONGTERM|DISEASE|DT|DICTIONARY	lynch syndrome	Lynch syndrome	174#188		We investigated the association of C677T and A1298C, two common polymorphisms in the methylenetetrahydrofolate reductase gene, with risk for early onset colorectal cancer in Lynch syndrome.
18061279	2008	J. Neuroimmunol.	0165-5728	ALL_TEXT_3/3	3	4	627	SYMBOL|DICTIONARY	bdnf	BDNF	38#42		D009103	LONGTERM|DICTIONARY	ms	MS	99#101	NaN	Our results show that C270T and G196A BDNF polymorphisms may affect susceptibility to and onset of MS, but further verification is needed, with special attention to gender differences.
19225526	2009	Genes Immun.	1476-5470	ALL_TEXT_2/3	2	3	6775	SYMBOL|DICTIONARY	stat4	STAT4	34#39		D008180	SYMBOL|DICTIONARY|EXTRACTED	sle	SLE	145#148	19225526-1-96-124	Our data confirmed association of STAT4 (rs7574865, odds ratio (OR) =1.71, P=3.55 x 10(-23)) and BLK (rs13277113, OR=0.77, P=1.34 x 10(-5)) with SLE.
19225526	2009	Genes Immun.	1476-5470	ALL_TEXT_2/3	2	3	640	SYMBOL|DICTIONARY	blk	BLK	97#100		D008180	SYMBOL|DICTIONARY|EXTRACTED	sle	SLE	145#148	19225526-1-96-124	Our data confirmed association of STAT4 (rs7574865, odds ratio (OR) =1.71, P=3.55 x 10(-23)) and BLK (rs13277113, OR=0.77, P=1.34 x 10(-5)) with SLE.
19225526	2009	Genes Immun.	1476-5470	ALL_TEXT_1/3	1	2	6775	SYMBOL|DICTIONARY	stat4	STAT4	160#165		D008180	SYMBOL|DISEASE|DN|DICTIONARY|EXTRACTED	sle	SLE	10#13	19225526-1-96-124	Using 910 SLE patients and 1440 healthy controls from Chinese living in Hong Kong, and 278 SLE patients and 383 controls in Thailand, we studied association of STAT4, BLK and PXK with the disease.
19225526	2009	Genes Immun.	1476-5470	ALL_TEXT_1/3	1	2	6775	SYMBOL|DICTIONARY	stat4	STAT4	160#165		D008180	SYMBOL|DISEASE|DN|DICTIONARY|EXTRACTED	sle	SLE	91#94	19225526-1-96-124	Using 910 SLE patients and 1440 healthy controls from Chinese living in Hong Kong, and 278 SLE patients and 383 controls in Thailand, we studied association of STAT4, BLK and PXK with the disease.
19225526	2009	Genes Immun.	1476-5470	ALL_TEXT_1/3	1	2	640	SYMBOL|DICTIONARY	blk	BLK	167#170		D008180	SYMBOL|DISEASE|DN|DICTIONARY|EXTRACTED	sle	SLE	10#13	19225526-1-96-124	Using 910 SLE patients and 1440 healthy controls from Chinese living in Hong Kong, and 278 SLE patients and 383 controls in Thailand, we studied association of STAT4, BLK and PXK with the disease.
19225526	2009	Genes Immun.	1476-5470	ALL_TEXT_1/3	1	2	640	SYMBOL|DICTIONARY	blk	BLK	167#170		D008180	SYMBOL|DISEASE|DN|DICTIONARY|EXTRACTED	sle	SLE	91#94	19225526-1-96-124	Using 910 SLE patients and 1440 healthy controls from Chinese living in Hong Kong, and 278 SLE patients and 383 controls in Thailand, we studied association of STAT4, BLK and PXK with the disease.
19225526	2009	Genes Immun.	1476-5470	ALL_TEXT_1/3	1	2	54899	SYMBOL|DICTIONARY	pxk	PXK	175#178		D008180	SYMBOL|DISEASE|DN|DICTIONARY|EXTRACTED	sle	SLE	10#13	19225526-1-96-124	Using 910 SLE patients and 1440 healthy controls from Chinese living in Hong Kong, and 278 SLE patients and 383 controls in Thailand, we studied association of STAT4, BLK and PXK with the disease.
19225526	2009	Genes Immun.	1476-5470	ALL_TEXT_1/3	1	2	54899	SYMBOL|DICTIONARY	pxk	PXK	175#178		D008180	SYMBOL|DISEASE|DN|DICTIONARY|EXTRACTED	sle	SLE	91#94	19225526-1-96-124	Using 910 SLE patients and 1440 healthy controls from Chinese living in Hong Kong, and 278 SLE patients and 383 controls in Thailand, we studied association of STAT4, BLK and PXK with the disease.
12928282	2003	Br J Ophthalmol	0007-1161	AIMS	1	1	6247	SYMBOL|GENE|GN|DICTIONARY	xlrs1	XLRS1	132#137		D041441	LONGTERM|DICTIONARY	x linked juvenile retinoschisis	X linked juvenile retinoschisis	38#69		To describe the clinical phenotype of X linked juvenile retinoschisis in eight Italian families with six different mutations in the XLRS1 gene.
18922923	2008	Cancer Res.	1538-7445	ALL_TEXT_1/3	1	2	5743	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	cox 2	COX-2	157#162	18922923-1-31-47	D002294	SYMBOL|EXTRACTED|()|DISEASE|DN	oscc	OSCC	58#62	18922923-2-33-56	A case-control study of 377 oral squamous cell carcinoma (OSCC) patients and 442 controls was conducted to evaluate the gene-environment interaction between COX-2 promoter polymorphisms and substance use of alcohol, betel quid, and cigarettes (ABC) in risk of OSCC.
18922923	2008	Cancer Res.	1538-7445	ALL_TEXT_1/3	1	2	5743	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	cox 2	COX-2	157#162	18922923-1-31-47	D002294	LONGTERM|DISEASE|DT|DICTIONARY|DA	oral squamous cell carcinoma	oral squamous cell carcinoma	28#56		A case-control study of 377 oral squamous cell carcinoma (OSCC) patients and 442 controls was conducted to evaluate the gene-environment interaction between COX-2 promoter polymorphisms and substance use of alcohol, betel quid, and cigarettes (ABC) in risk of OSCC.
18555606	2008	Neurosci. Lett.	0304-3940	ALL_TEXT_2/3	2	4	348	LONGTERM|DICTIONARY	apolipoprotein e	apolipoprotein E	197#213		D000544	SYMBOL|EXTRACTED	ad	AD	182#184	18555606-1-0-19	The aim of the present work is to investigate the usefulness of cerebrospinal fluid (CSF) beta-amyloid protein (Abeta1-42) and total tau protein (t-tau) analyses in the diagnosis of AD and whether apolipoprotein E (ApoE) epsilon4 allele is a factor for AD affecting Tunisian people.
18555606	2008	Neurosci. Lett.	0304-3940	ALL_TEXT_2/3	2	4	348	LONGTERM|DICTIONARY	apolipoprotein e	apolipoprotein E	197#213		D000544	SYMBOL|EXTRACTED	ad	AD	253#255	18555606-1-0-19	The aim of the present work is to investigate the usefulness of cerebrospinal fluid (CSF) beta-amyloid protein (Abeta1-42) and total tau protein (t-tau) analyses in the diagnosis of AD and whether apolipoprotein E (ApoE) epsilon4 allele is a factor for AD affecting Tunisian people.
18555606	2008	Neurosci. Lett.	0304-3940	ALL_TEXT_2/3	2	4	348	SYMBOL|EXTRACTED|()	apoe	ApoE	215#219	18555606-4-197-213	D000544	SYMBOL|EXTRACTED	ad	AD	182#184	18555606-1-0-19	The aim of the present work is to investigate the usefulness of cerebrospinal fluid (CSF) beta-amyloid protein (Abeta1-42) and total tau protein (t-tau) analyses in the diagnosis of AD and whether apolipoprotein E (ApoE) epsilon4 allele is a factor for AD affecting Tunisian people.
18555606	2008	Neurosci. Lett.	0304-3940	ALL_TEXT_2/3	2	4	348	SYMBOL|EXTRACTED|()	apoe	ApoE	215#219	18555606-4-197-213	D000544	SYMBOL|EXTRACTED	ad	AD	253#255	18555606-1-0-19	The aim of the present work is to investigate the usefulness of cerebrospinal fluid (CSF) beta-amyloid protein (Abeta1-42) and total tau protein (t-tau) analyses in the diagnosis of AD and whether apolipoprotein E (ApoE) epsilon4 allele is a factor for AD affecting Tunisian people.
18555606	2008	Neurosci. Lett.	0304-3940	ALL_TEXT_3/3	3	9	348	SYMBOL|EXTRACTED	apoe	ApoE	4#8	18555606-4-197-213	D000544	SYMBOL|DISEASE|DN|DICTIONARY|EXTRACTED	ad	AD	75#77	18555606-1-0-19	The ApoE epsilon4 allele frequency (29.5%) was significantly higher in the AD patients than in the nAD patients (17.1%) or in the control groups (9.5%).
20191381	2011	Breast Cancer Res. Treat.	1573-7217	ALL_TEXT_3/3	3	10	4595	SYMBOL|DICTIONARY	mutyh	MUTYH	21#26		D001943	LONGTERM|DISEASE|DN|DT|DICTIONARY	breast cancer	breast cancer	189#202		Importantly, the 11% MUTYH frequency among FCRC-AMS negative families was almost fivefold higher than the reported frequencies for FCRC-AMS negative families unselected for the presence of breast cancer patients (P = 0.03).
7987717	1995	Zhonghua Yi Xue Za Zhi	0376-2491	ALL_TEXT_3/3	3	10	3126	LONGTERM|DICTIONARY	dr4	DR4	14#17	NaN	D001172	LONGTERM|DICTIONARY	ra	RA	108#110	NaN	The different DR4 subtype structures and frequencies may account for the different associations of DR4 with RA in various ethnic groups.
7987717	1995	Zhonghua Yi Xue Za Zhi	0376-2491	ALL_TEXT_3/3	3	10	3126	LONGTERM|DICTIONARY	dr4	DR4	99#102	NaN	D001172	LONGTERM|DICTIONARY	ra	RA	108#110	NaN	The different DR4 subtype structures and frequencies may account for the different associations of DR4 with RA in various ethnic groups.
16816977	2007	Neurogenetics	1364-6745	ALL_TEXT_3/3	3	5	1815	SYMBOL|GENE|GN|DICTIONARY	drd4	DRD4	62#66		D010300	SYMBOL|EXTRACTED	pd	PD	102#104	16816977-1-141-160	Of the several markers analyzed, 120 bp duplication marker of DRD4 gene showed promising results with PD in both of the sample sets.
20724907	2010	Am. J. Med. Sci.	1538-2990	CONCLUSIONS	4	10	2876	SYMBOL|DICTIONARY|EXTRACTED	gpx1	GPX1	83#87	20724907-1-96-120	D000544	SYMBOL|EXTRACTED	ad	AD	53#55	20724907-1-184-201	Apo E is not a risk factor, nor a protective one for AD, whereas the leu allele of GPX1 is a possible risk factor for the disease.
11463752	2001	Hypertension	1524-4563	ALL_TEXT_1/3	1	1	133	LONGTERM|DICTIONARY	adrenomedullin	Adrenomedullin	0#14		D007022	LONGTERM|DICTIONARY	hypotensive	hypotensive	25#36	NaN	Adrenomedullin (AM) is a hypotensive peptide widely produced in the cardiovascular organs and tissues.
11463752	2001	Hypertension	1524-4563	ALL_TEXT_1/3	1	1	133	SYMBOL|EXTRACTED|()	am	AM	16#18	11463752-1-0-14	D007022	LONGTERM|DICTIONARY	hypotensive	hypotensive	25#36	NaN	Adrenomedullin (AM) is a hypotensive peptide widely produced in the cardiovascular organs and tissues.
20810156	2010	J. Allergy Clin. Immunol.	1097-6825	CONCLUSION	5	7	4048	SYMBOL|DICTIONARY|EXTRACTED	lta4h	LTA4H	0#5		D001249	LONGTERM|DICTIONARY	asthma	asthma	158#164		LTA4H and ALOX5AP gene polymorphisms modify the augmentation of bronchodilator responsiveness by leukotriene modifiers in Puerto Ricans but not Mexicans with asthma.
20810156	2010	J. Allergy Clin. Immunol.	1097-6825	CONCLUSION	5	7	241	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	alox5ap	ALOX5AP	10#17	20810156-2-34-80	D001249	LONGTERM|DICTIONARY	asthma	asthma	158#164		LTA4H and ALOX5AP gene polymorphisms modify the augmentation of bronchodilator responsiveness by leukotriene modifiers in Puerto Ricans but not Mexicans with asthma.
11793481	2002	Hum. Mutat.	1098-1004	ALL_TEXT_1/3	1	2	6448	SYMBOL|()|DICTIONARY|EXTRACTED	sgsh	SGSH	127#131	11793481-2-114-125	D009084	LONGTERM|DICTIONARY	deficient in mps iiia	deficient in MPS IIIA	139#160		MPS III results from a deficiency in one of the four enzymes involved in the degradation of heparan sulfate, with sulfamidase (SGSH) being deficient in MPS IIIA and a-N-acetylglucosaminidase (NAGLU) deficient in MPS IIIB.
11793481	2002	Hum. Mutat.	1098-1004	ALL_TEXT_1/3	1	2	4669	SYMBOL|DICTIONARY	mps iiib	MPS IIIB	212#220		D009084	LONGTERM|DICTIONARY	deficient in mps iiia	deficient in MPS IIIA	139#160		MPS III results from a deficiency in one of the four enzymes involved in the degradation of heparan sulfate, with sulfamidase (SGSH) being deficient in MPS IIIA and a-N-acetylglucosaminidase (NAGLU) deficient in MPS IIIB.
19446452	2009	Breast	1532-3080	ALL_TEXT_1/3	1	1	7515	SYMBOL|DICTIONARY	xrcc1	XRCC1	56#61		D001943	LONGTERM|DISEASE|DT|DICTIONARY	breast cancer	breast cancer	114#127		We performed a meta-analysis to investigate the role of XRCC1 polymorphisms Arg194Trp, Arg280His and Arg399Gln in breast cancer.
11793481	2002	Hum. Mutat.	1098-1004	ALL_TEXT_2/3	2	4	6448	SYMBOL|DICTIONARY|EXTRACTED	sgsh	SGSH	31#35	11793481-2-114-125	D009084	LONGTERM|DISEASE|DN|DICTIONARY	mps iiia	MPS IIIA	55#63		In this study two mutations of SGSH were identified in MPS IIIA patients: R74C and the novel mutation P288S, and one polymorphism (IVS1+23 C>G).
14558082	2003	Arthritis Rheum.	0004-3591	OBJECTIVE	1	1	3458	LONGTERM|DICTIONARY	interferon gamma	interferon-gamma	42#58		D001172	LONGTERM|DICTIONARY	rheumatoid arthritis	rheumatoid arthritis	178#198		To determine whether polymorphisms in the interferon-gamma (IFNgamma)/interleukin-26 (IL-26; formerly, AK155) gene cluster contribute to sex-based differential susceptibility to rheumatoid arthritis (RA).
14558082	2003	Arthritis Rheum.	0004-3591	OBJECTIVE	1	1	3458	SYMBOL|EXTRACTED|()	ifngamma	IFNgamma	60#68	14558082-1-42-58	D001172	LONGTERM|DICTIONARY	rheumatoid arthritis	rheumatoid arthritis	178#198		To determine whether polymorphisms in the interferon-gamma (IFNgamma)/interleukin-26 (IL-26; formerly, AK155) gene cluster contribute to sex-based differential susceptibility to rheumatoid arthritis (RA).
14558082	2003	Arthritis Rheum.	0004-3591	OBJECTIVE	1	1	55801	LONGTERM|DICTIONARY	interleukin 26	interleukin-26	70#84		D001172	LONGTERM|DICTIONARY	rheumatoid arthritis	rheumatoid arthritis	178#198		To determine whether polymorphisms in the interferon-gamma (IFNgamma)/interleukin-26 (IL-26; formerly, AK155) gene cluster contribute to sex-based differential susceptibility to rheumatoid arthritis (RA).
14558082	2003	Arthritis Rheum.	0004-3591	OBJECTIVE	1	1	55801	SYMBOL|DICTIONARY	il 26	IL-26	86#91		D001172	LONGTERM|DICTIONARY	rheumatoid arthritis	rheumatoid arthritis	178#198		To determine whether polymorphisms in the interferon-gamma (IFNgamma)/interleukin-26 (IL-26; formerly, AK155) gene cluster contribute to sex-based differential susceptibility to rheumatoid arthritis (RA).
14558082	2003	Arthritis Rheum.	0004-3591	OBJECTIVE	1	1	55801	SYMBOL|GENE|GN|DICTIONARY	ak155	AK155	103#108		D001172	LONGTERM|DICTIONARY	rheumatoid arthritis	rheumatoid arthritis	178#198		To determine whether polymorphisms in the interferon-gamma (IFNgamma)/interleukin-26 (IL-26; formerly, AK155) gene cluster contribute to sex-based differential susceptibility to rheumatoid arthritis (RA).
23313952	2013	Nat. Genet.	1546-1718	TITLE	0	0	4665	SYMBOL|DICTIONARY	nab2	NAB2	28#32		D054364	LONGTERM|DISEASE|DT|DICTIONARY	solitary fibrous tumor	solitary fibrous tumor	55#77		Identification of recurrent NAB2-STAT6 gene fusions in solitary fibrous tumor by integrative sequencing.
23313952	2013	Nat. Genet.	1546-1718	TITLE	0	0	6778	SYMBOL|GENE|GN|DICTIONARY	stat6	STAT6	33#38		D054364	LONGTERM|DISEASE|DT|DICTIONARY	solitary fibrous tumor	solitary fibrous tumor	55#77		Identification of recurrent NAB2-STAT6 gene fusions in solitary fibrous tumor by integrative sequencing.
23313952	2013	Nat. Genet.	1546-1718	ALL_TEXT_2/3	2	3	4665	SYMBOL|DICTIONARY	nab2	NAB2	76#80		D009369	LONGTERM|DICTIONARY	tumors	tumors	106#112		Transcriptome sequencing of 27 additional SFTs identified the presence of a NAB2-STAT6 gene fusion in all tumors.
23313952	2013	Nat. Genet.	1546-1718	ALL_TEXT_2/3	2	3	6778	SYMBOL|GENE|GN|DICTIONARY	stat6	STAT6	81#86		D009369	LONGTERM|DICTIONARY	tumors	tumors	106#112		Transcriptome sequencing of 27 additional SFTs identified the presence of a NAB2-STAT6 gene fusion in all tumors.
20237592	2010	Can. J. Physiol. Pharmacol.	1205-7541	TITLE	0	0	7349	LONGTERM|DICTIONARY	urocortin	urocortin	35#44		D006973	LONGTERM|DICTIONARY	hypertensive	hypertensive	119#131	NaN	Effect of long-term treatment with urocortin on the activity of somatic angiotensin-converting enzyme in spontaneously hypertensive rats.
20237592	2010	Can. J. Physiol. Pharmacol.	1205-7541	TITLE	0	0	1636	LONGTERM|GENE|GT|DICTIONARY	angiotensin converting enzyme	angiotensin-converting enzyme	72#101		D006973	LONGTERM|DICTIONARY	hypertensive	hypertensive	119#131	NaN	Effect of long-term treatment with urocortin on the activity of somatic angiotensin-converting enzyme in spontaneously hypertensive rats.
23313952	2013	Nat. Genet.	1546-1718	ALL_TEXT_3/3	3	5	4665	SYMBOL|DICTIONARY	nab2	NAB2	14#18		D054364	SYMBOL|DICTIONARY|EXTRACTED	sft	SFT	58#61	23313952-1-35-57	Expression of NAB2-STAT6 fusion proteins was confirmed in SFT, and the predicted fusion products harbor the early growth response (EGR)-binding domain of NAB2 fused to the activation domain of STAT6.
23313952	2013	Nat. Genet.	1546-1718	ALL_TEXT_3/3	3	5	6778	SYMBOL|DICTIONARY	stat6	STAT6	19#24		D054364	SYMBOL|DICTIONARY|EXTRACTED	sft	SFT	58#61	23313952-1-35-57	Expression of NAB2-STAT6 fusion proteins was confirmed in SFT, and the predicted fusion products harbor the early growth response (EGR)-binding domain of NAB2 fused to the activation domain of STAT6.
23313952	2013	Nat. Genet.	1546-1718	ALL_TEXT_3/3	3	5	4665	SYMBOL|DICTIONARY	nab2	NAB2	154#158		D054364	SYMBOL|DICTIONARY|EXTRACTED	sft	SFT	58#61	23313952-1-35-57	Expression of NAB2-STAT6 fusion proteins was confirmed in SFT, and the predicted fusion products harbor the early growth response (EGR)-binding domain of NAB2 fused to the activation domain of STAT6.
23313952	2013	Nat. Genet.	1546-1718	ALL_TEXT_3/3	3	5	6778	SYMBOL|DICTIONARY	stat6	STAT6	193#198		D054364	SYMBOL|DICTIONARY|EXTRACTED	sft	SFT	58#61	23313952-1-35-57	Expression of NAB2-STAT6 fusion proteins was confirmed in SFT, and the predicted fusion products harbor the early growth response (EGR)-binding domain of NAB2 fused to the activation domain of STAT6.
16757160	2007	Respir Med	0954-6111	TITLE	0	0	3566	SYMBOL|GENE|GN|DICTIONARY	il-4 receptor	IL-4 receptor	0#13		D001249	LONGTERM|DICTIONARY	asthma	asthma	40#46		IL-4 receptor genetic polymorphisms and asthma in Asian populations.
17054105	2007	Hum. Mutat.	1098-1004	TITLE	0	0	3265	SYMBOL|DICTIONARY|EXTRACTED	hras	HRAS	72#76		D056685	LONGTERM|DISEASE|DT|DICTIONARY	costello syndrome	Costello syndrome	97#114		Diversity, parental germline origin, and phenotypic spectrum of de novo HRAS missense changes in Costello syndrome.
17054105	2007	Hum. Mutat.	1098-1004	ALL_TEXT_1/3	1	1	3265	SYMBOL|()|DICTIONARY|EXTRACTED	hras	HRAS	76#80	17054105-1-24-74	D056685	LONGTERM|DISEASE|DT|DICTIONARY	costello syndrome	Costello syndrome	146#163		Activating mutations in v-Ha-ras Harvey rat sarcoma viral oncogene homolog (HRAS) have recently been identified as the molecular cause underlying Costello syndrome (CS).
17054105	2007	Hum. Mutat.	1098-1004	ALL_TEXT_1/3	1	1	3265	SYMBOL|()|DICTIONARY|EXTRACTED	hras	HRAS	76#80	17054105-1-24-74	D056685	SYMBOL|EXTRACTED|()	cs	CS	165#167	17054105-1-146-163	Activating mutations in v-Ha-ras Harvey rat sarcoma viral oncogene homolog (HRAS) have recently been identified as the molecular cause underlying Costello syndrome (CS).
17054105	2007	Hum. Mutat.	1098-1004	ALL_TEXT_1/3	1	2	3265	SYMBOL|DICTIONARY|EXTRACTED	hras	HRAS	72#76	17054105-1-24-74	D056685	SYMBOL|EXTRACTED	cs	CS	160#162	17054105-1-146-163	To further investigate the phenotypic spectrum associated with germline HRAS mutations and characterize their molecular diversity, subjects with a diagnosis of CS (N = 9), Noonan syndrome (NS; N = 36), cardiofaciocutaneous syndrome (CFCS; N = 4), or with a phenotype suggestive of these conditions but without a definitive diagnosis (N = 12) were screened for the entire coding sequence of the gene.
17054105	2007	Hum. Mutat.	1098-1004	ALL_TEXT_1/3	1	2	3265	SYMBOL|DICTIONARY|EXTRACTED	hras	HRAS	72#76	17054105-1-24-74	D009634	LONGTERM|DISEASE|DT|DICTIONARY	noonan syndrome	Noonan syndrome	172#187		To further investigate the phenotypic spectrum associated with germline HRAS mutations and characterize their molecular diversity, subjects with a diagnosis of CS (N = 9), Noonan syndrome (NS; N = 36), cardiofaciocutaneous syndrome (CFCS; N = 4), or with a phenotype suggestive of these conditions but without a definitive diagnosis (N = 12) were screened for the entire coding sequence of the gene.
17054105	2007	Hum. Mutat.	1098-1004	ALL_TEXT_1/3	1	2	3265	SYMBOL|DICTIONARY|EXTRACTED	hras	HRAS	72#76	17054105-1-24-74	C535579	LONGTERM|DISEASE|DT|DICTIONARY	cardiofaciocutaneous syndrome	cardiofaciocutaneous syndrome	202#231		To further investigate the phenotypic spectrum associated with germline HRAS mutations and characterize their molecular diversity, subjects with a diagnosis of CS (N = 9), Noonan syndrome (NS; N = 36), cardiofaciocutaneous syndrome (CFCS; N = 4), or with a phenotype suggestive of these conditions but without a definitive diagnosis (N = 12) were screened for the entire coding sequence of the gene.
17054105	2007	Hum. Mutat.	1098-1004	ALL_TEXT_2/3	2	3	3265	SYMBOL|DICTIONARY|EXTRACTED	hras	HRAS	23#27	17054105-1-24-74	D056685	SYMBOL|EXTRACTED	cs	CS	83#85	17054105-1-146-163	A de novo heterozygous HRAS change was detected in all the subjects diagnosed with CS, while no lesion was observed with any of the other phenotypes.
19210888	2009	Clin. Exp. Rheumatol.	0392-856X	CONCLUSIONS	4	10	26191	SYMBOL|DICTIONARY	ptpn22	PTPN22	108#114		D001171	SYMBOL|DICTIONARY|EXTRACTED	jia	JIA	227#230	19210888-1-0-29	Our data taken together with various findings in different populations suggest that associations related to PTPN22 seem to be more ethnicity-specific in contrast to the general and less population-dependent role of HLA-DRB1 in JIA.
19210888	2009	Clin. Exp. Rheumatol.	0392-856X	CONCLUSIONS	4	10	3123	SYMBOL|DICTIONARY	hla drb1	HLA-DRB1	215#223		D001171	SYMBOL|DICTIONARY|EXTRACTED	jia	JIA	227#230	19210888-1-0-29	Our data taken together with various findings in different populations suggest that associations related to PTPN22 seem to be more ethnicity-specific in contrast to the general and less population-dependent role of HLA-DRB1 in JIA.
17643058	2007	Int. Arch. Allergy Immunol.	1423-0097	CONCLUSIONS	4	10	2950	SYMBOL|GENE|GN|DICTIONARY	gstp1	GSTP1	32#37		D001249	LONGTERM|DICTIONARY	asthma	asthma	58#64		These findings suggest that the GSTP1 gene is a childhood asthma susceptible gene, and the GSTM1 gene is a modifier gene of GSTP1 for the risk of childhood asthma in the Japanese population.
17643058	2007	Int. Arch. Allergy Immunol.	1423-0097	CONCLUSIONS	4	10	2950	SYMBOL|GENE|GN|DICTIONARY	gstp1	GSTP1	32#37		D001249	LONGTERM|DICTIONARY	asthma	asthma	156#162		These findings suggest that the GSTP1 gene is a childhood asthma susceptible gene, and the GSTM1 gene is a modifier gene of GSTP1 for the risk of childhood asthma in the Japanese population.
17643058	2007	Int. Arch. Allergy Immunol.	1423-0097	CONCLUSIONS	4	10	2944	SYMBOL|GENE|GN|DICTIONARY	gstm1	GSTM1	91#96		D001249	LONGTERM|DICTIONARY	asthma	asthma	58#64		These findings suggest that the GSTP1 gene is a childhood asthma susceptible gene, and the GSTM1 gene is a modifier gene of GSTP1 for the risk of childhood asthma in the Japanese population.
17643058	2007	Int. Arch. Allergy Immunol.	1423-0097	CONCLUSIONS	4	10	2944	SYMBOL|GENE|GN|DICTIONARY	gstm1	GSTM1	91#96		D001249	LONGTERM|DICTIONARY	asthma	asthma	156#162		These findings suggest that the GSTP1 gene is a childhood asthma susceptible gene, and the GSTM1 gene is a modifier gene of GSTP1 for the risk of childhood asthma in the Japanese population.
17643058	2007	Int. Arch. Allergy Immunol.	1423-0097	CONCLUSIONS	4	10	2950	SYMBOL|DICTIONARY	gstp1	GSTP1	124#129		D001249	LONGTERM|DICTIONARY	asthma	asthma	58#64		These findings suggest that the GSTP1 gene is a childhood asthma susceptible gene, and the GSTM1 gene is a modifier gene of GSTP1 for the risk of childhood asthma in the Japanese population.
17643058	2007	Int. Arch. Allergy Immunol.	1423-0097	CONCLUSIONS	4	10	2950	SYMBOL|DICTIONARY	gstp1	GSTP1	124#129		D001249	LONGTERM|DICTIONARY	asthma	asthma	156#162		These findings suggest that the GSTP1 gene is a childhood asthma susceptible gene, and the GSTM1 gene is a modifier gene of GSTP1 for the risk of childhood asthma in the Japanese population.
19811440	2009	Immunol. Invest.	1532-4311	ALL_TEXT_1/3	1	2	7099	SYMBOL|GENE|GN|DICTIONARY	tlr4	TLR4	88#92		D055113	LONGTERM|DISEASE|DN|DICTIONARY	chronic periodontitis	chronic periodontitis	4#25		108 chronic periodontitis patients and 76 controls were genotyped for c.896A>G/1196C>T (TLR4 gene) and for c.-368G>C/ c.-838C>A (IL-18 promoter).
19811440	2009	Immunol. Invest.	1532-4311	ALL_TEXT_1/3	1	2	3606	SYMBOL|GENE|GN|DICTIONARY	il 18	IL-18	129#134		D055113	LONGTERM|DISEASE|DN|DICTIONARY	chronic periodontitis	chronic periodontitis	4#25		108 chronic periodontitis patients and 76 controls were genotyped for c.896A>G/1196C>T (TLR4 gene) and for c.-368G>C/ c.-838C>A (IL-18 promoter).
19384265	2009	Pharmacogenet. Genomics	1744-6872	TITLE	0	0	4524	SYMBOL|DICTIONARY	mthfr	MTHFR	43#48		D009069	LONGTERM|DICTIONARY	migraine disability	migraine disability	95#114		The effects of vitamin supplementation and MTHFR (C677T) genotype on homocysteine-lowering and migraine disability.
20638924	2010	Cancer Epidemiol	1877-783X	CONCLUSION	3	4	7157	SYMBOL|DICTIONARY	p53	p53	54#57		D001943	LONGTERM|DISEASE|DT|DICTIONARY	breast cancer	breast cancer	170#183		We introduced new data related to the contribution of p53 codon 72 to toxicity due to 5-fluorouracil and cyclophosphamide-based neoadjuvant chemotherapy in patients with breast cancer.
20638924	2010	Cancer Epidemiol	1877-783X	CONCLUSION	3	4	7157	SYMBOL|DICTIONARY	p53	p53	54#57		D064420	LONGTERM|DICTIONARY	toxicity	toxicity	70#78	NaN	We introduced new data related to the contribution of p53 codon 72 to toxicity due to 5-fluorouracil and cyclophosphamide-based neoadjuvant chemotherapy in patients with breast cancer.
1301936	1993	Hum. Mutat.	1059-7794	ALL_TEXT_1/3	1	1	4942	SYMBOL|()|DICTIONARY|EXTRACTED	oat	OAT	166#169	1301936-0-34-60	D015799	LONGTERM|DICTIONARY	gyrate atrophy of the choroid and retina	Gyrate atrophy of the choroid and retina	0#40		Gyrate atrophy of the choroid and retina (GA) is an autosomal recessive disorder in which a deficiency of the mitochondrial matrix enzyme ornithine aminotransferase (OAT) leads to progressive blindness.
1301936	1993	Hum. Mutat.	1059-7794	ALL_TEXT_1/3	1	1	4942	SYMBOL|()|DICTIONARY|EXTRACTED	oat	OAT	166#169	1301936-0-34-60	D030342	LONGTERM|DISEASE|DT|DICTIONARY	autosomal recessive disorder	autosomal recessive disorder	52#80		Gyrate atrophy of the choroid and retina (GA) is an autosomal recessive disorder in which a deficiency of the mitochondrial matrix enzyme ornithine aminotransferase (OAT) leads to progressive blindness.
1301936	1993	Hum. Mutat.	1059-7794	ALL_TEXT_1/3	1	1	4942	SYMBOL|()|DICTIONARY|EXTRACTED	oat	OAT	166#169	1301936-0-34-60	D008661	LONGTERM|DICTIONARY	deficiency of the mitochondrial matrix enzyme ornithine aminotransferase (oat) leads	deficiency of the mitochondrial matrix enzyme ornithine aminotransferase (OAT) leads	92#176		Gyrate atrophy of the choroid and retina (GA) is an autosomal recessive disorder in which a deficiency of the mitochondrial matrix enzyme ornithine aminotransferase (OAT) leads to progressive blindness.
1301936	1993	Hum. Mutat.	1059-7794	ALL_TEXT_1/3	1	1	4942	SYMBOL|()|DICTIONARY|EXTRACTED	oat	OAT	166#169	1301936-0-34-60	D001766	LONGTERM|DICTIONARY	blindness	blindness	192#201	NaN	Gyrate atrophy of the choroid and retina (GA) is an autosomal recessive disorder in which a deficiency of the mitochondrial matrix enzyme ornithine aminotransferase (OAT) leads to progressive blindness.
15902656	2005	Am. J. Hum. Genet.	0002-9297	ALL_TEXT_3/3	3	5	200576	SYMBOL|DICTIONARY	pip5k3	PIP5K3	110#116		C563256	SYMBOL|DICTIONARY|EXTRACTED	cfd	CFD	63#66	15902656-1-17-40	The histological and clinical characteristics of patients with CFD are consistent with biochemical studies of PIP5K3 that indicate a role in endosomal sorting.
15523642	2005	Hum. Mutat.	1098-1004	ALL_TEXT_1/3	1	3	4763	LONGTERM|DICTIONARY	nf1	NF1	193#196	NaN	D009456	LONGTERM|DICTIONARY|DISEASE|DA	neurofibromatosis type 1	neurofibromatosis type 1	167#191		Using cDNA-based mutation detection analysis, we have identified one missense and six nonsense mutations that lead to different extents of exon-lacking transcripts in neurofibromatosis type 1 (NF1) patients.
15523642	2005	Hum. Mutat.	1098-1004	ALL_TEXT_1/3	1	3	4763	LONGTERM|DICTIONARY	nf1	NF1	193#196	NaN	D009456	SYMBOL|()|DISEASE|DN|DICTIONARY|EXTRACTED	nf1	NF1	193#196	15523642-3-167-191	Using cDNA-based mutation detection analysis, we have identified one missense and six nonsense mutations that lead to different extents of exon-lacking transcripts in neurofibromatosis type 1 (NF1) patients.
11756990	2002	J. Infect. Dis.	0022-1899	ALL_TEXT_1/3	1	2	3126	LONGTERM|DICTIONARY	leukocyte antigen (hla) class ii	leukocyte antigen (HLA) class II	36#68	NaN	D007251	LONGTERM|DICTIONARY	influenza	influenza	97#106		In order to determine whether human leukocyte antigen (HLA) class II polymorphisms modulate anti-influenza antibody responses to vaccination, a cohort of HLA-typed at-risk donors was investigated.
15902656	2005	Am. J. Hum. Genet.	0002-9297	TITLE	0	0	200576	SYMBOL|DICTIONARY	pip5k3	PIP5K3	13#19		D003317	LONGTERM|DISEASE|DT|DICTIONARY	corneal dystrophy	corneal dystrophy	73#90		Mutations in PIP5K3 are associated with Franois-Neetens mouchete fleck corneal dystrophy.
15902656	2005	Am. J. Hum. Genet.	0002-9297	TITLE	0	0	200576	SYMBOL|DICTIONARY	pip5k3	PIP5K3	13#19		C563256	LONGTERM|DICTIONARY	ois-neetens	ois-Neetens	45#56	NaN	Mutations in PIP5K3 are associated with Franois-Neetens mouchete fleck corneal dystrophy.
15902656	2005	Am. J. Hum. Genet.	0002-9297	ALL_TEXT_2/3	2	2	200576	SYMBOL|DICTIONARY	pip5k3	PIP5K3	123#129		C563256	SYMBOL|DICTIONARY|EXTRACTED	cfd	CFD	27#30	15902656-1-17-40	Linkage analysis localized CFD to a 24-cM (18-Mb) interval of chromosome 2q35 flanked by D2S2289 and D2S126 and containing PIP5K3.
20100586	2011	Biol. Blood Marrow Transplant.	1523-6536	ALL_TEXT_1/3	1	1	7124	LONGTERM|GENE|GT|DICTIONARY	tumor necrosis factor (tnf)-alpha	Tumor necrosis factor (TNF)-alpha	0#33		D006086	LONGTERM|DISEASE|DT|DICTIONARY	acute graft versus host disease	acute graft-versus-host disease	117#148		Tumor necrosis factor (TNF)-alpha plays a significant role in conditioning related toxicities and the development of acute graft-versus-host disease (aGVHD).
20100586	2011	Biol. Blood Marrow Transplant.	1523-6536	ALL_TEXT_1/3	1	1	7124	LONGTERM|GENE|GT|DICTIONARY	tumor necrosis factor (tnf)-alpha	Tumor necrosis factor (TNF)-alpha	0#33		D006086	SYMBOL|EXTRACTED|()	agvhd	aGVHD	150#155	20100586-1-117-148	Tumor necrosis factor (TNF)-alpha plays a significant role in conditioning related toxicities and the development of acute graft-versus-host disease (aGVHD).
20100586	2011	Biol. Blood Marrow Transplant.	1523-6536	ALL_TEXT_1/3	1	1	7124	LONGTERM|GENE|GT|DICTIONARY	tumor necrosis factor (tnf)-alpha	Tumor necrosis factor (TNF)-alpha	0#33		D064420	LONGTERM|DICTIONARY	toxicities	toxicities	83#93	NaN	Tumor necrosis factor (TNF)-alpha plays a significant role in conditioning related toxicities and the development of acute graft-versus-host disease (aGVHD).
20100586	2011	Biol. Blood Marrow Transplant.	1523-6536	ALL_TEXT_1/3	1	1	7124	SYMBOL|EXTRACTED|()	tumor necrosis factor (tnf)-alpha	Tumor necrosis factor (TNF)-alpha	0#33	20100586-1-0-21	D006086	LONGTERM|DISEASE|DT|DICTIONARY	acute graft versus host disease	acute graft-versus-host disease	117#148		Tumor necrosis factor (TNF)-alpha plays a significant role in conditioning related toxicities and the development of acute graft-versus-host disease (aGVHD).
20100586	2011	Biol. Blood Marrow Transplant.	1523-6536	ALL_TEXT_1/3	1	1	7124	SYMBOL|EXTRACTED|()	tumor necrosis factor (tnf)-alpha	Tumor necrosis factor (TNF)-alpha	0#33	20100586-1-0-21	D006086	SYMBOL|EXTRACTED|()	agvhd	aGVHD	150#155	20100586-1-117-148	Tumor necrosis factor (TNF)-alpha plays a significant role in conditioning related toxicities and the development of acute graft-versus-host disease (aGVHD).
20100586	2011	Biol. Blood Marrow Transplant.	1523-6536	ALL_TEXT_1/3	1	1	7124	SYMBOL|EXTRACTED|()	tumor necrosis factor (tnf)-alpha	Tumor necrosis factor (TNF)-alpha	0#33	20100586-1-0-21	D064420	LONGTERM|DICTIONARY	toxicities	toxicities	83#93	NaN	Tumor necrosis factor (TNF)-alpha plays a significant role in conditioning related toxicities and the development of acute graft-versus-host disease (aGVHD).
12135317	2003	Hypertens. Res.	0916-9636	ALL_TEXT_3/3	3	11	7056	SYMBOL|EXTRACTED	tm	TM	51#53	12135317-1-0-14	D009203	LONGTERM|DICTIONARY	myocardial infarction	myocardial infarction	89#110		These results indicated that G-33A polymorphism in TM might be a genetic risk factor for myocardial infarction.
15956286	2005	Blood	0006-4971	ALL_TEXT_3/3	3	9	3779	LONGTERM|DICTIONARY	beta1	beta1	74#79		D013927	LONGTERM|DICTIONARY	thrombosis	thrombosis	181#191	NaN	This study thus presents the functional consequences of the platelet Q43P beta1-tubulin substitution that is frequent in the healthy population and may protect men against arterial thrombosis.
9747038	1998	J. Hum. Genet.	1434-5161	ALL_TEXT_1/3	1	1	5354	SYMBOL|()|GENE|GN|DICTIONARY	plp	PLP	41#44		D020371	LONGTERM|DISEASE|DT|DICTIONARY	pelizaeus merzbacher disease	Pelizaeus-Merzbacher disease	112#140		We investigated the proteolipid protein (PLP) gene in two brothers in a Japanese family with a connatal form of Pelizaeus-Merzbacher disease (PMD).
9747038	1998	J. Hum. Genet.	1434-5161	ALL_TEXT_1/3	1	1	5354	SYMBOL|()|GENE|GN|DICTIONARY	plp	PLP	41#44		D020371	SYMBOL|()|DICTIONARY|EXTRACTED	pmd	PMD	142#145	9747038-1-112-140	We investigated the proteolipid protein (PLP) gene in two brothers in a Japanese family with a connatal form of Pelizaeus-Merzbacher disease (PMD).
15956353	2005	J. Mol. Endocrinol.	0952-5041	ALL_TEXT_3/3	3	11	1594	SYMBOL|GENE|GN|DICTIONARY	cyp27b1	CYP27B1	30#37		D000224	LONGTERM|DISEASE|DT|DICTIONARY	autoimmune addison disease	autoimmune Addison's disease	73#101		We are able to confirm that a CYP27B1 promoter allele is associated with autoimmune Addison's disease, and extend this finding to include an associated promoter haplotype.
15523642	2005	Hum. Mutat.	1098-1004	ALL_TEXT_2/3	2	6	4763	LONGTERM|DICTIONARY	nf1	NF1	48#51	NaN	D009456	SYMBOL|DICTIONARY|EXTRACTED	nf1	NF1	48#51	15523642-3-167-191	Therefore, we examined the wild-type and mutant NF1 sequences with two available ESE-prediction programs.
20484924	2010	Int. Arch. Allergy Immunol.	1423-0097	TITLE	0	0	3596	LONGTERM|DICTIONARY	interleukin 13	Interleukin 13	0#14		D012220	LONGTERM|DICTIONARY	rhinitis	rhinitis	61#69		Interleukin 13 and interleukin 4 receptor- polymorphisms in rhinitis and asthma.
20484924	2010	Int. Arch. Allergy Immunol.	1423-0097	TITLE	0	0	3596	LONGTERM|DICTIONARY	interleukin 13	Interleukin 13	0#14		D001249	LONGTERM|DICTIONARY	asthma	asthma	74#80		Interleukin 13 and interleukin 4 receptor- polymorphisms in rhinitis and asthma.
20484924	2010	Int. Arch. Allergy Immunol.	1423-0097	BACKGROUND	1	3	3596	SYMBOL|DICTIONARY	il13	IL13	0#4		D001249	LONGTERM|DICTIONARY	asthma	asthma	48#54		IL13 and IL4R polymorphisms are associated with asthma and show gene-gene interaction in asthma.
20484924	2010	Int. Arch. Allergy Immunol.	1423-0097	BACKGROUND	1	3	3596	SYMBOL|DICTIONARY	il13	IL13	0#4		D001249	LONGTERM|DICTIONARY	asthma	asthma	89#95		IL13 and IL4R polymorphisms are associated with asthma and show gene-gene interaction in asthma.
20484924	2010	Int. Arch. Allergy Immunol.	1423-0097	BACKGROUND	1	3	3566	SYMBOL|DICTIONARY	il4r	IL4R	9#13		D001249	LONGTERM|DICTIONARY	asthma	asthma	48#54		IL13 and IL4R polymorphisms are associated with asthma and show gene-gene interaction in asthma.
20484924	2010	Int. Arch. Allergy Immunol.	1423-0097	BACKGROUND	1	3	3566	SYMBOL|DICTIONARY	il4r	IL4R	9#13		D001249	LONGTERM|DICTIONARY	asthma	asthma	89#95		IL13 and IL4R polymorphisms are associated with asthma and show gene-gene interaction in asthma.
16054149	2006	Atherosclerosis	0021-9150	TITLE	0	0	116519	LONGTERM|GENE|GN|DICTIONARY	apolipoprotein a5	apolipoprotein A5	22#39		D003324	LONGTERM|DISEASE|DT|DICTIONARY	coronary artery disease	coronary artery disease	76#99		Genetic variations of apolipoprotein A5 gene is associated with the risk of coronary artery disease among Chinese in Taiwan.
16054149	2006	Atherosclerosis	0021-9150	ALL_TEXT_1/3	1	2	116519	SYMBOL|DICTIONARY	apoa5	APOA5	132#137		D003324	LONGTERM|DISEASE|DT|DICTIONARY	coronary artery disease	coronary artery disease	29#52		Triglyceride plays a role in coronary artery disease (CAD), so this case-control study tested for a possible link between these two APOA5 polymorphisms, their common haplotypes and the risk of CAD.
16054149	2006	Atherosclerosis	0021-9150	ALL_TEXT_1/3	1	2	116519	SYMBOL|DICTIONARY	apoa5	APOA5	132#137		D003324	SYMBOL|()|DICTIONARY|EXTRACTED	cad	CAD	54#57	16054149-2-29-52	Triglyceride plays a role in coronary artery disease (CAD), so this case-control study tested for a possible link between these two APOA5 polymorphisms, their common haplotypes and the risk of CAD.
16054149	2006	Atherosclerosis	0021-9150	ALL_TEXT_1/3	1	2	116519	SYMBOL|DICTIONARY	apoa5	APOA5	132#137		D003324	SYMBOL|DICTIONARY|EXTRACTED	cad	CAD	193#196	16054149-2-29-52	Triglyceride plays a role in coronary artery disease (CAD), so this case-control study tested for a possible link between these two APOA5 polymorphisms, their common haplotypes and the risk of CAD.
20484924	2010	Int. Arch. Allergy Immunol.	1423-0097	RESULTS	3	8	3596	SYMBOL|DICTIONARY	il13	IL13	0#4		D001249	LONGTERM|DICTIONARY	asthma	asthma	81#87		IL13 Arg130Gln (rs20541) and G870A (rs1295685) were consistently associated with asthma and serum IgE in both asthma populations.
20484924	2010	Int. Arch. Allergy Immunol.	1423-0097	RESULTS	3	8	3596	SYMBOL|DICTIONARY	il13	IL13	0#4		D001249	LONGTERM|DICTIONARY	asthma	asthma	110#116		IL13 Arg130Gln (rs20541) and G870A (rs1295685) were consistently associated with asthma and serum IgE in both asthma populations.
17956895	2008	Hum. Mol. Genet.	1460-2083	ALL_TEXT_3/3	3	6	25978	SYMBOL|DICTIONARY|EXTRACTED	chmp2b	CHMP2B	50#56	17956895-1-4-42	D009410	LONGTERM|DICTIONARY	basal degeneration	basal degeneration	107#125	NaN	We also describe a missense mutation in exon 5 of CHMP2B (p.Asn143Ser) in a familial patient with cortical basal degeneration.
17956895	2008	Hum. Mol. Genet.	1460-2083	ALL_TEXT_3/3	3	5	25978	SYMBOL|DICTIONARY|EXTRACTED	chmp2b	CHMP2B	60#66	17956895-1-4-42	D057174	SYMBOL|DICTIONARY|EXTRACTED	ftld	FTLD	110#114	17956895-1-86-119	Together, these data suggest that C-truncating mutations in CHMP2B might underlie the pathogenic mechanism in FTLD by disturbing endosome function.
15901993	2005	Eur. J. Cancer Prev.	0959-8278	ALL_TEXT_3/3	3	5	1544	SYMBOL|NUMBER|DICTIONARY	cyp1a2	CYP1A2	9#15		D018281	SYMBOL|DICTIONARY|EXTRACTED	cca	CCA	105#108	15901993-2-101-119	Although CYP1A2*1A allele, NAT1*10 allele, and the NAT2 slow acetylator alleles were not associated with CCA risk, among the male subjects, the genotype CYP1A2*1A/*1A conferred a decreased risk of the cancer (adjusted odds ratio (OR) 0.28, 95% confidence interval (CI) 0.08-0.94) compared with CYP1A2*1F/1*F. Frequency distributions of rapid NAT2*13 and two slow alleles (*6B and *7A), but not the other major alleles, were associated with lower CCA risk.
15901993	2005	Eur. J. Cancer Prev.	0959-8278	ALL_TEXT_3/3	3	5	1544	SYMBOL|NUMBER|DICTIONARY	cyp1a2	CYP1A2	9#15		D009369	LONGTERM|DISEASE|DT|DICTIONARY	cancer	cancer	201#207		Although CYP1A2*1A allele, NAT1*10 allele, and the NAT2 slow acetylator alleles were not associated with CCA risk, among the male subjects, the genotype CYP1A2*1A/*1A conferred a decreased risk of the cancer (adjusted odds ratio (OR) 0.28, 95% confidence interval (CI) 0.08-0.94) compared with CYP1A2*1F/1*F. Frequency distributions of rapid NAT2*13 and two slow alleles (*6B and *7A), but not the other major alleles, were associated with lower CCA risk.
15901993	2005	Eur. J. Cancer Prev.	0959-8278	ALL_TEXT_3/3	3	5	1544	SYMBOL|NUMBER|DICTIONARY	cyp1a2	CYP1A2	9#15		D018281	SYMBOL|DICTIONARY|EXTRACTED	cca	CCA	446#449	15901993-2-101-119	Although CYP1A2*1A allele, NAT1*10 allele, and the NAT2 slow acetylator alleles were not associated with CCA risk, among the male subjects, the genotype CYP1A2*1A/*1A conferred a decreased risk of the cancer (adjusted odds ratio (OR) 0.28, 95% confidence interval (CI) 0.08-0.94) compared with CYP1A2*1F/1*F. Frequency distributions of rapid NAT2*13 and two slow alleles (*6B and *7A), but not the other major alleles, were associated with lower CCA risk.
15901993	2005	Eur. J. Cancer Prev.	0959-8278	ALL_TEXT_3/3	3	5	9	SYMBOL|NUMBER|DICTIONARY	nat1	NAT1	27#31		D018281	SYMBOL|DICTIONARY|EXTRACTED	cca	CCA	105#108	15901993-2-101-119	Although CYP1A2*1A allele, NAT1*10 allele, and the NAT2 slow acetylator alleles were not associated with CCA risk, among the male subjects, the genotype CYP1A2*1A/*1A conferred a decreased risk of the cancer (adjusted odds ratio (OR) 0.28, 95% confidence interval (CI) 0.08-0.94) compared with CYP1A2*1F/1*F. Frequency distributions of rapid NAT2*13 and two slow alleles (*6B and *7A), but not the other major alleles, were associated with lower CCA risk.
15901993	2005	Eur. J. Cancer Prev.	0959-8278	ALL_TEXT_3/3	3	5	9	SYMBOL|NUMBER|DICTIONARY	nat1	NAT1	27#31		D009369	LONGTERM|DISEASE|DT|DICTIONARY	cancer	cancer	201#207		Although CYP1A2*1A allele, NAT1*10 allele, and the NAT2 slow acetylator alleles were not associated with CCA risk, among the male subjects, the genotype CYP1A2*1A/*1A conferred a decreased risk of the cancer (adjusted odds ratio (OR) 0.28, 95% confidence interval (CI) 0.08-0.94) compared with CYP1A2*1F/1*F. Frequency distributions of rapid NAT2*13 and two slow alleles (*6B and *7A), but not the other major alleles, were associated with lower CCA risk.
15901993	2005	Eur. J. Cancer Prev.	0959-8278	ALL_TEXT_3/3	3	5	9	SYMBOL|NUMBER|DICTIONARY	nat1	NAT1	27#31		D018281	SYMBOL|DICTIONARY|EXTRACTED	cca	CCA	446#449	15901993-2-101-119	Although CYP1A2*1A allele, NAT1*10 allele, and the NAT2 slow acetylator alleles were not associated with CCA risk, among the male subjects, the genotype CYP1A2*1A/*1A conferred a decreased risk of the cancer (adjusted odds ratio (OR) 0.28, 95% confidence interval (CI) 0.08-0.94) compared with CYP1A2*1F/1*F. Frequency distributions of rapid NAT2*13 and two slow alleles (*6B and *7A), but not the other major alleles, were associated with lower CCA risk.
15901993	2005	Eur. J. Cancer Prev.	0959-8278	ALL_TEXT_3/3	3	5	10	SYMBOL|DICTIONARY	nat2	NAT2	51#55		D018281	SYMBOL|DICTIONARY|EXTRACTED	cca	CCA	105#108	15901993-2-101-119	Although CYP1A2*1A allele, NAT1*10 allele, and the NAT2 slow acetylator alleles were not associated with CCA risk, among the male subjects, the genotype CYP1A2*1A/*1A conferred a decreased risk of the cancer (adjusted odds ratio (OR) 0.28, 95% confidence interval (CI) 0.08-0.94) compared with CYP1A2*1F/1*F. Frequency distributions of rapid NAT2*13 and two slow alleles (*6B and *7A), but not the other major alleles, were associated with lower CCA risk.
15901993	2005	Eur. J. Cancer Prev.	0959-8278	ALL_TEXT_3/3	3	5	10	SYMBOL|DICTIONARY	nat2	NAT2	51#55		D009369	LONGTERM|DISEASE|DT|DICTIONARY	cancer	cancer	201#207		Although CYP1A2*1A allele, NAT1*10 allele, and the NAT2 slow acetylator alleles were not associated with CCA risk, among the male subjects, the genotype CYP1A2*1A/*1A conferred a decreased risk of the cancer (adjusted odds ratio (OR) 0.28, 95% confidence interval (CI) 0.08-0.94) compared with CYP1A2*1F/1*F. Frequency distributions of rapid NAT2*13 and two slow alleles (*6B and *7A), but not the other major alleles, were associated with lower CCA risk.
15901993	2005	Eur. J. Cancer Prev.	0959-8278	ALL_TEXT_3/3	3	5	10	SYMBOL|DICTIONARY	nat2	NAT2	51#55		D018281	SYMBOL|DICTIONARY|EXTRACTED	cca	CCA	446#449	15901993-2-101-119	Although CYP1A2*1A allele, NAT1*10 allele, and the NAT2 slow acetylator alleles were not associated with CCA risk, among the male subjects, the genotype CYP1A2*1A/*1A conferred a decreased risk of the cancer (adjusted odds ratio (OR) 0.28, 95% confidence interval (CI) 0.08-0.94) compared with CYP1A2*1F/1*F. Frequency distributions of rapid NAT2*13 and two slow alleles (*6B and *7A), but not the other major alleles, were associated with lower CCA risk.
15901993	2005	Eur. J. Cancer Prev.	0959-8278	ALL_TEXT_3/3	3	5	1544	SYMBOL|NUMBER|DICTIONARY	cyp1a2	CYP1A2	153#159		D018281	SYMBOL|DICTIONARY|EXTRACTED	cca	CCA	105#108	15901993-2-101-119	Although CYP1A2*1A allele, NAT1*10 allele, and the NAT2 slow acetylator alleles were not associated with CCA risk, among the male subjects, the genotype CYP1A2*1A/*1A conferred a decreased risk of the cancer (adjusted odds ratio (OR) 0.28, 95% confidence interval (CI) 0.08-0.94) compared with CYP1A2*1F/1*F. Frequency distributions of rapid NAT2*13 and two slow alleles (*6B and *7A), but not the other major alleles, were associated with lower CCA risk.
15901993	2005	Eur. J. Cancer Prev.	0959-8278	ALL_TEXT_3/3	3	5	1544	SYMBOL|NUMBER|DICTIONARY	cyp1a2	CYP1A2	153#159		D009369	LONGTERM|DISEASE|DT|DICTIONARY	cancer	cancer	201#207		Although CYP1A2*1A allele, NAT1*10 allele, and the NAT2 slow acetylator alleles were not associated with CCA risk, among the male subjects, the genotype CYP1A2*1A/*1A conferred a decreased risk of the cancer (adjusted odds ratio (OR) 0.28, 95% confidence interval (CI) 0.08-0.94) compared with CYP1A2*1F/1*F. Frequency distributions of rapid NAT2*13 and two slow alleles (*6B and *7A), but not the other major alleles, were associated with lower CCA risk.
15901993	2005	Eur. J. Cancer Prev.	0959-8278	ALL_TEXT_3/3	3	5	1544	SYMBOL|NUMBER|DICTIONARY	cyp1a2	CYP1A2	153#159		D018281	SYMBOL|DICTIONARY|EXTRACTED	cca	CCA	446#449	15901993-2-101-119	Although CYP1A2*1A allele, NAT1*10 allele, and the NAT2 slow acetylator alleles were not associated with CCA risk, among the male subjects, the genotype CYP1A2*1A/*1A conferred a decreased risk of the cancer (adjusted odds ratio (OR) 0.28, 95% confidence interval (CI) 0.08-0.94) compared with CYP1A2*1F/1*F. Frequency distributions of rapid NAT2*13 and two slow alleles (*6B and *7A), but not the other major alleles, were associated with lower CCA risk.
15901993	2005	Eur. J. Cancer Prev.	0959-8278	ALL_TEXT_3/3	3	5	1544	SYMBOL|NUMBER|DICTIONARY	cyp1a2	CYP1A2	294#300		D018281	SYMBOL|DICTIONARY|EXTRACTED	cca	CCA	105#108	15901993-2-101-119	Although CYP1A2*1A allele, NAT1*10 allele, and the NAT2 slow acetylator alleles were not associated with CCA risk, among the male subjects, the genotype CYP1A2*1A/*1A conferred a decreased risk of the cancer (adjusted odds ratio (OR) 0.28, 95% confidence interval (CI) 0.08-0.94) compared with CYP1A2*1F/1*F. Frequency distributions of rapid NAT2*13 and two slow alleles (*6B and *7A), but not the other major alleles, were associated with lower CCA risk.
15901993	2005	Eur. J. Cancer Prev.	0959-8278	ALL_TEXT_3/3	3	5	1544	SYMBOL|NUMBER|DICTIONARY	cyp1a2	CYP1A2	294#300		D009369	LONGTERM|DISEASE|DT|DICTIONARY	cancer	cancer	201#207		Although CYP1A2*1A allele, NAT1*10 allele, and the NAT2 slow acetylator alleles were not associated with CCA risk, among the male subjects, the genotype CYP1A2*1A/*1A conferred a decreased risk of the cancer (adjusted odds ratio (OR) 0.28, 95% confidence interval (CI) 0.08-0.94) compared with CYP1A2*1F/1*F. Frequency distributions of rapid NAT2*13 and two slow alleles (*6B and *7A), but not the other major alleles, were associated with lower CCA risk.
15901993	2005	Eur. J. Cancer Prev.	0959-8278	ALL_TEXT_3/3	3	5	1544	SYMBOL|NUMBER|DICTIONARY	cyp1a2	CYP1A2	294#300		D018281	SYMBOL|DICTIONARY|EXTRACTED	cca	CCA	446#449	15901993-2-101-119	Although CYP1A2*1A allele, NAT1*10 allele, and the NAT2 slow acetylator alleles were not associated with CCA risk, among the male subjects, the genotype CYP1A2*1A/*1A conferred a decreased risk of the cancer (adjusted odds ratio (OR) 0.28, 95% confidence interval (CI) 0.08-0.94) compared with CYP1A2*1F/1*F. Frequency distributions of rapid NAT2*13 and two slow alleles (*6B and *7A), but not the other major alleles, were associated with lower CCA risk.
15901993	2005	Eur. J. Cancer Prev.	0959-8278	ALL_TEXT_3/3	3	5	10	SYMBOL|NUMBER|DICTIONARY	nat2	NAT2	342#346		D018281	SYMBOL|DICTIONARY|EXTRACTED	cca	CCA	105#108	15901993-2-101-119	Although CYP1A2*1A allele, NAT1*10 allele, and the NAT2 slow acetylator alleles were not associated with CCA risk, among the male subjects, the genotype CYP1A2*1A/*1A conferred a decreased risk of the cancer (adjusted odds ratio (OR) 0.28, 95% confidence interval (CI) 0.08-0.94) compared with CYP1A2*1F/1*F. Frequency distributions of rapid NAT2*13 and two slow alleles (*6B and *7A), but not the other major alleles, were associated with lower CCA risk.
15901993	2005	Eur. J. Cancer Prev.	0959-8278	ALL_TEXT_3/3	3	5	10	SYMBOL|NUMBER|DICTIONARY	nat2	NAT2	342#346		D009369	LONGTERM|DISEASE|DT|DICTIONARY	cancer	cancer	201#207		Although CYP1A2*1A allele, NAT1*10 allele, and the NAT2 slow acetylator alleles were not associated with CCA risk, among the male subjects, the genotype CYP1A2*1A/*1A conferred a decreased risk of the cancer (adjusted odds ratio (OR) 0.28, 95% confidence interval (CI) 0.08-0.94) compared with CYP1A2*1F/1*F. Frequency distributions of rapid NAT2*13 and two slow alleles (*6B and *7A), but not the other major alleles, were associated with lower CCA risk.
15901993	2005	Eur. J. Cancer Prev.	0959-8278	ALL_TEXT_3/3	3	5	10	SYMBOL|NUMBER|DICTIONARY	nat2	NAT2	342#346		D018281	SYMBOL|DICTIONARY|EXTRACTED	cca	CCA	446#449	15901993-2-101-119	Although CYP1A2*1A allele, NAT1*10 allele, and the NAT2 slow acetylator alleles were not associated with CCA risk, among the male subjects, the genotype CYP1A2*1A/*1A conferred a decreased risk of the cancer (adjusted odds ratio (OR) 0.28, 95% confidence interval (CI) 0.08-0.94) compared with CYP1A2*1F/1*F. Frequency distributions of rapid NAT2*13 and two slow alleles (*6B and *7A), but not the other major alleles, were associated with lower CCA risk.
17956895	2008	Hum. Mol. Genet.	1460-2083	ALL_TEXT_2/3	2	3	25978	SYMBOL|DICTIONARY|EXTRACTED	chmp2b	CHMP2B	31#37	17956895-1-4-42	D057174	SYMBOL|DISEASE|DN|DICTIONARY|EXTRACTED	familial ftld	familial FTLD	127#140	17956895-1-86-119	Extensive mutation analysis of CHMP2B in Belgian patients (N = 146) identified one nonsense mutation in exon 5 (c.493C>T) in a familial FTLD patient, predicting a C-truncated protein p.Gln165X analogous to the Danish mutant proteins.
17956895	2008	Hum. Mol. Genet.	1460-2083	ALL_TEXT_1/3	1	1	25978	LONGTERM|GENE|GN|DICTIONARY	charged multivesicular body protein 2b	charged multivesicular body protein 2B	4#42		D057174	LONGTERM|DICTIONARY	frontotemporal lobar degeneration	frontotemporal lobar degeneration	86#119		The charged multivesicular body protein 2B gene (CHMP2B) was recently associated with frontotemporal lobar degeneration (FTLD) linked to chromosome 3 in a Danish FTLD family (FTD-3).
17956895	2008	Hum. Mol. Genet.	1460-2083	ALL_TEXT_1/3	1	1	25978	LONGTERM|GENE|GN|DICTIONARY	charged multivesicular body protein 2b	charged multivesicular body protein 2B	4#42		D057174	SYMBOL|()|DICTIONARY|EXTRACTED	ftld	FTLD	121#125	17956895-1-86-119	The charged multivesicular body protein 2B gene (CHMP2B) was recently associated with frontotemporal lobar degeneration (FTLD) linked to chromosome 3 in a Danish FTLD family (FTD-3).
17956895	2008	Hum. Mol. Genet.	1460-2083	ALL_TEXT_1/3	1	1	25978	LONGTERM|GENE|GN|DICTIONARY	charged multivesicular body protein 2b	charged multivesicular body protein 2B	4#42		D057174	SYMBOL|GFAM|FN|DICTIONARY|EXTRACTED	ftld	FTLD	162#166	17956895-1-86-119	The charged multivesicular body protein 2B gene (CHMP2B) was recently associated with frontotemporal lobar degeneration (FTLD) linked to chromosome 3 in a Danish FTLD family (FTD-3).
17956895	2008	Hum. Mol. Genet.	1460-2083	ALL_TEXT_1/3	1	1	25978	SYMBOL|()|DICTIONARY|EXTRACTED	chmp2b	CHMP2B	49#55	17956895-1-4-42	D057174	LONGTERM|DICTIONARY	frontotemporal lobar degeneration	frontotemporal lobar degeneration	86#119		The charged multivesicular body protein 2B gene (CHMP2B) was recently associated with frontotemporal lobar degeneration (FTLD) linked to chromosome 3 in a Danish FTLD family (FTD-3).
17956895	2008	Hum. Mol. Genet.	1460-2083	ALL_TEXT_1/3	1	1	25978	SYMBOL|()|DICTIONARY|EXTRACTED	chmp2b	CHMP2B	49#55	17956895-1-4-42	D057174	SYMBOL|()|DICTIONARY|EXTRACTED	ftld	FTLD	121#125	17956895-1-86-119	The charged multivesicular body protein 2B gene (CHMP2B) was recently associated with frontotemporal lobar degeneration (FTLD) linked to chromosome 3 in a Danish FTLD family (FTD-3).
17956895	2008	Hum. Mol. Genet.	1460-2083	ALL_TEXT_1/3	1	1	25978	SYMBOL|()|DICTIONARY|EXTRACTED	chmp2b	CHMP2B	49#55	17956895-1-4-42	D057174	SYMBOL|GFAM|FN|DICTIONARY|EXTRACTED	ftld	FTLD	162#166	17956895-1-86-119	The charged multivesicular body protein 2B gene (CHMP2B) was recently associated with frontotemporal lobar degeneration (FTLD) linked to chromosome 3 in a Danish FTLD family (FTD-3).
17956895	2008	Hum. Mol. Genet.	1460-2083	TITLE	0	0	25978	SYMBOL|DICTIONARY|EXTRACTED	chmp2b	CHMP2B	0#6		D057174	LONGTERM|DICTIONARY	frontotemporal lobar degeneration	frontotemporal lobar degeneration	33#66		CHMP2B C-truncating mutations in frontotemporal lobar degeneration are associated with an aberrant endosomal phenotype in vitro.
20570322	2010	Gynecol. Oncol.	1095-6859	TITLE	0	0	672	SYMBOL|DICTIONARY	brca1	BRCA1	14#19		D005185	LONGTERM|DICTIONARY	carcinoma of the fallopian tube	carcinoma of the fallopian tube	67#98		Prevalence of BRCA1 and BRCA2 germ line mutations among women with carcinoma of the fallopian tube.
20570322	2010	Gynecol. Oncol.	1095-6859	TITLE	0	0	675	SYMBOL|DICTIONARY	brca2	BRCA2	24#29		D005185	LONGTERM|DICTIONARY	carcinoma of the fallopian tube	carcinoma of the fallopian tube	67#98		Prevalence of BRCA1 and BRCA2 germ line mutations among women with carcinoma of the fallopian tube.
20570322	2010	Gynecol. Oncol.	1095-6859	OBJECTIVES	1	1	672	SYMBOL|DICTIONARY	brca1	BRCA1	60#65		D005185	LONGTERM|DICTIONARY	carcinoma of the fallopian tube	carcinoma of the fallopian tube	121#152		The purpose of this study is to determine the prevalence of BRCA1 and BRCA2 mutations among a large series of women with carcinoma of the fallopian tube.
20570322	2010	Gynecol. Oncol.	1095-6859	OBJECTIVES	1	1	675	SYMBOL|DICTIONARY	brca2	BRCA2	70#75		D005185	LONGTERM|DICTIONARY	carcinoma of the fallopian tube	carcinoma of the fallopian tube	121#152		The purpose of this study is to determine the prevalence of BRCA1 and BRCA2 mutations among a large series of women with carcinoma of the fallopian tube.
15956286	2005	Blood	0006-4971	TITLE	0	0	81027	SYMBOL|DICTIONARY	tubb1	TUBB1	4#9		D002318	LONGTERM|DISEASE|DT|DICTIONARY	cardiovascular disease	cardiovascular disease	59#81		The TUBB1 Q43P functional polymorphism reduces the risk of cardiovascular disease in men by modulating platelet function and structure.
15788153	2005	Microbes Infect.	1286-4579	ALL_TEXT_1/3	1	3	4055	SYMBOL|EXTRACTED	ltbetar	LTbetaR	21#28	15788153-1-28-53	D000740	LONGTERM|DICTIONARY	anemia	anemia	115#121		Higher resistance of LTbetaR-deficient mice correlates with an earlier onset of reticulocytosis, and the period of anemia is shorter.
15788153	2005	Microbes Infect.	1286-4579	ALL_TEXT_1/3	1	2	4055	SYMBOL|EXTRACTED	ltbetar	LTbetaR	43#50	15788153-1-28-53	D008288	LONGTERM|DICTIONARY	malaria	malaria	129#136		Surprisingly, however, we find that female LTbetaR-deficient mice are even more resistant to blood stages of Plasmodium chabaudi malaria than wild-type C57BL/6 mice.
15788153	2005	Microbes Infect.	1286-4579	TITLE	0	0	4055	LONGTERM|GENE|GT|DICTIONARY	lymphotoxin beta receptor	lymphotoxin beta receptor	58#83		D008288	LONGTERM|DICTIONARY	malaria	malaria	124#131		Testosterone responsiveness of spleen and liver in female lymphotoxin beta receptor-deficient mice resistant to blood-stage malaria.
20659174	2011	Genes Brain Behav.	1601-183X	ALL_TEXT_2/3	2	3	3164	SYMBOL|DICTIONARY	nr4a1	NR4A1	168#173		D012559	LONGTERM|DISEASE|DN|DICTIONARY	schizophrenia	schizophrenia	314#327		We have, therefore, analysed the association of six single nucleotide polymorphisms (SNPs) within the three genes belonging to the NR4A orphan nuclear receptor family, NR4A1 (rs2603751, rs2701124), NR4A2 (rs12803, rs834835) and NR4A3 (rs1131339, rs1405209), with the degree of smoking in a sample of 204 unrelated schizophrenia patients, which included 126 smokers and 78 non-smokers.
20659174	2011	Genes Brain Behav.	1601-183X	ALL_TEXT_2/3	2	3	4929	SYMBOL|DICTIONARY	nr4a2	NR4A2	198#203		D012559	LONGTERM|DISEASE|DN|DICTIONARY	schizophrenia	schizophrenia	314#327		We have, therefore, analysed the association of six single nucleotide polymorphisms (SNPs) within the three genes belonging to the NR4A orphan nuclear receptor family, NR4A1 (rs2603751, rs2701124), NR4A2 (rs12803, rs834835) and NR4A3 (rs1131339, rs1405209), with the degree of smoking in a sample of 204 unrelated schizophrenia patients, which included 126 smokers and 78 non-smokers.
20659174	2011	Genes Brain Behav.	1601-183X	ALL_TEXT_2/3	2	3	8013	SYMBOL|DICTIONARY	nr4a3	NR4A3	228#233		D012559	LONGTERM|DISEASE|DN|DICTIONARY	schizophrenia	schizophrenia	314#327		We have, therefore, analysed the association of six single nucleotide polymorphisms (SNPs) within the three genes belonging to the NR4A orphan nuclear receptor family, NR4A1 (rs2603751, rs2701124), NR4A2 (rs12803, rs834835) and NR4A3 (rs1131339, rs1405209), with the degree of smoking in a sample of 204 unrelated schizophrenia patients, which included 126 smokers and 78 non-smokers.
15718509	2005	Stroke	1524-4628	CONCLUSIONS	4	10	12	SYMBOL|GENE|GN|DICTIONARY	serpina3	SERPINA3	24#32		D013345	SYMBOL|DICTIONARY|EXTRACTED	sah	SAH	88#91	15718509-3-38-61	The A/T polymorphism of SERPINA3 gene is associated with the risk factor for aneurysmal SAH.
15718509	2005	Stroke	1524-4628	CONCLUSIONS	4	10	12	SYMBOL|GENE|GN|DICTIONARY	serpina3	SERPINA3	24#32		D000783	LONGTERM|DICTIONARY	aneurysmal	aneurysmal	77#87	NaN	The A/T polymorphism of SERPINA3 gene is associated with the risk factor for aneurysmal SAH.
19643966	2010	Invest. Ophthalmol. Vis. Sci.	1552-5783	TITLE	0	0	4060	LONGTERM|GENE|GN|DICTIONARY	lumican	lumican	19#26		D009216	LONGTERM|DICTIONARY	high myopia	high myopia	68#79		Association of the lumican gene functional 3'-UTR polymorphism with high myopia.
15788153	2005	Microbes Infect.	1286-4579	ALL_TEXT_3/3	3	9	4055	SYMBOL|EXTRACTED	ltbetar	LTbetaR	191#198	15788153-1-28-53	D008288	LONGTERM|DICTIONARY	malaria	malaria	145#152		Collectively, our data suggest that testosterone dysregulates the inflammatory response in spleen and liver during their differentiation to anti-malaria effectors in malaria-resistant female LTbetaR-deficient mice, thus contributing to the testosterone-induced lethal outcome of malaria.
15788153	2005	Microbes Infect.	1286-4579	ALL_TEXT_3/3	3	9	4055	SYMBOL|EXTRACTED	ltbetar	LTbetaR	191#198	15788153-1-28-53	D008288	LONGTERM|DICTIONARY	malaria	malaria	166#173		Collectively, our data suggest that testosterone dysregulates the inflammatory response in spleen and liver during their differentiation to anti-malaria effectors in malaria-resistant female LTbetaR-deficient mice, thus contributing to the testosterone-induced lethal outcome of malaria.
15788153	2005	Microbes Infect.	1286-4579	ALL_TEXT_3/3	3	9	4055	SYMBOL|EXTRACTED	ltbetar	LTbetaR	191#198	15788153-1-28-53	D008288	LONGTERM|DICTIONARY	malaria	malaria	279#286		Collectively, our data suggest that testosterone dysregulates the inflammatory response in spleen and liver during their differentiation to anti-malaria effectors in malaria-resistant female LTbetaR-deficient mice, thus contributing to the testosterone-induced lethal outcome of malaria.
20179607	2010	J. Cardiovasc. Pharmacol.	1533-4023	ALL_TEXT_1/3	1	2	1636	SYMBOL|()|GENE|GN|DICTIONARY|EXTRACTED	ace	ACE	97#100	20179607-2-66-95	D017379	LONGTERM|DICTIONARY	left ventricular hypertrophy	left ventricular hypertrophy	130#158		An association between the insertion/deletion polymorphism of the angiotensin-converting enzyme (ACE) gene and the progression of left ventricular hypertrophy in patients with hypertrophic cardiomyopathy has been reported.
20179607	2010	J. Cardiovasc. Pharmacol.	1533-4023	ALL_TEXT_1/3	1	2	1636	SYMBOL|()|GENE|GN|DICTIONARY|EXTRACTED	ace	ACE	97#100	20179607-2-66-95	D002312	LONGTERM|DICTIONARY	hypertrophic cardiomyopathy	hypertrophic cardiomyopathy	176#203		An association between the insertion/deletion polymorphism of the angiotensin-converting enzyme (ACE) gene and the progression of left ventricular hypertrophy in patients with hypertrophic cardiomyopathy has been reported.
20389122	2010	Neuroepidemiology	1423-0208	RESULTS	3	9	348	SYMBOL|DICTIONARY	apoe4	APOE4	100#105		D000544	SYMBOL|EXTRACTED	ad	AD	77#79	20389122-2-123-142	A lower initial MMSE score was associated with higher mortality for probable AD, PD, and MCI, while APOE4 predicted mortality for PD and LBD.
20389122	2010	Neuroepidemiology	1423-0208	RESULTS	3	9	348	SYMBOL|DICTIONARY	apoe4	APOE4	100#105		D010300	SYMBOL|EXTRACTED	pd	PD	81#83	20389122-4-120-139	A lower initial MMSE score was associated with higher mortality for probable AD, PD, and MCI, while APOE4 predicted mortality for PD and LBD.
20389122	2010	Neuroepidemiology	1423-0208	RESULTS	3	9	348	SYMBOL|DICTIONARY	apoe4	APOE4	100#105		D003072	SYMBOL|DICTIONARY|EXTRACTED	mci	MCI	89#92	20389122-4-156-181	A lower initial MMSE score was associated with higher mortality for probable AD, PD, and MCI, while APOE4 predicted mortality for PD and LBD.
20389122	2010	Neuroepidemiology	1423-0208	RESULTS	3	9	348	SYMBOL|DICTIONARY	apoe4	APOE4	100#105		D010300	SYMBOL|EXTRACTED	pd	PD	130#132	20389122-4-120-139	A lower initial MMSE score was associated with higher mortality for probable AD, PD, and MCI, while APOE4 predicted mortality for PD and LBD.
20389122	2010	Neuroepidemiology	1423-0208	RESULTS	3	9	348	SYMBOL|DICTIONARY	apoe4	APOE4	100#105		D020961	SYMBOL|DICTIONARY|EXTRACTED	lbd	LBD	137#140	20389122-4-239-256	A lower initial MMSE score was associated with higher mortality for probable AD, PD, and MCI, while APOE4 predicted mortality for PD and LBD.
12165742	2003	Med. Sci. Monit.	1234-1010	MATERIAL/METHODS	2	3	10	SYMBOL|DICTIONARY	nat2	NAT2	64#68		D003110	LONGTERM|DISEASE|DT|DICTIONARY	colon cancer	colon cancer	47#59		Odd ratio was employed to evaluate the risk of colon cancer and NAT2 rapid acetylation status.
12165742	2003	Med. Sci. Monit.	1234-1010	BACKGROUND	1	2	10	SYMBOL|DICTIONARY	nat2	NAT2	28#32		D003110	LONGTERM|DISEASE|DT|DICTIONARY	colon cancer	colon cancer	61#73		To clarify the influence of NAT2 rapid acetylation status on colon cancer risk, we have performed a meta-analysis of 20 published case-control studies (4431 cases, 4547 controls).
16511860	2006	Mov. Disord.	0885-3185	ALL_TEXT_1/3	1	1	120892	LONGTERM|DICTIONARY|GENE|GA	leucine rich repeat kinase 2	leucine-rich repeat kinase 2	17#45		D010300	LONGTERM|DICTIONARY	parkinson disease	Parkinson's disease	116#135		Mutations in the leucine-rich repeat kinase 2 (LRRK2) gene have been shown to cause autosomal dominant and sporadic Parkinson's disease (PD).
16511860	2006	Mov. Disord.	0885-3185	ALL_TEXT_1/3	1	1	120892	LONGTERM|DICTIONARY|GENE|GA	leucine rich repeat kinase 2	leucine-rich repeat kinase 2	17#45		D010300	SYMBOL|EXTRACTED|()	pd	PD	137#139	16511860-1-116-135	Mutations in the leucine-rich repeat kinase 2 (LRRK2) gene have been shown to cause autosomal dominant and sporadic Parkinson's disease (PD).
16511860	2006	Mov. Disord.	0885-3185	ALL_TEXT_1/3	1	1	120892	SYMBOL|()|GENE|GN|DICTIONARY|EXTRACTED	lrrk2	LRRK2	47#52	16511860-1-17-45	D010300	LONGTERM|DICTIONARY	parkinson disease	Parkinson's disease	116#135		Mutations in the leucine-rich repeat kinase 2 (LRRK2) gene have been shown to cause autosomal dominant and sporadic Parkinson's disease (PD).
16511860	2006	Mov. Disord.	0885-3185	ALL_TEXT_1/3	1	1	120892	SYMBOL|()|GENE|GN|DICTIONARY|EXTRACTED	lrrk2	LRRK2	47#52	16511860-1-17-45	D010300	SYMBOL|EXTRACTED|()	pd	PD	137#139	16511860-1-116-135	Mutations in the leucine-rich repeat kinase 2 (LRRK2) gene have been shown to cause autosomal dominant and sporadic Parkinson's disease (PD).
16511860	2006	Mov. Disord.	0885-3185	TITLE	0	0	120892	SYMBOL|DICTIONARY|EXTRACTED	lrrk2	LRRK2	15#20		D010300	LONGTERM|DISEASE|DT|DICTIONARY	parkinson disease	Parkinson's disease	69#88		Lack of G2019S LRRK2 mutation in a cohort of Taiwanese with sporadic Parkinson's disease.
16331614	2006	Int. J. Cancer	0020-7136	TITLE	0	0	672	SYMBOL|DICTIONARY	brca1	BRCA1	45#50		D001943	LONGTERM|DISEASE|DT|DICTIONARY	contralateral breast cancer	contralateral breast cancer	14#41		Tamoxifen and contralateral breast cancer in BRCA1 and BRCA2 carriers: an update.
16331614	2006	Int. J. Cancer	0020-7136	TITLE	0	0	675	SYMBOL|DICTIONARY	brca2	BRCA2	55#60		D001943	LONGTERM|DISEASE|DT|DICTIONARY	contralateral breast cancer	contralateral breast cancer	14#41		Tamoxifen and contralateral breast cancer in BRCA1 and BRCA2 carriers: an update.
16331614	2006	Int. J. Cancer	0020-7136	ALL_TEXT_1/3	1	1	672	SYMBOL|DICTIONARY	brca1	BRCA1	25#30		D001943	LONGTERM|DISEASE|DT|DICTIONARY	breast cancer	breast cancer	64#77		Women with a mutation in BRCA1 or BRCA2 face a lifetime risk of breast cancer of approximately 80%, and following the first diagnosis the 10-year risk of contralateral breast cancer is approximately 30%.
16331614	2006	Int. J. Cancer	0020-7136	ALL_TEXT_1/3	1	1	672	SYMBOL|DICTIONARY	brca1	BRCA1	25#30		D001943	LONGTERM|DISEASE|DT|DICTIONARY	contralateral breast cancer	contralateral breast cancer	154#181		Women with a mutation in BRCA1 or BRCA2 face a lifetime risk of breast cancer of approximately 80%, and following the first diagnosis the 10-year risk of contralateral breast cancer is approximately 30%.
16331614	2006	Int. J. Cancer	0020-7136	ALL_TEXT_1/3	1	1	675	SYMBOL|DICTIONARY	brca2	BRCA2	34#39		D001943	LONGTERM|DISEASE|DT|DICTIONARY	breast cancer	breast cancer	64#77		Women with a mutation in BRCA1 or BRCA2 face a lifetime risk of breast cancer of approximately 80%, and following the first diagnosis the 10-year risk of contralateral breast cancer is approximately 30%.
16331614	2006	Int. J. Cancer	0020-7136	ALL_TEXT_1/3	1	1	675	SYMBOL|DICTIONARY	brca2	BRCA2	34#39		D001943	LONGTERM|DISEASE|DT|DICTIONARY	contralateral breast cancer	contralateral breast cancer	154#181		Women with a mutation in BRCA1 or BRCA2 face a lifetime risk of breast cancer of approximately 80%, and following the first diagnosis the 10-year risk of contralateral breast cancer is approximately 30%.
20389122	2010	Neuroepidemiology	1423-0208	BACKGROUND	1	2	348	LONGTERM|DICTIONARY	apolipoprotein e	apolipoprotein E	65#81		D000544	LONGTERM|DISEASE|DT|DICTIONARY	alzheimer disease	Alzheimer's disease	123#142		Data on the role of the Mini Mental State Examination (MMSE) and apolipoprotein E (APOE) in survival are sparse except for Alzheimer's disease (AD).
20389122	2010	Neuroepidemiology	1423-0208	BACKGROUND	1	2	348	LONGTERM|DICTIONARY	apolipoprotein e	apolipoprotein E	65#81		D000544	SYMBOL|EXTRACTED|()	ad	AD	144#146	20389122-2-123-142	Data on the role of the Mini Mental State Examination (MMSE) and apolipoprotein E (APOE) in survival are sparse except for Alzheimer's disease (AD).
20389122	2010	Neuroepidemiology	1423-0208	BACKGROUND	1	2	348	SYMBOL|()|DICTIONARY|EXTRACTED	apoe	APOE	83#87	20389122-2-65-81	D000544	LONGTERM|DISEASE|DT|DICTIONARY	alzheimer disease	Alzheimer's disease	123#142		Data on the role of the Mini Mental State Examination (MMSE) and apolipoprotein E (APOE) in survival are sparse except for Alzheimer's disease (AD).
20389122	2010	Neuroepidemiology	1423-0208	BACKGROUND	1	2	348	SYMBOL|()|DICTIONARY|EXTRACTED	apoe	APOE	83#87	20389122-2-65-81	D000544	SYMBOL|EXTRACTED|()	ad	AD	144#146	20389122-2-123-142	Data on the role of the Mini Mental State Examination (MMSE) and apolipoprotein E (APOE) in survival are sparse except for Alzheimer's disease (AD).
16331614	2006	Int. J. Cancer	0020-7136	ALL_TEXT_2/3	2	4	672	SYMBOL|DICTIONARY	brca1	BRCA1	56#61		D001943	LONGTERM|DISEASE|DT|DICTIONARY	bilateral breast cancer	bilateral breast cancer	26#49		We studied 285 women with bilateral breast cancer and a BRCA1 or BRCA2 mutation, and 751 control women with unilateral breast cancer and a BRCA1 or BRCA2 mutation in a matched case-control study.
16331614	2006	Int. J. Cancer	0020-7136	ALL_TEXT_2/3	2	4	672	SYMBOL|DICTIONARY	brca1	BRCA1	56#61		D001943	LONGTERM|DISEASE|DT|DICTIONARY	unilateral breast cancer	unilateral breast cancer	108#132		We studied 285 women with bilateral breast cancer and a BRCA1 or BRCA2 mutation, and 751 control women with unilateral breast cancer and a BRCA1 or BRCA2 mutation in a matched case-control study.
16331614	2006	Int. J. Cancer	0020-7136	ALL_TEXT_2/3	2	4	675	SYMBOL|DICTIONARY	brca2	BRCA2	65#70		D001943	LONGTERM|DISEASE|DT|DICTIONARY	bilateral breast cancer	bilateral breast cancer	26#49		We studied 285 women with bilateral breast cancer and a BRCA1 or BRCA2 mutation, and 751 control women with unilateral breast cancer and a BRCA1 or BRCA2 mutation in a matched case-control study.
16331614	2006	Int. J. Cancer	0020-7136	ALL_TEXT_2/3	2	4	675	SYMBOL|DICTIONARY	brca2	BRCA2	65#70		D001943	LONGTERM|DISEASE|DT|DICTIONARY	unilateral breast cancer	unilateral breast cancer	108#132		We studied 285 women with bilateral breast cancer and a BRCA1 or BRCA2 mutation, and 751 control women with unilateral breast cancer and a BRCA1 or BRCA2 mutation in a matched case-control study.
16331614	2006	Int. J. Cancer	0020-7136	ALL_TEXT_2/3	2	4	672	SYMBOL|DICTIONARY	brca1	BRCA1	139#144		D001943	LONGTERM|DISEASE|DT|DICTIONARY	bilateral breast cancer	bilateral breast cancer	26#49		We studied 285 women with bilateral breast cancer and a BRCA1 or BRCA2 mutation, and 751 control women with unilateral breast cancer and a BRCA1 or BRCA2 mutation in a matched case-control study.
16331614	2006	Int. J. Cancer	0020-7136	ALL_TEXT_2/3	2	4	672	SYMBOL|DICTIONARY	brca1	BRCA1	139#144		D001943	LONGTERM|DISEASE|DT|DICTIONARY	unilateral breast cancer	unilateral breast cancer	108#132		We studied 285 women with bilateral breast cancer and a BRCA1 or BRCA2 mutation, and 751 control women with unilateral breast cancer and a BRCA1 or BRCA2 mutation in a matched case-control study.
16331614	2006	Int. J. Cancer	0020-7136	ALL_TEXT_2/3	2	4	675	SYMBOL|DICTIONARY	brca2	BRCA2	148#153		D001943	LONGTERM|DISEASE|DT|DICTIONARY	bilateral breast cancer	bilateral breast cancer	26#49		We studied 285 women with bilateral breast cancer and a BRCA1 or BRCA2 mutation, and 751 control women with unilateral breast cancer and a BRCA1 or BRCA2 mutation in a matched case-control study.
16331614	2006	Int. J. Cancer	0020-7136	ALL_TEXT_2/3	2	4	675	SYMBOL|DICTIONARY	brca2	BRCA2	148#153		D001943	LONGTERM|DISEASE|DT|DICTIONARY	unilateral breast cancer	unilateral breast cancer	108#132		We studied 285 women with bilateral breast cancer and a BRCA1 or BRCA2 mutation, and 751 control women with unilateral breast cancer and a BRCA1 or BRCA2 mutation in a matched case-control study.
16331614	2006	Int. J. Cancer	0020-7136	ALL_TEXT_3/3	3	7	672	SYMBOL|DICTIONARY	brca1	BRCA1	115#120		D001943	LONGTERM|DISEASE|DT|DICTIONARY	contralateral breast cancer	contralateral breast cancer	32#59		The multivariate odds ratio for contralateral breast cancer associated with tamoxifen use was 0.50 for carriers of BRCA1 mutations (95% CI, 0.30-0.85) and was 0.42 for carriers of BRCA2 mutations (95% CI, 0.17-1.02).
16331614	2006	Int. J. Cancer	0020-7136	ALL_TEXT_3/3	3	7	675	SYMBOL|DICTIONARY	brca2	BRCA2	180#185		D001943	LONGTERM|DISEASE|DT|DICTIONARY	contralateral breast cancer	contralateral breast cancer	32#59		The multivariate odds ratio for contralateral breast cancer associated with tamoxifen use was 0.50 for carriers of BRCA1 mutations (95% CI, 0.30-0.85) and was 0.42 for carriers of BRCA2 mutations (95% CI, 0.17-1.02).
21300947	2011	Arch. Gen. Psychiatry	1538-3636	CONCLUSIONS	8	11	627	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	bdnf	BDNF	4#8	21300947-1-4-37	D000544	SYMBOL|EXTRACTED	ad	AD	185#187	21300947-1-100-117	The BDNF gene confers risk in an age-dependent manner on the brain structures and cognitive functions that are consistent with the neural circuitry vulnerable in the earliest stages of AD.
16004559	2006	Pharmacogenomics	1462-2416	OBJECTIVES	1	1	5243	SYMBOL|()|GENE|GN|DICTIONARY	abcb1	ABCB1	140#145		D004827	LONGTERM|DISEASE|DN|DICTIONARY	epilepsy	epilepsy	161#169		The aim of this study was to investigate the association of the complex haplotype system of the adenosine triphosphate-binding cassette B1 (ABCB1) gene with the epilepsy treatment response.
16004559	2006	Pharmacogenomics	1462-2416	METHODS AND RESULTS	2	6	7368	SYMBOL|DICTIONARY	cgt	CGT	44#47		D012640	LONGTERM|DICTIONARY	seizure	seizure	124#131		In contrast, patients with the TTC/TTC, TTC/CGT, TTC/TGT, CGT/CGT and TGT/CGT haplotype combinations were more likely to be seizure-free (all p-values<0.0001 except CGT/CGT [p=0.0063]).
16004559	2006	Pharmacogenomics	1462-2416	METHODS AND RESULTS	2	6	81890	SYMBOL|DICTIONARY	tgt	TGT	53#56		D012640	LONGTERM|DICTIONARY	seizure	seizure	124#131		In contrast, patients with the TTC/TTC, TTC/CGT, TTC/TGT, CGT/CGT and TGT/CGT haplotype combinations were more likely to be seizure-free (all p-values<0.0001 except CGT/CGT [p=0.0063]).
16004559	2006	Pharmacogenomics	1462-2416	METHODS AND RESULTS	2	6	7368	SYMBOL|DICTIONARY	cgt	CGT	58#61		D012640	LONGTERM|DICTIONARY	seizure	seizure	124#131		In contrast, patients with the TTC/TTC, TTC/CGT, TTC/TGT, CGT/CGT and TGT/CGT haplotype combinations were more likely to be seizure-free (all p-values<0.0001 except CGT/CGT [p=0.0063]).
16004559	2006	Pharmacogenomics	1462-2416	METHODS AND RESULTS	2	6	7368	SYMBOL|DICTIONARY	cgt	CGT	62#65		D012640	LONGTERM|DICTIONARY	seizure	seizure	124#131		In contrast, patients with the TTC/TTC, TTC/CGT, TTC/TGT, CGT/CGT and TGT/CGT haplotype combinations were more likely to be seizure-free (all p-values<0.0001 except CGT/CGT [p=0.0063]).
16004559	2006	Pharmacogenomics	1462-2416	METHODS AND RESULTS	2	6	81890	SYMBOL|DICTIONARY	tgt	TGT	70#73		D012640	LONGTERM|DICTIONARY	seizure	seizure	124#131		In contrast, patients with the TTC/TTC, TTC/CGT, TTC/TGT, CGT/CGT and TGT/CGT haplotype combinations were more likely to be seizure-free (all p-values<0.0001 except CGT/CGT [p=0.0063]).
16004559	2006	Pharmacogenomics	1462-2416	METHODS AND RESULTS	2	6	7368	SYMBOL|DICTIONARY	cgt	CGT	74#77		D012640	LONGTERM|DICTIONARY	seizure	seizure	124#131		In contrast, patients with the TTC/TTC, TTC/CGT, TTC/TGT, CGT/CGT and TGT/CGT haplotype combinations were more likely to be seizure-free (all p-values<0.0001 except CGT/CGT [p=0.0063]).
16004559	2006	Pharmacogenomics	1462-2416	METHODS AND RESULTS	2	6	7368	SYMBOL|DICTIONARY	cgt	CGT	165#168		D012640	LONGTERM|DICTIONARY	seizure	seizure	124#131		In contrast, patients with the TTC/TTC, TTC/CGT, TTC/TGT, CGT/CGT and TGT/CGT haplotype combinations were more likely to be seizure-free (all p-values<0.0001 except CGT/CGT [p=0.0063]).
16004559	2006	Pharmacogenomics	1462-2416	METHODS AND RESULTS	2	6	7368	SYMBOL|DICTIONARY	cgt	CGT	169#172		D012640	LONGTERM|DICTIONARY	seizure	seizure	124#131		In contrast, patients with the TTC/TTC, TTC/CGT, TTC/TGT, CGT/CGT and TGT/CGT haplotype combinations were more likely to be seizure-free (all p-values<0.0001 except CGT/CGT [p=0.0063]).
20674764	2011	Microbes Infect.	1769-714X	ALL_TEXT_3/3	3	9	51311	SYMBOL|DICTIONARY	tlr8	TLR8	17#21		D006479	SYMBOL|EXTRACTED|DISEASE|DN	cchf	CCHF	52#56	20674764-1-8-31	The frequency of TLR8 -129G/G genotype in the fatal CCHF patients was significantly higher than that of the non-fatal patients (p=0.026).
20674764	2011	Microbes Infect.	1769-714X	ALL_TEXT_3/3	3	8	51311	SYMBOL|DICTIONARY	tlr8	TLR8	74#78		D006479	SYMBOL|EXTRACTED|DISEASE|DN	cchf	CCHF	138#142	20674764-1-8-31	We found that heterozygous plus homozygous mutant genotypes frequency for TLR8 Met1Val and for TLR9 -1486T/C were significantly higher in CCHF patients than controls (p=0.038 and p=0.009, respectively).
20674764	2011	Microbes Infect.	1769-714X	ALL_TEXT_3/3	3	8	54106	SYMBOL|DICTIONARY	tlr9	TLR9	95#99		D006479	SYMBOL|EXTRACTED|DISEASE|DN	cchf	CCHF	138#142	20674764-1-8-31	We found that heterozygous plus homozygous mutant genotypes frequency for TLR8 Met1Val and for TLR9 -1486T/C were significantly higher in CCHF patients than controls (p=0.038 and p=0.009, respectively).
20674764	2011	Microbes Infect.	1769-714X	TITLE	0	0	51311	LONGTERM|DICTIONARY	toll-like receptor 8 and 9	Toll-like receptor 8 and 9	0#26		D006479	LONGTERM|DICTIONARY	crimean-congo hemorrhagic fever	Crimean-Congo hemorrhagic fever	44#75		Toll-like receptor 8 and 9 polymorphisms in Crimean-Congo hemorrhagic fever.
20674764	2011	Microbes Infect.	1769-714X	TITLE	0	0	54106	LONGTERM|DICTIONARY	toll-like receptor 8 and 9	Toll-like receptor 8 and 9	0#26		D006479	LONGTERM|DICTIONARY	crimean-congo hemorrhagic fever	Crimean-Congo hemorrhagic fever	44#75		Toll-like receptor 8 and 9 polymorphisms in Crimean-Congo hemorrhagic fever.
19450125	2009	Pharmacogenomics	1744-8042	RESULTS	3	8	54658	SYMBOL|NUMBER|DICTIONARY	ugt1a1	UGT1A1	44#50		D003967	LONGTERM|DICTIONARY	diarrhea	diarrhea	153#161		However, individuals carrying two copies of UGT1A1*28 (p = 0.04; OR: 14; 95% CI: 1.1-185) or c.-3156G>A (p = 0.03) had a significantly increased risk of diarrhea over all cycles.
18088253	2008	J. Intern. Med.	1365-2796	CONCLUSIONS	3	9	1493	SYMBOL|DICTIONARY	cd152	CD152	134#139		D009157	SYMBOL|EXTRACTED	mg	MG	56#58	18088253-2-125-142	The two SNPs in the promoter region are associated with MG and might cause abnormal alternative splicing and affect the expression of CD152, thereby contributing to the pathogenesis of MG.
18088253	2008	J. Intern. Med.	1365-2796	CONCLUSIONS	3	9	1493	SYMBOL|DICTIONARY	cd152	CD152	134#139		D009157	SYMBOL|EXTRACTED	mg	MG	185#187	18088253-2-125-142	The two SNPs in the promoter region are associated with MG and might cause abnormal alternative splicing and affect the expression of CD152, thereby contributing to the pathogenesis of MG.
16495393	2006	N. Engl. J. Med.	1533-4406	CONCLUSIONS	4	11	2064	SYMBOL|DICTIONARY	her2/neu	HER2/neu	150#158		D001943	LONGTERM|DISEASE|DT|DICTIONARY	breast cancer	breast cancer	114#127		A short course of trastuzumab administered concomitantly with docetaxel or vinorelbine is effective in women with breast cancer who have an amplified HER2/neu gene.
16495393	2006	N. Engl. J. Med.	1533-4406	CONCLUSIONS	4	11	2064	SYMBOL|GENE|GN|DICTIONARY	her2/neu	HER2/neu	150#158		D001943	LONGTERM|DISEASE|DT|DICTIONARY	breast cancer	breast cancer	114#127		A short course of trastuzumab administered concomitantly with docetaxel or vinorelbine is effective in women with breast cancer who have an amplified HER2/neu gene.
20096741	2010	Hum. Immunol.	1879-1166	ALL_TEXT_3/3	3	5	3305	SYMBOL|DICTIONARY	vegf and hsp70-hom	VEGF and HSP70-hom	29#47		D011471	LONGTERM|DISEASE|DT|DICTIONARY	increase of prostate carcinoma	increase of prostate carcinoma	165#195		For the combined analysis of VEGF and HSP70-hom, we found a positive gradient in the odds ratios (ORs) related to the number of high-risk genotypes with a 3.53-fold increase of prostate carcinoma risk (OR = 3.53; p = 0.015).
20096741	2010	Hum. Immunol.	1879-1166	ALL_TEXT_3/3	3	5	7422	SYMBOL|DICTIONARY	vegf and hsp70-hom	VEGF and HSP70-hom	29#47		D011471	LONGTERM|DISEASE|DT|DICTIONARY	increase of prostate carcinoma	increase of prostate carcinoma	165#195		For the combined analysis of VEGF and HSP70-hom, we found a positive gradient in the odds ratios (ORs) related to the number of high-risk genotypes with a 3.53-fold increase of prostate carcinoma risk (OR = 3.53; p = 0.015).
20096741	2010	Hum. Immunol.	1879-1166	ALL_TEXT_3/3	3	5	3305	SYMBOL|DICTIONARY	vegf and hsp70-hom	VEGF and HSP70-hom	29#47		D011471	LONGTERM|DISEASE|DT|DICTIONARY	increase of prostate carcinoma	increase of prostate carcinoma	165#195		For the combined analysis of VEGF and HSP70-hom, we found a positive gradient in the odds ratios (ORs) related to the number of high-risk genotypes with a 3.53-fold increase of prostate carcinoma risk (OR = 3.53; p = 0.015).
20096741	2010	Hum. Immunol.	1879-1166	ALL_TEXT_3/3	3	5	7422	SYMBOL|DICTIONARY	vegf and hsp70-hom	VEGF and HSP70-hom	29#47		D011471	LONGTERM|DISEASE|DT|DICTIONARY	increase of prostate carcinoma	increase of prostate carcinoma	165#195		For the combined analysis of VEGF and HSP70-hom, we found a positive gradient in the odds ratios (ORs) related to the number of high-risk genotypes with a 3.53-fold increase of prostate carcinoma risk (OR = 3.53; p = 0.015).
19228880	2009	FASEB J.	1530-6860	ALL_TEXT_3/3	3	9	2944	SYMBOL|DICTIONARY|EXTRACTED	gstm1	GSTM1	49#54	19228880-1-113-141	D001943	LONGTERM|DISEASE|DT|DICTIONARY	breast cancer	breast cancer	60#73		These results indicate a U-shaped association of GSTM1 with breast cancer, which challenges the linear gene-dosage effect of GSTM1 that was previously proposed.
19228880	2009	FASEB J.	1530-6860	ALL_TEXT_3/3	3	9	2944	SYMBOL|DICTIONARY|EXTRACTED	gstm1	GSTM1	125#130	19228880-1-113-141	D001943	LONGTERM|DISEASE|DT|DICTIONARY	breast cancer	breast cancer	60#73		These results indicate a U-shaped association of GSTM1 with breast cancer, which challenges the linear gene-dosage effect of GSTM1 that was previously proposed.
19228880	2009	FASEB J.	1530-6860	ALL_TEXT_3/3	3	8	2944	SYMBOL|DICTIONARY|EXTRACTED	gstm1	GSTM1	65#70	19228880-1-113-141	D001943	LONGTERM|DISEASE|DT|DICTIONARY	breast cancer	breast cancer	108#121		It seems that approximately 60-70% expression from one allele of GSTM1 could suffice for protection against breast cancer; null activity and overactivity of GSTM1 are both disadvantageous.
19228880	2009	FASEB J.	1530-6860	ALL_TEXT_3/3	3	8	2944	SYMBOL|DICTIONARY|EXTRACTED	gstm1	GSTM1	157#162	19228880-1-113-141	D001943	LONGTERM|DISEASE|DT|DICTIONARY	breast cancer	breast cancer	108#121		It seems that approximately 60-70% expression from one allele of GSTM1 could suffice for protection against breast cancer; null activity and overactivity of GSTM1 are both disadvantageous.
18088253	2008	J. Intern. Med.	1365-2796	TITLE	0	0	1493	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	ctla 4	CTLA-4	39#45		D009157	LONGTERM|DICTIONARY	myasthenia gravis	myasthenia gravis	121#138		Two SNPs in the promoter region of the CTLA-4 gene affect binding of transcription factors and are associated with human myasthenia gravis.
18088253	2008	J. Intern. Med.	1365-2796	RESULTS	2	6	1493	SYMBOL|GENE|GN|DICTIONARY	cd152	CD152	55#60		D009157	SYMBOL|EXTRACTED	mg	MG	77#79	18088253-2-125-142	We present new genetic associations of two SNPs in the CD152 gene with human MG.
20377893	2010	BMC Med. Genet.	1471-2350	BACKGROUND	1	3	60314	SYMBOL|GENE|GN|DICTIONARY	myg1	MYG1	55#59		D014820	LONGTERM|DICTIONARY	vitiligo	vitiligo	138#146		Our aim was to examine nine known polymorphisms in the MYG1 gene, to investigate their functionality, and to study their association with vitiligo susceptibility.
15953084	2005	Clin. Exp. Dermatol.	0307-6938	ALL_TEXT_3/3	3	8	1041	SYMBOL|DICTIONARY|EXTRACTED	cdsn	CDSN	49#53	15953084-0-0-14	D011565	LONGTERM|DISEASE|DN|DICTIONARY	psoriasis	psoriasis	74#83		However the lack of association with HLA-Cw6 and CDSN alleles in Japanese psoriasis patients may be because Japanese patients exhibit a form of psoriasis similar to late onset or Type II psoriasis vulgaris in contrast to early onset or Type I disease characterizing our Caucasian population.
15953084	2005	Clin. Exp. Dermatol.	0307-6938	ALL_TEXT_3/3	3	8	1041	SYMBOL|DICTIONARY|EXTRACTED	cdsn	CDSN	49#53	15953084-0-0-14	D011565	LONGTERM|DICTIONARY	psoriasis	psoriasis	144#153		However the lack of association with HLA-Cw6 and CDSN alleles in Japanese psoriasis patients may be because Japanese patients exhibit a form of psoriasis similar to late onset or Type II psoriasis vulgaris in contrast to early onset or Type I disease characterizing our Caucasian population.
15953084	2005	Clin. Exp. Dermatol.	0307-6938	ALL_TEXT_3/3	3	8	1041	SYMBOL|DICTIONARY|EXTRACTED	cdsn	CDSN	49#53	15953084-0-0-14	D011565	LONGTERM|DICTIONARY	type ii psoriasis vulgaris	Type II psoriasis vulgaris	179#205		However the lack of association with HLA-Cw6 and CDSN alleles in Japanese psoriasis patients may be because Japanese patients exhibit a form of psoriasis similar to late onset or Type II psoriasis vulgaris in contrast to early onset or Type I disease characterizing our Caucasian population.
15953084	2005	Clin. Exp. Dermatol.	0307-6938	ALL_TEXT_3/3	3	8	1041	SYMBOL|DICTIONARY|EXTRACTED	cdsn	CDSN	49#53	15953084-0-0-14	D004194	LONGTERM|DICTIONARY	type i disease	Type I disease	236#250	NaN	However the lack of association with HLA-Cw6 and CDSN alleles in Japanese psoriasis patients may be because Japanese patients exhibit a form of psoriasis similar to late onset or Type II psoriasis vulgaris in contrast to early onset or Type I disease characterizing our Caucasian population.
16054149	2006	Atherosclerosis	0021-9150	ALL_TEXT_3/3	3	10	116519	SYMBOL|GENE|GN|DICTIONARY	apoa5	APOA5	44#49		D003324	SYMBOL|DICTIONARY|EXTRACTED	cad	CAD	112#115	16054149-2-29-52	These results indicate that the variants of APOA5 gene modulate plasma triglyceride and may use them to predict CAD susceptibility in Taiwanese Chinese.
11769724	2002	Zhonghua Nei Ke Za Zhi	0578-1426	TITLE	0	0	348	LONGTERM|NUMBER|DICTIONARY	apolipoprotein e 4	Apolipoprotein E 4	1#19		D000544	LONGTERM|DISEASE|DT|DICTIONARY	alzheimer disease	Alzheimer's disease	46#65		[Apolipoprotein E 4 gene is a risk factor for Alzheimer's disease].
19523860	2011	Urol. Oncol.	1873-2496	TITLE	0	0	7157	SYMBOL|DICTIONARY	tp53	TP53	12#16		D001749	LONGTERM|DISEASE|DT|DICTIONARY	bladder cancer	bladder cancer	96#110		The role of TP53 PRO47SER and ARG72PRO single nucleotide polymorphisms in the susceptibility to bladder cancer.
15953084	2005	Clin. Exp. Dermatol.	0307-6938	TITLE	0	0	1041	LONGTERM|DICTIONARY|GENE|GA	corneodesmosin	Corneodesmosin	0#14		D011565	LONGTERM|DICTIONARY	psoriasis vulgaris	psoriasis vulgaris	44#62		Corneodesmosin (CDSN) gene association with psoriasis vulgaris in Caucasian but not in Japanese populations.
15953084	2005	Clin. Exp. Dermatol.	0307-6938	TITLE	0	0	1041	SYMBOL|()|GENE|GN|DICTIONARY|EXTRACTED	cdsn	CDSN	16#20	15953084-0-0-14	D011565	LONGTERM|DICTIONARY	psoriasis vulgaris	psoriasis vulgaris	44#62		Corneodesmosin (CDSN) gene association with psoriasis vulgaris in Caucasian but not in Japanese populations.
18163425	2008	Prostate	0270-4137	CONCLUSION	4	10	8797	SYMBOL|DICTIONARY	tnfrsf10a	TNFRSF10A	21#30		D011471	LONGTERM|DISEASE|DT|DICTIONARY	prostate cancer	prostate cancer	97#112		We conclude that the TNFRSF10A Glu228Ala polymorphism may be a novel independent risk factor for prostate cancer metastases after radiation therapy.
18163425	2008	Prostate	0270-4137	CONCLUSION	4	10	8797	SYMBOL|DICTIONARY	tnfrsf10a	TNFRSF10A	21#30		D009362	LONGTERM|DICTIONARY	metastases	metastases	113#123		We conclude that the TNFRSF10A Glu228Ala polymorphism may be a novel independent risk factor for prostate cancer metastases after radiation therapy.
15953084	2005	Clin. Exp. Dermatol.	0307-6938	ALL_TEXT_1/3	1	2	1041	LONGTERM|DICTIONARY|GENE|GA	corneodesmosin	corneodesmosin	79#93		D011565	LONGTERM|DICTIONARY	psoriasis	psoriasis	135#144		This region is characterized by strong linkage disequilibrium and contains the corneodesmosin (CSDN) gene, an attractive candidate for psoriasis susceptibility based on its putative biological function in keratinocyte adhesion, and HLA-Cw6, an established marker for psoriasis susceptibility.
15953084	2005	Clin. Exp. Dermatol.	0307-6938	ALL_TEXT_1/3	1	2	1041	LONGTERM|DICTIONARY|GENE|GA	corneodesmosin	corneodesmosin	79#93		D011565	LONGTERM|DICTIONARY	psoriasis	psoriasis	267#276		This region is characterized by strong linkage disequilibrium and contains the corneodesmosin (CSDN) gene, an attractive candidate for psoriasis susceptibility based on its putative biological function in keratinocyte adhesion, and HLA-Cw6, an established marker for psoriasis susceptibility.
11769724	2002	Zhonghua Nei Ke Za Zhi	0578-1426	OBJECTIVE	1	1	348	LONGTERM|DICTIONARY	apolipoprotein e	apolipoprotein E	56#72		D000544	LONGTERM|DISEASE|DT|DICTIONARY	alzheimer disease	Alzheimer disease	28#45		To study the association of Alzheimer disease (AD) with apolipoprotein E (ApoE) epsilon 4 allele and to find the biological peripheral markers for the laboratory diagnosis of AD.
11769724	2002	Zhonghua Nei Ke Za Zhi	0578-1426	OBJECTIVE	1	1	348	LONGTERM|DICTIONARY	apolipoprotein e	apolipoprotein E	56#72		D000544	SYMBOL|EXTRACTED|()	ad	AD	47#49	11769724-1-28-45	To study the association of Alzheimer disease (AD) with apolipoprotein E (ApoE) epsilon 4 allele and to find the biological peripheral markers for the laboratory diagnosis of AD.
11769724	2002	Zhonghua Nei Ke Za Zhi	0578-1426	OBJECTIVE	1	1	348	LONGTERM|DICTIONARY	apolipoprotein e	apolipoprotein E	56#72		D000544	SYMBOL|EXTRACTED	ad	AD	175#177	11769724-1-28-45	To study the association of Alzheimer disease (AD) with apolipoprotein E (ApoE) epsilon 4 allele and to find the biological peripheral markers for the laboratory diagnosis of AD.
11769724	2002	Zhonghua Nei Ke Za Zhi	0578-1426	OBJECTIVE	1	1	348	SYMBOL|EXTRACTED|()	apoe	ApoE	74#78	11769724-1-56-72	D000544	LONGTERM|DISEASE|DT|DICTIONARY	alzheimer disease	Alzheimer disease	28#45		To study the association of Alzheimer disease (AD) with apolipoprotein E (ApoE) epsilon 4 allele and to find the biological peripheral markers for the laboratory diagnosis of AD.
11769724	2002	Zhonghua Nei Ke Za Zhi	0578-1426	OBJECTIVE	1	1	348	SYMBOL|EXTRACTED|()	apoe	ApoE	74#78	11769724-1-56-72	D000544	SYMBOL|EXTRACTED|()	ad	AD	47#49	11769724-1-28-45	To study the association of Alzheimer disease (AD) with apolipoprotein E (ApoE) epsilon 4 allele and to find the biological peripheral markers for the laboratory diagnosis of AD.
11769724	2002	Zhonghua Nei Ke Za Zhi	0578-1426	OBJECTIVE	1	1	348	SYMBOL|EXTRACTED|()	apoe	ApoE	74#78	11769724-1-56-72	D000544	SYMBOL|EXTRACTED	ad	AD	175#177	11769724-1-28-45	To study the association of Alzheimer disease (AD) with apolipoprotein E (ApoE) epsilon 4 allele and to find the biological peripheral markers for the laboratory diagnosis of AD.
15953084	2005	Clin. Exp. Dermatol.	0307-6938	ALL_TEXT_3/3	3	7	1041	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	cdsn	CDSN	34#38	15953084-0-0-14	D011565	LONGTERM|DICTIONARY	psoriasis	psoriasis	74#83		This data supports a role for the CDSN gene in Caucasian populations with psoriasis.
19350382	2009	Cell. Mol. Neurobiol.	1573-6830	ALL_TEXT_2/3	2	5	5728	SYMBOL|DICTIONARY	pten	PTEN	27#31		D009369	LONGTERM|DICTIONARY	tumors	tumors	67#73		In our investigation, MMAC/PTEN mutations were detected in 2 of 28 tumors (7.14%).
11746272	2002	Prostate	0270-4137	CONCLUSIONS	4	9	7157	SYMBOL|DICTIONARY	p53	p53	13#16		D011471	LONGTERM|DISEASE|DT|DICTIONARY	prostate cancer	prostate cancer	75#90		Men with the p53 codon 72 Pro/Pro genotype appear to be at reduced risk of prostate cancer.
11244459	2001	Int. J. Obes. Relat. Metab. Disord.	-	OBJECTIVES	2	2	5443	SYMBOL|DICTIONARY|EXTRACTED	pomc	POMC	43#47	11244459-1-47-66	D009765	LONGTERM|DICTIONARY	obesity	obesity	104#111		To verify the presence of mutations of the POMC coding region in Italian children with very early onset obesity.
11244459	2001	Int. J. Obes. Relat. Metab. Disord.	-	BACKGROUND	1	1	5443	LONGTERM|DICTIONARY	proopiomelanocortin	proopiomelanocortin	47#66		D009765	LONGTERM|DICTIONARY	obesity	obesity	137#144		Although linkage studies strongly suggest that proopiomelanocortin (POMC) alterations could play a role in the genetic predisposition to obesity, systematic POMC mutational analysis did not completely confirm this hypothesis.
11244459	2001	Int. J. Obes. Relat. Metab. Disord.	-	BACKGROUND	1	1	5443	SYMBOL|()|DICTIONARY|EXTRACTED	pomc	POMC	68#72	11244459-1-47-66	D009765	LONGTERM|DICTIONARY	obesity	obesity	137#144		Although linkage studies strongly suggest that proopiomelanocortin (POMC) alterations could play a role in the genetic predisposition to obesity, systematic POMC mutational analysis did not completely confirm this hypothesis.
11244459	2001	Int. J. Obes. Relat. Metab. Disord.	-	BACKGROUND	1	1	5443	SYMBOL|DICTIONARY|EXTRACTED	pomc	POMC	157#161	11244459-1-47-66	D009765	LONGTERM|DICTIONARY	obesity	obesity	137#144		Although linkage studies strongly suggest that proopiomelanocortin (POMC) alterations could play a role in the genetic predisposition to obesity, systematic POMC mutational analysis did not completely confirm this hypothesis.
11244459	2001	Int. J. Obes. Relat. Metab. Disord.	-	TITLE	0	0	5443	LONGTERM|DICTIONARY	proopiomelanocortin	proopiomelanocortin	27#46		D009765	LONGTERM|DICTIONARY	obese	obese	71#76		Molecular screening of the proopiomelanocortin (POMC ) gene in Italian obese children: report of three new mutations.
11244459	2001	Int. J. Obes. Relat. Metab. Disord.	-	TITLE	0	0	5443	SYMBOL|DICTIONARY|EXTRACTED	pomc	POMC	48#52		D009765	LONGTERM|DICTIONARY	obese	obese	71#76		Molecular screening of the proopiomelanocortin (POMC ) gene in Italian obese children: report of three new mutations.
19350382	2009	Cell. Mol. Neurobiol.	1573-6830	ALL_TEXT_1/3	1	2	5728	SYMBOL|DICTIONARY	pten	PTEN	180#184		D009369	LONGTERM|DICTIONARY	tumors	tumors	64#70		It is known that there are variations in genetic alterations in tumors that develop in patients with different ethnic backgrounds; thus, we aimed to evaluate the incidence of MMAC/PTEN mutations and protein expression among various low grade gliomas of Turkish patients.
19350382	2009	Cell. Mol. Neurobiol.	1573-6830	ALL_TEXT_1/3	1	2	5728	SYMBOL|DICTIONARY	pten	PTEN	180#184		D005910	LONGTERM|DICTIONARY	gliomas	gliomas	242#249		It is known that there are variations in genetic alterations in tumors that develop in patients with different ethnic backgrounds; thus, we aimed to evaluate the incidence of MMAC/PTEN mutations and protein expression among various low grade gliomas of Turkish patients.
11746272	2002	Prostate	0270-4137	TITLE	0	0	7157	SYMBOL|DICTIONARY	p53	p53	40#43		D011471	LONGTERM|DISEASE|DT|DICTIONARY	lower prostate cancer	lower prostate cancer	49#70		Association of codon 72 polymorphism of p53 with lower prostate cancer risk.
11244459	2001	Int. J. Obes. Relat. Metab. Disord.	-	RESULTS	4	9	5443	SYMBOL|DICTIONARY|EXTRACTED	pomc	POMC	129#133	11244459-1-47-66	D009765	LONGTERM|DICTIONARY	obese	obese	96#101		They showed leptin levels adjusted for BMI, gender and pubertal stage significantly higher than obese subjects homozyous for the POMC wild-type allele.
19902201	2010	Immunogenetics	1432-1211	ALL_TEXT_1/3	1	1	7128	LONGTERM|DICTIONARY|GENE|GA	tumor necrosis factor alpha induced protein 3	tumor necrosis factor-alpha-induced protein 3	131#176		D012214	LONGTERM|DISEASE|DT|DICTIONARY	rheumatic heart disease	rheumatic heart disease	296#319		In a pair-matched case-control study (239 versus 478) conducted in Chinese Han population, we investigated the association between tumor necrosis factor-alpha-induced protein 3 (TNFAIP3) gene, tumor necrosis factor receptor-associated factor 1 (TRAF1) gene, complement component 5 (C5) gene, and rheumatic heart disease (RHD).
19902201	2010	Immunogenetics	1432-1211	ALL_TEXT_1/3	1	1	7128	LONGTERM|DICTIONARY|GENE|GA	tumor necrosis factor alpha induced protein 3	tumor necrosis factor-alpha-induced protein 3	131#176		D012214	SYMBOL|()|DICTIONARY|EXTRACTED	rhd	RHD	321#324	19902201-1-296-319	In a pair-matched case-control study (239 versus 478) conducted in Chinese Han population, we investigated the association between tumor necrosis factor-alpha-induced protein 3 (TNFAIP3) gene, tumor necrosis factor receptor-associated factor 1 (TRAF1) gene, complement component 5 (C5) gene, and rheumatic heart disease (RHD).
19902201	2010	Immunogenetics	1432-1211	ALL_TEXT_1/3	1	1	7128	SYMBOL|()|GENE|GN|DICTIONARY|EXTRACTED	tnfaip3	TNFAIP3	178#185	19902201-1-131-176	D012214	LONGTERM|DISEASE|DT|DICTIONARY	rheumatic heart disease	rheumatic heart disease	296#319		In a pair-matched case-control study (239 versus 478) conducted in Chinese Han population, we investigated the association between tumor necrosis factor-alpha-induced protein 3 (TNFAIP3) gene, tumor necrosis factor receptor-associated factor 1 (TRAF1) gene, complement component 5 (C5) gene, and rheumatic heart disease (RHD).
19902201	2010	Immunogenetics	1432-1211	ALL_TEXT_1/3	1	1	7128	SYMBOL|()|GENE|GN|DICTIONARY|EXTRACTED	tnfaip3	TNFAIP3	178#185	19902201-1-131-176	D012214	SYMBOL|()|DICTIONARY|EXTRACTED	rhd	RHD	321#324	19902201-1-296-319	In a pair-matched case-control study (239 versus 478) conducted in Chinese Han population, we investigated the association between tumor necrosis factor-alpha-induced protein 3 (TNFAIP3) gene, tumor necrosis factor receptor-associated factor 1 (TRAF1) gene, complement component 5 (C5) gene, and rheumatic heart disease (RHD).
19902201	2010	Immunogenetics	1432-1211	ALL_TEXT_1/3	1	1	7185	SYMBOL|()|GENE|GN|DICTIONARY	traf1	TRAF1	245#250		D012214	LONGTERM|DISEASE|DT|DICTIONARY	rheumatic heart disease	rheumatic heart disease	296#319		In a pair-matched case-control study (239 versus 478) conducted in Chinese Han population, we investigated the association between tumor necrosis factor-alpha-induced protein 3 (TNFAIP3) gene, tumor necrosis factor receptor-associated factor 1 (TRAF1) gene, complement component 5 (C5) gene, and rheumatic heart disease (RHD).
19902201	2010	Immunogenetics	1432-1211	ALL_TEXT_1/3	1	1	7185	SYMBOL|()|GENE|GN|DICTIONARY	traf1	TRAF1	245#250		D012214	SYMBOL|()|DICTIONARY|EXTRACTED	rhd	RHD	321#324	19902201-1-296-319	In a pair-matched case-control study (239 versus 478) conducted in Chinese Han population, we investigated the association between tumor necrosis factor-alpha-induced protein 3 (TNFAIP3) gene, tumor necrosis factor receptor-associated factor 1 (TRAF1) gene, complement component 5 (C5) gene, and rheumatic heart disease (RHD).
19902201	2010	Immunogenetics	1432-1211	ALL_TEXT_1/3	1	1	727	SYMBOL|EXTRACTED|()|GENE|GN	c5	C5	282#284	19902201-1-258-280	D012214	LONGTERM|DISEASE|DT|DICTIONARY	rheumatic heart disease	rheumatic heart disease	296#319		In a pair-matched case-control study (239 versus 478) conducted in Chinese Han population, we investigated the association between tumor necrosis factor-alpha-induced protein 3 (TNFAIP3) gene, tumor necrosis factor receptor-associated factor 1 (TRAF1) gene, complement component 5 (C5) gene, and rheumatic heart disease (RHD).
19902201	2010	Immunogenetics	1432-1211	ALL_TEXT_1/3	1	1	727	SYMBOL|EXTRACTED|()|GENE|GN	c5	C5	282#284	19902201-1-258-280	D012214	SYMBOL|()|DICTIONARY|EXTRACTED	rhd	RHD	321#324	19902201-1-296-319	In a pair-matched case-control study (239 versus 478) conducted in Chinese Han population, we investigated the association between tumor necrosis factor-alpha-induced protein 3 (TNFAIP3) gene, tumor necrosis factor receptor-associated factor 1 (TRAF1) gene, complement component 5 (C5) gene, and rheumatic heart disease (RHD).
19902201	2010	Immunogenetics	1432-1211	ALL_TEXT_1/3	1	1	7185	LONGTERM|GENE|GN|GT|DICTIONARY	tumor necrosis factor receptor-associated factor 1	tumor necrosis factor receptor-associated factor 1	193#243		D012214	LONGTERM|DISEASE|DT|DICTIONARY	rheumatic heart disease	rheumatic heart disease	296#319		In a pair-matched case-control study (239 versus 478) conducted in Chinese Han population, we investigated the association between tumor necrosis factor-alpha-induced protein 3 (TNFAIP3) gene, tumor necrosis factor receptor-associated factor 1 (TRAF1) gene, complement component 5 (C5) gene, and rheumatic heart disease (RHD).
19902201	2010	Immunogenetics	1432-1211	ALL_TEXT_1/3	1	1	7185	LONGTERM|GENE|GN|GT|DICTIONARY	tumor necrosis factor receptor-associated factor 1	tumor necrosis factor receptor-associated factor 1	193#243		D012214	SYMBOL|()|DICTIONARY|EXTRACTED	rhd	RHD	321#324	19902201-1-296-319	In a pair-matched case-control study (239 versus 478) conducted in Chinese Han population, we investigated the association between tumor necrosis factor-alpha-induced protein 3 (TNFAIP3) gene, tumor necrosis factor receptor-associated factor 1 (TRAF1) gene, complement component 5 (C5) gene, and rheumatic heart disease (RHD).
19902201	2010	Immunogenetics	1432-1211	TITLE	0	0	7128	SYMBOL|DICTIONARY|EXTRACTED	tnfaip3	TNFAIP3	15#22		D012214	LONGTERM|DISEASE|DT|DICTIONARY	rheumatic heart disease	rheumatic heart disease	41#64		Association of TNFAIP3 polymorphism with rheumatic heart disease in Chinese Han population.
19902201	2010	Immunogenetics	1432-1211	ALL_TEXT_2/3	2	3	7128	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	tnfaip3	TNFAIP3	75#82	19902201-1-131-176	D012214	SYMBOL|DICTIONARY|EXTRACTED	rhd	RHD	105#108	19902201-1-296-319	However, we determined that the tSNP, rs582757, located at intron_5 of the TNFAIP3 gene, associated with RHD in Chinese Han population.
19902201	2010	Immunogenetics	1432-1211	ALL_TEXT_1/3	1	2	727	SYMBOL|EXTRACTED|GENE|GN	c5	C5	103#105	19902201-1-258-280	D012214	SYMBOL|DICTIONARY|EXTRACTED	rhd	RHD	32#35	19902201-1-296-319	We observed no association with RHD for the five tagging single nucleotide polymorphisms (tSNP) in the C5 gene, the three tSNPs in the TNFAIP3 gene, or the two tSNPs in the TRAF1 gene.
19902201	2010	Immunogenetics	1432-1211	ALL_TEXT_1/3	1	2	7128	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	tnfaip3	TNFAIP3	135#142	19902201-1-131-176	D012214	SYMBOL|DICTIONARY|EXTRACTED	rhd	RHD	32#35	19902201-1-296-319	We observed no association with RHD for the five tagging single nucleotide polymorphisms (tSNP) in the C5 gene, the three tSNPs in the TNFAIP3 gene, or the two tSNPs in the TRAF1 gene.
19902201	2010	Immunogenetics	1432-1211	ALL_TEXT_1/3	1	2	7185	SYMBOL|GENE|GN|DICTIONARY	traf1	TRAF1	173#178		D012214	SYMBOL|DICTIONARY|EXTRACTED	rhd	RHD	32#35	19902201-1-296-319	We observed no association with RHD for the five tagging single nucleotide polymorphisms (tSNP) in the C5 gene, the three tSNPs in the TNFAIP3 gene, or the two tSNPs in the TRAF1 gene.
19420919	2009	Cerebrovasc. Dis.	1421-9786	TITLE	0	0	6401	LONGTERM|GENE|GN|DICTIONARY	e selectin	E-selectin	0#10		D002544	LONGTERM|DICTIONARY	ischemic stroke	ischemic stroke	60#75		E-selectin genetic variation as a susceptibility factor for ischemic stroke.
19902201	2010	Immunogenetics	1432-1211	ALL_TEXT_3/3	3	7	7128	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	tnfaip3	TNFAIP3	61#68	19902201-1-131-176	D012214	SYMBOL|DICTIONARY|EXTRACTED	rhd	RHD	113#116	19902201-1-296-319	Therefore, we report a new genetic variant (rs582757) in the TNFAIP3 gene that associated with the prevalence of RHD in Chinese Han population.
12960748	2004	Psychiatr. Genet.	0955-8829	OBJECTIVE	1	1	1565	SYMBOL|DICTIONARY	cyp2d6	CYP2D6	121#127		D001480	LONGTERM|DICTIONARY	extrapyramidal symptoms	extrapyramidal symptoms	73#96		The purpose of this study was to examine whether the neuroleptic-induced extrapyramidal symptoms are associated with the CYP2D6 activity.
16517578	2006	Thorax	0040-6376	BACKGROUND	1	3	7124	SYMBOL|EXTRACTED	tnfalpha	TNFalpha	58#66	16517578-2-18-46	D001249	LONGTERM|DICTIONARY	asthma	asthma	150#156		A number of studies have investigated the polymorphism of TNFalpha-308 gene promoter (substitution G-->A, designated as TNF1 and TNF2) in relation to asthma susceptibility in different populations.
16517578	2006	Thorax	0040-6376	BACKGROUND	1	2	7124	SYMBOL|EXTRACTED|()	tnfalpha	TNFalpha	48#56	16517578-2-18-46	D001249	LONGTERM|DICTIONARY	asthma	asthma	95#101		The gene encoding tumour necrosis factor alpha (TNFalpha) is one of several candidate loci for asthma pathogenesis and is highly polymorphic.
20564317	2010	Prostate	1097-0045	CONCLUSION	4	9	4524	SYMBOL|DICTIONARY|EXTRACTED	mthfr	MTHFR	34#39	20564317-1-46-81	D011471	LONGTERM|DISEASE|DT|DICTIONARY	prostate cancer	prostate cancer	96#111		These data suggest that all three MTHFR polymorphisms may play a pivotal role in the developing prostate cancer.
16277672	2006	Arthritis Res. Ther.	1478-6362	ALL_TEXT_1/3	1	2	26191	SYMBOL|NUMBER|DICTIONARY	ptpn22	PTPN22	54#60		D001172	LONGTERM|DICTIONARY	rheumatoid arthritis	rheumatoid arthritis	121#141		An association has recently been reported between the PTPN22-620W functional allele and rheumatoid factor-positive (RF+) rheumatoid arthritis (RA), among other autoimmune diseases.
16277672	2006	Arthritis Res. Ther.	1478-6362	ALL_TEXT_1/3	1	2	26191	SYMBOL|NUMBER|DICTIONARY	ptpn22	PTPN22	54#60		D001172	SYMBOL|EXTRACTED|()	ra	RA	143#145	16277672-2-121-141	An association has recently been reported between the PTPN22-620W functional allele and rheumatoid factor-positive (RF+) rheumatoid arthritis (RA), among other autoimmune diseases.
16277672	2006	Arthritis Res. Ther.	1478-6362	ALL_TEXT_1/3	1	2	26191	SYMBOL|NUMBER|DICTIONARY	ptpn22	PTPN22	54#60		D001327	LONGTERM|DICTIONARY	autoimmune diseases	autoimmune diseases	160#179		An association has recently been reported between the PTPN22-620W functional allele and rheumatoid factor-positive (RF+) rheumatoid arthritis (RA), among other autoimmune diseases.
16517578	2006	Thorax	0040-6376	METHODS	2	5	7124	SYMBOL|EXTRACTED	tnfalpha	TNFalpha	90#98	16517578-2-18-46	D001249	LONGTERM|DICTIONARY	asthma	asthma	140#146		To address the inconsistent findings in studies of the association of the polymorphism of TNFalpha-308 gene promoter with susceptibility to asthma, a systematic review was undertaken of the published data and a meta-analysis was performed.
19224585	2009	Hum. Mutat.	1098-1004	ALL_TEXT_1/3	1	2	7157	SYMBOL|DICTIONARY	tp53	TP53	89#93		D015179	SYMBOL|DICTIONARY|EXTRACTED	crc	CRC	298#301	19224585-1-56-73	To assess the role of genetic variants on the disease, we genotyped polymorphisms in the TP53 (rs17878362:A(1)>A(2), rs1042522:G>C, rs12947788:C>T, and rs17884306:G>A), CDKN1A (rs1801270:C>A and rs1059234:C>T), and CDKN2A (rs3731249:G>A, rs11515:C>G, and rs3088440:C>T) genes in 614 hospital-based CRC cases and 614 matched controls from the country.
19224585	2009	Hum. Mutat.	1098-1004	ALL_TEXT_1/3	1	2	1026	SYMBOL|DICTIONARY	cdkn1a	CDKN1A	169#175		D015179	SYMBOL|DICTIONARY|EXTRACTED	crc	CRC	298#301	19224585-1-56-73	To assess the role of genetic variants on the disease, we genotyped polymorphisms in the TP53 (rs17878362:A(1)>A(2), rs1042522:G>C, rs12947788:C>T, and rs17884306:G>A), CDKN1A (rs1801270:C>A and rs1059234:C>T), and CDKN2A (rs3731249:G>A, rs11515:C>G, and rs3088440:C>T) genes in 614 hospital-based CRC cases and 614 matched controls from the country.
19224585	2009	Hum. Mutat.	1098-1004	ALL_TEXT_1/3	1	2	1029	SYMBOL|DICTIONARY	cdkn2a	CDKN2A	215#221		D015179	SYMBOL|DICTIONARY|EXTRACTED	crc	CRC	298#301	19224585-1-56-73	To assess the role of genetic variants on the disease, we genotyped polymorphisms in the TP53 (rs17878362:A(1)>A(2), rs1042522:G>C, rs12947788:C>T, and rs17884306:G>A), CDKN1A (rs1801270:C>A and rs1059234:C>T), and CDKN2A (rs3731249:G>A, rs11515:C>G, and rs3088440:C>T) genes in 614 hospital-based CRC cases and 614 matched controls from the country.
20564317	2010	Prostate	1097-0045	RESULTS	3	4	4524	SYMBOL|NUMBER|DICTIONARY|EXTRACTED	mthfr	MTHFR	18#23	20564317-1-46-81	D011471	LONGTERM|DISEASE|DT|DICTIONARY	prostate cancer	prostate cancer	106#121		We found that the MTHFR 677TT and 1298CC genotypes were associated with an about 40% reduction in risk of prostate cancer (adjusted OR=0.59, 95% CI=0.41-0.94, and adjusted OR=0.58, 95% CI=0.32-0.91, respectively) compared to the 677CC, and 1298AA genotypes.
12135317	2003	Hypertens. Res.	0916-9636	TITLE	0	0	7056	LONGTERM|GENE|GN|DICTIONARY	thrombomodulin	thrombomodulin	41#55		D009203	LONGTERM|DICTIONARY	myocardial infarction	myocardial infarction	66#87		Association of G-33A polymorphism in the thrombomodulin gene with myocardial infarction in Koreans.
12135317	2003	Hypertens. Res.	0916-9636	ALL_TEXT_1/3	1	2	7056	SYMBOL|EXTRACTED|GENE|GN	tm	TM	90#92	12135317-1-0-14	D009203	LONGTERM|DICTIONARY	myocardial infarction	myocardial infarction	147#168		In this study, we examined the effects of 3 single-nucleotide polymorphisms (SNPs) in the TM gene (G-33A, C1418T and C1922T) on the development of myocardial infarction (MI) in Koreans.
12135317	2003	Hypertens. Res.	0916-9636	ALL_TEXT_1/3	1	2	7056	SYMBOL|EXTRACTED|GENE|GN	tm	TM	90#92	12135317-1-0-14	D009203	SYMBOL|EXTRACTED|()	mi	MI	170#172	12135317-2-147-168	In this study, we examined the effects of 3 single-nucleotide polymorphisms (SNPs) in the TM gene (G-33A, C1418T and C1922T) on the development of myocardial infarction (MI) in Koreans.
16625233	2006	J Hum Hypertens	0950-9240	TITLE	0	0	5468	LONGTERM|DICTIONARY	peroxisome proliferator-activated receptor-gamma2	peroxisome proliferator-activated receptor-gamma2	48#97	NaN	D009765	LONGTERM|DISEASE|DN|DICTIONARY	obese	obese	150#155		Association between the Pro12Ala variant of the peroxisome proliferator-activated receptor-gamma2 gene and increased 24-h diastolic blood pressure in obese patients with type II diabetes.
16625233	2006	J Hum Hypertens	0950-9240	TITLE	0	0	5468	LONGTERM|DICTIONARY	peroxisome proliferator-activated receptor-gamma2	peroxisome proliferator-activated receptor-gamma2	48#97	NaN	D003924	LONGTERM|DICTIONARY	type ii diabetes	type II diabetes	170#186		Association between the Pro12Ala variant of the peroxisome proliferator-activated receptor-gamma2 gene and increased 24-h diastolic blood pressure in obese patients with type II diabetes.
19470260	2009	Zhongguo Dang Dai Er Ke Za Zhi	1008-8830	RESULTS	3	5	28	SYMBOL|DICTIONARY	abo	ABO	60#63		D001289	SYMBOL|DICTIONARY|EXTRACTED	adhd	ADHD	93#97	19470260-1-63-103	TDT results showed significant differences in the allele of ABO between the 96 children with ADHD and within-family controls (chi2=6.017, df=2, P< 0.05).
12888635	2003	J. Nutr.	0022-3166	ALL_TEXT_1/3	1	3	154	SYMBOL|GENE|GN|DICTIONARY	beta 2 adrenoceptor	beta(2)-adrenoceptor	173#193		D009765	LONGTERM|DICTIONARY	obese	obese	22#27		A case-control study (obese subjects vs. normal weight controls) was conducted to assess a possible effect modification on obesity risk of the Gln27Glu polymorphism for the beta(2)-adrenoceptor gene depending on dietary intake.
12888635	2003	J. Nutr.	0022-3166	ALL_TEXT_1/3	1	3	154	SYMBOL|GENE|GN|DICTIONARY	beta 2 adrenoceptor	beta(2)-adrenoceptor	173#193		D009765	LONGTERM|DICTIONARY	obesity	obesity	123#130		A case-control study (obese subjects vs. normal weight controls) was conducted to assess a possible effect modification on obesity risk of the Gln27Glu polymorphism for the beta(2)-adrenoceptor gene depending on dietary intake.
20570322	2010	Gynecol. Oncol.	1095-6859	CONCLUSIONS	4	14	672	LONGTERM|DICTIONARY	brca	BRCA	27#31	NaN	D005185	LONGTERM|DISEASE|DT|DICTIONARY	fallopian tube cancer	fallopian tube cancer	66#87		The highest frequencies of BRCA mutations were seen in women with fallopian tube cancer diagnosed under age 60, in Jewish women, in women with a family history of breast or ovarian cancer, and in women with a personal history of breast cancer.
20570322	2010	Gynecol. Oncol.	1095-6859	CONCLUSIONS	4	14	672	LONGTERM|DICTIONARY	brca	BRCA	27#31	NaN	D001943	LONGTERM|DISEASE|DT|DICTIONARY	breast cancer	breast cancer	229#242		The highest frequencies of BRCA mutations were seen in women with fallopian tube cancer diagnosed under age 60, in Jewish women, in women with a family history of breast or ovarian cancer, and in women with a personal history of breast cancer.
20570322	2010	Gynecol. Oncol.	1095-6859	CONCLUSIONS	4	14	672	LONGTERM|DICTIONARY	brca	BRCA	27#31	NaN	D061325	LONGTERM|DISEASE|DT|DICTIONARY	breast or ovarian cancer	breast or ovarian cancer	163#187		The highest frequencies of BRCA mutations were seen in women with fallopian tube cancer diagnosed under age 60, in Jewish women, in women with a family history of breast or ovarian cancer, and in women with a personal history of breast cancer.
20662556	2010	DNA Cell Biol.	1557-7430	ALL_TEXT_1/3	1	1	3603	LONGTERM|DICTIONARY	interleukin 16	Interleukin-16	0#14		D004715	LONGTERM|DICTIONARY	endometriosis	endometriosis	132#145		Interleukin-16 (IL-16), a proinflammatory cytokine, plays a pivotal role in inflammatory diseases as well as in the pathogenesis of endometriosis.
20662556	2010	DNA Cell Biol.	1557-7430	ALL_TEXT_1/3	1	1	3603	SYMBOL|()|DICTIONARY|EXTRACTED	il 16	IL-16	16#21	20662556-1-0-14	D004715	LONGTERM|DICTIONARY	endometriosis	endometriosis	132#145		Interleukin-16 (IL-16), a proinflammatory cytokine, plays a pivotal role in inflammatory diseases as well as in the pathogenesis of endometriosis.
19420919	2009	Cerebrovasc. Dis.	1421-9786	ALL_TEXT_3/3	3	8	6401	LONGTERM|GENE|GN|DICTIONARY	e selectin	E-selectin	38#48		D002544	LONGTERM|DICTIONARY	ischemic stroke	ischemic stroke	110#125		The combination of 2 minor alleles of E-selectin genes appeared to be the strongest susceptibility factor for ischemic stroke (adjusted OR: 5.89, 95% CI: 2.84-12.21, p = 0.0001).
20662556	2010	DNA Cell Biol.	1557-7430	TITLE	0	0	3603	LONGTERM|GENE|GN|DICTIONARY	interleukin 16	interleukin-16	18#32		D010146	LONGTERM|DISEASE|DN|DICTIONARY	pain	pain	69#73		Association of an interleukin-16 gene polymorphism with the risk and pain phenotype of endometriosis.
20662556	2010	DNA Cell Biol.	1557-7430	TITLE	0	0	3603	LONGTERM|GENE|GN|DICTIONARY	interleukin 16	interleukin-16	18#32		D004715	LONGTERM|DICTIONARY	endometriosis	endometriosis	87#100		Association of an interleukin-16 gene polymorphism with the risk and pain phenotype of endometriosis.
19350382	2009	Cell. Mol. Neurobiol.	1573-6830	ALL_TEXT_3/3	3	9	5728	SYMBOL|DICTIONARY	pten	PTEN	28#32		D005910	LONGTERM|DICTIONARY	gliomas	gliomas	97#104		In conclusion, reduced MMAC/PTEN expression by genetic and/or epigenetic mechanisms in low grade gliomas might be associated with glioma tumorigenesis.
19350382	2009	Cell. Mol. Neurobiol.	1573-6830	ALL_TEXT_3/3	3	9	5728	SYMBOL|DICTIONARY	pten	PTEN	28#32		D005910	LONGTERM|DISEASE|DN|DICTIONARY	glioma tumorigenesis	glioma tumorigenesis	130#150		In conclusion, reduced MMAC/PTEN expression by genetic and/or epigenetic mechanisms in low grade gliomas might be associated with glioma tumorigenesis.
19350382	2009	Cell. Mol. Neurobiol.	1573-6830	ALL_TEXT_3/3	3	9	5728	SYMBOL|DICTIONARY	pten	PTEN	28#32		D005910	LONGTERM|DICTIONARY	glioma tumorigenesis	glioma tumorigenesis	130#150		In conclusion, reduced MMAC/PTEN expression by genetic and/or epigenetic mechanisms in low grade gliomas might be associated with glioma tumorigenesis.
9535412	1998	Hypertension	0194-911X	ALL_TEXT_2/3	2	3	1636	LONGTERM|GENE|GT|DICTIONARY|GA	angiotensin converting enzyme	angiotensin-converting enzyme	108#137		D006973	LONGTERM|DICTIONARY	hypertensive	hypertensive	8#20	NaN	In both hypertensive and normotensive groups, a deletion (D)/insertion (I) polymorphism in intron 16 of the angiotensin-converting enzyme (ACE) gene was determined by polymerase chain reaction.
9535412	1998	Hypertension	0194-911X	ALL_TEXT_2/3	2	3	1636	SYMBOL|()|GENE|GN|DICTIONARY|EXTRACTED	ace	ACE	139#142	9535412-3-108-137	D006973	LONGTERM|DICTIONARY	hypertensive	hypertensive	8#20	NaN	In both hypertensive and normotensive groups, a deletion (D)/insertion (I) polymorphism in intron 16 of the angiotensin-converting enzyme (ACE) gene was determined by polymerase chain reaction.
15266614	2005	Am. J. Med. Genet. A	1552-4825	ALL_TEXT_1/3	1	2	3077	LONGTERM|GENE|GN|DICTIONARY	hemochromatosis	hemochromatosis	177#192		D019190	LONGTERM|DICTIONARY	iron overload	iron overload	120#133		We hypothesized that increased levels of serum bilirubin may play a protective role against oxidative stress induced by iron overload in carriers of mutations in the hereditary hemochromatosis gene (HFE).
10541293	1999	J. Am. Soc. Nephrol.	1046-6673	ALL_TEXT_1/3	1	1	5311	SYMBOL|DICTIONARY	pkd2	PKD2	127#131		D007674	LONGTERM|DISEASE|DT|DICTIONARY	autosomal dominant polycystic kidney disease	autosomal dominant polycystic kidney disease	56#100		It is estimated that approximately 15% of families with autosomal dominant polycystic kidney disease (ADPKD) have mutations in PKD2.
10541293	1999	J. Am. Soc. Nephrol.	1046-6673	ALL_TEXT_1/3	1	1	5311	SYMBOL|DICTIONARY	pkd2	PKD2	127#131		D007674	LONGTERM|()|DICTIONARY|EXTRACTED	adpkd	ADPKD	102#107	10541293-1-56-100	It is estimated that approximately 15% of families with autosomal dominant polycystic kidney disease (ADPKD) have mutations in PKD2.
15562935	2005	Clin Cardiol	0160-9289	RESULTS	4	9	4973	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	lox 1	LOX- 1	17#23		D003251	LONGTERM|DICTIONARY	stenosis	stenosis	124#132	NaN	The frequency of LOX- 1 gene variants (C/C or C/G) was lower in patients with significant than in those with normal/minimal stenosis (36 vs. 49%, p < 0.01).
19523860	2011	Urol. Oncol.	1873-2496	ALL_TEXT_3/3	3	7	7157	LONGTERM|DICTIONARY	tp53	TP53	32#36	NaN	D001749	LONGTERM|DISEASE|DT|DICTIONARY	bladder cancer	bladder cancer	175#189		We concluded that the effect of TP53Arg72Pro, described in some studies as an important risk factor, may not be an independent, but an age-related factor of susceptibility to bladder cancer.
17005168	2007	Clin. Chim. Acta	0009-8981	CONCLUSIONS	4	9	2944	SYMBOL|DICTIONARY|EXTRACTED	gstm1	GSTM1	61#66	17005168-1-94-122	C535575	SYMBOL|DICTIONARY|EXTRACTED	hnscc	HNSCC	126#131	17005168-1-24-61	The present study confirms a role for genetic alterations of GSTM1 detoxifying enzyme as a risk factor for the development of HNSCC in patients from the Italian Lazio Region, independently of age, sex and other confounding variables.
17005168	2007	Clin. Chim. Acta	0009-8981	RESULTS	3	5	2944	SYMBOL|DICTIONARY|EXTRACTED	gstm1	GSTM1	59#64	17005168-1-94-122	D006258	LONGTERM|DISEASE|DT|DICTIONARY	head and neck cancer	head and neck cancer	34#54		A significant association between head and neck cancer and GSTM1 null genotype was observed both considering benign disease controls (p=0.001, OR=2.613; 95% C.I.=1.48-4.62), and healthy donors (p=0.0003, OR=3.35; 95% C.I.
15562935	2005	Clin Cardiol	0160-9289	BACKGROUND	1	3	4973	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	lox 1	LOX-1	10#15	15562935-1-48-61	D009203	LONGTERM|DICTIONARY	myocardial infarction	myocardial infarction	77#98		Recently, LOX-1 gene polymorphism (G501C) was reported to be associated with myocardial infarction (MI).
15562935	2005	Clin Cardiol	0160-9289	BACKGROUND	1	3	4973	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	lox 1	LOX-1	10#15	15562935-1-48-61	D009203	SYMBOL|EXTRACTED|()	mi	MI	100#102	15562935-3-77-98	Recently, LOX-1 gene polymorphism (G501C) was reported to be associated with myocardial infarction (MI).
17005168	2007	Clin. Chim. Acta	0009-8981	BACKGROUND	1	1	2944	LONGTERM|DICTIONARY	glutathione s transferase m1	glutathione S-transferase M1	94#122		C535575	LONGTERM|DISEASE|DT|DICTIONARY	head and neck squamous cell carcinoma	head and neck squamous cell carcinoma	24#61		The association between head and neck squamous cell carcinoma (HNSCC) and allelic variants of glutathione S-transferase M1 (GSTM1) and -T1 (GSTT1) is currently controversial.
17005168	2007	Clin. Chim. Acta	0009-8981	BACKGROUND	1	1	2944	LONGTERM|DICTIONARY	glutathione s transferase m1	glutathione S-transferase M1	94#122		C535575	SYMBOL|()|DICTIONARY|EXTRACTED	hnscc	HNSCC	63#68	17005168-1-24-61	The association between head and neck squamous cell carcinoma (HNSCC) and allelic variants of glutathione S-transferase M1 (GSTM1) and -T1 (GSTT1) is currently controversial.
17005168	2007	Clin. Chim. Acta	0009-8981	BACKGROUND	1	1	2944	SYMBOL|()|DICTIONARY|EXTRACTED	gstm1	GSTM1	124#129	17005168-1-94-122	C535575	LONGTERM|DISEASE|DT|DICTIONARY	head and neck squamous cell carcinoma	head and neck squamous cell carcinoma	24#61		The association between head and neck squamous cell carcinoma (HNSCC) and allelic variants of glutathione S-transferase M1 (GSTM1) and -T1 (GSTT1) is currently controversial.
17005168	2007	Clin. Chim. Acta	0009-8981	BACKGROUND	1	1	2944	SYMBOL|()|DICTIONARY|EXTRACTED	gstm1	GSTM1	124#129	17005168-1-94-122	C535575	SYMBOL|()|DICTIONARY|EXTRACTED	hnscc	HNSCC	63#68	17005168-1-24-61	The association between head and neck squamous cell carcinoma (HNSCC) and allelic variants of glutathione S-transferase M1 (GSTM1) and -T1 (GSTT1) is currently controversial.
17005168	2007	Clin. Chim. Acta	0009-8981	BACKGROUND	1	1	2952	SYMBOL|()|DICTIONARY	gstt1	GSTT1	140#145		C535575	LONGTERM|DISEASE|DT|DICTIONARY	head and neck squamous cell carcinoma	head and neck squamous cell carcinoma	24#61		The association between head and neck squamous cell carcinoma (HNSCC) and allelic variants of glutathione S-transferase M1 (GSTM1) and -T1 (GSTT1) is currently controversial.
17005168	2007	Clin. Chim. Acta	0009-8981	BACKGROUND	1	1	2952	SYMBOL|()|DICTIONARY	gstt1	GSTT1	140#145		C535575	SYMBOL|()|DICTIONARY|EXTRACTED	hnscc	HNSCC	63#68	17005168-1-24-61	The association between head and neck squamous cell carcinoma (HNSCC) and allelic variants of glutathione S-transferase M1 (GSTM1) and -T1 (GSTT1) is currently controversial.
17005168	2007	Clin. Chim. Acta	0009-8981	TITLE	0	0	2952	SYMBOL|DICTIONARY	gstt1	GSTT1	0#5		D006258	LONGTERM|DISEASE|DN|DT|DICTIONARY	head and neck cancer	head and neck cancer	41#61		GSTT1 and GSTM1 allelic polymorphisms in head and neck cancer patients from Italian Lazio Region.
17005168	2007	Clin. Chim. Acta	0009-8981	TITLE	0	0	2944	SYMBOL|DICTIONARY|EXTRACTED	gstm1	GSTM1	10#15		D006258	LONGTERM|DISEASE|DN|DT|DICTIONARY	head and neck cancer	head and neck cancer	41#61		GSTT1 and GSTM1 allelic polymorphisms in head and neck cancer patients from Italian Lazio Region.
17005168	2007	Clin. Chim. Acta	0009-8981	BACKGROUND	1	2	2952	SYMBOL|DICTIONARY	gstt1	GSTT1	50#55		D006258	LONGTERM|DISEASE|DN|DT|DICTIONARY	head and neck cancer	head and neck cancer	98#118		The present study investigates the prevalences of GSTT1 and GSTM1 polymorphism in a cohort of 100 head and neck cancer patients, 100 healthy donors and 200 controls with non-neoplastic head and neck diseases from Italian Lazio Region.
17005168	2007	Clin. Chim. Acta	0009-8981	BACKGROUND	1	2	2944	SYMBOL|DICTIONARY|EXTRACTED	gstm1	GSTM1	60#65	17005168-1-94-122	D006258	LONGTERM|DISEASE|DN|DT|DICTIONARY	head and neck cancer	head and neck cancer	98#118		The present study investigates the prevalences of GSTT1 and GSTM1 polymorphism in a cohort of 100 head and neck cancer patients, 100 healthy donors and 200 controls with non-neoplastic head and neck diseases from Italian Lazio Region.
16211375	2006	Diabetologia	0012-186X	AIMS/HYPOTHESIS	1	2	59272	LONGTERM|DICTIONARY	angiotensin i converting enzyme 2	Angiotensin I converting enzyme 2	0#33		D007674	LONGTERM|DISEASE|DT|DICTIONARY	kidney disease	kidney disease	93#107		Angiotensin I converting enzyme 2 (ACE2), a new component of the RAS, has been implicated in kidney disease, hypertension and cardiac function.
16211375	2006	Diabetologia	0012-186X	AIMS/HYPOTHESIS	1	2	59272	LONGTERM|DICTIONARY	angiotensin i converting enzyme 2	Angiotensin I converting enzyme 2	0#33		D006973	LONGTERM|DICTIONARY	hypertension	hypertension	109#121		Angiotensin I converting enzyme 2 (ACE2), a new component of the RAS, has been implicated in kidney disease, hypertension and cardiac function.
16211375	2006	Diabetologia	0012-186X	AIMS/HYPOTHESIS	1	2	59272	SYMBOL|()|DICTIONARY|EXTRACTED	ace2	ACE2	35#39	16211375-2-0-33	D007674	LONGTERM|DISEASE|DT|DICTIONARY	kidney disease	kidney disease	93#107		Angiotensin I converting enzyme 2 (ACE2), a new component of the RAS, has been implicated in kidney disease, hypertension and cardiac function.
16211375	2006	Diabetologia	0012-186X	AIMS/HYPOTHESIS	1	2	59272	SYMBOL|()|DICTIONARY|EXTRACTED	ace2	ACE2	35#39	16211375-2-0-33	D006973	LONGTERM|DICTIONARY	hypertension	hypertension	109#121		Angiotensin I converting enzyme 2 (ACE2), a new component of the RAS, has been implicated in kidney disease, hypertension and cardiac function.
19080705	2009	Zhonghua Yi Xue Za Zhi	0376-2491	CONCLUSION	4	14	5075	SYMBOL|GENE|GN|DICTIONARY	pax1	PAX1	24#28		D012600	SYMBOL|EXTRACTED	cs	CS	83#85	19080705-1-66-86	The genetic variants of PAX1 gene may not be associated with the susceptibility to CS and different clinical phenotypes of CS in Chinese Han population.
19080705	2009	Zhonghua Yi Xue Za Zhi	0376-2491	CONCLUSION	4	14	5075	SYMBOL|GENE|GN|DICTIONARY	pax1	PAX1	24#28		D012600	SYMBOL|EXTRACTED	cs	CS	123#125	19080705-1-66-86	The genetic variants of PAX1 gene may not be associated with the susceptibility to CS and different clinical phenotypes of CS in Chinese Han population.
20816194	2010	J. Allergy Clin. Immunol.	1097-6825	RESULTS	4	6	6774	SYMBOL|DICTIONARY|EXTRACTED	stat3	STAT3	14#19	20816194-2-32-82	D007589	SYMBOL|EXTRACTED	hies	HIES	35#39	20816194-1-0-19	Patients with STAT3 mutations with HIES showed significantly lower T(H)17 cell counts compared with patients with wild-type STAT3 and control subjects.
20816194	2010	J. Allergy Clin. Immunol.	1097-6825	RESULTS	4	6	6774	SYMBOL|DICTIONARY|EXTRACTED	stat3	STAT3	124#129	20816194-2-32-82	D007589	SYMBOL|EXTRACTED	hies	HIES	35#39	20816194-1-0-19	Patients with STAT3 mutations with HIES showed significantly lower T(H)17 cell counts compared with patients with wild-type STAT3 and control subjects.
12771801	2003	J. Urol.	0022-5347	TITLE	0	0	6716	SYMBOL|DICTIONARY	srd5a2	SRD5A2	20#26		D011471	LONGTERM|DISEASE|DT|DICTIONARY	prostate cancer	prostate cancer	45#60		Association of V89L SRD5A2 polymorphism with prostate cancer development in a Japanese population.
15257748	2004	J. Clin. Periodontol.	0303-6979	OBJECTIVES	1	2	4312	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	mmp 1	MMP-1	107#112	15257748-1-0-26	D055113	LONGTERM|DICTIONARY	chronic periodontitis	chronic periodontitis	122#143		Therefore, the aim of our study was to examine the association between three promoter polymorphisms of the MMP-1 gene and chronic periodontitis susceptibility and/or severity in a Czech population.
15257748	2004	J. Clin. Periodontol.	0303-6979	TITLE	0	0	4312	LONGTERM|GENE|GN|DICTIONARY	matrix metalloproteinase 1	matrix metalloproteinase-1	26#52		D055113	LONGTERM|DICTIONARY	chronic periodontitis	chronic periodontitis	108#129		Genetic variations in the matrix metalloproteinase-1 promoter and risk of susceptibility and/or severity of chronic periodontitis in the Czech population.
15257748	2004	J. Clin. Periodontol.	0303-6979	OBJECTIVES	1	1	4312	LONGTERM|DICTIONARY	matrix metalloproteinase 1	Matrix metalloproteinase-1	0#26		D055113	LONGTERM|DICTIONARY	chronic periodontitis	chronic periodontitis	128#149		Matrix metalloproteinase-1 (MMP-1) is a potent enzyme degrading extracellular matrix that was implicated in the pathogenesis of chronic periodontitis.
15257748	2004	J. Clin. Periodontol.	0303-6979	OBJECTIVES	1	1	4312	SYMBOL|()|DICTIONARY|EXTRACTED	mmp 1	MMP-1	28#33	15257748-1-0-26	D055113	LONGTERM|DICTIONARY	chronic periodontitis	chronic periodontitis	128#149		Matrix metalloproteinase-1 (MMP-1) is a potent enzyme degrading extracellular matrix that was implicated in the pathogenesis of chronic periodontitis.
20393813	2010	J. Mol. Neurosci.	1559-1166	ALL_TEXT_2/3	2	4	3586	SYMBOL|DICTIONARY	il 10	IL-10	85#90		D012559	LONGTERM|DICTIONARY	schizophrenia	schizophrenia	140#153		The aim of the study was to identify whether polymorphisms of interleukin (IL)-6 and IL-10 are risk factors for the development of paranoid schizophrenia in case-control study.
20393813	2010	J. Mol. Neurosci.	1559-1166	ALL_TEXT_2/3	2	4	3569	SYMBOL|DICTIONARY	interleukin (il)-6	interleukin (IL)-6	62#80		D012559	LONGTERM|DICTIONARY	schizophrenia	schizophrenia	140#153		The aim of the study was to identify whether polymorphisms of interleukin (IL)-6 and IL-10 are risk factors for the development of paranoid schizophrenia in case-control study.
17316890	2007	Lung Cancer	0169-5002	ALL_TEXT_3/3	3	8	7515	SYMBOL|DICTIONARY	xrcc1	XRCC1	44#49		D009369	LONGTERM|DISEASE|DT|DICTIONARY	cancer	cancer	71#77		To our knowledge, this is first report that XRCC1 Pro206Pro influences cancer risk.
17186461	2007	Am. J. Hum. Genet.	0002-9297	ALL_TEXT_3/3	3	12	5663	SYMBOL|DICTIONARY|EXTRACTED	psen1	PSEN1	4#9	17186461-5-39-51	D003643	LONGTERM|DICTIONARY	death	death	147#152	NaN	The PSEN1 mutation was associated with complete penetrance and progressive disease that resulted in the necessity of cardiac transplantation or in death.
17186461	2007	Am. J. Hum. Genet.	0002-9297	ALL_TEXT_3/3	3	15	5663	SYMBOL|DICTIONARY|EXTRACTED	psen1	PSEN1	25#30	17186461-5-39-51	D002311	SYMBOL|DICTIONARY|EXTRACTED	dcm	DCM	71#74	17186461-2-35-57	These data indicate that PSEN1 and PSEN2 mutations are associated with DCM and heart failure and implicate novel mechanisms of myocardial disease.
17186461	2007	Am. J. Hum. Genet.	0002-9297	ALL_TEXT_3/3	3	15	5663	SYMBOL|DICTIONARY|EXTRACTED	psen1	PSEN1	25#30	17186461-5-39-51	D006333	LONGTERM|DICTIONARY	heart failure	heart failure	79#92		These data indicate that PSEN1 and PSEN2 mutations are associated with DCM and heart failure and implicate novel mechanisms of myocardial disease.
17186461	2007	Am. J. Hum. Genet.	0002-9297	ALL_TEXT_3/3	3	15	5663	SYMBOL|DICTIONARY|EXTRACTED	psen1	PSEN1	25#30	17186461-5-39-51	D009202	LONGTERM|DISEASE|DT|DICTIONARY	myocardial disease	myocardial disease	127#145		These data indicate that PSEN1 and PSEN2 mutations are associated with DCM and heart failure and implicate novel mechanisms of myocardial disease.
17186461	2007	Am. J. Hum. Genet.	0002-9297	ALL_TEXT_3/3	3	15	5664	SYMBOL|DICTIONARY|EXTRACTED	psen2	PSEN2	35#40	17186461-5-63-75	D002311	SYMBOL|DICTIONARY|EXTRACTED	dcm	DCM	71#74	17186461-2-35-57	These data indicate that PSEN1 and PSEN2 mutations are associated with DCM and heart failure and implicate novel mechanisms of myocardial disease.
17186461	2007	Am. J. Hum. Genet.	0002-9297	ALL_TEXT_3/3	3	15	5664	SYMBOL|DICTIONARY|EXTRACTED	psen2	PSEN2	35#40	17186461-5-63-75	D006333	LONGTERM|DICTIONARY	heart failure	heart failure	79#92		These data indicate that PSEN1 and PSEN2 mutations are associated with DCM and heart failure and implicate novel mechanisms of myocardial disease.
17186461	2007	Am. J. Hum. Genet.	0002-9297	ALL_TEXT_3/3	3	15	5664	SYMBOL|DICTIONARY|EXTRACTED	psen2	PSEN2	35#40	17186461-5-63-75	D009202	LONGTERM|DISEASE|DT|DICTIONARY	myocardial disease	myocardial disease	127#145		These data indicate that PSEN1 and PSEN2 mutations are associated with DCM and heart failure and implicate novel mechanisms of myocardial disease.
17316890	2007	Lung Cancer	0169-5002	TITLE	0	0	7515	SYMBOL|DICTIONARY	xrcc1	XRCC1	20#25		D008175	LONGTERM|DISEASE|DT|DICTIONARY	lung cancer	lung cancer	56#67		The DNA repair gene XRCC1 and genetic susceptibility of lung cancer in a northeastern Chinese population.
17316890	2007	Lung Cancer	0169-5002	ALL_TEXT_1/3	1	1	7515	SYMBOL|DICTIONARY	xrcc1	XRCC1	42#47		D008175	LONGTERM|DISEASE|DT|DICTIONARY	lung cancer	lung cancer	77#88		To evaluate the effect of DNA repair gene XRCC1 polymorphisms on the risk of lung cancer in a northeastern Chinese population, we studied five cSNPs in the XRCC1 gene, three that lead to non-synonymous changes: Arg194Trp, Arg280 His and Arg399Gln and two that lead to synonymous changes: Pro206Pro and Gln632Gln.
17316890	2007	Lung Cancer	0169-5002	ALL_TEXT_1/3	1	1	7515	SYMBOL|GENE|GN|DICTIONARY	xrcc1	XRCC1	156#161		D008175	LONGTERM|DISEASE|DT|DICTIONARY	lung cancer	lung cancer	77#88		To evaluate the effect of DNA repair gene XRCC1 polymorphisms on the risk of lung cancer in a northeastern Chinese population, we studied five cSNPs in the XRCC1 gene, three that lead to non-synonymous changes: Arg194Trp, Arg280 His and Arg399Gln and two that lead to synonymous changes: Pro206Pro and Gln632Gln.
17316890	2007	Lung Cancer	0169-5002	ALL_TEXT_3/3	3	7	7515	SYMBOL|DICTIONARY	xrcc1	XRCC1	29#34		D008175	LONGTERM|DISEASE|DT|DICTIONARY	lung cancer	lung cancer	150#161		Our results suggest that the XRCC1 Pro206Pro polymorphism or the haplotype encompassing the minor allele may contribute to genetic susceptibility for lung cancer in this northeastern Chinese population.
15940757	2005	J. Rheumatol.	0315-162X	TITLE	0	0	2944	LONGTERM|DICTIONARY	glutathione s transferase m1	Glutathione S-transferase M1	0#28		D001172	LONGTERM|DICTIONARY	rheumatoid arthritis	rheumatoid arthritis	55#75		Glutathione S-transferase M1, T1, and P1 genotypes and rheumatoid arthritis.
21270338	2011	Sci Transl Med	1946-6242	ALL_TEXT_3/3	3	8	7389	SYMBOL|DICTIONARY|EXTRACTED	urod	UROD	0#4		D009369	LONGTERM|DISEASE|DT|DICTIONARY	cancer	cancer	76#82		UROD down-regulation also radiosensitized several different models of human cancer, as well as sensitized tumors to chemotherapeutic agents, including 5-fluorouracil, cisplatin, and paclitaxel.
21270338	2011	Sci Transl Med	1946-6242	ALL_TEXT_3/3	3	8	7389	SYMBOL|DICTIONARY|EXTRACTED	urod	UROD	0#4		D009369	LONGTERM|DICTIONARY	tumors	tumors	106#112		UROD down-regulation also radiosensitized several different models of human cancer, as well as sensitized tumors to chemotherapeutic agents, including 5-fluorouracil, cisplatin, and paclitaxel.
20393813	2010	J. Mol. Neurosci.	1559-1166	ALL_TEXT_2/3	2	5	3569	SYMBOL|DICTIONARY	il 6	IL-6	0#4		D012559	LONGTERM|DICTIONARY	schizophrenia	schizophrenia	109#122		IL-6 (-174G/C; rs 1800795) and IL-10 (-1082G/A; rs 1800896) promoter polymorphisms in patients with paranoid schizophrenia and healthy individuals were genotyped using polymerase chain reaction-restriction fragment length polymorphism method.
20393813	2010	J. Mol. Neurosci.	1559-1166	ALL_TEXT_2/3	2	5	3586	SYMBOL|DICTIONARY	il 10	IL-10	31#36		D012559	LONGTERM|DICTIONARY	schizophrenia	schizophrenia	109#122		IL-6 (-174G/C; rs 1800795) and IL-10 (-1082G/A; rs 1800896) promoter polymorphisms in patients with paranoid schizophrenia and healthy individuals were genotyped using polymerase chain reaction-restriction fragment length polymorphism method.
16211375	2006	Diabetologia	0012-186X	TITLE	0	0	59272	LONGTERM|DICTIONARY	angiotensin i converting enzyme 2	angiotensin I converting enzyme 2	35#68		D003928	LONGTERM|DICTIONARY	diabetic nephropathy	diabetic nephropathy	73#93		Polymorphisms in the gene encoding angiotensin I converting enzyme 2 and diabetic nephropathy.
12081984	2002	Circulation	1524-4539	METHODS AND RESULTS	2	6	6532	SYMBOL|DICTIONARY	slc6a4	SLC6A4	4#10		D009203	SYMBOL|EXTRACTED	mi	MI	101#103	12081984-1-32-53	The SLC6A4 polymorphism has been investigated by polymerase chain reaction in 671 male patients with MI and in 688 controls from the Etude Cas-Tmoins de l'Infarctus du Myocarde (ECTIM) multicentric study.
21153458	2011	Tumour Biol.	1423-0380	ALL_TEXT_1/3	1	1	5743	LONGTERM|DICTIONARY	cyclooxygenase 2	cyclooxygenase-2	48#64		D009369	LONGTERM|DICTIONARY	tumours	tumours	93#100		Inflammation and hormonal signalling induce the cyclooxygenase-2 (COX-2) expression in solid tumours including breast cancer, which in turn affects cell proliferation, apoptosis and metastasis.
21153458	2011	Tumour Biol.	1423-0380	ALL_TEXT_1/3	1	1	5743	LONGTERM|DICTIONARY	cyclooxygenase 2	cyclooxygenase-2	48#64		D001943	LONGTERM|DISEASE|DT|DICTIONARY	breast cancer	breast cancer	111#124		Inflammation and hormonal signalling induce the cyclooxygenase-2 (COX-2) expression in solid tumours including breast cancer, which in turn affects cell proliferation, apoptosis and metastasis.
21153458	2011	Tumour Biol.	1423-0380	ALL_TEXT_1/3	1	1	5743	LONGTERM|DICTIONARY	cyclooxygenase 2	cyclooxygenase-2	48#64		D009362	LONGTERM|DICTIONARY	metastasis	metastasis	182#192		Inflammation and hormonal signalling induce the cyclooxygenase-2 (COX-2) expression in solid tumours including breast cancer, which in turn affects cell proliferation, apoptosis and metastasis.
21153458	2011	Tumour Biol.	1423-0380	ALL_TEXT_1/3	1	1	5743	LONGTERM|DICTIONARY	cyclooxygenase 2	cyclooxygenase-2	48#64		D007249	LONGTERM|DICTIONARY	inflammation	Inflammation	0#12	NaN	Inflammation and hormonal signalling induce the cyclooxygenase-2 (COX-2) expression in solid tumours including breast cancer, which in turn affects cell proliferation, apoptosis and metastasis.
21153458	2011	Tumour Biol.	1423-0380	ALL_TEXT_1/3	1	1	5743	SYMBOL|()|DICTIONARY|EXTRACTED	cox 2	COX-2	66#71	21153458-1-48-64	D009369	LONGTERM|DICTIONARY	tumours	tumours	93#100		Inflammation and hormonal signalling induce the cyclooxygenase-2 (COX-2) expression in solid tumours including breast cancer, which in turn affects cell proliferation, apoptosis and metastasis.
21153458	2011	Tumour Biol.	1423-0380	ALL_TEXT_1/3	1	1	5743	SYMBOL|()|DICTIONARY|EXTRACTED	cox 2	COX-2	66#71	21153458-1-48-64	D001943	LONGTERM|DISEASE|DT|DICTIONARY	breast cancer	breast cancer	111#124		Inflammation and hormonal signalling induce the cyclooxygenase-2 (COX-2) expression in solid tumours including breast cancer, which in turn affects cell proliferation, apoptosis and metastasis.
21153458	2011	Tumour Biol.	1423-0380	ALL_TEXT_1/3	1	1	5743	SYMBOL|()|DICTIONARY|EXTRACTED	cox 2	COX-2	66#71	21153458-1-48-64	D009362	LONGTERM|DICTIONARY	metastasis	metastasis	182#192		Inflammation and hormonal signalling induce the cyclooxygenase-2 (COX-2) expression in solid tumours including breast cancer, which in turn affects cell proliferation, apoptosis and metastasis.
21153458	2011	Tumour Biol.	1423-0380	ALL_TEXT_1/3	1	1	5743	SYMBOL|()|DICTIONARY|EXTRACTED	cox 2	COX-2	66#71	21153458-1-48-64	D007249	LONGTERM|DICTIONARY	inflammation	Inflammation	0#12	NaN	Inflammation and hormonal signalling induce the cyclooxygenase-2 (COX-2) expression in solid tumours including breast cancer, which in turn affects cell proliferation, apoptosis and metastasis.
17932345	2008	Cancer Epidemiol. Biomarkers Prev.	1055-9965	BACKGROUND	1	4	10333	SYMBOL|DICTIONARY	tlr6	TLR6	71#75		D011471	LONGTERM|DISEASE|DT|DICTIONARY	prostate cancer	prostate cancer	116#131		A Swedish study observed associations between sequence variants in the TLR6-TLR1-TLR10 gene cluster and the risk of prostate cancer.
17932345	2008	Cancer Epidemiol. Biomarkers Prev.	1055-9965	BACKGROUND	1	4	7096	SYMBOL|DICTIONARY	tlr1	TLR1	76#80		D011471	LONGTERM|DISEASE|DT|DICTIONARY	prostate cancer	prostate cancer	116#131		A Swedish study observed associations between sequence variants in the TLR6-TLR1-TLR10 gene cluster and the risk of prostate cancer.
17932345	2008	Cancer Epidemiol. Biomarkers Prev.	1055-9965	BACKGROUND	1	4	81793	SYMBOL|GENE|GN|DICTIONARY	tlr10	TLR10	81#86		D011471	LONGTERM|DISEASE|DT|DICTIONARY	prostate cancer	prostate cancer	116#131		A Swedish study observed associations between sequence variants in the TLR6-TLR1-TLR10 gene cluster and the risk of prostate cancer.
15734955	2005	Cancer Epidemiol. Biomarkers Prev.	1055-9965	ALL_TEXT_1/3	1	3	7515	SYMBOL|DICTIONARY	xrcc1	XRCC1	169#174		D001943	LONGTERM|DISEASE|DT|DICTIONARY	breast cancer	breast cancer	225#238		Using the Long Island Breast Cancer Study Project, a population-based case-control study, we evaluated the hypothesis that two common single nucleotide polymorphisms of XRCC1 (codon 194 Arg-->Trp and 399 Arg-->Gln) influence breast cancer susceptibility and interact with polycyclic aromatic hydrocarbon (PAH)-DNA adducts, cigarette smoking, and intake of fruits and vegetables and antioxidants.
15734955	2005	Cancer Epidemiol. Biomarkers Prev.	1055-9965	TITLE	0	0	7515	SYMBOL|DICTIONARY	xrcc1	XRCC1	17#22		D001943	LONGTERM|DISEASE|DT|DICTIONARY	breast cancer	breast cancer	144#157		Polymorphisms in XRCC1 modify the association between polycyclic aromatic hydrocarbon-DNA adducts, cigarette smoking, dietary antioxidants, and breast cancer risk.
16094257	2005	Psychiatr. Genet.	0955-8829	OBJECTIVES	1	2	57132	LONGTERM|DICTIONARY	chmp1.5	CHMP1.5	143#150	NaN	D001714	LONGTERM|DISEASE|DT|DICTIONARY	bipolar disorder	bipolar disorder	202#218		We hypothesized that the linkage in this region might be due to a gene in close physical proximity to G-olf, and we examined variations in the CHMP1.5 gene within intron 5 of G-olf for association with bipolar disorder.
16945136	2006	BMC Cancer	1471-2407	BACKGROUND	1	6	2876	SYMBOL|()|GENE|GN|DICTIONARY	gpx 1	GPX-1	88#93		D001943	LONGTERM|DISEASE|DT|DICTIONARY	breast cancer	breast cancer	189#202		Polymorphisms in the manganese superoxide dismutase (MnSOD) and glutathione peroxidase (GPX-1) genes have been proposed as low penetrance alleles, and have not been clearly associated with breast cancer.
16945136	2006	BMC Cancer	1471-2407	BACKGROUND	1	6	6648	LONGTERM|DICTIONARY	manganese superoxide dismutase	manganese superoxide dismutase	21#51	NaN	D001943	LONGTERM|DISEASE|DT|DICTIONARY	breast cancer	breast cancer	189#202		Polymorphisms in the manganese superoxide dismutase (MnSOD) and glutathione peroxidase (GPX-1) genes have been proposed as low penetrance alleles, and have not been clearly associated with breast cancer.
20504252	2010	Pharmacogenomics	1744-8042	CONCLUSION	5	12	3358	SYMBOL|GENE|GN|DICTIONARY	htr2c	HTR2C	92#97		D015430	LONGTERM|DICTIONARY	bwg	BWG	130#133	NaN	The results contribute to the accumulating evidence for an association of the X-chromosomal HTR2C gene with antipsychotic-induced BWG.
16945136	2006	BMC Cancer	1471-2407	TITLE	0	0	2876	SYMBOL|DICTIONARY	gpx 1	GPX-1	42#47		D001943	LONGTERM|DISEASE|DT|DICTIONARY	breast cancer	breast cancer	52#65		Gene x Gene interaction between MnSOD and GPX-1 and breast cancer risk: a nested case-control study.
16945136	2006	BMC Cancer	1471-2407	BACKGROUND	1	1	672	SYMBOL|DICTIONARY	brca1	BRCA1	37#42		D001943	LONGTERM|DISEASE|DT|DICTIONARY	breast cancer	breast cancer	103#116		Germ-line mutations in genes such as BRCA1, BRCA2, and ATM can cause a substantial increase in risk of breast cancer.
16945136	2006	BMC Cancer	1471-2407	BACKGROUND	1	1	675	SYMBOL|DICTIONARY	brca2	BRCA2	44#49		D001943	LONGTERM|DISEASE|DT|DICTIONARY	breast cancer	breast cancer	103#116		Germ-line mutations in genes such as BRCA1, BRCA2, and ATM can cause a substantial increase in risk of breast cancer.
17352815	2007	BMC Med. Genet.	1471-2350	TITLE	0	0	1072	SYMBOL|GENE|GN|DICTIONARY	cfl1	CFL1	20#24		D016135	LONGTERM|DICTIONARY	spina bifida	spina bifida	48#60		Association between CFL1 gene polymorphisms and spina bifida risk in a California population.
17352815	2007	BMC Med. Genet.	1471-2350	METHODS	2	5	1072	SYMBOL|GENE|GN|DICTIONARY	cfl1	CFL1	30#34		D016135	LONGTERM|DICTIONARY	spina bifida	spina bifida	253#265		Having re-sequenced the human CFL1 gene and identified five common single nucleotide polymorphisms (SNPs) in our target population, we investigated whether there existed a possible association between the genetic variations of the CFL1 gene and risk of spina bifida.
17352815	2007	BMC Med. Genet.	1471-2350	METHODS	2	5	1072	SYMBOL|GENE|GN|DICTIONARY	cfl1	CFL1	231#235		D016135	LONGTERM|DICTIONARY	spina bifida	spina bifida	253#265		Having re-sequenced the human CFL1 gene and identified five common single nucleotide polymorphisms (SNPs) in our target population, we investigated whether there existed a possible association between the genetic variations of the CFL1 gene and risk of spina bifida.
9149321	1997	Psychiatr. Genet.	0955-8829	ALL_TEXT_3/3	3	9	6532	LONGTERM|DICTIONARY	serotonin transporter	serotonin transporter	66#87	NaN	D003866	LONGTERM|DICTIONARY	major depression	major depression	135#151		The findings support the hypothesis that allelic variation in the serotonin transporter gene may contribute to susceptibility for both major depression and bipolar disorder.
9149321	1997	Psychiatr. Genet.	0955-8829	ALL_TEXT_3/3	3	9	6532	LONGTERM|DICTIONARY	serotonin transporter	serotonin transporter	66#87	NaN	D001714	LONGTERM|DISEASE|DT|DICTIONARY	bipolar disorder	bipolar disorder	156#172		The findings support the hypothesis that allelic variation in the serotonin transporter gene may contribute to susceptibility for both major depression and bipolar disorder.
16154235	2006	Neurobiol. Aging	1558-1497	TITLE	0	0	7422	LONGTERM|GENE|GN|GT|DICTIONARY	vascular endothelial growth factor	vascular endothelial growth factor	25#59		D000544	LONGTERM|DISEASE|DT|DICTIONARY	alzheimer disease	Alzheimer's disease	93#112		Association study of the vascular endothelial growth factor gene with the risk of developing Alzheimer's disease.
14691540	2006	PLoS Biol.	1545-7885	ALL_TEXT_1/3	1	1	2572	SYMBOL|DICTIONARY	gad2	GAD2	9#13		D009765	LONGTERM|DICTIONARY	obesity	obesity	105#112		The gene GAD2 encoding the glutamic acid decarboxylase enzyme (GAD65) is a positional candidate gene for obesity on Chromosome 10p11-12, a susceptibility locus for morbid obesity in four independent ethnic populations.
14691540	2006	PLoS Biol.	1545-7885	ALL_TEXT_1/3	1	1	2572	SYMBOL|DICTIONARY	gad2	GAD2	9#13		D009767	LONGTERM|DICTIONARY	morbid obesity	morbid obesity	164#178		The gene GAD2 encoding the glutamic acid decarboxylase enzyme (GAD65) is a positional candidate gene for obesity on Chromosome 10p11-12, a susceptibility locus for morbid obesity in four independent ethnic populations.
14691540	2006	PLoS Biol.	1545-7885	ALL_TEXT_1/3	1	1	2572	SYMBOL|()|DICTIONARY	gad65	GAD65	63#68		D009765	LONGTERM|DICTIONARY	obesity	obesity	105#112		The gene GAD2 encoding the glutamic acid decarboxylase enzyme (GAD65) is a positional candidate gene for obesity on Chromosome 10p11-12, a susceptibility locus for morbid obesity in four independent ethnic populations.
14691540	2006	PLoS Biol.	1545-7885	ALL_TEXT_1/3	1	1	2572	SYMBOL|()|DICTIONARY	gad65	GAD65	63#68		D009767	LONGTERM|DICTIONARY	morbid obesity	morbid obesity	164#178		The gene GAD2 encoding the glutamic acid decarboxylase enzyme (GAD65) is a positional candidate gene for obesity on Chromosome 10p11-12, a susceptibility locus for morbid obesity in four independent ethnic populations.
14717782	2004	Br. J. Haematol.	0007-1048	ALL_TEXT_1/3	1	3	7450	SYMBOL|DICTIONARY|EXTRACTED	vwf	VWF	23#26	14717782-1-4-25	D003327	SYMBOL|DICTIONARY|EXTRACTED	chd	CHD	48#51	14717782-1-64-86	To investigate whether VWF has a causal role in CHD, we designed a case-cohort study, including 352 subjects with CHD and a random cohort (n = 736), and prospectively examined the association of the -1793 C/G polymorphism with CHD in subjects with and without advanced atherosclerosis.
14717782	2004	Br. J. Haematol.	0007-1048	ALL_TEXT_1/3	1	3	7450	SYMBOL|DICTIONARY|EXTRACTED	vwf	VWF	23#26	14717782-1-4-25	D003327	SYMBOL|DICTIONARY|EXTRACTED	chd	CHD	114#117	14717782-1-64-86	To investigate whether VWF has a causal role in CHD, we designed a case-cohort study, including 352 subjects with CHD and a random cohort (n = 736), and prospectively examined the association of the -1793 C/G polymorphism with CHD in subjects with and without advanced atherosclerosis.
14717782	2004	Br. J. Haematol.	0007-1048	ALL_TEXT_1/3	1	3	7450	SYMBOL|DICTIONARY|EXTRACTED	vwf	VWF	23#26	14717782-1-4-25	D003327	SYMBOL|DICTIONARY|EXTRACTED	chd	CHD	227#230	14717782-1-64-86	To investigate whether VWF has a causal role in CHD, we designed a case-cohort study, including 352 subjects with CHD and a random cohort (n = 736), and prospectively examined the association of the -1793 C/G polymorphism with CHD in subjects with and without advanced atherosclerosis.
14717782	2004	Br. J. Haematol.	0007-1048	ALL_TEXT_1/3	1	3	7450	SYMBOL|DICTIONARY|EXTRACTED	vwf	VWF	23#26	14717782-1-4-25	D050197	LONGTERM|DICTIONARY	atherosclerosis	atherosclerosis	269#284		To investigate whether VWF has a causal role in CHD, we designed a case-cohort study, including 352 subjects with CHD and a random cohort (n = 736), and prospectively examined the association of the -1793 C/G polymorphism with CHD in subjects with and without advanced atherosclerosis.
18573495	2009	Atherosclerosis	1879-1484	METHODS AND RESULTS	2	7	1401	SYMBOL|DICTIONARY|EXTRACTED	crp	CRP	84#87	18573495-1-32-50	D009765	LONGTERM|DICTIONARY	obese	obese	155#160		However, global ILIB gene variation was associated with year 7 to year 15 change in CRP (global nominal p=0.004, multiple testing corrected p=0.048) among obese blacks.
18573495	2009	Atherosclerosis	1879-1484	OBJECTIVE	1	3	3553	SYMBOL|DICTIONARY	il 1	IL-1	77#81		D009765	LONGTERM|DICTIONARY	obesity	obesity	9#16		Further, obesity, a state of low-grade inflammation that influences cellular IL-1 functions may modify this association.
18573495	2009	Atherosclerosis	1879-1484	OBJECTIVE	1	3	3553	SYMBOL|DICTIONARY	il 1	IL-1	77#81		D007249	LONGTERM|DICTIONARY	inflammation	inflammation	39#51	NaN	Further, obesity, a state of low-grade inflammation that influences cellular IL-1 functions may modify this association.
16538170	2006	Pharmacogenet. Genomics	1744-6872	TITLE	0	0	196	LONGTERM|()|GENE|GT|DICTIONARY	aryl hydrocarbon receptor	aryl hydrocarbon receptor	44#69		D001943	LONGTERM|DISEASE|DT|DICTIONARY	breast cancer	breast cancer	100#113		Population-based case-control study of AhR (aryl hydrocarbon receptor) and CYP1A2 polymorphisms and breast cancer risk.
16538170	2006	Pharmacogenet. Genomics	1744-6872	TITLE	0	0	1544	SYMBOL|DICTIONARY	cyp1a2	CYP1A2	75#81		D001943	LONGTERM|DISEASE|DT|DICTIONARY	breast cancer	breast cancer	100#113		Population-based case-control study of AhR (aryl hydrocarbon receptor) and CYP1A2 polymorphisms and breast cancer risk.
16538170	2006	Pharmacogenet. Genomics	1744-6872	ALL_TEXT_1/3	1	2	1544	SYMBOL|DICTIONARY	cyp1a2	CYP1A2	0#6		D001943	LONGTERM|DISEASE|DT|DICTIONARY	breast cancer	breast cancer	139#152		CYP1A2 is one of the major CYP1 enzymes that catalyse 2-hydroxylation of estrogen, a hormone that plays a critical role in the etiology of breast cancer.
16538170	2006	Pharmacogenet. Genomics	1744-6872	ALL_TEXT_1/3	1	2	1543	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	cyp1	CYP1	27#31	16538170-1-108-112	D001943	LONGTERM|DISEASE|DT|DICTIONARY	breast cancer	breast cancer	139#152		CYP1A2 is one of the major CYP1 enzymes that catalyse 2-hydroxylation of estrogen, a hormone that plays a critical role in the etiology of breast cancer.
17846284	2007	Circulation	1524-4539	CONCLUSIONS	3	11	183	LONGTERM|GENE|GN|DICTIONARY	angiotensinogen	angiotensinogen	103#118		D003327	SYMBOL|DICTIONARY|EXTRACTED	chd	CHD	187#190	17846284-2-105-127	Additional very large-scale studies are warranted to provide conclusive evidence on the effects of the angiotensinogen gene and other genes within the renin-angiotensin system on risk of CHD.
17846284	2007	Circulation	1524-4539	CONCLUSIONS	3	11	5972	LONGTERM|DICTIONARY	renin	renin	151#156		D003327	SYMBOL|DICTIONARY|EXTRACTED	chd	CHD	187#190	17846284-2-105-127	Additional very large-scale studies are warranted to provide conclusive evidence on the effects of the angiotensinogen gene and other genes within the renin-angiotensin system on risk of CHD.
18573495	2009	Atherosclerosis	1879-1484	METHODS AND RESULTS	2	8	1401	SYMBOL|DICTIONARY|EXTRACTED	crp	CRP	129#132	18573495-1-32-50	D009765	LONGTERM|DICTIONARY	obese	obese	162#167		Compared to the commonest haplotype, a common haplotype that includes the SNP rs1143642 was associated with greater increases in CRP from year 7 to year 15 among obese blacks and whites while another common haplotype that includes the SNP rs3917356 was associated with decreased change in CRP from year 7 to year 15 among obese blacks.
18573495	2009	Atherosclerosis	1879-1484	METHODS AND RESULTS	2	8	1401	SYMBOL|DICTIONARY|EXTRACTED	crp	CRP	129#132	18573495-1-32-50	D009765	LONGTERM|DICTIONARY	obese	obese	322#327		Compared to the commonest haplotype, a common haplotype that includes the SNP rs1143642 was associated with greater increases in CRP from year 7 to year 15 among obese blacks and whites while another common haplotype that includes the SNP rs3917356 was associated with decreased change in CRP from year 7 to year 15 among obese blacks.
18573495	2009	Atherosclerosis	1879-1484	METHODS AND RESULTS	2	8	1401	SYMBOL|DICTIONARY|EXTRACTED	crp	CRP	289#292	18573495-1-32-50	D009765	LONGTERM|DICTIONARY	obese	obese	162#167		Compared to the commonest haplotype, a common haplotype that includes the SNP rs1143642 was associated with greater increases in CRP from year 7 to year 15 among obese blacks and whites while another common haplotype that includes the SNP rs3917356 was associated with decreased change in CRP from year 7 to year 15 among obese blacks.
18573495	2009	Atherosclerosis	1879-1484	METHODS AND RESULTS	2	8	1401	SYMBOL|DICTIONARY|EXTRACTED	crp	CRP	289#292	18573495-1-32-50	D009765	LONGTERM|DICTIONARY	obese	obese	322#327		Compared to the commonest haplotype, a common haplotype that includes the SNP rs1143642 was associated with greater increases in CRP from year 7 to year 15 among obese blacks and whites while another common haplotype that includes the SNP rs3917356 was associated with decreased change in CRP from year 7 to year 15 among obese blacks.
16538170	2006	Pharmacogenet. Genomics	1744-6872	ALL_TEXT_3/3	3	7	1544	SYMBOL|DICTIONARY	cyp1a2	CYP1A2	45#51		D001943	LONGTERM|DISEASE|DT|DICTIONARY	breast cancer	breast cancer	66#79		However, no association was observed between CYP1A2 genotypes and breast cancer risk, although the CYP1A2*1F polymorphism was found to be related to CYP1A2 activity.
16538170	2006	Pharmacogenet. Genomics	1744-6872	ALL_TEXT_3/3	3	7	1544	SYMBOL|NUMBER|DICTIONARY	cyp1a2	CYP1A2	99#105		D001943	LONGTERM|DISEASE|DT|DICTIONARY	breast cancer	breast cancer	66#79		However, no association was observed between CYP1A2 genotypes and breast cancer risk, although the CYP1A2*1F polymorphism was found to be related to CYP1A2 activity.
16538170	2006	Pharmacogenet. Genomics	1744-6872	ALL_TEXT_3/3	3	7	1544	SYMBOL|DICTIONARY	cyp1a2	CYP1A2	149#155		D001943	LONGTERM|DISEASE|DT|DICTIONARY	breast cancer	breast cancer	66#79		However, no association was observed between CYP1A2 genotypes and breast cancer risk, although the CYP1A2*1F polymorphism was found to be related to CYP1A2 activity.
19390641	2009	Mol. Vis.	1090-0535	PURPOSE	1	1	6247	LONGTERM|DICTIONARY	x-linked retinoschisis	X-linked retinoschisis	0#22	NaN	D041441	LONGTERM|DICTIONARY	x linked retinoschisis	X-linked retinoschisis	0#22		X-linked retinoschisis (XLRS) is a recessively inherited disorder that causes macular degeneration and resultant visual defect in young males.
19390641	2009	Mol. Vis.	1090-0535	PURPOSE	1	1	6247	LONGTERM|DICTIONARY	x-linked retinoschisis	X-linked retinoschisis	0#22	NaN	D041441	SYMBOL|EXTRACTED|()	xlrs	XLRS	24#28	19390641-1-0-22	X-linked retinoschisis (XLRS) is a recessively inherited disorder that causes macular degeneration and resultant visual defect in young males.
19390641	2009	Mol. Vis.	1090-0535	PURPOSE	1	1	6247	LONGTERM|DICTIONARY	x-linked retinoschisis	X-linked retinoschisis	0#22	NaN	D008268	LONGTERM|DICTIONARY	macular degeneration	macular degeneration	78#98		X-linked retinoschisis (XLRS) is a recessively inherited disorder that causes macular degeneration and resultant visual defect in young males.
19390641	2009	Mol. Vis.	1090-0535	PURPOSE	1	1	6247	LONGTERM|DICTIONARY	x-linked retinoschisis	X-linked retinoschisis	0#22	NaN	D014786	LONGTERM|DICTIONARY	visual defect	visual defect	113#126	NaN	X-linked retinoschisis (XLRS) is a recessively inherited disorder that causes macular degeneration and resultant visual defect in young males.
19390641	2009	Mol. Vis.	1090-0535	PURPOSE	1	1	6247	LONGTERM|DICTIONARY	x-linked retinoschisis	X-linked retinoschisis	0#22	NaN	D030342	LONGTERM|DICTIONARY	recessively inherited disorder	recessively inherited disorder	35#65	NaN	X-linked retinoschisis (XLRS) is a recessively inherited disorder that causes macular degeneration and resultant visual defect in young males.
19390641	2009	Mol. Vis.	1090-0535	PURPOSE	1	1	6247	LONGTERM|DICTIONARY	xlrs	XLRS	24#28	NaN	D041441	LONGTERM|DICTIONARY	x linked retinoschisis	X-linked retinoschisis	0#22		X-linked retinoschisis (XLRS) is a recessively inherited disorder that causes macular degeneration and resultant visual defect in young males.
19390641	2009	Mol. Vis.	1090-0535	PURPOSE	1	1	6247	LONGTERM|DICTIONARY	xlrs	XLRS	24#28	NaN	D041441	SYMBOL|EXTRACTED|()	xlrs	XLRS	24#28	19390641-1-0-22	X-linked retinoschisis (XLRS) is a recessively inherited disorder that causes macular degeneration and resultant visual defect in young males.
19390641	2009	Mol. Vis.	1090-0535	PURPOSE	1	1	6247	LONGTERM|DICTIONARY	xlrs	XLRS	24#28	NaN	D008268	LONGTERM|DICTIONARY	macular degeneration	macular degeneration	78#98		X-linked retinoschisis (XLRS) is a recessively inherited disorder that causes macular degeneration and resultant visual defect in young males.
19390641	2009	Mol. Vis.	1090-0535	PURPOSE	1	1	6247	LONGTERM|DICTIONARY	xlrs	XLRS	24#28	NaN	D014786	LONGTERM|DICTIONARY	visual defect	visual defect	113#126	NaN	X-linked retinoschisis (XLRS) is a recessively inherited disorder that causes macular degeneration and resultant visual defect in young males.
19390641	2009	Mol. Vis.	1090-0535	PURPOSE	1	1	6247	LONGTERM|DICTIONARY	xlrs	XLRS	24#28	NaN	D030342	LONGTERM|DICTIONARY	recessively inherited disorder	recessively inherited disorder	35#65	NaN	X-linked retinoschisis (XLRS) is a recessively inherited disorder that causes macular degeneration and resultant visual defect in young males.
14691540	2006	PLoS Biol.	1545-7885	ALL_TEXT_2/3	2	5	2572	SYMBOL|GENE|GN|DICTIONARY	gad2	GAD2	101#105		D007340	LONGTERM|CLINE|CN|DICTIONARY	insulinoma	insulinoma	14#24		In the murine insulinoma cell line betaTC3, the G at-risk allele of SNP -243 A>G increased six times GAD2 promoter activity (p < 0.0001) and induced a 6-fold higher affinity for nuclear extracts.
15523642	2005	Hum. Mutat.	1098-1004	TITLE	0	0	4763	LONGTERM|DICTIONARY	nf1	NF1	142#145	NaN	D009456	SYMBOL|DICTIONARY|EXTRACTED	nf1	NF1	142#145		Disruption of exonic splicing enhancer elements is the principal cause of exon skipping associated with seven nonsense or missense alleles of NF1.
20393813	2010	J. Mol. Neurosci.	1559-1166	ALL_TEXT_3/3	3	8	3586	SYMBOL|GENE|GN|DICTIONARY	il 10	IL-10	46#51		D012559	LONGTERM|DICTIONARY	schizophrenia	schizophrenia	114#127		The presence of allele G at position -1082 of IL-10 promoter sequence correlates with increasing risk of paranoid schizophrenia in the Polish population.
15182647	2004	Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi	1007-8738	TITLE	0	0	57379	LONGTERM|GENE|GN|DICTIONARY	activation induced cytidine deaminase	activation-induced cytidine deaminase	21#58		C565292	LONGTERM|DICTIONARY	atopic asthma	atopic asthma	81#94		[Correlation between activation-induced cytidine deaminase gene polymorphism and atopic asthma and plasma IgE in adult].
19892319	2010	Biol. Psychiatry	1873-2402	BACKGROUND	1	1	1312	LONGTERM|DICTIONARY	catechol o methyltransferase	catechol-O-methyltransferase	54#82		D012559	LONGTERM|DICTIONARY	schizophrenia	schizophrenia	162#175		A valine(158)methionine (val(158)met) polymorphism in catechol-O-methyltransferase (COMT) modulates cortical dopaminergic catabolism and has been associated with schizophrenia.
19892319	2010	Biol. Psychiatry	1873-2402	BACKGROUND	1	1	1312	SYMBOL|()|DICTIONARY|EXTRACTED	comt	COMT	84#88	19892319-1-54-82	D012559	LONGTERM|DICTIONARY	schizophrenia	schizophrenia	162#175		A valine(158)methionine (val(158)met) polymorphism in catechol-O-methyltransferase (COMT) modulates cortical dopaminergic catabolism and has been associated with schizophrenia.
9823305	1998	Cancer Res.	0008-5472	TITLE	0	0	1545	LONGTERM|DICTIONARY	cytochrome p450 1b1	cytochrome P450 1B1	15#34		D001943	LONGTERM|DISEASE|DT|DICTIONARY	breast cancer	breast cancer	89#102		Association of cytochrome P450 1B1 (CYP1B1) polymorphism with steroid receptor status in breast cancer.
9823305	1998	Cancer Res.	0008-5472	TITLE	0	0	1545	SYMBOL|()|DICTIONARY|EXTRACTED	cyp1b1	CYP1B1	36#42	9823305-0-15-34	D001943	LONGTERM|DISEASE|DT|DICTIONARY	breast cancer	breast cancer	89#102		Association of cytochrome P450 1B1 (CYP1B1) polymorphism with steroid receptor status in breast cancer.
19892319	2010	Biol. Psychiatry	1873-2402	TITLE	0	0	1312	LONGTERM|DICTIONARY	catechol o methyltransferase	Catechol-o-methyltransferase	0#28		D012559	LONGTERM|DICTIONARY	schizophrenia	schizophrenia	134#147		Catechol-o-methyltransferase valine(158)methionine genotype and resting regional cerebral blood flow in medication-free patients with schizophrenia.
20006740	2010	Mitochondrion	1872-8278	ALL_TEXT_1/3	1	1	5781	SYMBOL|GENE|GN|DICTIONARY	ptpn11	PTPN11	13#19		D009634	LONGTERM|DISEASE|DT|DICTIONARY	noonan syndrome	Noonan syndrome	70#85		Mutations in PTPN11 gene was responsible for approximately 50% of the Noonan syndrome (NS), however, we did not find any mutation in PTPN11 in any of seven NS patients analysed.
20006740	2010	Mitochondrion	1872-8278	ALL_TEXT_1/3	1	1	5781	SYMBOL|GENE|GN|DICTIONARY	ptpn11	PTPN11	13#19		D009634	SYMBOL|EXTRACTED|()	ns	NS	87#89	20006740-1-70-85	Mutations in PTPN11 gene was responsible for approximately 50% of the Noonan syndrome (NS), however, we did not find any mutation in PTPN11 in any of seven NS patients analysed.
20006740	2010	Mitochondrion	1872-8278	ALL_TEXT_1/3	1	1	5781	SYMBOL|DICTIONARY	ptpn11	PTPN11	133#139		D009634	LONGTERM|DISEASE|DT|DICTIONARY	noonan syndrome	Noonan syndrome	70#85		Mutations in PTPN11 gene was responsible for approximately 50% of the Noonan syndrome (NS), however, we did not find any mutation in PTPN11 in any of seven NS patients analysed.
20006740	2010	Mitochondrion	1872-8278	ALL_TEXT_1/3	1	1	5781	SYMBOL|DICTIONARY	ptpn11	PTPN11	133#139		D009634	SYMBOL|EXTRACTED|()	ns	NS	87#89	20006740-1-70-85	Mutations in PTPN11 gene was responsible for approximately 50% of the Noonan syndrome (NS), however, we did not find any mutation in PTPN11 in any of seven NS patients analysed.
20377893	2010	BMC Med. Genet.	1471-2350	CONCLUSIONS	4	12	60314	SYMBOL|GENE|GN|DICTIONARY	myg1	MYG1	33#37		D014820	LONGTERM|DICTIONARY	vitiligo	vitiligo	281#289		Our study demonstrated that both MYG1 promoter polymorphism -119C/G and Arg4Gln polymorphism in the mitochondrial signal of Myg1 have a functional impact on the regulation of the MYG1 gene and promoter polymorphism (-119C/G) is related with suspectibility for actively progressing vitiligo.
20377893	2010	BMC Med. Genet.	1471-2350	CONCLUSIONS	4	12	60314	SYMBOL|DICTIONARY	myg1	Myg1	124#128		D014820	LONGTERM|DICTIONARY	vitiligo	vitiligo	281#289		Our study demonstrated that both MYG1 promoter polymorphism -119C/G and Arg4Gln polymorphism in the mitochondrial signal of Myg1 have a functional impact on the regulation of the MYG1 gene and promoter polymorphism (-119C/G) is related with suspectibility for actively progressing vitiligo.
20377893	2010	BMC Med. Genet.	1471-2350	CONCLUSIONS	4	12	60314	SYMBOL|GENE|GN|DICTIONARY	myg1	MYG1	179#183		D014820	LONGTERM|DICTIONARY	vitiligo	vitiligo	281#289		Our study demonstrated that both MYG1 promoter polymorphism -119C/G and Arg4Gln polymorphism in the mitochondrial signal of Myg1 have a functional impact on the regulation of the MYG1 gene and promoter polymorphism (-119C/G) is related with suspectibility for actively progressing vitiligo.
20393813	2010	J. Mol. Neurosci.	1559-1166	ALL_TEXT_3/3	3	9	3586	SYMBOL|GENE|GN|DICTIONARY	il 10	IL-10	52#57		D012559	LONGTERM|DICTIONARY	schizophrenia	schizophrenia	179#192		The coexistence of genotype GG at position -1082 of IL-10 promoter sequence and genotype GC at position -174 of IL-6 promoter sequence correlates with increasing risk of paranoid schizophrenia in the Polish population.
20393813	2010	J. Mol. Neurosci.	1559-1166	ALL_TEXT_3/3	3	9	3569	SYMBOL|GENE|GN|DICTIONARY	il 6	IL-6	112#116		D012559	LONGTERM|DICTIONARY	schizophrenia	schizophrenia	179#192		The coexistence of genotype GG at position -1082 of IL-10 promoter sequence and genotype GC at position -174 of IL-6 promoter sequence correlates with increasing risk of paranoid schizophrenia in the Polish population.
12220434	2003	Clin. Genet.	0009-9163	ALL_TEXT_1/3	1	3	367	SYMBOL|EXTRACTED	ar	AR	196#198	12220434-2-9-26	D007248	LONGTERM|NUMBER|DICTIONARY	male infertility	male infertility	55#71		To assess the contribution of these genetic defects to male infertility, 61 Israeli men with severe oligo- (n = 15) or azoospermia (n = 46), were screened for Y chromosome microdeletions, and the AR-(CAG)n repeat length.
12220434	2003	Clin. Genet.	0009-9163	ALL_TEXT_1/3	1	3	367	SYMBOL|EXTRACTED	ar	AR	196#198	12220434-2-9-26	D053713	LONGTERM|DICTIONARY	azoospermia	azoospermia	119#130		To assess the contribution of these genetic defects to male infertility, 61 Israeli men with severe oligo- (n = 15) or azoospermia (n = 46), were screened for Y chromosome microdeletions, and the AR-(CAG)n repeat length.
12220434	2003	Clin. Genet.	0009-9163	ALL_TEXT_1/3	1	3	367	SYMBOL|EXTRACTED	ar	AR	196#198	12220434-2-9-26	D030342	LONGTERM|DICTIONARY	genetic defects	genetic defects	36#51	NaN	To assess the contribution of these genetic defects to male infertility, 61 Israeli men with severe oligo- (n = 15) or azoospermia (n = 46), were screened for Y chromosome microdeletions, and the AR-(CAG)n repeat length.
12220434	2003	Clin. Genet.	0009-9163	ALL_TEXT_1/3	1	2	367	LONGTERM|GENE|GT|DICTIONARY	androgen receptor	androgen receptor	9#26		D007248	LONGTERM|DICTIONARY	male infertility	male infertility	82#98		Abnormal androgen receptor (AR) structure or function has also been implicated in male infertility.
12220434	2003	Clin. Genet.	0009-9163	ALL_TEXT_1/3	1	2	367	SYMBOL|EXTRACTED|()	ar	AR	28#30	12220434-2-9-26	D007248	LONGTERM|DICTIONARY	male infertility	male infertility	82#98		Abnormal androgen receptor (AR) structure or function has also been implicated in male infertility.
15834927	2005	Hepatology	0270-9139	ALL_TEXT_3/3	3	12	4524	SYMBOL|DICTIONARY|EXTRACTED	mthfr	MTHFR	69#74	15834927-2-47-82	D005234	LONGTERM|DICTIONARY	steatosis	steatosis	58#67		On univariate analysis, fibrosis was associated with age, steatosis, MTHFR, homocysteinemia and HAI; however, on multivariate analysis, liver fibrosis was independently associated with age (P = .03), HAI (P = .0001), and steatosis (P = .007).
15834927	2005	Hepatology	0270-9139	ALL_TEXT_3/3	3	12	4524	SYMBOL|DICTIONARY|EXTRACTED	mthfr	MTHFR	69#74	15834927-2-47-82	C566403	LONGTERM|DICTIONARY	homocysteinemia	homocysteinemia	76#91		On univariate analysis, fibrosis was associated with age, steatosis, MTHFR, homocysteinemia and HAI; however, on multivariate analysis, liver fibrosis was independently associated with age (P = .03), HAI (P = .0001), and steatosis (P = .007).
15834927	2005	Hepatology	0270-9139	ALL_TEXT_3/3	3	12	4524	SYMBOL|DICTIONARY|EXTRACTED	mthfr	MTHFR	69#74	15834927-2-47-82	D008103	LONGTERM|DICTIONARY	liver fibrosis	liver fibrosis	136#150		On univariate analysis, fibrosis was associated with age, steatosis, MTHFR, homocysteinemia and HAI; however, on multivariate analysis, liver fibrosis was independently associated with age (P = .03), HAI (P = .0001), and steatosis (P = .007).
15834927	2005	Hepatology	0270-9139	ALL_TEXT_3/3	3	12	4524	SYMBOL|DICTIONARY|EXTRACTED	mthfr	MTHFR	69#74	15834927-2-47-82	D005234	LONGTERM|DICTIONARY	steatosis	steatosis	221#230		On univariate analysis, fibrosis was associated with age, steatosis, MTHFR, homocysteinemia and HAI; however, on multivariate analysis, liver fibrosis was independently associated with age (P = .03), HAI (P = .0001), and steatosis (P = .007).
15834927	2005	Hepatology	0270-9139	ALL_TEXT_3/3	3	13	4524	SYMBOL|DICTIONARY|EXTRACTED	mthfr	MTHFR	48#53	15834927-2-47-82	D020138	LONGTERM|DICTIONARY	hyperhomocysteinemia	hyperhomocysteinemia	89#109		In conclusion, a genetic background such as the MTHFR C677T polymorphism responsible for hyperhomocysteinemia plays a role in the development of higher degree of steatosis, which in turn accelerates the progression of liver fibrosis in CHC.
15834927	2005	Hepatology	0270-9139	ALL_TEXT_3/3	3	13	4524	SYMBOL|DICTIONARY|EXTRACTED	mthfr	MTHFR	48#53	15834927-2-47-82	D005234	LONGTERM|DICTIONARY	steatosis	steatosis	162#171		In conclusion, a genetic background such as the MTHFR C677T polymorphism responsible for hyperhomocysteinemia plays a role in the development of higher degree of steatosis, which in turn accelerates the progression of liver fibrosis in CHC.
15834927	2005	Hepatology	0270-9139	ALL_TEXT_3/3	3	13	4524	SYMBOL|DICTIONARY|EXTRACTED	mthfr	MTHFR	48#53	15834927-2-47-82	D008103	LONGTERM|DICTIONARY	liver fibrosis	liver fibrosis	218#232		In conclusion, a genetic background such as the MTHFR C677T polymorphism responsible for hyperhomocysteinemia plays a role in the development of higher degree of steatosis, which in turn accelerates the progression of liver fibrosis in CHC.
15834927	2005	Hepatology	0270-9139	ALL_TEXT_3/3	3	13	4524	SYMBOL|DICTIONARY|EXTRACTED	mthfr	MTHFR	48#53	15834927-2-47-82	D019698	SYMBOL|DICTIONARY|EXTRACTED	chc	CHC	236#239	15834927-3-112-131	In conclusion, a genetic background such as the MTHFR C677T polymorphism responsible for hyperhomocysteinemia plays a role in the development of higher degree of steatosis, which in turn accelerates the progression of liver fibrosis in CHC.
9475597	1998	Am. J. Med. Genet.	0148-7299	ALL_TEXT_1/3	1	1	2477	SYMBOL|DICTIONARY	fraxa	FRAXA	110#115		D005600	LONGTERM|DISEASE|DT|DICTIONARY	fragile x syndrome	fragile X syndrome	194#212		We report on the allele distribution in a normal Chilean population at 2 microsatellite loci neighbouring the FRAXA locus and at the CGG repeat in the 5' end of the FMR-1 gene, which causes the fragile X syndrome.
9475597	1998	Am. J. Med. Genet.	0148-7299	ALL_TEXT_1/3	1	1	2332	SYMBOL|GENE|GN|DICTIONARY	fmr 1	FMR-1	165#170		D005600	LONGTERM|DISEASE|DT|DICTIONARY	fragile x syndrome	fragile X syndrome	194#212		We report on the allele distribution in a normal Chilean population at 2 microsatellite loci neighbouring the FRAXA locus and at the CGG repeat in the 5' end of the FMR-1 gene, which causes the fragile X syndrome.
19390641	2009	Mol. Vis.	1090-0535	PURPOSE	1	3	6247	SYMBOL|GENE|GN|DICTIONARY	rs1	RS1	48#51		D041441	SYMBOL|EXTRACTED	xlrs	XLRS	81#85	19390641-1-0-22	We characterized the mutational spectrum of the RS1 gene in Korean patients with XLRS, and aimed to provide genetic information of XLRS in an Asian population.
19390641	2009	Mol. Vis.	1090-0535	PURPOSE	1	3	6247	SYMBOL|GENE|GN|DICTIONARY	rs1	RS1	48#51		D041441	SYMBOL|EXTRACTED	xlrs	XLRS	131#135	19390641-1-0-22	We characterized the mutational spectrum of the RS1 gene in Korean patients with XLRS, and aimed to provide genetic information of XLRS in an Asian population.
17609663	2007	Br. J. Cancer	0007-0920	ALL_TEXT_3/3	3	12	5743	SYMBOL|DICTIONARY|EXTRACTED	cox2	COX2	39#43	17609663-1-34-50	D011471	LONGTERM|DISEASE|DT|DICTIONARY	prostate cancer	prostate cancer	63#78		Our findings suggest that variation in COX2 is associated with prostate cancer risk.
8741319	1996	Acta Paediatr Jpn	0374-5600	ALL_TEXT_2/3	2	2	7490	SYMBOL|GENE|GN|DICTIONARY	wt1	WT1	65#68		D030321	LONGTERM|DISEASE|DT|DICTIONARY	denys drash syndrome	Denys-Drash syndrome	0#20		Denys-Drash syndrome was suspected and molecular analysis of the WT1 gene was performed, although no Wilms' tumor was identified.
8741319	1996	Acta Paediatr Jpn	0374-5600	ALL_TEXT_2/3	2	2	7490	SYMBOL|GENE|GN|DICTIONARY	wt1	WT1	65#68		D009396	LONGTERM|DISEASE|DT|DICTIONARY	wilms tumor	Wilms' tumor	101#113		Denys-Drash syndrome was suspected and molecular analysis of the WT1 gene was performed, although no Wilms' tumor was identified.
19066720	2009	Neurol. Sci.	1590-1874	ALL_TEXT_3/3	3	3	348	SYMBOL|EXTRACTED	apoe	ApoE	41#45	19066720-1-251-267	D004833	SYMBOL|DISEASE|DN|DICTIONARY|EXTRACTED	tle disease	TLE disease	77#88	19066720-1-134-156	We were thus able to confirm the role of ApoE, IL-1alpha and IL-1RA genes in TLE disease, but failed to confirm the involvement of IL-1beta and PDYN.
19066720	2009	Neurol. Sci.	1590-1874	ALL_TEXT_3/3	3	3	3557	SYMBOL|GENE|GN|DICTIONARY	il 1ra	IL-1RA	61#67		D004833	SYMBOL|DISEASE|DN|DICTIONARY|EXTRACTED	tle disease	TLE disease	77#88	19066720-1-134-156	We were thus able to confirm the role of ApoE, IL-1alpha and IL-1RA genes in TLE disease, but failed to confirm the involvement of IL-1beta and PDYN.
19066720	2009	Neurol. Sci.	1590-1874	ALL_TEXT_3/3	3	3	5173	SYMBOL|DICTIONARY|EXTRACTED	pdyn	PDYN	144#148	19066720-1-279-291	D004833	SYMBOL|DISEASE|DN|DICTIONARY|EXTRACTED	tle disease	TLE disease	77#88	19066720-1-134-156	We were thus able to confirm the role of ApoE, IL-1alpha and IL-1RA genes in TLE disease, but failed to confirm the involvement of IL-1beta and PDYN.
19066720	2009	Neurol. Sci.	1590-1874	ALL_TEXT_3/3	3	3	3552	LONGTERM|DICTIONARY	il-1alpha	IL-1alpha	47#56	NaN	D004833	SYMBOL|DISEASE|DN|DICTIONARY|EXTRACTED	tle disease	TLE disease	77#88	19066720-1-134-156	We were thus able to confirm the role of ApoE, IL-1alpha and IL-1RA genes in TLE disease, but failed to confirm the involvement of IL-1beta and PDYN.
19066720	2009	Neurol. Sci.	1590-1874	ALL_TEXT_3/3	3	3	3553	LONGTERM|DICTIONARY	il-1beta	IL-1beta	131#139	NaN	D004833	SYMBOL|DISEASE|DN|DICTIONARY|EXTRACTED	tle disease	TLE disease	77#88	19066720-1-134-156	We were thus able to confirm the role of ApoE, IL-1alpha and IL-1RA genes in TLE disease, but failed to confirm the involvement of IL-1beta and PDYN.
19066720	2009	Neurol. Sci.	1590-1874	ALL_TEXT_1/3	1	1	3557	SYMBOL|()|DICTIONARY	il 1ra	IL-1RA	242#248		D004833	LONGTERM|DICTIONARY	temporal lobe epilepsy	temporal lobe epilepsy	134#156		The objective of this study is to replicate previously published results regarding the involvement of several susceptibility genes in temporal lobe epilepsy (TLE): interleukin 1beta (IL-1beta), interleukin 1beta (IL-1alpha), interleukin 1RA (IL-1RA), apolipoprotein E (ApoE) and prodynorphin (PDYN).
19066720	2009	Neurol. Sci.	1590-1874	ALL_TEXT_1/3	1	1	3557	SYMBOL|()|DICTIONARY	il 1ra	IL-1RA	242#248		D004833	SYMBOL|()|DICTIONARY|EXTRACTED	tle	TLE	158#161	19066720-1-134-156	The objective of this study is to replicate previously published results regarding the involvement of several susceptibility genes in temporal lobe epilepsy (TLE): interleukin 1beta (IL-1beta), interleukin 1beta (IL-1alpha), interleukin 1RA (IL-1RA), apolipoprotein E (ApoE) and prodynorphin (PDYN).
19066720	2009	Neurol. Sci.	1590-1874	ALL_TEXT_1/3	1	1	348	LONGTERM|DICTIONARY	apolipoprotein e	apolipoprotein E	251#267		D004833	LONGTERM|DICTIONARY	temporal lobe epilepsy	temporal lobe epilepsy	134#156		The objective of this study is to replicate previously published results regarding the involvement of several susceptibility genes in temporal lobe epilepsy (TLE): interleukin 1beta (IL-1beta), interleukin 1beta (IL-1alpha), interleukin 1RA (IL-1RA), apolipoprotein E (ApoE) and prodynorphin (PDYN).
19066720	2009	Neurol. Sci.	1590-1874	ALL_TEXT_1/3	1	1	348	LONGTERM|DICTIONARY	apolipoprotein e	apolipoprotein E	251#267		D004833	SYMBOL|()|DICTIONARY|EXTRACTED	tle	TLE	158#161	19066720-1-134-156	The objective of this study is to replicate previously published results regarding the involvement of several susceptibility genes in temporal lobe epilepsy (TLE): interleukin 1beta (IL-1beta), interleukin 1beta (IL-1alpha), interleukin 1RA (IL-1RA), apolipoprotein E (ApoE) and prodynorphin (PDYN).
19066720	2009	Neurol. Sci.	1590-1874	ALL_TEXT_1/3	1	1	348	SYMBOL|EXTRACTED|()	apoe	ApoE	269#273	19066720-1-251-267	D004833	LONGTERM|DICTIONARY	temporal lobe epilepsy	temporal lobe epilepsy	134#156		The objective of this study is to replicate previously published results regarding the involvement of several susceptibility genes in temporal lobe epilepsy (TLE): interleukin 1beta (IL-1beta), interleukin 1beta (IL-1alpha), interleukin 1RA (IL-1RA), apolipoprotein E (ApoE) and prodynorphin (PDYN).
19066720	2009	Neurol. Sci.	1590-1874	ALL_TEXT_1/3	1	1	348	SYMBOL|EXTRACTED|()	apoe	ApoE	269#273	19066720-1-251-267	D004833	SYMBOL|()|DICTIONARY|EXTRACTED	tle	TLE	158#161	19066720-1-134-156	The objective of this study is to replicate previously published results regarding the involvement of several susceptibility genes in temporal lobe epilepsy (TLE): interleukin 1beta (IL-1beta), interleukin 1beta (IL-1alpha), interleukin 1RA (IL-1RA), apolipoprotein E (ApoE) and prodynorphin (PDYN).
19066720	2009	Neurol. Sci.	1590-1874	ALL_TEXT_1/3	1	1	5173	SYMBOL|()|DICTIONARY|EXTRACTED	pdyn	PDYN	293#297	19066720-1-279-291	D004833	LONGTERM|DICTIONARY	temporal lobe epilepsy	temporal lobe epilepsy	134#156		The objective of this study is to replicate previously published results regarding the involvement of several susceptibility genes in temporal lobe epilepsy (TLE): interleukin 1beta (IL-1beta), interleukin 1beta (IL-1alpha), interleukin 1RA (IL-1RA), apolipoprotein E (ApoE) and prodynorphin (PDYN).
19066720	2009	Neurol. Sci.	1590-1874	ALL_TEXT_1/3	1	1	5173	SYMBOL|()|DICTIONARY|EXTRACTED	pdyn	PDYN	293#297	19066720-1-279-291	D004833	SYMBOL|()|DICTIONARY|EXTRACTED	tle	TLE	158#161	19066720-1-134-156	The objective of this study is to replicate previously published results regarding the involvement of several susceptibility genes in temporal lobe epilepsy (TLE): interleukin 1beta (IL-1beta), interleukin 1beta (IL-1alpha), interleukin 1RA (IL-1RA), apolipoprotein E (ApoE) and prodynorphin (PDYN).
19066720	2009	Neurol. Sci.	1590-1874	ALL_TEXT_1/3	1	1	3552	LONGTERM|DICTIONARY	il-1alpha	IL-1alpha	213#222	NaN	D004833	LONGTERM|DICTIONARY	temporal lobe epilepsy	temporal lobe epilepsy	134#156		The objective of this study is to replicate previously published results regarding the involvement of several susceptibility genes in temporal lobe epilepsy (TLE): interleukin 1beta (IL-1beta), interleukin 1beta (IL-1alpha), interleukin 1RA (IL-1RA), apolipoprotein E (ApoE) and prodynorphin (PDYN).
19066720	2009	Neurol. Sci.	1590-1874	ALL_TEXT_1/3	1	1	3552	LONGTERM|DICTIONARY	il-1alpha	IL-1alpha	213#222	NaN	D004833	SYMBOL|()|DICTIONARY|EXTRACTED	tle	TLE	158#161	19066720-1-134-156	The objective of this study is to replicate previously published results regarding the involvement of several susceptibility genes in temporal lobe epilepsy (TLE): interleukin 1beta (IL-1beta), interleukin 1beta (IL-1alpha), interleukin 1RA (IL-1RA), apolipoprotein E (ApoE) and prodynorphin (PDYN).
19066720	2009	Neurol. Sci.	1590-1874	ALL_TEXT_1/3	1	1	3553	LONGTERM|DICTIONARY	interleukin 1beta	interleukin 1beta	164#181	NaN	D004833	LONGTERM|DICTIONARY	temporal lobe epilepsy	temporal lobe epilepsy	134#156		The objective of this study is to replicate previously published results regarding the involvement of several susceptibility genes in temporal lobe epilepsy (TLE): interleukin 1beta (IL-1beta), interleukin 1beta (IL-1alpha), interleukin 1RA (IL-1RA), apolipoprotein E (ApoE) and prodynorphin (PDYN).
19066720	2009	Neurol. Sci.	1590-1874	ALL_TEXT_1/3	1	1	3553	LONGTERM|DICTIONARY	interleukin 1beta	interleukin 1beta	164#181	NaN	D004833	SYMBOL|()|DICTIONARY|EXTRACTED	tle	TLE	158#161	19066720-1-134-156	The objective of this study is to replicate previously published results regarding the involvement of several susceptibility genes in temporal lobe epilepsy (TLE): interleukin 1beta (IL-1beta), interleukin 1beta (IL-1alpha), interleukin 1RA (IL-1RA), apolipoprotein E (ApoE) and prodynorphin (PDYN).
19066720	2009	Neurol. Sci.	1590-1874	ALL_TEXT_1/3	1	1	3553	LONGTERM|DICTIONARY	il-1beta	IL-1beta	183#191	NaN	D004833	LONGTERM|DICTIONARY	temporal lobe epilepsy	temporal lobe epilepsy	134#156		The objective of this study is to replicate previously published results regarding the involvement of several susceptibility genes in temporal lobe epilepsy (TLE): interleukin 1beta (IL-1beta), interleukin 1beta (IL-1alpha), interleukin 1RA (IL-1RA), apolipoprotein E (ApoE) and prodynorphin (PDYN).
19066720	2009	Neurol. Sci.	1590-1874	ALL_TEXT_1/3	1	1	3553	LONGTERM|DICTIONARY	il-1beta	IL-1beta	183#191	NaN	D004833	SYMBOL|()|DICTIONARY|EXTRACTED	tle	TLE	158#161	19066720-1-134-156	The objective of this study is to replicate previously published results regarding the involvement of several susceptibility genes in temporal lobe epilepsy (TLE): interleukin 1beta (IL-1beta), interleukin 1beta (IL-1alpha), interleukin 1RA (IL-1RA), apolipoprotein E (ApoE) and prodynorphin (PDYN).
19066720	2009	Neurol. Sci.	1590-1874	ALL_TEXT_1/3	1	1	3553	LONGTERM|DICTIONARY	interleukin 1beta	interleukin 1beta	194#211	NaN	D004833	LONGTERM|DICTIONARY	temporal lobe epilepsy	temporal lobe epilepsy	134#156		The objective of this study is to replicate previously published results regarding the involvement of several susceptibility genes in temporal lobe epilepsy (TLE): interleukin 1beta (IL-1beta), interleukin 1beta (IL-1alpha), interleukin 1RA (IL-1RA), apolipoprotein E (ApoE) and prodynorphin (PDYN).
19066720	2009	Neurol. Sci.	1590-1874	ALL_TEXT_1/3	1	1	3553	LONGTERM|DICTIONARY	interleukin 1beta	interleukin 1beta	194#211	NaN	D004833	SYMBOL|()|DICTIONARY|EXTRACTED	tle	TLE	158#161	19066720-1-134-156	The objective of this study is to replicate previously published results regarding the involvement of several susceptibility genes in temporal lobe epilepsy (TLE): interleukin 1beta (IL-1beta), interleukin 1beta (IL-1alpha), interleukin 1RA (IL-1RA), apolipoprotein E (ApoE) and prodynorphin (PDYN).
9545398	1998	Am. J. Hum. Genet.	0002-9297	ALL_TEXT_1/3	1	3	695	LONGTERM|DICTIONARY	btk	Btk	45#48	NaN	C537409	SYMBOL|DICTIONARY|EXTRACTED	xla	XLA	141#144	9545398-1-32-59	The remaining patients may have mutations in Btk that are difficult to identify, or they may have defects that are phenotypically similar to XLA but genotypically different.
9545398	1998	Am. J. Hum. Genet.	0002-9297	ALL_TEXT_1/3	1	2	695	LONGTERM|DICTIONARY	btk	Btk	56#59	NaN	C537409	SYMBOL|DICTIONARY|EXTRACTED	xla	XLA	94#97	9545398-1-32-59	Most laboratories have been able to detect mutations in Btk in 80%-90% of males with presumed XLA.
9545398	1998	Am. J. Hum. Genet.	0002-9297	ALL_TEXT_1/3	1	1	695	LONGTERM|DICTIONARY	btk	Btk	119#122	NaN	C537409	LONGTERM|DICTIONARY	x linked agammaglobulinemia	X-linked agammaglobulinemia	32#59		In 1993, two groups showed that X-linked agammaglobulinemia (XLA) was due to mutations in a tyrosine kinase now called Btk.
9545398	1998	Am. J. Hum. Genet.	0002-9297	ALL_TEXT_1/3	1	1	695	LONGTERM|DICTIONARY	btk	Btk	119#122	NaN	C537409	SYMBOL|()|DICTIONARY|EXTRACTED	xla	XLA	61#64	9545398-1-32-59	In 1993, two groups showed that X-linked agammaglobulinemia (XLA) was due to mutations in a tyrosine kinase now called Btk.
19420919	2009	Cerebrovasc. Dis.	1421-9786	ALL_TEXT_2/3	2	5	6401	LONGTERM|DICTIONARY	e selectin	E-selectin	68#78		D020521	LONGTERM|DISEASE|DN|DICTIONARY	stroke	stroke	130#136		The frequency of minor allele (R) and heterozygous (RS) genotype of E-selectin S128R polymorphism was significantly higher in the stroke patients than in the controls.
15091236	2004	Laryngoscope	0023-852X	CONCLUSION	5	8	2706	SYMBOL|DICTIONARY	dfnb1	DFNB1	59#64		D000013	LONGTERM|DISEASE|DN|DICTIONARY	multiple congenital anomaly syndrome	multiple congenital anomaly syndrome	71#107		The case reports reveal a coincidental association between DFNB1 and a multiple congenital anomaly syndrome.
9545398	1998	Am. J. Hum. Genet.	0002-9297	ALL_TEXT_2/3	2	6	695	LONGTERM|DICTIONARY	btk	Btk	158#161	NaN	C537409	SYMBOL|DICTIONARY|EXTRACTED	xla	XLA	87#90	9545398-1-32-59	Excluding the patients in whom the marked decrease in B cell numbers characteristic of XLA could not be confirmed by immunofluorescence studies, mutations in Btk were identified in 43 of 46 patients with presumed sporadic XLA.
9545398	1998	Am. J. Hum. Genet.	0002-9297	ALL_TEXT_2/3	2	6	695	LONGTERM|DICTIONARY	btk	Btk	158#161	NaN	C537409	SYMBOL|DICTIONARY|EXTRACTED	xla	XLA	222#225	9545398-1-32-59	Excluding the patients in whom the marked decrease in B cell numbers characteristic of XLA could not be confirmed by immunofluorescence studies, mutations in Btk were identified in 43 of 46 patients with presumed sporadic XLA.
9545398	1998	Am. J. Hum. Genet.	0002-9297	ALL_TEXT_2/3	2	5	695	LONGTERM|DICTIONARY	btk	Btk	13#16	NaN	D004194	LONGTERM|DICTIONARY	sporadic disease	sporadic disease	126#142	NaN	Mutations in Btk were identified in 38 of 40 families with more than one affected family member and in 56 of 61 families with sporadic disease.
22264700	2012	Pediatr. Neurol.	1873-5150	ALL_TEXT_1/3	1	2	7054	LONGTERM|GENE|GN|DICTIONARY	tyrosine hydroxylase	tyrosine hydroxylase	145#165		C537537	LONGTERM|DICTIONARY	tyrosine hydroxylase deficiency	tyrosine hydroxylase deficiency	75#106		From 1999 to May 2011, we enrolled six infants who had been diagnosed with tyrosine hydroxylase deficiency by identifying point mutations on the tyrosine hydroxylase gene.
15091236	2004	Laryngoscope	0023-852X	TITLE	0	0	2706	LONGTERM|GENE|GN|DICTIONARY	connexin 26	connexin 26	37#48		D003638	LONGTERM|DICTIONARY	deafness	deafness	70#78	NaN	Nonsyndromic 35 delG mutation of the connexin 26 gene associated with deafness in syndromic children: two case reports.
11517440	2001	J. Infect. Dis.	0022-1899	ALL_TEXT_1/3	1	1	3586	SYMBOL|DICTIONARY	interleukin (il)-10	interleukin (IL)-10	66#85		D020031	LONGTERM|DICTIONARY	epstein-barr virus (ebv) infection	Epstein-Barr virus (EBV) infection	129#163		In total, 116 children were investigated to determine whether the interleukin (IL)-10 polymorphism influences the age at primary Epstein-Barr virus (EBV) infection.
11517440	2001	J. Infect. Dis.	0022-1899	ALL_TEXT_1/3	1	1	3586	SYMBOL|DICTIONARY	interleukin (il)-10	interleukin (IL)-10	66#85		D020031	LONGTERM|DISEASE|DT|DICTIONARY	epstein-barr virus (ebv) infection	Epstein-Barr virus (EBV) infection	129#163		In total, 116 children were investigated to determine whether the interleukin (IL)-10 polymorphism influences the age at primary Epstein-Barr virus (EBV) infection.
20072949	2010	Pol J Pathol	1233-9687	ALL_TEXT_1/3	1	2	1586	SYMBOL|DICTIONARY	cyp17	CYP17	37#42		D001943	LONGTERM|DISEASE|DT|DICTIONARY	breast cancer	breast cancer	90#103		We hypothesise that polymorphisms of CYP17 and CYP19 gene can predict higher incidence of breast cancer.
20072949	2010	Pol J Pathol	1233-9687	ALL_TEXT_1/3	1	2	1588	SYMBOL|GENE|GN|DICTIONARY	cyp19	CYP19	47#52		D001943	LONGTERM|DISEASE|DT|DICTIONARY	breast cancer	breast cancer	90#103		We hypothesise that polymorphisms of CYP17 and CYP19 gene can predict higher incidence of breast cancer.
20072949	2010	Pol J Pathol	1233-9687	ALL_TEXT_2/3	2	3	1586	SYMBOL|DICTIONARY	cyp17	CYP17	121#126		D001943	LONGTERM|DISEASE|DT|DICTIONARY	breast cancer	breast cancer	181#194		In the present work the distribution of genotypes and frequency of alleles of the T/C polymorphism in promoter region of CYP17 and Trp/Arg polymorphism in codon 39 of CYP19 gene in breast cancer women were investigated.
20072949	2010	Pol J Pathol	1233-9687	ALL_TEXT_2/3	2	3	1588	SYMBOL|GENE|GN|DICTIONARY	cyp19	CYP19	167#172		D001943	LONGTERM|DISEASE|DT|DICTIONARY	breast cancer	breast cancer	181#194		In the present work the distribution of genotypes and frequency of alleles of the T/C polymorphism in promoter region of CYP17 and Trp/Arg polymorphism in codon 39 of CYP19 gene in breast cancer women were investigated.
20072949	2010	Pol J Pathol	1233-9687	TITLE	0	0	1586	SYMBOL|DICTIONARY	cyp17	CYP17	4#9		D001943	LONGTERM|DISEASE|DT|DICTIONARY	sporadic breast cancer	sporadic breast cancer	70#92		The CYP17 and CYP19 gene single nucleotide polymorphism in women with sporadic breast cancer.
20072949	2010	Pol J Pathol	1233-9687	TITLE	0	0	1588	SYMBOL|GENE|GN|DICTIONARY	cyp19	CYP19	14#19		D001943	LONGTERM|DISEASE|DT|DICTIONARY	sporadic breast cancer	sporadic breast cancer	70#92		The CYP17 and CYP19 gene single nucleotide polymorphism in women with sporadic breast cancer.
11935341	2002	Hum. Genet.	0340-6717	ALL_TEXT_2/3	2	3	23209	SYMBOL|GENE|GN|DICTIONARY	mlc1	MLC1	17#21		C536141	SYMBOL|EXTRACTED	mlc	MLC	111#114	11935341-1-0-58	Mutations in the MLC1 gene, encoding a putative membrane protein, have been recently identified as a cause for MLC.
11857544	2002	Am. J. Med. Genet.	0148-7299	ALL_TEXT_3/3	3	6	1130	SYMBOL|DICTIONARY	chs1	CHS1	78#82		D002609	SYMBOL|DICTIONARY|EXTRACTED	chs	CHS	34#37	11857544-1-0-24	In patients with severe childhood CHS, we found only functionally null mutant CHS1 alleles, whereas in patients with the adolescent and adult forms of CHS we also found missense mutant alleles that likely encode CHS1 polypeptides with partial function.
11857544	2002	Am. J. Med. Genet.	0148-7299	ALL_TEXT_3/3	3	6	1130	SYMBOL|DICTIONARY	chs1	CHS1	78#82		D002609	SYMBOL|DICTIONARY|EXTRACTED	chs	CHS	151#154	11857544-1-0-24	In patients with severe childhood CHS, we found only functionally null mutant CHS1 alleles, whereas in patients with the adolescent and adult forms of CHS we also found missense mutant alleles that likely encode CHS1 polypeptides with partial function.
11857544	2002	Am. J. Med. Genet.	0148-7299	ALL_TEXT_3/3	3	6	1130	SYMBOL|DICTIONARY	chs1	CHS1	212#216		D002609	SYMBOL|DICTIONARY|EXTRACTED	chs	CHS	34#37	11857544-1-0-24	In patients with severe childhood CHS, we found only functionally null mutant CHS1 alleles, whereas in patients with the adolescent and adult forms of CHS we also found missense mutant alleles that likely encode CHS1 polypeptides with partial function.
11857544	2002	Am. J. Med. Genet.	0148-7299	ALL_TEXT_3/3	3	6	1130	SYMBOL|DICTIONARY	chs1	CHS1	212#216		D002609	SYMBOL|DICTIONARY|EXTRACTED	chs	CHS	151#154	11857544-1-0-24	In patients with severe childhood CHS, we found only functionally null mutant CHS1 alleles, whereas in patients with the adolescent and adult forms of CHS we also found missense mutant alleles that likely encode CHS1 polypeptides with partial function.
20072949	2010	Pol J Pathol	1233-9687	ALL_TEXT_3/3	3	8	1586	SYMBOL|GENE|GN|DICTIONARY	cyp17	CYP17	64#69		D001943	LONGTERM|DISEASE|DT|DICTIONARY	breast cancer	breast cancer	115#128		The results support the hypothesis that the T/C polymorphism of CYP17 gene may be associated with the incidence of breast cancer in women from Lodz region of Poland.
11857544	2002	Am. J. Med. Genet.	0148-7299	ALL_TEXT_3/3	3	5	1130	SYMBOL|GENE|GN|DICTIONARY	chs1	CHS1	67#71		D002609	SYMBOL|DICTIONARY|EXTRACTED	chs	CHS	175#178	11857544-1-0-24	Here, we describe the organization and genomic DNA sequence of the CHS1 gene and mutation analysis of 21 unrelated patients with the childhood, adolescent, and adult forms of CHS.
15380041	2005	Arthritis Res. Ther.	1478-6362	ALL_TEXT_2/3	2	3	2099	LONGTERM|GENE|GN|DICTIONARY	er alpha	ER-alpha	95#103		D010003	SYMBOL|EXTRACTED	oa	OA	170#172	15380041-1-98-112	Haplotyping analysis was used to determine the relationship between three polymorphisms in the ER-alpha gene (intron 1 T/C, intron 1 A/G and exon 8 G/A) and primary knee OA.
15380041	2005	Arthritis Res. Ther.	1478-6362	ALL_TEXT_1/3	1	2	2099	LONGTERM|GENE|GN|DICTIONARY	er alpha	ER-alpha	15#23		D010003	SYMBOL|EXTRACTED	oa	OA	82#84	15380041-1-98-112	To investigate ER-alpha gene polymorphisms for its associations with primary knee OA, we conducted a case-control association study in patients with primary knee OA (n = 151) and healthy individuals (n = 397) in the Korean population.
15380041	2005	Arthritis Res. Ther.	1478-6362	ALL_TEXT_1/3	1	2	2099	LONGTERM|GENE|GN|DICTIONARY	er alpha	ER-alpha	15#23		D010003	SYMBOL|EXTRACTED	oa	OA	162#164	15380041-1-98-112	To investigate ER-alpha gene polymorphisms for its associations with primary knee OA, we conducted a case-control association study in patients with primary knee OA (n = 151) and healthy individuals (n = 397) in the Korean population.
21313874	2011	Pak. J. Biol. Sci.	1028-8880	ALL_TEXT_3/3	3	9	3458	LONGTERM|DICTIONARY	ifn-gamma	IFN-gamma	67#76	NaN	D002006	LONGTERM|DICTIONARY	brucellosis	brucellosis	116#127		The present study suggests that the variant genotypes of G6544A of IFN-gamma might be associated with focal form of brucellosis and play as a genetic risk factor in brucellosis.
21313874	2011	Pak. J. Biol. Sci.	1028-8880	ALL_TEXT_3/3	3	9	3458	LONGTERM|DICTIONARY	ifn-gamma	IFN-gamma	67#76	NaN	D002006	LONGTERM|DICTIONARY	brucellosis	brucellosis	165#176		The present study suggests that the variant genotypes of G6544A of IFN-gamma might be associated with focal form of brucellosis and play as a genetic risk factor in brucellosis.
15380041	2005	Arthritis Res. Ther.	1478-6362	TITLE	0	0	2099	LONGTERM|GENE|GT|DICTIONARY	estrogen receptor-alpha	Estrogen receptor-alpha	0#23		D020370	LONGTERM|DICTIONARY	knee osteoarthritis	knee osteoarthritis	66#85		Estrogen receptor-alpha gene haplotype is associated with primary knee osteoarthritis in Korean population.
15380041	2005	Arthritis Res. Ther.	1478-6362	ALL_TEXT_3/3	3	8	2099	LONGTERM|GENE|GN|DICTIONARY	er alpha	ER-alpha	79#87		D010003	SYMBOL|DISEASE|DN|DICTIONARY|EXTRACTED	oa	OA	20#22	15380041-1-98-112	Although the number OA patients studied is small, the present study shows that ER-alpha gene haplotype may be associated with primary knee OA, and genetic variations in the ER-alpha gene may be involved in OA.
15380041	2005	Arthritis Res. Ther.	1478-6362	ALL_TEXT_3/3	3	8	2099	LONGTERM|GENE|GN|DICTIONARY	er alpha	ER-alpha	79#87		D010003	SYMBOL|EXTRACTED	oa	OA	139#141	15380041-1-98-112	Although the number OA patients studied is small, the present study shows that ER-alpha gene haplotype may be associated with primary knee OA, and genetic variations in the ER-alpha gene may be involved in OA.
15380041	2005	Arthritis Res. Ther.	1478-6362	ALL_TEXT_3/3	3	8	2099	LONGTERM|GENE|GN|DICTIONARY	er alpha	ER-alpha	79#87		D010003	SYMBOL|EXTRACTED	oa	OA	206#208	15380041-1-98-112	Although the number OA patients studied is small, the present study shows that ER-alpha gene haplotype may be associated with primary knee OA, and genetic variations in the ER-alpha gene may be involved in OA.
15380041	2005	Arthritis Res. Ther.	1478-6362	ALL_TEXT_3/3	3	8	2099	LONGTERM|GENE|GN|DICTIONARY	er alpha	ER-alpha	173#181		D010003	SYMBOL|DISEASE|DN|DICTIONARY|EXTRACTED	oa	OA	20#22	15380041-1-98-112	Although the number OA patients studied is small, the present study shows that ER-alpha gene haplotype may be associated with primary knee OA, and genetic variations in the ER-alpha gene may be involved in OA.
15380041	2005	Arthritis Res. Ther.	1478-6362	ALL_TEXT_3/3	3	8	2099	LONGTERM|GENE|GN|DICTIONARY	er alpha	ER-alpha	173#181		D010003	SYMBOL|EXTRACTED	oa	OA	139#141	15380041-1-98-112	Although the number OA patients studied is small, the present study shows that ER-alpha gene haplotype may be associated with primary knee OA, and genetic variations in the ER-alpha gene may be involved in OA.
15380041	2005	Arthritis Res. Ther.	1478-6362	ALL_TEXT_3/3	3	8	2099	LONGTERM|GENE|GN|DICTIONARY	er alpha	ER-alpha	173#181		D010003	SYMBOL|EXTRACTED	oa	OA	206#208	15380041-1-98-112	Although the number OA patients studied is small, the present study shows that ER-alpha gene haplotype may be associated with primary knee OA, and genetic variations in the ER-alpha gene may be involved in OA.
11895223	2002	Clin. Endocrinol. (Oxf)	0300-0664	DESIGN	3	6	3123	SYMBOL|DICTIONARY	drb1	DRB1	48#52		D006111	LONGTERM|DISEASE|DT|DICTIONARY	graves disease	Graves' disease	27#42		The protective alleles for Graves' disease were DRB1 *0901 (0.9% vs. 20.2%; RR = 0.04; Pc < 0.001), DRB1*1001 (0.0% vs. 11%; RR = 0.0%; Pc < 0.01) and DRB4 *0101 (0.0% vs. 12.5%; RR = 0.0; Pc < 0.05).
11895223	2002	Clin. Endocrinol. (Oxf)	0300-0664	DESIGN	3	6	3123	SYMBOL|NUMBER|DICTIONARY	drb1	DRB1	100#104		D006111	LONGTERM|DISEASE|DT|DICTIONARY	graves disease	Graves' disease	27#42		The protective alleles for Graves' disease were DRB1 *0901 (0.9% vs. 20.2%; RR = 0.04; Pc < 0.001), DRB1*1001 (0.0% vs. 11%; RR = 0.0%; Pc < 0.01) and DRB4 *0101 (0.0% vs. 12.5%; RR = 0.0; Pc < 0.05).
11895223	2002	Clin. Endocrinol. (Oxf)	0300-0664	DESIGN	3	6	3126	SYMBOL|DICTIONARY	drb4	DRB4	151#155		D006111	LONGTERM|DISEASE|DT|DICTIONARY	graves disease	Graves' disease	27#42		The protective alleles for Graves' disease were DRB1 *0901 (0.9% vs. 20.2%; RR = 0.04; Pc < 0.001), DRB1*1001 (0.0% vs. 11%; RR = 0.0%; Pc < 0.01) and DRB4 *0101 (0.0% vs. 12.5%; RR = 0.0; Pc < 0.05).
11895223	2002	Clin. Endocrinol. (Oxf)	0300-0664	TITLE	0	0	3125	SYMBOL|DICTIONARY	hla drb3	HLA-DRB3	0#8		D006111	LONGTERM|DISEASE|DT|DICTIONARY	graves disease	Graves' disease	33#48		HLA-DRB3*0101 is associated with Graves' disease in Jamaicans.
17868277	2008	Eur. J. Neurol.	1468-1331	ALL_TEXT_1/3	1	2	3383	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	icam 1	ICAM-1	46#52	17868277-1-0-33	D009103	LONGTERM|DICTIONARY	multiple sclerosis	multiple sclerosis	105#123		This study was conducted to determine whether ICAM-1 gene polymorphism influences the risk of developing multiple sclerosis in an Iranian population.
17868277	2008	Eur. J. Neurol.	1468-1331	ALL_TEXT_1/3	1	1	3383	LONGTERM|DICTIONARY	intercellular adhesion molecule 1	Intercellular adhesion molecule-1	0#33		D009103	LONGTERM|DICTIONARY	multiple sclerosis	multiple sclerosis	164#182		Intercellular adhesion molecule-1 (ICAM-1), an important molecule in leucocyte activation and migration, is expressed on the CNS endothelial cells of patients with multiple sclerosis.
17868277	2008	Eur. J. Neurol.	1468-1331	ALL_TEXT_1/3	1	1	3383	SYMBOL|()|DICTIONARY|EXTRACTED	icam 1	ICAM-1	35#41	17868277-1-0-33	D009103	LONGTERM|DICTIONARY	multiple sclerosis	multiple sclerosis	164#182		Intercellular adhesion molecule-1 (ICAM-1), an important molecule in leucocyte activation and migration, is expressed on the CNS endothelial cells of patients with multiple sclerosis.
17868277	2008	Eur. J. Neurol.	1468-1331	TITLE	0	0	3383	LONGTERM|GENE|GN|DICTIONARY	intercellular adhesion molecule 1	Intercellular adhesion molecule-1	0#33		D009103	LONGTERM|DICTIONARY	multiple sclerosis	multiple sclerosis	77#95		Intercellular adhesion molecule-1 gene polymorphism in Iranian patients with multiple sclerosis.
10835642	2000	Nat. Genet.	1061-4036	ALL_TEXT_3/3	3	6	368	SYMBOL|()|DICTIONARY	abcc6	ABCC6	204#209		D011561	SYMBOL|DICTIONARY|EXTRACTED	pxe	PXE	133#136	10835642-1-0-24	Here we report the exclusion of five of these genes and the identification of the first mutations responsible for the development of PXE in a gene encoding a protein associated with multidrug resistance (ABCC6).
17868277	2008	Eur. J. Neurol.	1468-1331	ALL_TEXT_3/3	3	6	3383	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	icam 1	ICAM-1	30#36	17868277-1-0-33	D009103	LONGTERM|DICTIONARY	multiple sclerosis	multiple sclerosis	79#97		We concluded that role of the ICAM-1 gene polymorphisms in the pathogenesis of multiple sclerosis is still controversial and should be studied further.
9865924	1999	Clin. Cancer Res.	1078-0432	ALL_TEXT_3/3	3	7	1728	SYMBOL|DICTIONARY|EXTRACTED	nqo1	NQO1	126#130	9865924-0-35-57	D003110	LONGTERM|DISEASE|DT|CLINE|CN|DICTIONARY	colon carcinoma	colon carcinoma	71#86		Additionally, we report the establishment of a stable line of BE human colon carcinoma cells transfected with wild-type human NQO1 (BE-NQ7).
6991409	1980	Hypertension	0194-911X	ALL_TEXT_3/3	3	6	5972	LONGTERM|DICTIONARY	renin	renin	101#106		D007022	LONGTERM|DICTIONARY	hypotensive	hypotensive	61#72	NaN	When return of reservoir fluid was prevented, animals became hypotensive after central clonidine and renin tended to increase.
21313874	2011	Pak. J. Biol. Sci.	1028-8880	ALL_TEXT_2/3	2	6	3458	SYMBOL|GENE|GN|DICTIONARY	ifn gamma	IFN-gamma	59#68		D002006	LONGTERM|DICTIONARY	brucellosis	brucellosis	128#139		Allelic and genotype frequencies of G5644A polymorphism of IFN-gamma gene were not significantly differed between patients with brucellosis and controls (p > 0.05).
20546854	2010	Thromb. Res.	1879-2472	CONCLUSION	4	13	2147	SYMBOL|EXTRACTED|GENE|GN	pt	PT	43#45	20546854-11-25-36	D054198	SYMBOL|EXTRACTED	all	ALL	35#38	20546854-1-60-88	It is suggested that patients with ALL and PT gene mutation may have a higher risk of clotting complications in comparison to patients with factor V Leiden mutation.
12358323	2003	Eur. Respir. J.	0903-1936	ALL_TEXT_1/3	1	1	659	SYMBOL|()|GENE|GN|DICTIONARY	bmpr2	BMPR2	228#233		D006976	LONGTERM|DICTIONARY	pulmonary arterial hypertension	pulmonary arterial hypertension	52#83		This study investigated whether patients developing pulmonary arterial hypertension (PAH) after exposure to the appetite suppressants fenfluramine and dexfenfluramine have mutations in the bone morphogenetic protein receptor 2 (BMPR2) gene, as reported in primary pulmonary hypertension.
12358323	2003	Eur. Respir. J.	0903-1936	ALL_TEXT_1/3	1	1	659	SYMBOL|()|GENE|GN|DICTIONARY	bmpr2	BMPR2	228#233		D006976	SYMBOL|()|DICTIONARY|EXTRACTED	pah	PAH	85#88	12358323-1-52-83	This study investigated whether patients developing pulmonary arterial hypertension (PAH) after exposure to the appetite suppressants fenfluramine and dexfenfluramine have mutations in the bone morphogenetic protein receptor 2 (BMPR2) gene, as reported in primary pulmonary hypertension.
12358323	2003	Eur. Respir. J.	0903-1936	ALL_TEXT_1/3	1	1	659	SYMBOL|()|GENE|GN|DICTIONARY	bmpr2	BMPR2	228#233		D006976	LONGTERM|DICTIONARY	primary pulmonary hypertension	primary pulmonary hypertension	256#286		This study investigated whether patients developing pulmonary arterial hypertension (PAH) after exposure to the appetite suppressants fenfluramine and dexfenfluramine have mutations in the bone morphogenetic protein receptor 2 (BMPR2) gene, as reported in primary pulmonary hypertension.
18997459	2009	Ann. Nutr. Metab.	1421-9697	AIMS	1	1	7124	LONGTERM|DICTIONARY	tumor necrosis factor alpha	tumor necrosis factor-alpha	141#168		D054058	LONGTERM|DISEASE|DT|DICTIONARY	acute coronary syndrome	acute coronary syndrome	100#123		To evaluate the effect of atorvastatin on bone mass and markers of bone remodeling in patients with acute coronary syndrome depending on the tumor necrosis factor-alpha (TNFalpha)-308 G/A polymorphism.
18997459	2009	Ann. Nutr. Metab.	1421-9697	AIMS	1	1	7124	SYMBOL|EXTRACTED|()	tnfalpha	TNFalpha	170#178	18997459-1-141-168	D054058	LONGTERM|DISEASE|DT|DICTIONARY	acute coronary syndrome	acute coronary syndrome	100#123		To evaluate the effect of atorvastatin on bone mass and markers of bone remodeling in patients with acute coronary syndrome depending on the tumor necrosis factor-alpha (TNFalpha)-308 G/A polymorphism.
18997459	2009	Ann. Nutr. Metab.	1421-9697	TITLE	0	0	7124	LONGTERM|DICTIONARY	tnfalpha	TNFalpha	14#22	NaN	D054058	LONGTERM|DISEASE|DT|DICTIONARY	acute coronary syndrome	acute coronary syndrome	125#148		Effect of the TNFalpha-308 G/A polymorphism on the changes produced by atorvastatin in bone mineral density in patients with acute coronary syndrome.
20816194	2010	J. Allergy Clin. Immunol.	1097-6825	CONCLUSION	5	11	6774	SYMBOL|DICTIONARY|EXTRACTED	stat3	STAT3	134#139	20816194-2-32-82	D007589	SYMBOL|EXTRACTED	hies	HIES	124#128	20816194-1-0-19	Based on our patient cohort, we propose key findings that, when combined with T(H)17 cell numbers, predict patients with AD-HIES with STAT3 mutations, supporting early diagnosis of AD-HIES.
20816194	2010	J. Allergy Clin. Immunol.	1097-6825	CONCLUSION	5	11	6774	SYMBOL|DICTIONARY|EXTRACTED	stat3	STAT3	134#139	20816194-2-32-82	D007589	SYMBOL|EXTRACTED	hies	HIES	184#188	20816194-1-0-19	Based on our patient cohort, we propose key findings that, when combined with T(H)17 cell numbers, predict patients with AD-HIES with STAT3 mutations, supporting early diagnosis of AD-HIES.
18499652	2009	Eur. Heart J.	1522-9645	CONCLUSION	3	8	1401	LONGTERM|GENE|GT|DICTIONARY	c reactive protein	C-reactive protein	17#35		D003324	SYMBOL|DICTIONARY|EXTRACTED	cad	CAD	58#61	18499652-3-245-268	A causal role of C-reactive protein in the development of CAD would require that genetic PM resulting in long-term modulation of the concentration of C-reactive protein be themselves associated with CAD.
18499652	2009	Eur. Heart J.	1522-9645	CONCLUSION	3	8	1401	LONGTERM|GENE|GT|DICTIONARY	c reactive protein	C-reactive protein	17#35		D003324	SYMBOL|DICTIONARY|EXTRACTED	cad	CAD	199#202	18499652-3-245-268	A causal role of C-reactive protein in the development of CAD would require that genetic PM resulting in long-term modulation of the concentration of C-reactive protein be themselves associated with CAD.
18499652	2009	Eur. Heart J.	1522-9645	CONCLUSION	3	8	1401	LONGTERM|GENE|GT|DICTIONARY	c reactive protein	C-reactive protein	150#168		D003324	SYMBOL|DICTIONARY|EXTRACTED	cad	CAD	58#61	18499652-3-245-268	A causal role of C-reactive protein in the development of CAD would require that genetic PM resulting in long-term modulation of the concentration of C-reactive protein be themselves associated with CAD.
18499652	2009	Eur. Heart J.	1522-9645	CONCLUSION	3	8	1401	LONGTERM|GENE|GT|DICTIONARY	c reactive protein	C-reactive protein	150#168		D003324	SYMBOL|DICTIONARY|EXTRACTED	cad	CAD	199#202	18499652-3-245-268	A causal role of C-reactive protein in the development of CAD would require that genetic PM resulting in long-term modulation of the concentration of C-reactive protein be themselves associated with CAD.
11778498	2002	Zhonghua Jie He He Hu Xi Za Zhi	1001-0939	RESULTS	3	10	154	SYMBOL|NUMBER|DICTIONARY	beta 2 ar	beta 2-AR	26#35		D013224	LONGTERM|DICTIONARY	asthmatics	asthmatics	48#58		The frequency of genotype beta 2-AR 164 loci in asthmatics: Thr/Thr genotype accounts for 10%, Thr/Ile 83% and Ile/Ile 7%.
20520848	2010	PLoS Med.	1549-1676	METHODS AND FINDINGS	2	4	79068	SYMBOL|DICTIONARY	fto	FTO	80#83		D009765	LONGTERM|DICTIONARY	obesity	obesity	162#169		"Eight variants that showed individual associations with childhood BMI (in/near: FTO, MC4R, TMEM18, GNPDA2, KCTD15, NEGR1, BDNF, and ETV5) were used to derive an ""obesity-risk-allele score"" comprising the total number of risk alleles (range: 2-15 alleles) in each child with complete genotype data (n = 7,146)."
20520848	2010	PLoS Med.	1549-1676	METHODS AND FINDINGS	2	4	4160	SYMBOL|DICTIONARY	mc4r	MC4R	85#89		D009765	LONGTERM|DICTIONARY	obesity	obesity	162#169		"Eight variants that showed individual associations with childhood BMI (in/near: FTO, MC4R, TMEM18, GNPDA2, KCTD15, NEGR1, BDNF, and ETV5) were used to derive an ""obesity-risk-allele score"" comprising the total number of risk alleles (range: 2-15 alleles) in each child with complete genotype data (n = 7,146)."
20520848	2010	PLoS Med.	1549-1676	METHODS AND FINDINGS	2	4	129787	SYMBOL|DICTIONARY	tmem18	TMEM18	91#97		D009765	LONGTERM|DICTIONARY	obesity	obesity	162#169		"Eight variants that showed individual associations with childhood BMI (in/near: FTO, MC4R, TMEM18, GNPDA2, KCTD15, NEGR1, BDNF, and ETV5) were used to derive an ""obesity-risk-allele score"" comprising the total number of risk alleles (range: 2-15 alleles) in each child with complete genotype data (n = 7,146)."
20520848	2010	PLoS Med.	1549-1676	METHODS AND FINDINGS	2	4	132789	SYMBOL|DICTIONARY	gnpda2	GNPDA2	99#105		D009765	LONGTERM|DICTIONARY	obesity	obesity	162#169		"Eight variants that showed individual associations with childhood BMI (in/near: FTO, MC4R, TMEM18, GNPDA2, KCTD15, NEGR1, BDNF, and ETV5) were used to derive an ""obesity-risk-allele score"" comprising the total number of risk alleles (range: 2-15 alleles) in each child with complete genotype data (n = 7,146)."
20520848	2010	PLoS Med.	1549-1676	METHODS AND FINDINGS	2	4	79047	SYMBOL|DICTIONARY	kctd15	KCTD15	107#113		D009765	LONGTERM|DICTIONARY	obesity	obesity	162#169		"Eight variants that showed individual associations with childhood BMI (in/near: FTO, MC4R, TMEM18, GNPDA2, KCTD15, NEGR1, BDNF, and ETV5) were used to derive an ""obesity-risk-allele score"" comprising the total number of risk alleles (range: 2-15 alleles) in each child with complete genotype data (n = 7,146)."
20520848	2010	PLoS Med.	1549-1676	METHODS AND FINDINGS	2	4	257194	SYMBOL|DICTIONARY	negr1	NEGR1	115#120		D009765	LONGTERM|DICTIONARY	obesity	obesity	162#169		"Eight variants that showed individual associations with childhood BMI (in/near: FTO, MC4R, TMEM18, GNPDA2, KCTD15, NEGR1, BDNF, and ETV5) were used to derive an ""obesity-risk-allele score"" comprising the total number of risk alleles (range: 2-15 alleles) in each child with complete genotype data (n = 7,146)."
20520848	2010	PLoS Med.	1549-1676	METHODS AND FINDINGS	2	4	627	SYMBOL|DICTIONARY	bdnf	BDNF	122#126		D009765	LONGTERM|DICTIONARY	obesity	obesity	162#169		"Eight variants that showed individual associations with childhood BMI (in/near: FTO, MC4R, TMEM18, GNPDA2, KCTD15, NEGR1, BDNF, and ETV5) were used to derive an ""obesity-risk-allele score"" comprising the total number of risk alleles (range: 2-15 alleles) in each child with complete genotype data (n = 7,146)."
20520848	2010	PLoS Med.	1549-1676	METHODS AND FINDINGS	2	4	2119	SYMBOL|DICTIONARY	etv5	ETV5	132#136		D009765	LONGTERM|DICTIONARY	obesity	obesity	162#169		"Eight variants that showed individual associations with childhood BMI (in/near: FTO, MC4R, TMEM18, GNPDA2, KCTD15, NEGR1, BDNF, and ETV5) were used to derive an ""obesity-risk-allele score"" comprising the total number of risk alleles (range: 2-15 alleles) in each child with complete genotype data (n = 7,146)."
11778498	2002	Zhonghua Jie He He Hu Xi Za Zhi	1001-0939	RESULTS	3	12	154	SYMBOL|NUMBER|DICTIONARY	beta 2 ar	beta 2-AR	36#45		D013224	LONGTERM|DICTIONARY	asthmatic	asthmatic	99#108		In addition, our study reveals that beta 2-AR 16 locus genetic polymorphism is in association with asthmatic severity.
11778498	2002	Zhonghua Jie He He Hu Xi Za Zhi	1001-0939	CONCLUSIONS	4	13	154	SYMBOL|NUMBER|DICTIONARY	beta 2 ar	beta 2-AR	27#36		D001249	LONGTERM|DICTIONARY	asthma	asthma	86#92		These results suggest that beta 2-AR 16 locus genetic polymorphism is correlated with asthma severity in the people of the Han nationality of northern China.
18499652	2009	Eur. Heart J.	1522-9645	METHODS AND RESULTS	2	3	1401	LONGTERM|GENE|GT|DICTIONARY	c reactive protein	C-reactive protein	139#157		D003324	LONGTERM|DISEASE|DT|DICTIONARY	coronary artery disease	coronary artery disease	245#268		We analysed the association between three genetic polymorphisms (PM) (-717C>T, rs2794521; +1059G>C, rs1800947; +1444C>T, rs1130864) at the C-reactive protein locus and related haplotypes with both circulating C-reactive protein and angiographic coronary artery disease (CAD).
18499652	2009	Eur. Heart J.	1522-9645	METHODS AND RESULTS	2	3	1401	LONGTERM|GENE|GT|DICTIONARY	c reactive protein	C-reactive protein	139#157		D003324	SYMBOL|()|DICTIONARY|EXTRACTED	cad	CAD	270#273	18499652-3-245-268	We analysed the association between three genetic polymorphisms (PM) (-717C>T, rs2794521; +1059G>C, rs1800947; +1444C>T, rs1130864) at the C-reactive protein locus and related haplotypes with both circulating C-reactive protein and angiographic coronary artery disease (CAD).
18499652	2009	Eur. Heart J.	1522-9645	METHODS AND RESULTS	2	3	1401	LONGTERM|GENE|GT|DICTIONARY	c reactive protein	C-reactive protein	209#227		D003324	LONGTERM|DISEASE|DT|DICTIONARY	coronary artery disease	coronary artery disease	245#268		We analysed the association between three genetic polymorphisms (PM) (-717C>T, rs2794521; +1059G>C, rs1800947; +1444C>T, rs1130864) at the C-reactive protein locus and related haplotypes with both circulating C-reactive protein and angiographic coronary artery disease (CAD).
18499652	2009	Eur. Heart J.	1522-9645	METHODS AND RESULTS	2	3	1401	LONGTERM|GENE|GT|DICTIONARY	c reactive protein	C-reactive protein	209#227		D003324	SYMBOL|()|DICTIONARY|EXTRACTED	cad	CAD	270#273	18499652-3-245-268	We analysed the association between three genetic polymorphisms (PM) (-717C>T, rs2794521; +1059G>C, rs1800947; +1444C>T, rs1130864) at the C-reactive protein locus and related haplotypes with both circulating C-reactive protein and angiographic coronary artery disease (CAD).
18499652	2009	Eur. Heart J.	1522-9645	AIMS	1	2	1401	LONGTERM|GENE|GT|DICTIONARY	c reactive protein	C-reactive protein	19#37		D050197	LONGTERM|DICTIONARY	atherosclerosis	atherosclerosis	60#75		The causal role of C-reactive protein in the development of atherosclerosis remains controversial.
18499652	2009	Eur. Heart J.	1522-9645	TITLE	0	0	1401	LONGTERM|GENE|GT|DICTIONARY	c reactive protein	C-reactive protein	0#18		D003324	LONGTERM|DISEASE|DT|DICTIONARY	coronary artery disease	coronary artery disease	102#125		C-reactive protein genotypes associated with circulating C-reactive protein but not with angiographic coronary artery disease: the LURIC study.
18499652	2009	Eur. Heart J.	1522-9645	TITLE	0	0	1401	LONGTERM|GENE|GT|DICTIONARY	c reactive protein	C-reactive protein	57#75		D003324	LONGTERM|DISEASE|DT|DICTIONARY	coronary artery disease	coronary artery disease	102#125		C-reactive protein genotypes associated with circulating C-reactive protein but not with angiographic coronary artery disease: the LURIC study.
18499652	2009	Eur. Heart J.	1522-9645	METHODS AND RESULTS	2	7	1401	LONGTERM|GENE|GT|DICTIONARY	c reactive protein	C-reactive protein	51#69		D003324	SYMBOL|DICTIONARY|EXTRACTED	cad	CAD	134#137	18499652-3-245-268	None of the genetic variants affecting circulating C-reactive protein was consistently associated with the prevalence of angiographic CAD.
18499652	2009	Eur. Heart J.	1522-9645	METHODS AND RESULTS	2	4	1401	LONGTERM|GENE|GT|DICTIONARY	c reactive protein	C-reactive protein	21#39		D003324	SYMBOL|DICTIONARY|EXTRACTED	cad	CAD	76#79	18499652-3-245-268	The concentration of C-reactive protein was similar in patients with stable CAD and in controls, but increased in patients presenting with acute coronary syndromes.
18499652	2009	Eur. Heart J.	1522-9645	METHODS AND RESULTS	2	4	1401	LONGTERM|GENE|GT|DICTIONARY	c reactive protein	C-reactive protein	21#39		D054058	LONGTERM|DICTIONARY	acute coronary syndromes	acute coronary syndromes	139#163		The concentration of C-reactive protein was similar in patients with stable CAD and in controls, but increased in patients presenting with acute coronary syndromes.
19673907	2011	Cephalalgia	1468-2982	ALL_TEXT_3/3	3	6	4524	SYMBOL|NUMBER|DICTIONARY	mthfr	MTHFR	4#9		D020325	SYMBOL|EXTRACTED	ma	MA	64#66	19673907-5-91-109	The MTHFR 677TT genotype was associated with a reduced risk for MA, which only appeared for attacks fewer than six times/year (age-adjusted odds ratio 0.78; 95% confidence interval 0.61, 0.99).
12767526	2003	Cancer Lett.	0304-3835	ALL_TEXT_3/3	3	4	1543	SYMBOL|DICTIONARY	cyp1a1	CYP1A1	29#35		D011471	LONGTERM|DISEASE|DT|DICTIONARY	prostate cancer	prostate cancer	74#89		These finding suggested that CYP1A1 polymorphisms has an association with prostate cancer risk, especially with progression of prostate cancer.
12767526	2003	Cancer Lett.	0304-3835	ALL_TEXT_3/3	3	4	1543	SYMBOL|DICTIONARY	cyp1a1	CYP1A1	29#35		D011471	LONGTERM|DISEASE|DT|DICTIONARY	prostate cancer	prostate cancer	127#142		These finding suggested that CYP1A1 polymorphisms has an association with prostate cancer risk, especially with progression of prostate cancer.
19420919	2009	Cerebrovasc. Dis.	1421-9786	ALL_TEXT_1/3	1	1	6401	LONGTERM|GENE|GN|DICTIONARY	e selectin	E-selectin	24#34		D050197	LONGTERM|DICTIONARY	atherosclerosis	atherosclerosis	83#98		The polymorphism of the E-selectin gene has been implicated in the pathogenesis of atherosclerosis.
12767526	2003	Cancer Lett.	0304-3835	ALL_TEXT_2/3	2	2	1543	SYMBOL|DICTIONARY	cyp1a1	CYP1A1	57#63		D011471	LONGTERM|DISEASE|DT|DICTIONARY	prostate cancer	prostate cancer	103#118		Although the individual analysis of m1 or m2 genotype of CYP1A1 showed no significant association with prostate cancer risk, the presence of any mutated alleles significantly increased prostate cancer risk in comparison with wild-type genotypes by combination analysis (odds ratio [OR]=2.38; 95% confidence interval [CI]=1.72-3.29; P=0.0069).
12767526	2003	Cancer Lett.	0304-3835	ALL_TEXT_2/3	2	2	1543	SYMBOL|DICTIONARY	cyp1a1	CYP1A1	57#63		D011471	LONGTERM|DISEASE|DT|DICTIONARY	prostate cancer	prostate cancer	185#200		Although the individual analysis of m1 or m2 genotype of CYP1A1 showed no significant association with prostate cancer risk, the presence of any mutated alleles significantly increased prostate cancer risk in comparison with wild-type genotypes by combination analysis (odds ratio [OR]=2.38; 95% confidence interval [CI]=1.72-3.29; P=0.0069).
16234515	2005	J. Clin. Oncol.	0732-183X	PATIENTS AND METHODS	2	2	672	SYMBOL|DICTIONARY	brca1	BRCA1	100#105		D001943	LONGTERM|DISEASE|DT|DICTIONARY	breast cancer	breast cancer	32#45		We analyzed 1,439 patients with breast cancer and 1,866 matched controls derived from a registry of BRCA1 and BRCA2 carriers.
16234515	2005	J. Clin. Oncol.	0732-183X	PATIENTS AND METHODS	2	2	675	SYMBOL|DICTIONARY	brca2	BRCA2	110#115		D001943	LONGTERM|DISEASE|DT|DICTIONARY	breast cancer	breast cancer	32#45		We analyzed 1,439 patients with breast cancer and 1,866 matched controls derived from a registry of BRCA1 and BRCA2 carriers.
20644276	2010	Neurol India	0028-3886	TITLE	0	0	348	LONGTERM|DICTIONARY	apolipoprotein e	Apolipoprotein-E	0#16		D009157	LONGTERM|DICTIONARY	myasthenia gravis	myasthenia gravis	31#48		Apolipoprotein-E genotypes and myasthenia gravis.
16234515	2005	J. Clin. Oncol.	0732-183X	TITLE	0	0	672	SYMBOL|DICTIONARY	brca1	BRCA1	55#60		D001943	LONGTERM|DISEASE|DT|DICTIONARY	breast cancer	Breast cancer	0#13		Breast cancer risk following bilateral oophorectomy in BRCA1 and BRCA2 mutation carriers: an international case-control study.
16234515	2005	J. Clin. Oncol.	0732-183X	TITLE	0	0	675	SYMBOL|DICTIONARY	brca2	BRCA2	65#70		D001943	LONGTERM|DISEASE|DT|DICTIONARY	breast cancer	Breast cancer	0#13		Breast cancer risk following bilateral oophorectomy in BRCA1 and BRCA2 mutation carriers: an international case-control study.
12828656	2003	J. Periodont. Res.	0022-3484	RESULTS	3	6	4049	SYMBOL|EXTRACTED	lt alpha	LT-alpha	43#51	12828656-3-338-355	D055113	LONGTERM|DICTIONARY	chronic periodontitis	chronic periodontitis	119#140		The proportion of individuals carrying the LT-alpha 1/1 genotype was significantly lower in the group of patients with chronic periodontitis (0.8%) than in the control group (8.8%) (P < 0.0094, Pcorr < 0.05).
17102945	2007	Rheumatol. Int.	0172-8172	CONCLUSION	4	8	4210	SYMBOL|DICTIONARY	mefv	MEFV	26#30		D000686	LONGTERM|DICTIONARY	amyloidosis	amyloidosis	129#140		Though the effects of the MEFV genotypes seem clear, there are definitely other modifying factors or genes on the development of amyloidosis and on the course of the disease.
12767526	2003	Cancer Lett.	0304-3835	ALL_TEXT_1/3	1	1	1543	SYMBOL|DICTIONARY	cyp1a1	CYP1A1	45#51		D011471	LONGTERM|DISEASE|DT|DICTIONARY	familial prostate cancer	familial prostate cancer	56#80		Association between genetic polymorphisms of CYP1A1 and familial prostate cancer risk was examined by a case-control study of 185 individuals.
16234515	2005	J. Clin. Oncol.	0732-183X	RESULTS	3	4	672	SYMBOL|DICTIONARY	brca1	BRCA1	112#117		D001943	LONGTERM|DISEASE|DT|DICTIONARY	breast cancer	breast cancer	82#95		A previous history of oophorectomy was associated with a significant reduction in breast cancer risk of 56% for BRCA1 carriers (OR = 0.44; 95% CI, 0.29 to 0.66) and of 46% for BRCA2 carriers (OR = 0.57; 95% CI, 0.28 to 1.15).
16234515	2005	J. Clin. Oncol.	0732-183X	RESULTS	3	4	675	SYMBOL|DICTIONARY	brca2	BRCA2	176#181		D001943	LONGTERM|DISEASE|DT|DICTIONARY	breast cancer	breast cancer	82#95		A previous history of oophorectomy was associated with a significant reduction in breast cancer risk of 56% for BRCA1 carriers (OR = 0.44; 95% CI, 0.29 to 0.66) and of 46% for BRCA2 carriers (OR = 0.57; 95% CI, 0.28 to 1.15).
9714430	1998	Am. J. Med. Genet.	0148-7299	ALL_TEXT_1/3	1	1	4023	LONGTERM|DICTIONARY|GENE|GA	lipoprotein lipase	lipoprotein lipase	17#35		D008072	LONGTERM|DICTIONARY	familial chylomicronemia	familial chylomicronemia	79#103		Mutations in the lipoprotein lipase (LPL) gene are the most important cause of familial chylomicronemia with over 70 mutations being recorded to date.
9714430	1998	Am. J. Med. Genet.	0148-7299	ALL_TEXT_1/3	1	1	4023	SYMBOL|()|GENE|GN|DICTIONARY|EXTRACTED	lpl	LPL	37#40	9714430-0-31-49	D008072	LONGTERM|DICTIONARY	familial chylomicronemia	familial chylomicronemia	79#103		Mutations in the lipoprotein lipase (LPL) gene are the most important cause of familial chylomicronemia with over 70 mutations being recorded to date.
17102945	2007	Rheumatol. Int.	0172-8172	TITLE	0	0	100507436	SYMBOL|GENE|GN|DICTIONARY	mica	MICA	37#41		D000686	LONGTERM|DICTIONARY	amyloidosis	amyloidosis	98#109		The contribution of genotypes at the MICA gene triplet repeat polymorphisms and MEFV mutations to amyloidosis and course of the disease in the patients with familial Mediterranean fever.
17102945	2007	Rheumatol. Int.	0172-8172	TITLE	0	0	100507436	SYMBOL|GENE|GN|DICTIONARY	mica	MICA	37#41		D010505	LONGTERM|DICTIONARY	familial mediterranean fever	familial Mediterranean fever	157#185		The contribution of genotypes at the MICA gene triplet repeat polymorphisms and MEFV mutations to amyloidosis and course of the disease in the patients with familial Mediterranean fever.
17102945	2007	Rheumatol. Int.	0172-8172	TITLE	0	0	4210	SYMBOL|DICTIONARY	mefv	MEFV	80#84		D000686	LONGTERM|DICTIONARY	amyloidosis	amyloidosis	98#109		The contribution of genotypes at the MICA gene triplet repeat polymorphisms and MEFV mutations to amyloidosis and course of the disease in the patients with familial Mediterranean fever.
17102945	2007	Rheumatol. Int.	0172-8172	TITLE	0	0	4210	SYMBOL|DICTIONARY	mefv	MEFV	80#84		D010505	LONGTERM|DICTIONARY	familial mediterranean fever	familial Mediterranean fever	157#185		The contribution of genotypes at the MICA gene triplet repeat polymorphisms and MEFV mutations to amyloidosis and course of the disease in the patients with familial Mediterranean fever.
17102945	2007	Rheumatol. Int.	0172-8172	OBJECTIVE	1	1	4210	SYMBOL|DICTIONARY	mefv	MEFV	27#31		D010505	LONGTERM|DICTIONARY	familial mediterranean fever	familial Mediterranean fever	188#216		To evaluate the effects of MEFV genotypes and the major histocompatibility complex class I chain-related gene A (MICA) triplet repeat polymorphism on the severity and clinical features of familial Mediterranean fever (FMF) and amyloidosis in a group of Turkish FMF patients.
17102945	2007	Rheumatol. Int.	0172-8172	OBJECTIVE	1	1	4210	SYMBOL|DICTIONARY	mefv	MEFV	27#31		D010505	SYMBOL|()|DICTIONARY|EXTRACTED	fmf	FMF	218#221	17102945-1-188-216	To evaluate the effects of MEFV genotypes and the major histocompatibility complex class I chain-related gene A (MICA) triplet repeat polymorphism on the severity and clinical features of familial Mediterranean fever (FMF) and amyloidosis in a group of Turkish FMF patients.
17102945	2007	Rheumatol. Int.	0172-8172	OBJECTIVE	1	1	4210	SYMBOL|DICTIONARY	mefv	MEFV	27#31		D000686	LONGTERM|DICTIONARY	amyloidosis	amyloidosis	227#238		To evaluate the effects of MEFV genotypes and the major histocompatibility complex class I chain-related gene A (MICA) triplet repeat polymorphism on the severity and clinical features of familial Mediterranean fever (FMF) and amyloidosis in a group of Turkish FMF patients.
17102945	2007	Rheumatol. Int.	0172-8172	OBJECTIVE	1	1	4210	SYMBOL|DICTIONARY	mefv	MEFV	27#31		D010505	SYMBOL|DISEASE|DN|DICTIONARY|EXTRACTED	fmf	FMF	261#264	17102945-1-188-216	To evaluate the effects of MEFV genotypes and the major histocompatibility complex class I chain-related gene A (MICA) triplet repeat polymorphism on the severity and clinical features of familial Mediterranean fever (FMF) and amyloidosis in a group of Turkish FMF patients.
18998014	2009	Saudi Med J	0379-5284	CONCLUSION	4	9	3123	SYMBOL|DICTIONARY	drb1	DRB1	109#113		D014397	LONGTERM|DICTIONARY	pulmonary tuberculosis	pulmonary tuberculosis	47#69		In addition, cavity formation in patients with pulmonary tuberculosis seems to be favored by presence of the DRB1*04 allele.
18998014	2009	Saudi Med J	0379-5284	CONCLUSION	4	8	3123	SYMBOL|DICTIONARY	drb1	DRB1	4#8		D014397	LONGTERM|DICTIONARY	pulmonary tuberculosis	pulmonary tuberculosis	56#78		The DRB1*04 allele is associated with susceptibility to pulmonary tuberculosis, whereas DRB1*11 is associated with protection from pulmonary tuberculosis in the Syrian population.
18998014	2009	Saudi Med J	0379-5284	CONCLUSION	4	8	3123	SYMBOL|DICTIONARY	drb1	DRB1	4#8		D014397	LONGTERM|DICTIONARY	pulmonary tuberculosis	pulmonary tuberculosis	131#153		The DRB1*04 allele is associated with susceptibility to pulmonary tuberculosis, whereas DRB1*11 is associated with protection from pulmonary tuberculosis in the Syrian population.
18998014	2009	Saudi Med J	0379-5284	CONCLUSION	4	8	3123	SYMBOL|NUMBER|DICTIONARY	drb1	DRB1	88#92		D014397	LONGTERM|DICTIONARY	pulmonary tuberculosis	pulmonary tuberculosis	56#78		The DRB1*04 allele is associated with susceptibility to pulmonary tuberculosis, whereas DRB1*11 is associated with protection from pulmonary tuberculosis in the Syrian population.
18998014	2009	Saudi Med J	0379-5284	CONCLUSION	4	8	3123	SYMBOL|NUMBER|DICTIONARY	drb1	DRB1	88#92		D014397	LONGTERM|DICTIONARY	pulmonary tuberculosis	pulmonary tuberculosis	131#153		The DRB1*04 allele is associated with susceptibility to pulmonary tuberculosis, whereas DRB1*11 is associated with protection from pulmonary tuberculosis in the Syrian population.
19073975	2008	N. Engl. J. Med.	1533-4406	TITLE	0	0	79068	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	fto	FTO	22#25		D009765	LONGTERM|DICTIONARY	obesity	obesity	3#10		An obesity-associated FTO gene variant and increased energy intake in children.
19073975	2008	N. Engl. J. Med.	1533-4406	BACKGROUND	1	1	79068	SYMBOL|()|GENE|GN|DICTIONARY|EXTRACTED	fto	FTO	50#53	19073975-1-17-48	D009765	LONGTERM|DICTIONARY	obesity	obesity	114#121		Variation in the fat mass and obesity-associated (FTO) gene has provided the most robust associations with common obesity to date.
18998014	2009	Saudi Med J	0379-5284	METHODS	2	2	3123	SYMBOL|DICTIONARY	drb1	DRB1	88#92		D014376	LONGTERM|DICTIONARY	tuberculosis	Tuberculosis	186#198		We used the polymerase chain reaction with sequence specific primer method to study the DRB1* locus in 147 Syrian patients with positive sputum smear or sputum culture for Mycobacterium Tuberculosis strains, and 209 Syrian healthy matching individuals with negative tuberculin skin test.
12828656	2003	J. Periodont. Res.	0022-3484	BACKGROUND	1	2	7124	LONGTERM|GENE|GT|DICTIONARY	tumor necrosis factor	Tumor necrosis factor	0#21		D010510	LONGTERM|DISEASE|DT|DICTIONARY	periodontal disease	periodontal disease	174#193		Tumor necrosis factor (TNF), a pluripotent proinflammatory cytokine that is able to induce tissue destruction and bone resorption, has been implicated in the pathogenesis of periodontal disease.
12828656	2003	J. Periodont. Res.	0022-3484	BACKGROUND	1	2	7124	SYMBOL|EXTRACTED|()	tnf	TNF	23#26	12828656-2-0-21	D010510	LONGTERM|DISEASE|DT|DICTIONARY	periodontal disease	periodontal disease	174#193		Tumor necrosis factor (TNF), a pluripotent proinflammatory cytokine that is able to induce tissue destruction and bone resorption, has been implicated in the pathogenesis of periodontal disease.
18998014	2009	Saudi Med J	0379-5284	RESULTS	3	7	3123	SYMBOL|DICTIONARY	drb1	DRB1	69#73		D008171	LONGTERM|DICTIONARY	pulmonary cavitation	pulmonary cavitation	13#33		In addition, pulmonary cavitation was significantly increased in the DRB1*04 positive patients compared to patients without the DRB1*04 allele (33% in DRB1*04 positive patients versus 16% in DRB1*04 negative patients, OR=2.7, p=0.04).
18998014	2009	Saudi Med J	0379-5284	RESULTS	3	7	3123	SYMBOL|DICTIONARY	drb1	DRB1	128#132		D008171	LONGTERM|DICTIONARY	pulmonary cavitation	pulmonary cavitation	13#33		In addition, pulmonary cavitation was significantly increased in the DRB1*04 positive patients compared to patients without the DRB1*04 allele (33% in DRB1*04 positive patients versus 16% in DRB1*04 negative patients, OR=2.7, p=0.04).
18998014	2009	Saudi Med J	0379-5284	RESULTS	3	7	3123	SYMBOL|DICTIONARY	drb1	DRB1	151#155		D008171	LONGTERM|DICTIONARY	pulmonary cavitation	pulmonary cavitation	13#33		In addition, pulmonary cavitation was significantly increased in the DRB1*04 positive patients compared to patients without the DRB1*04 allele (33% in DRB1*04 positive patients versus 16% in DRB1*04 negative patients, OR=2.7, p=0.04).
18998014	2009	Saudi Med J	0379-5284	RESULTS	3	7	3123	SYMBOL|DICTIONARY	drb1	DRB1	191#195		D008171	LONGTERM|DICTIONARY	pulmonary cavitation	pulmonary cavitation	13#33		In addition, pulmonary cavitation was significantly increased in the DRB1*04 positive patients compared to patients without the DRB1*04 allele (33% in DRB1*04 positive patients versus 16% in DRB1*04 negative patients, OR=2.7, p=0.04).
20644276	2010	Neurol India	0028-3886	ALL_TEXT_3/3	3	5	348	SYMBOL|DICTIONARY|EXTRACTED	apo e	Apo-E	88#93	20644276-3-52-68	D009157	SYMBOL|EXTRACTED	mg	MG	33#35	20644276-1-11-28	Comparison between patients with MG and controls showed no significant association with Apo-E allelic variants.
12728591	2003	Vnitr Lek	0042-773X	TITLE	0	0	1636	SYMBOL|GENE|GN|DICTIONARY	ace	ACE	11#14		D003920	LONGTERM|DICTIONARY	diabetes	diabetes	86#94		[Effect of ACE gene polymorphism on left ventricular function in patients with type 2 diabetes].
12728591	2003	Vnitr Lek	0042-773X	TITLE	0	0	1636	SYMBOL|GENE|GN|DICTIONARY	ace	ACE	11#14		D017827	LONGTERM|DICTIONARY	type	type	79#83		[Effect of ACE gene polymorphism on left ventricular function in patients with type 2 diabetes].
12728591	2003	Vnitr Lek	0042-773X	ALL_TEXT_1/3	1	1	1636	SYMBOL|GENE|GN|DICTIONARY	ace	ACE	43#46		D003924	LONGTERM|DICTIONARY	diabetes type 2	diabetes type 2	111#126		The authors evaluated the influence of the ACE gene polymorphism on left ventricular function in patients with diabetes type 2.
20056646	2010	Cancer Epidemiol. Biomarkers Prev.	1538-7755	RESULTS	3	10	4292	SYMBOL|DICTIONARY	mlh1	MLH1	30#34		D001523	LONGTERM|DICTIONARY	more aggressive disease	more aggressive disease	92#115	NaN	A nonsynonymous coding SNP in MLH1, rs1799977 (I219V), was also found to be associated with more aggressive disease.
12728591	2003	Vnitr Lek	0042-773X	ALL_TEXT_3/3	3	5	1636	SYMBOL|GENE|GN|DICTIONARY	ace	ACE	103#106		D009203	LONGTERM|DICTIONARY	myocardial infarction	myocardial infarction	16#37		The presence of myocardial infarction, ischemic heart disease and hypertension had no association with ACE gene polymorphism (p = 0.53, p = 0.61 and p = 0.64).
12728591	2003	Vnitr Lek	0042-773X	ALL_TEXT_3/3	3	5	1636	SYMBOL|GENE|GN|DICTIONARY	ace	ACE	103#106		D017202	LONGTERM|DISEASE|DT|DICTIONARY	ischemic heart disease	ischemic heart disease	39#61		The presence of myocardial infarction, ischemic heart disease and hypertension had no association with ACE gene polymorphism (p = 0.53, p = 0.61 and p = 0.64).
12728591	2003	Vnitr Lek	0042-773X	ALL_TEXT_3/3	3	5	1636	SYMBOL|GENE|GN|DICTIONARY	ace	ACE	103#106		D006973	LONGTERM|DICTIONARY	hypertension	hypertension	66#78		The presence of myocardial infarction, ischemic heart disease and hypertension had no association with ACE gene polymorphism (p = 0.53, p = 0.61 and p = 0.64).
12728591	2003	Vnitr Lek	0042-773X	ALL_TEXT_3/3	3	6	1636	SYMBOL|GENE|GN|DICTIONARY	ace	ACE	47#50		D003924	LONGTERM|DICTIONARY	diabetes type 2	diabetes type 2	158#173		In conclusion, there is no association between ACE gene polymorphism and systolic and diastolic function of the left ventricle in this group of patients with diabetes type 2.
12010932	2002	Heart	1468-201X	OBJECTIVE	2	2	4846	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	enos	eNOS	51#55	12010932-1-20-53	D003324	LONGTERM|DISEASE|DT|DICTIONARY	coronary artery disease	coronary artery disease	136#159		To assess whether Glu298-->Asp polymorphism of the eNOS gene is associated with the occurrence and severity of angiographically defined coronary artery disease in the Italian population.
20130978	2010	Cancer Causes Control	1573-7225	OBJECTIVE	1	3	672	SYMBOL|DICTIONARY	brca1	BRCA1	85#90		D001943	SYMBOL|EXTRACTED	cbc	CBC	70#73	20130978-2-79-106	In this study, we evaluated the association between these factors and CBC risk among BRCA1 and BRCA2 (BRCA1/2) mutation carriers and non-carriers.
20130978	2010	Cancer Causes Control	1573-7225	OBJECTIVE	1	3	675	SYMBOL|DICTIONARY	brca2	BRCA2	95#100		D001943	SYMBOL|EXTRACTED	cbc	CBC	70#73	20130978-2-79-106	In this study, we evaluated the association between these factors and CBC risk among BRCA1 and BRCA2 (BRCA1/2) mutation carriers and non-carriers.
20130978	2010	Cancer Causes Control	1573-7225	OBJECTIVE	1	3	672	SYMBOL|NUMBER|DICTIONARY	brca1	BRCA1	102#107		D001943	SYMBOL|EXTRACTED	cbc	CBC	70#73	20130978-2-79-106	In this study, we evaluated the association between these factors and CBC risk among BRCA1 and BRCA2 (BRCA1/2) mutation carriers and non-carriers.
17151092	2007	Carcinogenesis	0143-3334	ALL_TEXT_3/3	3	10	11221	SYMBOL|DICTIONARY|EXTRACTED	mkp5	MKP5	67#71	17151092-3-41-87	D053448	LONGTERM|DICTIONARY	decreasing prostatic inflammation	decreasing prostatic inflammation	198#231	NaN	In summary, our findings show direct anti-inflammatory activity of MKP5 in prostate cells and suggest that up-regulation of MKP5 by phytochemicals may contribute to their chemopreventive actions by decreasing prostatic inflammation.
17151092	2007	Carcinogenesis	0143-3334	ALL_TEXT_3/3	3	10	11221	SYMBOL|DICTIONARY|EXTRACTED	mkp5	MKP5	124#128	17151092-3-41-87	D053448	LONGTERM|DICTIONARY	decreasing prostatic inflammation	decreasing prostatic inflammation	198#231	NaN	In summary, our findings show direct anti-inflammatory activity of MKP5 in prostate cells and suggest that up-regulation of MKP5 by phytochemicals may contribute to their chemopreventive actions by decreasing prostatic inflammation.
20130978	2010	Cancer Causes Control	1573-7225	TITLE	0	0	672	SYMBOL|DICTIONARY	brca1	BRCA1	64#69		D001943	LONGTERM|DISEASE|DT|DICTIONARY	contralateral breast cancer	contralateral breast cancer	33#60		Reproductive factors and risk of contralateral breast cancer by BRCA1 and BRCA2 mutation status: results from the WECARE study.
20130978	2010	Cancer Causes Control	1573-7225	TITLE	0	0	675	SYMBOL|DICTIONARY	brca2	BRCA2	74#79		D001943	LONGTERM|DISEASE|DT|DICTIONARY	contralateral breast cancer	contralateral breast cancer	33#60		Reproductive factors and risk of contralateral breast cancer by BRCA1 and BRCA2 mutation status: results from the WECARE study.
20555002	2010	In Vivo	0258-851X	RESULTS	3	10	7422	SYMBOL|DICTIONARY|EXTRACTED	vegf	VEGF	11#15	20555002-2-8-42	D004715	LONGTERM|DICTIONARY	endometriosis	endometriosis	62#75		Women with VEGF +405 CC genotype had 2.3-fold higher risk for endometriosis.
20555002	2010	In Vivo	0258-851X	RESULTS	3	11	7422	SYMBOL|DICTIONARY|EXTRACTED	vegf	VEGF	0#4		D004715	LONGTERM|DICTIONARY	endometriosis	endometriosis	76#89		VEGF +405 GC genotype and G allele in the control group was higher than the endometriosis group (p=0.039, p=0.027 respectively).
20056646	2010	Cancer Epidemiol. Biomarkers Prev.	1538-7755	RESULTS	3	9	4292	SYMBOL|DICTIONARY	mlh1	MLH1	32#36		D011471	LONGTERM|DISEASE|DT|DICTIONARY	prostate cancer	prostate cancer	77#92		Among Caucasian men, one SNP in MLH1 (rs9852810) was associated with overall prostate cancer risk [odds ratio, 1.21; 95% confidence interval (95% CI), 1.02, 1.44; P = 0.03], more aggressive prostate cancer (odds ratio, 1.49; 95% CI, 1.15, 1.91; P < 0.01), and prostate cancer recurrence (hazard ratio, 1.83; 95% CI, 1.18, 2.86; P < 0.01), but not prostate cancer-specific mortality.
20056646	2010	Cancer Epidemiol. Biomarkers Prev.	1538-7755	RESULTS	3	9	4292	SYMBOL|DICTIONARY	mlh1	MLH1	32#36		D011471	LONGTERM|DISEASE|DT|DICTIONARY	prostate cancer	prostate cancer	190#205		Among Caucasian men, one SNP in MLH1 (rs9852810) was associated with overall prostate cancer risk [odds ratio, 1.21; 95% confidence interval (95% CI), 1.02, 1.44; P = 0.03], more aggressive prostate cancer (odds ratio, 1.49; 95% CI, 1.15, 1.91; P < 0.01), and prostate cancer recurrence (hazard ratio, 1.83; 95% CI, 1.18, 2.86; P < 0.01), but not prostate cancer-specific mortality.
20056646	2010	Cancer Epidemiol. Biomarkers Prev.	1538-7755	RESULTS	3	9	4292	SYMBOL|DICTIONARY	mlh1	MLH1	32#36		D011471	LONGTERM|DISEASE|DT|DICTIONARY	prostate cancer	prostate cancer	260#275		Among Caucasian men, one SNP in MLH1 (rs9852810) was associated with overall prostate cancer risk [odds ratio, 1.21; 95% confidence interval (95% CI), 1.02, 1.44; P = 0.03], more aggressive prostate cancer (odds ratio, 1.49; 95% CI, 1.15, 1.91; P < 0.01), and prostate cancer recurrence (hazard ratio, 1.83; 95% CI, 1.18, 2.86; P < 0.01), but not prostate cancer-specific mortality.
20056646	2010	Cancer Epidemiol. Biomarkers Prev.	1538-7755	RESULTS	3	9	4292	SYMBOL|DICTIONARY	mlh1	MLH1	32#36		D011471	LONGTERM|DISEASE|DT|DICTIONARY	prostate cancer	prostate cancer	347#362		Among Caucasian men, one SNP in MLH1 (rs9852810) was associated with overall prostate cancer risk [odds ratio, 1.21; 95% confidence interval (95% CI), 1.02, 1.44; P = 0.03], more aggressive prostate cancer (odds ratio, 1.49; 95% CI, 1.15, 1.91; P < 0.01), and prostate cancer recurrence (hazard ratio, 1.83; 95% CI, 1.18, 2.86; P < 0.01), but not prostate cancer-specific mortality.
12010932	2002	Heart	1468-201X	TITLE	0	0	4846	LONGTERM|GENE|GN|DICTIONARY	endothelial nitric oxide synthase	endothelial nitric oxide synthase	52#85		D003324	LONGTERM|DISEASE|DT|DICTIONARY	coronary artery disease	coronary artery disease	160#183		Evidence for association of a common variant of the endothelial nitric oxide synthase gene (Glu298-->Asp polymorphism) to the presence, extent, and severity of coronary artery disease.
16219118	2006	Psychol Med	0033-2917	CONCLUSIONS	4	8	3084	SYMBOL|DICTIONARY	nrg1	NRG1	0#4		D012559	LONGTERM|DICTIONARY	schizophrenia	schizophrenia	25#38		NRG1, if a true gene for schizophrenia, accounts for a small fraction of the disease in most populations.
16219118	2006	Psychol Med	0033-2917	CONCLUSIONS	4	9	3084	SYMBOL|DICTIONARY	nrg1	NRG1	20#24		D012559	LONGTERM|DICTIONARY	schizophrenia	schizophrenia	30#43		The confirmation of NRG1 as a schizophrenia susceptibility gene will require studies with a comprehensive set of markers and in larger samples.
12828656	2003	J. Periodont. Res.	0022-3484	CONCLUSION	4	9	4049	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	lt alpha	LT-alpha	115#123	12828656-3-338-355	D055113	LONGTERM|DICTIONARY	chronic periodontitis	chronic periodontitis	218#239		We also showed that, comparing the two genes, the 1/1 genotype of the NcoI polymorphism in the first intron of the LT-alpha gene is a more informative marker and it may be one of the protective genetic factors against chronic periodontitis in our population.
12028996	2002	Clin. Chem.	0009-9147	METHODS	2	4	1589	SYMBOL|GENE|GN|DICTIONARY	cyp21	CYP21	146#151		D000312	SYMBOL|DISEASE|DN|DICTIONARY|EXTRACTED	cah	CAH	20#23	12028996-1-0-30	DNA samples from 40 CAH patients previously genotyped by direct DNA sequencing were reanalyzed by allele-specific amplification of the functional CYP21 gene followed by a multiplex minisequencing reaction using 13 primers.
18543221	2009	Zhonghua Yi Xue Yi Chuan Xue Za Zhi	1003-9406	OBJECTIVE	1	1	183	LONGTERM|DICTIONARY	angiotensinogen	angiotensinogen	50#65		D020246	LONGTERM|DICTIONARY	deep venous thrombosis	deep venous thrombosis	120#142		To investigate the association of polymorphism of angiotensinogen (AGT) -6G/A, -20A/C and T174M with the development of deep venous thrombosis.
18543221	2009	Zhonghua Yi Xue Yi Chuan Xue Za Zhi	1003-9406	OBJECTIVE	1	1	183	SYMBOL|()|DICTIONARY|EXTRACTED	agt	AGT	67#70	18543221-1-50-65	D020246	LONGTERM|DICTIONARY	deep venous thrombosis	deep venous thrombosis	120#142		To investigate the association of polymorphism of angiotensinogen (AGT) -6G/A, -20A/C and T174M with the development of deep venous thrombosis.
18543221	2009	Zhonghua Yi Xue Yi Chuan Xue Za Zhi	1003-9406	TITLE	0	0	183	LONGTERM|GENE|GN|DICTIONARY	angiotensinogen	angiotensinogen	51#66		D020246	LONGTERM|DICTIONARY	deep venous thrombosis	deep venous thrombosis	76#98		[Study on the association between polymorphisms in angiotensinogen gene and deep venous thrombosis].
12028996	2002	Clin. Chem.	0009-9147	BACKGROUND	1	1	1589	SYMBOL|()|DICTIONARY	cyp21	CYP21	194#199		D000312	LONGTERM|DICTIONARY	congenital adrenal hyperplasia	Congenital adrenal hyperplasia	0#30		Congenital adrenal hyperplasia (CAH) is a frequent autosomal recessive disease, with a wide range of clinical manifestations, most commonly attributable to mutations in the 21-hydroxylase gene (CYP21).
12028996	2002	Clin. Chem.	0009-9147	BACKGROUND	1	1	1589	SYMBOL|()|DICTIONARY	cyp21	CYP21	194#199		D000312	SYMBOL|()|DICTIONARY|EXTRACTED	cah	CAH	32#35	12028996-1-0-30	Congenital adrenal hyperplasia (CAH) is a frequent autosomal recessive disease, with a wide range of clinical manifestations, most commonly attributable to mutations in the 21-hydroxylase gene (CYP21).
12028996	2002	Clin. Chem.	0009-9147	BACKGROUND	1	1	1589	SYMBOL|()|DICTIONARY	cyp21	CYP21	194#199		D030342	LONGTERM|DICTIONARY	autosomal recessive disease	autosomal recessive disease	51#78	NaN	Congenital adrenal hyperplasia (CAH) is a frequent autosomal recessive disease, with a wide range of clinical manifestations, most commonly attributable to mutations in the 21-hydroxylase gene (CYP21).
16932953	2007	Eur. J. Clin. Pharmacol.	0031-6970	CONCLUSION	4	9	5243	SYMBOL|GENE|GN|DICTIONARY	mdr1	MDR1	60#64		D001172	SYMBOL|EXTRACTED	ra	RA	113#115	16932953-1-0-20	The results from the present study suggest that the 3435C>T MDR1 gene polymorphism may influence the efficacy of RA therapy with disease-modifying antirheumatic drugs.
12010932	2002	Heart	1468-201X	RESULTS	4	5	4846	SYMBOL|EXTRACTED	enos	eNOS	23#27	12010932-1-20-53	D003324	LONGTERM|DISEASE|DT|DICTIONARY	coronary artery disease	coronary artery disease	75#98		The frequencies of the eNOS Glu/Glu, Glu/Asp, and Asp/Asp genotypes in the coronary artery disease group were significantly different from those of controls (45.3%, 38.8%, and 15.9% v 42.1%, 51.8%, and 6.1%, respectively; chi2 = 8.589, p = 0.0136).
16932953	2007	Eur. J. Clin. Pharmacol.	0031-6970	TITLE	0	0	5243	SYMBOL|GENE|GN|DICTIONARY	mdr1	MDR1	22#26		D001172	LONGTERM|DISEASE|DN|DICTIONARY	rheumatoid arthritis	rheumatoid arthritis	48#68		The effect of 3435C>T MDR1 gene polymorphism on rheumatoid arthritis treatment with disease-modifying antirheumatic drugs.
18786162	2009	Genes Brain Behav.	1601-183X	ALL_TEXT_3/3	3	10	348	SYMBOL|EXTRACTED	apoe	ApoE	66#70	18786162-1-25-41	D000544	SYMBOL|EXTRACTED	ad	AD	138#140	18786162-1-121-140	The present preliminary study indicates that polymorphisms of the ApoE and the BDNF genes could affect disease progression in preclinical AD and implies that the Met-BDNF polymorphism could be an additional risk factor for rapid disease progression in preclinical AD.
18786162	2009	Genes Brain Behav.	1601-183X	ALL_TEXT_3/3	3	10	348	SYMBOL|EXTRACTED	apoe	ApoE	66#70	18786162-1-25-41	D000544	SYMBOL|EXTRACTED	ad	AD	264#266	18786162-1-121-140	The present preliminary study indicates that polymorphisms of the ApoE and the BDNF genes could affect disease progression in preclinical AD and implies that the Met-BDNF polymorphism could be an additional risk factor for rapid disease progression in preclinical AD.
18786162	2009	Genes Brain Behav.	1601-183X	ALL_TEXT_3/3	3	10	627	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	bdnf	BDNF	79#83	18786162-2-80-113	D000544	SYMBOL|EXTRACTED	ad	AD	138#140	18786162-1-121-140	The present preliminary study indicates that polymorphisms of the ApoE and the BDNF genes could affect disease progression in preclinical AD and implies that the Met-BDNF polymorphism could be an additional risk factor for rapid disease progression in preclinical AD.
18786162	2009	Genes Brain Behav.	1601-183X	ALL_TEXT_3/3	3	10	627	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	bdnf	BDNF	79#83	18786162-2-80-113	D000544	SYMBOL|EXTRACTED	ad	AD	264#266	18786162-1-121-140	The present preliminary study indicates that polymorphisms of the ApoE and the BDNF genes could affect disease progression in preclinical AD and implies that the Met-BDNF polymorphism could be an additional risk factor for rapid disease progression in preclinical AD.
18786162	2009	Genes Brain Behav.	1601-183X	ALL_TEXT_3/3	3	10	627	SYMBOL|DICTIONARY|EXTRACTED	bdnf	BDNF	166#170	18786162-2-80-113	D000544	SYMBOL|EXTRACTED	ad	AD	138#140	18786162-1-121-140	The present preliminary study indicates that polymorphisms of the ApoE and the BDNF genes could affect disease progression in preclinical AD and implies that the Met-BDNF polymorphism could be an additional risk factor for rapid disease progression in preclinical AD.
18786162	2009	Genes Brain Behav.	1601-183X	ALL_TEXT_3/3	3	10	627	SYMBOL|DICTIONARY|EXTRACTED	bdnf	BDNF	166#170	18786162-2-80-113	D000544	SYMBOL|EXTRACTED	ad	AD	264#266	18786162-1-121-140	The present preliminary study indicates that polymorphisms of the ApoE and the BDNF genes could affect disease progression in preclinical AD and implies that the Met-BDNF polymorphism could be an additional risk factor for rapid disease progression in preclinical AD.
18001531	2008	Zhonghua Yi Xue Za Zhi	0376-2491	OBJECTIVE	1	1	3990	LONGTERM|DICTIONARY	hepatic lipase	hepatic lipase	124#138	NaN	D002544	LONGTERM|DISEASE|DN|DICTIONARY	cerebral infarction	cerebral infarction	195#214		To investigate the single nucleotide polymorphism (SNP), the distribution of their haplotypes and linkage disequilibrium of hepatic lipase (HL) gene promoter 250G/A, 514C/T, 710T/C and 763A/G in cerebral infarction patients of Shanghai.
18001531	2008	Zhonghua Yi Xue Za Zhi	0376-2491	OBJECTIVE	1	1	3990	LONGTERM|DICTIONARY	hepatic lipase	hepatic lipase	124#138	NaN	D056486	LONGTERM|DICTIONARY	hepatic lipase	hepatic lipase	124#138	NaN	To investigate the single nucleotide polymorphism (SNP), the distribution of their haplotypes and linkage disequilibrium of hepatic lipase (HL) gene promoter 250G/A, 514C/T, 710T/C and 763A/G in cerebral infarction patients of Shanghai.
18001531	2008	Zhonghua Yi Xue Za Zhi	0376-2491	OBJECTIVE	1	1	3990	LONGTERM|DICTIONARY	hepatic lipase	hepatic lipase	124#138	NaN	D056486	LONGTERM|DICTIONARY	hl	HL	140#142	NaN	To investigate the single nucleotide polymorphism (SNP), the distribution of their haplotypes and linkage disequilibrium of hepatic lipase (HL) gene promoter 250G/A, 514C/T, 710T/C and 763A/G in cerebral infarction patients of Shanghai.
18001531	2008	Zhonghua Yi Xue Za Zhi	0376-2491	OBJECTIVE	1	1	3990	LONGTERM|DICTIONARY	hl	HL	140#142	NaN	D002544	LONGTERM|DISEASE|DN|DICTIONARY	cerebral infarction	cerebral infarction	195#214		To investigate the single nucleotide polymorphism (SNP), the distribution of their haplotypes and linkage disequilibrium of hepatic lipase (HL) gene promoter 250G/A, 514C/T, 710T/C and 763A/G in cerebral infarction patients of Shanghai.
18001531	2008	Zhonghua Yi Xue Za Zhi	0376-2491	OBJECTIVE	1	1	3990	LONGTERM|DICTIONARY	hl	HL	140#142	NaN	D056486	LONGTERM|DICTIONARY	hepatic lipase	hepatic lipase	124#138	NaN	To investigate the single nucleotide polymorphism (SNP), the distribution of their haplotypes and linkage disequilibrium of hepatic lipase (HL) gene promoter 250G/A, 514C/T, 710T/C and 763A/G in cerebral infarction patients of Shanghai.
18001531	2008	Zhonghua Yi Xue Za Zhi	0376-2491	OBJECTIVE	1	1	3990	LONGTERM|DICTIONARY	hl	HL	140#142	NaN	D056486	LONGTERM|DICTIONARY	hl	HL	140#142	NaN	To investigate the single nucleotide polymorphism (SNP), the distribution of their haplotypes and linkage disequilibrium of hepatic lipase (HL) gene promoter 250G/A, 514C/T, 710T/C and 763A/G in cerebral infarction patients of Shanghai.
9823305	1998	Cancer Res.	0008-5472	ALL_TEXT_3/3	3	9	5241	LONGTERM|GENE|GT|DICTIONARY	progesterone receptor	progesterone receptor	132#153		D001943	LONGTERM|DICTIONARY	breast cancers	breast cancers	163#177		Caucasian patients with the m1 Val/Val genotype have a significantly higher percentage of estrogen receptor-positive (P = 0.02) and progesterone receptor-positive breast cancers (P = 0.003).
11422615	2001	J. Gastroenterol. Hepatol.	0815-9319	METHODS	2	2	9	LONGTERM|DICTIONARY	n acetyltransferase 1	N-acetyltransferase 1	41#62		D015179	LONGTERM|DISEASE|DT|DICTIONARY	colorectal cancer	colorectal cancer	236#253		The frequency of polymorphisms involving N-acetyltransferase 1 (NAT1), NAT2, cytochrome P450 1A1 (CYP1A1), CYP2D6, CYP2E1, glutathione S-transferase M1 (GSTM1), GSTT1 and apolipoprotein E were compared in 219 white adults with sporadic colorectal cancer and 200 white controls attending for blood donation at a blood bank.
11422615	2001	J. Gastroenterol. Hepatol.	0815-9319	METHODS	2	2	9	SYMBOL|()|DICTIONARY|EXTRACTED	nat1	NAT1	64#68	11422615-2-41-62	D015179	LONGTERM|DISEASE|DT|DICTIONARY	colorectal cancer	colorectal cancer	236#253		The frequency of polymorphisms involving N-acetyltransferase 1 (NAT1), NAT2, cytochrome P450 1A1 (CYP1A1), CYP2D6, CYP2E1, glutathione S-transferase M1 (GSTM1), GSTT1 and apolipoprotein E were compared in 219 white adults with sporadic colorectal cancer and 200 white controls attending for blood donation at a blood bank.
11422615	2001	J. Gastroenterol. Hepatol.	0815-9319	METHODS	2	2	10	SYMBOL|DICTIONARY	nat2	NAT2	71#75		D015179	LONGTERM|DISEASE|DT|DICTIONARY	colorectal cancer	colorectal cancer	236#253		The frequency of polymorphisms involving N-acetyltransferase 1 (NAT1), NAT2, cytochrome P450 1A1 (CYP1A1), CYP2D6, CYP2E1, glutathione S-transferase M1 (GSTM1), GSTT1 and apolipoprotein E were compared in 219 white adults with sporadic colorectal cancer and 200 white controls attending for blood donation at a blood bank.
11422615	2001	J. Gastroenterol. Hepatol.	0815-9319	METHODS	2	2	1543	LONGTERM|DICTIONARY	cytochrome p450 1a1	cytochrome P450 1A1	77#96		D015179	LONGTERM|DISEASE|DT|DICTIONARY	colorectal cancer	colorectal cancer	236#253		The frequency of polymorphisms involving N-acetyltransferase 1 (NAT1), NAT2, cytochrome P450 1A1 (CYP1A1), CYP2D6, CYP2E1, glutathione S-transferase M1 (GSTM1), GSTT1 and apolipoprotein E were compared in 219 white adults with sporadic colorectal cancer and 200 white controls attending for blood donation at a blood bank.
11422615	2001	J. Gastroenterol. Hepatol.	0815-9319	METHODS	2	2	1543	SYMBOL|()|DICTIONARY|EXTRACTED	cyp1a1	CYP1A1	98#104	11422615-2-77-96	D015179	LONGTERM|DISEASE|DT|DICTIONARY	colorectal cancer	colorectal cancer	236#253		The frequency of polymorphisms involving N-acetyltransferase 1 (NAT1), NAT2, cytochrome P450 1A1 (CYP1A1), CYP2D6, CYP2E1, glutathione S-transferase M1 (GSTM1), GSTT1 and apolipoprotein E were compared in 219 white adults with sporadic colorectal cancer and 200 white controls attending for blood donation at a blood bank.
11422615	2001	J. Gastroenterol. Hepatol.	0815-9319	METHODS	2	2	1565	SYMBOL|DICTIONARY	cyp2d6	CYP2D6	107#113		D015179	LONGTERM|DISEASE|DT|DICTIONARY	colorectal cancer	colorectal cancer	236#253		The frequency of polymorphisms involving N-acetyltransferase 1 (NAT1), NAT2, cytochrome P450 1A1 (CYP1A1), CYP2D6, CYP2E1, glutathione S-transferase M1 (GSTM1), GSTT1 and apolipoprotein E were compared in 219 white adults with sporadic colorectal cancer and 200 white controls attending for blood donation at a blood bank.
11422615	2001	J. Gastroenterol. Hepatol.	0815-9319	METHODS	2	2	1571	SYMBOL|DICTIONARY	cyp2e1	CYP2E1	115#121		D015179	LONGTERM|DISEASE|DT|DICTIONARY	colorectal cancer	colorectal cancer	236#253		The frequency of polymorphisms involving N-acetyltransferase 1 (NAT1), NAT2, cytochrome P450 1A1 (CYP1A1), CYP2D6, CYP2E1, glutathione S-transferase M1 (GSTM1), GSTT1 and apolipoprotein E were compared in 219 white adults with sporadic colorectal cancer and 200 white controls attending for blood donation at a blood bank.
11422615	2001	J. Gastroenterol. Hepatol.	0815-9319	METHODS	2	2	2944	LONGTERM|DICTIONARY	glutathione s transferase m1	glutathione S-transferase M1	123#151		D015179	LONGTERM|DISEASE|DT|DICTIONARY	colorectal cancer	colorectal cancer	236#253		The frequency of polymorphisms involving N-acetyltransferase 1 (NAT1), NAT2, cytochrome P450 1A1 (CYP1A1), CYP2D6, CYP2E1, glutathione S-transferase M1 (GSTM1), GSTT1 and apolipoprotein E were compared in 219 white adults with sporadic colorectal cancer and 200 white controls attending for blood donation at a blood bank.
11422615	2001	J. Gastroenterol. Hepatol.	0815-9319	METHODS	2	2	2944	SYMBOL|()|DICTIONARY|EXTRACTED	gstm1	GSTM1	153#158	11422615-2-123-151	D015179	LONGTERM|DISEASE|DT|DICTIONARY	colorectal cancer	colorectal cancer	236#253		The frequency of polymorphisms involving N-acetyltransferase 1 (NAT1), NAT2, cytochrome P450 1A1 (CYP1A1), CYP2D6, CYP2E1, glutathione S-transferase M1 (GSTM1), GSTT1 and apolipoprotein E were compared in 219 white adults with sporadic colorectal cancer and 200 white controls attending for blood donation at a blood bank.
11422615	2001	J. Gastroenterol. Hepatol.	0815-9319	METHODS	2	2	2952	SYMBOL|DICTIONARY	gstt1	GSTT1	161#166		D015179	LONGTERM|DISEASE|DT|DICTIONARY	colorectal cancer	colorectal cancer	236#253		The frequency of polymorphisms involving N-acetyltransferase 1 (NAT1), NAT2, cytochrome P450 1A1 (CYP1A1), CYP2D6, CYP2E1, glutathione S-transferase M1 (GSTM1), GSTT1 and apolipoprotein E were compared in 219 white adults with sporadic colorectal cancer and 200 white controls attending for blood donation at a blood bank.
11422615	2001	J. Gastroenterol. Hepatol.	0815-9319	METHODS	2	2	348	LONGTERM|DICTIONARY	apolipoprotein e	apolipoprotein E	171#187		D015179	LONGTERM|DISEASE|DT|DICTIONARY	colorectal cancer	colorectal cancer	236#253		The frequency of polymorphisms involving N-acetyltransferase 1 (NAT1), NAT2, cytochrome P450 1A1 (CYP1A1), CYP2D6, CYP2E1, glutathione S-transferase M1 (GSTM1), GSTT1 and apolipoprotein E were compared in 219 white adults with sporadic colorectal cancer and 200 white controls attending for blood donation at a blood bank.
14713779	2004	J. Urol.	0022-5347	CONCLUSIONS	4	10	4953	SYMBOL|DICTIONARY|EXTRACTED	odc	ODC	4#7	14713779-1-79-102	D011471	LONGTERM|DISEASE|DT|DICTIONARY	prostate cancer	prostate cancer	87#102		The ODC A allele was not associated with a statistically significant increased risk of prostate cancer.
16257277	2006	Bone	8756-3282	CONCLUSIONS	4	9	3553	SYMBOL|GENE|GN|DICTIONARY	il1b	IL1B	53#57		D010001	SYMBOL|EXTRACTED	pdb	PDB	130#133	16257277-1-73-94	Our results suggest that the -511 CC genotype of the IL1B gene could be related to resistance to bisphosphonates in patients with PDB.
19891592	2010	DNA Cell Biol.	1557-7430	ALL_TEXT_1/3	1	1	4627	SYMBOL|()|DICTIONARY	myh9	MYH9	33#37		D002972	LONGTERM|DICTIONARY	cleft palate	cleft palate	142#154		Myosin heavy chain 9, nonmuscle (MYH9) and environmental factors have been shown to be associated with nonsyndromic cleft lip with or without cleft palate in several populations.
19891592	2010	DNA Cell Biol.	1557-7430	ALL_TEXT_1/3	1	1	4627	SYMBOL|()|DICTIONARY	myh9	MYH9	33#37		D002971	LONGTERM|DICTIONARY	nonsyndromic cleft lip	nonsyndromic cleft lip	103#125	NaN	Myosin heavy chain 9, nonmuscle (MYH9) and environmental factors have been shown to be associated with nonsyndromic cleft lip with or without cleft palate in several populations.
20854105	2011	Genet Test Mol Biomarkers	1945-0257	TITLE	0	0	9156	SYMBOL|DICTIONARY|EXTRACTED	exo1	EXO1	10#14		D015179	LONGTERM|DISEASE|DT|DICTIONARY	colorectal cancer	colorectal cancer	49#66		Impact of EXO1 polymorphism in susceptibility to colorectal cancer.
19891592	2010	DNA Cell Biol.	1557-7430	ALL_TEXT_1/3	1	2	4627	SYMBOL|DICTIONARY	myh9	MYH9	47#51		C566121	LONGTERM|DICTIONARY	orofacial cleft	orofacial cleft	94#109		Our study aimed to confirm the contribution of MYH9 and environmental factors to nonsyndromic orofacial cleft risk in western Han Chinese.
15024131	2004	Proc. Natl. Acad. Sci. U.S.A.	0027-8424	ALL_TEXT_3/3	3	7	925	LONGTERM|DICTIONARY	cd8	CD8	178#181	NaN	D004342	LONGTERM|DICTIONARY	hypersensitivity	hypersensitivity	26#42	NaN	Individuals with abacavir hypersensitivity demonstrated increased monocyte tumor necrosis factor expression in response to ex vivo abacavir stimulation, which was abrogated with CD8(+) T cell depletion.
12728975	2003	J Chin Med Assoc	1726-4901	CONCLUSIONS	4	10	183	SYMBOL|DICTIONARY|EXTRACTED	agt	AGT	3#6	12728975-1-78-93	D003928	LONGTERM|DICTIONARY	diabetic nephropathy	diabetic nephropathy	107#127		In AGT point mutation at 235, there were significantly higher frequencies of alleles, but not genotypes in diabetic nephropathy.
17352815	2007	BMC Med. Genet.	1471-2350	CONCLUSION	4	10	1072	SYMBOL|GENE|GN|DICTIONARY	cfl1	CFL1	32#36		D016135	LONGTERM|DICTIONARY	spina bifida	spina bifida	68#80		The sequence variation of human CFL1 gene is a genetic modifier for spina bifida risk in this California population.
26095815	2016	Placenta	1532-3102	DISCUSSION	4	12	23526	LONGTERM|DICTIONARY	ha-1	HA-1	10#14	NaN	D011225	LONGTERM|DICTIONARY	preeclampsia	preeclampsia	218#230	NaN	Increased HA-1 expression, combined with increased preeclamptic syncytiotrophoblast deportation, provides a novel potential mechanism for exposure of the maternal immune system to increased fetal antigenic load during preeclampsia.
7902317	1994	Hum. Genet.	0340-6717	ALL_TEXT_1/3	1	1	410	LONGTERM|DICTIONARY	arylsulfatase a	arylsulfatase A	140#155		D007966	LONGTERM|DICTIONARY	metachromatic leukodystrophy	Metachromatic leukodystrophy	0#28		Metachromatic leukodystrophy (MLD) is a lysosomal storage disease with autosomal recessive inheritance caused by a deficiency of the enzyme arylsulfatase A (ASA).
7902317	1994	Hum. Genet.	0340-6717	ALL_TEXT_1/3	1	1	410	LONGTERM|DICTIONARY	arylsulfatase a	arylsulfatase A	140#155		D007966	SYMBOL|()|DICTIONARY|EXTRACTED	mld	MLD	30#33	7902317-1-0-28	Metachromatic leukodystrophy (MLD) is a lysosomal storage disease with autosomal recessive inheritance caused by a deficiency of the enzyme arylsulfatase A (ASA).
7902317	1994	Hum. Genet.	0340-6717	ALL_TEXT_1/3	1	1	410	LONGTERM|DICTIONARY	arylsulfatase a	arylsulfatase A	140#155		D016464	LONGTERM|DISEASE|DT|DICTIONARY	lysosomal storage disease	lysosomal storage disease	40#65		Metachromatic leukodystrophy (MLD) is a lysosomal storage disease with autosomal recessive inheritance caused by a deficiency of the enzyme arylsulfatase A (ASA).
18442637	2008	Metab. Clin. Exp.	0026-0495	TITLE	0	0	1312	LONGTERM|DICTIONARY	catechol o methyltransferase	Catechol O-methyltransferase	0#28		D056128	LONGTERM|DICTIONARY	abdominal obesity	abdominal obesity	72#89		Catechol O-methyltransferase val158-met polymorphism is associated with abdominal obesity and blood pressure in men.
18442637	2008	Metab. Clin. Exp.	0026-0495	ALL_TEXT_1/3	1	1	1312	LONGTERM|DICTIONARY	catechol o methyltransferase	Catechol O-methyltransferase	0#28		D009765	LONGTERM|DICTIONARY	obesity	obesity	153#160		Catechol O-methyltransferase (COMT) degrades catecholamines and estrogens, both of which are of known importance for cardiovascular risk factors such as obesity and hypertension.
18442637	2008	Metab. Clin. Exp.	0026-0495	ALL_TEXT_1/3	1	1	1312	LONGTERM|DICTIONARY	catechol o methyltransferase	Catechol O-methyltransferase	0#28		D006973	LONGTERM|DICTIONARY	hypertension	hypertension	165#177		Catechol O-methyltransferase (COMT) degrades catecholamines and estrogens, both of which are of known importance for cardiovascular risk factors such as obesity and hypertension.
18442637	2008	Metab. Clin. Exp.	0026-0495	ALL_TEXT_1/3	1	1	1312	SYMBOL|()|DICTIONARY|EXTRACTED	comt	COMT	30#34	18442637-1-0-28	D009765	LONGTERM|DICTIONARY	obesity	obesity	153#160		Catechol O-methyltransferase (COMT) degrades catecholamines and estrogens, both of which are of known importance for cardiovascular risk factors such as obesity and hypertension.
18442637	2008	Metab. Clin. Exp.	0026-0495	ALL_TEXT_1/3	1	1	1312	SYMBOL|()|DICTIONARY|EXTRACTED	comt	COMT	30#34	18442637-1-0-28	D006973	LONGTERM|DICTIONARY	hypertension	hypertension	165#177		Catechol O-methyltransferase (COMT) degrades catecholamines and estrogens, both of which are of known importance for cardiovascular risk factors such as obesity and hypertension.
20047977	2010	Am. J. Epidemiol.	1476-6256	TITLE	0	0	7124	LONGTERM|GENE|GT|DICTIONARY	tumor necrosis factor	Tumor necrosis factor	0#21		D008228	LONGTERM|DICTIONARY	non hodgkin lymphoma	non-Hodgkin lymphoma	82#102		Tumor necrosis factor (TNF) and lymphotoxin-alpha (LTA) polymorphisms and risk of non-Hodgkin lymphoma in the InterLymph Consortium.
20047977	2010	Am. J. Epidemiol.	1476-6256	TITLE	0	0	7124	SYMBOL|()|DICTIONARY|EXTRACTED	tnf	TNF	23#26	20047977-0-0-21	D008228	LONGTERM|DICTIONARY	non hodgkin lymphoma	non-Hodgkin lymphoma	82#102		Tumor necrosis factor (TNF) and lymphotoxin-alpha (LTA) polymorphisms and risk of non-Hodgkin lymphoma in the InterLymph Consortium.
20047977	2010	Am. J. Epidemiol.	1476-6256	TITLE	0	0	4049	LONGTERM|DICTIONARY	lymphotoxin alpha	lymphotoxin-alpha	32#49		D008228	LONGTERM|DICTIONARY	non hodgkin lymphoma	non-Hodgkin lymphoma	82#102		Tumor necrosis factor (TNF) and lymphotoxin-alpha (LTA) polymorphisms and risk of non-Hodgkin lymphoma in the InterLymph Consortium.
16135441	2005	Yi Chuan	0253-9772	ALL_TEXT_3/3	3	6	5630	SYMBOL|GENE|GN|DICTIONARY	prph	PRPH	43#47		D009216	LONGTERM|DICTIONARY	high myopia	high myopia	77#88		We found no evidence that mutations in the PRPH gene are responsible for the high myopia in Chinese.
21151597	2011	Mol. Vis.	1090-0535	CONCLUSIONS	4	8	149233	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	il23r	IL23R	61#66	21151597-1-80-103	D005642	LONGTERM|DICTIONARY	fuchs' syndrome	Fuchs' syndrome	91#106	NaN	Our results suggested that the rs11209032 AA genotype of the IL23R gene may predispose for Fuchs' syndrome in Chinese patients.
16135441	2005	Yi Chuan	0253-9772	TITLE	0	0	5630	LONGTERM|GENE|GN|DICTIONARY	peripherin	peripherin	18#28		D009216	LONGTERM|DICTIONARY	high myopia	high myopia	61#72		[Variation of the peripherin gene in Chinese with or without high myopia].
16135441	2005	Yi Chuan	0253-9772	ALL_TEXT_1/3	1	1	5630	LONGTERM|GENE|GN|DICTIONARY	peripherin	peripherin	35#45		D009216	LONGTERM|DICTIONARY	high myopia	high myopia	83#94		To analyze the relationship of the peripherin gene(PRPH, OMIM17071) mutations with high myopia,genomic DNA was collected from 180 probands with high myopia (<or=-6.0 dipoters) and 60 unrelated persons without high myopia.
16135441	2005	Yi Chuan	0253-9772	ALL_TEXT_1/3	1	1	5630	LONGTERM|GENE|GN|DICTIONARY	peripherin	peripherin	35#45		D009216	LONGTERM|DICTIONARY	high myopia	high myopia	144#155		To analyze the relationship of the peripherin gene(PRPH, OMIM17071) mutations with high myopia,genomic DNA was collected from 180 probands with high myopia (<or=-6.0 dipoters) and 60 unrelated persons without high myopia.
16135441	2005	Yi Chuan	0253-9772	ALL_TEXT_1/3	1	1	5630	LONGTERM|GENE|GN|DICTIONARY	peripherin	peripherin	35#45		D009216	LONGTERM|DICTIONARY	high myopia	high myopia	209#220		To analyze the relationship of the peripherin gene(PRPH, OMIM17071) mutations with high myopia,genomic DNA was collected from 180 probands with high myopia (<or=-6.0 dipoters) and 60 unrelated persons without high myopia.
16135441	2005	Yi Chuan	0253-9772	ALL_TEXT_1/3	1	1	5630	SYMBOL|DICTIONARY	prph	PRPH	51#55		D009216	LONGTERM|DICTIONARY	high myopia	high myopia	83#94		To analyze the relationship of the peripherin gene(PRPH, OMIM17071) mutations with high myopia,genomic DNA was collected from 180 probands with high myopia (<or=-6.0 dipoters) and 60 unrelated persons without high myopia.
16135441	2005	Yi Chuan	0253-9772	ALL_TEXT_1/3	1	1	5630	SYMBOL|DICTIONARY	prph	PRPH	51#55		D009216	LONGTERM|DICTIONARY	high myopia	high myopia	144#155		To analyze the relationship of the peripherin gene(PRPH, OMIM17071) mutations with high myopia,genomic DNA was collected from 180 probands with high myopia (<or=-6.0 dipoters) and 60 unrelated persons without high myopia.
16135441	2005	Yi Chuan	0253-9772	ALL_TEXT_1/3	1	1	5630	SYMBOL|DICTIONARY	prph	PRPH	51#55		D009216	LONGTERM|DICTIONARY	high myopia	high myopia	209#220		To analyze the relationship of the peripherin gene(PRPH, OMIM17071) mutations with high myopia,genomic DNA was collected from 180 probands with high myopia (<or=-6.0 dipoters) and 60 unrelated persons without high myopia.
12377406	2002	Cancer Genet. Cytogenet.	0165-4608	ALL_TEXT_1/3	1	1	10728	SYMBOL|DICTIONARY	p23	p23	17#20		D011471	LONGTERM|DISEASE|DT|DICTIONARY	prostate cancer	prostate cancer	94#109		The 8p22 through p23 region has been identified as a potential site for genes associated with prostate cancer.
17907287	2007	World J. Gastroenterol.	1007-9327	TITLE	0	0	10392	SYMBOL|()|DICTIONARY	nod1	NOD1	52#56		D003424	LONGTERM|DISEASE|DN|DT|DICTIONARY	crohn disease	Crohn's disease	98#113		Influence of a nucleotide oligomerization domain 1 (NOD1) polymorphism and NOD2 mutant alleles on Crohn's disease phenotype.
17907287	2007	World J. Gastroenterol.	1007-9327	TITLE	0	0	64127	SYMBOL|DICTIONARY	nod2	NOD2	75#79		D003424	LONGTERM|DISEASE|DN|DT|DICTIONARY	crohn disease	Crohn's disease	98#113		Influence of a nucleotide oligomerization domain 1 (NOD1) polymorphism and NOD2 mutant alleles on Crohn's disease phenotype.
17907287	2007	World J. Gastroenterol.	1007-9327	AIM	1	1	10392	SYMBOL|()|DICTIONARY	nod1	NOD1	69#73		D003424	LONGTERM|DISEASE|DN|DT|DICTIONARY	crohn disease	Crohn's disease	116#131		To examine genetic variation of nucleotide oligomerization domain 1 (NOD1) and NOD2, their respective influences on Crohn's disease phenotype and gene-gene interactions.
17907287	2007	World J. Gastroenterol.	1007-9327	AIM	1	1	64127	SYMBOL|DICTIONARY	nod2	NOD2	79#83		D003424	LONGTERM|DISEASE|DN|DT|DICTIONARY	crohn disease	Crohn's disease	116#131		To examine genetic variation of nucleotide oligomerization domain 1 (NOD1) and NOD2, their respective influences on Crohn's disease phenotype and gene-gene interactions.
15901993	2005	Eur. J. Cancer Prev.	0959-8278	ALL_TEXT_1/3	1	2	1544	SYMBOL|DICTIONARY	cyp1a2	CYP1A2	61#67		D018281	LONGTERM|DICTIONARY	cholangiocarcinoma	cholangiocarcinoma	101#119		The present study aimed to evaluate the relationship between CYP1A2, NAT1 and NAT2 polymorphisms and cholangiocarcinoma (CCA), the most prevalent cancer in the north-east of Thailand.
15901993	2005	Eur. J. Cancer Prev.	0959-8278	ALL_TEXT_1/3	1	2	1544	SYMBOL|DICTIONARY	cyp1a2	CYP1A2	61#67		D018281	SYMBOL|()|DICTIONARY|EXTRACTED	cca	CCA	121#124	15901993-2-101-119	The present study aimed to evaluate the relationship between CYP1A2, NAT1 and NAT2 polymorphisms and cholangiocarcinoma (CCA), the most prevalent cancer in the north-east of Thailand.
15901993	2005	Eur. J. Cancer Prev.	0959-8278	ALL_TEXT_1/3	1	2	1544	SYMBOL|DICTIONARY	cyp1a2	CYP1A2	61#67		D009369	LONGTERM|DISEASE|DT|DICTIONARY	cancer	cancer	146#152		The present study aimed to evaluate the relationship between CYP1A2, NAT1 and NAT2 polymorphisms and cholangiocarcinoma (CCA), the most prevalent cancer in the north-east of Thailand.
15901993	2005	Eur. J. Cancer Prev.	0959-8278	ALL_TEXT_1/3	1	2	9	SYMBOL|DICTIONARY	nat1	NAT1	69#73		D018281	LONGTERM|DICTIONARY	cholangiocarcinoma	cholangiocarcinoma	101#119		The present study aimed to evaluate the relationship between CYP1A2, NAT1 and NAT2 polymorphisms and cholangiocarcinoma (CCA), the most prevalent cancer in the north-east of Thailand.
15901993	2005	Eur. J. Cancer Prev.	0959-8278	ALL_TEXT_1/3	1	2	9	SYMBOL|DICTIONARY	nat1	NAT1	69#73		D018281	SYMBOL|()|DICTIONARY|EXTRACTED	cca	CCA	121#124	15901993-2-101-119	The present study aimed to evaluate the relationship between CYP1A2, NAT1 and NAT2 polymorphisms and cholangiocarcinoma (CCA), the most prevalent cancer in the north-east of Thailand.
15901993	2005	Eur. J. Cancer Prev.	0959-8278	ALL_TEXT_1/3	1	2	9	SYMBOL|DICTIONARY	nat1	NAT1	69#73		D009369	LONGTERM|DISEASE|DT|DICTIONARY	cancer	cancer	146#152		The present study aimed to evaluate the relationship between CYP1A2, NAT1 and NAT2 polymorphisms and cholangiocarcinoma (CCA), the most prevalent cancer in the north-east of Thailand.
15901993	2005	Eur. J. Cancer Prev.	0959-8278	ALL_TEXT_1/3	1	2	10	SYMBOL|DICTIONARY	nat2	NAT2	78#82		D018281	LONGTERM|DICTIONARY	cholangiocarcinoma	cholangiocarcinoma	101#119		The present study aimed to evaluate the relationship between CYP1A2, NAT1 and NAT2 polymorphisms and cholangiocarcinoma (CCA), the most prevalent cancer in the north-east of Thailand.
15901993	2005	Eur. J. Cancer Prev.	0959-8278	ALL_TEXT_1/3	1	2	10	SYMBOL|DICTIONARY	nat2	NAT2	78#82		D018281	SYMBOL|()|DICTIONARY|EXTRACTED	cca	CCA	121#124	15901993-2-101-119	The present study aimed to evaluate the relationship between CYP1A2, NAT1 and NAT2 polymorphisms and cholangiocarcinoma (CCA), the most prevalent cancer in the north-east of Thailand.
15901993	2005	Eur. J. Cancer Prev.	0959-8278	ALL_TEXT_1/3	1	2	10	SYMBOL|DICTIONARY	nat2	NAT2	78#82		D009369	LONGTERM|DISEASE|DT|DICTIONARY	cancer	cancer	146#152		The present study aimed to evaluate the relationship between CYP1A2, NAT1 and NAT2 polymorphisms and cholangiocarcinoma (CCA), the most prevalent cancer in the north-east of Thailand.
15901993	2005	Eur. J. Cancer Prev.	0959-8278	TITLE	0	0	1544	SYMBOL|DICTIONARY	cyp1a2	CYP1A2	45#51		D018281	LONGTERM|DICTIONARY	cholangiocarcinoma	cholangiocarcinoma	113#131		Association between genetic polymorphisms of CYP1A2, arylamine N-acetyltransferase 1 and 2 and susceptibility to cholangiocarcinoma.
15901993	2005	Eur. J. Cancer Prev.	0959-8278	ALL_TEXT_1/3	1	1	1544	SYMBOL|DICTIONARY	cyp1a2	CYP1A2	6#12		D009369	LONGTERM|DICTIONARY	cancers	cancers	284#291		Human CYP1A2 and arylamine N-acetyltransferases, which are encoded by the polymorphic CYP1A2 and NAT genes respectively, have been shown to have wide interindividual variations in metabolic capacity and may be potential modifiers of an individual's susceptibility to certain types of cancers.
15901993	2005	Eur. J. Cancer Prev.	0959-8278	ALL_TEXT_1/3	1	1	1544	SYMBOL|DICTIONARY	cyp1a2	CYP1A2	86#92		D009369	LONGTERM|DICTIONARY	cancers	cancers	284#291		Human CYP1A2 and arylamine N-acetyltransferases, which are encoded by the polymorphic CYP1A2 and NAT genes respectively, have been shown to have wide interindividual variations in metabolic capacity and may be potential modifiers of an individual's susceptibility to certain types of cancers.
15901993	2005	Eur. J. Cancer Prev.	0959-8278	ALL_TEXT_1/3	1	1	6046	SYMBOL|GENE|GN|DICTIONARY	nat	NAT	97#100		D009369	LONGTERM|DICTIONARY	cancers	cancers	284#291		Human CYP1A2 and arylamine N-acetyltransferases, which are encoded by the polymorphic CYP1A2 and NAT genes respectively, have been shown to have wide interindividual variations in metabolic capacity and may be potential modifiers of an individual's susceptibility to certain types of cancers.
15901993	2005	Eur. J. Cancer Prev.	0959-8278	ALL_TEXT_3/3	3	7	10	SYMBOL|DICTIONARY	nat2	NAT2	29#33		D018281	SYMBOL|DICTIONARY|EXTRACTED	cca	CCA	87#90	15901993-2-101-119	This study suggests that the NAT2 polymorphism may be a modifier of individual risk to CCA.
17907287	2007	World J. Gastroenterol.	1007-9327	RESULTS	3	8	64127	SYMBOL|DICTIONARY	nod2	NOD2	22#26		D004194	LONGTERM|DICTIONARY	disease vs 2	disease vs 2	230#242	NaN	L1007finsC and double NOD2 mutation conferred the highest risk for severity of disease (26.3% with penetrating disease vs 3.8% with non-penetrating or stricturing behavior presented L1007finsC, P = 0.01 and 21.0% with penetrating disease vs 2.5% with non-penentrating or stricturing behavior carried double NOD2 mutation, P = 0.007).
17907287	2007	World J. Gastroenterol.	1007-9327	RESULTS	3	8	64127	SYMBOL|DICTIONARY	nod2	NOD2	307#311		D004194	LONGTERM|DICTIONARY	disease vs 2	disease vs 2	230#242	NaN	L1007finsC and double NOD2 mutation conferred the highest risk for severity of disease (26.3% with penetrating disease vs 3.8% with non-penetrating or stricturing behavior presented L1007finsC, P = 0.01 and 21.0% with penetrating disease vs 2.5% with non-penentrating or stricturing behavior carried double NOD2 mutation, P = 0.007).
17714919	2008	J. Dermatol. Sci.	0923-1811	RESULTS	4	6	3558	SYMBOL|DICTIONARY	il 2	IL-2	23#27		D011565	LONGTERM|DISEASE|DN|DICTIONARY	psoriasis	psoriasis	191#200		The combined effect of IL-2 -330*G and IL-4 -590*C showed that the positive combination of IL-2 -330*G and IL-4 -590*C alleles were more significantly associated with the late-onset group of psoriasis patients than the controls.
17714919	2008	J. Dermatol. Sci.	0923-1811	RESULTS	4	6	3565	SYMBOL|DICTIONARY	il 4	IL-4	39#43		D011565	LONGTERM|DISEASE|DN|DICTIONARY	psoriasis	psoriasis	191#200		The combined effect of IL-2 -330*G and IL-4 -590*C showed that the positive combination of IL-2 -330*G and IL-4 -590*C alleles were more significantly associated with the late-onset group of psoriasis patients than the controls.
17714919	2008	J. Dermatol. Sci.	0923-1811	RESULTS	4	6	3558	SYMBOL|DICTIONARY	il 2	IL-2	91#95		D011565	LONGTERM|DISEASE|DN|DICTIONARY	psoriasis	psoriasis	191#200		The combined effect of IL-2 -330*G and IL-4 -590*C showed that the positive combination of IL-2 -330*G and IL-4 -590*C alleles were more significantly associated with the late-onset group of psoriasis patients than the controls.
17714919	2008	J. Dermatol. Sci.	0923-1811	RESULTS	4	6	3565	SYMBOL|DICTIONARY	il 4	IL-4	107#111		D011565	LONGTERM|DISEASE|DN|DICTIONARY	psoriasis	psoriasis	191#200		The combined effect of IL-2 -330*G and IL-4 -590*C showed that the positive combination of IL-2 -330*G and IL-4 -590*C alleles were more significantly associated with the late-onset group of psoriasis patients than the controls.
17714919	2008	J. Dermatol. Sci.	0923-1811	CONCLUSIONS	5	7	3558	SYMBOL|DICTIONARY	il 2	IL-2	56#60		D011565	LONGTERM|DICTIONARY	psoriasis	psoriasis	98#107		These results suggest that the genetic polymorphisms of IL-2 and IL-4 genes can be susceptible to psoriasis in Korean, especially late-onset psoriasis group.
17714919	2008	J. Dermatol. Sci.	0923-1811	CONCLUSIONS	5	7	3558	SYMBOL|DICTIONARY	il 2	IL-2	56#60		D011565	LONGTERM|DICTIONARY	psoriasis	psoriasis	141#150		These results suggest that the genetic polymorphisms of IL-2 and IL-4 genes can be susceptible to psoriasis in Korean, especially late-onset psoriasis group.
17714919	2008	J. Dermatol. Sci.	0923-1811	CONCLUSIONS	5	7	3565	SYMBOL|GENE|GN|DICTIONARY	il 4	IL-4	65#69		D011565	LONGTERM|DICTIONARY	psoriasis	psoriasis	98#107		These results suggest that the genetic polymorphisms of IL-2 and IL-4 genes can be susceptible to psoriasis in Korean, especially late-onset psoriasis group.
17714919	2008	J. Dermatol. Sci.	0923-1811	CONCLUSIONS	5	7	3565	SYMBOL|GENE|GN|DICTIONARY	il 4	IL-4	65#69		D011565	LONGTERM|DICTIONARY	psoriasis	psoriasis	141#150		These results suggest that the genetic polymorphisms of IL-2 and IL-4 genes can be susceptible to psoriasis in Korean, especially late-onset psoriasis group.
17714919	2008	J. Dermatol. Sci.	0923-1811	METHODS	3	4	3558	SYMBOL|DICTIONARY	il 2	IL-2	37#41		D011565	LONGTERM|DISEASE|DN|DICTIONARY	psoriasis	psoriasis	132#141		We investigated the polymorphisms of IL-2 -330, IL-4 -590, IL-4 receptor +1902, IL-10 -1082 and -819, and IFN-gamma intron 1 in 114 psoriasis patients and 281 healthy normal controls in Korean.
17714919	2008	J. Dermatol. Sci.	0923-1811	METHODS	3	4	3565	SYMBOL|DICTIONARY	il 4	IL-4	48#52		D011565	LONGTERM|DISEASE|DN|DICTIONARY	psoriasis	psoriasis	132#141		We investigated the polymorphisms of IL-2 -330, IL-4 -590, IL-4 receptor +1902, IL-10 -1082 and -819, and IFN-gamma intron 1 in 114 psoriasis patients and 281 healthy normal controls in Korean.
17714919	2008	J. Dermatol. Sci.	0923-1811	METHODS	3	4	3565	SYMBOL|GENE|GN|DICTIONARY	il 4	IL-4	59#63		D011565	LONGTERM|DISEASE|DN|DICTIONARY	psoriasis	psoriasis	132#141		We investigated the polymorphisms of IL-2 -330, IL-4 -590, IL-4 receptor +1902, IL-10 -1082 and -819, and IFN-gamma intron 1 in 114 psoriasis patients and 281 healthy normal controls in Korean.
17714919	2008	J. Dermatol. Sci.	0923-1811	METHODS	3	4	3586	SYMBOL|DICTIONARY	il 10	IL-10	80#85		D011565	LONGTERM|DISEASE|DN|DICTIONARY	psoriasis	psoriasis	132#141		We investigated the polymorphisms of IL-2 -330, IL-4 -590, IL-4 receptor +1902, IL-10 -1082 and -819, and IFN-gamma intron 1 in 114 psoriasis patients and 281 healthy normal controls in Korean.
17714919	2008	J. Dermatol. Sci.	0923-1811	METHODS	3	4	3458	LONGTERM|DICTIONARY	ifn-gamma	IFN-gamma	106#115	NaN	D011565	LONGTERM|DISEASE|DN|DICTIONARY	psoriasis	psoriasis	132#141		We investigated the polymorphisms of IL-2 -330, IL-4 -590, IL-4 receptor +1902, IL-10 -1082 and -819, and IFN-gamma intron 1 in 114 psoriasis patients and 281 healthy normal controls in Korean.
17714919	2008	J. Dermatol. Sci.	0923-1811	RESULTS	4	5	3558	SYMBOL|DICTIONARY	il 2	IL-2	0#4		D011565	LONGTERM|DISEASE|DN|DICTIONARY	psoriasis	psoriasis	63#72		IL-2 -330*G and IL-4 -590*C alleles significantly increased in psoriasis patients, especially late-onset group, compared to the control.
17714919	2008	J. Dermatol. Sci.	0923-1811	RESULTS	4	5	3565	SYMBOL|DICTIONARY	il 4	IL-4	16#20		D011565	LONGTERM|DISEASE|DN|DICTIONARY	psoriasis	psoriasis	63#72		IL-2 -330*G and IL-4 -590*C alleles significantly increased in psoriasis patients, especially late-onset group, compared to the control.
18285546	2008	Blood	1528-0020	ALL_TEXT_3/3	3	8	5054	SYMBOL|DICTIONARY	pai 1	PAI-1	0#5		D013927	LONGTERM|DICTIONARY	thrombosis	thrombosis	80#90	NaN	PAI-1 polymorphisms and PAI-1 serum levels have previously been associated with thrombosis.
18285546	2008	Blood	1528-0020	ALL_TEXT_3/3	3	8	5054	SYMBOL|DICTIONARY	pai 1	PAI-1	24#29		D013927	LONGTERM|DICTIONARY	thrombosis	thrombosis	80#90	NaN	PAI-1 polymorphisms and PAI-1 serum levels have previously been associated with thrombosis.
18285546	2008	Blood	1528-0020	ALL_TEXT_3/3	3	9	5054	SYMBOL|GENE|GN|DICTIONARY	pai 1	PAI-1	17#22		D010020	LONGTERM|DICTIONARY	osteonecrosis	osteonecrosis	67#80	NaN	We conclude that PAI-1 genetic variation may contribute to risk of osteonecrosis.
17714919	2008	J. Dermatol. Sci.	0923-1811	TITLE	0	0	3558	SYMBOL|DICTIONARY	il 2	IL-2	16#20		D011565	LONGTERM|DICTIONARY	psoriasis	psoriasis	54#63		Associations of IL-2 and IL-4 gene polymorphisms with psoriasis in the Korean population.
17714919	2008	J. Dermatol. Sci.	0923-1811	TITLE	0	0	3565	SYMBOL|GENE|GN|DICTIONARY	il 4	IL-4	25#29		D011565	LONGTERM|DICTIONARY	psoriasis	psoriasis	54#63		Associations of IL-2 and IL-4 gene polymorphisms with psoriasis in the Korean population.
20047977	2010	Am. J. Epidemiol.	1476-6256	ALL_TEXT_3/3	3	8	7124	SYMBOL|DICTIONARY|EXTRACTED	tnf	TNF	72#75	20047977-0-0-21	D016393	SYMBOL|DICTIONARY|EXTRACTED	dlbcl	DLBCL	47#52	20047977-4-171-200	These findings strengthen previous results for DLBCL and the LTA 252A>G/TNF -308A locus and provide robust evidence that these TNF/LTA gene variants, or others in linkage disequilibrium, are involved in NHL etiology.
20047977	2010	Am. J. Epidemiol.	1476-6256	ALL_TEXT_3/3	3	8	7124	SYMBOL|DICTIONARY|EXTRACTED	tnf	TNF	72#75	20047977-0-0-21	D008228	SYMBOL|DICTIONARY|EXTRACTED	nhl	NHL	203#206	20047977-1-194-214	These findings strengthen previous results for DLBCL and the LTA 252A>G/TNF -308A locus and provide robust evidence that these TNF/LTA gene variants, or others in linkage disequilibrium, are involved in NHL etiology.
20047977	2010	Am. J. Epidemiol.	1476-6256	ALL_TEXT_3/3	3	8	7124	SYMBOL|DICTIONARY|EXTRACTED	tnf	TNF	127#130	20047977-0-0-21	D016393	SYMBOL|DICTIONARY|EXTRACTED	dlbcl	DLBCL	47#52	20047977-4-171-200	These findings strengthen previous results for DLBCL and the LTA 252A>G/TNF -308A locus and provide robust evidence that these TNF/LTA gene variants, or others in linkage disequilibrium, are involved in NHL etiology.
20047977	2010	Am. J. Epidemiol.	1476-6256	ALL_TEXT_3/3	3	8	7124	SYMBOL|DICTIONARY|EXTRACTED	tnf	TNF	127#130	20047977-0-0-21	D008228	SYMBOL|DICTIONARY|EXTRACTED	nhl	NHL	203#206	20047977-1-194-214	These findings strengthen previous results for DLBCL and the LTA 252A>G/TNF -308A locus and provide robust evidence that these TNF/LTA gene variants, or others in linkage disequilibrium, are involved in NHL etiology.
18285546	2008	Blood	1528-0020	ALL_TEXT_2/3	2	4	7298	SYMBOL|DICTIONARY	tyms	TYMS	17#21		D010020	LONGTERM|DICTIONARY	osteonecrosis	osteonecrosis	141#154	NaN	Candidate genes (TYMS, MTHFR, ABCB1, BGLAP, ACP5, LRP5, ESR1, PAI-1, VDR, PTH, and PTHR) were chosen based on putative mechanisms underlying osteonecrosis risk.
18285546	2008	Blood	1528-0020	ALL_TEXT_2/3	2	4	4524	SYMBOL|DICTIONARY	mthfr	MTHFR	23#28		D010020	LONGTERM|DICTIONARY	osteonecrosis	osteonecrosis	141#154	NaN	Candidate genes (TYMS, MTHFR, ABCB1, BGLAP, ACP5, LRP5, ESR1, PAI-1, VDR, PTH, and PTHR) were chosen based on putative mechanisms underlying osteonecrosis risk.
18285546	2008	Blood	1528-0020	ALL_TEXT_2/3	2	4	5243	SYMBOL|DICTIONARY	abcb1	ABCB1	30#35		D010020	LONGTERM|DICTIONARY	osteonecrosis	osteonecrosis	141#154	NaN	Candidate genes (TYMS, MTHFR, ABCB1, BGLAP, ACP5, LRP5, ESR1, PAI-1, VDR, PTH, and PTHR) were chosen based on putative mechanisms underlying osteonecrosis risk.
18285546	2008	Blood	1528-0020	ALL_TEXT_2/3	2	4	632	SYMBOL|DICTIONARY	bglap	BGLAP	37#42		D010020	LONGTERM|DICTIONARY	osteonecrosis	osteonecrosis	141#154	NaN	Candidate genes (TYMS, MTHFR, ABCB1, BGLAP, ACP5, LRP5, ESR1, PAI-1, VDR, PTH, and PTHR) were chosen based on putative mechanisms underlying osteonecrosis risk.
18285546	2008	Blood	1528-0020	ALL_TEXT_2/3	2	4	54	SYMBOL|DICTIONARY	acp5	ACP5	44#48		D010020	LONGTERM|DICTIONARY	osteonecrosis	osteonecrosis	141#154	NaN	Candidate genes (TYMS, MTHFR, ABCB1, BGLAP, ACP5, LRP5, ESR1, PAI-1, VDR, PTH, and PTHR) were chosen based on putative mechanisms underlying osteonecrosis risk.
18285546	2008	Blood	1528-0020	ALL_TEXT_2/3	2	4	4041	SYMBOL|DICTIONARY	lrp5	LRP5	50#54		D010020	LONGTERM|DICTIONARY	osteonecrosis	osteonecrosis	141#154	NaN	Candidate genes (TYMS, MTHFR, ABCB1, BGLAP, ACP5, LRP5, ESR1, PAI-1, VDR, PTH, and PTHR) were chosen based on putative mechanisms underlying osteonecrosis risk.
18285546	2008	Blood	1528-0020	ALL_TEXT_2/3	2	4	2099	SYMBOL|DICTIONARY	esr1	ESR1	56#60		D010020	LONGTERM|DICTIONARY	osteonecrosis	osteonecrosis	141#154	NaN	Candidate genes (TYMS, MTHFR, ABCB1, BGLAP, ACP5, LRP5, ESR1, PAI-1, VDR, PTH, and PTHR) were chosen based on putative mechanisms underlying osteonecrosis risk.
18285546	2008	Blood	1528-0020	ALL_TEXT_2/3	2	4	5054	SYMBOL|DICTIONARY	pai 1	PAI-1	62#67		D010020	LONGTERM|DICTIONARY	osteonecrosis	osteonecrosis	141#154	NaN	Candidate genes (TYMS, MTHFR, ABCB1, BGLAP, ACP5, LRP5, ESR1, PAI-1, VDR, PTH, and PTHR) were chosen based on putative mechanisms underlying osteonecrosis risk.
18285546	2008	Blood	1528-0020	ALL_TEXT_2/3	2	4	7421	SYMBOL|DICTIONARY	vdr	VDR	69#72		D010020	LONGTERM|DICTIONARY	osteonecrosis	osteonecrosis	141#154	NaN	Candidate genes (TYMS, MTHFR, ABCB1, BGLAP, ACP5, LRP5, ESR1, PAI-1, VDR, PTH, and PTHR) were chosen based on putative mechanisms underlying osteonecrosis risk.
18285546	2008	Blood	1528-0020	ALL_TEXT_2/3	2	4	5741	SYMBOL|DICTIONARY	pth	PTH	74#77		D010020	LONGTERM|DICTIONARY	osteonecrosis	osteonecrosis	141#154	NaN	Candidate genes (TYMS, MTHFR, ABCB1, BGLAP, ACP5, LRP5, ESR1, PAI-1, VDR, PTH, and PTHR) were chosen based on putative mechanisms underlying osteonecrosis risk.
18285546	2008	Blood	1528-0020	ALL_TEXT_2/3	2	4	5745	SYMBOL|DICTIONARY	pthr	PTHR	83#87		D010020	LONGTERM|DICTIONARY	osteonecrosis	osteonecrosis	141#154	NaN	Candidate genes (TYMS, MTHFR, ABCB1, BGLAP, ACP5, LRP5, ESR1, PAI-1, VDR, PTH, and PTHR) were chosen based on putative mechanisms underlying osteonecrosis risk.
18285546	2008	Blood	1528-0020	ALL_TEXT_2/3	2	6	5054	SYMBOL|DICTIONARY	pai 1	PAI-1	2#7		D010020	LONGTERM|DICTIONARY	osteonecrosis	osteonecrosis	58#71	NaN	A PAI-1 polymorphism (rs6092) was associated with risk of osteonecrosis in univariate (P = .002; odds ratio = 2.79) and multivariate (P = .002; odds ratio = 2.89) analyses (adjusting for gender, age, and treatment arm).
18285546	2008	Blood	1528-0020	ALL_TEXT_3/3	3	7	5054	SYMBOL|DICTIONARY	pai 1	PAI-1	40#45		D010020	LONGTERM|DICTIONARY	osteonecrosis	osteonecrosis	125#138	NaN	Overall, 21 of 78 (26.9%) children with PAI-1 GA/AA genotypes, versus 25 of 214 (11.7%) children with GG genotype, developed osteonecrosis.
18285546	2008	Blood	1528-0020	TITLE	0	0	5054	SYMBOL|DICTIONARY	pai 1	PAI-1	2#7		D054198	LONGTERM|DICTIONARY	acute lymphoblastic leukemia	acute lymphoblastic leukemia	72#100		A PAI-1 (SERPINE1) polymorphism predicts osteonecrosis in children with acute lymphoblastic leukemia: a report from the Children's Oncology Group.
18285546	2008	Blood	1528-0020	TITLE	0	0	5054	SYMBOL|DICTIONARY	pai 1	PAI-1	2#7		D010020	LONGTERM|DICTIONARY	osteonecrosis	osteonecrosis	41#54	NaN	A PAI-1 (SERPINE1) polymorphism predicts osteonecrosis in children with acute lymphoblastic leukemia: a report from the Children's Oncology Group.
18285546	2008	Blood	1528-0020	TITLE	0	0	5054	SYMBOL|()|DICTIONARY|EXTRACTED	serpine1	SERPINE1	9#17	18285546-0-2-7	D054198	LONGTERM|DICTIONARY	acute lymphoblastic leukemia	acute lymphoblastic leukemia	72#100		A PAI-1 (SERPINE1) polymorphism predicts osteonecrosis in children with acute lymphoblastic leukemia: a report from the Children's Oncology Group.
18285546	2008	Blood	1528-0020	TITLE	0	0	5054	SYMBOL|()|DICTIONARY|EXTRACTED	serpine1	SERPINE1	9#17	18285546-0-2-7	D010020	LONGTERM|DICTIONARY	osteonecrosis	osteonecrosis	41#54	NaN	A PAI-1 (SERPINE1) polymorphism predicts osteonecrosis in children with acute lymphoblastic leukemia: a report from the Children's Oncology Group.
21151597	2011	Mol. Vis.	1090-0535	TITLE	0	0	149233	SYMBOL|DICTIONARY|EXTRACTED	il23r	IL23R	17#22		D005642	LONGTERM|DICTIONARY	fuchs' syndrome	Fuchs' syndrome	27#42	NaN	Polymorphisms of IL23R and Fuchs' syndrome in a Chinese Han population.
16154235	2006	Neurobiol. Aging	1558-1497	ALL_TEXT_1/3	1	2	7422	LONGTERM|GENE|GT|DICTIONARY	vascular endothelial growth factor	vascular endothelial growth factor	49#83		D019636	LONGTERM|DICTIONARY	neurodegenerative disorders	neurodegenerative disorders	151#178		Converging evidence points to a pivotal role for vascular endothelial growth factor (VEGF) in neuronal protection, and the lack of activity of this in neurodegenerative disorders.
16154235	2006	Neurobiol. Aging	1558-1497	ALL_TEXT_1/3	1	2	7422	SYMBOL|()|DICTIONARY|EXTRACTED	vegf	VEGF	85#89	16154235-2-49-83	D019636	LONGTERM|DICTIONARY	neurodegenerative disorders	neurodegenerative disorders	151#178		Converging evidence points to a pivotal role for vascular endothelial growth factor (VEGF) in neuronal protection, and the lack of activity of this in neurodegenerative disorders.
19723304	2009	BMC Med. Genet.	1471-2350	BACKGROUND	1	3	10392	SYMBOL|GENE|GN|DICTIONARY	nod1	Nod1	38#42		D003093	LONGTERM|DISEASE|DN|DICTIONARY	ulcerative colitis	ulcerative colitis	111#129		However, a very similar gene encoding Nod1 protein still has not been well documented for its association with ulcerative colitis patients.
20662556	2010	DNA Cell Biol.	1557-7430	ALL_TEXT_1/3	1	2	3603	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	il 16	IL-16	57#62	20662556-1-0-14	D004715	LONGTERM|DICTIONARY	endometriosis	endometriosis	123#136		The aim of this study was to evaluate the association of IL-16 gene polymorphisms with the risk and clinical phenotypes of endometriosis in Chinese women.
9759613	1998	Thromb. Haemost.	0340-6245	ALL_TEXT_2/3	2	4	462	LONGTERM|DICTIONARY	at	AT	19#21	NaN	D020152	LONGTERM|DICTIONARY	at	AT	19#21	NaN	DNA studies of the AT gene were performed, using polymerase chain reaction single-strand conformation polymorphism (PCR-SSCP) analysis, followed by direct sequencing of the seven exons and intron-exon junction regions.
20662556	2010	DNA Cell Biol.	1557-7430	ALL_TEXT_3/3	3	6	3603	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	il 16	IL-16	63#68	20662556-1-0-14	D004715	LONGTERM|DICTIONARY	endometriosis	endometriosis	105#118		Our results suggest that the rs4778889 T/C polymorphism of the IL-16 gene may be associated with risk of endometriosis in the Chinese population, especially in patients with pain phenotype.
20662556	2010	DNA Cell Biol.	1557-7430	ALL_TEXT_3/3	3	6	3603	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	il 16	IL-16	63#68	20662556-1-0-14	D010146	LONGTERM|DISEASE|DN|DICTIONARY	pain	pain	174#178		Our results suggest that the rs4778889 T/C polymorphism of the IL-16 gene may be associated with risk of endometriosis in the Chinese population, especially in patients with pain phenotype.
11463752	2001	Hypertension	1524-4563	TITLE	0	0	133	LONGTERM|GENE|GN|DICTIONARY	adrenomedullin	adrenomedullin	41#55		D006973	LONGTERM|DICTIONARY	hypertension	hypertension	114#126		Microsatellite DNA polymorphism of human adrenomedullin gene in normotensive subjects and patients with essential hypertension.
20683028	2010	Anticancer Res.	1791-7530	RESULTS AND CONCLUSION	3	9	1545	SYMBOL|NUMBER|DICTIONARY|EXTRACTED	cyp1b1	CYP1B1	52#58	20683028-2-0-19	D001943	LONGTERM|DISEASE|DN|DT|DICTIONARY	breast cancer	Breast cancer	0#13		Breast cancer patients were detected to posses more CYP1B1*3 mutant alleles than the controls (p=0.043).
19643966	2010	Invest. Ophthalmol. Vis. Sci.	1552-5783	CONCLUSIONS	4	11	4060	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	lum	LUM	32#35	19643966-1-4-11	D009216	LONGTERM|DICTIONARY	high myopia	high myopia	88#99		These observations suggest that LUM gene polymorphisms contribute to the development of high myopia.
19161138	2009	Am. J. Med. Genet. A	1552-4833	TITLE	0	0	4205	LONGTERM|GENE|GN|DICTIONARY	myocyte enhancer factor 2a	myocyte enhancer factor 2A	25#51		D017379	LONGTERM|DICTIONARY	left ventricular hypertrophy	left ventricular hypertrophy	82#110		Mutation analysis of the myocyte enhancer factor 2A gene (MEF2A) in patients with left ventricular hypertrophy/hypertrophic cardiomyopathy.
19161138	2009	Am. J. Med. Genet. A	1552-4833	TITLE	0	0	4205	LONGTERM|GENE|GN|DICTIONARY	myocyte enhancer factor 2a	myocyte enhancer factor 2A	25#51		D002312	LONGTERM|DICTIONARY	hypertrophic cardiomyopathy	hypertrophic cardiomyopathy	111#138		Mutation analysis of the myocyte enhancer factor 2A gene (MEF2A) in patients with left ventricular hypertrophy/hypertrophic cardiomyopathy.
19161138	2009	Am. J. Med. Genet. A	1552-4833	TITLE	0	0	4205	SYMBOL|()|DICTIONARY|EXTRACTED	mef2a	MEF2A	58#63	19161138-0-25-51	D017379	LONGTERM|DICTIONARY	left ventricular hypertrophy	left ventricular hypertrophy	82#110		Mutation analysis of the myocyte enhancer factor 2A gene (MEF2A) in patients with left ventricular hypertrophy/hypertrophic cardiomyopathy.
19161138	2009	Am. J. Med. Genet. A	1552-4833	TITLE	0	0	4205	SYMBOL|()|DICTIONARY|EXTRACTED	mef2a	MEF2A	58#63	19161138-0-25-51	D002312	LONGTERM|DICTIONARY	hypertrophic cardiomyopathy	hypertrophic cardiomyopathy	111#138		Mutation analysis of the myocyte enhancer factor 2A gene (MEF2A) in patients with left ventricular hypertrophy/hypertrophic cardiomyopathy.
15956634	2005	JAMA	1538-3598	TITLE	0	0	348	LONGTERM|DICTIONARY	apolipoprotein e	Apolipoprotein E	0#16		D051436	LONGTERM|DISEASE|DT|DICTIONARY	chronic kidney disease	chronic kidney disease	36#58		Apolipoprotein E and progression of chronic kidney disease.
2480601	1990	Proc. Natl. Acad. Sci. U.S.A.	0027-8424	ALL_TEXT_2/3	2	5	5354	SYMBOL|GENE|GN|DICTIONARY	plp	PLP	67#70		D020371	SYMBOL|DICTIONARY|EXTRACTED	pmd	PMD	117#120	2480601-1-0-28	The polymerase chain reaction was used to amplify the exons of the PLP gene of an affected male from a large Indiana PMD kindred.
8741319	1996	Acta Paediatr Jpn	0374-5600	TITLE	0	0	7490	SYMBOL|GENE|GN|DICTIONARY	wt1	WT1	42#45		D030321	LONGTERM|DISEASE|DT|DICTIONARY	denys drash syndrome	Denys-Drash syndrome	69#89		A newly identified exonic mutation of the WT1 gene in a patient with Denys-Drash syndrome.
19210888	2009	Clin. Exp. Rheumatol.	0392-856X	CONCLUSIONS	4	9	26191	SYMBOL|DICTIONARY	ptpn22	PTPN22	32#38		D001327	LONGTERM|DICTIONARY	autoimmunity	autoimmunity	66#78		However, C1858T polymorphism of PTPN22, another candidate gene of autoimmunity seems to be independent of JIA in Hungarian patients.
19210888	2009	Clin. Exp. Rheumatol.	0392-856X	CONCLUSIONS	4	9	26191	SYMBOL|DICTIONARY	ptpn22	PTPN22	32#38		D001171	SYMBOL|DICTIONARY|EXTRACTED	jia	JIA	106#109	19210888-1-0-29	However, C1858T polymorphism of PTPN22, another candidate gene of autoimmunity seems to be independent of JIA in Hungarian patients.
12948282	2003	Cancer Causes Control	0957-5243	TITLE	0	0	6648	LONGTERM|DICTIONARY	manganese superoxide dismutase	Manganese superoxide dismutase	0#30	NaN	D011471	LONGTERM|DISEASE|DT|DICTIONARY	prostate cancer	prostate cancer	90#105		Manganese superoxide dismutase (MnSOD) polymorphism, alpha-tocopherol supplementation and prostate cancer risk in the alpha-tocopherol, beta-carotene cancer prevention study (Finland).
12948282	2003	Cancer Causes Control	0957-5243	TITLE	0	0	6648	LONGTERM|DICTIONARY	manganese superoxide dismutase	Manganese superoxide dismutase	0#30	NaN	D009369	LONGTERM|DISEASE|DT|DICTIONARY	cancer	cancer	150#156		Manganese superoxide dismutase (MnSOD) polymorphism, alpha-tocopherol supplementation and prostate cancer risk in the alpha-tocopherol, beta-carotene cancer prevention study (Finland).
19420919	2009	Cerebrovasc. Dis.	1421-9786	ALL_TEXT_3/3	3	9	6401	LONGTERM|DICTIONARY	e selectin	E-selectin	32#42		D002544	LONGTERM|DICTIONARY	ischemic stroke	ischemic stroke	111#126		Our study demonstrates that the E-selectin S128R and L554F polymorphisms are associated with susceptibility to ischemic stroke.
12930595	2004	Thyroid	1050-7256	TITLE	0	0	7253	LONGTERM|GENE|GN|GT|DICTIONARY	thyrotropin receptor	thyrotropin receptor	67#87		D006111	LONGTERM|DISEASE|DT|DICTIONARY	graves disease	Graves' disease	15#30		Association of Graves' disease with intragenic polymorphism of the thyrotropin receptor gene in a cohort of Singapore patients of multi-ethnic origins.
19369177	2009	J. Formos. Med. Assoc.	0929-6646	CONCLUSION	4	10	1312	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	comt	COMT	68#72	19369177-1-71-99	D012559	LONGTERM|DICTIONARY	schizophrenia	schizophrenia	113#126		The SNP rs165599, which has been mapped to the 3'-UTR region of the COMT gene, was significantly associated with schizophrenia in our family study, and possibly associated with the age of onset, delusion/hallucination symptom dimension, and CPT performance.
19369177	2009	J. Formos. Med. Assoc.	0929-6646	CONCLUSION	4	10	1312	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	comt	COMT	68#72	19369177-1-71-99	D006212	LONGTERM|DISEASE|DN|DICTIONARY	hallucination	hallucination	204#217		The SNP rs165599, which has been mapped to the 3'-UTR region of the COMT gene, was significantly associated with schizophrenia in our family study, and possibly associated with the age of onset, delusion/hallucination symptom dimension, and CPT performance.
10993992	2000	Neurology	0028-3878	OBJECTIVE	1	1	1471	LONGTERM|GENE|GN|DICTIONARY	cystatin c	cystatin C	59#69		D000544	LONGTERM|DICTIONARY	ad	AD	103#105	NaN	To investigate whether or not a coding polymorphism in the cystatin C gene (CST3) contributes risk for AD.
10993992	2000	Neurology	0028-3878	OBJECTIVE	1	1	1471	SYMBOL|()|DICTIONARY|EXTRACTED	cst3	CST3	76#80	10993992-1-59-69	D000544	LONGTERM|DICTIONARY	ad	AD	103#105	NaN	To investigate whether or not a coding polymorphism in the cystatin C gene (CST3) contributes risk for AD.
11895872	2002	Cancer Epidemiol. Biomarkers Prev.	1055-9965	ALL_TEXT_3/3	3	10	1586	SYMBOL|DICTIONARY	cyp17	CYP17	25#30		D011471	LONGTERM|DISEASE|DT|DICTIONARY	familial prostate cancer	familial prostate cancer	81#105		It is also possible that CYP17 interacts with other genes that influence risk of familial prostate cancer.
20543710	2011	J. Glaucoma	1536-481X	TITLE	0	0	348	LONGTERM|DICTIONARY	apolipoprotein e	Apolipoprotein E	0#16		D017889	LONGTERM|DISEASE|DT|DICTIONARY	pseudoexfoliation syndrome	pseudoexfoliation syndrome	30#56		Apolipoprotein E genotypes in pseudoexfoliation syndrome and pseudoexfoliation glaucoma.
20543710	2011	J. Glaucoma	1536-481X	TITLE	0	0	348	LONGTERM|DICTIONARY	apolipoprotein e	Apolipoprotein E	0#16		D017889	LONGTERM|DICTIONARY	pseudoexfoliation glaucoma	pseudoexfoliation glaucoma	61#87		Apolipoprotein E genotypes in pseudoexfoliation syndrome and pseudoexfoliation glaucoma.
16313808	2007	Zhonghua Yi Xue Za Zhi	0376-2491	CONCLUSION	4	10	3586	SYMBOL|DICTIONARY	il 10	IL-10	66#71		D001161	SYMBOL|EXTRACTED	as	AS	150#152	16313808-1-218-234	We use IL-10G/G genotype to modulate the high production of serum IL-10, to decline inflammatory reaction and to keep away from microinflammation and AS in ESRD patients.
16313808	2007	Zhonghua Yi Xue Za Zhi	0376-2491	CONCLUSION	4	10	3586	SYMBOL|DICTIONARY	il 10	IL-10	66#71		D007676	SYMBOL|DISEASE|DN|DICTIONARY|EXTRACTED	esrd	ESRD	156#160	16313808-1-150-173	We use IL-10G/G genotype to modulate the high production of serum IL-10, to decline inflammatory reaction and to keep away from microinflammation and AS in ESRD patients.
21685359	2011	J. Natl. Cancer Inst.	1460-2105	CONCLUSION	4	11	6275	SYMBOL|DICTIONARY	s100a4	S100A4	21#27		D009362	LONGTERM|DICTIONARY	metastasis	metastasis	36#46		Niclosamide inhibits S100A4-induced metastasis formation in a mouse model of colon cancer and has therapeutic potential.
21685359	2011	J. Natl. Cancer Inst.	1460-2105	CONCLUSION	4	11	6275	SYMBOL|DICTIONARY	s100a4	S100A4	21#27		D003110	LONGTERM|DISEASE|DT|DICTIONARY	colon cancer	colon cancer	77#89		Niclosamide inhibits S100A4-induced metastasis formation in a mouse model of colon cancer and has therapeutic potential.
11474225	2001	Nephron	1660-8151	RESULTS	3	4	1636	SYMBOL|DICTIONARY|EXTRACTED	ace	ACE	0#3		D005923	SYMBOL|DICTIONARY|EXTRACTED	fsgs	FSGS	57#61	11474225-1-137-179	ACE genotypes did not affect renal survival in the whole FSGS group nor in the steroid-resistant subgroup.
19891592	2010	DNA Cell Biol.	1557-7430	ALL_TEXT_3/3	3	7	4627	SYMBOL|DICTIONARY	myh9	MYH9	99#103		C566121	LONGTERM|DICTIONARY	orofacial cleft	orofacial cleft	159#174		Risk factors identified in our study may provide a better understanding of the etiological role of MYH9 and influence of environmental factors in nonsyndromic orofacial cleft incidence.
15022317	2004	Arthritis Rheum.	0004-3591	TITLE	0	0	3123	SYMBOL|DICTIONARY	drb1	DRB1	76#80		D001172	LONGTERM|DICTIONARY	rheumatoid arthritis	rheumatoid arthritis	38#58		Additional genetic susceptibility for rheumatoid arthritis telomeric of the DRB1 locus.
16257277	2006	Bone	8756-3282	METHODS	2	4	3553	SYMBOL|GENE|GN|DICTIONARY	il1b	IL1B	60#64		D010001	SYMBOL|EXTRACTED	pdb	PDB	250#253	16257277-1-73-94	We have studied -511 C/T and +3953 T/C polymorphisms of the IL1B gene, a HinfI polymorphism in the 5'UTR of the IL1R1 gene, and a variable number of tandem repeats (VNTR) in the intron 2 of the IL1RN gene, in 165 patients diagnosed as suffering from PDB and in 122 healthy controls.
16257277	2006	Bone	8756-3282	METHODS	2	4	3554	SYMBOL|GENE|GN|DICTIONARY	il1r1	IL1R1	112#117		D010001	SYMBOL|EXTRACTED	pdb	PDB	250#253	16257277-1-73-94	We have studied -511 C/T and +3953 T/C polymorphisms of the IL1B gene, a HinfI polymorphism in the 5'UTR of the IL1R1 gene, and a variable number of tandem repeats (VNTR) in the intron 2 of the IL1RN gene, in 165 patients diagnosed as suffering from PDB and in 122 healthy controls.
16257277	2006	Bone	8756-3282	METHODS	2	4	3557	SYMBOL|GENE|GN|DICTIONARY	il1rn	IL1RN	194#199		D010001	SYMBOL|EXTRACTED	pdb	PDB	250#253	16257277-1-73-94	We have studied -511 C/T and +3953 T/C polymorphisms of the IL1B gene, a HinfI polymorphism in the 5'UTR of the IL1R1 gene, and a variable number of tandem repeats (VNTR) in the intron 2 of the IL1RN gene, in 165 patients diagnosed as suffering from PDB and in 122 healthy controls.
7902317	1994	Hum. Genet.	0340-6717	TITLE	0	0	410	LONGTERM|DICTIONARY	arylsulfatase a	arylsulfatase A	95#110		D007966	LONGTERM|DICTIONARY	adult type metachromatic leukodystrophy	adult-type metachromatic leukodystrophy	3#42		An adult-type metachromatic leukodystrophy caused by substitution of serine for glycine-122 in arylsulfatase A.
16257277	2006	Bone	8756-3282	INTRODUCTION	1	3	3553	SYMBOL|DICTIONARY	il1	IL1	82#85		D010001	SYMBOL|EXTRACTED	pdb	PDB	210#213	16257277-1-73-94	We have assessed whether genetic variability in genes coding of proteins from the IL1 pathway clustered in chromosome 2 is associated with clinical characteristics and the therapeutic response of patients with PDB.
16257277	2006	Bone	8756-3282	TITLE	0	0	3553	SYMBOL|GENE|GN|DICTIONARY	il1b	IL1B	9#13		D010001	LONGTERM|DICTIONARY	paget disease of bone	Paget disease of bone	92#113		-511 C/T IL1B gene polymorphism is associated to resistance to bisphosphonates treatment in Paget disease of bone.
11474225	2001	Nephron	1660-8151	CONCLUSION	4	6	1636	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	ace	ACE	81#84	11474225-1-51-80	D005923	SYMBOL|DICTIONARY|EXTRACTED	fsgs	FSGS	44#48	11474225-1-137-179	The present study of Japanese children with FSGS showed that the D allele of the ACE gene is associated with the development of FSGS, but not associated with the progression of FSGS which was greatly ameliorated with ciclosporin, irrespective of ACE genotypes.
11474225	2001	Nephron	1660-8151	CONCLUSION	4	6	1636	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	ace	ACE	81#84	11474225-1-51-80	D005923	SYMBOL|DICTIONARY|EXTRACTED	fsgs	FSGS	128#132	11474225-1-137-179	The present study of Japanese children with FSGS showed that the D allele of the ACE gene is associated with the development of FSGS, but not associated with the progression of FSGS which was greatly ameliorated with ciclosporin, irrespective of ACE genotypes.
11474225	2001	Nephron	1660-8151	CONCLUSION	4	6	1636	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	ace	ACE	81#84	11474225-1-51-80	D005923	SYMBOL|DICTIONARY|EXTRACTED	fsgs	FSGS	177#181	11474225-1-137-179	The present study of Japanese children with FSGS showed that the D allele of the ACE gene is associated with the development of FSGS, but not associated with the progression of FSGS which was greatly ameliorated with ciclosporin, irrespective of ACE genotypes.
11474225	2001	Nephron	1660-8151	CONCLUSION	4	6	1636	SYMBOL|DICTIONARY|EXTRACTED	ace	ACE	246#249	11474225-1-51-80	D005923	SYMBOL|DICTIONARY|EXTRACTED	fsgs	FSGS	44#48	11474225-1-137-179	The present study of Japanese children with FSGS showed that the D allele of the ACE gene is associated with the development of FSGS, but not associated with the progression of FSGS which was greatly ameliorated with ciclosporin, irrespective of ACE genotypes.
11474225	2001	Nephron	1660-8151	CONCLUSION	4	6	1636	SYMBOL|DICTIONARY|EXTRACTED	ace	ACE	246#249	11474225-1-51-80	D005923	SYMBOL|DICTIONARY|EXTRACTED	fsgs	FSGS	128#132	11474225-1-137-179	The present study of Japanese children with FSGS showed that the D allele of the ACE gene is associated with the development of FSGS, but not associated with the progression of FSGS which was greatly ameliorated with ciclosporin, irrespective of ACE genotypes.
11474225	2001	Nephron	1660-8151	CONCLUSION	4	6	1636	SYMBOL|DICTIONARY|EXTRACTED	ace	ACE	246#249	11474225-1-51-80	D005923	SYMBOL|DICTIONARY|EXTRACTED	fsgs	FSGS	177#181	11474225-1-137-179	The present study of Japanese children with FSGS showed that the D allele of the ACE gene is associated with the development of FSGS, but not associated with the progression of FSGS which was greatly ameliorated with ciclosporin, irrespective of ACE genotypes.
11474225	2001	Nephron	1660-8151	BACKGROUND	1	1	1636	LONGTERM|GENE|GT|DICTIONARY	angiotensin converting enzyme	angiotensin-converting enzyme	51#80		D005923	SYMBOL|()|DICTIONARY|EXTRACTED	fsgs	FSGS	181#185	11474225-1-137-179	There is little information on the significance of angiotensin-converting enzyme (ACE) genotypes and medical treatments in children with primary focal segmental glomerulosclerosis (FSGS).
11474225	2001	Nephron	1660-8151	BACKGROUND	1	1	1636	LONGTERM|GENE|GT|DICTIONARY	angiotensin converting enzyme	angiotensin-converting enzyme	51#80		D005923	LONGTERM|DICTIONARY	focal segmental glomerulosclerosis	focal segmental glomerulosclerosis	145#179		There is little information on the significance of angiotensin-converting enzyme (ACE) genotypes and medical treatments in children with primary focal segmental glomerulosclerosis (FSGS).
11474225	2001	Nephron	1660-8151	BACKGROUND	1	1	1636	SYMBOL|()|DICTIONARY|EXTRACTED	ace	ACE	82#85	11474225-1-51-80	D005923	SYMBOL|()|DICTIONARY|EXTRACTED	fsgs	FSGS	181#185	11474225-1-137-179	There is little information on the significance of angiotensin-converting enzyme (ACE) genotypes and medical treatments in children with primary focal segmental glomerulosclerosis (FSGS).
11474225	2001	Nephron	1660-8151	BACKGROUND	1	1	1636	SYMBOL|()|DICTIONARY|EXTRACTED	ace	ACE	82#85	11474225-1-51-80	D005923	LONGTERM|DICTIONARY	focal segmental glomerulosclerosis	focal segmental glomerulosclerosis	145#179		There is little information on the significance of angiotensin-converting enzyme (ACE) genotypes and medical treatments in children with primary focal segmental glomerulosclerosis (FSGS).
20543710	2011	J. Glaucoma	1536-481X	PURPOSE	1	6	348	SYMBOL|DICTIONARY	apoe	APOE	49#53		D017889	LONGTERM|DICTIONARY	pex glaucoma	PEX glaucoma	102#114		In this study, we therefore investigated whether APOE alleles are associated with PEX syndrome and/or PEX glaucoma (PEXG) in 2 large cohorts of German and Italian origin.
14974362	2004	Pol. Merkur. Lekarski	1426-9686	ALL_TEXT_2/3	2	3	1636	LONGTERM|GENE|GT|DICTIONARY|GA	angiotensin converting enzyme	angiotensin converting enzyme	275#304		D006973	LONGTERM|DICTIONARY	hypertension	hypertension	22#34		In our studies on the hypertension in kidney disease we have choosen the evaluation of incidence of hypertension in the early stage of primary glomerulonephritis (GN) and the comparison of distribution of genotypes and alleles depending on insertion/deletion polymorphism of angiotensin converting enzyme (ACE) gene in patients with early stage of GN and healthy subjects.
14974362	2004	Pol. Merkur. Lekarski	1426-9686	ALL_TEXT_2/3	2	3	1636	LONGTERM|GENE|GT|DICTIONARY|GA	angiotensin converting enzyme	angiotensin converting enzyme	275#304		D007674	LONGTERM|DISEASE|DT|DICTIONARY	kidney disease	kidney disease	38#52		In our studies on the hypertension in kidney disease we have choosen the evaluation of incidence of hypertension in the early stage of primary glomerulonephritis (GN) and the comparison of distribution of genotypes and alleles depending on insertion/deletion polymorphism of angiotensin converting enzyme (ACE) gene in patients with early stage of GN and healthy subjects.
14974362	2004	Pol. Merkur. Lekarski	1426-9686	ALL_TEXT_2/3	2	3	1636	LONGTERM|GENE|GT|DICTIONARY|GA	angiotensin converting enzyme	angiotensin converting enzyme	275#304		D006973	LONGTERM|DICTIONARY	hypertension	hypertension	100#112		In our studies on the hypertension in kidney disease we have choosen the evaluation of incidence of hypertension in the early stage of primary glomerulonephritis (GN) and the comparison of distribution of genotypes and alleles depending on insertion/deletion polymorphism of angiotensin converting enzyme (ACE) gene in patients with early stage of GN and healthy subjects.
14974362	2004	Pol. Merkur. Lekarski	1426-9686	ALL_TEXT_2/3	2	3	1636	LONGTERM|GENE|GT|DICTIONARY|GA	angiotensin converting enzyme	angiotensin converting enzyme	275#304		D005921	LONGTERM|DICTIONARY	glomerulonephritis	glomerulonephritis	143#161		In our studies on the hypertension in kidney disease we have choosen the evaluation of incidence of hypertension in the early stage of primary glomerulonephritis (GN) and the comparison of distribution of genotypes and alleles depending on insertion/deletion polymorphism of angiotensin converting enzyme (ACE) gene in patients with early stage of GN and healthy subjects.
14974362	2004	Pol. Merkur. Lekarski	1426-9686	ALL_TEXT_2/3	2	3	1636	LONGTERM|GENE|GT|DICTIONARY|GA	angiotensin converting enzyme	angiotensin converting enzyme	275#304		D005921	SYMBOL|EXTRACTED|()	gn	GN	163#165	14974362-3-143-161	In our studies on the hypertension in kidney disease we have choosen the evaluation of incidence of hypertension in the early stage of primary glomerulonephritis (GN) and the comparison of distribution of genotypes and alleles depending on insertion/deletion polymorphism of angiotensin converting enzyme (ACE) gene in patients with early stage of GN and healthy subjects.
14974362	2004	Pol. Merkur. Lekarski	1426-9686	ALL_TEXT_2/3	2	3	1636	LONGTERM|GENE|GT|DICTIONARY|GA	angiotensin converting enzyme	angiotensin converting enzyme	275#304		D005921	SYMBOL|EXTRACTED	gn	GN	348#350	14974362-3-143-161	In our studies on the hypertension in kidney disease we have choosen the evaluation of incidence of hypertension in the early stage of primary glomerulonephritis (GN) and the comparison of distribution of genotypes and alleles depending on insertion/deletion polymorphism of angiotensin converting enzyme (ACE) gene in patients with early stage of GN and healthy subjects.
14974362	2004	Pol. Merkur. Lekarski	1426-9686	ALL_TEXT_2/3	2	3	1636	SYMBOL|()|GENE|GN|DICTIONARY|EXTRACTED	ace	ACE	306#309	14974362-3-275-304	D006973	LONGTERM|DICTIONARY	hypertension	hypertension	22#34		In our studies on the hypertension in kidney disease we have choosen the evaluation of incidence of hypertension in the early stage of primary glomerulonephritis (GN) and the comparison of distribution of genotypes and alleles depending on insertion/deletion polymorphism of angiotensin converting enzyme (ACE) gene in patients with early stage of GN and healthy subjects.
14974362	2004	Pol. Merkur. Lekarski	1426-9686	ALL_TEXT_2/3	2	3	1636	SYMBOL|()|GENE|GN|DICTIONARY|EXTRACTED	ace	ACE	306#309	14974362-3-275-304	D007674	LONGTERM|DISEASE|DT|DICTIONARY	kidney disease	kidney disease	38#52		In our studies on the hypertension in kidney disease we have choosen the evaluation of incidence of hypertension in the early stage of primary glomerulonephritis (GN) and the comparison of distribution of genotypes and alleles depending on insertion/deletion polymorphism of angiotensin converting enzyme (ACE) gene in patients with early stage of GN and healthy subjects.
14974362	2004	Pol. Merkur. Lekarski	1426-9686	ALL_TEXT_2/3	2	3	1636	SYMBOL|()|GENE|GN|DICTIONARY|EXTRACTED	ace	ACE	306#309	14974362-3-275-304	D006973	LONGTERM|DICTIONARY	hypertension	hypertension	100#112		In our studies on the hypertension in kidney disease we have choosen the evaluation of incidence of hypertension in the early stage of primary glomerulonephritis (GN) and the comparison of distribution of genotypes and alleles depending on insertion/deletion polymorphism of angiotensin converting enzyme (ACE) gene in patients with early stage of GN and healthy subjects.
14974362	2004	Pol. Merkur. Lekarski	1426-9686	ALL_TEXT_2/3	2	3	1636	SYMBOL|()|GENE|GN|DICTIONARY|EXTRACTED	ace	ACE	306#309	14974362-3-275-304	D005921	LONGTERM|DICTIONARY	glomerulonephritis	glomerulonephritis	143#161		In our studies on the hypertension in kidney disease we have choosen the evaluation of incidence of hypertension in the early stage of primary glomerulonephritis (GN) and the comparison of distribution of genotypes and alleles depending on insertion/deletion polymorphism of angiotensin converting enzyme (ACE) gene in patients with early stage of GN and healthy subjects.
14974362	2004	Pol. Merkur. Lekarski	1426-9686	ALL_TEXT_2/3	2	3	1636	SYMBOL|()|GENE|GN|DICTIONARY|EXTRACTED	ace	ACE	306#309	14974362-3-275-304	D005921	SYMBOL|EXTRACTED|()	gn	GN	163#165	14974362-3-143-161	In our studies on the hypertension in kidney disease we have choosen the evaluation of incidence of hypertension in the early stage of primary glomerulonephritis (GN) and the comparison of distribution of genotypes and alleles depending on insertion/deletion polymorphism of angiotensin converting enzyme (ACE) gene in patients with early stage of GN and healthy subjects.
14974362	2004	Pol. Merkur. Lekarski	1426-9686	ALL_TEXT_2/3	2	3	1636	SYMBOL|()|GENE|GN|DICTIONARY|EXTRACTED	ace	ACE	306#309	14974362-3-275-304	D005921	SYMBOL|EXTRACTED	gn	GN	348#350	14974362-3-143-161	In our studies on the hypertension in kidney disease we have choosen the evaluation of incidence of hypertension in the early stage of primary glomerulonephritis (GN) and the comparison of distribution of genotypes and alleles depending on insertion/deletion polymorphism of angiotensin converting enzyme (ACE) gene in patients with early stage of GN and healthy subjects.
16322490	2006	Stroke	1524-4628	RESULTS	3	7	7124	LONGTERM|DICTIONARY	tnf-alpha	TNF-alpha	0#9	NaN	D020300	SYMBOL|DICTIONARY|EXTRACTED	ich	ICH	59#62	16322490-1-95-118	TNF-alpha-238G>A was associated with increased risk of new ICH after diagnosis (chi2; P=0.003).
11474225	2001	Nephron	1660-8151	RESULTS	3	3	1636	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	ace	ACE	37#40	11474225-1-51-80	D005923	SYMBOL|DICTIONARY|EXTRACTED	fsgs	FSGS	96#100	11474225-1-137-179	The incidence of the D allele of the ACE gene was higher in the whole group of 43 children with FSGS and in a subgroup of 28 steroid-resistant FSGS children (p < 0.05) than in the 130 children of the healthy control group (0.48, 0.48, and 0.33, respectively).
11474225	2001	Nephron	1660-8151	RESULTS	3	3	1636	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	ace	ACE	37#40	11474225-1-51-80	D005923	SYMBOL|DICTIONARY|EXTRACTED	fsgs	FSGS	143#147	11474225-1-137-179	The incidence of the D allele of the ACE gene was higher in the whole group of 43 children with FSGS and in a subgroup of 28 steroid-resistant FSGS children (p < 0.05) than in the 130 children of the healthy control group (0.48, 0.48, and 0.33, respectively).
9521595	1998	Hum. Genet.	0340-6717	TITLE	0	0	1080	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	cftr	CFTR	16#20		D003550	LONGTERM|DISEASE|DN|DICTIONARY	cystic fibrosis	cystic fibrosis	37#52		Analysis of the CFTR gene in Turkish cystic fibrosis patients: identification of three novel mutations (3172delAC, P1013L and M1028I).
16168297	2005	J. Am. Coll. Cardiol.	1558-3597	CONCLUSIONS	5	10	4846	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	enos	eNOS	26#30	16168297-1-74-107	D009203	SYMBOL|EXTRACTED	mi	MI	69#71	16168297-1-132-153	G894T polymorphism on the eNOS gene increases the risk for premature MI and modifies the response of vascular endothelium during the acute phase of MI by affecting the release of vWF, IL-6, and oxidative stress status, an effect diminished one year after the event.
16168297	2005	J. Am. Coll. Cardiol.	1558-3597	CONCLUSIONS	5	10	4846	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	enos	eNOS	26#30	16168297-1-74-107	D009203	SYMBOL|EXTRACTED	mi	MI	148#150	16168297-1-132-153	G894T polymorphism on the eNOS gene increases the risk for premature MI and modifies the response of vascular endothelium during the acute phase of MI by affecting the release of vWF, IL-6, and oxidative stress status, an effect diminished one year after the event.
16168297	2005	J. Am. Coll. Cardiol.	1558-3597	CONCLUSIONS	5	10	7450	SYMBOL|EXTRACTED	vwf	vWF	179#182	16168297-1-182-203	D009203	SYMBOL|EXTRACTED	mi	MI	69#71	16168297-1-132-153	G894T polymorphism on the eNOS gene increases the risk for premature MI and modifies the response of vascular endothelium during the acute phase of MI by affecting the release of vWF, IL-6, and oxidative stress status, an effect diminished one year after the event.
16168297	2005	J. Am. Coll. Cardiol.	1558-3597	CONCLUSIONS	5	10	7450	SYMBOL|EXTRACTED	vwf	vWF	179#182	16168297-1-182-203	D009203	SYMBOL|EXTRACTED	mi	MI	148#150	16168297-1-132-153	G894T polymorphism on the eNOS gene increases the risk for premature MI and modifies the response of vascular endothelium during the acute phase of MI by affecting the release of vWF, IL-6, and oxidative stress status, an effect diminished one year after the event.
16168297	2005	J. Am. Coll. Cardiol.	1558-3597	CONCLUSIONS	5	10	3569	SYMBOL|DICTIONARY	il 6	IL-6	184#188		D009203	SYMBOL|EXTRACTED	mi	MI	69#71	16168297-1-132-153	G894T polymorphism on the eNOS gene increases the risk for premature MI and modifies the response of vascular endothelium during the acute phase of MI by affecting the release of vWF, IL-6, and oxidative stress status, an effect diminished one year after the event.
16168297	2005	J. Am. Coll. Cardiol.	1558-3597	CONCLUSIONS	5	10	3569	SYMBOL|DICTIONARY	il 6	IL-6	184#188		D009203	SYMBOL|EXTRACTED	mi	MI	148#150	16168297-1-132-153	G894T polymorphism on the eNOS gene increases the risk for premature MI and modifies the response of vascular endothelium during the acute phase of MI by affecting the release of vWF, IL-6, and oxidative stress status, an effect diminished one year after the event.
19643966	2010	Invest. Ophthalmol. Vis. Sci.	1552-5783	PURPOSE	1	3	4060	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	lum	LUM	46#49	19643966-1-4-11	D009216	LONGTERM|DICTIONARY	high myopia	high myopia	140#151		Single-nucleotide polymorphisms (SNPs) in the LUM gene were determined in an investigation of whether LUM gene polymorphisms correlate with high myopia.
19643966	2010	Invest. Ophthalmol. Vis. Sci.	1552-5783	PURPOSE	1	3	4060	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	lum	LUM	102#105	19643966-1-4-11	D009216	LONGTERM|DICTIONARY	high myopia	high myopia	140#151		Single-nucleotide polymorphisms (SNPs) in the LUM gene were determined in an investigation of whether LUM gene polymorphisms correlate with high myopia.
17257320	2007	Tissue Antigens	0001-2815	ALL_TEXT_2/3	2	5	3123	SYMBOL|DICTIONARY	drb1	DRB1	61#65		D006509	SYMBOL|DISEASE|DN|DICTIONARY|EXTRACTED	hbv infection	HBV infection	39#52	17257320-1-0-11	In this study, the association between HBV infection and HLA-DRB1 alleles in Han individuals in northwestern China was studied for the first time.
18234410	2008	Prog. Neuropsychopharmacol. Biol. Psychiatry	0278-5846	ALL_TEXT_3/3	3	15	4524	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	mthfr	MTHFR	33#38	18234410-4-4-39	D020138	LONGTERM|DICTIONARY	hyperhomocysteinemia	hyperhomocysteinemia	68#88		In conclusion, C677T variants of MTHFR gene have no contribution in hyperhomocysteinemia in epileptic patients receiving CBZ or VPA.
18234410	2008	Prog. Neuropsychopharmacol. Biol. Psychiatry	0278-5846	ALL_TEXT_3/3	3	15	4524	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	mthfr	MTHFR	33#38	18234410-4-4-39	D004827	LONGTERM|DISEASE|DN|DICTIONARY	epileptic	epileptic	92#101		In conclusion, C677T variants of MTHFR gene have no contribution in hyperhomocysteinemia in epileptic patients receiving CBZ or VPA.
18234410	2008	Prog. Neuropsychopharmacol. Biol. Psychiatry	0278-5846	ALL_TEXT_3/3	3	13	4524	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	mthfr	MTHFR	41#46	18234410-4-4-39	D004827	LONGTERM|DISEASE|DN|DICTIONARY	epileptic	epileptic	95#104		We also determined the C677T variants of MTHFR gene (as normal, heterozygote or homozygote) in epileptic patients.
21983886	2012	Arch. Toxicol.	1432-0738	ALL_TEXT_3/3	3	10	7515	LONGTERM|DICTIONARY	xrcc1	XRCC1	52#57		D054198	LONGTERM|DICTIONARY	childhood all	childhood ALL	137#150		With the inadequate polymorphic DNA repair protein, XRCC1, this situation ultimately leads to significantly increased susceptibility for childhood ALL.
11641043	2002	Toxicol. Lett.	0378-4274	ALL_TEXT_2/3	2	5	7040	LONGTERM|DICTIONARY	tgf-beta1	TGF-beta1	94#103	NaN	D002277	LONGTERM|DICTIONARY	carcinomas	carcinomas	42#52		Mutations occurred in 80% +/- and 75% +/+ carcinomas, but in only 50% of the adenomas of both TGF-beta1 genotypes.
11641043	2002	Toxicol. Lett.	0378-4274	ALL_TEXT_2/3	2	5	7040	LONGTERM|DICTIONARY	tgf-beta1	TGF-beta1	94#103	NaN	D000236	LONGTERM|DICTIONARY	adenomas	adenomas	77#85		Mutations occurred in 80% +/- and 75% +/+ carcinomas, but in only 50% of the adenomas of both TGF-beta1 genotypes.
11641043	2002	Toxicol. Lett.	0378-4274	ALL_TEXT_1/3	1	3	3845	LONGTERM|DICTIONARY	k-ras	K-ras	83#88	NaN	D008175	LONGTERM|DICTIONARY	lung tumors	lung tumors	17#28		Urethane-induced lung tumors in AJBL6 TGF-beta1 +/- and +/+ mice were examined for K-ras mutations by polymerase chain reaction/single strand conformation polymorphism analysis and sequencing.
11641043	2002	Toxicol. Lett.	0378-4274	ALL_TEXT_1/3	1	3	7040	LONGTERM|DICTIONARY	tgf-beta1	TGF-beta1	38#47	NaN	D008175	LONGTERM|DICTIONARY	lung tumors	lung tumors	17#28		Urethane-induced lung tumors in AJBL6 TGF-beta1 +/- and +/+ mice were examined for K-ras mutations by polymerase chain reaction/single strand conformation polymorphism analysis and sequencing.
11641043	2002	Toxicol. Lett.	0378-4274	ALL_TEXT_1/3	1	2	1026	LONGTERM|DICTIONARY	p21	p21	95#98	NaN	D008175	LONGTERM|DICTIONARY	lung tumors	lung tumors	163#174		Since the growth inhibitory activity of TGF-beta1 in epithelial cells is associated with K-ras p21, and K-ras mutations commonly occur in chemically-induced mouse lung tumors, we postulated that tumors in heterozygous TGF-beta1 mice might be more likely to have K-ras mutations compared with tumors in wildtype TGF-beta1 mice.
11641043	2002	Toxicol. Lett.	0378-4274	ALL_TEXT_1/3	1	2	1026	LONGTERM|DICTIONARY	p21	p21	95#98	NaN	D009369	LONGTERM|DICTIONARY	tumors	tumors	195#201		Since the growth inhibitory activity of TGF-beta1 in epithelial cells is associated with K-ras p21, and K-ras mutations commonly occur in chemically-induced mouse lung tumors, we postulated that tumors in heterozygous TGF-beta1 mice might be more likely to have K-ras mutations compared with tumors in wildtype TGF-beta1 mice.
11641043	2002	Toxicol. Lett.	0378-4274	ALL_TEXT_1/3	1	2	1026	LONGTERM|DICTIONARY	p21	p21	95#98	NaN	D009369	LONGTERM|DICTIONARY	tumors	tumors	292#298		Since the growth inhibitory activity of TGF-beta1 in epithelial cells is associated with K-ras p21, and K-ras mutations commonly occur in chemically-induced mouse lung tumors, we postulated that tumors in heterozygous TGF-beta1 mice might be more likely to have K-ras mutations compared with tumors in wildtype TGF-beta1 mice.
11641043	2002	Toxicol. Lett.	0378-4274	ALL_TEXT_1/3	1	2	3845	LONGTERM|DICTIONARY	k-ras	K-ras	89#94	NaN	D008175	LONGTERM|DICTIONARY	lung tumors	lung tumors	163#174		Since the growth inhibitory activity of TGF-beta1 in epithelial cells is associated with K-ras p21, and K-ras mutations commonly occur in chemically-induced mouse lung tumors, we postulated that tumors in heterozygous TGF-beta1 mice might be more likely to have K-ras mutations compared with tumors in wildtype TGF-beta1 mice.
11641043	2002	Toxicol. Lett.	0378-4274	ALL_TEXT_1/3	1	2	3845	LONGTERM|DICTIONARY	k-ras	K-ras	89#94	NaN	D009369	LONGTERM|DICTIONARY	tumors	tumors	195#201		Since the growth inhibitory activity of TGF-beta1 in epithelial cells is associated with K-ras p21, and K-ras mutations commonly occur in chemically-induced mouse lung tumors, we postulated that tumors in heterozygous TGF-beta1 mice might be more likely to have K-ras mutations compared with tumors in wildtype TGF-beta1 mice.
11641043	2002	Toxicol. Lett.	0378-4274	ALL_TEXT_1/3	1	2	3845	LONGTERM|DICTIONARY	k-ras	K-ras	89#94	NaN	D009369	LONGTERM|DICTIONARY	tumors	tumors	292#298		Since the growth inhibitory activity of TGF-beta1 in epithelial cells is associated with K-ras p21, and K-ras mutations commonly occur in chemically-induced mouse lung tumors, we postulated that tumors in heterozygous TGF-beta1 mice might be more likely to have K-ras mutations compared with tumors in wildtype TGF-beta1 mice.
11641043	2002	Toxicol. Lett.	0378-4274	ALL_TEXT_1/3	1	2	3845	LONGTERM|DICTIONARY	k-ras	K-ras	104#109	NaN	D008175	LONGTERM|DICTIONARY	lung tumors	lung tumors	163#174		Since the growth inhibitory activity of TGF-beta1 in epithelial cells is associated with K-ras p21, and K-ras mutations commonly occur in chemically-induced mouse lung tumors, we postulated that tumors in heterozygous TGF-beta1 mice might be more likely to have K-ras mutations compared with tumors in wildtype TGF-beta1 mice.
11641043	2002	Toxicol. Lett.	0378-4274	ALL_TEXT_1/3	1	2	3845	LONGTERM|DICTIONARY	k-ras	K-ras	104#109	NaN	D009369	LONGTERM|DICTIONARY	tumors	tumors	195#201		Since the growth inhibitory activity of TGF-beta1 in epithelial cells is associated with K-ras p21, and K-ras mutations commonly occur in chemically-induced mouse lung tumors, we postulated that tumors in heterozygous TGF-beta1 mice might be more likely to have K-ras mutations compared with tumors in wildtype TGF-beta1 mice.
11641043	2002	Toxicol. Lett.	0378-4274	ALL_TEXT_1/3	1	2	3845	LONGTERM|DICTIONARY	k-ras	K-ras	104#109	NaN	D009369	LONGTERM|DICTIONARY	tumors	tumors	292#298		Since the growth inhibitory activity of TGF-beta1 in epithelial cells is associated with K-ras p21, and K-ras mutations commonly occur in chemically-induced mouse lung tumors, we postulated that tumors in heterozygous TGF-beta1 mice might be more likely to have K-ras mutations compared with tumors in wildtype TGF-beta1 mice.
11641043	2002	Toxicol. Lett.	0378-4274	ALL_TEXT_1/3	1	2	3845	LONGTERM|DICTIONARY	k-ras	K-ras	262#267	NaN	D008175	LONGTERM|DICTIONARY	lung tumors	lung tumors	163#174		Since the growth inhibitory activity of TGF-beta1 in epithelial cells is associated with K-ras p21, and K-ras mutations commonly occur in chemically-induced mouse lung tumors, we postulated that tumors in heterozygous TGF-beta1 mice might be more likely to have K-ras mutations compared with tumors in wildtype TGF-beta1 mice.
11641043	2002	Toxicol. Lett.	0378-4274	ALL_TEXT_1/3	1	2	3845	LONGTERM|DICTIONARY	k-ras	K-ras	262#267	NaN	D009369	LONGTERM|DICTIONARY	tumors	tumors	195#201		Since the growth inhibitory activity of TGF-beta1 in epithelial cells is associated with K-ras p21, and K-ras mutations commonly occur in chemically-induced mouse lung tumors, we postulated that tumors in heterozygous TGF-beta1 mice might be more likely to have K-ras mutations compared with tumors in wildtype TGF-beta1 mice.
11641043	2002	Toxicol. Lett.	0378-4274	ALL_TEXT_1/3	1	2	3845	LONGTERM|DICTIONARY	k-ras	K-ras	262#267	NaN	D009369	LONGTERM|DICTIONARY	tumors	tumors	292#298		Since the growth inhibitory activity of TGF-beta1 in epithelial cells is associated with K-ras p21, and K-ras mutations commonly occur in chemically-induced mouse lung tumors, we postulated that tumors in heterozygous TGF-beta1 mice might be more likely to have K-ras mutations compared with tumors in wildtype TGF-beta1 mice.
11641043	2002	Toxicol. Lett.	0378-4274	ALL_TEXT_1/3	1	2	7040	LONGTERM|DICTIONARY	tgf-beta1	TGF-beta1	40#49	NaN	D008175	LONGTERM|DICTIONARY	lung tumors	lung tumors	163#174		Since the growth inhibitory activity of TGF-beta1 in epithelial cells is associated with K-ras p21, and K-ras mutations commonly occur in chemically-induced mouse lung tumors, we postulated that tumors in heterozygous TGF-beta1 mice might be more likely to have K-ras mutations compared with tumors in wildtype TGF-beta1 mice.
11641043	2002	Toxicol. Lett.	0378-4274	ALL_TEXT_1/3	1	2	7040	LONGTERM|DICTIONARY	tgf-beta1	TGF-beta1	40#49	NaN	D009369	LONGTERM|DICTIONARY	tumors	tumors	195#201		Since the growth inhibitory activity of TGF-beta1 in epithelial cells is associated with K-ras p21, and K-ras mutations commonly occur in chemically-induced mouse lung tumors, we postulated that tumors in heterozygous TGF-beta1 mice might be more likely to have K-ras mutations compared with tumors in wildtype TGF-beta1 mice.
11641043	2002	Toxicol. Lett.	0378-4274	ALL_TEXT_1/3	1	2	7040	LONGTERM|DICTIONARY	tgf-beta1	TGF-beta1	40#49	NaN	D009369	LONGTERM|DICTIONARY	tumors	tumors	292#298		Since the growth inhibitory activity of TGF-beta1 in epithelial cells is associated with K-ras p21, and K-ras mutations commonly occur in chemically-induced mouse lung tumors, we postulated that tumors in heterozygous TGF-beta1 mice might be more likely to have K-ras mutations compared with tumors in wildtype TGF-beta1 mice.
11641043	2002	Toxicol. Lett.	0378-4274	ALL_TEXT_1/3	1	2	7040	LONGTERM|DICTIONARY	tgf-beta1	TGF-beta1	218#227	NaN	D008175	LONGTERM|DICTIONARY	lung tumors	lung tumors	163#174		Since the growth inhibitory activity of TGF-beta1 in epithelial cells is associated with K-ras p21, and K-ras mutations commonly occur in chemically-induced mouse lung tumors, we postulated that tumors in heterozygous TGF-beta1 mice might be more likely to have K-ras mutations compared with tumors in wildtype TGF-beta1 mice.
11641043	2002	Toxicol. Lett.	0378-4274	ALL_TEXT_1/3	1	2	7040	LONGTERM|DICTIONARY	tgf-beta1	TGF-beta1	218#227	NaN	D009369	LONGTERM|DICTIONARY	tumors	tumors	195#201		Since the growth inhibitory activity of TGF-beta1 in epithelial cells is associated with K-ras p21, and K-ras mutations commonly occur in chemically-induced mouse lung tumors, we postulated that tumors in heterozygous TGF-beta1 mice might be more likely to have K-ras mutations compared with tumors in wildtype TGF-beta1 mice.
11641043	2002	Toxicol. Lett.	0378-4274	ALL_TEXT_1/3	1	2	7040	LONGTERM|DICTIONARY	tgf-beta1	TGF-beta1	218#227	NaN	D009369	LONGTERM|DICTIONARY	tumors	tumors	292#298		Since the growth inhibitory activity of TGF-beta1 in epithelial cells is associated with K-ras p21, and K-ras mutations commonly occur in chemically-induced mouse lung tumors, we postulated that tumors in heterozygous TGF-beta1 mice might be more likely to have K-ras mutations compared with tumors in wildtype TGF-beta1 mice.
11641043	2002	Toxicol. Lett.	0378-4274	ALL_TEXT_1/3	1	2	7040	LONGTERM|DICTIONARY	tgf-beta1	TGF-beta1	311#320	NaN	D008175	LONGTERM|DICTIONARY	lung tumors	lung tumors	163#174		Since the growth inhibitory activity of TGF-beta1 in epithelial cells is associated with K-ras p21, and K-ras mutations commonly occur in chemically-induced mouse lung tumors, we postulated that tumors in heterozygous TGF-beta1 mice might be more likely to have K-ras mutations compared with tumors in wildtype TGF-beta1 mice.
11641043	2002	Toxicol. Lett.	0378-4274	ALL_TEXT_1/3	1	2	7040	LONGTERM|DICTIONARY	tgf-beta1	TGF-beta1	311#320	NaN	D009369	LONGTERM|DICTIONARY	tumors	tumors	195#201		Since the growth inhibitory activity of TGF-beta1 in epithelial cells is associated with K-ras p21, and K-ras mutations commonly occur in chemically-induced mouse lung tumors, we postulated that tumors in heterozygous TGF-beta1 mice might be more likely to have K-ras mutations compared with tumors in wildtype TGF-beta1 mice.
11641043	2002	Toxicol. Lett.	0378-4274	ALL_TEXT_1/3	1	2	7040	LONGTERM|DICTIONARY	tgf-beta1	TGF-beta1	311#320	NaN	D009369	LONGTERM|DICTIONARY	tumors	tumors	292#298		Since the growth inhibitory activity of TGF-beta1 in epithelial cells is associated with K-ras p21, and K-ras mutations commonly occur in chemically-induced mouse lung tumors, we postulated that tumors in heterozygous TGF-beta1 mice might be more likely to have K-ras mutations compared with tumors in wildtype TGF-beta1 mice.
9521595	1998	Hum. Genet.	0340-6717	ALL_TEXT_1/3	1	1	1080	LONGTERM|DICTIONARY|GENE|GA	cystic fibrosis transmembrane conductance regulator	cystic fibrosis transmembrane conductance regulator	128#179		D003550	LONGTERM|DICTIONARY	cystic fibrosis	cystic fibrosis	38#53		In order to determine the spectrum of cystic fibrosis (CF) mutations in the Turkish population, a complete coding region of the cystic fibrosis transmembrane conductance regulator (CFTR) gene including exon-intron boundaries, on 122 unrelated CF chromosomes from 73 Turkish CF families was analysed by denaturing gradient gel electrophoresis and multiplex heteroduplex analysis on MDE gel matrix.
9521595	1998	Hum. Genet.	0340-6717	ALL_TEXT_1/3	1	1	1080	LONGTERM|DICTIONARY|GENE|GA	cystic fibrosis transmembrane conductance regulator	cystic fibrosis transmembrane conductance regulator	128#179		D003550	SYMBOL|EXTRACTED|()	cf	CF	55#57	9521595-1-38-53	In order to determine the spectrum of cystic fibrosis (CF) mutations in the Turkish population, a complete coding region of the cystic fibrosis transmembrane conductance regulator (CFTR) gene including exon-intron boundaries, on 122 unrelated CF chromosomes from 73 Turkish CF families was analysed by denaturing gradient gel electrophoresis and multiplex heteroduplex analysis on MDE gel matrix.
9521595	1998	Hum. Genet.	0340-6717	ALL_TEXT_1/3	1	1	1080	LONGTERM|DICTIONARY|GENE|GA	cystic fibrosis transmembrane conductance regulator	cystic fibrosis transmembrane conductance regulator	128#179		D003550	SYMBOL|EXTRACTED	cf	CF	243#245	9521595-1-38-53	In order to determine the spectrum of cystic fibrosis (CF) mutations in the Turkish population, a complete coding region of the cystic fibrosis transmembrane conductance regulator (CFTR) gene including exon-intron boundaries, on 122 unrelated CF chromosomes from 73 Turkish CF families was analysed by denaturing gradient gel electrophoresis and multiplex heteroduplex analysis on MDE gel matrix.
9521595	1998	Hum. Genet.	0340-6717	ALL_TEXT_1/3	1	1	1080	LONGTERM|DICTIONARY|GENE|GA	cystic fibrosis transmembrane conductance regulator	cystic fibrosis transmembrane conductance regulator	128#179		D003550	SYMBOL|EXTRACTED	cf	CF	274#276	9521595-1-38-53	In order to determine the spectrum of cystic fibrosis (CF) mutations in the Turkish population, a complete coding region of the cystic fibrosis transmembrane conductance regulator (CFTR) gene including exon-intron boundaries, on 122 unrelated CF chromosomes from 73 Turkish CF families was analysed by denaturing gradient gel electrophoresis and multiplex heteroduplex analysis on MDE gel matrix.
9521595	1998	Hum. Genet.	0340-6717	ALL_TEXT_1/3	1	1	1080	SYMBOL|()|GENE|GN|DICTIONARY|EXTRACTED	cftr	CFTR	181#185	9521595-1-128-179	D003550	LONGTERM|DICTIONARY	cystic fibrosis	cystic fibrosis	38#53		In order to determine the spectrum of cystic fibrosis (CF) mutations in the Turkish population, a complete coding region of the cystic fibrosis transmembrane conductance regulator (CFTR) gene including exon-intron boundaries, on 122 unrelated CF chromosomes from 73 Turkish CF families was analysed by denaturing gradient gel electrophoresis and multiplex heteroduplex analysis on MDE gel matrix.
9521595	1998	Hum. Genet.	0340-6717	ALL_TEXT_1/3	1	1	1080	SYMBOL|()|GENE|GN|DICTIONARY|EXTRACTED	cftr	CFTR	181#185	9521595-1-128-179	D003550	SYMBOL|EXTRACTED|()	cf	CF	55#57	9521595-1-38-53	In order to determine the spectrum of cystic fibrosis (CF) mutations in the Turkish population, a complete coding region of the cystic fibrosis transmembrane conductance regulator (CFTR) gene including exon-intron boundaries, on 122 unrelated CF chromosomes from 73 Turkish CF families was analysed by denaturing gradient gel electrophoresis and multiplex heteroduplex analysis on MDE gel matrix.
9521595	1998	Hum. Genet.	0340-6717	ALL_TEXT_1/3	1	1	1080	SYMBOL|()|GENE|GN|DICTIONARY|EXTRACTED	cftr	CFTR	181#185	9521595-1-128-179	D003550	SYMBOL|EXTRACTED	cf	CF	243#245	9521595-1-38-53	In order to determine the spectrum of cystic fibrosis (CF) mutations in the Turkish population, a complete coding region of the cystic fibrosis transmembrane conductance regulator (CFTR) gene including exon-intron boundaries, on 122 unrelated CF chromosomes from 73 Turkish CF families was analysed by denaturing gradient gel electrophoresis and multiplex heteroduplex analysis on MDE gel matrix.
9521595	1998	Hum. Genet.	0340-6717	ALL_TEXT_1/3	1	1	1080	SYMBOL|()|GENE|GN|DICTIONARY|EXTRACTED	cftr	CFTR	181#185	9521595-1-128-179	D003550	SYMBOL|EXTRACTED	cf	CF	274#276	9521595-1-38-53	In order to determine the spectrum of cystic fibrosis (CF) mutations in the Turkish population, a complete coding region of the cystic fibrosis transmembrane conductance regulator (CFTR) gene including exon-intron boundaries, on 122 unrelated CF chromosomes from 73 Turkish CF families was analysed by denaturing gradient gel electrophoresis and multiplex heteroduplex analysis on MDE gel matrix.
14974362	2004	Pol. Merkur. Lekarski	1426-9686	ALL_TEXT_3/3	3	8	1636	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	ace	ACE	59#62	14974362-3-275-304	D005921	SYMBOL|EXTRACTED	gn	GN	121#123	14974362-3-143-161	Further studies are needed for verification of the role of ACE gene polymorphism in the predisposition to development of GN and associated arterial hypertension.
14974362	2004	Pol. Merkur. Lekarski	1426-9686	ALL_TEXT_3/3	3	8	1636	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	ace	ACE	59#62	14974362-3-275-304	D006973	LONGTERM|DICTIONARY	arterial hypertension	arterial hypertension	139#160		Further studies are needed for verification of the role of ACE gene polymorphism in the predisposition to development of GN and associated arterial hypertension.
20615671	2011	Eur. Psychiatry	1778-3585	ALL_TEXT_3/3	3	10	84062	SYMBOL|DICTIONARY|EXTRACTED	dtnbp1	DTNBP1	27#33	20615671-1-0-30	D012559	LONGTERM|DICTIONARY	schizophrenia	schizophrenia	58#71		These results suggest that DTNBP1 is a good candidate for schizophrenia risk and rs9370822 is either functionally important or in disequilibrium with a functional SNP, although our observations should be viewed with caution until they are independently replicated.
19631393	2009	J. Neuroimmunol.	1872-8421	ALL_TEXT_2/3	2	2	4318	SYMBOL|DICTIONARY	mmp 9	MMP-9	61#66		D009103	SYMBOL|EXTRACTED	ms	MS	127#129	19631393-1-0-18	This study was carried out in order to determine whether the MMP-9 C(-1562)T and (CA)(13-25) polymorphisms are associated with MS. A total of 165 patients (92 whites/73 mulattos) and 191 controls (96 whites/95 mulattos) were enrolled in the study.
19800393	2010	Neurosci. Lett.	1872-7972	TITLE	0	0	120892	SYMBOL|DICTIONARY	lrrk2	LRRK2	72#77		D010300	LONGTERM|DISEASE|DT|DICTIONARY	parkinson disease	Parkinson's disease	41#60		Identification of four novel potentially Parkinson's disease associated LRRK2 variations among Iranian patients.
12827651	2003	Am. J. Hematol.	0361-8609	ALL_TEXT_3/3	3	10	2952	SYMBOL|DICTIONARY	gstt1	GSTT1	161#166		D015470	LONGTERM|DICTIONARY	acute leukemia	acute leukemia	139#153		These results suggested that there are no significant associations between the studied genotypes and the risk of developing either form of acute leukemia except GSTT1 null and homozygosity for CYP1A1 genotypes that may play protective roles in the development of ANLL in Turkish children.
12827651	2003	Am. J. Hematol.	0361-8609	ALL_TEXT_3/3	3	10	2952	SYMBOL|DICTIONARY	gstt1	GSTT1	161#166		D015470	SYMBOL|DICTIONARY|EXTRACTED	anll	ANLL	263#267	12827651-2-73-104	These results suggested that there are no significant associations between the studied genotypes and the risk of developing either form of acute leukemia except GSTT1 null and homozygosity for CYP1A1 genotypes that may play protective roles in the development of ANLL in Turkish children.
12827651	2003	Am. J. Hematol.	0361-8609	ALL_TEXT_3/3	3	10	1543	SYMBOL|DICTIONARY	cyp1a1	CYP1A1	193#199		D015470	LONGTERM|DICTIONARY	acute leukemia	acute leukemia	139#153		These results suggested that there are no significant associations between the studied genotypes and the risk of developing either form of acute leukemia except GSTT1 null and homozygosity for CYP1A1 genotypes that may play protective roles in the development of ANLL in Turkish children.
12827651	2003	Am. J. Hematol.	0361-8609	ALL_TEXT_3/3	3	10	1543	SYMBOL|DICTIONARY	cyp1a1	CYP1A1	193#199		D015470	SYMBOL|DICTIONARY|EXTRACTED	anll	ANLL	263#267	12827651-2-73-104	These results suggested that there are no significant associations between the studied genotypes and the risk of developing either form of acute leukemia except GSTT1 null and homozygosity for CYP1A1 genotypes that may play protective roles in the development of ANLL in Turkish children.
22570617	2012	PLoS Genet.	1553-7404	ALL_TEXT_2/3	2	5	100048912	SYMBOL|DICTIONARY	cdkn2bas	CDKN2BAS	170#178		C562750	SYMBOL|DICTIONARY|EXTRACTED	poag	POAG	160#164	22570617-3-89-116	The overall meta-analysis of the GLAUGEN and NEIGHBOR dataset results (3,146 cases and 3,487 controls) identified significant associations between two loci and POAG: the CDKN2BAS region on 9p21 (rs2157719 [G], OR=0.69 [95%CI 0.63-0.75], p=1.8610), and the SIX1/SIX6 region on chromosome 14q23 (rs10483727 [A], OR=1.32 [95%CI 1.21-1.43], p=3.8710).
22570617	2012	PLoS Genet.	1553-7404	ALL_TEXT_2/3	2	5	6495	SYMBOL|DICTIONARY	six1	SIX1	264#268		C562750	SYMBOL|DICTIONARY|EXTRACTED	poag	POAG	160#164	22570617-3-89-116	The overall meta-analysis of the GLAUGEN and NEIGHBOR dataset results (3,146 cases and 3,487 controls) identified significant associations between two loci and POAG: the CDKN2BAS region on 9p21 (rs2157719 [G], OR=0.69 [95%CI 0.63-0.75], p=1.8610), and the SIX1/SIX6 region on chromosome 14q23 (rs10483727 [A], OR=1.32 [95%CI 1.21-1.43], p=3.8710).
22570617	2012	PLoS Genet.	1553-7404	ALL_TEXT_2/3	2	5	4990	SYMBOL|DICTIONARY	six6	SIX6	269#273		C562750	SYMBOL|DICTIONARY|EXTRACTED	poag	POAG	160#164	22570617-3-89-116	The overall meta-analysis of the GLAUGEN and NEIGHBOR dataset results (3,146 cases and 3,487 controls) identified significant associations between two loci and POAG: the CDKN2BAS region on 9p21 (rs2157719 [G], OR=0.69 [95%CI 0.63-0.75], p=1.8610), and the SIX1/SIX6 region on chromosome 14q23 (rs10483727 [A], OR=1.32 [95%CI 1.21-1.43], p=3.8710).
22570617	2012	PLoS Genet.	1553-7404	ALL_TEXT_3/3	3	9	7040	LONGTERM|DICTIONARY	tgf-beta	TGF-beta	64#72	NaN	D005901	LONGTERM|DICTIONARY	glaucoma	glaucoma	124#132		These results suggest that neuro-protective therapies targeting TGF-beta signaling could be effective for multiple forms of glaucoma.
19495527	2010	Singapore Med J	0037-5675	TITLE	0	0	4204	SYMBOL|DICTIONARY|EXTRACTED	mecp2	MECP2	0#5		D015518	LONGTERM|DISEASE|DN|DT|DICTIONARY	rett syndrome	Rett syndrome	29#42		MECP2 mutations in Malaysian Rett syndrome patients.
12879272	2004	Rheumatol. Int.	0172-8172	ALL_TEXT_3/3	3	6	2952	SYMBOL|DICTIONARY	gstt1	GSTT1	29#34		D002340	LONGTERM|DICTIONARY	carotid atherosclerosis	carotid atherosclerosis	77#100		This study suggests that the GSTT1-0 genotype might have an interaction with carotid atherosclerosis related to RA in Korean postmenopausal RA women without histories of smoking.
12879272	2004	Rheumatol. Int.	0172-8172	ALL_TEXT_3/3	3	6	2952	SYMBOL|DICTIONARY	gstt1	GSTT1	29#34		D001172	LONGTERM|DICTIONARY	ra	RA	112#114	NaN	This study suggests that the GSTT1-0 genotype might have an interaction with carotid atherosclerosis related to RA in Korean postmenopausal RA women without histories of smoking.
12879272	2004	Rheumatol. Int.	0172-8172	ALL_TEXT_3/3	3	6	2952	SYMBOL|DICTIONARY	gstt1	GSTT1	29#34		D001172	LONGTERM|DICTIONARY	ra	RA	140#142	NaN	This study suggests that the GSTT1-0 genotype might have an interaction with carotid atherosclerosis related to RA in Korean postmenopausal RA women without histories of smoking.
16788379	2006	Pharmacogenet. Genomics	1744-6872	CONCLUSIONS	4	10	2099	LONGTERM|GENE|GT|DICTIONARY	estrogen receptor	estrogen receptor	89#106		D001943	LONGTERM|DISEASE|DT|DICTIONARY	breast cancer	breast cancer	158#171		These data suggest that the Leu84Phe polymorphism affect the capacity of MGMT to inhibit estrogen receptor-mediated cell proliferation and is associated with breast cancer risk.
12879272	2004	Rheumatol. Int.	0172-8172	TITLE	0	0	2944	LONGTERM|DICTIONARY	glutathione s transferase m1	Glutathione S-transferase M1	0#28		D002340	LONGTERM|DICTIONARY	carotid atherosclerosis	carotid atherosclerosis	64#87		Glutathione S-transferase M1, T1, and P1 gene polymorphisms and carotid atherosclerosis in Korean patients with rheumatoid arthritis.
12879272	2004	Rheumatol. Int.	0172-8172	TITLE	0	0	2944	LONGTERM|DICTIONARY	glutathione s transferase m1	Glutathione S-transferase M1	0#28		D001172	LONGTERM|DICTIONARY	rheumatoid arthritis	rheumatoid arthritis	112#132		Glutathione S-transferase M1, T1, and P1 gene polymorphisms and carotid atherosclerosis in Korean patients with rheumatoid arthritis.
15253766	2005	Clin. Genet.	0009-9163	ALL_TEXT_1/3	1	4	2706	SYMBOL|GENE|GN|DICTIONARY	gjb2	GJB2	81#85		D003638	LONGTERM|DICTIONARY	congenital deafness	congenital deafness	112#131		We investigated and report here the spectrum and frequencies of mutations in the GJB2 gene among 156 unrelated, congenital deafness Czech patients.
19495527	2010	Singapore Med J	0037-5675	INTRODUCTION	1	2	4204	LONGTERM|DICTIONARY	methyl cpg binding protein 2	methyl-CpG-binding protein-2	85#113		D015518	SYMBOL|EXTRACTED	rs	RS	37#39	19495527-1-0-13	The X-linked dominant inheritance of RS has been mapped to the gene that encodes the methyl-CpG-binding protein-2 (MECP2) at Xq28.
19495527	2010	Singapore Med J	0037-5675	INTRODUCTION	1	2	4204	SYMBOL|()|DICTIONARY|EXTRACTED	mecp2	MECP2	115#120	19495527-2-85-113	D015518	SYMBOL|EXTRACTED	rs	RS	37#39	19495527-1-0-13	The X-linked dominant inheritance of RS has been mapped to the gene that encodes the methyl-CpG-binding protein-2 (MECP2) at Xq28.
18671953	2008	Brain Res.	0006-8993	ALL_TEXT_1/3	1	1	347	LONGTERM|DICTIONARY	apolipoprotein d	Apolipoprotein D	0#16		D000544	LONGTERM|DISEASE|DT|DICTIONARY	alzheimer disease	Alzheimer's disease	143#162		Apolipoprotein D (apoD) is a lipoprotein-associated glycoprotein that is increased in the hippocampus and cerebrospinal fluid of patients with Alzheimer's disease (AD), which implies that apoD might be involved in the pathogenesis of AD.
18671953	2008	Brain Res.	0006-8993	ALL_TEXT_1/3	1	1	347	LONGTERM|DICTIONARY	apolipoprotein d	Apolipoprotein D	0#16		D000544	SYMBOL|EXTRACTED|()	ad	AD	164#166	18671953-1-143-162	Apolipoprotein D (apoD) is a lipoprotein-associated glycoprotein that is increased in the hippocampus and cerebrospinal fluid of patients with Alzheimer's disease (AD), which implies that apoD might be involved in the pathogenesis of AD.
18671953	2008	Brain Res.	0006-8993	ALL_TEXT_1/3	1	1	347	LONGTERM|DICTIONARY	apolipoprotein d	Apolipoprotein D	0#16		D000544	SYMBOL|EXTRACTED	ad	AD	234#236	18671953-1-143-162	Apolipoprotein D (apoD) is a lipoprotein-associated glycoprotein that is increased in the hippocampus and cerebrospinal fluid of patients with Alzheimer's disease (AD), which implies that apoD might be involved in the pathogenesis of AD.
18671953	2008	Brain Res.	0006-8993	TITLE	0	0	347	LONGTERM|GENE|GN|DICTIONARY	apolipoprotein d	apolipoprotein D	41#57		D000544	LONGTERM|DISEASE|DT|DICTIONARY	alzheimer disease	Alzheimer's disease	76#95		Association between polymorphisms in the apolipoprotein D gene and sporadic Alzheimer's disease.
21094227	2011	Toxicol. Lett.	1879-3169	TITLE	0	0	3565	SYMBOL|DICTIONARY	il 4	IL-4	0#4		D056486	LONGTERM|DICTIONARY	liver injury	liver injury	36#48	NaN	IL-4 mediates dicloxacillin-induced liver injury in mice.
15824150	2005	Cancer Epidemiol. Biomarkers Prev.	1055-9965	ALL_TEXT_3/3	3	10	472	SYMBOL|DICTIONARY|EXTRACTED	atm	ATM	55#58	15824150-1-49-78	D001943	LONGTERM|DISEASE|DT|DICTIONARY	breast cancer	breast cancer	104#117		Our results thus suggest that genetic polymorphisms of ATM play an important role in the development of breast cancer in Korean women.
21094227	2011	Toxicol. Lett.	1879-3169	ALL_TEXT_3/3	3	9	11251	SYMBOL|()|DICTIONARY|EXTRACTED	crth2	CRTh2	69#74	21094227-9-0-67	D007249	LONGTERM|DICTIONARY	allergic inflammation	allergic inflammation	176#197	NaN	Chemoattractant receptor-homologous molecule expressed on Th2 cells (CRTh2) is a cognate receptor for prostaglandin (PG) D(2), and is suggested to be involved in Th2-dependent allergic inflammation.
21094227	2011	Toxicol. Lett.	1879-3169	ALL_TEXT_3/3	3	9	9464	LONGTERM|DICTIONARY	th2	Th2	58#61		D007249	LONGTERM|DICTIONARY	allergic inflammation	allergic inflammation	176#197	NaN	Chemoattractant receptor-homologous molecule expressed on Th2 cells (CRTh2) is a cognate receptor for prostaglandin (PG) D(2), and is suggested to be involved in Th2-dependent allergic inflammation.
20522430	2010	J. Med. Genet.	1468-6244	ALL_TEXT_1/3	1	3	6323	SYMBOL|DICTIONARY	scn1a	SCN1A	139#144		D004831	SYMBOL|DISEASE|DN|DICTIONARY	ds	DS	63#65		OBJECTIVES AND PATIENTS 19 selected families with at least one DS patient were studied to describe the mechanisms accounting for inherited SCN1A mutations in DS.
20373279	2011	Exp. Clin. Endocrinol. Diabetes	1439-3646	ALL_TEXT_1/3	1	2	79068	SYMBOL|DICTIONARY	fto	FTO	44#47		D015430	LONGTERM|DICTIONARY	weight gain	weight gain	65#76	NaN	The aim of this study was to investigate if FTO genotype affects weight gain in adulthood.
20373279	2011	Exp. Clin. Endocrinol. Diabetes	1439-3646	TITLE	0	0	79068	SYMBOL|DICTIONARY	fto	FTO	0#3		D009765	LONGTERM|DICTIONARY	obese	obese	32#37		FTO genotype and weight gain in obese and normal weight adults from a Norwegian population based cohort (the HUNT study).
20373279	2011	Exp. Clin. Endocrinol. Diabetes	1439-3646	TITLE	0	0	79068	SYMBOL|DICTIONARY	fto	FTO	0#3		D015430	LONGTERM|DICTIONARY	weight gain	weight gain	17#28	NaN	FTO genotype and weight gain in obese and normal weight adults from a Norwegian population based cohort (the HUNT study).
20373279	2011	Exp. Clin. Endocrinol. Diabetes	1439-3646	ALL_TEXT_1/3	1	1	79068	SYMBOL|DICTIONARY	fto	FTO	43#46		D009765	LONGTERM|DICTIONARY	obesity	obesity	82#89		The fat mass and obesity associated gene ( FTO) is associated with bodyweight and obesity.
20373279	2011	Exp. Clin. Endocrinol. Diabetes	1439-3646	ALL_TEXT_2/3	2	6	79068	SYMBOL|DICTIONARY	fto	FTO	29#32		D009765	LONGTERM|DICTIONARY	obesity	obesity	37#44		A strong association between FTO and obesity was found, consistent with an additive gene effect.
15472214	2004	J. Clin. Endocrinol. Metab.	0021-972X	ALL_TEXT_3/3	3	11	5468	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	ppar gamma	PPAR-gamma	133#143	15472214-3-0-48	D011085	SYMBOL|DICTIONARY|EXTRACTED	pcos	PCOS	82#86	15472214-1-0-25	In conclusion, our results confirm that adiponectin concentrations are similar in PCOS and controls and demonstrate no effect of the PPAR-gamma gene Pro12Ala polymorphism on serum adiponectin levels.
15472214	2004	J. Clin. Endocrinol. Metab.	0021-972X	ALL_TEXT_3/3	3	11	9370	LONGTERM|DICTIONARY	adiponectin	adiponectin	40#51	NaN	D011085	SYMBOL|DICTIONARY|EXTRACTED	pcos	PCOS	82#86	15472214-1-0-25	In conclusion, our results confirm that adiponectin concentrations are similar in PCOS and controls and demonstrate no effect of the PPAR-gamma gene Pro12Ala polymorphism on serum adiponectin levels.
15472214	2004	J. Clin. Endocrinol. Metab.	0021-972X	ALL_TEXT_3/3	3	11	9370	LONGTERM|DICTIONARY	adiponectin	adiponectin	180#191	NaN	D011085	SYMBOL|DICTIONARY|EXTRACTED	pcos	PCOS	82#86	15472214-1-0-25	In conclusion, our results confirm that adiponectin concentrations are similar in PCOS and controls and demonstrate no effect of the PPAR-gamma gene Pro12Ala polymorphism on serum adiponectin levels.
16160007	2006	Blood	0006-4971	ALL_TEXT_1/3	1	1	11093	SYMBOL|DICTIONARY	adamts13	ADAMTS13	25#33		D011697	LONGTERM|DICTIONARY	thrombotic thrombocytopenic purpura	thrombotic thrombocytopenic purpura	70#105		Sequence analysis of the ADAMTS13 locus of 2 patients with hereditary thrombotic thrombocytopenic purpura (TTP) revealed the homozygous presence of 4 single nucleotide polymorphisms (SNPs) (R7W, Q448E, P618A, A732V) and a rare missense mutation (R1336W).
16160007	2006	Blood	0006-4971	ALL_TEXT_1/3	1	1	11093	SYMBOL|DICTIONARY	adamts13	ADAMTS13	25#33		D011697	SYMBOL|()|DICTIONARY|EXTRACTED	ttp	TTP	107#110	16160007-1-70-105	Sequence analysis of the ADAMTS13 locus of 2 patients with hereditary thrombotic thrombocytopenic purpura (TTP) revealed the homozygous presence of 4 single nucleotide polymorphisms (SNPs) (R7W, Q448E, P618A, A732V) and a rare missense mutation (R1336W).
14732601	2004	Biol. Psychiatry	0006-3223	TITLE	0	0	9145	LONGTERM|GENE|GN|DICTIONARY	synaptogyrin 1	synaptogyrin 1	27#41		D012559	LONGTERM|DICTIONARY	schizophrenia	schizophrenia	64#77		A nonsense mutation in the synaptogyrin 1 gene in a family with schizophrenia.
15057267	2005	Genes Immun.	1466-4879	ALL_TEXT_2/3	2	4	3586	SYMBOL|DICTIONARY|EXTRACTED	il 10	IL- 10	75#81		D003922	SYMBOL|EXTRACTED	t1d	T1D	117#120	15057267-1-59-74	In fact, this is the first association study investigating the role of the IL- 10 polymorphisms in susceptibility to T1D in a Caucasian population.
15292102	2005	J. Androl.	0196-3635	ALL_TEXT_2/3	2	4	1636	SYMBOL|DICTIONARY	ace	ACE	60#63		D007172	SYMBOL|EXTRACTED	ed	ED	107#109	15292102-2-179-199	We analyzed the frequencies of 894 G/T (Glu298Asp) eNOS and ACE I/D polymorphisms in Mexican patients with ED (n=53) and in an age-matched control group (n=62).
15057267	2005	Genes Immun.	1466-4879	ALL_TEXT_3/3	3	6	3586	SYMBOL|DICTIONARY|EXTRACTED	il 10	IL-10	34#39	15057267-3-6-20	C565730	LONGTERM|DICTIONARY	autoimmune diabetes	autoimmune diabetes	47#66		Our results prove a minor role of IL-10 in the autoimmune diabetes risk, although we found the same association trend with IL-10G(*)12 allele as was previously observed for multiple sclerosis and rheumatoid arthritis.
15057267	2005	Genes Immun.	1466-4879	ALL_TEXT_3/3	3	6	3586	SYMBOL|DICTIONARY|EXTRACTED	il 10	IL-10	34#39	15057267-3-6-20	D009103	LONGTERM|DICTIONARY	multiple sclerosis	multiple sclerosis	173#191		Our results prove a minor role of IL-10 in the autoimmune diabetes risk, although we found the same association trend with IL-10G(*)12 allele as was previously observed for multiple sclerosis and rheumatoid arthritis.
15057267	2005	Genes Immun.	1466-4879	ALL_TEXT_3/3	3	6	3586	SYMBOL|DICTIONARY|EXTRACTED	il 10	IL-10	34#39	15057267-3-6-20	D001172	LONGTERM|DICTIONARY	rheumatoid arthritis	rheumatoid arthritis	196#216		Our results prove a minor role of IL-10 in the autoimmune diabetes risk, although we found the same association trend with IL-10G(*)12 allele as was previously observed for multiple sclerosis and rheumatoid arthritis.
15057267	2005	Genes Immun.	1466-4879	TITLE	0	0	3586	LONGTERM|DICTIONARY	interleukin 10	Interleukin-10	0#14		D003922	LONGTERM|DISEASE|DN|DICTIONARY	type 1 diabetes	type 1 diabetes	40#55		Interleukin-10 polymorphisms in Spanish type 1 diabetes patients.
15292102	2005	J. Androl.	0196-3635	TITLE	0	0	4846	LONGTERM|DICTIONARY	endothelial nitric oxide synthase	endothelial nitric oxide synthase	10#43		D007172	LONGTERM|DICTIONARY	erectile dysfunction	erectile dysfunction	78#98		Glu298Asp endothelial nitric oxide synthase polymorphism is a risk factor for erectile dysfunction in the Mexican Mestizo population.
15292102	2005	J. Androl.	0196-3635	ALL_TEXT_1/3	1	2	4846	LONGTERM|DICTIONARY	endothelial nitric oxide synthase	Endothelial nitric oxide synthase	0#33		D008107	LONGTERM|DICTIONARY	endothelial dysfunction	endothelial dysfunction	121#144		Endothelial nitric oxide synthase (eNOS) and angiotensin-converting enzyme (ACE) polymorphisms have been associated with endothelial dysfunction, which is described as a cause of erectile dysfunction (ED).
15292102	2005	J. Androl.	0196-3635	ALL_TEXT_1/3	1	2	4846	LONGTERM|DICTIONARY	endothelial nitric oxide synthase	Endothelial nitric oxide synthase	0#33		D007172	LONGTERM|DICTIONARY	erectile dysfunction	erectile dysfunction	179#199		Endothelial nitric oxide synthase (eNOS) and angiotensin-converting enzyme (ACE) polymorphisms have been associated with endothelial dysfunction, which is described as a cause of erectile dysfunction (ED).
15292102	2005	J. Androl.	0196-3635	ALL_TEXT_1/3	1	2	4846	LONGTERM|DICTIONARY	endothelial nitric oxide synthase	Endothelial nitric oxide synthase	0#33		D007172	SYMBOL|EXTRACTED|()	ed	ED	201#203	15292102-2-179-199	Endothelial nitric oxide synthase (eNOS) and angiotensin-converting enzyme (ACE) polymorphisms have been associated with endothelial dysfunction, which is described as a cause of erectile dysfunction (ED).
15292102	2005	J. Androl.	0196-3635	ALL_TEXT_1/3	1	2	1636	LONGTERM|GENE|GT|DICTIONARY	angiotensin converting enzyme	angiotensin-converting enzyme	45#74		D008107	LONGTERM|DICTIONARY	endothelial dysfunction	endothelial dysfunction	121#144		Endothelial nitric oxide synthase (eNOS) and angiotensin-converting enzyme (ACE) polymorphisms have been associated with endothelial dysfunction, which is described as a cause of erectile dysfunction (ED).
15292102	2005	J. Androl.	0196-3635	ALL_TEXT_1/3	1	2	1636	LONGTERM|GENE|GT|DICTIONARY	angiotensin converting enzyme	angiotensin-converting enzyme	45#74		D007172	LONGTERM|DICTIONARY	erectile dysfunction	erectile dysfunction	179#199		Endothelial nitric oxide synthase (eNOS) and angiotensin-converting enzyme (ACE) polymorphisms have been associated with endothelial dysfunction, which is described as a cause of erectile dysfunction (ED).
15292102	2005	J. Androl.	0196-3635	ALL_TEXT_1/3	1	2	1636	LONGTERM|GENE|GT|DICTIONARY	angiotensin converting enzyme	angiotensin-converting enzyme	45#74		D007172	SYMBOL|EXTRACTED|()	ed	ED	201#203	15292102-2-179-199	Endothelial nitric oxide synthase (eNOS) and angiotensin-converting enzyme (ACE) polymorphisms have been associated with endothelial dysfunction, which is described as a cause of erectile dysfunction (ED).
15292102	2005	J. Androl.	0196-3635	ALL_TEXT_1/3	1	2	1636	SYMBOL|()|DICTIONARY|EXTRACTED	ace	ACE	76#79	15292102-2-45-74	D008107	LONGTERM|DICTIONARY	endothelial dysfunction	endothelial dysfunction	121#144		Endothelial nitric oxide synthase (eNOS) and angiotensin-converting enzyme (ACE) polymorphisms have been associated with endothelial dysfunction, which is described as a cause of erectile dysfunction (ED).
15292102	2005	J. Androl.	0196-3635	ALL_TEXT_1/3	1	2	1636	SYMBOL|()|DICTIONARY|EXTRACTED	ace	ACE	76#79	15292102-2-45-74	D007172	LONGTERM|DICTIONARY	erectile dysfunction	erectile dysfunction	179#199		Endothelial nitric oxide synthase (eNOS) and angiotensin-converting enzyme (ACE) polymorphisms have been associated with endothelial dysfunction, which is described as a cause of erectile dysfunction (ED).
15292102	2005	J. Androl.	0196-3635	ALL_TEXT_1/3	1	2	1636	SYMBOL|()|DICTIONARY|EXTRACTED	ace	ACE	76#79	15292102-2-45-74	D007172	SYMBOL|EXTRACTED|()	ed	ED	201#203	15292102-2-179-199	Endothelial nitric oxide synthase (eNOS) and angiotensin-converting enzyme (ACE) polymorphisms have been associated with endothelial dysfunction, which is described as a cause of erectile dysfunction (ED).
12913211	2004	Neurology	1526-632X	ALL_TEXT	1	2	3009	LONGTERM|DICTIONARY	h1/h2	H1/H2	100#105	NaN	D013494	LONGTERM|DICTIONARY	progressive supranuclear palsy	progressive supranuclear palsy	191#221		The authors show that this polymorphism is in complete linkage disequilibrium with the extended tau H1/H2 haplotype and that the Q variant and QQ genotype of Q7R are strongly associated with progressive supranuclear palsy, implicating it as a possibly important pathogenic candidate.
12913211	2004	Neurology	1526-632X	ALL_TEXT	1	2	6019	LONGTERM|DICTIONARY	h1/h2	H1/H2	100#105	NaN	D013494	LONGTERM|DICTIONARY	progressive supranuclear palsy	progressive supranuclear palsy	191#221		The authors show that this polymorphism is in complete linkage disequilibrium with the extended tau H1/H2 haplotype and that the Q variant and QQ genotype of Q7R are strongly associated with progressive supranuclear palsy, implicating it as a possibly important pathogenic candidate.
12880539	2004	Ann. Clin. Biochem.	0004-5632	TITLE	0	0	348	LONGTERM|GENE|GN|DICTIONARY	apolipoprotein e	Apolipoprotein E	0#16		D009203	LONGTERM|DICTIONARY	myocardial infarction	myocardial infarction	63#84		Apolipoprotein E gene polymorphisms in patients with premature myocardial infarction: a case-controlled study in Asian Indians in North India.
12880539	2004	Ann. Clin. Biochem.	0004-5632	OBJECTIVES	1	2	348	LONGTERM|DICTIONARY	apolipoprotein e	apolipoprotein E	52#68		D009203	LONGTERM|DICTIONARY	myocardial infarction	myocardial infarction	109#130		However, there are no reports regarding the role of apolipoprotein E (apo E) gene polymorphisms in premature myocardial infarction (MI) in this population.
12880539	2004	Ann. Clin. Biochem.	0004-5632	OBJECTIVES	1	2	348	SYMBOL|()|GENE|GN|DICTIONARY	apo e	apo E	70#75		D009203	LONGTERM|DICTIONARY	myocardial infarction	myocardial infarction	109#130		However, there are no reports regarding the role of apolipoprotein E (apo E) gene polymorphisms in premature myocardial infarction (MI) in this population.
21685359	2011	J. Natl. Cancer Inst.	1460-2105	BACKGROUND	1	2	6275	SYMBOL|DICTIONARY	s100a4	S100A4	0#6		D009362	LONGTERM|DICTIONARY	metastasis	metastasis	62#72		S100A4, a calcium-binding protein, is implicated in promoting metastasis formation in colon cancer.
21685359	2011	J. Natl. Cancer Inst.	1460-2105	BACKGROUND	1	2	6275	SYMBOL|DICTIONARY	s100a4	S100A4	0#6		D003110	LONGTERM|DISEASE|DT|DICTIONARY	colon cancer	colon cancer	86#98		S100A4, a calcium-binding protein, is implicated in promoting metastasis formation in colon cancer.
21685359	2011	J. Natl. Cancer Inst.	1460-2105	TITLE	0	0	6275	SYMBOL|DICTIONARY	s100a4	S100A4	46#52		D003110	LONGTERM|DISEASE|DT|DICTIONARY	colon cancer	colon cancer	88#100		Novel effect of antihelminthic Niclosamide on S100A4-mediated metastatic progression in colon cancer.
12915675	2003	J. Clin. Endocrinol. Metab.	0021-972X	ALL_TEXT_1/3	1	3	4353	SYMBOL|DICTIONARY|EXTRACTED	mpo	MPO	177#180	12915675-1-0-15	D050197	LONGTERM|DICTIONARY	atherosclerosis	atherosclerosis	96#111		We investigated the effect of long-term hormone replacement therapy (HRT) on the progression of atherosclerosis in a 5-yr follow-up study of postmenopausal women with different MPO genotypes.
12915675	2003	J. Clin. Endocrinol. Metab.	0021-972X	ALL_TEXT_1/3	1	3	4353	SYMBOL|DICTIONARY|EXTRACTED	mpo	MPO	177#180	12915675-1-0-15	D016609	LONGTERM|DICTIONARY	hormone replacement therapy	hormone replacement therapy	40#67	NaN	We investigated the effect of long-term hormone replacement therapy (HRT) on the progression of atherosclerosis in a 5-yr follow-up study of postmenopausal women with different MPO genotypes.
12915675	2003	J. Clin. Endocrinol. Metab.	0021-972X	ALL_TEXT_1/3	1	3	4353	SYMBOL|DICTIONARY|EXTRACTED	mpo	MPO	177#180	12915675-1-0-15	D016609	LONGTERM|DICTIONARY	hrt	HRT	69#72	NaN	We investigated the effect of long-term hormone replacement therapy (HRT) on the progression of atherosclerosis in a 5-yr follow-up study of postmenopausal women with different MPO genotypes.
2480601	1990	Proc. Natl. Acad. Sci. U.S.A.	0027-8424	TITLE	0	0	5354	LONGTERM|DICTIONARY	proteolipid protein	proteolipid protein	47#66	NaN	D020371	LONGTERM|DISEASE|DT|DICTIONARY	pelizaeus merzbacher disease	Pelizaeus-Merzbacher disease	0#28		Pelizaeus-Merzbacher disease: tight linkage to proteolipid protein gene exon variant.
15207432	2004	Arch Gerontol Geriatr Suppl	0924-7947	ALL_TEXT_1/3	1	3	4524	SYMBOL|NUMBER|DICTIONARY|EXTRACTED	mthfr	MTHFR	9#14	15207432-0-24-59	D020138	LONGTERM|DICTIONARY	hyperhomocysteinemia	hyperhomocysteinemia	81#101		Both the MTHFR 677C-->T and the 1298A-->C polymorphisms are associated with mild hyperhomocysteinemia, particularly in conditions of low folate status.
20699619	2010	J Nutrigenet Nutrigenomics	1661-6499	CONCLUSIONS	4	12	6721	SYMBOL|DICTIONARY	srebp 2	SREBP-2	0#7		D018149	SYMBOL|EXTRACTED	igt	IGT	48#51	20699619-1-4-30	SREBP-2 shows altered insulin responsiveness in IGT men compared with NGT men, while there were no differences in basal gene expression.
17701750	2007	Biomarkers	1354-750X	ALL_TEXT_3/3	3	10	7517	SYMBOL|DICTIONARY	xrcc3	XRCC3	30#35		D001943	LONGTERM|DISEASE|DT|DICTIONARY	breast cancer	breast cancer	130#143		Our findings suggest that the XRCC3 Thr241Met polymorphism is likely to play a modifying role in the individual susceptibility to breast cancer among Thai women as already shown for women of European ancestry.
21187522	2011	Anticancer Res.	1791-7530	TITLE	0	0	3845	SYMBOL|DICTIONARY	kras	KRAS	0#4		D015179	LONGTERM|DISEASE|DT|DICTIONARY	colorectal cancer	colorectal cancer	32#49		KRAS genotyping as biomarker in colorectal cancer: a comparison of three commercial kits on histologic material.
12355549	2002	Environ. Mol. Mutagen.	0893-6692	ALL_TEXT_3/3	3	6	9	SYMBOL|NUMBER|DICTIONARY|EXTRACTED	nat1	NAT1	16#20	12355549-1-0-21	D011471	LONGTERM|DISEASE|DT|DICTIONARY	increased prostate cancer	increased prostate cancer	214#239		Combinations of NAT1*10 with NAT2 slow acetylator genotypes (OR, 5.08; 95% CI, 1.56-16.5; P = 0.008) or with NAT2 very slow (homozygous NAT2*5) acetylator genotypes (OR, 7.50; 95% CI, 1.55-15.4; P = 0.016) further increased prostate cancer risk.
12355549	2002	Environ. Mol. Mutagen.	0893-6692	ALL_TEXT_3/3	3	6	10	SYMBOL|DICTIONARY|EXTRACTED	nat2	NAT2	29#33	12355549-1-33-54	D011471	LONGTERM|DISEASE|DT|DICTIONARY	increased prostate cancer	increased prostate cancer	214#239		Combinations of NAT1*10 with NAT2 slow acetylator genotypes (OR, 5.08; 95% CI, 1.56-16.5; P = 0.008) or with NAT2 very slow (homozygous NAT2*5) acetylator genotypes (OR, 7.50; 95% CI, 1.55-15.4; P = 0.016) further increased prostate cancer risk.
12355549	2002	Environ. Mol. Mutagen.	0893-6692	ALL_TEXT_3/3	3	6	10	SYMBOL|DICTIONARY|EXTRACTED	nat2	NAT2	109#113	12355549-1-33-54	D011471	LONGTERM|DISEASE|DT|DICTIONARY	increased prostate cancer	increased prostate cancer	214#239		Combinations of NAT1*10 with NAT2 slow acetylator genotypes (OR, 5.08; 95% CI, 1.56-16.5; P = 0.008) or with NAT2 very slow (homozygous NAT2*5) acetylator genotypes (OR, 7.50; 95% CI, 1.55-15.4; P = 0.016) further increased prostate cancer risk.
12355549	2002	Environ. Mol. Mutagen.	0893-6692	ALL_TEXT_3/3	3	6	10	SYMBOL|NUMBER|DICTIONARY|EXTRACTED	nat2	NAT2	136#140	12355549-1-33-54	D011471	LONGTERM|DISEASE|DT|DICTIONARY	increased prostate cancer	increased prostate cancer	214#239		Combinations of NAT1*10 with NAT2 slow acetylator genotypes (OR, 5.08; 95% CI, 1.56-16.5; P = 0.008) or with NAT2 very slow (homozygous NAT2*5) acetylator genotypes (OR, 7.50; 95% CI, 1.55-15.4; P = 0.016) further increased prostate cancer risk.
16234515	2005	J. Clin. Oncol.	0732-183X	PURPOSE	1	1	672	SYMBOL|DICTIONARY	brca1	BRCA1	141#146		D001943	LONGTERM|DISEASE|DT|DICTIONARY	breast cancer	breast cancer	83#96		The purpose of this study was to estimate the extent of protection offered against breast cancer by prophylactic oophorectomy in carriers of BRCA1 or BRCA2 mutations and to determine to what extent risk reduction varies with age at oophorectomy, age at diagnosis, and time elapsed since surgery.
16234515	2005	J. Clin. Oncol.	0732-183X	PURPOSE	1	1	675	SYMBOL|DICTIONARY	brca2	BRCA2	150#155		D001943	LONGTERM|DISEASE|DT|DICTIONARY	breast cancer	breast cancer	83#96		The purpose of this study was to estimate the extent of protection offered against breast cancer by prophylactic oophorectomy in carriers of BRCA1 or BRCA2 mutations and to determine to what extent risk reduction varies with age at oophorectomy, age at diagnosis, and time elapsed since surgery.
9047388	1997	Oncogene	0950-9232	ALL_TEXT_3/3	3	7	1029	SYMBOL|GENE|GN|DICTIONARY	p16	p16	88#91		D009369	LONGTERM|DICTIONARY	tumors	tumors	25#31		In addition, of the five tumors with human papillomavirus detected, only one also had a p16 gene alteration.
14732601	2004	Biol. Psychiatry	0006-3223	CONCLUSIONS	4	8	9145	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	syngr1	SYNGR1	12#18	14732601-3-8-22	D012559	LONGTERM|DICTIONARY	schizophrenia	schizophrenia	136#149		Because the SYNGR1 gene is involved in presynaptic pathways, reduced levels of this protein might play some role in the pathogenesis of schizophrenia.
12746438	2003	J. Biol. Chem.	0021-9258	ALL_TEXT_2/3	2	4	351	LONGTERM|GENE|GT|DICTIONARY	beta amyloid precursor protein	beta-amyloid precursor protein	49#79		D000544	SYMBOL|EXTRACTED	ad	AD	149#151	12746438-1-210-229	Transgenic mice overexpressing a mutant gene for beta-amyloid precursor protein (APP) show behavioral and histopathological abnormalities resembling AD and, therefore, were used as an AD model.
12746438	2003	J. Biol. Chem.	0021-9258	ALL_TEXT_2/3	2	4	351	LONGTERM|GENE|GT|DICTIONARY	beta amyloid precursor protein	beta-amyloid precursor protein	49#79		D000544	SYMBOL|EXTRACTED	ad	AD	184#186	12746438-1-210-229	Transgenic mice overexpressing a mutant gene for beta-amyloid precursor protein (APP) show behavioral and histopathological abnormalities resembling AD and, therefore, were used as an AD model.
12746438	2003	J. Biol. Chem.	0021-9258	ALL_TEXT_2/3	2	4	351	SYMBOL|()|DICTIONARY|EXTRACTED	app	APP	81#84	12746438-4-49-79	D000544	SYMBOL|EXTRACTED	ad	AD	149#151	12746438-1-210-229	Transgenic mice overexpressing a mutant gene for beta-amyloid precursor protein (APP) show behavioral and histopathological abnormalities resembling AD and, therefore, were used as an AD model.
12746438	2003	J. Biol. Chem.	0021-9258	ALL_TEXT_2/3	2	4	351	SYMBOL|()|DICTIONARY|EXTRACTED	app	APP	81#84	12746438-4-49-79	D000544	SYMBOL|EXTRACTED	ad	AD	184#186	12746438-1-210-229	Transgenic mice overexpressing a mutant gene for beta-amyloid precursor protein (APP) show behavioral and histopathological abnormalities resembling AD and, therefore, were used as an AD model.
16128377	2006	Acta Cardiol	0001-5385	BACKGROUND	1	1	1636	LONGTERM|GENE|GT|DICTIONARY|GA	angiotensin converting enzyme	angiotensin-converting enzyme	91#120		D002318	LONGTERM|DISEASE|DT|DICTIONARY	cardiovascular disease	cardiovascular disease	158#180		An increasing number of studies with conflicting results regarding the association between angiotensin-converting enzyme (ACE) gene deletion polymorphism and cardiovascular disease has recently been published.
16128377	2006	Acta Cardiol	0001-5385	BACKGROUND	1	1	1636	SYMBOL|()|GENE|GN|DICTIONARY|EXTRACTED	ace	ACE	122#125	16128377-1-91-120	D002318	LONGTERM|DISEASE|DT|DICTIONARY	cardiovascular disease	cardiovascular disease	158#180		An increasing number of studies with conflicting results regarding the association between angiotensin-converting enzyme (ACE) gene deletion polymorphism and cardiovascular disease has recently been published.
9047388	1997	Oncogene	0950-9232	ALL_TEXT_1/3	1	1	1029	SYMBOL|DICTIONARY	p16	p16	85#88		D009369	LONGTERM|DISEASE|DT|DICTIONARY	tumor	tumor	62#67		Alterations, especially homozygous deletions, of the putative tumor suppressor gene, p16 (p16INK4A, MTS1, CDKN2) have been found in tumor cell lines from a variety of neoplasms.
9047388	1997	Oncogene	0950-9232	ALL_TEXT_1/3	1	1	1029	SYMBOL|DICTIONARY	p16	p16	85#88		D009369	LONGTERM|DISEASE|DT|CLINE|CN|DICTIONARY	tumor	tumor	132#137		Alterations, especially homozygous deletions, of the putative tumor suppressor gene, p16 (p16INK4A, MTS1, CDKN2) have been found in tumor cell lines from a variety of neoplasms.
9047388	1997	Oncogene	0950-9232	ALL_TEXT_1/3	1	1	1029	SYMBOL|DICTIONARY	p16	p16	85#88		D009369	LONGTERM|DICTIONARY	neoplasms	neoplasms	167#176		Alterations, especially homozygous deletions, of the putative tumor suppressor gene, p16 (p16INK4A, MTS1, CDKN2) have been found in tumor cell lines from a variety of neoplasms.
9047388	1997	Oncogene	0950-9232	ALL_TEXT_1/3	1	1	1029	SYMBOL|DICTIONARY	p16ink4a	p16INK4A	90#98		D009369	LONGTERM|DISEASE|DT|DICTIONARY	tumor	tumor	62#67		Alterations, especially homozygous deletions, of the putative tumor suppressor gene, p16 (p16INK4A, MTS1, CDKN2) have been found in tumor cell lines from a variety of neoplasms.
9047388	1997	Oncogene	0950-9232	ALL_TEXT_1/3	1	1	1029	SYMBOL|DICTIONARY	p16ink4a	p16INK4A	90#98		D009369	LONGTERM|DISEASE|DT|CLINE|CN|DICTIONARY	tumor	tumor	132#137		Alterations, especially homozygous deletions, of the putative tumor suppressor gene, p16 (p16INK4A, MTS1, CDKN2) have been found in tumor cell lines from a variety of neoplasms.
9047388	1997	Oncogene	0950-9232	ALL_TEXT_1/3	1	1	1029	SYMBOL|DICTIONARY	p16ink4a	p16INK4A	90#98		D009369	LONGTERM|DICTIONARY	neoplasms	neoplasms	167#176		Alterations, especially homozygous deletions, of the putative tumor suppressor gene, p16 (p16INK4A, MTS1, CDKN2) have been found in tumor cell lines from a variety of neoplasms.
9047388	1997	Oncogene	0950-9232	ALL_TEXT_1/3	1	1	1029	SYMBOL|DICTIONARY	mts1	MTS1	100#104		D009369	LONGTERM|DISEASE|DT|DICTIONARY	tumor	tumor	62#67		Alterations, especially homozygous deletions, of the putative tumor suppressor gene, p16 (p16INK4A, MTS1, CDKN2) have been found in tumor cell lines from a variety of neoplasms.
9047388	1997	Oncogene	0950-9232	ALL_TEXT_1/3	1	1	1029	SYMBOL|DICTIONARY	mts1	MTS1	100#104		D009369	LONGTERM|DISEASE|DT|CLINE|CN|DICTIONARY	tumor	tumor	132#137		Alterations, especially homozygous deletions, of the putative tumor suppressor gene, p16 (p16INK4A, MTS1, CDKN2) have been found in tumor cell lines from a variety of neoplasms.
9047388	1997	Oncogene	0950-9232	ALL_TEXT_1/3	1	1	1029	SYMBOL|DICTIONARY	mts1	MTS1	100#104		D009369	LONGTERM|DICTIONARY	neoplasms	neoplasms	167#176		Alterations, especially homozygous deletions, of the putative tumor suppressor gene, p16 (p16INK4A, MTS1, CDKN2) have been found in tumor cell lines from a variety of neoplasms.
9047388	1997	Oncogene	0950-9232	ALL_TEXT_1/3	1	1	1029	SYMBOL|DICTIONARY	cdkn2	CDKN2	106#111		D009369	LONGTERM|DISEASE|DT|DICTIONARY	tumor	tumor	62#67		Alterations, especially homozygous deletions, of the putative tumor suppressor gene, p16 (p16INK4A, MTS1, CDKN2) have been found in tumor cell lines from a variety of neoplasms.
9047388	1997	Oncogene	0950-9232	ALL_TEXT_1/3	1	1	1029	SYMBOL|DICTIONARY	cdkn2	CDKN2	106#111		D009369	LONGTERM|DISEASE|DT|CLINE|CN|DICTIONARY	tumor	tumor	132#137		Alterations, especially homozygous deletions, of the putative tumor suppressor gene, p16 (p16INK4A, MTS1, CDKN2) have been found in tumor cell lines from a variety of neoplasms.
9047388	1997	Oncogene	0950-9232	ALL_TEXT_1/3	1	1	1029	SYMBOL|DICTIONARY	cdkn2	CDKN2	106#111		D009369	LONGTERM|DICTIONARY	neoplasms	neoplasms	167#176		Alterations, especially homozygous deletions, of the putative tumor suppressor gene, p16 (p16INK4A, MTS1, CDKN2) have been found in tumor cell lines from a variety of neoplasms.
20973260	2010	Int. J. Gynecol. Cancer	1525-1438	TITLE	0	0	7422	LONGTERM|GENE|GN|GT|DICTIONARY	vascular endothelial growth factor	vascular endothelial growth factor	15#49		D010051	LONGTERM|DISEASE|DT|DICTIONARY	epithelial ovarian cancer	epithelial ovarian cancer	92#117		Association of vascular endothelial growth factor gene polymorphisms with susceptibility to epithelial ovarian cancer.
15207432	2004	Arch Gerontol Geriatr Suppl	0924-7947	ALL_TEXT_2/3	2	4	4524	SYMBOL|DICTIONARY|EXTRACTED	mthfr	MTHFR	24#29	15207432-0-24-59	D000544	LONGTERM|DICTIONARY	alzheimer dementia	Alzheimer dementia	328#346		The prevalence of these MTHFR polymorphisms and their relationships with plasma total Hcy (tHcy), serum folate and cognitive function was evaluated in 194 elderly Italian individuals: 122 healthy controls (73.8 +/- 7.1 years of age), 24 cognitively- impaired- not-demented individuals (78.6 +/- 9.3 years), and 48 subjects with Alzheimer dementia (AD = 26), vascular dementia (VD =22; 85.5 +/- 7.0 years).
15207432	2004	Arch Gerontol Geriatr Suppl	0924-7947	ALL_TEXT_2/3	2	4	4524	SYMBOL|DICTIONARY|EXTRACTED	mthfr	MTHFR	24#29	15207432-0-24-59	D000544	SYMBOL|EXTRACTED	ad	AD	348#350	15207432-4-328-346	The prevalence of these MTHFR polymorphisms and their relationships with plasma total Hcy (tHcy), serum folate and cognitive function was evaluated in 194 elderly Italian individuals: 122 healthy controls (73.8 +/- 7.1 years of age), 24 cognitively- impaired- not-demented individuals (78.6 +/- 9.3 years), and 48 subjects with Alzheimer dementia (AD = 26), vascular dementia (VD =22; 85.5 +/- 7.0 years).
15207432	2004	Arch Gerontol Geriatr Suppl	0924-7947	ALL_TEXT_2/3	2	4	4524	SYMBOL|DICTIONARY|EXTRACTED	mthfr	MTHFR	24#29	15207432-0-24-59	D015140	LONGTERM|DICTIONARY	vascular dementia	vascular dementia	358#375		The prevalence of these MTHFR polymorphisms and their relationships with plasma total Hcy (tHcy), serum folate and cognitive function was evaluated in 194 elderly Italian individuals: 122 healthy controls (73.8 +/- 7.1 years of age), 24 cognitively- impaired- not-demented individuals (78.6 +/- 9.3 years), and 48 subjects with Alzheimer dementia (AD = 26), vascular dementia (VD =22; 85.5 +/- 7.0 years).
17603900	2007	BMC Cancer	1471-2407	CONCLUSION	4	9	1545	SYMBOL|NUMBER|DICTIONARY	cyp1b1	CYP1B1	108#114		D015179	SYMBOL|DICTIONARY|EXTRACTED	crc	CRC	73#76	17603900-2-156-173	Also, it is suggested that the association between cigarette smoking and CRC could be differentiated by the CYP1B1 1294G allele.
17603900	2007	BMC Cancer	1471-2407	CONCLUSION	4	8	1545	SYMBOL|NUMBER|DICTIONARY	cyp1b1	CYP1B1	65#71		D015179	SYMBOL|DICTIONARY|EXTRACTED	crc	CRC	123#126	17603900-2-156-173	Our results showed that the interaction between polymorphisms in CYP1B1 1294G and SULT1A1*2 may play a significant role on CRC in the Chinese population.
17603900	2007	BMC Cancer	1471-2407	CONCLUSION	4	8	6817	SYMBOL|NUMBER|DICTIONARY	sult1a1	SULT1A1	82#89		D015179	SYMBOL|DICTIONARY|EXTRACTED	crc	CRC	123#126	17603900-2-156-173	Our results showed that the interaction between polymorphisms in CYP1B1 1294G and SULT1A1*2 may play a significant role on CRC in the Chinese population.
12913211	2004	Neurology	1526-632X	TITLE	0	0	246744	LONGTERM|GENE|GN|DICTIONARY	saitohin	Saitohin	26#34		D013494	LONGTERM|DICTIONARY	progressive supranuclear palsy	progressive supranuclear palsy	56#86		Strong association of the Saitohin gene Q7 variant with progressive supranuclear palsy.
16690408	2006	Hum. Immunol.	0198-8859	ALL_TEXT_3/3	3	10	6891	SYMBOL|GENE|GN|DICTIONARY	tap2	TAP2	28#32		D010392	SYMBOL|EXTRACTED	pv	PV	88#90	16690408-1-0-18	It is therefore likely that TAP2 genes are involved in susceptibility to development of PV.
17603900	2007	BMC Cancer	1471-2407	BACKGROUND	1	2	1544	SYMBOL|DICTIONARY	cyp1a2	CYP1A2	84#90		D015179	LONGTERM|DISEASE|DT|DICTIONARY	colorectal cancer	colorectal cancer	156#173		Our objective was to measure the interactions between common polymorphisms of P450 (CYP1A2, CYP1B1, CYP2E1), GSTM1 and T1, SULT1A1 and cigarette smoking in colorectal cancer (CRC).
17603900	2007	BMC Cancer	1471-2407	BACKGROUND	1	2	1544	SYMBOL|DICTIONARY	cyp1a2	CYP1A2	84#90		D015179	SYMBOL|()|DICTIONARY|EXTRACTED	crc	CRC	175#178	17603900-2-156-173	Our objective was to measure the interactions between common polymorphisms of P450 (CYP1A2, CYP1B1, CYP2E1), GSTM1 and T1, SULT1A1 and cigarette smoking in colorectal cancer (CRC).
17603900	2007	BMC Cancer	1471-2407	BACKGROUND	1	2	1545	SYMBOL|DICTIONARY	cyp1b1	CYP1B1	92#98		D015179	LONGTERM|DISEASE|DT|DICTIONARY	colorectal cancer	colorectal cancer	156#173		Our objective was to measure the interactions between common polymorphisms of P450 (CYP1A2, CYP1B1, CYP2E1), GSTM1 and T1, SULT1A1 and cigarette smoking in colorectal cancer (CRC).
17603900	2007	BMC Cancer	1471-2407	BACKGROUND	1	2	1545	SYMBOL|DICTIONARY	cyp1b1	CYP1B1	92#98		D015179	SYMBOL|()|DICTIONARY|EXTRACTED	crc	CRC	175#178	17603900-2-156-173	Our objective was to measure the interactions between common polymorphisms of P450 (CYP1A2, CYP1B1, CYP2E1), GSTM1 and T1, SULT1A1 and cigarette smoking in colorectal cancer (CRC).
17603900	2007	BMC Cancer	1471-2407	BACKGROUND	1	2	1571	SYMBOL|DICTIONARY	cyp2e1	CYP2E1	100#106		D015179	LONGTERM|DISEASE|DT|DICTIONARY	colorectal cancer	colorectal cancer	156#173		Our objective was to measure the interactions between common polymorphisms of P450 (CYP1A2, CYP1B1, CYP2E1), GSTM1 and T1, SULT1A1 and cigarette smoking in colorectal cancer (CRC).
17603900	2007	BMC Cancer	1471-2407	BACKGROUND	1	2	1571	SYMBOL|DICTIONARY	cyp2e1	CYP2E1	100#106		D015179	SYMBOL|()|DICTIONARY|EXTRACTED	crc	CRC	175#178	17603900-2-156-173	Our objective was to measure the interactions between common polymorphisms of P450 (CYP1A2, CYP1B1, CYP2E1), GSTM1 and T1, SULT1A1 and cigarette smoking in colorectal cancer (CRC).
17603900	2007	BMC Cancer	1471-2407	BACKGROUND	1	2	2944	SYMBOL|DICTIONARY	gstm1	GSTM1	109#114		D015179	LONGTERM|DISEASE|DT|DICTIONARY	colorectal cancer	colorectal cancer	156#173		Our objective was to measure the interactions between common polymorphisms of P450 (CYP1A2, CYP1B1, CYP2E1), GSTM1 and T1, SULT1A1 and cigarette smoking in colorectal cancer (CRC).
17603900	2007	BMC Cancer	1471-2407	BACKGROUND	1	2	2944	SYMBOL|DICTIONARY	gstm1	GSTM1	109#114		D015179	SYMBOL|()|DICTIONARY|EXTRACTED	crc	CRC	175#178	17603900-2-156-173	Our objective was to measure the interactions between common polymorphisms of P450 (CYP1A2, CYP1B1, CYP2E1), GSTM1 and T1, SULT1A1 and cigarette smoking in colorectal cancer (CRC).
17603900	2007	BMC Cancer	1471-2407	BACKGROUND	1	2	6817	SYMBOL|DICTIONARY	sult1a1	SULT1A1	123#130		D015179	LONGTERM|DISEASE|DT|DICTIONARY	colorectal cancer	colorectal cancer	156#173		Our objective was to measure the interactions between common polymorphisms of P450 (CYP1A2, CYP1B1, CYP2E1), GSTM1 and T1, SULT1A1 and cigarette smoking in colorectal cancer (CRC).
17603900	2007	BMC Cancer	1471-2407	BACKGROUND	1	2	6817	SYMBOL|DICTIONARY	sult1a1	SULT1A1	123#130		D015179	SYMBOL|()|DICTIONARY|EXTRACTED	crc	CRC	175#178	17603900-2-156-173	Our objective was to measure the interactions between common polymorphisms of P450 (CYP1A2, CYP1B1, CYP2E1), GSTM1 and T1, SULT1A1 and cigarette smoking in colorectal cancer (CRC).
9047388	1997	Oncogene	0950-9232	ALL_TEXT_1/3	1	2	1029	SYMBOL|GENE|GN|DICTIONARY	p16	p16	38#41		D009369	LONGTERM|DICTIONARY	primary tumors	primary tumors	186#200		Recent studies have reported frequent p16 gene deletions in cell lines from squamous cell carcinomas of the head and neck (SCCHN), although the prevalence of alterations was variable in primary tumors.
9047388	1997	Oncogene	0950-9232	ALL_TEXT_1/3	1	2	1029	SYMBOL|GENE|GN|DICTIONARY	p16	p16	38#41		C535575	LONGTERM|DICTIONARY	squamous cell carcinomas of the head and neck	squamous cell carcinomas of the head and neck	76#121		Recent studies have reported frequent p16 gene deletions in cell lines from squamous cell carcinomas of the head and neck (SCCHN), although the prevalence of alterations was variable in primary tumors.
17603900	2007	BMC Cancer	1471-2407	RESULTS	3	6	1545	SYMBOL|NUMBER|DICTIONARY	cyp1b1	CYP1B1	116#122		D015179	SYMBOL|DICTIONARY|EXTRACTED	crc	CRC	140#143	17603900-2-156-173	The results of the gene-environment analyses revealed that an interaction existed between cigarette smoking and the CYP1B1 1294G allele for CRC (COR = 2.62, 95%CI: 1.01-6.72), the COR for the interaction of CYP1B1 1294G and smoking history > 35 pack-years was 3.47 (95%CI: 1.12-10.80).
17603900	2007	BMC Cancer	1471-2407	RESULTS	3	6	1545	SYMBOL|NUMBER|DICTIONARY	cyp1b1	CYP1B1	207#213		D015179	SYMBOL|DICTIONARY|EXTRACTED	crc	CRC	140#143	17603900-2-156-173	The results of the gene-environment analyses revealed that an interaction existed between cigarette smoking and the CYP1B1 1294G allele for CRC (COR = 2.62, 95%CI: 1.01-6.72), the COR for the interaction of CYP1B1 1294G and smoking history > 35 pack-years was 3.47 (95%CI: 1.12-10.80).
12165742	2003	Med. Sci. Monit.	1234-1010	CONCLUSIONS	4	10	10	SYMBOL|DICTIONARY	nat2	NAT2	68#72		D003110	LONGTERM|DISEASE|DT|DICTIONARY	colon cancer	colon cancer	111#123		The results of our meta-analyses do not support the hypothesis that NAT2 alone is an important risk factor for colon cancer and suggests that NAT2 rapid acetylation status has no specific effect on the risk of developing colon cancer.
12165742	2003	Med. Sci. Monit.	1234-1010	CONCLUSIONS	4	10	10	SYMBOL|DICTIONARY	nat2	NAT2	68#72		D003110	LONGTERM|DISEASE|DT|DICTIONARY	colon cancer	colon cancer	221#233		The results of our meta-analyses do not support the hypothesis that NAT2 alone is an important risk factor for colon cancer and suggests that NAT2 rapid acetylation status has no specific effect on the risk of developing colon cancer.
12165742	2003	Med. Sci. Monit.	1234-1010	CONCLUSIONS	4	10	10	SYMBOL|DICTIONARY	nat2	NAT2	142#146		D003110	LONGTERM|DISEASE|DT|DICTIONARY	colon cancer	colon cancer	111#123		The results of our meta-analyses do not support the hypothesis that NAT2 alone is an important risk factor for colon cancer and suggests that NAT2 rapid acetylation status has no specific effect on the risk of developing colon cancer.
12165742	2003	Med. Sci. Monit.	1234-1010	CONCLUSIONS	4	10	10	SYMBOL|DICTIONARY	nat2	NAT2	142#146		D003110	LONGTERM|DISEASE|DT|DICTIONARY	colon cancer	colon cancer	221#233		The results of our meta-analyses do not support the hypothesis that NAT2 alone is an important risk factor for colon cancer and suggests that NAT2 rapid acetylation status has no specific effect on the risk of developing colon cancer.
15190266	2005	Genes Immun.	1466-4879	ALL_TEXT_3/3	3	7	3552	SYMBOL|DICTIONARY	il1a	IL1A	20#24		D010003	SYMBOL|EXTRACTED	oa	OA	109#111	15190266-2-147-161	However, within the IL1A-IL1B-IL1RN complex, we identified a common haplotype conferring a four-fold risk of OA (P=0.00043; Pc=0.0043) and one IL1B-IL1RN haplotype conferring a four-fold reduced risk (P=0.0036; Pc=0.029).
15190266	2005	Genes Immun.	1466-4879	ALL_TEXT_3/3	3	7	3553	SYMBOL|DICTIONARY	il1b	IL1B	25#29		D010003	SYMBOL|EXTRACTED	oa	OA	109#111	15190266-2-147-161	However, within the IL1A-IL1B-IL1RN complex, we identified a common haplotype conferring a four-fold risk of OA (P=0.00043; Pc=0.0043) and one IL1B-IL1RN haplotype conferring a four-fold reduced risk (P=0.0036; Pc=0.029).
15190266	2005	Genes Immun.	1466-4879	ALL_TEXT_3/3	3	7	3557	SYMBOL|DICTIONARY	il1rn	IL1RN	30#35		D010003	SYMBOL|EXTRACTED	oa	OA	109#111	15190266-2-147-161	However, within the IL1A-IL1B-IL1RN complex, we identified a common haplotype conferring a four-fold risk of OA (P=0.00043; Pc=0.0043) and one IL1B-IL1RN haplotype conferring a four-fold reduced risk (P=0.0036; Pc=0.029).
15190266	2005	Genes Immun.	1466-4879	ALL_TEXT_3/3	3	7	3553	SYMBOL|DICTIONARY	il1b	IL1B	143#147		D010003	SYMBOL|EXTRACTED	oa	OA	109#111	15190266-2-147-161	However, within the IL1A-IL1B-IL1RN complex, we identified a common haplotype conferring a four-fold risk of OA (P=0.00043; Pc=0.0043) and one IL1B-IL1RN haplotype conferring a four-fold reduced risk (P=0.0036; Pc=0.029).
15190266	2005	Genes Immun.	1466-4879	ALL_TEXT_3/3	3	7	3557	SYMBOL|DICTIONARY	il1rn	IL1RN	148#153		D010003	SYMBOL|EXTRACTED	oa	OA	109#111	15190266-2-147-161	However, within the IL1A-IL1B-IL1RN complex, we identified a common haplotype conferring a four-fold risk of OA (P=0.00043; Pc=0.0043) and one IL1B-IL1RN haplotype conferring a four-fold reduced risk (P=0.0036; Pc=0.029).
10619808	2000	Am. J. Respir. Crit. Care Med.	1073-449X	ALL_TEXT_3/3	3	8	7356	SYMBOL|GENE|GN|DICTIONARY	cc16	CC16	61#65		D001249	LONGTERM|DICTIONARY	asthma	asthma	105#111		This provides further evidence for a significant role of the CC16 gene, 38A allele in the development of asthma.
15190266	2005	Genes Immun.	1466-4879	ALL_TEXT_1/3	1	2	3554	SYMBOL|GENE|GN|DICTIONARY	il1r1	IL1R1	61#66		D010003	LONGTERM|DICTIONARY	osteoarthritis	osteoarthritis	147#161		We explored the linkage between nine polymorphic loci in the IL1R1 promoter, eight in the IL1A-IL1B-IL1RN gene complex, and their association with osteoarthritis (OA), a common complex disease associated with low-level inflammation.
15190266	2005	Genes Immun.	1466-4879	ALL_TEXT_1/3	1	2	3554	SYMBOL|GENE|GN|DICTIONARY	il1r1	IL1R1	61#66		D010003	SYMBOL|EXTRACTED|()	oa	OA	163#165	15190266-2-147-161	We explored the linkage between nine polymorphic loci in the IL1R1 promoter, eight in the IL1A-IL1B-IL1RN gene complex, and their association with osteoarthritis (OA), a common complex disease associated with low-level inflammation.
15190266	2005	Genes Immun.	1466-4879	ALL_TEXT_1/3	1	2	3554	SYMBOL|GENE|GN|DICTIONARY	il1r1	IL1R1	61#66		D007249	LONGTERM|DICTIONARY	low-level inflammation	low-level inflammation	209#231	NaN	We explored the linkage between nine polymorphic loci in the IL1R1 promoter, eight in the IL1A-IL1B-IL1RN gene complex, and their association with osteoarthritis (OA), a common complex disease associated with low-level inflammation.
15190266	2005	Genes Immun.	1466-4879	ALL_TEXT_1/3	1	2	3552	SYMBOL|DICTIONARY	il1a	IL1A	90#94		D010003	LONGTERM|DICTIONARY	osteoarthritis	osteoarthritis	147#161		We explored the linkage between nine polymorphic loci in the IL1R1 promoter, eight in the IL1A-IL1B-IL1RN gene complex, and their association with osteoarthritis (OA), a common complex disease associated with low-level inflammation.
15190266	2005	Genes Immun.	1466-4879	ALL_TEXT_1/3	1	2	3552	SYMBOL|DICTIONARY	il1a	IL1A	90#94		D010003	SYMBOL|EXTRACTED|()	oa	OA	163#165	15190266-2-147-161	We explored the linkage between nine polymorphic loci in the IL1R1 promoter, eight in the IL1A-IL1B-IL1RN gene complex, and their association with osteoarthritis (OA), a common complex disease associated with low-level inflammation.
15190266	2005	Genes Immun.	1466-4879	ALL_TEXT_1/3	1	2	3552	SYMBOL|DICTIONARY	il1a	IL1A	90#94		D007249	LONGTERM|DICTIONARY	low-level inflammation	low-level inflammation	209#231	NaN	We explored the linkage between nine polymorphic loci in the IL1R1 promoter, eight in the IL1A-IL1B-IL1RN gene complex, and their association with osteoarthritis (OA), a common complex disease associated with low-level inflammation.
15190266	2005	Genes Immun.	1466-4879	ALL_TEXT_1/3	1	2	3553	SYMBOL|DICTIONARY	il1b	IL1B	95#99		D010003	LONGTERM|DICTIONARY	osteoarthritis	osteoarthritis	147#161		We explored the linkage between nine polymorphic loci in the IL1R1 promoter, eight in the IL1A-IL1B-IL1RN gene complex, and their association with osteoarthritis (OA), a common complex disease associated with low-level inflammation.
15190266	2005	Genes Immun.	1466-4879	ALL_TEXT_1/3	1	2	3553	SYMBOL|DICTIONARY	il1b	IL1B	95#99		D010003	SYMBOL|EXTRACTED|()	oa	OA	163#165	15190266-2-147-161	We explored the linkage between nine polymorphic loci in the IL1R1 promoter, eight in the IL1A-IL1B-IL1RN gene complex, and their association with osteoarthritis (OA), a common complex disease associated with low-level inflammation.
15190266	2005	Genes Immun.	1466-4879	ALL_TEXT_1/3	1	2	3553	SYMBOL|DICTIONARY	il1b	IL1B	95#99		D007249	LONGTERM|DICTIONARY	low-level inflammation	low-level inflammation	209#231	NaN	We explored the linkage between nine polymorphic loci in the IL1R1 promoter, eight in the IL1A-IL1B-IL1RN gene complex, and their association with osteoarthritis (OA), a common complex disease associated with low-level inflammation.
15190266	2005	Genes Immun.	1466-4879	ALL_TEXT_1/3	1	2	3557	SYMBOL|GENE|GN|DICTIONARY	il1rn	IL1RN	100#105		D010003	LONGTERM|DICTIONARY	osteoarthritis	osteoarthritis	147#161		We explored the linkage between nine polymorphic loci in the IL1R1 promoter, eight in the IL1A-IL1B-IL1RN gene complex, and their association with osteoarthritis (OA), a common complex disease associated with low-level inflammation.
15190266	2005	Genes Immun.	1466-4879	ALL_TEXT_1/3	1	2	3557	SYMBOL|GENE|GN|DICTIONARY	il1rn	IL1RN	100#105		D010003	SYMBOL|EXTRACTED|()	oa	OA	163#165	15190266-2-147-161	We explored the linkage between nine polymorphic loci in the IL1R1 promoter, eight in the IL1A-IL1B-IL1RN gene complex, and their association with osteoarthritis (OA), a common complex disease associated with low-level inflammation.
15190266	2005	Genes Immun.	1466-4879	ALL_TEXT_1/3	1	2	3557	SYMBOL|GENE|GN|DICTIONARY	il1rn	IL1RN	100#105		D007249	LONGTERM|DICTIONARY	low-level inflammation	low-level inflammation	209#231	NaN	We explored the linkage between nine polymorphic loci in the IL1R1 promoter, eight in the IL1A-IL1B-IL1RN gene complex, and their association with osteoarthritis (OA), a common complex disease associated with low-level inflammation.
19631393	2009	J. Neuroimmunol.	1872-8421	TITLE	0	0	4318	LONGTERM|DICTIONARY	matrix metalloproteinase 9	Matrix metalloproteinase-9	0#26		D009103	LONGTERM|DICTIONARY	multiple sclerosis	multiple sclerosis	72#90		Matrix metalloproteinase-9 genotypes and haplotypes are associated with multiple sclerosis and with the degree of disability of the disease.
19631393	2009	J. Neuroimmunol.	1872-8421	TITLE	0	0	4318	LONGTERM|DICTIONARY	matrix metalloproteinase 9	Matrix metalloproteinase-9	0#26		D009069	LONGTERM|DICTIONARY	disability of the disease	disability of the disease	114#139	NaN	Matrix metalloproteinase-9 genotypes and haplotypes are associated with multiple sclerosis and with the degree of disability of the disease.
15190266	2005	Genes Immun.	1466-4879	TITLE	0	0	3554	SYMBOL|DICTIONARY	il1r1	IL1R1	54#59		D020370	LONGTERM|DICTIONARY	knee osteoarthritis	knee osteoarthritis	107#126		Extended haplotypes and linkage disequilibrium in the IL1R1-IL1A-IL1B-IL1RN gene cluster: association with knee osteoarthritis.
15190266	2005	Genes Immun.	1466-4879	TITLE	0	0	3552	SYMBOL|DICTIONARY	il1a	IL1A	60#64		D020370	LONGTERM|DICTIONARY	knee osteoarthritis	knee osteoarthritis	107#126		Extended haplotypes and linkage disequilibrium in the IL1R1-IL1A-IL1B-IL1RN gene cluster: association with knee osteoarthritis.
15190266	2005	Genes Immun.	1466-4879	TITLE	0	0	3553	SYMBOL|DICTIONARY	il1b	IL1B	65#69		D020370	LONGTERM|DICTIONARY	knee osteoarthritis	knee osteoarthritis	107#126		Extended haplotypes and linkage disequilibrium in the IL1R1-IL1A-IL1B-IL1RN gene cluster: association with knee osteoarthritis.
15190266	2005	Genes Immun.	1466-4879	TITLE	0	0	3557	SYMBOL|GENE|GN|DICTIONARY	il1rn	IL1RN	70#75		D020370	LONGTERM|DICTIONARY	knee osteoarthritis	knee osteoarthritis	107#126		Extended haplotypes and linkage disequilibrium in the IL1R1-IL1A-IL1B-IL1RN gene cluster: association with knee osteoarthritis.
10619808	2000	Am. J. Respir. Crit. Care Med.	1073-449X	TITLE	0	0	7356	SYMBOL|DICTIONARY	cc16	CC16	27#31		D001249	LONGTERM|DICTIONARY	asthma	asthma	67#73		Association between plasma CC16 levels, the A38G polymorphism, and asthma.
10619808	2000	Am. J. Respir. Crit. Care Med.	1073-449X	ALL_TEXT_1/3	1	1	7356	SYMBOL|()|GENE|GN|DICTIONARY	cc16	CC16	69#73		D001249	LONGTERM|DICTIONARY	asthma	asthma	95#101		The effect of the A38G polymorphism on Clara cell secretory protein (CC16) gene expression and asthma was investigated by measuring plasma CC16 levels in 100 asthmatic and nonasthmatic children.
10619808	2000	Am. J. Respir. Crit. Care Med.	1073-449X	ALL_TEXT_1/3	1	1	7356	SYMBOL|DICTIONARY	cc16	CC16	139#143		D001249	LONGTERM|DICTIONARY	asthma	asthma	95#101		The effect of the A38G polymorphism on Clara cell secretory protein (CC16) gene expression and asthma was investigated by measuring plasma CC16 levels in 100 asthmatic and nonasthmatic children.
10619808	2000	Am. J. Respir. Crit. Care Med.	1073-449X	ALL_TEXT_3/3	3	6	7356	SYMBOL|DICTIONARY	cc16	CC16	53#57		D001249	LONGTERM|DICTIONARY	asthma	asthma	93#99		However, this was reduced when corrected from plasma CC16 level, suggesting that the odds of asthma was largely mediated through altered plasma CC16 levels.
10619808	2000	Am. J. Respir. Crit. Care Med.	1073-449X	ALL_TEXT_3/3	3	6	7356	SYMBOL|DICTIONARY	cc16	CC16	144#148		D001249	LONGTERM|DICTIONARY	asthma	asthma	93#99		However, this was reduced when corrected from plasma CC16 level, suggesting that the odds of asthma was largely mediated through altered plasma CC16 levels.
10619808	2000	Am. J. Respir. Crit. Care Med.	1073-449X	ALL_TEXT_3/3	3	7	7356	SYMBOL|DICTIONARY	cc16	CC16	52#56		D001249	LONGTERM|DICTIONARY	asthma	asthma	135#141		The 38A sequence was associated with reduced plasma CC16 levels and individuals with lower plasma CC16 levels were more likely to have asthma.
10619808	2000	Am. J. Respir. Crit. Care Med.	1073-449X	ALL_TEXT_3/3	3	7	7356	SYMBOL|DICTIONARY	cc16	CC16	98#102		D001249	LONGTERM|DICTIONARY	asthma	asthma	135#141		The 38A sequence was associated with reduced plasma CC16 levels and individuals with lower plasma CC16 levels were more likely to have asthma.
16006970	2005	J. Urol.	0022-5347	CONCLUSIONS	4	10	3569	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	il 6	IL-6	81#85	16006970-1-2-15	D001523	LONGTERM|DICTIONARY	aggressiveness	aggressiveness	100#114		: These data demonstrate a strong association of the -174G>C polymorphism of the IL-6 gene with the aggressiveness and recurrence of prostate cancer, suggesting that genetic predisposition of genetic differences in the human IL-6 gene could be linked to the risk of recurrent prostate cancer.
16006970	2005	J. Urol.	0022-5347	CONCLUSIONS	4	10	3569	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	il 6	IL-6	81#85	16006970-1-2-15	D011471	LONGTERM|DISEASE|DT|DICTIONARY	prostate cancer	prostate cancer	133#148		: These data demonstrate a strong association of the -174G>C polymorphism of the IL-6 gene with the aggressiveness and recurrence of prostate cancer, suggesting that genetic predisposition of genetic differences in the human IL-6 gene could be linked to the risk of recurrent prostate cancer.
16006970	2005	J. Urol.	0022-5347	CONCLUSIONS	4	10	3569	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	il 6	IL-6	81#85	16006970-1-2-15	D011471	LONGTERM|DISEASE|DT|DICTIONARY	prostate cancer	prostate cancer	276#291		: These data demonstrate a strong association of the -174G>C polymorphism of the IL-6 gene with the aggressiveness and recurrence of prostate cancer, suggesting that genetic predisposition of genetic differences in the human IL-6 gene could be linked to the risk of recurrent prostate cancer.
16006970	2005	J. Urol.	0022-5347	CONCLUSIONS	4	10	3569	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	il 6	IL-6	225#229	16006970-1-2-15	D001523	LONGTERM|DICTIONARY	aggressiveness	aggressiveness	100#114		: These data demonstrate a strong association of the -174G>C polymorphism of the IL-6 gene with the aggressiveness and recurrence of prostate cancer, suggesting that genetic predisposition of genetic differences in the human IL-6 gene could be linked to the risk of recurrent prostate cancer.
16006970	2005	J. Urol.	0022-5347	CONCLUSIONS	4	10	3569	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	il 6	IL-6	225#229	16006970-1-2-15	D011471	LONGTERM|DISEASE|DT|DICTIONARY	prostate cancer	prostate cancer	133#148		: These data demonstrate a strong association of the -174G>C polymorphism of the IL-6 gene with the aggressiveness and recurrence of prostate cancer, suggesting that genetic predisposition of genetic differences in the human IL-6 gene could be linked to the risk of recurrent prostate cancer.
16006970	2005	J. Urol.	0022-5347	CONCLUSIONS	4	10	3569	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	il 6	IL-6	225#229	16006970-1-2-15	D011471	LONGTERM|DISEASE|DT|DICTIONARY	prostate cancer	prostate cancer	276#291		: These data demonstrate a strong association of the -174G>C polymorphism of the IL-6 gene with the aggressiveness and recurrence of prostate cancer, suggesting that genetic predisposition of genetic differences in the human IL-6 gene could be linked to the risk of recurrent prostate cancer.
1930854	1991	Am. J. Hypertens.	0895-7061	ALL_TEXT_3/3	3	8	5741	LONGTERM|DICTIONARY	parathyroid hormone	parathyroid hormone	40#59		D006973	LONGTERM|DICTIONARY	hypertensive	hypertensive	148#160	NaN	These results suggest that an excess of parathyroid hormone may be involved in the increase of Ca(2+)-dependent K+ efflux present in some essential hypertensive patients.
8822954	1996	Blood	0006-4971	ALL_TEXT_2/3	2	4	2821	SYMBOL|DICTIONARY|EXTRACTED	gpi	GPI	28#31	8822954-1-32-59	D006521	LONGTERM|DICTIONARY	chronic active hepatitis	chronic active hepatitis	63#87		A 54-year-old Japanese man (GPI Iwate) was hospitalized due to chronic active hepatitis, and compensated hemolysis was noted.
8822954	1996	Blood	0006-4971	ALL_TEXT_2/3	2	4	2821	SYMBOL|DICTIONARY|EXTRACTED	gpi	GPI	28#31	8822954-1-32-59	D006461	LONGTERM|DICTIONARY	hemolysis	hemolysis	105#114	NaN	A 54-year-old Japanese man (GPI Iwate) was hospitalized due to chronic active hepatitis, and compensated hemolysis was noted.
15562935	2005	Clin Cardiol	0160-9289	RESULTS	4	10	4973	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	lox 1	LOX-1	17#22	15562935-1-48-61	D009203	SYMBOL|EXTRACTED	mi	MI	86#88	15562935-3-77-98	The frequency of LOX-1 gene variants did not differ between patients with and without MI (34 vs. 37%).
19602897	2009	Intervirology	1423-0100	METHODS	2	3	3077	SYMBOL|GENE|GN|DICTIONARY	hfe	HFE	171#174		D005355	LONGTERM|DICTIONARY	fibrosis	fibrosis	55#63	NaN	The hepatic iron deposition, histological activity and fibrosis were assessed by appropriate pathological scoring systems, clinical data including serum iron indices, and HFE gene mutation.
19602897	2009	Intervirology	1423-0100	METHODS	2	3	3077	SYMBOL|GENE|GN|DICTIONARY	hfe	HFE	171#174		D056486	LONGTERM|DICTIONARY	hepatic iron deposition	hepatic iron deposition	4#27	NaN	The hepatic iron deposition, histological activity and fibrosis were assessed by appropriate pathological scoring systems, clinical data including serum iron indices, and HFE gene mutation.
15562935	2005	Clin Cardiol	0160-9289	CONCLUSIONS	5	13	4973	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	lox 1	LOX-1	4#9	15562935-1-48-61	D003324	SYMBOL|DICTIONARY|EXTRACTED	cad	CAD	90#93	15562935-4-84-107	The LOX-1 gene variants at 501 were found to be inversely associated with the severity of CAD.
19602897	2009	Intervirology	1423-0100	OBJECTIVES	1	1	3077	SYMBOL|GENE|GN|DICTIONARY	hfe	HFE	116#119		D019698	LONGTERM|DICTIONARY	chronic hepatitis c	chronic hepatitis C	159#178		We studied the status of hepatic iron deposition and its relationship with blood iron indices, liver histology, and HFE gene mutations in Korean patients with chronic hepatitis C (CH-C).
19602897	2009	Intervirology	1423-0100	OBJECTIVES	1	1	3077	SYMBOL|GENE|GN|DICTIONARY	hfe	HFE	116#119		D019698	SYMBOL|EXTRACTED|()	ch c	CH-C	180#184	19602897-1-159-178	We studied the status of hepatic iron deposition and its relationship with blood iron indices, liver histology, and HFE gene mutations in Korean patients with chronic hepatitis C (CH-C).
19602897	2009	Intervirology	1423-0100	OBJECTIVES	1	1	3077	SYMBOL|GENE|GN|DICTIONARY	hfe	HFE	116#119		D056486	LONGTERM|DICTIONARY	hepatic iron deposition	hepatic iron deposition	25#48	NaN	We studied the status of hepatic iron deposition and its relationship with blood iron indices, liver histology, and HFE gene mutations in Korean patients with chronic hepatitis C (CH-C).
19602897	2009	Intervirology	1423-0100	TITLE	0	0	3077	SYMBOL|DICTIONARY	hfe	HFE	30#33		D008103	LONGTERM|DICTIONARY	hepatic fibrosis	hepatic fibrosis	48#64		Hepatic iron, serum ferritin, HFE mutation, and hepatic fibrosis in chronic hepatitis C.
19602897	2009	Intervirology	1423-0100	TITLE	0	0	3077	SYMBOL|DICTIONARY	hfe	HFE	30#33		D019698	LONGTERM|DICTIONARY	chronic hepatitis c	chronic hepatitis C	68#87		Hepatic iron, serum ferritin, HFE mutation, and hepatic fibrosis in chronic hepatitis C.
12750963	2004	J. Hum. Genet.	1434-5161	TITLE	0	0	2246	SYMBOL|DICTIONARY|EXTRACTED	fgf1	FGF1	57#61		D002532	LONGTERM|DICTIONARY	intracranial aneurysm	intracranial aneurysm	90#111		Association of positional and functional candidate genes FGF1, FBN2, and LOX on 5q31 with intracranial aneurysm.
12750963	2004	J. Hum. Genet.	1434-5161	TITLE	0	0	2201	SYMBOL|DICTIONARY|EXTRACTED	fbn2	FBN2	63#67		D002532	LONGTERM|DICTIONARY	intracranial aneurysm	intracranial aneurysm	90#111		Association of positional and functional candidate genes FGF1, FBN2, and LOX on 5q31 with intracranial aneurysm.
12750963	2004	J. Hum. Genet.	1434-5161	TITLE	0	0	4015	SYMBOL|DICTIONARY	lox	LOX	73#76		D002532	LONGTERM|DICTIONARY	intracranial aneurysm	intracranial aneurysm	90#111		Association of positional and functional candidate genes FGF1, FBN2, and LOX on 5q31 with intracranial aneurysm.
20558149	2010	Brain Res.	1872-6240	TITLE	0	0	1378	LONGTERM|DICTIONARY	complement receptor 1	Complement receptor 1	0#21	NaN	D000544	LONGTERM|DISEASE|DT|DICTIONARY	alzheimer's disease	Alzheimer's disease	59#78		Complement receptor 1 polymorphisms and risk of late-onset Alzheimer's disease.
12750963	2004	J. Hum. Genet.	1434-5161	ALL_TEXT_1/3	1	2	2246	LONGTERM|DICTIONARY	fibroblast growth factor 1	fibroblast growth factor 1	69#95		D002532	SYMBOL|EXTRACTED	ia	IA	190#192	12750963-1-55-76	In the present study, we focus on 5q31, where three candidate genes, fibroblast growth factor 1 (FGF1), fibrillin 2 (FBN2), and lysyl oxidase gene ( LOX) lie, and evaluate associations with IA.
12750963	2004	J. Hum. Genet.	1434-5161	ALL_TEXT_1/3	1	2	2246	SYMBOL|()|DICTIONARY|EXTRACTED	fgf1	FGF1	97#101	12750963-2-69-95	D002532	SYMBOL|EXTRACTED	ia	IA	190#192	12750963-1-55-76	In the present study, we focus on 5q31, where three candidate genes, fibroblast growth factor 1 (FGF1), fibrillin 2 (FBN2), and lysyl oxidase gene ( LOX) lie, and evaluate associations with IA.
12750963	2004	J. Hum. Genet.	1434-5161	ALL_TEXT_1/3	1	2	2201	LONGTERM|DICTIONARY	fibrillin 2	fibrillin 2	104#115		D002532	SYMBOL|EXTRACTED	ia	IA	190#192	12750963-1-55-76	In the present study, we focus on 5q31, where three candidate genes, fibroblast growth factor 1 (FGF1), fibrillin 2 (FBN2), and lysyl oxidase gene ( LOX) lie, and evaluate associations with IA.
12750963	2004	J. Hum. Genet.	1434-5161	ALL_TEXT_1/3	1	2	2201	SYMBOL|()|DICTIONARY|EXTRACTED	fbn2	FBN2	117#121	12750963-2-104-115	D002532	SYMBOL|EXTRACTED	ia	IA	190#192	12750963-1-55-76	In the present study, we focus on 5q31, where three candidate genes, fibroblast growth factor 1 (FGF1), fibrillin 2 (FBN2), and lysyl oxidase gene ( LOX) lie, and evaluate associations with IA.
12750963	2004	J. Hum. Genet.	1434-5161	ALL_TEXT_1/3	1	2	4015	SYMBOL|DICTIONARY	lox	LOX	149#152		D002532	SYMBOL|EXTRACTED	ia	IA	190#192	12750963-1-55-76	In the present study, we focus on 5q31, where three candidate genes, fibroblast growth factor 1 (FGF1), fibrillin 2 (FBN2), and lysyl oxidase gene ( LOX) lie, and evaluate associations with IA.
12750963	2004	J. Hum. Genet.	1434-5161	ALL_TEXT_1/3	1	2	4015	LONGTERM|GENE|GN|DICTIONARY	lysyl oxidase gene	lysyl oxidase gene	128#146		D002532	SYMBOL|EXTRACTED	ia	IA	190#192	12750963-1-55-76	In the present study, we focus on 5q31, where three candidate genes, fibroblast growth factor 1 (FGF1), fibrillin 2 (FBN2), and lysyl oxidase gene ( LOX) lie, and evaluate associations with IA.
12750963	2004	J. Hum. Genet.	1434-5161	ALL_TEXT_3/3	3	7	2201	SYMBOL|DICTIONARY|EXTRACTED	fbn2	FBN2	19#23	12750963-2-104-115	D002532	SYMBOL|EXTRACTED	ia	IA	37#39	12750963-1-55-76	No associations of FBN2 and LOX with IA were detected in the present study.
12750963	2004	J. Hum. Genet.	1434-5161	ALL_TEXT_3/3	3	7	4015	SYMBOL|DICTIONARY	lox	LOX	28#31		D002532	SYMBOL|EXTRACTED	ia	IA	37#39	12750963-1-55-76	No associations of FBN2 and LOX with IA were detected in the present study.
19224585	2009	Hum. Mutat.	1098-1004	ALL_TEXT_3/3	3	7	7157	SYMBOL|GENE|GN|DICTIONARY	tp53	TP53	32#36		D003110	LONGTERM|DICTIONARY	colon (global p<0.0001) and rectal cancers	colon (global P<0.0001) and rectal cancers	57#99		The effect of haplotypes in the TP53 gene was similar in colon (global P<0.0001) and rectal cancers (P=0.006).
7581378	1995	Hum. Mol. Genet.	0964-6906	ALL_TEXT_2/3	2	3	2263	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	fgfr2	FGFR2	27#32	7581378-1-26-61	D003394	LONGTERM|DISEASE|DN|DT|DICTIONARY	pfeiffer and crouzon syndrome	Pfeiffer and Crouzon syndrome	71#100		Identical mutations in the FGFR2 gene have been reported to cause both Pfeiffer and Crouzon syndrome phenotypes.
15958759	2005	Ann. Rheum. Dis.	0003-4967	BACKGROUND	1	1	4210	SYMBOL|DICTIONARY	mefv	MEFV	86#90		D010505	LONGTERM|DICTIONARY	familial mediterranean fever	familial Mediterranean fever	134#162		Pyrin is a newly recognised intracellular regulator of inflammation, and mutations in MEFV, the gene encoding pyrin, are the cause of familial Mediterranean fever.
15958759	2005	Ann. Rheum. Dis.	0003-4967	BACKGROUND	1	1	4210	SYMBOL|DICTIONARY	mefv	MEFV	86#90		D007249	LONGTERM|DICTIONARY	inflammation	inflammation	55#67	NaN	Pyrin is a newly recognised intracellular regulator of inflammation, and mutations in MEFV, the gene encoding pyrin, are the cause of familial Mediterranean fever.
19064752	2009	Arch. Neurol.	1538-3687	CONCLUSIONS	5	9	6653	SYMBOL|DICTIONARY|EXTRACTED	sorl1	SORL1	12#17	19064752-1-81-106	D000544	SYMBOL|EXTRACTED	ad	AD	45#47	19064752-1-204-221	Variants of SORL1 previously associated with AD are also associated with MRI and neuropathological measures of neurodegenerative and cerebrovascular disease.
19064752	2009	Arch. Neurol.	1538-3687	CONCLUSIONS	5	9	6653	SYMBOL|DICTIONARY|EXTRACTED	sorl1	SORL1	12#17	19064752-1-81-106	D004194	LONGTERM|DISEASE|DT|DICTIONARY	cerebrovascular disease	cerebrovascular disease	133#156		Variants of SORL1 previously associated with AD are also associated with MRI and neuropathological measures of neurodegenerative and cerebrovascular disease.
12669197	2004	Diabetologia	0012-186X	METHODS	2	5	3172	LONGTERM|DICTIONARY	hnf-4alpha	HNF-4alpha	154#164	NaN	D003920	LONGTERM|DICTIONARY	diabetes	diabetes	67#75		We screened 423 unrelated Japanese patients with late-onset Type 2 diabetes and 354 unrelated non-diabetic control subjects for the T130I mutation in the HNF-4alpha gene.
12669197	2004	Diabetologia	0012-186X	METHODS	2	5	3172	LONGTERM|DICTIONARY	hnf-4alpha	HNF-4alpha	154#164	NaN	D017827	LONGTERM|DICTIONARY	type	Type	60#64		We screened 423 unrelated Japanese patients with late-onset Type 2 diabetes and 354 unrelated non-diabetic control subjects for the T130I mutation in the HNF-4alpha gene.
15958759	2005	Ann. Rheum. Dis.	0003-4967	OBJECTIVE	2	2	4210	SYMBOL|DICTIONARY	mefv	MEFV	35#39		D001172	LONGTERM|DICTIONARY	rheumatoid arthritis	rheumatoid arthritis	60#80		To determine if known mutations of MEFV are associated with rheumatoid arthritis (RA) morbidity or can modify RA severity.
15958759	2005	Ann. Rheum. Dis.	0003-4967	OBJECTIVE	2	2	4210	SYMBOL|DICTIONARY	mefv	MEFV	35#39		D001172	SYMBOL|EXTRACTED|()	ra	RA	82#84	15958759-2-60-80	To determine if known mutations of MEFV are associated with rheumatoid arthritis (RA) morbidity or can modify RA severity.
15958759	2005	Ann. Rheum. Dis.	0003-4967	OBJECTIVE	2	2	4210	SYMBOL|DICTIONARY	mefv	MEFV	35#39		D001172	SYMBOL|EXTRACTED	ra	RA	110#112	15958759-2-60-80	To determine if known mutations of MEFV are associated with rheumatoid arthritis (RA) morbidity or can modify RA severity.
12669197	2004	Diabetologia	0012-186X	TITLE	0	0	3172	LONGTERM|DICTIONARY	hnf-4alpha	HNF-4alpha	18#28	NaN	D003920	LONGTERM|DICTIONARY	type 2 diabetes mellitus	Type 2 diabetes mellitus	114#138		T130I mutation in HNF-4alpha gene is a loss-of-function mutation in hepatocytes and is associated with late-onset Type 2 diabetes mellitus in Japanese subjects.
12669197	2004	Diabetologia	0012-186X	AIMS/HYPOTHESIS	1	1	3172	LONGTERM|DICTIONARY	hepatocyte nuclear factor (hnf)-4alpha	hepatocyte nuclear factor (HNF)-4alpha	13#51	NaN	D003920	LONGTERM|DICTIONARY	diabetes of the young	diabetes of the young	88#109		Mutations in hepatocyte nuclear factor (HNF)-4alpha gene cause a form of maturity-onset diabetes of the young (MODY1).
19064752	2009	Arch. Neurol.	1538-3687	DESIGN, SETTING, AND PATIENTS	3	3	6653	SYMBOL|DICTIONARY|EXTRACTED	sorl1	SORL1	49#54	19064752-1-81-106	D001284	LONGTERM|DICTIONARY	cerebral atrophy	cerebral atrophy	84#100		We evaluated the association of 30 SNPs spanning SORL1 with MRI measures of general cerebral atrophy, hippocampal atrophy, white matter hyperintensities, and overall cerebrovascular disease in 44 African American and 182 white sibships from the MIRAGE Study.
19064752	2009	Arch. Neurol.	1538-3687	DESIGN, SETTING, AND PATIENTS	3	3	6653	SYMBOL|DICTIONARY|EXTRACTED	sorl1	SORL1	49#54	19064752-1-81-106	D004194	LONGTERM|DISEASE|DT|DICTIONARY	overall cerebrovascular disease	overall cerebrovascular disease	158#189		We evaluated the association of 30 SNPs spanning SORL1 with MRI measures of general cerebral atrophy, hippocampal atrophy, white matter hyperintensities, and overall cerebrovascular disease in 44 African American and 182 white sibships from the MIRAGE Study.
19064752	2009	Arch. Neurol.	1538-3687	DESIGN, SETTING, AND PATIENTS	3	3	6653	SYMBOL|DICTIONARY|EXTRACTED	sorl1	SORL1	49#54	19064752-1-81-106	D056784	LONGTERM|DICTIONARY	white matter hyperintensities	white matter hyperintensities	123#152	NaN	We evaluated the association of 30 SNPs spanning SORL1 with MRI measures of general cerebral atrophy, hippocampal atrophy, white matter hyperintensities, and overall cerebrovascular disease in 44 African American and 182 white sibships from the MIRAGE Study.
19064752	2009	Arch. Neurol.	1538-3687	OBJECTIVE	2	2	6653	SYMBOL|DICTIONARY|EXTRACTED	sorl1	SORL1	28#33	19064752-1-81-106	D014652	LONGTERM|DISEASE|DT|DICTIONARY	vascular disease	vascular disease	123#139		To test the hypothesis that SORL1 is associated with brain magnetic resonance imaging (MRI) measurements of atrophy and/or vascular disease.
19064752	2009	Arch. Neurol.	1538-3687	OBJECTIVE	2	2	6653	SYMBOL|DICTIONARY|EXTRACTED	sorl1	SORL1	28#33	19064752-1-81-106	D001284	LONGTERM|DICTIONARY	atrophy	atrophy	108#115	NaN	To test the hypothesis that SORL1 is associated with brain magnetic resonance imaging (MRI) measurements of atrophy and/or vascular disease.
19064752	2009	Arch. Neurol.	1538-3687	BACKGROUND	1	1	6653	SYMBOL|()|DICTIONARY|EXTRACTED	sorl1	SORL1	108#113	19064752-1-81-106	D000544	LONGTERM|DISEASE|DT|DICTIONARY	alzheimer disease	Alzheimer disease	204#221		Single-nucleotide polymorphisms (SNPs) in 2 distinct regions of the gene for the sortilin-related receptor (SORL1) (bounded by consecutively numbered SNPs 8-10 and 22-25) were shown to be associated with Alzheimer disease (AD) in multiple ethnically diverse samples.
19064752	2009	Arch. Neurol.	1538-3687	BACKGROUND	1	1	6653	SYMBOL|()|DICTIONARY|EXTRACTED	sorl1	SORL1	108#113	19064752-1-81-106	D000544	SYMBOL|EXTRACTED|()	ad	AD	223#225	19064752-1-204-221	Single-nucleotide polymorphisms (SNPs) in 2 distinct regions of the gene for the sortilin-related receptor (SORL1) (bounded by consecutively numbered SNPs 8-10 and 22-25) were shown to be associated with Alzheimer disease (AD) in multiple ethnically diverse samples.
19064752	2009	Arch. Neurol.	1538-3687	TITLE	0	0	6653	SYMBOL|DICTIONARY|EXTRACTED	sorl1	SORL1	36#41		D000544	LONGTERM|DISEASE|DT|DICTIONARY	alzheimer disease	Alzheimer disease	104#121		Association of distinct variants in SORL1 with cerebrovascular and neurodegenerative changes related to Alzheimer disease.
19094875	2009	Med Clin (Barc)	0025-7753	BACKGROUND AND OBJECTIVE	1	1	1312	LONGTERM|DICTIONARY	cathecol-o-methyl transferase	Cathecol-O-methyl transferase	0#29	NaN	D012559	LONGTERM|DICTIONARY	schizophrenia	schizophrenia	90#103		Cathecol-O-methyl transferase (COMT) is one of the most plausible susceptibility genes of schizophrenia risk.
16226919	2006	Mol. Ther.	1525-0016	ALL_TEXT_1/3	1	1	6121	SYMBOL|DICTIONARY	rpe65	RPE65	68#73		D003677	LONGTERM|DICTIONARY	rpe65 deficiency	RPE65 deficiency	178#194		The short- and long-term effects of gene therapy using AAV-mediated RPE65 transfer to canine retinal pigment epithelium were investigated in dogs affected with disease caused by RPE65 deficiency.
16226919	2006	Mol. Ther.	1525-0016	ALL_TEXT_1/3	1	1	6121	SYMBOL|DICTIONARY	rpe65	RPE65	178#183		D003677	LONGTERM|DICTIONARY	rpe65 deficiency	RPE65 deficiency	178#194		The short- and long-term effects of gene therapy using AAV-mediated RPE65 transfer to canine retinal pigment epithelium were investigated in dogs affected with disease caused by RPE65 deficiency.
26141506	2015	Chem. Biol. Interact.	1872-7786	ALL_TEXT_3/3	3	7	7124	LONGTERM|DICTIONARY	tnf-a	TNF-a	108#113	NaN	D006930	LONGTERM|DICTIONARY	hyperalgesia	hyperalgesia	80#92		CT administration produced a significantly reduction (p<0.05) in the mechanical hyperalgesia induced by CG, TNF-, PGE2 and DA when compared with control group.
17609663	2007	Br. J. Cancer	0007-0920	ALL_TEXT_1/3	1	3	5743	SYMBOL|DICTIONARY|EXTRACTED	cox2	COX2	80#84	17609663-1-34-50	D011471	LONGTERM|DISEASE|DT|DICTIONARY	prostate cancer	prostate cancer	151#166		Nonsteroidal anti-inflammatory drugs (NSAIDs) inhibit the enzymatic activity of COX2 and long-term use of NSAIDs appears to modestly lower the risk of prostate cancer.
17609663	2007	Br. J. Cancer	0007-0920	ALL_TEXT_1/3	1	2	5743	LONGTERM|DICTIONARY	cyclooxygenase 2	Cyclooxygenase 2	0#16		D007249	LONGTERM|DICTIONARY	inflammation	inflammation	117#129	NaN	Cyclooxygenase 2 is the major enzyme that converts arachidonic acid to prostaglandins, which are potent mediators of inflammation.
17609663	2007	Br. J. Cancer	0007-0920	ALL_TEXT_1/3	1	1	5743	LONGTERM|DICTIONARY	cyclooxygenase 2	cyclooxygenase 2	34#50		D011471	LONGTERM|DISEASE|DT|DICTIONARY	prostate cancer	prostate cancer	74#89		Collective evidence suggests that cyclooxygenase 2 (COX2) plays a role in prostate cancer risk.
17609663	2007	Br. J. Cancer	0007-0920	ALL_TEXT_1/3	1	1	5743	SYMBOL|()|DICTIONARY|EXTRACTED	cox2	COX2	52#56	17609663-1-34-50	D011471	LONGTERM|DISEASE|DT|DICTIONARY	prostate cancer	prostate cancer	74#89		Collective evidence suggests that cyclooxygenase 2 (COX2) plays a role in prostate cancer risk.
17609663	2007	Br. J. Cancer	0007-0920	TITLE	0	0	5743	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	cox2	COX2	0#4		D011471	LONGTERM|DISEASE|DT|DICTIONARY	advanced prostate cancer	advanced prostate cancer	36#60		COX2 genetic variation, NSAIDs, and advanced prostate cancer risk.
1352745	1992	Clin. Exp. Immunol.	0009-9104	ALL_TEXT_1/3	1	2	1378	SYMBOL|EXTRACTED	cr1	CR1	10#13	1352745-0-7-10	D003922	SYMBOL|DICTIONARY|EXTRACTED	iddm	IDDM	63#67	1352745-0-64-99	Defective CR1 expression was found in 26% of the patients with IDDM compared with 9% of the controls (P less than 0.05) and 0% of the siblings.
17609663	2007	Br. J. Cancer	0007-0920	ALL_TEXT_2/3	2	5	5743	SYMBOL|DICTIONARY|EXTRACTED	cox2	COX2	47#51	17609663-1-34-50	D011471	LONGTERM|DISEASE|DT|DICTIONARY	advanced prostate cancer	advanced prostate cancer	111#135		Nine single-nucleotide polymorphisms (SNPs) in COX2 were genotyped among 1012 men in our case-control study of advanced prostate cancer.
17609663	2007	Br. J. Cancer	0007-0920	ALL_TEXT_1/3	1	4	5743	SYMBOL|DICTIONARY|EXTRACTED	cox2	COX2	52#56	17609663-1-34-50	D011471	LONGTERM|DISEASE|DT|DICTIONARY	advanced prostate cancer	advanced prostate cancer	80#104		We investigated whether common genetic variation in COX2 influences the risk of advanced prostate cancer.
19220408	2009	Epilepsia	1528-1167	METHODS	2	2	8645	SYMBOL|DICTIONARY	task 2	TASK-2	47#53		D004827	LONGTERM|DICTIONARY	epilepsy	epilepsy	192#200		We performed and immunohistochemical study for TASK-2 and double immunofluorescent staining for TASK-2 and glial fibrillary acidic protein (GFAP) in the rat hippocampus of pilocarpine-induced epilepsy models.
19220408	2009	Epilepsia	1528-1167	METHODS	2	2	8645	SYMBOL|DICTIONARY	task 2	TASK-2	96#102		D004827	LONGTERM|DICTIONARY	epilepsy	epilepsy	192#200		We performed and immunohistochemical study for TASK-2 and double immunofluorescent staining for TASK-2 and glial fibrillary acidic protein (GFAP) in the rat hippocampus of pilocarpine-induced epilepsy models.
19220408	2009	Epilepsia	1528-1167	PURPOSE	1	1	8645	SYMBOL|DICTIONARY	task 2	TASK-2	209#215		D004827	LONGTERM|DICTIONARY	epilepsy	epilepsy	160#168		To identify the modulation of Tandem of P-domains in a weak inwardly rectifying K(+) channel (TWIK)-related acid-sensitive K(+) (TASK)-2 channel expressions in epilepsy, we conducted a comparative analysis of TASK-2 channel immunoreactivity in the hippocampus of a pilocarpine-induced rat epilepsy model.
19220408	2009	Epilepsia	1528-1167	PURPOSE	1	1	8645	SYMBOL|DICTIONARY	task 2	TASK-2	209#215		D004827	LONGTERM|DICTIONARY	epilepsy	epilepsy	289#297		To identify the modulation of Tandem of P-domains in a weak inwardly rectifying K(+) channel (TWIK)-related acid-sensitive K(+) (TASK)-2 channel expressions in epilepsy, we conducted a comparative analysis of TASK-2 channel immunoreactivity in the hippocampus of a pilocarpine-induced rat epilepsy model.
20020061	2010	PLoS ONE	1932-6203	METHODOLOGY/PRINCIPAL FINDINGS	2	9	3845	SYMBOL|DICTIONARY	kras	KRAS	92#96		D009369	LONGTERM|DICTIONARY	primary tumors	primary tumors	110#124		Separately, the analysis of these 120 patients showed a tendency towards a higher degree of KRAS mutations in primary tumors of patients with lung metastases, although it did not reach statistical significance.
20020061	2010	PLoS ONE	1932-6203	METHODOLOGY/PRINCIPAL FINDINGS	2	9	3845	SYMBOL|DICTIONARY	kras	KRAS	92#96		D009362	LONGTERM|DICTIONARY	metastases	metastases	147#157		Separately, the analysis of these 120 patients showed a tendency towards a higher degree of KRAS mutations in primary tumors of patients with lung metastases, although it did not reach statistical significance.
19058873	2009	Lung Cancer	1872-8332	CONCLUSION	4	8	840	SYMBOL|DICTIONARY	casp7	CASP7	31#36		D008175	LONGTERM|DISEASE|DT|DICTIONARY	lung cancer	lung cancer	95#106		These results suggest that the CASP7 polymorphisms contribute to the genetic susceptibility to lung cancer.
15318030	2005	Psychiatr. Genet.	0955-8829	ALL_TEXT_1/3	1	2	151056	LONGTERM|GENE|GN|DICTIONARY	phospholipase a2	phospholipase A2	56#72		D012559	LONGTERM|DICTIONARY	schizophrenic	schizophrenic	168#181	NaN	In the present study, variants of four genes coding for phospholipase A2 enzyme groups (sPLA2, cPLA2, iPLA2 and PAFAH) were analysed in a case-control sample using 240 schizophrenic patients and 312 healthy controls.
15318030	2005	Psychiatr. Genet.	0955-8829	ALL_TEXT_1/3	1	2	5320	SYMBOL|DICTIONARY	spla2	sPLA2	88#93		D012559	LONGTERM|DICTIONARY	schizophrenic	schizophrenic	168#181	NaN	In the present study, variants of four genes coding for phospholipase A2 enzyme groups (sPLA2, cPLA2, iPLA2 and PAFAH) were analysed in a case-control sample using 240 schizophrenic patients and 312 healthy controls.
15318030	2005	Psychiatr. Genet.	0955-8829	ALL_TEXT_1/3	1	2	5321	SYMBOL|DICTIONARY	cpla2	cPLA2	95#100		D012559	LONGTERM|DICTIONARY	schizophrenic	schizophrenic	168#181	NaN	In the present study, variants of four genes coding for phospholipase A2 enzyme groups (sPLA2, cPLA2, iPLA2 and PAFAH) were analysed in a case-control sample using 240 schizophrenic patients and 312 healthy controls.
15318030	2005	Psychiatr. Genet.	0955-8829	ALL_TEXT_1/3	1	2	8398	SYMBOL|DICTIONARY	ipla2	iPLA2	102#107		D012559	LONGTERM|DICTIONARY	schizophrenic	schizophrenic	168#181	NaN	In the present study, variants of four genes coding for phospholipase A2 enzyme groups (sPLA2, cPLA2, iPLA2 and PAFAH) were analysed in a case-control sample using 240 schizophrenic patients and 312 healthy controls.
15318030	2005	Psychiatr. Genet.	0955-8829	ALL_TEXT_1/3	1	2	7941	SYMBOL|DICTIONARY	pafah	PAFAH	112#117		D012559	LONGTERM|DICTIONARY	schizophrenic	schizophrenic	168#181	NaN	In the present study, variants of four genes coding for phospholipase A2 enzyme groups (sPLA2, cPLA2, iPLA2 and PAFAH) were analysed in a case-control sample using 240 schizophrenic patients and 312 healthy controls.
19058873	2009	Lung Cancer	1872-8332	TITLE	0	0	840	LONGTERM|DICTIONARY	caspase7	Caspase7	21#29	NaN	D008175	LONGTERM|DISEASE|DT|DICTIONARY	lung cancer	lung cancer	51#62		Polymorphisms in the Caspase7 gene and the risk of lung cancer.
19058873	2009	Lung Cancer	1872-8332	BACKGROUND	1	1	840	SYMBOL|()|DICTIONARY	casp7	CASP7	10#15		D009369	LONGTERM|DISEASE|DT|DICTIONARY	cancer	cancer	222#228		Caspase7 (CASP7) is an executioner CASP that conducted a coordinated program of proteolysis that results in the destruction of critical cell structures, and it plays an important role in the development and progression of cancer.
19058873	2009	Lung Cancer	1872-8332	BACKGROUND	1	1	10491	SYMBOL|DICTIONARY	casp	CASP	35#39		D009369	LONGTERM|DISEASE|DT|DICTIONARY	cancer	cancer	222#228		Caspase7 (CASP7) is an executioner CASP that conducted a coordinated program of proteolysis that results in the destruction of critical cell structures, and it plays an important role in the development and progression of cancer.
19058873	2009	Lung Cancer	1872-8332	BACKGROUND	1	2	840	SYMBOL|GENE|GN|DICTIONARY	casp7	CASP7	99#104		D008175	LONGTERM|DISEASE|DT|DICTIONARY	lung cancer	lung cancer	137#148		The purpose of this study is to comprehensively evaluate potential functional polymorphisms in the CASP7 gene in relation to the risk of lung cancer.
11517440	2001	J. Infect. Dis.	0022-1899	ALL_TEXT_3/3	3	7	3586	SYMBOL|DICTIONARY	il 10	IL-10	28#33		D020031	LONGTERM|DISEASE|DT|DICTIONARY	ebv infection	EBV infection	83#96		These data suggest that the IL-10 ATA haplotype confers protection against primary EBV infection and that the effect is mediated by high IL-10 levels.
11517440	2001	J. Infect. Dis.	0022-1899	ALL_TEXT_3/3	3	7	3586	SYMBOL|DICTIONARY	il 10	IL-10	137#142		D020031	LONGTERM|DISEASE|DT|DICTIONARY	ebv infection	EBV infection	83#96		These data suggest that the IL-10 ATA haplotype confers protection against primary EBV infection and that the effect is mediated by high IL-10 levels.
20020061	2010	PLoS ONE	1932-6203	METHODOLOGY/PRINCIPAL FINDINGS	2	2	3845	SYMBOL|DICTIONARY	kras	KRAS	0#4		D015179	LONGTERM|DICTIONARY	colorectal tumors	colorectal tumors	164#181		KRAS mutations were retrospectively studied using polymerase chain reactions and subsequent sequencing of codons 12 and 13 (exon 2) in 110 patients with metastatic colorectal tumors.
24868163	2014	Vasc Health Risk Manag	1178-2048	RESULTS	3	6	1401	LONGTERM|GENE|GT|DICTIONARY	c reactive protein	C-reactive protein	199#217		D003324	SYMBOL|DICTIONARY|EXTRACTED	cad	CAD	63#66	24868163-2-285-308	There was no correlation between Cd, Pb, or Hg and severity of CAD although severity correlated positively with atherosclerosis parameters (uric acid, creatinine, triglycerides, blood urea nitrogen, C-reactive protein) and negatively with high density lipoprotein cholesterol.
24868163	2014	Vasc Health Risk Manag	1178-2048	RESULTS	3	6	1401	LONGTERM|GENE|GT|DICTIONARY	c reactive protein	C-reactive protein	199#217		D050197	LONGTERM|DICTIONARY	atherosclerosis	atherosclerosis	112#127		There was no correlation between Cd, Pb, or Hg and severity of CAD although severity correlated positively with atherosclerosis parameters (uric acid, creatinine, triglycerides, blood urea nitrogen, C-reactive protein) and negatively with high density lipoprotein cholesterol.
12827651	2003	Am. J. Hematol.	0361-8609	ALL_TEXT_1/3	1	3	4524	SYMBOL|DICTIONARY	mthfr	MTHFR	17#22		D054198	SYMBOL|EXTRACTED	all	ALL	62#65	12827651-2-26-54	The frequency of MTHFR genotype was insignificantly higher in ALL (7.7%) and ANLL (6.3%) than in controls (4.4%).
12827651	2003	Am. J. Hematol.	0361-8609	ALL_TEXT_1/3	1	3	4524	SYMBOL|DICTIONARY	mthfr	MTHFR	17#22		D015470	SYMBOL|DICTIONARY|EXTRACTED	anll	ANLL	77#81	12827651-2-73-104	The frequency of MTHFR genotype was insignificantly higher in ALL (7.7%) and ANLL (6.3%) than in controls (4.4%).
12827651	2003	Am. J. Hematol.	0361-8609	ALL_TEXT_1/3	1	1	4524	LONGTERM|DICTIONARY	methylenetetrahydrofolate reductase	methylenetetrahydrofolate reductase	12#47		D007938	LONGTERM|DICTIONARY	childhood leukemia	childhood leukemia	193#211		The role of methylenetetrahydrofolate reductase (MTHFR C677T), glutathione S-transferases (GSTM1 and GSTT1 null, GSTP1 Ile105Val), and cytochromes p450 (CYP1A1*2A) genotypes in the etiology of childhood leukemia was simultaneously investigated.
12827651	2003	Am. J. Hematol.	0361-8609	ALL_TEXT_1/3	1	1	4524	SYMBOL|DICTIONARY	mthfr	MTHFR	49#54		D007938	LONGTERM|DICTIONARY	childhood leukemia	childhood leukemia	193#211		The role of methylenetetrahydrofolate reductase (MTHFR C677T), glutathione S-transferases (GSTM1 and GSTT1 null, GSTP1 Ile105Val), and cytochromes p450 (CYP1A1*2A) genotypes in the etiology of childhood leukemia was simultaneously investigated.
12827651	2003	Am. J. Hematol.	0361-8609	ALL_TEXT_1/3	1	1	2944	SYMBOL|DICTIONARY	gstm1	GSTM1	91#96		D007938	LONGTERM|DICTIONARY	childhood leukemia	childhood leukemia	193#211		The role of methylenetetrahydrofolate reductase (MTHFR C677T), glutathione S-transferases (GSTM1 and GSTT1 null, GSTP1 Ile105Val), and cytochromes p450 (CYP1A1*2A) genotypes in the etiology of childhood leukemia was simultaneously investigated.
12827651	2003	Am. J. Hematol.	0361-8609	ALL_TEXT_1/3	1	1	2952	SYMBOL|DICTIONARY	gstt1	GSTT1	101#106		D007938	LONGTERM|DICTIONARY	childhood leukemia	childhood leukemia	193#211		The role of methylenetetrahydrofolate reductase (MTHFR C677T), glutathione S-transferases (GSTM1 and GSTT1 null, GSTP1 Ile105Val), and cytochromes p450 (CYP1A1*2A) genotypes in the etiology of childhood leukemia was simultaneously investigated.
12827651	2003	Am. J. Hematol.	0361-8609	ALL_TEXT_1/3	1	1	2950	SYMBOL|DICTIONARY	gstp1	GSTP1	113#118		D007938	LONGTERM|DICTIONARY	childhood leukemia	childhood leukemia	193#211		The role of methylenetetrahydrofolate reductase (MTHFR C677T), glutathione S-transferases (GSTM1 and GSTT1 null, GSTP1 Ile105Val), and cytochromes p450 (CYP1A1*2A) genotypes in the etiology of childhood leukemia was simultaneously investigated.
12827651	2003	Am. J. Hematol.	0361-8609	ALL_TEXT_1/3	1	1	1555	SYMBOL|DICTIONARY	p450	p450	147#151		D007938	LONGTERM|DICTIONARY	childhood leukemia	childhood leukemia	193#211		The role of methylenetetrahydrofolate reductase (MTHFR C677T), glutathione S-transferases (GSTM1 and GSTT1 null, GSTP1 Ile105Val), and cytochromes p450 (CYP1A1*2A) genotypes in the etiology of childhood leukemia was simultaneously investigated.
12827651	2003	Am. J. Hematol.	0361-8609	ALL_TEXT_1/3	1	1	1543	SYMBOL|NUMBER|DICTIONARY	cyp1a1	CYP1A1	153#159		D007938	LONGTERM|DICTIONARY	childhood leukemia	childhood leukemia	193#211		The role of methylenetetrahydrofolate reductase (MTHFR C677T), glutathione S-transferases (GSTM1 and GSTT1 null, GSTP1 Ile105Val), and cytochromes p450 (CYP1A1*2A) genotypes in the etiology of childhood leukemia was simultaneously investigated.
14521605	2004	J. Thromb. Haemost.	1538-7933	OBJECTIVE	2	4	7450	SYMBOL|DICTIONARY|EXTRACTED	vwf	VWF	216#219	14521605-1-58-79	C536458	SYMBOL|EXTRACTED|DISEASE|DN	plt vwd	plt-VWD	92#99	14521605-2-0-36	The present study aimed to determine whether G233S of GPIbalpha, a new mutation observed in plt-VWD patients, causes the plt-VWD phenotype and to examine whether conversions to other residues at this position affect VWF binding.
14521605	2004	J. Thromb. Haemost.	1538-7933	OBJECTIVE	2	4	7450	SYMBOL|DICTIONARY|EXTRACTED	vwf	VWF	216#219	14521605-1-58-79	C536458	SYMBOL|EXTRACTED|DISEASE|DN	plt vwd	plt-VWD	121#128	14521605-2-0-36	The present study aimed to determine whether G233S of GPIbalpha, a new mutation observed in plt-VWD patients, causes the plt-VWD phenotype and to examine whether conversions to other residues at this position affect VWF binding.
14521605	2004	J. Thromb. Haemost.	1538-7933	OBJECTIVE	2	4	2811	LONGTERM|DICTIONARY	gpibalpha	GPIbalpha	54#63	NaN	C536458	SYMBOL|EXTRACTED|DISEASE|DN	plt vwd	plt-VWD	92#99	14521605-2-0-36	The present study aimed to determine whether G233S of GPIbalpha, a new mutation observed in plt-VWD patients, causes the plt-VWD phenotype and to examine whether conversions to other residues at this position affect VWF binding.
14521605	2004	J. Thromb. Haemost.	1538-7933	OBJECTIVE	2	4	2811	LONGTERM|DICTIONARY	gpibalpha	GPIbalpha	54#63	NaN	C536458	SYMBOL|EXTRACTED|DISEASE|DN	plt vwd	plt-VWD	121#128	14521605-2-0-36	The present study aimed to determine whether G233S of GPIbalpha, a new mutation observed in plt-VWD patients, causes the plt-VWD phenotype and to examine whether conversions to other residues at this position affect VWF binding.
12827651	2003	Am. J. Hematol.	0361-8609	ALL_TEXT_3/3	3	7	1543	SYMBOL|NUMBER|DICTIONARY	cyp1a1	CYP1A1	11#17		D054198	SYMBOL|EXTRACTED|DISEASE|DN	all	ALL	54#57	12827651-2-26-54	Homozygous CYP1A1*2A genotype was underrepresented in ALL patients (1%) as compared to control (4.8%) but the differences did not reach to statistical significance (OR 0.21; 95% CI 0.03-1.72).
12827651	2003	Am. J. Hematol.	0361-8609	ALL_TEXT_2/3	2	6	2950	SYMBOL|DICTIONARY	gstp1	GSTP1	28#33		D054198	SYMBOL|EXTRACTED	all	ALL	90#93	12827651-2-26-54	The homozygous frequency of GSTP1 genotype did not differ significantly between groups of ALL (3.7%), ANLL patients (9.1%) and controls (4.9%).
12827651	2003	Am. J. Hematol.	0361-8609	ALL_TEXT_2/3	2	6	2950	SYMBOL|DICTIONARY	gstp1	GSTP1	28#33		D015470	SYMBOL|DISEASE|DN|DICTIONARY|EXTRACTED	anll	ANLL	102#106	12827651-2-73-104	The homozygous frequency of GSTP1 genotype did not differ significantly between groups of ALL (3.7%), ANLL patients (9.1%) and controls (4.9%).
14521605	2004	J. Thromb. Haemost.	1538-7933	BACKGROUND	1	1	7450	SYMBOL|()|DICTIONARY|EXTRACTED	vwf	VWF	81#84	14521605-1-58-79	D013927	LONGTERM|DICTIONARY	thrombosis	thrombosis	142#152	NaN	Interaction between platelet glycoprotein (GP)Ibalpha and von Willebrand factor (VWF) has critical roles in both physiological hemostasis and thrombosis.
12827651	2003	Am. J. Hematol.	0361-8609	ALL_TEXT_2/3	2	4	2944	SYMBOL|DICTIONARY	gstm1	GSTM1	26#31		D054198	SYMBOL|EXTRACTED|DISEASE|DN	all	ALL	67#70	12827651-2-26-54	Equal distribution of the GSTM1 null genotype was detected between ALL patients and controls (55%), while its incidence was slightly higher in ANLL patients (61.3%).
12827651	2003	Am. J. Hematol.	0361-8609	ALL_TEXT_2/3	2	4	2944	SYMBOL|DICTIONARY	gstm1	GSTM1	26#31		D015470	SYMBOL|DISEASE|DN|DICTIONARY|EXTRACTED	anll	ANLL	143#147	12827651-2-73-104	Equal distribution of the GSTM1 null genotype was detected between ALL patients and controls (55%), while its incidence was slightly higher in ANLL patients (61.3%).
12843182	2003	J. Clin. Endocrinol. Metab.	0021-972X	ALL_TEXT_1/3	1	2	7040	SYMBOL|GENE|GN|DICTIONARY	tgfb1	TGFB1	51#56		D003966	SYMBOL|DICTIONARY|EXTRACTED	ced	CED	0#3		CED is caused by various missense mutations in the TGFB1 gene that encodes TGFbeta1, the most common of which is an arginine-cysteine amino acid change at codon 218 (R218C) in the latency-associated peptide domain of TGFbeta1.
12843182	2003	J. Clin. Endocrinol. Metab.	0021-972X	ALL_TEXT_1/3	1	2	7040	LONGTERM|DICTIONARY	latency associated peptide	latency-associated peptide	180#206		D003966	SYMBOL|DICTIONARY|EXTRACTED	ced	CED	0#3		CED is caused by various missense mutations in the TGFB1 gene that encodes TGFbeta1, the most common of which is an arginine-cysteine amino acid change at codon 218 (R218C) in the latency-associated peptide domain of TGFbeta1.
16528020	2006	Am. J. Respir. Crit. Care Med.	1073-449X	OBJECTIVES	2	3	3654	SYMBOL|DICTIONARY	irak 1	IRAK-1	46#52		D018805	LONGTERM|DICTIONARY	sepsis	sepsis	147#153		To examine the functional significance of the IRAK-1 variant haplotype in modifying nuclear translocation of NF-kappaB and affecting outcomes from sepsis.
16528020	2006	Am. J. Respir. Crit. Care Med.	1073-449X	OBJECTIVES	2	3	4790	LONGTERM|DICTIONARY	nf-kappab	NF-kappaB	109#118	NaN	D018805	LONGTERM|DICTIONARY	sepsis	sepsis	147#153		To examine the functional significance of the IRAK-1 variant haplotype in modifying nuclear translocation of NF-kappaB and affecting outcomes from sepsis.
19362357	2009	J. Allergy Clin. Immunol.	1097-6825	RESULTS	4	12	30009	SYMBOL|DICTIONARY|EXTRACTED	tbx21	TBX21	42#47	19362357-1-20-46	D001249	LONGTERM|DICTIONARY	asthma	asthma	85#91		In a risk score model, the combination of TBX21 and HLX1 polymorphisms increased the asthma risk by more than 3-fold.
19362357	2009	J. Allergy Clin. Immunol.	1097-6825	RESULTS	4	12	3142	SYMBOL|DICTIONARY	hlx1	HLX1	52#56		D001249	LONGTERM|DICTIONARY	asthma	asthma	85#91		In a risk score model, the combination of TBX21 and HLX1 polymorphisms increased the asthma risk by more than 3-fold.
19362357	2009	J. Allergy Clin. Immunol.	1097-6825	CONCLUSIONS	5	14	30009	SYMBOL|DICTIONARY|EXTRACTED	tbx21	TBX21	34#39	19362357-1-20-46	D001249	LONGTERM|DICTIONARY	asthma	asthma	95#101		A risk score model indicates that TBX21 and HLX1 polymorphisms may have synergistic effects on asthma risk.
19362357	2009	J. Allergy Clin. Immunol.	1097-6825	CONCLUSIONS	5	14	3142	SYMBOL|DICTIONARY	hlx1	HLX1	44#48		D001249	LONGTERM|DICTIONARY	asthma	asthma	95#101		A risk score model indicates that TBX21 and HLX1 polymorphisms may have synergistic effects on asthma risk.
12843182	2003	J. Clin. Endocrinol. Metab.	0021-972X	ALL_TEXT_2/3	2	4	7048	SYMBOL|GFAM|FN|DICTIONARY	tgfbeta type ii receptor	TGFbeta type II receptor	204#228		D003966	SYMBOL|DISEASE|DN|DICTIONARY|EXTRACTED	ced	CED	124#127	12843182-1-0-26	Osteoclast formation was enhanced approximately 5-fold (P < 0.001) and bone resorption approximately 10-fold (P < 0.001) in CED patients, and the increase in osteoclast formation was inhibited by soluble TGFbeta type II receptor.
17131847	2007	Ann Acad Med Stetin	1427-440X	TITLE	0	0	1636	SYMBOL|GENE|GN|DICTIONARY	ace	ACE	31#34		D006973	LONGTERM|DISEASE|DN|DICTIONARY	hypertension	hypertension	80#92		[The hemostasis parameters and ACE gene polymorphism in patients with essential hypertension treated with perindopril].
7981680	1995	Hum. Mol. Genet.	0964-6906	ALL_TEXT_2/3	2	3	3481	SYMBOL|DICTIONARY|EXTRACTED	igf ii	IGF-II	0#6		D009369	LONGTERM|DICTIONARY	neoplasms	neoplasms	57#66		IGF-II expression is activated in several types of human neoplasms and an alteration of IGF-II imprinting has been described in Beckwith-Wiedemann syndrome and Wilms' tumor.
7981680	1995	Hum. Mol. Genet.	0964-6906	ALL_TEXT_2/3	2	3	3481	SYMBOL|DICTIONARY|EXTRACTED	igf ii	IGF-II	0#6		D001506	LONGTERM|DISEASE|DT|DICTIONARY	beckwith wiedemann syndrome	Beckwith-Wiedemann syndrome	128#155		IGF-II expression is activated in several types of human neoplasms and an alteration of IGF-II imprinting has been described in Beckwith-Wiedemann syndrome and Wilms' tumor.
7981680	1995	Hum. Mol. Genet.	0964-6906	ALL_TEXT_2/3	2	3	3481	SYMBOL|DICTIONARY|EXTRACTED	igf ii	IGF-II	0#6		D009396	LONGTERM|DISEASE|DT|DICTIONARY	wilms tumor	Wilms' tumor	160#172		IGF-II expression is activated in several types of human neoplasms and an alteration of IGF-II imprinting has been described in Beckwith-Wiedemann syndrome and Wilms' tumor.
7981680	1995	Hum. Mol. Genet.	0964-6906	ALL_TEXT_2/3	2	3	3481	SYMBOL|DICTIONARY|EXTRACTED	igf ii	IGF-II	88#94	7981680-1-0-29	D009369	LONGTERM|DICTIONARY	neoplasms	neoplasms	57#66		IGF-II expression is activated in several types of human neoplasms and an alteration of IGF-II imprinting has been described in Beckwith-Wiedemann syndrome and Wilms' tumor.
7981680	1995	Hum. Mol. Genet.	0964-6906	ALL_TEXT_2/3	2	3	3481	SYMBOL|DICTIONARY|EXTRACTED	igf ii	IGF-II	88#94	7981680-1-0-29	D001506	LONGTERM|DISEASE|DT|DICTIONARY	beckwith wiedemann syndrome	Beckwith-Wiedemann syndrome	128#155		IGF-II expression is activated in several types of human neoplasms and an alteration of IGF-II imprinting has been described in Beckwith-Wiedemann syndrome and Wilms' tumor.
7981680	1995	Hum. Mol. Genet.	0964-6906	ALL_TEXT_2/3	2	3	3481	SYMBOL|DICTIONARY|EXTRACTED	igf ii	IGF-II	88#94	7981680-1-0-29	D009396	LONGTERM|DISEASE|DT|DICTIONARY	wilms tumor	Wilms' tumor	160#172		IGF-II expression is activated in several types of human neoplasms and an alteration of IGF-II imprinting has been described in Beckwith-Wiedemann syndrome and Wilms' tumor.
20020061	2010	PLoS ONE	1932-6203	METHODOLOGY/PRINCIPAL FINDINGS	2	6	3845	SYMBOL|DICTIONARY	kras	KRAS	40#44		D009369	LONGTERM|DICTIONARY	primary tumors	primary tumors	14#28		Patients with primary tumors possessing KRAS mutations had a shorter disease-free survival period after metastasis resection (12.0 vs 18.0 months; P = 0.035) than those who did not.
16182378	2006	J. Neuroimmunol.	0165-5728	ALL_TEXT_3/3	3	15	1234	SYMBOL|DICTIONARY	ccr5*delta32	CCR5*Delta32	113#125		D009103	SYMBOL|EXTRACTED	ms	MS	70#72	16182378-1-63-81	Furthermore it does not segregate with patterns of immunopathology in MS. We did not find an association between CCR5*Delta32 mutation and disease severity and age of onset in MS.
16182378	2006	J. Neuroimmunol.	0165-5728	ALL_TEXT_3/3	3	15	1234	SYMBOL|DICTIONARY	ccr5*delta32	CCR5*Delta32	113#125		D009103	SYMBOL|EXTRACTED	ms	MS	176#178	16182378-1-63-81	Furthermore it does not segregate with patterns of immunopathology in MS. We did not find an association between CCR5*Delta32 mutation and disease severity and age of onset in MS.
16182378	2006	J. Neuroimmunol.	0165-5728	ALL_TEXT_3/3	3	14	1234	SYMBOL|DICTIONARY	ccr5	CCR5	0#4		D009103	SYMBOL|EXTRACTED	ms	MS	106#108	16182378-1-63-81	CCR5*Delta32 has a dose effect on CCR5 expression in the CNS, but is neither necessary for development of MS, nor CD3+ T cell recruitment into the CNS.
16182378	2006	J. Neuroimmunol.	0165-5728	ALL_TEXT_3/3	3	14	1234	SYMBOL|DICTIONARY	ccr5	CCR5	34#38		D009103	SYMBOL|EXTRACTED	ms	MS	106#108	16182378-1-63-81	CCR5*Delta32 has a dose effect on CCR5 expression in the CNS, but is neither necessary for development of MS, nor CD3+ T cell recruitment into the CNS.
7981680	1995	Hum. Mol. Genet.	0964-6906	ALL_TEXT_3/3	3	5	3481	SYMBOL|DICTIONARY|EXTRACTED	igf ii	IGF-II	6#12	7981680-1-0-29	D012208	LONGTERM|CLINE|CN|DICTIONARY	rhabdomyosarcoma	rhabdomyosarcoma	66#82		Since IGF-II has been indicated as an autocrine growth factor for rhabdomyosarcoma cells, these findings strongly suggest that acquisition of a double dosage of active IGF-II gene is an important step for the initiation or progression of rhabdomyosarcoma tumorigenesis.
7981680	1995	Hum. Mol. Genet.	0964-6906	ALL_TEXT_3/3	3	5	3481	SYMBOL|DICTIONARY|EXTRACTED	igf ii	IGF-II	6#12	7981680-1-0-29	D012208	LONGTERM|DISEASE|DN|DICTIONARY	rhabdomyosarcoma	rhabdomyosarcoma	238#254		Since IGF-II has been indicated as an autocrine growth factor for rhabdomyosarcoma cells, these findings strongly suggest that acquisition of a double dosage of active IGF-II gene is an important step for the initiation or progression of rhabdomyosarcoma tumorigenesis.
7981680	1995	Hum. Mol. Genet.	0964-6906	ALL_TEXT_3/3	3	5	3481	SYMBOL|DICTIONARY|EXTRACTED	igf ii	IGF-II	6#12	7981680-1-0-29	D012208	LONGTERM|DICTIONARY	rhabdomyosarcoma tumorigenesis	rhabdomyosarcoma tumorigenesis	238#268		Since IGF-II has been indicated as an autocrine growth factor for rhabdomyosarcoma cells, these findings strongly suggest that acquisition of a double dosage of active IGF-II gene is an important step for the initiation or progression of rhabdomyosarcoma tumorigenesis.
7981680	1995	Hum. Mol. Genet.	0964-6906	ALL_TEXT_3/3	3	5	3481	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	igf ii	IGF-II	168#174	7981680-1-0-29	D012208	LONGTERM|CLINE|CN|DICTIONARY	rhabdomyosarcoma	rhabdomyosarcoma	66#82		Since IGF-II has been indicated as an autocrine growth factor for rhabdomyosarcoma cells, these findings strongly suggest that acquisition of a double dosage of active IGF-II gene is an important step for the initiation or progression of rhabdomyosarcoma tumorigenesis.
7981680	1995	Hum. Mol. Genet.	0964-6906	ALL_TEXT_3/3	3	5	3481	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	igf ii	IGF-II	168#174	7981680-1-0-29	D012208	LONGTERM|DISEASE|DN|DICTIONARY	rhabdomyosarcoma	rhabdomyosarcoma	238#254		Since IGF-II has been indicated as an autocrine growth factor for rhabdomyosarcoma cells, these findings strongly suggest that acquisition of a double dosage of active IGF-II gene is an important step for the initiation or progression of rhabdomyosarcoma tumorigenesis.
7981680	1995	Hum. Mol. Genet.	0964-6906	ALL_TEXT_3/3	3	5	3481	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	igf ii	IGF-II	168#174	7981680-1-0-29	D012208	LONGTERM|DICTIONARY	rhabdomyosarcoma tumorigenesis	rhabdomyosarcoma tumorigenesis	238#268		Since IGF-II has been indicated as an autocrine growth factor for rhabdomyosarcoma cells, these findings strongly suggest that acquisition of a double dosage of active IGF-II gene is an important step for the initiation or progression of rhabdomyosarcoma tumorigenesis.
16318816	2007	Zhonghua Wai Ke Za Zhi	0529-5815	RESULTS	3	4	2944	SYMBOL|DICTIONARY	gstm1	GSTM1	55#60		D011471	SYMBOL|EXTRACTED	pc	PC	80#82	16318816-1-183-198	There was a significant difference in the frequency of GSTM1 [null] genotype in PC cases (57.8%) compared to healthy controls (41.7%) (chi(2) = 4.99, P = 0.025).
20857490	2011	Int. J. Cancer	1097-0215	TITLE	0	0	9149	SYMBOL|DICTIONARY	dyrk1b	dyrk1b	135#141		D010051	LONGTERM|DISEASE|DT|CLINE|CN|DICTIONARY	ovarian cancer	ovarian cancer	45#59		Transient arrest in a quiescent state allows ovarian cancer cells to survive suboptimal growth conditions and is mediated by both Mirk/dyrk1b and p130/RB2.
20857490	2011	Int. J. Cancer	1097-0215	TITLE	0	0	9149	SYMBOL|DICTIONARY	dyrk1b	dyrk1b	135#141		D006323	LONGTERM|DICTIONARY	transient arrest	Transient arrest	0#16		Transient arrest in a quiescent state allows ovarian cancer cells to survive suboptimal growth conditions and is mediated by both Mirk/dyrk1b and p130/RB2.
20857490	2011	Int. J. Cancer	1097-0215	TITLE	0	0	5934	LONGTERM|DICTIONARY	p130	p130	146#150	NaN	D010051	LONGTERM|DISEASE|DT|CLINE|CN|DICTIONARY	ovarian cancer	ovarian cancer	45#59		Transient arrest in a quiescent state allows ovarian cancer cells to survive suboptimal growth conditions and is mediated by both Mirk/dyrk1b and p130/RB2.
20857490	2011	Int. J. Cancer	1097-0215	TITLE	0	0	5934	LONGTERM|DICTIONARY	p130	p130	146#150	NaN	D006323	LONGTERM|DICTIONARY	transient arrest	Transient arrest	0#16		Transient arrest in a quiescent state allows ovarian cancer cells to survive suboptimal growth conditions and is mediated by both Mirk/dyrk1b and p130/RB2.
20857490	2011	Int. J. Cancer	1097-0215	TITLE	0	0	5934	LONGTERM|DICTIONARY	rb2	RB2	151#154	NaN	D010051	LONGTERM|DISEASE|DT|CLINE|CN|DICTIONARY	ovarian cancer	ovarian cancer	45#59		Transient arrest in a quiescent state allows ovarian cancer cells to survive suboptimal growth conditions and is mediated by both Mirk/dyrk1b and p130/RB2.
20857490	2011	Int. J. Cancer	1097-0215	TITLE	0	0	5934	LONGTERM|DICTIONARY	rb2	RB2	151#154	NaN	D006323	LONGTERM|DICTIONARY	transient arrest	Transient arrest	0#16		Transient arrest in a quiescent state allows ovarian cancer cells to survive suboptimal growth conditions and is mediated by both Mirk/dyrk1b and p130/RB2.
20857490	2011	Int. J. Cancer	1097-0215	ALL_TEXT_1/3	1	3	9149	SYMBOL|GENE|GN|DICTIONARY	mirk	Mirk	116#120		D010051	LONGTERM|DISEASE|DT|CLINE|CN|DICTIONARY	ovarian cancer	ovarian cancer	5#19		Some ovarian cancer cells were found in a G0 quiescent state, with the highest fraction in a line with an amplified Mirk gene.
19035720	2009	J. Neurosurg.	0022-3085	OBJECT	1	2	1278	SYMBOL|DICTIONARY	col1a2	COL1A2	115#121		D002532	SYMBOL|EXTRACTED|PLURAL	ias	IAs	153#156	19035720-1-72-94	In the present study, the authors investigated the correlation between the presence of the rs42524 polymorphism in COL1A2 and the occurrence of sporadic IAs in Chinese patients.
19035720	2009	J. Neurosurg.	0022-3085	METHODS	2	3	1278	SYMBOL|GENE|GN|DICTIONARY	col1a2	COL1A2	32#38		D002532	SYMBOL|EXTRACTED|PLURAL	ias	IAs	162#165	19035720-1-72-94	The polymorphism rs42524 of the COL1A2 gene was identified by polymerase chain reaction-based restriction analysis in genomic DNA from 226 patients with sporadic IAs (mean age 51.49 +/- 11.47 years) and 326 control participants (mean age 52.33 +/- 10.50 years).
19035720	2009	J. Neurosurg.	0022-3085	TITLE	0	0	1278	SYMBOL|DICTIONARY	col1a2	COL1A2	24#30		D002532	LONGTERM|DICTIONARY	intracranial aneurysms	intracranial aneurysms	44#66		Polymorphism rs42524 of COL1A2 and sporadic intracranial aneurysms in the Chinese population.
19035720	2009	J. Neurosurg.	0022-3085	OBJECT	1	1	1278	SYMBOL|GENE|GN|DICTIONARY	col1a2	COL1A2	4#10		D002532	LONGTERM|DICTIONARY	familial intracranial aneurysms	familial intracranial aneurysms	63#94		The COL1A2 gene at 7q22.1 has been shown to be associated with familial intracranial aneurysms (IAs) in the Japanese population.
19035720	2009	J. Neurosurg.	0022-3085	OBJECT	1	1	1278	SYMBOL|GENE|GN|DICTIONARY	col1a2	COL1A2	4#10		D002532	SYMBOL|EXTRACTED|PLURAL|()	ias	IAs	96#99	19035720-1-72-94	The COL1A2 gene at 7q22.1 has been shown to be associated with familial intracranial aneurysms (IAs) in the Japanese population.
19035720	2009	J. Neurosurg.	0022-3085	CONCLUSIONS	4	6	1278	SYMBOL|DICTIONARY	col1a2	COL1A2	28#34		D002532	SYMBOL|EXTRACTED|PLURAL	ias	IAs	79#82	19035720-1-72-94	The rs42524 polymorphism of COL1A2 could be a genetic risk factor for sporadic IAs among individuals of Chinese Han ethnicity.
19035720	2009	J. Neurosurg.	0022-3085	CONCLUSIONS	4	7	1278	SYMBOL|DICTIONARY	col1a2	COL1A2	59#65		D002532	SYMBOL|EXTRACTED|PLURAL	ias	IAs	70#73	19035720-1-72-94	This study is the first to confirm the association between COL1A2 and IAs.
20207535	2010	Eur. J. Cancer	1879-0852	TITLE	0	0	2944	SYMBOL|DICTIONARY	gstm1	GSTM1	0#5		D015179	LONGTERM|DISEASE|DT|DICTIONARY	colorectal cancer	colorectal cancer	31#48		GSTM1, GSTT1, GSTP1, GSTA1 and colorectal cancer risk: a comprehensive meta-analysis.
20207535	2010	Eur. J. Cancer	1879-0852	TITLE	0	0	2952	SYMBOL|DICTIONARY	gstt1	GSTT1	7#12		D015179	LONGTERM|DISEASE|DT|DICTIONARY	colorectal cancer	colorectal cancer	31#48		GSTM1, GSTT1, GSTP1, GSTA1 and colorectal cancer risk: a comprehensive meta-analysis.
20207535	2010	Eur. J. Cancer	1879-0852	TITLE	0	0	2950	SYMBOL|DICTIONARY	gstp1	GSTP1	14#19		D015179	LONGTERM|DISEASE|DT|DICTIONARY	colorectal cancer	colorectal cancer	31#48		GSTM1, GSTT1, GSTP1, GSTA1 and colorectal cancer risk: a comprehensive meta-analysis.
20207535	2010	Eur. J. Cancer	1879-0852	TITLE	0	0	2938	SYMBOL|DICTIONARY	gsta1	GSTA1	21#26		D015179	LONGTERM|DISEASE|DT|DICTIONARY	colorectal cancer	colorectal cancer	31#48		GSTM1, GSTT1, GSTP1, GSTA1 and colorectal cancer risk: a comprehensive meta-analysis.
17199794	2007	Nephrology (Carlton)	1320-5358	RESULTS	3	6	1636	SYMBOL|DICTIONARY|EXTRACTED	ace	ACE	4#7	17199794-1-51-82	C535761	SYMBOL|DICTIONARY|EXTRACTED	ins	INS	106#109	17199794-1-126-155	The ACE genotype was I/I, I/D and D/D in two, 12 and eight patients, respectively, with steroid-sensitive INS, and in one, eight and one patient, respectively, with steroid resistance.
20207535	2010	Eur. J. Cancer	1879-0852	ALL_TEXT_1/3	1	2	2944	SYMBOL|DICTIONARY	gstm1	GSTM1	52#57		D015179	LONGTERM|DISEASE|DT|DICTIONARY	colorectal cancer	colorectal cancer	170#187		Controversy exists about whether GST polymorphisms (GSTM1 null/present genotype, GSTT1 null/present genotype, GSTP1 Ile105Val and GSTA1 *A/*B) represent risk factors for colorectal cancer.
20207535	2010	Eur. J. Cancer	1879-0852	ALL_TEXT_1/3	1	2	2952	SYMBOL|DICTIONARY	gstt1	GSTT1	81#86		D015179	LONGTERM|DISEASE|DT|DICTIONARY	colorectal cancer	colorectal cancer	170#187		Controversy exists about whether GST polymorphisms (GSTM1 null/present genotype, GSTT1 null/present genotype, GSTP1 Ile105Val and GSTA1 *A/*B) represent risk factors for colorectal cancer.
20207535	2010	Eur. J. Cancer	1879-0852	ALL_TEXT_1/3	1	2	2950	SYMBOL|DICTIONARY	gstp1	GSTP1	110#115		D015179	LONGTERM|DISEASE|DT|DICTIONARY	colorectal cancer	colorectal cancer	170#187		Controversy exists about whether GST polymorphisms (GSTM1 null/present genotype, GSTT1 null/present genotype, GSTP1 Ile105Val and GSTA1 *A/*B) represent risk factors for colorectal cancer.
20207535	2010	Eur. J. Cancer	1879-0852	ALL_TEXT_1/3	1	2	2938	SYMBOL|DICTIONARY	gsta1	GSTA1	130#135		D015179	LONGTERM|DISEASE|DT|DICTIONARY	colorectal cancer	colorectal cancer	170#187		Controversy exists about whether GST polymorphisms (GSTM1 null/present genotype, GSTT1 null/present genotype, GSTP1 Ile105Val and GSTA1 *A/*B) represent risk factors for colorectal cancer.
17199794	2007	Nephrology (Carlton)	1320-5358	TITLE	0	0	1636	LONGTERM|GENE|GN|GT|DICTIONARY	angiotensin converting enzyme	Angiotensin converting enzyme	0#29		C535761	LONGTERM|DISEASE|DT|DICTIONARY	idiopathic nephrotic syndrome	idiopathic nephrotic syndrome	78#107		Angiotensin converting enzyme gene polymorphisms do not predict the course of idiopathic nephrotic syndrome in Swiss children.
17199794	2007	Nephrology (Carlton)	1320-5358	AIM	1	1	1636	LONGTERM|GENE|GT|DICTIONARY|GA	angiotensin i converting enzyme	angiotensin I converting enzyme	51#82		C535761	LONGTERM|DISEASE|DT|DICTIONARY	idiopathic nephrotic syndrome	idiopathic nephrotic syndrome	126#155		Contradictory reports exist about a correlation of angiotensin I converting enzyme (ACE) gene polymorphisms to the outcome of idiopathic nephrotic syndrome (INS) in children.
17199794	2007	Nephrology (Carlton)	1320-5358	AIM	1	1	1636	LONGTERM|GENE|GT|DICTIONARY|GA	angiotensin i converting enzyme	angiotensin I converting enzyme	51#82		C535761	SYMBOL|()|DICTIONARY|EXTRACTED	ins	INS	157#160	17199794-1-126-155	Contradictory reports exist about a correlation of angiotensin I converting enzyme (ACE) gene polymorphisms to the outcome of idiopathic nephrotic syndrome (INS) in children.
17199794	2007	Nephrology (Carlton)	1320-5358	AIM	1	1	1636	SYMBOL|()|GENE|GN|DICTIONARY|EXTRACTED	ace	ACE	84#87	17199794-1-51-82	C535761	LONGTERM|DISEASE|DT|DICTIONARY	idiopathic nephrotic syndrome	idiopathic nephrotic syndrome	126#155		Contradictory reports exist about a correlation of angiotensin I converting enzyme (ACE) gene polymorphisms to the outcome of idiopathic nephrotic syndrome (INS) in children.
17199794	2007	Nephrology (Carlton)	1320-5358	AIM	1	1	1636	SYMBOL|()|GENE|GN|DICTIONARY|EXTRACTED	ace	ACE	84#87	17199794-1-51-82	C535761	SYMBOL|()|DICTIONARY|EXTRACTED	ins	INS	157#160	17199794-1-126-155	Contradictory reports exist about a correlation of angiotensin I converting enzyme (ACE) gene polymorphisms to the outcome of idiopathic nephrotic syndrome (INS) in children.
17199794	2007	Nephrology (Carlton)	1320-5358	AIM	1	2	1636	SYMBOL|DICTIONARY|EXTRACTED	ace	ACE	33#36	17199794-1-51-82	C535761	SYMBOL|DICTIONARY|EXTRACTED	ins	INS	94#97	17199794-1-126-155	We investigated the frequency of ACE polymorphisms and their impact on the clinical course of INS in children in a Swiss hospital.
17199794	2007	Nephrology (Carlton)	1320-5358	METHODS	2	3	1636	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	ace	ACE	4#7	17199794-1-51-82	C535761	SYMBOL|DICTIONARY|EXTRACTED	ins	INS	110#113	17199794-1-126-155	The ACE gene polymorphism (I, insertion; D, deletion) was assessed in 32 children - 22 with steroid-sensitive INS and 10 with steroid-resistant INS - with a median age at onset of INS of 2.9 years (range 1.1-15.0).
17199794	2007	Nephrology (Carlton)	1320-5358	METHODS	2	3	1636	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	ace	ACE	4#7	17199794-1-51-82	C535761	SYMBOL|DICTIONARY|EXTRACTED	ins	INS	144#147	17199794-1-126-155	The ACE gene polymorphism (I, insertion; D, deletion) was assessed in 32 children - 22 with steroid-sensitive INS and 10 with steroid-resistant INS - with a median age at onset of INS of 2.9 years (range 1.1-15.0).
17199794	2007	Nephrology (Carlton)	1320-5358	METHODS	2	3	1636	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	ace	ACE	4#7	17199794-1-51-82	C535761	SYMBOL|DICTIONARY|EXTRACTED	ins	INS	180#183	17199794-1-126-155	The ACE gene polymorphism (I, insertion; D, deletion) was assessed in 32 children - 22 with steroid-sensitive INS and 10 with steroid-resistant INS - with a median age at onset of INS of 2.9 years (range 1.1-15.0).
10094550	1999	Hum. Mutat.	1059-7794	ALL_TEXT_1/3	1	1	6103	SYMBOL|GENE|GN|DICTIONARY	rpgr	RPGR	27#31		C564481	LONGTERM|DICTIONARY	x linked retinitis pigmentosa	X-linked retinitis pigmentosa	75#104		We have identified a novel RPGR gene mutation in a large Dutch family with X-linked retinitis pigmentosa (RP3).
10094550	1999	Hum. Mutat.	1059-7794	TITLE	0	0	6103	SYMBOL|GENE|GN|DICTIONARY	rpgr	RPGR	51#55		C564481	LONGTERM|DICTIONARY	x linked retinitis pigmentosa	X-linked retinitis pigmentosa	78#107		Identification of a 5' splice site mutation in the RPGR gene in a family with X-linked retinitis pigmentosa (RP3).
17199794	2007	Nephrology (Carlton)	1320-5358	RESULTS	3	9	1636	SYMBOL|DICTIONARY|EXTRACTED	ace	ACE	0#3		D009402	LONGTERM|DICTIONARY	minimal change glomerulopathy	minimal change glomerulopathy	84#113		ACE genotype was I/I, I/D and D/D in none, 12 and five patients, respectively, with minimal change glomerulopathy, and in one, five and two patients, respectively, with focal segmental glomerulosclerosis.
17199794	2007	Nephrology (Carlton)	1320-5358	RESULTS	3	9	1636	SYMBOL|DICTIONARY|EXTRACTED	ace	ACE	0#3		D005923	LONGTERM|DICTIONARY	focal segmental glomerulosclerosis	focal segmental glomerulosclerosis	169#203		ACE genotype was I/I, I/D and D/D in none, 12 and five patients, respectively, with minimal change glomerulopathy, and in one, five and two patients, respectively, with focal segmental glomerulosclerosis.
14697747	2004	Clin. Immunol.	1521-6616	TITLE	0	0	1234	LONGTERM|DICTIONARY	ccr5	CCR5	37#41		D010510	LONGTERM|DISEASE|DT|DICTIONARY	periodontal disease	periodontal disease	67#86		Prevalence of the chemokine receptor CCR5-Delta32 gene mutation in periodontal disease.
14697747	2004	Clin. Immunol.	1521-6616	ALL_TEXT_1/3	1	2	1234	SYMBOL|DICTIONARY	ccr5	CCR5	48#52		D010510	LONGTERM|DISEASE|DT|DICTIONARY	periodontal disease	periodontal disease	90#109		The present study compared the frequency of the CCR5-Delta32 mutation among subjects with periodontal disease and healthy control individuals.
14697747	2004	Clin. Immunol.	1521-6616	ALL_TEXT_1/3	1	3	1234	SYMBOL|DICTIONARY	ccr5	CCR5	22#26		D010518	LONGTERM|DICTIONARY	periodontitis	periodontitis	91#104		The prevalence of the CCR5-Delta32 mutation was determined in 81 patients with generalized periodontitis and 121 healthy controls.
16000320	2005	Hum. Mol. Genet.	0964-6906	ALL_TEXT_3/3	3	8	5795	SYMBOL|DICTIONARY|EXTRACTED	ptprj	PTPRJ	26#31	16000320-3-4-48	D001943	LONGTERM|DISEASE|DT|DICTIONARY	breast cancer	breast cancer	85#98		Thus, carrying a specific PTPRJ haplotype confers a protective effect on the risk of breast cancer.
14697747	2004	Clin. Immunol.	1521-6616	ALL_TEXT_3/3	3	7	1234	SYMBOL|DICTIONARY	ccr5	CCR5	21#25		D010518	LONGTERM|DISEASE|DN|DICTIONARY	periodontitis	periodontitis	63#76		The frequency of the CCR5-Delta32 allele was 9.9% (16/162) for periodontitis patients and 10.7% (26/216) for the healthy controls.
16000320	2005	Hum. Mol. Genet.	0964-6906	ALL_TEXT_2/3	2	5	5795	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	ptprj	PTPRJ	74#79	16000320-3-4-48	D001943	LONGTERM|DISEASE|DT|DICTIONARY	breast cancer	breast cancer	110#123		The purpose of this study was to determine whether common variants in the PTPRJ gene represent low penetrance breast cancer susceptibility alleles.
16000320	2005	Hum. Mol. Genet.	0964-6906	ALL_TEXT_2/3	2	4	5795	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	ptprj	PTPRJ	17#22	16000320-3-4-48	D009369	LONGTERM|DISEASE|DT|GFAM|FN|DICTIONARY	cancer	cancer	86#92		In addition, the PTPRJ gene has been shown to be somatically altered in several human cancer types such as colon, lung and breast cancers and to have the characteristics of a tumour-suppressor gene.
16000320	2005	Hum. Mol. Genet.	0964-6906	ALL_TEXT_2/3	2	4	5795	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	ptprj	PTPRJ	17#22	16000320-3-4-48	D001943	LONGTERM|DICTIONARY	colon, lung and breast cancers	colon, lung and breast cancers	107#137		In addition, the PTPRJ gene has been shown to be somatically altered in several human cancer types such as colon, lung and breast cancers and to have the characteristics of a tumour-suppressor gene.
16000320	2005	Hum. Mol. Genet.	0964-6906	TITLE	0	0	5795	LONGTERM|DICTIONARY	ptprj	Ptprj	65#70	NaN	D001943	LONGTERM|DISEASE|DT|DICTIONARY	breast cancer	breast cancer	76#89		Allelic association of the human homologue of the mouse modifier Ptprj with breast cancer.
16000320	2005	Hum. Mol. Genet.	0964-6906	ALL_TEXT_1/3	1	3	5795	LONGTERM|DICTIONARY	protein tyrosine phosphatase receptor type j	protein tyrosine phosphatase receptor type J	4#48		D003110	LONGTERM|DISEASE|DT|NUMBER|DICTIONARY	colon cancer-1	colon cancer-1	157#171		The protein tyrosine phosphatase receptor type J (PTPRJ) has been recently identified as being the protein encoded by the Scc1 mouse gene (susceptibility to colon cancer-1).
16000320	2005	Hum. Mol. Genet.	0964-6906	ALL_TEXT_1/3	1	3	5795	SYMBOL|()|DICTIONARY|EXTRACTED	ptprj	PTPRJ	50#55	16000320-3-4-48	D003110	LONGTERM|DISEASE|DT|NUMBER|DICTIONARY	colon cancer-1	colon cancer-1	157#171		The protein tyrosine phosphatase receptor type J (PTPRJ) has been recently identified as being the protein encoded by the Scc1 mouse gene (susceptibility to colon cancer-1).
16000320	2005	Hum. Mol. Genet.	0964-6906	ALL_TEXT_1/3	1	3	5795	SYMBOL|DICTIONARY	scc1	Scc1	122#126		D003110	LONGTERM|DISEASE|DT|NUMBER|DICTIONARY	colon cancer-1	colon cancer-1	157#171		The protein tyrosine phosphatase receptor type J (PTPRJ) has been recently identified as being the protein encoded by the Scc1 mouse gene (susceptibility to colon cancer-1).
16230779	2006	Endocrine	1355-008X	ALL_TEXT_2/3	2	6	5979	SYMBOL|DICTIONARY	ret	RET	213#216		D006965	LONGTERM|DICTIONARY	hyperplasia	hyperplasia	89#100		"To test the contributory role of the above polymorphisms for the development of ""C""-cell hyperplasia, we studied a group of 10 individuals selected for having a positive pentagastrin test despite the absence of a RET germline mutation."
12627470	2003	Am. J. Med. Genet. B Neuropsychiatr. Genet.	1552-4841	ALL_TEXT_3/3	3	5	2099	LONGTERM|DICTIONARY	eralpha	ERalpha	89#96	NaN	D001714	LONGTERM|DISEASE|DT|DICTIONARY	bipolar disorder	bipolar disorder	135#151		We found no evidence in our case control sample to support the involvement of any of the ERalpha variations in either the aetiology of bipolar disorder or puerperal triggering of bipolar episodes.
15912506	2005	Ann. Neurol.	0364-5134	ALL_TEXT_1/3	1	3	5133	SYMBOL|GENE|GN|DICTIONARY	pd 1	PD-1	54#58		D001327	LONGTERM|DICTIONARY	autoimmunity	autoimmunity	114#126		Recently, an intronic 7146G/A polymorphism within the PD-1 gene was described and suggested to be associated with autoimmunity.
15893594	2005	Brain Res. Mol. Brain Res.	0169-328X	ALL_TEXT_3/3	3	5	4524	SYMBOL|DICTIONARY	mthfr	MTHFR	55#60		D008881	LONGTERM|DICTIONARY	migraine	migraine	163#171		Multivariate analysis, including genotype data for the MTHFR C677T, provided evidence that the MTHFR (TT) and ACE (ID/DD) genotypes act in combination to increase migraine susceptibility (OR = 2.18, 95% CI: 1.15-4.16, P = 0.018).
15893594	2005	Brain Res. Mol. Brain Res.	0169-328X	ALL_TEXT_3/3	3	5	4524	SYMBOL|DICTIONARY	mthfr	MTHFR	55#60		C536170	LONGTERM|DICTIONARY	dd	DD	118#120	NaN	Multivariate analysis, including genotype data for the MTHFR C677T, provided evidence that the MTHFR (TT) and ACE (ID/DD) genotypes act in combination to increase migraine susceptibility (OR = 2.18, 95% CI: 1.15-4.16, P = 0.018).
15893594	2005	Brain Res. Mol. Brain Res.	0169-328X	ALL_TEXT_3/3	3	5	4524	SYMBOL|DICTIONARY	mthfr	MTHFR	95#100		D008881	LONGTERM|DICTIONARY	migraine	migraine	163#171		Multivariate analysis, including genotype data for the MTHFR C677T, provided evidence that the MTHFR (TT) and ACE (ID/DD) genotypes act in combination to increase migraine susceptibility (OR = 2.18, 95% CI: 1.15-4.16, P = 0.018).
15893594	2005	Brain Res. Mol. Brain Res.	0169-328X	ALL_TEXT_3/3	3	5	4524	SYMBOL|DICTIONARY	mthfr	MTHFR	95#100		C536170	LONGTERM|DICTIONARY	dd	DD	118#120	NaN	Multivariate analysis, including genotype data for the MTHFR C677T, provided evidence that the MTHFR (TT) and ACE (ID/DD) genotypes act in combination to increase migraine susceptibility (OR = 2.18, 95% CI: 1.15-4.16, P = 0.018).
15893594	2005	Brain Res. Mol. Brain Res.	0169-328X	ALL_TEXT_3/3	3	7	4524	SYMBOL|GENE|GN|DICTIONARY	mthfr	MTHFR	160#165		D008881	LONGTERM|DICTIONARY	migraine	migraine	67#75		In Caucasians, the ACE D allele confers a weak independent risk to migraine susceptibility and also appears to act in combination with the C677T variant in the MTHFR gene to confer a stronger influence on the disease.
15893594	2005	Brain Res. Mol. Brain Res.	0169-328X	TITLE	0	0	1636	LONGTERM|GENE|GT|DICTIONARY	angiotensin converting enzyme	angiotensin converting enzyme	20#49		D008881	LONGTERM|DICTIONARY	migraine	migraine	125#133		Genetic variants of angiotensin converting enzyme and methylenetetrahydrofolate reductase may act in combination to increase migraine susceptibility.
15893594	2005	Brain Res. Mol. Brain Res.	0169-328X	TITLE	0	0	4524	LONGTERM|DICTIONARY	methylenetetrahydrofolate reductase	methylenetetrahydrofolate reductase	54#89		D008881	LONGTERM|DICTIONARY	migraine	migraine	125#133		Genetic variants of angiotensin converting enzyme and methylenetetrahydrofolate reductase may act in combination to increase migraine susceptibility.
15893594	2005	Brain Res. Mol. Brain Res.	0169-328X	ALL_TEXT_1/3	1	2	4524	SYMBOL|DICTIONARY	mthfr	MTHFR	181#186		D008881	LONGTERM|DICTIONARY	migraine	migraine	86#94		This study was conducted to determine whether the ACE I/D gene variant is involved in migraine risk and whether this variant might act in combination with the previously implicated MTHFR C677T genetic variant in 270 migraine cases and 270 matched controls.
15893594	2005	Brain Res. Mol. Brain Res.	0169-328X	ALL_TEXT_1/3	1	2	4524	SYMBOL|DICTIONARY	mthfr	MTHFR	181#186		D008881	LONGTERM|DICTIONARY	migraine	migraine	216#224		This study was conducted to determine whether the ACE I/D gene variant is involved in migraine risk and whether this variant might act in combination with the previously implicated MTHFR C677T genetic variant in 270 migraine cases and 270 matched controls.
20135361	2010	In Vitro Cell. Dev. Biol. Anim.	1543-706X	TITLE	0	0	1029	SYMBOL|DICTIONARY	p16	p16	15#18		D000230	LONGTERM|CLINE|CN|DICTIONARY	adenocarcinoma	adenocarcinoma	97#111		Implication of p16 inactivation in tumorigenic activity of respiratory epithelial cell lines and adenocarcinoma cell line established from plutonium-induced lung tumor in rat.
20135361	2010	In Vitro Cell. Dev. Biol. Anim.	1543-706X	TITLE	0	0	1029	SYMBOL|DICTIONARY	p16	p16	15#18		D008175	LONGTERM|DISEASE|DT|DICTIONARY	lung tumor	lung tumor	157#167		Implication of p16 inactivation in tumorigenic activity of respiratory epithelial cell lines and adenocarcinoma cell line established from plutonium-induced lung tumor in rat.
11331106	2001	Alcohol	0741-8329	ALL_TEXT_2/3	2	4	1571	SYMBOL|GENE|GN|DICTIONARY	cyp2e1	CYP2E1	149#155		D019512	LONGTERM|DICTIONARY	alcoholic pancreatitis	alcoholic pancreatitis	181#203		The aim of this study was to investigate if this and other polymorphisms, at position -1019 [C(-1019)T], 4808 [G(4808)A], and 7668 [T(7668)A] of the CYP2E1 gene are associated with alcoholic pancreatitis.
11331106	2001	Alcohol	0741-8329	TITLE	0	0	1571	SYMBOL|GENE|GN|DICTIONARY	cyp2e1	CYP2E1	30#36		D019512	LONGTERM|DICTIONARY	alcoholic pancreatitis	alcoholic pancreatitis	59#81		Study of polymorphisms in the CYP2E1 gene in patients with alcoholic pancreatitis.
20135361	2010	In Vitro Cell. Dev. Biol. Anim.	1543-706X	ALL_TEXT_3/3	3	9	1029	SYMBOL|GENE|GN|DICTIONARY	p16	p16	52#55		D002471	LONGTERM|DICTIONARY	tumorigenicity	tumorigenicity	136#150	NaN	These results indicate that hypermethylation of the p16 promoter region occurs early in neoplastic transformation before acquisition of tumorigenicity in rat respiratory epithelium.
11331106	2001	Alcohol	0741-8329	ALL_TEXT_3/3	3	8	1571	SYMBOL|GENE|GN|DICTIONARY	cyp2e1	CYP2E1	86#92		D019512	LONGTERM|DICTIONARY	alcoholic pancreatitis	alcoholic pancreatitis	168#190		Therefore, our study results suggest to us that the polymorphisms investigated in the CYP2E1 gene are unlikely to be involved in the susceptibility and pathogenesis of alcoholic pancreatitis.
12140789	2003	Mol. Psychiatry	1359-4184	TITLE	0	0	4160	LONGTERM|GENE|GN|GT|DICTIONARY	melanocortin 4 receptor	melanocortin-4 receptor	79#102		D009765	LONGTERM|DICTIONARY	obesity	obesity	26#33		Genetic predisposition to obesity in bulimia nervosa: a mutation screen of the melanocortin-4 receptor gene.
12140789	2003	Mol. Psychiatry	1359-4184	TITLE	0	0	4160	LONGTERM|GENE|GN|GT|DICTIONARY	melanocortin 4 receptor	melanocortin-4 receptor	79#102		D052018	LONGTERM|DICTIONARY	bulimia nervosa	bulimia nervosa	37#52		Genetic predisposition to obesity in bulimia nervosa: a mutation screen of the melanocortin-4 receptor gene.
12140789	2003	Mol. Psychiatry	1359-4184	ALL_TEXT_2/3	2	3	4160	LONGTERM|GENE|GN|GT|DICTIONARY	melanocortin 4 receptor	melanocortin-4 receptor	56#79		D052018	SYMBOL|EXTRACTED	bn	BN	184#186	12140789-1-68-83	In order to investigate this hypothesis we screened the melanocortin-4 receptor gene (MC4R) for mutations using single strand conformation analysis in 81 female inpatients treated for BN.
12140789	2003	Mol. Psychiatry	1359-4184	ALL_TEXT_2/3	2	3	4160	SYMBOL|()|DICTIONARY|EXTRACTED	mc4r	MC4R	86#90	12140789-3-56-79	D052018	SYMBOL|EXTRACTED	bn	BN	184#186	12140789-1-68-83	In order to investigate this hypothesis we screened the melanocortin-4 receptor gene (MC4R) for mutations using single strand conformation analysis in 81 female inpatients treated for BN.
19423162	2009	Leuk. Res.	1873-5835	ALL_TEXT_3/3	3	5	4193	SYMBOL|DICTIONARY	mdm2	MDM2	4#8		D015470	SYMBOL|DICTIONARY|EXTRACTED	aml	AML	62#65	19423162-4-141-163	The MDM2 SNP309G allele was associated with increased risk of AML.
12140789	2003	Mol. Psychiatry	1359-4184	ALL_TEXT_2/3	2	4	4160	SYMBOL|DICTIONARY|EXTRACTED	mc4r	MC4R	92#96	12140789-3-56-79	D009765	LONGTERM|DICTIONARY	obesity	obesity	35#42		A single patient with both extreme obesity and BN had a haplo-insufficiency mutation in the MC4R.
12140789	2003	Mol. Psychiatry	1359-4184	ALL_TEXT_2/3	2	4	4160	SYMBOL|DICTIONARY|EXTRACTED	mc4r	MC4R	92#96	12140789-3-56-79	D052018	SYMBOL|EXTRACTED	bn	BN	47#49	12140789-1-68-83	A single patient with both extreme obesity and BN had a haplo-insufficiency mutation in the MC4R.
18937791	2009	Tissue Antigens	1399-0039	TITLE	0	0	7422	LONGTERM|GENE|GN|GT|DICTIONARY	vascular endothelial growth factor	vascular endothelial growth factor	62#96		D011565	LONGTERM|DICTIONARY	psoriasis	psoriasis	119#128		Association of the CTG (-2578/-460/+405) haplotype within the vascular endothelial growth factor gene with early-onset psoriasis.
18937791	2009	Tissue Antigens	1399-0039	ALL_TEXT_1/3	1	1	7422	LONGTERM|GENE|GT|DICTIONARY	vascular endothelial growth factor	vascular endothelial growth factor	16#50		D011565	LONGTERM|DICTIONARY	psoriasis	psoriasis	159#168		Polymorphism of vascular endothelial growth factor (VEGF) influences the VEGF production and is subjected to genetic susceptibility of many diseases including psoriasis.
18937791	2009	Tissue Antigens	1399-0039	ALL_TEXT_1/3	1	1	7422	LONGTERM|GENE|GT|DICTIONARY	vascular endothelial growth factor	vascular endothelial growth factor	16#50		D004194	LONGTERM|DICTIONARY	many diseases	many diseases	135#148		Polymorphism of vascular endothelial growth factor (VEGF) influences the VEGF production and is subjected to genetic susceptibility of many diseases including psoriasis.
18937791	2009	Tissue Antigens	1399-0039	ALL_TEXT_1/3	1	1	7422	SYMBOL|()|DICTIONARY|EXTRACTED	vegf	VEGF	52#56	18937791-1-16-50	D011565	LONGTERM|DICTIONARY	psoriasis	psoriasis	159#168		Polymorphism of vascular endothelial growth factor (VEGF) influences the VEGF production and is subjected to genetic susceptibility of many diseases including psoriasis.
18937791	2009	Tissue Antigens	1399-0039	ALL_TEXT_1/3	1	1	7422	SYMBOL|()|DICTIONARY|EXTRACTED	vegf	VEGF	52#56	18937791-1-16-50	D004194	LONGTERM|DICTIONARY	many diseases	many diseases	135#148		Polymorphism of vascular endothelial growth factor (VEGF) influences the VEGF production and is subjected to genetic susceptibility of many diseases including psoriasis.
18937791	2009	Tissue Antigens	1399-0039	ALL_TEXT_1/3	1	1	7422	SYMBOL|DICTIONARY|EXTRACTED	vegf	VEGF	73#77	18937791-1-16-50	D011565	LONGTERM|DICTIONARY	psoriasis	psoriasis	159#168		Polymorphism of vascular endothelial growth factor (VEGF) influences the VEGF production and is subjected to genetic susceptibility of many diseases including psoriasis.
18937791	2009	Tissue Antigens	1399-0039	ALL_TEXT_1/3	1	1	7422	SYMBOL|DICTIONARY|EXTRACTED	vegf	VEGF	73#77	18937791-1-16-50	D004194	LONGTERM|DICTIONARY	many diseases	many diseases	135#148		Polymorphism of vascular endothelial growth factor (VEGF) influences the VEGF production and is subjected to genetic susceptibility of many diseases including psoriasis.
19423162	2009	Leuk. Res.	1873-5835	ALL_TEXT_3/3	3	8	4193	SYMBOL|DICTIONARY	mdm2	MDM2	31#35		D015470	SYMBOL|DICTIONARY|EXTRACTED	aml	AML	128#131	19423162-4-141-163	These results suggest that the MDM2 SNP309 homozygous GG genotype may be a genetic susceptibility factor in the pathogenesis of AML.
19357349	2009	Carcinogenesis	1460-2180	TITLE	0	0	4092	SYMBOL|DICTIONARY	smad7	SMAD7	42#47		D003110	LONGTERM|DISEASE|DT|DICTIONARY	colon cancer	colon cancer	60#72		Association of common genetic variants in SMAD7 and risk of colon cancer.
21264219	2011	PLoS ONE	1932-6203	CONCLUSIONS/SIGNIFICANCE	3	10	205428	SYMBOL|DICTIONARY|EXTRACTED	dia1	DIA1	50#54	21264219-3-98-117	D008607	LONGTERM|DICTIONARY	mental retardation	mental retardation	259#277		Together, these results support a model where the DIA1 and DIA1R gene products regulate molecular traffic through the cellular secretory pathway or affect the function of secreted factors, and functional deficits cause disorders with ASD-like symptoms and/or mental retardation.
21264219	2011	PLoS ONE	1932-6203	CONCLUSIONS/SIGNIFICANCE	3	10	79742	SYMBOL|GENE|GN|DICTIONARY	dia1r	DIA1R	59#64		D008607	LONGTERM|DICTIONARY	mental retardation	mental retardation	259#277		Together, these results support a model where the DIA1 and DIA1R gene products regulate molecular traffic through the cellular secretory pathway or affect the function of secreted factors, and functional deficits cause disorders with ASD-like symptoms and/or mental retardation.
20842733	2011	Genes Chromosomes Cancer	1098-2264	ALL_TEXT_3/3	3	9	4524	SYMBOL|NUMBER|DICTIONARY	mthfr	MTHFR	272#277		D008175	LONGTERM|DISEASE|DN|DT|DICTIONARY	lung cancer	lung cancer	81#92		With regard to cytogenetic alterations, our results showed that lymphocytes from lung cancer patients exposed to the tobacco-specific carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone [NNK] had considerably increased frequency of cytogenetic damage in presence of MTHFR 677, MTHFR 1298, and SHMT allelic variants.
20842733	2011	Genes Chromosomes Cancer	1098-2264	ALL_TEXT_3/3	3	9	4524	SYMBOL|NUMBER|DICTIONARY	mthfr	MTHFR	283#288		D008175	LONGTERM|DISEASE|DN|DT|DICTIONARY	lung cancer	lung cancer	81#92		With regard to cytogenetic alterations, our results showed that lymphocytes from lung cancer patients exposed to the tobacco-specific carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone [NNK] had considerably increased frequency of cytogenetic damage in presence of MTHFR 677, MTHFR 1298, and SHMT allelic variants.
20842733	2011	Genes Chromosomes Cancer	1098-2264	ALL_TEXT_3/3	3	9	6470	SYMBOL|DICTIONARY	shmt	SHMT	299#303		D008175	LONGTERM|DISEASE|DN|DT|DICTIONARY	lung cancer	lung cancer	81#92		With regard to cytogenetic alterations, our results showed that lymphocytes from lung cancer patients exposed to the tobacco-specific carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone [NNK] had considerably increased frequency of cytogenetic damage in presence of MTHFR 677, MTHFR 1298, and SHMT allelic variants.
20196918	2010	Int. J. Neuropsychopharmacol.	1469-5111	ALL_TEXT_1/3	1	2	5020	SYMBOL|()|DICTIONARY|EXTRACTED	oxt	OXT	36#39	20196918-2-26-34	D012559	LONGTERM|DICTIONARY	schizophrenia	schizophrenia	46#59		Previous findings connect oxytocin (OXT) with schizophrenia and antipsychotic action.
10234503	1999	Eur. J. Hum. Genet.	1018-4813	ALL_TEXT_1/3	1	1	5080	SYMBOL|DICTIONARY	pax6	PAX6	44#48		D015783	LONGTERM|DICTIONARY	aniridia	aniridia	92#100		Mutations in the developmental control gene PAX6 have been shown to be the genetic cause of aniridia, which is a severe panocular eye disease characterised by iris hypoplasia.
10234503	1999	Eur. J. Hum. Genet.	1018-4813	ALL_TEXT_1/3	1	1	5080	SYMBOL|DICTIONARY	pax6	PAX6	44#48		D007499	LONGTERM|DICTIONARY	iris hypoplasia	iris hypoplasia	159#174		Mutations in the developmental control gene PAX6 have been shown to be the genetic cause of aniridia, which is a severe panocular eye disease characterised by iris hypoplasia.
10234503	1999	Eur. J. Hum. Genet.	1018-4813	ALL_TEXT_1/3	1	1	5080	SYMBOL|DICTIONARY	pax6	PAX6	44#48		D005128	LONGTERM|DISEASE|DT|DICTIONARY	panocular eye disease	panocular eye disease	120#141		Mutations in the developmental control gene PAX6 have been shown to be the genetic cause of aniridia, which is a severe panocular eye disease characterised by iris hypoplasia.
10234503	1999	Eur. J. Hum. Genet.	1018-4813	TITLE	0	0	5080	SYMBOL|NUMBER|DICTIONARY	pax6	PAX6	23#27		D015783	LONGTERM|DISEASE|DN|DICTIONARY	aniridia	aniridia	91#99		Mutational analysis of PAX6: 16 novel mutations including 5 missense mutations with a mild aniridia phenotype.
10234503	1999	Eur. J. Hum. Genet.	1018-4813	ALL_TEXT_1/3	1	3	5080	SYMBOL|DICTIONARY	pax6	PAX6	117#121		D015783	LONGTERM|DICTIONARY	aniridia	aniridia	155#163		Here we describe a mutational analysis of 27 Danish patients using a dideoxy fingerprinting method, which identified PAX6 mutations in 18 individuals with aniridia.
20709820	2011	Am. J. Respir. Crit. Care Med.	1535-4970	TITLE	0	0	636	SYMBOL|DICTIONARY	bicd1	BICD1	41#46		D004646	LONGTERM|DICTIONARY	emphysema	emphysema	76#85		Genome-wide association study identifies BICD1 as a susceptibility gene for emphysema.
9360549	1997	J. Clin. Endocrinol. Metab.	0021-972X	ALL_TEXT_2/3	2	4	190	SYMBOL|GENE|GN|DICTIONARY	dax 1	DAX-1	16#21		C536757	SYMBOL|DICTIONARY|EXTRACTED	x-linked ahc	X-linked AHC	68#80	9360549-1-100-137	We analyzed the DAX-1 gene from seven patients in six kindreds with X-linked AHC and identified one frameshift mutation, two missense mutations, and three deletion mutations.
9360549	1997	J. Clin. Endocrinol. Metab.	0021-972X	TITLE	0	0	190	SYMBOL|GENE|GN|DICTIONARY	dax 1	DAX-1	61#66		C536757	LONGTERM|DICTIONARY	x linked adrenal hypoplasia congenita	X-linked adrenal hypoplasia congenita	89#126		Three novel mutations and a de novo deletion mutation of the DAX-1 gene in patients with X-linked adrenal hypoplasia congenita.
9360549	1997	J. Clin. Endocrinol. Metab.	0021-972X	ALL_TEXT_1/3	1	1	190	SYMBOL|DICTIONARY	dax 1	DAX-1	4#9		C536757	SYMBOL|DICTIONARY|EXTRACTED	ahc	AHC	38#41	9360549-1-100-137	The DAX-1 [DSS (dosage sensitive sex)-AHC critical region on the X, gene 1] gene is responsible for X-linked adrenal hypoplasia congenita (AHC).
9360549	1997	J. Clin. Endocrinol. Metab.	0021-972X	ALL_TEXT_1/3	1	1	190	SYMBOL|DICTIONARY	dax 1	DAX-1	4#9		C536757	LONGTERM|DICTIONARY	x linked adrenal hypoplasia congenita	X-linked adrenal hypoplasia congenita	100#137		The DAX-1 [DSS (dosage sensitive sex)-AHC critical region on the X, gene 1] gene is responsible for X-linked adrenal hypoplasia congenita (AHC).
9360549	1997	J. Clin. Endocrinol. Metab.	0021-972X	ALL_TEXT_1/3	1	1	190	SYMBOL|DICTIONARY	dax 1	DAX-1	4#9		C536757	SYMBOL|()|DICTIONARY|EXTRACTED	ahc	AHC	139#142	9360549-1-100-137	The DAX-1 [DSS (dosage sensitive sex)-AHC critical region on the X, gene 1] gene is responsible for X-linked adrenal hypoplasia congenita (AHC).
19458483	2010	Cancer Biol. Ther.	1555-8576	TITLE	0	0	2073	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	ercc5	ERCC5	0#5		D015179	LONGTERM|DISEASE|DT|DICTIONARY	colorectal cancer	colorectal cancer	126#143		ERCC5 promoter polymorphisms at -763 and +25 predict the response to oxaliplatin-based chemotherapy in patients with advanced colorectal cancer.
19357349	2009	Carcinogenesis	1460-2180	ALL_TEXT_1/3	1	1	4092	SYMBOL|DICTIONARY	smad7	SMAD7	86#91		D015179	LONGTERM|DISEASE|DT|DICTIONARY	colorectal cancer	colorectal cancer	167#184		Two recent genome-wide association studies (GWAS) identified three common variants in SMAD7 (rs4464148, rs4939827 and rs12953717) that confer modest susceptibility to colorectal cancer.
20709820	2011	Am. J. Respir. Crit. Care Med.	1535-4970	MEASUREMENTS AND MAIN RESULTS	4	6	636	SYMBOL|DICTIONARY	bicd1	BICD1	65#70		D004646	LONGTERM|DICTIONARY	emphysema	emphysema	103#112		we identified association of a single-nucleotide polymorphism in BICD1 with the presence or absence of emphysema (P = 5.2  10(-7) with at least mild emphysema vs. control subjects; P = 4.8  10(-8) with moderate and more severe emphysema vs. control subjects).
20709820	2011	Am. J. Respir. Crit. Care Med.	1535-4970	MEASUREMENTS AND MAIN RESULTS	4	6	636	SYMBOL|DICTIONARY	bicd1	BICD1	65#70		D004646	LONGTERM|DICTIONARY	emphysema	emphysema	150#159		we identified association of a single-nucleotide polymorphism in BICD1 with the presence or absence of emphysema (P = 5.2  10(-7) with at least mild emphysema vs. control subjects; P = 4.8  10(-8) with moderate and more severe emphysema vs. control subjects).
20709820	2011	Am. J. Respir. Crit. Care Med.	1535-4970	MEASUREMENTS AND MAIN RESULTS	4	6	636	SYMBOL|DICTIONARY	bicd1	BICD1	65#70		D004646	LONGTERM|DICTIONARY	emphysema	emphysema	229#238		we identified association of a single-nucleotide polymorphism in BICD1 with the presence or absence of emphysema (P = 5.2  10(-7) with at least mild emphysema vs. control subjects; P = 4.8  10(-8) with moderate and more severe emphysema vs. control subjects).
16053028	2005	Sarcoidosis Vasc Diffuse Lung Dis	1124-0490	METHODS	2	2	3123	SYMBOL|DICTIONARY	drb 1	DRB 1	112#117		D012507	LONGTERM|DISEASE|DN|DICTIONARY	sarcoidosis	sarcoidosis	29#40		High resolution DQB 1 of 103 sarcoidosis patients was obtained by sequence-based typing; low resolution HLA-A/B/DRB 1 typing was performed by serological and molecular methods.
16053028	2005	Sarcoidosis Vasc Diffuse Lung Dis	1124-0490	METHODS	2	2	3105	SYMBOL|DICTIONARY	hla-a/b	HLA-A/B	104#111		D012507	LONGTERM|DISEASE|DN|DICTIONARY	sarcoidosis	sarcoidosis	29#40		High resolution DQB 1 of 103 sarcoidosis patients was obtained by sequence-based typing; low resolution HLA-A/B/DRB 1 typing was performed by serological and molecular methods.
16053028	2005	Sarcoidosis Vasc Diffuse Lung Dis	1124-0490	METHODS	2	2	3106	SYMBOL|DICTIONARY	hla-a/b	HLA-A/B	104#111		D012507	LONGTERM|DISEASE|DN|DICTIONARY	sarcoidosis	sarcoidosis	29#40		High resolution DQB 1 of 103 sarcoidosis patients was obtained by sequence-based typing; low resolution HLA-A/B/DRB 1 typing was performed by serological and molecular methods.
15675129	2005	Clin. Exp. Rheumatol.	0392-856X	RESULTS	3	5	3458	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	ifn gamma	IFN-gamma	66#75	15675129-2-112-128	D013700	SYMBOL|DICTIONARY|EXTRACTED	gca	GCA	102#105	15675129-1-61-81	No significant differences in the distribution of alleles for the IFN-gamma gene polymorphism between GCA and isolated PMR patients and controls were found.
15675129	2005	Clin. Exp. Rheumatol.	0392-856X	RESULTS	3	5	3458	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	ifn gamma	IFN-gamma	66#75	15675129-2-112-128	D011111	SYMBOL|DISEASE|DN|DICTIONARY|EXTRACTED	isolated pmr	isolated PMR	110#122	15675129-1-92-114	No significant differences in the distribution of alleles for the IFN-gamma gene polymorphism between GCA and isolated PMR patients and controls were found.
16053028	2005	Sarcoidosis Vasc Diffuse Lung Dis	1124-0490	TITLE	0	0	3119	SYMBOL|DICTIONARY	hla dqb1	HLA DQB1	15#23		D012507	LONGTERM|DISEASE|DN|DICTIONARY	sarcoidosis	sarcoidosis	32#43		Association of HLA DQB1 0602 in sarcoidosis patients with small fiber neuropathy.
16053028	2005	Sarcoidosis Vasc Diffuse Lung Dis	1124-0490	TITLE	0	0	3119	SYMBOL|DICTIONARY	hla dqb1	HLA DQB1	15#23		D009422	LONGTERM|DICTIONARY	neuropathy	neuropathy	70#80		Association of HLA DQB1 0602 in sarcoidosis patients with small fiber neuropathy.
15876692	2005	J. Appl. Genet.	1234-1983	ALL_TEXT_2/3	2	2	367	LONGTERM|GENE|GN|GT|DICTIONARY	androgen receptor	androgen receptor	46#63		D020966	SYMBOL|DICTIONARY|EXTRACTED	sbma	SBMA	0#4		SBMA is caused by CAG repeat expansion in the androgen receptor gene.
16507146	2006	Arthritis Res. Ther.	1478-6362	ALL_TEXT_3/3	3	11	3586	SYMBOL|DICTIONARY	il 10	IL-10	204#209		D008180	SYMBOL|DISEASE|DN|DICTIONARY|EXTRACTED	sle	SLE	27#30	16507146-1-103-131	In addition, evaluation of SLE patients administered antimalarial drugs for three or more years who did not require any other specific SLE treatment indicates that patients with the combined genotype low IL-10/high TNFalpha are the best responders to antimalarial therapy, developing mild disease with a good course under this treatment.
16507146	2006	Arthritis Res. Ther.	1478-6362	ALL_TEXT_3/3	3	11	3586	SYMBOL|DICTIONARY	il 10	IL-10	204#209		D008180	SYMBOL|DISEASE|DN|DICTIONARY|EXTRACTED	sle	SLE	135#138	16507146-1-103-131	In addition, evaluation of SLE patients administered antimalarial drugs for three or more years who did not require any other specific SLE treatment indicates that patients with the combined genotype low IL-10/high TNFalpha are the best responders to antimalarial therapy, developing mild disease with a good course under this treatment.
16507146	2006	Arthritis Res. Ther.	1478-6362	ALL_TEXT_3/3	3	11	7124	LONGTERM|DICTIONARY	tnfalpha	TNFalpha	215#223	NaN	D008180	SYMBOL|DISEASE|DN|DICTIONARY|EXTRACTED	sle	SLE	27#30	16507146-1-103-131	In addition, evaluation of SLE patients administered antimalarial drugs for three or more years who did not require any other specific SLE treatment indicates that patients with the combined genotype low IL-10/high TNFalpha are the best responders to antimalarial therapy, developing mild disease with a good course under this treatment.
16507146	2006	Arthritis Res. Ther.	1478-6362	ALL_TEXT_3/3	3	11	7124	LONGTERM|DICTIONARY	tnfalpha	TNFalpha	215#223	NaN	D008180	SYMBOL|DISEASE|DN|DICTIONARY|EXTRACTED	sle	SLE	135#138	16507146-1-103-131	In addition, evaluation of SLE patients administered antimalarial drugs for three or more years who did not require any other specific SLE treatment indicates that patients with the combined genotype low IL-10/high TNFalpha are the best responders to antimalarial therapy, developing mild disease with a good course under this treatment.
16507146	2006	Arthritis Res. Ther.	1478-6362	ALL_TEXT_3/3	3	12	3586	SYMBOL|DICTIONARY	il 10	IL-10	141#146		D008180	SYMBOL|DISEASE|DN|DICTIONARY|EXTRACTED	sle	SLE	94#97	16507146-1-103-131	In conclusion, we proposed that an antimalarial-mediated downregulation of TNFalpha levels in SLE patients is influenced by polymorphisms at IL-10 and TNFalpha promoters.
16507146	2006	Arthritis Res. Ther.	1478-6362	ALL_TEXT_3/3	3	12	7124	LONGTERM|DICTIONARY	tnfalpha	TNFalpha	75#83	NaN	D008180	SYMBOL|DISEASE|DN|DICTIONARY|EXTRACTED	sle	SLE	94#97	16507146-1-103-131	In conclusion, we proposed that an antimalarial-mediated downregulation of TNFalpha levels in SLE patients is influenced by polymorphisms at IL-10 and TNFalpha promoters.
16507146	2006	Arthritis Res. Ther.	1478-6362	ALL_TEXT_3/3	3	12	7124	LONGTERM|DICTIONARY	tnfalpha	TNFalpha	151#159	NaN	D008180	SYMBOL|DISEASE|DN|DICTIONARY|EXTRACTED	sle	SLE	94#97	16507146-1-103-131	In conclusion, we proposed that an antimalarial-mediated downregulation of TNFalpha levels in SLE patients is influenced by polymorphisms at IL-10 and TNFalpha promoters.
17116328	2007	Placenta	0143-4004	RESULT	3	9	183	SYMBOL|DICTIONARY|EXTRACTED	agt	AGT	0#3		D000037	LONGTERM|DICTIONARY	placental abruption	placental abruption	31#50	NaN	AGT mutant allele frequency in placental abruption (0.637) was significantly higher than in the control group (0.377) (p<0.001).
20020061	2010	PLoS ONE	1932-6203	METHODOLOGY/PRINCIPAL FINDINGS	2	8	3845	SYMBOL|DICTIONARY	kras	KRAS	170#174		D009369	LONGTERM|DICTIONARY	primary tumors	primary tumors	141#155		To further evaluate this finding we analyzed 120 additional patients with unresectable metastatic colorectal cancer who previously had their primary tumors evaluated for KRAS mutational status for clinical purposes.
20020061	2010	PLoS ONE	1932-6203	METHODOLOGY/PRINCIPAL FINDINGS	2	8	3845	SYMBOL|DICTIONARY	kras	KRAS	170#174		D015179	LONGTERM|DISEASE|DT|DICTIONARY	colorectal cancer	colorectal cancer	98#115		To further evaluate this finding we analyzed 120 additional patients with unresectable metastatic colorectal cancer who previously had their primary tumors evaluated for KRAS mutational status for clinical purposes.
17116328	2007	Placenta	0143-4004	TITLE	0	0	183	LONGTERM|DICTIONARY	angiotensinogen	angiotensinogen	55#70		D000037	LONGTERM|DICTIONARY	placental abruption	Placental abruption	0#19	NaN	Placental abruption is more frequent in women with the angiotensinogen Thr235 mutation.
18281036	2009	Fertil. Steril.	1556-5653	ALL_TEXT	1	2	367	LONGTERM|GENE|GT|DICTIONARY	androgen receptor	androgen receptor	66#83		D016649	SYMBOL|DICTIONARY|EXTRACTED	pof	POF	155#158	18281036-1-113-138	The results suggest that short CAG repeats with a relatively high androgen receptor function may constitute a susceptibility factor for the development of POF.
17116328	2007	Placenta	0143-4004	OBJECTIVE	1	3	183	SYMBOL|DICTIONARY|EXTRACTED	agt	AGT	44#47	17116328-2-37-52	D000037	LONGTERM|DICTIONARY	placental abruption	placental abruption	86#105	NaN	This study was done to evaluate whether the AGT Thr235 mutation increases the risk of placental abruption.
17919375	2008	Zhonghua Yi Xue Za Zhi	0376-2491	OBJECTIVE	1	1	7172	LONGTERM|DICTIONARY	thiopurine methyltransferase	thiopurine methyltransferase	52#80		D012216	LONGTERM|DICTIONARY	rheumatic diseases	rheumatic diseases	136#154		To discuss the relationship between the genotype of thiopurine methyltransferase (TPMT) and azathioprine tolerance in the patients with rheumatic diseases.
17919375	2008	Zhonghua Yi Xue Za Zhi	0376-2491	OBJECTIVE	1	1	7172	SYMBOL|()|DICTIONARY|EXTRACTED	tpmt	TPMT	82#86	17919375-1-52-80	D012216	LONGTERM|DICTIONARY	rheumatic diseases	rheumatic diseases	136#154		To discuss the relationship between the genotype of thiopurine methyltransferase (TPMT) and azathioprine tolerance in the patients with rheumatic diseases.
20616199	2010	Am. J. Epidemiol.	1476-6256	ALL_TEXT_2/3	2	3	7916	SYMBOL|DICTIONARY	bat2	BAT2	18#22		D009765	LONGTERM|DICTIONARY	obesity	obesity	204#211		Two SNPs near the BAT2 and MC4R genes and 3 SNPs within the FTO, SEC16B, and SH2B1 genes were significantly associated with body mass index (weight (kg)/height (m)(2)), body weight, and the prevalence of obesity.
20616199	2010	Am. J. Epidemiol.	1476-6256	ALL_TEXT_2/3	2	3	4160	SYMBOL|GENE|GN|DICTIONARY	mc4r	MC4R	27#31		D009765	LONGTERM|DICTIONARY	obesity	obesity	204#211		Two SNPs near the BAT2 and MC4R genes and 3 SNPs within the FTO, SEC16B, and SH2B1 genes were significantly associated with body mass index (weight (kg)/height (m)(2)), body weight, and the prevalence of obesity.
20616199	2010	Am. J. Epidemiol.	1476-6256	ALL_TEXT_2/3	2	3	79068	SYMBOL|DICTIONARY	fto	FTO	60#63		D009765	LONGTERM|DICTIONARY	obesity	obesity	204#211		Two SNPs near the BAT2 and MC4R genes and 3 SNPs within the FTO, SEC16B, and SH2B1 genes were significantly associated with body mass index (weight (kg)/height (m)(2)), body weight, and the prevalence of obesity.
20616199	2010	Am. J. Epidemiol.	1476-6256	ALL_TEXT_2/3	2	3	89866	SYMBOL|DICTIONARY	sec16b	SEC16B	65#71		D009765	LONGTERM|DICTIONARY	obesity	obesity	204#211		Two SNPs near the BAT2 and MC4R genes and 3 SNPs within the FTO, SEC16B, and SH2B1 genes were significantly associated with body mass index (weight (kg)/height (m)(2)), body weight, and the prevalence of obesity.
20616199	2010	Am. J. Epidemiol.	1476-6256	ALL_TEXT_2/3	2	3	25970	SYMBOL|GENE|GN|DICTIONARY	sh2b1	SH2B1	77#82		D009765	LONGTERM|DICTIONARY	obesity	obesity	204#211		Two SNPs near the BAT2 and MC4R genes and 3 SNPs within the FTO, SEC16B, and SH2B1 genes were significantly associated with body mass index (weight (kg)/height (m)(2)), body weight, and the prevalence of obesity.
10213916	1999	Neuroimmunomodulation	1021-7401	ALL_TEXT_2/3	2	5	7349	LONGTERM|DICTIONARY	urocortin	urocortin	28#37		D007022	LONGTERM|DICTIONARY	hypotension	hypotension	189#200	NaN	However, since subcutaneous urocortin has been shown to reduce arterial blood pressure, we tested the hypothesis that its antiedema and antiextravasatory effects were secondary to arterial hypotension.
1894189	1991	Haemostasis	0301-0147	ALL_TEXT_1/3	1	1	2147	LONGTERM|DICTIONARY	thrombin	thrombin	217#225	NaN	D004211	LONGTERM|DICTIONARY	intravascular coagulation	intravascular coagulation	34#59		Various reactions of disseminated intravascular coagulation (DIC) were experimentally induced by infusion of thrombokinase in rats, by administration of endotoxin in rabbits and pigs and by infusion of adrenaline and thrombin in dogs.
15912506	2005	Ann. Neurol.	0364-5134	TITLE	0	0	5133	LONGTERM|DICTIONARY	pd-1	PD-1	2#6	NaN	D009103	LONGTERM|DICTIONARY	multiple sclerosis	multiple sclerosis	62#80		A PD-1 polymorphism is associated with disease progression in multiple sclerosis.
19549929	2009	Toxicol Pathol	1533-1601	ALL_TEXT_3/3	3	6	7137	LONGTERM|DICTIONARY	ctni	cTnI	73#77	NaN	D006331	LONGTERM|DICTIONARY	cardiac injury	cardiac injury	132#146	NaN	In drug development studies in BALB/c mice with novel kinase inhibitors, cTnI concentration was a reliable stand-alone biomarker of cardiac injury and was used in combination with measurements of in vivo target inhibition to demonstrate an off-target contribution to cardiotoxicity.
19549929	2009	Toxicol Pathol	1533-1601	ALL_TEXT_3/3	3	6	7137	LONGTERM|DICTIONARY	ctni	cTnI	73#77	NaN	D066126	LONGTERM|DICTIONARY	cardiotoxicity	cardiotoxicity	267#281	NaN	In drug development studies in BALB/c mice with novel kinase inhibitors, cTnI concentration was a reliable stand-alone biomarker of cardiac injury and was used in combination with measurements of in vivo target inhibition to demonstrate an off-target contribution to cardiotoxicity.
19624571	2009	Ann. Hum. Genet.	1469-1809	TITLE	0	0	9692	SYMBOL|DICTIONARY	kiaa0391	KIAA0391	28#36		D009203	LONGTERM|DICTIONARY	myocardial infarction	myocardial infarction	86#107		Haplotypes encompassing the KIAA0391 and PSMA6 gene cluster confer a genetic link for myocardial infarction and coronary artery disease.
19624571	2009	Ann. Hum. Genet.	1469-1809	TITLE	0	0	9692	SYMBOL|DICTIONARY	kiaa0391	KIAA0391	28#36		D003324	LONGTERM|DISEASE|DT|DICTIONARY	coronary artery disease	coronary artery disease	112#135		Haplotypes encompassing the KIAA0391 and PSMA6 gene cluster confer a genetic link for myocardial infarction and coronary artery disease.
19624571	2009	Ann. Hum. Genet.	1469-1809	TITLE	0	0	5687	SYMBOL|GENE|GN|DICTIONARY	psma6	PSMA6	41#46		D009203	LONGTERM|DICTIONARY	myocardial infarction	myocardial infarction	86#107		Haplotypes encompassing the KIAA0391 and PSMA6 gene cluster confer a genetic link for myocardial infarction and coronary artery disease.
19624571	2009	Ann. Hum. Genet.	1469-1809	TITLE	0	0	5687	SYMBOL|GENE|GN|DICTIONARY	psma6	PSMA6	41#46		D003324	LONGTERM|DISEASE|DT|DICTIONARY	coronary artery disease	coronary artery disease	112#135		Haplotypes encompassing the KIAA0391 and PSMA6 gene cluster confer a genetic link for myocardial infarction and coronary artery disease.
20020061	2010	PLoS ONE	1932-6203	METHODOLOGY/PRINCIPAL FINDINGS	2	10	3845	SYMBOL|DICTIONARY	kras	KRAS	53#57		D009369	LONGTERM|DICTIONARY	primary tumors	primary tumors	102#116		Taken together the group of 230 patients showed that KRAS was mutated significantly more often in the primary tumors of patients with lung metastases (57% vs 35%; P = 0.006).
20020061	2010	PLoS ONE	1932-6203	METHODOLOGY/PRINCIPAL FINDINGS	2	10	3845	SYMBOL|DICTIONARY	kras	KRAS	53#57		D009362	LONGTERM|DICTIONARY	metastases	metastases	139#149		Taken together the group of 230 patients showed that KRAS was mutated significantly more often in the primary tumors of patients with lung metastases (57% vs 35%; P = 0.006).
16189508	2006	Mol. Psychiatry	1359-4184	ALL_TEXT_1/3	1	1	3084	LONGTERM|DICTIONARY	neuregulin 1	Neuregulin 1	0#12		D012559	LONGTERM|DICTIONARY	schizophrenia	schizophrenia	68#81		Neuregulin 1 (NRG1) is one of the most exciting candidate genes for schizophrenia in recent years since its first association with the disease in an Icelandic population.
16189508	2006	Mol. Psychiatry	1359-4184	ALL_TEXT_1/3	1	1	3084	SYMBOL|()|DICTIONARY|EXTRACTED	nrg1	NRG1	14#18	16189508-1-0-12	D012559	LONGTERM|DICTIONARY	schizophrenia	schizophrenia	68#81		Neuregulin 1 (NRG1) is one of the most exciting candidate genes for schizophrenia in recent years since its first association with the disease in an Icelandic population.
15834927	2005	Hepatology	0270-9139	TITLE	0	0	4524	SYMBOL|DICTIONARY|EXTRACTED	mthfr	MTHFR	29#34		D020138	LONGTERM|DICTIONARY	hyperhomocysteinemia	Hyperhomocysteinemia	0#20		Hyperhomocysteinemia and the MTHFR C677T polymorphism promote steatosis and fibrosis in chronic hepatitis C patients.
15834927	2005	Hepatology	0270-9139	TITLE	0	0	4524	SYMBOL|DICTIONARY|EXTRACTED	mthfr	MTHFR	29#34		D005234	LONGTERM|DICTIONARY	steatosis	steatosis	62#71		Hyperhomocysteinemia and the MTHFR C677T polymorphism promote steatosis and fibrosis in chronic hepatitis C patients.
15834927	2005	Hepatology	0270-9139	TITLE	0	0	4524	SYMBOL|DICTIONARY|EXTRACTED	mthfr	MTHFR	29#34		D019698	LONGTERM|DISEASE|DN|DICTIONARY	chronic hepatitis c	chronic hepatitis C	88#107		Hyperhomocysteinemia and the MTHFR C677T polymorphism promote steatosis and fibrosis in chronic hepatitis C patients.
15834927	2005	Hepatology	0270-9139	TITLE	0	0	4524	SYMBOL|DICTIONARY|EXTRACTED	mthfr	MTHFR	29#34		D005355	LONGTERM|DICTIONARY	fibrosis	fibrosis	76#84	NaN	Hyperhomocysteinemia and the MTHFR C677T polymorphism promote steatosis and fibrosis in chronic hepatitis C patients.
15834927	2005	Hepatology	0270-9139	ALL_TEXT_1/3	1	2	4524	LONGTERM|DICTIONARY	methylenetetrahydrofolate reductase	methylenetetrahydrofolate reductase	47#82		D020138	LONGTERM|DICTIONARY	hyperhomocysteinemia	Hyperhomocysteinemia	0#20		Hyperhomocysteinemia causes steatosis, and the methylenetetrahydrofolate reductase (MTHFR) C677T polymorphism induces hyperhomocysteinemia.
15834927	2005	Hepatology	0270-9139	ALL_TEXT_1/3	1	2	4524	LONGTERM|DICTIONARY	methylenetetrahydrofolate reductase	methylenetetrahydrofolate reductase	47#82		D005234	LONGTERM|DICTIONARY	steatosis	steatosis	28#37		Hyperhomocysteinemia causes steatosis, and the methylenetetrahydrofolate reductase (MTHFR) C677T polymorphism induces hyperhomocysteinemia.
15834927	2005	Hepatology	0270-9139	ALL_TEXT_1/3	1	2	4524	LONGTERM|DICTIONARY	methylenetetrahydrofolate reductase	methylenetetrahydrofolate reductase	47#82		D020138	LONGTERM|DICTIONARY	hyperhomocysteinemia	hyperhomocysteinemia	118#138		Hyperhomocysteinemia causes steatosis, and the methylenetetrahydrofolate reductase (MTHFR) C677T polymorphism induces hyperhomocysteinemia.
15834927	2005	Hepatology	0270-9139	ALL_TEXT_1/3	1	2	4524	LONGTERM|DICTIONARY	methylenetetrahydrofolate reductase	methylenetetrahydrofolate reductase	47#82		C537357	LONGTERM|DICTIONARY	methylenetetrahydrofolate reductase	methylenetetrahydrofolate reductase	47#82	NaN	Hyperhomocysteinemia causes steatosis, and the methylenetetrahydrofolate reductase (MTHFR) C677T polymorphism induces hyperhomocysteinemia.
15834927	2005	Hepatology	0270-9139	ALL_TEXT_1/3	1	2	4524	SYMBOL|()|DICTIONARY|EXTRACTED	mthfr	MTHFR	84#89	15834927-2-47-82	D020138	LONGTERM|DICTIONARY	hyperhomocysteinemia	Hyperhomocysteinemia	0#20		Hyperhomocysteinemia causes steatosis, and the methylenetetrahydrofolate reductase (MTHFR) C677T polymorphism induces hyperhomocysteinemia.
15834927	2005	Hepatology	0270-9139	ALL_TEXT_1/3	1	2	4524	SYMBOL|()|DICTIONARY|EXTRACTED	mthfr	MTHFR	84#89	15834927-2-47-82	D005234	LONGTERM|DICTIONARY	steatosis	steatosis	28#37		Hyperhomocysteinemia causes steatosis, and the methylenetetrahydrofolate reductase (MTHFR) C677T polymorphism induces hyperhomocysteinemia.
15834927	2005	Hepatology	0270-9139	ALL_TEXT_1/3	1	2	4524	SYMBOL|()|DICTIONARY|EXTRACTED	mthfr	MTHFR	84#89	15834927-2-47-82	D020138	LONGTERM|DICTIONARY	hyperhomocysteinemia	hyperhomocysteinemia	118#138		Hyperhomocysteinemia causes steatosis, and the methylenetetrahydrofolate reductase (MTHFR) C677T polymorphism induces hyperhomocysteinemia.
15834927	2005	Hepatology	0270-9139	ALL_TEXT_1/3	1	2	4524	SYMBOL|()|DICTIONARY|EXTRACTED	mthfr	MTHFR	84#89	15834927-2-47-82	C537357	LONGTERM|DICTIONARY	methylenetetrahydrofolate reductase	methylenetetrahydrofolate reductase	47#82	NaN	Hyperhomocysteinemia causes steatosis, and the methylenetetrahydrofolate reductase (MTHFR) C677T polymorphism induces hyperhomocysteinemia.
15834927	2005	Hepatology	0270-9139	ALL_TEXT_1/3	1	4	4524	SYMBOL|DICTIONARY|EXTRACTED	mthfr	MTHFR	161#166	15834927-2-47-82	D019698	SYMBOL|DISEASE|DN|DICTIONARY|EXTRACTED	chc	CHC	20#23	15834927-3-112-131	One hundred sixteen CHC patients were evaluated for HAI, fibrosis and steatosis grades, body mass index, HCV genotypes, HCV RNA levels, homocysteinemia, and the MTHFR C677T polymorphism.
15834927	2005	Hepatology	0270-9139	ALL_TEXT_1/3	1	4	4524	SYMBOL|DICTIONARY|EXTRACTED	mthfr	MTHFR	161#166	15834927-2-47-82	D005234	LONGTERM|DICTIONARY	steatosis	steatosis	70#79		One hundred sixteen CHC patients were evaluated for HAI, fibrosis and steatosis grades, body mass index, HCV genotypes, HCV RNA levels, homocysteinemia, and the MTHFR C677T polymorphism.
15834927	2005	Hepatology	0270-9139	ALL_TEXT_1/3	1	4	4524	SYMBOL|DICTIONARY|EXTRACTED	mthfr	MTHFR	161#166	15834927-2-47-82	C566403	LONGTERM|DICTIONARY	homocysteinemia	homocysteinemia	136#151		One hundred sixteen CHC patients were evaluated for HAI, fibrosis and steatosis grades, body mass index, HCV genotypes, HCV RNA levels, homocysteinemia, and the MTHFR C677T polymorphism.
15834927	2005	Hepatology	0270-9139	ALL_TEXT_1/3	1	4	4524	SYMBOL|DICTIONARY|EXTRACTED	mthfr	MTHFR	161#166	15834927-2-47-82	D005355	LONGTERM|DICTIONARY	fibrosis	fibrosis	57#65	NaN	One hundred sixteen CHC patients were evaluated for HAI, fibrosis and steatosis grades, body mass index, HCV genotypes, HCV RNA levels, homocysteinemia, and the MTHFR C677T polymorphism.
15834927	2005	Hepatology	0270-9139	ALL_TEXT_2/3	2	5	4524	SYMBOL|DICTIONARY|EXTRACTED	mthfr	MTHFR	60#65	15834927-2-47-82	D020138	LONGTERM|DICTIONARY	hyperhomocysteinemia	Hyperhomocysteinemia	0#20		Hyperhomocysteinemia was associated with the TT genotype of MTHFR (r = 0.367; P = .001).
11179016	2001	Am. J. Hum. Genet.	0002-9297	ALL_TEXT_1/3	1	1	3119	SYMBOL|DICTIONARY	hla dqb1	HLA-DQB1	141#149		D009290	LONGTERM|DICTIONARY	narcolepsy cataplexy	narcolepsy-cataplexy	6#26		Human narcolepsy-cataplexy, a sleep disorder associated with a centrally mediated hypocretin (orexin) deficiency, is tightly associated with HLA-DQB1*0602.
11179016	2001	Am. J. Hum. Genet.	0002-9297	ALL_TEXT_1/3	1	1	3119	SYMBOL|DICTIONARY	hla dqb1	HLA-DQB1	141#149		D012893	LONGTERM|DISEASE|DT|DICTIONARY	sleep disorder	sleep disorder	30#44		Human narcolepsy-cataplexy, a sleep disorder associated with a centrally mediated hypocretin (orexin) deficiency, is tightly associated with HLA-DQB1*0602.
11179016	2001	Am. J. Hum. Genet.	0002-9297	ALL_TEXT_1/3	1	1	3119	SYMBOL|DICTIONARY	hla dqb1	HLA-DQB1	141#149		D003677	LONGTERM|DICTIONARY	hypocretin (orexin) deficiency	hypocretin (orexin) deficiency	82#112		Human narcolepsy-cataplexy, a sleep disorder associated with a centrally mediated hypocretin (orexin) deficiency, is tightly associated with HLA-DQB1*0602.
8909447	1996	Neurology	0028-3878	ALL_TEXT_1/3	1	1	5621	LONGTERM|GENE|GT|DICTIONARY|GA	prion protein	prion protein	50#63		D030342	LONGTERM|DISEASE|DT|DICTIONARY	inherited prion disease	inherited prion disease	122#145		Four point mutations and one insertion within the prion protein (PrP) gene have been tightly linked to the development of inherited prion disease.
8909447	1996	Neurology	0028-3878	ALL_TEXT_1/3	1	1	5621	SYMBOL|()|GENE|GN|DICTIONARY|EXTRACTED	prp	PrP	65#68	8909447-1-50-63	D030342	LONGTERM|DISEASE|DT|DICTIONARY	inherited prion disease	inherited prion disease	122#145		Four point mutations and one insertion within the prion protein (PrP) gene have been tightly linked to the development of inherited prion disease.
11179016	2001	Am. J. Hum. Genet.	0002-9297	ALL_TEXT_1/3	1	3	3123	SYMBOL|DICTIONARY	hla drb1	HLA-DRB1	143#151		D009290	LONGTERM|DICTIONARY	narcoleptic	narcoleptic	45#56	NaN	In this work, 1,087 control subjects and 420 narcoleptic subjects with cataplexy, from three ethnic groups, were HLA typed, and the effects of HLA-DRB1, -DQA1, and -DQB1 were analyzed.
11179016	2001	Am. J. Hum. Genet.	0002-9297	ALL_TEXT_1/3	1	3	3119	LONGTERM|DICTIONARY	dqb1	DQB1	165#169	NaN	D009290	LONGTERM|DICTIONARY	narcoleptic	narcoleptic	45#56	NaN	In this work, 1,087 control subjects and 420 narcoleptic subjects with cataplexy, from three ethnic groups, were HLA typed, and the effects of HLA-DRB1, -DQA1, and -DQB1 were analyzed.
15987458	2006	Breast Cancer Res.	1465-542X	RESULTS	3	7	597	LONGTERM|DICTIONARY	a1/a1	A1/A1	88#93	NaN	D001943	LONGTERM|DISEASE|DT|DICTIONARY	breast cancer	breast cancer	140#153		The only associations near statistical significance were that postmenopausal women with A1/A1 (wild-type) genotype had an increased risk of breast cancer if they had ever used hormone replacement therapy (OR 2.40, 95% CI 1.0 to 5.7; P = 0.05) and if they had menopause after age 47 years (OR 2.59, 95% CI 1.0 to 7.0; P = 0.06).
11939812	2002	Arch Dermatol	0003-987X	CONCLUSIONS	8	17	9119	SYMBOL|DICTIONARY	k6hf	K6hf	52#56		D058247	LONGTERM|DISEASE|DT|DICTIONARY	loose anagen hair syndrome	loose anagen hair syndrome	83#109		Another keratin, and possibly the type I partner of K6hf, could be responsible for loose anagen hair syndrome in other patients, or the gene involved may be a minor gene.
11179016	2001	Am. J. Hum. Genet.	0002-9297	ALL_TEXT_2/3	2	6	3119	LONGTERM|DICTIONARY	dqb1	DQB1	68#72	NaN	D009290	LONGTERM|DICTIONARY	narcolepsy	narcolepsy	19#29		Relative risks for narcolepsy were next calculated for heterozygous DQB1*0602/other HLA class II allelic combinations.
17904846	2008	Breast	0960-9776	TITLE	0	0	2099	SYMBOL|DICTIONARY	esr1	ESR1	75#79		D001943	LONGTERM|DISEASE|DT|DICTIONARY	breast cancer	breast cancer	143#156		Association of repeat polymorphisms in the estrogen receptors alpha, beta (ESR1, ESR2) and androgen receptor (AR) genes with the occurrence of breast cancer.
17904846	2008	Breast	0960-9776	TITLE	0	0	2100	SYMBOL|DICTIONARY	esr2	ESR2	81#85		D001943	LONGTERM|DISEASE|DT|DICTIONARY	breast cancer	breast cancer	143#156		Association of repeat polymorphisms in the estrogen receptors alpha, beta (ESR1, ESR2) and androgen receptor (AR) genes with the occurrence of breast cancer.
17904846	2008	Breast	0960-9776	TITLE	0	0	367	LONGTERM|GENE|GT|DICTIONARY|GA	androgen receptor	androgen receptor	91#108		D001943	LONGTERM|DISEASE|DT|DICTIONARY	breast cancer	breast cancer	143#156		Association of repeat polymorphisms in the estrogen receptors alpha, beta (ESR1, ESR2) and androgen receptor (AR) genes with the occurrence of breast cancer.
17904846	2008	Breast	0960-9776	TITLE	0	0	367	SYMBOL|EXTRACTED|()|GENE|GN	ar	AR	110#112	17904846-0-91-108	D001943	LONGTERM|DISEASE|DT|DICTIONARY	breast cancer	breast cancer	143#156		Association of repeat polymorphisms in the estrogen receptors alpha, beta (ESR1, ESR2) and androgen receptor (AR) genes with the occurrence of breast cancer.
17904846	2008	Breast	0960-9776	ALL_TEXT_1/3	1	2	2099	SYMBOL|DICTIONARY	esr1	ESR1	67#71		D001943	LONGTERM|DISEASE|DT|DICTIONARY	breast cancer	breast cancer	115#128		To determine the possible contribution of genetic variation in the ESR1 (ER-alpha), ESR2 (ER-beta) and AR genes in breast cancer risk the -1174(TA)(7-27), c. 1092+3607(CA)(10-26) and c. 172(CAG)(6-40) repeat variants were studied in a case-control study of 79 women with sporadic breast cancer and 155 controls.
17904846	2008	Breast	0960-9776	ALL_TEXT_1/3	1	2	2099	SYMBOL|DICTIONARY	esr1	ESR1	67#71		D001943	LONGTERM|DISEASE|DT|DICTIONARY	sporadic breast cancer	sporadic breast cancer	271#293		To determine the possible contribution of genetic variation in the ESR1 (ER-alpha), ESR2 (ER-beta) and AR genes in breast cancer risk the -1174(TA)(7-27), c. 1092+3607(CA)(10-26) and c. 172(CAG)(6-40) repeat variants were studied in a case-control study of 79 women with sporadic breast cancer and 155 controls.
17904846	2008	Breast	0960-9776	ALL_TEXT_1/3	1	2	2099	LONGTERM|()|DICTIONARY|EXTRACTED	er alpha	ER-alpha	73#81	17904846-2-67-71	D001943	LONGTERM|DISEASE|DT|DICTIONARY	breast cancer	breast cancer	115#128		To determine the possible contribution of genetic variation in the ESR1 (ER-alpha), ESR2 (ER-beta) and AR genes in breast cancer risk the -1174(TA)(7-27), c. 1092+3607(CA)(10-26) and c. 172(CAG)(6-40) repeat variants were studied in a case-control study of 79 women with sporadic breast cancer and 155 controls.
17904846	2008	Breast	0960-9776	ALL_TEXT_1/3	1	2	2099	LONGTERM|()|DICTIONARY|EXTRACTED	er alpha	ER-alpha	73#81	17904846-2-67-71	D001943	LONGTERM|DISEASE|DT|DICTIONARY	sporadic breast cancer	sporadic breast cancer	271#293		To determine the possible contribution of genetic variation in the ESR1 (ER-alpha), ESR2 (ER-beta) and AR genes in breast cancer risk the -1174(TA)(7-27), c. 1092+3607(CA)(10-26) and c. 172(CAG)(6-40) repeat variants were studied in a case-control study of 79 women with sporadic breast cancer and 155 controls.
17904846	2008	Breast	0960-9776	ALL_TEXT_1/3	1	2	2100	SYMBOL|DICTIONARY	esr2	ESR2	84#88		D001943	LONGTERM|DISEASE|DT|DICTIONARY	breast cancer	breast cancer	115#128		To determine the possible contribution of genetic variation in the ESR1 (ER-alpha), ESR2 (ER-beta) and AR genes in breast cancer risk the -1174(TA)(7-27), c. 1092+3607(CA)(10-26) and c. 172(CAG)(6-40) repeat variants were studied in a case-control study of 79 women with sporadic breast cancer and 155 controls.
17904846	2008	Breast	0960-9776	ALL_TEXT_1/3	1	2	2100	SYMBOL|DICTIONARY	esr2	ESR2	84#88		D001943	LONGTERM|DISEASE|DT|DICTIONARY	sporadic breast cancer	sporadic breast cancer	271#293		To determine the possible contribution of genetic variation in the ESR1 (ER-alpha), ESR2 (ER-beta) and AR genes in breast cancer risk the -1174(TA)(7-27), c. 1092+3607(CA)(10-26) and c. 172(CAG)(6-40) repeat variants were studied in a case-control study of 79 women with sporadic breast cancer and 155 controls.
17904846	2008	Breast	0960-9776	ALL_TEXT_1/3	1	2	2100	SYMBOL|EXTRACTED|()	er beta	ER-beta	90#97	17904846-2-84-88	D001943	LONGTERM|DISEASE|DT|DICTIONARY	breast cancer	breast cancer	115#128		To determine the possible contribution of genetic variation in the ESR1 (ER-alpha), ESR2 (ER-beta) and AR genes in breast cancer risk the -1174(TA)(7-27), c. 1092+3607(CA)(10-26) and c. 172(CAG)(6-40) repeat variants were studied in a case-control study of 79 women with sporadic breast cancer and 155 controls.
17904846	2008	Breast	0960-9776	ALL_TEXT_1/3	1	2	2100	SYMBOL|EXTRACTED|()	er beta	ER-beta	90#97	17904846-2-84-88	D001943	LONGTERM|DISEASE|DT|DICTIONARY	sporadic breast cancer	sporadic breast cancer	271#293		To determine the possible contribution of genetic variation in the ESR1 (ER-alpha), ESR2 (ER-beta) and AR genes in breast cancer risk the -1174(TA)(7-27), c. 1092+3607(CA)(10-26) and c. 172(CAG)(6-40) repeat variants were studied in a case-control study of 79 women with sporadic breast cancer and 155 controls.
17904846	2008	Breast	0960-9776	ALL_TEXT_1/3	1	2	367	SYMBOL|EXTRACTED|GENE|GN	ar	AR	103#105	17904846-0-91-108	D001943	LONGTERM|DISEASE|DT|DICTIONARY	breast cancer	breast cancer	115#128		To determine the possible contribution of genetic variation in the ESR1 (ER-alpha), ESR2 (ER-beta) and AR genes in breast cancer risk the -1174(TA)(7-27), c. 1092+3607(CA)(10-26) and c. 172(CAG)(6-40) repeat variants were studied in a case-control study of 79 women with sporadic breast cancer and 155 controls.
17904846	2008	Breast	0960-9776	ALL_TEXT_1/3	1	2	367	SYMBOL|EXTRACTED|GENE|GN	ar	AR	103#105	17904846-0-91-108	D001943	LONGTERM|DISEASE|DT|DICTIONARY	sporadic breast cancer	sporadic breast cancer	271#293		To determine the possible contribution of genetic variation in the ESR1 (ER-alpha), ESR2 (ER-beta) and AR genes in breast cancer risk the -1174(TA)(7-27), c. 1092+3607(CA)(10-26) and c. 172(CAG)(6-40) repeat variants were studied in a case-control study of 79 women with sporadic breast cancer and 155 controls.
17260091	2008	Breast Cancer Res. Treat.	0167-6806	METHODS	2	4	4524	SYMBOL|DICTIONARY|EXTRACTED	mthfr	MTHFR	196#201	17260091-0-0-35	D001943	LONGTERM|DISEASE|DT|DICTIONARY	breast cancer	breast cancer	14#27		A total of 46 breast cancer cases and 80 unaffected controls matched to treatment allocation, years from randomization (+/-2 years) and age at randomization (+/-5 years), underwent genotyping for MTHFR C677T polymorphism using real time PCR.
17904846	2008	Breast	0960-9776	ALL_TEXT_2/3	2	4	2100	SYMBOL|DICTIONARY	esr2	ESR2	141#145		D001943	LONGTERM|DISEASE|DT|DICTIONARY	breast cancer	breast cancer	46#59		A significantly decreased odds ratio (OR) for breast cancer risk was observed in individuals having the LL and the SL genotypes for both the ESR2 (OR=0.010, 95% CI 0.003-0.036, p<0.001; OR=0.013, 95% CI 0.004-0.040, p<0.0001, respectively) and the AR gene (OR=0.040, 95% CI 0.011-0.138, p<0.0001; OR=0.189, 95% CI 0.10-0.359, p<0.0001, respectively), compared to SS genotype.
17904846	2008	Breast	0960-9776	ALL_TEXT_2/3	2	4	367	SYMBOL|EXTRACTED|GENE|GN	ar	AR	248#250	17904846-0-91-108	D001943	LONGTERM|DISEASE|DT|DICTIONARY	breast cancer	breast cancer	46#59		A significantly decreased odds ratio (OR) for breast cancer risk was observed in individuals having the LL and the SL genotypes for both the ESR2 (OR=0.010, 95% CI 0.003-0.036, p<0.001; OR=0.013, 95% CI 0.004-0.040, p<0.0001, respectively) and the AR gene (OR=0.040, 95% CI 0.011-0.138, p<0.0001; OR=0.189, 95% CI 0.10-0.359, p<0.0001, respectively), compared to SS genotype.
17904846	2008	Breast	0960-9776	ALL_TEXT_3/3	3	6	2100	SYMBOL|DICTIONARY	esr2	ESR2	111#115		D001943	LONGTERM|DISEASE|DT|DICTIONARY	breast cancer	breast cancer	34#47		In conclusion, an association for breast cancer risk between short (SS) alleles for the repeat variants of the ESR2 and AR genes was found in women of Greek descent.
17904846	2008	Breast	0960-9776	ALL_TEXT_3/3	3	6	367	SYMBOL|EXTRACTED|GENE|GN	ar	AR	120#122	17904846-0-91-108	D001943	LONGTERM|DISEASE|DT|DICTIONARY	breast cancer	breast cancer	34#47		In conclusion, an association for breast cancer risk between short (SS) alleles for the repeat variants of the ESR2 and AR genes was found in women of Greek descent.
17260091	2008	Breast Cancer Res. Treat.	0167-6806	TITLE	0	0	4524	LONGTERM|DICTIONARY	methylenetetrahydrofolate reductase	Methylenetetrahydrofolate reductase	0#35		D001943	LONGTERM|DISEASE|DT|DICTIONARY	breast cancer	breast cancer	48#61		Methylenetetrahydrofolate reductase (MTHFR) and breast cancer risk: a nested-case-control study and a pooled meta-analysis.
17260091	2008	Breast Cancer Res. Treat.	0167-6806	TITLE	0	0	4524	SYMBOL|()|DICTIONARY|EXTRACTED	mthfr	MTHFR	37#42	17260091-0-0-35	D001943	LONGTERM|DISEASE|DT|DICTIONARY	breast cancer	breast cancer	48#61		Methylenetetrahydrofolate reductase (MTHFR) and breast cancer risk: a nested-case-control study and a pooled meta-analysis.
15124102	2004	Am. J. Hum. Genet.	0002-9297	ALL_TEXT_3/3	3	8	1947	SYMBOL|DICTIONARY	efnb1	EFNB1	30#35		C536456	SYMBOL|DICTIONARY|EXTRACTED	cfns	CFNS	42#46	15124102-1-0-26	We conclude that mutations in EFNB1 cause CFNS.
14720258	2004	Clin. Exp. Allergy	0954-7894	OBJECTIVE	2	3	80332	SYMBOL|DICTIONARY	adam33	ADAM33	37#43		D001249	LONGTERM|DICTIONARY	asthma	asthma	64#70		We examined whether polymorphisms in ADAM33 are associated with asthma and related traits in two German populations.
17260091	2008	Breast Cancer Res. Treat.	0167-6806	CONCLUSIONS	4	8	4524	SYMBOL|DICTIONARY|EXTRACTED	mthfr	MTHFR	62#67	17260091-0-0-35	D001943	LONGTERM|DISEASE|DT|DICTIONARY	breast cancer	breast cancer	104#117		Our study lends support to a positive association between the MTHFR variant homozygous allele 677TT and breast cancer risk.
17986123	2008	Respirology	1323-7799	RESULTS	3	6	3458	SYMBOL|EXTRACTED	ifn gamma	IFN-gamma	43#52	17986123-2-19-35	D014397	SYMBOL|EXTRACTED	pulmonary tb	pulmonary TB	143#155	17986123-1-78-100	The genotype and allele frequencies of the IFN-gamma and IFN-gammaR1 gene polymorphisms did not differ significantly between the patients with pulmonary TB and controls.
17986123	2008	Respirology	1323-7799	RESULTS	3	6	3459	SYMBOL|EXTRACTED|GENE|GN	ifn gammar1	IFN-gammaR1	57#68	17986123-2-52-72	D014397	SYMBOL|EXTRACTED	pulmonary tb	pulmonary TB	143#155	17986123-1-78-100	The genotype and allele frequencies of the IFN-gamma and IFN-gammaR1 gene polymorphisms did not differ significantly between the patients with pulmonary TB and controls.
17986123	2008	Respirology	1323-7799	CONCLUSIONS	4	7	3458	SYMBOL|EXTRACTED	ifn gamma	IFN-gamma	4#13	17986123-2-19-35	D014397	SYMBOL|EXTRACTED	pulmonary tb	pulmonary TB	108#120	17986123-1-78-100	The IFN-gamma and IFN-gammaR1 gene polymorphisms do not appear to be responsible for host susceptibility to pulmonary TB in the Korean population.
17986123	2008	Respirology	1323-7799	CONCLUSIONS	4	7	3459	SYMBOL|EXTRACTED|GENE|GN	ifn gammar1	IFN-gammaR1	18#29	17986123-2-52-72	D014397	SYMBOL|EXTRACTED	pulmonary tb	pulmonary TB	108#120	17986123-1-78-100	The IFN-gamma and IFN-gammaR1 gene polymorphisms do not appear to be responsible for host susceptibility to pulmonary TB in the Korean population.
17986123	2008	Respirology	1323-7799	TITLE	0	0	3458	LONGTERM|DICTIONARY	interferon gamma	interferon-gamma	17#33		D014397	LONGTERM|DICTIONARY	pulmonary tuberculosis	pulmonary tuberculosis	76#98		Polymorphisms of interferon-gamma and interferon-gamma receptor 1 genes and pulmonary tuberculosis in Koreans.
17986123	2008	Respirology	1323-7799	TITLE	0	0	3459	LONGTERM|GENE|GN|DICTIONARY	interferon gamma receptor 1	interferon-gamma receptor 1	38#65		D014397	LONGTERM|DICTIONARY	pulmonary tuberculosis	pulmonary tuberculosis	76#98		Polymorphisms of interferon-gamma and interferon-gamma receptor 1 genes and pulmonary tuberculosis in Koreans.
17986123	2008	Respirology	1323-7799	BACKGROUND AND OBJECTIVE	1	2	3458	LONGTERM|DICTIONARY	interferon gamma	interferon-gamma	19#35		D014397	SYMBOL|EXTRACTED	pulmonary tb	pulmonary TB	111#123	17986123-1-78-100	The association of interferon-gamma (IFN-gamma) and IFN-gamma receptor 1 (IFN-gammaR1) gene polymorphisms with pulmonary TB is controversial.
17986123	2008	Respirology	1323-7799	BACKGROUND AND OBJECTIVE	1	2	3458	SYMBOL|EXTRACTED|()	ifn gamma	IFN-gamma	37#46	17986123-2-19-35	D014397	SYMBOL|EXTRACTED	pulmonary tb	pulmonary TB	111#123	17986123-1-78-100	The association of interferon-gamma (IFN-gamma) and IFN-gamma receptor 1 (IFN-gammaR1) gene polymorphisms with pulmonary TB is controversial.
17986123	2008	Respirology	1323-7799	BACKGROUND AND OBJECTIVE	1	2	3459	SYMBOL|DICTIONARY|GENE|GA	ifn gamma receptor 1	IFN-gamma receptor 1	52#72		D014397	SYMBOL|EXTRACTED	pulmonary tb	pulmonary TB	111#123	17986123-1-78-100	The association of interferon-gamma (IFN-gamma) and IFN-gamma receptor 1 (IFN-gammaR1) gene polymorphisms with pulmonary TB is controversial.
17986123	2008	Respirology	1323-7799	BACKGROUND AND OBJECTIVE	1	2	3459	SYMBOL|EXTRACTED|()|GENE|GN	ifn gammar1	IFN-gammaR1	74#85	17986123-2-52-72	D014397	SYMBOL|EXTRACTED	pulmonary tb	pulmonary TB	111#123	17986123-1-78-100	The association of interferon-gamma (IFN-gamma) and IFN-gamma receptor 1 (IFN-gammaR1) gene polymorphisms with pulmonary TB is controversial.
17986123	2008	Respirology	1323-7799	BACKGROUND AND OBJECTIVE	1	3	3458	SYMBOL|EXTRACTED	ifn gamma	IFN-gamma	44#53	17986123-2-19-35	D014397	SYMBOL|EXTRACTED	pulmonary tb	pulmonary TB	93#105	17986123-1-78-100	This study examined the association between IFN-gamma and IFN-gammaR1 gene polymorphisms and pulmonary TB among Koreans.
17986123	2008	Respirology	1323-7799	BACKGROUND AND OBJECTIVE	1	3	3459	SYMBOL|EXTRACTED|GENE|GN	ifn gammar1	IFN-gammaR1	58#69	17986123-2-52-72	D014397	SYMBOL|EXTRACTED	pulmonary tb	pulmonary TB	93#105	17986123-1-78-100	This study examined the association between IFN-gamma and IFN-gammaR1 gene polymorphisms and pulmonary TB among Koreans.
1352745	1992	Clin. Exp. Immunol.	0009-9104	TITLE	0	0	1378	SYMBOL|EXTRACTED|()	cr1	CR1	21#24	1352745-0-7-10	D003922	LONGTERM|DICTIONARY	insulin dependent diabetes mellitus	insulin-dependent diabetes mellitus	64#99		Normal C3b receptor (CR1) genomic polymorphism in patients with insulin-dependent diabetes mellitus (IDDM): is the low erythrocyte CR1 expression an acquired phenomenon?
1352745	1992	Clin. Exp. Immunol.	0009-9104	TITLE	0	0	1378	SYMBOL|EXTRACTED|()	cr1	CR1	21#24	1352745-0-7-10	D003922	SYMBOL|()|DICTIONARY|EXTRACTED	iddm	IDDM	101#105	1352745-0-64-99	Normal C3b receptor (CR1) genomic polymorphism in patients with insulin-dependent diabetes mellitus (IDDM): is the low erythrocyte CR1 expression an acquired phenomenon?
1352745	1992	Clin. Exp. Immunol.	0009-9104	TITLE	0	0	1378	SYMBOL|EXTRACTED	cr1	CR1	131#134	1352745-0-7-10	D003922	LONGTERM|DICTIONARY	insulin dependent diabetes mellitus	insulin-dependent diabetes mellitus	64#99		Normal C3b receptor (CR1) genomic polymorphism in patients with insulin-dependent diabetes mellitus (IDDM): is the low erythrocyte CR1 expression an acquired phenomenon?
1352745	1992	Clin. Exp. Immunol.	0009-9104	TITLE	0	0	1378	SYMBOL|EXTRACTED	cr1	CR1	131#134	1352745-0-7-10	D003922	SYMBOL|()|DICTIONARY|EXTRACTED	iddm	IDDM	101#105	1352745-0-64-99	Normal C3b receptor (CR1) genomic polymorphism in patients with insulin-dependent diabetes mellitus (IDDM): is the low erythrocyte CR1 expression an acquired phenomenon?
21313874	2011	Pak. J. Biol. Sci.	1028-8880	ALL_TEXT_2/3	2	4	3458	SYMBOL|GENE|GN|DICTIONARY	ifn gamma	IFN-gamma	81#90		D002006	LONGTERM|DICTIONARY	brucellosis	brucellosis	150#161		We investigated the allelic and genotypes distribution of A5644G polymorphism in IFN-gamma gene in an Iranian population comprising 259 patients with brucellosis and 238 healthy controls.
21313874	2011	Pak. J. Biol. Sci.	1028-8880	ALL_TEXT_1/3	1	2	3458	LONGTERM|DICTIONARY	ifn-gamma	IFN-gamma	0#9	NaN	D007239	LONGTERM|DICTIONARY	brucella infection	brucella infection	60#78	NaN	IFN-gamma plays a key role in the defense mechanism against brucella infection.
21313874	2011	Pak. J. Biol. Sci.	1028-8880	ALL_TEXT_1/3	1	3	3458	SYMBOL|GENE|GN|DICTIONARY	ifn gamma	IFN-gamma	93#102		D002006	LONGTERM|DICTIONARY	brucellosis	brucellosis	133#144		This study aimed to determine the influence of the polymorphism within the +5644 position of IFN-gamma gene on the susceptibility to brucellosis.
18393292	2008	Hepatology	1527-3350	UNLABELLED	1	2	7832	SYMBOL|DICTIONARY	tis21	TIS21	128#133		D006528	LONGTERM|DISEASE|DT|DICTIONARY	hepatocellular carcinoma	hepatocellular carcinoma	10#34		Growth of hepatocellular carcinoma (HCC), developed by a single injection of diethylnitrosamine (DEN), was the same in both the TIS21(+/+) and TIS21(-/-) mice until 6 months, whereas it was significantly higher in the TIS21(-/-) mice at 9 months.
18393292	2008	Hepatology	1527-3350	UNLABELLED	1	2	7832	SYMBOL|DICTIONARY	tis21	TIS21	128#133		D006528	SYMBOL|()|DICTIONARY|EXTRACTED	hcc	HCC	36#39	18393292-2-10-34	Growth of hepatocellular carcinoma (HCC), developed by a single injection of diethylnitrosamine (DEN), was the same in both the TIS21(+/+) and TIS21(-/-) mice until 6 months, whereas it was significantly higher in the TIS21(-/-) mice at 9 months.
18393292	2008	Hepatology	1527-3350	UNLABELLED	1	2	7832	SYMBOL|DICTIONARY	tis21	TIS21	143#148		D006528	LONGTERM|DISEASE|DT|DICTIONARY	hepatocellular carcinoma	hepatocellular carcinoma	10#34		Growth of hepatocellular carcinoma (HCC), developed by a single injection of diethylnitrosamine (DEN), was the same in both the TIS21(+/+) and TIS21(-/-) mice until 6 months, whereas it was significantly higher in the TIS21(-/-) mice at 9 months.
18393292	2008	Hepatology	1527-3350	UNLABELLED	1	2	7832	SYMBOL|DICTIONARY	tis21	TIS21	143#148		D006528	SYMBOL|()|DICTIONARY|EXTRACTED	hcc	HCC	36#39	18393292-2-10-34	Growth of hepatocellular carcinoma (HCC), developed by a single injection of diethylnitrosamine (DEN), was the same in both the TIS21(+/+) and TIS21(-/-) mice until 6 months, whereas it was significantly higher in the TIS21(-/-) mice at 9 months.
18393292	2008	Hepatology	1527-3350	UNLABELLED	1	2	7832	SYMBOL|DICTIONARY	tis21	TIS21	218#223		D006528	LONGTERM|DISEASE|DT|DICTIONARY	hepatocellular carcinoma	hepatocellular carcinoma	10#34		Growth of hepatocellular carcinoma (HCC), developed by a single injection of diethylnitrosamine (DEN), was the same in both the TIS21(+/+) and TIS21(-/-) mice until 6 months, whereas it was significantly higher in the TIS21(-/-) mice at 9 months.
18393292	2008	Hepatology	1527-3350	UNLABELLED	1	2	7832	SYMBOL|DICTIONARY	tis21	TIS21	218#223		D006528	SYMBOL|()|DICTIONARY|EXTRACTED	hcc	HCC	36#39	18393292-2-10-34	Growth of hepatocellular carcinoma (HCC), developed by a single injection of diethylnitrosamine (DEN), was the same in both the TIS21(+/+) and TIS21(-/-) mice until 6 months, whereas it was significantly higher in the TIS21(-/-) mice at 9 months.
14672398	2004	Breast Cancer Res. Treat.	0167-6806	ALL_TEXT_2/3	2	4	1869	SYMBOL|DICTIONARY	e2f1	E2F1	0#4		D009369	LONGTERM|DICTIONARY	tumors	tumors	62#68		E2F1 expression was significantly increased in pRB-expressing tumors and was associated with an S-phase fraction.
14672398	2004	Breast Cancer Res. Treat.	0167-6806	ALL_TEXT_2/3	2	4	5925	LONGTERM|DICTIONARY	prb	pRB	47#50	NaN	D009369	LONGTERM|DICTIONARY	tumors	tumors	62#68		E2F1 expression was significantly increased in pRB-expressing tumors and was associated with an S-phase fraction.
14672398	2004	Breast Cancer Res. Treat.	0167-6806	ALL_TEXT_1/3	1	1	1869	SYMBOL|DICTIONARY	e2f1	E2F1	19#23		D001943	LONGTERM|DICTIONARY	breast cancers	breast cancers	98#112		The expressions of E2F1 and retinoblastoma protein (pRB) were analyzed in 165 lymph node-positive breast cancers.
14672398	2004	Breast Cancer Res. Treat.	0167-6806	ALL_TEXT_1/3	1	1	5925	LONGTERM|DICTIONARY	prb	pRB	52#55	NaN	D001943	LONGTERM|DICTIONARY	breast cancers	breast cancers	98#112		The expressions of E2F1 and retinoblastoma protein (pRB) were analyzed in 165 lymph node-positive breast cancers.
18082567	2008	Hum. Immunol.	0198-8859	ALL_TEXT_1/3	1	2	4153	LONGTERM|DICTIONARY	mannose binding lectin	mannose-binding lectin	22#44		C563602	LONGTERM|DICTIONARY	mannose-binding lectin	mannose-binding lectin	22#44	NaN	The complement factor mannose-binding lectin (MBL) is associated with adverse pregnancy outcomes and has been suggested to play a role in abnormal placentation.
18082567	2008	Hum. Immunol.	0198-8859	ALL_TEXT_1/3	1	2	4153	SYMBOL|()|DICTIONARY|EXTRACTED	mbl	MBL	46#49	18082567-2-22-44	C563602	LONGTERM|DICTIONARY	mannose-binding lectin	mannose-binding lectin	22#44	NaN	The complement factor mannose-binding lectin (MBL) is associated with adverse pregnancy outcomes and has been suggested to play a role in abnormal placentation.
12377406	2002	Cancer Genet. Cytogenet.	0165-4608	ALL_TEXT_3/3	3	9	11178	SYMBOL|DICTIONARY	lzts1	LZTS1	48#53		D011471	LONGTERM|DISEASE|DT|DICTIONARY	prostate cancer	prostate cancer	57#72		These results add evidence supporting a role of LZTS1 in prostate cancer risk.
17419075	2007	Osteoarthr. Cartil.	1063-4584	TITLE	0	0	2099	LONGTERM|GENE|GT|DICTIONARY	estrogen receptor alpha	Estrogen receptor alpha	0#23		D015207	LONGTERM|DICTIONARY	radiographic hip osteoarthritis	radiographic hip osteoarthritis	76#107		Estrogen receptor alpha genotype is associated with a reduced prevalence of radiographic hip osteoarthritis in elderly Caucasian women.
12377406	2002	Cancer Genet. Cytogenet.	0165-4608	TITLE	0	0	11178	SYMBOL|GENE|GN|DICTIONARY	lzts1	LZTS1	34#39		D011471	LONGTERM|DISEASE|DT|DICTIONARY	prostate cancer	prostate cancer	65#80		Germline sequence variants of the LZTS1 gene are associated with prostate cancer risk.
18726117	2009	J. Cancer Res. Clin. Oncol.	1432-1335	CONCLUSIONS	4	12	1956	SYMBOL|DICTIONARY|EXTRACTED	egfr	EGFR	90#94	18726117-1-56-88	D002289	LONGTERM|DISEASE|DN|DICTIONARY|EXTRACTED	nsclc	NSCLC	30#35	18726117-2-55-81	In 46 total gefitinib treated NSCLC patients, the prognosis was not different between the EGFR wild type (GG) patients and AG+AA patients.
12377406	2002	Cancer Genet. Cytogenet.	0165-4608	ALL_TEXT_1/3	1	2	11178	SYMBOL|DICTIONARY	lzts1	LZTS1	9#14		D009369	LONGTERM|DISEASE|DT|DICTIONARY	tumor	tumor	92#97		The gene LZTS1 has been mapped to the 8p22 through p23 region and identified as a potential tumor suppressor based on loss of heterozygosity studies using primary esophageal tumors.
12377406	2002	Cancer Genet. Cytogenet.	0165-4608	ALL_TEXT_1/3	1	2	11178	SYMBOL|DICTIONARY	lzts1	LZTS1	9#14		D009369	LONGTERM|DICTIONARY	esophageal tumors	esophageal tumors	163#180		The gene LZTS1 has been mapped to the 8p22 through p23 region and identified as a potential tumor suppressor based on loss of heterozygosity studies using primary esophageal tumors.
12377406	2002	Cancer Genet. Cytogenet.	0165-4608	ALL_TEXT_1/3	1	2	10728	SYMBOL|DICTIONARY	p23	p23	51#54		D009369	LONGTERM|DISEASE|DT|DICTIONARY	tumor	tumor	92#97		The gene LZTS1 has been mapped to the 8p22 through p23 region and identified as a potential tumor suppressor based on loss of heterozygosity studies using primary esophageal tumors.
12377406	2002	Cancer Genet. Cytogenet.	0165-4608	ALL_TEXT_1/3	1	2	10728	SYMBOL|DICTIONARY	p23	p23	51#54		D009369	LONGTERM|DICTIONARY	esophageal tumors	esophageal tumors	163#180		The gene LZTS1 has been mapped to the 8p22 through p23 region and identified as a potential tumor suppressor based on loss of heterozygosity studies using primary esophageal tumors.
12377406	2002	Cancer Genet. Cytogenet.	0165-4608	ALL_TEXT_2/3	2	5	11178	SYMBOL|DICTIONARY	lzts1	LZTS1	51#56		D011471	LONGTERM|DISEASE|DT|DICTIONARY	hereditary prostate cancer	hereditary prostate cancer	119#145		In this study, a detailed DNA sequence analysis of LZTS1 was performed in a screening panel consisting of sporadic and hereditary prostate cancer (HPC) cases and unaffected controls.
12377406	2002	Cancer Genet. Cytogenet.	0165-4608	ALL_TEXT_2/3	2	5	11178	SYMBOL|DICTIONARY	lzts1	LZTS1	51#56		D011471	SYMBOL|()|DICTIONARY|EXTRACTED	hpc	HPC	147#150	12377406-5-119-145	In this study, a detailed DNA sequence analysis of LZTS1 was performed in a screening panel consisting of sporadic and hereditary prostate cancer (HPC) cases and unaffected controls.
9042911	1997	Am. J. Hum. Genet.	0002-9297	TITLE	0	0	7372	SYMBOL|GENE|GN|DICTIONARY	ump synthase	UMP synthase	31#43		D030342	LONGTERM|GFAM|FN|DICTIONARY	hereditary orotic aciduria	hereditary orotic aciduria	96#122		Molecular cloning of the human UMP synthase gene and characterization of point mutations in two hereditary orotic aciduria families.
16183801	2006	J. Med. Genet.	1468-6244	ALL_TEXT_3/3	3	7	4204	SYMBOL|DICTIONARY	mecp2	MECP2	133#138		D000013	LONGTERM|DICTIONARY	congenital anomalies	congenital anomalies	50#70		Five patients with large deletions had additional congenital anomalies, which was significantly more than in RTT patients with other MECP2 mutations (2/193; p<0.0001).
16183801	2006	J. Med. Genet.	1468-6244	ALL_TEXT_3/3	3	7	4204	SYMBOL|DICTIONARY	mecp2	MECP2	133#138		D015518	SYMBOL|DISEASE|DN|DICTIONARY|EXTRACTED	rtt	RTT	109#112	16183801-1-65-78	Five patients with large deletions had additional congenital anomalies, which was significantly more than in RTT patients with other MECP2 mutations (2/193; p<0.0001).
12880539	2004	Ann. Clin. Biochem.	0004-5632	CONCLUSION	4	9	348	LONGTERM|DICTIONARY	apo e4	apo E4	37#43	NaN	C536271	SYMBOL|EXTRACTED	premature mi	premature MI	106#118	12880539-2-109-130	Based on the robust association, the apo E4 allele should be considered as an independent risk factor for premature MI in Asian Indians.
18082567	2008	Hum. Immunol.	0198-8859	ALL_TEXT_2/3	2	6	4153	SYMBOL|DICTIONARY|EXTRACTED	mbl	MBL	33#36	18082567-2-22-44	D011225	LONGTERM|DICTIONARY	pre-eclampsia	pre-eclampsia	51#64		No association was found between MBL genotypes and pre-eclampsia; adjusted odds ratios and 95% confidence intervals (95% CI) for group B were 0.97 (95% CI = 0.46-2.07) and for group C were 1.44 (95% CI = 0.52-3.94).
15057267	2005	Genes Immun.	1466-4879	ALL_TEXT_3/3	3	5	3587	LONGTERM|DICTIONARY	il-10r	IL-10R	93#99	NaN	D003922	SYMBOL|EXTRACTED|DISEASE|DN	t1d	T1D	175#178	15057267-1-59-74	Three promoter polymorphisms (-1082G/A, -819C/T, -592C/A) and two CA-repeat microsatellites (IL-10R and IL-10G at -4 and -1.1 kb) were tested in a case-control study with 294 T1D patients and 574 healthy controls.
15057267	2005	Genes Immun.	1466-4879	ALL_TEXT_3/3	3	5	3587	LONGTERM|DICTIONARY	il-10r	IL-10R	93#99	NaN	D053842	LONGTERM|DICTIONARY	ca-repeat microsatellites	CA-repeat microsatellites	66#91	NaN	Three promoter polymorphisms (-1082G/A, -819C/T, -592C/A) and two CA-repeat microsatellites (IL-10R and IL-10G at -4 and -1.1 kb) were tested in a case-control study with 294 T1D patients and 574 healthy controls.
11303592	2001	Cancer Epidemiol. Biomarkers Prev.	1055-9965	ALL_TEXT_3/3	3	7	2944	SYMBOL|DICTIONARY	gstm1	GSTM1	125#130		D001943	LONGTERM|DISEASE|DT|DICTIONARY	breast cancer	breast cancer	49#62		A borderline significant increase in the risk of breast cancer was also seen for premenopausal women with the combination of GSTM1 null, GSTP1 Ile/Ile, and GSTT1 null genotypes (OR, 3.96; 95% CI, 0.99-15.8).
11303592	2001	Cancer Epidemiol. Biomarkers Prev.	1055-9965	ALL_TEXT_3/3	3	7	2950	SYMBOL|DICTIONARY	gstp1	GSTP1	137#142		D001943	LONGTERM|DISEASE|DT|DICTIONARY	breast cancer	breast cancer	49#62		A borderline significant increase in the risk of breast cancer was also seen for premenopausal women with the combination of GSTM1 null, GSTP1 Ile/Ile, and GSTT1 null genotypes (OR, 3.96; 95% CI, 0.99-15.8).
11303592	2001	Cancer Epidemiol. Biomarkers Prev.	1055-9965	ALL_TEXT_3/3	3	7	2952	SYMBOL|DICTIONARY	gstt1	GSTT1	156#161		D001943	LONGTERM|DISEASE|DT|DICTIONARY	breast cancer	breast cancer	49#62		A borderline significant increase in the risk of breast cancer was also seen for premenopausal women with the combination of GSTM1 null, GSTP1 Ile/Ile, and GSTT1 null genotypes (OR, 3.96; 95% CI, 0.99-15.8).
11303592	2001	Cancer Epidemiol. Biomarkers Prev.	1055-9965	ALL_TEXT_3/3	3	6	2947	SYMBOL|DICTIONARY	gstm3	GSTM3	106#111		D001943	LONGTERM|DISEASE|DT|DICTIONARY	breast cancer	breast cancer	33#46		Although only a moderate risk of breast cancer was seen for premenopausal women concurrently carrying the GSTM3*B allele containing genotypes and the GSTP1 Ile/ Ile genotype (OR, 2.07; 95% CI, 1.02-4.18), the risk rose steeply if they simultaneously lacked the GSTT1 gene (OR, 9.93, 95% CI, 1.10-90.0).
11303592	2001	Cancer Epidemiol. Biomarkers Prev.	1055-9965	ALL_TEXT_3/3	3	6	2950	SYMBOL|DICTIONARY	gstp1	GSTP1	150#155		D001943	LONGTERM|DISEASE|DT|DICTIONARY	breast cancer	breast cancer	33#46		Although only a moderate risk of breast cancer was seen for premenopausal women concurrently carrying the GSTM3*B allele containing genotypes and the GSTP1 Ile/ Ile genotype (OR, 2.07; 95% CI, 1.02-4.18), the risk rose steeply if they simultaneously lacked the GSTT1 gene (OR, 9.93, 95% CI, 1.10-90.0).
11303592	2001	Cancer Epidemiol. Biomarkers Prev.	1055-9965	ALL_TEXT_3/3	3	6	2952	SYMBOL|GENE|GN|DICTIONARY	gstt1	GSTT1	261#266		D001943	LONGTERM|DISEASE|DT|DICTIONARY	breast cancer	breast cancer	33#46		Although only a moderate risk of breast cancer was seen for premenopausal women concurrently carrying the GSTM3*B allele containing genotypes and the GSTP1 Ile/ Ile genotype (OR, 2.07; 95% CI, 1.02-4.18), the risk rose steeply if they simultaneously lacked the GSTT1 gene (OR, 9.93, 95% CI, 1.10-90.0).
15734955	2005	Cancer Epidemiol. Biomarkers Prev.	1055-9965	ALL_TEXT_3/3	3	12	7515	SYMBOL|DICTIONARY	xrcc1	XRCC1	60#65		D001943	LONGTERM|DISEASE|DT|DICTIONARY	breast cancer	breast cancer	167#180		However, there is evidence for interactions between the two XRCC1 single nucleotide polymorphisms and PAH-DNA adducts or fruit and vegetable and antioxidant intake on breast cancer risk.
11303592	2001	Cancer Epidemiol. Biomarkers Prev.	1055-9965	ALL_TEXT_2/3	2	4	2944	SYMBOL|DICTIONARY	gstm1	GSTM1	81#86		D001943	LONGTERM|DISEASE|DT|DICTIONARY	breast cancer	breast cancer	120#133		When the genes were studied separately, the only significant finding was between GSTM1 null genotype and postmenopausal breast cancer risk (OR, 1.49; 95% CI, 1.03-2.15).
15287851	2005	Liver Int.	1478-3223	RESULTS	3	8	28924	LONGTERM|DICTIONARY	a2-4	A2-4	83#87	NaN	D005355	LONGTERM|DICTIONARY	cirrhosis	cirrhosis	120#129		For C282Y heterozygous patients, the odds ratios for marked inflammatory activity (A2-4) and advanced liver fibrosis or cirrhosis (F2-4) are 4.9 and 4.6, respectively, compared with patients carrying homozygous wild-type alleles.
15287851	2005	Liver Int.	1478-3223	RESULTS	3	8	28924	LONGTERM|DICTIONARY	a2-4	A2-4	83#87	NaN	D005355	LONGTERM|DICTIONARY	fibrosis	fibrosis	108#116		For C282Y heterozygous patients, the odds ratios for marked inflammatory activity (A2-4) and advanced liver fibrosis or cirrhosis (F2-4) are 4.9 and 4.6, respectively, compared with patients carrying homozygous wild-type alleles.
11303592	2001	Cancer Epidemiol. Biomarkers Prev.	1055-9965	ALL_TEXT_1/3	1	1	373156	LONGTERM|DICTIONARY	glutathione s transferase	glutathione S-transferase	40#65		D001943	LONGTERM|DISEASE|DT|DICTIONARY	breast cancer	breast cancer	110#123		This study was undertaken to examine if glutathione S-transferase (GST) M1, M3, P1, and T1 genotypes affected breast cancer risk in Finnish women.
11303592	2001	Cancer Epidemiol. Biomarkers Prev.	1055-9965	TITLE	0	0	2944	LONGTERM|DICTIONARY	glutathione s transferase m1	Glutathione S-transferase M1	0#28		D001943	LONGTERM|DISEASE|DT|DICTIONARY	breast cancer	breast cancer	89#102		Glutathione S-transferase M1, M3, P1, and T1 genetic polymorphisms and susceptibility to breast cancer.
9550468	1998	Arthritis Rheum.	0004-3591	OBJECTIVE	1	1	596	SYMBOL|DICTIONARY	bcl 2	bcl-2	77#82		D008180	LONGTERM|DICTIONARY	systemic lupus erythematosus	systemic lupus erythematosus	158#186		To determine whether genes participating in programmed cell death, including bcl-2, IL-10, Fas-L, and CTLA-4, may contribute to the genetic predisposition to systemic lupus erythematosus (SLE).
9550468	1998	Arthritis Rheum.	0004-3591	OBJECTIVE	1	1	596	SYMBOL|DICTIONARY	bcl 2	bcl-2	77#82		D008180	SYMBOL|()|DICTIONARY|EXTRACTED	sle	SLE	188#191	9550468-1-158-186	To determine whether genes participating in programmed cell death, including bcl-2, IL-10, Fas-L, and CTLA-4, may contribute to the genetic predisposition to systemic lupus erythematosus (SLE).
9550468	1998	Arthritis Rheum.	0004-3591	OBJECTIVE	1	1	3586	SYMBOL|DICTIONARY	il 10	IL-10	84#89		D008180	LONGTERM|DICTIONARY	systemic lupus erythematosus	systemic lupus erythematosus	158#186		To determine whether genes participating in programmed cell death, including bcl-2, IL-10, Fas-L, and CTLA-4, may contribute to the genetic predisposition to systemic lupus erythematosus (SLE).
9550468	1998	Arthritis Rheum.	0004-3591	OBJECTIVE	1	1	3586	SYMBOL|DICTIONARY	il 10	IL-10	84#89		D008180	SYMBOL|()|DICTIONARY|EXTRACTED	sle	SLE	188#191	9550468-1-158-186	To determine whether genes participating in programmed cell death, including bcl-2, IL-10, Fas-L, and CTLA-4, may contribute to the genetic predisposition to systemic lupus erythematosus (SLE).
9550468	1998	Arthritis Rheum.	0004-3591	OBJECTIVE	1	1	1493	SYMBOL|DICTIONARY	ctla 4	CTLA-4	102#108		D008180	LONGTERM|DICTIONARY	systemic lupus erythematosus	systemic lupus erythematosus	158#186		To determine whether genes participating in programmed cell death, including bcl-2, IL-10, Fas-L, and CTLA-4, may contribute to the genetic predisposition to systemic lupus erythematosus (SLE).
9550468	1998	Arthritis Rheum.	0004-3591	OBJECTIVE	1	1	1493	SYMBOL|DICTIONARY	ctla 4	CTLA-4	102#108		D008180	SYMBOL|()|DICTIONARY|EXTRACTED	sle	SLE	188#191	9550468-1-158-186	To determine whether genes participating in programmed cell death, including bcl-2, IL-10, Fas-L, and CTLA-4, may contribute to the genetic predisposition to systemic lupus erythematosus (SLE).
9550468	1998	Arthritis Rheum.	0004-3591	OBJECTIVE	1	1	356	LONGTERM|DICTIONARY	fas-l	Fas-L	91#96	NaN	D008180	LONGTERM|DICTIONARY	systemic lupus erythematosus	systemic lupus erythematosus	158#186		To determine whether genes participating in programmed cell death, including bcl-2, IL-10, Fas-L, and CTLA-4, may contribute to the genetic predisposition to systemic lupus erythematosus (SLE).
9550468	1998	Arthritis Rheum.	0004-3591	OBJECTIVE	1	1	356	LONGTERM|DICTIONARY	fas-l	Fas-L	91#96	NaN	D008180	SYMBOL|()|DICTIONARY|EXTRACTED	sle	SLE	188#191	9550468-1-158-186	To determine whether genes participating in programmed cell death, including bcl-2, IL-10, Fas-L, and CTLA-4, may contribute to the genetic predisposition to systemic lupus erythematosus (SLE).
18565259	2008	Clin. Exp. Rheumatol.	0392-856X	OBJECTIVE	1	1	7124	LONGTERM|DICTIONARY	tnf-alpha	TNF-alpha	5#14	NaN	D001172	LONGTERM|DICTIONARY|DISEASE|DA	rheumatoid arthritis	rheumatoid arthritis	44#64		Anti-TNF-alpha therapies are widely used in rheumatoid arthritis (RA) patients.
18565259	2008	Clin. Exp. Rheumatol.	0392-856X	OBJECTIVE	1	1	7124	LONGTERM|DICTIONARY	tnf-alpha	TNF-alpha	5#14	NaN	D001172	SYMBOL|()|DISEASE|DN|DICTIONARY|EXTRACTED	ra	RA	66#68	18565259-1-44-64	Anti-TNF-alpha therapies are widely used in rheumatoid arthritis (RA) patients.
16025228	2005	Cardiovasc Drugs Ther	0920-3206	TITLE	0	0	186	LONGTERM|GFAM|FN|DICTIONARY	angiotensin ii type2 receptor	angiotensin II type2 receptor	88#117		D009202	LONGTERM|DICTIONARY	cardiomyopathy	cardiomyopathy	50#64		Taurine may prevent diabetic rats from developing cardiomyopathy also by downregulating angiotensin II type2 receptor expression.
16025228	2005	Cardiovasc Drugs Ther	0920-3206	TITLE	0	0	186	LONGTERM|GFAM|FN|DICTIONARY	angiotensin ii type2 receptor	angiotensin II type2 receptor	88#117		D003920	LONGTERM|DICTIONARY	diabetic	diabetic	20#28	NaN	Taurine may prevent diabetic rats from developing cardiomyopathy also by downregulating angiotensin II type2 receptor expression.
16025228	2005	Cardiovasc Drugs Ther	0920-3206	OBJECTIVE	1	3	183	LONGTERM|DICTIONARY	angiotensin ii	angiotensin II	70#84		D006984	LONGTERM|DICTIONARY	myocyte hypertrophy	myocyte hypertrophy	19#38	NaN	The development of myocyte hypertrophy has been largely attributed to angiotensin II, whose growth properties are antagonized by taurine.
16025228	2005	Cardiovasc Drugs Ther	0920-3206	OBJECTIVE	1	5	186	LONGTERM|DICTIONARY	at2	AT2	49#52	NaN	D058065	LONGTERM|DICTIONARY	diabetic cardiomyopathy	diabetic cardiomyopathy	95#118		This study investigates the roles of taurine and AT2 in rats with streptozotocin (STZ)-induced diabetic cardiomyopathy.
16025228	2005	Cardiovasc Drugs Ther	0920-3206	OBJECTIVE	1	4	183	LONGTERM|GFAM|FN|DICTIONARY	angiotensin ii	angiotensin II	42#56		D009202	LONGTERM|DICTIONARY	cardiomyopathy	cardiomyopathy	82#96		However, the interaction between taurine, angiotensin II type2 receptor (AT2) and cardiomyopathy related to angiotensin II is still unknown.
16025228	2005	Cardiovasc Drugs Ther	0920-3206	OBJECTIVE	1	4	183	LONGTERM|DICTIONARY	angiotensin ii	angiotensin II	108#122		D009202	LONGTERM|DICTIONARY	cardiomyopathy	cardiomyopathy	82#96		However, the interaction between taurine, angiotensin II type2 receptor (AT2) and cardiomyopathy related to angiotensin II is still unknown.
16025228	2005	Cardiovasc Drugs Ther	0920-3206	OBJECTIVE	1	4	186	LONGTERM|DICTIONARY	at2	AT2	73#76	NaN	D009202	LONGTERM|DICTIONARY	cardiomyopathy	cardiomyopathy	82#96		However, the interaction between taurine, angiotensin II type2 receptor (AT2) and cardiomyopathy related to angiotensin II is still unknown.
1930854	1991	Am. J. Hypertens.	0895-7061	ALL_TEXT_3/3	3	7	5741	LONGTERM|DICTIONARY	parathyroid hormone	parathyroid hormone	54#73		D006973	LONGTERM|DICTIONARY	hypertensives	hypertensives	123#136	NaN	In addition, a positive correlation was found between parathyroid hormone and quinine-sensitive K+ efflux in the above ten hypertensives (R = 0.85, P less than .001).
15057267	2005	Genes Immun.	1466-4879	ALL_TEXT_2/3	2	3	3586	LONGTERM|DICTIONARY	interleukin 10	interleukin-10	6#20		D001327	LONGTERM|DICTIONARY	autoimmune diseases	autoimmune diseases	105#124		Since interleukin-10 (IL-10) modulates immune and inflammatory responses and has been implicated in many autoimmune diseases, it seemed interesting to examine whether IL-10 polymorphisms participate in diabetes predisposition.
15057267	2005	Genes Immun.	1466-4879	ALL_TEXT_2/3	2	3	3586	LONGTERM|DICTIONARY	interleukin 10	interleukin-10	6#20		D003920	LONGTERM|DICTIONARY	diabetes predisposition	diabetes predisposition	202#225		Since interleukin-10 (IL-10) modulates immune and inflammatory responses and has been implicated in many autoimmune diseases, it seemed interesting to examine whether IL-10 polymorphisms participate in diabetes predisposition.
15057267	2005	Genes Immun.	1466-4879	ALL_TEXT_2/3	2	3	3586	SYMBOL|()|DICTIONARY|EXTRACTED	il 10	IL-10	22#27	15057267-3-6-20	D001327	LONGTERM|DICTIONARY	autoimmune diseases	autoimmune diseases	105#124		Since interleukin-10 (IL-10) modulates immune and inflammatory responses and has been implicated in many autoimmune diseases, it seemed interesting to examine whether IL-10 polymorphisms participate in diabetes predisposition.
15057267	2005	Genes Immun.	1466-4879	ALL_TEXT_2/3	2	3	3586	SYMBOL|()|DICTIONARY|EXTRACTED	il 10	IL-10	22#27	15057267-3-6-20	D003920	LONGTERM|DICTIONARY	diabetes predisposition	diabetes predisposition	202#225		Since interleukin-10 (IL-10) modulates immune and inflammatory responses and has been implicated in many autoimmune diseases, it seemed interesting to examine whether IL-10 polymorphisms participate in diabetes predisposition.
15057267	2005	Genes Immun.	1466-4879	ALL_TEXT_2/3	2	3	3586	SYMBOL|DICTIONARY|EXTRACTED	il 10	IL-10	167#172	15057267-3-6-20	D001327	LONGTERM|DICTIONARY	autoimmune diseases	autoimmune diseases	105#124		Since interleukin-10 (IL-10) modulates immune and inflammatory responses and has been implicated in many autoimmune diseases, it seemed interesting to examine whether IL-10 polymorphisms participate in diabetes predisposition.
15057267	2005	Genes Immun.	1466-4879	ALL_TEXT_2/3	2	3	3586	SYMBOL|DICTIONARY|EXTRACTED	il 10	IL-10	167#172	15057267-3-6-20	D003920	LONGTERM|DICTIONARY	diabetes predisposition	diabetes predisposition	202#225		Since interleukin-10 (IL-10) modulates immune and inflammatory responses and has been implicated in many autoimmune diseases, it seemed interesting to examine whether IL-10 polymorphisms participate in diabetes predisposition.
22388936	2012	Hum. Mol. Genet.	1460-2083	TITLE	0	0	23400	SYMBOL|DICTIONARY	atp13a2	ATP13A2	34#41		D009472	LONGTERM|DICTIONARY	neuronal ceroid lipofuscinosis	neuronal ceroid-lipofuscinosis	49#79		Mutation of the parkinsonism gene ATP13A2 causes neuronal ceroid-lipofuscinosis.
9550468	1998	Arthritis Rheum.	0004-3591	TITLE	0	0	3586	SYMBOL|DICTIONARY	il 10	IL-10	27#32		D008180	LONGTERM|DICTIONARY	systemic lupus erythematosus	systemic lupus erythematosus	86#114		Synergistic effect between IL-10 and bcl-2 genotypes in determining susceptibility to systemic lupus erythematosus.
9550468	1998	Arthritis Rheum.	0004-3591	TITLE	0	0	596	SYMBOL|DICTIONARY	bcl 2	bcl-2	37#42		D008180	LONGTERM|DICTIONARY	systemic lupus erythematosus	systemic lupus erythematosus	86#114		Synergistic effect between IL-10 and bcl-2 genotypes in determining susceptibility to systemic lupus erythematosus.
14508190	2004	J. Hypertens.	0263-6352	RESULTS	3	6	183	SYMBOL|DICTIONARY|EXTRACTED	agt	AGT	92#95	14508190-1-31-46	D006973	LONGTERM|DICTIONARY	hypertension	hypertension	163#175		However, one of the haplotypes defined by these five SNPs was significantly associated with AGT level (P = 0.046), although this haplotype was not associated with hypertension.
14508190	2004	J. Hypertens.	0263-6352	RESULTS	3	5	183	SYMBOL|DICTIONARY|EXTRACTED	agt	AGT	32#35	14508190-1-31-46	D006973	LONGTERM|DICTIONARY	hypertension	hypertension	45#57		No significant association with AGT level or hypertension was found in analyses of each of the five single SNPs.
14508190	2004	J. Hypertens.	0263-6352	METHODS	2	4	183	SYMBOL|DICTIONARY|EXTRACTED	agt	AGT	23#26	14508190-1-31-46	D006973	LONGTERM|DICTIONARY	hypertension	hypertension	37#49		Association studies of AGT level and hypertension were performed using these five tagging SNPs.
21187522	2011	Anticancer Res.	1791-7530	BACKGROUND/AIM	1	1	3845	SYMBOL|DICTIONARY	kras	KRAS	20#24		D015179	LONGTERM|GENE|GN|DISEASE|DT|DICTIONARY	colorectal cancer	colorectal cancer	39#56		The crucial role of KRAS status in new colorectal cancer target therapy raises the issue regarding which testing method to use.
14508190	2004	J. Hypertens.	0263-6352	OBJECTIVE	1	1	183	LONGTERM|DICTIONARY|GENE|GA	angiotensinogen	angiotensinogen	31#46		D006973	LONGTERM|DICTIONARY	hypertension	hypertension	77#89		To evaluate the association of angiotensinogen (AGT) gene with AGT level and hypertension based on the overall genetic variation of the AGT gene in among African-Americans.
14508190	2004	J. Hypertens.	0263-6352	OBJECTIVE	1	1	183	SYMBOL|()|GENE|GN|DICTIONARY|EXTRACTED	agt	AGT	48#51	14508190-1-31-46	D006973	LONGTERM|DICTIONARY	hypertension	hypertension	77#89		To evaluate the association of angiotensinogen (AGT) gene with AGT level and hypertension based on the overall genetic variation of the AGT gene in among African-Americans.
14508190	2004	J. Hypertens.	0263-6352	OBJECTIVE	1	1	183	SYMBOL|DICTIONARY|EXTRACTED	agt	AGT	63#66	14508190-1-31-46	D006973	LONGTERM|DICTIONARY	hypertension	hypertension	77#89		To evaluate the association of angiotensinogen (AGT) gene with AGT level and hypertension based on the overall genetic variation of the AGT gene in among African-Americans.
14508190	2004	J. Hypertens.	0263-6352	OBJECTIVE	1	1	183	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	agt	AGT	136#139	14508190-1-31-46	D006973	LONGTERM|DICTIONARY	hypertension	hypertension	77#89		To evaluate the association of angiotensinogen (AGT) gene with AGT level and hypertension based on the overall genetic variation of the AGT gene in among African-Americans.
14508190	2004	J. Hypertens.	0263-6352	TITLE	0	0	183	LONGTERM|DICTIONARY	angiotensinogen	angiotensinogen	24#39		D006973	LONGTERM|DICTIONARY	hypertension	hypertension	75#87		An association study of angiotensinogen polymorphisms with serum level and hypertension in an African-American population.
18349284	2008	Cancer Epidemiol. Biomarkers Prev.	1055-9965	ALL_TEXT_3/3	3	6	10	SYMBOL|NUMBER|DICTIONARY|EXTRACTED	nat2	NAT2	32#36	18349284-1-0-31	D009369	LONGTERM|DICTIONARY	tumors	tumors	4#10		The tumors in the patients with NAT2*7 allele tended to be high-grade astrocytoma or glioblastoma multiforme (P = 0.016).
18349284	2008	Cancer Epidemiol. Biomarkers Prev.	1055-9965	ALL_TEXT_3/3	3	6	10	SYMBOL|NUMBER|DICTIONARY|EXTRACTED	nat2	NAT2	32#36	18349284-1-0-31	D001254	LONGTERM|DICTIONARY	astrocytoma	astrocytoma	70#81		The tumors in the patients with NAT2*7 allele tended to be high-grade astrocytoma or glioblastoma multiforme (P = 0.016).
18349284	2008	Cancer Epidemiol. Biomarkers Prev.	1055-9965	ALL_TEXT_3/3	3	6	10	SYMBOL|NUMBER|DICTIONARY|EXTRACTED	nat2	NAT2	32#36	18349284-1-0-31	D005909	LONGTERM|DICTIONARY	glioblastoma	glioblastoma	85#97		The tumors in the patients with NAT2*7 allele tended to be high-grade astrocytoma or glioblastoma multiforme (P = 0.016).
18349284	2008	Cancer Epidemiol. Biomarkers Prev.	1055-9965	ALL_TEXT_3/3	3	7	10	SYMBOL|NUMBER|DICTIONARY|EXTRACTED	nat2	NAT2	55#59	18349284-1-0-31	D001932	LONGTERM|DICTIONARY	brain tumors	brain tumors	125#137		In conclusion, these data suggest that the presence of NAT2*7 allele might be a potential risk factor for the development of brain tumors in Taiwan.
18349284	2008	Cancer Epidemiol. Biomarkers Prev.	1055-9965	ALL_TEXT_3/3	3	5	10	SYMBOL|NUMBER|DICTIONARY|EXTRACTED	nat2	NAT2	18#22	18349284-1-0-31	D001932	LONGTERM|DISEASE|DT|DICTIONARY	brain tumor	brain tumor	84#95		The odds ratio of NAT2*7 allele frequency was significantly higher in patients with brain tumor than in controls (odds ratio, 6.786; 95% confidence interval, 2.06-22.37; P = 0.003); in the mean time, NAT2*4/*7 genotype was significantly more common in the patient group than in controls (odds ratio, 6.19; 95% confidence interval, 1.68-22.79; P = 0.0039).
18349284	2008	Cancer Epidemiol. Biomarkers Prev.	1055-9965	ALL_TEXT_3/3	3	5	10	SYMBOL|NUMBER|DICTIONARY|EXTRACTED	nat2	NAT2	200#204	18349284-1-0-31	D001932	LONGTERM|DISEASE|DT|DICTIONARY	brain tumor	brain tumor	84#95		The odds ratio of NAT2*7 allele frequency was significantly higher in patients with brain tumor than in controls (odds ratio, 6.786; 95% confidence interval, 2.06-22.37; P = 0.003); in the mean time, NAT2*4/*7 genotype was significantly more common in the patient group than in controls (odds ratio, 6.19; 95% confidence interval, 1.68-22.79; P = 0.0039).
18349284	2008	Cancer Epidemiol. Biomarkers Prev.	1055-9965	ALL_TEXT_1/3	1	2	10	SYMBOL|DICTIONARY|EXTRACTED	nat2	NAT2	19#23	18349284-1-0-31	D001932	LONGTERM|DICTIONARY	brain tumors	brain tumors	49#61		The association of NAT2 polymorphisms with adult brain tumors has been unclear.
18349284	2008	Cancer Epidemiol. Biomarkers Prev.	1055-9965	ALL_TEXT_2/3	2	3	10	SYMBOL|DICTIONARY|EXTRACTED	nat2	NAT2	27#31	18349284-1-0-31	D001932	LONGTERM|DICTIONARY	brain tumors	brain tumors	61#73		To investigate whether the NAT2 genotype is a risk factor of brain tumors, we determined the frequencies of three common polymorphisms in the NAT2 gene, NAT2*5 (T341C), NAT2*6 (G590A), and NAT2*7(G857A), in brain tumor patients and in age- and gender-matched control subjects (n = 27 in each group).
18349284	2008	Cancer Epidemiol. Biomarkers Prev.	1055-9965	ALL_TEXT_2/3	2	3	10	SYMBOL|DICTIONARY|EXTRACTED	nat2	NAT2	27#31	18349284-1-0-31	D001932	LONGTERM|DISEASE|DN|DT|DICTIONARY	brain tumor	brain tumor	207#218		To investigate whether the NAT2 genotype is a risk factor of brain tumors, we determined the frequencies of three common polymorphisms in the NAT2 gene, NAT2*5 (T341C), NAT2*6 (G590A), and NAT2*7(G857A), in brain tumor patients and in age- and gender-matched control subjects (n = 27 in each group).
18349284	2008	Cancer Epidemiol. Biomarkers Prev.	1055-9965	ALL_TEXT_2/3	2	3	10	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	nat2	NAT2	142#146	18349284-1-0-31	D001932	LONGTERM|DICTIONARY	brain tumors	brain tumors	61#73		To investigate whether the NAT2 genotype is a risk factor of brain tumors, we determined the frequencies of three common polymorphisms in the NAT2 gene, NAT2*5 (T341C), NAT2*6 (G590A), and NAT2*7(G857A), in brain tumor patients and in age- and gender-matched control subjects (n = 27 in each group).
18349284	2008	Cancer Epidemiol. Biomarkers Prev.	1055-9965	ALL_TEXT_2/3	2	3	10	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	nat2	NAT2	142#146	18349284-1-0-31	D001932	LONGTERM|DISEASE|DN|DT|DICTIONARY	brain tumor	brain tumor	207#218		To investigate whether the NAT2 genotype is a risk factor of brain tumors, we determined the frequencies of three common polymorphisms in the NAT2 gene, NAT2*5 (T341C), NAT2*6 (G590A), and NAT2*7(G857A), in brain tumor patients and in age- and gender-matched control subjects (n = 27 in each group).
18349284	2008	Cancer Epidemiol. Biomarkers Prev.	1055-9965	ALL_TEXT_2/3	2	3	10	SYMBOL|NUMBER|DICTIONARY|EXTRACTED	nat2	NAT2	153#157	18349284-1-0-31	D001932	LONGTERM|DICTIONARY	brain tumors	brain tumors	61#73		To investigate whether the NAT2 genotype is a risk factor of brain tumors, we determined the frequencies of three common polymorphisms in the NAT2 gene, NAT2*5 (T341C), NAT2*6 (G590A), and NAT2*7(G857A), in brain tumor patients and in age- and gender-matched control subjects (n = 27 in each group).
18349284	2008	Cancer Epidemiol. Biomarkers Prev.	1055-9965	ALL_TEXT_2/3	2	3	10	SYMBOL|NUMBER|DICTIONARY|EXTRACTED	nat2	NAT2	153#157	18349284-1-0-31	D001932	LONGTERM|DISEASE|DN|DT|DICTIONARY	brain tumor	brain tumor	207#218		To investigate whether the NAT2 genotype is a risk factor of brain tumors, we determined the frequencies of three common polymorphisms in the NAT2 gene, NAT2*5 (T341C), NAT2*6 (G590A), and NAT2*7(G857A), in brain tumor patients and in age- and gender-matched control subjects (n = 27 in each group).
18349284	2008	Cancer Epidemiol. Biomarkers Prev.	1055-9965	ALL_TEXT_2/3	2	3	10	SYMBOL|NUMBER|DICTIONARY|EXTRACTED	nat2	NAT2	169#173	18349284-1-0-31	D001932	LONGTERM|DICTIONARY	brain tumors	brain tumors	61#73		To investigate whether the NAT2 genotype is a risk factor of brain tumors, we determined the frequencies of three common polymorphisms in the NAT2 gene, NAT2*5 (T341C), NAT2*6 (G590A), and NAT2*7(G857A), in brain tumor patients and in age- and gender-matched control subjects (n = 27 in each group).
18349284	2008	Cancer Epidemiol. Biomarkers Prev.	1055-9965	ALL_TEXT_2/3	2	3	10	SYMBOL|NUMBER|DICTIONARY|EXTRACTED	nat2	NAT2	169#173	18349284-1-0-31	D001932	LONGTERM|DISEASE|DN|DT|DICTIONARY	brain tumor	brain tumor	207#218		To investigate whether the NAT2 genotype is a risk factor of brain tumors, we determined the frequencies of three common polymorphisms in the NAT2 gene, NAT2*5 (T341C), NAT2*6 (G590A), and NAT2*7(G857A), in brain tumor patients and in age- and gender-matched control subjects (n = 27 in each group).
18349284	2008	Cancer Epidemiol. Biomarkers Prev.	1055-9965	ALL_TEXT_2/3	2	3	10	SYMBOL|NUMBER|DICTIONARY|EXTRACTED	nat2	NAT2	189#193	18349284-1-0-31	D001932	LONGTERM|DICTIONARY	brain tumors	brain tumors	61#73		To investigate whether the NAT2 genotype is a risk factor of brain tumors, we determined the frequencies of three common polymorphisms in the NAT2 gene, NAT2*5 (T341C), NAT2*6 (G590A), and NAT2*7(G857A), in brain tumor patients and in age- and gender-matched control subjects (n = 27 in each group).
18349284	2008	Cancer Epidemiol. Biomarkers Prev.	1055-9965	ALL_TEXT_2/3	2	3	10	SYMBOL|NUMBER|DICTIONARY|EXTRACTED	nat2	NAT2	189#193	18349284-1-0-31	D001932	LONGTERM|DISEASE|DN|DT|DICTIONARY	brain tumor	brain tumor	207#218		To investigate whether the NAT2 genotype is a risk factor of brain tumors, we determined the frequencies of three common polymorphisms in the NAT2 gene, NAT2*5 (T341C), NAT2*6 (G590A), and NAT2*7(G857A), in brain tumor patients and in age- and gender-matched control subjects (n = 27 in each group).
18349284	2008	Cancer Epidemiol. Biomarkers Prev.	1055-9965	TITLE	0	0	10	SYMBOL|NUMBER|DICTIONARY|EXTRACTED	nat2	NAT2	0#4		D001932	LONGTERM|DICTIONARY	brain tumors	brain tumors	51#63		NAT2*7 allele is a potential risk factor for adult brain tumors in Taiwanese population.
16128377	2006	Acta Cardiol	0001-5385	RESULTS	3	16	1636	SYMBOL|DICTIONARY|EXTRACTED	ace	ACE	10#13	16128377-1-91-120	C536170	SYMBOL|DISEASE|DN|DICTIONARY	dd	DD	14#16		Moreover, ACE-DD significantly and early affected myocardial diastolic properties in the total group examined, also when stratified for age.
17540481	2009	Neurobiol. Aging	1558-1497	CONCLUSIONS	4	9	1401	SYMBOL|DICTIONARY|EXTRACTED	crp	CRP	7#10	17540481-1-61-79	D003704	LONGTERM|DICTIONARY	dementia	dementia	99#107		Higher CRP in those with APOE4 may be a marker of better immune function, leading to lower rate of dementia and AD.
17540481	2009	Neurobiol. Aging	1558-1497	CONCLUSIONS	4	9	1401	SYMBOL|DICTIONARY|EXTRACTED	crp	CRP	7#10	17540481-1-61-79	D000544	SYMBOL|EXTRACTED	ad	AD	112#114	17540481-2-97-116	Higher CRP in those with APOE4 may be a marker of better immune function, leading to lower rate of dementia and AD.
17540481	2009	Neurobiol. Aging	1558-1497	CONCLUSIONS	4	9	348	SYMBOL|DICTIONARY	apoe4	APOE4	25#30		D003704	LONGTERM|DICTIONARY	dementia	dementia	99#107		Higher CRP in those with APOE4 may be a marker of better immune function, leading to lower rate of dementia and AD.
17540481	2009	Neurobiol. Aging	1558-1497	CONCLUSIONS	4	9	348	SYMBOL|DICTIONARY	apoe4	APOE4	25#30		D000544	SYMBOL|EXTRACTED	ad	AD	112#114	17540481-2-97-116	Higher CRP in those with APOE4 may be a marker of better immune function, leading to lower rate of dementia and AD.
16128377	2006	Acta Cardiol	0001-5385	RESULTS	3	12	1636	SYMBOL|DICTIONARY|EXTRACTED	ace	ACE	7#10	16128377-1-91-120	D054058	SYMBOL|EXTRACTED	acs	ACS	128#131	16128377-10-204-228	2) the ACE-ID group (n = 335, 116 F/2 19 M, mean age 43.6 +/- 7 years) with 16 hypertensive subjects (4.7%) and 3 subjects with ACS.
16128377	2006	Acta Cardiol	0001-5385	RESULTS	3	12	1636	SYMBOL|DICTIONARY|EXTRACTED	ace	ACE	7#10	16128377-1-91-120	D006973	LONGTERM|DICTIONARY	hypertensive	hypertensive	79#91	NaN	2) the ACE-ID group (n = 335, 116 F/2 19 M, mean age 43.6 +/- 7 years) with 16 hypertensive subjects (4.7%) and 3 subjects with ACS.
16128377	2006	Acta Cardiol	0001-5385	RESULTS	3	13	1636	SYMBOL|DICTIONARY	ace	ACE	7#10		D006333	SYMBOL|EXTRACTED	hf	HF	112#114	16128377-10-156-169	3) the ACE-II group (n = 124, 45 F/79 M, mean age 42.5 +/- 6.9 years) with 2 hypertensive subjects (1.6%) and I HF subject.
16128377	2006	Acta Cardiol	0001-5385	RESULTS	3	13	1636	SYMBOL|DICTIONARY	ace	ACE	7#10		D006973	LONGTERM|DICTIONARY	hypertensive	hypertensive	77#89	NaN	3) the ACE-II group (n = 124, 45 F/79 M, mean age 42.5 +/- 6.9 years) with 2 hypertensive subjects (1.6%) and I HF subject.
16128377	2006	Acta Cardiol	0001-5385	RESULTS	3	10	1636	SYMBOL|DICTIONARY|EXTRACTED	ace	ACE	50#53	16128377-1-91-120	D006333	LONGTERM|DICTIONARY	heart failure	heart failure	156#169		We obtained 3 genetically distinct groups: I) the ACE-DD group (n = 225, 80 F/ 145 M, mean age 43.4 +/- 7.6 years) with 42 hypertensive subjects (18.3%), 5 heart failure (HF) subjects and 6 subjects with acute coronary syndromes (ACS).
16128377	2006	Acta Cardiol	0001-5385	RESULTS	3	10	1636	SYMBOL|DICTIONARY|EXTRACTED	ace	ACE	50#53	16128377-1-91-120	D006333	SYMBOL|EXTRACTED|()	hf	HF	171#173	16128377-10-156-169	We obtained 3 genetically distinct groups: I) the ACE-DD group (n = 225, 80 F/ 145 M, mean age 43.4 +/- 7.6 years) with 42 hypertensive subjects (18.3%), 5 heart failure (HF) subjects and 6 subjects with acute coronary syndromes (ACS).
16128377	2006	Acta Cardiol	0001-5385	RESULTS	3	10	1636	SYMBOL|DICTIONARY|EXTRACTED	ace	ACE	50#53	16128377-1-91-120	D054058	LONGTERM|DICTIONARY	acute coronary syndromes	acute coronary syndromes	204#228		We obtained 3 genetically distinct groups: I) the ACE-DD group (n = 225, 80 F/ 145 M, mean age 43.4 +/- 7.6 years) with 42 hypertensive subjects (18.3%), 5 heart failure (HF) subjects and 6 subjects with acute coronary syndromes (ACS).
16128377	2006	Acta Cardiol	0001-5385	RESULTS	3	10	1636	SYMBOL|DICTIONARY|EXTRACTED	ace	ACE	50#53	16128377-1-91-120	D054058	SYMBOL|EXTRACTED|()	acs	ACS	230#233	16128377-10-204-228	We obtained 3 genetically distinct groups: I) the ACE-DD group (n = 225, 80 F/ 145 M, mean age 43.4 +/- 7.6 years) with 42 hypertensive subjects (18.3%), 5 heart failure (HF) subjects and 6 subjects with acute coronary syndromes (ACS).
16128377	2006	Acta Cardiol	0001-5385	RESULTS	3	10	1636	SYMBOL|DICTIONARY|EXTRACTED	ace	ACE	50#53	16128377-1-91-120	C536170	LONGTERM|DICTIONARY	dd	DD	54#56	NaN	We obtained 3 genetically distinct groups: I) the ACE-DD group (n = 225, 80 F/ 145 M, mean age 43.4 +/- 7.6 years) with 42 hypertensive subjects (18.3%), 5 heart failure (HF) subjects and 6 subjects with acute coronary syndromes (ACS).
16128377	2006	Acta Cardiol	0001-5385	RESULTS	3	10	1636	SYMBOL|DICTIONARY|EXTRACTED	ace	ACE	50#53	16128377-1-91-120	D006973	LONGTERM|DICTIONARY	hypertensive	hypertensive	123#135	NaN	We obtained 3 genetically distinct groups: I) the ACE-DD group (n = 225, 80 F/ 145 M, mean age 43.4 +/- 7.6 years) with 42 hypertensive subjects (18.3%), 5 heart failure (HF) subjects and 6 subjects with acute coronary syndromes (ACS).
15660776	2005	Epilepsia	0013-9580	RESULTS	3	6	348	LONGTERM|DICTIONARY	apoe	ApoE	18#22	NaN	D004827	LONGTERM|DICTIONARY	epilepsy	epilepsy	67#75		The effect of the ApoE genotype was independent of both the age at epilepsy onset and disease duration as well as of a low educational level, which were separately associated with VLD (p values = 0.045, 0.001, and 0.001, respectively).
15660776	2005	Epilepsia	0013-9580	RESULTS	3	6	348	LONGTERM|DICTIONARY	apoe	ApoE	18#22	NaN	D007859	LONGTERM|DICTIONARY	vld	VLD	180#183	NaN	The effect of the ApoE genotype was independent of both the age at epilepsy onset and disease duration as well as of a low educational level, which were separately associated with VLD (p values = 0.045, 0.001, and 0.001, respectively).
1930854	1991	Am. J. Hypertens.	0895-7061	TITLE	0	0	5741	LONGTERM|DICTIONARY	parathyroid hormone	parathyroid hormone	19#38		D006973	LONGTERM|DICTIONARY	hypertensive	hypertensive	52#64	NaN	Elevated levels of parathyroid hormone in essential hypertensive patients with increased erythrocyte potassium efflux.
17540481	2009	Neurobiol. Aging	1558-1497	BACKGROUND	1	2	348	SYMBOL|DICTIONARY	apoe4	APOE4	8#13		D003704	LONGTERM|DICTIONARY	dementia	dementia	63#71		Whether APOE4 modifies the effects of CRP on rate of all cause dementia, cognitive impairment or Alzheimer's disease (AD) is not established.
17540481	2009	Neurobiol. Aging	1558-1497	BACKGROUND	1	2	348	SYMBOL|DICTIONARY	apoe4	APOE4	8#13		D003072	LONGTERM|DICTIONARY	cognitive impairment	cognitive impairment	73#93		Whether APOE4 modifies the effects of CRP on rate of all cause dementia, cognitive impairment or Alzheimer's disease (AD) is not established.
17540481	2009	Neurobiol. Aging	1558-1497	BACKGROUND	1	2	348	SYMBOL|DICTIONARY	apoe4	APOE4	8#13		D000544	LONGTERM|DISEASE|DT|DICTIONARY	alzheimer disease	Alzheimer's disease	97#116		Whether APOE4 modifies the effects of CRP on rate of all cause dementia, cognitive impairment or Alzheimer's disease (AD) is not established.
17540481	2009	Neurobiol. Aging	1558-1497	BACKGROUND	1	2	348	SYMBOL|DICTIONARY	apoe4	APOE4	8#13		D000544	SYMBOL|EXTRACTED|()	ad	AD	118#120	17540481-2-97-116	Whether APOE4 modifies the effects of CRP on rate of all cause dementia, cognitive impairment or Alzheimer's disease (AD) is not established.
17540481	2009	Neurobiol. Aging	1558-1497	BACKGROUND	1	2	1401	SYMBOL|DICTIONARY|EXTRACTED	crp	CRP	38#41	17540481-1-61-79	D003704	LONGTERM|DICTIONARY	dementia	dementia	63#71		Whether APOE4 modifies the effects of CRP on rate of all cause dementia, cognitive impairment or Alzheimer's disease (AD) is not established.
17540481	2009	Neurobiol. Aging	1558-1497	BACKGROUND	1	2	1401	SYMBOL|DICTIONARY|EXTRACTED	crp	CRP	38#41	17540481-1-61-79	D003072	LONGTERM|DICTIONARY	cognitive impairment	cognitive impairment	73#93		Whether APOE4 modifies the effects of CRP on rate of all cause dementia, cognitive impairment or Alzheimer's disease (AD) is not established.
17540481	2009	Neurobiol. Aging	1558-1497	BACKGROUND	1	2	1401	SYMBOL|DICTIONARY|EXTRACTED	crp	CRP	38#41	17540481-1-61-79	D000544	LONGTERM|DISEASE|DT|DICTIONARY	alzheimer disease	Alzheimer's disease	97#116		Whether APOE4 modifies the effects of CRP on rate of all cause dementia, cognitive impairment or Alzheimer's disease (AD) is not established.
17540481	2009	Neurobiol. Aging	1558-1497	BACKGROUND	1	2	1401	SYMBOL|DICTIONARY|EXTRACTED	crp	CRP	38#41	17540481-1-61-79	D000544	SYMBOL|EXTRACTED|()	ad	AD	118#120	17540481-2-97-116	Whether APOE4 modifies the effects of CRP on rate of all cause dementia, cognitive impairment or Alzheimer's disease (AD) is not established.
17540481	2009	Neurobiol. Aging	1558-1497	TITLE	0	0	1401	LONGTERM|GENE|GT|DICTIONARY	c reactive protein	C-reactive protein	0#18		D003704	LONGTERM|DICTIONARY	dementia	dementia	31#39		C-reactive protein and rate of dementia in carriers and non carriers of Apolipoprotein APOE4 genotype.
17540481	2009	Neurobiol. Aging	1558-1497	TITLE	0	0	348	SYMBOL|DICTIONARY	apoe4	APOE4	87#92		D003704	LONGTERM|DICTIONARY	dementia	dementia	31#39		C-reactive protein and rate of dementia in carriers and non carriers of Apolipoprotein APOE4 genotype.
17540481	2009	Neurobiol. Aging	1558-1497	RESULTS	3	7	348	SYMBOL|DICTIONARY	apoe4	APOE4	20#25		D003704	LONGTERM|DICTIONARY	dementia	dementia	57#65		Among those with no APOE4, there was no effect of CRP on dementia/CIND rates (HR: 0.94, 95% CL: 0.67-1.33).
17540481	2009	Neurobiol. Aging	1558-1497	RESULTS	3	7	1401	SYMBOL|DICTIONARY|EXTRACTED	crp	CRP	50#53	17540481-1-61-79	D003704	LONGTERM|DICTIONARY	dementia	dementia	57#65		Among those with no APOE4, there was no effect of CRP on dementia/CIND rates (HR: 0.94, 95% CL: 0.67-1.33).
17540481	2009	Neurobiol. Aging	1558-1497	RESULTS	3	6	348	SYMBOL|DICTIONARY	apoe4	APOE4	17#22		D003704	LONGTERM|DICTIONARY	dementia	dementia	72#80		Among those with APOE4, CRP was associated with lower rates of combined dementia/CIND (HR: 0.60, 95% CL: 0.20-0.91, p=0.03) from a fully adjusted model.
17540481	2009	Neurobiol. Aging	1558-1497	RESULTS	3	6	1401	SYMBOL|DICTIONARY|EXTRACTED	crp	CRP	24#27	17540481-1-61-79	D003704	LONGTERM|DICTIONARY	dementia	dementia	72#80		Among those with APOE4, CRP was associated with lower rates of combined dementia/CIND (HR: 0.60, 95% CL: 0.20-0.91, p=0.03) from a fully adjusted model.
17540481	2009	Neurobiol. Aging	1558-1497	METHODS	2	4	1401	SYMBOL|DICTIONARY|EXTRACTED	crp	CRP	41#44	17540481-1-61-79	D003704	LONGTERM|DICTIONARY	dementia	dementia	49#57		The association between high sensitivity CRP and dementia/CIND, all cause dementia and Alzheimer's disease by APOE4 status was examined in semi-parametric survival models with covariate adjustments.
17540481	2009	Neurobiol. Aging	1558-1497	METHODS	2	4	1401	SYMBOL|DICTIONARY|EXTRACTED	crp	CRP	41#44	17540481-1-61-79	D003704	LONGTERM|DICTIONARY	dementia	dementia	74#82		The association between high sensitivity CRP and dementia/CIND, all cause dementia and Alzheimer's disease by APOE4 status was examined in semi-parametric survival models with covariate adjustments.
17540481	2009	Neurobiol. Aging	1558-1497	METHODS	2	4	1401	SYMBOL|DICTIONARY|EXTRACTED	crp	CRP	41#44	17540481-1-61-79	D000544	LONGTERM|DISEASE|DT|DICTIONARY	alzheimer disease	Alzheimer's disease	87#106		The association between high sensitivity CRP and dementia/CIND, all cause dementia and Alzheimer's disease by APOE4 status was examined in semi-parametric survival models with covariate adjustments.
17540481	2009	Neurobiol. Aging	1558-1497	METHODS	2	4	348	SYMBOL|DICTIONARY	apoe4	APOE4	110#115		D003704	LONGTERM|DICTIONARY	dementia	dementia	49#57		The association between high sensitivity CRP and dementia/CIND, all cause dementia and Alzheimer's disease by APOE4 status was examined in semi-parametric survival models with covariate adjustments.
17540481	2009	Neurobiol. Aging	1558-1497	METHODS	2	4	348	SYMBOL|DICTIONARY	apoe4	APOE4	110#115		D003704	LONGTERM|DICTIONARY	dementia	dementia	74#82		The association between high sensitivity CRP and dementia/CIND, all cause dementia and Alzheimer's disease by APOE4 status was examined in semi-parametric survival models with covariate adjustments.
17540481	2009	Neurobiol. Aging	1558-1497	METHODS	2	4	348	SYMBOL|DICTIONARY	apoe4	APOE4	110#115		D000544	LONGTERM|DISEASE|DT|DICTIONARY	alzheimer disease	Alzheimer's disease	87#106		The association between high sensitivity CRP and dementia/CIND, all cause dementia and Alzheimer's disease by APOE4 status was examined in semi-parametric survival models with covariate adjustments.
18414696	2009	Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi	1003-9279	TITLE	0	0	1577	SYMBOL|GENE|GN|DICTIONARY	cyp3a5	CYP3A5	50#56		D019694	LONGTERM|DICTIONARY	chronic hepatitis b	chronic hepatitis B	103#122		[Relationship between the genetic polymorphism of CYP3A5 gene and the clinical response to bicyclol in chronic hepatitis B].
18414696	2009	Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi	1003-9279	OBJECTIVE	1	1	1577	SYMBOL|DICTIONARY	cyp3a5	CYP3A5	69#75		D019694	LONGTERM|DICTIONARY	chronic hepatitis b	chronic hepatitis B	136#155		To investigate the relationship between the genetic polymorphisms of CYP3A5 and the clinical effectiveness of Bicyclol on patients with chronic hepatitis B to make individual medication possible.
20068450	2010	Anesthesiology	1528-1175	RESULTS	3	9	5173	LONGTERM|DICTIONARY	dynorphin a (1-17	dynorphin A (1-17	38#55		D010146	LONGTERM|DICTIONARY	pain	pain	89#93		Furthermore, intrathecal injection of dynorphin A (1-17) at relatively high doses caused pain-associated behaviors and a remarkable increase in the activities of the cingulate cortex, somatosensory cortex, insular cortex, and medial and lateral thalamic nuclei in mice.
14970845	2004	Eur. J. Hum. Genet.	1018-4813	ALL_TEXT_1/3	1	1	5621	LONGTERM|GENE|GN|GT|DICTIONARY	prion protein	prion protein	4#17		D007562	LONGTERM|DISEASE|DT|DICTIONARY	creutzfeldt jakob disease	Creutzfeldt-Jakob disease	68#93		The prion protein gene (PRNP) plays a central role in the origin of Creutzfeldt-Jakob disease (CJD), but there is growing interest in other polymorphisms that may be involved in CJD.
14970845	2004	Eur. J. Hum. Genet.	1018-4813	ALL_TEXT_1/3	1	1	5621	LONGTERM|GENE|GN|GT|DICTIONARY	prion protein	prion protein	4#17		D007562	SYMBOL|()|DICTIONARY|EXTRACTED	cjd	CJD	95#98	14970845-1-68-93	The prion protein gene (PRNP) plays a central role in the origin of Creutzfeldt-Jakob disease (CJD), but there is growing interest in other polymorphisms that may be involved in CJD.
14970845	2004	Eur. J. Hum. Genet.	1018-4813	ALL_TEXT_1/3	1	1	5621	LONGTERM|GENE|GN|GT|DICTIONARY	prion protein	prion protein	4#17		D007562	SYMBOL|DICTIONARY|EXTRACTED	cjd	CJD	178#181	14970845-1-68-93	The prion protein gene (PRNP) plays a central role in the origin of Creutzfeldt-Jakob disease (CJD), but there is growing interest in other polymorphisms that may be involved in CJD.
12394840	2002	Transplantation	0041-1337	CONCLUSIONS	4	11	348	SYMBOL|GENE|GN|DICTIONARY	apo e	Apo E	93#98		D050171	LONGTERM|DICTIONARY	dyslipidemia	dyslipidemia	139#151		Thus, Apo E4 has a larger impact than Apo E2 on fasting-lipid profile in PTX candidates, and Apo E gene polymorphism does not worsen lipid dyslipidemia after PTX, despite introduction of immunosuppressant medications known to cause dyslipidemia.
12394840	2002	Transplantation	0041-1337	CONCLUSIONS	4	11	348	SYMBOL|GENE|GN|DICTIONARY	apo e	Apo E	93#98		D050171	LONGTERM|DICTIONARY	dyslipidemia	dyslipidemia	232#244		Thus, Apo E4 has a larger impact than Apo E2 on fasting-lipid profile in PTX candidates, and Apo E gene polymorphism does not worsen lipid dyslipidemia after PTX, despite introduction of immunosuppressant medications known to cause dyslipidemia.
20484924	2010	Int. Arch. Allergy Immunol.	1423-0097	RESULTS	3	9	3566	SYMBOL|DICTIONARY	il4r	IL4R	0#4		D001249	LONGTERM|DICTIONARY	asthma	asthma	74#80		IL4R Glu375Ala (rs1805011) and Ser411Leu (rs1805013) were associated with asthma in the asthma case-control population.
20484924	2010	Int. Arch. Allergy Immunol.	1423-0097	RESULTS	3	9	3566	SYMBOL|DICTIONARY	il4r	IL4R	0#4		D001249	LONGTERM|DICTIONARY	asthma	asthma	88#94		IL4R Glu375Ala (rs1805011) and Ser411Leu (rs1805013) were associated with asthma in the asthma case-control population.
9217972	1997	Brain Pathol.	1015-6305	ALL_TEXT_3/3	3	11	1029	SYMBOL|DICTIONARY	cdkn2	CDKN2	16#21		D005909	SYMBOL|DICTIONARY|EXTRACTED	gbm	GBM	40#43	9217972-1-0-23	The presence of CDKN2 deletions in most GBM with EGFR amplification and in generally older patients may provide one explanation for the potentially more aggressive nature of such tumors.
9217972	1997	Brain Pathol.	1015-6305	ALL_TEXT_3/3	3	11	1029	SYMBOL|DICTIONARY	cdkn2	CDKN2	16#21		D009369	LONGTERM|DICTIONARY	tumors	tumors	179#185		The presence of CDKN2 deletions in most GBM with EGFR amplification and in generally older patients may provide one explanation for the potentially more aggressive nature of such tumors.
9217972	1997	Brain Pathol.	1015-6305	ALL_TEXT_3/3	3	11	1956	SYMBOL|DICTIONARY	egfr	EGFR	49#53		D005909	SYMBOL|DICTIONARY|EXTRACTED	gbm	GBM	40#43	9217972-1-0-23	The presence of CDKN2 deletions in most GBM with EGFR amplification and in generally older patients may provide one explanation for the potentially more aggressive nature of such tumors.
9217972	1997	Brain Pathol.	1015-6305	ALL_TEXT_3/3	3	11	1956	SYMBOL|DICTIONARY	egfr	EGFR	49#53		D009369	LONGTERM|DICTIONARY	tumors	tumors	179#185		The presence of CDKN2 deletions in most GBM with EGFR amplification and in generally older patients may provide one explanation for the potentially more aggressive nature of such tumors.
16182378	2006	J. Neuroimmunol.	0165-5728	ALL_TEXT_3/3	3	13	1234	SYMBOL|DICTIONARY	ccr5	CCR5	56#60		D009103	SYMBOL|DISEASE|DN|DICTIONARY|EXTRACTED	ms	MS	133#135	16182378-1-63-81	Despite similar numbers of T-lymphocytes, there were no CCR5+ T-cells nor was CCR5 expressed in the CNS of a homozygous CCR5*Delta32 MS patient, and heterozygous patients had reduced CCR5 expression compared to wild type patients.
16182378	2006	J. Neuroimmunol.	0165-5728	ALL_TEXT_3/3	3	13	1234	SYMBOL|DICTIONARY	ccr5	CCR5	78#82		D009103	SYMBOL|DISEASE|DN|DICTIONARY|EXTRACTED	ms	MS	133#135	16182378-1-63-81	Despite similar numbers of T-lymphocytes, there were no CCR5+ T-cells nor was CCR5 expressed in the CNS of a homozygous CCR5*Delta32 MS patient, and heterozygous patients had reduced CCR5 expression compared to wild type patients.
16182378	2006	J. Neuroimmunol.	0165-5728	ALL_TEXT_3/3	3	13	1234	SYMBOL|DICTIONARY	ccr5	CCR5	120#124		D009103	SYMBOL|DISEASE|DN|DICTIONARY|EXTRACTED	ms	MS	133#135	16182378-1-63-81	Despite similar numbers of T-lymphocytes, there were no CCR5+ T-cells nor was CCR5 expressed in the CNS of a homozygous CCR5*Delta32 MS patient, and heterozygous patients had reduced CCR5 expression compared to wild type patients.
16182378	2006	J. Neuroimmunol.	0165-5728	ALL_TEXT_3/3	3	13	1234	SYMBOL|DICTIONARY	ccr5	CCR5	183#187		D009103	SYMBOL|DISEASE|DN|DICTIONARY|EXTRACTED	ms	MS	133#135	16182378-1-63-81	Despite similar numbers of T-lymphocytes, there were no CCR5+ T-cells nor was CCR5 expressed in the CNS of a homozygous CCR5*Delta32 MS patient, and heterozygous patients had reduced CCR5 expression compared to wild type patients.
10318961	1999	Proc. Natl. Acad. Sci. U.S.A.	0027-8424	ALL_TEXT_3/3	3	6	1268	LONGTERM|DICTIONARY	cb1	CB1	91#94	NaN	D002375	LONGTERM|DICTIONARY	catalepsy	catalepsy	24#33		Delta9-THC-induced ring-catalepsy, hypomobility, and hypothermia were completely absent in CB1 mutant mice.
10318961	1999	Proc. Natl. Acad. Sci. U.S.A.	0027-8424	ALL_TEXT_3/3	3	6	1268	LONGTERM|DICTIONARY	cb1	CB1	91#94	NaN	D007035	LONGTERM|DICTIONARY	hypothermia	hypothermia	53#64	NaN	Delta9-THC-induced ring-catalepsy, hypomobility, and hypothermia were completely absent in CB1 mutant mice.
10318961	1999	Proc. Natl. Acad. Sci. U.S.A.	0027-8424	TITLE	0	0	1268	SYMBOL|GENE|GN|DICTIONARY	cb1	CB1	66#69		D020018	LONGTERM|DICTIONARY	hypoactivity	hypoactivity	21#33	NaN	Increased mortality, hypoactivity, and hypoalgesia in cannabinoid CB1 receptor knockout mice.
11778498	2002	Zhonghua Jie He He Hu Xi Za Zhi	1001-0939	RESULTS	3	8	154	SYMBOL|NUMBER|DICTIONARY	beta 2 ar	beta 2-AR	26#35		D013224	LONGTERM|DICTIONARY	asthmatics	asthmatics	47#57		The frequency of genotype beta 2-AR 27 loci in asthmatics: Gln/Gln genotype accounts for 34%, Gln/Glu 56% and Glu/Glu 10%.
11778498	2002	Zhonghua Jie He He Hu Xi Za Zhi	1001-0939	RESULTS	3	6	154	SYMBOL|NUMBER|DICTIONARY	beta 2 ar	beta 2-AR	30#39		D013224	LONGTERM|DICTIONARY	asthmatics	asthmatics	51#61		(2) The frequency of genotype beta 2-AR 16 loci in asthmatics: Arg/Arg genotype accounts for 24%, Arg/Gly 45% and Gly/Gly 31%.
11159940	2001	Hum. Mol. Genet.	0964-6906	TITLE	0	0	8626	SYMBOL|DICTIONARY	p63	p63	85#88		C535847	LONGTERM|DISEASE|DT|DICTIONARY	hay wells syndrome	Hay-Wells syndrome	0#18		Hay-Wells syndrome is caused by heterozygous missense mutations in the SAM domain of p63.
11778498	2002	Zhonghua Jie He He Hu Xi Za Zhi	1001-0939	METHODS	2	2	154	SYMBOL|GENE|GN|DICTIONARY	beta 2 ar	beta 2-AR	86#95		D001249	LONGTERM|DICTIONARY	asthma	asthma	148#154		Allele Specific-PCR techniques were used to determine 16, 27 and 164 locus alleles of beta 2-AR genetic polymorphisms in 58 unrelated patients with asthma and 89 healthy controls from the people of the Han nationality of northern China.
15253766	2005	Clin. Genet.	0009-9163	TITLE	0	0	2706	SYMBOL|DICTIONARY|GENE|GA	gjb2	GJB2	45#49		D003638	LONGTERM|DICTIONARY	pre-lingual deafness	pre-lingual deafness	92#112	NaN	Spectrum and frequencies of mutations in the GJB2 (Cx26) gene among 156 Czech patients with pre-lingual deafness.
15253766	2005	Clin. Genet.	0009-9163	TITLE	0	0	2706	SYMBOL|()|GENE|GN|DICTIONARY|EXTRACTED	cx26	Cx26	51#55	15253766-0-45-49	D003638	LONGTERM|DICTIONARY	pre-lingual deafness	pre-lingual deafness	92#112	NaN	Spectrum and frequencies of mutations in the GJB2 (Cx26) gene among 156 Czech patients with pre-lingual deafness.
11778498	2002	Zhonghua Jie He He Hu Xi Za Zhi	1001-0939	OBJECTIVE	1	1	154	SYMBOL|GENE|GN|DICTIONARY	beta 2 ar	beta 2-AR	35#44		D001249	LONGTERM|DICTIONARY	asthma	asthma	70#76		To analyze the association between beta 2-AR genetic polymorphism and asthma in the people of the Han nationality of northern China.
20520958	2010	Arq Bras Endocrinol Metabol	1677-9487	RESULTS	3	6	3952	LONGTERM|DICTIONARY	leptin	leptin	123#129		D009765	LONGTERM|DICTIONARY	obesity	obesity	74#81		LEP I/G combined genotypes (I/IGG, I/IGA and I/IIGG) were associated with obesity, and increased BMI, waist circumference, leptin and triglycerides (p < 0.05).
20520958	2010	Arq Bras Endocrinol Metabol	1677-9487	RESULTS	3	6	3952	SYMBOL|DICTIONARY	lep	LEP	0#3		D009765	LONGTERM|DICTIONARY	obesity	obesity	74#81		LEP I/G combined genotypes (I/IGG, I/IGA and I/IIGG) were associated with obesity, and increased BMI, waist circumference, leptin and triglycerides (p < 0.05).
20520958	2010	Arq Bras Endocrinol Metabol	1677-9487	TITLE	0	0	3952	LONGTERM|GENE|GN|DICTIONARY	leptin	leptin	37#43		D009765	LONGTERM|DICTIONARY	obesity	obesity	53#60		Relationship between variants of the leptin gene and obesity and metabolic biomarkers in Brazilian individuals.
20520958	2010	Arq Bras Endocrinol Metabol	1677-9487	OBJECTIVE	1	1	3952	LONGTERM|GENE|GN|DICTIONARY	leptin	leptin	41#47		D009765	LONGTERM|DICTIONARY	obesity	obesity	63#70		The relationship between variants of the leptin gene (LEP) and obesity and metabolic biomarkers was investigated in Brazilian individuals.
12167522	2002	J Affect Disord	0165-0327	TITLE	0	0	3356	SYMBOL|()|DICTIONARY	htr2a	HTR2A	48#53		D001289	SYMBOL|()|DICTIONARY|EXTRACTED	adhd	ADHD	123#127	12167522-0-71-121	Polymorphism of the serotonin-2A receptor gene (HTR2A) associated with childhood attention deficit hyperactivity disorder (ADHD) in adult women with seasonal affective disorder.
12167522	2002	J Affect Disord	0165-0327	TITLE	0	0	3356	SYMBOL|()|DICTIONARY	htr2a	HTR2A	48#53		D016574	LONGTERM|DISEASE|DT|DICTIONARY	seasonal affective disorder	seasonal affective disorder	149#176		Polymorphism of the serotonin-2A receptor gene (HTR2A) associated with childhood attention deficit hyperactivity disorder (ADHD) in adult women with seasonal affective disorder.
12167522	2002	J Affect Disord	0165-0327	TITLE	0	0	3356	SYMBOL|()|DICTIONARY	htr2a	HTR2A	48#53		D001289	LONGTERM|DISEASE|DT|DICTIONARY	attention deficit hyperactivity disorder	attention deficit hyperactivity disorder	81#121		Polymorphism of the serotonin-2A receptor gene (HTR2A) associated with childhood attention deficit hyperactivity disorder (ADHD) in adult women with seasonal affective disorder.
20520958	2010	Arq Bras Endocrinol Metabol	1677-9487	RESULTS	3	8	3952	SYMBOL|DICTIONARY	lep	LEP	0#3		D006973	LONGTERM|DICTIONARY	hypertension	hypertension	52#64		LEP I/G combined genotypes were not associated with hypertension, hyperglycemia, dyslipidemia and coronary artery disease.
20520958	2010	Arq Bras Endocrinol Metabol	1677-9487	RESULTS	3	8	3952	SYMBOL|DICTIONARY	lep	LEP	0#3		D006943	LONGTERM|DICTIONARY	hyperglycemia	hyperglycemia	66#79		LEP I/G combined genotypes were not associated with hypertension, hyperglycemia, dyslipidemia and coronary artery disease.
20520958	2010	Arq Bras Endocrinol Metabol	1677-9487	RESULTS	3	8	3952	SYMBOL|DICTIONARY	lep	LEP	0#3		D050171	LONGTERM|DICTIONARY	dyslipidemia	dyslipidemia	81#93		LEP I/G combined genotypes were not associated with hypertension, hyperglycemia, dyslipidemia and coronary artery disease.
20520958	2010	Arq Bras Endocrinol Metabol	1677-9487	RESULTS	3	8	3952	SYMBOL|DICTIONARY	lep	LEP	0#3		D003324	LONGTERM|DISEASE|DT|DICTIONARY	coronary artery disease	coronary artery disease	98#121		LEP I/G combined genotypes were not associated with hypertension, hyperglycemia, dyslipidemia and coronary artery disease.
12167522	2002	J Affect Disord	0165-0327	INTRODUCTION	1	3	3356	SYMBOL|DICTIONARY	htr2a	HTR2A	52#57		D001289	SYMBOL|DICTIONARY|EXTRACTED	adhd	ADHD	100#104	12167522-0-71-121	The current study investigated whether variation in HTR2A was associated with symptoms of childhood ADHD in adult women with SAD.
12167522	2002	J Affect Disord	0165-0327	INTRODUCTION	1	3	3356	SYMBOL|DICTIONARY	htr2a	HTR2A	52#57		D016574	SYMBOL|DICTIONARY|EXTRACTED	sad	SAD	125#128	12167522-1-62-89	The current study investigated whether variation in HTR2A was associated with symptoms of childhood ADHD in adult women with SAD.
16012724	2005	Oncol. Rep.	1021-335X	ALL_TEXT_3/3	3	4	2264	SYMBOL|DICTIONARY	fgfr4	FGFR4	71#76		D001943	LONGTERM|DISEASE|DT|DICTIONARY	breast cancer	breast cancer	121#134		A pooled analysis of the present and published data on nodal status by FGFR4 genotypes revealed no association in either breast cancer [odds ratio (OR), 1.0; 95% confidence interval (CI), 0.7-1.4; 702 subjects] or colorectal cancer (OR, 1.4; 95% CI, 0.6-3.4; 260 cases).
16012724	2005	Oncol. Rep.	1021-335X	ALL_TEXT_3/3	3	4	2264	SYMBOL|DICTIONARY	fgfr4	FGFR4	71#76		D015179	LONGTERM|DISEASE|DT|DICTIONARY	colorectal cancer	colorectal cancer	214#231		A pooled analysis of the present and published data on nodal status by FGFR4 genotypes revealed no association in either breast cancer [odds ratio (OR), 1.0; 95% confidence interval (CI), 0.7-1.4; 702 subjects] or colorectal cancer (OR, 1.4; 95% CI, 0.6-3.4; 260 cases).
12167522	2002	J Affect Disord	0165-0327	INTRODUCTION	1	2	3356	SYMBOL|()|DICTIONARY	htr2a	HTR2A	76#81		D016574	SYMBOL|DICTIONARY|EXTRACTED	sad	SAD	103#106	12167522-1-62-89	There is also emerging evidence that variation of the 5-HT2A receptor gene (HTR2A) contributes to both SAD and ADHD.
12167522	2002	J Affect Disord	0165-0327	INTRODUCTION	1	2	3356	SYMBOL|()|DICTIONARY	htr2a	HTR2A	76#81		D001289	SYMBOL|DICTIONARY|EXTRACTED	adhd	ADHD	111#115	12167522-0-71-121	There is also emerging evidence that variation of the 5-HT2A receptor gene (HTR2A) contributes to both SAD and ADHD.
12167522	2002	J Affect Disord	0165-0327	INTRODUCTION	1	2	3356	SYMBOL|GENE|GN|DICTIONARY	5-ht2a receptor	5-HT2A receptor	54#69		D016574	SYMBOL|DICTIONARY|EXTRACTED	sad	SAD	103#106	12167522-1-62-89	There is also emerging evidence that variation of the 5-HT2A receptor gene (HTR2A) contributes to both SAD and ADHD.
12167522	2002	J Affect Disord	0165-0327	INTRODUCTION	1	2	3356	SYMBOL|GENE|GN|DICTIONARY	5-ht2a receptor	5-HT2A receptor	54#69		D001289	SYMBOL|DICTIONARY|EXTRACTED	adhd	ADHD	111#115	12167522-0-71-121	There is also emerging evidence that variation of the 5-HT2A receptor gene (HTR2A) contributes to both SAD and ADHD.
16012724	2005	Oncol. Rep.	1021-335X	TITLE	0	0	2264	SYMBOL|DICTIONARY	fgfr4	FGFR4	0#5		D001943	LONGTERM|DISEASE|DT|DICTIONARY	breast and colorectal cancer	breast and colorectal cancer	46#74		FGFR4 Gly388Arg polymorphism and prognosis of breast and colorectal cancer.
16012724	2005	Oncol. Rep.	1021-335X	ALL_TEXT_1/3	1	1	2264	SYMBOL|GENE|GN|DICTIONARY	fgfr4	FGFR4	40#45		D001943	LONGTERM|DISEASE|DT|DICTIONARY	breast and colorectal cancer	breast and colorectal cancer	91#119		A functional Gly388Arg variation in the FGFR4 gene has been reported to be associated with breast and colorectal cancer prognostic parameters.
20699619	2010	J Nutrigenet Nutrigenomics	1661-6499	RESULTS	3	10	6721	SYMBOL|DICTIONARY	srebp 2	SREBP-2	20#27		D018149	SYMBOL|EXTRACTED	igt	IGT	51#54	20699619-1-4-30	The upregulation of SREBP-2 was more pronounced in IGT men (p = 0.049).
11354633	2001	Hum. Genet.	0340-6717	ALL_TEXT_1/3	1	2	1080	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	cftr	CFTR	43#47	11354633-1-41-92	D001249	LONGTERM|DICTIONARY	asthma	asthma	145#151		Analysis of the whole coding region of the CFTR gene and its flanking intronic regions revealed that the proportion of CFTR mutations was 45% in asthma (P<0.05), 26.3% in DB (P>0.05), 16.7% in COPD (P>0.05), compared to 15.4% in the general population.
11354633	2001	Hum. Genet.	0340-6717	ALL_TEXT_1/3	1	2	1080	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	cftr	CFTR	43#47	11354633-1-41-92	D029424	SYMBOL|DICTIONARY|EXTRACTED	copd	COPD	193#197	11354633-1-314-351	Analysis of the whole coding region of the CFTR gene and its flanking intronic regions revealed that the proportion of CFTR mutations was 45% in asthma (P<0.05), 26.3% in DB (P>0.05), 16.7% in COPD (P>0.05), compared to 15.4% in the general population.
11354633	2001	Hum. Genet.	0340-6717	ALL_TEXT_1/3	1	2	1080	SYMBOL|DICTIONARY|EXTRACTED	cftr	CFTR	119#123	11354633-1-41-92	D001249	LONGTERM|DICTIONARY	asthma	asthma	145#151		Analysis of the whole coding region of the CFTR gene and its flanking intronic regions revealed that the proportion of CFTR mutations was 45% in asthma (P<0.05), 26.3% in DB (P>0.05), 16.7% in COPD (P>0.05), compared to 15.4% in the general population.
11354633	2001	Hum. Genet.	0340-6717	ALL_TEXT_1/3	1	2	1080	SYMBOL|DICTIONARY|EXTRACTED	cftr	CFTR	119#123	11354633-1-41-92	D029424	SYMBOL|DICTIONARY|EXTRACTED	copd	COPD	193#197	11354633-1-314-351	Analysis of the whole coding region of the CFTR gene and its flanking intronic regions revealed that the proportion of CFTR mutations was 45% in asthma (P<0.05), 26.3% in DB (P>0.05), 16.7% in COPD (P>0.05), compared to 15.4% in the general population.
11354633	2001	Hum. Genet.	0340-6717	ALL_TEXT_1/3	1	1	1080	LONGTERM|DICTIONARY|GENE|GA	cystic fibrosis transmembrane conductance regulator	cystic fibrosis transmembrane conductance regulator	41#92		D008171	LONGTERM|DISEASE|DT|DICTIONARY	pulmonary disease	pulmonary disease	152#169		In order to investigate the incidence of cystic fibrosis transmembrane conductance regulator (CFTR) gene mutations and unclassified variants in chronic pulmonary disease in children and adults, we studied 20 patients with asthma, 19 with disseminated bronchiectasis (DB) of unknown aetiology, and 12 patients with chronic obstructive pulmonary disease (COPD), and compared the results to 52 subjects from the general Greek population.
11354633	2001	Hum. Genet.	0340-6717	ALL_TEXT_1/3	1	1	1080	LONGTERM|DICTIONARY|GENE|GA	cystic fibrosis transmembrane conductance regulator	cystic fibrosis transmembrane conductance regulator	41#92		D001249	LONGTERM|NUMBER|DICTIONARY	asthma	asthma	222#228		In order to investigate the incidence of cystic fibrosis transmembrane conductance regulator (CFTR) gene mutations and unclassified variants in chronic pulmonary disease in children and adults, we studied 20 patients with asthma, 19 with disseminated bronchiectasis (DB) of unknown aetiology, and 12 patients with chronic obstructive pulmonary disease (COPD), and compared the results to 52 subjects from the general Greek population.
11354633	2001	Hum. Genet.	0340-6717	ALL_TEXT_1/3	1	1	1080	LONGTERM|DICTIONARY|GENE|GA	cystic fibrosis transmembrane conductance regulator	cystic fibrosis transmembrane conductance regulator	41#92		D001987	LONGTERM|DICTIONARY	bronchiectasis	bronchiectasis	251#265		In order to investigate the incidence of cystic fibrosis transmembrane conductance regulator (CFTR) gene mutations and unclassified variants in chronic pulmonary disease in children and adults, we studied 20 patients with asthma, 19 with disseminated bronchiectasis (DB) of unknown aetiology, and 12 patients with chronic obstructive pulmonary disease (COPD), and compared the results to 52 subjects from the general Greek population.
11354633	2001	Hum. Genet.	0340-6717	ALL_TEXT_1/3	1	1	1080	LONGTERM|DICTIONARY|GENE|GA	cystic fibrosis transmembrane conductance regulator	cystic fibrosis transmembrane conductance regulator	41#92		D029424	LONGTERM|DICTIONARY	chronic obstructive pulmonary disease	chronic obstructive pulmonary disease	314#351		In order to investigate the incidence of cystic fibrosis transmembrane conductance regulator (CFTR) gene mutations and unclassified variants in chronic pulmonary disease in children and adults, we studied 20 patients with asthma, 19 with disseminated bronchiectasis (DB) of unknown aetiology, and 12 patients with chronic obstructive pulmonary disease (COPD), and compared the results to 52 subjects from the general Greek population.
11354633	2001	Hum. Genet.	0340-6717	ALL_TEXT_1/3	1	1	1080	LONGTERM|DICTIONARY|GENE|GA	cystic fibrosis transmembrane conductance regulator	cystic fibrosis transmembrane conductance regulator	41#92		D029424	SYMBOL|()|DICTIONARY|EXTRACTED	copd	COPD	353#357	11354633-1-314-351	In order to investigate the incidence of cystic fibrosis transmembrane conductance regulator (CFTR) gene mutations and unclassified variants in chronic pulmonary disease in children and adults, we studied 20 patients with asthma, 19 with disseminated bronchiectasis (DB) of unknown aetiology, and 12 patients with chronic obstructive pulmonary disease (COPD), and compared the results to 52 subjects from the general Greek population.
11354633	2001	Hum. Genet.	0340-6717	ALL_TEXT_1/3	1	1	1080	SYMBOL|()|GENE|GN|DICTIONARY|EXTRACTED	cftr	CFTR	94#98	11354633-1-41-92	D008171	LONGTERM|DISEASE|DT|DICTIONARY	pulmonary disease	pulmonary disease	152#169		In order to investigate the incidence of cystic fibrosis transmembrane conductance regulator (CFTR) gene mutations and unclassified variants in chronic pulmonary disease in children and adults, we studied 20 patients with asthma, 19 with disseminated bronchiectasis (DB) of unknown aetiology, and 12 patients with chronic obstructive pulmonary disease (COPD), and compared the results to 52 subjects from the general Greek population.
11354633	2001	Hum. Genet.	0340-6717	ALL_TEXT_1/3	1	1	1080	SYMBOL|()|GENE|GN|DICTIONARY|EXTRACTED	cftr	CFTR	94#98	11354633-1-41-92	D001249	LONGTERM|NUMBER|DICTIONARY	asthma	asthma	222#228		In order to investigate the incidence of cystic fibrosis transmembrane conductance regulator (CFTR) gene mutations and unclassified variants in chronic pulmonary disease in children and adults, we studied 20 patients with asthma, 19 with disseminated bronchiectasis (DB) of unknown aetiology, and 12 patients with chronic obstructive pulmonary disease (COPD), and compared the results to 52 subjects from the general Greek population.
11354633	2001	Hum. Genet.	0340-6717	ALL_TEXT_1/3	1	1	1080	SYMBOL|()|GENE|GN|DICTIONARY|EXTRACTED	cftr	CFTR	94#98	11354633-1-41-92	D001987	LONGTERM|DICTIONARY	bronchiectasis	bronchiectasis	251#265		In order to investigate the incidence of cystic fibrosis transmembrane conductance regulator (CFTR) gene mutations and unclassified variants in chronic pulmonary disease in children and adults, we studied 20 patients with asthma, 19 with disseminated bronchiectasis (DB) of unknown aetiology, and 12 patients with chronic obstructive pulmonary disease (COPD), and compared the results to 52 subjects from the general Greek population.
11354633	2001	Hum. Genet.	0340-6717	ALL_TEXT_1/3	1	1	1080	SYMBOL|()|GENE|GN|DICTIONARY|EXTRACTED	cftr	CFTR	94#98	11354633-1-41-92	D029424	LONGTERM|DICTIONARY	chronic obstructive pulmonary disease	chronic obstructive pulmonary disease	314#351		In order to investigate the incidence of cystic fibrosis transmembrane conductance regulator (CFTR) gene mutations and unclassified variants in chronic pulmonary disease in children and adults, we studied 20 patients with asthma, 19 with disseminated bronchiectasis (DB) of unknown aetiology, and 12 patients with chronic obstructive pulmonary disease (COPD), and compared the results to 52 subjects from the general Greek population.
11354633	2001	Hum. Genet.	0340-6717	ALL_TEXT_1/3	1	1	1080	SYMBOL|()|GENE|GN|DICTIONARY|EXTRACTED	cftr	CFTR	94#98	11354633-1-41-92	D029424	SYMBOL|()|DICTIONARY|EXTRACTED	copd	COPD	353#357	11354633-1-314-351	In order to investigate the incidence of cystic fibrosis transmembrane conductance regulator (CFTR) gene mutations and unclassified variants in chronic pulmonary disease in children and adults, we studied 20 patients with asthma, 19 with disseminated bronchiectasis (DB) of unknown aetiology, and 12 patients with chronic obstructive pulmonary disease (COPD), and compared the results to 52 subjects from the general Greek population.
11354633	2001	Hum. Genet.	0340-6717	TITLE	0	0	1080	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	cftr	CFTR	0#4		D001249	LONGTERM|DICTIONARY	asthma	asthma	111#117		CFTR gene mutations--including three novel nucleotide substitutions--and haplotype background in patients with asthma, disseminated bronchiectasis and chronic obstructive pulmonary disease.
11354633	2001	Hum. Genet.	0340-6717	TITLE	0	0	1080	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	cftr	CFTR	0#4		D001987	LONGTERM|DICTIONARY	bronchiectasis	bronchiectasis	132#146		CFTR gene mutations--including three novel nucleotide substitutions--and haplotype background in patients with asthma, disseminated bronchiectasis and chronic obstructive pulmonary disease.
11354633	2001	Hum. Genet.	0340-6717	TITLE	0	0	1080	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	cftr	CFTR	0#4		D029424	LONGTERM|DISEASE|DT|DICTIONARY	chronic obstructive pulmonary disease	chronic obstructive pulmonary disease	151#188		CFTR gene mutations--including three novel nucleotide substitutions--and haplotype background in patients with asthma, disseminated bronchiectasis and chronic obstructive pulmonary disease.
11354633	2001	Hum. Genet.	0340-6717	ALL_TEXT_3/3	3	7	1080	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	cftr	CFTR	45#49	11354633-1-41-92	D001249	LONGTERM|DICTIONARY	asthma	asthma	58#64		These results confirm the involvement of the CFTR gene in asthma, DB and possibly in COPD.
11354633	2001	Hum. Genet.	0340-6717	ALL_TEXT_3/3	3	7	1080	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	cftr	CFTR	45#49	11354633-1-41-92	D029424	SYMBOL|DICTIONARY|EXTRACTED	copd	COPD	85#89	11354633-1-314-351	These results confirm the involvement of the CFTR gene in asthma, DB and possibly in COPD.
11354633	2001	Hum. Genet.	0340-6717	ALL_TEXT_3/3	3	6	1080	SYMBOL|DICTIONARY|EXTRACTED	cftr	CFTR	41#45	11354633-1-41-92	D001249	LONGTERM|DISEASE|DN|DICTIONARY	asthma	asthma	203#209		The study of the TGmTnM470 V polyvariant CFTR allele revealed the presence of CFTR function-modulating haplotypes TG13/T5/M470, TG11/T5/M470, TG12/T5/V470 and TG12/T7, combined with M470 or V470, in six asthma patients, four DB patients (P<0.01), and two COPD patients (P<0.05).
11354633	2001	Hum. Genet.	0340-6717	ALL_TEXT_3/3	3	6	1080	SYMBOL|DICTIONARY|EXTRACTED	cftr	CFTR	41#45	11354633-1-41-92	D029424	SYMBOL|DISEASE|DN|DICTIONARY|EXTRACTED	copd	COPD	255#259	11354633-1-314-351	The study of the TGmTnM470 V polyvariant CFTR allele revealed the presence of CFTR function-modulating haplotypes TG13/T5/M470, TG11/T5/M470, TG12/T5/V470 and TG12/T7, combined with M470 or V470, in six asthma patients, four DB patients (P<0.01), and two COPD patients (P<0.05).
11354633	2001	Hum. Genet.	0340-6717	ALL_TEXT_3/3	3	6	1080	SYMBOL|DICTIONARY|EXTRACTED	cftr	CFTR	78#82	11354633-1-41-92	D001249	LONGTERM|DISEASE|DN|DICTIONARY	asthma	asthma	203#209		The study of the TGmTnM470 V polyvariant CFTR allele revealed the presence of CFTR function-modulating haplotypes TG13/T5/M470, TG11/T5/M470, TG12/T5/V470 and TG12/T7, combined with M470 or V470, in six asthma patients, four DB patients (P<0.01), and two COPD patients (P<0.05).
11354633	2001	Hum. Genet.	0340-6717	ALL_TEXT_3/3	3	6	1080	SYMBOL|DICTIONARY|EXTRACTED	cftr	CFTR	78#82	11354633-1-41-92	D029424	SYMBOL|DISEASE|DN|DICTIONARY|EXTRACTED	copd	COPD	255#259	11354633-1-314-351	The study of the TGmTnM470 V polyvariant CFTR allele revealed the presence of CFTR function-modulating haplotypes TG13/T5/M470, TG11/T5/M470, TG12/T5/V470 and TG12/T7, combined with M470 or V470, in six asthma patients, four DB patients (P<0.01), and two COPD patients (P<0.05).
15956634	2005	JAMA	1538-3598	CONTEXT	1	2	348	SYMBOL|DICTIONARY|EXTRACTED	apoe	APOE	0#4		D051436	LONGTERM|DISEASE|DT|DICTIONARY	chronic kidney disease	chronic kidney disease	31#53		APOE allelic associations with chronic kidney disease beyond diabetic nephropathy are unknown, with no studies reported in high-risk African American populations.
15956634	2005	JAMA	1538-3598	CONTEXT	1	2	348	SYMBOL|DICTIONARY|EXTRACTED	apoe	APOE	0#4		D003928	LONGTERM|DICTIONARY	diabetic nephropathy	diabetic nephropathy	61#81		APOE allelic associations with chronic kidney disease beyond diabetic nephropathy are unknown, with no studies reported in high-risk African American populations.
15956634	2005	JAMA	1538-3598	OBJECTIVE	2	3	348	SYMBOL|DICTIONARY|EXTRACTED	apoe	APOE	75#79	15956634-1-0-16	D051436	LONGTERM|DISEASE|DT|DICTIONARY	chronic kidney disease	chronic kidney disease	24#46		To quantify the risk of chronic kidney disease progression associated with APOE in a population-based study including white, African American, diabetic, and nondiabetic individuals.
15956634	2005	JAMA	1538-3598	OBJECTIVE	2	3	348	SYMBOL|DICTIONARY|EXTRACTED	apoe	APOE	75#79	15956634-1-0-16	D003920	LONGTERM|DICTIONARY	diabetic	diabetic	143#151	NaN	To quantify the risk of chronic kidney disease progression associated with APOE in a population-based study including white, African American, diabetic, and nondiabetic individuals.
19446452	2009	Breast	1532-3080	TITLE	0	0	7515	SYMBOL|GENE|GN|DICTIONARY	xrcc1	XRCC1	0#5		D001943	LONGTERM|DISEASE|DT|DICTIONARY	breast cancer	breast cancer	29#42		XRCC1 gene polymorphisms and breast cancer risk in different populations: a meta-analysis.
19846968	2009	Anticancer Res.	1791-7530	BACKGROUND	1	2	7515	SYMBOL|GENE|GN|DICTIONARY	xrcc1	XRCC1	37#42		D006258	LONGTERM|DISEASE|DT|DICTIONARY	head and neck cancer	head and neck cancer	174#194		Because of the important role of the XRCC1 gene in DNA repair, we wanted to test the effects of the Arg194Trp and Arg399Gln polymorphisms of XRCC1 on the clinical outcome of head and neck cancer.
19846968	2009	Anticancer Res.	1791-7530	BACKGROUND	1	2	7515	SYMBOL|DICTIONARY	xrcc1	XRCC1	141#146		D006258	LONGTERM|DISEASE|DT|DICTIONARY	head and neck cancer	head and neck cancer	174#194		Because of the important role of the XRCC1 gene in DNA repair, we wanted to test the effects of the Arg194Trp and Arg399Gln polymorphisms of XRCC1 on the clinical outcome of head and neck cancer.
16183801	2006	J. Med. Genet.	1468-6244	ALL_TEXT_1/3	1	2	4204	SYMBOL|DICTIONARY	mecp2	MECP2	150#155		D015518	LONGTERM|DISEASE|DT|DICTIONARY	rett syndrome	Rett syndrome	68#81		We recruited 110 patients who fulfilled the diagnostic criteria for Rett syndrome and were referred to Cardiff for molecular analysis, but in whom an MECP2 mutation was not identifiable.
17949231	2008	Neoplasma	0028-2685	ALL_TEXT_3/3	3	5	3576	SYMBOL|DICTIONARY	il 8	IL-8	15#19		D001943	LONGTERM|DISEASE|DT|GFAM|FN|DICTIONARY	invasive ductal carcinoma type of breast cancer	invasive ductal carcinoma type of breast cancer	75#122		In conclusion, IL-8 -251T/A polymorphism is associated with development of invasive ductal carcinoma type of breast cancer while CXCR2 +1208C/T polymorphism may affect the disease progression.
17949231	2008	Neoplasma	0028-2685	ALL_TEXT_3/3	3	5	3576	SYMBOL|DICTIONARY	il 8	IL-8	15#19		D001943	LONGTERM|DISEASE|DT|DICTIONARY	invasive ductal carcinoma type of breast cancer	invasive ductal carcinoma type of breast cancer	75#122		In conclusion, IL-8 -251T/A polymorphism is associated with development of invasive ductal carcinoma type of breast cancer while CXCR2 +1208C/T polymorphism may affect the disease progression.
17949231	2008	Neoplasma	0028-2685	ALL_TEXT_3/3	3	5	3579	SYMBOL|DICTIONARY	cxcr2	CXCR2	129#134		D001943	LONGTERM|DISEASE|DT|GFAM|FN|DICTIONARY	invasive ductal carcinoma type of breast cancer	invasive ductal carcinoma type of breast cancer	75#122		In conclusion, IL-8 -251T/A polymorphism is associated with development of invasive ductal carcinoma type of breast cancer while CXCR2 +1208C/T polymorphism may affect the disease progression.
17949231	2008	Neoplasma	0028-2685	ALL_TEXT_3/3	3	5	3579	SYMBOL|DICTIONARY	cxcr2	CXCR2	129#134		D001943	LONGTERM|DISEASE|DT|DICTIONARY	invasive ductal carcinoma type of breast cancer	invasive ductal carcinoma type of breast cancer	75#122		In conclusion, IL-8 -251T/A polymorphism is associated with development of invasive ductal carcinoma type of breast cancer while CXCR2 +1208C/T polymorphism may affect the disease progression.
17949231	2008	Neoplasma	0028-2685	ALL_TEXT_3/3	3	4	3579	SYMBOL|DICTIONARY	cxcr2	CXCR2	60#65		D009369	LONGTERM|DICTIONARY	tumors	tumors	10#16		Also, ER- tumors showed an approximately significant higher CXCR2 +1208 TT genotype compared to ER+ tumors (18.6% and 7.1%, respectively; p=0.07).
17949231	2008	Neoplasma	0028-2685	ALL_TEXT_3/3	3	4	3579	SYMBOL|DICTIONARY	cxcr2	CXCR2	60#65		D009369	LONGTERM|DICTIONARY	tumors	tumors	100#106		Also, ER- tumors showed an approximately significant higher CXCR2 +1208 TT genotype compared to ER+ tumors (18.6% and 7.1%, respectively; p=0.07).
17949231	2008	Neoplasma	0028-2685	ALL_TEXT_1/3	1	1	3576	SYMBOL|DICTIONARY	il 8	IL-8	145#149		D001943	LONGTERM|DISEASE|DN|DT|DICTIONARY	breast cancer	breast cancer	35#48		A case-control study involving 257 breast cancer patients with invasive ductal carcinoma and 233 healthy women was carried out to explore if the IL-8 -251T/A polymorphism and the CXCR2 +1208 C/T polymorphism have a role in breast cancer susceptibility.
17949231	2008	Neoplasma	0028-2685	ALL_TEXT_1/3	1	1	3576	SYMBOL|DICTIONARY	il 8	IL-8	145#149		D044584	LONGTERM|DISEASE|DT|DICTIONARY	invasive ductal carcinoma	invasive ductal carcinoma	63#88		A case-control study involving 257 breast cancer patients with invasive ductal carcinoma and 233 healthy women was carried out to explore if the IL-8 -251T/A polymorphism and the CXCR2 +1208 C/T polymorphism have a role in breast cancer susceptibility.
17949231	2008	Neoplasma	0028-2685	ALL_TEXT_1/3	1	1	3576	SYMBOL|DICTIONARY	il 8	IL-8	145#149		D001943	LONGTERM|DISEASE|DT|DICTIONARY	breast cancer	breast cancer	223#236		A case-control study involving 257 breast cancer patients with invasive ductal carcinoma and 233 healthy women was carried out to explore if the IL-8 -251T/A polymorphism and the CXCR2 +1208 C/T polymorphism have a role in breast cancer susceptibility.
17949231	2008	Neoplasma	0028-2685	ALL_TEXT_1/3	1	1	3579	SYMBOL|DICTIONARY	cxcr2	CXCR2	179#184		D001943	LONGTERM|DISEASE|DN|DT|DICTIONARY	breast cancer	breast cancer	35#48		A case-control study involving 257 breast cancer patients with invasive ductal carcinoma and 233 healthy women was carried out to explore if the IL-8 -251T/A polymorphism and the CXCR2 +1208 C/T polymorphism have a role in breast cancer susceptibility.
17949231	2008	Neoplasma	0028-2685	ALL_TEXT_1/3	1	1	3579	SYMBOL|DICTIONARY	cxcr2	CXCR2	179#184		D044584	LONGTERM|DISEASE|DT|DICTIONARY	invasive ductal carcinoma	invasive ductal carcinoma	63#88		A case-control study involving 257 breast cancer patients with invasive ductal carcinoma and 233 healthy women was carried out to explore if the IL-8 -251T/A polymorphism and the CXCR2 +1208 C/T polymorphism have a role in breast cancer susceptibility.
17949231	2008	Neoplasma	0028-2685	ALL_TEXT_1/3	1	1	3579	SYMBOL|DICTIONARY	cxcr2	CXCR2	179#184		D001943	LONGTERM|DISEASE|DT|DICTIONARY	breast cancer	breast cancer	223#236		A case-control study involving 257 breast cancer patients with invasive ductal carcinoma and 233 healthy women was carried out to explore if the IL-8 -251T/A polymorphism and the CXCR2 +1208 C/T polymorphism have a role in breast cancer susceptibility.
17949231	2008	Neoplasma	0028-2685	TITLE	0	0	3576	LONGTERM|DICTIONARY	interleukin 8	interleukin-8	15#28		D001943	LONGTERM|DISEASE|DT|DICTIONARY	breast cancer	breast cancer	96#109		Association of interleukin-8 (IL-8 or CXCL8) -251T/A and CXCR2 +1208C/T gene polymorphisms with breast cancer.
17949231	2008	Neoplasma	0028-2685	TITLE	0	0	3576	SYMBOL|DICTIONARY	il 8	IL-8	30#34		D001943	LONGTERM|DISEASE|DT|DICTIONARY	breast cancer	breast cancer	96#109		Association of interleukin-8 (IL-8 or CXCL8) -251T/A and CXCR2 +1208C/T gene polymorphisms with breast cancer.
17949231	2008	Neoplasma	0028-2685	TITLE	0	0	3576	SYMBOL|DICTIONARY	cxcl8	CXCL8	38#43		D001943	LONGTERM|DISEASE|DT|DICTIONARY	breast cancer	breast cancer	96#109		Association of interleukin-8 (IL-8 or CXCL8) -251T/A and CXCR2 +1208C/T gene polymorphisms with breast cancer.
17949231	2008	Neoplasma	0028-2685	TITLE	0	0	3579	SYMBOL|DICTIONARY	cxcr2	CXCR2	57#62		D001943	LONGTERM|DISEASE|DT|DICTIONARY	breast cancer	breast cancer	96#109		Association of interleukin-8 (IL-8 or CXCL8) -251T/A and CXCR2 +1208C/T gene polymorphisms with breast cancer.
20979931	2011	Int J Clin Pharmacol Ther	0946-1965	METHODS	2	2	2067	LONGTERM|DICTIONARY	excision repair cross complementation group 1	excision repair cross-complementation Group 1	224#269		D015179	LONGTERM|DISEASE|DT|DICTIONARY	colorectal cancer	colorectal cancer	51#68		We retrospectively studied 51 Japanese adults with colorectal cancer who had received oxaliplatin-based chemotherapy to explore the pharmacogenetic association between oxaliplatin-induced neuropathy and polymorphisms of the excision repair cross-complementation Group 1 (ERCC1) and glutathione-S-transferases pi 1 (GSTP1) genes.
20979931	2011	Int J Clin Pharmacol Ther	0946-1965	METHODS	2	2	2067	LONGTERM|DICTIONARY	excision repair cross complementation group 1	excision repair cross-complementation Group 1	224#269		D009422	LONGTERM|DICTIONARY	neuropathy	neuropathy	188#198		We retrospectively studied 51 Japanese adults with colorectal cancer who had received oxaliplatin-based chemotherapy to explore the pharmacogenetic association between oxaliplatin-induced neuropathy and polymorphisms of the excision repair cross-complementation Group 1 (ERCC1) and glutathione-S-transferases pi 1 (GSTP1) genes.
20979931	2011	Int J Clin Pharmacol Ther	0946-1965	METHODS	2	2	2067	SYMBOL|()|DICTIONARY|EXTRACTED	ercc1	ERCC1	271#276	20979931-2-224-269	D015179	LONGTERM|DISEASE|DT|DICTIONARY	colorectal cancer	colorectal cancer	51#68		We retrospectively studied 51 Japanese adults with colorectal cancer who had received oxaliplatin-based chemotherapy to explore the pharmacogenetic association between oxaliplatin-induced neuropathy and polymorphisms of the excision repair cross-complementation Group 1 (ERCC1) and glutathione-S-transferases pi 1 (GSTP1) genes.
20979931	2011	Int J Clin Pharmacol Ther	0946-1965	METHODS	2	2	2067	SYMBOL|()|DICTIONARY|EXTRACTED	ercc1	ERCC1	271#276	20979931-2-224-269	D009422	LONGTERM|DICTIONARY	neuropathy	neuropathy	188#198		We retrospectively studied 51 Japanese adults with colorectal cancer who had received oxaliplatin-based chemotherapy to explore the pharmacogenetic association between oxaliplatin-induced neuropathy and polymorphisms of the excision repair cross-complementation Group 1 (ERCC1) and glutathione-S-transferases pi 1 (GSTP1) genes.
20979931	2011	Int J Clin Pharmacol Ther	0946-1965	METHODS	2	2	2950	SYMBOL|()|GENE|GN|DICTIONARY	gstp1	GSTP1	315#320		D015179	LONGTERM|DISEASE|DT|DICTIONARY	colorectal cancer	colorectal cancer	51#68		We retrospectively studied 51 Japanese adults with colorectal cancer who had received oxaliplatin-based chemotherapy to explore the pharmacogenetic association between oxaliplatin-induced neuropathy and polymorphisms of the excision repair cross-complementation Group 1 (ERCC1) and glutathione-S-transferases pi 1 (GSTP1) genes.
20979931	2011	Int J Clin Pharmacol Ther	0946-1965	METHODS	2	2	2950	SYMBOL|()|GENE|GN|DICTIONARY	gstp1	GSTP1	315#320		D009422	LONGTERM|DICTIONARY	neuropathy	neuropathy	188#198		We retrospectively studied 51 Japanese adults with colorectal cancer who had received oxaliplatin-based chemotherapy to explore the pharmacogenetic association between oxaliplatin-induced neuropathy and polymorphisms of the excision repair cross-complementation Group 1 (ERCC1) and glutathione-S-transferases pi 1 (GSTP1) genes.
12928685	2003	Eye (Lond)	0950-222X	TITLE	0	0	2153	LONGTERM|DICTIONARY	factor v leiden	factor V Leiden	8#23		D015356	LONGTERM|DICTIONARY	retinal artery occlusion	retinal artery occlusion	64#88		Role of factor V Leiden and prothrombin 20210A in patients with retinal artery occlusion.
15189946	2004	Chest	0012-3692	MEASUREMENTS AND RESULTS	6	12	3458	LONGTERM|DICTIONARY	ifn-gamma	IFN-gamma	213#222	NaN	D012770	LONGTERM|DICTIONARY	cardiogenic shock	cardiogenic shock	86#103	NaN	There were no significant differences in TNF-2 polymorphism between the patients with cardiogenic shock and a group of healthy control subjects (7 of 33 patients vs 13 of 48 subjects, respectively; p = 0.61), but IFN-gamma polymorphism was less common in the cardiogenic shock group (p = 0.034).
15189946	2004	Chest	0012-3692	MEASUREMENTS AND RESULTS	6	12	3458	LONGTERM|DICTIONARY	ifn-gamma	IFN-gamma	213#222	NaN	D012770	LONGTERM|DICTIONARY	cardiogenic shock	cardiogenic shock	259#276	NaN	There were no significant differences in TNF-2 polymorphism between the patients with cardiogenic shock and a group of healthy control subjects (7 of 33 patients vs 13 of 48 subjects, respectively; p = 0.61), but IFN-gamma polymorphism was less common in the cardiogenic shock group (p = 0.034).
12928685	2003	Eye (Lond)	0950-222X	PURPOSE	1	5	2153	LONGTERM|DICTIONARY	factor v leiden	factor V Leiden	93#108		D015356	LONGTERM|DICTIONARY	retinal artery occlusion	retinal artery occlusion	134#158		The purpose of the present study was therefore to investigate a possible association between factor V Leiden, prothrombin 20210A, and retinal artery occlusion.
18922928	2008	Cancer Res.	1538-7445	ALL_TEXT_3/3	3	10	3845	SYMBOL|DICTIONARY	kras	KRAS	29#33		D002289	LONGTERM|DICTIONARY|EXTRACTED	nsclc	NSCLC	112#117	18922928-3-189-215	The LCS6 variant allele in a KRAS miRANA complementary site is significantly associated with increased risk for NSCLC among moderate smokers and represents a new paradigm for let-7 miRNAs in lung cancer susceptibility.
18922928	2008	Cancer Res.	1538-7445	ALL_TEXT_3/3	3	10	3845	SYMBOL|DICTIONARY	kras	KRAS	29#33		D008175	LONGTERM|DISEASE|DT|DICTIONARY	lung cancer	lung cancer	191#202		The LCS6 variant allele in a KRAS miRANA complementary site is significantly associated with increased risk for NSCLC among moderate smokers and represents a new paradigm for let-7 miRNAs in lung cancer susceptibility.
15837080	2005	Int. J. Cardiol.	0167-5273	BACKGROUND	1	1	7056	LONGTERM|DICTIONARY	thrombomodulin	Thrombomodulin	0#14		D003324	LONGTERM|DISEASE|DT|DICTIONARY	coronary artery disease	coronary artery disease	255#278		Thrombomodulin (TM) is the anticoagulant endothelial cell membrane-bound protein cofactor in the thrombin-mediated activation of protein C. Recently, conflicting data have been reported regarding the possible contribution of the TM -33G>A polymorphism to coronary artery disease (CAD) or myocardial infarction (MI) in some Asian populations.
15837080	2005	Int. J. Cardiol.	0167-5273	BACKGROUND	1	1	7056	LONGTERM|DICTIONARY	thrombomodulin	Thrombomodulin	0#14		D003324	SYMBOL|()|DICTIONARY|EXTRACTED	cad	CAD	280#283	15837080-1-255-278	Thrombomodulin (TM) is the anticoagulant endothelial cell membrane-bound protein cofactor in the thrombin-mediated activation of protein C. Recently, conflicting data have been reported regarding the possible contribution of the TM -33G>A polymorphism to coronary artery disease (CAD) or myocardial infarction (MI) in some Asian populations.
15837080	2005	Int. J. Cardiol.	0167-5273	BACKGROUND	1	1	7056	LONGTERM|DICTIONARY	thrombomodulin	Thrombomodulin	0#14		D009203	LONGTERM|DICTIONARY	myocardial infarction	myocardial infarction	288#309		Thrombomodulin (TM) is the anticoagulant endothelial cell membrane-bound protein cofactor in the thrombin-mediated activation of protein C. Recently, conflicting data have been reported regarding the possible contribution of the TM -33G>A polymorphism to coronary artery disease (CAD) or myocardial infarction (MI) in some Asian populations.
15837080	2005	Int. J. Cardiol.	0167-5273	BACKGROUND	1	1	7056	LONGTERM|DICTIONARY	thrombomodulin	Thrombomodulin	0#14		D009203	SYMBOL|EXTRACTED|()	mi	MI	311#313	15837080-1-288-309	Thrombomodulin (TM) is the anticoagulant endothelial cell membrane-bound protein cofactor in the thrombin-mediated activation of protein C. Recently, conflicting data have been reported regarding the possible contribution of the TM -33G>A polymorphism to coronary artery disease (CAD) or myocardial infarction (MI) in some Asian populations.
15837080	2005	Int. J. Cardiol.	0167-5273	BACKGROUND	1	1	2147	LONGTERM|DICTIONARY	thrombin	thrombin	97#105	NaN	D003324	LONGTERM|DISEASE|DT|DICTIONARY	coronary artery disease	coronary artery disease	255#278		Thrombomodulin (TM) is the anticoagulant endothelial cell membrane-bound protein cofactor in the thrombin-mediated activation of protein C. Recently, conflicting data have been reported regarding the possible contribution of the TM -33G>A polymorphism to coronary artery disease (CAD) or myocardial infarction (MI) in some Asian populations.
15837080	2005	Int. J. Cardiol.	0167-5273	BACKGROUND	1	1	2147	LONGTERM|DICTIONARY	thrombin	thrombin	97#105	NaN	D003324	SYMBOL|()|DICTIONARY|EXTRACTED	cad	CAD	280#283	15837080-1-255-278	Thrombomodulin (TM) is the anticoagulant endothelial cell membrane-bound protein cofactor in the thrombin-mediated activation of protein C. Recently, conflicting data have been reported regarding the possible contribution of the TM -33G>A polymorphism to coronary artery disease (CAD) or myocardial infarction (MI) in some Asian populations.
15837080	2005	Int. J. Cardiol.	0167-5273	BACKGROUND	1	1	2147	LONGTERM|DICTIONARY	thrombin	thrombin	97#105	NaN	D009203	LONGTERM|DICTIONARY	myocardial infarction	myocardial infarction	288#309		Thrombomodulin (TM) is the anticoagulant endothelial cell membrane-bound protein cofactor in the thrombin-mediated activation of protein C. Recently, conflicting data have been reported regarding the possible contribution of the TM -33G>A polymorphism to coronary artery disease (CAD) or myocardial infarction (MI) in some Asian populations.
15837080	2005	Int. J. Cardiol.	0167-5273	BACKGROUND	1	1	2147	LONGTERM|DICTIONARY	thrombin	thrombin	97#105	NaN	D009203	SYMBOL|EXTRACTED|()	mi	MI	311#313	15837080-1-288-309	Thrombomodulin (TM) is the anticoagulant endothelial cell membrane-bound protein cofactor in the thrombin-mediated activation of protein C. Recently, conflicting data have been reported regarding the possible contribution of the TM -33G>A polymorphism to coronary artery disease (CAD) or myocardial infarction (MI) in some Asian populations.
17006606	2007	J. Hum. Genet.	1434-5161	ALL_TEXT_2/3	2	6	3553	SYMBOL|NUMBER|DICTIONARY	il1b	IL1B	8#12		D013274	LONGTERM|DICTIONARY	gastric adenocarcinoma	gastric adenocarcinoma	88#110		Neither IL1B-31, -511 nor FAS-670 polymorphisms showed significantly different risks of gastric adenocarcinoma.
17006606	2007	J. Hum. Genet.	1434-5161	ALL_TEXT_2/3	2	6	355	SYMBOL|NUMBER|DICTIONARY|EXTRACTED	fas	FAS	26#29	17006606-2-225-245	D013274	LONGTERM|DICTIONARY	gastric adenocarcinoma	gastric adenocarcinoma	88#110		Neither IL1B-31, -511 nor FAS-670 polymorphisms showed significantly different risks of gastric adenocarcinoma.
17006606	2007	J. Hum. Genet.	1434-5161	ALL_TEXT_1/3	1	3	3553	SYMBOL|DICTIONARY	il1b	IL1B	206#210		D009369	LONGTERM|DISEASE|DT|DICTIONARY	cancer	cancer	106#112		Based on recent papers describing the prognostic roles of the polymorphisms and the NFkappaB functions on cancer development, we sought to determine if Japanese gastric cancer patients were affected by the IL1B -31/-511 and FAS-670 polymorphisms.
17006606	2007	J. Hum. Genet.	1434-5161	ALL_TEXT_1/3	1	3	3553	SYMBOL|DICTIONARY	il1b	IL1B	206#210		D013274	LONGTERM|DISEASE|DN|DT|DICTIONARY	gastric cancer	gastric cancer	161#175		Based on recent papers describing the prognostic roles of the polymorphisms and the NFkappaB functions on cancer development, we sought to determine if Japanese gastric cancer patients were affected by the IL1B -31/-511 and FAS-670 polymorphisms.
17006606	2007	J. Hum. Genet.	1434-5161	ALL_TEXT_1/3	1	3	355	SYMBOL|NUMBER|DICTIONARY|EXTRACTED	fas	FAS	224#227	17006606-2-225-245	D009369	LONGTERM|DISEASE|DT|DICTIONARY	cancer	cancer	106#112		Based on recent papers describing the prognostic roles of the polymorphisms and the NFkappaB functions on cancer development, we sought to determine if Japanese gastric cancer patients were affected by the IL1B -31/-511 and FAS-670 polymorphisms.
17006606	2007	J. Hum. Genet.	1434-5161	ALL_TEXT_1/3	1	3	355	SYMBOL|NUMBER|DICTIONARY|EXTRACTED	fas	FAS	224#227	17006606-2-225-245	D013274	LONGTERM|DISEASE|DN|DT|DICTIONARY	gastric cancer	gastric cancer	161#175		Based on recent papers describing the prognostic roles of the polymorphisms and the NFkappaB functions on cancer development, we sought to determine if Japanese gastric cancer patients were affected by the IL1B -31/-511 and FAS-670 polymorphisms.
17006606	2007	J. Hum. Genet.	1434-5161	ALL_TEXT_1/3	1	3	4790	LONGTERM|DICTIONARY	nfkappab	NFkappaB	84#92	NaN	D009369	LONGTERM|DISEASE|DT|DICTIONARY	cancer	cancer	106#112		Based on recent papers describing the prognostic roles of the polymorphisms and the NFkappaB functions on cancer development, we sought to determine if Japanese gastric cancer patients were affected by the IL1B -31/-511 and FAS-670 polymorphisms.
17006606	2007	J. Hum. Genet.	1434-5161	ALL_TEXT_1/3	1	3	4790	LONGTERM|DICTIONARY	nfkappab	NFkappaB	84#92	NaN	D013274	LONGTERM|DISEASE|DN|DT|DICTIONARY	gastric cancer	gastric cancer	161#175		Based on recent papers describing the prognostic roles of the polymorphisms and the NFkappaB functions on cancer development, we sought to determine if Japanese gastric cancer patients were affected by the IL1B -31/-511 and FAS-670 polymorphisms.
17006606	2007	J. Hum. Genet.	1434-5161	ALL_TEXT_1/3	1	2	3553	LONGTERM|DICTIONARY	interleukin 1 beta	interleukin 1 beta	36#54		D009369	LONGTERM|DISEASE|DT|DICTIONARY	cancer	cancer	140#146		The signal transduction target upon interleukin 1 beta (IL1beta) stimulation, the nuclear factor of kappa B (NFkappaB) activation, supports cancer development, signal transduction in which is mediated by FS-7 cell-associated cell surface antigen (FAS) signaling.
17006606	2007	J. Hum. Genet.	1434-5161	ALL_TEXT_1/3	1	2	3553	SYMBOL|EXTRACTED|()	il1beta	IL1beta	56#63	17006606-2-36-54	D009369	LONGTERM|DISEASE|DT|DICTIONARY	cancer	cancer	140#146		The signal transduction target upon interleukin 1 beta (IL1beta) stimulation, the nuclear factor of kappa B (NFkappaB) activation, supports cancer development, signal transduction in which is mediated by FS-7 cell-associated cell surface antigen (FAS) signaling.
17006606	2007	J. Hum. Genet.	1434-5161	ALL_TEXT_1/3	1	2	4790	LONGTERM|DICTIONARY	nuclear factor of kappa b	nuclear factor of kappa B	82#107	NaN	D009369	LONGTERM|DISEASE|DT|DICTIONARY	cancer	cancer	140#146		The signal transduction target upon interleukin 1 beta (IL1beta) stimulation, the nuclear factor of kappa B (NFkappaB) activation, supports cancer development, signal transduction in which is mediated by FS-7 cell-associated cell surface antigen (FAS) signaling.
17006606	2007	J. Hum. Genet.	1434-5161	ALL_TEXT_1/3	1	2	4790	LONGTERM|DICTIONARY	nfkappab	NFkappaB	109#117	NaN	D009369	LONGTERM|DISEASE|DT|DICTIONARY	cancer	cancer	140#146		The signal transduction target upon interleukin 1 beta (IL1beta) stimulation, the nuclear factor of kappa B (NFkappaB) activation, supports cancer development, signal transduction in which is mediated by FS-7 cell-associated cell surface antigen (FAS) signaling.
17006606	2007	J. Hum. Genet.	1434-5161	ALL_TEXT_1/3	1	1	3553	SYMBOL|NUMBER|DICTIONARY	il1b	IL1B	115#119		D013274	LONGTERM|DISEASE|DT|DICTIONARY	gastric cancer	gastric cancer	85#99		Proinflammatory cytokine gene polymorphisms have been demonstrated to associate with gastric cancer risk, of which IL1B-31T/C and -511C/T changes have been well investigated due to the possibility that they may alter the IL1B transcription.
17006606	2007	J. Hum. Genet.	1434-5161	ALL_TEXT_1/3	1	1	3553	SYMBOL|DICTIONARY	il1b	IL1B	221#225		D013274	LONGTERM|DISEASE|DT|DICTIONARY	gastric cancer	gastric cancer	85#99		Proinflammatory cytokine gene polymorphisms have been demonstrated to associate with gastric cancer risk, of which IL1B-31T/C and -511C/T changes have been well investigated due to the possibility that they may alter the IL1B transcription.
17006606	2007	J. Hum. Genet.	1434-5161	TITLE	0	0	3553	SYMBOL|DICTIONARY	il1b	IL1B	45#49		D013274	LONGTERM|DICTIONARY	gastric adenocarcinoma	gastric adenocarcinoma	90#112		A polymorphism of C-to-T substitution at -31 IL1B is associated with the risk of advanced gastric adenocarcinoma in a Japanese population.
16824064	2006	J. Gastroenterol. Hepatol.	0815-9319	RESULTS	3	12	7157	SYMBOL|DICTIONARY	p53	p53	47#50		D013274	SYMBOL|EXTRACTED	msi-l/mss gc	MSI-L/MSS GC	100#112	16824064-1-0-17	The percentage of smokers and the frequency of p53 mutations were significantly lower in MSI-H than MSI-L/MSS GC.
16824064	2006	J. Gastroenterol. Hepatol.	0815-9319	RESULTS	3	12	7157	SYMBOL|DICTIONARY	p53	p53	47#50		C538322	LONGTERM|DICTIONARY	msi-h	MSI-H	89#94	NaN	The percentage of smokers and the frequency of p53 mutations were significantly lower in MSI-H than MSI-L/MSS GC.
16824064	2006	J. Gastroenterol. Hepatol.	0815-9319	RESULTS	3	10	3576	SYMBOL|DICTIONARY	il 8	IL-8	14#18		D013274	SYMBOL|EXTRACTED	msi-h gc	MSI-H GC	89#97	16824064-1-0-17	We found that IL-8 -251 T/T genotype was significantly associated with increased risk of MSI-H GC compared to MSI-L/MSS GC and controls.
16824064	2006	J. Gastroenterol. Hepatol.	0815-9319	RESULTS	3	10	3576	SYMBOL|DICTIONARY	il 8	IL-8	14#18		D013274	SYMBOL|EXTRACTED	msi-l/mss gc	MSI-L/MSS GC	110#122	16824064-1-0-17	We found that IL-8 -251 T/T genotype was significantly associated with increased risk of MSI-H GC compared to MSI-L/MSS GC and controls.
20799519	2010	P R Health Sci J	0738-0658	METHODS	2	4	1565	SYMBOL|DICTIONARY	cyp2d6	CYP2D6	130#136		D001523	LONGTERM|DICTIONARY	psychiatric	psychiatric	43#54	NaN	The study cohort comprised 40 Puerto Rican psychiatric patients referred because of suspected intolerance of drugs metabolized by CYP2D6, and five subjects without suspected adverse responses to these drugs.
16824064	2006	J. Gastroenterol. Hepatol.	0815-9319	CONCLUSIONS	4	14	3576	SYMBOL|NUMBER|DICTIONARY	il 8	IL-8	49#53		D013274	SYMBOL|EXTRACTED	msi-h gc	MSI-H GC	21#29	16824064-1-0-17	Our study shows that MSI-H GC is associated with IL-8-251 T/T (low expression genotype) and is inversely correlated with cigarette smoking.
19892845	2010	Clin. Chem.	1530-8561	METHODS	2	4	672	SYMBOL|DICTIONARY	brca1	BRCA1	65#70		D001943	LONGTERM|DISEASE|DT|DICTIONARY	sporadic breast cancer	sporadic breast cancer	130#152		Denaturing gradient gel electrophoresis was used to genotype the BRCA1 c.591C>T variant in 685 index cases of B(O)C families, 326 sporadic breast cancer cases, and 450 healthy controls from Spain.
16636019	2007	Gut	0017-5749	METHODS	3	3	4292	SYMBOL|DICTIONARY	mlh1	MLH1	157#161		D015179	SYMBOL|DICTIONARY|EXTRACTED	crc	CRC	31#34	16636019-1-26-43	In 281 patients diagnosed with CRC before the age of 50 years or with CRC and at least one additional HNPCC-associated cancer, germline mutation analysis in MLH1, MSH2 and MSH6 was carried out with denaturing gradient gel electrophoresis and multiplex ligation-dependent probe amplification.
16636019	2007	Gut	0017-5749	METHODS	3	3	4292	SYMBOL|DICTIONARY	mlh1	MLH1	157#161		D015179	SYMBOL|DICTIONARY|EXTRACTED	crc	CRC	70#73	16636019-1-26-43	In 281 patients diagnosed with CRC before the age of 50 years or with CRC and at least one additional HNPCC-associated cancer, germline mutation analysis in MLH1, MSH2 and MSH6 was carried out with denaturing gradient gel electrophoresis and multiplex ligation-dependent probe amplification.
16636019	2007	Gut	0017-5749	METHODS	3	3	4292	SYMBOL|DICTIONARY	mlh1	MLH1	157#161		D009369	LONGTERM|DISEASE|DT|DICTIONARY	cancer	cancer	119#125		In 281 patients diagnosed with CRC before the age of 50 years or with CRC and at least one additional HNPCC-associated cancer, germline mutation analysis in MLH1, MSH2 and MSH6 was carried out with denaturing gradient gel electrophoresis and multiplex ligation-dependent probe amplification.
16636019	2007	Gut	0017-5749	METHODS	3	3	4436	SYMBOL|DICTIONARY	msh2	MSH2	163#167		D015179	SYMBOL|DICTIONARY|EXTRACTED	crc	CRC	31#34	16636019-1-26-43	In 281 patients diagnosed with CRC before the age of 50 years or with CRC and at least one additional HNPCC-associated cancer, germline mutation analysis in MLH1, MSH2 and MSH6 was carried out with denaturing gradient gel electrophoresis and multiplex ligation-dependent probe amplification.
16636019	2007	Gut	0017-5749	METHODS	3	3	4436	SYMBOL|DICTIONARY	msh2	MSH2	163#167		D015179	SYMBOL|DICTIONARY|EXTRACTED	crc	CRC	70#73	16636019-1-26-43	In 281 patients diagnosed with CRC before the age of 50 years or with CRC and at least one additional HNPCC-associated cancer, germline mutation analysis in MLH1, MSH2 and MSH6 was carried out with denaturing gradient gel electrophoresis and multiplex ligation-dependent probe amplification.
16636019	2007	Gut	0017-5749	METHODS	3	3	4436	SYMBOL|DICTIONARY	msh2	MSH2	163#167		D009369	LONGTERM|DISEASE|DT|DICTIONARY	cancer	cancer	119#125		In 281 patients diagnosed with CRC before the age of 50 years or with CRC and at least one additional HNPCC-associated cancer, germline mutation analysis in MLH1, MSH2 and MSH6 was carried out with denaturing gradient gel electrophoresis and multiplex ligation-dependent probe amplification.
16636019	2007	Gut	0017-5749	METHODS	3	3	2956	SYMBOL|DICTIONARY	msh6	MSH6	172#176		D015179	SYMBOL|DICTIONARY|EXTRACTED	crc	CRC	31#34	16636019-1-26-43	In 281 patients diagnosed with CRC before the age of 50 years or with CRC and at least one additional HNPCC-associated cancer, germline mutation analysis in MLH1, MSH2 and MSH6 was carried out with denaturing gradient gel electrophoresis and multiplex ligation-dependent probe amplification.
16636019	2007	Gut	0017-5749	METHODS	3	3	2956	SYMBOL|DICTIONARY	msh6	MSH6	172#176		D015179	SYMBOL|DICTIONARY|EXTRACTED	crc	CRC	70#73	16636019-1-26-43	In 281 patients diagnosed with CRC before the age of 50 years or with CRC and at least one additional HNPCC-associated cancer, germline mutation analysis in MLH1, MSH2 and MSH6 was carried out with denaturing gradient gel electrophoresis and multiplex ligation-dependent probe amplification.
16636019	2007	Gut	0017-5749	METHODS	3	3	2956	SYMBOL|DICTIONARY	msh6	MSH6	172#176		D009369	LONGTERM|DISEASE|DT|DICTIONARY	cancer	cancer	119#125		In 281 patients diagnosed with CRC before the age of 50 years or with CRC and at least one additional HNPCC-associated cancer, germline mutation analysis in MLH1, MSH2 and MSH6 was carried out with denaturing gradient gel electrophoresis and multiplex ligation-dependent probe amplification.
19892845	2010	Clin. Chem.	1530-8561	METHODS	2	6	672	SYMBOL|DICTIONARY	brca1	BRCA1	141#146		D001943	LONGTERM|DICTIONARY	brca1	BRCA1	141#146	NaN	In vitro splicing analysis was performed in 7 c.591C>T carriers and 10 noncarriers. cDNAs were PCR-amplified with primers designed to detect BRCA1 alternative splicing isoforms.
16636019	2007	Gut	0017-5749	METHODS	3	4	4292	SYMBOL|DICTIONARY	mlh1	MLH1	70#74		D009369	LONGTERM|DICTIONARY	tumours	tumours	114#121		MSI analysis with five consensus markers and MMR protein staining for MLH1, MSH2 and MSH6 were carried out in the tumours.
16636019	2007	Gut	0017-5749	METHODS	3	4	4292	SYMBOL|DICTIONARY	mlh1	MLH1	70#74		D053842	LONGTERM|DICTIONARY	msi	MSI	0#3	NaN	MSI analysis with five consensus markers and MMR protein staining for MLH1, MSH2 and MSH6 were carried out in the tumours.
16636019	2007	Gut	0017-5749	METHODS	3	4	4436	SYMBOL|DICTIONARY	msh2	MSH2	76#80		D009369	LONGTERM|DICTIONARY	tumours	tumours	114#121		MSI analysis with five consensus markers and MMR protein staining for MLH1, MSH2 and MSH6 were carried out in the tumours.
16636019	2007	Gut	0017-5749	METHODS	3	4	4436	SYMBOL|DICTIONARY	msh2	MSH2	76#80		D053842	LONGTERM|DICTIONARY	msi	MSI	0#3	NaN	MSI analysis with five consensus markers and MMR protein staining for MLH1, MSH2 and MSH6 were carried out in the tumours.
16636019	2007	Gut	0017-5749	METHODS	3	4	2956	SYMBOL|DICTIONARY	msh6	MSH6	85#89		D009369	LONGTERM|DICTIONARY	tumours	tumours	114#121		MSI analysis with five consensus markers and MMR protein staining for MLH1, MSH2 and MSH6 were carried out in the tumours.
16636019	2007	Gut	0017-5749	METHODS	3	4	2956	SYMBOL|DICTIONARY	msh6	MSH6	85#89		D053842	LONGTERM|DICTIONARY	msi	MSI	0#3	NaN	MSI analysis with five consensus markers and MMR protein staining for MLH1, MSH2 and MSH6 were carried out in the tumours.
20100586	2011	Biol. Blood Marrow Transplant.	1523-6536	TITLE	0	0	7124	LONGTERM|GENE|GN|DICTIONARY	tumor necrosis factor alpha	Tumor necrosis factor-alpha	0#27		D006086	LONGTERM|DISEASE|DT|DICTIONARY	acute graft versus host disease	acute graft-versus-host disease	79#110		Tumor necrosis factor-alpha gene polymorphisms are associated with severity of acute graft-versus-host disease following matched unrelated donor bone marrow transplantation in children: a Pediatric Blood and Marrow Transplant Consortium study.
17955208	2008	Diabetologia	0012-186X	METHODS	2	4	7275	SYMBOL|DICTIONARY	tub	TUB	32#35		D009765	LONGTERM|DICTIONARY	obesity	obesity	71#78		We explored the hypothesis that TUB is a candidate gene for late-onset obesity in humans through testing the interaction of the SNPs by menopausal status.
18416843	2008	BMC Neurol	1471-2377	BACKGROUND	1	3	348	LONGTERM|GENE|GN|DICTIONARY	apolipoprotein e	apolipoprotein E	48#64		D000544	SYMBOL|EXTRACTED	ad	AD	116#118	18416843-1-86-105	We have described the allele frequencies of the apolipoprotein E gene (APOE) in a large population of patients with AD compared to the frequencies in a cognitively-normal control group, and estimated the effect of the APOE epsilon4 allele on the risk and the age at onset of AD in this population.
18416843	2008	BMC Neurol	1471-2377	BACKGROUND	1	3	348	LONGTERM|GENE|GN|DICTIONARY	apolipoprotein e	apolipoprotein E	48#64		D000544	SYMBOL|EXTRACTED	ad	AD	275#277	18416843-1-86-105	We have described the allele frequencies of the apolipoprotein E gene (APOE) in a large population of patients with AD compared to the frequencies in a cognitively-normal control group, and estimated the effect of the APOE epsilon4 allele on the risk and the age at onset of AD in this population.
18385420	2008	J. Am. Soc. Nephrol.	1533-3450	ALL_TEXT_3/3	3	8	1579	SYMBOL|NUMBER|DICTIONARY	cyp4a11	CYP4A11	16#23		D006973	LONGTERM|DICTIONARY	hypertensive	hypertensive	90#102		In summary, the CYP4A11 8590CC genotype is associated with increased BP in black men with hypertensive nephrosclerosis and is associated with adverse clinical outcomes in those with baseline proteinuria.
18385420	2008	J. Am. Soc. Nephrol.	1533-3450	ALL_TEXT_3/3	3	8	1579	SYMBOL|NUMBER|DICTIONARY	cyp4a11	CYP4A11	16#23		D009400	LONGTERM|DICTIONARY	nephrosclerosis	nephrosclerosis	103#118		In summary, the CYP4A11 8590CC genotype is associated with increased BP in black men with hypertensive nephrosclerosis and is associated with adverse clinical outcomes in those with baseline proteinuria.
18385420	2008	J. Am. Soc. Nephrol.	1533-3450	ALL_TEXT_3/3	3	8	1579	SYMBOL|NUMBER|DICTIONARY	cyp4a11	CYP4A11	16#23		D011507	LONGTERM|DICTIONARY	proteinuria	proteinuria	191#202	NaN	In summary, the CYP4A11 8590CC genotype is associated with increased BP in black men with hypertensive nephrosclerosis and is associated with adverse clinical outcomes in those with baseline proteinuria.
17955208	2008	Diabetologia	0012-186X	AIMS/HYPOTHESES	1	1	7275	SYMBOL|DICTIONARY	tub	TUB	68#71		D003920	LONGTERM|DICTIONARY	diabetes	diabetes	152#160		We recently reported significant associations between BMI and three TUB single nucleotide polymorphisms (SNPs) in two Dutch cohorts enriched for type 2 diabetes.
18385420	2008	J. Am. Soc. Nephrol.	1533-3450	ALL_TEXT_2/3	2	4	1579	SYMBOL|DICTIONARY	cyp4a11	CYP4A11	42#49		D007674	LONGTERM|DISEASE|DT|DICTIONARY	hypertensive renal disease	hypertensive renal disease	148#174		This study tested the hypothesis that the CYP4A11 T8590C polymorphism is associated with higher BP or clinical outcomes in 732 black Americans with hypertensive renal disease participating in the African American Study of Kidney Disease (AASK).
18385420	2008	J. Am. Soc. Nephrol.	1533-3450	ALL_TEXT_2/3	2	4	1579	SYMBOL|DICTIONARY	cyp4a11	CYP4A11	42#49		D007674	LONGTERM|DISEASE|DT|DICTIONARY	kidney disease	Kidney Disease	222#236		This study tested the hypothesis that the CYP4A11 T8590C polymorphism is associated with higher BP or clinical outcomes in 732 black Americans with hypertensive renal disease participating in the African American Study of Kidney Disease (AASK).
20799519	2010	P R Health Sci J	0738-0658	TITLE	0	0	1565	SYMBOL|DICTIONARY	cyp2d6	CYP2D6	49#55		D001943	LONGTERM|DISEASE|DN|DT|DICTIONARY	breast cancer	breast cancer	145#158		Genetic variants of the drug-metabolizing enzyme CYP2D6 in Puerto Rican psychiatry patients: a preliminary report and potential implications for breast cancer patients.
18385420	2008	J. Am. Soc. Nephrol.	1533-3450	ALL_TEXT_1/3	1	2	1579	SYMBOL|DICTIONARY	cyp4a11	CYP4A11	94#101		D006973	LONGTERM|DICTIONARY	hypertension	hypertension	24#36		Cyp4a deficiency causes hypertension in male mice, and a loss-of-function variant (T8590C) of CYP4A11 is associated with hypertension in white individuals.
18385420	2008	J. Am. Soc. Nephrol.	1533-3450	ALL_TEXT_1/3	1	2	1579	SYMBOL|DICTIONARY	cyp4a11	CYP4A11	94#101		D006973	LONGTERM|DICTIONARY	hypertension	hypertension	121#133		Cyp4a deficiency causes hypertension in male mice, and a loss-of-function variant (T8590C) of CYP4A11 is associated with hypertension in white individuals.
18385420	2008	J. Am. Soc. Nephrol.	1533-3450	ALL_TEXT_1/3	1	2	1579	SYMBOL|DICTIONARY	cyp4a11	CYP4A11	94#101		D003677	LONGTERM|DICTIONARY	cyp4a deficiency	Cyp4a deficiency	0#16		Cyp4a deficiency causes hypertension in male mice, and a loss-of-function variant (T8590C) of CYP4A11 is associated with hypertension in white individuals.
18385420	2008	J. Am. Soc. Nephrol.	1533-3450	ALL_TEXT_1/3	1	3	1579	SYMBOL|DICTIONARY	cyp4a11	CYP4A11	146#153		D006973	LONGTERM|DICTIONARY	hypertension	Hypertension	0#12		Hypertension and hypertensive renal disease are more common among black than white individuals, but the relationship between genetic variation at CYP4A11 and hypertension in black individuals is not known.
18385420	2008	J. Am. Soc. Nephrol.	1533-3450	ALL_TEXT_1/3	1	3	1579	SYMBOL|DICTIONARY	cyp4a11	CYP4A11	146#153		D007674	LONGTERM|DISEASE|DT|DICTIONARY	hypertensive renal disease	hypertensive renal disease	17#43		Hypertension and hypertensive renal disease are more common among black than white individuals, but the relationship between genetic variation at CYP4A11 and hypertension in black individuals is not known.
18385420	2008	J. Am. Soc. Nephrol.	1533-3450	ALL_TEXT_1/3	1	3	1579	SYMBOL|DICTIONARY	cyp4a11	CYP4A11	146#153		D006973	LONGTERM|DICTIONARY	hypertension	hypertension	158#170		Hypertension and hypertensive renal disease are more common among black than white individuals, but the relationship between genetic variation at CYP4A11 and hypertension in black individuals is not known.
20223440	2010	Am. J. Obstet. Gynecol.	1097-6868	RESULTS	3	8	2321	LONGTERM|DICTIONARY	fms like tyrosine kinase 1	fms-like tyrosine kinase 1	20#46		D011225	LONGTERM|DICTIONARY	preeclampsia	preeclampsia	309#321	NaN	In white women, the fms-like tyrosine kinase 1 rs722503 (OR, 2.12; 95% CI, 1.07-4.19; P=.03), fms-like tyrosine kinase 4 rs307826 (OR, 3.06; 95% CI, 1.18-7.91; P=.01), and vascular endothelial growth factor C rs7664413 (OR, 2.04; 95% CI, 0.99-4.17; P=.04) single nucleotide polymorphisms were associated with preeclampsia.
20223440	2010	Am. J. Obstet. Gynecol.	1097-6868	RESULTS	3	8	2324	LONGTERM|DICTIONARY	fms like tyrosine kinase 4	fms-like tyrosine kinase 4	94#120		D011225	LONGTERM|DICTIONARY	preeclampsia	preeclampsia	309#321	NaN	In white women, the fms-like tyrosine kinase 1 rs722503 (OR, 2.12; 95% CI, 1.07-4.19; P=.03), fms-like tyrosine kinase 4 rs307826 (OR, 3.06; 95% CI, 1.18-7.91; P=.01), and vascular endothelial growth factor C rs7664413 (OR, 2.04; 95% CI, 0.99-4.17; P=.04) single nucleotide polymorphisms were associated with preeclampsia.
20223440	2010	Am. J. Obstet. Gynecol.	1097-6868	RESULTS	3	8	7424	LONGTERM|DICTIONARY	vascular endothelial growth factor c	vascular endothelial growth factor C	172#208		D011225	LONGTERM|DICTIONARY	preeclampsia	preeclampsia	309#321	NaN	In white women, the fms-like tyrosine kinase 1 rs722503 (OR, 2.12; 95% CI, 1.07-4.19; P=.03), fms-like tyrosine kinase 4 rs307826 (OR, 3.06; 95% CI, 1.18-7.91; P=.01), and vascular endothelial growth factor C rs7664413 (OR, 2.04; 95% CI, 0.99-4.17; P=.04) single nucleotide polymorphisms were associated with preeclampsia.
20223440	2010	Am. J. Obstet. Gynecol.	1097-6868	CONCLUSION	4	9	2321	LONGTERM|DICTIONARY	fms-like tyrosine kinase 1 and vascular endothelial growth factor c	fms-like tyrosine kinase 1 and vascular endothelial growth factor C	26#93		D011225	LONGTERM|DICTIONARY	preeclampsia	preeclampsia	120#132	NaN	Allelic variations in the fms-like tyrosine kinase 1 and vascular endothelial growth factor C genes are associated with preeclampsia in both ethnic groups.
20223440	2010	Am. J. Obstet. Gynecol.	1097-6868	CONCLUSION	4	9	7424	LONGTERM|DICTIONARY	fms-like tyrosine kinase 1 and vascular endothelial growth factor c	fms-like tyrosine kinase 1 and vascular endothelial growth factor C	26#93		D011225	LONGTERM|DICTIONARY	preeclampsia	preeclampsia	120#132	NaN	Allelic variations in the fms-like tyrosine kinase 1 and vascular endothelial growth factor C genes are associated with preeclampsia in both ethnic groups.
20223440	2010	Am. J. Obstet. Gynecol.	1097-6868	CONCLUSION	4	9	2321	LONGTERM|GENE|GN|DICTIONARY	fms-like tyrosine kinase 1 and vascular endothelial growth factor c	fms-like tyrosine kinase 1 and vascular endothelial growth factor C	26#93		D011225	LONGTERM|DICTIONARY	preeclampsia	preeclampsia	120#132	NaN	Allelic variations in the fms-like tyrosine kinase 1 and vascular endothelial growth factor C genes are associated with preeclampsia in both ethnic groups.
20223440	2010	Am. J. Obstet. Gynecol.	1097-6868	CONCLUSION	4	9	7424	LONGTERM|GENE|GN|DICTIONARY	fms-like tyrosine kinase 1 and vascular endothelial growth factor c	fms-like tyrosine kinase 1 and vascular endothelial growth factor C	26#93		D011225	LONGTERM|DICTIONARY	preeclampsia	preeclampsia	120#132	NaN	Allelic variations in the fms-like tyrosine kinase 1 and vascular endothelial growth factor C genes are associated with preeclampsia in both ethnic groups.
16133961	2005	Dig. Dis. Sci.	0163-2116	ALL_TEXT_3/3	3	8	1557	SYMBOL|DICTIONARY	cyp2c19	CYP2C19	198#205		D013276	LONGTERM|DICTIONARY	gastric ulcer	gastric ulcer	71#84		Although both omeprazole and rabeprazole showed a high healing rate of gastric ulcer after the 8-week treatment period, the healing effect of rabeprazole appears to be relatively independent of the CYP2C19 status, resulting in an earlier repair of gastric mucosal damage evaluated endoscopically compared to that of omeprazole.
16133961	2005	Dig. Dis. Sci.	0163-2116	ALL_TEXT_3/3	3	8	1557	SYMBOL|DICTIONARY	cyp2c19	CYP2C19	198#205		D013272	LONGTERM|DICTIONARY	gastric mucosal damage	gastric mucosal damage	248#270	NaN	Although both omeprazole and rabeprazole showed a high healing rate of gastric ulcer after the 8-week treatment period, the healing effect of rabeprazole appears to be relatively independent of the CYP2C19 status, resulting in an earlier repair of gastric mucosal damage evaluated endoscopically compared to that of omeprazole.
20223440	2010	Am. J. Obstet. Gynecol.	1097-6868	RESULTS	3	7	2321	LONGTERM|DICTIONARY	fms like tyrosine kinase 1	fms-like tyrosine kinase 1	20#46		D011225	LONGTERM|DICTIONARY	preeclampsia	preeclampsia	377#389	NaN	In black women, the fms-like tyrosine kinase 1 rs12584067 (odds ratio [OR], 1.55; 95% confidence interval [CI], 1.01-2.36; P=.05) and rs7335588 (OR, 1.61; 95% CI, 1.06-2.43; P=.01) and the vascular endothelial growth factor C rs1485766 (OR, 1.56; 95% CI, 1.05-2.30; P=.03) and rs6838834 (OR, 1.60; 95% CI, 1.05-2.45; P=.03) single nucleotide polymorphisms were associated with preeclampsia.
20223440	2010	Am. J. Obstet. Gynecol.	1097-6868	RESULTS	3	7	7424	LONGTERM|DICTIONARY	vascular endothelial growth factor c	vascular endothelial growth factor C	189#225		D011225	LONGTERM|DICTIONARY	preeclampsia	preeclampsia	377#389	NaN	In black women, the fms-like tyrosine kinase 1 rs12584067 (odds ratio [OR], 1.55; 95% confidence interval [CI], 1.01-2.36; P=.05) and rs7335588 (OR, 1.61; 95% CI, 1.06-2.43; P=.01) and the vascular endothelial growth factor C rs1485766 (OR, 1.56; 95% CI, 1.05-2.30; P=.03) and rs6838834 (OR, 1.60; 95% CI, 1.05-2.45; P=.03) single nucleotide polymorphisms were associated with preeclampsia.
16788379	2006	Pharmacogenet. Genomics	1744-6872	TITLE	0	0	4255	LONGTERM|DICTIONARY	o6 methylguanine dna methyltransferase	O6-methylguanine DNA methyltransferase	17#55		D001943	LONGTERM|DISEASE|DT|DICTIONARY	breast cancer	breast cancer	60#73		Polymorphisms in O6-methylguanine DNA methyltransferase and breast cancer risk.
16788379	2006	Pharmacogenet. Genomics	1744-6872	OBJECTIVE	1	1	2099	LONGTERM|GENE|GT|DICTIONARY	estrogen receptor	estrogen receptor	84#101		D001943	LONGTERM|DISEASE|DT|DICTIONARY	breast cancer	breast cancer	45#58		Endogenous and exogenous estrogens influence breast cancer risk by interacting with estrogen receptor (ER).
16788379	2006	Pharmacogenet. Genomics	1744-6872	OBJECTIVE	1	1	2099	SYMBOL|EXTRACTED|()	er	ER	103#105	16788379-1-84-101	D001943	LONGTERM|DISEASE|DT|DICTIONARY	breast cancer	breast cancer	45#58		Endogenous and exogenous estrogens influence breast cancer risk by interacting with estrogen receptor (ER).
15057267	2005	Genes Immun.	1466-4879	ALL_TEXT_1/3	1	2	51497	LONGTERM|DICTIONARY	th1	Th1	39#42	NaN	C565730	LONGTERM|DICTIONARY	autoimmune diabetes	autoimmune diabetes	99#118		Evidence suggests that an imbalance in Th1/Th2 responses may play a key role in the development of autoimmune diabetes.
23566200	2013	Immunology	1365-2567	ALL_TEXT_2/3	2	8	151306	SYMBOL|DICTIONARY	tgr5	TGR5	18#22		D003424	SYMBOL|EXTRACTED	cd	CD	127#129	23566200-5-176-191	Next, we analysed TGR5 levels in lamina propria mononuclear cells (LPMCs) obtained from the intestinal mucosa of patients with CD.
15660776	2005	Epilepsia	0013-9580	RESULTS	3	5	348	LONGTERM|DICTIONARY	apoe	ApoE	19#23	NaN	D007859	LONGTERM|DICTIONARY	vld	VLD	81#84	NaN	The presence of an ApoE epsilon4 allele was associated with an increased risk of VLD (OR, 4.18; 95% CI, 1.66-10.55).
20018409	2012	Neurobiol. Aging	1558-1497	TITLE	0	0	120892	SYMBOL|DICTIONARY|EXTRACTED	lrrk2	LRRK2	0#5		D000544	LONGTERM|DISEASE|DT|DICTIONARY	alzheimer disease	Alzheimer's disease	30#49		LRRK2 variant associated with Alzheimer's disease.
16917940	2007	Am. J. Med. Genet. B Neuropsychiatr. Genet.	1552-4841	ALL_TEXT_3/3	3	11	1815	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	drd4	DRD4	84#88	16917940-0-24-44	D001289	SYMBOL|DICTIONARY|EXTRACTED	adhd	ADHD	18#22	16917940-1-70-110	We concluded that ADHD is not associated with a particular VNTR polymorphism of the DRD4 gene.
16917940	2007	Am. J. Med. Genet. B Neuropsychiatr. Genet.	1552-4841	ALL_TEXT_3/3	3	12	1815	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	drd4	DRD4	90#94	16917940-0-24-44	D001289	SYMBOL|DICTIONARY|EXTRACTED	adhd	ADHD	123#127	16917940-1-70-110	Further studies are needed to clarify the role of repeat length of the VNTR region of the DRD4 gene in the pathogenesis of ADHD.
1352745	1992	Clin. Exp. Immunol.	0009-9104	ALL_TEXT_3/3	3	6	1378	SYMBOL|EXTRACTED	cr1	CR1	37#40	1352745-0-7-10	D003922	SYMBOL|DICTIONARY|EXTRACTED	iddm	IDDM	118#122	1352745-0-64-99	The results confirm that erythrocyte CR1 expression is genetically determined, but the CR1 deficiency associated with IDDM seems to be an acquired rather than a genetic phenomenon.
1352745	1992	Clin. Exp. Immunol.	0009-9104	ALL_TEXT_3/3	3	6	1378	SYMBOL|EXTRACTED	cr1	CR1	87#90	1352745-0-7-10	D003922	SYMBOL|DICTIONARY|EXTRACTED	iddm	IDDM	118#122	1352745-0-64-99	The results confirm that erythrocyte CR1 expression is genetically determined, but the CR1 deficiency associated with IDDM seems to be an acquired rather than a genetic phenomenon.
25356585	2015	PLoS ONE	1932-6203	CONCLUSIONS	4	10	1513	LONGTERM|DICTIONARY	cathepsin k	cathepsin K	52#63		D005909	SYMBOL|DICTIONARY|EXTRACTED	gbm	GBM	67#70	25356585-2-126-149	The presence of high levels of inactive proforms of cathepsin K in GBM tissues and cells indicate that in GBM the proteolytic/collagenolytic role is not its primary function but it plays rather a different yet unknown role.
25356585	2015	PLoS ONE	1932-6203	CONCLUSIONS	4	10	1513	LONGTERM|DICTIONARY	cathepsin k	cathepsin K	52#63		D005909	SYMBOL|DICTIONARY|EXTRACTED	gbm	GBM	106#109	25356585-2-126-149	The presence of high levels of inactive proforms of cathepsin K in GBM tissues and cells indicate that in GBM the proteolytic/collagenolytic role is not its primary function but it plays rather a different yet unknown role.
12200750	2002	Metab. Clin. Exp.	0026-0495	ALL_TEXT_3/3	3	7	348	LONGTERM|DICTIONARY	apo e	apo E	28#33	NaN	C566031	LONGTERM|DICTIONARY	tg	TG	23#25	NaN	In addition, a fasting TG x apo E interaction on postprandial TG was shown (P <.01), and the correlation between fasting TG and TG AUIC was actually restricted to E2 or E4 carriers.
12200750	2002	Metab. Clin. Exp.	0026-0495	ALL_TEXT_3/3	3	7	348	LONGTERM|DICTIONARY	apo e	apo E	28#33	NaN	C566031	LONGTERM|DICTIONARY	tg	TG	62#64	NaN	In addition, a fasting TG x apo E interaction on postprandial TG was shown (P <.01), and the correlation between fasting TG and TG AUIC was actually restricted to E2 or E4 carriers.
12200750	2002	Metab. Clin. Exp.	0026-0495	ALL_TEXT_3/3	3	7	348	LONGTERM|DICTIONARY	apo e	apo E	28#33	NaN	C566031	LONGTERM|DICTIONARY	tg	TG	121#123	NaN	In addition, a fasting TG x apo E interaction on postprandial TG was shown (P <.01), and the correlation between fasting TG and TG AUIC was actually restricted to E2 or E4 carriers.
12200750	2002	Metab. Clin. Exp.	0026-0495	ALL_TEXT_3/3	3	7	348	LONGTERM|DICTIONARY	apo e	apo E	28#33	NaN	C566031	LONGTERM|DICTIONARY	tg	TG	128#130	NaN	In addition, a fasting TG x apo E interaction on postprandial TG was shown (P <.01), and the correlation between fasting TG and TG AUIC was actually restricted to E2 or E4 carriers.
19369177	2009	J. Formos. Med. Assoc.	0929-6646	TITLE	0	0	1312	SYMBOL|DICTIONARY|EXTRACTED	comt	COMT	32#36		D012559	LONGTERM|DICTIONARY	schizophrenia	schizophrenia	42#55		Association of the 3' region of COMT with schizophrenia in Taiwan.
19369177	2009	J. Formos. Med. Assoc.	0929-6646	BACKGROUND/PURPOSE	1	1	1312	LONGTERM|DICTIONARY|GENE|GA	catechol o methyltransferase	catechol-O-methyltransferase	71#99		D012559	LONGTERM|DICTIONARY	schizophrenia	schizophrenia	153#166		The Val108/158Met (rs4680) single nucleotide polymorphism (SNP) in the catechol-O-methyltransferase (COMT) gene contributes to genetic susceptibility to schizophrenia, which is specifically related to impairments in executive functioning.
19369177	2009	J. Formos. Med. Assoc.	0929-6646	BACKGROUND/PURPOSE	1	1	1312	SYMBOL|()|GENE|GN|DICTIONARY|EXTRACTED	comt	COMT	101#105	19369177-1-71-99	D012559	LONGTERM|DICTIONARY	schizophrenia	schizophrenia	153#166		The Val108/158Met (rs4680) single nucleotide polymorphism (SNP) in the catechol-O-methyltransferase (COMT) gene contributes to genetic susceptibility to schizophrenia, which is specifically related to impairments in executive functioning.
19369177	2009	J. Formos. Med. Assoc.	0929-6646	BACKGROUND/PURPOSE	1	2	1312	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	comt	COMT	90#94	19369177-1-71-99	D012559	LONGTERM|DICTIONARY	schizophrenia	schizophrenia	154#167		A different genomic region composed of three SNPs (rs737865, rs4680, rs165599) within the COMT gene has been reported to be significantly associated with schizophrenia in Ashkenazi Jews.
18368507	2009	Int Urol Nephrol	0301-1623	ALL_TEXT_3/3	3	8	6817	SYMBOL|DICTIONARY	sult1a1	SULT1A1	54#61		D011471	LONGTERM|DISEASE|DT|DICTIONARY	prostate cancer	prostate cancer	113#128		These findings suggested that genetic polymorphism of SULT1A1 might not be involved in genetic susceptibility to prostate cancer.
19362357	2009	J. Allergy Clin. Immunol.	1097-6825	TITLE	0	0	30009	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	tbx21	TBX21	0#5		D001249	LONGTERM|DICTIONARY	asthma	asthma	39#45		TBX21 gene variants increase childhood asthma risk in combination with HLX1 variants.
19362357	2009	J. Allergy Clin. Immunol.	1097-6825	TITLE	0	0	3142	SYMBOL|DICTIONARY	hlx1	HLX1	71#75		D001249	LONGTERM|DICTIONARY	asthma	asthma	39#45		TBX21 gene variants increase childhood asthma risk in combination with HLX1 variants.
19362357	2009	J. Allergy Clin. Immunol.	1097-6825	OBJECTIVE	2	2	30009	SYMBOL|DICTIONARY|EXTRACTED	tbx21	TBX21	32#37	19362357-1-20-46	D001249	LONGTERM|DICTIONARY	asthma	asthma	153#159		The role of genetic variants in TBX21 alone and in combination with HLX1 polymorphisms was investigated in the development of T(H)2-associated atopy and asthma.
19362357	2009	J. Allergy Clin. Immunol.	1097-6825	OBJECTIVE	2	2	3142	SYMBOL|DICTIONARY	hlx1	HLX1	68#72		D001249	LONGTERM|DICTIONARY	asthma	asthma	153#159		The role of genetic variants in TBX21 alone and in combination with HLX1 polymorphisms was investigated in the development of T(H)2-associated atopy and asthma.
18368507	2009	Int Urol Nephrol	0301-1623	ALL_TEXT_2/3	2	3	6817	SYMBOL|DICTIONARY	sult1a1	SULT1A1	98#105		D011471	LONGTERM|DISEASE|DT|DICTIONARY	familial prostate cancer	familial prostate cancer	111#135		The present study was conducted to confirm the association of a G638A polymorphism, Arg213His, in SULT1A1 with familial prostate cancer risk in a Japanese population.
18368507	2009	Int Urol Nephrol	0301-1623	ALL_TEXT_1/3	1	2	6817	SYMBOL|GENE|GN|DICTIONARY	sult1a1	SULT1A1	28#35		D009369	LONGTERM|DICTIONARY	cancers	cancers	103#110		Genetic polymorphism of the SULT1A1 gene, SULT1A1, was reported to be associated with risks of several cancers; however, one study showed no significant relation between SULT1A1 genotype with prostate cancer risk.
18368507	2009	Int Urol Nephrol	0301-1623	ALL_TEXT_1/3	1	2	6817	SYMBOL|GENE|GN|DICTIONARY	sult1a1	SULT1A1	28#35		D011471	LONGTERM|DISEASE|DT|DICTIONARY	prostate cancer	prostate cancer	192#207		Genetic polymorphism of the SULT1A1 gene, SULT1A1, was reported to be associated with risks of several cancers; however, one study showed no significant relation between SULT1A1 genotype with prostate cancer risk.
18368507	2009	Int Urol Nephrol	0301-1623	ALL_TEXT_1/3	1	2	6817	SYMBOL|DICTIONARY	sult1a1	SULT1A1	42#49		D009369	LONGTERM|DICTIONARY	cancers	cancers	103#110		Genetic polymorphism of the SULT1A1 gene, SULT1A1, was reported to be associated with risks of several cancers; however, one study showed no significant relation between SULT1A1 genotype with prostate cancer risk.
18368507	2009	Int Urol Nephrol	0301-1623	ALL_TEXT_1/3	1	2	6817	SYMBOL|DICTIONARY	sult1a1	SULT1A1	42#49		D011471	LONGTERM|DISEASE|DT|DICTIONARY	prostate cancer	prostate cancer	192#207		Genetic polymorphism of the SULT1A1 gene, SULT1A1, was reported to be associated with risks of several cancers; however, one study showed no significant relation between SULT1A1 genotype with prostate cancer risk.
18368507	2009	Int Urol Nephrol	0301-1623	ALL_TEXT_1/3	1	2	6817	SYMBOL|DICTIONARY	sult1a1	SULT1A1	170#177		D009369	LONGTERM|DICTIONARY	cancers	cancers	103#110		Genetic polymorphism of the SULT1A1 gene, SULT1A1, was reported to be associated with risks of several cancers; however, one study showed no significant relation between SULT1A1 genotype with prostate cancer risk.
18368507	2009	Int Urol Nephrol	0301-1623	ALL_TEXT_1/3	1	2	6817	SYMBOL|DICTIONARY	sult1a1	SULT1A1	170#177		D011471	LONGTERM|DISEASE|DT|DICTIONARY	prostate cancer	prostate cancer	192#207		Genetic polymorphism of the SULT1A1 gene, SULT1A1, was reported to be associated with risks of several cancers; however, one study showed no significant relation between SULT1A1 genotype with prostate cancer risk.
18368507	2009	Int Urol Nephrol	0301-1623	TITLE	0	0	6817	SYMBOL|DICTIONARY	sult1a1	SULT1A1	65#72		D011471	LONGTERM|DISEASE|DT|DICTIONARY	prostate cancer	prostate cancer	91#106		Further evidence for null association of phenol sulfotransferase SULT1A1 polymorphism with prostate cancer risk: a case-control study of familial prostate cancer in a Japanese population.
18368507	2009	Int Urol Nephrol	0301-1623	TITLE	0	0	6817	SYMBOL|DICTIONARY	sult1a1	SULT1A1	65#72		D011471	LONGTERM|DISEASE|DT|DICTIONARY	familial prostate cancer	familial prostate cancer	137#161		Further evidence for null association of phenol sulfotransferase SULT1A1 polymorphism with prostate cancer risk: a case-control study of familial prostate cancer in a Japanese population.
12932609	2003	J. Am. Coll. Cardiol.	0735-1097	METHODS	3	7	136319	LONGTERM|DICTIONARY	myotrophin	Myotrophin	0#10	NaN	D006333	SYMBOL|EXTRACTED|DISEASE|DN	hf	HF	50#52	12932609-1-73-86	Myotrophin was measured in plasma extracts of 120 HF patients and 130 age- and gender-matched normal controls.
12378512	2002	Hum. Pathol.	0046-8177	ALL_TEXT_3/3	3	10	7157	SYMBOL|DICTIONARY	p53	p53	141#144		D008113	LONGTERM|DICTIONARY	angiosarcoma of the liver	angiosarcoma of the liver	87#112		In conclusion, our data indicate that the INK4a-ARF locus is frequently inactivated in angiosarcoma of the liver and occurs independently of p53 mutations.
20816194	2010	J. Allergy Clin. Immunol.	1097-6825	RESULTS	4	9	6774	SYMBOL|DICTIONARY|EXTRACTED	stat3	STAT3	80#85	20816194-2-32-82	D000038	LONGTERM|DICTIONARY	abscesses	abscesses	9#18		Internal abscesses and severe infections were exclusively seen in patients with STAT3 mutations, who also had increased pneumatocele formation and skeletal or connective tissue manifestations compared with patients with wild-type STAT3.
20816194	2010	J. Allergy Clin. Immunol.	1097-6825	RESULTS	4	9	6774	SYMBOL|DICTIONARY|EXTRACTED	stat3	STAT3	80#85	20816194-2-32-82	D007239	LONGTERM|DICTIONARY	infections	infections	30#40		Internal abscesses and severe infections were exclusively seen in patients with STAT3 mutations, who also had increased pneumatocele formation and skeletal or connective tissue manifestations compared with patients with wild-type STAT3.
20816194	2010	J. Allergy Clin. Immunol.	1097-6825	RESULTS	4	9	6774	SYMBOL|DICTIONARY|EXTRACTED	stat3	STAT3	230#235	20816194-2-32-82	D000038	LONGTERM|DICTIONARY	abscesses	abscesses	9#18		Internal abscesses and severe infections were exclusively seen in patients with STAT3 mutations, who also had increased pneumatocele formation and skeletal or connective tissue manifestations compared with patients with wild-type STAT3.
20816194	2010	J. Allergy Clin. Immunol.	1097-6825	RESULTS	4	9	6774	SYMBOL|DICTIONARY|EXTRACTED	stat3	STAT3	230#235	20816194-2-32-82	D007239	LONGTERM|DICTIONARY	infections	infections	30#40		Internal abscesses and severe infections were exclusively seen in patients with STAT3 mutations, who also had increased pneumatocele formation and skeletal or connective tissue manifestations compared with patients with wild-type STAT3.
20816194	2010	J. Allergy Clin. Immunol.	1097-6825	BACKGROUND	1	2	6774	LONGTERM|DICTIONARY	signal transducer and activator of transcription 3	signal transducer and activator of transcription 3	32#82		D007589	SYMBOL|EXTRACTED	hies	HIES	130#134	20816194-1-0-19	The association of heterozygous signal transducer and activator of transcription 3 (STAT3) mutations with autosomal dominant (AD)-HIES allows the differentiation of AD-HIES from disorders associated with eczema and increased serum IgE levels, such as other primary immunodeficiencies and atopic dermatitis.
20816194	2010	J. Allergy Clin. Immunol.	1097-6825	BACKGROUND	1	2	6774	LONGTERM|DICTIONARY	signal transducer and activator of transcription 3	signal transducer and activator of transcription 3	32#82		D007589	SYMBOL|EXTRACTED	hies	HIES	168#172	20816194-1-0-19	The association of heterozygous signal transducer and activator of transcription 3 (STAT3) mutations with autosomal dominant (AD)-HIES allows the differentiation of AD-HIES from disorders associated with eczema and increased serum IgE levels, such as other primary immunodeficiencies and atopic dermatitis.
20816194	2010	J. Allergy Clin. Immunol.	1097-6825	BACKGROUND	1	2	6774	LONGTERM|DICTIONARY	signal transducer and activator of transcription 3	signal transducer and activator of transcription 3	32#82		D004485	LONGTERM|DICTIONARY	eczema	eczema	204#210		The association of heterozygous signal transducer and activator of transcription 3 (STAT3) mutations with autosomal dominant (AD)-HIES allows the differentiation of AD-HIES from disorders associated with eczema and increased serum IgE levels, such as other primary immunodeficiencies and atopic dermatitis.
20816194	2010	J. Allergy Clin. Immunol.	1097-6825	BACKGROUND	1	2	6774	LONGTERM|DICTIONARY	signal transducer and activator of transcription 3	signal transducer and activator of transcription 3	32#82		D007153	LONGTERM|DICTIONARY	immunodeficiencies	immunodeficiencies	265#283		The association of heterozygous signal transducer and activator of transcription 3 (STAT3) mutations with autosomal dominant (AD)-HIES allows the differentiation of AD-HIES from disorders associated with eczema and increased serum IgE levels, such as other primary immunodeficiencies and atopic dermatitis.
20816194	2010	J. Allergy Clin. Immunol.	1097-6825	BACKGROUND	1	2	6774	LONGTERM|DICTIONARY	signal transducer and activator of transcription 3	signal transducer and activator of transcription 3	32#82		D003876	LONGTERM|DICTIONARY	atopic dermatitis	atopic dermatitis	288#305		The association of heterozygous signal transducer and activator of transcription 3 (STAT3) mutations with autosomal dominant (AD)-HIES allows the differentiation of AD-HIES from disorders associated with eczema and increased serum IgE levels, such as other primary immunodeficiencies and atopic dermatitis.
20816194	2010	J. Allergy Clin. Immunol.	1097-6825	BACKGROUND	1	2	6774	SYMBOL|()|DICTIONARY|EXTRACTED	stat3	STAT3	84#89	20816194-2-32-82	D007589	SYMBOL|EXTRACTED	hies	HIES	130#134	20816194-1-0-19	The association of heterozygous signal transducer and activator of transcription 3 (STAT3) mutations with autosomal dominant (AD)-HIES allows the differentiation of AD-HIES from disorders associated with eczema and increased serum IgE levels, such as other primary immunodeficiencies and atopic dermatitis.
20816194	2010	J. Allergy Clin. Immunol.	1097-6825	BACKGROUND	1	2	6774	SYMBOL|()|DICTIONARY|EXTRACTED	stat3	STAT3	84#89	20816194-2-32-82	D007589	SYMBOL|EXTRACTED	hies	HIES	168#172	20816194-1-0-19	The association of heterozygous signal transducer and activator of transcription 3 (STAT3) mutations with autosomal dominant (AD)-HIES allows the differentiation of AD-HIES from disorders associated with eczema and increased serum IgE levels, such as other primary immunodeficiencies and atopic dermatitis.
20816194	2010	J. Allergy Clin. Immunol.	1097-6825	BACKGROUND	1	2	6774	SYMBOL|()|DICTIONARY|EXTRACTED	stat3	STAT3	84#89	20816194-2-32-82	D004485	LONGTERM|DICTIONARY	eczema	eczema	204#210		The association of heterozygous signal transducer and activator of transcription 3 (STAT3) mutations with autosomal dominant (AD)-HIES allows the differentiation of AD-HIES from disorders associated with eczema and increased serum IgE levels, such as other primary immunodeficiencies and atopic dermatitis.
20816194	2010	J. Allergy Clin. Immunol.	1097-6825	BACKGROUND	1	2	6774	SYMBOL|()|DICTIONARY|EXTRACTED	stat3	STAT3	84#89	20816194-2-32-82	D007153	LONGTERM|DICTIONARY	immunodeficiencies	immunodeficiencies	265#283		The association of heterozygous signal transducer and activator of transcription 3 (STAT3) mutations with autosomal dominant (AD)-HIES allows the differentiation of AD-HIES from disorders associated with eczema and increased serum IgE levels, such as other primary immunodeficiencies and atopic dermatitis.
20816194	2010	J. Allergy Clin. Immunol.	1097-6825	BACKGROUND	1	2	6774	SYMBOL|()|DICTIONARY|EXTRACTED	stat3	STAT3	84#89	20816194-2-32-82	D003876	LONGTERM|DICTIONARY	atopic dermatitis	atopic dermatitis	288#305		The association of heterozygous signal transducer and activator of transcription 3 (STAT3) mutations with autosomal dominant (AD)-HIES allows the differentiation of AD-HIES from disorders associated with eczema and increased serum IgE levels, such as other primary immunodeficiencies and atopic dermatitis.
20816194	2010	J. Allergy Clin. Immunol.	1097-6825	BACKGROUND	1	2	3497	LONGTERM|DICTIONARY	ige	IgE	231#234	NaN	D007589	SYMBOL|EXTRACTED	hies	HIES	130#134	20816194-1-0-19	The association of heterozygous signal transducer and activator of transcription 3 (STAT3) mutations with autosomal dominant (AD)-HIES allows the differentiation of AD-HIES from disorders associated with eczema and increased serum IgE levels, such as other primary immunodeficiencies and atopic dermatitis.
20816194	2010	J. Allergy Clin. Immunol.	1097-6825	BACKGROUND	1	2	3497	LONGTERM|DICTIONARY	ige	IgE	231#234	NaN	D007589	SYMBOL|EXTRACTED	hies	HIES	168#172	20816194-1-0-19	The association of heterozygous signal transducer and activator of transcription 3 (STAT3) mutations with autosomal dominant (AD)-HIES allows the differentiation of AD-HIES from disorders associated with eczema and increased serum IgE levels, such as other primary immunodeficiencies and atopic dermatitis.
20816194	2010	J. Allergy Clin. Immunol.	1097-6825	BACKGROUND	1	2	3497	LONGTERM|DICTIONARY	ige	IgE	231#234	NaN	D004485	LONGTERM|DICTIONARY	eczema	eczema	204#210		The association of heterozygous signal transducer and activator of transcription 3 (STAT3) mutations with autosomal dominant (AD)-HIES allows the differentiation of AD-HIES from disorders associated with eczema and increased serum IgE levels, such as other primary immunodeficiencies and atopic dermatitis.
20816194	2010	J. Allergy Clin. Immunol.	1097-6825	BACKGROUND	1	2	3497	LONGTERM|DICTIONARY	ige	IgE	231#234	NaN	D007153	LONGTERM|DICTIONARY	immunodeficiencies	immunodeficiencies	265#283		The association of heterozygous signal transducer and activator of transcription 3 (STAT3) mutations with autosomal dominant (AD)-HIES allows the differentiation of AD-HIES from disorders associated with eczema and increased serum IgE levels, such as other primary immunodeficiencies and atopic dermatitis.
20816194	2010	J. Allergy Clin. Immunol.	1097-6825	BACKGROUND	1	2	3497	LONGTERM|DICTIONARY	ige	IgE	231#234	NaN	D003876	LONGTERM|DICTIONARY	atopic dermatitis	atopic dermatitis	288#305		The association of heterozygous signal transducer and activator of transcription 3 (STAT3) mutations with autosomal dominant (AD)-HIES allows the differentiation of AD-HIES from disorders associated with eczema and increased serum IgE levels, such as other primary immunodeficiencies and atopic dermatitis.
22802922	2013	PLoS ONE	1932-6203	ALL_TEXT_1/3	1	2	540	SYMBOL|DICTIONARY	atp7b	ATP7B	99#104		D006527	LONGTERM|DISEASE|DT|DICTIONARY	wilson disease	Wilson's disease	3#19		In Wilson's disease (WD), this function is disrupted due to inactivation of the copper transporter ATP7B resulting in hepatic copper overload.
22802922	2013	PLoS ONE	1932-6203	ALL_TEXT_1/3	1	2	540	SYMBOL|DICTIONARY	atp7b	ATP7B	99#104		D006527	SYMBOL|EXTRACTED|()	wd	WD	21#23	22802922-2-3-19	In Wilson's disease (WD), this function is disrupted due to inactivation of the copper transporter ATP7B resulting in hepatic copper overload.
22802922	2013	PLoS ONE	1932-6203	ALL_TEXT_1/3	1	2	540	SYMBOL|DICTIONARY	atp7b	ATP7B	99#104		D008107	LONGTERM|DICTIONARY	hepatic copper overload	hepatic copper overload	118#141	NaN	In Wilson's disease (WD), this function is disrupted due to inactivation of the copper transporter ATP7B resulting in hepatic copper overload.
20816194	2010	J. Allergy Clin. Immunol.	1097-6825	METHODS	3	4	6774	SYMBOL|DICTIONARY|EXTRACTED	stat3	STAT3	100#105	20816194-2-32-82	D007589	SYMBOL|EXTRACTED	hies	HIES	200#204	20816194-1-0-19	The clinical phenotype (suggested by a National Institutes of Health [NIH] score of >or=40 points), STAT3 genotype, and T(H)17 cell counts were compared in a cohort of 78 patients suspected of having HIES.
10732801	2000	Neurogenetics	1364-6745	ALL_TEXT_2/3	2	3	7249	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	tsc2	TSC2	68#72	10732801-0-42-62	D014402	SYMBOL|GFAM|FN|DICTIONARY|EXTRACTED	tsc	TSC	84#87	10732801-1-0-26	Our laboratory has undertaken the complete mutation analysis of the TSC2 gene in 42 TSC families using single-strand conformation polymorphism analysis and reverse transcription-polymerase chain reaction.
16517152	2006	Eur. J. Cancer	0959-8049	ALL_TEXT_3/3	3	11	4153	SYMBOL|DICTIONARY|EXTRACTED	mbl	MBL	131#134	16517152-0-12-34	D009503	LONGTERM|DICTIONARY	neutropenic	neutropenic	43#54	NaN	However, most patients (61%) were severely neutropenic (<100 cells/microL), compromising the opsonophagocytic effector function of MBL.
18074111	2008	Mol. Cell. Biochem.	0300-8177	TITLE	0	0	4524	LONGTERM|DICTIONARY	methylene tetrahydrofolate reductase	methylene tetrahydrofolate reductase	54#90	NaN	D020138	LONGTERM|DICTIONARY	hyperhomocysteinemia	hyperhomocysteinemia	100#120		Association of polymorphism in the thermolabile 5, 10-methylene tetrahydrofolate reductase gene and hyperhomocysteinemia with coronary artery disease.
18074111	2008	Mol. Cell. Biochem.	0300-8177	TITLE	0	0	4524	LONGTERM|DICTIONARY	methylene tetrahydrofolate reductase	methylene tetrahydrofolate reductase	54#90	NaN	D003324	LONGTERM|DISEASE|DT|DICTIONARY	coronary artery disease	coronary artery disease	126#149		Association of polymorphism in the thermolabile 5, 10-methylene tetrahydrofolate reductase gene and hyperhomocysteinemia with coronary artery disease.
20393813	2010	J. Mol. Neurosci.	1559-1166	TITLE	0	0	3569	LONGTERM|DICTIONARY	interleukin 6	interleukin-6	31#44		D012559	LONGTERM|DICTIONARY	schizophrenia	schizophrenia	96#109		Functional polymorphism in the interleukin-6 and interleukin-10 genes in patients with paranoid schizophrenia--a case-control study.
20393813	2010	J. Mol. Neurosci.	1559-1166	TITLE	0	0	3586	LONGTERM|GENE|GN|DICTIONARY	interleukin 10	interleukin-10	49#63		D012559	LONGTERM|DICTIONARY	schizophrenia	schizophrenia	96#109		Functional polymorphism in the interleukin-6 and interleukin-10 genes in patients with paranoid schizophrenia--a case-control study.
23566200	2013	Immunology	1365-2567	ALL_TEXT_2/3	2	5	929	SYMBOL|DICTIONARY	cd14	CD14	145#149		D003424	LONGTERM|DISEASE|DT|DICTIONARY	crohn disease	Crohn's disease	176#191		Ms differentiated with macrophage colony-stimulating factor and interferon- (M-Ms), which are similar to the human intestinal lamina propria CD14(+) Ms that contribute to Crohn's disease (CD) pathogenesis by production of pro-inflammatory cytokines, highly expressed TGR5 compared with any other type of differentiated M and dendritic cells.
23566200	2013	Immunology	1365-2567	ALL_TEXT_2/3	2	5	929	SYMBOL|DICTIONARY	cd14	CD14	145#149		D003424	SYMBOL|EXTRACTED|()	cd	CD	193#195	23566200-5-176-191	Ms differentiated with macrophage colony-stimulating factor and interferon- (M-Ms), which are similar to the human intestinal lamina propria CD14(+) Ms that contribute to Crohn's disease (CD) pathogenesis by production of pro-inflammatory cytokines, highly expressed TGR5 compared with any other type of differentiated M and dendritic cells.
23566200	2013	Immunology	1365-2567	ALL_TEXT_2/3	2	5	151306	SYMBOL|DICTIONARY	tgr5	TGR5	272#276		D003424	LONGTERM|DISEASE|DT|DICTIONARY	crohn disease	Crohn's disease	176#191		Ms differentiated with macrophage colony-stimulating factor and interferon- (M-Ms), which are similar to the human intestinal lamina propria CD14(+) Ms that contribute to Crohn's disease (CD) pathogenesis by production of pro-inflammatory cytokines, highly expressed TGR5 compared with any other type of differentiated M and dendritic cells.
23566200	2013	Immunology	1365-2567	ALL_TEXT_2/3	2	5	151306	SYMBOL|DICTIONARY	tgr5	TGR5	272#276		D003424	SYMBOL|EXTRACTED|()	cd	CD	193#195	23566200-5-176-191	Ms differentiated with macrophage colony-stimulating factor and interferon- (M-Ms), which are similar to the human intestinal lamina propria CD14(+) Ms that contribute to Crohn's disease (CD) pathogenesis by production of pro-inflammatory cytokines, highly expressed TGR5 compared with any other type of differentiated M and dendritic cells.
15824150	2005	Cancer Epidemiol. Biomarkers Prev.	1055-9965	TITLE	0	0	472	LONGTERM|DICTIONARY	ataxia telangiectasia mutated	ataxia telangiectasia mutated	25#54		D001943	LONGTERM|DISEASE|DT|DICTIONARY	breast cancer	breast cancer	59#72		Genetic polymorphisms of ataxia telangiectasia mutated and breast cancer risk.
20533278	2010	Zhonghua Yi Xue Yi Chuan Xue Za Zhi	1003-9406	TITLE	0	0	100507436	SYMBOL|GENE|GN|DICTIONARY	mica	MICA	16#20		D015179	LONGTERM|DISEASE|DT|DICTIONARY	colorectal cancer	colorectal cancer	73#90		[Association of MICA gene polymorphism and serum soluble MICA level with colorectal cancer].
20010906	2010	Int J Obes (Lond)	1476-5497	CONCLUSION	4	12	4828	SYMBOL|DICTIONARY|EXTRACTED	nmb	NMB	48#51	20010906-1-0-12	D009765	LONGTERM|DICTIONARY	obesity	obesity	112#119		In European adolescents, the TT genotype of the NMB rs3809508 polymorphism was associated with a higher risk of obesity.
23566200	2013	Immunology	1365-2567	ALL_TEXT_3/3	3	9	151306	SYMBOL|DICTIONARY	tgr5	TGR5	79#83		D003424	SYMBOL|EXTRACTED	cd	CD	55#57	23566200-5-176-191	Compared with non-inflammatory bowel disease, inflamed CD LPMCs contained more TGR5 transcripts.
23566200	2013	Immunology	1365-2567	ALL_TEXT_3/3	3	9	151306	SYMBOL|DICTIONARY	tgr5	TGR5	79#83		D015212	LONGTERM|DISEASE|DT|DICTIONARY	non-inflammatory bowel disease	non-inflammatory bowel disease	14#44		Compared with non-inflammatory bowel disease, inflamed CD LPMCs contained more TGR5 transcripts.
19220408	2009	Epilepsia	1528-1167	RESULTS	3	4	8645	SYMBOL|DICTIONARY	task 2	TASK-2	31#37		D013226	LONGTERM|DICTIONARY	status epilepticus	status epilepticus	6#24		After status epilepticus (SE), TASK-2 immunoreactivity was increased in dentate granule cell layer and CA3 pyramidal cell layer, whereas its immunoreactivity was reduced in CA1 pyramidal cell layer.
19220408	2009	Epilepsia	1528-1167	RESULTS	3	4	8645	SYMBOL|DICTIONARY	task 2	TASK-2	31#37		D013226	SYMBOL|EXTRACTED|()	se	SE	26#28	19220408-4-6-24	After status epilepticus (SE), TASK-2 immunoreactivity was increased in dentate granule cell layer and CA3 pyramidal cell layer, whereas its immunoreactivity was reduced in CA1 pyramidal cell layer.
19220408	2009	Epilepsia	1528-1167	RESULTS	3	4	759	LONGTERM|DICTIONARY	ca1	CA1	173#176	NaN	D013226	LONGTERM|DICTIONARY	status epilepticus	status epilepticus	6#24		After status epilepticus (SE), TASK-2 immunoreactivity was increased in dentate granule cell layer and CA3 pyramidal cell layer, whereas its immunoreactivity was reduced in CA1 pyramidal cell layer.
19220408	2009	Epilepsia	1528-1167	RESULTS	3	4	759	LONGTERM|DICTIONARY	ca1	CA1	173#176	NaN	D013226	SYMBOL|EXTRACTED|()	se	SE	26#28	19220408-4-6-24	After status epilepticus (SE), TASK-2 immunoreactivity was increased in dentate granule cell layer and CA3 pyramidal cell layer, whereas its immunoreactivity was reduced in CA1 pyramidal cell layer.
19220408	2009	Epilepsia	1528-1167	RESULTS	3	4	761	LONGTERM|DICTIONARY	ca3	CA3	103#106	NaN	D013226	LONGTERM|DICTIONARY	status epilepticus	status epilepticus	6#24		After status epilepticus (SE), TASK-2 immunoreactivity was increased in dentate granule cell layer and CA3 pyramidal cell layer, whereas its immunoreactivity was reduced in CA1 pyramidal cell layer.
19220408	2009	Epilepsia	1528-1167	RESULTS	3	4	761	LONGTERM|DICTIONARY	ca3	CA3	103#106	NaN	D013226	SYMBOL|EXTRACTED|()	se	SE	26#28	19220408-4-6-24	After status epilepticus (SE), TASK-2 immunoreactivity was increased in dentate granule cell layer and CA3 pyramidal cell layer, whereas its immunoreactivity was reduced in CA1 pyramidal cell layer.
8757534	1996	Br. J. Haematol.	0007-1048	ALL_TEXT_1/3	1	1	2235	LONGTERM|GENE|GN|DICTIONARY	ferrochelatase	ferrochelatase	88#102		D046351	LONGTERM|DICTIONARY	erythropoietic protoporphyria	Erythropoietic protoporphyria	0#29		Erythropoietic protoporphyria (EPP) is a hereditary disorder caused by mutations of the ferrochelatase gene.
8757534	1996	Br. J. Haematol.	0007-1048	ALL_TEXT_1/3	1	1	2235	LONGTERM|GENE|GN|DICTIONARY	ferrochelatase	ferrochelatase	88#102		D046351	SYMBOL|()|DICTIONARY|EXTRACTED	epp	EPP	31#34	8757534-1-0-29	Erythropoietic protoporphyria (EPP) is a hereditary disorder caused by mutations of the ferrochelatase gene.
8757534	1996	Br. J. Haematol.	0007-1048	ALL_TEXT_1/3	1	1	2235	LONGTERM|GENE|GN|DICTIONARY	ferrochelatase	ferrochelatase	88#102		D030342	LONGTERM|DISEASE|DT|DICTIONARY	hereditary disorder	hereditary disorder	41#60		Erythropoietic protoporphyria (EPP) is a hereditary disorder caused by mutations of the ferrochelatase gene.
18644122	2008	BMC Med. Genet.	1471-2350	CONCLUSION	4	11	6555	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	slc10a2	SLC10A2	23#30	18644122-3-112-156	D015179	SYMBOL|DICTIONARY|EXTRACTED	crc	CRC	81#84	18644122-1-52-69	Common variants of the SLC10A2 gene are not associated with sporadic or familial CRC.
18644122	2008	BMC Med. Genet.	1471-2350	RESULTS	3	10	6555	SYMBOL|DICTIONARY|EXTRACTED	slc10a2	SLC10A2	49#56	18644122-3-112-156	D015179	SYMBOL|DICTIONARY|EXTRACTED	crc	CRC	94#97	18644122-1-52-69	However, we found no association with any of the SLC10A2 haplotypes with sporadic or familial CRC in our samples (all P values > 0.05).
9217972	1997	Brain Pathol.	1015-6305	TITLE	0	0	1956	SYMBOL|GENE|GN|DICTIONARY	egfr	EGFR	15#19		D005909	LONGTERM|DICTIONARY	glioblastoma	glioblastoma	77#89		Association of EGFR gene amplification and CDKN2 (p16/MTS1) gene deletion in glioblastoma multiforme.
9217972	1997	Brain Pathol.	1015-6305	TITLE	0	0	1029	SYMBOL|DICTIONARY	cdkn2	CDKN2	43#48		D005909	LONGTERM|DICTIONARY	glioblastoma	glioblastoma	77#89		Association of EGFR gene amplification and CDKN2 (p16/MTS1) gene deletion in glioblastoma multiforme.
9217972	1997	Brain Pathol.	1015-6305	TITLE	0	0	1029	SYMBOL|GENE|GN|DICTIONARY	mts1	MTS1	54#58		D005909	LONGTERM|DICTIONARY	glioblastoma	glioblastoma	77#89		Association of EGFR gene amplification and CDKN2 (p16/MTS1) gene deletion in glioblastoma multiforme.
12200750	2002	Metab. Clin. Exp.	0026-0495	ALL_TEXT_3/3	3	9	348	LONGTERM|DICTIONARY	apo e	apo E	42#47	NaN	D003924	LONGTERM|DICTIONARY|EXTRACTED	niddm	NIDDM	162#167	12200750-1-41-80	Our results indicate interactions between apo E polymorphism and aging, fasting TG level and BMI that may be important for analyzing postprandial TG clearance in NIDDM.
12200750	2002	Metab. Clin. Exp.	0026-0495	ALL_TEXT_3/3	3	9	348	LONGTERM|DICTIONARY	apo e	apo E	42#47	NaN	C566031	LONGTERM|DICTIONARY	tg	TG	80#82	NaN	Our results indicate interactions between apo E polymorphism and aging, fasting TG level and BMI that may be important for analyzing postprandial TG clearance in NIDDM.
12200750	2002	Metab. Clin. Exp.	0026-0495	ALL_TEXT_3/3	3	9	348	LONGTERM|DICTIONARY	apo e	apo E	42#47	NaN	C566031	LONGTERM|DICTIONARY	tg	TG	146#148	NaN	Our results indicate interactions between apo E polymorphism and aging, fasting TG level and BMI that may be important for analyzing postprandial TG clearance in NIDDM.
11730829	2002	Atherosclerosis	0021-9150	ALL_TEXT_3/3	3	6	338	LONGTERM|DICTIONARY	apob	apoB	72#76	NaN	D006949	LONGTERM|DICTIONARY	hyperlipidemia	hyperlipidemia	17#31		Individuals with hyperlipidemia at baseline and/or follow-up had higher apoB levels than those with consistently normal lipids (P<0.05), whereas small LDL size was associated with concurrent hyperlipidemia.
11730829	2002	Atherosclerosis	0021-9150	ALL_TEXT_3/3	3	6	338	LONGTERM|DICTIONARY	apob	apoB	72#76	NaN	D006949	LONGTERM|DICTIONARY	hyperlipidemia	hyperlipidemia	191#205		Individuals with hyperlipidemia at baseline and/or follow-up had higher apoB levels than those with consistently normal lipids (P<0.05), whereas small LDL size was associated with concurrent hyperlipidemia.
19904240	2010	Am. J. Gastroenterol.	1572-0241	RESULTS	3	10	3553	SYMBOL|NUMBER|DICTIONARY	il 1b	IL-1B	0#5		D013274	LONGTERM|DISEASE|DN|DT|DICTIONARY	gastric cancer	gastric cancer	62#76		IL-1B-511 genotypes were not associated with the prognosis of gastric cancer patients.
15024131	2004	Proc. Natl. Acad. Sci. U.S.A.	0027-8424	ALL_TEXT_3/3	3	8	3106	SYMBOL|NUMBER|DICTIONARY	hla b	HLA-B	44#49		D004342	LONGTERM|DICTIONARY	hypersensitivity	hypersensitivity	128#144	NaN	These data indicate that the concurrence of HLA-B*5701 and Hsp70-Hom M493T alleles is necessary for the development of abacavir hypersensitivity, which is likely to be mediated by an HLA-B*5701-restricted immune response to abacavir.
15024131	2004	Proc. Natl. Acad. Sci. U.S.A.	0027-8424	ALL_TEXT_3/3	3	8	3106	SYMBOL|NUMBER|DICTIONARY	hla b	HLA-B	183#188		D004342	LONGTERM|DICTIONARY	hypersensitivity	hypersensitivity	128#144	NaN	These data indicate that the concurrence of HLA-B*5701 and Hsp70-Hom M493T alleles is necessary for the development of abacavir hypersensitivity, which is likely to be mediated by an HLA-B*5701-restricted immune response to abacavir.
15024131	2004	Proc. Natl. Acad. Sci. U.S.A.	0027-8424	ALL_TEXT_3/3	3	8	3308	SYMBOL|DICTIONARY	hsp70	Hsp70	59#64		D004342	LONGTERM|DICTIONARY	hypersensitivity	hypersensitivity	128#144	NaN	These data indicate that the concurrence of HLA-B*5701 and Hsp70-Hom M493T alleles is necessary for the development of abacavir hypersensitivity, which is likely to be mediated by an HLA-B*5701-restricted immune response to abacavir.
20042177	2010	Am. J. Ophthalmol.	1879-1891	CONCLUSION	5	12	5444	SYMBOL|DICTIONARY|EXTRACTED	pon1	PON1	32#36	20042177-2-0-13	D008268	SYMBOL|DICTIONARY|EXTRACTED	amd	AMD	76#79	20042177-1-0-32	We report a weak association of PON1 Leu55Met with an increased risk of wet AMD, replicating previous reports.
20973260	2010	Int. J. Gynecol. Cancer	1525-1438	BACKGROUND	1	1	7422	LONGTERM|GENE|GT|DICTIONARY	vascular endothelial growth factor	Vascular endothelial growth factor	0#34		D009369	LONGTERM|DICTIONARY	malignancies	malignancies	192#204		Vascular endothelial growth factor (VEGF) is a major angiogenic factor involved in a number of pathological processes, including neovascularization, a crucial step in the development of solid malignancies.
20973260	2010	Int. J. Gynecol. Cancer	1525-1438	BACKGROUND	1	1	7422	SYMBOL|()|DICTIONARY|EXTRACTED	vegf	VEGF	36#40	20973260-1-0-34	D009369	LONGTERM|DICTIONARY	malignancies	malignancies	192#204		Vascular endothelial growth factor (VEGF) is a major angiogenic factor involved in a number of pathological processes, including neovascularization, a crucial step in the development of solid malignancies.
18576360	2008	Arthritis Rheum.	0004-3591	CONCLUSION	4	11	26191	SYMBOL|DICTIONARY	ptpn22	PTPN22	26#32		D001327	LONGTERM|DICTIONARY	autoimmune diseases	autoimmune diseases	70#89		Our results indicate that PTPN22, a shared genetic factor of multiple autoimmune diseases, also contributes to the genetic background of SSc.
18576360	2008	Arthritis Rheum.	0004-3591	CONCLUSION	4	11	26191	SYMBOL|DICTIONARY	ptpn22	PTPN22	26#32		D012595	SYMBOL|EXTRACTED	ssc	SSc	137#140	18576360-1-155-173	Our results indicate that PTPN22, a shared genetic factor of multiple autoimmune diseases, also contributes to the genetic background of SSc.
18576360	2008	Arthritis Rheum.	0004-3591	RESULTS	3	10	26191	SYMBOL|NUMBER|DICTIONARY	ptpn22	PTPN22	45#51		D012595	SYMBOL|EXTRACTED	ssc	SSc	110#113	18576360-1-155-173	The meta-analysis provided evidence that the PTPN22 1858T allele is involved in the genetic susceptibility to SSc in Caucasian (P = 8.39 x 10(-3), OR 1.08 [95% CI 1.02-1.15]) and mixed (P = 3.11 x 10(-3), OR 1.09 [95% CI 1.04-1.16]) populations, particularly in the anti-topo I-positive subset.
8757534	1996	Br. J. Haematol.	0007-1048	TITLE	0	0	2235	LONGTERM|GENE|GN|DICTIONARY	ferrochelatase	ferrochelatase	24#38		D046351	LONGTERM|DICTIONARY	erythropoietic protoporphyria	erythropoietic protoporphyria	60#89		A novel mutation in the ferrochelatase gene associated with erythropoietic protoporphyria.
15886814	2005	Thromb. Haemost.	0340-6245	ALL_TEXT_1/3	1	1	1524	SYMBOL|DICTIONARY	cx3cr1	CX3CR1	88#94		D050197	LONGTERM|DICTIONARY	atherosclerotic plaque	atherosclerotic plaque	147#169		Several lines of evidence suggest that the chemokine fractalkine (FKN) and its receptor CX3CR1 contribute to the accumulation of leukocytes in the atherosclerotic plaque.
15886814	2005	Thromb. Haemost.	0340-6245	ALL_TEXT_1/3	1	1	6376	LONGTERM|DICTIONARY	fractalkine	fractalkine	53#64	NaN	D050197	LONGTERM|DICTIONARY	atherosclerotic plaque	atherosclerotic plaque	147#169		Several lines of evidence suggest that the chemokine fractalkine (FKN) and its receptor CX3CR1 contribute to the accumulation of leukocytes in the atherosclerotic plaque.
18214481	2008	Cancer Chemother. Pharmacol.	0344-5704	CONCLUSIONS	4	8	360	SYMBOL|DICTIONARY	aqp3	AQP3	47#51		D010051	LONGTERM|DISEASE|DT|CLINE|CN|DICTIONARY	ovarian cancer	ovarian cancer	64#78		Collectively, our results provide evidence for AQP3-facilitated ovarian cancer cell migration, suggesting a novel function for AQP3 expression in high-grade tumors.
18214481	2008	Cancer Chemother. Pharmacol.	0344-5704	CONCLUSIONS	4	8	360	SYMBOL|DICTIONARY	aqp3	AQP3	47#51		D009369	LONGTERM|DICTIONARY	tumors	tumors	157#163		Collectively, our results provide evidence for AQP3-facilitated ovarian cancer cell migration, suggesting a novel function for AQP3 expression in high-grade tumors.
18214481	2008	Cancer Chemother. Pharmacol.	0344-5704	CONCLUSIONS	4	8	360	SYMBOL|DICTIONARY	aqp3	AQP3	127#131		D010051	LONGTERM|DISEASE|DT|CLINE|CN|DICTIONARY	ovarian cancer	ovarian cancer	64#78		Collectively, our results provide evidence for AQP3-facilitated ovarian cancer cell migration, suggesting a novel function for AQP3 expression in high-grade tumors.
18214481	2008	Cancer Chemother. Pharmacol.	0344-5704	CONCLUSIONS	4	8	360	SYMBOL|DICTIONARY	aqp3	AQP3	127#131		D009369	LONGTERM|DICTIONARY	tumors	tumors	157#163		Collectively, our results provide evidence for AQP3-facilitated ovarian cancer cell migration, suggesting a novel function for AQP3 expression in high-grade tumors.
20047977	2010	Am. J. Epidemiol.	1476-6256	ALL_TEXT_2/3	2	4	7124	SYMBOL|DICTIONARY|EXTRACTED	tnf	TNF	84#87	20047977-0-0-21	D008228	SYMBOL|DICTIONARY|EXTRACTED	nhl	NHL	104#107	20047977-1-194-214	"Consistent with previous findings, odds ratios were increased for ""new"" participant TNF -308A carriers (NHL: per-allele odds ratio (OR(allelic)) = 1.10, P(trend) = 0.001; diffuse large B-cell lymphoma (DLBCL): OR(allelic) = 1.23, P(trend) = 0.004)."
20047977	2010	Am. J. Epidemiol.	1476-6256	ALL_TEXT_2/3	2	4	7124	SYMBOL|DICTIONARY|EXTRACTED	tnf	TNF	84#87	20047977-0-0-21	D016393	LONGTERM|DICTIONARY	diffuse large b cell lymphoma	diffuse large B-cell lymphoma	171#200		"Consistent with previous findings, odds ratios were increased for ""new"" participant TNF -308A carriers (NHL: per-allele odds ratio (OR(allelic)) = 1.10, P(trend) = 0.001; diffuse large B-cell lymphoma (DLBCL): OR(allelic) = 1.23, P(trend) = 0.004)."
20047977	2010	Am. J. Epidemiol.	1476-6256	ALL_TEXT_2/3	2	4	7124	SYMBOL|DICTIONARY|EXTRACTED	tnf	TNF	84#87	20047977-0-0-21	D016393	SYMBOL|()|DICTIONARY|EXTRACTED	dlbcl	DLBCL	202#207	20047977-4-171-200	"Consistent with previous findings, odds ratios were increased for ""new"" participant TNF -308A carriers (NHL: per-allele odds ratio (OR(allelic)) = 1.10, P(trend) = 0.001; diffuse large B-cell lymphoma (DLBCL): OR(allelic) = 1.23, P(trend) = 0.004)."
17471286	2008	Pharmacogenomics J.	1473-1150	ALL_TEXT_3/3	3	6	3497	LONGTERM|DICTIONARY	ige	IgE	116#119	NaN	D004342	LONGTERM|DICTIONARY	hypersensitivity to betalactams	hypersensitivity to betalactams	129#160	NaN	In conclusion, our results suggest an ambivalent influence of a genetic determinant of pro-inflammatory pathways on IgE-mediated hypersensitivity to betalactams.
21300947	2011	Arch. Gen. Psychiatry	1538-3636	CONTEXT	1	1	627	LONGTERM|GENE|GT|DICTIONARY	brain derived neurotrophic factor	brain-derived neurotrophic factor	4#37		D000544	LONGTERM|DISEASE|DT|DICTIONARY	alzheimer disease	Alzheimer disease	100#117		The brain-derived neurotrophic factor (BDNF) Val66Met (rs6265) polymorphism may predict the risk of Alzheimer disease (AD).
21300947	2011	Arch. Gen. Psychiatry	1538-3636	CONTEXT	1	1	627	LONGTERM|GENE|GT|DICTIONARY	brain derived neurotrophic factor	brain-derived neurotrophic factor	4#37		D000544	SYMBOL|EXTRACTED|()	ad	AD	119#121	21300947-1-100-117	The brain-derived neurotrophic factor (BDNF) Val66Met (rs6265) polymorphism may predict the risk of Alzheimer disease (AD).
21300947	2011	Arch. Gen. Psychiatry	1538-3636	CONTEXT	1	1	627	SYMBOL|()|DICTIONARY|EXTRACTED	bdnf	BDNF	39#43	21300947-1-4-37	D000544	LONGTERM|DISEASE|DT|DICTIONARY	alzheimer disease	Alzheimer disease	100#117		The brain-derived neurotrophic factor (BDNF) Val66Met (rs6265) polymorphism may predict the risk of Alzheimer disease (AD).
21300947	2011	Arch. Gen. Psychiatry	1538-3636	CONTEXT	1	1	627	SYMBOL|()|DICTIONARY|EXTRACTED	bdnf	BDNF	39#43	21300947-1-4-37	D000544	SYMBOL|EXTRACTED|()	ad	AD	119#121	21300947-1-100-117	The brain-derived neurotrophic factor (BDNF) Val66Met (rs6265) polymorphism may predict the risk of Alzheimer disease (AD).
21300947	2011	Arch. Gen. Psychiatry	1538-3636	TITLE	0	0	627	LONGTERM|GENE|GT|DICTIONARY	brain derived neurotrophic factor	brain-derived neurotrophic factor	4#37		D000544	LONGTERM|DISEASE|DT|DICTIONARY	alzheimer disease	Alzheimer disease	94#111		The brain-derived neurotrophic factor Val66Met polymorphism and prediction of neural risk for Alzheimer disease.
12579739	2004	Yan Ke Xue Bao	1000-4432	CONCLUSION	4	10	6010	LONGTERM|GENE|GN|DICTIONARY	rhodopsin	rhodopsin	16#25		D012174	LONGTERM|DICTIONARY	retinitis pigmentosa	retinitis pigmentosa	76#96		Mutation in the rhodopsin gene is the common cause in Chinese patients with retinitis pigmentosa, either autosomal dominant, recessive or sporadic.
21300947	2011	Arch. Gen. Psychiatry	1538-3636	CONTEXT	1	2	627	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	bdnf	BDNF	44#48	21300947-1-4-37	D000544	SYMBOL|EXTRACTED	ad	AD	59#61	21300947-1-100-117	However, genetic association studies of the BDNF gene with AD have produced equivocal results.
18214481	2008	Cancer Chemother. Pharmacol.	0344-5704	TITLE	0	0	360	SYMBOL|DICTIONARY	aqp3	AQP3	32#36		D010051	LONGTERM|DISEASE|DT|CLINE|CN|DICTIONARY	ovarian cancer	ovarian cancer	79#93		Curcumin attenuates EGF-induced AQP3 up-regulation and cell migration in human ovarian cancer cells.
18214481	2008	Cancer Chemother. Pharmacol.	0344-5704	OBJECTIVE	1	2	360	SYMBOL|DICTIONARY	aqp3	AQP3	116#120		D010051	LONGTERM|DISEASE|DT|CLINE|CN|DICTIONARY	ovarian cancer	ovarian cancer	250#264		Based on the involvement of AQPs in angiogenesis and cell migration as well as our previous studies which show that AQP3 is involved in human skin fibroblasts cell migration, in this study, we investigated whether AQP3 is expressed in cultured human ovarian cancer cell line CaOV3 cells, and whether AQP3 expression in these cells enhances cell migration and metastatic potential.
18214481	2008	Cancer Chemother. Pharmacol.	0344-5704	OBJECTIVE	1	2	360	SYMBOL|DICTIONARY	aqp3	AQP3	214#218		D010051	LONGTERM|DISEASE|DT|CLINE|CN|DICTIONARY	ovarian cancer	ovarian cancer	250#264		Based on the involvement of AQPs in angiogenesis and cell migration as well as our previous studies which show that AQP3 is involved in human skin fibroblasts cell migration, in this study, we investigated whether AQP3 is expressed in cultured human ovarian cancer cell line CaOV3 cells, and whether AQP3 expression in these cells enhances cell migration and metastatic potential.
18214481	2008	Cancer Chemother. Pharmacol.	0344-5704	OBJECTIVE	1	2	360	SYMBOL|DICTIONARY	aqp3	AQP3	300#304		D010051	LONGTERM|DISEASE|DT|CLINE|CN|DICTIONARY	ovarian cancer	ovarian cancer	250#264		Based on the involvement of AQPs in angiogenesis and cell migration as well as our previous studies which show that AQP3 is involved in human skin fibroblasts cell migration, in this study, we investigated whether AQP3 is expressed in cultured human ovarian cancer cell line CaOV3 cells, and whether AQP3 expression in these cells enhances cell migration and metastatic potential.
20631561	2010	J Clin Psychopharmacol	1533-712X	TITLE	0	0	2166	SYMBOL|DICTIONARY	faah	FAAH	26#30		D015430	LONGTERM|DICTIONARY	weight gain	weight gain	130#141	NaN	Endocannabinoid Pro129Thr FAAH functional polymorphism but not 1359G/A CNR1 polymorphism is associated with antipsychotic-induced weight gain.
20631561	2010	J Clin Psychopharmacol	1533-712X	TITLE	0	0	1268	SYMBOL|DICTIONARY|EXTRACTED	cnr1	CNR1	71#75		D015430	LONGTERM|DICTIONARY	weight gain	weight gain	130#141	NaN	Endocannabinoid Pro129Thr FAAH functional polymorphism but not 1359G/A CNR1 polymorphism is associated with antipsychotic-induced weight gain.
18214481	2008	Cancer Chemother. Pharmacol.	0344-5704	RESULTS	3	7	360	SYMBOL|DICTIONARY	aqp3	AQP3	82#86		D010051	LONGTERM|DISEASE|DT|DICTIONARY	anti-ovarian cancer	anti-ovarian cancer	41#60		We also find that curcumin, a well known anti-ovarian cancer drug, down-regulates AQP3 expression and reduces cell migration in CaOV3, and the effects of curcumin are mediated, at least in part, by its inhibitory effects on EGFR and downstream AKT/ERK activation.
18214481	2008	Cancer Chemother. Pharmacol.	0344-5704	RESULTS	3	7	1956	SYMBOL|DICTIONARY	egfr	EGFR	224#228		D010051	LONGTERM|DISEASE|DT|DICTIONARY	anti-ovarian cancer	anti-ovarian cancer	41#60		We also find that curcumin, a well known anti-ovarian cancer drug, down-regulates AQP3 expression and reduces cell migration in CaOV3, and the effects of curcumin are mediated, at least in part, by its inhibitory effects on EGFR and downstream AKT/ERK activation.
18214481	2008	Cancer Chemother. Pharmacol.	0344-5704	RESULTS	3	7	207	SYMBOL|DICTIONARY	akt	AKT	244#247		D010051	LONGTERM|DISEASE|DT|DICTIONARY	anti-ovarian cancer	anti-ovarian cancer	41#60		We also find that curcumin, a well known anti-ovarian cancer drug, down-regulates AQP3 expression and reduces cell migration in CaOV3, and the effects of curcumin are mediated, at least in part, by its inhibitory effects on EGFR and downstream AKT/ERK activation.
17503474	2007	Am. J. Med. Genet. B Neuropsychiatr. Genet.	1552-4841	TITLE	0	0	54715	SYMBOL|DICTIONARY	fox1	FOX1	52#56		D001321	LONGTERM|DICTIONARY	autism	autism	81#87		Cytogenetic and molecular characterization of A2BP1/FOX1 as a candidate gene for autism.
14502680	2004	Mov. Disord.	0885-3185	ALL_TEXT_1/3	1	1	131	SYMBOL|GENE|GN|DICTIONARY	adh7	ADH7	57#61		D019578	LONGTERM|DICTIONARY	multiple system atrophy	multiple system atrophy	129#152		A polymerase chain reaction and direct sequencing of the ADH7 gene were carried out in 50 controls and 50 patients with probable multiple system atrophy (MSA).
14502680	2004	Mov. Disord.	0885-3185	ALL_TEXT_1/3	1	1	131	SYMBOL|GENE|GN|DICTIONARY	adh7	ADH7	57#61		D019578	SYMBOL|EXTRACTED|()	msa	MSA	154#157	14502680-1-129-152	A polymerase chain reaction and direct sequencing of the ADH7 gene were carried out in 50 controls and 50 patients with probable multiple system atrophy (MSA).
17503474	2007	Am. J. Med. Genet. B Neuropsychiatr. Genet.	1552-4841	ALL_TEXT_3/3	3	7	54715	SYMBOL|EXTRACTED	a2bp1	A2BP1	151#156	17503474-3-133-159	D001321	LONGTERM|DICTIONARY	autism	autism	188#194		Because of emerging evidence in the role of RNA processing and gene regulation in pervasive developmental disorders, we performed further screening of A2BP1 in additional individuals with autism from the Autism Genetics Resource Exchange (AGRE) collection.
17503474	2007	Am. J. Med. Genet. B Neuropsychiatr. Genet.	1552-4841	ALL_TEXT_3/3	3	7	54715	SYMBOL|EXTRACTED	a2bp1	A2BP1	151#156	17503474-3-133-159	D002658	LONGTERM|DICTIONARY	developmental disorders	developmental disorders	92#115		Because of emerging evidence in the role of RNA processing and gene regulation in pervasive developmental disorders, we performed further screening of A2BP1 in additional individuals with autism from the Autism Genetics Resource Exchange (AGRE) collection.
14763782	2004	Acta Odontol. Scand.	0001-6357	TITLE	0	0	3459	LONGTERM|GENE|GN|DICTIONARY	interferon gamma receptor 1	interferon-gamma receptor-1	20#47		D010518	LONGTERM|DICTIONARY	periodontitis	periodontitis	82#95		Polymorphisms in an interferon-gamma receptor-1 gene marker and susceptibility to periodontitis.
14763782	2004	Acta Odontol. Scand.	0001-6357	ALL_TEXT_1/3	1	2	3459	SYMBOL|()|DICTIONARY|EXTRACTED	ifngr1	IFNGR1	198#204	14763782-2-178-187	D007239	LONGTERM|DICTIONARY	infections	infections	230#240		Interferon (IFN)-gamma is a cytokine that plays a pivotal role in the defense against infection, and mutations in the gene coding for the ligand binding chain (alpha, R1) of the IFN-gamma receptor (IFNGR1) confer suseptibility on infections caused by poorly virulent mycobacteria.
14763782	2004	Acta Odontol. Scand.	0001-6357	ALL_TEXT_1/3	1	2	3458	LONGTERM|DICTIONARY	interferon (ifn)-gamma	Interferon (IFN)-gamma	0#22	NaN	D007239	LONGTERM|DICTIONARY	infections	infections	230#240		Interferon (IFN)-gamma is a cytokine that plays a pivotal role in the defense against infection, and mutations in the gene coding for the ligand binding chain (alpha, R1) of the IFN-gamma receptor (IFNGR1) confer suseptibility on infections caused by poorly virulent mycobacteria.
14763782	2004	Acta Odontol. Scand.	0001-6357	ALL_TEXT_3/3	3	6	3459	SYMBOL|DICTIONARY|EXTRACTED	ifngr1	IFNGR1	54#60	14763782-2-178-187	D010518	LONGTERM|DICTIONARY	periodontitis	periodontitis	122#135		We therefore cannot find any evidence to suggest that IFNGR1, as a single dominant gene, contributes to susceptibility to periodontitis.
19262575	2009	Genes Immun.	1476-5470	ALL_TEXT_3/3	3	8	3562	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	il3	IL3	49#52	19262575-5-71-84	D006111	SYMBOL|EXTRACTED	gd	GD	88#90	19262575-1-0-15	This study provides convincing evidence that the IL3 gene is a susceptibility locus for GD in the Chinese population.
15660776	2005	Epilepsia	0013-9580	TITLE	0	0	348	LONGTERM|DICTIONARY	apoe	ApoE	0#4	NaN	D004833	LONGTERM|DICTIONARY	temporal lobe epilepsy	temporal lobe epilepsy	73#95		ApoE epsilon4 allele and disease duration affect verbal learning in mild temporal lobe epilepsy.
11976977	2002	Neurol. Sci.	1590-1874	ALL_TEXT_1/3	1	2	2153	LONGTERM|DICTIONARY	factor v leiden	factor V Leiden	32#47		D008881	LONGTERM|DISEASE|DN|DICTIONARY	migraine	migraine	134#142		We investigated the presence of factor V Leiden and the serum level of anticardiolipin antibodies (aCL) in a consecutive series of 70 migraine patients (47 women; mean age, 34.1 years).
16259952	2006	Biochem. Biophys. Res. Commun.	0006-291X	TITLE	0	0	2626	SYMBOL|DICTIONARY	gata4	GATA4	0#5		D006332	LONGTERM|DICTIONARY	cardiac hypertrophy	cardiac hypertrophy	15#34	NaN	GATA4-mediated cardiac hypertrophy induced by d-myo-inositol 1,4,5-tris-phosphate.
16259952	2006	Biochem. Biophys. Res. Commun.	0006-291X	ALL_TEXT_3/3	3	5	2626	SYMBOL|DICTIONARY	gata4	GATA4	100#105		D006332	LONGTERM|DICTIONARY	cardiac hypertrophy	cardiac hypertrophy	65#84	NaN	The study shows that d-myo-inositol 1,4,5-tris-phosphate-induced cardiac hypertrophy is mediated by GATA4 but independent from the calcineurin pathway.
20047977	2010	Am. J. Epidemiol.	1476-6256	ALL_TEXT_3/3	3	6	7124	SYMBOL|DICTIONARY|EXTRACTED	tnf	TNF	15#18	20047977-0-0-21	D016393	SYMBOL|DICTIONARY|EXTRACTED	dlbcl	DLBCL	105#110	20047977-4-171-200	The LTA 252A>G/TNF -308G>A haplotype containing the LTA/TNF variant alleles was strongly associated with DLBCL (P = 2.9 x 10(-8)).
20047977	2010	Am. J. Epidemiol.	1476-6256	ALL_TEXT_3/3	3	6	7124	SYMBOL|DICTIONARY|EXTRACTED	tnf	TNF	56#59	20047977-0-0-21	D016393	SYMBOL|DICTIONARY|EXTRACTED	dlbcl	DLBCL	105#110	20047977-4-171-200	The LTA 252A>G/TNF -308G>A haplotype containing the LTA/TNF variant alleles was strongly associated with DLBCL (P = 2.9 x 10(-8)).
15142050	2004	Clin Transplant	0902-0063	RESULTS	3	14	348	LONGTERM|DICTIONARY	apo e	apo E	165#170	NaN	D050197	LONGTERM|DISEASE|DT|DICTIONARY	atherosclerotic vascular disease	atherosclerotic vascular disease	217#249		Multiple regression analysis showed that allograft functions were negatively correlated with elevated acute phase reactants (p < 0.01) and only the age, but not the apo E genotypes, was an independent risk factor for atherosclerotic vascular disease (p < 0.01).
15956634	2005	JAMA	1538-3598	CONCLUSIONS	6	14	348	SYMBOL|DICTIONARY|EXTRACTED	apoe	APOE	140#144	15956634-1-0-16	D051436	LONGTERM|DISEASE|DT|DICTIONARY	chronic kidney disease	chronic kidney disease	172#194		Our study suggests that nonlipid-mediated pathways, such as cellular mechanisms of kidney remodeling, may be involved in the association of APOE alleles and progression of chronic kidney disease.
23264560	2013	Dis Model Mech	1754-8411	TITLE	0	0	4838	SYMBOL|DICTIONARY	nodal	NODAL	0#5		D016142	SYMBOL|DICTIONARY|EXTRACTED	hpe	HPE	59#62		NODAL and SHH dose-dependent double inhibition promotes an HPE-like phenotype in chick embryos.
23264560	2013	Dis Model Mech	1754-8411	TITLE	0	0	6469	SYMBOL|DICTIONARY	shh	SHH	10#13		D016142	SYMBOL|DICTIONARY|EXTRACTED	hpe	HPE	59#62		NODAL and SHH dose-dependent double inhibition promotes an HPE-like phenotype in chick embryos.
23264560	2013	Dis Model Mech	1754-8411	ALL_TEXT_2/3	2	6	4838	SYMBOL|DICTIONARY	nodal	NODAL	73#78		D016142	SYMBOL|DICTIONARY|EXTRACTED	hpe	HPE	14#17	23264560-1-0-17	Screening for HPE-associated genes in humans suggests the involvement of NODAL or SHH signaling, or both.
19842025	2010	Inflammation	1573-2576	ALL_TEXT_3/3	3	6	3576	SYMBOL|DICTIONARY|EXTRACTED	il 8	IL-8	28#32	19842025-1-0-13	D017676	SYMBOL|EXTRACTED	olp	OLP	86#89	19842025-1-121-139	The study suggests that the IL-8 polymorphisms may be associated with the severity of OLP in this Chinese cohort.
8884076	1997	Clin. Genet.	0009-9163	ALL_TEXT_1/3	1	1	1281	SYMBOL|()|DICTIONARY	col3a1	COL3A1	185#191		D004535	LONGTERM|DICTIONARY	ehlers danlos syndrome type iv	Ehlers-Danlos syndrome type IV	20#50		Three patients with Ehlers-Danlos syndrome type IV (EDS IV) and biochemical evidence of structural defects in collagen III were investigated for mutations within the collagen III gene (COL3A1).
8884076	1997	Clin. Genet.	0009-9163	ALL_TEXT_1/3	1	1	1281	SYMBOL|()|DICTIONARY	col3a1	COL3A1	185#191		D004535	LONGTERM|()|DICTIONARY	eds iv	EDS IV	52#58		Three patients with Ehlers-Danlos syndrome type IV (EDS IV) and biochemical evidence of structural defects in collagen III were investigated for mutations within the collagen III gene (COL3A1).
19842025	2010	Inflammation	1573-2576	ALL_TEXT_1/3	1	2	3576	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	il 8	IL-8	102#106	19842025-1-0-13	D017676	SYMBOL|EXTRACTED	olp	OLP	117#120	19842025-1-121-139	The aim of this study was to investigate the association of single nucleotide polymorphisms (SNPs) of IL-8 gene with OLP in a Chinese population.
19842025	2010	Inflammation	1573-2576	ALL_TEXT_2/3	2	3	3576	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	il 8	IL-8	17#21	19842025-1-0-13	D017676	SYMBOL|EXTRACTED	olp	OLP	150#153	19842025-1-121-139	Four SNPs of the IL-8 gene at positions -845 T/C (rs2227532), -738 T/A, -251 A/T (rs4073) and +781 C/T (rs2227306) were analyzed in 109 patients with OLP and 101 normal controls using polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) method.
19842025	2010	Inflammation	1573-2576	TITLE	0	0	3576	LONGTERM|GENE|GN|DICTIONARY	interleukin 8	interleukin-8	15#28		D017676	LONGTERM|DICTIONARY	oral lichen planus	oral lichen planus	68#86		Association of interleukin-8 gene polymorphisms and haplotypes with oral lichen planus in a Chinese population.
19842025	2010	Inflammation	1573-2576	ALL_TEXT_1/3	1	1	3576	LONGTERM|DICTIONARY	interleukin 8	Interleukin-8	0#13		D017676	LONGTERM|DICTIONARY	oral lichen planus	oral lichen planus	121#139		Interleukin-8 (IL-8), a CXC chemokine with multiple biological functions, plays an important role in the pathogenesis of oral lichen planus (OLP).
19842025	2010	Inflammation	1573-2576	ALL_TEXT_1/3	1	1	3576	LONGTERM|DICTIONARY	interleukin 8	Interleukin-8	0#13		D017676	SYMBOL|EXTRACTED|()	olp	OLP	141#144	19842025-1-121-139	Interleukin-8 (IL-8), a CXC chemokine with multiple biological functions, plays an important role in the pathogenesis of oral lichen planus (OLP).
19842025	2010	Inflammation	1573-2576	ALL_TEXT_1/3	1	1	3576	SYMBOL|()|DICTIONARY|EXTRACTED	il 8	IL-8	15#19	19842025-1-0-13	D017676	LONGTERM|DICTIONARY	oral lichen planus	oral lichen planus	121#139		Interleukin-8 (IL-8), a CXC chemokine with multiple biological functions, plays an important role in the pathogenesis of oral lichen planus (OLP).
19842025	2010	Inflammation	1573-2576	ALL_TEXT_1/3	1	1	3576	SYMBOL|()|DICTIONARY|EXTRACTED	il 8	IL-8	15#19	19842025-1-0-13	D017676	SYMBOL|EXTRACTED|()	olp	OLP	141#144	19842025-1-121-139	Interleukin-8 (IL-8), a CXC chemokine with multiple biological functions, plays an important role in the pathogenesis of oral lichen planus (OLP).
21992601	2012	J. Cell. Mol. Med.	1582-4934	ALL_TEXT_2/3	2	5	952	SYMBOL|DICTIONARY	cd38	CD38	70#74		D014947	LONGTERM|DICTIONARY	injury in the glomeruli of cd38	injury in the glomeruli of CD38	43#74	NaN	Morphological examinations showed profound injury in the glomeruli of CD38(-/-) or CD38-shRNA mice compared to CD38(+/+) mice.
21992601	2012	J. Cell. Mol. Med.	1582-4934	ALL_TEXT_2/3	2	5	952	SYMBOL|DICTIONARY	cd38	CD38	83#87		D014947	LONGTERM|DICTIONARY	injury in the glomeruli of cd38	injury in the glomeruli of CD38	43#74	NaN	Morphological examinations showed profound injury in the glomeruli of CD38(-/-) or CD38-shRNA mice compared to CD38(+/+) mice.
21992601	2012	J. Cell. Mol. Med.	1582-4934	ALL_TEXT_2/3	2	5	952	SYMBOL|DICTIONARY	cd38	CD38	111#115		D014947	LONGTERM|DICTIONARY	injury in the glomeruli of cd38	injury in the glomeruli of CD38	43#74	NaN	Morphological examinations showed profound injury in the glomeruli of CD38(-/-) or CD38-shRNA mice compared to CD38(+/+) mice.
21153458	2011	Tumour Biol.	1423-0380	ALL_TEXT_3/3	3	9	5743	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	cox 2	COX-2	33#38	21153458-1-48-64	D001943	LONGTERM|DISEASE|DT|DICTIONARY	breast carcinoma	breast carcinoma	116#132		However, hypermethylation of the COX-2 promoter correlated with a better overall survival in Tunisian patients with breast carcinoma.
26437028	2016	Nat. Genet.	1546-1718	ALL_TEXT_3/3	3	3	118856	SYMBOL|DICTIONARY	mmp21	Mmp21	13#18		D059446	LONGTERM|DICTIONARY	heterotaxy	heterotaxy	70#80		In addition, Mmp21-mutant mice and mmp21-morphant zebrafish displayed heterotaxy and abnormal cardiac looping, respectively, suggesting a new role for extracellular matrix remodeling in the establishment of laterality in vertebrates.
26437028	2016	Nat. Genet.	1546-1718	ALL_TEXT_3/3	3	3	118856	SYMBOL|DICTIONARY	mmp21	mmp21	35#40		D059446	LONGTERM|DICTIONARY	heterotaxy	heterotaxy	70#80		In addition, Mmp21-mutant mice and mmp21-morphant zebrafish displayed heterotaxy and abnormal cardiac looping, respectively, suggesting a new role for extracellular matrix remodeling in the establishment of laterality in vertebrates.
26437028	2016	Nat. Genet.	1546-1718	ALL_TEXT_2/3	2	2	118856	SYMBOL|DICTIONARY	mmp21	MMP21	129#134		D059446	LONGTERM|DICTIONARY	heterotaxy	heterotaxy	198#208		By whole-exome sequencing, whole-genome sequencing and high-throughput cohort resequencing, we identified recessive mutations in MMP21 (encoding matrix metallopeptidase 21) in nine index cases with heterotaxy.
26437028	2016	Nat. Genet.	1546-1718	ALL_TEXT_2/3	2	2	118856	LONGTERM|DICTIONARY	matrix metallopeptidase 21	matrix metallopeptidase 21	145#171		D059446	LONGTERM|DICTIONARY	heterotaxy	heterotaxy	198#208		By whole-exome sequencing, whole-genome sequencing and high-throughput cohort resequencing, we identified recessive mutations in MMP21 (encoding matrix metallopeptidase 21) in nine index cases with heterotaxy.
17192049	2007	Cancer Biomark	1574-0153	ALL_TEXT_2/3	2	2	1543	SYMBOL|GENE|GN|DICTIONARY	cyp1a1	CYP1A1	186#192		D011471	LONGTERM|DISEASE|DT|DICTIONARY	prostate cancer	prostate cancer	201#216		To evaluate this phenomenon, the association between two single nucleotide polymorphisms (A to G transition in exon7 leading to amino acid substitution Ile462Val and T3801C at 3'UTR) of CYP1A1 gene in prostate cancer were analyzed in a case-control study of 100 individuals in South Indian population.
20237358	2010	Reprod Sci	1933-7205	ALL_TEXT_3/3	3	6	6347	SYMBOL|DICTIONARY|EXTRACTED	mcp 1	MCP-1	16#21	20237358-1-49-79	D000292	LONGTERM|DISEASE|DT|DICTIONARY	pelvic inflammatory disease	pelvic inflammatory disease	116#143		Elevated plasma MCP-1 could be a biological marker for the diagnosis and to be a new strategy for target therapy of pelvic inflammatory disease.
20467232	2010	Tohoku J. Exp. Med.	1349-3329	TITLE	0	0	217	LONGTERM|DICTIONARY	aldehyde dehydrogenase-2	aldehyde dehydrogenase-2	20#44	NaN	D009203	LONGTERM|DICTIONARY	myocardial infarction	myocardial infarction	153#174		The polymorphism in aldehyde dehydrogenase-2 gene is associated with elevated plasma levels of high-sensitivity C-reactive protein in the early phase of myocardial infarction.
15932363	2005	Aliment. Pharmacol. Ther.	0269-2813	BACKGROUND	1	2	2520	LONGTERM|DICTIONARY	gastrin	gastrin	48#55		D005764	LONGTERM|DICTIONARY	reflux oesophagitis	reflux oesophagitis	106#125		This influence on metabolism might affect serum gastrin levels, and safety, during long-term treatment of reflux oesophagitis.
15932363	2005	Aliment. Pharmacol. Ther.	0269-2813	TITLE	0	0	1557	SYMBOL|DICTIONARY	cyp2c19	CYP2C19	10#17		D005764	LONGTERM|DICTIONARY	reflux oesophagitis	reflux oesophagitis	108#127		Effect of CYP2C19 polymorphism on the safety and efficacy of omeprazole in Japanese patients with recurrent reflux oesophagitis.
15932363	2005	Aliment. Pharmacol. Ther.	0269-2813	METHODS	3	4	1557	LONGTERM|DICTIONARY	cytochrome p450 2c19	cytochrome P450 2C19	78#98		D005764	LONGTERM|DICTIONARY	reflux oesophagitis	reflux oesophagitis	48#67		A total of 119 Japanese patients with recurrent reflux oesophagitis underwent cytochrome P450 2C19 genotyping prior to receiving daily omeprazole 10 mg or 20 mg for 6-12 months, during which adverse event frequency, serum gastrin levels and endoscopic findings were monitored.
15932363	2005	Aliment. Pharmacol. Ther.	0269-2813	METHODS	3	4	2520	LONGTERM|DICTIONARY	gastrin	gastrin	222#229		D005764	LONGTERM|DICTIONARY	reflux oesophagitis	reflux oesophagitis	48#67		A total of 119 Japanese patients with recurrent reflux oesophagitis underwent cytochrome P450 2C19 genotyping prior to receiving daily omeprazole 10 mg or 20 mg for 6-12 months, during which adverse event frequency, serum gastrin levels and endoscopic findings were monitored.
19369177	2009	J. Formos. Med. Assoc.	0929-6646	CONCLUSION	4	11	1312	SYMBOL|DICTIONARY|EXTRACTED	comt	COMT	11#15	19369177-1-71-99	D012559	LONGTERM|DICTIONARY	schizophrenia	schizophrenia	55#68		Therefore, COMT may contribute to the genetic risk for schizophrenia not through the Val108/158Met polymorphism, but through other variants that are situated 3' to this region, in the Taiwanese population.
11859714	2002	Zhonghua Zhong Liu Za Zhi	0253-3766	OBJECTIVE	1	1	2944	SYMBOL|()|DICTIONARY	gstm1	GSTM1	42#47		D006528	LONGTERM|DISEASE|DT|DICTIONARY	hepatocellular carcinoma	hepatocellular carcinoma	75#99		To study the glutathione-S-tranterase M1 (GSTM1) genotype in patients with hepatocellular carcinoma (HCC) with aflatoxin B1(AFB1) in a high risk region in Guangxi.
11859714	2002	Zhonghua Zhong Liu Za Zhi	0253-3766	OBJECTIVE	1	1	2944	SYMBOL|()|DICTIONARY	gstm1	GSTM1	42#47		D006528	SYMBOL|()|DICTIONARY|EXTRACTED	hcc	HCC	101#104	11859714-1-75-99	To study the glutathione-S-tranterase M1 (GSTM1) genotype in patients with hepatocellular carcinoma (HCC) with aflatoxin B1(AFB1) in a high risk region in Guangxi.
19132772	2009	World J. Gastroenterol.	2219-2840	RESULTS	3	8	3557	SYMBOL|NUMBER|DICTIONARY	il 1rn	IL-1RN	37#43		D013274	SYMBOL|EXTRACTED	gc	GC	136#138	19132772-1-37-51	IL-1beta+3954_T/C (OR 2.1, 1.0-4.3), IL-1RN*2/L (OR 3.5, 1.7-7.3) and IL-10-592_C/A (OR 3.2, 1.5-6.8) were individually associated with GC, and a combination of these cytokine polymorphisms with H pylori vacA s1b and m1 further increased the risk (OR 7.2, 1.4-36.4).
19132772	2009	World J. Gastroenterol.	2219-2840	RESULTS	3	8	3586	SYMBOL|NUMBER|DICTIONARY	il 10	IL-10	70#75		D013274	SYMBOL|EXTRACTED	gc	GC	136#138	19132772-1-37-51	IL-1beta+3954_T/C (OR 2.1, 1.0-4.3), IL-1RN*2/L (OR 3.5, 1.7-7.3) and IL-10-592_C/A (OR 3.2, 1.5-6.8) were individually associated with GC, and a combination of these cytokine polymorphisms with H pylori vacA s1b and m1 further increased the risk (OR 7.2, 1.4-36.4).
11859714	2002	Zhonghua Zhong Liu Za Zhi	0253-3766	RESULTS	3	4	2944	SYMBOL|DICTIONARY	gstm1	GSTM1	17#22		D006528	SYMBOL|DISEASE|DN|DICTIONARY|EXTRACTED	hcc	HCC	40#43	11859714-1-75-99	The frequency of GSTM1-null genotype in HCC patients was 102/162(63%), in local residents it was 92/177(52%) and in young men from outside it was 13/40(33%), which were significantly different.
12492589	2003	Br. J. Haematol.	0007-1048	TITLE	0	0	2212	LONGTERM|DICTIONARY	fcgamma receptor iia	Fcgamma receptor IIa	0#20	NaN	D016553	LONGTERM|DICTIONARY	immune thrombocytopenic purpura	immune thrombocytopenic purpura	57#88		Fcgamma receptor IIa and IIIa polymorphisms in childhood immune thrombocytopenic purpura.
11859714	2002	Zhonghua Zhong Liu Za Zhi	0253-3766	CONCLUSION	4	6	2944	SYMBOL|GENE|GN|DICTIONARY	gstm1	GSTM1	0#5		D006528	SYMBOL|DICTIONARY|EXTRACTED	hcc	HCC	54#57	11859714-1-75-99	GSTM1 genetic deletion predisposes the individuals to HCC.
15876692	2005	J. Appl. Genet.	1234-1983	TITLE	0	0	367	LONGTERM|GENE|GT|DICTIONARY|GA	androgen receptor	androgen receptor	31#48		D020966	SYMBOL|DISEASE|DN|DICTIONARY|EXTRACTED	sbma	SBMA	62#66		CAG repeat polymorphism in the androgen receptor (AR) gene of SBMA patients and a control group.
15876692	2005	J. Appl. Genet.	1234-1983	TITLE	0	0	367	SYMBOL|EXTRACTED|()|GENE|GN	ar	AR	50#52	15876692-0-31-48	D020966	SYMBOL|DISEASE|DN|DICTIONARY|EXTRACTED	sbma	SBMA	62#66		CAG repeat polymorphism in the androgen receptor (AR) gene of SBMA patients and a control group.
18820912	2009	Ann. Hematol.	1432-0584	ALL_TEXT_3/3	3	11	3077	SYMBOL|DICTIONARY	hfe1	HFE1	98#102		D001523	LONGTERM|DICTIONARY	aggressiveness	aggressiveness	80#94		IVS1-24 C>G on the ferroportin gene seems to be a genetic modifier for clinical aggressiveness of HFE1 haemochromatosis.
18820912	2009	Ann. Hematol.	1432-0584	ALL_TEXT_3/3	3	11	3077	SYMBOL|DICTIONARY	hfe1	HFE1	98#102		D006432	LONGTERM|DICTIONARY	haemochromatosis	haemochromatosis	103#119		IVS1-24 C>G on the ferroportin gene seems to be a genetic modifier for clinical aggressiveness of HFE1 haemochromatosis.
20555002	2010	In Vivo	0258-851X	TITLE	0	0	7422	LONGTERM|GENE|GT|DICTIONARY	vascular endothelial growth factor	vascular endothelial growth factor	20#54		D004715	LONGTERM|DICTIONARY	endometriosis	endometriosis	87#100		Genetic variants of vascular endothelial growth factor and risk for the development of endometriosis.
21992601	2012	J. Cell. Mol. Med.	1582-4934	ALL_TEXT_2/3	2	6	952	SYMBOL|DICTIONARY	cd38	CD38	35#39		D007674	LONGTERM|DISEASE|DN|DICTIONARY	glomerular injury	glomerular injury	14#31		This enhanced glomerular injury in CD38(-/-) or CD38-shRNA mice was accompanied by increased albuminuria and proteinuria.
21992601	2012	J. Cell. Mol. Med.	1582-4934	ALL_TEXT_2/3	2	6	952	SYMBOL|DICTIONARY	cd38	CD38	35#39		D000419	LONGTERM|DICTIONARY	albuminuria	albuminuria	93#104	NaN	This enhanced glomerular injury in CD38(-/-) or CD38-shRNA mice was accompanied by increased albuminuria and proteinuria.
21992601	2012	J. Cell. Mol. Med.	1582-4934	ALL_TEXT_2/3	2	6	952	SYMBOL|DICTIONARY	cd38	CD38	35#39		D011507	LONGTERM|DICTIONARY	proteinuria	proteinuria	109#120	NaN	This enhanced glomerular injury in CD38(-/-) or CD38-shRNA mice was accompanied by increased albuminuria and proteinuria.
21992601	2012	J. Cell. Mol. Med.	1582-4934	ALL_TEXT_2/3	2	6	952	SYMBOL|DICTIONARY	cd38	CD38	48#52		D007674	LONGTERM|DISEASE|DN|DICTIONARY	glomerular injury	glomerular injury	14#31		This enhanced glomerular injury in CD38(-/-) or CD38-shRNA mice was accompanied by increased albuminuria and proteinuria.
21992601	2012	J. Cell. Mol. Med.	1582-4934	ALL_TEXT_2/3	2	6	952	SYMBOL|DICTIONARY	cd38	CD38	48#52		D000419	LONGTERM|DICTIONARY	albuminuria	albuminuria	93#104	NaN	This enhanced glomerular injury in CD38(-/-) or CD38-shRNA mice was accompanied by increased albuminuria and proteinuria.
21992601	2012	J. Cell. Mol. Med.	1582-4934	ALL_TEXT_2/3	2	6	952	SYMBOL|DICTIONARY	cd38	CD38	48#52		D011507	LONGTERM|DICTIONARY	proteinuria	proteinuria	109#120	NaN	This enhanced glomerular injury in CD38(-/-) or CD38-shRNA mice was accompanied by increased albuminuria and proteinuria.
15082902	2004	J. Korean Med. Sci.	1011-8934	ALL_TEXT_3/3	3	9	672	LONGTERM|DICTIONARY	brca	BRCA	28#32	NaN	D001943	LONGTERM|DISEASE|DT|DICTIONARY	breast cancer	breast cancer	122#135		These findings suggest that BRCA gene mutation analysis should be performed on Korean patients with high-risk factors for breast cancer.
24211273	2014	Toxicol. Appl. Pharmacol.	1096-0333	ALL_TEXT_2/3	2	5	1268	SYMBOL|GENE|GN|DICTIONARY	cb1	CB1	68#71		D064420	LONGTERM|DICTIONARY	cytotoxicity	cytotoxicity	4#16	NaN	The cytotoxicity was suppressed by preincubation with the selective CB1 receptor antagonist AM251, but not with the selective CB2 receptor antagonist AM630.
24211273	2014	Toxicol. Appl. Pharmacol.	1096-0333	ALL_TEXT_2/3	2	5	1269	SYMBOL|GENE|GN|DICTIONARY	cb2	CB2	126#129		D064420	LONGTERM|DICTIONARY	cytotoxicity	cytotoxicity	4#16	NaN	The cytotoxicity was suppressed by preincubation with the selective CB1 receptor antagonist AM251, but not with the selective CB2 receptor antagonist AM630.
20220260	2010	Ann Saudi Med	0975-4466	CONCLUSION	4	10	729230	SYMBOL|GENE|GN|DICTIONARY	ccr2	CCR2	168#172		D001249	LONGTERM|DICTIONARY	asthma	asthma	79#85		The previous association of the CCR532 deletion with protection from childhood asthma appears to be explained by linkage disequilibrium with the -G190A mutation in the CCR2 receptor gene.
9382152	1997	Am. J. Med. Genet.	0148-7299	TITLE	0	0	4693	SYMBOL|GENE|GN|DICTIONARY	norrin	norrin	52#58		C537849	LONGTERM|DISEASE|DT|DICTIONARY	norrie disease	Norrie disease	93#107		Two new missense mutations (A105T and C110G) in the norrin gene in two Italian families with Norrie disease and familial exudative vitreoretinopathy.
9382152	1997	Am. J. Med. Genet.	0148-7299	TITLE	0	0	4693	SYMBOL|GENE|GN|DICTIONARY	norrin	norrin	52#58		C580083	LONGTERM|DICTIONARY	familial exudative vitreoretinopathy	familial exudative vitreoretinopathy	112#148		Two new missense mutations (A105T and C110G) in the norrin gene in two Italian families with Norrie disease and familial exudative vitreoretinopathy.
15927975	2006	Circulation	1524-4539	METHODS AND RESULTS	2	10	7422	LONGTERM|GENE|GT|DICTIONARY	vascular endothelial growth factor	vascular endothelial growth factor	146#180		D006976	SYMBOL|DICTIONARY|EXTRACTED	pah	PAH	272#275	15927975-1-6-37	Moreover, cells within neointimal lesions exhibited increased levels of proliferation and were located in a tissue microenvironment enriched with vascular endothelial growth factor, tenascin-C, and activated matrix metalloproteinase-9, factors already implicated in human PAH.
15927975	2006	Circulation	1524-4539	METHODS AND RESULTS	2	10	7422	LONGTERM|GENE|GT|DICTIONARY	vascular endothelial growth factor	vascular endothelial growth factor	146#180		D001927	LONGTERM|DICTIONARY	neointimal lesions	neointimal lesions	23#41	NaN	Moreover, cells within neointimal lesions exhibited increased levels of proliferation and were located in a tissue microenvironment enriched with vascular endothelial growth factor, tenascin-C, and activated matrix metalloproteinase-9, factors already implicated in human PAH.
15927975	2006	Circulation	1524-4539	METHODS AND RESULTS	2	10	3371	LONGTERM|DICTIONARY	tenascin c	tenascin-C	182#192		D006976	SYMBOL|DICTIONARY|EXTRACTED	pah	PAH	272#275	15927975-1-6-37	Moreover, cells within neointimal lesions exhibited increased levels of proliferation and were located in a tissue microenvironment enriched with vascular endothelial growth factor, tenascin-C, and activated matrix metalloproteinase-9, factors already implicated in human PAH.
15927975	2006	Circulation	1524-4539	METHODS AND RESULTS	2	10	3371	LONGTERM|DICTIONARY	tenascin c	tenascin-C	182#192		D001927	LONGTERM|DICTIONARY	neointimal lesions	neointimal lesions	23#41	NaN	Moreover, cells within neointimal lesions exhibited increased levels of proliferation and were located in a tissue microenvironment enriched with vascular endothelial growth factor, tenascin-C, and activated matrix metalloproteinase-9, factors already implicated in human PAH.
15927975	2006	Circulation	1524-4539	METHODS AND RESULTS	2	10	4318	LONGTERM|GENE|GN|DICTIONARY	matrix metalloproteinase 9	matrix metalloproteinase-9	208#234		D006976	SYMBOL|DICTIONARY|EXTRACTED	pah	PAH	272#275	15927975-1-6-37	Moreover, cells within neointimal lesions exhibited increased levels of proliferation and were located in a tissue microenvironment enriched with vascular endothelial growth factor, tenascin-C, and activated matrix metalloproteinase-9, factors already implicated in human PAH.
15927975	2006	Circulation	1524-4539	METHODS AND RESULTS	2	10	4318	LONGTERM|GENE|GN|DICTIONARY	matrix metalloproteinase 9	matrix metalloproteinase-9	208#234		D001927	LONGTERM|DICTIONARY	neointimal lesions	neointimal lesions	23#41	NaN	Moreover, cells within neointimal lesions exhibited increased levels of proliferation and were located in a tissue microenvironment enriched with vascular endothelial growth factor, tenascin-C, and activated matrix metalloproteinase-9, factors already implicated in human PAH.
19698145	2009	J Neuroinflammation	1742-2094	CONCLUSION	4	8	3569	SYMBOL|DICTIONARY	il 6	IL-6	38#42		D000544	SYMBOL|EXTRACTED	ad	AD	163#165	19698145-1-44-63	We suggest that dysregulation of both IL-6 and IL-10 in some elderly people, due in part to genetic variations in the two genes, contributes to the development of AD.
19698145	2009	J Neuroinflammation	1742-2094	CONCLUSION	4	8	3586	SYMBOL|DICTIONARY	il 10	IL-10	47#52		D000544	SYMBOL|EXTRACTED	ad	AD	163#165	19698145-1-44-63	We suggest that dysregulation of both IL-6 and IL-10 in some elderly people, due in part to genetic variations in the two genes, contributes to the development of AD.
20084546	2010	Breast Cancer Res. Treat.	1573-7217	ALL_TEXT_2/3	2	5	3486	SYMBOL|DICTIONARY|EXTRACTED	igfbp3	IGFBP3	71#77	20084546-1-42-86	D001943	LONGTERM|DISEASE|DT|DICTIONARY	breast cancer	breast cancer	32#45		Overall, significantly elevated breast cancer risk was associated with IGFBP3 C allele when all studies were pooled into the meta-analysis (CC vs. AA: OR = 1.06, 95% CI = 1.02-1.11; dominant model: OR = 1.04, 95% CI = 1.00-1.07).
22119709	2012	Toxicol. Appl. Pharmacol.	1096-0333	ALL_TEXT_3/3	3	11	1269	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	cb2	CB2	64#67	22119709-0-0-22	D003092	LONGTERM|DICTIONARY	chronic colitis	chronic colitis	95#110		These findings suggest that JWH-133 mediates its effect through CB2 receptors, and ameliorates chronic colitis by inducing apoptosis in activated T cells, reducing the numbers of activated T cells, and suppressing induction of mast cells, NK cells, and neutrophils at sites of inflammation in the LP.
22119709	2012	Toxicol. Appl. Pharmacol.	1096-0333	ALL_TEXT_3/3	3	11	1269	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	cb2	CB2	64#67	22119709-0-0-22	D007249	LONGTERM|DICTIONARY	inflammation	inflammation	277#289	NaN	These findings suggest that JWH-133 mediates its effect through CB2 receptors, and ameliorates chronic colitis by inducing apoptosis in activated T cells, reducing the numbers of activated T cells, and suppressing induction of mast cells, NK cells, and neutrophils at sites of inflammation in the LP.
20084546	2010	Breast Cancer Res. Treat.	1573-7217	TITLE	0	0	3486	SYMBOL|DICTIONARY|EXTRACTED	igfbp3	IGFBP3	0#6		D001943	LONGTERM|DISEASE|DT|DICTIONARY	breast cancer	breast cancer	31#44		IGFBP3 A-202C polymorphism and breast cancer susceptibility: a meta-analysis involving 33,557 cases and 45,254 controls.
20084546	2010	Breast Cancer Res. Treat.	1573-7217	ALL_TEXT_1/3	1	1	3486	LONGTERM|DICTIONARY	insulin like growth factor binding protein 3	insulin-like growth factor binding protein 3	42#86		D001943	LONGTERM|DISEASE|DT|DICTIONARY	breast cancer	breast cancer	120#133		Published data on the association between insulin-like growth factor binding protein 3 (IGFBP3) A-202C polymorphism and breast cancer risk are inconclusive.
20084546	2010	Breast Cancer Res. Treat.	1573-7217	ALL_TEXT_1/3	1	1	3486	SYMBOL|()|DICTIONARY|EXTRACTED	igfbp3	IGFBP3	88#94	20084546-1-42-86	D001943	LONGTERM|DISEASE|DT|DICTIONARY	breast cancer	breast cancer	120#133		Published data on the association between insulin-like growth factor binding protein 3 (IGFBP3) A-202C polymorphism and breast cancer risk are inconclusive.
15075790	2004	Eur. J. Cancer Prev.	0959-8278	ALL_TEXT_1/3	1	2	1029	SYMBOL|DICTIONARY	ink4a	INK4A	73#78		D008545	LONGTERM|DICTIONARY	melanoma	melanoma	92#100		In this pilot study using a novel study design, we evaluated the role of INK4A mutations in melanoma by comparing patients with multiple primary melanomas to those with single primaries.
15075790	2004	Eur. J. Cancer Prev.	0959-8278	ALL_TEXT_1/3	1	2	1029	SYMBOL|DICTIONARY	ink4a	INK4A	73#78		D008545	LONGTERM|DICTIONARY	melanomas	melanomas	145#154		In this pilot study using a novel study design, we evaluated the role of INK4A mutations in melanoma by comparing patients with multiple primary melanomas to those with single primaries.
20977478	2011	J. Neurochem.	1471-4159	ALL_TEXT_3/3	3	11	6470	SYMBOL|DICTIONARY|EXTRACTED	shmt1	SHMT1	42#47	20977478-0-70-75	D012559	LONGTERM|DICTIONARY	schizophrenia	schizophrenia	52#65		We detected a nominal association between SHMT1 and schizophrenia.
20084546	2010	Breast Cancer Res. Treat.	1573-7217	ALL_TEXT_3/3	3	9	3486	SYMBOL|DICTIONARY|EXTRACTED	igfbp3	IGFBP3	52#58	20084546-1-42-86	D001943	LONGTERM|DISEASE|DT|DICTIONARY	breast cancer	breast cancer	114#127		In conclusion, this meta-analysis suggests that the IGFBP3 C allele is a low-penetrant risk factor for developing breast cancer.
22802922	2013	PLoS ONE	1932-6203	ALL_TEXT_3/3	3	10	1317	SYMBOL|DICTIONARY	ctr1	Ctr1	33#37		D007674	LONGTERM|DICTIONARY	scc-mediated removal of copper via kidney	SCC-mediated removal of copper via kidney	61#102	NaN	Thus, hepatic down-regulation of Ctr1 allows switching to an SCC-mediated removal of copper via kidney when liver function is impaired.
15190266	2005	Genes Immun.	1466-4879	ALL_TEXT_3/3	3	9	3552	SYMBOL|DICTIONARY	il1a	IL1A	61#65		D010003	SYMBOL|EXTRACTED	oa	OA	116#118	15190266-2-147-161	Here, the effects of the haplotypes were confirmed: the risk IL1A-IL1B-IL1RN haplotype conferred a two-fold risk of OA (P=0.02), and the protective IL1B-IL1RN haplotype conferred a five-fold reduced risk of OA (P=0.0000008).
15190266	2005	Genes Immun.	1466-4879	ALL_TEXT_3/3	3	9	3552	SYMBOL|DICTIONARY	il1a	IL1A	61#65		D010003	SYMBOL|EXTRACTED	oa	OA	207#209	15190266-2-147-161	Here, the effects of the haplotypes were confirmed: the risk IL1A-IL1B-IL1RN haplotype conferred a two-fold risk of OA (P=0.02), and the protective IL1B-IL1RN haplotype conferred a five-fold reduced risk of OA (P=0.0000008).
15190266	2005	Genes Immun.	1466-4879	ALL_TEXT_3/3	3	9	3553	SYMBOL|DICTIONARY	il1b	IL1B	66#70		D010003	SYMBOL|EXTRACTED	oa	OA	116#118	15190266-2-147-161	Here, the effects of the haplotypes were confirmed: the risk IL1A-IL1B-IL1RN haplotype conferred a two-fold risk of OA (P=0.02), and the protective IL1B-IL1RN haplotype conferred a five-fold reduced risk of OA (P=0.0000008).
15190266	2005	Genes Immun.	1466-4879	ALL_TEXT_3/3	3	9	3553	SYMBOL|DICTIONARY	il1b	IL1B	66#70		D010003	SYMBOL|EXTRACTED	oa	OA	207#209	15190266-2-147-161	Here, the effects of the haplotypes were confirmed: the risk IL1A-IL1B-IL1RN haplotype conferred a two-fold risk of OA (P=0.02), and the protective IL1B-IL1RN haplotype conferred a five-fold reduced risk of OA (P=0.0000008).
15190266	2005	Genes Immun.	1466-4879	ALL_TEXT_3/3	3	9	3557	SYMBOL|DICTIONARY	il1rn	IL1RN	71#76		D010003	SYMBOL|EXTRACTED	oa	OA	116#118	15190266-2-147-161	Here, the effects of the haplotypes were confirmed: the risk IL1A-IL1B-IL1RN haplotype conferred a two-fold risk of OA (P=0.02), and the protective IL1B-IL1RN haplotype conferred a five-fold reduced risk of OA (P=0.0000008).
15190266	2005	Genes Immun.	1466-4879	ALL_TEXT_3/3	3	9	3557	SYMBOL|DICTIONARY	il1rn	IL1RN	71#76		D010003	SYMBOL|EXTRACTED	oa	OA	207#209	15190266-2-147-161	Here, the effects of the haplotypes were confirmed: the risk IL1A-IL1B-IL1RN haplotype conferred a two-fold risk of OA (P=0.02), and the protective IL1B-IL1RN haplotype conferred a five-fold reduced risk of OA (P=0.0000008).
15190266	2005	Genes Immun.	1466-4879	ALL_TEXT_3/3	3	9	3553	SYMBOL|DICTIONARY	il1b	IL1B	148#152		D010003	SYMBOL|EXTRACTED	oa	OA	116#118	15190266-2-147-161	Here, the effects of the haplotypes were confirmed: the risk IL1A-IL1B-IL1RN haplotype conferred a two-fold risk of OA (P=0.02), and the protective IL1B-IL1RN haplotype conferred a five-fold reduced risk of OA (P=0.0000008).
15190266	2005	Genes Immun.	1466-4879	ALL_TEXT_3/3	3	9	3553	SYMBOL|DICTIONARY	il1b	IL1B	148#152		D010003	SYMBOL|EXTRACTED	oa	OA	207#209	15190266-2-147-161	Here, the effects of the haplotypes were confirmed: the risk IL1A-IL1B-IL1RN haplotype conferred a two-fold risk of OA (P=0.02), and the protective IL1B-IL1RN haplotype conferred a five-fold reduced risk of OA (P=0.0000008).
15190266	2005	Genes Immun.	1466-4879	ALL_TEXT_3/3	3	9	3557	SYMBOL|DICTIONARY	il1rn	IL1RN	153#158		D010003	SYMBOL|EXTRACTED	oa	OA	116#118	15190266-2-147-161	Here, the effects of the haplotypes were confirmed: the risk IL1A-IL1B-IL1RN haplotype conferred a two-fold risk of OA (P=0.02), and the protective IL1B-IL1RN haplotype conferred a five-fold reduced risk of OA (P=0.0000008).
15190266	2005	Genes Immun.	1466-4879	ALL_TEXT_3/3	3	9	3557	SYMBOL|DICTIONARY	il1rn	IL1RN	153#158		D010003	SYMBOL|EXTRACTED	oa	OA	207#209	15190266-2-147-161	Here, the effects of the haplotypes were confirmed: the risk IL1A-IL1B-IL1RN haplotype conferred a two-fold risk of OA (P=0.02), and the protective IL1B-IL1RN haplotype conferred a five-fold reduced risk of OA (P=0.0000008).
18569231	2008	J Asthma	1532-4303	ALL_TEXT_1/3	1	1	154	SYMBOL|GENE|GN|DICTIONARY	beta 2 adrenoceptor	beta(2)-adrenoceptor	95#115		D001249	LONGTERM|DICTIONARY	asthma	asthma	189#195		The aim of this study was to determine the influence of single nucleotide polymorphisms in the beta(2)-adrenoceptor gene, on the response to inhaled beta(2)-agonists in children with acute asthma.
19904240	2010	Am. J. Gastroenterol.	1572-0241	RESULTS	3	6	3553	SYMBOL|NUMBER|DICTIONARY	il 1b	IL-1B	43#48		D013274	LONGTERM|DISEASE|DT|DICTIONARY	gastric cancer	gastric cancer	82#96		Compared with the CC genotype, carriers of IL-1B-511 TT genotype had an increased gastric cancer risk (odds ratio (OR)=1.97, 95% confidence interval (CI)=1.29-3.01, P=0.0016).
20555002	2010	In Vivo	0258-851X	BACKGROUND/AIMS	1	2	7422	LONGTERM|GENE|GT|DICTIONARY	vascular endothelial growth factor	vascular endothelial growth factor	8#42		D004715	LONGTERM|DICTIONARY	endometriosis	endometriosis	124#137		Whether vascular endothelial growth factor (VEGF) -460 C/T and +405 G/C polymorphisms are associated with susceptibility to endometriosis was investigated.
20555002	2010	In Vivo	0258-851X	BACKGROUND/AIMS	1	2	7422	SYMBOL|()|DICTIONARY|EXTRACTED	vegf	VEGF	44#48	20555002-2-8-42	D004715	LONGTERM|DICTIONARY	endometriosis	endometriosis	124#137		Whether vascular endothelial growth factor (VEGF) -460 C/T and +405 G/C polymorphisms are associated with susceptibility to endometriosis was investigated.
18455351	2008	Int. J. Dev. Neurosci.	0736-5748	ALL_TEXT_3/3	3	7	759	LONGTERM|DICTIONARY	ca1	CA1	50#53	NaN	D013226	SYMBOL|EXTRACTED	se	SE	65#67	18455351-3-138-156	Rosiglitazone also prevented neuronal loss in the CA1 area after SE observed by Nissl-staining.
18455351	2008	Int. J. Dev. Neurosci.	0736-5748	ALL_TEXT_3/3	3	7	759	LONGTERM|DICTIONARY	ca1	CA1	50#53	NaN	D009410	LONGTERM|DICTIONARY	neuronal loss	neuronal loss	29#42	NaN	Rosiglitazone also prevented neuronal loss in the CA1 area after SE observed by Nissl-staining.
12930688	2004	Zhonghua Yi Xue Za Zhi	0376-2491	RESULTS	3	5	4436	SYMBOL|GENE|GN|DICTIONARY	msh2	MSH2	35#39		D015179	SYMBOL|DICTIONARY|EXTRACTED	crc	CRC	109#112	12930688-1-140-158	A large DNA (exon 1-6) deletion in MSH2 gene and a missense mutation Met242Ile in MLH1 gene were unveiled in CRC tissues of two patients with MSI(+)-H.
12930688	2004	Zhonghua Yi Xue Za Zhi	0376-2491	RESULTS	3	5	4436	SYMBOL|GENE|GN|DICTIONARY	msh2	MSH2	35#39		D053842	LONGTERM|DICTIONARY	msi	MSI	142#145	NaN	A large DNA (exon 1-6) deletion in MSH2 gene and a missense mutation Met242Ile in MLH1 gene were unveiled in CRC tissues of two patients with MSI(+)-H.
12930688	2004	Zhonghua Yi Xue Za Zhi	0376-2491	RESULTS	3	5	4292	SYMBOL|GENE|GN|DICTIONARY	mlh1	MLH1	82#86		D015179	SYMBOL|DICTIONARY|EXTRACTED	crc	CRC	109#112	12930688-1-140-158	A large DNA (exon 1-6) deletion in MSH2 gene and a missense mutation Met242Ile in MLH1 gene were unveiled in CRC tissues of two patients with MSI(+)-H.
12930688	2004	Zhonghua Yi Xue Za Zhi	0376-2491	RESULTS	3	5	4292	SYMBOL|GENE|GN|DICTIONARY	mlh1	MLH1	82#86		D053842	LONGTERM|DICTIONARY	msi	MSI	142#145	NaN	A large DNA (exon 1-6) deletion in MSH2 gene and a missense mutation Met242Ile in MLH1 gene were unveiled in CRC tissues of two patients with MSI(+)-H.
19904240	2010	Am. J. Gastroenterol.	1572-0241	METHODS	2	5	3553	SYMBOL|NUMBER|DICTIONARY	il 1b	IL-1B	16#21		D013274	LONGTERM|DICTIONARY	gastric cancers	gastric cancers	94#109		Polymorphism in IL-1B-511 was analyzed by PCR-restriction fragment length polymorphism on 501 gastric cancers and 500 healthy controls.
23055271	2013	Ann. Neurol.	1531-8249	TITLE	0	0	10318	SYMBOL|DICTIONARY	tnip1	TNIP1	61#66		D009157	LONGTERM|DICTIONARY	myasthenia gravis	myasthenia gravis	9#26		Risk for myasthenia gravis maps to a (151) ProAla change in TNIP1 and to human leukocyte antigen-B*08.
20810156	2010	J. Allergy Clin. Immunol.	1097-6825	METHODS	3	3	241	SYMBOL|DICTIONARY|EXTRACTED	alox5ap	ALOX5AP	78#85	20810156-2-34-80	D001249	LONGTERM|DICTIONARY	asthma	asthma	70#76		In a cross-sectional study of 293 Mexicans and 356 Puerto Ricans with asthma, ALOX5AP and LTA4H genes were sequenced, and interactions between gene polymorphisms and bronchodilator responsiveness to albuterol were compared between leukotriene modifier users and nonusers.
20810156	2010	J. Allergy Clin. Immunol.	1097-6825	METHODS	3	3	4048	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	lta4h	LTA4H	90#95	20810156-2-95-121	D001249	LONGTERM|DICTIONARY	asthma	asthma	70#76		In a cross-sectional study of 293 Mexicans and 356 Puerto Ricans with asthma, ALOX5AP and LTA4H genes were sequenced, and interactions between gene polymorphisms and bronchodilator responsiveness to albuterol were compared between leukotriene modifier users and nonusers.
20402821	2010	Int. J. Immunogenet.	1744-313X	ALL_TEXT_3/3	3	8	2952	SYMBOL|DICTIONARY	gstt1	GSTT1	48#53		D029424	SYMBOL|DICTIONARY|EXTRACTED	copd	COPD	83#87	20402821-1-0-37	The frequencies of homozygous null genotypes of GSTT1 were significantly higher in COPD cases as compared with controls (40% versus 14.0%) suggesting that the theta-glutathione S-transferases null genotype may be associated with the susceptibility to COPD.
20402821	2010	Int. J. Immunogenet.	1744-313X	ALL_TEXT_3/3	3	8	2952	SYMBOL|DICTIONARY	gstt1	GSTT1	48#53		D029424	SYMBOL|DICTIONARY|EXTRACTED	copd	COPD	251#255	20402821-1-0-37	The frequencies of homozygous null genotypes of GSTT1 were significantly higher in COPD cases as compared with controls (40% versus 14.0%) suggesting that the theta-glutathione S-transferases null genotype may be associated with the susceptibility to COPD.
20402821	2010	Int. J. Immunogenet.	1744-313X	ALL_TEXT_2/3	2	6	2944	SYMBOL|DICTIONARY	gstm1	GSTM1	17#22		D029424	SYMBOL|DICTIONARY|EXTRACTED	copd	COPD	61#65	20402821-1-0-37	The frequency of GSTM1 homozygous null genotype was 28.0% in COPD cases when compared with controls (32.0%).
20402821	2010	Int. J. Immunogenet.	1744-313X	ALL_TEXT_3/3	3	7	2944	SYMBOL|DICTIONARY	gstm1	GSTM1	89#94		D029424	SYMBOL|DICTIONARY|EXTRACTED	copd	COPD	56#60	20402821-1-0-37	The difference was not significant showing that risk of COPD was not associated with the GSTM1 null genotypes.
20402821	2010	Int. J. Immunogenet.	1744-313X	ALL_TEXT_2/3	2	5	2944	SYMBOL|DICTIONARY	gstm1	GSTM1	25#30		D029424	SYMBOL|DISEASE|DN|DICTIONARY|EXTRACTED	copd	COPD	53#57	20402821-1-0-37	Genetic polymorphisms of GSTM1 and GSTT1 genes in 50 COPD patients and 50 healthy controls were investigated using multiplex polymerase chain reaction-restriction fragment length polymorphism techniques to determine whether polymorphisms of these genes are linked to genetic susceptibility to COPD.All subjects were males and smokers.
20402821	2010	Int. J. Immunogenet.	1744-313X	ALL_TEXT_2/3	2	5	2944	SYMBOL|DICTIONARY	gstm1	GSTM1	25#30		D029424	SYMBOL|DICTIONARY|EXTRACTED	copd	COPD	293#297	20402821-1-0-37	Genetic polymorphisms of GSTM1 and GSTT1 genes in 50 COPD patients and 50 healthy controls were investigated using multiplex polymerase chain reaction-restriction fragment length polymorphism techniques to determine whether polymorphisms of these genes are linked to genetic susceptibility to COPD.All subjects were males and smokers.
20402821	2010	Int. J. Immunogenet.	1744-313X	ALL_TEXT_2/3	2	5	2952	SYMBOL|GENE|GN|DICTIONARY	gstt1	GSTT1	35#40		D029424	SYMBOL|DISEASE|DN|DICTIONARY|EXTRACTED	copd	COPD	53#57	20402821-1-0-37	Genetic polymorphisms of GSTM1 and GSTT1 genes in 50 COPD patients and 50 healthy controls were investigated using multiplex polymerase chain reaction-restriction fragment length polymorphism techniques to determine whether polymorphisms of these genes are linked to genetic susceptibility to COPD.All subjects were males and smokers.
20402821	2010	Int. J. Immunogenet.	1744-313X	ALL_TEXT_2/3	2	5	2952	SYMBOL|GENE|GN|DICTIONARY	gstt1	GSTT1	35#40		D029424	SYMBOL|DICTIONARY|EXTRACTED	copd	COPD	293#297	20402821-1-0-37	Genetic polymorphisms of GSTM1 and GSTT1 genes in 50 COPD patients and 50 healthy controls were investigated using multiplex polymerase chain reaction-restriction fragment length polymorphism techniques to determine whether polymorphisms of these genes are linked to genetic susceptibility to COPD.All subjects were males and smokers.
20402821	2010	Int. J. Immunogenet.	1744-313X	TITLE	0	0	2944	LONGTERM|DICTIONARY	glutathione s transferase m1	glutathione S-transferase M1	16#44		D029424	SYMBOL|DICTIONARY|EXTRACTED	copd	COPD	65#69		Polymorphism of glutathione S-transferase M1 and T1 gene loci in COPD.
10822820	2000	Genetika	0016-6758	ALL_TEXT_1/3	1	1	3578	LONGTERM|DICTIONARY|GENE|GA	interleukin 9	interleukin 9	83#96		D001249	LONGTERM|DICTIONARY	bronchial asthma	bronchial asthma	140#156		The T113M polymorphism resulting from the missense mutation in exon 5 of the human interleukin 9 (IL9) gene was tested for association with bronchial asthma (BA).
10822820	2000	Genetika	0016-6758	ALL_TEXT_1/3	1	1	3578	LONGTERM|DICTIONARY|GENE|GA	interleukin 9	interleukin 9	83#96		D001249	SYMBOL|EXTRACTED|()	ba	BA	158#160	10822820-1-140-156	The T113M polymorphism resulting from the missense mutation in exon 5 of the human interleukin 9 (IL9) gene was tested for association with bronchial asthma (BA).
10822820	2000	Genetika	0016-6758	ALL_TEXT_1/3	1	1	3578	SYMBOL|()|GENE|GN|DICTIONARY|EXTRACTED	il9	IL9	98#101	10822820-1-83-96	D001249	LONGTERM|DICTIONARY	bronchial asthma	bronchial asthma	140#156		The T113M polymorphism resulting from the missense mutation in exon 5 of the human interleukin 9 (IL9) gene was tested for association with bronchial asthma (BA).
10822820	2000	Genetika	0016-6758	ALL_TEXT_1/3	1	1	3578	SYMBOL|()|GENE|GN|DICTIONARY|EXTRACTED	il9	IL9	98#101	10822820-1-83-96	D001249	SYMBOL|EXTRACTED|()	ba	BA	158#160	10822820-1-140-156	The T113M polymorphism resulting from the missense mutation in exon 5 of the human interleukin 9 (IL9) gene was tested for association with bronchial asthma (BA).
21992601	2012	J. Cell. Mol. Med.	1582-4934	TITLE	0	0	952	SYMBOL|GENE|GN|DICTIONARY	cd38	CD38	15#19		D007674	LONGTERM|DICTIONARY	glomerular sclerosis	glomerular sclerosis	78#98		Implication of CD38 gene in podocyte epithelial-to-mesenchymal transition and glomerular sclerosis.
12782962	2004	Psychiatr. Genet.	0955-8829	CONCLUSIONS	4	10	2913	SYMBOL|DICTIONARY	grm3	GRM3	115#119		D012559	LONGTERM|DICTIONARY	schizophrenia	schizophrenia	61#74		Our data indicate that at least one susceptibility locus for schizophrenia is situated within or very close to the GRM3 region in the Japanese patients.
19224585	2009	Hum. Mutat.	1098-1004	ALL_TEXT_3/3	3	9	7157	SYMBOL|GENE|GN|DICTIONARY	tp53	TP53	73#77		D015179	SYMBOL|DICTIONARY|EXTRACTED	crc	CRC	96#99	19224585-1-56-73	The results from this study suggest that prevalent haplotypes within the TP53 gene may modulate CRC risks in the population.
11719088	2002	Mutat. Res.	0027-5107	ALL_TEXT_3/3	3	8	3845	LONGTERM|DICTIONARY	k-ras	K-ras	28#33	NaN	D010190	LONGTERM|DICTIONARY	pancreatic tumors	pancreatic tumors	67#84		Mutation at codon 12 of the K-ras gene was found in 25 (81%) of 31 pancreatic tumors, including three G-to-A transitions and 22 G-to-T transversions.
20610570	2010	Endocrinology	1945-7170	ALL_TEXT_2/3	2	5	3569	LONGTERM|DICTIONARY	il6	Il6	0#3	NaN	D007752	LONGTERM|DICTIONARY	preterm delivery	preterm delivery	98#114	NaN	Il6 null mutant mice were also refractory to low doses of lipopolysaccharide sufficient to induce preterm delivery in wild-type mice.
11719088	2002	Mutat. Res.	0027-5107	ALL_TEXT_3/3	3	7	4968	SYMBOL|GENE|GN|DICTIONARY	hogg1	hOGG1	48#53		D010190	LONGTERM|DISEASE|DT|DICTIONARY	pancreatic tumor	pancreatic tumor	74#90		However, one novel polymorphism/mutation of the hOGG1 gene was found in a pancreatic tumor.
20237358	2010	Reprod Sci	1933-7205	ALL_TEXT_3/3	3	5	6347	SYMBOL|DICTIONARY|EXTRACTED	mcp 1	MCP-1	33#38	20237358-1-49-79	D000292	SYMBOL|DICTIONARY|EXTRACTED	pid	PID	87#90	20237358-1-131-158	There was no association between MCP-1 -2518G/A SNP and its gene expression levels and PID susceptibility.
17307802	2008	Carcinogenesis	0143-3334	ALL_TEXT_1/3	1	1	1543	SYMBOL|DICTIONARY	cyp1a1	CYP1A1	202#208		D009369	LONGTERM|DISEASE|DT|DICTIONARY	cancer	cancer	98#104		To test the hypothesis of interaction among genetic variants in increasing the individual risk of cancer, we have studied the cumulative effect on lung cancer risk of variants in three metabolic genes, CYP1A1, GSTM1 and GSTT1, which are involved in the metabolism of the tobacco smoke constituents and environmental contaminants, polycyclic aromatic hydrocarbons and of other lung carcinogens.
17307802	2008	Carcinogenesis	0143-3334	ALL_TEXT_1/3	1	1	1543	SYMBOL|DICTIONARY	cyp1a1	CYP1A1	202#208		D008175	LONGTERM|DISEASE|DT|DICTIONARY	lung cancer	lung cancer	147#158		To test the hypothesis of interaction among genetic variants in increasing the individual risk of cancer, we have studied the cumulative effect on lung cancer risk of variants in three metabolic genes, CYP1A1, GSTM1 and GSTT1, which are involved in the metabolism of the tobacco smoke constituents and environmental contaminants, polycyclic aromatic hydrocarbons and of other lung carcinogens.
17307802	2008	Carcinogenesis	0143-3334	ALL_TEXT_1/3	1	1	2944	SYMBOL|DICTIONARY	gstm1	GSTM1	210#215		D009369	LONGTERM|DISEASE|DT|DICTIONARY	cancer	cancer	98#104		To test the hypothesis of interaction among genetic variants in increasing the individual risk of cancer, we have studied the cumulative effect on lung cancer risk of variants in three metabolic genes, CYP1A1, GSTM1 and GSTT1, which are involved in the metabolism of the tobacco smoke constituents and environmental contaminants, polycyclic aromatic hydrocarbons and of other lung carcinogens.
17307802	2008	Carcinogenesis	0143-3334	ALL_TEXT_1/3	1	1	2944	SYMBOL|DICTIONARY	gstm1	GSTM1	210#215		D008175	LONGTERM|DISEASE|DT|DICTIONARY	lung cancer	lung cancer	147#158		To test the hypothesis of interaction among genetic variants in increasing the individual risk of cancer, we have studied the cumulative effect on lung cancer risk of variants in three metabolic genes, CYP1A1, GSTM1 and GSTT1, which are involved in the metabolism of the tobacco smoke constituents and environmental contaminants, polycyclic aromatic hydrocarbons and of other lung carcinogens.
17307802	2008	Carcinogenesis	0143-3334	ALL_TEXT_1/3	1	1	2952	SYMBOL|DICTIONARY	gstt1	GSTT1	220#225		D009369	LONGTERM|DISEASE|DT|DICTIONARY	cancer	cancer	98#104		To test the hypothesis of interaction among genetic variants in increasing the individual risk of cancer, we have studied the cumulative effect on lung cancer risk of variants in three metabolic genes, CYP1A1, GSTM1 and GSTT1, which are involved in the metabolism of the tobacco smoke constituents and environmental contaminants, polycyclic aromatic hydrocarbons and of other lung carcinogens.
17307802	2008	Carcinogenesis	0143-3334	ALL_TEXT_1/3	1	1	2952	SYMBOL|DICTIONARY	gstt1	GSTT1	220#225		D008175	LONGTERM|DISEASE|DT|DICTIONARY	lung cancer	lung cancer	147#158		To test the hypothesis of interaction among genetic variants in increasing the individual risk of cancer, we have studied the cumulative effect on lung cancer risk of variants in three metabolic genes, CYP1A1, GSTM1 and GSTT1, which are involved in the metabolism of the tobacco smoke constituents and environmental contaminants, polycyclic aromatic hydrocarbons and of other lung carcinogens.
17307802	2008	Carcinogenesis	0143-3334	ALL_TEXT_3/3	3	5	1543	SYMBOL|NUMBER|DICTIONARY	cyp1a1	CYP1A1	62#68		D008175	LONGTERM|DISEASE|DT|DICTIONARY	lung cancer	lung cancer	12#23		The risk of lung cancer was increased with the combination of CYP1A1*2B or CYP1A1*4 alleles and the double deletion of both GSTM1 and GSTT1 up to an odds ratio (OR) of 8.25 (95% confidence interval 2.29-29.77) for the combination including CYP1A1*4; among never smokers, the latter combination was associated with an OR of 16.19 (1.90-137).
17307802	2008	Carcinogenesis	0143-3334	ALL_TEXT_3/3	3	5	1543	SYMBOL|NUMBER|DICTIONARY	cyp1a1	CYP1A1	75#81		D008175	LONGTERM|DISEASE|DT|DICTIONARY	lung cancer	lung cancer	12#23		The risk of lung cancer was increased with the combination of CYP1A1*2B or CYP1A1*4 alleles and the double deletion of both GSTM1 and GSTT1 up to an odds ratio (OR) of 8.25 (95% confidence interval 2.29-29.77) for the combination including CYP1A1*4; among never smokers, the latter combination was associated with an OR of 16.19 (1.90-137).
17307802	2008	Carcinogenesis	0143-3334	ALL_TEXT_3/3	3	5	2944	SYMBOL|DICTIONARY	gstm1	GSTM1	124#129		D008175	LONGTERM|DISEASE|DT|DICTIONARY	lung cancer	lung cancer	12#23		The risk of lung cancer was increased with the combination of CYP1A1*2B or CYP1A1*4 alleles and the double deletion of both GSTM1 and GSTT1 up to an odds ratio (OR) of 8.25 (95% confidence interval 2.29-29.77) for the combination including CYP1A1*4; among never smokers, the latter combination was associated with an OR of 16.19 (1.90-137).
17307802	2008	Carcinogenesis	0143-3334	ALL_TEXT_3/3	3	5	2952	SYMBOL|DICTIONARY	gstt1	GSTT1	134#139		D008175	LONGTERM|DISEASE|DT|DICTIONARY	lung cancer	lung cancer	12#23		The risk of lung cancer was increased with the combination of CYP1A1*2B or CYP1A1*4 alleles and the double deletion of both GSTM1 and GSTT1 up to an odds ratio (OR) of 8.25 (95% confidence interval 2.29-29.77) for the combination including CYP1A1*4; among never smokers, the latter combination was associated with an OR of 16.19 (1.90-137).
17307802	2008	Carcinogenesis	0143-3334	ALL_TEXT_3/3	3	5	1543	SYMBOL|NUMBER|DICTIONARY	cyp1a1	CYP1A1	240#246		D008175	LONGTERM|DISEASE|DT|DICTIONARY	lung cancer	lung cancer	12#23		The risk of lung cancer was increased with the combination of CYP1A1*2B or CYP1A1*4 alleles and the double deletion of both GSTM1 and GSTT1 up to an odds ratio (OR) of 8.25 (95% confidence interval 2.29-29.77) for the combination including CYP1A1*4; among never smokers, the latter combination was associated with an OR of 16.19 (1.90-137).
19408338	2009	Inflamm. Bowel Dis.	1536-4844	TITLE	0	0	2312	LONGTERM|DICTIONARY	filaggrin	Filaggrin	0#9		D015212	LONGTERM|DISEASE|DT|DICTIONARY	inflammatory bowel disease	inflammatory bowel disease	88#114		Filaggrin loss-of-function variants are associated with atopic comorbidity in pediatric inflammatory bowel disease.
19408338	2009	Inflamm. Bowel Dis.	1536-4844	TITLE	0	0	2312	LONGTERM|DICTIONARY	filaggrin	Filaggrin	0#9		C566404	LONGTERM|DICTIONARY	atopic comorbidity	atopic comorbidity	56#74	NaN	Filaggrin loss-of-function variants are associated with atopic comorbidity in pediatric inflammatory bowel disease.
19408338	2009	Inflamm. Bowel Dis.	1536-4844	BACKGROUND	1	3	2312	SYMBOL|DICTIONARY|EXTRACTED	flg	FLG	42#45	19408338-2-0-9	D015212	SYMBOL|DICTIONARY|EXTRACTED	ibd	IBD	72#75	19408338-1-10-36	The aim was to assess the contribution of FLG null-alleles to pediatric IBD susceptibility and to coexistent atopy (eczema, asthma, allergic rhinitis, or food allergy).
19408338	2009	Inflamm. Bowel Dis.	1536-4844	BACKGROUND	1	3	2312	SYMBOL|DICTIONARY|EXTRACTED	flg	FLG	42#45	19408338-2-0-9	D004485	LONGTERM|DICTIONARY	eczema	eczema	116#122		The aim was to assess the contribution of FLG null-alleles to pediatric IBD susceptibility and to coexistent atopy (eczema, asthma, allergic rhinitis, or food allergy).
19408338	2009	Inflamm. Bowel Dis.	1536-4844	BACKGROUND	1	3	2312	SYMBOL|DICTIONARY|EXTRACTED	flg	FLG	42#45	19408338-2-0-9	D006255	LONGTERM|DICTIONARY	allergic rhinitis	allergic rhinitis	132#149		The aim was to assess the contribution of FLG null-alleles to pediatric IBD susceptibility and to coexistent atopy (eczema, asthma, allergic rhinitis, or food allergy).
19408338	2009	Inflamm. Bowel Dis.	1536-4844	BACKGROUND	1	3	2312	SYMBOL|DICTIONARY|EXTRACTED	flg	FLG	42#45	19408338-2-0-9	D005512	LONGTERM|DICTIONARY	food allergy	food allergy	154#166		The aim was to assess the contribution of FLG null-alleles to pediatric IBD susceptibility and to coexistent atopy (eczema, asthma, allergic rhinitis, or food allergy).
19408338	2009	Inflamm. Bowel Dis.	1536-4844	BACKGROUND	1	3	2312	SYMBOL|DICTIONARY|EXTRACTED	flg	FLG	42#45	19408338-2-0-9	C564133	LONGTERM|DICTIONARY	atopy	atopy	109#114	NaN	The aim was to assess the contribution of FLG null-alleles to pediatric IBD susceptibility and to coexistent atopy (eczema, asthma, allergic rhinitis, or food allergy).
19408338	2009	Inflamm. Bowel Dis.	1536-4844	BACKGROUND	1	3	2312	SYMBOL|DICTIONARY|EXTRACTED	flg	FLG	42#45	19408338-2-0-9	D001249	LONGTERM|DICTIONARY	asthma	asthma	124#130	NaN	The aim was to assess the contribution of FLG null-alleles to pediatric IBD susceptibility and to coexistent atopy (eczema, asthma, allergic rhinitis, or food allergy).
20520958	2010	Arq Bras Endocrinol Metabol	1677-9487	CONCLUSIONS	4	9	3952	SYMBOL|DICTIONARY	lep	LEP	0#3		D009765	LONGTERM|DICTIONARY	obesity	obesity	47#54		LEP I/G combined genotypes are associated with obesity-related metabolic biomarkers and phenotype in a gender-dependent manner.
16182378	2006	J. Neuroimmunol.	0165-5728	ALL_TEXT_2/3	2	7	1234	SYMBOL|DICTIONARY	ccr5*delta32	CCR5*Delta32	30#42		D009103	SYMBOL|EXTRACTED	ms	MS	75#77	16182378-1-63-81	We studied the association of CCR5*Delta32 with the course and severity of MS in 221 patients from a population-based cohort in Olmsted County, MN, and with patterns of immunopathology in 94 patients with biopsy-derived, pathologically confirmed demyelinating disease participating in the MS Lesion Project.
16182378	2006	J. Neuroimmunol.	0165-5728	ALL_TEXT_2/3	2	7	1234	SYMBOL|DICTIONARY	ccr5*delta32	CCR5*Delta32	30#42		D003711	LONGTERM|DISEASE|DT|DICTIONARY	demyelinating disease	demyelinating disease	246#267		We studied the association of CCR5*Delta32 with the course and severity of MS in 221 patients from a population-based cohort in Olmsted County, MN, and with patterns of immunopathology in 94 patients with biopsy-derived, pathologically confirmed demyelinating disease participating in the MS Lesion Project.
16182378	2006	J. Neuroimmunol.	0165-5728	ALL_TEXT_2/3	2	7	1234	SYMBOL|DICTIONARY	ccr5*delta32	CCR5*Delta32	30#42		D009103	SYMBOL|EXTRACTED	ms	MS	289#291	16182378-1-63-81	We studied the association of CCR5*Delta32 with the course and severity of MS in 221 patients from a population-based cohort in Olmsted County, MN, and with patterns of immunopathology in 94 patients with biopsy-derived, pathologically confirmed demyelinating disease participating in the MS Lesion Project.
18273796	2008	Genet. Mol. Res.	1676-5680	ALL_TEXT_3/3	3	12	3952	SYMBOL|DICTIONARY|EXTRACTED	lep	LEP	29#32	18273796-2-42-48	D009765	LONGTERM|DICTIONARY	obesity	obesity	103#110		The haplotype combination of LEP c.-2548G>A and LEPR p.Q223R variants was related to a 58% increase in obesity risk.
18273796	2008	Genet. Mol. Res.	1676-5680	ALL_TEXT_3/3	3	12	3953	SYMBOL|DICTIONARY|EXTRACTED	lepr	LEPR	48#52	18273796-2-59-74	D009765	LONGTERM|DICTIONARY	obesity	obesity	103#110		The haplotype combination of LEP c.-2548G>A and LEPR p.Q223R variants was related to a 58% increase in obesity risk.
12579522	2003	Cell Biochem. Funct.	0263-6484	TITLE	0	0	133	LONGTERM|DICTIONARY	adrenomedullin	adrenomedullin	44#58		D001321	LONGTERM|DICTIONARY	autism	autism	62#68		Pathophysiological role of nitric oxide and adrenomedullin in autism.
16182378	2006	J. Neuroimmunol.	0165-5728	ALL_TEXT_1/3	1	4	1230	SYMBOL|DICTIONARY	ccr1	CCR1	13#17		D001927	LONGTERM|DICTIONARY	pattern iii lesions	pattern III lesions	62#81	NaN	In contrast, CCR1 and CCR5 cells were equal in all regions of pattern III lesions.
16182378	2006	J. Neuroimmunol.	0165-5728	ALL_TEXT_1/3	1	4	1234	LONGTERM|DICTIONARY	ccr5	CCR5	22#26	NaN	D001927	LONGTERM|DICTIONARY	pattern iii lesions	pattern III lesions	62#81	NaN	In contrast, CCR1 and CCR5 cells were equal in all regions of pattern III lesions.
11579943	2002	Intern. Med.	0918-2918	CONCLUSION	4	12	3077	SYMBOL|DICTIONARY	hfe	HFE	53#56		D006432	LONGTERM|DICTIONARY	hemochromatosis	hemochromatosis	87#102		Our results suggested that neither C282Y nor H63D in HFE affect Japanese patients with hemochromatosis or chronic hepatitis C.
11579943	2002	Intern. Med.	0918-2918	CONCLUSION	4	12	3077	SYMBOL|DICTIONARY	hfe	HFE	53#56		D019698	LONGTERM|DICTIONARY	chronic hepatitis c	chronic hepatitis C	106#125		Our results suggested that neither C282Y nor H63D in HFE affect Japanese patients with hemochromatosis or chronic hepatitis C.
19408338	2009	Inflamm. Bowel Dis.	1536-4844	RESULTS	3	5	2312	SYMBOL|DICTIONARY|EXTRACTED	flg	FLG	47#50	19408338-2-0-9	D015212	SYMBOL|DISEASE|DN|DICTIONARY|EXTRACTED	ibd	IBD	15#18	19408338-1-10-36	In all, 11% of IBD patients carried at least 1 FLG null-allele compared to 11% of population controls (P > 0.4).
18273796	2008	Genet. Mol. Res.	1676-5680	ALL_TEXT_3/3	3	10	3952	SYMBOL|DICTIONARY|EXTRACTED	lep	LEP	94#97	18273796-2-42-48	D009765	LONGTERM|DICTIONARY	obese	obese	120#125		Haplotype analysis has shown an association between the G/G allelic combination of c.-2548G>A LEP and c.668A>G LEPR, in obese subjects.
18273796	2008	Genet. Mol. Res.	1676-5680	ALL_TEXT_3/3	3	10	3953	SYMBOL|DICTIONARY|EXTRACTED	lepr	LEPR	111#115	18273796-2-59-74	D009765	LONGTERM|DICTIONARY	obese	obese	120#125		Haplotype analysis has shown an association between the G/G allelic combination of c.-2548G>A LEP and c.668A>G LEPR, in obese subjects.
16182378	2006	J. Neuroimmunol.	0165-5728	ALL_TEXT_2/3	2	9	1234	SYMBOL|DICTIONARY	ccr5	CCR5	51#55		D004194	LONGTERM|DICTIONARY	disease course	disease course	215#229	NaN	There was no association of carrier status for the CCR5*Delta32 mutation with disease severity as analyzed using the disease severity score (ranking of EDSS/duration stratified by duration), age of onset, gender or disease course (bout onset versus primary progressive).
19408338	2009	Inflamm. Bowel Dis.	1536-4844	METHODS	2	4	2312	SYMBOL|DICTIONARY|EXTRACTED	flg	FLG	0#3		D015212	SYMBOL|NUMBER|DICTIONARY|EXTRACTED	ibd	IBD	70#73	19408338-1-10-36	FLG variants (R501X and 2282del4) were genotyped in 403 children with IBD, 683 parents, and 996 population controls.
12930688	2004	Zhonghua Yi Xue Za Zhi	0376-2491	TITLE	0	0	4436	SYMBOL|DICTIONARY	msh2	MSH2	22#26		D015179	LONGTERM|DISEASE|DT|DICTIONARY	colorectal cancer	colorectal cancer	57#74		[Mutation analysis on MSH2 and MLH1 genes in patients of colorectal cancer at early age].
12930688	2004	Zhonghua Yi Xue Za Zhi	0376-2491	TITLE	0	0	4292	SYMBOL|GENE|GN|DICTIONARY	mlh1	MLH1	31#35		D015179	LONGTERM|DISEASE|DT|DICTIONARY	colorectal cancer	colorectal cancer	57#74		[Mutation analysis on MSH2 and MLH1 genes in patients of colorectal cancer at early age].
15071492	2005	Genes Immun.	1466-4879	ALL_TEXT_3/3	3	10	7124	SYMBOL|EXTRACTED	tnf alpha	TNF-alpha	108#117	15071492-1-13-40	D006526	SYMBOL|EXTRACTED|DISEASE|DN	hcv infection	HCV infection	145#158	15071492-1-109-120	Further study of this polymorphism and haplotype is needed to understand these associations and the role of TNF-alpha in determining outcomes of HCV infection.
19408338	2009	Inflamm. Bowel Dis.	1536-4844	RESULTS	3	7	2312	SYMBOL|DICTIONARY|EXTRACTED	flg	FLG	14#17	19408338-2-0-9	D004485	LONGTERM|DICTIONARY	eczema	eczema	49#55		The effect of FLG null-alleles was strongest for eczema (19% versus 7%, P = 0.0003; OR 3.3, 95% CI 1.7-6.6) and food allergy (28% versus 8%, P = 0.0001; OR 4.5, 95% CI 2.0-10.0).
19408338	2009	Inflamm. Bowel Dis.	1536-4844	RESULTS	3	7	2312	SYMBOL|DICTIONARY|EXTRACTED	flg	FLG	14#17	19408338-2-0-9	D005512	LONGTERM|DICTIONARY	food allergy	food allergy	112#124		The effect of FLG null-alleles was strongest for eczema (19% versus 7%, P = 0.0003; OR 3.3, 95% CI 1.7-6.6) and food allergy (28% versus 8%, P = 0.0001; OR 4.5, 95% CI 2.0-10.0).
25356585	2015	PLoS ONE	1932-6203	RESULTS	3	5	7037	LONGTERM|GENE|GT|DICTIONARY	transferrin receptor	transferrin receptor	178#198		D005909	SYMBOL|DICTIONARY|EXTRACTED	gbm	GBM	76#79	25356585-2-126-149	Of the 311 protease genes identified to be differentially expressed in both GBM tissues and cells, 5 genes were highly overexpressed, 2 genes coding for non-peptidase homologues transferrin receptor (TFRC) and G protein-coupled receptor 56 (GPR56), as well as 3 genes coding for the proteases endoplasmic reticulum aminopeptidase 2 (ERAP2), glutamine-fructose-6-phosphate transaminase 2 (GFPT2) and cathepsin K (CTSK), whereas one gene, that of the serine protease carboxypeptidase E (CPE) was strongly reduced in expression.
25356585	2015	PLoS ONE	1932-6203	RESULTS	3	5	7037	SYMBOL|()|DICTIONARY|EXTRACTED	tfrc	TFRC	200#204	25356585-5-178-198	D005909	SYMBOL|DICTIONARY|EXTRACTED	gbm	GBM	76#79	25356585-2-126-149	Of the 311 protease genes identified to be differentially expressed in both GBM tissues and cells, 5 genes were highly overexpressed, 2 genes coding for non-peptidase homologues transferrin receptor (TFRC) and G protein-coupled receptor 56 (GPR56), as well as 3 genes coding for the proteases endoplasmic reticulum aminopeptidase 2 (ERAP2), glutamine-fructose-6-phosphate transaminase 2 (GFPT2) and cathepsin K (CTSK), whereas one gene, that of the serine protease carboxypeptidase E (CPE) was strongly reduced in expression.
25356585	2015	PLoS ONE	1932-6203	RESULTS	3	5	9289	LONGTERM|DICTIONARY	g protein coupled receptor 56	G protein-coupled receptor 56	210#239		D005909	SYMBOL|DICTIONARY|EXTRACTED	gbm	GBM	76#79	25356585-2-126-149	Of the 311 protease genes identified to be differentially expressed in both GBM tissues and cells, 5 genes were highly overexpressed, 2 genes coding for non-peptidase homologues transferrin receptor (TFRC) and G protein-coupled receptor 56 (GPR56), as well as 3 genes coding for the proteases endoplasmic reticulum aminopeptidase 2 (ERAP2), glutamine-fructose-6-phosphate transaminase 2 (GFPT2) and cathepsin K (CTSK), whereas one gene, that of the serine protease carboxypeptidase E (CPE) was strongly reduced in expression.
25356585	2015	PLoS ONE	1932-6203	RESULTS	3	5	9289	SYMBOL|()|DICTIONARY|EXTRACTED	gpr56	GPR56	241#246	25356585-5-210-239	D005909	SYMBOL|DICTIONARY|EXTRACTED	gbm	GBM	76#79	25356585-2-126-149	Of the 311 protease genes identified to be differentially expressed in both GBM tissues and cells, 5 genes were highly overexpressed, 2 genes coding for non-peptidase homologues transferrin receptor (TFRC) and G protein-coupled receptor 56 (GPR56), as well as 3 genes coding for the proteases endoplasmic reticulum aminopeptidase 2 (ERAP2), glutamine-fructose-6-phosphate transaminase 2 (GFPT2) and cathepsin K (CTSK), whereas one gene, that of the serine protease carboxypeptidase E (CPE) was strongly reduced in expression.
25356585	2015	PLoS ONE	1932-6203	RESULTS	3	5	64167	LONGTERM|DICTIONARY	endoplasmic reticulum aminopeptidase 2	endoplasmic reticulum aminopeptidase 2	293#331		D005909	SYMBOL|DICTIONARY|EXTRACTED	gbm	GBM	76#79	25356585-2-126-149	Of the 311 protease genes identified to be differentially expressed in both GBM tissues and cells, 5 genes were highly overexpressed, 2 genes coding for non-peptidase homologues transferrin receptor (TFRC) and G protein-coupled receptor 56 (GPR56), as well as 3 genes coding for the proteases endoplasmic reticulum aminopeptidase 2 (ERAP2), glutamine-fructose-6-phosphate transaminase 2 (GFPT2) and cathepsin K (CTSK), whereas one gene, that of the serine protease carboxypeptidase E (CPE) was strongly reduced in expression.
25356585	2015	PLoS ONE	1932-6203	RESULTS	3	5	64167	SYMBOL|()|DICTIONARY|EXTRACTED	erap2	ERAP2	333#338	25356585-5-293-331	D005909	SYMBOL|DICTIONARY|EXTRACTED	gbm	GBM	76#79	25356585-2-126-149	Of the 311 protease genes identified to be differentially expressed in both GBM tissues and cells, 5 genes were highly overexpressed, 2 genes coding for non-peptidase homologues transferrin receptor (TFRC) and G protein-coupled receptor 56 (GPR56), as well as 3 genes coding for the proteases endoplasmic reticulum aminopeptidase 2 (ERAP2), glutamine-fructose-6-phosphate transaminase 2 (GFPT2) and cathepsin K (CTSK), whereas one gene, that of the serine protease carboxypeptidase E (CPE) was strongly reduced in expression.
25356585	2015	PLoS ONE	1932-6203	RESULTS	3	5	9945	LONGTERM|DICTIONARY	glutamine fructose 6 phosphate transaminase 2	glutamine-fructose-6-phosphate transaminase 2	341#386		D005909	SYMBOL|DICTIONARY|EXTRACTED	gbm	GBM	76#79	25356585-2-126-149	Of the 311 protease genes identified to be differentially expressed in both GBM tissues and cells, 5 genes were highly overexpressed, 2 genes coding for non-peptidase homologues transferrin receptor (TFRC) and G protein-coupled receptor 56 (GPR56), as well as 3 genes coding for the proteases endoplasmic reticulum aminopeptidase 2 (ERAP2), glutamine-fructose-6-phosphate transaminase 2 (GFPT2) and cathepsin K (CTSK), whereas one gene, that of the serine protease carboxypeptidase E (CPE) was strongly reduced in expression.
25356585	2015	PLoS ONE	1932-6203	RESULTS	3	5	9945	SYMBOL|()|DICTIONARY|EXTRACTED	gfpt2	GFPT2	388#393	25356585-5-341-386	D005909	SYMBOL|DICTIONARY|EXTRACTED	gbm	GBM	76#79	25356585-2-126-149	Of the 311 protease genes identified to be differentially expressed in both GBM tissues and cells, 5 genes were highly overexpressed, 2 genes coding for non-peptidase homologues transferrin receptor (TFRC) and G protein-coupled receptor 56 (GPR56), as well as 3 genes coding for the proteases endoplasmic reticulum aminopeptidase 2 (ERAP2), glutamine-fructose-6-phosphate transaminase 2 (GFPT2) and cathepsin K (CTSK), whereas one gene, that of the serine protease carboxypeptidase E (CPE) was strongly reduced in expression.
25356585	2015	PLoS ONE	1932-6203	RESULTS	3	5	1513	LONGTERM|DICTIONARY	cathepsin k	cathepsin K	399#410		D005909	SYMBOL|DICTIONARY|EXTRACTED	gbm	GBM	76#79	25356585-2-126-149	Of the 311 protease genes identified to be differentially expressed in both GBM tissues and cells, 5 genes were highly overexpressed, 2 genes coding for non-peptidase homologues transferrin receptor (TFRC) and G protein-coupled receptor 56 (GPR56), as well as 3 genes coding for the proteases endoplasmic reticulum aminopeptidase 2 (ERAP2), glutamine-fructose-6-phosphate transaminase 2 (GFPT2) and cathepsin K (CTSK), whereas one gene, that of the serine protease carboxypeptidase E (CPE) was strongly reduced in expression.
25356585	2015	PLoS ONE	1932-6203	RESULTS	3	5	1513	SYMBOL|()|DICTIONARY|EXTRACTED	ctsk	CTSK	412#416	25356585-5-399-410	D005909	SYMBOL|DICTIONARY|EXTRACTED	gbm	GBM	76#79	25356585-2-126-149	Of the 311 protease genes identified to be differentially expressed in both GBM tissues and cells, 5 genes were highly overexpressed, 2 genes coding for non-peptidase homologues transferrin receptor (TFRC) and G protein-coupled receptor 56 (GPR56), as well as 3 genes coding for the proteases endoplasmic reticulum aminopeptidase 2 (ERAP2), glutamine-fructose-6-phosphate transaminase 2 (GFPT2) and cathepsin K (CTSK), whereas one gene, that of the serine protease carboxypeptidase E (CPE) was strongly reduced in expression.
25356585	2015	PLoS ONE	1932-6203	RESULTS	3	5	1363	LONGTERM|DICTIONARY	carboxypeptidase e	carboxypeptidase E	465#483		D005909	SYMBOL|DICTIONARY|EXTRACTED	gbm	GBM	76#79	25356585-2-126-149	Of the 311 protease genes identified to be differentially expressed in both GBM tissues and cells, 5 genes were highly overexpressed, 2 genes coding for non-peptidase homologues transferrin receptor (TFRC) and G protein-coupled receptor 56 (GPR56), as well as 3 genes coding for the proteases endoplasmic reticulum aminopeptidase 2 (ERAP2), glutamine-fructose-6-phosphate transaminase 2 (GFPT2) and cathepsin K (CTSK), whereas one gene, that of the serine protease carboxypeptidase E (CPE) was strongly reduced in expression.
12782962	2004	Psychiatr. Genet.	0955-8829	OBJECTIVES	1	3	2913	SYMBOL|()|DICTIONARY	grm3	GRM3	63#67		D012559	LONGTERM|DICTIONARY	schizophrenia	schizophrenia	88#101		We focused on the metabotropic glutamate receptor type 3 gene (GRM3) as a candidate for schizophrenia susceptibility.
25256182	2015	Stroke	1524-4628	CONCLUSIONS	4	11	9734	SYMBOL|DICTIONARY	hdac9	HDAC9	137#142		D002544	LONGTERM|DICTIONARY	ischemic stroke	ischemic stroke	64#79		This region on chromosome 7 has been previously associated with ischemic stroke and the large vessel stroke occlusive subtype (including HDAC9), suggesting a possible genetic link between this stroke subtype and IA.
25256182	2015	Stroke	1524-4628	CONCLUSIONS	4	11	9734	SYMBOL|DICTIONARY	hdac9	HDAC9	137#142		D020521	LONGTERM|DICTIONARY	stroke	stroke	101#107		This region on chromosome 7 has been previously associated with ischemic stroke and the large vessel stroke occlusive subtype (including HDAC9), suggesting a possible genetic link between this stroke subtype and IA.
25256182	2015	Stroke	1524-4628	CONCLUSIONS	4	11	9734	SYMBOL|DICTIONARY	hdac9	HDAC9	137#142		D020521	LONGTERM|GFAM|FN|DICTIONARY	stroke	stroke	193#199		This region on chromosome 7 has been previously associated with ischemic stroke and the large vessel stroke occlusive subtype (including HDAC9), suggesting a possible genetic link between this stroke subtype and IA.
25256182	2015	Stroke	1524-4628	CONCLUSIONS	4	11	9734	SYMBOL|DICTIONARY	hdac9	HDAC9	137#142		D002532	SYMBOL|EXTRACTED	ia	IA	212#214	25256182-1-95-117	This region on chromosome 7 has been previously associated with ischemic stroke and the large vessel stroke occlusive subtype (including HDAC9), suggesting a possible genetic link between this stroke subtype and IA.
12879272	2004	Rheumatol. Int.	0172-8172	ALL_TEXT_1/3	1	1	2944	LONGTERM|DICTIONARY	glutathione s transferase m1	glutathione S-transferase M1	57#85		D002340	LONGTERM|DICTIONARY	carotid atherosclerosis	carotid atherosclerosis	139#162		We assessed the contribution of genetic polymorphisms of glutathione S-transferase M1 ( GSTM1), T1 ( GSTT1), and P1 ( GSTP1, Ile105Val) to carotid atherosclerosis in 40 postmenopausal rheumatoid arthritic (RA) women without histories of smoking.
12879272	2004	Rheumatol. Int.	0172-8172	ALL_TEXT_1/3	1	1	2944	LONGTERM|DICTIONARY	glutathione s transferase m1	glutathione S-transferase M1	57#85		D001172	LONGTERM|DICTIONARY	rheumatoid arthritic	rheumatoid arthritic	184#204	NaN	We assessed the contribution of genetic polymorphisms of glutathione S-transferase M1 ( GSTM1), T1 ( GSTT1), and P1 ( GSTP1, Ile105Val) to carotid atherosclerosis in 40 postmenopausal rheumatoid arthritic (RA) women without histories of smoking.
12879272	2004	Rheumatol. Int.	0172-8172	ALL_TEXT_1/3	1	1	2944	LONGTERM|DICTIONARY	glutathione s transferase m1	glutathione S-transferase M1	57#85		D001172	LONGTERM|DICTIONARY	ra	RA	206#208	NaN	We assessed the contribution of genetic polymorphisms of glutathione S-transferase M1 ( GSTM1), T1 ( GSTT1), and P1 ( GSTP1, Ile105Val) to carotid atherosclerosis in 40 postmenopausal rheumatoid arthritic (RA) women without histories of smoking.
12879272	2004	Rheumatol. Int.	0172-8172	ALL_TEXT_1/3	1	1	2944	SYMBOL|DICTIONARY	gstm1	GSTM1	88#93		D002340	LONGTERM|DICTIONARY	carotid atherosclerosis	carotid atherosclerosis	139#162		We assessed the contribution of genetic polymorphisms of glutathione S-transferase M1 ( GSTM1), T1 ( GSTT1), and P1 ( GSTP1, Ile105Val) to carotid atherosclerosis in 40 postmenopausal rheumatoid arthritic (RA) women without histories of smoking.
12879272	2004	Rheumatol. Int.	0172-8172	ALL_TEXT_1/3	1	1	2944	SYMBOL|DICTIONARY	gstm1	GSTM1	88#93		D001172	LONGTERM|DICTIONARY	rheumatoid arthritic	rheumatoid arthritic	184#204	NaN	We assessed the contribution of genetic polymorphisms of glutathione S-transferase M1 ( GSTM1), T1 ( GSTT1), and P1 ( GSTP1, Ile105Val) to carotid atherosclerosis in 40 postmenopausal rheumatoid arthritic (RA) women without histories of smoking.
12879272	2004	Rheumatol. Int.	0172-8172	ALL_TEXT_1/3	1	1	2944	SYMBOL|DICTIONARY	gstm1	GSTM1	88#93		D001172	LONGTERM|DICTIONARY	ra	RA	206#208	NaN	We assessed the contribution of genetic polymorphisms of glutathione S-transferase M1 ( GSTM1), T1 ( GSTT1), and P1 ( GSTP1, Ile105Val) to carotid atherosclerosis in 40 postmenopausal rheumatoid arthritic (RA) women without histories of smoking.
12879272	2004	Rheumatol. Int.	0172-8172	ALL_TEXT_1/3	1	1	2952	SYMBOL|DICTIONARY	gstt1	GSTT1	101#106		D002340	LONGTERM|DICTIONARY	carotid atherosclerosis	carotid atherosclerosis	139#162		We assessed the contribution of genetic polymorphisms of glutathione S-transferase M1 ( GSTM1), T1 ( GSTT1), and P1 ( GSTP1, Ile105Val) to carotid atherosclerosis in 40 postmenopausal rheumatoid arthritic (RA) women without histories of smoking.
12879272	2004	Rheumatol. Int.	0172-8172	ALL_TEXT_1/3	1	1	2952	SYMBOL|DICTIONARY	gstt1	GSTT1	101#106		D001172	LONGTERM|DICTIONARY	rheumatoid arthritic	rheumatoid arthritic	184#204	NaN	We assessed the contribution of genetic polymorphisms of glutathione S-transferase M1 ( GSTM1), T1 ( GSTT1), and P1 ( GSTP1, Ile105Val) to carotid atherosclerosis in 40 postmenopausal rheumatoid arthritic (RA) women without histories of smoking.
12879272	2004	Rheumatol. Int.	0172-8172	ALL_TEXT_1/3	1	1	2952	SYMBOL|DICTIONARY	gstt1	GSTT1	101#106		D001172	LONGTERM|DICTIONARY	ra	RA	206#208	NaN	We assessed the contribution of genetic polymorphisms of glutathione S-transferase M1 ( GSTM1), T1 ( GSTT1), and P1 ( GSTP1, Ile105Val) to carotid atherosclerosis in 40 postmenopausal rheumatoid arthritic (RA) women without histories of smoking.
12879272	2004	Rheumatol. Int.	0172-8172	ALL_TEXT_1/3	1	1	2950	SYMBOL|DICTIONARY	gstp1	GSTP1	118#123		D002340	LONGTERM|DICTIONARY	carotid atherosclerosis	carotid atherosclerosis	139#162		We assessed the contribution of genetic polymorphisms of glutathione S-transferase M1 ( GSTM1), T1 ( GSTT1), and P1 ( GSTP1, Ile105Val) to carotid atherosclerosis in 40 postmenopausal rheumatoid arthritic (RA) women without histories of smoking.
12879272	2004	Rheumatol. Int.	0172-8172	ALL_TEXT_1/3	1	1	2950	SYMBOL|DICTIONARY	gstp1	GSTP1	118#123		D001172	LONGTERM|DICTIONARY	rheumatoid arthritic	rheumatoid arthritic	184#204	NaN	We assessed the contribution of genetic polymorphisms of glutathione S-transferase M1 ( GSTM1), T1 ( GSTT1), and P1 ( GSTP1, Ile105Val) to carotid atherosclerosis in 40 postmenopausal rheumatoid arthritic (RA) women without histories of smoking.
12879272	2004	Rheumatol. Int.	0172-8172	ALL_TEXT_1/3	1	1	2950	SYMBOL|DICTIONARY	gstp1	GSTP1	118#123		D001172	LONGTERM|DICTIONARY	ra	RA	206#208	NaN	We assessed the contribution of genetic polymorphisms of glutathione S-transferase M1 ( GSTM1), T1 ( GSTT1), and P1 ( GSTP1, Ile105Val) to carotid atherosclerosis in 40 postmenopausal rheumatoid arthritic (RA) women without histories of smoking.
17785557	2007	Clin. Cancer Res.	1078-0432	RESULTS	3	8	6387	SYMBOL|DICTIONARY	cxcl12	CXCL12	17#23		D009362	LONGTERM|DICTIONARY	metastasis	metastasis	145#155		The frequency of CXCL12 AA genotype was significantly higher in a group of patients with lymph node metastasis (23%) compared with those without metastasis (7%).
17785557	2007	Clin. Cancer Res.	1078-0432	RESULTS	3	8	6387	SYMBOL|DICTIONARY	cxcl12	CXCL12	17#23		D009362	LONGTERM|DICTIONARY	metastasis	metastasis	100#110		The frequency of CXCL12 AA genotype was significantly higher in a group of patients with lymph node metastasis (23%) compared with those without metastasis (7%).
19673907	2011	Cephalalgia	1468-2982	ALL_TEXT_1/3	1	1	4524	SYMBOL|NUMBER|DICTIONARY	mthfr	MTHFR	31#36		D008881	LONGTERM|DICTIONARY	migraine	migraine	75#83		Data on the association of the MTHFR 677CT and ACE D/I polymorphisms with migraine severity, measured by attack frequency, are scarce.
19673907	2011	Cephalalgia	1468-2982	ALL_TEXT_1/3	1	1	1636	SYMBOL|DICTIONARY	ace	ACE	48#51		D008881	LONGTERM|DICTIONARY	migraine	migraine	75#83		Data on the association of the MTHFR 677CT and ACE D/I polymorphisms with migraine severity, measured by attack frequency, are scarce.
19996333	2010	Thorax	1468-3296	RESULT	3	9	2944	SYMBOL|DICTIONARY	gstm1	GSTM1	100#105		D001249	LONGTERM|DICTIONARY	asthma	asthma	27#33		"Furthermore, the increased asthma risk associated with h0111101 was restricted to children with the GSTM1 ""null"" genotype (interaction p=0.002, HR 1.89, 95% CI 1.34 to 2.60)."
17785557	2007	Clin. Cancer Res.	1078-0432	PURPOSE	1	3	6387	SYMBOL|DICTIONARY	cxcl12	CXCL12	58#64		D011471	LONGTERM|DISEASE|DT|DICTIONARY	prostate cancer	prostate cancer	87#102		Currently, there are no reports investigating the role of CXCL12 G801A polymorphism in prostate cancer (PC).
17785557	2007	Clin. Cancer Res.	1078-0432	PURPOSE	1	3	6387	SYMBOL|DICTIONARY	cxcl12	CXCL12	58#64		D011471	SYMBOL|EXTRACTED|()	pc	PC	104#106	17785557-3-87-102	Currently, there are no reports investigating the role of CXCL12 G801A polymorphism in prostate cancer (PC).
17785557	2007	Clin. Cancer Res.	1078-0432	TITLE	0	0	6387	SYMBOL|DICTIONARY	cxcl12	CXCL12	0#6		D011471	LONGTERM|DISEASE|DT|DICTIONARY	sporadic prostate cancer	sporadic prostate cancer	47#71		CXCL12 G801A polymorphism is a risk factor for sporadic prostate cancer susceptibility.
17785557	2007	Clin. Cancer Res.	1078-0432	PURPOSE	1	1	6387	SYMBOL|DICTIONARY	cxcl12	CXCL12	14#20		D009362	LONGTERM|DICTIONARY	metastasis	metastasis	89#99		The chemokine CXCL12 and its receptor CXCR4 have been found to be associated with cancer metastasis.
17785557	2007	Clin. Cancer Res.	1078-0432	PURPOSE	1	1	7852	SYMBOL|DICTIONARY	cxcr4	CXCR4	38#43		D009362	LONGTERM|DICTIONARY	metastasis	metastasis	89#99		The chemokine CXCL12 and its receptor CXCR4 have been found to be associated with cancer metastasis.
17785557	2007	Clin. Cancer Res.	1078-0432	EXPERIMENTAL DESIGN	2	6	6387	SYMBOL|DICTIONARY	cxcl12	CXCL12	33#39		D011471	SYMBOL|EXTRACTED	pc	PC	134#136	17785557-3-87-102	To investigate the effect of the CXCL12 G801A polymorphism on CXCL12 and CXCR4 expression, immunohistochemistry was done in genotyped PC tissues.
17785557	2007	Clin. Cancer Res.	1078-0432	EXPERIMENTAL DESIGN	2	6	6387	SYMBOL|DICTIONARY	cxcl12	CXCL12	62#68		D011471	SYMBOL|EXTRACTED	pc	PC	134#136	17785557-3-87-102	To investigate the effect of the CXCL12 G801A polymorphism on CXCL12 and CXCR4 expression, immunohistochemistry was done in genotyped PC tissues.
17785557	2007	Clin. Cancer Res.	1078-0432	EXPERIMENTAL DESIGN	2	6	7852	SYMBOL|DICTIONARY	cxcr4	CXCR4	73#78		D011471	SYMBOL|EXTRACTED	pc	PC	134#136	17785557-3-87-102	To investigate the effect of the CXCL12 G801A polymorphism on CXCL12 and CXCR4 expression, immunohistochemistry was done in genotyped PC tissues.
12767526	2003	Cancer Lett.	0304-3835	TITLE	0	0	1543	SYMBOL|DICTIONARY	cytochrome p450 (cyp) 1a1	cytochrome P450 (CYP) 1A1	43#68		D011471	LONGTERM|DISEASE|DT|DICTIONARY	familial prostate cancer	familial prostate cancer	82#106		Association of the genetic polymorphism in cytochrome P450 (CYP) 1A1 with risk of familial prostate cancer in a Japanese population: a case-control study.
15082902	2004	J. Korean Med. Sci.	1011-8934	ALL_TEXT_1/3	1	3	672	LONGTERM|DICTIONARY	brca	BRCA	37#41	NaN	D001943	LONGTERM|DISEASE|DN|DT|DICTIONARY	korean breast cancer	Korean breast cancer	87#107		We assayed germline mutations in the BRCA genes to evaluate their genetic pathology in Korean breast cancer patients.
8627522	1996	J. Pharmacol. Exp. Ther.	0022-3565	ALL_TEXT_3/3	3	12	3357	SYMBOL|GENE|GN|DICTIONARY	5 ht2b	5-HT2B	51#57		D006973	LONGTERM|DICTIONARY	hypertensive	hypertensive	103#115	NaN	PCR analyses indicated an increase in mRNA for the 5-HT2B receptor in mesenteric arteries of DOCA-salt hypertensive arteries, supporting an increase in receptor number.
12782962	2004	Psychiatr. Genet.	0955-8829	TITLE	0	0	2913	SYMBOL|()|DICTIONARY	grm3	GRM3	91#95		D012559	LONGTERM|DICTIONARY	schizophrenia	schizophrenia	102#115		Positive associations of polymorphisms in the metabotropic glutamate receptor type 3 gene (GRM3) with schizophrenia.
8000303	1995	Cancer Epidemiol. Biomarkers Prev.	1055-9965	TITLE	0	0	1543	SYMBOL|DICTIONARY	cyp1a1	CYP1A1	12#18		D001943	LONGTERM|DISEASE|DT|DICTIONARY	breast cancer	breast cancer	106#119		Genetics of CYP1A1: coamplification of specific alleles by polymerase chain reaction and association with breast cancer.
8000303	1995	Cancer Epidemiol. Biomarkers Prev.	1055-9965	ALL_TEXT_1/3	1	1	1543	SYMBOL|DICTIONARY	cyp1a1	CYP1A1	0#6		D009369	LONGTERM|DISEASE|DT|DICTIONARY	cancer	cancer	92#98		CYP1A1 is a gene of the cytochrome P-450 family that has been proposed to be a biomarker of cancer risk.
20558149	2010	Brain Res.	1872-6240	ALL_TEXT_1/3	1	1	351	LONGTERM|DICTIONARY	abeta	Abeta	26#31	NaN	D000544	LONGTERM|DISEASE|DT|DICTIONARY	alzheimer disease	Alzheimer's disease	97#116		The amyloid beta-protein (Abeta)-induced complement system activation plays an important role in Alzheimer's disease (AD).
20558149	2010	Brain Res.	1872-6240	ALL_TEXT_1/3	1	1	351	LONGTERM|DICTIONARY	abeta	Abeta	26#31	NaN	D000544	SYMBOL|EXTRACTED|()	ad	AD	118#120	20558149-1-97-116	The amyloid beta-protein (Abeta)-induced complement system activation plays an important role in Alzheimer's disease (AD).
19673907	2011	Cephalalgia	1468-2982	TITLE	0	0	4524	SYMBOL|NUMBER|DICTIONARY	mthfr	MTHFR	0#5		D008881	LONGTERM|DICTIONARY	migraine	migraine	44#52		MTHFR 677C->T and ACE D/I polymorphisms and migraine attack frequency in women.
19673907	2011	Cephalalgia	1468-2982	TITLE	0	0	1636	SYMBOL|DICTIONARY	ace	ACE	18#21		D008881	LONGTERM|DICTIONARY	migraine	migraine	44#52		MTHFR 677C->T and ACE D/I polymorphisms and migraine attack frequency in women.
20513142	2010	Hum. Mutat.	1098-1004	ALL_TEXT_3/3	3	8	4208	SYMBOL|DICTIONARY	mef2c	MEF2C	67#72		D015518	LONGTERM|DISEASE|DT|DICTIONARY	rett syndrome	Rett syndrome	96#109		We therefore conclude that the phenotypic overlap of patients with MEF2C mutations and atypical Rett syndrome is due to the involvement of a common pathway.
19350382	2009	Cell. Mol. Neurobiol.	1573-6830	ALL_TEXT_2/3	2	4	5728	SYMBOL|GENE|GN|DICTIONARY	pten	PTEN	32#36		D009369	LONGTERM|DICTIONARY	tumors	tumors	77#83		Additionally, the level of MMAC/PTEN protein expression in the tissues of 26 tumors was assessed by immunohistochemistry.
20513142	2010	Hum. Mutat.	1098-1004	TITLE	0	0	4208	SYMBOL|DICTIONARY	mef2c	MEF2C	13#18		D008607	LONGTERM|DICTIONARY	mental retardation	mental retardation	99#117		Mutations in MEF2C from the 5q14.3q15 microdeletion syndrome region are a frequent cause of severe mental retardation and diminish MECP2 and CDKL5 expression.
20513142	2010	Hum. Mutat.	1098-1004	TITLE	0	0	4204	SYMBOL|DICTIONARY	mecp2	MECP2	131#136		D008607	LONGTERM|DICTIONARY	mental retardation	mental retardation	99#117		Mutations in MEF2C from the 5q14.3q15 microdeletion syndrome region are a frequent cause of severe mental retardation and diminish MECP2 and CDKL5 expression.
20513142	2010	Hum. Mutat.	1098-1004	TITLE	0	0	6792	SYMBOL|DICTIONARY	cdkl5	CDKL5	141#146		D008607	LONGTERM|DICTIONARY	mental retardation	mental retardation	99#117		Mutations in MEF2C from the 5q14.3q15 microdeletion syndrome region are a frequent cause of severe mental retardation and diminish MECP2 and CDKL5 expression.
19262575	2009	Genes Immun.	1476-5470	TITLE	0	0	3562	LONGTERM|GENE|GN|DICTIONARY	interleukin 3	interleukin 3	21#34		D006111	LONGTERM|DISEASE|DT|DICTIONARY	graves disease	Graves' disease	87#102		Polymorphisms in the interleukin 3 gene show strong association with susceptibility to Graves' disease in Chinese population.
21300947	2011	Arch. Gen. Psychiatry	1538-3636	MAIN OUTCOME MEASURES	6	8	627	SYMBOL|DICTIONARY|EXTRACTED	bdnf	BDNF	4#8	21300947-1-4-37	D009135	LONGTERM|DICTIONARY	thickness	thickness	64#73	NaN	The BDNF Val66Met genotype, apolipoprotein E genotype, cortical thickness, microstructural integrity of white matter tracts, and episodic memory performance were evaluated.
21300947	2011	Arch. Gen. Psychiatry	1538-3636	MAIN OUTCOME MEASURES	6	8	348	LONGTERM|DICTIONARY	apolipoprotein e	apolipoprotein E	28#44		D009135	LONGTERM|DICTIONARY	thickness	thickness	64#73	NaN	The BDNF Val66Met genotype, apolipoprotein E genotype, cortical thickness, microstructural integrity of white matter tracts, and episodic memory performance were evaluated.
19115152	2009	Turk J Gastroenterol	2148-5607	BACKGROUND/AIMS	1	4	5243	SYMBOL|GENE|GN|DICTIONARY	mdr1	MDR1	32#36		D015212	LONGTERM|DISEASE|DT|DICTIONARY	inflammatory bowel disease	inflammatory bowel disease	93#119		Therefore, the mutations of the MDR1 gene are thought to be related with the pathogenesis of inflammatory bowel disease.
19115152	2009	Turk J Gastroenterol	2148-5607	BACKGROUND/AIMS	1	5	5243	SYMBOL|GENE|GN|DICTIONARY	mdr1	MDR1	74#78		D015212	LONGTERM|DISEASE|DT|DICTIONARY	inflammatory bowel disease	inflammatory bowel disease	109#135		The aim of this study was to investigate the G2677T/A polymorphism in the MDR1 gene in Turkish patients with inflammatory bowel disease and a healthy control group.
19115152	2009	Turk J Gastroenterol	2148-5607	TITLE	0	0	5243	SYMBOL|GENE|GN|DICTIONARY	mdr1	MDR1	57#61		D015212	LONGTERM|DISEASE|DT|DICTIONARY	inflammatory bowel disease	inflammatory bowel disease	92#118		Effects of polymorphism in G2677T/A triallelic region of MDR1 gene in Turkish patients with inflammatory bowel disease.
16344274	2006	Carcinogenesis	0143-3334	ALL_TEXT_2/3	2	4	126	SYMBOL|NUMBER|DICTIONARY	adh3	ADH3	130#134		D001943	LONGTERM|DISEASE|DT|DICTIONARY	breast cancer	breast cancer	172#185		Using data from the Long Island Breast Cancer Study Project, we examined whether fast metabolizers of alcohol, as measured by the ADH3(1-1) genotype, have a higher risk of breast cancer from alcohol intake compared with those individuals who are slow metabolizers, but consume similar amounts of alcohol.
10091612	1999	Mov. Disord.	0885-3185	TITLE	0	0	4129	LONGTERM|DICTIONARY|GENE|GA	monoamine oxidase b	monoamine oxidase B	18#37		D010300	LONGTERM|DISEASE|DT|DICTIONARY	parkinson disease	Parkinson's disease	70#89		Variations in the monoamine oxidase B (MAOB) gene are associated with Parkinson's disease.
10091612	1999	Mov. Disord.	0885-3185	TITLE	0	0	4129	SYMBOL|()|GENE|GN|DICTIONARY|EXTRACTED	maob	MAOB	39#43	10091612-0-18-37	D010300	LONGTERM|DISEASE|DT|DICTIONARY	parkinson disease	Parkinson's disease	70#89		Variations in the monoamine oxidase B (MAOB) gene are associated with Parkinson's disease.
19058785	2009	Biol. Psychiatry	1873-2402	RESULTS	3	8	477	SYMBOL|GENE|GN|DICTIONARY	atp1a2	ATP1A2	42#48		D001714	SYMBOL|EXTRACTED	bd	BD	118#120	19058785-2-27-44	Haplotype analysis of the alpha2 isoform (ATP1A2 gene) showed a significant association with two loci haplotypes with BD (rs2295623: rs2070704; global p value = .0198, following a permutation test).
16344274	2006	Carcinogenesis	0143-3334	TITLE	0	0	126	SYMBOL|DICTIONARY	adh3	ADH3	0#4		D001943	LONGTERM|DISEASE|DT|DICTIONARY	breast cancer	breast cancer	34#47		ADH3 genotype, alcohol intake and breast cancer risk.
10091612	1999	Mov. Disord.	0885-3185	ALL_TEXT_3/3	3	7	4129	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	maob	MAOB	168#172	10091612-0-18-37	D010300	SYMBOL|EXTRACTED	pd	PD	213#215	10091612-1-71-90	After statistical adjustment for potential confounders using a logistic regression analysis, the (GT) repeat alleles > or =188 base pairs in the intron 2 marker of the MAOB gene were significantly associated with PD (OR = 4.60; p<0.00005; 95% CI = 1.97-10.77).
10091612	1999	Mov. Disord.	0885-3185	ALL_TEXT_3/3	3	7	4129	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	maob	MAOB	168#172	10091612-0-18-37	D013915	LONGTERM|DICTIONARY	gt	GT	98#100	NaN	After statistical adjustment for potential confounders using a logistic regression analysis, the (GT) repeat alleles > or =188 base pairs in the intron 2 marker of the MAOB gene were significantly associated with PD (OR = 4.60; p<0.00005; 95% CI = 1.97-10.77).
19058785	2009	Biol. Psychiatry	1873-2402	RESULTS	3	7	146	LONGTERM|DICTIONARY	alpha1	alpha1	74#80	NaN	D001714	SYMBOL|EXTRACTED	bd	BD	37#39	19058785-2-27-44	Significant nominal association with BD was observed for six single SNPs (alpha1: rs11805078; alpha2: rs2070704, rs1016732, rs2854248, and rs2295623; alpha3: rs919390) in the three genes of Na+, K+-ATPase alpha isoforms.
15649153	2005	Pigment Cell Res.	0893-5785	ALL_TEXT_2/3	2	3	1493	SYMBOL|GENE|GN|DICTIONARY	ctla4	CTLA4	91#96		D001327	LONGTERM|DICTIONARY	autoimmune disorders	autoimmune disorders	106#126		Several studies have disclosed an association between the previously known variants of the CTLA4 gene and autoimmune disorders, but no study has as yet found any definite association between vitiligo and the CTLA4 polymorphisms.
15649153	2005	Pigment Cell Res.	0893-5785	ALL_TEXT_2/3	2	3	1493	SYMBOL|GENE|GN|DICTIONARY	ctla4	CTLA4	91#96		D014820	LONGTERM|DICTIONARY	vitiligo	vitiligo	191#199		Several studies have disclosed an association between the previously known variants of the CTLA4 gene and autoimmune disorders, but no study has as yet found any definite association between vitiligo and the CTLA4 polymorphisms.
15649153	2005	Pigment Cell Res.	0893-5785	ALL_TEXT_2/3	2	3	1493	SYMBOL|DICTIONARY	ctla4	CTLA4	208#213		D001327	LONGTERM|DICTIONARY	autoimmune disorders	autoimmune disorders	106#126		Several studies have disclosed an association between the previously known variants of the CTLA4 gene and autoimmune disorders, but no study has as yet found any definite association between vitiligo and the CTLA4 polymorphisms.
15649153	2005	Pigment Cell Res.	0893-5785	ALL_TEXT_2/3	2	3	1493	SYMBOL|DICTIONARY	ctla4	CTLA4	208#213		D014820	LONGTERM|DICTIONARY	vitiligo	vitiligo	191#199		Several studies have disclosed an association between the previously known variants of the CTLA4 gene and autoimmune disorders, but no study has as yet found any definite association between vitiligo and the CTLA4 polymorphisms.
20100586	2011	Biol. Blood Marrow Transplant.	1523-6536	ALL_TEXT_3/3	3	13	7132	SYMBOL|DICTIONARY	tnfrsf1a	TNFRSF1A	40#48		D006086	SYMBOL|EXTRACTED	agvhd	aGVHD	94#99	20100586-1-117-148	No correlation between selected SNPs in TNFRSF1A or TNFRSF1B and the incidence or severity of aGVHD was found.
20100586	2011	Biol. Blood Marrow Transplant.	1523-6536	ALL_TEXT_3/3	3	13	7133	SYMBOL|DICTIONARY	tnfrsf1b	TNFRSF1B	52#60		D006086	SYMBOL|EXTRACTED	agvhd	aGVHD	94#99	20100586-1-117-148	No correlation between selected SNPs in TNFRSF1A or TNFRSF1B and the incidence or severity of aGVHD was found.
15649153	2005	Pigment Cell Res.	0893-5785	TITLE	0	0	1493	SYMBOL|DICTIONARY	ctla4	CTLA4	0#5		D014820	LONGTERM|DICTIONARY	vitiligo	vitiligo	40#48		CTLA4 polymorphisms are associated with vitiligo, in patients with concomitant autoimmune diseases.
15649153	2005	Pigment Cell Res.	0893-5785	TITLE	0	0	1493	SYMBOL|DICTIONARY	ctla4	CTLA4	0#5		D001327	LONGTERM|DICTIONARY	autoimmune diseases	autoimmune diseases	79#98		CTLA4 polymorphisms are associated with vitiligo, in patients with concomitant autoimmune diseases.
15649153	2005	Pigment Cell Res.	0893-5785	ALL_TEXT_3/3	3	7	1493	SYMBOL|GENE|GN|DICTIONARY	ctla4	CTLA4	51#56		D014820	LONGTERM|DICTIONARY	vitiligo	vitiligo	94#102		The results indicate that the polymorphisms in the CTLA4 gene region confer susceptibility to vitiligo when occurring together with other autoimmune diseases, but not in patients with isolated vitiligo.
15649153	2005	Pigment Cell Res.	0893-5785	ALL_TEXT_3/3	3	7	1493	SYMBOL|GENE|GN|DICTIONARY	ctla4	CTLA4	51#56		D001327	LONGTERM|DICTIONARY	autoimmune diseases	autoimmune diseases	138#157		The results indicate that the polymorphisms in the CTLA4 gene region confer susceptibility to vitiligo when occurring together with other autoimmune diseases, but not in patients with isolated vitiligo.
15649153	2005	Pigment Cell Res.	0893-5785	ALL_TEXT_3/3	3	7	1493	SYMBOL|GENE|GN|DICTIONARY	ctla4	CTLA4	51#56		D014820	LONGTERM|DICTIONARY	vitiligo	vitiligo	193#201		The results indicate that the polymorphisms in the CTLA4 gene region confer susceptibility to vitiligo when occurring together with other autoimmune diseases, but not in patients with isolated vitiligo.
20979931	2011	Int J Clin Pharmacol Ther	0946-1965	RESULTS	3	5	2067	SYMBOL|DICTIONARY|EXTRACTED	ercc1	ERCC1	0#5		D009422	LONGTERM|DICTIONARY	neuropathy	neuropathy	148#158		ERCC1 C118T and GSTP1 Ile105Val polymorphisms were not significantly associated with an increased risk of developing Grade 2 or more severe chronic neuropathy.
20979931	2011	Int J Clin Pharmacol Ther	0946-1965	RESULTS	3	5	2950	SYMBOL|DICTIONARY	gstp1	GSTP1	16#21		D009422	LONGTERM|DICTIONARY	neuropathy	neuropathy	148#158		ERCC1 C118T and GSTP1 Ile105Val polymorphisms were not significantly associated with an increased risk of developing Grade 2 or more severe chronic neuropathy.
20979931	2011	Int J Clin Pharmacol Ther	0946-1965	RESULTS	3	4	2950	SYMBOL|DICTIONARY	gstp1	GSTP1	8#13		D009422	LONGTERM|DICTIONARY	neuropathy	neuropathy	46#56		For the GSTP1 Ile105Val polymorphism, chronic neuropathy developed earlier in patients with the reference Ile/Ile genotype (6 cycles) than in those with Ile/Val and Val/Val genotypes (9 cycles; p = 0.0321).
19235789	2010	Int J Geriatr Psychiatry	1099-1166	CONCLUSION	4	8	1815	SYMBOL|DICTIONARY	drd4	DRD4	106#110		D003866	LONGTERM|DICTIONARY	depression	depression	133#143		Our data, in combination with a review of the literature, reveal a potential role for the VNTR variant of DRD4 in the development of depression in AD patients.
19235789	2010	Int J Geriatr Psychiatry	1099-1166	CONCLUSION	4	8	1815	SYMBOL|DICTIONARY	drd4	DRD4	106#110		D000544	SYMBOL|DISEASE|DN|DICTIONARY|EXTRACTED	ad	AD	147#149	19235789-1-0-19	Our data, in combination with a review of the literature, reveal a potential role for the VNTR variant of DRD4 in the development of depression in AD patients.
20979931	2011	Int J Clin Pharmacol Ther	0946-1965	TITLE	0	0	2067	SYMBOL|DICTIONARY|EXTRACTED	ercc1	ERCC1	88#93		D010523	LONGTERM|DICTIONARY	peripheral neuropathy	peripheral neuropathy	41#62		Associations between oxaliplatin-induced peripheral neuropathy and polymorphisms of the ERCC1 and GSTP1 genes.
20979931	2011	Int J Clin Pharmacol Ther	0946-1965	TITLE	0	0	2950	SYMBOL|GENE|GN|DICTIONARY	gstp1	GSTP1	98#103		D010523	LONGTERM|DICTIONARY	peripheral neuropathy	peripheral neuropathy	41#62		Associations between oxaliplatin-induced peripheral neuropathy and polymorphisms of the ERCC1 and GSTP1 genes.
20979931	2011	Int J Clin Pharmacol Ther	0946-1965	RESULTS	3	3	2067	SYMBOL|DICTIONARY|EXTRACTED	ercc1	ERCC1	8#13	20979931-2-224-269	D009422	LONGTERM|DICTIONARY	neuropathy	neuropathy	50#60		For the ERCC1 C118T polymorphism, Grade 1 chronic neuropathy developed earlier in patients with C/T and T/T genotypes (median number of treatment cycles at onset = 6) than in those with the reference C/C genotype (7 cycles; p = 0.0162 by the generalized Wilcoxon test).
20638924	2010	Cancer Epidemiol	1877-783X	PURPOSE	1	1	5243	SYMBOL|()|GENE|GN|DICTIONARY	mdr1	MDR1	82#86		D001943	LONGTERM|DISEASE|DN|DT|DICTIONARY	breast cancer	breast cancer	110#123		To investigate the role of TSER (TYMS), C677T (MTHFR), Arg72Pro (p53) and C3435T (MDR1) gene polymorphisms in breast cancer patients treated with 5-fluorouracil and cyclophosphamide-based neoadjuvant chemotherapy.
20638924	2010	Cancer Epidemiol	1877-783X	PURPOSE	1	1	7157	LONGTERM|DICTIONARY	p53	p53	65#68	NaN	D001943	LONGTERM|DISEASE|DN|DT|DICTIONARY	breast cancer	breast cancer	110#123		To investigate the role of TSER (TYMS), C677T (MTHFR), Arg72Pro (p53) and C3435T (MDR1) gene polymorphisms in breast cancer patients treated with 5-fluorouracil and cyclophosphamide-based neoadjuvant chemotherapy.
11992568	2002	Am. J. Med. Genet.	0148-7299	ALL_TEXT_1/3	1	1	1636	SYMBOL|DICTIONARY	dcp1	DCP1	211#215		D000544	LONGTERM|DISEASE|DT|DICTIONARY	alzheimer disease	Alzheimer disease	32#49		In a study of 261 patients with Alzheimer disease (AD) and 306 cognitively normal control subjects from Germany, Switzerland, and Italy, we found no association between genotype counts or allelic frequencies of DCP1, the gene encoding angiotensin-converting enzyme.
11992568	2002	Am. J. Med. Genet.	0148-7299	ALL_TEXT_1/3	1	1	1636	SYMBOL|DICTIONARY	dcp1	DCP1	211#215		D000544	SYMBOL|EXTRACTED|()	ad	AD	51#53	11992568-1-32-49	In a study of 261 patients with Alzheimer disease (AD) and 306 cognitively normal control subjects from Germany, Switzerland, and Italy, we found no association between genotype counts or allelic frequencies of DCP1, the gene encoding angiotensin-converting enzyme.
11992568	2002	Am. J. Med. Genet.	0148-7299	ALL_TEXT_1/3	1	1	1636	LONGTERM|GENE|GT|DICTIONARY	angiotensin converting enzyme	angiotensin-converting enzyme	235#264		D000544	LONGTERM|DISEASE|DT|DICTIONARY	alzheimer disease	Alzheimer disease	32#49		In a study of 261 patients with Alzheimer disease (AD) and 306 cognitively normal control subjects from Germany, Switzerland, and Italy, we found no association between genotype counts or allelic frequencies of DCP1, the gene encoding angiotensin-converting enzyme.
11992568	2002	Am. J. Med. Genet.	0148-7299	ALL_TEXT_1/3	1	1	1636	LONGTERM|GENE|GT|DICTIONARY	angiotensin converting enzyme	angiotensin-converting enzyme	235#264		D000544	SYMBOL|EXTRACTED|()	ad	AD	51#53	11992568-1-32-49	In a study of 261 patients with Alzheimer disease (AD) and 306 cognitively normal control subjects from Germany, Switzerland, and Italy, we found no association between genotype counts or allelic frequencies of DCP1, the gene encoding angiotensin-converting enzyme.
20615671	2011	Eur. Psychiatry	1778-3585	TITLE	0	0	84062	SYMBOL|()|DICTIONARY|EXTRACTED	dtnbp1	DTNBP1	42#48		D012559	LONGTERM|DICTIONARY	schizophrenia	schizophrenia	98#111		Analysis of HapMap tag-SNPs in dysbindin (DTNBP1) reveals evidence of consistent association with schizophrenia.
20615671	2011	Eur. Psychiatry	1778-3585	ALL_TEXT_1/3	1	3	84062	SYMBOL|DICTIONARY|EXTRACTED	dtnbp1	DTNBP1	0#6		D012559	LONGTERM|DISEASE|DN|DICTIONARY	schizophrenia	schizophrenia	69#82		DTNBP1 is widely expressed in brain, levels are reduced in brains of schizophrenia patients and a DTNBP1 polymorphism has been associated with reduced brain expression.
20615671	2011	Eur. Psychiatry	1778-3585	ALL_TEXT_1/3	1	3	84062	SYMBOL|DICTIONARY|EXTRACTED	dtnbp1	DTNBP1	98#104	20615671-1-0-30	D012559	LONGTERM|DISEASE|DN|DICTIONARY	schizophrenia	schizophrenia	69#82		DTNBP1 is widely expressed in brain, levels are reduced in brains of schizophrenia patients and a DTNBP1 polymorphism has been associated with reduced brain expression.
21992601	2012	J. Cell. Mol. Med.	1582-4934	ALL_TEXT_3/3	3	9	952	SYMBOL|DICTIONARY	cd38	CD38	69#73		D007674	LONGTERM|DISEASE|DN|DICTIONARY	glomerular injury	glomerular injury	257#274		In conclusion, our observations reveal that the normal expression of CD38 importantly contributes to the differentiation and function of podocytes and the defect of this gene expression may be a critical mechanism inducing EMT and consequently resulting in glomerular injury and sclerosis.
21992601	2012	J. Cell. Mol. Med.	1582-4934	ALL_TEXT_3/3	3	9	952	SYMBOL|DICTIONARY	cd38	CD38	69#73		D012598	LONGTERM|DICTIONARY	sclerosis	sclerosis	279#288	NaN	In conclusion, our observations reveal that the normal expression of CD38 importantly contributes to the differentiation and function of podocytes and the defect of this gene expression may be a critical mechanism inducing EMT and consequently resulting in glomerular injury and sclerosis.
20615671	2011	Eur. Psychiatry	1778-3585	ALL_TEXT_2/3	2	5	84062	SYMBOL|DICTIONARY|EXTRACTED	dtnbp1	DTNBP1	76#82	20615671-1-0-30	D012559	LONGTERM|DICTIONARY	schizophrenia	schizophrenia	136#149		Using a haplotype block-based gene-tagging approach we genotyped 13 SNPs in DTNBP1 to investigate possible associations with DTNBP1 and schizophrenia.
20615671	2011	Eur. Psychiatry	1778-3585	ALL_TEXT_2/3	2	5	84062	SYMBOL|DICTIONARY|EXTRACTED	dtnbp1	DTNBP1	125#131	20615671-1-0-30	D012559	LONGTERM|DICTIONARY	schizophrenia	schizophrenia	136#149		Using a haplotype block-based gene-tagging approach we genotyped 13 SNPs in DTNBP1 to investigate possible associations with DTNBP1 and schizophrenia.
20112360	2010	Arthritis Rheum.	0004-3591	RESULTS	3	5	10466	SYMBOL|GENE|GN|DICTIONARY	cog5	COG5	91#95		D010003	SYMBOL|EXTRACTED	oa	OA	205#207	20112360-1-36-50	The C allele of rs3815148 on chromosome 7q22 (minor allele frequency 23%; intron 12 of the COG5 gene) was associated with a 1.14-fold increased risk (95% confidence interval 1.09-1.19) of knee and/or hand OA (P = 8 x 10(-8)) and also with a 30% increased risk of knee OA progression (95% confidence interval 1.03-1.64) (P = 0.03).
20112360	2010	Arthritis Rheum.	0004-3591	RESULTS	3	5	10466	SYMBOL|GENE|GN|DICTIONARY	cog5	COG5	91#95		D010003	SYMBOL|EXTRACTED	oa	OA	268#270	20112360-1-36-50	The C allele of rs3815148 on chromosome 7q22 (minor allele frequency 23%; intron 12 of the COG5 gene) was associated with a 1.14-fold increased risk (95% confidence interval 1.09-1.19) of knee and/or hand OA (P = 8 x 10(-8)) and also with a 30% increased risk of knee OA progression (95% confidence interval 1.03-1.64) (P = 0.03).
19237575	2009	Proc. Natl. Acad. Sci. U.S.A.	1091-6490	ALL_TEXT_2/3	2	4	965	SYMBOL|GFAM|FN|DICTIONARY	cd58	CD58	84#88		D009103	SYMBOL|EXTRACTED	ms	MS	200#202	19237575-1-0-18	This protective rs2300747(G) allele is associated with a dose-dependent increase in CD58 mRNA expression in lymphoblastic cell lines (P = 1.1 x 10(-10)) and in peripheral blood mononuclear cells from MS subjects (P = 0.0037).
20558149	2010	Brain Res.	1872-6240	ALL_TEXT_1/3	1	3	1378	SYMBOL|GENE|GN|DICTIONARY	cr1	CR1	170#173		D000544	SYMBOL|EXTRACTED	ad	AD	184#186	20558149-1-97-116	A recent large genome-wide association study (GWAS) has identified significant association of two single nucleotide polymorphisms (SNPs) (rs6656401 and rs3818361) in the CR1 gene with AD in Caucasians.
15809232	2005	Alcohol Alcohol.	0735-0414	CONCLUSIONS	4	8	348	SYMBOL|DICTIONARY	apo e	APO E	23#28		D002340	LONGTERM|DICTIONARY	carotid atherosclerosis	carotid atherosclerosis	50#73		The association of the APO E epsilon4 allele with carotid atherosclerosis was significant in younger patients.
7783416	1995	Kidney Int.	0085-2538	TITLE	0	0	1636	SYMBOL|GENE|GN|DICTIONARY	ace	ACE	15#18		D003928	LONGTERM|DICTIONARY	diabetic nephropathy	diabetic nephropathy	41#61		Association of ACE gene polymorphism and diabetic nephropathy? The Diabetic Nephropathy Study Group.
7783416	1995	Kidney Int.	0085-2538	TITLE	0	0	1636	SYMBOL|GENE|GN|DICTIONARY	ace	ACE	15#18		D003928	LONGTERM|DICTIONARY	diabetic nephropathy	Diabetic Nephropathy	67#87		Association of ACE gene polymorphism and diabetic nephropathy? The Diabetic Nephropathy Study Group.
7783416	1995	Kidney Int.	0085-2538	ALL_TEXT_1/3	1	1	1636	LONGTERM|GENE|GT|DICTIONARY	angiotensin i converting enzyme	angiotensin I converting enzyme	128#159		D003928	LONGTERM|DICTIONARY	diabetic nephropathy	diabetic nephropathy	180#200		In patients with type 1 diabetes an association has been found between an insertion/deletion (I/D) polymorphism in the gene for angiotensin I converting enzyme and the presence of diabetic nephropathy.
7783416	1995	Kidney Int.	0085-2538	ALL_TEXT_1/3	1	1	1636	LONGTERM|GENE|GT|DICTIONARY	angiotensin i converting enzyme	angiotensin I converting enzyme	128#159		D003920	LONGTERM|DICTIONARY	diabetes	diabetes	24#32		In patients with type 1 diabetes an association has been found between an insertion/deletion (I/D) polymorphism in the gene for angiotensin I converting enzyme and the presence of diabetic nephropathy.
7783416	1995	Kidney Int.	0085-2538	ALL_TEXT_1/3	1	1	1636	LONGTERM|GENE|GT|DICTIONARY	angiotensin i converting enzyme	angiotensin I converting enzyme	128#159		D017827	LONGTERM|DICTIONARY	type	type	17#21		In patients with type 1 diabetes an association has been found between an insertion/deletion (I/D) polymorphism in the gene for angiotensin I converting enzyme and the presence of diabetic nephropathy.
20383754	2011	Obes Surg	1708-0428	TITLE	0	0	7421	LONGTERM|GENE|GT|DICTIONARY	vitamin d receptor	Vitamin D receptor	0#18		D006962	LONGTERM|DICTIONARY	secondary hyperparathyroidism	secondary hyperparathyroidism	36#65		Vitamin D receptor polymorphisms in secondary hyperparathyroidism after Scopinaro's biliopancreatic diversion.
20112360	2010	Arthritis Rheum.	0004-3591	RESULTS	3	9	2845	SYMBOL|DICTIONARY	gpr22	GPR22	0#5		D010003	SYMBOL|EXTRACTED	oa	OA	92#94	20112360-1-36-50	GPR22-positive chondrocyte-like cells were also found in osteophytes in instability-induced OA.
21131976	2011	Nat. Genet.	1546-1718	ALL_TEXT_3/3	3	3	9533	SYMBOL|DICTIONARY	polr1c	POLR1C	56#62		D008342	SYMBOL|DICTIONARY|EXTRACTED	tcs	TCS	89#92	21131976-1-114-139	Furthermore, we discovered mutations in both alleles of POLR1C in three individuals with TCS.
21131976	2011	Nat. Genet.	1546-1718	ALL_TEXT_2/3	2	2	51082	SYMBOL|DICTIONARY	polr1d	POLR1D	66#72		D008342	SYMBOL|DICTIONARY|EXTRACTED	tcs	TCS	97#100	21131976-1-114-139	Subsequently, we detected 20 additional heterozygous mutations of POLR1D in 252 individuals with TCS.
21131976	2011	Nat. Genet.	1546-1718	ALL_TEXT_1/3	1	1	51082	SYMBOL|DICTIONARY	polr1d	POLR1D	84#90		D008342	LONGTERM|DISEASE|DT|DICTIONARY	treacher collins syndrome	Treacher Collins syndrome	114#139		We identified a deletion of a gene encoding a subunit of RNA polymerases I and III, POLR1D, in an individual with Treacher Collins syndrome (TCS).
21131976	2011	Nat. Genet.	1546-1718	ALL_TEXT_1/3	1	1	51082	SYMBOL|DICTIONARY	polr1d	POLR1D	84#90		D008342	SYMBOL|()|DICTIONARY|EXTRACTED	tcs	TCS	141#144	21131976-1-114-139	We identified a deletion of a gene encoding a subunit of RNA polymerases I and III, POLR1D, in an individual with Treacher Collins syndrome (TCS).
15983957	2005	Am. J. Kidney Dis.	1523-6838	CONCLUSION	4	11	7369	SYMBOL|DICTIONARY	umod	UMOD	101#105		D007674	SYMBOL|EXTRACTED|DISEASE|DN	gckd	GCKD	67#71	15983957-1-142-172	A second family reported to date is described, confirming that the GCKD phenotype may be caused by a UMOD mutation.
12782962	2004	Psychiatr. Genet.	0955-8829	METHODS	2	4	2913	SYMBOL|DICTIONARY	grm3	GRM3	128#132		D012559	LONGTERM|DICTIONARY	schizophrenics	schizophrenics	22#36		We genotyped Japanese schizophrenics (n=100) and controls (n=100) for six single nucleotide polymorphisms (SNPs) located in the GRM3 region at intervals of approximately 50 kb.
19419979	2009	Biol Res Nurs	1099-8004	TITLE	0	0	7124	LONGTERM|DICTIONARY	tumor necrosis factor alpha	tumor necrosis factor alpha	54#81		D012893	LONGTERM|DICTIONARY	sleep disturbance	sleep disturbance	102#119		Preliminary evidence of a genetic association between tumor necrosis factor alpha and the severity of sleep disturbance and morning fatigue.
19419979	2009	Biol Res Nurs	1099-8004	TITLE	0	0	7124	LONGTERM|DICTIONARY	tumor necrosis factor alpha	tumor necrosis factor alpha	54#81		D005221	LONGTERM|DICTIONARY	fatigue	fatigue	132#139		Preliminary evidence of a genetic association between tumor necrosis factor alpha and the severity of sleep disturbance and morning fatigue.
19419979	2009	Biol Res Nurs	1099-8004	ALL_TEXT_1/3	1	2	7124	LONGTERM|DICTIONARY	tumor necrosis factor alpha	tumor necrosis factor-alpha	118#145		D012893	LONGTERM|DICTIONARY	sleep disturbance	sleep disturbance	233#250		In this study, we sought to determine whether a functional genetic variation in a prominent proinflammatory cytokine, tumor necrosis factor-alpha (TNFA-308G>A [rs1800629] promoter polymorphism) was associated with overall ratings of sleep disturbance and fatigue as well as with the trajectories of these symptoms.
19419979	2009	Biol Res Nurs	1099-8004	ALL_TEXT_1/3	1	2	7124	LONGTERM|DICTIONARY	tumor necrosis factor alpha	tumor necrosis factor-alpha	118#145		D005221	LONGTERM|DICTIONARY	fatigue	fatigue	255#262		In this study, we sought to determine whether a functional genetic variation in a prominent proinflammatory cytokine, tumor necrosis factor-alpha (TNFA-308G>A [rs1800629] promoter polymorphism) was associated with overall ratings of sleep disturbance and fatigue as well as with the trajectories of these symptoms.
19419979	2009	Biol Res Nurs	1099-8004	ALL_TEXT_1/3	1	2	7124	SYMBOL|NUMBER|DICTIONARY	tnfa	TNFA	147#151		D012893	LONGTERM|DICTIONARY	sleep disturbance	sleep disturbance	233#250		In this study, we sought to determine whether a functional genetic variation in a prominent proinflammatory cytokine, tumor necrosis factor-alpha (TNFA-308G>A [rs1800629] promoter polymorphism) was associated with overall ratings of sleep disturbance and fatigue as well as with the trajectories of these symptoms.
19419979	2009	Biol Res Nurs	1099-8004	ALL_TEXT_1/3	1	2	7124	SYMBOL|NUMBER|DICTIONARY	tnfa	TNFA	147#151		D005221	LONGTERM|DICTIONARY	fatigue	fatigue	255#262		In this study, we sought to determine whether a functional genetic variation in a prominent proinflammatory cytokine, tumor necrosis factor-alpha (TNFA-308G>A [rs1800629] promoter polymorphism) was associated with overall ratings of sleep disturbance and fatigue as well as with the trajectories of these symptoms.
19419979	2009	Biol Res Nurs	1099-8004	ALL_TEXT_2/3	2	4	7124	SYMBOL|DICTIONARY	tnfa	TNFA	64#68		D012893	LONGTERM|DICTIONARY	sleep disturbance	sleep disturbance	107#124		Multiple linear regression was used to assess the effect of the TNFA genotype and other covariates on mean sleep disturbance and fatigue scores.
19419979	2009	Biol Res Nurs	1099-8004	ALL_TEXT_2/3	2	4	7124	SYMBOL|DICTIONARY	tnfa	TNFA	64#68		D005221	LONGTERM|DICTIONARY	fatigue	fatigue	129#136		Multiple linear regression was used to assess the effect of the TNFA genotype and other covariates on mean sleep disturbance and fatigue scores.
19419979	2009	Biol Res Nurs	1099-8004	ALL_TEXT_3/3	3	5	7124	SYMBOL|DICTIONARY	tnfa	TNFA	65#69		D004195	LONGTERM|DICTIONARY	hierarchical linear modeling	Hierarchical linear modeling	0#28	NaN	Hierarchical linear modeling was used to determine the effect of TNFA genotype on the trajectories of these symptoms.
19419979	2009	Biol Res Nurs	1099-8004	ALL_TEXT_3/3	3	8	7124	SYMBOL|GENE|GN|DICTIONARY	tnfa	TNFA	106#110		D012893	LONGTERM|DICTIONARY	sleep disturbance	sleep disturbance	136#153		Findings provide preliminary evidence of an association between a functional promoter polymorphism in the TNFA gene and the severity of sleep disturbance and morning fatigue in oncology patients and their family caregivers.
19419979	2009	Biol Res Nurs	1099-8004	ALL_TEXT_3/3	3	8	7124	SYMBOL|GENE|GN|DICTIONARY	tnfa	TNFA	106#110		D005221	LONGTERM|DICTIONARY	fatigue	fatigue	166#173		Findings provide preliminary evidence of an association between a functional promoter polymorphism in the TNFA gene and the severity of sleep disturbance and morning fatigue in oncology patients and their family caregivers.
18064451	2008	Immunogenetics	0093-7711	ALL_TEXT_1/3	1	3	3565	SYMBOL|DICTIONARY	il4	IL4	55#58		D003922	SYMBOL|EXTRACTED	t1d	T1D	41#44	18064451-2-103-118	Our aim was to assess the involvement on T1D and RA of IL4 polymorphisms considered individually and in combination with other polymorphisms in 5q31-33, specifically in the OCTN locus, where the L503F polymorphism has been associated with Crohn's disease and other Th1 diseases.
18064451	2008	Immunogenetics	0093-7711	ALL_TEXT_1/3	1	3	3565	SYMBOL|DICTIONARY	il4	IL4	55#58		D001172	SYMBOL|EXTRACTED	ra	RA	49#51	18064451-2-129-149	Our aim was to assess the involvement on T1D and RA of IL4 polymorphisms considered individually and in combination with other polymorphisms in 5q31-33, specifically in the OCTN locus, where the L503F polymorphism has been associated with Crohn's disease and other Th1 diseases.
18064451	2008	Immunogenetics	0093-7711	ALL_TEXT_1/3	1	3	3565	SYMBOL|DICTIONARY	il4	IL4	55#58		D003424	LONGTERM|DISEASE|DT|DICTIONARY	crohn disease	Crohn's disease	239#254		Our aim was to assess the involvement on T1D and RA of IL4 polymorphisms considered individually and in combination with other polymorphisms in 5q31-33, specifically in the OCTN locus, where the L503F polymorphism has been associated with Crohn's disease and other Th1 diseases.
18064451	2008	Immunogenetics	0093-7711	ALL_TEXT_1/3	1	3	51497	LONGTERM|DICTIONARY	th1	Th1	265#268	NaN	D003922	SYMBOL|EXTRACTED	t1d	T1D	41#44	18064451-2-103-118	Our aim was to assess the involvement on T1D and RA of IL4 polymorphisms considered individually and in combination with other polymorphisms in 5q31-33, specifically in the OCTN locus, where the L503F polymorphism has been associated with Crohn's disease and other Th1 diseases.
18064451	2008	Immunogenetics	0093-7711	ALL_TEXT_1/3	1	3	51497	LONGTERM|DICTIONARY	th1	Th1	265#268	NaN	D001172	SYMBOL|EXTRACTED	ra	RA	49#51	18064451-2-129-149	Our aim was to assess the involvement on T1D and RA of IL4 polymorphisms considered individually and in combination with other polymorphisms in 5q31-33, specifically in the OCTN locus, where the L503F polymorphism has been associated with Crohn's disease and other Th1 diseases.
18064451	2008	Immunogenetics	0093-7711	ALL_TEXT_1/3	1	3	51497	LONGTERM|DICTIONARY	th1	Th1	265#268	NaN	D003424	LONGTERM|DISEASE|DT|DICTIONARY	crohn disease	Crohn's disease	239#254		Our aim was to assess the involvement on T1D and RA of IL4 polymorphisms considered individually and in combination with other polymorphisms in 5q31-33, specifically in the OCTN locus, where the L503F polymorphism has been associated with Crohn's disease and other Th1 diseases.
18064451	2008	Immunogenetics	0093-7711	TITLE	0	0	3565	SYMBOL|DICTIONARY	il4	IL4	0#3		D003922	LONGTERM|DICTIONARY	type 1 diabetes	type 1 diabetes	48#63		IL4 in the 5q31 context: association studies of type 1 diabetes and rheumatoid arthritis in the Spanish population.
18064451	2008	Immunogenetics	0093-7711	TITLE	0	0	3565	SYMBOL|DICTIONARY	il4	IL4	0#3		D001172	LONGTERM|DICTIONARY	rheumatoid arthritis	rheumatoid arthritis	68#88		IL4 in the 5q31 context: association studies of type 1 diabetes and rheumatoid arthritis in the Spanish population.
18064451	2008	Immunogenetics	0093-7711	ALL_TEXT_3/3	3	7	3565	SYMBOL|DICTIONARY	il4	IL4	12#15		D003922	SYMBOL|EXTRACTED	t1d	T1D	50#53	18064451-2-103-118	The -590C/T IL4 SNP was not found associated with T1D or RA when individual analyses were performed.
18064451	2008	Immunogenetics	0093-7711	ALL_TEXT_3/3	3	7	3565	SYMBOL|DICTIONARY	il4	IL4	12#15		D001172	SYMBOL|EXTRACTED	ra	RA	57#59	18064451-2-129-149	The -590C/T IL4 SNP was not found associated with T1D or RA when individual analyses were performed.
18082567	2008	Hum. Immunol.	0198-8859	TITLE	0	0	4153	LONGTERM|DICTIONARY	mannose binding lectin	Mannose-binding lectin	0#22		D011225	LONGTERM|DICTIONARY	pre-eclampsia	pre-eclampsia	37#50		Mannose-binding lectin genotypes and pre-eclampsia: a case-control study.
19904240	2010	Am. J. Gastroenterol.	1572-0241	CONCLUSIONS	4	11	3553	SYMBOL|DICTIONARY	il 1b	IL-1B	0#5		D013274	LONGTERM|DISEASE|DT|DICTIONARY	gastric cancer	gastric cancer	50#64		IL-1B polymorphism influences certain subtypes of gastric cancer according to the clinical and pathological features.
17419075	2007	Osteoarthr. Cartil.	1063-4584	PURPOSE	1	1	2099	SYMBOL|()|DICTIONARY|EXTRACTED	esr1	ESR1	101#105	17419075-1-85-94	D015207	LONGTERM|DICTIONARY	radiographic hip osteoarthritis	radiographic hip osteoarthritis	134#165		This study evaluated the association between polymorphisms in the estrogen receptor (ER) alpha gene (ESR1) and prevalent and incident radiographic hip osteoarthritis (RHOA) in a large, well-defined prospective cohort of elderly Caucasian women.
17419075	2007	Osteoarthr. Cartil.	1063-4584	PURPOSE	1	1	2099	LONGTERM|GENE|GT|DICTIONARY	estrogen receptor (er) alpha	estrogen receptor (ER) alpha	66#94		D015207	LONGTERM|DICTIONARY	radiographic hip osteoarthritis	radiographic hip osteoarthritis	134#165		This study evaluated the association between polymorphisms in the estrogen receptor (ER) alpha gene (ESR1) and prevalent and incident radiographic hip osteoarthritis (RHOA) in a large, well-defined prospective cohort of elderly Caucasian women.
17419075	2007	Osteoarthr. Cartil.	1063-4584	PURPOSE	1	1	2099	LONGTERM|GENE|GN|DICTIONARY	estrogen receptor (er) alpha	estrogen receptor (ER) alpha	66#94		D015207	LONGTERM|DICTIONARY	radiographic hip osteoarthritis	radiographic hip osteoarthritis	134#165		This study evaluated the association between polymorphisms in the estrogen receptor (ER) alpha gene (ESR1) and prevalent and incident radiographic hip osteoarthritis (RHOA) in a large, well-defined prospective cohort of elderly Caucasian women.
18082567	2008	Hum. Immunol.	0198-8859	ALL_TEXT_1/3	1	3	4153	SYMBOL|DICTIONARY|EXTRACTED	mbl	MBL	24#27	18082567-2-22-44	D011225	LONGTERM|DICTIONARY	pre-eclampsia	pre-eclampsia	89#102		We investigated whether MBL genotypes are associated with the systemic maternal syndrome pre-eclampsia.
18082567	2008	Hum. Immunol.	0198-8859	ALL_TEXT_2/3	2	4	4153	SYMBOL|GENE|GN|DICTIONARY	mbl2	MBL2	0#4		D011225	LONGTERM|DICTIONARY	pre-eclampsia	pre-eclampsia	89#102		MBL2 gene polymorphisms were determined in a case-control study including 157 women with pre-eclampsia (case subjects) and 157 women with uncomplicated pregnancies (control subjects).
18082567	2008	Hum. Immunol.	0198-8859	ALL_TEXT_3/3	3	7	4153	SYMBOL|DICTIONARY|EXTRACTED	mbl	MBL	26#29	18082567-2-22-44	D004461	LONGTERM|DICTIONARY	eclampsia	eclampsia	69#78		A trend was found between MBL genotype groups B and C and severe pre-eclampsia or eclampsia.
18082567	2008	Hum. Immunol.	0198-8859	ALL_TEXT_3/3	3	7	4153	SYMBOL|DICTIONARY|EXTRACTED	mbl	MBL	26#29	18082567-2-22-44	D004461	LONGTERM|DICTIONARY	eclampsia	eclampsia	82#91		A trend was found between MBL genotype groups B and C and severe pre-eclampsia or eclampsia.
18082567	2008	Hum. Immunol.	0198-8859	ALL_TEXT_3/3	3	8	4153	SYMBOL|DICTIONARY|EXTRACTED	mbl	MBL	0#3		D011225	LONGTERM|DICTIONARY	pre-eclampsia	pre-eclampsia	51#64		MBL genotypes were not found to be associated with pre-eclampsia; however low-MBL production genotypes might be considered as disease modifier.
18082567	2008	Hum. Immunol.	0198-8859	ALL_TEXT_3/3	3	8	4153	SYMBOL|DICTIONARY|EXTRACTED	mbl	MBL	78#81	18082567-2-22-44	D011225	LONGTERM|DICTIONARY	pre-eclampsia	pre-eclampsia	51#64		MBL genotypes were not found to be associated with pre-eclampsia; however low-MBL production genotypes might be considered as disease modifier.
18082567	2008	Hum. Immunol.	0198-8859	ALL_TEXT_3/3	3	9	4153	SYMBOL|DICTIONARY|EXTRACTED	mbl	MBL	19#22	18082567-2-22-44	D007249	LONGTERM|DICTIONARY	inflammation	inflammation	63#75	NaN	This suggests that MBL may play a role in modulating placental inflammation by facilitating clearance of apoptotic cells and cell debris.
20383754	2011	Obes Surg	1708-0428	CONCLUSION	4	8	7421	LONGTERM|GENE|GN|GT|DICTIONARY	vitamin d receptor	vitamin D receptor	144#162		D006962	LONGTERM|DICTIONARY	secondary hyperparathyroidism	secondary hyperparathyroidism	8#37		Chronic secondary hyperparathyroidism after biliopancreatic diversion in patients with normal levels of 25-hydroxyvitamin D is not dependent on vitamin D receptor gene polymorphisms.
20703234	2011	Hypertens. Res.	1348-4214	ALL_TEXT_1/3	1	1	185	SYMBOL|()|GENE|GN|DICTIONARY|EXTRACTED	at1r	AT1R	126#130	20703234-1-94-124	D006973	LONGTERM|DICTIONARY	hypertension	hypertension	140#152		Mounting evidence suggests the potential susceptibility of individuals with a mutation in the angiotensin II type I receptor (AT1R) gene to hypertension.
22122352	2012	Am. J. Reprod. Immunol.	1600-0897	CONCLUSION	4	9	3569	SYMBOL|DICTIONARY|EXTRACTED	il 6	IL-6	191#195	22122352-2-68-81	D007752	LONGTERM|DICTIONARY	preterm labor	preterm labor	84#97		Our preliminary results suggest that vaginal progesterone might prevent spontaneous preterm labor through a mechanism involving anti-inflammatory effects on UCFs, particularly suppression of IL-6 production.
21270338	2011	Sci Transl Med	1946-6242	ALL_TEXT_2/3	2	4	7389	SYMBOL|DICTIONARY|EXTRACTED	urod	UROD	0#4		D006258	SYMBOL|EXTRACTED|CLINE|CN	hnc	HNC	90#93	21270338-1-0-20	UROD knockdown plus radiation induced caspase-mediated apoptosis and cell cycle arrest in HNC cells in vitro and suppressed the in vivo tumor-forming capacity of HNC cells, as well as delayed the growth of established tumor xenografts in mice.
21270338	2011	Sci Transl Med	1946-6242	ALL_TEXT_2/3	2	4	7389	SYMBOL|DICTIONARY|EXTRACTED	urod	UROD	0#4		D009369	LONGTERM|DISEASE|DT|DICTIONARY	tumor	tumor	136#141		UROD knockdown plus radiation induced caspase-mediated apoptosis and cell cycle arrest in HNC cells in vitro and suppressed the in vivo tumor-forming capacity of HNC cells, as well as delayed the growth of established tumor xenografts in mice.
21270338	2011	Sci Transl Med	1946-6242	ALL_TEXT_2/3	2	4	7389	SYMBOL|DICTIONARY|EXTRACTED	urod	UROD	0#4		D006258	SYMBOL|EXTRACTED|CLINE|CN	hnc	HNC	162#165	21270338-1-0-20	UROD knockdown plus radiation induced caspase-mediated apoptosis and cell cycle arrest in HNC cells in vitro and suppressed the in vivo tumor-forming capacity of HNC cells, as well as delayed the growth of established tumor xenografts in mice.
21270338	2011	Sci Transl Med	1946-6242	ALL_TEXT_2/3	2	4	7389	SYMBOL|DICTIONARY|EXTRACTED	urod	UROD	0#4		D009369	LONGTERM|DISEASE|DT|DICTIONARY	tumor	tumor	218#223		UROD knockdown plus radiation induced caspase-mediated apoptosis and cell cycle arrest in HNC cells in vitro and suppressed the in vivo tumor-forming capacity of HNC cells, as well as delayed the growth of established tumor xenografts in mice.
19673907	2011	Cephalalgia	1468-2982	ALL_TEXT_3/3	3	7	1636	SYMBOL|DICTIONARY	ace	ACE	57#60		D020325	SYMBOL|EXTRACTED	ma	MA	104#106	19673907-5-91-109	We did not find a specific pattern of association of the ACE D/I polymorphism with attack frequency for MA or MoA.
19673907	2011	Cephalalgia	1468-2982	ALL_TEXT_3/3	3	7	1636	SYMBOL|DICTIONARY	ace	ACE	57#60		D020326	SYMBOL|EXTRACTED	moa	MoA	110#113	19673907-5-222-243	We did not find a specific pattern of association of the ACE D/I polymorphism with attack frequency for MA or MoA.
15738346	2005	Hypertension	1524-4563	TITLE	0	0	10891	SYMBOL|DICTIONARY	pgc 1alpha	PGC-1alpha	0#10		D006973	LONGTERM|DICTIONARY	hypertension	hypertension	50#62		PGC-1alpha Gly482Ser polymorphism associates with hypertension among Danish whites.
20484924	2010	Int. Arch. Allergy Immunol.	1423-0097	CONCLUSION	4	12	3596	SYMBOL|DICTIONARY	il13	IL13	71#75		D001249	LONGTERM|DICTIONARY	asthma	asthma	102#108		In addition, the study replicates a previously reported interaction of IL13 and IL4R polymorphisms in asthma.
20484924	2010	Int. Arch. Allergy Immunol.	1423-0097	CONCLUSION	4	12	3566	SYMBOL|DICTIONARY	il4r	IL4R	80#84		D001249	LONGTERM|DICTIONARY	asthma	asthma	102#108		In addition, the study replicates a previously reported interaction of IL13 and IL4R polymorphisms in asthma.
12918850	2003	J. Heart Valve Dis.	0966-8519	RESULTS	3	8	2200	SYMBOL|DICTIONARY|EXTRACTED	fbn1	FBN1	49#53	12918850-6-49-60	D008945	SYMBOL|DICTIONARY|EXTRACTED	mvp	MVP	29#32	12918850-3-50-71	Odds ratios (OR) for risk of MVP associated with FBN1 exon 15 TT and exon 27 GG genotypes were 2.40 (95% CI 1.32-4.39) and 3.61 (95% CI 1.01-12.89), respectively.
21270338	2011	Sci Transl Med	1946-6242	ALL_TEXT_2/3	2	6	7389	SYMBOL|DICTIONARY|EXTRACTED	urod	UROD	10#14	21270338-3-0-30	D006258	SYMBOL|EXTRACTED|DISEASE|DN	hnc	HNC	50#53	21270338-1-0-20	Moreover, UROD was significantly overexpressed in HNC patient biopsies.
20615671	2011	Eur. Psychiatry	1778-3585	ALL_TEXT_2/3	2	4	84062	SYMBOL|DICTIONARY|EXTRACTED	dtnbp1	DTNBP1	36#42	20615671-1-0-30	D012559	LONGTERM|DICTIONARY	schizophrenia	schizophrenia	88#101		Despite numerous genetic studies no DTNBP1 polymorphism has been strongly implicated in schizophrenia aetiology.
19262575	2009	Genes Immun.	1476-5470	ALL_TEXT_3/3	3	5	3562	LONGTERM|DICTIONARY	interleukin 3	interleukin 3	71#84		D006111	SYMBOL|EXTRACTED	gd	GD	111#113	19262575-1-0-15	Initial analysis suggested that a non-synonymous SNP rs40401 (P27S) of interleukin 3 (IL3) was associated with GD, and further fine-mapping showed that rs40401, or its perfect proxy SNP rs31480 in the 5' flanking region of IL3, fully accounted for the association signal at this locus.
19262575	2009	Genes Immun.	1476-5470	ALL_TEXT_3/3	3	5	3562	SYMBOL|()|DICTIONARY|EXTRACTED	il3	IL3	86#89	19262575-5-71-84	D006111	SYMBOL|EXTRACTED	gd	GD	111#113	19262575-1-0-15	Initial analysis suggested that a non-synonymous SNP rs40401 (P27S) of interleukin 3 (IL3) was associated with GD, and further fine-mapping showed that rs40401, or its perfect proxy SNP rs31480 in the 5' flanking region of IL3, fully accounted for the association signal at this locus.
19262575	2009	Genes Immun.	1476-5470	ALL_TEXT_3/3	3	5	3562	SYMBOL|DICTIONARY|EXTRACTED	il3	IL3	223#226	19262575-5-71-84	D006111	SYMBOL|EXTRACTED	gd	GD	111#113	19262575-1-0-15	Initial analysis suggested that a non-synonymous SNP rs40401 (P27S) of interleukin 3 (IL3) was associated with GD, and further fine-mapping showed that rs40401, or its perfect proxy SNP rs31480 in the 5' flanking region of IL3, fully accounted for the association signal at this locus.
10200057	1999	Hum. Mutat.	1059-7794	ALL_TEXT_3/3	3	6	5053	SYMBOL|GENE|GN|DICTIONARY	pah	PAH	51#54		D010661	LONGTERM|DICTIONARY	hpa	HPA	168#171	NaN	We report here two new mutations in exon 11 of the PAH gene (GenBank U49897), V1163delTG and P362T (using cDNA sequence), detected during the analysis of 57 PKU and 36 HPA patients belonging to 84 unrelated families detected under a neonatal screening program performed in Catalonia.
15809232	2005	Alcohol Alcohol.	0735-0414	RESULTS	3	6	1636	SYMBOL|DICTIONARY	ace	ACE	33#36		D002340	LONGTERM|DICTIONARY	carotid atherosclerosis	carotid atherosclerosis	58#81		No association was shown between ACE I/D polymorphism and carotid atherosclerosis.
20484924	2010	Int. Arch. Allergy Immunol.	1423-0097	RESULTS	3	10	3596	SYMBOL|DICTIONARY	il13	IL13	28#32		D001249	LONGTERM|DICTIONARY	asthma	asthma	129#135		Combining risk genotypes of IL13 Arg130Gln with IL4R Glu375Ala, and IL13 C-1111T with IL4R Ser478Pro yielded increased risks for asthma compared to their separate effects.
20484924	2010	Int. Arch. Allergy Immunol.	1423-0097	RESULTS	3	10	3566	SYMBOL|DICTIONARY	il4r	IL4R	48#52		D001249	LONGTERM|DICTIONARY	asthma	asthma	129#135		Combining risk genotypes of IL13 Arg130Gln with IL4R Glu375Ala, and IL13 C-1111T with IL4R Ser478Pro yielded increased risks for asthma compared to their separate effects.
20484924	2010	Int. Arch. Allergy Immunol.	1423-0097	RESULTS	3	10	3596	SYMBOL|DICTIONARY	il13	IL13	68#72		D001249	LONGTERM|DICTIONARY	asthma	asthma	129#135		Combining risk genotypes of IL13 Arg130Gln with IL4R Glu375Ala, and IL13 C-1111T with IL4R Ser478Pro yielded increased risks for asthma compared to their separate effects.
20484924	2010	Int. Arch. Allergy Immunol.	1423-0097	RESULTS	3	10	3566	SYMBOL|DICTIONARY	il4r	IL4R	86#90		D001249	LONGTERM|DICTIONARY	asthma	asthma	129#135		Combining risk genotypes of IL13 Arg130Gln with IL4R Glu375Ala, and IL13 C-1111T with IL4R Ser478Pro yielded increased risks for asthma compared to their separate effects.
21270338	2011	Sci Transl Med	1946-6242	TITLE	0	0	7389	LONGTERM|DICTIONARY	uroporphyrinogen decarboxylase	Uroporphyrinogen decarboxylase	0#30		D006258	LONGTERM|DISEASE|DT|DICTIONARY	head and neck cancer	head and neck cancer	64#84		Uroporphyrinogen decarboxylase is a radiosensitizing target for head and neck cancer.
12200750	2002	Metab. Clin. Exp.	0026-0495	ALL_TEXT_2/3	2	6	348	LONGTERM|DICTIONARY	apo e	apo E	41#46	NaN	C566031	LONGTERM|DICTIONARY	tg	TG	75#77	NaN	Multivariate analysis indicated an age x apo E interaction on postprandial TG (P <.01), since the unfavorable effect of E2 and E4 allele on TG AUIC was unmasked by aging.
12200750	2002	Metab. Clin. Exp.	0026-0495	ALL_TEXT_2/3	2	6	348	LONGTERM|DICTIONARY	apo e	apo E	41#46	NaN	C566031	LONGTERM|DICTIONARY	tg	TG	140#142	NaN	Multivariate analysis indicated an age x apo E interaction on postprandial TG (P <.01), since the unfavorable effect of E2 and E4 allele on TG AUIC was unmasked by aging.
17473385	2007	Dis. Markers	0278-0240	ALL_TEXT_1/3	1	1	4023	LONGTERM|GENE|GN|DICTIONARY	lipoprotein lipase	lipoprotein lipase	33#51		D003324	LONGTERM|DISEASE|DT|DICTIONARY	coronary artery disease	coronary artery disease	128#151		Our aim was to determine whether lipoprotein lipase gene PvuII polymorphism can be considered as an independent risk factor for coronary artery disease (CAD) by conducting a meta-analysis of all available published trials, including our own study.
17473385	2007	Dis. Markers	0278-0240	ALL_TEXT_1/3	1	1	4023	LONGTERM|GENE|GN|DICTIONARY	lipoprotein lipase	lipoprotein lipase	33#51		D003324	SYMBOL|()|DICTIONARY|EXTRACTED	cad	CAD	153#156	17473385-1-128-151	Our aim was to determine whether lipoprotein lipase gene PvuII polymorphism can be considered as an independent risk factor for coronary artery disease (CAD) by conducting a meta-analysis of all available published trials, including our own study.
15071492	2005	Genes Immun.	1466-4879	ALL_TEXT_1/3	1	1	7124	SYMBOL|EXTRACTED|()	tnf alpha	TNF-alpha	42#51	15071492-1-13-40	D006526	LONGTERM|DISEASE|DN|DICTIONARY|DA	a hepatitis c virus (hcv) infection	a hepatitis C virus (HCV) infection	107#142		The cytokine tumor necrosis factor alpha (TNF-alpha) is important in generating an immune response against a hepatitis C virus (HCV) infection.
15071492	2005	Genes Immun.	1466-4879	ALL_TEXT_1/3	1	1	7124	SYMBOL|EXTRACTED|()	tnf alpha	TNF-alpha	42#51	15071492-1-13-40	D006526	SYMBOL|EXTRACTED|()|DISEASE|DN	a hepatitis c virus (hcv) infection	a hepatitis C virus (HCV) infection	107#142	15071492-1-109-120	The cytokine tumor necrosis factor alpha (TNF-alpha) is important in generating an immune response against a hepatitis C virus (HCV) infection.
12200750	2002	Metab. Clin. Exp.	0026-0495	ALL_TEXT_1/3	1	2	348	SYMBOL|DICTIONARY	apo e	Apo E	0#5		D003924	LONGTERM|DICTIONARY|EXTRACTED	niddm	NIDDM	46#51	12200750-1-41-80	Apo E genotyping was performed in consecutive NIDDM hospitalized patients in order to recruite size-adjusted groups of each apo E genotype.
12200750	2002	Metab. Clin. Exp.	0026-0495	TITLE	0	0	348	LONGTERM|DICTIONARY	apolipoprotein e	apolipoprotein E	107#123		D003924	LONGTERM|DICTIONARY	non insulin dependent diabetes mellitus	non-insulin-dependent diabetes mellitus	154#193		The effect of age, body mass index, and fasting triglyceride level on postprandial lipemia is dependent on apolipoprotein E polymorphism in subjects with non-insulin-dependent diabetes mellitus.
12200750	2002	Metab. Clin. Exp.	0026-0495	TITLE	0	0	348	LONGTERM|DICTIONARY	apolipoprotein e	apolipoprotein E	107#123		C566031	LONGTERM|DICTIONARY	triglyceride	triglyceride	48#60	NaN	The effect of age, body mass index, and fasting triglyceride level on postprandial lipemia is dependent on apolipoprotein E polymorphism in subjects with non-insulin-dependent diabetes mellitus.
12200750	2002	Metab. Clin. Exp.	0026-0495	TITLE	0	0	348	LONGTERM|DICTIONARY	apolipoprotein e	apolipoprotein E	107#123		D006949	LONGTERM|DICTIONARY	postprandial lipemia	postprandial lipemia	70#90	NaN	The effect of age, body mass index, and fasting triglyceride level on postprandial lipemia is dependent on apolipoprotein E polymorphism in subjects with non-insulin-dependent diabetes mellitus.
15824150	2005	Cancer Epidemiol. Biomarkers Prev.	1055-9965	ALL_TEXT_1/3	1	1	472	LONGTERM|DICTIONARY	ataxia telangiectasia mutated	ataxia telangiectasia mutated	49#78		D001943	LONGTERM|DISEASE|DT|DICTIONARY	breast cancer	breast cancer	104#117		To evaluate the role of genetic polymorphisms of ataxia telangiectasia mutated (ATM) in the etiology of breast cancer, a hospital-based case-control study was conducted in Korea.
15824150	2005	Cancer Epidemiol. Biomarkers Prev.	1055-9965	ALL_TEXT_1/3	1	1	472	SYMBOL|()|DICTIONARY|EXTRACTED	atm	ATM	80#83	15824150-1-49-78	D001943	LONGTERM|DISEASE|DT|DICTIONARY	breast cancer	breast cancer	104#117		To evaluate the role of genetic polymorphisms of ataxia telangiectasia mutated (ATM) in the etiology of breast cancer, a hospital-based case-control study was conducted in Korea.
18074111	2008	Mol. Cell. Biochem.	0300-8177	OBJECTIVE	1	1	4524	SYMBOL|()|GENE|GN|DICTIONARY	mthfr	MTHFR	68#73		D003324	LONGTERM|DISEASE|DT|DICTIONARY	coronary artery disease	coronary artery disease	284#307		To determine the incidence of methylene tetrahydrofolate reductase (MTHFR) gene 677C-->T polymorphism and plasma homocysteine (Hcy) levels in a group of subjects who underwent coronary angiography, in an attempt to establish a correlation between these parameters and the severity of coronary artery disease (CAD) and to investigate the correlation between hyperhomocysteinemia (HHcy) and the presence of 677C-->T polymorphism.
18074111	2008	Mol. Cell. Biochem.	0300-8177	OBJECTIVE	1	1	4524	SYMBOL|()|GENE|GN|DICTIONARY	mthfr	MTHFR	68#73		D003324	SYMBOL|()|DICTIONARY|EXTRACTED	cad	CAD	309#312	18074111-1-284-307	To determine the incidence of methylene tetrahydrofolate reductase (MTHFR) gene 677C-->T polymorphism and plasma homocysteine (Hcy) levels in a group of subjects who underwent coronary angiography, in an attempt to establish a correlation between these parameters and the severity of coronary artery disease (CAD) and to investigate the correlation between hyperhomocysteinemia (HHcy) and the presence of 677C-->T polymorphism.
18074111	2008	Mol. Cell. Biochem.	0300-8177	OBJECTIVE	1	1	4524	SYMBOL|()|GENE|GN|DICTIONARY	mthfr	MTHFR	68#73		D020138	LONGTERM|DICTIONARY	hyperhomocysteinemia	hyperhomocysteinemia	357#377		To determine the incidence of methylene tetrahydrofolate reductase (MTHFR) gene 677C-->T polymorphism and plasma homocysteine (Hcy) levels in a group of subjects who underwent coronary angiography, in an attempt to establish a correlation between these parameters and the severity of coronary artery disease (CAD) and to investigate the correlation between hyperhomocysteinemia (HHcy) and the presence of 677C-->T polymorphism.
18074111	2008	Mol. Cell. Biochem.	0300-8177	OBJECTIVE	1	1	4524	SYMBOL|()|GENE|GN|DICTIONARY	mthfr	MTHFR	68#73		D020138	SYMBOL|EXTRACTED|()	hhcy	HHcy	379#383	18074111-1-357-377	To determine the incidence of methylene tetrahydrofolate reductase (MTHFR) gene 677C-->T polymorphism and plasma homocysteine (Hcy) levels in a group of subjects who underwent coronary angiography, in an attempt to establish a correlation between these parameters and the severity of coronary artery disease (CAD) and to investigate the correlation between hyperhomocysteinemia (HHcy) and the presence of 677C-->T polymorphism.
15824150	2005	Cancer Epidemiol. Biomarkers Prev.	1055-9965	ALL_TEXT_3/3	3	7	472	SYMBOL|DICTIONARY|EXTRACTED	atm	ATM	4#7	15824150-1-49-78	D001943	LONGTERM|DISEASE|DT|DICTIONARY	increased breast cancer	increased breast cancer	101#124		The ATM IVS21 + 1049 TC or CC, IVS34 + 60 GA or AA, and 3393 TG or GG genotypes were associated with increased breast cancer risk, particularly in premenopausal women [odds ratios (OR), 1.51; 95% confidence interval (CI), 1.11-2.05; OR, 1.42; 95% CI, 1.08-1.88; and OR, 1.37; 95% CI, 1.04-1.80, respectively].
15624175	2005	Electrophoresis	0173-0835	ALL_TEXT_1/3	1	2	183	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	agt	AGT	26#29	15624175-1-0-15	D006973	LONGTERM|DICTIONARY	hypertension	hypertension	73#85		In our study, the role of AGT gene as a putatively predisposing gene for hypertension was evaluated by genotyping a A (-6) G polymorphism in the core promoter region in 123 patients with essential hypertension and 103 healthy controls.
15624175	2005	Electrophoresis	0173-0835	ALL_TEXT_1/3	1	2	183	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	agt	AGT	26#29	15624175-1-0-15	D006973	LONGTERM|DICTIONARY	hypertension	hypertension	197#209		In our study, the role of AGT gene as a putatively predisposing gene for hypertension was evaluated by genotyping a A (-6) G polymorphism in the core promoter region in 123 patients with essential hypertension and 103 healthy controls.
15624175	2005	Electrophoresis	0173-0835	ALL_TEXT_1/3	1	1	183	LONGTERM|DICTIONARY|GENE|GA	angiotensinogen	Angiotensinogen	0#15		D006973	LONGTERM|DICTIONARY	hypertension	hypertension	89#101		Angiotensinogen (AGT) gene has been regarded as one of the candidate genes for essential hypertension.
15624175	2005	Electrophoresis	0173-0835	ALL_TEXT_1/3	1	1	183	SYMBOL|()|GENE|GN|DICTIONARY|EXTRACTED	agt	AGT	17#20	15624175-1-0-15	D006973	LONGTERM|DICTIONARY	hypertension	hypertension	89#101		Angiotensinogen (AGT) gene has been regarded as one of the candidate genes for essential hypertension.
8822954	1996	Blood	0006-4971	ALL_TEXT_1/3	1	2	2821	SYMBOL|DICTIONARY|EXTRACTED	gpi	GPI	17#20	8822954-1-32-59	D012141	LONGTERM|DISEASE|DT|DICTIONARY	upper respiratory tract infection	upper respiratory tract infection	156#189		A Japanese girl (GPI Fukuoka) had an episode of prolonged neonatal jaundice and at 3 years of age was admitted due to acute hemolytic crisis occurring with upper respiratory tract infection.
8822954	1996	Blood	0006-4971	ALL_TEXT_1/3	1	2	2821	SYMBOL|DICTIONARY|EXTRACTED	gpi	GPI	17#20	8822954-1-32-59	D007567	LONGTERM|DICTIONARY	prolonged neonatal jaundice	prolonged neonatal jaundice	48#75		A Japanese girl (GPI Fukuoka) had an episode of prolonged neonatal jaundice and at 3 years of age was admitted due to acute hemolytic crisis occurring with upper respiratory tract infection.
8822954	1996	Blood	0006-4971	ALL_TEXT_1/3	1	2	2821	SYMBOL|DICTIONARY|EXTRACTED	gpi	GPI	17#20	8822954-1-32-59	D006461	LONGTERM|DICTIONARY	hemolytic crisis	hemolytic crisis	124#140	NaN	A Japanese girl (GPI Fukuoka) had an episode of prolonged neonatal jaundice and at 3 years of age was admitted due to acute hemolytic crisis occurring with upper respiratory tract infection.
19874431	2010	J Eur Acad Dermatol Venereol	1468-3083	BACKGROUND	1	1	2312	LONGTERM|GENE|GN|DICTIONARY	filaggrin	filaggrin	27#36		D003876	LONGTERM|DICTIONARY	atopic dermatitis	atopic dermatitis	102#119		Recently, mutations in the filaggrin gene (FLG) have been shown to be a major predisposing factor for atopic dermatitis (AD).
19874431	2010	J Eur Acad Dermatol Venereol	1468-3083	BACKGROUND	1	1	2312	LONGTERM|GENE|GN|DICTIONARY	filaggrin	filaggrin	27#36		D003876	SYMBOL|EXTRACTED|()	ad	AD	121#123	19874431-1-102-119	Recently, mutations in the filaggrin gene (FLG) have been shown to be a major predisposing factor for atopic dermatitis (AD).
15024131	2004	Proc. Natl. Acad. Sci. U.S.A.	0027-8424	TITLE	0	0	3106	SYMBOL|NUMBER|DICTIONARY	hla b	HLA-B	57#62		D004342	LONGTERM|DICTIONARY	hypersensitivity	hypersensitivity	27#43	NaN	Predisposition to abacavir hypersensitivity conferred by HLA-B*5701 and a haplotypic Hsp70-Hom variant.
15024131	2004	Proc. Natl. Acad. Sci. U.S.A.	0027-8424	TITLE	0	0	3308	SYMBOL|DICTIONARY	hsp70	Hsp70	85#90		D004342	LONGTERM|DICTIONARY	hypersensitivity	hypersensitivity	27#43	NaN	Predisposition to abacavir hypersensitivity conferred by HLA-B*5701 and a haplotypic Hsp70-Hom variant.
15024131	2004	Proc. Natl. Acad. Sci. U.S.A.	0027-8424	ALL_TEXT_1/3	1	2	3106	SYMBOL|NUMBER|DICTIONARY	hla b	HLA-B	46#51		D004342	LONGTERM|DICTIONARY	hypersensitivity	hypersensitivity	84#100	NaN	We have previously shown that the presence of HLA-B*5701 strongly predicts abacavir hypersensitivity and have identified a potential susceptibility locus within a 300-kb region between the MEGT1 and C4A6 loci in the central MHC.
15024131	2004	Proc. Natl. Acad. Sci. U.S.A.	0027-8424	ALL_TEXT_1/3	1	2	58530	SYMBOL|DICTIONARY	megt1	MEGT1	189#194		D004342	LONGTERM|DICTIONARY	hypersensitivity	hypersensitivity	84#100	NaN	We have previously shown that the presence of HLA-B*5701 strongly predicts abacavir hypersensitivity and have identified a potential susceptibility locus within a 300-kb region between the MEGT1 and C4A6 loci in the central MHC.
15024131	2004	Proc. Natl. Acad. Sci. U.S.A.	0027-8424	ALL_TEXT_1/3	1	2	720	SYMBOL|DICTIONARY	c4a6	C4A6	199#203		D004342	LONGTERM|DICTIONARY	hypersensitivity	hypersensitivity	84#100	NaN	We have previously shown that the presence of HLA-B*5701 strongly predicts abacavir hypersensitivity and have identified a potential susceptibility locus within a 300-kb region between the MEGT1 and C4A6 loci in the central MHC.
20483145	2010	J. Neurol. Sci.	1878-5883	CONCLUSION	4	10	4210	SYMBOL|DICTIONARY	mefv	MEFV	73#77		D009103	SYMBOL|DISEASE|DN|DICTIONARY|EXTRACTED	ms	MS	56#58	20483145-1-0-18	The results of this study supported the hypothesis that MS patients with MEFV mutation seem to have the susceptibility to develop a more progressive disease.
20483145	2010	J. Neurol. Sci.	1878-5883	CONCLUSION	4	11	4210	SYMBOL|DICTIONARY	mefv	MEFV	34#38		D009103	SYMBOL|EXTRACTED	ms	MS	74#76	20483145-1-0-18	Moreover, these data suggest that MEFV mutations may increase the risk of MS development.
20622171	2010	Diabetes	1939-327X	RESULTS	3	9	266812	SYMBOL|DICTIONARY	nap1l5	NAP1L5	93#99		D009765	LONGTERM|DICTIONARY	obesity	obesity	47#54		Several CNVs disrupt known candidate genes for obesity, such as a 3.3-Mb deletion disrupting NAP1L5 and a 2.1-Mb deletion disrupting UCP1 and IL15.
20622171	2010	Diabetes	1939-327X	RESULTS	3	9	7350	SYMBOL|DICTIONARY	ucp1	UCP1	133#137		D009765	LONGTERM|DICTIONARY	obesity	obesity	47#54		Several CNVs disrupt known candidate genes for obesity, such as a 3.3-Mb deletion disrupting NAP1L5 and a 2.1-Mb deletion disrupting UCP1 and IL15.
20622171	2010	Diabetes	1939-327X	RESULTS	3	9	3600	SYMBOL|DICTIONARY	il15	IL15	142#146		D009765	LONGTERM|DICTIONARY	obesity	obesity	47#54		Several CNVs disrupt known candidate genes for obesity, such as a 3.3-Mb deletion disrupting NAP1L5 and a 2.1-Mb deletion disrupting UCP1 and IL15.
21270338	2011	Sci Transl Med	1946-6242	ALL_TEXT_3/3	3	9	7389	SYMBOL|DICTIONARY|EXTRACTED	urod	UROD	29#33	21270338-3-0-30	D009369	LONGTERM|DISEASE|DT|DICTIONARY	tumor	tumor	46#51		Thus, our study has revealed UROD as a potent tumor-selective sensitizer for both radiation and chemotherapy, with potential relevance to many human malignancies.
21270338	2011	Sci Transl Med	1946-6242	ALL_TEXT_3/3	3	9	7389	SYMBOL|DICTIONARY|EXTRACTED	urod	UROD	29#33	21270338-3-0-30	D009369	LONGTERM|DICTIONARY	malignancies	malignancies	149#161		Thus, our study has revealed UROD as a potent tumor-selective sensitizer for both radiation and chemotherapy, with potential relevance to many human malignancies.
9886312	1999	Br. J. Haematol.	0007-1048	TITLE	0	0	2815	SYMBOL|DICTIONARY	gpix	GPIX	126#130		D001606	LONGTERM|DISEASE|DT|DICTIONARY	bernard soulier syndrome	Bernard-Soulier syndrome	17#41		A new variant of Bernard-Soulier syndrome characterized by dysfunctional glycoprotein (GP) Ib and severely reduced amounts of GPIX and GPV.
19904240	2010	Am. J. Gastroenterol.	1572-0241	OBJECTIVES	1	2	3553	SYMBOL|NUMBER|DICTIONARY	il 1b	IL-1B	48#53		D013274	LONGTERM|DISEASE|DT|DICTIONARY	gastric cancer	gastric cancer	75#89		We investigated whether the association between IL-1B-511 polymorphism and gastric cancer risk varies by clinically important tumor characteristics and the prognostic value of this polymorphism in a large population-based case-control study among Chinese.
19904240	2010	Am. J. Gastroenterol.	1572-0241	OBJECTIVES	1	2	3553	SYMBOL|NUMBER|DICTIONARY	il 1b	IL-1B	48#53		D009369	LONGTERM|DISEASE|DT|DICTIONARY	tumor	tumor	126#131		We investigated whether the association between IL-1B-511 polymorphism and gastric cancer risk varies by clinically important tumor characteristics and the prognostic value of this polymorphism in a large population-based case-control study among Chinese.
19904240	2010	Am. J. Gastroenterol.	1572-0241	TITLE	0	0	3553	SYMBOL|NUMBER|DICTIONARY	il 1b	IL-1B	0#5		D013274	LONGTERM|DISEASE|DT|DICTIONARY	gastric cancer	gastric cancer	80#94		IL-1B-511 polymorphism is associated with increased risk of certain subtypes of gastric cancer in Chinese: a case-control study.
19904240	2010	Am. J. Gastroenterol.	1572-0241	OBJECTIVES	1	1	3553	SYMBOL|()|DICTIONARY	il 1b	IL-1B	35#40		D013274	LONGTERM|DISEASE|DT|DICTIONARY	gastric cancer	gastric cancer	64#78		The association of interleukin-1B (IL-1B)-511 polymorphism with gastric cancer is still controversial, and the association of IL-1B-511 polymorphism with subtypes of gastric cancer is still largely unknown.
19904240	2010	Am. J. Gastroenterol.	1572-0241	OBJECTIVES	1	1	3553	SYMBOL|()|DICTIONARY	il 1b	IL-1B	35#40		D013274	LONGTERM|DISEASE|DT|DICTIONARY	gastric cancer	gastric cancer	166#180		The association of interleukin-1B (IL-1B)-511 polymorphism with gastric cancer is still controversial, and the association of IL-1B-511 polymorphism with subtypes of gastric cancer is still largely unknown.
19904240	2010	Am. J. Gastroenterol.	1572-0241	OBJECTIVES	1	1	3553	SYMBOL|NUMBER|DICTIONARY	il 1b	IL-1B	126#131		D013274	LONGTERM|DISEASE|DT|DICTIONARY	gastric cancer	gastric cancer	64#78		The association of interleukin-1B (IL-1B)-511 polymorphism with gastric cancer is still controversial, and the association of IL-1B-511 polymorphism with subtypes of gastric cancer is still largely unknown.
19904240	2010	Am. J. Gastroenterol.	1572-0241	OBJECTIVES	1	1	3553	SYMBOL|NUMBER|DICTIONARY	il 1b	IL-1B	126#131		D013274	LONGTERM|DISEASE|DT|DICTIONARY	gastric cancer	gastric cancer	166#180		The association of interleukin-1B (IL-1B)-511 polymorphism with gastric cancer is still controversial, and the association of IL-1B-511 polymorphism with subtypes of gastric cancer is still largely unknown.
17151092	2007	Carcinogenesis	0143-3334	ALL_TEXT_3/3	3	9	11221	SYMBOL|DICTIONARY|EXTRACTED	mkp5	MKP5	106#110	17151092-3-41-87	D011471	SYMBOL|EXTRACTED|CLINE|CN	pca	PCa	24#27	17151092-1-45-60	Moreover, we found that PCa cell lines DU 145, PC-3, LNCaP and LAPC-4 retained the ability to up-regulate MKP5 following curcumin, resveratrol and [6]-gingerol exposure, suggesting utility of these phytochemicals in PCa treatment.
17151092	2007	Carcinogenesis	0143-3334	ALL_TEXT_3/3	3	9	3853	LONGTERM|DICTIONARY	pc-3	PC-3	47#51	NaN	D011471	SYMBOL|EXTRACTED|CLINE|CN	pca	PCa	24#27	17151092-1-45-60	Moreover, we found that PCa cell lines DU 145, PC-3, LNCaP and LAPC-4 retained the ability to up-regulate MKP5 following curcumin, resveratrol and [6]-gingerol exposure, suggesting utility of these phytochemicals in PCa treatment.
16860143	2006	J. Pediatr.	0022-3476	ALL_TEXT_2/3	2	4	5551	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	prf1	PRF1	166#170	16860143-1-17-25	D051359	SYMBOL|DICTIONARY|EXTRACTED	hlh	HLH	99#102	16860143-1-83-117	To test the hypothesis that this mutation represents a single haplotype, DNA from 23 patients with HLH and 30 African-American control subjects was sequenced for the PRF1 gene, including portions of the intron containing known single nucleotide polymorphisms (SNPs).
19190165	2009	Cancer Epidemiol. Biomarkers Prev.	1055-9965	ALL_TEXT_2/3	2	4	10111	SYMBOL|DICTIONARY	rad50	Rad50	41#46		D001943	LONGTERM|DISEASE|DT|DICTIONARY	breast cancer	breast cancer	94#107		In particular, the c.687delT mutation in Rad50 conferred an odds ratio of 4.3 for the risk of breast cancer in a study of Finnish breast cancer families.
19190165	2009	Cancer Epidemiol. Biomarkers Prev.	1055-9965	ALL_TEXT_2/3	2	4	10111	SYMBOL|DICTIONARY	rad50	Rad50	41#46		D001943	LONGTERM|DISEASE|DT|GFAM|FN|DICTIONARY	breast cancer	breast cancer	130#143		In particular, the c.687delT mutation in Rad50 conferred an odds ratio of 4.3 for the risk of breast cancer in a study of Finnish breast cancer families.
19190165	2009	Cancer Epidemiol. Biomarkers Prev.	1055-9965	ALL_TEXT_2/3	2	3	10111	SYMBOL|DICTIONARY	rad50	Rad50	182#187		D001943	LONGTERM|DISEASE|DT|DICTIONARY	breast cancer	breast cancer	100#113		Additional genes involved in DNA double-strand break repair have more recently been associated with breast cancer risk: heterozygosity for deleterious mutations in components of the Rad50-Mre11-Nbs1 complex seems to predispose to breast cancer.
19190165	2009	Cancer Epidemiol. Biomarkers Prev.	1055-9965	ALL_TEXT_2/3	2	3	10111	SYMBOL|DICTIONARY	rad50	Rad50	182#187		D001943	LONGTERM|DISEASE|DT|DICTIONARY	breast cancer	breast cancer	230#243		Additional genes involved in DNA double-strand break repair have more recently been associated with breast cancer risk: heterozygosity for deleterious mutations in components of the Rad50-Mre11-Nbs1 complex seems to predispose to breast cancer.
19190165	2009	Cancer Epidemiol. Biomarkers Prev.	1055-9965	ALL_TEXT_2/3	2	3	4361	SYMBOL|DICTIONARY	mre11	Mre11	188#193		D001943	LONGTERM|DISEASE|DT|DICTIONARY	breast cancer	breast cancer	100#113		Additional genes involved in DNA double-strand break repair have more recently been associated with breast cancer risk: heterozygosity for deleterious mutations in components of the Rad50-Mre11-Nbs1 complex seems to predispose to breast cancer.
19190165	2009	Cancer Epidemiol. Biomarkers Prev.	1055-9965	ALL_TEXT_2/3	2	3	4361	SYMBOL|DICTIONARY	mre11	Mre11	188#193		D001943	LONGTERM|DISEASE|DT|DICTIONARY	breast cancer	breast cancer	230#243		Additional genes involved in DNA double-strand break repair have more recently been associated with breast cancer risk: heterozygosity for deleterious mutations in components of the Rad50-Mre11-Nbs1 complex seems to predispose to breast cancer.
19190165	2009	Cancer Epidemiol. Biomarkers Prev.	1055-9965	ALL_TEXT_2/3	2	3	4683	SYMBOL|DICTIONARY	nbs1	Nbs1	194#198		D001943	LONGTERM|DISEASE|DT|DICTIONARY	breast cancer	breast cancer	100#113		Additional genes involved in DNA double-strand break repair have more recently been associated with breast cancer risk: heterozygosity for deleterious mutations in components of the Rad50-Mre11-Nbs1 complex seems to predispose to breast cancer.
19190165	2009	Cancer Epidemiol. Biomarkers Prev.	1055-9965	ALL_TEXT_2/3	2	3	4683	SYMBOL|DICTIONARY	nbs1	Nbs1	194#198		D001943	LONGTERM|DISEASE|DT|DICTIONARY	breast cancer	breast cancer	230#243		Additional genes involved in DNA double-strand break repair have more recently been associated with breast cancer risk: heterozygosity for deleterious mutations in components of the Rad50-Mre11-Nbs1 complex seems to predispose to breast cancer.
19190165	2009	Cancer Epidemiol. Biomarkers Prev.	1055-9965	ALL_TEXT_1/3	1	2	672	SYMBOL|DICTIONARY	brca1	BRCA1	0#5		D009369	LONGTERM|DISEASE|DT|DICTIONARY	cancer	cancer	145#151		BRCA1 and BRCA2 are the major genes for high-penetrance familial breast and ovarian cancer, whereas mutations in ATM or Chek2 confer more modest cancer risk.
19190165	2009	Cancer Epidemiol. Biomarkers Prev.	1055-9965	ALL_TEXT_1/3	1	2	672	SYMBOL|DICTIONARY	brca1	BRCA1	0#5		D061325	LONGTERM|DISEASE|DT|DICTIONARY	familial breast and ovarian cancer	familial breast and ovarian cancer	56#90		BRCA1 and BRCA2 are the major genes for high-penetrance familial breast and ovarian cancer, whereas mutations in ATM or Chek2 confer more modest cancer risk.
19190165	2009	Cancer Epidemiol. Biomarkers Prev.	1055-9965	ALL_TEXT_1/3	1	2	675	SYMBOL|DICTIONARY	brca2	BRCA2	10#15		D009369	LONGTERM|DISEASE|DT|DICTIONARY	cancer	cancer	145#151		BRCA1 and BRCA2 are the major genes for high-penetrance familial breast and ovarian cancer, whereas mutations in ATM or Chek2 confer more modest cancer risk.
19190165	2009	Cancer Epidemiol. Biomarkers Prev.	1055-9965	ALL_TEXT_1/3	1	2	675	SYMBOL|DICTIONARY	brca2	BRCA2	10#15		D061325	LONGTERM|DISEASE|DT|DICTIONARY	familial breast and ovarian cancer	familial breast and ovarian cancer	56#90		BRCA1 and BRCA2 are the major genes for high-penetrance familial breast and ovarian cancer, whereas mutations in ATM or Chek2 confer more modest cancer risk.
19190165	2009	Cancer Epidemiol. Biomarkers Prev.	1055-9965	ALL_TEXT_1/3	1	2	472	SYMBOL|DICTIONARY	atm	ATM	113#116		D009369	LONGTERM|DISEASE|DT|DICTIONARY	cancer	cancer	145#151		BRCA1 and BRCA2 are the major genes for high-penetrance familial breast and ovarian cancer, whereas mutations in ATM or Chek2 confer more modest cancer risk.
19190165	2009	Cancer Epidemiol. Biomarkers Prev.	1055-9965	ALL_TEXT_1/3	1	2	472	SYMBOL|DICTIONARY	atm	ATM	113#116		D061325	LONGTERM|DISEASE|DT|DICTIONARY	familial breast and ovarian cancer	familial breast and ovarian cancer	56#90		BRCA1 and BRCA2 are the major genes for high-penetrance familial breast and ovarian cancer, whereas mutations in ATM or Chek2 confer more modest cancer risk.
19190165	2009	Cancer Epidemiol. Biomarkers Prev.	1055-9965	ALL_TEXT_1/3	1	2	11200	SYMBOL|DICTIONARY	chek2	Chek2	120#125		D009369	LONGTERM|DISEASE|DT|DICTIONARY	cancer	cancer	145#151		BRCA1 and BRCA2 are the major genes for high-penetrance familial breast and ovarian cancer, whereas mutations in ATM or Chek2 confer more modest cancer risk.
19190165	2009	Cancer Epidemiol. Biomarkers Prev.	1055-9965	ALL_TEXT_1/3	1	2	11200	SYMBOL|DICTIONARY	chek2	Chek2	120#125		D061325	LONGTERM|DISEASE|DT|DICTIONARY	familial breast and ovarian cancer	familial breast and ovarian cancer	56#90		BRCA1 and BRCA2 are the major genes for high-penetrance familial breast and ovarian cancer, whereas mutations in ATM or Chek2 confer more modest cancer risk.
10091612	1999	Mov. Disord.	0885-3185	ALL_TEXT_1/3	1	1	4129	LONGTERM|GENE|GN|DICTIONARY	monoamine oxidase b	monoamine oxidase B	4#23		D010300	LONGTERM|DICTIONARY	parkinson disease	Parkinson's disease	71#90		The monoamine oxidase B gene (MAOB; Xp15.21-4) is a candidate gene for Parkinson's disease (PD) given its role in dopamine metabolism and its possible role in the activation of neurotoxins.
10091612	1999	Mov. Disord.	0885-3185	ALL_TEXT_1/3	1	1	4129	LONGTERM|GENE|GN|DICTIONARY	monoamine oxidase b	monoamine oxidase B	4#23		D010300	SYMBOL|EXTRACTED|()	pd	PD	92#94	10091612-1-71-90	The monoamine oxidase B gene (MAOB; Xp15.21-4) is a candidate gene for Parkinson's disease (PD) given its role in dopamine metabolism and its possible role in the activation of neurotoxins.
19115152	2009	Turk J Gastroenterol	2148-5607	CONCLUSIONS	4	10	5243	SYMBOL|GENE|GN|DICTIONARY	mdr1	MDR1	57#61		D003424	LONGTERM|DISEASE|DT|DICTIONARY	crohn disease	Crohn's disease	105#120		In this study, the G2677T/A polymorphism observed in the MDR1 gene was not found to be a risk factor for Crohn's disease or ulcerative colitis.
19115152	2009	Turk J Gastroenterol	2148-5607	CONCLUSIONS	4	10	5243	SYMBOL|GENE|GN|DICTIONARY	mdr1	MDR1	57#61		D003093	LONGTERM|DICTIONARY	ulcerative colitis	ulcerative colitis	124#142		In this study, the G2677T/A polymorphism observed in the MDR1 gene was not found to be a risk factor for Crohn's disease or ulcerative colitis.
16702373	2006	Cancer Epidemiol. Biomarkers Prev.	1055-9965	TITLE	0	0	4683	LONGTERM|DICTIONARY	nijmegen breakage syndrome 1	Nijmegen breakage syndrome 1	12#40	NaN	D049932	LONGTERM|DISEASE|DT|NUMBER|DICTIONARY	nijmegen breakage syndrome 1	Nijmegen breakage syndrome 1	12#40		Role of the Nijmegen breakage syndrome 1 gene in familial and sporadic prostate cancer.
16702373	2006	Cancer Epidemiol. Biomarkers Prev.	1055-9965	TITLE	0	0	4683	LONGTERM|DICTIONARY	nijmegen breakage syndrome 1	Nijmegen breakage syndrome 1	12#40	NaN	D011471	LONGTERM|DISEASE|DT|DICTIONARY	sporadic prostate cancer	sporadic prostate cancer	62#86		Role of the Nijmegen breakage syndrome 1 gene in familial and sporadic prostate cancer.
11992568	2002	Am. J. Med. Genet.	0148-7299	TITLE	0	0	1636	SYMBOL|DICTIONARY	dcp1	DCP1	23#27		D000544	LONGTERM|DISEASE|DT|DICTIONARY	alzheimer disease	Alzheimer disease	52#69		No association between DCP1 genotype and late-onset Alzheimer disease.
19141695	2009	Am. J. Clin. Nutr.	1938-3207	BACKGROUND	1	3	2695	SYMBOL|DICTIONARY|EXTRACTED	gip	GIP	29#32	19141695-2-0-44	D065626	LONGTERM|DICTIONARY|EXTRACTED	nafld	NAFLD	81#86	19141695-1-62-94	We hypothesized that altered GIP secretion may contribute to the pathogenesis of NAFLD.
10091612	1999	Mov. Disord.	0885-3185	ALL_TEXT_3/3	3	9	4129	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	maob	MAOB	33#37	10091612-0-18-37	D010300	SYMBOL|EXTRACTED	pd	PD	68#70	10091612-1-71-90	The GT repeat in intron 2 of the MAOB gene is a powerful marker for PD in this large Australian cohort.
10091612	1999	Mov. Disord.	0885-3185	ALL_TEXT_3/3	3	9	4129	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	maob	MAOB	33#37	10091612-0-18-37	D013915	LONGTERM|DICTIONARY	gt	GT	4#6	NaN	The GT repeat in intron 2 of the MAOB gene is a powerful marker for PD in this large Australian cohort.
11992568	2002	Am. J. Med. Genet.	0148-7299	ALL_TEXT_3/3	3	3	1636	SYMBOL|DICTIONARY	dcp1	DCP1	47#51		D000544	SYMBOL|EXTRACTED	ad	AD	67#69	11992568-1-32-49	Critical review about all studies available on DCP1 genotyping and AD, age-associated cognitive decline, longevity, and other conditions revealed remarkable inconsistencies.
11992568	2002	Am. J. Med. Genet.	0148-7299	ALL_TEXT_3/3	3	3	1636	SYMBOL|DICTIONARY	dcp1	DCP1	47#51		D003072	LONGTERM|DICTIONARY	cognitive decline	cognitive decline	86#103		Critical review about all studies available on DCP1 genotyping and AD, age-associated cognitive decline, longevity, and other conditions revealed remarkable inconsistencies.
16860143	2006	J. Pediatr.	0022-3476	ALL_TEXT_1/3	1	1	5551	SYMBOL|()|DICTIONARY|EXTRACTED	prf1	PRF1	32#36	16860143-1-17-25	D051359	LONGTERM|DICTIONARY	hemophagocytic lymphohistiocytosis	hemophagocytic lymphohistiocytosis	83#117		Mutations of the perforin gene (PRF1) are present in a proportion of patients with hemophagocytic lymphohistiocytosis (HLH).
16860143	2006	J. Pediatr.	0022-3476	ALL_TEXT_1/3	1	1	5551	SYMBOL|()|DICTIONARY|EXTRACTED	prf1	PRF1	32#36	16860143-1-17-25	D051359	SYMBOL|()|DICTIONARY|EXTRACTED	hlh	HLH	119#122	16860143-1-83-117	Mutations of the perforin gene (PRF1) are present in a proportion of patients with hemophagocytic lymphohistiocytosis (HLH).
12747597	2003	Clin. Chem. Lab. Med.	1434-6621	ALL_TEXT_3/3	3	8	185	SYMBOL|DICTIONARY	at1r	AT1R	56#60		D003324	LONGTERM|DICTIONARY	coronary atherosclerosis	coronary atherosclerosis	177#201		This study does not support the role of the ACE I/D and AT1R A1166C polymorphisms in the determination of the left ventricular size and performance in patients with significant coronary atherosclerosis.
12747597	2003	Clin. Chem. Lab. Med.	1434-6621	ALL_TEXT_3/3	3	8	1636	SYMBOL|DICTIONARY	ace	ACE	44#47		D003324	LONGTERM|DICTIONARY	coronary atherosclerosis	coronary atherosclerosis	177#201		This study does not support the role of the ACE I/D and AT1R A1166C polymorphisms in the determination of the left ventricular size and performance in patients with significant coronary atherosclerosis.
15253766	2005	Clin. Genet.	0009-9163	ALL_TEXT_1/3	1	1	2706	SYMBOL|()|DICTIONARY	gjb2	GJB2	43#47		D003638	LONGTERM|DICTIONARY	pre-lingual deafness	pre-lingual deafness	109#129	NaN	Mutations in the gene gap junction beta 2 (GJB2), the gene for the connexin 26, are the most common cause of pre-lingual deafness worldwide.
15253766	2005	Clin. Genet.	0009-9163	ALL_TEXT_1/3	1	1	2706	LONGTERM|DICTIONARY	connexin 26	connexin 26	67#78		D003638	LONGTERM|DICTIONARY	pre-lingual deafness	pre-lingual deafness	109#129	NaN	Mutations in the gene gap junction beta 2 (GJB2), the gene for the connexin 26, are the most common cause of pre-lingual deafness worldwide.
15124102	2004	Am. J. Hum. Genet.	0002-9297	ALL_TEXT_1/3	1	2	1947	SYMBOL|GENE|GN|DICTIONARY	efnb1	EFNB1	109#114		C536456	SYMBOL|DICTIONARY|EXTRACTED	cfns	CFNS	36#40	15124102-1-0-26	Recently, we have mapped a gene for CFNS in the pericentromeric region of the X chromosome that contains the EFNB1 gene, which encodes the ephrin-B1 ligand for Eph receptors.
15124102	2004	Am. J. Hum. Genet.	0002-9297	ALL_TEXT_1/3	1	2	1947	LONGTERM|DICTIONARY	ephrin b1	ephrin-B1	139#148		C536456	SYMBOL|DICTIONARY|EXTRACTED	cfns	CFNS	36#40	15124102-1-0-26	Recently, we have mapped a gene for CFNS in the pericentromeric region of the X chromosome that contains the EFNB1 gene, which encodes the ephrin-B1 ligand for Eph receptors.
17597242	2007	Neurosci. Res.	0168-0102	ALL_TEXT_2/3	2	3	7157	SYMBOL|DICTIONARY	trp53	Trp53	0#5		D009369	LONGTERM|DISEASE|DT|DICTIONARY	tumor	tumor	66#71		Trp53 (transformation related protein 53, also known as p53) is a tumor suppressor gene that activates the expression of genes involved in inducing growth arrest of cells in response to multiple forms of cellular stress and it plays a significant role in apoptotic cell death during the early development of the nervous system.
17597242	2007	Neurosci. Res.	0168-0102	ALL_TEXT_2/3	2	3	7157	LONGTERM|DICTIONARY	transformation related protein 53	transformation related protein 53	7#40		D009369	LONGTERM|DISEASE|DT|DICTIONARY	tumor	tumor	66#71		Trp53 (transformation related protein 53, also known as p53) is a tumor suppressor gene that activates the expression of genes involved in inducing growth arrest of cells in response to multiple forms of cellular stress and it plays a significant role in apoptotic cell death during the early development of the nervous system.
17597242	2007	Neurosci. Res.	0168-0102	TITLE	0	0	7157	SYMBOL|DICTIONARY	trp53	Trp53	15#20		D008607	LONGTERM|DICTIONARY	nonsyndromic mental retardation	nonsyndromic mental retardation	59#90		Association of Trp53 polymorphic variants at codon 72 with nonsyndromic mental retardation.
20237358	2010	Reprod Sci	1933-7205	ALL_TEXT_2/3	2	3	6347	SYMBOL|DICTIONARY|EXTRACTED	mcp 1	MCP-1	16#21	20237358-1-49-79	D000292	SYMBOL|DICTIONARY|EXTRACTED	pid	PID	66#69	20237358-1-131-158	We found plasma MCP-1 was significantly elevated in patients with PID compared to that in normal controls and decreased significantly compared to that in patients with PID after they received treatment.
20237358	2010	Reprod Sci	1933-7205	ALL_TEXT_2/3	2	3	6347	SYMBOL|DICTIONARY|EXTRACTED	mcp 1	MCP-1	16#21	20237358-1-49-79	D000292	SYMBOL|DICTIONARY|EXTRACTED	pid	PID	168#171	20237358-1-131-158	We found plasma MCP-1 was significantly elevated in patients with PID compared to that in normal controls and decreased significantly compared to that in patients with PID after they received treatment.
17597242	2007	Neurosci. Res.	0168-0102	ALL_TEXT_3/3	3	5	7157	SYMBOL|DICTIONARY	p53	p53	45#48		D008607	LONGTERM|DICTIONARY	nonsyndromic mental retardation	nonsyndromic mental retardation	91#122		We observed that the Pro72/Pro72 genotype of p53 is much less represented in children with nonsyndromic mental retardation than in controls (6.5% versus 14.08%) (OR=0.42; 95% CI 0.21-0.83).
